
TITLE I
Article 1 

1. The purpose of this Regulation is to ensure a high level of protection of human health and the environment as well as the free movement of substances, mixtures and articles as referred to in Article 4(8) by:
(a) harmonising the criteria for classification of substances and mixtures, and the rules on labelling and packaging for hazardous substances and mixtures;
(b) providing an obligation for:
((i)) manufacturers, importers and downstream users to classify substances and mixtures placed on the market;
((ii)) suppliers to label and package substances and mixtures placed on the market;
((iii)) manufacturers, producers of articles and importers to classify those substances not placed on the market that are subject to registration or notification under Regulation (EC) No 1907/2006;
(c) providing an obligation for manufacturers and importers of substances to notify the Agency of such classifications and label elements if these have not been submitted to the Agency as part of a registration under Regulation (EC) No 1907/2006;
(d) establishing a list of substances with their harmonised classifications and labelling elements at Community level in Part 3 of Annex VI;
(e) establishing a classification and labelling inventory of substances, which is made up of all notifications, submissions and harmonised classifications and labelling elements referred to in points (c) and (d).
2. This Regulation shall not apply to the following:
(a) radioactive substances and mixtures within the scope of Council Directive 96/29/Euratom of 13 May 1996 laying down basic safety standards for the protection of the health of workers and the general public against the danger arising from ionising radiation;
(b) substances and mixtures which are subject to customs supervision, provided that they do not undergo any treatment or processing, and which are in temporary storage, or in a free zone or free warehouse with a view to re-exportation, or in transit;
(c) non-isolated intermediates;
(d) substances and mixtures for scientific research and development, which are not placed on the market, provided they are used under controlled conditions in accordance with Community workplace and environmental legislation.
3. Waste as defined in Directive 2006/12/EC of the European Parliament and of the Council of 5 April 2006 on waste is not a substance, mixture or article within the meaning of Article 2 of this Regulation.
4. Member States may allow for exemptions from this Regulation in specific cases for certain substances or mixtures, where necessary in the interests of defence.
5. This Regulation shall not apply to substances and mixtures in the following forms, which are in the finished state, intended for the final user:
(a) medicinal products as defined in Directive 2001/83/EC;
(b) veterinary medicinal products as defined in Directive 2001/82/EC;
(c) cosmetic products as defined in Directive 76/768/EEC;
(d) medical devices as defined in Directives 90/385/EEC and 93/42/EEC, which are invasive or used in direct physical contact with the human body, and in Directive 98/79/EC;
(e) food or feeding stuffs as defined in Regulation (EC) No 178/2002 including when they are used:
((i)) as a food additive in foodstuffs within the scope of Directive 89/107/EEC;
((ii)) as a flavouring in foodstuffs within the scope of Directive 88/388/EEC and Decision 1999/217/EC;
((iii)) as an additive in feeding stuffs within the scope of Regulation (EC) No 1831/2003;
((iv)) in animal nutrition within the scope of Directive 82/471/EEC.
6. Save where Article 33 applies this Regulation shall not apply to the transport of dangerous goods by air, sea, road, rail or inland waterways.
Article 2 
For the purpose of this Regulation, the following definitions shall apply:

1.. ‘hazard class’ means the nature of the physical, health or environmental hazard;
2.. ‘hazard category’ means the division of criteria within each hazard class, specifying hazard severity;
3.. ‘hazard pictogram’ means a graphical composition that includes a symbol plus other graphic elements, such as a border, background pattern or colour that is intended to convey specific information on the hazard concerned;
4.. ‘signal word’ means a word that indicates the relative level of severity of hazards to alert the reader to a potential hazard; the following two levels are distinguished:

((a)) ‘Danger’ means a signal word indicating the more severe hazard categories;
((b)) ‘Warning’ means a signal word indicating the less severe hazard categories;
5.. ‘hazard statement’ means a phrase assigned to a hazard class and category that describes the nature of the hazards of a hazardous substance or mixture, including, where appropriate, the degree of hazard;
6.. ‘precautionary statement’ means a phrase that describes recommended measure(s) to minimise or prevent adverse effects resulting from exposure to a hazardous substance or mixture due to its use or disposal;
7.. ‘substance’ means a chemical element and its compounds in the natural state or obtained by any manufacturing process, including any additive necessary to preserve its stability and any impurity deriving from the process used, but excluding any solvent which may be separated without affecting the stability of the substance or changing its composition;
8.. ‘mixture’ means a mixture or solution composed of two or more substances;
9.. ‘article’ means an object which during production is given a special shape, surface or design which determines its function to a greater degree than does its chemical composition;
10.. ‘producer of an article’ means any natural or legal person who makes or assembles an article within the Community;
11.. ‘polymer’ means a substance consisting of molecules characterised by the sequence of one or more types of monomer units. Such molecules must be distributed over a range of molecular weights wherein differences in the molecular weight are primarily attributable to differences in the number of monomer units. A polymer comprises the following:

((a)) a simple weight majority of molecules containing at least three monomer units which are covalently bound to at least one other monomer unit or other reactant;
((b)) less than a simple weight majority of molecules of the same molecular weight.
In the context of this definition a ‘monomer unit’ means the reacted form of a monomer substance in a polymer;
12.. ‘monomer’ means a substance which is capable of forming covalent bonds with a sequence of additional like or unlike molecules under the conditions of the relevant polymer-forming reaction used for the particular process;
13.. ‘registrant’ means the manufacturer or the importer of a substance or the producer or importer of an article submitting a registration for a substance under Regulation (EC) No 1907/2006;
14.. ‘manufacturing’ means production or extraction of substances in the natural state;
15.. ‘manufacturer’ means any natural or legal person established within the Community who manufactures a substance within the Community;
16.. ‘import’ means the physical introduction into the customs territory of the Community;
17.. ‘importer’ means any natural or legal person established within the Community who is responsible for import;
18.. ‘placing on the market’ means supplying or making available, whether in return for payment or free of charge, to a third party. Import shall be deemed to be placing on the market;
19.. ‘downstream user’ means any natural or legal person established within the Community, other than the manufacturer or the importer, who uses a substance, either on its own or in a mixture, in the course of his industrial or professional activities. A distributor or a consumer is not a downstream user. A re-importer exempted pursuant to Article 2(7)(c) of Regulation (EC) No 1907/2006 shall be regarded as a downstream user;
20.. ‘distributor’ means any natural or legal person established within the Community, including a retailer, who only stores and places on the market a substance, on its own or in a mixture, for third parties;
21.. ‘intermediate’ means a substance that is manufactured for and consumed in or used for chemical processing in order to be transformed into another substance (hereinafter referred to as ‘synthesis’);
22.. ‘non-isolated intermediate’ means an intermediate that during synthesis is not intentionally removed (except for sampling) from the equipment in which the synthesis takes place. Such equipment includes the reaction vessel, its ancillary equipment, and any equipment through which the substance(s) pass(es) during a continuous flow or batch process as well as the pipework for transfer from one vessel to another for the purpose of the next reaction step, but it excludes tanks or other vessels in which the substance(s) are stored after the manufacture;
23.. ‘the Agency’ means the European Chemicals Agency established by Regulation (EC) No 1907/2006;
24.. ‘competent authority’ means the authority or authorities or bodies established by the Member States to carry out the obligations arising from this Regulation;
25.. ‘use’ means any processing, formulation, consumption, storage, keeping, treatment, filling into containers, transfer from one container to another, mixing, production of an article or any other utilisation;
26.. ‘supplier’ means any manufacturer, importer, downstream user or distributor placing on the market a substance, on its own or in a mixture, or a mixture;
27.. ‘alloy’ means a metallic material, homogeneous on a macroscopic scale, consisting of two or more elements so combined that they cannot be readily separated by mechanical means; alloys are considered to be mixtures for the purposes of this Regulation;
28.. ‘UN RTDG’ means the United Nations Recommendations on the Transport of Dangerous Goods;
29.. ‘notifier’ means the manufacturer or the importer, or group of manufacturers or importers notifying to the Agency;
30.. ‘scientific research and development’ means any scientific experimentation, analysis or chemical research carried out under controlled conditions;
31.. ‘cut-off value’ means a threshold of any classified impurity, additive or individual constituent in a substance or in a mixture, above which threshold these shall be taken into account for determining if the substance or the mixture, respectively, shall be classified;
32.. ‘concentration limit’ means a threshold of any classified impurity, additive or individual constituent in a substance or in a mixture that may trigger classification of the substance or the mixture, respectively;
33.. ‘differentiation’ means distinction within hazard classes depending on the route of exposure or the nature of the effects;
34.. ‘M-factor’ means a multiplying factor. It is applied to the concentration of a substance classified as hazardous to the aquatic environment acute category 1 or chronic category 1, and is used to derive by the summation method the classification of a mixture in which the substance is present;
35.. ‘package’ means the complete product of the packing operation, consisting of the packaging and its contents;
36.. ‘packaging’ means one or more receptacles and any other components or materials necessary for the receptacles to perform their containment and other safety functions;
37.. ‘intermediate packaging’ means packaging placed between inner packaging, or articles, and outer packaging.
Article 3 
A substance or a mixture fulfilling the criteria relating to physical hazards, health hazards or environmental hazards, laid down in Parts 2 to 5 of Annex I is hazardous and shall be classified in relation to the respective hazard classes provided for in that Annex.
Where, in Annex I, hazard classes are differentiated on the basis of the route of exposure or the nature of the effects, the substance or mixture shall be classified in accordance with such differentiation.
Article 4 

1. Manufacturers, importers and downstream users shall classify substances or mixtures in accordance with Title II before placing them on the market.
2. Without prejudice to the requirements of paragraph 1, manufacturers, producers of articles and importers shall classify those substances not placed on the market in accordance with Title II where:
(a) Articles 6, 7(1) or (5), 17 or 18 of Regulation (EC) No 1907/2006 provide for registration of a substance;
(b) Articles 7(2) or 9 of Regulation (EC) No 1907/2006 provide for notification.
3. If a substance is subject to harmonised classification and labelling in accordance with Title V through an entry in Part 3 of Annex VI, that substance shall be classified in accordance with that entry, and a classification of that substance in accordance with Title II shall not be performed for the hazard classes or differentiations covered by that entry.However, where the substance also falls within one or more hazard classes or differentiations not covered by an entry in Part 3 of Annex VI, classification under Title II shall be carried out for those hazard classes or differentiations.
4. Where a substance or mixture is classified as hazardous, suppliers shall ensure that the substance or mixture is labelled and packaged in accordance with Titles III and IV, before placing it on the market.
5. In fulfilling their responsibilities under paragraph 4, distributors may use the classification for a substance or mixture derived in accordance with Title II by an actor in the supply chain.
6. In fulfilling their responsibilities under paragraphs 1 and 4, downstream users may use the classification of a substance or mixture derived in accordance with Title II by an actor in the supply chain, provided that they do not change the composition of the substance or mixture.
7. A mixture referred to in Part 2 of Annex II that contains any substance classified as hazardous shall not be placed on the market, unless it is labelled in accordance with Title III.
8. For the purposes of this Regulation, the articles referred to in section 2.1 of Annex I shall be classified, labelled and packaged in accordance with the rules for substances and mixtures before being placed on the market.
9. Suppliers in a supply chain shall cooperate to meet the requirements for classification, labelling and packaging in this Regulation.
10. Substances and mixtures shall not be placed on the market unless they comply with this Regulation.
TITLE II
CHAPTER 1
Article 5 

1. Manufacturers, importers and downstream users of a substance shall identify the relevant available information for the purposes of determining whether the substance entails a physical, health or environmental hazard as set out in Annex I, and, in particular, the following:
(a) data generated in accordance with any of the methods referred to in Article 8(3);
(b) epidemiological data and experience on the effects on humans, such as occupational data and data from accident databases;
(c) any other information generated in accordance with section 1 of Annex XI to Regulation (EC) No 1907/2006;
(d) any new scientific information;
(e) any other information generated under internationally recognised chemical programmes.
The information shall relate to the forms or physical states in which the substance is placed on the market and in which it can reasonably be expected to be used.
2. Manufacturers, importers and downstream users shall examine the information referred to in paragraph 1 to ascertain whether it is adequate, reliable and scientifically valid for the purpose of the evaluation pursuant to Chapter 2 of this Title.
Article 6 

1. Manufacturers, importers and downstream users of a mixture shall identify the relevant available information on the mixture itself or the substances contained in it for the purposes of determining whether the mixture entails a physical, health or environmental hazard as set out in Annex I, and, in particular, the following:
(a) data generated in accordance with any of the methods referred to in Article 8(3) on the mixture itself or the substances contained in it;
(b) epidemiological data and experience on the effects on humans for the mixture itself or the substances contained in it, such as occupational data or data from accident databases;
(c) any other information generated in accordance with section 1 of Annex XI to Regulation (EC) No 1907/2006 for the mixture itself or the substances contained in it;
(d) any other information generated under internationally recognised chemical programmes for the mixture itself or the substances contained in it.
The information shall relate to the forms or physical states in which the mixture is placed on the market and, when relevant, in which it can reasonably be expected to be used.
2. Subject to paragraphs 3 and 4, where the information referred to in paragraph 1 is available for the mixture itself, and the manufacturer, importer or downstream user has ascertained that information to be adequate and reliable and where applicable, scientifically valid, that manufacturer, importer or downstream user shall use that information for the purposes of the evaluation pursuant to Chapter 2 of this Title.
3. For the evaluation of mixtures pursuant to Chapter 2 of this Title in relation to the ‘germ cell mutagenicity’, ‘carcinogenicity’ and ‘reproductive toxicity’ hazard classes referred to in sections 3.5.3.1, 3.6.3.1 and 3.7.3.1 of Annex I, the manufacturer, importer or downstream user shall only use the relevant available information referred to in paragraph 1 for the substances in the mixture.Further, in cases where the available test data on the mixture itself demonstrate germ cell mutagenic, carcinogenic or toxic to reproduction effects which have not been identified from the information on the individual substances, those data shall also be taken into account.
4. For the evaluation of mixtures pursuant to Chapter 2 of this Title in relation to the ‘biodegradation and bioaccumulation’ properties within the ‘hazardous to the aquatic environment’ hazard class referred to in sections 4.1.2.8 and 4.1.2.9 of Annex I, the manufacturer, importer or downstream user shall only use the relevant available information referred to in paragraph 1 for the substances in the mixture.
5. Where no or inadequate test data on the mixture itself of the kind referred to in paragraph 1 are available, the manufacturer, importer or downstream user shall use other available information on individual substances and similar tested mixtures which may also be considered relevant for the purposes of determining whether the mixture is hazardous, provided that that manufacturer, importer or downstream user has ascertained that information to be adequate and reliable for the purpose of the evaluation pursuant to Article 9(4).
Article 7 

1. Where new tests are carried out for the purposes of this Regulation, tests on animals within the meaning of Directive 86/609/EEC shall be undertaken only where no other alternatives, which provide adequate reliability and quality of data, are possible.
2. Tests on non-human primates shall be prohibited for the purposes of this Regulation.
3. Tests on humans shall not be performed for the purposes of this Regulation. Data obtained from other sources, such as clinical studies, can however be used for the purposes of this Regulation.
Article 8 

1. For the purposes of determining whether a substance or a mixture entails a health or environmental hazard as set out in Annex I to this Regulation, the manufacturer, importer or downstream user may, provided that he has exhausted all other means of generating information including by applying the rules provided for in section 1 of Annex XI to Regulation (EC) No 1907/2006, perform new tests.
2. For the purposes of determining whether a substance or a mixture entails any of the physical hazards referred to in Part 2 of Annex I, the manufacturer, importer or downstream user shall perform the tests required in that Part, unless there is adequate and reliable information already available.
3. The tests referred to in paragraph 1 shall be conducted in accordance with one of the following methods:
(a) the test methods referred to in Article 13(3) of Regulation (EC) No 1907/2006;or
(b) sound scientific principles that are internationally recognised or methods validated according to international procedures.
4. Where the manufacturer, importer or downstream user carries out new ecotoxicological or toxicological tests and analyses, these shall be carried out in compliance with Article 13(4) of Regulation (EC) No 1907/2006.
5. Where new tests for physical hazards are carried out for the purposes of this Regulation, they shall be carried out, at the latest from 1 January 2014, in compliance with a relevant recognised quality system or by laboratories complying with a relevant recognised standard.
6. Tests that are carried out for the purposes of this Regulation shall be carried out on the substance or on the mixture in the form(s) or physical state(s) in which the substance or mixture is placed on the market and in which it can reasonably be expected to be used.
CHAPTER 2
Article 9 

1. Manufacturers, importers and downstream users of a substance or a mixture shall evaluate the information identified in accordance with Chapter 1 of this Title by applying to it the criteria for classification for each hazard class or differentiation in Parts 2 to 5 of Annex I, so as to ascertain the hazards associated with the substance or mixture.
2. In evaluating available test data for a substance or a mixture which have been obtained from test methods other than those referred to in Article 8(3), manufacturers, importers and downstream users shall compare the test methods employed with those indicated in that Article in order to determine whether the use of those test methods affects the evaluation referred to in paragraph 1 of this Article.
3. Where the criteria cannot be applied directly to available identified information, manufacturers, importers and downstream users shall carry out an evaluation by applying a weight of evidence determination using expert judgement in accordance with section 1.1.1 of Annex I to this Regulation, weighing all available information having a bearing on the determination of the hazards of the substance or the mixture, and in accordance with section 1.2 of Annex XI to Regulation (EC) No 1907/2006.
4. Where only the information referred to in Article 6(5) is available, manufacturers, importers and downstream users shall apply the bridging principles referred to in section 1.1.3 and in each section of Parts 3 and 4 of Annex I for the purposes of the evaluation.However, where that information permits the application neither of the bridging principles nor the principles for using expert judgement and weight of evidence determination as described in Part 1 of Annex I, manufacturers, importers and downstream users shall evaluate the information by applying the other method or methods described in each section of Parts 3 and 4 of Annex I.
5. When evaluating the available information for the purposes of classification, the manufacturers, importers and downstream users shall consider the forms or physical states in which the substance or mixture is placed on the market and in which it can reasonably be expected to be used.
Article 10 

1. Specific concentration limits and generic concentration limits are limits assigned to a substance indicating a threshold at or above which the presence of that substance in another substance or in a mixture as an identified impurity, additive or individual constituent leads to the classification of the substance or mixture as hazardous.Specific concentration limits shall be set by the manufacturer, importer or downstream user where adequate and reliable scientific information shows that the hazard of a substance is evident when the substance is present at a level below the concentrations set for any hazard class in Part 2 of Annex I or below the generic concentration limits set for any hazard class in Parts 3, 4 and 5 of Annex I.In exceptional circumstances specific concentration limits may be set by the manufacturer, importer or downstream user where he has adequate, reliable and conclusive scientific information that a hazard of a substance classified as hazardous is not evident at a level above the concentrations set for the relevant hazard class in Part 2 of Annex I or above the generic concentration limits set for the relevant hazard class in Parts 3, 4 and 5 of that Annex.
2. M-factors for substances classified as hazardous to the aquatic environment, acute category 1 or chronic category 1, shall be established by manufacturers, importers and downstream users.
3. Notwithstanding paragraph 1, specific concentration limits shall not be set for harmonised hazard classes or differentiations for substances included in Part 3 of Annex VI.
4. Notwithstanding paragraph 2, M-factors shall not be set for harmonised hazard classes or differentiations for substances included in Part 3 of Annex VI for which an M-factor is given in that Part.However, where an M-factor is not given in Part 3 of Annex VI for substances classified as hazardous to the aquatic environment, acute category 1 or chronic category 1, an M-factor based on available data for the substance shall be set by the manufacturer, importer or downstream user. When a mixture including the substance is classified by the manufacturer, importer or downstream user using the summation method, this M-factor shall be used.
5. In setting the specific concentration limit or M-factor manufacturers, importers and downstream users shall take into account any specific concentration limits or M-factors for that substance which have been included in the classification and labelling inventory.
6. Specific concentration limits set in accordance with paragraph 1 shall take precedence over the concentrations in the relevant sections of Part 2 of Annex I or the generic concentration limits for classification in the relevant sections of Parts 3, 4 and 5 of Annex I.
7. The Agency shall provide further guidance for the application of paragraphs 1 and 2.
Article 11 

1. Where a substance contains another substance, itself classified as hazardous, whether in the form of an identified impurity, additive or individual constituent, this shall be taken into account for the purposes of classification, if the concentration of the identified impurity, additive or individual constituent is equal to, or greater than, the applicable cut-off value in accordance with paragraph 3.
2. Where a mixture contains a substance classified as hazardous, whether as a component or in the form of an identified impurity or additive, this information shall be taken into account for the purposes of classification, if the concentration of that substance is equal to or greater than its cut-off value in accordance with paragraph 3.
3. The cut-off value referred to in paragraphs 1 and 2 shall be determined as set out in section 1.1.2.2 of Annex I.
Article 12 
Where, as a result of the evaluation carried out pursuant to Article 9, the following properties or effects are identified, manufacturers, importers and downstream users shall take them into account for the purposes of classification:

((a)) adequate and reliable information demonstrates that in practice the physical hazards of a substance or a mixture differ from those shown by tests;
((b)) conclusive scientific experimental data show that the substance or mixture is not biologically available and those data have been ascertained to be adequate and reliable;
((c)) adequate and reliable scientific information demonstrates the potential occurrence of synergistic or antagonistic effects among the substances in a mixture for which the evaluation was decided on the basis of the information for the substances in the mixture.
Article 13 
If the evaluation undertaken pursuant to Article 9 and Article 12 shows that the hazards associated with the substance or mixture meet the criteria for classification in one or more hazard classes or differentiations in Parts 2 to 5 of Annex I, manufacturers, importers and downstream users shall classify the substance or mixture in relation to the relevant hazard class or classes or differentiations by assigning the following:

((a)) one or more hazard categories for each relevant hazard class or differentiation;
((b)) subject to Article 21, one or more hazard statements corresponding to each hazard category assigned in accordance with (a).
Article 14 

1. The classification of a mixture shall not be affected where the evaluation of the information indicates any of the following:
(a) that the substances in the mixture react slowly with atmospheric gases, in particular oxygen, carbon dioxide, water vapour, to form different substances at low concentration;
(b) that the substances in the mixture react very slowly with other substances in the mixture to form different substances at low concentration;
(c) that the substances in the mixture may self-polymerise to form oligomers or polymers, at low concentration.
2. A mixture need not be classified for explosive, oxidising, or flammable properties as referred to in Part 2 of Annex I provided that any of the following requirements are met:
(a) none of the substances in the mixture possesses any of those properties and, on the basis of the information available to the supplier, the mixture is unlikely to present hazards of this kind;
(b) in the event of a change in the composition of a mixture, scientific evidence indicates that an evaluation of the information on the mixture will not lead to a change in classification;
(c) where a mixture is placed on the market in the form of an aerosol dispenser, it satisfies Article 8(1a) of Council Directive 75/324/EEC of 20 May 1975 on the approximation of the laws of the Member States relating to aerosol dispensers.
Article 15 

1. Manufacturers, importers and downstream users shall take all reasonable steps available to them to make themselves aware of new scientific or technical information that may affect the classification of the substances or mixtures they place on the market. When a manufacturer, importer or downstream user becomes aware of such information which he considers to be adequate and reliable, that manufacturer, importer or downstream user shall without undue delay carry out a new evaluation in accordance with this Chapter.
2. Where the manufacturer, importer or downstream user introduces a change to a mixture that has been classified as hazardous, that manufacturer, importer or downstream user shall carry out a new evaluation in accordance with this Chapter where the change is either of the following:
(a) a change in the composition of the initial concentration of one or more of the hazardous constituents in concentrations at or above the limits in Table 1.2 of Part 1 of Annex I;
(b) a change in the composition involving the substitution or addition of one or more constituents in concentrations at or above the cut-off value referred to in Article 11(3).
3. A new evaluation in accordance with paragraphs 1 and 2 shall not be required if there is valid scientific justification that this will not result in a change of classification.
4. Manufacturers, importers and downstream users shall adapt the classification of the substance or the mixture in accordance with the results of the new evaluation except where there are harmonised hazard classes or differentiations for substances included in Part 3 of Annex VI.
5. For paragraphs 1 to 4 of this Article, when the substance or mixture concerned is within the scope of Directive 91/414/EEC or Directive 98/8/EC, the requirements of those Directives shall also apply.
Article 16 

1. Manufacturers and importers may classify a substance differently from the classification already included in the classification and labelling inventory, provided they submit the reasons for the classification to the Agency together with the notification in accordance with Article 40.
2. Paragraph 1 shall not apply if the classification included in the classification and labelling inventory is a harmonised classification included in Part 3 of Annex VI.
TITLE III
CHAPTER 1
Article 17 

1. A substance or mixture classified as hazardous and contained in packaging shall bear a label including the following elements:
(a) the name, address and telephone number of the supplier(s);
(b) the nominal quantity of the substance or mixture in the package made available to the general public, unless this quantity is specified elsewhere on the package;
(c) product identifiers as specified in Article 18;
(d) where applicable, hazard pictograms in accordance with Article 19;
(e) where applicable, signal words in accordance with Article 20;
(f) where applicable, hazard statements in accordance with Article 21;
(g) where applicable, the appropriate precautionary statements in accordance with Article 22;
(h) where applicable, a section for supplemental information in accordance with Article 25.
2. The label shall be written in the official language(s) of the Member State(s) where the substance or mixture is placed on the market, unless the Member State(s) concerned provide(s) otherwise.Suppliers may use more languages on their labels than those required by the Member States, provided that the same details appear in all languages used.
Article 18 

1. The label shall include details permitting the identification of the substance or mixture (hereinafter referred to as ‘product identifiers’).The term used for identification of the substance or mixture shall be the same as that used in the safety data sheet drawn up in accordance with Article 31 of Regulation (EC) No 1907/2006 (hereinafter referred to as ‘safety data sheet’), without prejudice to Article 17(2) of this Regulation.
2. The product identifier for a substance shall consist of at least the following:
(a) if the substance is included in Part 3 of Annex VI, a name and an identification number as given therein;
(b) if the substance is not included in Part 3 of Annex VI, but appears in the classification and labelling inventory, a name and an identification number as given therein;
(c) if the substance is not included in Part 3 of Annex VI nor in the classification and labelling inventory, the number provided by the CAS (hereinafter referred to as ‘the CAS number’), together with the name set out in the nomenclature provided by the IUPAC (hereinafter referred to as ‘the IUPAC Nomenclature’), or the CAS number together with another international chemical name(s); or
(d) if the CAS number is not available, the name set out in the IUPAC Nomenclature or another international chemical name(s).
Where the name in the IUPAC nomenclature exceeds 100 characters, one of the other names (usual name, trade name, abbreviation) referred to in section 2.1.2 of Annex VI to Regulation (EC) No 1907/2006 may be used provided that the notification in accordance with Article 40 includes both the name set out in the IUPAC Nomenclature and the other name used.
3. The product identifier for a mixture shall consist of both of the following:
(a) the trade name or the designation of the mixture;
(b) the identity of all substances in the mixture that contribute to the classification of the mixture as regards acute toxicity, skin corrosion or serious eye damage, germ cell mutagenicity, carcinogenicity, reproductive toxicity, respiratory or skin sensitisation, specific target organ toxicity (STOT) or aspiration hazard.
Where, in the case referred to in (b), that requirement leads to the provision of multiple chemical names, a maximum of four chemical names shall suffice, unless more than four names are needed to reflect the nature and the severity of the hazards.The chemical names selected shall identify the substances primarily responsible for the major health hazards which have given rise to the classification and the choice of the corresponding hazard statements.
Article 19 

1. The label shall include the relevant hazard pictogram(s), intended to convey specific information on the hazard concerned.
2. Subject to Article 33, hazard pictograms shall fulfil the requirements laid down in section 1.2.1 of Annex I and in Annex V.
3. The hazard pictogram relevant for each specific classification is set out in the tables indicating the label elements required for each hazard class in Annex I.
Article 20 

1. The label shall include the relevant signal word in accordance with the classification of the hazardous substance or mixture.
2. The signal word relevant for each specific classification is set out in the tables indicating the label elements required for each hazard class in Parts 2 to 5 of Annex I.
3. Where the signal word ‘Danger’ is used on the label, the signal word ‘Warning’ shall not appear on the label.
Article 21 

1. The label shall include the relevant hazard statements in accordance with the classification of the hazardous substance or mixture.
2. The hazard statements relevant for each classification are set out in the tables indicating the label elements required for each hazard class in Parts 2 to 5 of Annex I.
3. Where a substance is included in Part 3 of Annex VI, the hazard statement relevant for each specific classification covered by the entry in that Part shall be used on the label, together with the hazard statements referred to in paragraph 2 for any other classification not covered by that entry.
4. The hazard statements shall be worded in accordance with Annex III.
Article 22 

1. The label shall include the relevant precautionary statements.
2. The precautionary statements shall be selected from those set out in the tables in Parts 2 to 5 of Annex I indicating the label elements for each hazard class.
3. The precautionary statements shall be selected in accordance with the criteria laid down in Part 1 of Annex IV taking into account the hazard statements and the intended or identified use or uses of the substance or the mixture.
4. The precautionary statements shall be worded in accordance with Part 2 of Annex IV.
Article 23 
The specific provisions on labelling laid down in section 1.3 of Annex I shall apply in respect of the following:

((a)) transportable gas cylinders;
((b)) gas containers intended for propane, butane or liquefied petroleum gas;
((c)) aerosols and containers fitted with a sealed spray attachment and containing substances or mixtures classified as presenting an aspiration hazard;
((d)) metals in massive form, alloys, mixtures containing polymers, mixtures containing elastomers;
((e)) explosives, as referred to in section 2.1 of Annex I, placed on the market with a view to obtaining an explosive or pyrotechnic effect.
Article 24 

1. The manufacturer, importer or downstream user of a substance in a mixture may submit a request to the Agency to use an alternative chemical name which refers to that substance in a mixture either by means of a name that identifies the most important functional chemical groups or by means of an alternative designation, where the substance meets the criteria set out in Part 1 of Annex I and where he can demonstrate that disclosure on the label or in the safety data sheet of the chemical identity of that substance puts the confidential nature of his business, in particular his intellectual property rights, at risk.
2. Any request referred to in paragraph 1 of this Article shall be made in the format referred to in Article 111 of Regulation (EC) No 1907/2006 and shall be accompanied by a fee.The level of the fees shall be determined by the Commission in accordance with the regulatory procedure referred to in Article 54(2) of this Regulation.A reduced fee shall be set for SMEs.
3. The Agency may require further information from the manufacturer, importer or downstream user making the request if such information is necessary to take a decision. If the Agency raises no objection within six weeks of the request or the receipt of further required information, the use of the requested name shall be deemed to be allowed.
4. If the Agency does not accept the request, the practical arrangements referred to in Article 118(3) of Regulation (EC) No 1907/2006 shall apply.
5. The Agency shall inform competent authorities of the outcome of the request in accordance with paragraph 3 or 4 and provide them with the information submitted by the manufacturer, importer or downstream user.
6. Where new information shows that an alternative chemical name used does not provide sufficient information for necessary health and safety precautions to be taken at the workplace and to ensure that risks from handling the mixture can be controlled, the Agency shall review its decision on the use of that alternative chemical name. The Agency may withdraw its decision or amend it by a decision specifying which alternative chemical name is allowed to be used. If the Agency withdraws or amends its decision, the practical arrangements referred to in Article 118(3) of Regulation (EC) No 1907/2006 shall apply.
7. Where the use of an alternative chemical name has been allowed, but the classification of the substance in a mixture for which the alternative name is used no longer meets the criteria set out in section 1.4.1 of Annex I, the supplier of that substance in a mixture shall use the product identifier for the substance in accordance with Article 18 on the label and in the safety data sheet, and not the alternative chemical name.
8. For substances, whether on their own or in a mixture, where a justification in accordance with Article 10(a)(xi) of Regulation (EC) No 1907/2006 regarding information referred to in Article 119(2)(f) or (g) of that Regulation has been accepted as valid by the Agency, the manufacturer, importer or downstream user may use on the label and in the safety data sheet a name that will be made publicly available over the Internet. For those substances in a mixture for which Article 119(2)(f) or (g) of that Regulation no longer applies, the manufacturer, importer or downstream user may submit a request to the Agency to use an alternative chemical name as provided for in paragraph 1 of this Article.
9. Where the supplier of a mixture, before 1 June 2015, has demonstrated under Article 15 of Directive 1999/45/EC that the disclosure of the chemical identity of a substance in a mixture puts the confidential nature of his business at risk, he can continue to use the agreed alternative name for the purposes of this Regulation.
Article 25 

1. Statements shall be included in the section for supplemental information on the label where a substance or mixture classified as hazardous has the physical properties or health properties referred to in sections 1.1 and 1.2 of Annex II.The statements shall be worded in accordance with sections 1.1 and 1.2 of Annex II and Part 2 of Annex III.Where a substance is included in Part 3 of Annex VI, any supplemental hazard statements given therein for the substance shall be included in the supplemental information on the label.
2. A statement shall be included in the section for supplemental information on the label where a substance or mixture classified as hazardous falls within the scope of Directive 91/414/EEC.The statement shall be worded in accordance with Part 4 of Annex II and Part 3 of Annex III to this Regulation.
3. The supplier may include supplemental information in the section for supplemental information on the label other than that referred to in paragraphs 1 and 2, provided that that information does not make it more difficult to identify the label elements referred to in Article 17(1) (a) to (g) and that it provides further details and does not contradict or cast doubt on the validity of the information specified by those elements.
4. Statements such as ‘non-toxic’, ‘non-harmful’, ‘non-polluting’, ‘ecological’ or any other statements indicating that the substance or mixture is not hazardous or any other statements that are inconsistent with the classification of that substance or mixture shall not appear on the label or packaging of any substance or mixture.
5. Where a substance or mixture is classified in accordance with Part 5 of Annex I,
(a) the hazard pictogram shall not be included on the label;
(b) the signal words, hazard statements and precautionary statements shall be placed in the supplemental information section of the label.
6. Where a mixture contains any substance classified as hazardous, it shall be labelled in accordance with Part 2 of Annex II.The statements shall be worded in accordance with Part 3 of Annex III and shall be placed in the supplemental information section of the label.The label shall also include the product identifier referred to in Article 18 and the name, address and telephone number of the supplier of the mixture.
Article 26 

1. Where the classification of a substance or mixture would result in more than one hazard pictogram on the label, the following rules of precedence shall apply to reduce the number of hazard pictograms required:
(a) if the hazard pictogram ‘GHS01’ applies, the use of the hazard pictograms ‘GHS02’ and ‘GHS03’ shall be optional, except in cases where more than one of these hazard pictograms are compulsory;
(b) if the hazard pictogram ‘GHS06’ applies, the hazard pictogram ‘GHS07’ shall not appear;
(c) if the hazard pictogram ‘GHS05’ applies, the hazard pictogram ‘GHS07’ shall not appear for skin or eye irritation;
(d) if the hazard pictogram ‘GHS08’ applies for respiratory sensitisation, the hazard pictogram ‘GHS07’ shall not appear for skin sensitisation or for skin and eye irritation.
2. Where the classification of a substance or mixture would result in more than one hazard pictogram for the same hazard class the label shall include the hazard pictogram corresponding to the most severe hazard category for each hazard class concerned.For substances that are included in Part 3 of Annex VI and also subject to classification pursuant to Title II, the label shall include the hazard pictogram corresponding to the most severe hazard category for each relevant hazard class.
Article 27 
If a substance or mixture is classified within several hazard classes or differentiations of a hazard class, all hazard statements resulting from the classification shall appear on the label, unless there is evident duplication or redundancy.
Article 28 

1. Where the selection of the precautionary statements results in certain precautionary statements being clearly redundant or unnecessary given the specific substance, mixture or packaging, such statements shall be omitted from the label.
2. Where the substance or mixture is supplied to the general public, one precautionary statement addressing the disposal of that substance or mixture as well as the disposal of packaging shall appear on the label, unless not required under Article 22.In all other cases, a precautionary statement addressing disposal shall not be required, where it is clear that the disposal of the substance or mixture or the packaging does not present a hazard to human health or the environment.
3. Not more than six precautionary statements shall appear on the label, unless necessary to reflect the nature and the severity of the hazards.
Article 29 

1. Where the packaging of a substance or a mixture is either in such a shape or form or is so small that it is impossible to meet the requirements of Article 31 for a label in the languages of the Member State in which the substance or mixture is placed on the market, the label elements in accordance with the first subparagraph of Article 17(2) shall be provided in accordance with section 1.5.1 of Annex I.
2. If the full label information cannot be provided in the way specified in paragraph 1 the label information may be reduced in accordance with section 1.5.2 of Annex I.
3. When a hazardous substance or mixture referred to in Part 5 of Annex II is supplied to the general public without packaging it shall be accompanied by a copy of the label elements in accordance with Article 17.
4. For certain mixtures classified as hazardous to the environment, exemptions to certain provisions on environmental labelling or specific provisions in relation to environmental labelling may be determined in accordance with the procedure referred to in Article 53, where it can be demonstrated that there would be a reduction in the environmental impact. Such exemptions or specific provisions are defined in Part 2 of Annex II.
5. The Commission may request the Agency to prepare and submit to it further draft exemptions from labelling and packaging requirements.
Article 30 

1. The supplier shall ensure that the label is updated, without undue delay, following any change to the classification and labelling of that substance or mixture, where the new hazard is more severe or where new supplemental labelling elements are required under Article 25, taking into account the nature of the change as regards the protection of human health and the environment. Suppliers shall cooperate in accordance with Article 4(9) to complete the changes to the labelling without undue delay.
2. Where labelling changes are required other than those referred to in paragraph 1, the supplier shall ensure that the label is updated within 18 months.
3. The supplier of a substance or a mixture within the scope of Directives 91/414/EEC or 98/8/EC shall update the label in accordance with those Directives.
CHAPTER 2
Article 31 

1. Labels shall be firmly affixed to one or more surfaces of the packaging immediately containing the substance or mixture and shall be readable horizontally when the package is set down normally.
2. The colour and presentation of any label shall be such that the hazard pictogram stands out clearly.
3. The label elements referred to in Article 17(1) shall be clearly and indelibly marked. They shall stand out clearly from the background and be of such size and spacing as to be easily read.
4. The shape, colour and the size of a hazard pictogram as well as the dimensions of the label shall be as set out in section 1.2.1 of Annex I.
5. A label shall not be required when the label elements referred to in Article 17(1) are shown clearly on the packaging itself. In such cases, the requirements of this Chapter applicable to a label shall be applied to the information shown on the packaging.
Article 32 

1. The hazard pictograms, signal word, hazard statements and precautionary statements shall be located together on the label.
2. The supplier may decide the order of the hazard statements on the label. However, subject to paragraph 4, all hazard statements shall be grouped on the label by language.The supplier may decide the order of the precautionary statements on the label. However, subject to paragraph 4, all precautionary statements shall be grouped on the label by language.
3. Groups of hazard statements and groups of precautionary statements referred to in paragraph 2 shall be located together on the label by language.
4. The supplemental information shall be placed in the supplemental information section referred to in Article 25, and shall be located with the other label elements specified in Article 17(1)(a) to (g).
5. In addition to its use in hazard pictograms, colour may be used on other areas of the label to implement special labelling requirements.
6. Label elements resulting from the requirements provided for in other Community acts shall be placed in the section for supplemental information on the label referred to in Article 25.
Article 33 

1. Where a package consists of an outer and an inner packaging, together with any intermediate packaging, and the outer packaging meets labelling provisions in accordance with the rules on the transport of dangerous goods, the inner and any intermediate packaging shall be labelled in accordance with this Regulation. The outer packaging may also be labelled in accordance with this Regulation. Where the hazard pictogram(s) required by this Regulation relate to the same hazard as in the rules for the transport of dangerous goods, the hazard pictogram(s) required by this Regulation need not appear on the outer packaging.
2. Where the outer packaging of a package is not required to meet labelling provisions in accordance with rules on the transport of dangerous goods, both the outer and any inner packaging, including any intermediate packaging, shall be labelled in accordance with this Regulation. However, if the outer packaging permits the inner or intermediate packaging labelling to be clearly seen, the outer packaging need not be labelled.
3. Single packages that meet the labelling provisions in accordance with the rules on the transport of dangerous goods shall be labelled both in accordance with this Regulation and the rules on the transport of dangerous goods. Where the hazard pictogram(s) required by this Regulation relate to the same hazard as in rules on the transport of dangerous goods, the hazard pictogram(s) required by this Regulation need not appear.
Article 34 

1. By 20 January 2012, the Agency shall carry out a study on the communication of information to the general public on the safe use of substances and mixtures and the potential need for additional information on labels. This study shall be carried out in consultation with competent authorities and stakeholders and drawing as appropriate on relevant best practice.
2. Without prejudice to the labelling rules provided for in this Title, the Commission shall, on the basis of the study referred to in paragraph 1, submit a report to the European Parliament and the Council and, if justified, present a legislative proposal to amend this Regulation.
TITLE IV
Article 35 

1. Packaging containing hazardous substances or mixtures shall satisfy the following requirements:
(a) the packaging shall be designed and constructed so that its contents cannot escape, except in cases where other more specific safety devices are prescribed;
(b) the materials constituting the packaging and fastenings shall not be susceptible to damage by the contents, or liable to form hazardous compounds with the contents;
(c) the packaging and fastenings shall be strong and solid throughout to ensure that they will not loosen and will safely meet the normal stresses and strains of handling;
(d) packaging fitted with replaceable fastening devices shall be designed so that it can be refastened repeatedly without the contents escaping.
2. Packaging containing a hazardous substance or a mixture supplied to the general public shall not have either a shape or design likely to attract or arouse the active curiosity of children or to mislead consumers, or have a similar presentation or a design used for foodstuff or animal feeding stuff or medicinal or cosmetic products, which would mislead consumers.Where the packaging contains a substance or mixture which meets the requirements in section 3.1.1 of Annex II it shall have a child-resistant fastening in accordance with sections 3.1.2, 3.1.3 and 3.1.4.2 of Annex II.Where the packaging contains a substance or mixture which meets the requirements in section 3.2.1 of Annex II it shall bear a tactile warning of danger in accordance with section 3.2.2 of Annex II.
3. The packaging of substances and mixtures shall be deemed to satisfy the requirements of paragraph 1(a), (b) and (c) if it complies with the requirements of the rules on the transport of dangerous goods by air, sea, road, rail or inland waterways.
TITLE V
CHAPTER 1
Article 36 

1. A substance that fulfils the criteria set out in Annex I for the following shall normally be subject to harmonised classification and labelling in accordance with Article 37:
(a) respiratory sensitisation, category 1 (Annex I, section 3.4);
(b) germ cell mutagenicity, category 1A, 1B or 2 (Annex I, section 3.5);
(c) carcinogenicity, category 1A, 1B or 2 (Annex I, section 3.6);
(d) reproductive toxicity, category 1A, 1B or 2 (Annex I, section 3.7).
2. A substance that is an active substance in the meaning of Directive 91/414/EEC or Directive 98/8/EC shall normally be subject to harmonised classification and labelling. For such substances, the procedures set out in Article 37, paragraphs 1, 4, 5 and 6 shall apply.
3. Where a substance fulfils the criteria for other hazard classes or differentiations than those referred to in paragraph 1 and does not fall under paragraph 2, a harmonised classification and labelling in accordance with Article 37 may also be added to Annex VI on a case-by-case basis, if justification is provided demonstrating the need for such action at Community level.
Article 37 

1. A competent authority may submit to the Agency a proposal for harmonised classification and labelling of substances and, where appropriate, specific concentration limits or M-factors, or a proposal for a revision thereof.The proposal shall follow the format set out in Part 2 of Annex VI and contain the relevant information provided for in Part 1 of Annex VI.
2. A manufacturer, importer or downstream user of a substance may submit to the Agency a proposal for harmonised classification and labelling of that substance and, where appropriate, specific concentration limits or M-factors, provided that there is no entry in Part 3 of Annex VI for such a substance in relation to the hazard class or differentiation covered by that proposal.The proposal shall be drawn up in accordance with the relevant Parts of sections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006 and it shall follow the format set out in Part B of the Chemical Safety Report of section 7 of that Annex. It shall contain the relevant information provided for in Part 1 of Annex VI to this Regulation. Article 111 of Regulation (EC) No 1907/2006 shall apply.
3. Where the proposal of the manufacturer, importer or downstream user concerns the harmonised classification and labelling of a substance in accordance with Article 36(3), it shall be accompanied by the fee determined by the Commission in accordance with the regulatory procedure referred to in Article 54(2).
4. The Committee for Risk Assessment of the Agency set up pursuant to Article 76(1)(c) of Regulation (EC) No 1907/2006 shall adopt an opinion on any proposal submitted pursuant to paragraphs 1 or 2 within 18 months of receipt of the proposal, giving the parties concerned the opportunity to comment. The Agency shall forward this opinion and any comments to the Commission.
5. Where the Commission finds that the harmonisation of the classification and labelling of the substance concerned is appropriate, it shall, without undue delay, submit a draft decision concerning the inclusion of that substance together with the relevant classification and labelling elements in Table 3.1 of Part 3 of Annex VI and, where appropriate, the specific concentration limits or M-factors.A corresponding entry shall be included in Table 3.2 of Part 3 of Annex VI subject to the same conditions, until 31 May 2015.That measure, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 54(3). On imperative grounds of urgency, the Commission may have recourse to the urgency procedure referred to in Article 54(4).
6. Manufacturers, importers and downstream users who have new information which may lead to a change of the harmonised classification and labelling elements of a substance in Part 3 of Annex VI shall submit a proposal in accordance with the second subparagraph of paragraph 2 to the competent authority in one of the Member States in which the substance is placed on the market.
Article 38 

1. Any opinion referred to in Article 37(4) and any decision according to Article 37(5) shall at least specify for each substance:
(a) the identity of the substance as specified in sections 2.1 to 2.3.4 of Annex VI to Regulation (EC) No 1907/2006;
(b) the classification of the substance referred to in Article 36, including a statement of reasons;
(c) the specific concentration limits or M-factors, where applicable;
(d) the label elements specified in points (d), (e) and (f) of Article 17(1) for the substance, together with any supplemental hazard statements for the substance, determined in accordance with Article 25(1);
(e) any other parameter enabling an assessment to be made of the health or environmental hazard of mixtures containing the hazardous substance in question or of substances containing such hazardous substances as identified impurities, additives and constituents, if relevant.
2. When making publicly available an opinion or a decision as referred to in Article 37(4) and (5) of this Regulation, Article 118(2) and Article 119 of Regulation (EC) No 1907/2006 shall apply.
CHAPTER 2
Article 39 
This Chapter shall apply to:

((a)) substances subject to registration in accordance with Regulation (EC) No 1907/2006;
((b)) substances within the scope of Article 1 which meet the criteria for classification as hazardous and are placed on the market either on their own or in a mixture above the concentration limits specified in this Regulation or Directive 1999/45/EC, where relevant, which results in the classification of the mixture as hazardous.
Article 40 

1. Any manufacturer or importer, or group of manufacturers or importers (hereinafter referred to as ‘the notifier(s)’), who places on the market a substance referred to in Article 39, shall notify to the Agency the following information in order for it to be included in the inventory referred to in Article 42:
(a) the identity of the notifier(s) responsible for placing the substance or substances on the market as specified in section 1 of Annex VI to Regulation (EC) No 1907/2006;
(b) the identity of the substance or substances as specified in section 2.1 to 2.3.4 to Annex VI to Regulation (EC) No 1907/2006;
(c) the classification of the substance or substances in accordance with Article 13;
(d) where a substance has been classified in some but not all hazard classes or differentiations, an indication of whether this is due to lack of data, inconclusive data, or data which are conclusive although insufficient for classification;
(e) specific concentration limits or M-factors, where applicable, in accordance with Article 10 of this Regulation together with a justification using the relevant Parts of sections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006;
(f) the label elements specified in points (d), (e) and (f) of Article 17(1) for the substance or substances together with any supplemental hazard statements for the substance, determined in accordance with Article 25(1).
The information referred to in (a) to (f) shall not be notified, if it has been submitted to the Agency as part of a registration pursuant to Regulation (EC) No 1907/2006, or if it has already been notified by that notifier.The notifier shall submit this information in the format specified pursuant to Article 111 of Regulation (EC) No 1907/2006.
2. The information listed in paragraph 1 shall be updated and notified to the Agency by the notifier(s) concerned when, pursuant to the review in Article 15(1), a decision to change the classification and labelling of the substance has been taken.
3. Substances placed on the market on or after 1 December 2010 shall be notified in accordance with paragraph 1 within one month after their placing on the market.However, substances placed on the market before 1 December 2010 may be notified in accordance with paragraph 1 before that date.
Article 41 
Where the notification in Article 40(1) results in different entries on the inventory referred to in Article 42 for the same substance, the notifiers and registrants shall make every effort to come to an agreed entry to be included in the inventory. The notifiers shall inform the Agency accordingly.
Article 42 

1. The Agency shall establish and maintain a classification and labelling inventory in the form of a database.The information notified pursuant to Article 40(1) shall be included in the inventory, as well as information submitted as part of registrations under Regulation (EC) No 1907/2006.Information in the inventory which corresponds to the information referred to in Article 119(1) of Regulation (EC) No 1907/2006 shall be publicly accessible. The Agency shall grant access to the other information on each substance in the inventory to the notifiers and registrants who have submitted information on that substance in accordance with Article 29(1) of Regulation (EC) No 1907/2006. It shall grant access to such information to other parties subject to Article 118 of that Regulation.
2. The Agency shall update the inventory when it receives updated information in accordance with Article 40(2) or Article 41.
3. In addition to the information referred to in paragraph 1, the Agency shall, where applicable, include the following information in each entry:
(a) whether, in respect of the entry, there is harmonised classification and labelling at Community level by inclusion in Part 3 of Annex VI;
(b) whether, in respect of the entry, it is a joint entry between registrants of the same substance as referred to in Article 11(1) of Regulation (EC) No 1907/2006;
(c) whether it is an agreed entry of two or more notifiers or registrants in accordance with Article 41;
(d) whether the entry differs from another entry on the inventory for the same substance.
The information referred to in (a) shall be updated where a decision is taken in accordance with Article 37(5).
TITLE VI
Article 43 
Member States shall appoint the competent authority or competent authorities responsible for proposals for harmonised classification and labelling and the authorities responsible for the enforcement of the obligations set out in this Regulation.
The competent authorities and the authorities responsible for enforcement shall cooperate with each other in the performance of their tasks under this Regulation and shall give the corresponding authorities of other Member States all necessary and useful support to this end.
Article 44 
Member States shall establish national helpdesks to provide advice to manufacturers, importers, distributors, downstream users and any other interested parties on their respective responsibilities and obligations under this Regulation.
Article 45 

1. Member States shall appoint a body or bodies responsible for receiving information relevant, in particular, for formulating preventative and curative measures, in particular in the event of emergency health response, from importers and downstream users placing mixtures on the market. This information shall include the chemical composition of mixtures placed on the market and classified as hazardous on the basis of their health or physical effects, including the chemical identity of substances in mixtures for which a request for use of an alternative chemical name has been accepted by the Agency, in accordance with Article 24.
2. The appointed bodies shall provide all requisite guarantees for maintaining the confidentiality of the information received. Such information may only be used:
(a) to meet medical demand by formulating preventative and curative measures, in particular in the event of an emergency;and
(b) where requested by the Member State, to undertake statistical analysis to identify where improved risk management measures may be needed.
The information shall not be used for other purposes.
3. The appointed bodies shall have at their disposal all the information required from the importers and downstream users responsible for marketing to carry out the tasks for which they are responsible.
4. By 20 January 2012 the Commission shall carry out a review to assess the possibility of harmonising the information referred to in paragraph 1, including establishing a format for the submission of information by importers and downstream users to appointed bodies. On the basis of this review, and following consultation with relevant stakeholders such as the European Association of Poison Centres and Clinical Toxicologists (EAPCCT), the Commission may adopt a Regulation adding an Annex to this Regulation.Those measures, designed to amend non-essential elements of this Regulation, by supplementing it, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 54(3).
Article 46 

1. Member States shall take all necessary measures, including maintaining a system of official controls, to ensure that substances and mixtures are not placed on the market, unless they have been classified, labelled, notified and packaged in accordance with this Regulation.
2. Member States shall submit a report to the Agency every five years by 1 July on the results of the official controls, and other enforcement measures taken. The first report shall be submitted by 20 January 2012. The Agency shall make those reports available to the Commission, which shall take them into account for its report under Article 117 of Regulation (EC) No 1907/2006.
3. The Forum referred to in Article 76(1)(f) of Regulation (EC) No 1907/2006 shall undertake the tasks specified in Article 77(4)(a) to (g) of Regulation (EC) No 1907/2006 concerning enforcement of this Regulation.
Article 47 
Member States shall introduce penalties for non-compliance with this Regulation and shall take all measures necessary to ensure that this Regulation is applied. The penalties must be effective, proportionate and dissuasive. Member States shall notify the Commission of the provisions for penalties by 20 June 2010 and shall notify it without delay of any subsequent amendment affecting them.
TITLE VII
Article 48 

1. Any advertisement for a substance classified as hazardous shall mention the hazard classes or hazard categories concerned.
2. Any advertisement for a mixture classified as hazardous or covered by Article 25(6) which allows a member of the general public to conclude a contract for purchase without first having sight of the label shall mention the type or types of hazard indicated on the label.The first subparagraph shall be without prejudice to Directive 97/7/EC of the European Parliament and of the Council of 20 May 1997 on the protection of consumers in respect of distance contracts.
Article 49 

1. The supplier shall assemble and keep available all the information used by that supplier for the purposes of classification and labelling under this Regulation for a period of at least 10 years after the substance or the mixture was last supplied by that supplier.The supplier shall keep this information together with the information required in Article 36 of Regulation (EC) No 1907/2006.
2. In the event of a supplier ceasing activity, or transferring part or all of his operations to a third party, the party responsible for liquidating the supplier's undertaking or assuming responsibility for the placing on the market of the substance or mixture concerned shall be bound by the obligation in paragraph 1 in place of the supplier.
3. The competent authority or the enforcement authorities of a Member State in which a supplier is established or the Agency may require the supplier to submit to it any information referred to in the first subparagraph of paragraph 1.However, where that information is available to the Agency as part of a registration pursuant to Regulation (EC) No 1907/2006 or a notification pursuant to Article 40 of this Regulation, the Agency shall use that information and the authority shall address itself to the Agency.
Article 50 

1. The Agency shall provide the Member States and the institutions of the Community with the best possible scientific and technical advice on questions relating to chemicals which fall within its remit and which are referred to it in accordance with this Regulation.
2. The Secretariat of the Agency shall:
(a) provide industry with technical and scientific guidance and tools where appropriate on how to comply with the obligations laid down by this Regulation;
(b) provide competent authorities with technical and scientific guidance on the operation of this Regulation and provide support to the helpdesks established by Member States under Article 44.
Article 51 
On grounds relating to the classification, labelling or packaging of substances and mixtures within the meaning of this Regulation, Member States shall not prohibit, restrict or impede the placing on the market of substances or mixtures which comply with this Regulation and, where appropriate, with Community acts adopted in implementation of this Regulation.
Article 52 

1. Where a Member State has justifiable grounds for believing that a substance or a mixture, although satisfying the requirements of this Regulation, constitutes a serious risk to human health or the environment due to reasons of classification, labelling or packaging, it may take appropriate provisional measures. The Member State shall immediately inform the Commission, the Agency and the other Member States thereof, giving the reasons for its decision.
2. Within 60 days of receipt of the information from the Member State, the Commission shall in accordance with the regulatory procedure referred to in Article 54(2) either authorise the provisional measure for a time period defined in the decision or require the Member State to revoke the provisional measure.
3. In the case of an authorisation of a provisional measure related to classification or labelling of a substance as referred to in paragraph 2, the competent authority of the Member State concerned shall in accordance with the procedure laid down in Article 37 submit a proposal to the Agency for harmonised classification and labelling, within three months of the date of the Commission decision.
Article 53 

1. The Commission may adjust and adapt Articles 6(5), 11(3), 12, 14, 18(3)(b), 23, 25 to 29 and 35(2) second and third subparagraph and Annexes I to VII to technical and scientific progress, including taking due account of the further development of the GHS, in particular any UN amendments relating to the use of information on similar mixtures, and considering the developments in internationally recognised chemical programmes and of the data from accident databases. Those measures, designed to amend non-essential elements of this Regulation, shall be adopted in accordance with the regulatory procedure with scrutiny referred to in Article 54(3). On imperative grounds of urgency, the Commission may have recourse to the urgency procedure referred to in Article 54(4).
2. Member States and the Commission shall, in the manner appropriate to their role in the relevant UN fora, promote the harmonisation of the criteria for classification and labelling of persistent, bioaccumulative and toxic (PBT) and very persistent and very bioaccumulative (vPvB) substances at the level of the UN.
Article 54 

1. The Commission shall be assisted by the Committee instituted by Article 133 of Regulation (EC) No 1907/2006.
2. Where reference is made to this paragraph, Articles 5 and 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.The period laid down in Article 5 (6) of Decision 1999/468/EC shall be set at three months.
3. Where reference is made to this paragraph, Article 5a(1) to (4) and Article 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.
4. Where reference is made to this paragraph, Article 5a(1), (2), (4) and (6) and Article 7 of Decision 1999/468/EC shall apply, having regard to the provisions of Article 8 thereof.
Article 55 
Directive 67/548/EEC shall be amended as follows:

1.. in Article 1(2), the second subparagraph shall be deleted;
2.. Article 4 shall be amended as follows:

((a)) paragraph 3 shall be replaced by the following:
'
3. Where an entry containing the harmonised classification and labelling for a particular substance has been included in Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, the substance shall be classified in accordance with that entry and paragraphs 1 and 2 shall not apply to the danger categories covered by that entry.';
((b)) paragraph 4 shall be deleted;
3.. Article 5 shall be amended as follows:

((a)) paragraph 1, second subparagraph shall be deleted;
((b)) paragraph 2 shall be replaced by the following:
'
2. The measures in the first subparagraph of paragraph 1 shall apply until the substance is listed in Part 3 of Annex VI to Regulation (EC) No 1272/2008 for the danger categories covered by that entry or until a decision not to list it has been taken in accordance with the procedure laid down in Article 37 of Regulation (EC) No 1272/2008.';
4.. Article 6 shall be replaced by the following:
'
Article 6 
Manufacturers, distributors and importers of substances which appear in the EINECS but for which no entry has been included in Part 3 of Annex VI to Regulation (EC) No 1272/2008 shall carry out an investigation to make themselves aware of the relevant and accessible data which exist concerning the properties of such substances. On the basis of this information, they shall package and provisionally label dangerous substances according to the rules laid down in Articles 22 to 25 of this Directive and the criteria in Annex VI to this Directive.';
5.. Article 22(3) and (4) shall be deleted;
6.. Article 23(2) shall be amended as follows:

((a)) in point (a), the words ‘Annex I’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’;
((b)) in point (c), the words ‘Annex I’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’;
((c)) in point (d), the words ‘Annex I’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’;
((d)) in point (e), the words ‘Annex I’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’;
((e)) in point (f), the words ‘Annex I’ shall be replaced by ‘Part 3 of Annex VI of Regulation (EC) No 1272/2008’;
7.. Article 24(4) second subparagraph shall be deleted;
8.. Article 28 shall be deleted;
9.. Article 31(2) and (3) shall be deleted;
10.. the following Article shall be inserted after Article 32:
'
Article 32a 
Articles 22 to 25 shall not apply to substances from 1 December 2010.';
11.. Annex I shall be deleted.
Article 56 
Directive 1999/45/EC shall be amended as follows:

1.. in Article 3(2), first indent, the words ‘Annex I to Directive 67/548/EEC’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures.
2.. the words ‘Annex I to Directive 67/548/EEC’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’ in:

((a)) Article 3(3);
((b)) Article 10(2), points 2.3.1, 2.3.2, 2.3.3 and 2.4 first indent;
((c)) Annex II, points (a) and (b) and the last paragraph of the Introduction;
((d)) Annex II, Part A,

— point 1.1.1 (a) and (b),
— point 1.2 (a) and (b),
— point 2.1.1 (a) and (b),
— point 2.2 (a) and (b),
— point 2.3 (a) and (b),
— point 3.1.1 (a) and (b),
— point 3.3 (a) and (b),
— point 3.4 (a) and (b),
— point 4.1.1 (a) and (b),
— point 4.2.1 (a) and (b),
— point 5.1.1 (a) and (b),
— point 5.2.1 (a) and (b),
— point 5.3.1 (a) and (b),
— point 5.4.1 (a) and (b),
— point 6.1 (a) and (b),
— point 6.2 (a) and (b),
— point 7.1 (a) and (b),
— point 7.2 (a) and (b),
— point 8.1 (a) and (b),
— point 8.2 (a) and (b),
— point 9.1 (a) and (b),
— point 9.2 (a) and (b),
— point 9.3 (a) and (b),
— point 9.4 (a) and (b);
((e)) Annex II, the introductory paragraph of Part B;
((f)) Annex III, point (a) and (b) of the Introduction;
((g)) Annex III, Part A, section (a) Aquatic environment

— point 1.1 (a) and (b),
— point 2.1 (a) and (b),
— point 3.1 (a) and (b),
— point 4.1 (a) and (b),
— point 5.1 (a) and (b),
— point 6.1 (a) and (b),
((h)) Annex III, Part A, section (b) Non-aquatic environment point 1.1 (a) and (b);
((i)) Annex V, section A points 3 and 4;
((j)) Annex V, section B point 9;
((k)) Annex VI, Part A, the third column of the table under point 2;
((l)) Annex VI Part B point 1, first paragraph, and the first column of the table under point 3;
((m)) Annex VIII, Appendix 1, second column of the table;
((n)) Annex VIII, Appendix 2, second column of the table;
3.. in Annex VI, Part B, point 1, paragraph 3 first indent and paragraph 5, the words ‘Annex I’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’;
4.. in Annex VI, Part B, point 4.2, final paragraph, the words ‘Annex I to Directive 67/548/EEC (19th adaptation)’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’.
Article 57 
Regulation (EC) No 1907/2006 shall be amended as from the entry into force of this Regulation as follows:

1.. Article 14(2) shall be amended as follows:

((a)) point (b) shall be replaced by the following:
'
((b)) the specific concentration limits that have been set in Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures;
((ba)) for substances classified as hazardous to the aquatic environment, if a multiplying factor (hereinafter referred to as “M-factor”) has been set in Part 3 of Annex VI to Regulation (EC) No 1272/2008, the cut-off value in Table 1.1 of Annex I to that Regulation adjusted using the calculation set out in section 4.1 of Annex I to that Regulation;';
((b)) point (e) shall be replaced by the following:
'
((e)) the specific concentration limits given in an agreed entry in the classification and labelling inventory referred to in Article 42 of Regulation (EC) No 1272/2008;
((ea)) for substances classified as hazardous to the aquatic environment, if an M-factor has been set in an agreed entry in the classification and labelling inventory referred to in Article 42 of Regulation (EC) No 1272/2008, the cut-off value in Table 1.1 of Annex I to that Regulation adjusted using the calculation set out in section 4.1 of Annex I to that Regulation;';
2.. Article 31 shall be amended as follows:

((a)) paragraph 8 shall be replaced by the following:
'
8. A safety data sheet shall be provided free of charge on paper or electronically no later than the date on which the substance or mixture is first supplied.';
((b)) the following paragraph shall be added:
'
10. Where substances are classified in accordance with Regulation (EC) No 1272/2008 during the period from its entry into force until 1 December 2010, that classification may be added in the safety data sheet together with the classification in accordance with Directive 67/548/EEC.From 1 December 2010 until 1 June 2015, the safety data sheets for substances shall contain the classification according to both Directive 67/548/EEC and Regulation (EC) No 1272/2008.Where mixtures are classified in accordance with Regulation (EC) No 1272/2008 during the period from its entry into force until 1 June 2015, that classification may be added in the safety data sheet, together with the classification in accordance with Directive 1999/45/EC. However, until 1 June 2015, where substances or mixtures are both classified and labelled in accordance with Regulation (EC) No 1272/2008 that classification shall be provided in the safety data sheet, together with the classification in accordance with Directives 67/548/EEC and 1999/45/EC respectively, for the substance, the mixture and its constituents.';
3.. Article 56(6)(b) shall be replaced by the following:
'
((b)) for all other substances, below the lowest of the concentration limits specified in Directive 1999/45/EC or in Part 3 of Annex VI to Regulation (EC) No 1272/2008 which result in the classification of the mixture as dangerous.';
4.. Article 59(2) and 3 shall be amended as follows:

((a)) in paragraph 2, the second sentence shall be replaced by the following:
'The dossier may be limited, if appropriate, to a reference to an entry in Part 3 of Annex VI to Regulation (EC) No 1272/2008.';
((b)) in paragraph 3, the second sentence shall be replaced by the following:
'The dossier may be limited, if appropriate, to a reference to an entry in Part 3 of Annex VI to Regulation (EC) No 1272/2008.';
5.. in Article 76(1)(c), the words ‘Title XI’ shall be replaced by ‘Title V of Regulation (EC) No 1272/2008’;
6.. Article 77 shall be amended as follows:

((a)) in paragraph 2, the first sentence of point (e) shall be replaced by the following:
'
((e)) establishing and maintaining database(s) with information on all registered substances, the classification and labelling inventory and the harmonised classification and labelling list established in accordance with Regulation (EC) No 1272/2008;';
((b)) in paragraph 3, point (a), the words ‘Titles VI to XI’ shall be replaced by ‘Titles VI to X’;
7.. Title XI shall be deleted;
8.. Annex XV, sections I and II shall be amended as follows:

((a)) section I shall be amended as follows:

((i)) the first indent shall be deleted;
((ii)) the second indent shall be replaced by the following:
'
— the identification of CMRs, PBTs, vPvBs, or a substance of equivalent concern in accordance with Article 59,';
((b)) in section II, point 1 shall be deleted;
9.. the table in Annex XVII shall be amended as follows:

((a)) the column ‘Designation of the substance, of the groups of substances or of the preparation’, shall be amended as follows:

((i)) entries 28, 29 and 30 shall be replaced by the following:
'
28. 

— Carcinogen category 1A (Table 3.1)/carcinogen category 1 (Table 3.2) listed in Appendix 1
— Carcinogen category 1B (Table 3.1)/carcinogen category 2 (Table 3.2) listed in Appendix 2

29. 

— Mutagen category 1A (Table 3.1)/mutagen category 1 (Table 3.2) listed in Appendix 3
— Mutagen category 1B (Table 3.1)/mutagen category 2 (Table 3.2) listed in Appendix 4

30. 

— Reproductive toxicant category 1A adverse effects on sexual function and fertility or on development (Table 3.1) or reproductive toxicant category 1 with R60 (May impair fertility) or R61 (May cause harm to the unborn child) (Table 3.2) listed in Appendix 5
— Reproductive toxicant category 1B adverse effects on sexual function and fertility or on development (Table 3.1) or reproductive toxicant category 2 with R60 (May impair fertility) or R61 (May cause harm to the unborn child) (Table 3.2) listed in Appendix 6
';
((b)) in the column ‘Conditions of restriction’, in entry 28, the first indent of point 1 shall be replaced by the following:
'
— either the relevant specific concentration limit specified in Part 3 of Annex VI to Regulation (EC) No 1272/2008, or';
10.. Appendices 1 to 6 to Annex XVII shall be amended as follows:

((a)) the Foreword shall be amended as follows:

((i)) in the section entitled ‘Substances’, the words ‘Annex I to Directive 67/548/EEC’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’;
((ii)) in the section entitled ‘Index number’, the words ‘Annex I to Directive 67/548/EEC’ shall be replaced by ‘Part 3 of Annex VI to Regulation (EC) No 1272/2008’;
((iii)) in the section entitled ‘Notes’, the words ‘the foreword of Annex I to Directive 67/548/EEC’ shall be replaced by ‘Part 1 of Annex VI to Regulation (EC) No 1272/2008’;
((iv)) Note A shall be replaced by the following:
'
Without prejudice to Article 17(2) of Regulation (EC) No 1272/2008, the name of the substance must appear on the label in the form of one of the designations given in Part 3 of Annex VI to that Regulation.

In that Part, use is sometimes made of a general description such as “... compounds” or “... salts”. In this case, the supplier who places such a substance on the market is required to state on the label the correct name, due account being taken of Section 1.1.1.4 of Annex VI to Regulation (EC) No 1272/2008.

In accordance with Regulation (EC) No 1272/2008, where a substance is included in Part 3 of Annex VI to that Regulation, the labelling elements relevant for each specific classification covered by the entry in that Part shall be included in the label, together with the applicable label elements for any other classification not covered by that entry, and any other applicable label elements in accordance with Article 17 of that Regulation.

For substances belonging to one particular group of substances included in Part 3 of Annex VI to Regulation (EC) No 1272/2008, the labelling elements relevant for each specific classification covered by the entry in that Part shall be included in the label, together with the applicable label elements for any other classification not covered by that entry, and any other applicable label elements in accordance with Article 17 of that Regulation.

For substances belonging to more than one group of substances included in Part 3 of Annex VI to Regulation (EC) No 1272/2008, the labelling elements relevant for each specific classification covered by both entries in that Part shall be included in the label, together with the applicable label elements for any other classification not covered by that entry, and any other applicable label elements in accordance with Article 17 of that Regulation. In cases where two different classifications are given in the two entries for the same hazard class or differentiation, the classification reflecting the more severe classification shall be used.
';
((v)) Note D shall be replaced by the following:
'
Certain substances which are susceptible to spontaneous polymerisation or decomposition are generally placed on the market in a stabilised form. It is in this form that they are listed in Part 3 of Annex VI to Regulation (EC) No 1272/2008.

However, such substances are sometimes placed on the market in a non-stabilised form. In this case, the supplier who places such a substance on the market must state on the label the name of the substance followed by the words “non-stabilised”.
';
((vi)) Note E shall be deleted;
((vii)) Note H shall be replaced by the following:
'
The classification and label shown for this substance applies to the hazard or hazards indicated by the hazard statement or hazard statements in combination with the hazard classification shown. The requirements of Article 4 of Regulation (EC) No 1272/2008 on suppliers of this substance apply to all other hazard classes, differentiations and categories.

The final label shall follow the requirements of section 1.2 of Annex I to Regulation (EC) No 1272/2008.
';
((viii)) Note K shall be replaced by the following:
'
The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w 1,3-butadiene (Einecs No 203-450-8). If the substance is not classified as a carcinogen or mutagen, at least the precautionary statements (P102-)P210-P403 should apply. This note applies only to certain complex oil-derived substances in Part 3 of Annex VI to Regulation (EC) No 1272/2008.
';
((ix)) Note S shall be replaced by the following:
'
This substance may not require a label according to Article 17 of Regulation (EC) No 1272/2008 (see section 1.3 of Annex I to that Regulation).
';
((b)) in Appendix 1, the title shall be replaced by the following:
'Point 28 — Carcinogens: category 1A (Table 3.1)/category 1 (Table 3.2)';
((c)) Appendix 2 shall be amended as follows:

((i)) the title shall be replaced by ‘Point 28 — Carcinogens: category 1B (Table 3.1)/ category 2 (Table 3.2)’;
((ii)) in the entries index Nos 024-017-00-8, 611-024-001, 611-029-00-9, 611-030-00-4 and 650-017-00-8, the words ‘Annex I to Directive 67/548/EEC’ shall be replaced by ‘Annex VI to Regulation (EC) No 1272/2008.’;
((d)) in Appendix 3, the title shall be replaced by the following:
'Point 29 — Mutagens: category 1A (Table 3.1)/category 1 (Table 3.2)';
((e)) in Appendix 4, the title shall be replaced by the following:
'Point 29 — Mutagens: category 1B (Table 3.1)/category 2 (Table 3.2)';
((f)) in Appendix 5, the title shall be replaced by the following:
'Point 30 — Reproductive toxicants: category 1A (Table 3.1)/category 1 (Table 3.2)';
((g)) in Appendix 6, the title shall be replaced by the following:
'Point 30 — Reproductive toxicants: category 1B (Table 3.1)/category 2 (Table 3.2)';
11.. the word ‘preparation’ or ‘preparations’ within the meaning of Article 3 (2) of Regulation (EC) 1907/2006 shall be replaced by ‘mixture’ or ‘mixtures’ respectively throughout the text.
Article 58 
Regulation (EC) No 1907/2006 shall be amended from 1 December 2010 as follows:

1.. in Article 14(4), the introductory sentence shall be replaced by the following:
'
4. If, as a result of carrying out steps (a) to (d) of paragraph 3, the registrant concludes that the substance fulfils the criteria for any of the following hazard classes or categories set out in Annex I to Regulation (EC) No 1272/2008:
(a) hazard classes 2.1 to 2.4, 2.6 and 2.7, 2.8 types A and B, 2.9, 2.10, 2.12, 2.13 categories 1 and 2, 2.14 categories 1 and 2, 2.15 types A to F;
(b) hazard classes 3.1 to 3.6, 3.7 adverse effects on sexual function and fertility or on development, 3.8 effects other than narcotic effects, 3.9 and 3.10;
(c) hazard class 4.1;
(d) hazard class 5.1,
or is assessed to be a PBT or vPvB, the chemical safety assessment shall include the following additional steps:';
2.. Article 31 shall be amended as follows

((a)) paragraph 1(a) shall be replaced by the following:
'
((a)) where a substance meets the criteria for classification as hazardous in accordance with Regulation (EC) No 1272/2008 or a mixture meets the criteria for classification as dangerous in accordance with Directive 1999/45/EC; or';
((b)) paragraph 4 shall be replaced by the following:
'
4. The safety data sheet need not be supplied where substances that are hazardous in accordance with Regulation (EC) No 1272/2008 or mixtures that are dangerous in accordance with Directive 1999/45/EC, offered or sold to the general public, are provided with sufficient information to enable users to take the necessary measures as regards the protection of human health, safety and the environment, unless requested by a downstream user or distributor.';
3.. Article 40(1) shall be replaced by the following:
'
1. The Agency shall examine any testing proposal set out in a registration or a downstream user report for provision of the information specified in Annexes IX and X for a substance. Priority shall be given to registrations of substances which have or may have PBT, vPvB, sensitising and/or carcinogenic, mutagenic or toxic for reproduction (CMR) properties, or substances above 100 tonnes per year with uses resulting in widespread and diffuse exposure, provided they fulfil the criteria for any of the following hazard classes or categories set out in Annex I of Regulation (EC) No 1272/2008:
(a) hazard classes 2.1 to 2.4, 2.6 and 2.7, 2.8 types A and B, 2.9, 2.10, 2.12, 2.13 categories 1 and 2, 2.14 categories 1 and 2, 2.15 types A to F;
(b) hazard classes 3.1 to 3.6, 3.7 adverse effects on sexual function and fertility or on development, 3.8 effects other than narcotic effects, 3.9 and 3.10;
(c) hazard class 4.1;
(d) hazard class 5.1.';
4.. Article 57(a), (b) and (c) shall be replaced by the following:
'
((a)) substances meeting the criteria for classification in the hazard class carcinogenicity category 1A or 1B in accordance with section 3.6 of Annex I to Regulation (EC) No 1272/2008;
((b)) substances meeting the criteria for classification in the hazard class germ cell mutagenicity category 1A or 1B in accordance with section 3.5 of Annex I to Regulation (EC) No 1272/2008;
((c)) substances meeting the criteria for classification in the hazard class reproductive toxicity category 1A or 1B, adverse effects on sexual function and fertility or on development in accordance with section 3.7 of Annex I to Regulation(EC) No 1272/2008;';
5.. in Article 65 the words ‘Directive 67/548/EEC’ shall be replaced by ‘Directive 67/548/EEC and Regulation (EC) No 1272/2008’;
6.. Article 68(2) shall be replaced by the following:
'
2. For a substance on its own, in a mixture or in an article which meets the criteria for classification in the hazard classes carcinogenicity, germ cell mutagenicity or reproductive toxicity, category 1A or 1B, and could be used by consumers and for which restrictions to consumer use are proposed by the Commission, Annex XVII shall be amended in accordance with the procedure referred to in Article 133(4). Articles 69 to 73 shall not apply.';
7.. Article 119 shall be amended as follows:

((a)) in paragraph 1, point (a) shall be replaced by the following:
'
((a)) without prejudice to paragraph 2(f) and (g) of this Article, the name in the IUPAC nomenclature for substances fulfilling the criteria for any of the following hazard classes or categories set out in Annex I to Regulation (EC) No 1272/2008:

— hazard classes 2.1 to 2.4, 2.6 and 2.7, 2.8 types A and B, 2.9, 2.10, 2.12, 2.13 categories 1 and 2, 2.14 categories 1 and 2, 2.15 types A to F;
— hazard classes 3.1 to 3.6, 3.7 adverse effects on sexual function and fertility or on development, 3.8 effects other than narcotic effects, 3.9 and 3.10;
— hazard class 4.1;
— hazard class 5.1.';
((b)) paragraph 2 shall be amended as follows:

((i)) point (f) shall be replaced by the following:
'
((f)) subject to Article 24 of Regulation (EC) No 1272/2008, the name in the IUPAC nomenclature for non-phase-in substances referred to in paragraph 1(a) of this Article for a period of six years;'
((ii)) in point (g), the introductory phrase shall be replaced by the following:
'
((g)) subject to Article 24 of Regulation (EC) No 1272/2008, the name in the IUPAC nomenclature for substances referred to in paragraph 1(a) of this Article that are only used as one or more of the following:';
8.. in Article 138(1), the second sentence of the introductory phrase shall be replaced by the following:
'However, for substances meeting the criteria for classification in the hazard classes carcinogenicity, germ cell mutagenicity or reproductive toxicity, category 1A or 1B, in accordance with Regulation (EC) No 1272/2008, the review shall be carried out by 1 June 2014.';
9.. Annex III shall be amended as follows:

((a)) point (a) shall be replaced by the following:
'
((a)) substances for which it is predicted (i.e. by the application of (Q)SARs or other evidence) that they are likely to meet the criteria for category 1A or 1B classification in the hazard classes carcinogenicity, germ cell mutagenicity or reproductive toxicity or the criteria in Annex XIII;';
((b)) in point (b), point (ii) shall be replaced by the following:
'
((ii)) for which it is predicted (i.e. by application of (Q)SARs or other evidence) that they are likely to meet the classification criteria for any health or environmental hazard classes or differentiations under Regulation (EC) No 1272/2008.';
10.. in Annex V, point 8, the words ‘Directive 67/548/EEC’ shall be replaced by ‘Regulation (EC) No 1272/2008’;
11.. in Annex VI, sections 4.1, 4.2 and 4.3 shall be replaced by the following:
'
4.1 
In addition, for each entry, the reasons why no classification is given for a hazard class or differentiation of a hazard class should be provided (i.e. if data are lacking, inconclusive, or conclusive but not sufficient for classification),

4.2 The resulting hazard label for the substance(s), resulting from the application of Title III of Regulation (EC) No 1272/2008,

4.3 Specific concentration limits, where applicable, resulting from the application of Article 10 of Regulation (EC) No 1272/2008 and Articles 4 to 7 of Directive 1999/45/EC.
';
12.. Annex VIII shall be amended as follows:

((a)) in column 2, the second indent of point 8.4.2 shall be replaced by the following:
'
— the substance is known to be carcinogenic category 1A or 1B or germ cell mutagenic category 1A, 1B or 2.';
((b)) in column 2, the second and third paragraphs of point 8.7.1 shall be replaced by the following:
'If a substance is known to have an adverse effect on fertility, meeting the criteria for classification as toxic for reproduction category 1A or 1B: May damage fertility (H360F), and the available data are adequate to support a robust risk assessment, then no further testing for fertility will be necessary. However, testing for developmental toxicity must be considered.If a substance is known to cause developmental toxicity, meeting the criteria for classification as toxic for reproduction category 1A or 1B: May damage the unborn child (H360D), and the available data are adequate to support a robust risk assessment, then no further testing for developmental toxicity will be necessary. However, testing for effects on fertility must be considered.';
13.. in Annex IX, column 2, point 8.7, the second and third paragraphs shall be replaced by the following:
'If a substance is known to have an adverse effect on fertility, meeting the criteria for classification as toxic for reproduction category 1A or 1B: May damage fertility (H360F), and the available data are adequate to support a robust risk assessment, then no further testing for fertility will be necessary. However, testing for developmental toxicity must be considered.If a substance is known to cause developmental toxicity, meeting the criteria for classification as toxic for reproduction category 1A or 1B: May damage the unborn child (H360D), and the available data are adequate to support a robust risk assessment, then no further testing for developmental toxicity will be necessary. However, testing for effects on fertility must be considered.';
14.. Annex X shall be amended as follows:

((a)) in column 2, point 8.7, the second and third paragraphs shall be replaced by the following:
'If a substance is known to have an adverse effect on fertility, meeting the criteria for classification as toxic for reproduction category 1A or 1B: May damage fertility (H360F), and the available data are adequate to support a robust risk assessment, then no further testing for fertility will be necessary. However, testing for developmental toxicity must be considered.If a substance is known to cause developmental toxicity, meeting the criteria for classification as toxic for reproduction category 1A or 1B: May damage the unborn child (H360D), and the available data are adequate to support a robust risk assessment, then no further testing for developmental toxicity will be necessary. However, testing for effects on fertility must be considered.'
((b)) in column 2, point 8.9.1, the second indent of the first paragraph shall be replaced by the following:
'
— the substance is classified as germ cell mutagen category 2 or there is evidence from the repeated dose study(ies) that the substance is able to induce hyperplasia and/or pre-neoplastic lesions.'
((c)) in column 2, the second paragraph of point 8.9.1 shall be replaced by the following:
'If the substance is classified as germ cell mutagen category 1A or 1B, the default presumption would be that a genotoxic mechanism for carcinogenicity is likely. In these cases, a carcinogenicity test will normally not be required.';
15.. in Annex XIII, the second and third indents of point 1.3 shall be replaced by the following:
'
— the substance is classified as carcinogenic (category 1A or 1B), germ cell mutagenic (category 1A or 1B), or toxic for reproduction (category 1A, 1B or 2), or
— there is other evidence of chronic toxicity, as identified by the classifications STOT (repeated exposure), category 1 (oral, dermal, inhalation of gases/vapours, inhalation of dust/mist/fume) or category 2 (oral, dermal, inhalation of gases/vapours, inhalation of dust/mist/fume) according to Regulation (EC) No 1272/2008';
16.. in the table in Annex XVII, the column ‘Designation of the substance, of the groups of substances or of the mixture’ shall be amended as follows:

((a)) entry 3 shall be replaced by the following:
'
3. 

((a)) hazard classes 2.1 to 2.4, 2.6 and 2.7, 2.8 types A and B, 2.9, 2.10, 2.12, 2.13 categories 1 and 2, 2.14 categories 1 and 2, 2.15 types A to F;
((b)) hazard classes 3.1 to 3.6, 3.7 adverse effects on sexual function and fertility or on development, 3.8 effects other than narcotic effects, 3.9 and 3.10;
((c)) hazard class 4.1;
((d)) hazard class 5.1.
';
((b)) entry 40 shall be replaced by the following:
'
40. Substances classified as flammable gases category 1 or 2, flammable liquids categories 1, 2 or 3, flammable solids category 1 or 2, substances and mixtures which, in contact with water, emit flammable gases, category 1, 2 or 3, pyrophoric liquids category 1 or pyrophoric solids category 1, regardless of whether they appear in Part 3 of Annex VI to that Regulation or not.
'.
Article 59 
Regulation (EC) No 1907/2006 shall be amended from 1 June 2015 as follows:

1.. Article 14(2) shall be replaced by the following:
'
2. A chemical safety assessment in accordance with paragraph 1 need not be performed for a substance which is present in a mixture if the concentration of the substance in the mixture is less than
(a) the cut-off value referred to in Article 11, paragraph 3 of Regulation (EC) No 1272/2008;
(b) 0,1 % weight by weight (w/w), if the substance meets the criteria in Annex XIII to this Regulation.';
2.. Article 31 shall be amended as follows:

((a)) in paragraph 1, point (a) shall be replaced by the following:
'
((a)) where a substance or mixture meets the criteria for classification as hazardous in accordance with Regulation (EC) No 1272/2008; or';
((b)) paragraph 3 shall be replaced by the following:
'
3. The supplier shall provide the recipient at his request with a safety data sheet compiled in accordance with Annex II, where a mixture does not meet the criteria for classification as hazardous in accordance with Titles I and II of Regulation (EC) No 1272/2008, but contains:
(a) in an individual concentration of ≥ 1 % by weight for non-gaseous mixtures and ≥ 0,2 % by volume for gaseous mixtures at least one substance posing human health or environmental hazards; or
(b) in an individual concentration of ≥ 0,1 % by weight for non-gaseous mixtures at least one substance that is carcinogenic category 2 or toxic to reproduction category 1A, 1B and 2, skin sensitiser category 1, respiratory sensitiser category 1, or has effects on or via lactation or is persistent, bioaccumulative and toxic (PBT) in accordance with the criteria set out in Annex XIII or very persistent and very bioaccumulative (vPvB) in accordance with the criteria set out in Annex XIII or has been included for reasons other than those referred to in point (a) in the list established in accordance with Article 59(1); or
(c) a substance for which there are Community workplace exposure limits';
((c)) paragraph 4 shall be replaced by the following:
'
4. The safety data sheet need not be supplied where hazardous substances or mixtures offered or sold to the general public are provided with sufficient information to enable users to take the necessary measures as regards the protection of human health, safety and the environment, unless requested by a downstream user or distributor.';
3.. Article 56(6)(b) shall be replaced by the following:
'
((b)) for all other substances, below the values specified in Article 11(3) of Regulation (EC) No 1272/2008 which result in the classification of the mixture as hazardous.';
4.. in Article 65 the words ‘and Directive 1999/45/EC’ shall be deleted;
5.. Annex II shall be amended as follows:

((a)) point 1.1 shall be replaced by:
'
1.1. 
The term used for identification of a substance shall be identical to that provided on the label in accordance with Article 18(2) of Regulation (EC) No 1272/2008.

The term used for identification of a mixture shall be identical to that provided on the label in accordance with Article 18(3)(a) of Regulation (EC) No 1272/2008.
';
((b)) footnote 1 to point 3.3(a), first indent, shall be deleted;
((c)) point 3.6 shall be replaced by:
'
3.6. 
The name used on the safety data sheet (including for the purposes of paragraphs 1.1, 3.2, 3.3 and 3.5) shall be the same as that used on the label, agreed in accordance with the procedure set out in Article 24 of Regulation (EC) No 1272/2008.
';
6.. in Annex VI section 4.3 shall be replaced by the following:
'
4.3 Specific concentration limits, where applicable, resulting from the application of Article 10 of Regulation (EC) No 1272/2008.
';
7.. Annex XVII shall be amended as follows:

((a)) in the column ‘Designation of the substance, of the groups of substances or of the mixture’ of the table in entry 3, the words ‘which are regarded as dangerous in accordance with Directive 1999/45/EC or are’ shall be deleted;
((b)) in the column ‘Conditions of restriction’ of the table, entry 28 shall be amended as follows:

((i)) the second indent of point 1 shall be replaced by the following:
'
— the relevant generic concentration limit specified in Part 3 of Annex I of Regulation (EC) No 1272/2008.';
((ii)) point 2 (d) shall be replaced by the following:
'
((d)) artists’ paints covered by Regulation (EC) No 1272/2008.'.
Article 60 
Directive 67/548/EEC and Directive 1999/45/EC shall be repealed with effect from 1 June 2015.
Article 61 

1. Until 1 December 2010, substances shall be classified, labelled and packaged in accordance with Directive 67/548/EEC.Until 1 June 2015, mixtures shall be classified, labelled and packaged in accordance with Directive 1999/45/EC.
2. By way of derogation from the second subparagraph of Article 62 of this Regulation and in addition to the requirements of paragraph 1 of this Article, substances and mixtures may, before 1 December 2010 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with this Regulation. In that case, the provisions on labelling and packaging in Directives 67/548/EEC and 1999/45/EC shall not apply.
3. From 1 December 2010 until 1 June 2015, substances shall be classified in accordance with both Directive 67/548/EEC and this Regulation. They shall be labelled and packaged in accordance with this Regulation.
4. By way of derogation from the second subparagraph of Article 62 of this Regulation, substances classified, labelled and packaged in accordance with Directive 67/548/EEC and already placed on the market before 1 December 2010, are not required to be relabelled and repackaged in accordance with this Regulation until 1 December 2012.By way of derogation from the second subparagraph of Article 62 of this Regulation, mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC and already placed on the market before 1 June 2015 are not required to be relabelled and repackaged in accordance with this Regulation until 1 June 2017.
5. Where a substance or mixture has been classified in accordance with Directive 67/548/EEC or 1999/45/EC before 1 December 2010 or 1 June 2015 respectively, manufacturers, importers and downstream users may amend the classification of the substance or mixture using the conversion table in Annex VII to this Regulation.
6. Until 1 December 2011 a Member State may maintain any existing and more stringent classification and labelling of substances entered into Part 3 of Annex VI to this Regulation, provided that these classifications and labelling elements have been notified to the Commission in accordance with the safeguard clause in Directive 67/548/EEC before 20 January 2009 and that the Member State submits a proposal for harmonised classification and labelling containing these classifications and labelling elements to the Agency in accordance with Article 37(1) of this Regulation by 1 June 2009.It is a precondition that a decision on the proposed classification and labelling by the Commission in accordance with the safeguard clause of Directive 67/548/EEC has not yet been taken before 20 January 2009.If the proposed harmonised classification and labelling submitted under the first subparagraph is not included or is included in an amended form in Part 3 of Annex VI in accordance with Article 37(5), the exemption in the first subparagraph of this paragraph is no longer valid.
Article 62 
This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union.
Titles II, III and IV shall apply in respect of substances from 1 December 2010 and in respect of mixtures from 1 June 2015.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Strasbourg, 16 December 2008.
For the European Parliament
The President
H.-G. PÖTTERING
For the Council
The President
B. LE MAIRE
ANNEX I
This annex sets out the criteria for classification in hazard classes and in their differentiations and sets out additional provisions on how the criteria may be met.

1.  1.0. 
Gas means a substance which:


((i)) at 50 oC has a vapour pressure greater than 300 kPa (absolute); or
((ii)) is completely gaseous at 20 oC at a standard pressure of 101,3 kPa;

Liquid means a substance or mixture which:


((i)) at 50 oC has a vapour pressure of not more than 300 kPa (3 bar);
((ii)) is not completely gaseous at 20 oC and at a standard pressure of 101,3 kPa; and
((iii)) which has a melting point or initial melting point of 20 oC or less at a standard pressure of 101,3 kPa;

Solid means a substance or mixture which does not meet the definitions of liquid or gas.
 1.1.  1.1.0. 
Suppliers in a supply chain shall cooperate to meet the requirements for classification, labelling and packaging set out in this Regulation.

Suppliers in an industry sector may cooperate to manage the transitional arrangements in Article 61 for substances and mixtures placed on the market.

Suppliers in an industry sector may cooperate through formation of a network or by other means to share data and expertise when classifying substances and mixtures in accordance with Title II of this Regulation. In these circumstances suppliers in an industry sector shall document fully the basis on which classification decisions are made and shall make available to the competent authorities and, on request, to the relevant enforcement authorities the documentation, together with the data and information on which classifications are based. However, where suppliers in an industry sector cooperate in this way, each supplier shall remain fully responsible for the classification, labelling and packaging of substances and mixtures he places on the market, and for meeting any other requirements of this Regulation.

The network may also be used to exchange information and best practices with a view to simplifying fulfilment of the notification obligations.
 1.1.1.  1.1.1.1. Where the criteria cannot be applied directly to available identified information, or where only the information referred to in Article 6(5) is available, the weight of evidence determination using expert judgment shall be applied in accordance with Article 9(3) or 9(4) respectively.
 1.1.1.2. The approach to classifying mixtures may include the application of expert judgement in a number of areas in order to ensure existing information can be used for as many mixtures as possible in order to provide protection for human health and the environment. Expert judgement may also be required in interpreting data for hazard classification of substances, especially where weight of evidence determinations are needed.
 1.1.1.3. A weight of evidence determination means that all available information bearing on the determination of hazard is considered together, such as the results of suitable in vitro tests, relevant animal data, information from the application of the category approach (grouping, read-across), (Q)SAR results, human experience such as occupational data and data from accident databases, epidemiological and clinical studies and well-documented case reports and observations. The quality and consistency of the data shall be given appropriate weight. Information on substances or mixtures related to the substance or mixture being classified shall be considered as appropriate, as well as site of action and mechanism or mode of action study results. Both positive and negative results shall be assembled together in a single weight of evidence determination.
 1.1.1.4. For the purpose of classification for health hazards (Part 3) established hazardous effects seen in appropriate animal studies or from human experience that are consistent with the criteria for classification shall normally justify classification. Where evidence is available from both humans and animals and there is a conflict between the findings, the quality and reliability of the evidence from both sources shall be evaluated in order to resolve the question of classification. Generally, adequate, reliable and representative data on humans (including epidemiological studies, scientifically valid case studies as specified in this Annex or statistically backed experience) shall have precedence over other data. However, even well-designed and conducted epidemiological studies may lack a sufficient number of subjects to detect relatively rare but still significant effects, to assess potentially confounding factors. Therefore, positive results from well-conducted animal studies are not necessarily negated by the lack of positive human experience but require an assessment of the robustness, quality and statistical power of both the human and animal data.
 1.1.1.5. For the purpose of classification for health hazards (Part 3) route of exposure, mechanistic information and metabolism studies are pertinent to determining the relevance of an effect in humans. When such information, as far as there is reassurance about the robustness and quality of the data, raises doubt about relevance in humans, a lower classification may be warranted. When there is scientific evidence that the mechanism or mode of action is not relevant to humans, the substance or mixture should not be classified.
 1.1.2.  1.1.2.1. Specific concentration limits or M-factors shall be applied in accordance with Article 10.
 1.1.2.2.  1.1.2.2.1. Cut-off values indicate when the presence of a substance needs to be taken into account for the purposes of classification of a substance or a mixture containing that hazardous substance, whether as an identified impurity, additive, or individual constituent (see Article 11).
 1.1.2.2.2. 

((a)) For health and environmental hazards in Parts 3, 4 and 5 of this Annex:

((i)) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the lower of the specific concentration limit and the relevant generic cut-off value in Table 1.1; or
((ii)) for substances where a specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the specific concentration limit set either in Part 3 of Annex VI or in the classification and labelling inventory; or
((iii)) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is mentioned in Table 1.1, the relevant generic cut-off value set out in that table; or
((iv)) for substances where no specific concentration limit is set for the relevant hazard class or differentiation either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, and where the hazard class or differentiation is not mentioned in Table 1.1, the generic concentration limit for classification in the relevant sections of Parts 3, 4 and 5 of this Annex.
((b)) For aquatic environmental hazards in section 4.1 of this Annex:

((i)) for substances where an M-factor has been set for the relevant hazard category either in Part 3 of Annex VI, or in the classification and labelling inventory referred to in Article 42, the generic cut-off value in Table 1.1 adjusted using the calculation set out in section 4.1 of this Annex; or
((ii)) for substances where no M-factor is set for the relevant hazard category either in Part 3 of Annex VI or in the classification and labelling inventory referred to in Article 42, the relevant generic cut-off value set out in Table 1.1.


Hazard class Generic cut-off values to be taken into account
Acute Toxicity: 

— Category 1-3 0,1 %

— Category 4 1 %
Skin corrosion/Irritation 1 %
Serious damage to eyes/eye irritation 1 %
Hazardous to Aquatic Environment 

— Acute Category 1 0,1 %

— Chronic Category 1 0,1 %

— Chronic Category 2-4 1 %



Generic cut-off values are in weight percentages except for gaseous mixtures where they are in volume percentage. 1.1.3. 
Where the mixture itself has not been tested to determine its hazardous properties, but there are sufficient data on similar tested mixtures and individual hazardous ingredient substances to adequately characterise the hazards of the mixture, these data shall be used in accordance with the following bridging rules referred to in Article 9(4) for each individual hazard class in Part 3 and Part 4 of this Annex, subject to any specific provisions for mixtures in each hazard class.
 1.1.3.1. 
If a mixture is diluted with a substance (diluent) which has an equivalent or lower hazard category classification than the least hazardous original ingredient substance and which is not expected to affect the hazard classification of other ingredient substances, then one of the following shall be applied:


— the new mixture shall be classified as equivalent to the original mixture;
— the method explained in each section of Part 3 and in Part 4 for classification of mixtures when data are available for all components or only some components of the mixture;
— in the case of acute toxicity, the method for classification of mixtures based on ingredients of the mixture (additivity formula).
 1.1.3.2. 
The hazard category of one production batch of a mixture can be assumed to be substantially equivalent to that of another production batch of the same commercial product, and produced by or under the control of the same supplier, unless there is reason to believe there is significant variation such that the hazard classification of the batch has changed. If the latter occurs, a new evaluation is necessary.
 1.1.3.3. 
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, if a mixture is classified in the highest hazard category or sub-category, and the concentration of the ingredients of the mixture that are in that category or sub-category is increased, the new mixture shall be classified in that category or sub-category without additional testing.
 1.1.3.4. 
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.8, 3.9, 3.10 and 4.1, for three mixtures with identical hazardous ingredients, where mixtures A and B are in the same hazard category and mixture C has the same active hazardous ingredients with concentrations intermediate to the concentrations of those hazardous ingredients in mixtures A and B, then mixture C is assumed to be in the same hazard category as A and B.
 1.1.3.5. 
Given the following:


((a)) two mixtures each containing two ingredients:

((i)) A + B
((ii)) C + B;
((b)) the concentration of ingredient B is essentially the same in both mixtures;
((c)) the concentration of ingredient A in mixture (i) equals that of ingredient C in mixture (ii);
((d)) hazard data for A and C are available and substantially equivalent, i.e. they are in the same hazard category and are not expected to affect the hazard classification of B.

If mixture (i) is already classified in a particular hazard class based on test data, mixture (ii) shall be assigned the same hazard category.
 1.1.3.6. 
The following variations in initial concentration are defined for the application of Article 15(2)(a):


Initial concentration range of the constituent Permitted variation in initial concentration of the constituent
≤ 2,5 % ± 30 %
2,5 < C ≤  10 % ± 20 %
10 < C ≤  25 % ± 10 %
25 < C ≤  100 % ± 5 %
 1.1.3.7. 
In the case of the classification of mixtures covered by sections 3.1, 3.2, 3.3, 3.4, 3.8 and 3.9, an aerosol form of a mixture shall be classified in the same hazard category as the non-aerosolised form of the mixture, provided that the added propellant does not affect the hazardous properties of the mixture upon spraying and scientific evidence is available demonstrating that the aerosolised form is not more hazardous than the nonaerosolised form.
 1.2.  1.2.1.  1.2.1.1. Hazard pictograms as laid down in Annex V shall have a black symbol on a white background with a red frame sufficiently wide to be clearly visible.
 1.2.1.2. Hazard pictograms shall be in the shape of a square set at a point. Each hazard pictogram shall cover at least one fifteenth of the surface area of the harmonised label but the minimum area shall not be less than 1 cm2.
 1.2.1.3. 

Table 1.3
Dimension of labels
Capacity of the package Dimensions (in millimetres)
Not exceeding 3 litres: If possible, at least 52 × 74
Greater than 3 litres but, not exceeding 50 litres: At least 74 × 105
Greater than 50 litres but not exceeding 500 litres: At least 105 × 148
Greater than 500 litres: At least 148 × 210 1.3. 
In accordance with Article 23 the following derogations shall apply:
 1.3.1. 
For transportable gas cylinders, one of the following shall be permitted to be used for gas cylinders with a water capacity of less than or equal to 150 litres:


((a)) A format and dimensions following the prescriptions of the current edition of Standard ISO 7225 relating to ‘Gas cylinders — Precautionary labels’. In this case, the label can bear the generic name or industrial or commercial name of the substance or mixture provided that the hazardous substances in a mixture are shown on the body of the gas cylinder in a clear and indelible way.
((b)) The information specified in Article 17 provided on a durable information disc or label held captive on the cylinder.
 1.3.2.  1.3.2.1. If propane, butane and liquefied petroleum gas or a mixture containing these substances classified in accordance with the criteria of this Annex, is placed on the market in closed refillable cylinders or in non-refillable cartridges within the scope of EN 417 as fuel gases which are only released for combustion (current edition of EN 417, relating to ‘Non-refillable metallic gas cartridges for liquefied petroleum gases, with or without a valve, for use with portable appliances; construction, inspection, testing and marking’), these cylinders or cartridges shall only be labelled with the appropriate pictogram and the hazard and precautionary statements concerning flammability.
 1.3.2.2. No information concerning the effects on human health and the environment is required on the label. Instead the supplier shall provide the information concerning effects on human health and the environment to downstream users or distributors by means of the safety data sheet (SDS).
 1.3.2.3. For consumers, sufficient information shall be transmitted to enable them to take all necessary measures for health and safety.
 1.3.3. 
With regard to the application of section 3.10.4, substances or mixtures classified in accordance with the criteria of sections 3.10.2 and 3.10.3 need not be labelled for this hazard when placed on the market in aerosol containers or in containers fitted with a sealed spray attachment.
 1.3.4.  1.3.4.1. Metals in massive form, alloys, mixtures containing polymers and mixtures containing elastomers do not require a label according to this Annex, if they do not present a hazard to human health by inhalation, ingestion or contact with skin or to the aquatic environment in the form in which they are placed on the market, although classified as hazardous in accordance with the criteria of this Annex.
 1.3.4.2. Instead, the supplier shall provide the information to downstream users or distributors by means of the SDS.
 1.3.5. 
Explosives, as referred to in section 2.1, placed on the market with a view to obtaining an explosive or pyrotechnic effect shall be labelled and packaged in accordance with the requirements for explosives only.
 1.4.  1.4.1. 

((I)) the substance has not been assigned a Community workplace exposure limit; and
((II)) the manufacturer, importer or downstream user can demonstrate that the use of the alternative chemical name meets the need to provide enough information for necessary health and safety precautions to be taken in the workplace and the need to ensure that risks from handling the mixture can be controlled; and
((III)) the substance is classified exclusively as one or more of the following hazard categories:

((a)) any of the hazard categories referred to in Part 2 of this Annex;
((b)) Acute toxicity, Category 4;
((c)) Skin corrosion/irritation, Category 2;
((d)) Serious eye damage/eye irritation, Category 2;
((e)) Specific target organ toxicity — Single exposure, Category 2 or 3;
((f)) Specific target organ toxicity — Repeated exposure, Category 2;
((g)) Hazardous to the aquatic environment — Chronic, Category 3 or 4.
 1.4.2. 
In the case of substances occurring in nature, a chemical name or chemical names of the type ‘essential oil of …’ or ‘extract of …’ may be used instead of the chemical names of the components of that essential oil or extract as referred to in Article 18(3)(b).
 1.5.  1.5.1.  1.5.1.1. 

((a)) in fold-out labels; or
((b)) on tie-on tags; or
((c)) on an outer packaging.
 1.5.1.2. The label on any inner packaging shall contain at least hazard pictograms, the product identifier referred to in Article 18 and name and telephone number of the supplier of the substance or mixture.
 1.5.2.  1.5.2.1.  1.5.2.1.1. 

((a)) the contents of the package do not exceed 125 ml; and
((b)) the substance or mixture is classified in one or more of the following hazard categories:

1)) Oxidising gases of category 1;
2)) Gases under pressure;
3)) Flammable liquids of category 2 or 3;
4)) Flammable solids of category 1 or 2;
5)) Self-reactive substances or mixtures Types C to F;
6)) Self-heating substances or mixtures of category 2;
7)) Substances and mixtures which, in contact with water, emit flammable gases of categories 1, 2 or 3;
8)) Oxidising liquids of category 2 or 3;
9)) Oxidising solids of category 2 or 3;
10)) Organic peroxides Types C to F;
11)) Acute toxicity of category 4, if the substances or mixtures are not supplied to the general public;
12)) Skin irritation of category 2;
13)) Eye irritation of category 2;
14)) Specific target organ toxicity — single exposure of category 2 or 3, if the substance or mixture is not supplied to the general public;
15)) Specific target organ toxicity — repeated exposure of category 2, if the substance or mixture is not supplied to the general public;
16)) Hazardous to the aquatic environment — Acute of category 1;
17)) Hazardous to the aquatic environment — Chronic of category 1 or 2.
The exemptions for labelling of small packages of aerosols as flammable laid down in Directive 75/324/EEC shall apply to aerosol dispensers.
 1.5.2.1.2. 

((a)) the contents of the package do not exceed 125 ml; and
((b)) the substance or mixture is classified in one or more of the following hazard categories:

1)) Flammable gases of category 2;
2)) Reproductive toxicity: effects on or via lactation;
3)) Hazardous to the aquatic environment — Chronic of category 3 or 4.
 1.5.2.1.3. 

((a)) the contents of the package do not exceed 125 ml; and
((b)) the substance or mixture is classified in one or more of the following hazard categories:

1)) Corrosive to metals.
 1.5.2.2. 
The label elements required by Article 17 may be omitted from soluble packaging intended for single use where:


((a)) The content of each soluble packaging does not exceed a volume of 25 ml;
((b)) The classification of the contents of the soluble packaging is exclusively one or more of the hazard categories in 1.5.2.1.1 (b); and
((c)) The soluble packaging is contained within outer packaging that fully meets the requirements of Article 17.
 1.5.2.3. Section 1.5.2.2 shall not apply to substances or mixtures within the scope of Directives 91/414/EEC or 98/8/EC.

2.  2.1.  2.1.1.  2.1.1.1. 

((a)) explosive substances and mixtures;
((b)) explosive articles, except devices containing explosive substances or mixtures in such quantity or of such a character that their inadvertent or accidental ignition or initiation shall not cause any effect external to the device either by projection, fire, smoke, heat or loud noise; and
((c)) substances, mixtures and articles not mentioned in points (a) and (b) which are manufactured with a view to producing a practical, explosive or pyrotechnic effect.
 2.1.1.2. 
An explosive substance or mixture is a solid or liquid substance or mixture of substances which is in itself capable by chemical reaction of producing gas at such a temperature and pressure and at such a speed as to cause damage to the surroundings. Pyrotechnic substances are included even when they do not evolve gases.

A pyrotechnic substance or mixture is a substance or mixture of substances designed to produce an effect by heat, light, sound, gas or smoke or a combination of these as the result of non-detonative self-sustaining exothermic chemical reactions.

An unstable explosive is an explosive substance or mixture which is thermally unstable and/or too sensitive for normal handling, transport and use.

An explosive article is an article containing one or more explosive substances or mixtures.

A pyrotechnic article is an article containing one or more pyrotechnic substances or mixtures.

An intentional explosive is a substance, mixture or article which is manufactured with a view to producing a practical, explosive or pyrotechnic effect.
 2.1.2.  2.1.2.1. Substances, mixtures and articles of this class are classified as an unstable explosive on the basis of the flowchart in Figure 2.1.2. The test methods are described in Part I of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.
 2.1.2.2. 

((a)) Division 1.1 Substances, mixtures and articles which have a mass explosion hazard (a mass explosion is one which affects almost the entire quantity present virtually instantaneously);
((b)) Division 1.2 Substances, mixtures and articles which have a projection hazard but not a mass explosion hazard;
((c)) Division 1.3 Substances, mixtures and articles which have a fire hazard and either a minor blast hazard or a minor projection hazard or both, but not a mass explosion hazard:

((i)) combustion of which gives rise to considerable radiant heat; or
((ii)) which burn one after another, producing minor blast or projection effects or both;
((d)) Division 1.4 Substances, mixtures and articles which present no significant hazard:

— substances, mixtures and articles which present only a small hazard in the event of ignition or initiation. The effects are largely confined to the package and no projection of fragments of appreciable size or range is to be expected. An external fire shall not cause virtually instantaneous explosion of almost the entire contents of the package;
((e)) Division 1.5 Very insensitive substances or mixtures which have a mass explosion hazard:

— substances and mixtures which have a mass explosion hazard but are so insensitive that there is very little probability of initiation or of transition from burning to detonation under normal conditions;
((f)) Division 1.6 Extremely insensitive articles which do not have a mass explosion hazard:

— articles which contain only extremely insensitive detonating substances or mixtures and which demonstrate a negligible probability of accidental initiation or propagation.
 2.1.2.3. 

Table 2.1.1
Criteria for explosives
Category Criteria
Unstable explosives or explosives of Divisions 1.1 to 1.6 For explosives of Divisions 1.1 to 1.6, the following are the core set of tests that need to be performed:
Explosibility: according to UN Test Series 2 (section 12 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria). Intentional explosives shall not be subject to UN Test Series 2.
Sensitiveness: according to UN Test Series 3 (section 13 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).
Thermal stability: according to UN Test 3(c) (sub-section 13.6.1 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).Further tests are necessary to allocate the correct Division.
 2.1.2.4. If explosives are unpackaged or repacked in packaging other than the original or similar packaging, they shall be retested.
 2.1.3. 
Label elements shall be used for substances, mixtures or articles meeting the criteria for classification in this hazard class in accordance with Table 2.1.2.

NOTE to Table 2.1.2: Unpackaged explosives or explosives repacked in packaging other than the original or similar packaging shall include all of the following label elements:


((a)) the pictogram: exploding bomb;
((b)) the signal word: ‘Danger’; and
((c)) the hazard statement: ‘explosive; mass explosion hazard’

unless the hazard is shown to correspond to one of the hazard categories in Table 2.1.2, in which case the corresponding symbol, the signal word and/or the hazard statement shall be assigned.


Classification Unstable Explosive Division 1.1 Division 1.2 Division 1.3 Division 1.4 Division 1.5 Division 1.6
GHS Pictograms       
Signal Word Danger Danger Danger Danger Warning Danger No signal word
Hazard Statement H200: Unstable Explosive H201: Explosive; mass explosion hazard H202: Explosive; severe projection hazard H203: Explosive; fire, blast or projection hazard H204: Fire or projection hazard H205: May mass explode in fire No hazard statement
Precautionary StatementPrevention P201P202P281 P210P230P240P250P280 P210P230P240P250P280 P210P230P240P250P280 P210P240P250P280 P210P230P240P250P280 No precautionary statement
Precautionary StatementResponse P372P373P380 P370+P380P372P373 P370+P380P372P373 P370+P380P372P373 P370+P380P372P373 P370+P380P372P373 No precautionary statement
Precautionary StatementStorage P401 P401 P401 P401 P401 P401 No precautionary statement
Precautionary StatementDisposal P501 P501 P501 P501 P501 P501 No precautionary statement
 2.1.4.  2.1.4.1. 
The first step is to ascertain whether the substance or mixture has explosive effects (Test Series 1). The second step is the acceptance procedure (Test Series 2 to 4) and the third step is the assignment to a hazard division (Test Series 5 to 7). The assessment whether a candidate for ‘ammonium nitrate emulsion or suspension or gel, intermediate for blasting explosives (ANE)’ is insensitive enough for inclusion as an oxidising liquid (section 2.13) or an oxidising solid (section 2.14) is answered by Test Series 8 tests.

Explosive substances and mixtures wetted with water or alcohols, or diluted with other substances to suppress their explosive properties, may be treated differently in terms of classification and other hazard classes may apply, according to their physical properties (see also Annex II section 1.1.).

Certain physical hazards (due to explosive properties) are altered by dilution, as is the case for desensitised explosives, by inclusion in a mixture or article, packaging or other factors.

The classification procedure is set out in the following decision logic (see Figures 2.1.1 to 2.1.4).

Figure 2.1.1
Figure 2.1.2
Figure 2.1.3
Figure 2.1.4 2.1.4.2. 
Explosive properties are associated with the presence of certain chemical groups in a molecule which can react to produce very rapid increases in temperature or pressure. The screening procedure is aimed at identifying the presence of such reactive groups and the potential for rapid energy release. If the screening procedure identifies the substance or mixture to be a potential explosive, the acceptance procedure (see section 10.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria) has to be performed.
Neither a Series 1 type (a) propagation of detonation test nor a Series 2 type (a) test of sensitivity to detonative shock is required if the exothermic decomposition energy of organic materials is less than 800 J/g. 2.1.4.3. 

((a)) There are no chemical groups associated with explosive properties present in the molecule. Examples of groups which may indicate explosive properties are given in Table A6.1 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or
((b)) The substance contains chemical groups associated with explosive properties which include oxygen and the calculated oxygen balance is less than - 200;
The oxygen balance is calculated for the chemical reaction:
CxHyOz+ [x+ (y/4)-(z/2)] O2 → x CO2 + (y/2) H2O
Using the formula:
Oxygen balance = -1 600 [2x + (y/2)-z]/molecular weight;
((c)) When the organic substance or a homogenous mixture of organic substances contains chemical groups associated with explosive properties but the exothermic decomposition energy is less than 500 J/g and the onset of exothermic decomposition is below 500 oC. The exothermic decomposition energy can be determined using a suitable calorimetric technique; or
((d)) For mixtures of inorganic oxidising substances with organic material(s), the concentration of the inorganic oxidising substance is:

— less than 15 % by mass, if the oxidising substance is assigned to Categories 1 or 2;
— less than 30 % by mass, if the oxidising substance is assigned to Category 3.
 2.1.4.4. In the case of mixtures containing any known explosives, the acceptance procedure has to be performed.
 2.2.  2.2.1. 
Flammable gas means a gas or gas mixture having a flammable range with air at 20 oC and a standard pressure of 101,3 kPa.
 2.2.2.  2.2.2.1. 
Category Criteria
1 Gases, which at 20 oC and a standard pressure of 101,3 kPa:
((a)) are ignitable when in a mixture of 13 % or less by volume in air; or
((b)) have a flammable range with air of at least 12 percentage points regardless of the lower flammable limit.
2 Gases, other than those of Category 1, which, at 20 oC and a standard pressure of 101,3 kPa, have a flammable range while mixed in air.For the classification of aerosols, see 2.3. 2.2.3. 
Label elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.2.2.


Classification Category 1 Category 2
GHS Pictogram  No pictogram
Signal Word Danger Warning
Hazard Statement H220: Extremely flammable gas H221: Flammable gas
Precautionary StatementPrevention P210 P210
Precautionary StatementResponse P377P381 P377P381
Precautionary StatementStorage P403 P403
Precautionary StatementDisposal  
 2.2.4.  2.2.4.1. Flammability shall be determined by tests or, for mixtures where there are sufficient data available, by calculation in accordance with the methods adopted by ISO (see ISO 10156 as amended, Gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet). Where insufficient data are available to use these methods, test method EN 1839 as amended (Determination of explosion limits of gases and vapours) can be used.
 2.3.  2.3.1. 
Aerosols, this means aerosol dispensers, are any non-refillable receptacles made of metal, glass or plastics and containing a gas compressed, liquefied or dissolved under pressure, with or without a liquid, paste or powder, and fitted with a release device allowing the contents to be ejected as solid or liquid particles in suspension in a gas, as a foam, paste or powder or in a liquid state or in a gaseous state.
 2.3.2.  2.3.2.1. 
— Liquids with a flash point ≤ 93 oC, which includes Flammable Liquids according to section 2.6;
— Flammable gases (see 2.2);
— Flammable solids (see 2.7).Flammable components do not cover pyrophoric, self-heating or water-reactive substances and mixtures because such components are never used as aerosol contents. 2.3.2.2. 
Figure 2.3.1(a) for flammable aerosolsFor spray aerosols, go to decision logic 2.3.1 (b);For foam aerosols, got to decision logic 2.3.1 (c).
Figure 2.3.1(b) for spray aerosols
Figure 2.3.1(c) for foam aerosols 2.3.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.3.2.


Classification Category 1 Category 2
GHS Pictograms  
Signal Word Danger Warning
Hazard Statement H222: Extremely flammable aerosol H223: Flammable aerosol
Precautionary StatementPrevention P210P211P251 P210P211P251
Precautionary StatementResponse  
Precautionary StatementStorage P410 + P412 P410 + P412
Precautionary StatementDisposal  
 2.3.4.  2.3.4.1. 
For a composite aerosol formulation, the chemical heat of combustion is the summation of the weighted heats of combustion for the individual components, as follows:
ΔHc (product)=Σniwi % × ΔHc(i)
where:

ΔHcchemical heat of combustion (kJ/g);wi %mass fraction of component i in the product;ΔHc(i)specific heat of combustion (kJ/g)of component i in the product.

The chemical heats of combustion can be found in the literature, calculated or determined by tests (see ASTM D 240 as amended — Standard Test Methods for Heat of Combustion of Liquid Hydrocarbon Fuels by Bomb Calorimeter, EN/ISO 13943 as amended, 86.l to 86.3 — Fire safety — Vocabulary, and NFPA 30B as amended — Code for the Manufacture and Storage of Aerosol Products).
 2.4.  2.4.1. 
Oxidising gas means any gas or gas mixture which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.
 2.4.2.  2.4.2.1. 
Category Criteria
1 Any gas which may, generally by providing oxygen, cause or contribute to the combustion of other material more than air does.‘Gases which cause or contribute to the combustion of other material more than air’ means pure gases or gas mixtures with an oxidising power greater than 23,5 % as determined by a method specified in ISO 10156 as amended or 10156-2 as amended. 2.4.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.4.2.


Classification Category 1
GHS Pictogram 
Signal Word Danger
Hazard Statement H270: May cause or intensify fire; oxidiser
Precautionary StatementPrevention P220P244
Precautionary StatementResponse P370 + P376
Precautionary StatementStorage P403
Precautionary StatementDisposal 
 2.4.4. 
To classify an oxidising gas, tests or calculation methods as described in ISO 10156 as amended, gases and gas mixtures — Determination of fire potential and oxidising ability for the selection of cylinder valve outlet and ISO 10156-2 as amended, gas cylinders — gases and gas mixtures — Determination of oxidising ability of toxic and corrosive gases and gas mixtures — shall be performed.
 2.5.  2.5.1.  2.5.1.1. 
They comprise compressed gases, liquefied gases, dissolved gases and refrigerated liquefied gases.
 2.5.1.2. The critical temperature is the temperature above which a pure gas cannot be liquefied, regardless of the degree of compression.
 2.5.2. 
Gases shall be classified, according to their physical state when packaged, in one of four groups in accordance with Table 2.5.1:


Group Criteria
Compressed gas A gas which when packaged under pressure is entirely gaseous at - 50 oC; including all gases with a critical temperature ≤ - 50 oC.
Liquefied gas A gas which, when packaged under pressure, is partially liquid at temperatures above - 50 oC. A distinction is made between:
((i)) high pressure liquefied gas: a gas with a critical temperature between - 50 oC and + 65 oC; and
((ii)) low pressure liquefied gas: a gas with a critical temperature above + 65 oC.
Refrigerated liquefied gas A gas which when packaged is made partially liquid because of its low temperature.
Dissolved gas A gas which when packaged under pressure is dissolved in a liquid phase solvent.
 2.5.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.5.2.


Classification Compressed gas Liquefied gas Refrigerated liquefied gas Dissolved gas
GHS Pictograms    
Signal Word Warning Warning Warning Warning
Hazard Statement H280: Contains gas under pressure; may explode if heated H280: Contains gas under pressure; may explode if heated H281: Contains refrigerated gas; may cause cryogenic burns or injury H280: Contains gas under pressure; may explode if heated
Precautionary StatementPrevention   P282 
Precautionary StatementResponse   P336P315 
Precautionary StatementStorage P410 + P403 P410 + P403 P403 P410 + P403
Precautionary StatementDisposal    
 2.5.4. 
For this group of gases, the following information is required to be known:


— the vapour pressure at 50 oC;
— the physical state at 20 oC at standard ambient pressure;
— the critical temperature.

Data can be found in the literature, calculated or determined by testing. Most pure gases are already classified in the UN Recommendations on the Transport of Dangerous Goods, Model Regulations.
 2.6.  2.6.1. 
Flammable liquid means a liquid having a flash point of not more than 60 oC.
 2.6.2.  2.6.2.1. 

Table 2.6.1
Criteria for flammable liquids
Category Criteria
1 Flash point < 23 oC and initial boiling point ≤ 35 oC
2 Flash point < 23 oC and initial boiling point > 35 oC
3 Flash point ≥ 23 oC and ≤ 60 oC
 2.6.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.6.2.


Classification Category 1 Category 2 Category 3
GHS Pictograms   
Signal Word Danger Danger Warning
Hazard Statement H224: Extremely flammable liquid and vapour H225: Highly flammable liquid and vapour H226: Flammable liquid and vapour
Precautionary StatementPrevention P210P233P240P241P242P243P280 P210P233P240P241P242P243P280 P210P233P240P241P242P243P280
Precautionary StatementResponse P303 + P361 + P353P370 + P378 P303 + P361 + P353P370 + P378 P303 + P361 + P353P370 + P378
Precautionary StatementStorage P403 + P235 P403 + P235 P403 + P235
Precautionary StatementDisposal P501 P501 P501
 2.6.4.  2.6.4.1. For the classification of flammable liquids data on flash point and initial boiling point are needed. Data can be determined by testing, found in literature or calculated. If data are not available, the flash point and the initial boiling point shall be determined through testing. For flash point determination a closed-cup method shall be used.
 2.6.4.2. 

((a)) the composition of the mixture is accurately known (if the material has a specified range of composition, the composition with the lowest calculated flash point shall be selected for assessment);
((b)) the lower explosion limit of each component is known (an appropriate correlation has to be applied when these data are extrapolated to other temperatures than test conditions) as well as a method for calculating the lower explosion limit;
((c)) the temperature dependence of the saturated vapour pressure and of the activity coefficient is known for each component as present in the mixture;
((d)) the liquid phase is homogeneous.
 2.6.4.3. One suitable method is described in Gmehling and Rasmussen (Ind. Eng. Fundament, 21, 186, (1982)). For a mixture containing non-volatile components the flash point is calculated from the volatile components. It is considered that a non-volatile component only slightly decreases the partial pressure of the solvents and the calculated flash point is only slightly below the measured value.
 2.6.4.4. 

Table 2.6.3
Methods for determining the flash point of flammable liquids
European standards: EN ISO 1516 as amendedDetermination of flash/no flash — Closed cup equilibrium method
EN ISO 1523 as amendedDetermination of flash point — Closed cup equilibrium method
EN ISO 2719 as amendedDetermination of flash point — Pensky-Martens closed cup method
EN ISO 3679 as amendedDetermination of flash point — Rapid equilibrium closed cup method
EN ISO 3680 as amendedDetermination of flash/no flash — Rapid equilibrium closed cup method
EN ISO 13736 as amendedPetroleum products and other liquids — Determination of flash point — Abel closed cup method
National standards:
Association française de normalisation, AFNOR: NF M07-036 as amendedDétermination du point d'éclair — Vase clos Abel-Pensky(identical to DIN 51755)
British Standards Institute, BS 2000 Part 170 as amended(identical to EN ISO 13736)
Deutsches Institut für Normung DIN 51755 (flash points below 65 C) as amended Prüfung von Mineralölen und anderen brennbaren Flüssigkeiten; Bestimmung des Flammpunktes im geschlossenen Tiegel, nach Abel-Pensky(identical to NF M07-036) 2.6.4.5. Liquids with a flash point of more than 35 oC need not be classified in Category 3 if negative results have been obtained in the sustained combustibility test L.2, Part III, section 32 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria.
 2.7.  2.7.1.  2.7.1.1. 
Readily combustible solids are powdered, granular, or pasty substances or mixtures which are dangerous if they can be easily ignited by brief contact with an ignition source, such as a burning match, and if the flame spreads rapidly.
 2.7.2.  2.7.2.1. Powdered, granular or pasty substances or mixtures (except powders of metals or metal alloys — see 2.7.2.2) shall be classified as readily combustible solids when the time of burning of one or more of the test runs, performed in accordance with the test method described in Part III, sub-section 33.2.1, of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, is less than 45 seconds or the rate of burning is more than 2,2 mm/s.
 2.7.2.2. Powders of metals or metal alloys shall be classified as flammable solids when they can be ignited and the reaction spreads over the whole length of the sample in 10 minutes or less.
 2.7.2.3. 

Table 2.7.1
Criteria for flammable solids
Category Criteria
1 Burning rate testSubstances and mixtures other than metal powders:
((a)) wetted zone does not stop fire and
((b)) burning time < 45 seconds or burning rate > 2,2 mm/sMetal powdersburning time ≤ 5 minutes
2 Burning rate testSubstances and mixtures other than metal powders:
((a)) wetted zone stops the fire for at least 4 minutes and
((b)) burning time < 45 seconds or burning rate > 2,2 mm/sMetal powdersburning time > 5 minutes and ≤ 10 minutesThe test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form. 2.7.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.7.2.


Classification Category 1 Category 2
GHS Pictograms  
Signal Word Danger Warning
Hazard Statement H228: Flammable Solid H228: Flammable Solid
Precautionary StatementPrevention P210P240P241P280 P210P240P241P280
Precautionary StatementResponse P370 + P378 P370 + P378
Precautionary StatementStorage  
Precautionary StatementDisposal  
 2.8.  2.8.1.  2.8.1.1. Self-reactive substances or mixtures are thermally unstable liquid or solid substances or mixtures liable to undergo a strongly exothermic decomposition even without participation of oxygen (air). This definition excludes substances and mixtures classified according to this Part as explosives, organic peroxides or as oxidising.
 2.8.1.2. A self-reactive substance or mixture is regarded as possessing explosive properties when in laboratory testing the formulation is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.
 2.8.2.  2.8.2.1. 

((a)) they are explosives, according to the criteria given in 2.1;
((b)) they are oxidising liquids or solids, according to the criteria given in 2.13 or 2.14, except that mixtures of oxidising substances, which contain 5 % or more of combustible organic substances shall be classified as self-reactive substances according to the procedure defined in 2.8.2.2;
((c)) they are organic peroxides, according to the criteria given in 2.15;
((d)) their heat of decomposition is less than 300 J/g; or
((e)) their self-accelerating decomposition temperature (SADT) is greater than 75 oC for a 50 kg package.
 2.8.2.2. 
Such a mixture showing the properties of a self-reactive substance type B to F (see 2.8.2.3) shall be classified as a self-reactive substance.

Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.
 2.8.2.3. 

((a)) any self-reactive substance or mixture which can detonate or deflagrate rapidly, as packaged, shall be defined as self-reactive substance TYPE A;
((b)) any self-reactive substance or mixture possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as self-reactive substance TYPE B;
((c)) any self-reactive substance or mixture possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as self-reactive substance TYPE C;
((d)) any self-reactive substance or mixture which in laboratory testing:

((i)) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or
((ii)) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or
((iii)) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;
shall be defined as self-reactive substance TYPE D;
((e)) any self-reactive substance or mixture which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as self-reactive substance TYPE E;
((f)) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as self-reactive substance TYPE F;
((g)) any self-reactive substance or mixture which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable (SADT is 60 oC to 75 oC for a 50 kg package), and, for liquid mixtures, a diluent having a boiling point not less than 150 oC is used for desensitisation shall be defined as self-reactive substance TYPE G. If the mixture is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the mixture shall be defined as self-reactive substance TYPE F.

Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.
 2.8.2.4. 
Self-reactive substances need to be subjected to temperature control if their SADT is less than or equal to 55 oC. Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in, Part II, section 28 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.
 2.8.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.8.1.


Classification Type A Type B Type C & D Type E & F Type G
GHS Pictograms     There are no label elements allocated to this hazard category
Signal Word Danger Danger Danger Warning
Hazard Statement H240: Heating may cause an explosion H241: Heating may cause a fire or explosion H242: Heating may cause a fire H242: Heating may cause a fire
Precautionary StatementPrevention P210P220P234P280 P210P220P234P280 P210P220P234P280 P210P220P234P280
Precautionary StatementResponse P370 + P378P370 + P380 + P375 P370 + P378P370 + P380 + P375 P370 + P378 P370 + P378 
Precautionary StatementStorage P403 + P235P411P420 P403 + P235P411P420 P403 + P235P411P420 P403 + P235 P411P420 
Precautionary StatementDisposal P501 P501 P501 P501 

Type G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.
 2.8.4.  2.8.4.1. The properties of self-reactive substances or mixtures which are decisive for their classification shall be determined experimentally. The classification of a self reactive substance or mixture shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.8.1.
 2.8.4.2. 

((a)) There are no chemical groups present in the molecule associated with explosive or self reactive properties. Examples of such groups are given in Tables A6.1 and A6.2 in Appendix 6 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria; or
((b)) For a single organic substance or a homogeneous mixture of organic substances, the estimated SADT for a 50 kg package is greater than 75 oC or the exothermic decomposition energy is less than 300J/g. The onset temperature and decomposition energy can be estimated using a suitable calorimetric technique (see Part II, sub-section 20.3.3.3 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria).

Figure 2.8.1 2.9.  2.9.1. 
Pyrophoric liquid means a liquid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.
 2.9.2.  2.9.2.1. 

Table 2.9.1
Criteria for pyrophoric liquids
Category Criteria
1 The liquid ignites within 5 min when added to an inert carrier and exposed to air, or it ignites or chars a filter paper on contact with air within 5 min. 2.9.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.9.2.


Classification Category 1
GHS Pictogram 
Signal Word Danger
Hazard Statement H250: Catches fire spontaneously if exposed to air
Precautionary StatementPrevention P210P222P280
Precautionary StatementResponse P302 + P334P370 + P378
Precautionary StatementStorage P422
Precautionary StatementDisposal 
 2.9.4.  2.9.4.1. The classification procedure for pyrophoric liquids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).
 2.10.  2.10.1. 
Pyrophoric solid means a solid substance or mixture which, even in small quantities, is liable to ignite within five minutes after coming into contact with air.
 2.10.2.  2.10.2.1. 

Table 2.10.1
Criteria for pyrophoric solids
Category Criteria
1 The solid ignites within 5 minutes of coming into contact with air.The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form. 2.10.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.10.2.


Classification Category 1
GHS Pictogram 
Signal Word Danger
Hazard Statement H250: Catches fire spontaneously if exposed to air
Precautionary StatementPrevention P210P222P280
Precautionary StatementResponse P335 + P334P370 +P378
Precautionary StatementStorage P422
Precautionary StatementDisposal 
 2.10.4.  2.10.4.1. The classification procedure for pyrophoric solids need not be applied when experience in manufacture or handling shows that the substance or mixture does not ignite spontaneously on coming into contact with air at normal temperatures (i.e. the substance is known to be stable at room temperature for prolonged periods of time (days)).
 2.11.  2.11.1.  2.11.1.1. A self-heating substance or mixture is a liquid or solid substance or mixture, other than a pyrophoric liquid or solid, which, by reaction with air and without energy supply, is liable to self-heat; this substance or mixture differs from a pyrophoric liquid or solid in that it will ignite only when in large amounts (kilograms) and after long periods of time (hours or days).
 2.11.1.2. Self-heating of substances or mixtures, leading to spontaneous combustion, is caused by reaction of the substance or mixture with oxygen (in the air) and the heat developed not being conducted away rapidly enough to the surroundings. Spontaneous combustion occurs when the rate of heat production exceeds the rate of heat loss and the auto-ignition temperature is reached.
 2.11.2.  2.11.2.1. 

((a)) a positive result is obtained using a 25 mm cube sample at 140 oC;
((b)) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3;
((c)) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 100 mm cube sample at 100 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres;
((d)) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.
 2.11.2.2. 
Category Criteria
1 A positive result is obtained in a test using a 25 mm sample cube at 140 oC
2 
((a)) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and the substance or mixture is to be packed in packages with a volume of more than 3 m3; or
((b)) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC, a positive result is obtained in a test using a 100 mm cube sample at 120 oC and the substance or mixture is to be packed in packages with a volume of more than 450 litres; or
((c)) a positive result is obtained in a test using a 100 mm sample cube at 140 oC and a negative result is obtained in a test using a 25 mm cube sample at 140 oC and a positive result is obtained in a test using a 100 mm cube sample at 100 oC.The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form. 2.11.2.3. Substances and mixtures with a temperature of spontaneous combustion higher than 50 oC for a volume of 27 m3 shall not be classified as a self-heating substance or mixture.
 2.11.2.4. Substances and mixtures with a spontaneous ignition temperature higher than 50 oC for a volume of 450 litres shall not be assigned to Category 1 of this class.
 2.11.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.11.2.


Classification Category 1 Category 2
GHS Pictograms  
Signal Word Danger Warning
Hazard Statement H251: Self-heating; may catch fire H252: Self-heating in large quantities; may catch fire
Precautionary StatementPrevention P235 + P410P280 P235 + P410P280
Precautionary StatementResponse  
Precautionary StatementStorage P407P413P420 P407P413P420
Precautionary StatementDisposal  
 2.11.4.  2.11.4.1. For detailed schemes for the decision logic for classification and the tests to be carried out for ascertaining the different categories, see Figure 2.11.1.
 2.11.4.2. 

((a)) The Grewer Oven test (VDI guideline 2263, Part 1, 1990, Test methods for the Determination of the Safety Characteristics of Dusts) with an onset temperature 80 K above the reference temperature for a volume of 1 l;
((b)) The Bulk Powder Screening Test (Gibson, N. Harper, D.J. Rogers, R.Evaluation of the fire and explosion risks in drying powders, Plant Operations Progress, 4 (3), 181-189, 1985) with an onset temperature 60 K above the reference temperature for a volume of 1 l.

Figure 2.11.1. 2.12.  2.12.1. 
Substances or mixtures which, in contact with water, emit flammable gases means solid or liquid substances or mixtures which, by interaction with water, are liable to become spontaneously flammable or to give off flammable gases in dangerous quantities.
 2.12.2.  2.12.2.1. 
Category Criteria
1 Any substance or mixture which reacts vigorously with water at ambient temperatures and demonstrates generally a tendency for the gas produced to ignite spontaneously, or which reacts readily with water at ambient temperatures such that the rate of evolution of flammable gas is equal to or greater than 10 litres per kilogram of substance over any one minute.
2 Any substance or mixture which reacts readily with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 20 litres per kilogram of substance per hour, and which does not meet the criteria for Category 1.
3 Any substance or mixture which reacts slowly with water at ambient temperatures such that the maximum rate of evolution of flammable gas is equal to or greater than 1 litre per kilogram of substance per hour, and which does not meet the criteria for Categories 1 and 2.The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance must also be tested in the new form. 2.12.2.2. A substance or mixture shall be classified as a substance or mixture which in contact with water emits flammable gases if spontaneous ignition takes place in any step of the test procedure.
 2.12.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.12.2.


Classification Category 1 Category 2 Category 3
GHS Pictograms   
Signal Word Danger Danger Warning
Hazard Statement H260: In contact with water releases flammable gases which may ignite spontaneously H261: In contact with water releases flammable gases H261: In contact with water releases flammable gases
Precautionary StatementPrevention P223P231 + P232P280 P223P231 + P232P280 P231 + P232P280
Precautionary StatementResponse P335 + P334P370 + P378 P335 + P334P370 + P378 P370 + P378
Precautionary StatementStorage P402 + P404 P402 + P404 P402 + P404
Precautionary StatementDisposal P501 P501 P501
 2.12.4.  2.12.4.1. 

((a)) the chemical structure of the substance or mixture does not contain metals or metalloids; or
((b)) experience in production or handling shows that the substance or mixture does not react with water, e.g. the substance is manufactured with water or washed with water; or
((c)) the substance or mixture is known to be soluble in water to form a stable mixture.
 2.13.  2.13.1. 
Oxidising liquid means a liquid substance or mixture which, while in itself not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.
 2.13.2.  2.13.2.1. 

Table 2.13.1
Criteria for oxidising liquids
Category Criteria
1 Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, spontaneously ignites; or the mean pressure rise time of a 1:1 mixture, by mass, of substance (or mixture) and cellulose is less than that of a 1:1 mixture, by mass, of 50 % perchloric acid and cellulose.
2 Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 40 % aqueous sodium chlorate solution and cellulose; and the criteria for Category 1 are not met.
3 Any substance or mixture which, in the 1:1 mixture, by mass, of substance (or mixture) and cellulose tested, exhibits a mean pressure rise time less than or equal to the mean pressure rise time of a 1:1 mixture, by mass, of 65 % aqueous nitric acid and cellulose; and the criteria for Category 1 and 2 are not met. 2.13.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.13.2.


Classification Category 1 Category 2 Category 3
GHS Pictograms   
Signal Word Danger Danger Warning
Hazard Statement H271:May cause fire or explosion; strong oxidiser H272: May intensify fire; oxidiser H272: May intensify fire; oxidiser
Precautionary StatementPrevention P210P220P221P280P283 P210P220P221P280 P210P220P221P280
Precautionary StatementResponse P306 + P360P371 + P380 + P375P370 + P378 P370 + P378 P370 + P378
Precautionary StatementStorage   
Precautionary StatementDisposal P501 P501 P501
 2.13.4.  2.13.4.1. 

((a)) the substance or mixture does not contain oxygen, fluorine or chlorine; or
((b)) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.
 2.13.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.
 2.13.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.
 2.13.4.4. In cases where substances or mixtures generate a pressure rise (too high or too low), caused by chemical reactions not characterising the oxidising properties of the substance or mixture, the test described in Part III, sub-section 34.4.2 of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria shall be repeated with an inert substance, e.g. diatomite (kieselguhr), in place of the cellulose in order to clarify the nature of the reaction and to check for a false positive result.
 2.14.  2.14.1. 
Oxidising solid means a solid substance or mixture which, while in itself is not necessarily combustible, may, generally by yielding oxygen, cause, or contribute to, the combustion of other material.
 2.14.2.  2.14.2.1. 
Category Criteria
1 Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time less than the mean burning time of a 3:2 mixture, by mass, of potassium bromate and cellulose.
2 Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 2:3 mixture (by mass) of potassium bromate and cellulose and the criteria for Category 1 are not met.
3 Any substance or mixture which, in the 4:1 or 1:1 sample-to-cellulose ratio (by mass) tested, exhibits a mean burning time equal to or less than the mean burning time of a 3:7 mixture (by mass) of potassium bromate and cellulose and the criteria for Categories 1 and 2 are not met.Some oxidising solids also present explosion hazards under certain conditions (when stored in large quantities). Some types of ammonium nitrate may give rise to an explosion hazard under extreme conditions and the ‘Resistance to detonation test’ (BC Code, Annex 3, Test 5) can be used to assess this hazard. Appropriate information shall be made in the SDS.The test shall be performed on the substance or mixture in its physical form as presented. If, for example, for the purposes of supply or transport, the same chemical is to be presented in a physical form different from that which was tested and which is considered likely to materially alter its performance in a classification test, the substance shall also be tested in the new form. 2.14.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.14.2.


 Category 1 Category 2 Category 3
GHS Pictograms   
Signal Word Danger Danger Warning
Hazard Statement H271: May cause fire or explosion; strong oxidiser H272: May intensify fire; oxidiser H272: May intensify fire; oxidiser
Precautionary StatementPrevention P210P220P221P280P283 P210P220P221P280 P210P220P221P280
Precautionary StatementResponse P306 + P360P371 + P380 + P375P370 + P378 P370 + P378 P370 + P378
Precautionary StatementStorage   
Precautionary StatementDisposal P501 P501 P501
 2.14.4.  2.14.4.1. 

((a)) the substance or mixture does not contain oxygen, fluorine or chlorine; or
((b)) the substance or mixture contains oxygen, fluorine or chlorine and these elements are chemically bonded only to carbon or hydrogen.
 2.14.4.2. For inorganic substances or mixtures the classification procedure for this class shall not apply if they do not contain oxygen or halogen atoms.
 2.14.4.3. In the event of divergence between test results and known experience in the handling and use of substances or mixtures which shows them to be oxidising, judgments based on known experience shall take precedence over test results.
 2.15.  2.15.1.  2.15.1.1. 

((i)) be liable to explosive decomposition;
((ii)) burn rapidly;
((iii)) be sensitive to impact or friction;
((iv)) react dangerously with other substances.
 2.15.1.2. An organic peroxide is regarded as possessing explosive properties when in laboratory testing the mixture (formulation) is liable to detonate, to deflagrate rapidly or to show a violent effect when heated under confinement.
 2.15.2.  2.15.2.1. 
((a)) not more than 1,0 % available oxygen from the organic peroxides when containing not more than 1,0 % hydrogen peroxide; or
((b)) not more than 0,5 % available oxygen from the organic peroxides when containing more than 1,0 % but not more than 7,0 % hydrogen peroxide.The available oxygen content ( %) of an organic peroxide mixture is given by the formula:16×Σnini×cimiwhere:ninumber of peroxygen groups per molecule of organic peroxide i;ciconcentration (mass %) of organic peroxide i;mimolecular mass of organic peroxide i. 2.15.2.2. 

((a)) any organic peroxide which, as packaged, can detonate or deflagrate rapidly shall be defined as organic peroxide TYPE A;
((b)) any organic peroxide possessing explosive properties and which, as packaged, neither detonates nor deflagrates rapidly, but is liable to undergo a thermal explosion in that package shall be defined as organic peroxide TYPE B;
((c)) any organic peroxide possessing explosive properties when the substance or mixture as packaged cannot detonate or deflagrate rapidly or undergo a thermal explosion shall be defined as organic peroxide TYPE C;
((d)) any organic peroxide which in laboratory testing:

((i)) detonates partially, does not deflagrate rapidly and shows no violent effect when heated under confinement; or
((ii)) does not detonate at all, deflagrates slowly and shows no violent effect when heated under confinement; or
((iii)) does not detonate or deflagrate at all and shows a medium effect when heated under confinement;
shall be defined as organic peroxide TYPE D;
((e)) any organic peroxide which, in laboratory testing, neither detonates nor deflagrates at all and shows low or no effect when heated under confinement shall be defined as organic peroxide TYPE E;
((f)) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows only a low or no effect when heated under confinement as well as low or no explosive power shall be defined as organic peroxide TYPE F;
((g)) any organic peroxide which, in laboratory testing, neither detonates in the cavitated state nor deflagrates at all and shows no effect when heated under confinement nor any explosive power, provided that it is thermally stable, i.e. the SADT is 60 oC or higher for a 50 kg package, and, for liquid mixtures, a diluent having a boiling point of not less than 150 oC is used for desensitisation, shall be defined as organic peroxide TYPE G. If the organic peroxide is not thermally stable or a diluent having a boiling point less than 150 oC is used for desensitisation, the organic peroxide shall be defined as organic peroxide TYPE F.
Where the test is conducted in the package form and the packaging is changed, a further test shall be conducted where it is considered that the change in packaging will affect the outcome of the test.
 2.15.2.3. 
The following organic peroxides need to be subjected to temperature control:


((a)) Organic peroxide types B and C with an SADT ≤ 50 C;
((b)) Organic peroxide type D showing a medium effect when heated under confinement with an SADT ≤ 50 oC or showing a low or no effect when heated under confinement with an SADT ≤ 45 oC; and
((c)) Organic peroxide types E and F with an SADT ≤ 45 oC.

Test methods for determining the SADT as well as the derivation of control and emergency temperatures are given in the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria, Part II, section 28. The test selected shall be conducted in a manner which is representative, both in size and material, of the package.
 2.15.3. 
Label elements shall be used for substances or mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.15.1.


Classification Type A Type B Type C & D Type E & F Type G
GHS Pictograms     There are no label elements allocated to this hazard category
Signal Word Danger Danger Danger Warning
Hazard Statement H240: Heating may cause an explosion H241: Heating may cause a fire or explosion H242: Heating may cause a fire H242: Heating may cause a fire
Precautionary StatementPrevention P210P220P234P280 P210P220P234P280 P210P220P234P280 P210P220P234P280
Precautionary StatementResponse     
Precautionary StatementStorage P411 + P235P410P420 P411 + P235P410P420 P411 + P235P410P420 P411 + P235P410P420 
Precautionary StatementDisposal P501 P501 P501 P501 

Type G has no hazard communication elements assigned but shall be considered for properties belonging to other hazard classes.
 2.15.4.  2.15.4.1. Organic peroxides are classified by definition based on their chemical structure and on the available oxygen and hydrogen peroxide contents of the mixture (see 2.15.2.1). The properties of organic peroxides which are necessary for their classification shall be determined experimentally. The classification of organic peroxides shall be performed in accordance with test series A to H as described in Part II of the UN Recommendations on the Transport of Dangerous Goods, Manual of Tests and Criteria. The procedure for classification is described in Figure 2.15.1.
 2.15.4.2. 
Note: The sum of the individual parts can be more hazardous than the individual components.

Figure 2.15.1 2.16.  2.16.1. 
A substance or a mixture that is corrosive to metals means a substance or a mixture which by chemical action will materially damage, or even destroy, metals.
 2.16.2.  2.16.2.1. 
Category Criteria
1 Corrosion rate on either steel or aluminium surfaces exceeding 6,25 mm per year at a test temperature of 55 oC when tested on both materials.Where an initial test on either steel or aluminium indicates the substance or mixture being tested is corrosive the follow up test on the other metal is not required. 2.16.3. 
Label elements shall be used for substances and mixtures meeting the criteria for classification in this hazard class in accordance with Table 2.16.2.


Classification Category 1
GHS Pictogram 
Signal Word Warning
Hazard Statement H290: May be corrosive to metals
Precautionary StatementPrevention P234
Precautionary StatementResponse P390
Precautionary StatementStorage P406
Precautionary StatementDisposal 
 2.16.4.  2.16.4.1. 

((a)) for the purposes of testing steel, steel types

— S235JR+CR (1.0037 resp.St 37-2),
— S275J2G3+CR (1.0144 resp.St 44-3), ISO 3574 as amended, Unified Numbering System (UNS) G 10200, or SAE 1020;
((b)) for the purposes of testing aluminium: non-clad types 7075-T6 or AZ5GU-T6.

3.  3.1.  3.1.1.  3.1.1.1. Acute toxicity means those adverse effects occurring following oral or dermal administration of a single dose of a substance or a mixture, or multiple doses given within 24 hours, or an inhalation exposure of 4 hours.
 3.1.1.2. 

— Acute oral toxicity;
— Acute dermal toxicity;
— Acute inhalation toxicity.
 3.1.2.  3.1.2.1. 

Table 3.1.1
Acute toxicity hazard categories and acute toxicity estimates (ATE) defining the respective categories
Exposure Route Category 1 Category 2 Category 3 Category 4
Oral (mg/kg bodyweight)See Note (a) ATE ≤ 5 5 < ATE ≤ 50 50 < ATE ≤ 300 300 < ATE ≤ 2 000
Dermal (mg/kgbodyweight)See Note (a) ATE ≤ 50 50 < ATE ≤ 200 200 < ATE ≤ 1 000 1 000 < ATE ≤ 2 000
Gases (ppmV    
see: Note (a)Note (b) ATE ≤ 100 100 < ATE ≤ 500 500 < ATE ≤ 2 500 2 500 < ATE ≤ 20 000
Vapours (mg/l)    
see: Note (a)Note (b)Note (c) ATE ≤ 0,5 0,5 < ATE ≤ 2,0 2,0 < ATE ≤ 10,0 10,0 < ATE ≤ 20,0
Dusts and Mists (mg/l)    
see: Note (a)Note (b) ATE ≤ 0,05 0,05 < ATE ≤ 0,5 0,5 < ATE ≤ 1,0 1,0 < ATE ≤ 5,0

((a)) The acute toxicity estimate (ATE) for the classification of a substance or ingredient in a mixture is derived using:

— the LD50/LC50 where available,
— the appropriate conversion value from Table 3.1.2 that relates to the results of a range test, or
— the appropriate conversion value from Table 3.1.2 that relates to a classification category.
((b)) Generic concentration limits for inhalation toxicity in the table are based on 4 hour testing exposures. Conversion of existing inhalation toxicity data which have been generated using a 1 hour exposure can be carried out by dividing by a factor of 2 for gases and vapours and 4 for dusts and mists.
((c)) For some substances or mixtures the test atmosphere will not just be a vapour but will consist of a mixture of liquid and vapour phases. For other substances or mixtures the test atmosphere may consist of a vapour which is near the gaseous phase. In these latter cases, classification shall be based on ppmV as follows: Category 1 (100 ppmV), Category 2 (500 ppmV), Category 3 (2 500 ppmV), Category 4 (20 000 ppmV).
The terms ‘dust’, ‘mist’ and ‘vapour’ are defined as follows:

— Dust: solid particles of a substance or mixture suspended in a gas (usually air);
— Mist: liquid droplets of a substance or mixture suspended in a gas (usually air);
— Vapour: the gaseous form of a substance or mixture released from its liquid or solid state.
Dust is generally formed by mechanical processes. Mist is generally formed by condensation of supersaturated vapours or by physical shearing of liquids. Dusts and mists generally have sizes ranging from less than 1 to about 100 μm. 3.1.2.2.  3.1.2.2.1. The preferred test species for evaluation of acute toxicity by the oral and inhalation routes is the rat, while the rat or rabbit are preferred for evaluation of acute dermal toxicity. When experimental data for acute toxicity are available in several animal species, scientific judgement shall be used in selecting the most appropriate LD50 value from among valid, well-performed tests.
 3.1.2.3.  3.1.2.3.1. Units for inhalation toxicity are a function of the form of the inhaled material. Values for dusts and mists are expressed in mg/l. Values for gases are expressed in ppmV. Acknowledging the difficulties in testing vapours, some of which consist of mixtures of liquid and vapour phases, the table provides values in units of mg/l. However, for those vapours which are near the gaseous phase, classification shall be based on ppmV.
 3.1.2.3.2. Of particular importance in classifying for inhalation toxicity is the use of well articulated values in the high toxicity categories for dusts and mists. Inhaled particles between 1 and 4 microns mean mass aerodynamic diameter (MMAD) will deposit in all regions of the rat respiratory tract. This particle size range corresponds to a maximum dose of about 2 mg/l. In order to achieve applicability of animal experiments to human exposure, dusts and mists would ideally be tested in this range in rats.
 3.1.2.3.3. In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity was corrosivity, the substance or mixture shall also be labelled as ‘corrosive to the respiratory tract’ (see note 1 in 3.1.4.1). Corrosion of the respiratory tract is defined by destruction of the respiratory tract tissue after a single, limited period of exposure analogous to skin corrosion; this includes destruction of the mucosa. The corrosivity evaluation can be based on expert judgment using such evidence as: human and animal experience, existing (in vitro) data, pH values, information from similar substances or any other pertinent data.
 3.1.3.  3.1.3.1. The criteria for classification of substances for acute toxicity as outlined in section 3.1.2 are based on lethal dose data (tested or derived). For mixtures, it is necessary to obtain or derive information that allows the criteria to be applied to the mixture for the purpose of classification. The approach to classification for acute toxicity is tiered, and is dependent upon the amount of information available for the mixture itself and for its ingredients. The flow chart of Figure 3.1.1 outlines the process to be followed.
 3.1.3.2. For acute toxicity each route of exposure shall be considered for the classification of mixtures, but only one route of exposure is needed as long as this route is followed (estimated or tested) for all ingredients. If the acute toxicity is determined for more than one route of exposure, the more severe hazard category will be used for classification. All available information shall be considered and all relevant routes of exposure shall be identified for hazard communication.
 3.1.3.3. 

((a)) the ‘relevant ingredients’ of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a reason to suspect that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for acute toxicity (see Table 1.1).
((b)) where a classified mixture is used as an ingredient of another mixture, the actual or derived acute toxicity estimate (ATE) for that mixture may be used, when calculating the classification of the new mixture using the formulas in section 3.1.3.6.1 and paragraph 3.1.3.6.2.3.

Figure 3.1.1 3.1.3.4.  3.1.3.4.1. Where the mixture itself has been tested to determine its acute toxicity, it shall be classified according to the same criteria as those used for substances, presented in Table 3.1.1. If test data for the mixture are not available, the procedures presented under sections 3.1.3.5 and 3.1.3.6 shall be followed.
 3.1.3.5.  3.1.3.5.1. Where the mixture itself has not been tested to determine its acute toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
 3.1.3.5.2. If a mixture is diluted with water or other totally non-toxic material, the toxicity of the mixture can be calculated from test data on the undiluted mixture.
 3.1.3.6.  3.1.3.6.1. 
In order to ensure that classification of the mixture is accurate, and that the calculation need only be performed once for all systems, sectors, and categories, the acute toxicity estimate (ATE) of ingredients shall be considered as follows:


((a)) include ingredients with a known acute toxicity, which fall into any of the acute toxicity categories shown in Table 3.1.1;
((b)) ignore ingredients that are presumed not acutely toxic (e.g., water, sugar);
((c)) ignore ingredients if the oral limit test does not show acute toxicity at 2 000 mg/kg bodyweight.

Ingredients that fall within the scope of this paragraph are considered to be ingredients with a known acute toxicity estimate (ATE).

The ATE of the mixture is determined by calculation from the ATE values for all relevant ingredients according to the following formula for Oral, Dermal or Inhalation Toxicity:

100ATEmix=ΣnCiATEi

where:

Ciconcentration of ingredient i ( % w/w or % v/v)ithe individual ingredient from 1 to nnthe number of ingredientsATEiAcute Toxicity Estimate of ingredient i.
 3.1.3.6.2.  3.1.3.6.2.1. 
This includes evaluation of:


((a)) extrapolation between oral, dermal and inhalation acute toxicity estimates. Such an evaluation could require appropriate pharmacodynamic and pharmacokinetic data;
((b)) evidence from human exposure that indicates toxic effects but does not provide lethal dose data;
((c)) evidence from any other toxicity tests/assays available on the substance that indicates toxic acute effects but does not necessarily provide lethal dose data; or
((d)) data from closely analogous substances using structure/activity relationships.

This approach generally requires substantial supplemental technical information, and a highly trained and experienced expert (expert judgement, see section 1.1.1), to reliably estimate acute toxicity. If such information is not available, proceed to paragraph 3.1.3.6.2.3.
 3.1.3.6.2.2. In the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, it is concluded that the mixture cannot be attributed a definitive acute toxicity estimate. In this situation the mixture shall be classified based on the known ingredients only, with the additional statement that x percent of the mixture consists of ingredient(s) of unknown toxicity.
 3.1.3.6.2.3. 100-Σ C unknown if > 10 %ATEmix=ΣnCiATEi

Exposure routes Classification Category or experimentally obtained acute toxicity range estimate Converted acute toxicity point estimate(see Note 1)
Oral(mg/kg bodyweight) 0 < Category 1 ≤ 55 < Category 2 ≤ 5050 < Category 3 ≤ 300300 < Category 4 ≤ 2 000 0,55100500
Dermal(mg/kg bodyweight) 0 < Category 1 ≤ 5050 < Category 2 ≤ 200200 < Category 3 ≤ 1 0001 000 < Category 4 ≤ 2 000 5503001 100
Gases(ppmV) 0 < Category 1 ≤ 100100 < Category 2 ≤ 500500 < Category 3 ≤ 2 5002 500 < Category 4 ≤ 20 000 101007004 500
Vapours(mg/l) 0 < Category 1 ≤ 0,50,5 < Category 2 ≤ 2,02,0 < Category 3 ≤ 10,010,0 < Category 4 ≤ 20,0 0,050,5311
Dust/mist(mg/l) 0< Category 1 ≤ 0,050,05 < Category 2 ≤ 0,50,5 < Category 3 ≤ 1,01,0 < Category 4 ≤ 5,0 0,0050,050,51,5
These values are designed to be used in the calculation of the ATE for classification of a mixture based on its components and do not represent test results. 3.1.4.  3.1.4.1. 

Table 3.1.3
Acute toxicity label elements
Classification Category 1 Category 2 Category 3 Category 4
GHS Pictograms    
Signal Word Danger Danger Danger Warning
Hazard Statement:
— Oral H300:Fatal if swallowed H300:Fatal if swallowed H301:Toxic if swallowed H302:Harmful if swallowed

— Dermal H310:Fatal in contact with skin H310:Fatal in contact with skin H311: Toxic in contact with skin H312: Harmful in contact with skin

— Inhalation
(see Note 1) H330:Fatal if inhaled H330: Fatal if inhaled H331: Toxic if inhaled H332: Harmful if inhaled
Precautionary Statement Prevention (oral) P264P270 P264P270 P264P270 P264P270
Precautionary Statement Response (oral) P301 + P310P321P330 P301 + P310P321P330 P301 + P310P321P330 P301 + P312P330
Precautionary Statement Storage (oral) P405 P405 P405 
Precautionary Statement Disposal (oral) P501 P501 P501 P501
Precautionary Statement Prevention (dermal) P262P264P270P280 P262P264P270P280 P280 P280
Precautionary Statement Response (dermal) P302 + P350P310P322P361P363 P302 + P350P310P322P361P363 P302 + P352P312P322P361P363 P302 + P352P312P322P363
Precautionary Statement Storage (dermal) P405 P405 P405 
Precautionary Statement Disposal (dermal) P501 P501 P501 P501
Precautionary Statement Prevention (inhalation) P260P271P284 P260P271P284 P261P271 P261P271
Precautionary Statement Response (inhalation) P304 + P340P310P320 P304 + P340P310P320 P304 + P340P311P321 P304 + P340P312
Precautionary Statement Storage (inhalation) P403 + P233P405 P403 + P233P405 P403 + P233P405 
Precautionary Statement Disposal (inhalation) P501 P501 P501 In addition to classification for inhalation toxicity, if data are available that indicates that the mechanism of toxicity is corrosivity, the substance or mixture shall also be labelled as EUH071: ‘corrosive to the respiratory tract’ — see advice at 3.1.2.3.3. In addition to an appropriate acute toxicity pictogram, a corrosivity pictogram (used for skin and eye corrosivity) may be added together with the statement ‘corrosive to the respiratory tract’.In the event that an ingredient without any useable information at all is used in a mixture at a concentration of 1 % or greater, the mixture shall be labelled with the additional statement that ‘x percent of the mixture consists of ingredient(s) of unknown toxicity’ — see advice at 3.1.3.6.2.2. 3.2.  3.2.1.  3.2.1.1. 
Skin Irritation means the production of reversible damage to the skin following the application of a test substance for up to 4 hours.
 3.2.2.  3.2.2.1. Several factors need to be considered in determining the corrosion and irritation potential of substances before testing is undertaken. Solid substances (powders) may become corrosive or irritant when moistened or in contact with moist skin or mucous membranes. Existing human experience and animal data from single or repeated exposure shall be the first line of analysis, as they give information directly relevant to effects on the skin. In vitro alternatives that have been validated and accepted may also be used to help make classification decisions (see Article 5). In some cases enough information may be available from structurally related compounds to make classification decisions.
 3.2.2.2. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may indicate the potential to cause skin effects, especially when buffering capacity is known, although the correlation is not perfect. Generally, such substances are expected to produce significant effects on the skin. If consideration of alkali/acid reserve suggests the substance may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.
 3.2.2.3. If a substance is highly toxic by the dermal route, a skin irritation/corrosion study is not practicable since the amount of test substance to be applied considerably exceeds the toxic dose and, consequently, results in the death of the animals. When observations are made of skin irritation/corrosion in acute toxicity studies and are observed up through the limit dose, additional testing is not needed, provided that the dilutions used and species tested are equivalent.
 3.2.2.4. 
Although information might be gained from the evaluation of single parameters within a tier (see paragraph 3.2.2.5), e.g. caustic alkalis with extreme pH shall be considered as skin corrosives, there is merit in considering the totality of existing information and making an overall weight of evidence determination. This is especially true when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon existing human experience and data, followed by animal experience and testing data, followed by other sources of information, but case-by-case determinations are necessary.
 3.2.2.5. A tiered approach to the evaluation of initial information shall be considered, where applicable, recognising that all elements may not be relevant in certain cases.
 3.2.2.6.  3.2.2.6.1. On the basis of the results of animal testing a substance is classified as corrosive, as shown in Table 3.2.1. A corrosive substance is a substance that produces destruction of skin tissue, namely, visible necrosis through the epidermis and into the dermis, in at least 1 tested animal after exposure up to a 4 hour duration. Corrosive reactions are typified by ulcers, bleeding, bloody scabs and, by the end of observation at 14 days, by discoloration due to blanching of the skin, complete areas of alopecia and scars. Histopathology shall be considered to discern questionable lesions.
 3.2.2.6.2. Three subcategories are provided within the corrosive category: subcategory 1A — where responses are noted following up to 3 minutes exposure and up to 1 hour observation; subcategory 1B — where responses are described following exposure between 3 minutes and 1 hour and observations up to 14 days; and subcategory 1C — where responses occur after exposures between 1 hour and 4 hours and observations up to 14 days.
 3.2.2.6.3. The use of human data is discussed in paragraphs 3.2.2.1 and 3.2.2.4 and also in paragraphs 1.1.1.3, 1.1.1.4 and.1.1.1.5.


Table 3.2.1
Skin Corrosive category and subcategories
  Corrosive in > 1 of 3 animals
 Corrosive subcategories Exposure Observation
Category 1: Corrosive 1A ≤ 3 minutes ≤ 1 hour
1B > 3 minutes - ≤ 1 hour ≤ 14 days
1C > 1 hour - ≤ 4 hours ≤ 14 days 3.2.2.7.  3.2.2.7.1. 

Table 3.2.2
Skin irritation category
Category Criteria
Category 2: Irritant  (1) Mean value of ≥ 2,3 - ≤ 4,0 for erythema/eschar or for oedema in at least 2 of 3 tested animals from gradings at 24, 48 and 72 hours after patch removal or, if reactions are delayed, from grades on 3 consecutive days after the onset of skin reactions; or
 (2) Inflammation that persists to the end of the observation period normally 14 days in at least 2 animals, particularly taking into account alopecia (limited area), hyperkeratosis, hyperplasia, and scaling; or
 (3) In some cases where there is pronounced variability of response among animals, with very definite positive effects related to chemical exposure in a single animal but less than the criteria above.
 3.2.2.8.  3.2.2.8.1. Animal irritant responses within a test can be quite variable, as they are with corrosion. The major criterion for classification of a substance as irritant to skin, as shown in paragraph 3.2.2.7.1, is the mean value of the scores for either erythema/eschar or oedema calculated in at least 2 of 3 tested animals. A separate irritant criterion accommodates cases when there is a significant irritant response but less than the mean score criterion for a positive test. For example, a test material might be designated as an irritant if at least 1 of 3 tested animals shows a very elevated mean score throughout the study, including lesions persisting at the end of an observation period of normally 14 days. Other responses could also fulfil this criterion. However, it should be ascertained that the responses are the result of chemical exposure.
 3.2.2.8.2. Reversibility of skin lesions is another consideration in evaluating irritant responses. When inflammation persists to the end of the observation period in 2 or more test animals, taking into consideration alopecia (limited area), hyperkeratosis, hyperplasia and scaling, then a material shall be considered to be an irritant.
 3.2.3.  3.2.3.1.  3.2.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies to develop data for these hazard classes.
 3.2.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of substances and mixtures that can give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture, classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and irritation (paragraph 3.2.2.5), to help ensure an accurate classification as well as avoid unnecessary animal testing. A mixture is considered corrosive to skin (Skin Corrosive Category 1) if it has a pH of 2 or less or a pH of 11,5 or greater. If consideration of alkali/acid reserve suggests the substance or mixture may not be corrosive despite the low or high pH value, then further testing shall be carried out to confirm this, preferably by use of an appropriate validated in vitro test.
 3.2.3.2.  3.2.3.2.1. Where the mixture itself has not been tested to determine its skin irritation/corrosion hazards, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
 3.2.3.3.  3.2.3.3.1. 
Assumption: the ‘relevant ingredients’ of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g., in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % can still be relevant for classifying the mixture for skin irritation/corrosion.
 3.2.3.3.2. In general, the approach to classification of mixtures as irritant or corrosive to skin when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification with Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as corrosive or irritant when the sum of the concentrations of such components exceeds a concentration limit.
 3.2.3.3.3. Table 3.2.3 provides the generic concentration limits to be used to determine if the mixture is considered to be an irritant or a corrosive to the skin.
 3.2.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.2.3.3.1 and 3.2.3.3.2 may not be applicable given that many of such substances are corrosive or irritant at concentrations < 1 %.
 3.2.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as a classification criterion (see paragraph 3.2.3.1.2) since pH is a better indicator of corrosion than the concentration limits of Table 3.2.3.
 3.2.3.3.4.3. A mixture containing ingredients that are corrosive or irritant to the skin and that cannot be classified on the basis of the additivity approach (Table 3.2.3), due to chemical characteristics that make this approach unworkable, shall be classified as Skin Corrosive Category 1A, 1B or 1C if it contains ≥ 1 % of an ingredient classified in Category 1A, 1B or 1C respectively or as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.2.3 does not apply is summarised in Table 3.2.4.
 3.2.3.3.5. On occasion, reliable data may show that the skin corrosion/irritation hazard of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4. In these cases the mixture shall be classified according to that data (see also Articles 10 and 11). On other occasions, when it is expected that the skin corrosion/irritation hazard of an ingredient is not evident when present at a level above the generic concentration limits mentioned in Tables 3.2.3 and 3.2.4, testing of the mixture shall be considered. In those cases the tiered weight of evidence strategy shall be applied, as described in paragraph 3.2.2.5.
 3.2.3.3.6. If there are data showing that (an) ingredient(s) is/are corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.


Sum of ingredients classified as: Concentration triggering classification of a mixture as:
 Skin Corrosive Skin Irritant
 Category 1(see note below) Category 2
Skin Corrosive Categories 1A, 1B, 1C ≥ 5 % ≥ 1 % but < 5 %
Skin irritant Category 2  ≥ 10 %
(10 × Skin Corrosive Category 1A, 1B, 1C) + Skin irritant Category 2  ≥ 10 %
The sum of all ingredients of a mixture classified as Skin Corrosive Category 1A, 1B or 1C respectively, shall each be ≥ 5 % respectively in order to classify the mixture as either Skin Corrosive Category 1A, 1B or 1C. If the sum of the Skin Corrosive Category 1A ingredients is < 5 % but the sum of Category 1A+1B ingredients is ≥ 5 %, the mixture shall be classified as Skin Corrosive Category 1B. Similarly, if the sum of Skin Corrosive Category 1A+1B ingredients is < 5 % but the sum of Category 1A+1B+1C ingredients is ≥ 5 % the mixture shall be classified as Skin Corrosive Category 1C.

Ingredient: Concentration: Mixture classified as: Skin
Acid with pH ≤ 2 ≥ 1 % Category 1
Base with pH ≥ 11,5 ≥ 1 % Category 1
Other corrosive (Categories 1A, 1B, 1C) ingredients for which additivity does not apply ≥ 1 % Category 1
Other irritant (Category 2) ingredients for which additivity does not apply, including acids and bases ≥ 3 % Category 2
 3.2.4.  3.2.4.1. 

Table 3.2.5
Label elements for skin corrosion/irritation
Classification Category 1 A/1 B/1 C Category 2
GHS Pictograms  
Signal Word Danger Warning
Hazard Statement H314: Causes severe skin burns and eye damage H315: Causes skin irritation
Precautionary StatementPrevention P260P264P280 P264P280
Precautionary StatementResponse P301 + P330 + P331P303 + P361 + P353P363P304 + P340P310P321P305 + P351 + P338 P302 + P352P321P332 + P313P362
Precautionary StatementStorage P405 
Precautionary StatementDisposal P501  3.3.  3.3.1.  3.3.1.1. 
Eye irritation means the production of changes in the eye following the application of test substance to the anterior surface of the eye, which are fully reversible within 21 days of application.
 3.3.2.  3.3.2.1. The classification system for substances involves a tiered testing and evaluation scheme, combining pre-existing information on serious ocular tissue damage and on eye irritation (including data relating to historical human or animal experience) as well as considerations on (Q)SAR and the output of validated in vitro tests in order to avoid unnecessary animal testing.
 3.3.2.2. Before any in vivo testing for serious eye damage/eye irritation is carried out, all existing information on a substance shall be reviewed. Preliminary decisions can often be made from existing data as to whether a substance causes serious (i.e. irreversible) damage to the eyes. If a substance can be classified on the basis of these data, no testing is required.
 3.3.2.3. Several factors need to be considered in determining the serious eye damage or irritation potential of a substance before testing is undertaken. Accumulated human and animal experience shall be the first line of analysis, as it gives information directly relevant to effects on the eye. In some cases enough information may be available from structurally related compounds to make hazard decisions. Likewise, pH extremes like ≤ 2 and ≥ 11,5 may produce serious eye damage, especially when associated with significant buffering capacity. Such substances are expected to produce significant effects on the eyes. Possible skin corrosion has to be evaluated prior to consideration of serious eye damage/eye irritation in order to avoid testing for local effects on eyes with skin corrosive substances. Skin corrosive substances shall be considered as leading to serious damage to the eyes as well (Category 1), while skin irritant substances may be considered as leading to eye irritation (Category 2). In vitro alternatives that have been validated and accepted can be used to make classification decisions (see Article 5).
 3.3.2.4. All the above information that is available on a substance shall be used in determining the need for in vivo eye irritation testing. Although information may be gained from the evaluation of single parameters within a tier (e.g. caustic alkalis with extreme pH shall be considered as local corrosives), the totality of existing information shall be considered in making an overall weight of evidence determination, particularly when there is information available on some but not all parameters. Generally, primary emphasis shall be placed upon expert judgement, considering human experience with the substance, followed by the outcome of skin irritation testing and of well-validated alternative methods. Animal testing with corrosive substances or mixtures shall be avoided whenever possible.
 3.3.2.5. A tiered approach to the evaluation of initial information shall be considered where applicable, while recognising that all elements may not be relevant in certain cases.
 3.3.2.6.  3.3.2.6.1. 

Table 3.3.1
Category for irreversible eye effects
Category Criteria
Irreversible effects on the eye(Category 1) If, when applied to the eye of an animal, a substance produces:
— at least in one animal effects on the cornea, iris or conjunctiva that are not expected to reverse or have not fully reversed within an observation period of normally 21 days; and/or
— at least in 2 of 3 tested animals, a positive response of:
— corneal opacity ≥ 3 and/or
— iritis > 1,5calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material. 3.3.2.6.2. The use of human data is discussed in paragraphs 3.3.2.1, 3.3.2.4, and also in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.
 3.3.2.7.  3.3.2.7.1. 

Table 3.3.2
Category for reversible eye effects
Category Criteria
Irritating to eyes(Category 2) if, when applied to the eye of an animal, a substance produces:
— at least in 2 of 3 tested animals, a positive response of:
— corneal opacity ≥ 1 and/or
— iritis ≥ 1, and/or
— conjunctival redness ≥ 2 and/or
— conjunctival oedema (chemosis) ≥ 2
— calculated as the mean scores following grading at 24, 48 and 72 hours after installation of the test material, and which fully reverses within an observation period of 21 days 3.3.2.7.2. For those substances where there is pronounced variability among animal responses, this information shall be taken into account in determining the classification.
 3.3.3.  3.3.3.1.  3.3.3.1.1. The mixture will be classified using the criteria for substances, and taking into account the testing and evaluation strategies used to develop data for these hazard classes.
 3.3.3.1.2. Unlike other hazard classes, there are alternative tests available for skin corrosivity of certain types of mixtures that give an accurate result for classification purposes, as well as being simple and relatively inexpensive to perform. When considering testing of the mixture classifiers are encouraged to use a tiered weight of evidence strategy as included in the criteria for classification of substances for skin corrosion and serious eye damage and eye irritation to help ensure an accurate classification, as well as avoid unnecessary animal testing. A mixture is considered to cause serious eye damage (Category 1) if it has a pH ≤ 2,0 or ≥ 11,5. If consideration of alkali/acid reserve suggests the mixture may not have the potential to cause serious eye damage despite the low or high pH value, then further testing needs to be carried out to confirm this, preferably by use of an appropriate validated in vitro test.
 3.3.3.2.  3.3.3.2.1. Where the mixture itself has not been tested to determine its skin corrosivity or potential to cause serious eye damage or irritation, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
 3.3.3.3.  3.3.3.3.1. 
Assumption: The ‘relevant ingredients’ of a mixture are those which are present in concentrations of 1 % (w/w for solids, liquids, dusts, mists and vapours and v/v for gases) or greater, unless there is a presumption (e.g. in the case of corrosive ingredients) that an ingredient present at a concentration of less than 1 % is still relevant for classifying the mixture for eye irritation/serious eye damage.
 3.3.3.3.2. In general, the approach to classification of mixtures as eye irritant or seriously damaging to the eye when data are available on the components, but not on the mixture as a whole, is based on the theory of additivity, such that each corrosive or irritant component contributes to the overall irritant or corrosive properties of the mixture in proportion to its potency and concentration. A weighting factor of 10 is used for corrosive components when they are present at a concentration below the generic concentration limit for classification in Category 1, but are at a concentration that will contribute to the classification of the mixture as an irritant. The mixture is classified as seriously damaging to the eye or eye irritant when the sum of the concentrations of such components exceeds a concentration limit.
 3.3.3.3.3. Table 3.3.3 provides the generic concentration limits to be used to determine if the mixture shall be classified as irritant or as seriously damaging to the eye.
 3.3.3.3.4.1. Particular care must be taken when classifying certain types of mixtures containing substances such as acids and bases, inorganic salts, aldehydes, phenols, and surfactants. The approach explained in paragraphs 3.3.3.3.1 and 3.3.3.3.2 might not work given that many of such substances are corrosive or irritant at concentrations < 1 %.
 3.3.3.3.4.2. For mixtures containing strong acids or bases the pH shall be used as classification criteria (see paragraph 3.3.2.3) since pH will be a better indicator of serious eye damage than the generic concentration limits of Table 3.3.3.
 3.3.3.3.4.3. A mixture containing corrosive or irritant ingredients that cannot be classified based on the additivity approach (Table 3.3.3), due to chemical characteristics that make this approach unworkable, shall be classified as Category 1 for effects on the eye if it contains ≥ 1 % of a corrosive ingredient and as Category 2 when it contains ≥ 3 % of an irritant ingredient. Classification of mixtures with ingredients for which the approach in Table 3.3.3 does not apply is summarised in Table 3.3.4.
 3.3.3.3.5. On occasion, reliable data may show that the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4. In these cases the mixture shall be classified according to those data. On other occasions, when it is expected that the skin corrosion/irritation hazards or the reversible/irreversible eye effects of an ingredient will not be evident when present at a level above the generic concentration limits mentioned in Tables 3.3.3 and 3.3.4, testing of the mixture shall be considered. In those cases, the tiered weight of evidence strategy shall be applied.
 3.3.3.3.6. If there are data showing that (an) ingredient(s) may be corrosive or irritant at a concentration of < 1 % (corrosive) or < 3 % (irritant), the mixture shall be classified accordingly.


Sum of ingredients classified as: Concentration triggering classification of a mixture as:
Irreversible Eye Effects Reversible Eye Effects
Category 1 Category 2
Eye Effects Category 1 or Skin Corrosive Category 1A, 1B, 1C ≥ 3 % ≥ 1 % but < 3 %
Eye Effects Category 2  ≥ 10 %
(10 × Eye Effects Category 1) + Eye effects Category 2  ≥ 10 %
Skin Corrosive Category 1A, 1B, 1C + Eye effects Category 1 ≥ 3 % ≥ 1 % but < 3 %
10 × (Skin Corrosive Category 1A, 1B, 1C + Eye Effects Category 1) + Eye Effects Category 2  ≥ 10 %


Ingredient Concentration Mixture classified as: Eye
Acid with pH ≤ 2 ≥ 1 % Category 1
Base with pH ≥ 11,5 ≥ 1 % Category 1
Other corrosive (Category 1) ingredients for which additivity does not apply ≥ 1 % Category 1
Other irritant (Category 2) ingredients for which additivity does not apply, including acids and bases ≥ 3 % Category 2
 3.3.4.  3.3.4.1. 

Table 3.3.5
Label elements for serious eye damage/eye irritation
Classification Category 1 Category 2
GHS Pictograms  
Signal Word Danger Warning
Hazard Statement H318: Causes serious eye damage H319: Causes serious eye irritation
Precautionary StatementPrevention P280 P264P280
Precautionary StatementResponse P305 + P351 + P338P310 P305 + P351 + P338P337 + P313
Precautionary StatementStorage  
Precautionary StatementDisposal   3.4.  3.4.1.  3.4.1.1. Respiratory sensitiser means a substance that will lead to hypersensitivity of the airways following inhalation of the substance.
 3.4.1.2. Skin sensitiser means a substance that will lead to an allergic response following skin contact.
 3.4.1.3. For the purpose of section 3.4, sensitisation includes two phases: the first phase is induction of specialised immunological memory in an individual by exposure to an allergen. The second phase is elicitation, i.e. production of a cell-mediated or antibody-mediated allergic response by exposure of a sensitised individual to an allergen.
 3.4.1.4. For respiratory sensitisation, the pattern of induction followed by elicitation phases is shared in common with skin sensitisation. For skin sensitisation, an induction phase is required in which the immune system learns to react; clinical symptoms can then arise when subsequent exposure is sufficient to elicit a visible skin reaction (elicitation phase). As a consequence, predictive tests usually follow this pattern in which there is an induction phase, the response to which is measured by a standardised elicitation phase, typically involving a patch test. The local lymph node assay is the exception, directly measuring the induction response. Evidence of skin sensitisation in humans normally is assessed by a diagnostic patch test.
 3.4.1.5. Usually, for both skin and respiratory sensitisation, lower levels are necessary for elicitation than are required for induction. Provisions for alerting sensitised individuals to the presence of a particular sensitiser in a mixture can be found at section 3.4.4.
 3.4.1.6. 

— Respiratory Sensitisation;
— Skin Sensitisation.
 3.4.2.  3.4.2.1. 
Substances shall be classified as respiratory sensitisers (Category 1) in accordance with the criteria in Table 3.4.1:


Category Criteria
Category 1 Substances shall be classified as respiratory sensitisers (Category 1) in accordance with the following criteria:
((a)) if there is evidence in humans that the substance can lead to specific respiratory hypersensitivity and/or
((b)) if there are positive results from an appropriate animal test.
 3.4.2.1.1  3.4.2.1.1.1. Evidence that a substance can induce specific respiratory hypersensitivity will normally be based on human experience. In this context, hypersensitivity is normally seen as asthma, but other hypersensitivity reactions such as rhinitis/conjunctivitis and alveolitis are also considered. The condition will have the clinical character of an allergic reaction. However, immunological mechanisms do not have to be demonstrated.
 3.4.2.1.1.2. 

((a)) the size of the population exposed;
((b)) the extent of exposure.

The use of human data is discussed in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.
 3.4.2.1.1.3. 

((a)) clinical history and data from appropriate lung function tests related to exposure to the substance, confirmed by other supportive evidence which may include:

((i)) in vivo immunological test (e.g. skin prick test);
((ii)) in vitro immunological test (e.g. serological analysis);
((iii)) studies that indicate other specific hypersensitivity reactions where immunological mechanisms of action have not been proven, e.g. repeated low-level irritation, pharmacologically mediated effects;
((iv)) a chemical structure related to substances known to cause respiratory hypersensitivity;
((b)) data from one or more positive bronchial challenge tests with the substance conducted according to accepted guidelines for the determination of a specific hypersensitivity reaction.
 3.4.2.1.1.4. Clinical history shall include both medical and occupational history to determine a relationship between exposure to a specific substance and development of respiratory hypersensitivity. Relevant information includes aggravating factors both in the home and workplace, the onset and progress of the disease, family history and medical history of the patient in question. The medical history shall also include a note of other allergic or airway disorders from childhood, and smoking history.
 3.4.2.1.1.5. The results of positive bronchial challenge tests are considered to provide sufficient evidence for classification on their own. It is however recognised that in practice many of the examinations listed above will already have been carried out.
 3.4.2.1.2.  3.4.2.1.2.1. 

((i)) measurements of Immunoglobulin E (IgE) and other specific immunological parameters in mice;
((ii)) specific pulmonary responses in guinea pigs.
 3.4.2.2.  3.4.2.2.1. 

Table 3.4.2
Hazard category for skin sensitisers
Category Criteria
Category 1 Substances shall be classified as skin sensitisers (Category 1) in accordance with the following criteria:
((i)) if there is evidence in humans that the substance can lead to sensitisation by skin contact in a substantial number of persons, or
((ii)) if there are positive results from an appropriate animal test (see specific criteria in paragraph 3.4.2.2.4.1). 3.4.2.2.2.  3.4.2.2.2.1. 

((a)) positive data from patch testing, normally obtained in more than one dermatology clinic;
((b)) epidemiological studies showing allergic contact dermatitis caused by the substance; Situations in which a high proportion of those exposed exhibit characteristic symptoms are to be looked at with special concern, even if the number of cases is small;
((c)) positive data from appropriate animal studies;
((d)) positive data from experimental studies on humans (see Article 7(3));
((e)) well documented episodes of allergic contact dermatitis, normally obtained in more than one dermatology clinic.

The use of human data is discussed in paragraphs 1.1.1.3, 1.1.1.4 and 1.1.1.5.
 3.4.2.2.2.2. Positive effects seen in either humans or animals will normally justify classification. Evidence from animal studies (see section 3.4.2.2.4) is usually much more reliable than evidence from human exposure. However, in cases where evidence is available from both sources, and there is conflict between the results, the quality and reliability of the evidence from both sources must be assessed in order to resolve the question of classification on a case-by-case basis. Normally, human data are not generated in controlled experiments with volunteers for the purpose of hazard classification but rather as part of risk assessment to confirm lack of effects seen in animal tests. Consequently, positive human data on skin sensitisation are usually derived from case-control or other, less defined studies. Evaluation of human data must therefore be carried out with caution, as the frequency of cases reflect, in addition to the intrinsic properties of the substances, factors such as the exposure situation, bioavailability, individual predisposition and preventive measures taken. Negative human data can not normally be used to negate positive results from animal studies.
 3.4.2.2.2.3. 

((a)) isolated episodes of allergic contact dermatitis;
((b)) epidemiological studies of limited power, e.g. where chance, bias or confounders have not been ruled out fully with reasonable confidence;
((c)) data from animal tests, performed according to existing guidelines, which do not meet the criteria for a positive result described in paragraph 3.4.2.2.4.1, but which are sufficiently close to the limit to be considered significant;
((d)) positive data from non-standard methods;
((e)) positive results from close structural analogues.
 3.4.2.2.3.  3.4.2.2.3.1. Some substances meeting the criteria for classification as respiratory sensitisers may in addition cause immunological contact urticaria. Consideration shall be given to classifying these substances also as skin sensitisers and including information concerning contact urticaria on the label or in the SDS using appropriate warning information.
 3.4.2.2.3.2. For substances which produce signs of immunological contact urticaria but which do not fulfil the criteria as a respiratory sensitiser, consideration shall be given to classification as a skin sensitiser. There is no recognised animal model available to identify substances which cause immunological contact urticaria. Therefore, classification will normally be based on human evidence, which will be similar to that for skin sensitisation.
 3.4.2.2.4.  3.4.2.2.4.1. When an adjuvant type guinea pig test method for skin sensitisation is used, a response of at least 30 % of the animals is considered as positive. For a non-adjuvant guinea pig test method a response of at least 15 % of the animals is considered positive. Test methods for skin sensitisation described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (‘Test Method Regulation’) shall be used, or other methods provided that they are well-validated and scientific justification is given.
 3.4.3.  3.4.3.1.  3.4.3.1.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture can be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose used does not render the results inconclusive.
 3.4.3.2.  3.4.3.2.1. Where the mixture itself has not been tested to determine its sensitising properties, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging rules set out in section 1.1.3.
 3.4.3.3.  3.4.3.3.1. The mixture shall be classified as a respiratory or skin sensitiser when at least one ingredient has been classified as a respiratory or skin sensitiser and is present at or above the appropriate generic concentration limit as shown in Table 3.4.3 for solid/liquid and gas respectively.
 3.4.3.3.2. Some substances that are classified as sensitisers may elicit a response, when present in a mixture in quantities below the concentrations established in Table 3.4.1, in individuals who are already sensitised to the substance or mixture (see Note 1 to Table 3.4.3).

Ingredient classified as: Concentration triggering classification of a mixture as:
Skin Sensitiser Respiratory Sensitiser
All physical states Solid/Liquid Gas
Skin Sensitiser ≥ 0,1 %(Note 1) — —
≥ 1,0 %(Note 2) — —
Respiratory Sensitiser — ≥ 0,1 %(Note 1) ≥ 0,1 %(Note 1)
— ≥ 1,0 %(Note 3) ≥ 0,2 %(Note 3)This concentration limit is generally used for the application of the special labelling requirements of Annex II section 2.8 to protect already sensitised individuals. A SDS is required for the mixture containing an ingredient above this concentration.This concentration limit is used to trigger classification of a mixture as a skin sensitiser.This concentration limit is used to trigger classification of a mixture as a respiratory sensitiser. 3.4.4.  3.4.4.1. 

Table 3.4.4
Respiratory or skin sensitisation label elements.
Classification Respiratory sensitisation Skin sensitisation
Category 1 Category 1
GHS Pictograms  
Signal Word Danger Warning
Hazard Statement H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled H317: May cause an allergic skin reaction
Precautionary Statement Prevention P261P285 P261P272P280
Precautionary Statement Response P304 + P341P342+ P311 P302 + P352P333 + P313P321P363
Precautionary Statement Storage  
Precautionary Statement Disposal P501 P501 3.5.  3.5.1.  3.5.1.1. A mutation means a permanent change in the amount or structure of the genetic material in a cell. The term ‘mutation’ applies both to heritable genetic changes that may be manifested at the phenotypic level and to the underlying DNA modifications when known (including specific base pair changes and chromosomal translocations). The term ‘mutagenic’ and ‘mutagen’ will be used for agents giving rise to an increased occurrence of mutations in populations of cells and/or organisms.
 3.5.1.2. The more general terms ‘genotoxic’ and ‘genotoxicity’ apply to agents or processes which alter the structure, information content, or segregation of DNA, including those which cause DNA damage by interfering with normal replication processes, or which in a non-physiological manner (temporarily) alter its replication. Genotoxicity test results are usually taken as indicators for mutagenic effects.
 3.5.2.  3.5.2.1. This hazard class is primarily concerned with substances that may cause mutations in the germ cells of humans that can be transmitted to the progeny. However, the results from mutagenicity or genotoxicity tests in vitro and in mammalian somatic and germ cells in vivo are also considered in classifying substances and mixtures within this hazard class.
 3.5.2.2. 

Table 3.5.1
Hazard categories for germ cell mutagens
Categories Criteria
CATEGORY 1: Substances known to induce heritable mutations or to be regarded as if they induce heritable mutations in the germ cells of humans.Substances known to induce heritable mutations in the germ cells of humans.
Category 1A: The classification in Category 1A is based on positive evidence from human epidemiological studies.Substances to be regarded as if they induce heritable mutations in the germ cells of humans.
Category 1B: The classification in Category 1B is based on:
— positive result(s) from in vivo heritable germ cell mutagenicity tests in mammals; or
— positive result(s) from in vivo somatic cell mutagenicity tests in mammals, in combination with some evidence that the substance has potential to cause mutations to germ cells. It is possible to derive this supporting evidence from mutagenicity/genotoxicity tests in germ cells in vivo, or by demonstrating the ability of the substance or its metabolite(s) to interact with the genetic material of germ cells; or
— positive results from tests showing mutagenic effects in the germ cells of humans, without demonstration of transmission to progeny; for example, an increase in the frequency of aneuploidy in sperm cells of exposed people.
CATEGORY 2: Substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humansThe classification in Category 2 is based on:
— positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:
— somatic cell mutagenicity tests in vivo, in mammals; or
— other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.Note: Substances which are positive in in vitro mammalian mutagenicity assays, and which also show chemical structure activity relationship to known germ cell mutagens, shall be considered for classification as Category 2 mutagens. 3.5.2.3.  3.5.2.3.1. To arrive at a classification, test results are considered from experiments determining mutagenic and/or genotoxic effects in germ and/or somatic cells of exposed animals. Mutagenic and/or genotoxic effects determined in in vitro tests shall also be considered.
 3.5.2.3.2. The system is hazard based, classifying substances on the basis of their intrinsic ability to induce mutations in germ cells. The scheme is, therefore, not meant for the (quantitative) risk assessment of substances.
 3.5.2.3.3. Classification for heritable effects in human germ cells is made on the basis of well conducted, sufficiently validated tests, preferably as described in Regulation (EC) No 440/2008 adopted in accordance with Article 13(3) of Regulation (EC) No 1907/2006 (‘Test Method Regulation’) such as those listed in the following paragraphs. Evaluation of the test results shall be done using expert judgement and all the available evidence shall be weighed in arriving at a classification.
 3.5.2.3.4. 

— rodent dominant lethal mutation test;
— mouse heritable translocation assay.
 3.5.2.3.5. 

— mammalian bone marrow chromosome aberration test;
— mouse spot test;
— mammalian erythrocyte micronucleus test.
 3.5.2.3.6. 

((a)) mutagenicity tests:

— mammalian spermatogonial chromosome aberration test;
— spermatid micronucleus assay;
((b)) Genotoxicity tests:

— sister chromatid exchange analysis in spermatogonia;
— unscheduled DNA synthesis test (UDS) in testicular cells.
 3.5.2.3.7. 

— liver Unscheduled synthesis test (UDS) in vivo;
— mammalian bone marrow Sister Chromatid Exchanges (SCE);
 3.5.2.3.8. 

— in vitro mammalian chromosome aberration test;
— in vitro mammalian cell gene mutation test;
— bacterial reverse mutation tests.
 3.5.2.3.9. The classification of individual substances shall be based on the total weight of evidence available, using expert judgement (See 1.1.1). In those instances where a single well-conducted test is used for classification, it shall provide clear and unambiguously positive results. If new, well validated, tests arise these may also be used in the total weight of evidence to be considered. The relevance of the route of exposure used in the study of the substance compared to the route of human exposure shall also be taken into account.
 3.5.3.  3.5.3.1.  3.5.3.1.1. 
 Concentration limits triggering classification of a mixture as:
Ingredient classified as: Category 1A mutagen Category 1B mutagen Category 2 mutagen
Category 1A mutagen ≥ 0,1 % — —
Category 1B mutagen — ≥ 0,1 % —
Category 2 mutagen — — ≥ 1,0 %The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units). 3.5.3.2.  3.5.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as germ cell mutagens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of germ cell mutagenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.
 3.5.3.3.  3.5.3.3.1. Where the mixture itself has not been tested to determine its germ cell mutagenicity hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.5.3.2.1), to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.
 3.5.4.  3.5.4.1. 

Table 3.5.3
Label elements of germ cell mutagenicity
Classification Category 1A or Category 1B Category 2
GHS Pictograms  
Signal Word Danger Warning
Hazard Statement H340: May cause genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H341: Suspected of causing genetic defects (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary StatementPrevention P201P202P281 P201P202P281
Precautionary StatementResponse P308 + P313 P308 + P313
Precautionary StatementStorage P405 P405
Precautionary StatementDisposal P501 P501 3.5.5. 
It is increasingly accepted that the process of chemical-induced tumorigenesis in humans and animals involves genetic changes for example in proto-oncogenes and/or tumour suppresser genes of somatic cells. Therefore, the demonstration of mutagenic properties of substances in somatic and/or germ cells of mammals in vivo may have implications for the potential classification of these substances as carcinogens (see also Carcinogenicity, section 3.6, paragraph 3.6.2.2.6).
 3.6.  3.6.1.  3.6.1.1. Carcinogen means a substance or a mixture of substances which induce cancer or increase its incidence. Substances which have induced benign and malignant tumours in well performed experimental studies on animals are considered also to be presumed or suspected human carcinogens unless there is strong evidence that the mechanism of tumour formation is not relevant for humans.
 3.6.2.  3.6.2.1. 

Table 3.6.1
Hazard categories for carcinogens
Categories Criteria
CATEGORY 1: Known or presumed human carcinogensA substance is classified in Category 1 for carcinogenicity on the basis of epidemiological and/or animal data. A substance may be further distinguished as:
Category 1A: Category 1A, known to have carcinogenic potential for humans, classification is largely based on human evidence, or
Category 1B: Category 1B, presumed to have carcinogenic potential for humans, classification is largely based on animal evidence.
 The classification in Category 1A and 1B is based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived from:
— human studies that establish a causal relationship between human exposure to a substance and the development of cancer (known human carcinogen); or
— animal experiments for which there is sufficient evidence to demonstrate animal carcinogenicity (presumed human carcinogen).
 In addition, on a case-by-case basis, scientific judgement may warrant a decision of presumed human carcinogenicity derived from studies showing limited evidence of carcinogenicity in humans together with limited evidence of carcinogenicity in experimental animals.
CATEGORY 2: Suspected human carcinogensThe placing of a substance in Category 2 is done on the basis of evidence obtained from human and/or animal studies, but which is not sufficiently convincing to place the substance in Category 1A or 1B, based on strength of evidence together with additional considerations (see section 3.6.2.2). Such evidence may be derived either from limited evidence of carcinogenicity in human studies or from limited evidence of carcinogenicity in animal studies.
 3.6.2.2.  3.6.2.2.1. Classification as a carcinogen is made on the basis of evidence from reliable and acceptable studies and is intended to be used for substances which have an intrinsic property to cause cancer. The evaluations shall be based on all existing data, peer-reviewed published studies and additional acceptable data.
 3.6.2.2.2. Classification of a substance as a carcinogen is a process that involves two interrelated determinations: evaluations of strength of evidence and consideration of all other relevant information to place substances with human cancer potential into hazard categories.
 3.6.2.2.3. 

((a)) Carcinogenicity in humans
The evidence relevant to carcinogenicity from studies in humans is classified into one of the following categories:

— sufficient evidence of carcinogenicity: a causal relationship has been established between exposure to the agent and human cancer. That is, a positive relationship has been observed between the exposure and cancer in studies in which chance, bias and confounding could be ruled out with reasonable confidence;
— limited evidence of carcinogenicity: a positive association has been observed between exposure to the agent and cancer for which a causal interpretation is considered to be credible, but chance, bias or confounding could not be ruled out with reasonable confidence.
((b)) Carcinogenicity in experimental animals
Carcinogenicity in experimental animals can be evaluated using conventional bioassays, bioassays that employ genetically modified animals, and other in-vivo bioassays that focus on one or more of the critical stages of carcinogenesis. In the absence of data from conventional long-term bioassays or from assays with neoplasia as the end-point, consistently positive results in several models that address several stages in the multistage process of carcinogenesis should be considered in evaluating the degree of evidence of carcinogenicity in experimental animals. The evidence relevant to carcinogenicity in experimental animals is classified into one of the following categories:

— sufficient evidence of carcinogenicity: a causal relationship has been established between the agent and an increased incidence of malignant neoplasms or of an appropriate combination of benign and malignant neoplasms in (a) two or more species of animals or (b) two or more independent studies in one species carried out at different times or in different laboratories or under different protocols. An increased incidence of tumours in both sexes of a single species in a well-conducted study, ideally conducted under Good Laboratory Practices, can also provide sufficient evidence. A single study in one species and sex might be considered to provide sufficient evidence of carcinogenicity when malignant neoplasms occur to an unusual degree with regard to incidence, site, type of tumour or age at onset, or when there are strong findings of tumours at multiple sites;
— limited evidence of carcinogenicity: the data suggest a carcinogenic effect but are limited for making a definitive evaluation because, e.g. (a) the evidence of carcinogenicity is restricted to a single experiment; (b) there are unresolved questions regarding the adequacy of the design, conduct or interpretation of the studies; (c) the agent increases the incidence only of benign neoplasms or lesions of uncertain neoplastic potential; or (d) the evidence of carcinogenicity is restricted to studies that demonstrate only promoting activity in a narrow range of tissues or organs.
 3.6.2.2.4. Additional considerations (as part of the weight of evidence approach (see 1.1.1)). Beyond the determination of the strength of evidence for carcinogenicity, a number of other factors need to be considered that influence the overall likelihood that a substance poses a carcinogenic hazard in humans. The full list of factors that influence this determination would be very lengthy, but some of the more important ones are considered here.
 3.6.2.2.5. The factors can be viewed as either increasing or decreasing the level of concern for human carcinogenicity. The relative emphasis accorded to each factor depends upon the amount and coherence of evidence bearing on each. Generally there is a requirement for more complete information to decrease than to increase the level of concern. Additional considerations should be used in evaluating the tumour findings and the other factors in a case-by-case manner.
 3.6.2.2.6. 

((a)) tumour type and background incidence;
((b)) multi-site responses;
((c)) progression of lesions to malignancy;
((d)) reduced tumour latency;
((e)) whether responses are in single or both sexes;
((f)) whether responses are in a single species or several species;
((g)) structural similarity to a substance(s) for which there is good evidence of carcinogenicity;
((h)) routes of exposure;
((i)) comparison of absorption, distribution, metabolism and excretion between test animals and humans;
((j)) the possibility of a confounding effect of excessive toxicity at test doses;
((k)) mode of action and its relevance for humans, such as cytotoxicity with growth stimulation, mitogenesis, immunosuppression, mutagenicity.
Mutagenicity: it is recognised that genetic events are central in the overall process of cancer development. Therefore evidence of mutagenic activity in vivo may indicate that a substance has a potential for carcinogenic effects.
 3.6.2.2.7. A substance that has not been tested for carcinogenicity may in certain instances be classified in Category 1A, Category 1B or Category 2 based on tumour data from a structural analogue together with substantial support from consideration of other important factors such as formation of common significant metabolites, e.g. for benzidine congener dyes.
 3.6.2.2.8. The classification shall take into consideration whether or not the substance is absorbed by a given route(s); or whether there are only local tumours at the site of administration for the tested route(s), and adequate testing by other major route(s) show lack of carcinogenicity.
 3.6.2.2.9. It is important that whatever is known of the physico-chemical, toxicokinetic and toxicodynamic properties of the substances, as well as any available relevant information on chemical analogues, i.e. structure activity relationship, is taken into consideration when undertaking classification.
 3.6.3.  3.6.3.1.  3.6.3.1.1. 
Ingredient classified as: Generic concentration limits triggering classification of a mixture as:
Category 1A carcinogen Category 1B carcinogen Category 2 carcinogen
Category 1A carcinogen ≥ 0,1 % — —
Category 1B carcinogen — ≥ 0,1 % —
Category 2 carcinogen — — ≥ 1,0 % [Note 1]The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).If a Category 2 carcinogen is present in the mixture as an ingredient at a concentration ≥ 0,1 % a SDS shall be available for the mixture upon request. 3.6.3.2.  3.6.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients classified as carcinogens. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual ingredients. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of carcinogenicity test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.
 3.6.3.3.  3.6.3.3.1. Where the mixture itself has not been tested to determine its carcinogenic hazard, but there are sufficient data on the individual ingredients and similar tested mixtures (subject to paragraph 3.6.3.2.1) to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.
 3.6.4.  3.6.4.1. 

Table 3.6.3
Label elements for carcinogenicity
Classification Category 1A or Category 1B Category 2
GHS Pictograms  
Signal Word Danger Warning
Hazard Statement H350: May cause cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H351: Suspected of causing cancer (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary StatementPrevention P201P202P281 P201P202P281
Precautionary StatementResponse P308 + P313 P308 + P313
Precautionary StatementStorage P405 P405
Precautionary StatementDisposal P501 P501 3.7.  3.7.1.  3.7.1.1. 
In this classification system, reproductive toxicity is subdivided under two main headings:


((a)) adverse effects on sexual function and fertility;
((b)) adverse effects on development of the offspring.

Some reproductive toxic effects cannot be clearly assigned to either impairment of sexual function and fertility or to developmental toxicity. Nonetheless, substances with these effects, or mixtures containing them, shall be classified as reproductive toxicants.
 3.7.1.2. 

— adverse effects
— on sexual function and fertility, or
— on development;
— effects on or via lactation.
 3.7.1.3. 
Any effect of substances that has the potential to interfere with sexual function and fertility. This includes, but is not limited to, alterations to the female and male reproductive system, adverse effects on onset of puberty, gamete production and transport, reproductive cycle normality, sexual behaviour, fertility, parturition, pregnancy outcomes, premature reproductive senescence, or modifications in other functions that are dependent on the integrity of the reproductive systems.
 3.7.1.4. 
Developmental toxicity includes, in its widest sense, any effect which interferes with normal development of the conceptus, either before or after birth, and resulting from exposure of either parent prior to conception, or exposure of the developing offspring during prenatal development, or postnatally, to the time of sexual maturation. However, it is considered that classification under the heading of developmental toxicity is primarily intended to provide a hazard warning for pregnant women, and for men and women of reproductive capacity. Therefore, for pragmatic purposes of classification, developmental toxicity essentially means adverse effects induced during pregnancy, or as a result of parental exposure. These effects can be manifested at any point in the life span of the organism. The major manifestations of developmental toxicity include (1) death of the developing organism, (2) structural abnormality, (3) altered growth, and (4) functional deficiency.
 3.7.1.5. Adverse effects on or via lactation are also included in reproductive toxicity, but for classification purposes, such effects are treated separately (see Table 3.7.1 (b)). This is because it is desirable to be able to classify substances specifically for an adverse effect on lactation so that a specific hazard warning about this effect can be provided for lactating mothers.
 3.7.2.  3.7.2.1.  3.7.2.1.1. 

Table 3.7.1(a)
Hazard categories for reproductive toxicants
Categories Criteria
CATEGORY 1 Known or presumed human reproductive toxicantSubstances are classified in Category 1 for reproductive toxicity when they are known to have produced an adverse effect on sexual function and fertility, or on development in humans or when there is evidence from animal studies, possibly supplemented with other information, to provide a strong presumption that the substance has the capacity to interfere with reproduction in humans. The classification of a substance is further distinguished on the basis of whether the evidence for classification is primarily from human data (Category 1A) or from animal data (Category 1B).
Category 1A Known human reproductive toxicantThe classification of a substance in Category 1A is largely based on evidence from humans.
Category 1B Presumed human reproductive toxicantThe classification of a substance in Category 1B is largely based on data from animal studies. Such data shall provide clear evidence of an adverse effect on sexual function and fertility or on development in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of other toxic effects. However, when there is mechanistic information that raises doubt about the relevance of the effect for humans, classification in Category 2 may be more appropriate.
CATEGORY 2 Suspected human reproductive toxicantSubstances are classified in Category 2 for reproductive toxicity when there is some evidence from humans or experimental animals, possibly supplemented with other information, of an adverse effect on sexual function and fertility, or on development, and where the evidence is not sufficiently convincing to place the substance in Category 1. If deficiencies in the study make the quality of evidence less convincing, Category 2 could be the more appropriate classification.Such effects shall have been observed in the absence of other toxic effects, or if occurring together with other toxic effects the adverse effect on reproduction is considered not to be a secondary non-specific consequence of the other toxic effects.

Table 3.7.1(b)
Hazard category for lactation effects
EFFECTS ON OR VIA LACTATION
Effects on or via lactation are allocated to a separate single category. It is recognised that for many substances there is no information on the potential to cause adverse effects on the offspring via lactation. However, substances which are absorbed by women and have been shown to interfere with lactation, or which may be present (including metabolites) in breast milk in amounts sufficient to cause concern for the health of a breastfed child, shall be classified and labelled to indicate this property hazardous to breastfed babies. This classification can be assigned on the:
((a)) human evidence indicating a hazard to babies during the lactation period; and/or
((b)) results of one or two generation studies in animals which provide clear evidence of adverse effect in the offspring due to transfer in the milk or adverse effect on the quality of the milk; and/or
((c)) absorption, metabolism, distribution and excretion studies that indicate the likelihood that the substance is present in potentially toxic levels in breast milk. 3.7.2.2.  3.7.2.2.1. 
The classification of a substance is derived from the hazard categories in the following order of precedence: Category 1A, Category 1B, Category 2 and the additional Category for effects on or via lactation. If a substance meets the criteria for classification into both of the main categories (for example Category 1B for effects on sexual function and fertility and also Category 2 for development) then both hazard differentiations shall be communicated by the respective hazard statements. Classification in the additional category for effects on or via lactation will be considered irrespective of a classification into Category 1A, Category 1B or Category 2.
 3.7.2.2.2. In the evaluation of toxic effects on the developing offspring, it is important to consider the possible influence of maternal toxicity (see section 3.7.2.4).
 3.7.2.2.3. For human evidence to provide the primary basis for a Category 1A classification there must be reliable evidence of an adverse effect on reproduction in humans. Evidence used for classification shall ideally be from well conducted epidemiological studies which include the use of appropriate controls, balanced assessment, and due consideration of bias or confounding factors. Less rigorous data from studies in humans shall be supplemented with adequate data from studies in experimental animals and classification in Category 1B shall be considered.
 3.7.2.3.  3.7.2.3.1. Classification as a reproductive toxicant is made on the basis of an assessment of the total weight of evidence, see section 1.1.1. This means that all available information that bears on the determination of reproductive toxicity is considered together, such as epidemiological studies and case reports in humans and specific reproduction studies along with sub-chronic, chronic and special study results in animals that provide relevant information regarding toxicity to reproductive and related endocrine organs. Evaluation of substances chemically related to the substance under study may also be included, particularly when information on the substance is scarce. The weight given to the available evidence will be influenced by factors such as the quality of the studies, consistency of results, nature and severity of effects, the presence of maternal toxicity in experimental animal studies, level of statistical significance for inter-group differences, number of endpoints affected, relevance of route of administration to humans and freedom from bias. Both positive and negative results are assembled together into a weight of evidence determination. A single, positive study performed according to good scientific principles and with statistically or biologically significant positive results may justify classification (see also 3.7.2.2.3).
 3.7.2.3.2. Toxicokinetic studies in animals and humans, site of action and mechanism or mode of action study results may provide relevant information which reduces or increases concerns about the hazard to human health. If it is conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals should not be classified.
 3.7.2.3.3. If, in some reproductive toxicity studies in experimental animals the only effects recorded are considered to be of low or minimal toxicological significance, classification may not necessarily be the outcome. These effects include small changes in semen parameters or in the incidence of spontaneous defects in the foetus, small changes in the proportions of common foetal variants such as are observed in skeletal examinations, or in foetal weights, or small differences in postnatal developmental assessments.
 3.7.2.3.4. Data from animal studies ideally shall provide clear evidence of specific reproductive toxicity in the absence of other systemic toxic effects. However, if developmental toxicity occurs together with other toxic effects in the dam, the potential influence of the generalised adverse effects shall be assessed to the extent possible. The preferred approach is to consider adverse effects in the embryo/foetus first, and then evaluate maternal toxicity, along with any other factors which are likely to have influenced these effects, as part of the weight of evidence. In general, developmental effects that are observed at maternally toxic doses shall not be automatically discounted. Discounting developmental effects that are observed at maternally toxic doses can only be done on a case-by-case basis when a causal relationship is established or refuted.
 3.7.2.3.5. If appropriate information is available it is important to try to determine whether developmental toxicity is due to a specific maternally mediated mechanism or to a non-specific secondary mechanism, like maternal stress and the disruption of homeostasis. Generally, the presence of maternal toxicity shall not be used to negate findings of embryo/foetal effects, unless it can be clearly demonstrated that the effects are secondary non-specific effects. This is especially the case when the effects in the offspring are significant, e.g. irreversible effects such as structural malformations. In some situations it can be assumed that reproductive toxicity is due to a secondary consequence of maternal toxicity and discount the effects, if the substance is so toxic that dams fail to thrive and there is severe inanition, they are incapable of nursing pups; or they are prostrate or dying.
 3.7.2.4.  3.7.2.4.1. Development of the offspring throughout gestation and during the early postnatal stages can be influenced by toxic effects in the mother either through non-specific mechanisms related to stress and the disruption of maternal homeostasis, or by specific maternally-mediated mechanisms. In the interpretation of the developmental outcome to decide classification for developmental effects it is important to consider the possible influence of maternal toxicity. This is a complex issue because of uncertainties surrounding the relationship between maternal toxicity and developmental outcome. Expert judgement and a weight of evidence approach, using all available studies, shall be used to determine the degree of influence that shall be attributed to maternal toxicity when interpreting the criteria for classification for developmental effects. The adverse effects in the embryo/foetus shall be first considered, and then maternal toxicity, along with any other factors which are likely to have influenced these effects, as weight of evidence, to help reach a conclusion about classification.
 3.7.2.4.2. Based on pragmatic observation, maternal toxicity may, depending on severity, influence development via non-specific secondary mechanisms, producing effects such as depressed foetal weight, retarded ossification, and possibly resorptions and certain malformations in some strains of certain species. However, the limited number of studies which have investigated the relationship between developmental effects and general maternal toxicity have failed to demonstrate a consistent, reproducible relationship across species. Developmental effects which occur even in the presence of maternal toxicity are considered to be evidence of developmental toxicity, unless it can be unequivocally demonstrated on a case-by-case basis that the developmental effects are secondary to maternal toxicity. Moreover, classification shall be considered where there is a significant toxic effect in the offspring, e.g. irreversible effects such as structural malformations, embryo/foetal lethality, significant post-natal functional deficiencies.
 3.7.2.4.3. Classification shall not automatically be discounted for substances that produce developmental toxicity only in association with maternal toxicity, even if a specific maternally-mediated mechanism has been demonstrated. In such a case, classification in Category 2 may be considered more appropriate than Category 1. However, when a substance is so toxic that maternal death or severe inanition results, or the dams are prostrate and incapable of nursing the pups, it is reasonable to assume that developmental toxicity is produced solely as a secondary consequence of maternal toxicity and discount the developmental effects. Classification is not necessarily the outcome in the case of minor developmental changes, when there is only a small reduction in foetal/pup body weight or retardation of ossification when seen in association with maternal toxicity.
 3.7.2.4.4. 
Maternal mortality:

an increased incidence of mortality among the treated dams over the controls shall be considered evidence of maternal toxicity if the increase occurs in a dose-related manner and can be attributed to the systemic toxicity of the test material. Maternal mortality greater than 10 % is considered excessive and the data for that dose level shall not normally be considered for further evaluation.

Mating index

(no. animals with seminal plugs or sperm/no. mated × 100)

Fertility index

(no. animals with implants/no. of matings × 100)

Gestation length

(if allowed to deliver)

Body weight and body weight change:

Consideration of the maternal body weight change and/or adjusted (corrected) maternal body weight shall be included in the evaluation of maternal toxicity whenever such data are available. The calculation of an adjusted (corrected) mean maternal body weight change, which is the difference between the initial and terminal body weight minus the gravid uterine weight (or alternatively, the sum of the weights of the foetuses), may indicate whether the effect is maternal or intrauterine. In rabbits, the body weight gain may not be useful indicators of maternal toxicity because of normal fluctuations in body weight during pregnancy.

Food and water consumption (if relevant):

The observation of a significant decrease in the average food or water consumption in treated dams compared to the control group is useful in evaluating maternal toxicity, particularly when the test material is administered in the diet or drinking water. Changes in food or water consumption need to be evaluated in conjunction with maternal body weights when determining if the effects noted are reflective of maternal toxicity or more simply, unpalatability of the test material in feed or water.

Clinical evaluations (including clinical signs, markers, haematology and clinical chemistry studies):

The observation of increased incidence of significant clinical signs of toxicity in treated dams relative to the control group is useful in evaluating maternal toxicity. If this is to be used as the basis for the assessment of maternal toxicity, the types, incidence, degree and duration of clinical signs shall be reported in the study. Clinical signs of maternal intoxication include: coma, prostration, hyperactivity, loss of righting reflex, ataxia, or laboured breathing.

Post-mortem data:

Increased incidence and/or severity of post-mortem findings may be indicative of maternal toxicity. This can include gross or microscopic pathological findings or organ weight data, including absolute organ weight, organ-to-body weight ratio, or organ-to-brain weight ratio. When supported by findings of adverse histopathological effects in the affected organ(s), the observation of a significant change in the average weight of suspected target organ(s) of treated dams, compared to those in the control group, may be considered evidence of maternal toxicity.
 3.7.2.5.  3.7.2.5.1. A number of internationally accepted test methods are available; these include methods for developmental toxicity testing (e.g. OECD Test Guideline 414), and methods for one or two-generation toxicity testing (e.g. OECD Test Guidelines 415, 416).
 3.7.2.5.2. Results obtained from Screening Tests (e.g. OECD Guidelines 421 — Reproduction/Developmental Toxicity Screening Test, and 422 — Combined Repeated Dose Toxicity Study with Reproduction/Development Toxicity Screening Test) can also be used to justify classification, although it is recognised that the quality of this evidence is less reliable than that obtained through full studies.
 3.7.2.5.3. Adverse effects or changes, seen in short- or long-term repeated dose toxicity studies, which are judged likely to impair reproductive function and which occur in the absence of significant generalised toxicity, may be used as a basis for classification, e.g. histopathological changes in the gonads.
 3.7.2.5.4. Evidence from in vitro assays, or non-mammalian tests, and from analogous substances using structure-activity relationship (SAR), can contribute to the procedure for classification. In all cases of this nature, expert judgement must be used to assess the adequacy of the data. Inadequate data shall not be used as a primary support for classification.
 3.7.2.5.5. It is preferable that animal studies are conducted using appropriate routes of administration which relate to the potential route of human exposure. However, in practice, reproductive toxicity studies are commonly conducted using the oral route, and such studies will normally be suitable for evaluating the hazardous properties of the substance with respect to reproductive toxicity. However, if it can be conclusively demonstrated that the clearly identified mechanism or mode of action has no relevance for humans or when the toxicokinetic differences are so marked that it is certain that the hazardous property will not be expressed in humans then a substance which produces an adverse effect on reproduction in experimental animals shall not be classified.
 3.7.2.5.6. Studies involving routes of administration such as intravenous or intraperitoneal injection, which result in exposure of the reproductive organs to unrealistically high levels of the test substance, or elicit local damage to the reproductive organs, including irritation, must be interpreted with extreme caution and on their own are not normally the basis for classification.
 3.7.2.5.7. There is general agreement about the concept of a limit dose, above which the production of an adverse effect is considered to be outside the criteria which lead to classification, but not regarding the inclusion within the criteria of a specific dose as a limit dose. However, some guidelines for test methods, specify a limit dose, others qualify the limit dose with a statement that higher doses may be necessary if anticipated human exposure is sufficiently high that an adequate margin of exposure is not achieved. Also, due to species differences in toxicokinetics, establishing a specific limit dose may not be adequate for situations where humans are more sensitive than the animal model.
 3.7.2.5.8. In principle, adverse effects on reproduction seen only at very high dose levels in animal studies (for example doses that induce prostration, severe inappetence, excessive mortality) would not normally lead to classification, unless other information is available, e.g. toxicokinetics information indicating that humans may be more susceptible than animals, to suggest that classification is appropriate. Please also refer to the section on maternal toxicity (3.7.2.4) for further guidance in this area.
 3.7.2.5.9. However, specification of the actual ‘limit dose’ will depend upon the test method that has been employed to provide the test results, e.g. in the OECD Test Guideline for repeated dose toxicity studies by the oral route, an upper dose of 1 000 mg/kg has been recommended as a limit dose, unless expected human response indicates the need for a higher dose level.
 3.7.3.  3.7.3.1.  3.7.3.1.1. The mixture shall be classified as a reproductive toxicant when at least one ingredient has been classified as a Category 1A, Category 1B or Category 2 reproductive toxicant and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for Category 1A, Category 1B and Category 2 respectively.
 3.7.3.1.2. The mixture shall be classified for effects on or via lactation when at least one ingredient has been classified for effects on or via lactation and is present at or above the appropriate generic concentration limit as shown in Table 3.7.2 for the additional category for effects on or via lactation.

Ingredient classified as: Generic concentration limits triggering classification of a mixture as:
Category 1A reproductive toxicant Category 1B reproductive toxicant Category 2 reproductive toxicant Additional category for effects on or via lactation
Category 1A reproductive toxicant ≥ 0,3 %[Note 1]   
Category 1B reproductive toxicant  ≥ 0,3 %[Note 1]  
Category 2 reproductive toxicant   ≥ 3,0 %[Note 1] 
Additional category for effects on or via lactation    ≥ 0,3 %[Note 1]The concentration limits in the table above apply to solids and liquids (w/w units) as well as gases (v/v units).If a Category 1 or Category 2 reproductive toxicant or a substance classified for effects on or via lactation is present in the mixture as an ingredient at a concentration above 0,1 %, a SDS shall be available for the mixture upon request. 3.7.3.2.  3.7.3.2.1. Classification of mixtures will be based on the available test data for the individual ingredients of the mixture using concentration limits for the ingredients of the mixture. On a case-by-case basis, test data on mixtures may be used for classification when demonstrating effects that have not been established from the evaluation based on the individual components. In such cases, the test results for the mixture as a whole must be shown to be conclusive taking into account dose and other factors such as duration, observations, sensitivity and statistical analysis of reproduction test systems. Adequate documentation supporting the classification shall be retained and made available for review upon request.
 3.7.3.3.  3.7.3.3.1. Subject to paragraph 3.7.3.2.1, where the mixture itself has not been tested to determine its reproductive toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the applicable bridging rules set out in section 1.1.3.
 3.7.4.  3.7.4.1. 

Table 3.7.3
Label elements for reproductive toxicity
Classification Category 1A or Category 1B Category 2 Additional category for effects on or via lactation
GHS Pictograms   No pictogram
Signal Word Danger Warning No signal word
Hazard Statement H360: May damage fertility or the unborn child (state specific effect if known)(state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H361: Suspected of damaging fertility or the unborn child (state specific effect if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H362: May cause harm to breast-fed children.
Precautionary Statement Prevention P201P202P281 P201P202P281 P201P260P263P264P270
Precautionary Statement Response P308 + P313 P308 + P313 P308 + P313
Precautionary Statement Storage P405 P405 
Precautionary Statement Disposal P501 P501  3.8.  3.8.1.  3.8.1.1. Specific target organ toxicity (single exposure) is defined as specific, non lethal target organ toxicity arising from a single exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed and not specifically addressed in sections 3.1 to 3.7 and 3.10 are included (see also 3.8.1.6).
 3.8.1.2. Classification identifies the substance or mixture as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.
 3.8.1.3. These adverse health effects produced by a single exposure include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism, and these changes are relevant for human health.
 3.8.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.
 3.8.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.
 3.8.1.6. 

((a)) Acute toxicity (section 3.1);
((b)) Skin corrosion/irritation (section 3.2);
((c)) Serious eye damage/eye irritation (section 3.3);
((d)) Respiratory or skin sensitisation (section 3.4);
((e)) Germ cell mutagenicity (section 3.5);
((f)) Carcinogenicity (section 3.6);
((g)) Reproductive toxicity (section 3.7); and
((h)) Aspiration toxicity (section 3.10).
 3.8.1.7. 

— Specific target organ toxicity — single exposure, Category 1 and 2;
— Specific target organ toxicity — single exposure, Category 3.

See Table 3.8.1.


Table 3.8.1
Categories for specific target organ toxicity-single exposure
Categories Criteria
Category 1 Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following single exposureSubstances are classified in Category 1 for specific target organ toxicity (single exposure) on the basis of:
((a)) reliable and good quality evidence from human cases or epidemiological studies; or
((b)) observations from appropriate studies in experimental animals in which significant and/or severe toxic effects of relevance to human health were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) to be used as part of weight-of-evidence evaluation.
Category 2 Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following single exposureSubstances are classified in Category 2 for specific target organ toxicity (single exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.8.2.1.9) in order to help in classification.In exceptional cases, human evidence can also be used to place a substance in Category 2 (see 3.8.2.1.6).
Category 3 Transient target organ effectsThis category only includes narcotic effects and respiratory tract irritation. These are target organ effects for which a substance does not meet the criteria to be classified in Categories 1 or 2 indicated above. These are effects which adversely alter human function for a short duration after exposure and from which humans may recover in a reasonable period without leaving significant alteration of structure or function. Substances are classified specifically for these effects as laid down in 3.8.2.2.
Note: Attempts shall be made to determine the primary target organ of toxicity and to classify for that purpose, such as hepatotoxicants, neurotoxicants. The data shall be carefully evaluated and, where possible, secondary effects should not be included (e.g. a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems). 3.8.2.  3.8.2.1.  3.8.2.1.1. Substances are classified for immediate or delayed effects separately, by the use of expert judgement (see 1.1.1) on the basis of the weight of all evidence available, including the use of recommended guidance values (see 3.8.2.1.9). Substances are then placed in Category 1 or 2, depending upon the nature and severity of the effect(s) observed (Table 3.8.1).
 3.8.2.1.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified (see 3.8.1.5).
 3.8.2.1.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.
 3.8.2.1.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification.
 3.8.2.1.5. The information required to evaluate specific target organ toxicity comes either from single exposure in humans, such as: exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are acute toxicity studies which can include clinical observations and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Results of acute toxicity studies conducted in other species may also provide relevant information.
 3.8.2.1.6. 

((a)) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification, and/or
((b)) based on the nature and severity of effects.

Dose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.
 3.8.2.1.7.  3.8.2.1.7.1. Classification is supported by evidence associating single exposure to the substance with a consistent and identifiable toxic effect.
 3.8.2.1.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.
 3.8.2.1.7.3. 

((a)) morbidity resulting from single exposure;
((b)) significant functional changes, more than transient in nature, in the respiratory system, central or peripheral nervous systems, other organs or other organ systems, including signs of central nervous system depression and effects on special senses (such as sight, hearing and sense of smell);
((c)) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;
((d)) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;
((e)) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;
((f)) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction;
((g)) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.
 3.8.2.1.8. 
It is recognised that effects may be seen that does not justify classification. Such effects in humans and/or animals include, but are not limited to:


((a)) clinical observations or small changes in bodyweight gain, food consumption or water intake that may have some toxicological importance but that do not, by themselves, indicate ‘significant’ toxicity;
((b)) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;
((c)) changes in organ weights with no evidence of organ dysfunction;
((d)) adaptive responses that are not considered toxicologically relevant;
((e)) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.
 3.8.2.1.9.  3.8.2.1.9.1. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration ‘guidance values’ are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged.
 3.8.2.1.9.2. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the dose/concentration at which these effects were seen, in relation to the suggested guidance values, provides useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the dose/concentration).
 3.8.2.1.9.3. 
 Guidance value ranges for:
Route of exposure Units Category 1 Category 2 Category 3
Oral (rat) mg/kg body weight C ≤ 300 2 000 ≥ C > 300 Guidance values do not apply b
Dermal (rat or rabbit) mg/kg body weight C ≤ 1 000 2 000 ≥ C > 1 000
Inhalation (rat) gas ppmV/4h C ≤ 2 500 20 000 ≥ C > 2 500
Inhalation (rat) vapour mg/l/4h C ≤ 10 20 ≥ C > 10
Inhalation (rat) dust/mist/fume mg/l/4h C ≤ 1,0 5,0 ≥ C > 1,0
((a)) The guidance values and ranges mentioned in Table 3.8.2 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decision about classification. They are not intended as strict demarcation values.
((b)) Guidance values are not provided for Category 3 substances since this classification is primarily based on human data. Animal data, if available, shall be included in the weight of evidence evaluation. 3.8.2.1.10.  3.8.2.1.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.
 3.8.2.1.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to single exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because specific target organ toxicity observed was considered not relevant or significant to humans, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.
 3.8.2.1.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.
 3.8.2.1.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection
 3.8.2.2.  3.8.2.2.1. 
The criteria for classifying substances as Category 3 for respiratory tract irritation are:


((a)) respiratory irritant effects (characterised by localised redness, oedema, pruritis and/or pain) that impair function with symptoms such as cough, pain, choking, and breathing difficulties are included. This evaluation will be based primarily on human data;
((b)) subjective human observations could be supported by objective measurements of clear respiratory tract irritation (RTI) (such as electrophysiological responses, biomarkers of inflammation in nasal or bronchoalveolar lavage fluids);
((c)) the symptoms observed in humans shall also be typical of those that would be produced in the exposed population rather than being an isolated idiosyncratic reaction or response triggered only in individuals with hypersensitive airways. Ambiguous reports simply of ‘irritation’ shall be excluded as this term is commonly used to describe a wide range of sensations including those such as smell, unpleasant taste, a tickling sensation, and dryness, which are outside the scope of classification for respiratory irritation;
((d)) there are currently no validated animal tests that deal specifically with RTI, however, useful information may be obtained from the single and repeated inhalation toxicity tests. For example, animal studies may provide useful information in terms of clinical signs of toxicity (dyspnoea, rhinitis etc) and histopathology (e.g. hyperemia, edema, minimal inflammation, thickened mucous layer) which are reversible and may be reflective of the characteristic clinical symptoms described above. Such animal studies can be used as part of weight of evidence evaluation;
((e)) this special classification would occur only when more severe organ effects including in the respiratory system are not observed.
 3.8.2.2.2 
The criteria for classifying substances as Category 3 for narcotic effects are:


((a)) central nervous system depression including narcotic effects in humans such as drowsiness, narcosis, reduced alertness, loss of reflexes, lack of coordination, and vertigo are included. These effects can also be manifested as severe headache or nausea, and can lead to reduced judgment, dizziness, irritability, fatigue, impaired memory function, deficits in perception and coordination, reaction time, or sleepiness;
((b)) narcotic effects observed in animal studies may include lethargy, lack of coordination, loss of righting reflex, and ataxia. If these effects are not transient in nature, then they shall be considered to support classification for Category 1 or 2 specific target organ toxicity single exposure.
 3.8.3.  3.8.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following single exposure.
 3.8.3.2.  3.8.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture, then the mixture shall be classified by weight of evidence evaluation of these data (see 1.1.1.4). Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.
 3.8.3.3.  3.8.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.
 3.8.3.4.  3.8.3.4.1. Where there is no reliable evidence or test data for the specific mixture itself, and the bridging principles cannot be used to enable classification, then classification of the mixture is based on the classification of the ingredient substances. In this case, the mixture shall be classified as a specific target organ toxicant (specific organ specified), following single exposure, when at least one ingredient has been classified as a Category 1 or Category 2 specific target organ toxicant and is present at or above the appropriate generic concentration limit as mentioned in Table 3.8.3 for Category 1 and 2 respectively.
 3.8.3.4.2. These generic concentration limits and consequent classifications shall be applied appropriately to single-dose specific target organ toxicants.
 3.8.3.4.3. 
Ingredient classified as: Generic concentration limits triggering classification of the mixture as:
Category 1 Category 2
Category 1Specific Target Organ Toxicant Concentration ≥ 10 % 1,0 % ≤ concentration < 10 %
Category 2Specific Target Organ Toxicant  Concentration ≥ 10 % [(Note 1)]If a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request. 3.8.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.
 3.8.3.4.5. Care shall be exercised when extrapolating toxicity of a mixture that contains Category 3 ingredient(s). A generic concentration limit of 20 % is appropriate; however, it shall be recognised that this concentration limit may be higher or lower depending on the Category 3 ingredient(s) and that some effects such as respiratory tract irritation may not occur below a certain concentration while other effects such as narcotic effects may occur below this 20 % value. Expert judgement shall be exercised.
 3.8.4.  3.8.4.1 

Table 3.8.4
Label elements for specific target organ toxicity after single exposure
Classification Category 1 Category 2 Category 3
GHS Pictograms   
Signal Word Danger Warning Warning
Hazard Statement H370: Causes damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H371: May cause damage to organs (or state all organs affected, if known) (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H335: May cause respiratory irritation; orH336: May cause drowsiness or dizziness
Precautionary Statement Prevention P260P264P270 P260P264P270 P261P271
Precautionary Statement Response P307 + P311P321 P309 + P311 P304 + P340P312
Precautionary Statement Storage P405 P405 P403 + P233P405
Precautionary Statement Disposal P501 P501 P501 3.9.  3.9.1.  3.9.1.1. Target organ toxicity (repeated exposure) means specific, target organ toxicity arising from a repeated exposure to a substance or mixture. All significant health effects that can impair function, both reversible and irreversible, immediate and/or delayed are included. However, other specific toxic effects that are specifically addressed in sections 3.1 to 3.8 and 3.10 are not included here.
 3.9.1.2. Classification for target organ toxicity (repeated exposure) identifies the substance as being a specific target organ toxicant and, as such, it may present a potential for adverse health effects in people who are exposed to it.
 3.9.1.3. These adverse health effects include consistent and identifiable toxic effects in humans, or, in experimental animals, toxicologically significant changes which have affected the function or morphology of a tissue/organ, or have produced serious changes to the biochemistry or haematology of the organism and these changes are relevant for human health.
 3.9.1.4. Assessment shall take into consideration not only significant changes in a single organ or biological system but also generalised changes of a less severe nature involving several organs.
 3.9.1.5. Specific target organ toxicity can occur by any route that is relevant for humans, i.e. principally oral, dermal or inhalation.
 3.9.1.6. Non-lethal toxic effects observed after a single-event exposure are classified as described in Specific target organ toxicity — Single exposure (section 3.8) and are therefore excluded from section 3.9.
 3.9.2.  3.9.2.1. 
Categories Criteria
Category 1 Substances that have produced significant toxicity in humans or that, on the basis of evidence from studies in experimental animals, can be presumed to have the potential to produce significant toxicity in humans following repeated exposure.Substances are classified in Category 1 for target organ toxicity (repeat exposure) on the basis of:
— reliable and good quality evidence from human cases or epidemiological studies; or
— observations from appropriate studies in experimental animals in which significant and/or severe toxic effects, of relevance to human health, were produced at generally low exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9), to be used as part of a weight-of- evidence evaluation.
Category 2 Substances that, on the basis of evidence from studies in experimental animals can be presumed to have the potential to be harmful to human health following repeated exposure.Substances are classified in category 2 for target organ toxicity (repeat exposure) on the basis of observations from appropriate studies in experimental animals in which significant toxic effects, of relevance to human health, were produced at generally moderate exposure concentrations. Guidance dose/concentration values are provided below (see 3.9.2.9) in order to help in classification.In exceptional cases human evidence can also be used to place a substance in Category 2 (see 3.9.2.6).Attempts shall be made to determine the primary target organ of toxicity and classify for that purpose, such as hepatotoxicants, neurotoxicants. One shall carefully evaluate the data and, where possible, not include secondary effects (a hepatotoxicant can produce secondary effects in the nervous or gastro-intestinal systems). 3.9.2.2. The relevant route or routes of exposure by which the classified substance produces damage shall be identified.
 3.9.2.3. Classification is determined by expert judgement (see section 1.1.1), on the basis of the weight of all evidence available including the guidance presented below.
 3.9.2.4. Weight of evidence of all data (see section 1.1.1), including human incidents, epidemiology, and studies conducted in experimental animals, is used to substantiate specific target organ toxic effects that merit classification. This taps the considerable body of industrial toxicology data collected over the years. Evaluation shall be based on all existing data, including peer-reviewed published studies and additional acceptable data.
 3.9.2.5. The information required to evaluate specific target organ toxicity comes either from repeated exposure in humans, such as exposure at home, in the workplace or environmentally, or from studies conducted in experimental animals. The standard animal studies in rats or mice that provide this information are 28 day, 90 day or lifetime studies (up to 2 years) that include haematological, clinicochemical and detailed macroscopic and microscopic examination to enable the toxic effects on target tissues/organs to be identified. Data from repeat dose studies performed in other species shall also be used, if available. Other long-term exposure studies, such as on carcinogenicity, neurotoxicity or reproductive toxicity, may also provide evidence of specific target organ toxicity that could be used in the assessment of classification.
 3.9.2.6. 

((a)) when the weight of human evidence is not sufficiently convincing to warrant Category 1 classification; and/or
((b)) based on the nature and severity of effects.

Dose/concentration levels in humans shall not be considered in the classification and any available evidence from animal studies shall be consistent with the Category 2 classification. In other words, if there are also animal data available on the substance that warrant Category 1 classification, the substance shall be classified as Category 1.
 3.9.2.7.  3.9.2.7.1. Reliable evidence associating repeated exposure to the substance with a consistent and identifiable toxic effect demonstrates support for the classification.
 3.9.2.7.2. Evidence from human experience/incidents is usually restricted to reports of adverse health consequence, often with uncertainty about exposure conditions, and may not provide the scientific detail that can be obtained from well-conducted studies in experimental animals.
 3.9.2.7.3. 

((a)) morbidity or death resulting from repeated or long-term exposure. Morbidity or death may result from repeated exposure, even to relatively low doses/concentrations, due to bioaccumulation of the substance or its metabolites, and/or due to the overwhelming of the de-toxification process by repeated exposure to the substance or its metabolites;
((b)) significant functional changes in the central or peripheral nervous systems or other organ systems, including signs of central nervous system depression and effects on special senses (e.g. sight, hearing and sense of smell);
((c)) any consistent and significant adverse change in clinical biochemistry, haematology, or urinalysis parameters;
((d)) significant organ damage noted at necropsy and/or subsequently seen or confirmed at microscopic examination;
((e)) multi-focal or diffuse necrosis, fibrosis or granuloma formation in vital organs with regenerative capacity;
((f)) morphological changes that are potentially reversible but provide clear evidence of marked organ dysfunction (e.g., severe fatty change in the liver);
((g)) evidence of appreciable cell death (including cell degeneration and reduced cell number) in vital organs incapable of regeneration.
 3.9.2.8.  3.9.2.8.1. 

((a)) clinical observations or small changes in bodyweight gain, food consumption or water intake that have toxicological importance but that do not, by themselves, indicate ‘significant’ toxicity;
((b)) small changes in clinical biochemistry, haematology or urinalysis parameters and/or transient effects, when such changes or effects are of doubtful or minimal toxicological importance;
((c)) changes in organ weights with no evidence of organ dysfunction;
((d)) adaptive responses that are not considered toxicologically relevant;
((e)) substance-induced species-specific mechanisms of toxicity, i.e. demonstrated with reasonable certainty to be not relevant for human health, shall not justify classification.
 3.9.2.9.  3.9.2.9.1. In studies conducted in experimental animals, reliance on observation of effects alone, without reference to the duration of experimental exposure and dose/concentration, omits a fundamental concept of toxicology, i.e. all substances are potentially toxic, and what determines the toxicity is a function of the dose/concentration and the duration of exposure. In most studies conducted in experimental animals the test guidelines use an upper limit dose value.
 3.9.2.9.2. In order to help reach a decision about whether a substance shall be classified or not, and to what degree it shall be classified (Category 1 or Category 2), dose/concentration ‘guidance values’ are provided for consideration of the dose/concentration which has been shown to produce significant health effects. The principal argument for proposing such guidance values is that all substances are potentially toxic and there has to be a reasonable dose/concentration above which a degree of toxic effect is acknowledged. Also, repeated-dose studies conducted in experimental animals are designed to produce toxicity at the highest dose used in order to optimise the test objective and so most studies will reveal some toxic effect at least at this highest dose. What is therefore to be decided is not only what effects have been produced, but also at what dose/concentration they were produced and how relevant is that for humans.
 3.9.2.9.3. Thus, in animal studies, when significant toxic effects are observed that indicate classification, consideration of the duration of experimental exposure and the dose/concentration at which these effects were seen, in relation to the suggested guidance values, can provide useful information to help assess the need to classify (since the toxic effects are a consequence of the hazardous property(ies) and also the duration of exposure and the dose/concentration).
 3.9.2.9.4. The decision to classify at all can be influenced by reference to the dose/concentration guidance values at or below which a significant toxic effect has been observed.
 3.9.2.9.5. The guidance values refer to effects seen in a standard 90-day toxicity study conducted in rats. They can be used as a basis to extrapolate equivalent guidance values for toxicity studies of greater or lesser duration, using dose/exposure time extrapolation similar to Haber's rule for inhalation, which states essentially that the effective dose is directly proportional to the exposure concentration and the duration of exposure. The assessment shall be done on a case-by-case basis; for a 28-day study the guidance values below is increased by a factor of three.
 3.9.2.9.6. 

Table 3.9.2
Guidance values to assist in Category 1 classification
Route of exposure Units Guidance values (dose/concentration)
Oral (rat) mg/kg body weight/day C ≤ 10
Dermal (rat or rabbit) mg/kg body weight/day C ≤ 20
Inhalation (rat)gas ppmV/6h/day C ≤ 50
Inhalation (rat)vapour mg/litre/6h/day C ≤ 0,2
Inhalation (rat) dust/mist/fume mg/litre/6h/day C ≤ 0,02 3.9.2.9.7. 

Table 3.9.3
Guidance values to assist in Category 2 classification
Route of Exposure Units Guidance Value Ranges:(dose/concentration)
Oral (rat) mg/kg body weight/day 10 < C ≤ 100
Dermal (rat or rabbit) mg/kg body weight/day 20 < C ≤ 200
Inhalation (rat) gas ppmV/6h/day 50 < C ≤ 250
Inhalation (rat)vapour mg/litre/6h/day 0,2 < C ≤ 1,0
Inhalation (rat) dust/mist/fume mg/litre/6h/day 0,02 < C ≤ 0,2 3.9.2.9.8. The guidance values and ranges mentioned in paragraphs 3.9.2.9.6 and 3.9.2.9.7 are intended only for guidance purposes, i.e. to be used as part of the weight of evidence approach, and to assist with decisions about classification. They are not intended as strict demarcation values.
 3.9.2.9.9. Thus it is feasible that a specific profile of toxicity occurs in repeat-dose animal studies at a dose/concentration below the guidance value, such as < 100 mg/kg bw/day by the oral route, however the nature of the effect, such as nephrotoxicity seen only in male rats of a particular strain known to be susceptible to this effect may result in the decision not to classify. Conversely, a specific profile of toxicity may be seen in animal studies occurring at above a guidance value, such as ≥ 100 mg/kg bw/day by the oral route, and in addition there is supplementary information from other sources, such as other long-term administration studies, or human case experience, which supports a conclusion that, in view of the weight of evidence, classification is the prudent action to take.
 3.9.2.10.  3.9.2.10.1. When a substance is characterised only by use of animal data (typical of new substances, but also true for many existing substances), the classification process includes reference to dose/concentration guidance values as one of the elements that contribute to the weight of evidence approach.
 3.9.2.10.2. When well-substantiated human data are available showing a specific target organ toxic effect that can be reliably attributed to repeated or prolonged exposure to a substance, the substance shall normally be classified. Positive human data, regardless of probable dose, predominates over animal data. Thus, if a substance is unclassified because no specific target organ toxicity was seen at or below the dose/concentration guidance value for animal testing, if subsequent human incident data become available showing a specific target organ toxic effect, the substance shall be classified.
 3.9.2.10.3. A substance that has not been tested for specific target organ toxicity may, where appropriate, be classified on the basis of data from a validated structure activity relationship and expert judgement-based extrapolation from a structural analogue that has previously been classified together with substantial support from consideration of other important factors such as formation of common significant metabolites.
 3.9.2.10.4. Saturated vapour concentration shall be considered, where appropriate, as an additional element to provide for specific health and safety protection
 3.9.3.  3.9.3.1. Mixtures are classified using the same criteria as for substances, or alternatively as described below. As with substances, mixtures shall be classified for specific target organ toxicity following repeated exposure.
 3.9.3.2.  3.9.3.2.1. When reliable and good quality evidence from human experience or appropriate studies in experimental animals, as described in the criteria for substances, is available for the mixture (see 1.1.1.4), then the mixture shall be classified by weight of evidence evaluation of these data. Care shall be exercised in evaluating data on mixtures, that the dose, duration, observation or analysis, do not render the results inconclusive.
 3.9.3.3.  3.9.3.3.1. Where the mixture itself has not been tested to determine its specific target organ toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazards of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3.
 3.9.3.4.  3.9.3.4.1. 
Ingredient classified as: Generic concentration limits triggering classification of the mixture as:
Category 1 Category 2
Category 1Specific Target Organ Toxicant Concentration ≥ 10 % 1,0 % ≤ concentration < 10 %
Category 2Specific Target Organ Toxicant  Concentration ≥ 10 % [(Note 1)]If a Category 2 specific target organ toxicant is present in the mixture as an ingredient at a concentration ≥ 1,0 % a SDS shall be available for the mixture upon request. 3.9.3.4.2. These generic concentration limits and consequent classifications apply to repeated-dose target organ toxicants.
 3.9.3.4.3. Mixtures shall be classified for either or both single- and repeated-dose toxicity independently.
 3.9.3.4.4. Care shall be exercised when toxicants affecting more than one organ system are combined that the potentiation or synergistic interactions are considered, because certain substances can cause target organ toxicity at < 1 % concentration when other ingredients in the mixture are known to potentiate its toxic effect.
 3.9.4.  3.9.4.1. 

Table 3.9.5
Label elements for specific target organ toxicity after repeated exposure
Classification Category 1 Category 2
GHS Pictograms  
Signal word Danger Warning
Hazard Statement H372: Causes damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard) H373: May cause damage to organs (state all organs affected, if known) through prolonged or repeated exposure (state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard)
Precautionary Statement Prevention P260P264P270 P260
Precautionary Statement Response P314 P314
Precautionary Statement Storage  
Precautionary Statement Disposal P501 P501 3.10.  3.10.1.  3.10.1.1. These criteria provide a means of classifying substances or mixtures that may pose an aspiration toxicity hazard to humans.
 3.10.1.2 ‘Aspiration’ means the entry of a liquid or solid substance or mixture directly through the oral or nasal cavity, or indirectly from vomiting, into the trachea and lower respiratory system.
 3.10.1.3. Aspiration toxicity includes severe acute effects such as chemical pneumonia, varying degrees of pulmonary injury or death following aspiration.
 3.10.1.4. Aspiration is initiated at the moment of inspiration, in the time required to take one breath, as the causative material lodges at the crossroad of the upper respiratory and digestive tracts in the laryngopharyngeal region.
 3.10.1.5. Aspiration of a substance or mixture can occur as it is vomited following ingestion. This has consequences for labelling, particularly where, due to acute toxicity, a recommendation may be considered to induce vomiting after ingestion. However, if the substance/mixture also presents an aspiration toxicity hazard, the recommendation to induce vomiting shall be modified.
 3.10.1.6.  3.10.1.6.1. A review of the medical literature on chemical aspiration revealed that some hydrocarbons (petroleum distillates) and certain chlorinated hydrocarbons have been shown to pose an aspiration hazard in humans.
 3.10.1.6.2. Dynamic viscosity mPa sDensity g/cm3=Kinematic viscosity mm2/s 3.10.1.6.3. 
Aerosol and mist forms of a substance or a mixture (product) are usually dispensed in containers such as self-pressurised containers, trigger and pump sprayers. The key to classifying these products is whether a pool of product is formed in the mouth, which then may be aspirated. If the mist or aerosol from a pressurised container is fine, a pool may not be formed. On the other hand, if a pressurised container dispenses product in a stream, a pool may be formed that may then be aspirated. Usually, the mist produced by trigger and pump sprayers is coarse and therefore, a pool may be formed that then may be aspirated. When the pump mechanism may be removed, and the contents are available to be swallowed then the classification of the substance or mixture shall be considered.
 3.10.2. 

Category Criteria
Category 1 Substances known to cause human aspiration toxicity hazards or to be regarded as if they cause human aspiration toxicity hazardA substance is classified in Category 1:
((a)) based on reliable and good quality human evidence
or
((b)) if it is a hydrocarbon and has a kinematic viscosity of 20,5 mm2/s or less, measured at 40 oC.
Substances in Category 1 include but are not limited to certain hydrocarbons, turpentine and pine oil. 3.10.3.  3.10.3.1. 
A mixture is classified in Category 1 based on reliable and good quality human evidence.
 3.10.3.2.  3.10.3.2.1. Where the mixture itself has not been tested to determine its aspiration toxicity, but there are sufficient data on the individual ingredients and similar tested mixtures to adequately characterise the hazard of the mixture, these data shall be used in accordance with the bridging principles set out in section 1.1.3. However, in the case of application of the dilution bridging principle, the concentration of aspiration toxicant(s) shall be 10 % or more.
 3.10.3.3.  3.10.3.3.1.  3.10.3.3.1.1. A mixture which contains a total of 10 % or more of a substance or substances classified in Category 1, and has a kinematic viscosity of 20,5 mm2 /s or less, measured at 40 oC, shall be classified in Category 1.
 3.10.3.3.1.2. In the case of a mixture which separates into two or more distinct layers, one of which contains 10 % or more of a substance or substances classified in Category 1 and has a kinematic viscosity of 20,5 mmo /s or less, measured at 40 oC, then the entire mixture is classified in Category 1.
 3.10.4.  3.10.4.1. 

Table 3.10.2
Aspiration toxicity label elements
Classification Category 1
GHS Pictogram 
Signal Word Danger
Hazard Statement H304: May be fatal if swallowed and enters airways
Precautionary StatementPrevention 
Precautionary StatementResponse P301 + P310P331
Precautionary StatementStorage P405
Precautionary StatementDisposal P501
4.  4.1.  4.1.1.  4.1.1.1. 
Acute aquatic toxicity means the intrinsic property of a substance to be injurious to an organism in a short-term exposure to that substance.

Availability of a substance means the extent to which this substance becomes a soluble or disaggregate species. For metal availability, the extent to which the metal ion portion of a metal (Mo) compound can disaggregate from the rest of the compound (molecule).

Bioavailability (or biological availability) means the extent to which a substance is taken up by an organism, and distributed to an area within the organism. It is dependent upon physico-chemical properties of the substance, anatomy and physiology of the organism, pharmacokinetics, and route of exposure. Availability is not a prerequisite for bioavailability.

Bioaccumulation means the net result of uptake, transformation and elimination of a substance in an organism due to all routes of exposure (i.e. air, water, sediment/soil and food).

Bioconcentration means the net result of uptake, transformation and elimination of a substance in an organism due to waterborne exposure.

Chronic aquatic toxicity means the intrinsic property of a substance to cause adverse effects to aquatic organisms during exposures which are determined in relation to the life-cycle of the organism.

Degradation means the decomposition of organic molecules to smaller molecules and eventually to carbon dioxide, water and salts.
 4.1.1.2.  4.1.1.2.0. 

— Acute aquatic hazard;
— Chronic (long term) aquatic hazard.
 4.1.1.2.1. 

— Acute aquatic toxicity;
— Potential for or actual bioaccumulation;
— Degradation (biotic or abiotic) for organic chemicals; and
— Chronic aquatic toxicity.
 4.1.1.2.2. Preferably data shall be derived using the standardised test methods referred to in Article 8(3). In practice data from other standardised test methods such as national methods shall also be used where they are considered as equivalent. Where valid data are available from non-standard testing and from non-testing methods, these shall be considered in classification provided they fulfil the requirements specified in section 1 of Annex XI to Regulation (EC) No 1907/2006. In general, both freshwater and marine species toxicity data are considered suitable for use in classification provided the test method used are equivalent. Where such data are not available classification shall be based on the best available data. See also Part 1.
 4.1.1.3.  4.1.1.3.1. Classification of substances and mixtures for environmental hazards requires the identification of the hazards they present to the aquatic environment. The aquatic environment is considered in terms of the aquatic organisms that live in the water, and the aquatic ecosystem of which they are part. The basis, therefore, of the identification of hazard is the aquatic toxicity of the substance or mixture, although this shall be modified by taking account of further information on the degradation and bioaccumulation behaviour, if appropriate.
 4.1.1.3.2. While the classification system applies to all substances and mixtures, it is recognised that for special cases the Agency will issue guidance.
 4.1.2.  4.1.2.1. The core classification system for substances consists of one acute classification category and three chronic classification categories. The acute and the chronic classification categories are applied independently. The criteria for classification of a substance in acute Category 1 are defined on the basis of acute aquatic toxicity data only (EC50 or LC50). The criteria for classification of a substance into the chronic categories combine two types of information, i.e. acute aquatic toxicity data and environmental fate data (degradability and bioaccumulation data).
 4.1.2.2. The system also introduces a ‘safety net’ classification (referred to as Chronic Category 4) for use when the data available do not allow classification under the formal criteria but there are nevertheless some grounds for concern (see example in table 4.1.0).
 4.1.2.3. The system for classification recognises that the core intrinsic hazard to aquatic organisms is represented by both the acute and chronic toxicity of a substance. Separate hazard categories are defined for both properties representing a gradation in the level of hazard identified. The lowest of the available toxicity values shall normally be used to define the appropriate hazard category(ies). There are circumstances, however, when a weight of evidence approach is appropriate.
 4.1.2.4. The principal hazard of a ‘hazardous to the aquatic environment’ substance is defined by chronic toxicity, although acute toxicity at L(E)C50 levels ≤ 1 mg/l are also considered hazardous. The intrinsic properties of a lack of rapid degradability and/or a potential to bioconcentrate in combination with acute toxicity are used to assign a substance to a chronic (long term) hazard category.
 4.1.2.5. Substances with acute toxicities well below 1 mg/l contribute as components of a mixture to the toxicity of the mixture even at a low concentration and shall normally be given increased weight in applying the summation of classification approach (see note 1 of Table 4.1.0 and 4.1.3.5.5).
 4.1.2.6. 
Acute (short-term) aquatic hazard
Acute Category 1 (Note 1)
96 hr LC50 (for fish) ≤ 1 mg/l and/or
48 hr EC50 (for crustacea) ≤ 1 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants) ≤ 1 mg/l. (Note 2)
Chronic (long-term) aquatic hazard
Chronic Category 1 (Note 1)
96 hr LC50 (for fish) ≤ 1 mg/l and/or
48 hr EC50 (for crustacea) ≤ 1 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants) ≤ 1 mg/l (Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4).
Chronic Category 2
96 hr LC50 (for fish) > 1 to ≤ 10 mg/l and/or
48 hr EC50 (for crustacea) > 1 to ≤ 10 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants) > 1 to ≤ 10 mg/l (Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4), unless the chronic toxicity NOECs are > 1 mg/l.
Chronic Category 3
96 hr LC50 (for fish) > 10 to ≤ 100 mg/l and/or
48 hr EC50 (for crustacea) > 10 to ≤ 100 mg/l and/or
72 or 96 hr ErC50 (for algae or other aquatic plants) > 10 to ≤ 100 mg/l (Note 2)
and the substance is not rapidly degradable and/or the experimentally determined BCF ≥ 500 (or, if absent, the log Kow ≥ 4) unless the chronic toxicity NOECs are > 1 mg/l.
‘Safety net’ classificationChronic Category 4Cases when data do not allow classification under the above criteria but there are nevertheless some grounds for concern. This includes, for example, poorly soluble substances for which no acute toxicity is recorded at levels up to the water solubility (note 3), and which are not rapidly degradable and have an experimentally determined BCF ≥ 500 (or, if absent, a log Kow ≥ 4), indicating a potential to bioaccumulate, will be classified in this category unless other scientific evidence exists showing classification to be unnecessary. Such evidence includes chronic toxicity NOECs > water solubility or > 1 mg/l, or evidence of rapid degradation in the environment.When classifying substances as Acute Category 1 and/or Chronic Category 1 it is necessary at the same time to indicate an appropriate M-factor (see table 4.1.3).Classification shall be based on the ErC50 [= EC50 (growth rate)]. In circumstances where the basis of the EC50 is not specified or no ErC50 is recorded, classification shall be based on the lowest EC50 available.‘No acute toxicity’ is taken to mean that the L(E)C50(s) is/are above the water solubility. Also for poorly soluble substances, (water solubility < 1 mg/l), where there is evidence that the acute test does not provide a true measure of the intrinsic toxicity. 4.1.2.7.  4.1.2.7.1. Acute aquatic toxicity is normally determined using a fish 96 hour LC50, a crustacea species 48 hour EC50 and/or an algal species 72 or 96 hour EC50. These species cover a range of trophic levels and taxa and are considered as surrogate for all aquatic organisms. Data on other species (e.g. Lemna spp.) shall also be considered if the test methodology is suitable. The aquatic plant growth inhibition tests are normally considered as chronic tests but the EC50s are treated as acute values for classification purposes (see note 2).
 4.1.2.7.2. For determining chronic aquatic toxicity for classification purposes data generated according to the standardised test methods referred to in Article 8(3) shall be accepted, as well as results obtained from other validated and internationally accepted test methods. The NOECS or other equivalent L(E)Cx (e.g. EC10) shall be used.
 4.1.2.8.  4.1.2.8.1. Bioaccumulation of substances within aquatic organisms can give rise to toxic effects over longer time scales even when actual water concentrations are low. For organic substances the potential for bioaccumulation shall normally be determined by using the octanol/water partition coefficient, usually reported as a log Kow. The relationship between the log Kow of an organic substance and its bioconcentration as measured by the bioconcentration factor (BCF) in fish has considerable scientific literature support. Using a cut-off value of log Kow ≥ 4 is intended to identify only those substances with a real potential to bioconcentrate. While this represents a potential to bioaccumulate, an experimentally determined BCF provides a better measure and shall be used in preference if available. A BCF in fish of ≥ 500 is indicative of the potential to bioconcentrate for classification purposes.
 4.1.2.9.  4.1.2.9.1. Substances that rapidly degrade can be quickly removed from the environment. While effects of such substances can occur, particularly in the event of a spillage or accident, they are localised and of short duration. In the absence of rapid degradation in the environment a substance in the water has the potential to exert toxicity over a wide temporal and spatial scale.
 4.1.2.9.2. One way of demonstrating rapid degradation utilises the biodegradation screening tests designed to determine whether an organic substance is ‘readily biodegradable’. Where such data are not available, a BOD(5 days)/COD ratio ≥ 0,5 is considered as indicative of rapid degradation. Thus, a substance which passes this screening test is considered likely to biodegrade ‘rapidly’ in the aquatic environment, and is thus unlikely to be persistent. However, a fail in the screening test does not necessarily mean that the substance will not degrade rapidly in the environment. Other evidence of rapid degradation in the environment may therefore also be considered and are of particular importance where the substances are inhibitory to microbial activity at the concentration levels used in standard testing. Thus, a further classification criterion is included which allows the use of data to show that the substance did actually degrade biotically or abiotically in the aquatic environment by > 70 % in 28 days. Thus, if degradation is demonstrated under environmentally realistic conditions, then the criterion of ‘rapid degradability’ is met.
 4.1.2.9.3. Many degradation data are available in the form of degradation half-lives and these can be used in defining rapid degradation provided that ultimate biodegradation of the substance, i.e. full mineralisation, is achieved. Primary biodegradation does not normally suffice in the assessment of rapid degradability unless it can be demonstrated that the degradation products do not fulfil the criteria for classification as hazardous to the aquatic environment.
 4.1.2.9.4. The criteria used reflect the fact that environmental degradation may be biotic or abiotic. Hydrolysis can be considered if the hydrolysis products do not fulfil the criteria for classification as hazardous to the aquatic environment.
 4.1.2.9.5. 

((a)) if, in 28-day ready biodegradation studies, at least the following levels of degradation are achieved;

((i)) tests based on dissolved organic carbon: 70 %
((ii)) tests based on oxygen depletion or carbon dioxide generation: 60 % of theoretical maximum.
These levels of biodegradation must be achieved within 10 days of the start of degradation which point is taken as the time when 10 % of the substance has been degraded; or
((b)) if, in those cases where only BOD and COD data are available, when the ratio of BOD5/COD is ≥ 0,5; or
((c)) if other convincing scientific evidence is available to demonstrate that the substance can be degraded (biotically and/or abiotically) in the aquatic environment to a level > 70 % within a 28-day period.
 4.1.2.10.  4.1.2.10.1. For inorganic compounds and metals, the concept of degradability as applied to organic compounds has limited or no meaning. Rather, such substances may be transformed by normal environmental processes to either increase or decrease the bioavailability of the toxic species. Equally the use of bioaccumulation data shall be treated with care.
 4.1.2.10.2. Poorly soluble inorganic compounds and metals may be acutely or chronically toxic in the aquatic environment depending on the intrinsic toxicity of the bioavailable inorganic species and the rate and amount of this species which enter solution.
 4.1.3.  4.1.3.1. 
The ‘relevant components’ of a mixture are those which are classified ‘Acute Category 1’ or ‘Chronic Category 1’ and present in a concentration of 0,1 % (w/w) or greater, and those which are classified ‘Chronic Category 2’, ‘Chronic Category 3’ or ‘Chronic Category 4’ and present in a concentration of 1 % (w/w) or greater, unless there is a presumption (such as in the case of highly toxic components (see 4.1.3.5.5.5)) that a component present in a lower concentration can still be relevant for classifying the mixture for aquatic environmental hazards. Generally, for substances classified as ‘Acute Category 1’ or ‘Chronic Category 1’ the concentration to be taken into account is (0,1/M) %. (For explanation M-factor see 4.1.3.5.5.5).
 4.1.3.2. 
Elements of the tiered approach include:


— classification based on tested mixtures;
— classification based on bridging principles;
— the use of ‘summation of classified components’ and/or an ‘additivity formula’.
 Figure 4.1.2  4.1.3.3.  4.1.3.3.1. When the mixture as a whole has been tested to determine its aquatic toxicity, it is classified according to the criteria that have been agreed for substances, but only for acute hazard. The classification is normally based on the data for fish, crustacea and algae/plants. Classification of mixtures by using LC50 or EC50 data for the mixture as a whole is not possible for chronic categories since both toxicity data and environmental fate data are needed, and there are no degradability and bioaccumulation data for mixtures as a whole. It is not possible to apply the criteria for chronic classification because the data from degradability and bioaccumulation tests of mixtures cannot be interpreted; they are meaningful only for single substances.
 4.1.3.3.2. 

((a)) L(E)C50 (LC50 or EC50) of the tested mixture ≤ 100 mg/l and NOEC of the tested mixture ≤ 1 mg/l or unknown:

— Classify mixture as Acute Category 1 (LC50 or EC50 of the tested mixture ≤ 1 mg/l) or no need for acute classification (LC50 and EC50 of the tested mixture > 1 mg/l).
— Apply summation method (see 4.1.3.5.5) for chronic classification (Chronic Category 1, 2, 3, 4 or no need for chronic classification).
((b)) L(E)C50 of the tested mixture ≤ 100 mg/l and NOEC(s) of the tested mixture > 1 mg/l:

— No need to classify for acute hazard
— Apply summation method (see 4.1.3.5.5) for classification as Chronic Category 1. If the mixture is not classified as Chronic Category 1, then there is no need for chronic classification.
((c)) L(E)C50(s) of the tested mixture > 100 mg/l, or above the water solubility, and NOEC of the tested mixture ≤ 1 mg/l or unknown:

— No need to classify for acute hazard
— Apply summation method (see 4.1.3.5.5) for Chronic classification (Chronic Category 4 or no need for chronic classification).
((d)) L(E)C50(s) of the tested mixture > 100 mg/l, or above the water solubility, and NOEC(s) of the tested mixture > 1 mg/l:

— No need to classify for acute or chronic (long-term) hazard.
 4.1.3.4.  4.1.3.4.1. Where the mixture itself has not been tested to determine its aquatic environmental hazard, but there are sufficient data on the individual components and similar tested mixtures to adequately characterise the hazards of the mixture, this data shall be used in accordance with the bridging rules set out in section 1.1.3. However, in relation to application of the bridging rule for dilution, paragraphs 4.1.3.4.2 and 4.1.3.4.3 shall be used.
 4.1.3.4.2. Dilution: if a mixture is formed by diluting another mixture or a substance classified for its aquatic environmental hazard with a diluent which has an equivalent or lower aquatic hazard classification than the least toxic original component and which is not expected to affect the aquatic hazards of other components, then the mixture may be classified as equivalent to the original mixture or substance.
 4.1.3.4.3. If a mixture is formed by diluting another classified mixture or substance with water or other totally non-toxic material, the toxicity of the mixture can be calculated from the original mixture or substance
 4.1.3.5.  4.1.3.5.1. The classification of a mixture is based on summation of the classification of its components. The percentage of components classified as ‘Acute’ or ‘Chronic’ is fed straight in to the summation method. Details of the summation method are described in 4.1.3.5.5.
 4.1.3.5.2. ΣCiC(E)L50m = ΣηCiC(E)L50i
where:

Ciconcentration of component i (weight percentage)L(E)C50 i(mg/l) LC50 or EC50 for component iηnumber of componentsL(E)C50 mL(E) C50 of the part of the mixture with test data
 4.1.3.5.3. When applying the additivity formula for part of the mixture, it is preferable to calculate the toxicity of this part of the mixture using for each substance toxicity values that relate to the same taxonomic group (i.e. fish, daphnia, algae or equivalent) and then to use the highest toxicity (lowest value) obtained (i.e. use the most sensitive of the three taxonomic groups). However, when toxicity data for each component are not available in the same taxonomic group, the toxicity value of each component is selected in the same manner that toxicity values are selected for the classification of substances, i.e. the higher toxicity (from the most sensitive test organism) is used. The calculated acute toxicity is then used to assess whether this part of the mixture shall be classified as Acute Category 1 using the same criteria described for substances.
 4.1.3.5.4. If a mixture is classified in more than one way, the method yielding the more conservative result shall be used.
 4.1.3.5.5.  4.1.3.5.5.1.  4.1.3.5.5.1.1. In case of the substance classification categories Acute Category 1 or Chronic Category 1 to Chronic Category 3, the underlying toxicity criteria differ by a factor of 10 in moving from one category to another. Substances with a classification in a high toxicity band therefore contribute to the classification of a mixture in a lower band. The calculation of these classification categories therefore needs to consider the contribution of all substances classified as Acute Category 1/Chronic Category 1, Chronic Category 2 and Chronic Category 3 together.
 4.1.3.5.5.1.2. When a mixture contains components classified as Acute Category 1 or Chronic Category 1, attention must be paid to the fact that such components, when their acute toxicity is below 1 mg/l contribute to the toxicity of the mixture even at a low concentration. Active ingredients in pesticides often possess such high aquatic toxicity but also some other substances like organometallic compounds. Under these circumstances the application of the normal generic concentration limits leads to an ‘under-classification’ of the mixture. Therefore, multiplying factors shall be applied to account for highly toxic components, as described in paragraph 4.1.3.5.5.5.
 4.1.3.5.5.2.  4.1.3.5.5.2.1. In general a more severe classification for mixtures overrides a less severe classification, e.g. a classification for chronic toxicity with Chronic Category 1 overrides a classification with Chronic Category 2. As a consequence, in this example, the classification procedure is already completed if the result of the classification is Chronic Category 1. A more severe classification than Chronic Category 1 is not possible. Therefore it is not necessary to undergo the further classification procedure.
 4.1.3.5.5.3.  4.1.3.5.5.3.1. First all components classified as Acute Category 1 are considered. If the sum of these components is greater than 25 % the whole mixture is classified as Acute Category 1.
 4.1.3.5.5.3.2. 

Table 4.1.1
Classification of a mixture for acute hazards, based on summation of classified components
Sum of components classified as: Mixture is classified as:
Acute Category 1 × M ≥ 25 % Acute Category 1
 4.1.3.5.5.4.  4.1.3.5.5.4.1. First all components classified as Chronic Category 1 are considered. If the sum of these components multiplied by their corresponding M-factors is equal to or greater than 25 % the mixture is classified as Chronic Category 1. If the result of the calculation is a classification of the mixture as Chronic Category 1 the classification procedure is completed.
 4.1.3.5.5.4.2. In cases where the mixture is not classified as Chronic Category 1, classification of the mixture as Chronic Category 2 is considered. A mixture is classified as Chronic Category 2 if 10 times the sum of all components classified as Chronic Category 1 multiplied by their corresponding M-factors plus the sum of all components classified as Chronic Category 2 is equal to or greater than 25 %. If the result of the calculation is classification of the mixture as Chronic Category 2, the classification process is completed.
 4.1.3.5.5.4.3. In cases where the mixture is not classified either as Chronic Category 1 or Chronic Category 2, classification of the mixture as Chronic Category 3 is considered. A mixture is classified as Chronic Category 3 if 100 times the sum of all components classified as Chronic Category 1 multiplied by their corresponding M-factors plus 10 times the sum of all components classified with Chronic Category 2 plus the sum of all components classified as Chronic Category 3 is ≥ 25 %.
 4.1.3.5.5.4.4. If the mixture is still not classified in Chronic Category 1, 2 or 3, classification of the mixture as Chronic Category 4 shall be considered. A mixture is classified as Chronic Category 4 if the sum of the percentages of components classified as Chronic Category 1, 2, 3 and 4 is equal to or greater than 25 %.
 4.1.3.5.5.4.5. 

Table 4.1.2
Classification of a mixture for chronic (long term) hazards, based on summation of classified components
Sum of components classified as: Mixture is classified as:
Chronic Category 1 × M ≥ 25 % Chronic Category 1
(M × 10 × Chronic Category 1) + Chronic Category 2 ≥ 25 % Chronic Category 2
(M × 100 × Chronic Category 1) + (10 × Chronic Category 2) + Chronic Category 3 ≥ 25 % Chronic Category 3
Chronic Category 1 + Chronic Category 2 + Chronic Category 3 + Chronic Category 4 ≥ 25 % Chronic Category 4
 4.1.3.5.5.5.  4.1.3.5.5.5.1. 

— The tiered approach described in 4.1.3.5.5.3 and 4.1.3.5.5.4 using a weighted sum by multiplying the concentrations of Acute Category 1 and Chronic Category 1 components by a factor, instead of merely adding up the percentages. This means that the concentration of ‘Acute Category 1’ in the left column of Table 4.1.1 and the concentration of ‘Chronic Category 1’ in the left column of Table 4.1.2 are multiplied by the appropriate multiplying factor. The multiplying factors to be applied to these components are defined using the toxicity value, as summarised in Table 4.1.3. Therefore, in order to classify a mixture containing Acute/Chronic Category 1 components, the classifier needs to be informed of the value of the M-factor in order to apply the summation method;
— The additivity formula (see 4.1.3.5.2) provided that toxicity data are available for all highly toxic components in the mixture and there is convincing evidence that all other components, including those for which specific acute toxicity data are not available, are of low or no toxicity and do not significantly contribute to the environmental hazard of the mixture.


Table 4.1.3
Multiplying factors for highly toxic components of mixtures
L(E)C50 value Multiplying factor (M)
0,1 < L(E) C50 ≤ 1 1
0,01 < L(E) C50 ≤ 0,1 10
0,001 < L(E) C50 ≤ 0,01 100
0,0001 < L(E) C50 ≤ 0,001 1 000
0,00001 < L(E) C50 ≤ 0,0001 10 000
(continue in factor 10 intervals)  4.1.3.6.  4.1.3.6.1. In the event that no useable information on acute and/or chronic (long term) aquatic hazard is available for one or more relevant components, it is concluded that the mixture cannot be attributed to one or more definitive hazard category(ies). In this situation the mixture shall be classified based on the known components only, with the additional statement in the SDS that: ‘Contains x % of components with unknown hazards to the aquatic environment’.
 4.1.4.  4.1.4.1. 
ACUTE
 Category 1
GHS Pictogram 
Signal Word Warning
Hazard Statement H400: Very toxic to aquatic life
Precautionary Statement Prevention P273
Precautionary Statement Response P391
Precautionary Statement Storage 
Precautionary Statement Disposal P501CHRONIC
 Category 1 Category 2 Category 3 Category 4
GHS Pictograms   No pictogram is used No pictogram is used
Signal Word Warning No signal word is used No signal word is used No signal word is used
Hazard Statement H410: Very toxic to aquatic life with long lasting effects H411: Toxic to aquatic life with long lasting effects H412: Harmful to aquatic life with long lasting effects H413: May cause long lasting harmful effects to aquatic life
Precautionary Statement Prevention P273 P273 P273 P273
Precautionary Statement Response P391 P391  
Precautionary Statement Storage    
Precautionary Statement Disposal P501 P501 P501 P501
5.  5.1.  5.1.1.  5.1.1.1. Substance Hazardous to the Ozone Layer means a substance which, on the basis of the available evidence concerning its properties and its predicted or observed environmental fate and behaviour may present a danger to the structure and/or the functioning of the stratospheric ozone layer. This includes substances which are listed in Annex I to Regulation (EC) No 2037/2000 of the European Parliament and of the Council of 29 June 2000 on substances that deplete the ozone layer and its subsequent amendments.
 5.1.2.  5.1.2.1. A substance shall be classified as Hazardous to the Ozone Layer if the available evidence concerning its properties and its predicted or observed environmental fate and behaviour indicate that it may present a danger to the structure and/or the functioning of the stratospheric ozone layer.
 5.1.3.  5.1.3.1. 

Table 5.1
Generic concentration limits for substances (in a mixture), classified as Hazardous to the Ozone Layer, that trigger classification of the mixture as Hazardous to the Ozone Layer
Classification of the substance Classification of the mixture
Hazardous to the ozone layer C > 0,1 % 5.1.4.  5.1.4.1. 

Table 5.2
Label elements for Hazardous to the Ozone Layer
Symbol/pictogram 
Signal Word Danger
Hazard Statement EUH059: Hazardous to the Ozone Layer
Precautionary Statements P273P501
ANNEX II
This Annex consists of 5 parts:

— Part 1 contains special rules for the labelling of certain classified substances and mixtures.
— Part 2 sets out rules for additional hazard statements to be included on the label of certain mixtures.
— Part 3 sets out special rules for packaging.
— Part 4 sets out a special rule for the labelling of plant protection products.
— Part 5 sets up a list of hazardous substances and mixtures to which Article 29(3) applies.

1. 
The statements set out in sections 1.1 and 1.2 shall be assigned in accordance with Article 25(1) to substances and mixtures classified for physical, health or environmental hazards.
 1.1.  1.1.1. 
For explosive substances and mixtures as referred to in section 2.1 of Annex I, placed on the market wetted with water or alcohols or diluted with other substances to suppress their explosive properties.
 1.1.2. 
For substances and mixtures which are unstable at ambient temperatures, such as acetylene.
 1.1.3. 
For substances and mixtures which react violently with water, such as acetyl chloride, alkali metals, titanium tetrachloride.
 1.1.4. 
For substances and mixtures not classified as flammable themselves, which may form flammable/explosive vapour-air mixtures. For substances this might be the case for halogenated hydrocarbons and for mixtures this might be the case due to a volatile flammable component or due to the loss of a volatile non-flammable component.
 1.1.5. 
For substances and mixtures which may form explosive peroxides during storage, such as diethyl ether, 1,4-dioxane.
 1.1.6. 
For substances and mixtures not in themselves classified as explosive in accordance with section 2.1 of Annex I, but which may nevertheless display explosive properties in practice if heated under sufficient confinement. In particular, substances which decompose explosively if heated in a steel drum do not show this effect if heated in less-strong containers.
 1.2.  1.2.1. 
For substances and mixtures which in contact with water or damp air, evolve gases classified for acute toxicity in category 1, 2 or 3 in potentially dangerous amounts, such as aluminium phosphide, phosphorus pentasulphide.
 1.2.2. 
For substances and mixtures which react with acids to evolve gases classified for acute toxicity in category 3 in dangerous amounts, such as sodium hypochlorite, barium polysulphide.
 1.2.3. 
For substances and mixtures which react with acids to evolve gases classified for acute toxicity in category 1 or 2 in dangerous amounts, such as salts of hydrogen cyanide, sodium azide.
 1.2.4. 
For substances and mixtures which may cause concern as a result of skin dryness, flaking or cracking but which do not meet the criteria for skin irritancy in section 3.2 of Annex I, based on either:


— practical observations; or
— relevant evidence concerning their predicted effects on the skin.
 1.2.5. 
For substances or mixtures where an eye irritation test has resulted in overt signs of systemic toxicity or mortality among the animals tested, which is likely to be attributed to absorption of the substance or mixture through the mucous membranes of the eye. The statement shall also be applied if there is evidence in humans for systemic toxicity after eye contact.

The statement shall also be applied where a substance or a mixture contains another substance labelled for this effect, if the concentration of this substance is equal to, or greater than 0,1 %, unless otherwise specified in part 3 of Annex VI.
 1.2.6. 
For substances and mixtures in addition to classification for inhalation toxicity, if data are available that indicate that the mechanism of toxicity is corrosivity, in accordance with section 3.1.2.3.3 and Note 1 of Table 3.1.3 in Annex I.

For substances and mixtures in addition to classification for skin corrosivity, if no acute inhalation test data are available and which may be inhaled.

2. 
The statements set out in sections 2.1 to 2.10 shall be assigned to mixtures in accordance with Article 25(6).
 2.1. 
The label on the packaging of paints and varnishes containing lead in quantities exceeding 0,15 % (expressed as weight of metal) of the total weight of the mixture, as determined in accordance with ISO standard 6503, shall bear the following statement:

EUH201 — ‘Contains lead. Should not be used on surfaces liable to be chewed or sucked by children’

In the case of packages the contents of which are less than 125 ml, the statement may be as follows:

EUH201A — ‘Warning! Contains lead’
 2.2. 
The label on the immediate packaging of adhesives based on cyanoacrylate shall bear the following statement:

EUH202 — ‘Cyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children’

Appropriate advice on safety shall accompany the package.
 2.3. 
Unless cements or cement mixtures are already classified and labelled as a sensitiser with the hazard statement H317, ‘May cause an allergic skin reaction’, the label on the packaging of cements and cement mixtures that contain, when they are hydrated, more than 0,0002 % soluble chromium (VI) of the total dry weight of the cement shall bear the statement:

EUH203 — ‘Contains chromium (VI). May produce an allergic reaction’

If reducing agents are used, then the packaging of cement or cement-containing mixtures shall include information on the packing date, the storage conditions and the storage period appropriate to maintaining the activity of the reducing agent and to keeping the content of soluble chromium VI below 0,0002 %.
 2.4. 
Unless already identified on the label of the packaging, mixtures containing isocyanates (as monomers, oligomers, prepolymers, etc., or as mixtures thereof) shall bear the following statement:

EUH204 — ‘Contains isocyanates. May produce an allergic reaction.’
 2.5. 
Unless already identified on the label of the packaging, mixtures containing epoxy constituents with an average molecular weight ≤ 700 shall bear the following statement:

EUH205 — ‘Contains epoxy constituents. May produce an allergic reaction.’
 2.6. 
The label on the packaging of mixtures containing more than 1 % of active chlorine shall bear the following statement:

EUH206 — ‘Warning! Do not use together with other products. May release dangerous gases (chlorine)’
 2.7. 
The label on the packaging of the above mentioned mixtures shall bear the following statement:

EUH207 — ‘Warning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions’
 2.8. 
The label on the packaging of mixtures containing at least one substance classified as sensitising and present in a concentration equal to or greater than 0,1 % or in a concentration equal to or greater than that specified under a specific note for the substance in part 3 of Annex VI shall bear the statement:

EUH208 — ‘Contains (name of sensitising substance). May produce an allergic reaction’
 2.9. 
For liquid mixtures which show no flashpoint or a flashpoint higher than 60 oC but not more than 93 oC and contain a halogenated hydrocarbon and more than 5 % highly flammable or flammable substances, the label on the packaging shall bear one of the following statements, depending on whether the substances referred to above are highly flammable or flammable:

EUH209 — ‘Can become highly flammable in use’ or

EUH209A — ‘Can become flammable in use’
 2.10. 
For mixtures not classified as hazardous but which contain:


— ≥ 0,1 % of a substance classified as skin sensitiser category 1, respiratory sensitiser category 1, or carcinogenic category 2; or
— ≥ 0,1 % of a substance classified as toxic to reproduction categories 1A, 1B or 2, or with effects on or via lactation; or
— at least one substance in an individual concentration of ≥ 1 % by weight for non-gaseous mixtures and ≥ 0,2 % by volume for gaseous mixtures either:
— classified with other health or environmental hazards; or
— for which there are Community workplace exposure limits

the label on the packaging shall bear the statement:

EUH210 — ‘Safety data sheet available on request’.
 2.11 
Note that aerosols are also subject to the labelling provisions in accordance with points 2.2 and 2.3 in the Annex to Directive 75/324/EEC.

3.  3.1.  3.1.1.  3.1.1.1. Packaging of whatever capacity containing a substance or mixture supplied to the general public and classified for acute toxicity, categories 1 to 3, STOT — single exposure category 1, STOT — repeated exposure category 1, or skin corrosion category 1 shall be fitted with child-resistant fastenings.
 3.1.1.2. Packaging of whatever capacity containing a substance or mixture supplied to the general public presenting an aspiration hazard and classified according to sections 3.10.2 and 3.10.3 of Annex I and labelled according to section 3.10.4.1 of Annex I, with the exception of substances and mixtures placed on the market in the form of aerosols or in a container fitted with a sealed spray attachment, shall be fitted with child-resistant fastenings.
 3.1.1.3 
No Identification of the substance Concentration limit
CAS No Name EC No
1 67-56-1 methanol 200-659-6 ≥ 3 %
2 75-09-2 dichloromethane 200-838-9 ≥ 1 % 3.1.2 
Child-resistant fastenings used on reclosable packages shall comply with EN ISO standard 8317 as amended relating to ‘Child-resistant packages — Requirements and methods of testing for reclosable packages’ adopted by the European Committee for standardisation (CEN) and the International Standard Organisation (ISO).
 3.1.3 
Child-resistant fastenings used on non-reclosable packages shall comply with CEN standard EN 862 as amended relating to ‘Packaging — Child-resistant packaging — Requirements and testing procedures for non-reclosable packages for non-pharmaceutical products’ adopted by the European Committee for Standardisation (CEN).
 3.1.4  3.1.4.1. Evidence of conformity with the above standards may be certified only by laboratories which conform with Standard EN ISO/IEC 17025 as amended.
 3.1.4.2. 
If it seems obvious that packaging is sufficiently safe for children because they cannot get access to the contents without the help of a tool, the test referred to in section 3.1.2 or 3.1.3 does not need to be performed.

In all other cases and when there are sufficient grounds for doubting the security of the closure for a child, the national authority may ask the person responsible for putting the product on the market to give it a certificate from a certifying laboratory, referred to in section 3.1.4.1, stating that either:


— the type of closure is such that it is not necessary to perform the test referred to in section 3.1.2. or 3.1.3; or
— the closure has been tested and has been found to conform with the standards referred to above.
 3.2.  3.2.1. 
Where substances or mixtures are supplied to the general public and classified for acute toxicity, skin corrosion, germ cell mutagenicity category 2, carcinogenicity category 2, reproductive toxicity category 2, respiratory sensitisation, or Stot, categories 1 and 2, aspiration hazard, or flammable gases, liquids and solids in categories 1 and 2, the packaging of whatever capacity, shall be fitted with a tactile warning of danger.
 3.2.2  3.2.2.1 This provision does not apply to aerosols which are only classified and labelled as ‘extremely flammable aerosols’ or ‘flammable aerosols’.
 3.2.2.2. The technical specifications for tactile warning devices shall conform to EN ISO standard 11683 as amended ‘Packaging — Tactile warnings of danger-Requirements’.

4. 
Without prejudice to the information required in accordance with Article 16 of Directive 91/414/EEC and Annex V of that Directive, the labelling for plant protection products subject to Directive 91/414/EEC shall also include the following wording:

EUH401 — ‘To avoid risks to human health and the environment, comply with the instructions for use’

5. 

— Ready mixed cement and concrete in the wet state.

ANNEX III
1. 
The hazard statements shall be applied in accordance with Parts 2, 3 and 4 of Annex I.


H200 Language 2.1 — Explosives, Unstable explosives
 BG Нестабилен експлозив.
 ES Explosivo inestable.
 CS Nestabilní výbušnina.
 DA Ustabilt eksplosiv.
 DE Instabil, explosiv.
 ET Ebapüsiv lõhkeaine.
 EL Ασταθή εκρηκτικά.
 EN Unstable explosives.
 FR Explosif instable.
 GA Pléascáin éagobhsaí.
 IT Esplosivo instabile.
 LV Nestabili sprādzienbīstami materiāli.
 LT Nestabilios sprogios medžiagos.
 HU Instabil robbanóanyagok.
 MT Splussivi instabbli.
 NL Instabiele ontplofbare stof.
 PL Materiały wybuchowe niestabilne.
 PT Explosivo instável.
 RO Exploziv instabil.
 SK Nestabilné výbušniny.
 SL Nestabilni eksplozivi.
 FI Epästabiili räjähde.
 SV Instabilt explosivt.



H201 Language 2.1 — Explosives, Division 1.1
 BG Експлозив; опасност от масова експлозия.
 ES Explosivo; peligro de explosión en masa.
 CS Výbušnina; nebezpečí masivního výbuchu.
 DA Eksplosiv, masseeksplosionsfare.
 DE Explosiv, Gefahr der Massenexplosion.
 ET Plahvatusohtlik; massiplahvatusoht.
 EL Εκρηκτικό· κίνδυνος μαζικής έκρηξης.
 EN Explosive; mass explosion hazard.
 FR Explosif; danger d'explosion en masse.
 GA Pléascach; guais mhórphléasctha.
 IT Esplosivo; pericolo di esplosione di massa.
 LV Sprādzienbīstams; masveida sprādzienbīstamība.
 LT Sprogios medžiagos, kelia masinio sprogimo pavojų.
 HU Robbanóanyag; teljes tömeg felrobbanásának veszélye.
 MT Splussiv; periklu li jisplodu kollha f'daqqa.
 NL Ontplofbare stof; gevaar voor massa-explosie.
 PL Materiał wybuchowy; zagrożenie wybuchem masowym.
 PT Explosivo; perigo de explosão em massa.
 RO Exploziv; pericol de explozie în masă.
 SK Výbušnina, nebezpečenstvo rozsiahleho výbuchu.
 SL Eksplozivno; nevarnost eksplozije v masi.
 FI Räjähde; massaräjähdysvaara.
 SV Explosivt. Fara för massexplosion.


H202 Language 2.1 — Explosives, Division 1.2
 BG Експлозив; сериозна опасност от разпръскване.
 ES Explosivo; grave peligro de proyección.
 CS Výbušnina; vážné nebezpečí zasažení částicemi.
 DA Eksplosiv, alvorlig fare for udslyngning af fragmenter.
 DE Explosiv; große Gefahr durch Splitter, Spreng- und Wurfstücke.
 ET Plahvatusohtlik; suur laialipaiskumisoht.
 EL Εκρηκτικό· σοβαρός κίνδυνος εκτόξευσης.
 EN Explosive, severe projection hazard.
 FR Explosif; danger sérieux de projection.
 GA Pléascach, guais throm teilgin.
 IT Esplosivo; grave pericolo di proiezione.
 LV Sprādzienbīstams; augsta izmetes bīstamība.
 LT Sprogios medžiagos, kelia didelį išsvaidymo pavojų.
 HU Robbanóanyag; kivetés súlyos veszélye.
 MT Splussiv, periklu serju ta' projezzjoni.
 NL Ontplofbare stof, ernstig gevaar voor scherfwerking.
 PL Materiał wybuchowy, poważne zagrożenie rozrzutem.
 PT Explosivo, perigo grave de projecções.
 RO Exploziv; pericol grav de proiectare.
 SK Výbušnina, závažné nebezpečenstvo rozletenia úlomkov.
 SL Eksplozivno, velika nevarnost za nastanek drobcev.
 FI Räjähde; vakava sirpalevaara.
 SV Explosivt. Allvarlig fara för splitter och kaststycken.


H203 Language 2.1 — Explosives, Division 1.3
 BG Експлозив; опасност от пожар, взрив или разпръскване.
 ES Explosivo; peligro de incendio, de onda expansiva o de proyección.
 CS Výbušnina; nebezpečí požáru, tlakové vlny nebo zasažení částicemi.
 DA Eksplosiv, fare for brand, eksplosion eller udslyngning af fragmenter.
 DE Explosiv; Gefahr durch Feuer, Luftdruck oder Splitter, Spreng- und Wurfstücke.
 ET Plahvatusohtlik; süttimis-, plahvatus- või laialipaiskumisoht.
 EL Εκρηκτικό· κίνδυνος πυρκαγιάς, ανατίναξης ή εκτόξευσης.
 EN Explosive; fire, blast or projection hazard.
 FR Explosif; danger d'incendie, d'effet de souffle ou de projection.
 GA Pléascach; guais dóiteáin, phléasctha nó teilgin.
 IT Esplosivo; pericolo di incendio, di spostamento d'aria o di proiezione.
 LV Sprādzienbīstams; uguns, triecienviļņa vai izmetes bīstamība.
 LT Sprogios medžiagos, kelia gaisro, sprogimo arba išsvaidymo pavojų.
 HU Robbanóanyag; tűz, robbanás vagy kivetés veszélye.
 MT Splussiv; periklu ta' nar, blast jew projezzjoni.
 NL Ontplofbare stof; gevaar voor brand, luchtdrukwerking of scherfwerking.
 PL Materiał wybuchowy; zagrożenie pożarem, wybuchem lub rozrzutem.
 PT Explosivo; perigo de incêndio, sopro ou projecções.
 RO Exploziv; pericol de incendiu, detonare sau proiectare.
 SK Výbušnina, nebezpečenstvo požiaru, výbuchu alebo rozletenia úlomkov.
 SL Eksplozivno; nevarnost za nastanek požara, udarnega vala ali drobcev.
 FI Räjähde; palo-, räjähdys- tai sirpalevaara.
 SV Explosivt. Fara för brand, tryckvåg eller splitter och kaststycken.


H204 Language 2.1 — Explosives, Division 1.4
 BG Опасност от пожар или разпръскване.
 ES Peligro de incendio o de proyección.
 CS Nebezpečí požáru nebo zasažení částicemi.
 DA Fare for brand eller udslyngning af fragmenter.
 DE Gefahr durch Feuer oder Splitter, Spreng- und Wurfstücke.
 ET Süttimis- või laialipaiskumisoht.
 EL Κίνδυνος πυρκαγιάς ή εκτόξευσης.
 EN Fire or projection hazard.
 FR Danger d'incendie ou de projection.
 GA Guais dóiteáin nó teilgin.
 IT Pericolo di incendio o di proiezione.
 LV Uguns vai izmetes bīstamība.
 LT Gaisro arba išsvaidymo pavojus.
 HU Tűz vagy kivetés veszélye.
 MT Periklu ta' nar jew ta' projezzjoni.
 NL Gevaar voor brand of scherfwerking.
 PL Zagrożenie pożarem lub rozrzutem.
 PT Perigo de incêndio ou projecções.
 RO Pericol de incendiu sau de proiectare.
 SK Nebezpečenstvo požiaru alebo rozletenia úlomkov.
 SL Nevarnost za nastanek požara ali drobcev.
 FI Palo- tai sirpalevaara.
 SV Fara för brand eller splitter och kaststycken.


H205 Language 2.1 — Explosives, Division 1.5
 BG Може да предизвика масова експлозия при пожар.
 ES Peligro de explosión en masa en caso de incendio.
 CS Při požáru může způsobit masivní výbuch.
 DA Fare for masseeksplosion ved brand.
 DE Gefahr der Massenexplosion bei Feuer.
 ET Süttimise korral massiplahvatusoht.
 EL Κίνδυνος μαζικής έκρηξης σε περίπτωση πυρκαγιάς.
 EN May mass explode in fire.
 FR Danger d'explosion en masse en cas d'incendie.
 GA D'fhéadfadh sé go mbeadh mórphléascadh i dtine.
 IT Pericolo di esplosione di massa in caso d'incendio.
 LV Ugunī var masveidā eksplodēt.
 LT Per gaisrą gali sukelti masinį sprogimą.
 HU Tűz hatására a teljes tömeg felrobbanhat.
 MT Jista' jisplodi f'daqqa fin-nar.
 NL Gevaar voor massa-explosie bij brand.
 PL Może wybuchać masowo w przypadku pożaru.
 PT Perigo de explosão em massa em caso de incêndio.
 RO Pericol de explozie în masă în caz de incendiu.
 SK Nebezpečenstvo rozsiahleho výbuchu pri požiari.
 SL Pri požaru lahko eksplodira v masi.
 FI Koko massa voi räjähtää tulessa.
 SV Fara för massexplosion vid brand.


H220 Language 2.2 — Flammable gases, Hazard Category 1
 BG Изключително запалим газ.
 ES Gas extremadamente inflamable.
 CS Extrémně hořlavý plyn.
 DA Yderst brandfarlig gas.
 DE Extrem entzündbares Gas.
 ET Eriti tuleohtlik gaas.
 EL Εξαιρετικά εύφλεκτο αέριο.
 EN Extremely flammable gas.
 FR Gaz extrêmement inflammable.
 GA Gás fíor-inadhainte.
 IT Gas altamente infiammabile.
 LV Īpaši viegli uzliesmojoša gāze.
 LT Ypač degios dujos.
 HU Rendkívül tűzveszélyes gáz.
 MT Gass li jaqbad malajr ħafna.
 NL Zeer licht ontvlambaar gas.
 PL Skrajnie łatwopalny gaz.
 PT Gás extremamente inflamável.
 RO Gaz extrem de inflamabil.
 SK Mimoriadne horľavý plyn.
 SL Zelo lahko vnetljiv plin.
 FI Erittäin helposti syttyvä kaasu.
 SV Extremt brandfarlig gas.


H221 Language 2.2 — Flammable gases, Hazard Category 2
 BG Запалим газ.
 ES Gas inflamable.
 CS Hořlavý plyn.
 DA Brandfarlig gas.
 DE Entzündbares Gas.
 ET Tuleohtlik gaas.
 EL Εύφλεκτο αέριο.
 EN Flammable gas.
 FR Gaz inflammable.
 GA Gás inadhainte.
 IT Gas infiammabile.
 LV Uzliesmojoša gāze.
 LT Degios dujos.
 HU Tűzveszélyes gáz.
 MT Gass li jaqbad.
 NL Ontvlambaar gas.
 PL Gaz łatwopalny.
 PT Gás inflamável.
 RO Gaz inflamabil.
 SK Horľavý plyn.
 SL Vnetljiv plin.
 FI Syttyvä kaasu.
 SV Brandfarlig gas.


H222 Language 2.3 — Flammable aerosols, Hazard Category 1
 BG Изключително запалим аерозол.
 ES Aerosol extremadamente inflamable.
 CS Extrémně hořlavý aerosol.
 DA Yderst brandfarlig aerosol.
 DE Extrem entzündbares Aerosol.
 ET Eriti tuleohtlik aerosool.
 EL Εξαιρετικά εύφλεκτο αερόλυμα.
 EN Extremely flammable aerosol.
 FR Aérosol extrêmement inflammable.
 GA Aerasól fíor-inadhainte.
 IT Aerosol altamente infiammabile.
 LV Īpaši viegli uzliesmojošs aerosols.
 LT Ypač degus aerozolis.
 HU Rendkívül tűzveszélyes aeroszol.
 MT Aerosol li jaqbad malajr ħafna.
 NL Zeer licht ontvlambare aerosol.
 PL Skrajnie łatwopalny aerozol.
 PT Aerossol extremamente inflamável.
 RO Aerosol extrem de inflamabil.
 SK Mimoriadne horľavý aerosól.
 SL Zelo lahko vnetljiv aerosol.
 FI Erittäin helposti syttyvä aerosoli.
 SV Extremt brandfarlig aerosol.


H223 Language 2.3 — Flammable aerosols, Hazard Category 2
 BG Запалим аерозол.
 ES Aerosol inflamable.
 CS Hořlavý aerosol.
 DA Brandfarlig aerosol.
 DE Entzündbares Aerosol.
 ET Tuleohtlik aerosool.
 EL Εύφλεκτο αερόλυμα.
 EN Flammable aerosol.
 FR Aérosol inflammable.
 GA Aerasól inadhainte.
 IT Aerosol infiammabile.
 LV Uzliesmojošs aerosols.
 LT Degus aerozolis.
 HU Tűzveszélyes aeroszol.
 MT Aerosol li jaqbad.
 NL Ontvlambare aerosol.
 PL Aerozol łatwopalny.
 PT Aerossol inflamável.
 RO Aerosol inflamabil.
 SK Horľavý aerosól.
 SL Vnetljiv aerosol.
 FI Syttyvä aerosoli.
 SV Brandfarlig aerosol.


H224 Language 2.6 — Flammable liquids, Hazard Category 1
 BG Изключително запалими течност и пари.
 ES Líquido y vapores extremadamente inflamables.
 CS Extrémně hořlavá kapalina a páry.
 DA Yderst brandfarlig væske og damp.
 DE Flüssigkeit und Dampf extrem entzündbar.
 ET Eriti tuleohtlik vedelik ja aur.
 EL Υγρό και ατμοί εξαιρετικά εύφλεκτα.
 EN Extremely flammable liquid and vapour.
 FR Liquide et vapeurs extrêmement inflammables.
 GA Leacht fíor-inadhainte agus gal fhíor-inadhainte.
 IT Liquido e vapori altamente infiammabili.
 LV Īpaši viegli uzliesmojošs šķidrums un tvaiki.
 LT Ypač degūs skystis ir garai.
 HU Rendkívül tűzveszélyes folyadék és gőz.
 MT Likwidu u fwar li jaqbdu malajr ħafna.
 NL Zeer licht ontvlambare vloeistof en damp.
 PL Skrajnie łatwopalna ciecz i pary.
 PT Líquido e vapor extremamente inflamáveis.
 RO Lichid şi vapori extrem de inflamabili.
 SK Mimoriadne horľavá kvapalina a pary.
 SL Zelo lahko vnetljiva tekočina in hlapi.
 FI Erittäin helposti syttyvä neste ja höyry.
 SV Extremt brandfarlig vätska och ånga.


H225 Language 2.6 — Flammable liquids, Hazard Category 2
 BG Силно запалими течност и пари.
 ES Líquido y vapores muy inflamables.
 CS Vysoce hořlavá kapalina a páry.
 DA Meget brandfarlig væske og damp.
 DE Flüssigkeit und Dampf leicht entzündbar.
 ET Väga tuleohtlik vedelik ja aur.
 EL Υγρό και ατμοί πολύ εύφλεκτα.
 EN Highly flammable liquid and vapour.
 FR Liquide et vapeurs très inflammables.
 GA Leacht an-inadhainte agus gal an-inadhainte.
 IT Liquido e vapori facilmente infiammabili.
 LV Viegli uzliesmojošs šķidrums un tvaiki.
 LT Labai degūs skystis ir garai.
 HU Fokozottan tűzveszélyes folyadék és gőz.
 MT Likwidu u fwar li jaqbdu malajr ħafna.
 NL Licht ontvlambare vloeistof en damp.
 PL Wysoce łatwopalna ciecz i pary.
 PT Líquido e vapor facilmente inflamáveis.
 RO Lichid şi vapori foarte inflamabili.
 SK Veľmi horľavá kvapalina a pary.
 SL Lahko vnetljiva tekočina in hlapi.
 FI Helposti syttyvä neste ja höyry.
 SV Mycket brandfarlig vätska och ånga.


H226 Language 2.6 — Flammable liquids, Hazard Category 3
 BG Запалими течност и пари.
 ES Líquidos y vapores inflamables.
 CS Hořlavá kapalina a páry.
 DA Brandfarlig væske og damp.
 DE Flüssigkeit und Dampf entzündbar.
 ET Tuleohtlik vedelik ja aur.
 EL Υγρό και ατμοί εύφλεκτα.
 EN Flammable liquid and vapour.
 FR Liquide et vapeurs inflammables.
 GA Leacht inadhainte agus gal inadhainte.
 IT Liquido e vapori infiammabili.
 LV Uzliesmojošs šķidrums un tvaiki.
 LT Degūs skystis ir garai.
 HU Tűzveszélyes folyadék és gőz.
 MT Likwidu u fwar li jaqbdu.
 NL Ontvlambare vloeistof en damp.
 PL Łatwopalna ciecz i pary.
 PT Líquido e vapor inflamáveis.
 RO Lichid şi vapori inflamabili.
 SK Horľavá kvapalina a pary.
 SL Vnetljiva tekočina in hlapi.
 FI Syttyvä neste ja höyry.
 SV Brandfarlig vätska och ånga.


H228 Language 2.7 — Flammable solids, Hazard Category 1, 2
 BG Запалимо твърдо вещество.
 ES Sólido inflamable.
 CS Hořlavá tuhá látka.
 DA Brandfarligt fast stof.
 DE Entzündbarer Feststoff.
 ET Tuleohtlik tahke aine.
 EL Εύφλεκτο στερεό.
 EN Flammable solid.
 FR Matière solide inflammable.
 GA Solad inadhainte.
 IT Solido infiammabile.
 LV Uzliesmojoša cieta viela.
 LT Degi kietoji medžiaga.
 HU Tűzveszélyes szilárd anyag.
 MT Solidu li jaqbad.
 NL Ontvlambare vaste stof.
 PL Substancja stała łatwopalna.
 PT Sólido inflamável.
 RO Solid inflamabil.
 SK Horľavá tuhá látka.
 SL Vnetljiva trdna snov.
 FI Syttyvä kiinteä aine.
 SV Brandfarligt fast ämne.


H240 Language 2.8 — Self-Reactive Substances and Mixtures, Type A2.1.5 — Organic Peroxides, Type A
 BG Може да предизвика експлозия при нагряване.
 ES Peligro de explosión en caso de calentamiento.
 CS Zahřívání může způsobit výbuch.
 DA Eksplosionsfare ved opvarmning.
 DE Erwärmung kann Explosion verursachen.
 ET Kuumenemisel võib plahvatada.
 EL Η θέρμανση μπορεί να προκαλέσει έκρηξη.
 EN Heating may cause an explosion.
 FR Peut exploser sous l'effet de la chaleur.
 GA D'fhéadfadh téamh a bheith ina chúis le pléascadh.
 IT Rischio di esplosione per riscaldamento.
 LV Sakaršana var izraisīt eksploziju.
 LT Kaitinant gali sprogti.
 HU Hő hatására robbanhat.
 MT It-tisħin jista' jikkawża splużjoni.
 NL Ontploffingsgevaar bij verwarming.
 PL Ogrzanie grozi wybuchem.
 PT Risco de explosão sob a acção do calor.
 RO Pericol de explozie în caz de încălzire.
 SK Zahrievanie môže spôsobiť výbuch.
 SL Segrevanje lahko povzroči eksplozijo.
 FI Räjähdysvaarallinen kuumennettaessa.
 SV Explosivt vid uppvärmning.


H241 Language 2.8 — Self-Reactive Substances and Mixtures, Type B2.1.5 — Organic Peroxides, Type B
 BG Може да предизвика пожар или експлозия при нагряване.
 ES Peligro de incendio o explosión en caso de calentamiento.
 CS Zahřívání může způsobit požár nebo výbuch.
 DA Brand- eller eksplosionsfare ved opvarmning.
 DE Erwärmung kann Brand oder Explosion verursachen.
 ET Kuumenemisel võib süttida või plahvatada.
 EL Η θέρμανση μπορεί να προκαλέσει πυρκαγιά ή έκρηξη.
 EN Heating may cause a fire or explosion.
 FR Peut s'enflammer ou exploser sous l'effet de la chaleur.
 GA D'fhéadfadh téamh a bheith ina chúis le dóiteán nó le pléascadh.
 IT Rischio d'incendio o di esplosione per riscaldamento.
 LV Sakaršana var izraisīt degšanu vai eksploziju.
 LT Kaitinant gali sukelti gaisrą arba sprogti.
 HU Hő hatására meggyulladhat vagy robbanhat.
 MT It-tisħin jista' jikkawża nar jew splużjoni.
 NL Brand- of ontploffingsgevaar bij verwarming.
 PL Ogrzanie może spowodować pożar lub wybuch.
 PT Risco de explosão ou de incêndio sob a acção do calor.
 RO Pericol de incendiu sau de explozie în caz de încălzire.
 SK Zahrievanie môže spôsobiť požiar alebo výbuch.
 SL Segrevanje lahko povzroči požar ali eksplozijo.
 FI Räjähdys- tai palovaarallinen kuumennettaessa.
 SV Brandfarligt eller explosivt vid uppvärmning.


H242 Language 2.8 — Self-Reactive Substances and Mixtures, Types C, D, E, F2.1.5 — Organic Peroxides, Types C, D, E, F
 BG Може да предизвика пожар при нагряване.
 ES Peligro de incendio en caso de calentamiento.
 CS Zahřívání může způsobit požár.
 DA Brandfare ved opvarmning.
 DE Erwärmung kann Brand verursachen.
 ET Kuumenemisel võib süttida.
 EL Η θέρμανση μπορεί να προκαλέσει πυρκαγιά.
 EN Heating may cause a fire.
 FR Peut s'enflammer sous l'effet de la chaleur.
 GA D'fhéadfadh téamh a bheith ina chúis le dóiteán.
 IT Rischio d'incendio per riscaldamento.
 LV Sakaršana var izraisīt degšanu.
 LT Kaitinant gali sukelti gaisrą.
 HU Hő hatására meggyulladhat.
 MT It-tisħin jista' jikkawża nar.
 NL Brandgevaar bij verwarming.
 PL Ogrzanie może spowodować pożar.
 PT Risco de incêndio sob a acção do calor.
 RO Pericol de incendiu în caz de încălzire.
 SK Zahrievanie môže spôsobiť požiar.
 SL Segrevanje lahko povzroči požar.
 FI Palovaarallinen kuumennettaessa.
 SV Brandfarligt vid uppvärmning.


H250 Language 2.9 — Pyrophoric Liquids, Hazard Category 12.10 — Pyorphoric Solids, Hazard Category 1
 BG Самозапалва се при контакт с въздух.
 ES Se inflama espontáneamente en contacto con el aire.
 CS Při styku se vzduchem se samovolně vznítí.
 DA Selvantænder ved kontakt med luft.
 DE Entzündet sich in Berührung mit Luft von selbst.
 ET Kokkupuutel õhuga süttib iseenesest.
 EL Αυταναφλέγεται εάν εκτεθεί στον αέρα.
 EN Catches fire spontaneously if exposed to air.
 FR S'enflamme spontanément au contact de l'air.
 GA Téann trí thine go spontáineach má nochtar don aer.
 IT Spontaneamente infiammabile all'aria.
 LV Spontāni aizdegas saskarē ar gaisu.
 LT Veikiami oro savaime užsidega.
 HU Levegővel érintkezve önmagától meggyullad.
 MT Jieħu n-nar spontanjament jekk ikun espost għall-arja.
 NL Vat spontaan vlam bij blootstelling aan lucht.
 PL Zapala się samorzutnie w przypadku wystawienia na działanie powietrza.
 PT Risco de inflamação espontânea em contacto com o ar.
 RO Se aprinde spontan, în contact cu aerul.
 SK Pri kontakte so vzduchuom sa spontánne vznieti.
 SL Samodejno se vžge na zraku.
 FI Syttyy itsestään palamaan joutuessaan kosketuksiin ilman kanssa.
 SV Spontanantänder vid kontakt med luft.


H251 Language 2.11 — Self-Heating Substances and Mixtures, Hazard Category 1
 BG Самонагряващо се: може да се запали.
 ES Se calienta espontáneamente; puede inflamarse.
 CS Samovolně se zahřívá: může se vznítit.
 DA Selvopvarmende, kan selvantænde.
 DE Selbsterhitzungsfähig; kann in Brand geraten.
 ET Isekuumenev, võib süttida.
 EL Αυτοθερμαίνεται: μπορεί να αναφλεγεί.
 EN Self-heating: may catch fire.
 FR Matière auto-échauffante; peut s'enflammer.
 GA Féintéamh: d'fhéadfadh sé dul trí thine.
 IT Autoriscaldante; può infiammarsi.
 LV Pašsasilstošs; var aizdegties.
 LT Savaime kaistančios, gali užsidegti.
 HU Önmelegedő: meggyulladhat.
 MT Jisħon waħdu: jista' jieħu n-nar.
 NL Vatbaar voor zelfverhitting: kan vlam vatten.
 PL Substancja samonagrzewająca się: może się zapalić.
 PT Susceptível de auto-aquecimento: risco de inflamação.
 RO Se autoîncălzeşte, pericol de aprindere.
 SK Samovoľne sa zahrieva; môže sa vznietiť.
 SL Samosegrevanje: lahko povzroči požar.
 FI Itsestään kuumeneva; voi syttyä palamaan.
 SV Självupphettande. Kan börja brinna.


H252 Language 2.11 — Self-Heating Substances and Mixtures, Hazard Category 2
 BG Самонагряващо се в големи количества; може да се запали.
 ES Se calienta espontáneamente en grandes cantidades; puede inflamarse.
 CS Ve velkém množství se samovolně zahřívá; může se vznítit.
 DA Selvopvarmende i store mængder, kan selvantænde.
 DE In großen Mengen selbsterhitzungsfähig; kann in Brand geraten.
 ET Suurtes kogustes isekuumenev, võib süttida.
 EL Σε μεγάλες ποσότητες αυτοθερμαίνεται: μπορεί να αναφλεγεί.
 EN Self-heating in large quantities; may catch fire.
 FR Matière auto-échauffante en grandes quantités; peut s'enflammer.
 GA Féintéamh ina mhórchainníochtaí; d'fhéadfadh sé dul trí thine.
 IT Autoriscaldante in grandi quantità; può infiammarsi.
 LV Lielos apjomos pašsasilstošs; var aizdegties.
 LT Laikant dideliais kiekiais savaime kaista, gali užsidegti.
 HU Nagy mennyiségben önmelegedő; meggyulladhat.
 MT Jisħon waħdu f'kwantitajiet kbar; jista' jieħu n-nar.
 NL In grote hoeveelheden vatbaar voor zelfverhitting; kan vlam vatten.
 PL Substancja samonagrzewająca się w dużych ilościach; może się zapalić.
 PT Susceptível de auto-aquecimento em grandes quantidades: risco de inflamação.
 RO Se autoîncălzeşte, în cantităţi mari pericol de aprindere.
 SK Vo veľkých množstvách sa samovoľne zahrieva; môže sa vznietiť.
 SL Samosegrevanje v velikih količinah; lahko povzroči požar.
 FI Suurina määrinä itsestään kuumeneva; voi syttyä palamaan.
 SV Självupphettande i stora mängder. Kan börja brinna.


H260 Language 2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 1
 BG При контакт с вода отделя запалими газове, които могат да се самозапалят.
 ES En contacto con el agua desprende gases inflamables que pueden inflamarse espontáneamente.
 CS Při styku s vodou uvolňuje hořlavé plyny, které se mohou samovolně vznítit.
 DA Ved kontakt med vand udvikles brandfarlige gasser, som kan selvantænde.
 DE In Berührung mit Wasser entstehen entzündbare Gase, die sich spontan entzünden können.
 ET Kokkupuutel veega eraldab tuleohtlikke gaase, mis võivad iseenesest süttida.
 EL Σε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια τα οποία μπορούν να αυτοαναφλεγούν.
 EN In contact with water releases flammable gases which may ignite spontaneously.
 FR Dégage au contact de l'eau des gaz inflammables qui peuvent s'enflammer spontanément.
 GA I dteagmháil le huisce scaoiltear gáis inadhainte a d'fhéadfadh uathadhaint.
 IT A contatto con l'acqua libera gas infiammabili che possono infiammarsi spontaneamente.
 LV Nonākot saskarē ar ūdeni, izdala uzliesmojošas gāzes, kas var spontāni aizdegties.
 LT Kontaktuodami su vandeniu išskiria degias dujas, kurios gali savaime užsidegti.
 HU Vízzel érintkezve öngyulladásra hajlamos tűzveszélyes gázokat bocsát ki.
 MT Meta jmiss ma' l-ilma jerħi gassijiet li jaqbdu li jistgħu jieħdu n-nar spontanjament.
 NL In contact met water komen ontvlambare gassen vrij die spontaan kunnen ontbranden.
 PL W kontakcie z wodą uwalniają łatwopalne gazy, które mogą ulegać samozapaleniu.
 PT Em contacto com a água liberta gases que se podem inflamar espontaneamente.
 RO În contact cu apa degajă gaze inflamabile care se pot aprinde spontan.
 SK Pri kontakte s vodou uvoľňuje horľavé plyny, ktoré sa môžu spontánne zapáliť.
 SL V stiku z vodo se sproščajo vnetljivi plini, ki se lahko samodejno vžgejo.
 FI Kehittää itsestään syttyviä kaasuja veden kanssa.
 SV Vid kontakt med vatten utvecklas brandfarliga gaser som kan självantända.


H261 Language 2.12 — Substances and Mixtures which, in contact with water, emit flammable gases, Hazard Category 2
 BG При контакт с вода отделя запалими газове.
 ES En contacto con el agua desprende gases inflamables.
 CS Při styku s vodou uvolňuje hořlavé plyny.
 DA Ved kontakt med vand udvikles brandfarlige gasser.
 DE In Berührung mit Wasser entstehen entzündbare Gase.
 ET Kokkupuutel veega eraldab tuleohtlikke gaase.
 EL Σε επαφή με το νερό ελευθερώνει εύφλεκτα αέρια.
 EN In contact with water releases flammable gases.
 FR Dégage au contact de l'eau des gaz inflammables.
 GA I dteagmháil le huisce scaoiltear gáis inadhainte.
 IT A contatto con l'acqua libera gas infiammabili.
 LV Nonākot saskarē ar ūdeni, izdala uzliesmojošu gāzi.
 LT Kontaktuodami su vandeniu išskiria degias dujas
 HU Vízzel érintkezve tűzveszélyes gázokat bocsát ki.
 MT Meta jmiss ma' l-ilma jerħi gassijiet li jaqbdu.
 NL In contact met water komen ontvlambare gassen vrij.
 PL W kontakcie z wodą uwalnia łatwopalne gazy.
 PT Em contacto com a água liberta gases inflamáveis.
 RO În contact cu apa degajă gaze inflamabile.
 SK Pri kontakte s vodou uvoľňuje horľavé plyny.
 SL V stiku z vodo se sproščajo vnetljivi plini.
 FI Kehittää syttyviä kaasuja veden kanssa.
 SV Vid kontakt med vatten utvecklas brandfarliga gaser.


H270 Language 2.4 — Oxidising Gases, Hazard Category 1
 BG Може да предивзика или усили пожар; окислител.
 ES Puede provocar o agravar un incendio; comburente.
 CS Může způsobit nebo zesílit požár; oxidant.
 DA Kan forårsage eller forstærke brand, brandnærende.
 DE Kann Brand verursachen oder verstärken; Oxidationsmittel.
 ET Võib põhjustada süttimise või soodustada põlemist; oksüdeerija.
 EL Μπορεί να προκαλέσει ή να αναζωπυρώσει πυρκαγιά· οξειδωτικό.
 EN May cause or intensify fire; oxidiser.
 FR Peut provoquer ou aggraver un incendie; comburant.
 GA D'fhéadfadh sé a bheith ina chúis le tine nó cur le tine; ocsaídeoir.
 IT Può provocare o aggravare un incendio; comburente.
 LV Var izraisīt vai pastiprināt degšanu, oksidētājs.
 LT Gali sukelti arba padidinti gaisrą, oksidatorius.
 HU Tüzet okozhat vagy fokozhatja a tűz intenzitását, oxidáló hatású.
 MT Jista' jikkawża jew iżid in-nar; ossidant.
 NL Kan brand veroorzaken of bevorderen; oxiderend.
 PL Może spowodować lub intensyfikować pożar; utleniacz.
 PT Pode provocar ou agravar incêndios; comburente.
 RO Poate provoca sau agrava un incendiu; oxidant.
 SK Môže spôsobiť alebo prispieť k rozvoju požiaru; oxidačné činidlo.
 SL Lahko povzroči ali okrepi požar; oksidativna snov.
 FI Aiheuttaa tulipalon vaaran tai edistää tulipaloa; hapettava.
 SV Kan orsaka eller intensifiera brand. Oxiderande.


H271 Language 2.13 — Oxidising Liquids, Hazard Category 12.14 — Oxidising Solids, Hazard Category 1
 BG Може да предизвика пожар или експлозия; силен окислител.
 ES Puede provocar un incendio o una explosión; muy comburente.
 CS Může způsobit požár nebo výbuch; silný oxidant.
 DA Kan forårsage brand eller eksplosion, stærkt brandnærende.
 DE Kann Brand oder Explosion verursachen; starkes Oxidationsmittel.
 ET Võib põhjustada süttimise või plahvatuse; tugev oksüdeerija.
 EL Μπορεί να προκαλέσει πυρκαγιά ή έκρηξη· ισχυρό οξειδωτικό.
 EN May cause fire or explosion; strong oxidiser.
 FR Peut provoquer un incendie ou une explosion; comburant puissant.
 GA D'fhéadfadh sé a bheith ina chúis le tine nó le pléascadh; an-ocsaídeoir.
 IT Può provocare un incendio o un'esplosione; molto comburente.
 LV Var izraisīt degšanu vai eksploziju, oksidētājs.
 LT Gali sukelti gaisrą arba sprogimą, stiprus oksidatorius.
 HU Tüzet vagy robbanást okozhat; erősen oxidáló hatású.
 MT Jista' jikkawża nar jew splużjoni; ossidant qawwi.
 NL Kan brand of ontploffingen veroorzaken; sterk oxiderend.
 PL Może spowodować pożar lub wybuch; silny utleniacz.
 PT Risco de incêndio ou de explosão; muito comburente.
 RO Poate provoca un incendiu sau o explozie; oxidant puternic.
 SK Môže spôsobiť požiar alebo výbuch; silné oxidačné činidlo.
 SL Lahko povzroči požar ali eksplozijo; močna oksidativna snov.
 FI Aiheuttaa tulipalo- tai räjähdysvaaran; voimakkaasti hapettava.
 SV Kan orsaka brand eller explosion. Starkt oxiderande.


H272 Language 2.13 — Oxidising Liquids, Hazard Category 2, 32.14 — Oxidising Solids, Hazard Category 2, 3
 BG Може да усили пожара; окислител.
 ES Puede agravar un incendio; comburente.
 CS Může zesílit požár; oxidant.
 DA Kan forstærke brand, brandnærende.
 DE Kann Brand verstärken; Oxidationsmittel.
 ET Võib soodustada põlemist; oksüdeerija.
 EL Μπορεί να αναζωπυρώσει την πυρκαγιά· οξειδωτικό.
 EN May intensify fire; oxidiser.
 FR Peut aggraver un incendie; comburant.
 GA D'fhéadfadh sé cur le tine; ocsaídeoir.
 IT Può aggravare un incendio; comburente.
 LV Var pastiprināt degšanu; oksidētājs.
 LT Gali padidinti gaisrą, oksidatorius.
 HU Fokozhatja a tűz intenzitását; oxidáló hatású.
 MT Jista' jżid in-nar; ossidant.
 NL Kan brand bevorderen; oxiderend.
 PL Może intensyfikować pożar; utleniacz.
 PT Pode agravar incêndios; comburente.
 RO Poate agrava un incendiu; oxidant.
 SK Môže prispieť k rozvoju požiaru; oxidačné činidlo.
 SL Lahko okrepi požar; oksidativna snov.
 FI Voi edistää tulipaloa; hapettava.
 SV Kan intensifiera brand. Oxiderande.


H280 Language 2.5 — Gases under pressure:Compressed gasLiquefied gasDissolved gas
 BG Съдържа газ под налягане; може да експлодира при нагряване.
 ES Contiene gas a presión; peligro de explosión en caso de calentamiento.
 CS Obsahuje plyn pod tlakem; při zahřívání může vybuchnout.
 DA Indeholder gas under tryk, kan eksplodere ved opvarmning.
 DE Enthält Gas unter Druck; kann bei Erwärmung explodieren.
 ET Sisaldab rõhu all olevat gaasi, kuumenemisel võib plahvatada.
 EL Περιέχει αέριο υπό πίεση· εάν θερμανθεί, μπορεί να εκραγεί.
 EN Contains gas under pressure; may explode if heated.
 FR Contient un gaz sous pression; peut exploser sous l'effet de la chaleur.
 GA Gás istigh ann, faoi bhrú; d'fhéadfadh sé pléascadh, má théitear.
 IT Contiene gas sotto pressione; può esplodere se riscaldato.
 LV Satur gāzi zem spiediena; karstumā var eksplodēt.
 LT Turi slėgio veikiamų dujų, kaitinant gali sprogti.
 HU Nyomás alatt lévő gázt tartalmaz; hő hatására robbanhat.
 MT Fih gass taħt pressjoni; jista' jisplodi jekk jissaħħan.
 NL Bevat gas onder druk; kan ontploffen bij verwarming.
 PL Zawiera gaz pod ciśnieniem; ogrzanie grozi wybuchem.
 PT Contém gás sob pressão; risco de explosão sob a acção do calor.
 RO Conţine un gaz sub presiune; pericol de explozie în caz de încălzire.
 SK Obsahuje plyn pod tlakom, pri zahriatí môže vybuchnúť.
 SL Vsebuje plin pod tlakom; segrevanje lahko povzroči eksplozijo.
 FI Sisältää paineen alaista kaasua; voi räjähtää kuumennettaessa.
 SV Innehåller gas under tryck. Kan explodera vid uppvärmning.


H281 Language 2.5 — Gases under pressure: Refrigerated liquefied gas
 BG Съдържа охладен газ; може да причини криогенни изгаряния или наранявания.
 ES Contiene un gas refrigerado; puede provocar quemaduras o lesiones criogénicas.
 CS Obsahuje zchlazený plyn; může způsobit omrzliny nebo poškození chladem.
 DA Indeholder nedkølet gas, kan forårsage kuldeskader.
 DE Enthält tiefkaltes Gas; kann Kälteverbrennungen oder -Verletzungen verursachen.
 ET Sisaldab külmutatud gaasi; võib põhjustada külmapõletusi või -kahjustusi.
 EL Περιέχει αέριο υπό ψύξη· μπορεί να προκαλέσει εγκαύματα ψύχους ή τραυματισμούς.
 EN Contains refrigerated gas; may cause cryogenic burns or injury.
 FR Contient un gaz réfrigéré; peut causer des brûlures ou blessures cryogéniques.
 GA Gás cuisnithe istigh ann; d'fhéadfadh sé a bheith ina chúis le dónna crióigineacha nó le díobháil chrióigineach.
 IT Contiene gas refrigerato; può provocare ustioni o lesioni criogeniche.
 LV Satur atdzesētu gāzi; var radīt kriogēnus apdegumus vai ievainojumus.
 LT Turi atšaldytų dujų, gali sukelti kriogeninius nušalimus arba pažeidimus.
 HU Mélyhűtött gázt tartalmaz; fagymarást vagy sérülést okozhat.
 MT Fih gass imkessaħ; jista' jikkawża ħruq jew dannu minn temperaturi baxxi.
 NL Bevat sterk gekoeld gas; kan cryogene brandwonden of letsel veroorzaken.
 PL Zawiera schłodzony gaz; może spowodować oparzenia kriogeniczne lub obrażenia.
 PT Contém gás refrigerado; pode provocar queimaduras ou lesões criogénicas.
 RO Conţine un gaz răcit; poate cauza arsuri sau leziuni criogenice.
 SK Obsahuje schladený plyn; môže spôsobiť kryogénne popáleniny alebo poranenia.
 SL Vsebuje ohlajen utekočinjen plin; lahko povzroči ozebline ali poškodbe.
 FI Sisältää jäähdytettyä kaasua; voi aiheuttaa jäätymisvamman.
 SV Innehåller kyld gas. Kan orsaka svåra köldskador.


H290 Language 2.16 — Corrosive to metals, Hazard Category 1
 BG Може да бъде корозивно за металите.
 ES Puede ser corrosivo para los metales.
 CS Může být korozivní pro kovy.
 DA Kan ætse metaller.
 DE Kann gegenüber Metallen korrosiv sein.
 ET Võib söövitada metalle.
 EL Μπορεί να διαβρώσει μέταλλα.
 EN May be corrosive to metals.
 FR Peut être corrosif pour les métaux.
 GA D'fhéadfadh sé a bheith creimneach do mhiotail.
 IT Può essere corrosivo per i metalli.
 LV Var kodīgi iedarboties uz metāliem.
 LT Gali ėsdinti metalus.
 HU Fémekre korrozív hatású lehet.
 MT Jista' jkun korrużiv għall-metalli.
 NL Kan bijtend zijn voor metalen.
 PL Może powodować korozję metali.
 PT Pode ser corrosivo para os metais.
 RO Poate fi corosiv pentru metale.
 SK Môže byť korozívna pre kovy.
 SL Lahko je jedko za kovine.
 FI Voi syövyttää metalleja.
 SV Kan vara korrosivt för metaller.


H300 Language 3.1 — Acute toxicity (oral), Hazard Category 1, 2
 BG Смъртоносeн при поглъщане.
 ES Mortal en caso de ingestión.
 CS Při požití může způsobit smrt.
 DA Livsfarlig ved indtagelse.
 DE Lebensgefahr bei Verschlucken.
 ET Allaneelamisel surmav.
 EL Θανατηφόρο σε περίπτωση κατάποσης.
 EN Fatal if swallowed.
 FR Mortel en cas d'ingestion.
 GA Marfach má shlogtar.
 IT Letale se ingerito.
 LV Norijot iestājas nāve.
 LT Mirtina prarijus.
 HU Lenyelve halálos.
 MT Fatali jekk jinbela’.
 NL Dodelijk bij inslikken.
 PL Połknięcie grozi śmiercią.
 PT Mortal por ingestão.
 RO Mortal în caz de înghiţire.
 SK Smrteľný po požití.
 SL Smrtno pri zaužitju.
 FI Tappavaa nieltynä.
 SV Dödligt vid förtäring.


H301 Language 3.1 — Acute toxicity (oral), Hazard Category 3
 BG Токсичен при поглъщане.
 ES Tóxico en caso de ingestión.
 CS Toxický při požití.
 DA Giftig ved indtagelse.
 DE Giftig bei Verschlucken.
 ET Allaneelamisel mürgine.
 EL Τοξικό σε περίπτωση κατάποσης.
 EN Toxic if swallowed.
 FR Toxique en cas d'ingestion.
 GA Tocsaineach má shlogtar.
 IT Tossico se ingerito.
 LV Toksisks, ja norij.
 LT Toksiška prarijus.
 HU Lenyelve mérgező.
 MT Tossiku jekk jinbela’.
 NL Giftig bij inslikken.
 PL Działa toksycznie po połknięciu.
 PT Tóxico por ingestão.
 RO Toxic în caz de înghiţire.
 SK Toxický po požití.
 SL Strupeno pri zaužitju.
 FI Myrkyllistä nieltynä.
 SV Giftigt vid förtäring.


H302 Language 3.1 — Acute toxicity (oral), Hazard Category 4
 BG Вреден при поглъщане.
 ES Nocivo en caso de ingestión.
 CS Zdraví škodlivý při požití.
 DA Farlig ved indtagelse.
 DE Gesundheitsschädlich bei Verschlucken.
 ET Allaneelamisel kahjulik.
 EL Επιβλαβές σε περίπτωση κατάποσης.
 EN Harmful if swallowed.
 FR Nocif en cas d'ingestion.
 GA Díobhálach má shlogtar.
 IT Nocivo se ingerito.
 LV Kaitīgs, ja norij.
 LT Kenksminga prarijus.
 HU Lenyelve ártalmas.
 MT Jagħmel il-ħsara jekk jinbela’.
 NL Schadelijk bij inslikken.
 PL Działa szkodliwie po połknięciu.
 PT Nocivo por ingestão.
 RO Nociv în caz de înghiţire.
 SK Škodlivý po požití.
 SL Zdravju škodljivo pri zaužitju.
 FI Haitallista nieltynä.
 SV Skadligt vid förtäring.


H304 Language 3.10 — Aspiration hazard, Hazard Category 1
 BG Може да бъде смъртоносен при поглъщане и навлизане в дихателните пътища.
 ES Puede ser mortal en caso de ingestión y penetración en las vías respiratorias.
 CS Při požití a vniknutí do dýchacích cest může způsobit smrt.
 DA Kan være livsfarligt, hvis det indtages og kommer i luftvejene.
 DE Kann bei Verschlucken und Eindringen in die Atemwege tödlich sein.
 ET Allaneelamisel või hingamisteedesse sattumisel võib olla surmav.
 EL Μπορεί να προκαλέσει θάνατο σε περίπτωση κατάποσης και διείσδυσης στις αναπνευστικές οδούς.
 EN May be fatal if swallowed and enters airways.
 FR Peut être mortel en cas d'ingestion et de pénétration dans les voies respiratoires.
 GA D'fhéadfadh sé a bheith marfach má shlogtar é agus má théann sé isteach sna haerbhealaí.
 HU Lenyelve és a légutakba kerülve halálos lehet.
 IT Può essere letale in caso di ingestione e di penetrazione nelle vie respiratorie.
 LV Var izraisīt nāvi, ja norij vai iekļūst elpceļos.
 LT Prarijus ir patekus į kvėpavimo takus, gali sukelti mirtį.
 MT Jista’ jkun fatali jekk jinbela’ u jidħol fil-pajpijiet tan-nifs.
 NL Kan dodelijk zijn als de stof bij inslikken in de luchtwegen terechtkomt.
 PL Połknięcie i dostanie się przez drogi oddechowe może grozić śmiercią.
 PT Pode ser mortal por ingestão e penetração nas vias respiratórias.
 RO Poate fi mortal în caz de înghiţire şi de pătrundere în căile respiratorii.
 SK Môže byť smrteľný po požití a vniknutí do dýchacích ciest.
 SL Pri zaužitju in vstopu v dihalne poti je lahko smrtno.
 FI Voi olla tappavaa nieltynä ja joutuessaan hengitysteihin.
 SV Kan vara dödligt vid förtäring om det kommer ner i luftvägarna.


H310 Language 3.1 — Acute toxicity (dermal), Hazard Category 1, 2
 BG Смъртоносeн при контакт с кожата.
 ES Mortal en contacto con la piel.
 CS Při styku s kůží může způsobit smrt.
 DA Livsfarlig ved hudkontakt.
 DE Lebensgefahr bei Hautkontakt.
 ET Nahale sattumisel surmav.
 EL Θανατηφόρο σε επαφή με το δέρμα.
 EN Fatal in contact with skin.
 FR Mortel par contact cutané.
 GA Marfach i dteagmháil leis an gcraiceann.
 HU Bőrrel érintkezve halálos.
 IT Letale per contatto con la pelle.
 LV Nonākot saskarē ar ādu, iestājas nāve.
 LT Mirtina susilietus su oda.
 MT Fatali jekk imiss mal-ġilda.
 NL Dodelijk bij contact met de huid.
 PL Grozi śmiercią w kontacie ze skórą.
 PT Mortal em contacto com a pele.
 RO Mortal în contact cu pielea.
 SK Smrteľný pri kontakte s pokožkou.
 SL Smrtno v stiku s kožo.
 FI Tappavaa joutuessaan iholle.
 SV Dödligt vid hudkontakt.


H311 Language 3.1 — Acute toxicity (dermal), Hazard Category 3
 BG Токсичен при контакт с кожата.
 ES Tóxico en contacto con la piel.
 CS Toxický při styku s kůží.
 DA Giftig ved hudkontakt.
 DE Giftig bei Hautkontakt.
 ET Nahale sattumisel mürgine.
 EL Τοξικό σε επαφή με το δέρμα.
 EN Toxic in contact with skin.
 FR Toxique par contact cutané.
 GA Tocsaineach i dteagmháil leis an gcraiceann.
 IT Tossico per contatto con la pelle.
 LV Toksisks, ja nonāk saskarē ar ādu.
 LT Toksiška susilietus su oda.
 HU Bőrrel érintkezve mérgező.
 MT Tossiku meta jmiss mal-ġilda.
 NL Giftig bij contact met de huid.
 PL Działa toksycznie w kontakcie ze skórą.
 PT Tóxico em contacto com a pele.
 RO Toxic în contact cu pielea.
 SK Toxický pri kontakte s pokožkou.
 SL Strupeno v stiku s kožo.
 FI Myrkyllistä joutuessaan iholle.
 SV Giftigt vid hudkontakt.


H312 Language 3.1 — Acute toxicity (dermal), Hazard Category 4
 BG Вреден при контакт с кожата.
 ES Nocivo en contacto con la piel.
 CS Zdraví škodlivý při styku s kůží.
 DA Farlig ved hudkontakt.
 DE Gesundheitsschädlich bei Hautkontakt.
 ET Nahale sattumisel kahjulik.
 EL Επιβλαβές σε επαφή με το δέρμα.
 EN Harmful in contact with skin.
 FR Nocif par contact cutané.
 GA Díobhálach i dteagmháil leis an gcraiceann.
 IT Nocivo per contatto con la pelle.
 LV Kaitīgs, ja nonāk saskarē ar ādu.
 LT Kenksminga susilietus su oda.
 HU Bőrrel érintkezve ártalmas.
 MT Jagħmel il-ħsara meta jmiss mal-ġilda.
 NL Schadelijk bij contact met de huid.
 PL Działa szkodliwie w kontakcie ze skórą.
 PT Nocivo em contacto com a pele.
 RO Nociv în contact cu pielea.
 SK Škodlivý pri kontakte s pokožkou.
 SL Zdravju škodljivo v stiku s kožo.
 FI Haitallista joutuessaan iholle.
 SV Skadligt vid hudkontakt.


H314 Language 3.2 — Skin corrosion/irritation, Hazard Category 1A, 1B, 1C
 BG Причинява тежки изгаряния на кожата и сериозно увреждане на очите.
 ES Provoca quemaduras graves en la piel y lesiones oculares graves.
 CS Způsobuje těžké poleptání kůže a poškození očí.
 DA Forårsager svære forbrændinger af huden og øjenskader.
 DE Verursacht schwere Verätzungen der Haut und schwere Augenschäden.
 ET Põhjustab rasket nahasöövitust ja silmakahjustusi.
 EL Προκαλεί σοβαρά δερματικά εγκαύματα και οφθαλμικές βλάβες.
 EN Causes severe skin burns and eye damage.
 FR Provoque des brûlures de la peau et des lésions oculaires graves.
 GA Ina chúis le dónna tromchúiseacha craicinn agus le damáiste don tsúil.
 IT Provoca gravi ustioni cutanee e gravi lesioni oculari.
 LV Izraisa smagus ādas apdegumus un acu bojājumus.
 LT Smarkiai nudegina odą ir pažeidžia akis.
 HU Súlyos égési sérülést és szemkárosodást okoz.
 MT Jagħmel ħruq serju lill-ġilda u ħsara lill-għajnejn.
 NL Veroorzaakt ernstige brandwonden en oogletsel.
 PL Powoduje poważne oparzenia skóry oraz uszkodzenia oczu.
 PT Provoca queimaduras na pele e lesões oculares graves.
 RO Provoacă arsuri grave ale pielii şi lezarea ochilor.
 SK Spôsobuje vážne poleptanie kože a poškodenie očí.
 SL Povzroča hude opekline kože in poškodbe oči.
 FI Voimakkaasti ihoa syövyttävää ja silmiä vaurioittavaa.
 SV Orsakar allvarliga frätskador på hud och ögon.


H315 Language 3.2 — Skin corrosion/irritation, Hazard Category 2
 BG Предизвиква дразнене на кожата.
 ES Provoca irritación cutánea.
 CS Dráždí kůži.
 DA Forårsager hudirritation.
 DE Verursacht Hautreizungen.
 ET Põhjustab nahaärritust.
 EL Προκαλεί ερεθισμό του δέρματος.
 EN Causes skin irritation.
 FR Provoque une irritation cutanée.
 GA Ina chúis le greannú craicinn.
 IT Provoca irritazione cutanea.
 LV Kairina ādu.
 LT Dirgina odą.
 HU Bőrirritáló hatású.
 MT Jagħmel irritazzjoni tal-ġilda.
 NL Veroorzaakt huidirritatie.
 PL Działa drażniąco na skórę.
 PT Provoca irritação cutânea.
 RO Provoacă iritarea pielii.
 SK Dráždi kožu.
 SL Povzroča draženje kože.
 FI Ärsyttää ihoa.
 SV Irriterar huden.


H317 Language 3.4 — Sensitisation — Skin, Hazard Category 1
 BG Може да причини алергична кожна реакция.
 ES Puede provocar una reacción alérgica en la piel.
 CS Může vyvolat alergickou kožní reakci.
 DA Kan forårsage allergisk hudreaktion.
 DE Kann allergische Hautreaktionen verursachen.
 ET Võib põhjustada allergilist nahareaktsiooni.
 EL Μπορεί να προκαλέσει αλλεργική δερματική αντίδραση.
 EN May cause an allergic skin reaction.
 FR Peut provoquer une allergie cutanée.
 GA D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach craicinn.
 IT Può provocare una reazione allergica cutanea.
 LV Var izraisīt alerģisku ādas reakciju.
 LT Gali sukelti alerginę odos reakciją.
 HU Allergiás bőrreakciót válthat ki.
 MT Jista’ jikkawża reazzjoni allerġika tal-ġilda.
 NL Kan een allergische huidreactie veroorzaken.
 PL Może powodować reakcję alergiczną skóry.
 PT Pode provocar uma reacção alérgica cutânea.
 RO Poate provoca o reacţie alergică a pielii.
 SK Môže vyvolať alergickú kožnú reakciu.
 SL Lahko povzroči alergijski odziv kože.
 FI Voi aiheuttaa allergisen ihoreaktion.
 SV Kan orsaka allergisk hudreaktion.


H318 Language 3.3 — Serious eye damage/eye irritation, Hazard Category 1
 BG Предизвиква сериозно увреждане на очите.
 ES Provoca lesiones oculares graves.
 CS Způsobuje vážné poškození očí.
 DA Forårsager alvorlig øjenskade.
 DE Verursacht schwere Augenschäden.
 ET Põhjustab raskeid silmakahjustusi.
 EL Προκαλεί σοβαρή οφθαλμική βλάβη.
 EN Causes serious eye damage.
 FR Provoque des lésions oculaires graves.
 GA Ina chúis le damáiste tromchúiseach don tsúil.
 IT Provoca gravi lesioni oculari.
 LV Izraisa nopietnus acu bojājumus.
 LT Smarkiai pažeidžia akis.
 HU Súlyos szemkárosodást okoz.
 MT Jagħmel ħsara serja lill-għajnejn.
 NL Veroorzaakt ernstig oogletsel.
 PL Powoduje poważne uszkodzenie oczu.
 PT Provoca lesões oculares graves.
 RO Provoacă leziuni oculare grave.
 SK Spôsobuje vážne poškodenie očí.
 SL Povzroča hude poškodbe oči.
 FI Vaurioittaa vakavasti silmiä.
 SV Orsakar allvarliga ögonskador.


H319 Language 3.3 — Serious eye damage/eye irritation, Hazard Category 2
 BG Предизвиква сериозно дразнене на очите.
 ES Provoca irritación ocular grave.
 CS Způsobuje vážné podráždění očí.
 DA Forårsager alvorlig øjenirritation.
 DE Verursacht schwere Augenreizung.
 ET Põhjustab tugevat silmade ärritust.
 EL Προκαλεί σοβαρό οφθαλμικό ερεθισμό.
 EN Causes serious eye irritation.
 FR Provoque une sévère irritation des yeux.
 GA Ina chúis le greannú tromchúiseach don tsúil.
 IT Provoca grave irritazione oculare.
 LV Izraisa nopietnu acu kairinājumu.
 LT Sukelia smarkų akių dirginimą.
 HU Súlyos szemirritációt okoz.
 MT Jagħmel irritazzjoni serja lill-għajnejn.
 NL Veroorzaakt ernstige oogirritatie.
 PL Działa drażniąco na oczy.
 PT Provoca irritação ocular grave.
 RO Provoacă o iritare gravă a ochilor.
 SK Spôsobuje vážne podráždenie očí.
 SL Povzroča hudo draženje oči.
 FI Ärsyttää voimakkaasti silmiä.
 SV Orsakar allvarlig ögonirritation.


H330 Language 3.1 — Acute toxicity (inhal.), Hazard Category 1, 2
 BG Смъртоносен при вдишване.
 ES Mortal en caso de inhalación.
 CS Při vdechování může způsobit smrt.
 DA Livsfarlig ved indånding.
 DE Lebensgefahr bei Einatmen.
 ET Sissehingamisel surmav.
 EL Θανατηφόρο σε περίπτωση εισπνοής.
 EN Fatal if inhaled.
 FR Mortel par inhalation.
 GA Marfach má ionanálaítear.
 IT Letale se inalato.
 LV Ieelpojot, iestājas nāve.
 LT Mirtina įkvėpus.
 HU Belélegezve halálos.
 MT Fatali jekk jinxtamm.
 NL Dodelijk bij inademing.
 PL Wdychanie grozi śmiercią.
 PT Mortal por inalação.
 RO Mortal în caz de inhalare.
 SK Smrteľný pri vdýchnutí.
 SL Smrtno pri vdihavanju.
 FI Tappavaa hengitettynä.
 SV Dödligt vid inandning.


H331 Language 3.1 — Acute toxicity (inhal.), Hazard Category 3
 BG Токсичен при вдишване.
 ES Tóxico en caso de inhalación.
 CS Toxický při vdechování.
 DA Giftig ved indånding.
 DE Giftig bei Einatmen.
 ET Sissehingamisel mürgine.
 EL Τοξικό σε περίπτωση εισπνοής.
 EN Toxic if inhaled.
 FR Toxique par inhalation.
 GA Tocsaineach má ionanálaítear.
 IT Tossico se inalato.
 LV Toksisks ieelpojot.
 LT Toksiška įkvėpus.
 HU Belélegezve mérgező.
 MT Tossiku jekk jinxtamm.
 NL Giftig bij inademing.
 PL Działa toksycznie w następstwie wdychania.
 PT Tóxico por inalação.
 RO Toxic în caz de inhalare.
 SK Toxický pri vdýchnutí.
 SL Strupeno pri vdihavanju.
 FI Myrkyllistä hengitettynä.
 SV Giftigt vid inandning.


H332 Language 3.1 — Acute toxicity (inhal.), Hazard Category 4
 BG Вреден при вдишване.
 ES Nocivo en caso de inhalación.
 CS Zdraví škodlivý při vdechování.
 DA Farlig ved indånding.
 DE Gesundheitsschädlich bei Einatmen.
 ET Sissehingamisel kahjulik.
 EL Επιβλαβές σε περίπτωση εισπνοής.
 EN Harmful if inhaled.
 FR Nocif par inhalation.
 GA Díobhálach má ionanálaítear.
 IT Nocivo se inalato.
 LV Kaitīgs ieelpojot.
 LT Kenksminga įkvėpus.
 HU Belélegezve ártalmas.
 MT Jagħmel il-ħsara jekk jinxtamm.
 NL Schadelijk bij inademing.
 PL Działa szkodliwie w następstwie wdychania.
 PT Nocivo por inalação.
 RO Nociv în caz de inhalare.
 SK Škodlivý pri vdýchnutí.
 SL Zdravju škodljivo pri vdihavanju.
 FI Haitallista hengitettynä.
 SV Skadligt vid inandning.


H334 Language 3.4 — Sensitisation — Respirat., Hazard Category 1
 BG Може да причини алергични или астматични симптоми или затруднения в дишането при вдишване.
 ES Puede provocar síntomas de alergia o asma o dificultades respiratorias en caso de inhalación.
 CS Při vdechování může vyvolat příznaky alergie nebo astmatu nebo dýchací potíže.
 DA Kan forårsage allergi- eller astmasymptomer eller åndedrætsbesvær ved indånding.
 DE Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen.
 ET Sissehingamisel võib põhjustada allergia- või astma sümptomeid või hingamisraskusi.
 EL Μπορεί να προκαλέσει αλλεργία ή συμπτώματα άσθματος ή δύσπνοια σε περίπτωση εισπνοής.
 EN May cause allergy or asthma symptoms or breathing difficulties if inhaled.
 FR Peut provoquer des symptômes allergiques ou d'asthme ou des difficultés respiratoires par inhalation.
 GA D'fhéadfadh sé a bheith ina chúis le siomptóim ailléirge nó asma nó le deacrachtaí análaithe má ionanálaítear é.
 IT Può provocare sintomi allergici o asmatici o difficoltà respiratorie se inalato.
 LV Ja ieelpo, var izraisīt alerģiju vai astmas simptomus, vai apgrūtināt elpošanu.
 LT Įkvėpus gali sukelti alerginę reakciją, astmos simptomus arba apsunkinti kvėpavimą.
 HU Belélegezve allergiás és asztmás tüneteket, és nehéz légzést okozhat.
 MT Jista’ jikkawża sintomi ta' allerġija jew ta’ ażma jew diffikultajiet biex jittieħed in-nifs jekk jinxtamm.
 NL Kan bij inademing allergie- of astmasymptomen of ademhalingsmoeilijkheden veroorzaken.
 PL Może powodować objawy alergii lub astmy lub trudności w oddychaniu w następstwie wdychania.
 PT Quando inalado, pode provocar sintomas de alergia ou de asma ou dificuldades respiratórias.
 RO Poate provoca simptome de alergie sau astm sau dificultăţi de respiraţie în caz de inhalare.
 SK Pri vdýchnutí môže vyvolať alergiu alebo príznaky astmy, alebo dýchacie ťažkosti.
 SL Lahko povzroči simptome alergije ali astme ali težave z dihanjem pri vdihavanju.
 FI Voi aiheuttaa hengitettynä allergia- tai astmaoireita tai hengitysvaikeuksia.
 SV Kan orsaka allergi- eller astmasymtom eller andningssvårigheter vid inandning.


H335 Language 3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Respiratory tract irritation
 BG Може да предизвика дразнене на дихателните пътища.
 ES Puede irritar las vías respiratorias.
 CS Může způsobit podráždění dýchacích cest.
 DA Kan forårsage irritation af luftvejene.
 DE Kann die Atemwege reizen.
 ET Võib põhjustada hingamisteede ärritust.
 EL Μπορεί να προκαλέσει ερεθισμό της αναπνευστικής οδού.
 EN May cause respiratory irritation.
 FR Peut irriter les voies respiratoires.
 GA D'fhéadfadh sé a bheith ina chúis le greannú riospráide.
 IT Può irritare le vie respiratorie.
 LV Var izraisīt elpceļu kairinājumu.
 LT Gali dirginti kvėpavimo takus.
 HU Légúti irritációt okozhat.
 MT Jista’ jikkawża irritazzjoni respiratorja.
 NL Kan irritatie van de luchtwegen veroorzaken.
 PL Może powodować podrażnienie dróg oddechowych.
 PT Pode provocar irritação das vias respiratórias.
 RO Poate provoca iritarea căilor respiratorii.
 SK Môže spôsobiť podráždenie dýchacích ciest.
 SL Lahko povzroči draženje dihalnih poti.
 FI Saattaa aiheuttaa hengitysteiden ärsytystä.
 SV Kan orsaka irritation i luftvägarna.


H336 Language 3.8 — Specific target organ toxicity — Single exposure, Hazard Category 3, Narcosis
 BG Може да предизвика сънливост или световъртеж.
 ES Puede provocar somnolencia o vértigo.
 CS Může způsobit ospalost nebo závratě.
 DA Kan forårsage sløvhed eller svimmelhed.
 DE Kann Schläfrigkeit und Benommenheit verursachen.
 ET Võib põhjustada unisust või peapööritust.
 EL Μπορεί να προκαλέσει υπνηλία ή ζάλη.
 EN May cause drowsiness or dizziness.
 FR Peut provoquer somnolence ou vertiges.
 GA D'fhéadfadh sé a bheith ina chúis le codlatacht nó le meadhrán.
 IT Può provocare sonnolenza o vertigini.
 LV Var izraisīt miegainību vai reiboņus.
 LT Gali sukelti mieguistumą arba galvos svaigimą.
 HU Álmosságot vagy szédülést okozhat.
 MT Jista’ jikkawża ħedla jew sturdament.
 NL Kan slaperigheid of duizeligheid veroorzaken.
 PL Może wywoływać uczucie senności lub zawroty głowy.
 PT Pode provocar sonolência ou vertigens.
 RO Poate provoca somnolenţă sau ameţeală.
 SK Môže spôsobiť ospalosť alebo závraty.
 SL Lahko povzroči zaspanost ali omotico.
 FI Saattaa aiheuttaa uneliaisuutta ja huimausta.
 SV Kan göra att man blir dåsig eller omtöcknad.


H340 Language 3.5 — Germ cell mutagenicity, Hazard Category 1A, 1B
 BG Може да причини генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Puede provocar defectos genéticos <Indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía >.
 CS Může vyvolat genetické poškození <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Kan forårsage genetiske defekter <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Kann genetische Defekte verursachen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Võib põhjustada geneetilisi defekte <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Μπορεί να προκαλέσει γενετικά ελαττώματα < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
 EN May cause genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Peut induire des anomalies génétiques <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA D'fhéadfadh sé a bheith ina chúis le héalanga géiniteacha <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Può provocare alterazioni genetiche <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Var izraisīt ģenētiskus bojājumus <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Gali sukelti genetinius defektus <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Genetikai károsodást okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
 MT Jista’ jikkawża difetti ġenetiċi <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
 NL Kan genetische schade veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Może powodować wady genetyczne <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
 PT Pode provocar anomalias genéticas <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Poate provoca anomalii genetice <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Môže spôsobovať genetické poškodenie <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Lahko povzroči genetske okvare <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Saattaa aiheuttaa perimävaurioita <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Kan orsaka genetiska defekter <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H341 Language 3.5 — Germ cell mutagenicity, Hazard Category 2
 BG Предполага се, че причинява генетични дефекти < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Se sospecha que provoca defectos genéticos <Indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Podezření na genetické poškození <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Mistænkt for at forårsage genetiske defekter <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Kann vermutlich genetische Defekte verursachen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Arvatavasti põhjustab geneetilisi defekte <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Ύποπτο για πρόκληση γενετικών ελαττωμάτων <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
 EN Suspected of causing genetic defects <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Susceptible d'induire des anomalies génétiques <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA Ceaptar go bhféadfadh sé a bheith ina chúis le héalanga géiniteacha <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Sospettato di provocare alterazioni genetiche <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Ir aizdomas, ka var izraisīt ģenētiskus bojājumus <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Įtariama, kad gali sukelti genetinius defektus <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Feltehetően genetikai károsodást okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
 MT Suspettat li jikkawża difetti ġenetiċi <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
 NL Verdacht van het veroorzaken van genetische schade <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Podejrzewa się, że powoduje wady genetyczne <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
 PT Suspeito de provocar anomalias genéticas <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Susceptibil de a provoca anomalii genetice < indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Podozrenie, že spôsobuje genetické poškodenie <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Sum povzročitve genetskih okvar <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Epäillään aiheuttavan perimävaurioita <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Misstänks kunna orsaka genetiska defekter <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H350 Language 3.6 — Carcinogenicity, Hazard Category 1A, 1B
 BG Може да причини рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Puede provocar cáncer <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Může vyvolat rakovinu <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Kan fremkalde kræft <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Kann Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Võib põhjustada vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Μπορεί να προκαλέσει καρκίνο <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
 EN May cause cancer <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Peut provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA D'fhéadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Può provocare il cancro<indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Var izraisīt vēzi <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Gali sukelti vėžį <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Rákot okozhat < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
 MT Jista’ jikkawża l-kanċer <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
 NL Kan kanker veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>
 PL Może powodować raka <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
 PT Pode provocar cancro <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Poate provoca cancer <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Môže spôsobiť rakovinu <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Lahko povzroči raka <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Saattaa aiheuttaa syöpää <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Kan orsaka cancer <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H351 Language 3.6 — Carcinogenicity, Hazard Category 2
 BG Предполага се, че причинява рак < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Se sospecha que provoca cáncer <indíquese la vía de exposición si se se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Podezření na vyvolání rakoviny <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Mistænkt for at fremkalde kræft <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Kann vermutlich Krebs erzeugen <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Arvatavasti põhjustab vähktõbe <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Ύποπτο για πρόκληση καρκίνου <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
 EN Suspected of causing cancer <state route of exposure if it is conclusively proven that no other routs of exposure cause the hazard>.
 FR Susceptible de provoquer le cancer <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA Ceaptar go bhféadfadh sé a bheith ina chúis le hailse <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Sospettato di provocare il cancro <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Ir aizdomas, ka var izraisīt vēzi <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Įtariama, kad sukelia vėžį <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Feltehetően rákot okoz < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
 MT Suspettat li jikkawża l-kanċer <ara l-mod ta’ espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu >.
 NL Verdacht van het veroorzaken van kanker <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Podejrzewa się, że powoduje raka <podać drogę narażenia, jeżeli definitywnie udowodniono, że inna droga narażenia nie powoduje zagrożenia>.
 PT Suspeito de provocar cancro <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Susceptibil de a provoca cancer <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Podozrenie, že spôsobuje rakovinu <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Sum povzročitve raka <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Epäillään aiheuttavan syöpää <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Misstänks kunna orsaka cancer <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H360 Language 3.7 — Reproductive toxicity, Hazard Category 1A, 1B
 BG Може да увреди оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Puede perjudicar la fertilidad o dañar al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Může poškodit reprodukční schopnost nebo plod v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Kan skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Kann die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen <konkrete Wirkung angeben, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Võib kahjustada viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Μπορεί να βλάψει τη γονιμότητα ή το έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
 EN May damage fertility or the unborn child <state specific effect if known > <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Peut nuire à la fertilité ou au fœtus <indiquer l'effet spécifique s'il est connu> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA D'fhéadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn <tabhair an tsainéifeacht más eol > <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Può nuocere alla fertilità o al feto <indicare l'effetto specifico, se noto><indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Var kaitēt auglībai vai nedzimušajam bērnam <norādīt īpašo ietekmi, ja tā ir zināma> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Gali pakenkti vaisingumui arba negimusiam vaikui <nurodyti konkretų poveikį, jeigu žinomas> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Károsíthatja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
 MT Jista' jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf <semmi l-effett speċifiku jekk ikun magħruf> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
 NL Kan de vruchtbaarheid of het ongeboren kind schaden <specifiek effect vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Może działać szkodliwie na płodność lub na dziecko w łonie matki <podać szczególny skutek, jeżeli jest znany> <podać drogę narażenia, jeżeli definitywnie udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
 PT Pode afectar a fertilidade ou o nascituro <indicar o efeito específico se este for conhecido> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Poate dăuna fertilităţii sau fătului <indicaţi efectul specific, dacă este cunoscut><indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Môže spôsobiť poškodenie plodnosti alebo nenarodeného dieťaťa <uveďte konkrétny účinok, ak je známy > <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Lahko škoduje plodnosti ali nerojenemu otroku <navesti posebni učinek, če je znan> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Saattaa heikentää hedelmällisyyttä tai vaurioittaa sikiötä <mainitaan tiedetty spesifinen vaikutus> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Kan skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H361 Language 3.7 — Reproductive toxicity, Hazard Category 2
 BG Предполага се, че уврежда оплодителната способност или плода < да се посочи конкретното въздействие, ако е известно > < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Se sospecha que perjudica la fertilidad o daña al feto <indíquese el efecto específico si se conoce> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Podezření na poškození reprodukční schopnosti nebo plodu v těle matky <uveďte specifický účinek, je-li znám> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Mistænkt for at skade forplantningsevnen eller det ufødte barn <angiv specifik effekt, hvis kendt> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Kann vermutlich die Fruchtbarkeit beeinträchtigen oder das Kind im Mutterleib schädigen < konkrete Wirkung angebe, n sofern bekannt > <Expositionsweg angeben, sofern schlüssig belegt ist, dass die Gefahr bei keinem anderen Expositionsweg besteht>
 ET Arvatavasti kahjustab viljakust või loodet <märkida spetsiifiline toime, kui see on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Ύποπτο για πρόκληση βλάβης στη γονιμότητα ή στο έμβρυο <αναφέρεται η ειδική επίπτωση εάν είναι γνωστή> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
 EN Suspected of damaging fertility or the unborn child <state specific effect if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Susceptible de nuire à la fertilité ou au fœtus <indiquer l'effet s'il est connu> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA Ceaptar go bhféadfadh sé damáiste a dhéanamh do thorthúlacht nó don leanbh sa bhroinn <tabhair an tsainéifeacht más eol > <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Sospettato di nuocere alla fertilità o al feto <indicare l'effetto specifico, se noto> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Ir aizdomas, ka var kaitēt auglībai vai nedzimušajam bērnam <norādīt īpašo ietekmi, ja tā ir zināma> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Įtariama, kad kenkia vaisingumui arba negimusiam vaikui <nurodyti konkretų poveikį, jeigu žinomas> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Feltehetően károsítja a termékenységet vagy a születendő gyermeket < ha ismert, meg kell adni a konkrét hatást > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
 MT Suspettat li jagħmel ħsara lill-fertilità jew lit-tarbija li għadha fil-ġuf <semmi l-effett speċifiku jekk ikun magħruf> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu >.
 NL Kan mogelijks de vruchtbaarheid of het ongeboren kind schaden <specifiek effect vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Podejrzewa się, że działa szkodliwie na płodność lub na dziecko w łonie matki <podać szczególny skutek, jeżeli jest znany> <podać drogę narażenia, jeżeli definitywnie udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
 PT Suspeito de afectar a fertilidade ou o nascituro <indicar o efeito específico se este for conhecido> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Susceptibil de a dăuna fertilităţii sau fătului <indicaţi efectul specific, dacă este cunoscut><indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Podozrenie, že spôsobuje poškodenie plodnosti alebo nenarodeného dieťaťa <uveďte konkrétny účinok, ak je známy > <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Sum škodljivosti za plodnost ali nerojenega otroka <navesti posebni učinek, če je znan> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Epäillään heikentävän hedelmällisyyttä tai vaurioittavan sikiötä <mainitaan tiedetty spesifinen vaikutus> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Misstänks kunna skada fertiliteten eller det ofödda barnet <ange specifik effekt om denna är känd> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H362 Language 3.7 — Reproductive toxicity, Additional category, Effects on or via lactation
 BG Може да бъде вреден за кърмачета.
 ES Puede perjudicar a los niños alimentados con leche materna.
 CS Může poškodit kojence prostřednictvím mateřského mléka.
 DA Kan skade børn, der ammes.
 DE Kann Säuglinge über die Muttermilch schädigen.
 ET Võib kahjustada rinnaga toidetavat last.
 EL Μπορεί να βλάψει τα βρέφη που τρέφονται με μητρικό γάλα.
 EN May cause harm to breast-fed children.
 FR Peut être nocif pour les bébés nourris au lait maternel.
 GA D'fhéadfadh sé díobháil a dhéanamh do leanaí diúil.
 IT Può essere nocivo per i lattanti allattati al seno.
 LV Var radīt kaitējumu ar krūti barotam bērnam.
 LT Gali pakenkti žindomam vaikui.
 HU A szoptatott gyermeket károsíthatja.
 MT Jista’ jagħmel ħsara lit-tfal imreddgħa.
 NL Kan schadelijk zijn via borstvoeding.
 PL Może działać szkodliwie na dzieci karmione piersią.
 PT Pode ser nocivo para as crianças alimentadas com leite materno.
 RO Poate dăuna copiilor alăptaţi la sân.
 SK Môže spôsobiť poškodenie u dojčených detí.
 SL Lahko škoduje dojenim otrokom.
 FI Saattaa aiheuttaa haittaa rintaruokinnassa oleville lapsille.
 SV Kan skada spädbarn som ammas.


H370 Language 3.8 — Specific target organ toxicity — single exposure, Hazard Category 1
 BG Причинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Provoca daños en los órganos <o indíquense todos los órganos afectados, si se conocen> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Způsobuje poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Forårsager organskader <eller angiv alle berørte organer, hvis de kendes> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Schädigt die Organe <oder alle betroffenen Organe nennen, sofern bekannt> <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Kahjustab elundeid <või märkida kõik mõjutatud elundid, kui need on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Προκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
 EN Causes damage to organs <or state all organs affected, if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Risque avéré d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA Déanann sé damáiste d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Provoca danni agli organi <o indicare tutti gli organi interessati, se noti> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Rada orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Kenkia organams <arba nurodyti visus veikiamus organus, jeigu žinomi> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
 MT Jagħmel ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
 NL Veroorzaakt schade aan organen <of alle betrokken organen vermelden indien bekend> <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Powoduje uszkodzenie narządów <podać szczególny skutek, jeśli jest znany> <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
 PT Afecta os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Provoacă leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Spôsobuje poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe> <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Orsakar organskador <eller ange vilka organ som påverkas om detta är känt> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H371 Language 3.8 — Specific target organ toxicity — Single exposure, Hazard Category 2
 BG Може да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни> < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Puede provocar daños en los órganos <o indíquense todos los órganos afectados, si se conocen> <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Může způsobit poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Kan forårsage organskader <eller angiv alle berørte organer, hvis de kendes> <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Kann die Organe schädigen <oder alle betroffenen Organe nennen, sofern bekann> <Expositionsweg angeben, sofern schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Võib kahjustada elundeid <või märkida kõik mõjutatud elundid, kui need on teada> <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Μπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
 EN May cause damage to organs <or state all organs affected, if known> <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Risque présumé d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA D'fhéadfadh damáiste a dhéanamh d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Può provocare danni agli organi <o indicare tutti gli organi interessati, se noti> <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Var izraisīt orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Gali pakenkti organams <arba nurodyti visus veikiamus organus, jeigu žinomi> <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Károsíthatja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek > < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt >.
 MT Jista’ jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta'’ espożizzjoni ieħor ma jikkawża l-periklu>.
 NL Kan schade aan organen <of alle betrokken organen vermelden indien bekend> veroorzaken <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Może powodować uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy> <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
 PT Pode afectar os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Poate provoca leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Môže spôsobiť poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe> <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Lahko škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Saattaa vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Kan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H372 Language 3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 1
 BG Причинява увреждане на органите < или да се посочат всички засегнати органи, ако са известни > посредством продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Provoca daños en los órganos <indíquense todos los órganos afectados, si se conocen> tras exposiciones prolongadas o repetidas <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Způsobuje poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> při prodloužené nebo opakované expozici <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Forårsager organskader <eller angiv alle berørte organer, hvis de kendes> ved længerevarende eller gentagen eksponering <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Schädigt die Organe <alle betroffenen Organe nennen> bei längerer oder wiederholter Exposition <Expositionsweg angeben, wenn schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Kahjustab elundeid <või märkida kõik mõjutatud elundid, kui need on teada> pikaajalisel või korduval kokkupuutel <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Προκαλεί βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση < αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης >.
 EN Causes damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Risque avéré d'effets graves pour les organes <indiquer tous les organes affectés, s'ils sont connus> à la suite d'expositions répétées ou d'une exposition prolongée <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA Déanann damáiste d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> trí nochtadh fada nó ilnochtadh <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Provoca danni agli organi <o indicare tutti gli organi interessati, se noti> in caso di esposizione prolungata o ripetuta <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Izraisa orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> ilgstošas vai atkārtotas iedarbības rezultātā <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Kenkia organams <arba nurodyti visus veikiamus organus, jeigu žinoma>, jeigu medžiaga veikia ilgai arba kartotinai <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Ismétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsítja a szerveket < vagy meg kell adni az összes érintett szervet, ha ismertek >.
 MT Jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> minħabba espożizzjoni fit-tul jew ripetuta <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
 NL Veroorzaakt schade aan organen <of alle betrokken organen vermelden indien bekend> bij langdurige of herhaalde blootstelling <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Powoduje uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy > poprzez długotrwałe lub powtarzane narażenie <podać drogę narażenia, jeżeli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
 PT Afecta os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> após exposição prolongada ou repetida <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Provoacă leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> în caz de expunere prelungită sau repetată <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Spôsobuje poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe>pri dlhšej alebo opakovanej expozícii <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> pri dolgotrajni ali ponavljajoči se izpostavljenosti <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> pitkäaikaisessa tai toistuvassa altistumisessa <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>.
 SV Orsakar organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H373 Language 3.9 — Specific target organ toxicity — Repeated exposure, Hazard Category 2
 BG Може да причини увреждане на органите < или да се посочат всички засегнати органи, ако са известни > при продължителна или повтаряща се експозиция < да се посочи пътят на експозицията, ако е доказано убедително, че няма друг път на експозиция, който води до същата опасност >.
 ES Puede provocar daños en los órganos <indíquense todos los órganos afectados, si se conocen> tras exposiciones prolongadas o repetidas <indíquese la vía de exposición si se ha demostrado concluyentemente que el peligro no se produce por ninguna otra vía>.
 CS Může způsobit poškození orgánů <nebo uvést všechny postižené orgány, jsou-li známy> při prodloužené nebo opakované expozici <uveďte cestu expozice, je-li přesvědčivě prokázáno, že ostatní cesty expozice nejsou nebezpečné>.
 DA Kan forårsage organskader <eller angiv alle berørte organer, hvis de kendes> ved længerevarende eller gentagen eksponering <angiv eksponeringsvej, hvis det er endeligt påvist, at faren ikke kan frembringes ad nogen anden eksponeringsvej>.
 DE Kann die Organe schädigen <alle betroffenen Organe nennen, sofern bekannt> bei längerer oder wiederholter Exposition <Expositionsweg angeben, wenn schlüssig belegt ist, dass diese Gefahr bei keinem anderen Expositionsweg besteht>.
 ET Võib kahjustada elundeid <või märkida kõik mõjutatud elundid, kui need on teada> pikaajalisel või korduval kokkupuutel <märkida kokkupuuteviis, kui on veenvalt tõestatud, et muud kokkupuuteviisid ei ole ohtlikud>.
 EL Μπορεί να προκαλέσει βλάβες στα όργανα <ή αναφέρονται όλα τα όργανα που βλάπτονται, εάν είναι γνωστά> ύστερα από παρατεταμένη ή επανειλημμένη έκθεση <αναφέρεται η οδός έκθεσης αν έχει αποδειχθεί αδιαμφισβήτητα ότι δεν υπάρχει κίνδυνος από τις άλλες οδούς έκθεσης>.
 EN May cause damage to organs <or state all organs affected, if known> through prolonged or repeated exposure <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>.
 FR Risque présumé d'effets graves pour les organes <ou indiquer tous les organes affectés, s'ils sont connus> à la suite d'expositions répétées ou d'une exposition prolongée <indiquer la voie d'exposition s'il est formellement prouvé qu'aucune autre voie d'exposition ne conduit au même danger>.
 GA D'fhéadfadh sé damáiste a dhéanamh d'orgáin <nó tabhair na horgáin go léir a bhuailtear, más eol> trí nochtadh fada nó ilnochtadh <tabhair an bealach nochta má tá sé cruthaithe go cinntitheach nach bealach nochta ar bith eile is cúis leis an nguais>.
 IT Può provocare danni agli organi <o indicare tutti gli organi interessati, se noti> in caso di esposizione prolungata o ripetuta <indicare la via di esposizione se è accertato che nessun'altra via di esposizione comporta il medesimo pericolo>.
 LV Var izraisīt orgānu bojājumus <vai norādīt visus skartos orgānus, ja tie ir zināmi> ilgstošas vai atkārtotas iedarbības rezultātā <norādīt iedarbības ceļu, ja ir nepārprotami pierādīts, ka citi iedarbības ceļi nerada bīstamību>.
 LT Gali pakenkti organams <arba nurodyti visus veikiamus organus, jeigu žinomi>, jeigu medžiaga veikia ilgai arba kartotinai <nurodyti veikimo būdą, jeigu įtikinamai nustatyta, kad kiti veikimo būdai nepavojingi>.
 HU Ismétlődő vagy hosszabb expozíció esetén < meg kell adni az expozíciós útvonalat, ha meggyőzően bizonyított, hogy más expozíciós útvonal nem okozza a veszélyt > károsíthatja a szerveket > vagy meg kell adni az összes érintett szervet, ha ismertek >.
 MT Jista’ jikkawża ħsara lill-organi <jew semmi l-organi kollha affettwati, jekk ikunu magħrufa> minħabba espożizzjoni fit-tul jew ripetuta <semmi l-mod ta' espożizzjoni jekk ikun pruvat b'mod konklużiv li l-ebda mod ta' espożizzjoni ieħor ma jikkawża l-periklu>.
 NL Kan schade aan organen <of alle betrokken organen vermelden indien bekend> veroorzaken bij langdurige of herhaalde blootstelling <blootstellingsroute vermelden indien afdoende bewezen is dat het gevaar bij andere blootstellingsroutes niet aanwezig is>.
 PL Może powodować uszkodzenie narządów <podać wszystkie znane narządy, których to dotyczy > poprzez długotrwałe lub narażenie powtarzane <podać drogę narażenia, jeśli udowodniono, że inne drogi narażenia nie stwarzają zagrożenia>.
 PT Pode afectar os órgãos <ou indicar todos os órgãos afectados, se forem conhecidos> após exposição prolongada ou repetida <indicar a via de exposição se existirem provas concludentes de que o perigo não decorre de nenhuma outra via de exposição>.
 RO Poate provoca leziuni ale organelor <sau indicaţi toate organele afectate, dacă sunt cunoscute> în caz de expunere prelungită sau repetată <indicaţi calea de expunere, dacă există probe concludente că nicio altă cale de expunere nu provoacă acest pericol>.
 SK Môže spôsobiť poškodenie orgánov <alebo uveďte všetky zasiahnuté orgány, ak sú známe>pri dlhšej alebo opakovanej expozícii <uveďte spôsob expozície, ak sa presvedčivo preukáže, že iné spôsoby expozície nevyvolávajú nebezpečenstvo>.
 SL Lahko škoduje organom <ali navesti vse organe, na katere vpliva, če je znano> pri dolgotrajni ali ponavljajoči se izpostavljenosti <navesti način izpostavljenosti, če je prepričljivo dokazano, da noben drug način izpostavljenosti ne povzroča takšne nevarnosti>.
 FI Saattaa vahingoittaa elimiä <tai mainitaan kaikki tiedetyt kohde-elimet> pitkäaikaisessa tai toistuvassa altistumisessa <mainitaan altistumisreitti, jos on kiistatta osoitettu, että vaara ei voi aiheutua muiden altistumisreittien kautta>
 SV Kan orsaka organskador <eller ange vilka organ som påverkas om detta är känt> genom lång eller upprepad exponering <ange exponeringsväg om det är definitivt bevisat att faran inte kan orsakas av några andra exponeringsvägar>.


H400 Language 4.1 — Hazardous to the aquatic environment — AcuteHazard, Category 1
 BG Силно токсичен за водните организми.
 ES Muy tóxico para los organismos acuáticos.
 CS Vysoce toxický pro vodní organismy.
 DA Meget giftig for vandlevende organismer.
 DE Sehr giftig für Wasserorganismen.
 ET Väga mürgine veeorganismidele.
 EL Πολύ τοξικό για τους υδρόβιους οργανισμούς.
 EN Very toxic to aquatic life.
 FR Très toxique pour les organismes aquatiques.
 GA An-tocsaineach don saol uisceach.
 IT Molto tossico per gli organismi acquatici.
 LV Ļoti toksisks ūdens organismiem.
 LT Labai toksiška vandens organizmams.
 HU Nagyon mérgező a vízi élővilágra.
 MT Tossiku ħafna għall-organiżmi akwatiċi.
 NL Zeer giftig voor in het water levende organismen.
 PL Działa bardzo toksycznie na organizmy wodne.
 PT Muito tóxico para os organismos aquáticos.
 RO Foarte toxic pentru mediul acvatic.
 SK Veľmi toxický pre vodné organizmy.
 SL Zelo strupeno za vodne organizme.
 FI Erittäin myrkyllistä vesieliöille.
 SV Mycket giftigt för vattenlevande organismer.


H410 Language 4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 1
 BG Силно токсичен за водните организми, с дълготраен ефект.
 ES Muy tóxico para los organismos acuáticos, con efectos nocivos duraderos.
 CS Vysoce toxický pro vodní organismy, s dlouhodobými účinky.
 DA Meget giftig med langvarige virkninger for vandlevende organismer.
 DE Sehr giftig für Wasserorganismen mit langfristiger Wirkung.
 ET Väga mürgine veeorganismidele, pikaajaline toime.
 EL Πολύ τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
 EN Very toxic to aquatic life with long lasting effects.
 FR Très toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.
 GA An-tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.
 IT Molto tossico per gli organismi acquatici con effetti di lunga durata.
 LV Ļoti toksisks ūdens organismiem ar ilgstošām sekām.
 LT Labai toksiška vandens organizmams, sukelia ilgalaikius pakitimus.
 HU Nagyon mérgező a vízi élővilágra, hosszan tartó károsodást okoz.
 MT Tossiku ħafna għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
 NL Zeer giftig voor in het water levende organismen, met langdurige gevolgen.
 PL Działa bardzo toksycznie na organizmy wodne, powodując długotrwałe skutki.
 PT Muito tóxico para os organismos aquáticos com efeitos duradouros.
 RO Foarte toxic pentru mediul acvatic cu efecte pe termen lung.
 SK Veľmi toxický pre vodné organizmy, s dlhodobými účinkami.
 SL Zelo strupeno za vodne organizme, z dolgotrajnimi učinki.
 FI Erittäin myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.
 SV Mycket giftigt för vattenlevande organismer med långtidseffekter.


H411 Language 4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 2
 BG Токсичен за водните организми, с дълготраен ефект.
 ES Tóxico para los organismos acuáticos, con efectos nocivos duraderos.
 CS Toxický pro vodní organismy, s dlouhodobými účinky.
 DA Giftig for vandlevende organismer, med langvarige virkninger.
 DE Giftig für Wasserorganismen, mit langfristiger Wirkung.
 ET Mürgine veeorganismidele, pikaajaline toime.
 EL Τοξικό για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
 EN Toxic to aquatic life with long lasting effects.
 FR Toxique pour les organismes aquatiques, entraîne des effets néfastes à long terme.
 GA Tocsaineach don saol uisceach, le héifeachtaí fadtréimhseacha.
 IT Tossico per gli organismi acquatici con effetti di lunga durata.
 LV Toksisks ūdens organismiem ar ilgstošām sekām.
 LT Toksiška vandens organizmams, sukelia ilgalaikius pakitimus.
 HU Mérgező a vízi élővilágra, hosszan tartó károsodást okoz.
 MT Tossiku għall-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
 NL Giftig voor in het water levende organismen, met langdurige gevolgen.
 PL Działa toksycznie na organizmy wodne, powodując długotrwałe skutki.
 PT Tóxico para os organismos aquáticos com efeitos duradouros.
 RO Toxic pentru mediul acvatic cu efecte pe termen lung.
 SK Toxický pre vodné organizmy, s dlhodobými účinkami.
 SL Strupeno za vodne organizme, z dolgotrajnimi učinki.
 FI Myrkyllistä vesieliöille, pitkäaikaisia haittavaikutuksia.
 SV Giftigt för vattenlevande organismer med långtidseffekter.


H412 Language 4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 3
 BG Вреден за водните организми, с дълготраен ефект.
 ES Nocivo para los organismos acuáticos, con efectos nocivos duraderos.
 CS Škodlivý pro vodní organismy, s dlouhodobými účinky.
 DA Skadelig for vandlevende organismer, med langvarige virkninger.
 DE Schädlich für Wasserorganismen, mit langfristiger Wirkung.
 ET Ohtlik veeorganismidele, pikaajaline toime.
 EL Επιβλαβές για τους υδρόβιους οργανισμούς, με μακροχρόνιες επιπτώσεις.
 EN Harmful to aquatic life with long lasting effects.
 FR Nocif pour les organismes aquatiques, entraîne des effets néfastes à long terme.
 GA Díobhálach don saol uisceach, le héifeachtaí fadtréimhseacha.
 IT Nocivo per gli organismi acquatici con effetti di lunga durata.
 LV Kaitīgs ūdens organismiem ar ilgstošām sekām.
 LT Kenksminga vandens organizmams, sukelia ilgalaikius pakitimus.
 HU Ártalmas a vízi élővilágra, hosszan tartó károsodást okoz.
 MT Jagħmel ħsara lill-organiżmi akwatiċi b'mod li jħalli effetti dejjiema.
 NL Schadelijk voor in het water levende organismen, met langdurige gevolgen.
 PL Działa szkodliwie na organizmy wodne, powodując długotrwałe skutki.
 PT Nocivo para os organismos aquáticos com efeitos duradouros.
 RO Nociv pentru mediul acvatic cu efecte pe termen lung.
 SK Škodlivý pre vodné organizmy, s dlhodobými účinkami.
 SL Škodljivo za vodne organizme, z dolgotrajnimi učinki.
 FI Haitallista vesieliöille, pitkäaikaisia haittavaikutuksia.
 SV Skadliga långtidseffekter för vattenlevande organismer.


H413 Language 4.1 — Hazardous to the aquatic environment — Chronic Hazard, Category 4
 BG Може да причини дълготраен вреден ефект за водните организми.
 ES Puede ser nocivo para los organismos acuáticos, con efectos nocivos duraderos.
 CS Může vyvolat dlouhodobé škodlivé účinky pro vodní organismy.
 DA Kan forårsage langvarige skadelige virkninger for vandlevende organismer.
 DE Kann für Wasserorganismen schädlich sein, mit langfristiger Wirkung.
 ET Võib avaldada veeorganismidele pikaajalist kahjulikku toimet.
 EL Μπορεί να προκαλέσει μακροχρόνιες επιπτώσεις στους υδρόβιους οργανισμούς.
 EN May cause long lasting harmful effects to aquatic life.
 FR Peut être nocif à long terme pour les organismes aquatiques.
 GA D'fhéadfadh sé a bheith ina chúis le héifeachtaí fadtréimhseacha díobhálacha ar an saol uisceach.
 IT Può essere nocivo per gli organismi acquatici con effetti di lunga durata.
 LV Var radīt ilgstošas kaitīgas sekas ūdens organismiem.
 LT Gali sukelti ilgalaikį kenksmingą poveikį vandens organizmams.
 HU Hosszan tartó ártalmas hatást gyakorolhat a vízi élővilágra.
 MT Jista’ jikkawża effetti ta' ħsara dejjiema lill-organiżmi akwatiċi.
 NL Kan langdurige schadelijke gevolgen voor in het water levende organismen hebben.
 PL Może powodować długotrwałe szkodliwe skutki dla organizmów wodnych.
 PT Pode provocar efeitos nocivos duradouros nos organismos aquáticos.
 RO Poate provoca efecte nocive pe termen lung asupra mediului acvatic.
 SK Môže mať dlhodobé škodlivé účinky na vodné organizmy.
 SL Lahko ima dolgotrajne škodljive učinke na vodne organizme.
 FI Voi aiheuttaa pitkäaikaisia haittavaikutuksia vesieliöille.
 SV Kan ge skadliga långtidseffekter på vattenlevande organismer.

2. 

EUH 001 Language 
 BG Експлозивен в сухо състояние.
 ES Explosivo en estado seco.
 CS Výbušný v suchém stavu.
 DA Eksplosiv i tør tilstand.
 DE In trockenem Zustand explosionsgefährlich.
 ET Plahvatusohtlik kuivana.
 EL Εκρηκτικό σε ξηρή κατάσταση.
 EN Explosive when dry.
 FR Explosif à l'état sec.
 GA Pléascach agus é tirim.
 IT Esplosivo allo stato secco.
 LV Sprādzienbīstams sausā veidā.
 LT Sausos būsenos gali sprogti.
 HU Száraz állapotban robbanásveszélyes.
 MT Jisplodi meta jinxef.
 NL In droge toestand ontplofbaar.
 PL Produkt wybuchowy w stanie suchym.
 PT Explosivo no estado seco.
 RO Exploziv în stare uscată.
 SK V suchom stave výbušný.
 SL Eksplozivno v suhem stanju.
 FI Räjähtävää kuivana.
 SV Explosivt i torrt tillstånd.


EUH 006 Language 
 BG Експлозивен при или без контакт с въздуха.
 ES Explosivo en contacto o sin contacto con el aire.
 CS Výbušný za přístupu i bez přístupu vzduchu.
 DA Eksplosiv ved og uden kontakt med luft.
 DE Mit und ohne Luft explosionsfähig.
 ET Plahvatusohtlik õhuga kokkupuutel või kokkupuuteta.
 EL Εκρηκτικό σε επαφή ή χωρίς επαφή με τον αέρα.
 EN Explosive with or without contact with air.
 FR Danger d'explosion en contact ou sans contact avec l'air.
 GA Pléascach i dteagmháil le haer nó gan é.
 IT Esplosivo a contatto o senza contatto con l'aria.
 LV Sprādzienbīstams gaisa un bezgaisa vidē.
 LT Gali sprogti ore arba beorėje erdvėje.
 HU Levegővel érintkezve vagy anélkül is robbanásveszélyes.
 MT Jista' jisplodi b'kuntatt jew bla kuntatt ma' l-ajra.
 NL Ontplofbaar met en zonder lucht.
 PL Produkt wybuchowy z dostępem lub bez dostępu powietrza.
 PT Perigo de explosão com ou sem contacto com o ar.
 RO Exploziv în contact sau fără contactul cu aerul.
 SK Výbušné pri kontakte alebo bez kontaktu so vzduchom.
 SL Eksplozivno v stiku z zrakom ali brez stika z zrakom.
 FI Räjähtävää sellaisenaan tai ilman kanssa.
 SV Explosivt vid eller utan kontakt med luft.


EUH 014 Language 
 BG Реагира бурно с вода.
 ES Reacciona violentamente con el agua.
 CS Prudce reaguje s vodou.
 DA Reagerer voldsomt med vand.
 DE Reagiert heftig mit Wasser.
 ET Reageerib ägedalt veega.
 EL Αντιδρά βίαια με νερό.
 EN Reacts violently with water.
 FR Réagit violemment au contact de l'eau.
 GA Imoibríonn go foirtil le huisce.
 IT Reagisce violentemente con l'acqua.
 LV Aktīvi reaģē ar ūdeni.
 LT Smarkiai reaguoja su vandeniu.
 HU Vízzel hevesen reagál.
 MT Jirreaġixxi bil-qawwa meta jmiss l-ilma.
 NL Reageert heftig met water.
 PL Reaguje gwałtownie z wodą.
 PT Reage violentamente em contacto com a água.
 RO Reacţionează violent în contact cu apa.
 SK Prudko reaguje s vodou.
 SL Burno reagira z vodo.
 FI Reagoi voimakkaasti veden kanssa.
 SV Reagerar häftigt med vatten.


EUH 018 Language 
 BG При употреба може да се образува запалима/експлозивна паровъздушнa смес.
 ES Al usarlo pueden formarse mezclas aire-vapor explosivas o inflamables.
 CS Při používání může vytvářet hořlavé nebo výbušné směsi par se vzduchem.
 DA Ved brug kan brandbarlige dampe/eksplosive damp-luftblandinger dannes.
 DE Kann bei Verwendung explosionsfähige/entzündbare Dampf/Luft-Gemische bilden.
 ET Kasutamisel võib moodustuda tule-/plahvatusohtlik auru-õhu segu.
 EL Κατά τη χρήση μπορεί να σχηματίσει εύφλεκτα/εκρηκτικά μείγματα ατμού-αέρος.
 EN In use may form flammable/explosive vapour-air mixture.
 FR Lors de l'utilisation, formation possible de mélange vapeur-air inflammable/explosif.
 GA Agus é á úsáid d'fhéadfaí meascán inadhainte/pléascach gaile-aeir a chruthú.
 IT Durante l'uso può formarsi una miscela vapore-aria esplosiva/infiammabile.
 LV Izmantojot var veidot uzliesmojošu vai sprādzienbīstamu tvaiku un gaisa maisījumu.
 LT Naudojama gali sudaryti degius (sprogius) garų-oro mišinius.
 HU A használat során tűzveszélyes/robbanásveszélyes gőz/levegő elegy keletkezhet.
 MT Meta jintuża jista' jifforma taħlitiet esplussivi jew li jaqbdu jekk jitħallat ma' l-arja.
 NL Kan bij gebruik een ontvlambaar/ontplofbaar damp-luchtmengsel vormen.
 PL Podczas stosowania mogą powstawać łatwopalne lub wybuchowe mieszaniny par z powietrzem.
 PT Pode formar mistura vapor-ar explosiva/inflamável durante a utilização.
 RO În timpul utilizării poate forma un amestec vapori-aer, inflamabil/exploziv.
 SK Pri použití môže vytvárat’ horľavú/výbušnú zmes pár so vzduchom.
 SL Pri uporabi lahko tvori vnetljivo/eksplozivno zmes hlapi-zrak.
 FI Käytössä voi muodostua syttyvä/räjähtävä höyry-ilmaseos.
 SV Vid användning kan brännbara/explosiva ång-luftblandningar bildas.


EUH 019 Language 
 BG Може да образува експлозивни пероксиди.
 ES Puede formar peróxidos explosivos.
 CS Může vytvářet výbušné peroxidy.
 DA Kan danne eksplosive peroxider.
 DE Kann explosionsfähige Peroxide bilden.
 ET Võib moodustada plahvatusohtlikke peroksiide.
 EL Μπορεί να σχηματίσει εκρηκτικά υπεροξείδια.
 EN May form explosive peroxides.
 FR Peut former des peroxydes explosifs.
 GA D'fhéadfadh sé sárocsaídí pléascacha a chruthú.
 IT Può formare perossidi esplosivi.
 LV Var veidot sprādzienbīstamus peroksīdus.
 LT Gali sudaryti sprogius peroksidus.
 HU Robbanásveszélyes peroxidokat képezhet.
 MT Jista' jifforma perossidi esplussivi.
 NL Kan ontplofbare peroxiden vormen.
 PL Może tworzyć wybuchowe nadtlenki.
 PT Pode formar peróxidos explosivos.
 RO Poate forma peroxizi explozivi.
 SK Môže vytvárat’ výbušné peroxidy.
 SL Lahko tvori eksplozivne perokside.
 FI Saattaa muodostaa räjähtäviä peroksideja.
 SV Kan bilda explosiva peroxider.


EUH 044 Language 
 BG Риск от експлозия при нагряване в затворено пространство.
 ES Riesgo de explosión al calentarlo en ambiente confinado.
 CS Nebezpečí výbuchu při zahřátí v uzavřeném obalu.
 DA Eksplosionsfarlig ved opvarmning under indeslutning.
 DE Explosionsgefahr bei Erhitzen unter Einschluss.
 ET Plahvatusohtlik kuumutamisel kinnises mahutis.
 EL Κίνδυνος εκρήξεως εάν θερμανθεί υπό περιορισμό.
 EN Risk of explosion if heated under confinement.
 FR Risque d'explosion si chauffé en ambiance confinée.
 GA Baol pléasctha arna théamh i limistéar iata.
 IT Rischio di esplosione per riscaldamento in ambiente confinato.
 LV Sprādziena draudi, karsējot slēgtā vidē.
 LT Gali sprogti, jei kaitinama sandariai uždaryta.
 HU Zárt térben hő hatására robbanhat.
 MT Riskju ta' splużjoni jekk jissaħħan fil-magħluq.
 NL Ontploffingsgevaar bij verwarming in afgesloten toestand.
 PL Zagrożenie wybuchem po ogrzaniu w zamkniętym pojemniku.
 PT Risco de explosão se aquecido em ambiente fechado.
 RO Risc de explozie, dacă este încălzit în spaţiu închis.
 SK Riziko výbuchu pri zahrievaní v uzavretom priestore.
 SL Nevarnost eksplozije ob segrevanju v zaprtem prostoru.
 FI Räjähdysvaara kuumennettaessa suljetussa astiassa.
 SV Explosionsrisk vid uppvärmning i sluten behållare.


EUH 029 Language 
 BG При контакт с вода се отделя токсичен газ.
 ES En contacto con agua libera gases tóxicos.
 CS Uvolňuje toxický plyn při styku s vodou.
 DA Udvikler giftig gas ved kontakt med vand.
 DE Entwickelt bei Berührung mit Wasser giftige Gase.
 ET Kokkupuutel veega eraldub mürgine gaas.
 EL Σε επαφή με το νερό ελευθερώνονται τοξικά αέρια.
 EN Contact with water liberates toxic gas.
 FR Au contact de l'eau, dégage des gaz toxiques.
 GA I dteagmháil le huisce scaoiltear gás tocsaineach.
 IT A contatto con l'acqua libera un gas tossico.
 LV Saskaroties ar ūdeni, izdala toksiskas gāzes.
 LT Kontaktuodama su vandeniu išskiria toksiškas dujas.
 HU Vízzel érintkezve mérgező gázok képződnek.
 MT Jitfa' gass tossiku meta jmiss l-ilma.
 NL Vormt giftig gas in contact met water.
 PL W kontakcie z wodą uwalnia toksyczne gazy.
 PT Em contacto com a água liberta gases tóxicos.
 RO În contact cu apa, degajă un gaz toxic.
 SK Pri kontakte s vodou uvoľňuje toxický plyn.
 SL V stiku z vodo se sprošča strupen plin.
 FI Kehittää myrkyllistä kaasua veden kanssa.
 SV Utvecklar giftig gas vid kontakt med vatten.


EUH 031 Language 
 BG При контакт с киселини се отделя токсичен газ.
 ES En contacto con ácidos libera gases tóxicos.
 CS Uvolňuje toxický plyn při styku s kyselinami.
 DA Udvikler giftig gas ved kontakt med syre.
 DE Entwickelt bei Berührung mit Säure giftige Gase.
 ET Kokkupuutel hapetega eraldub mürgine gaas.
 EL Σε επαφή με οξέα ελευθερώνονται τοξικά αέρια.
 EN Contact with acids liberates toxic gas.
 FR Au contact d'un acide, dégage un gaz toxique.
 GA I dteagmháil le haigéid scaoiltear gás tocsaineach.
 IT A contatto con acidi libera gas tossici.
 LV Saskaroties ar skābēm, izdala toksiskas gāzes.
 LT Kontaktuodama su rūgštimis išskiria toksiškas dujas.
 HU Savval érintkezve mérgező gázok képződnek.
 MT Jitfa' gass tossiku meta jmiss l-aċidi.
 NL Vormt giftig gas in contact met zuren.
 PL W kontakcie z kwasami uwalnia toksyczne gazy.
 PT Em contacto com ácidos liberta gases tóxicos.
 RO În contact cu acizi, degajă un gaz toxic.
 SK Pri kontakte s kyselinami uvoľňuje toxický plyn.
 SL V stiku s kislinami se sprošča strupen plin.
 FI Kehittää myrkyllistä kaasua hapon kanssa.
 SV Utvecklar giftig gas vid kontakt med syra.


EUH 032 Language 
 BG При контакт с киселини се отделя силно токсичен газ.
 ES En contacto con ácidos libera gases muy tóxicos.
 CS Uvolňuje vysoce toxický plyn při styku s kyselinami.
 DA Udvikler meget giftig gas ved kontakt med syre.
 DE Entwickelt bei Berührung mit Säure sehr giftige Gase.
 ET Kokkupuutel hapetega eraldub väga mürgine gaas.
 EL Σε επαφή με οξέα ελευθερώνονται πολύ τοξικά αέρια.
 EN Contact with acids liberates very toxic gas.
 FR Au contact d'un acide, dégage un gaz très toxique.
 GA I dteagmháil le haigéid scaoiltear gás an-tocsaineach.
 IT A contatto con acidi libera gas molto tossici.
 LV Saskaroties ar skābēm, izdala ļoti toksiskas gāzes.
 LT Kontaktuodama su rūgštimis išskiria labai toksiškas dujas.
 HU Savval érintkezve nagyon mérgező gázok képződnek.
 MT Jitfa' gass tossiku ħafna meta jmiss l-aċidi.
 NL Vormt zeer giftig gas in contact met zuren.
 PL W kontakcie z kwasami uwalnia bardzo toksyczne gazy.
 PT Em contacto com ácidos liberta gases muito tóxicos.
 RO În contact cu acizi, degajă un gaz foarte toxic.
 SK Pri kontakte s kyselinami uvoľňuje veľmi toxický plyn.
 SL V stiku s kislinami se sprošča zelo strupen plin.
 FI Kehittää erittäin myrkyllistä kaasua hapon kanssa.
 SV Utvecklar mycket giftig gas vid kontakt med syra.


EUH 066 Language 
 BG Повтарящата се експозиция може да предизвика изсушаване или напукване на кожата.
 ES La exposición repetida puede provocar sequedad o formación de grietas en la piel.
 CS Opakovaná expozice může způsobit vysušení nebo popraskání kůže.
 DA Gentagen kontakt kan give tør eller revnet hud.
 DE Wiederholter Kontakt kann zu spröder oder rissiger Haut führen.
 ET Korduv kokkupuude võib põhjustada naha kuivust või lõhenemist.
 EL Παρατεταμένη έκθεση μπορεί να προκαλέσει ξηρότητα δέρματος ή σκάσιμο.
 EN Repeated exposure may cause skin dryness or cracking.
 FR L'exposition répétée peut provoquer dessèchement ou gerçures de la peau.
 GA D'fhéadfadh tirimeacht chraicinn nó scoilteadh craicinn a bheith mar thoradh ar ilnochtadh.
 IT L'esposizione ripetuta può provocare secchezza o screpolature della pelle.
 LV Atkārtota iedarbība var radīt sausu ādu vai izraisīt tās sprēgāšanu.
 LT Pakartotinis poveikis gali sukelti odos džiūvimą arba skilinėjimą.
 HU Ismétlődő expozíció a bőr kiszáradását vagy megrepedezését okozhatja.
 MT Espożizzjoni ripetuta tista' tikkaġuna nxif jew qsim tal-ġilda.
 NL Herhaalde blootstelling kan een droge of een gebarsten huid veroorzaken.
 PL Powtarzające się narażenie może powodować wysuszanie lub pękanie skóry.
 PT Pode provocar pele seca ou gretada, por exposição repetida.
 RO Expunerea repetată poate provoca uscarea sau crăparea pielii.
 SK Opakovaná expozícia môže spôsobit’ vysušenie alebo popraskanie pokožky.
 SL Ponavljajoča izpostavljenost lahko povzroči nastanek suhe ali razpokane kože.
 FI Toistuva altistus voi aiheuttaa ihon kuivumista tai halkeilua.
 SV Upprepad kontakt kan ge torr hud eller hudsprickor.


EUH 070 Language 
 BG Токсично при контакт с очите.
 ES Tóxico en contacto con los ojos.
 CS Toxický při styku s očima.
 DA Giftig ved kontakt med øjnene.
 DE Giftig bei Berührung mit den Augen.
 ET Silma sattumisel mürgine.
 EL Τοξικό σε επαφή με τα μάτια.
 EN Toxic by eye contact.
 FR Toxique par contact oculaire.
 GA Tocsaineach trí theagmháil leis an tsúil.
 IT Tossico per contatto oculare.
 LV Toksisks saskarē ar acīm.
 LT Toksiška patekus į akis.
 HU Szembe kerülve mérgező.
 MT Tossiku meta jmiss ma’ l-għajnejn.
 NL Giftig bij oogcontact.
 PL Działa toksycznie w kontakcie z oczami.
 PT Tóxico por contacto com os olhos.
 RO Toxic în caz de contact cu ochii.
 SK Toxické pri kontakte s očami.
 SL Strupeno ob stiku z očmi.
 FI Myrkyllistä joutuessaan silmään.
 SV Giftigt vid kontakt med ögonen.


EUH 071 Language 
 BG Корозивен за дихателните пътища.
 ES Corrosivo para las vías respiratorias.
 CS Způsobuje poleptání dýchacích cest.
 DA Ætsende for luftvejene.
 DE Wirkt ätzend auf die Atemwege.
 ET Söövitav hingamisteedele.
 EL Διαβρωτικό της αναπνευστικής οδού.
 EN Corrosive to the respiratory tract.
 FR Corrosif pour les voies respiratoires.
 GA Creimneach don chonair riospráide.
 IT Corrosivo per le vie respiratorie.
 LV Kodīgs elpceļiem.
 LT Ėsdina kvėpavimo takus.
 HU Maró hatású a légutakra.
 MT Korrużiv għas-sistema respiratorja.
 NL Bijtend voor de luchtwegen.
 PL Działa żrąco na drogi oddechowe.
 PT Corrosivo para as vias respiratórias.
 RO Corosiv pentru căile respiratorii.
 SK Žieravé pre dýchacie cesty.
 SL Jedko za dihalne poti.
 FI Hengityselimiä syövyttävää.
 SV Frätande på luftvägarna.


EUH 059 Language Additional EU Hazard Class
 BG Опасно за озоновия слой.
 ES Peligroso para la capa de ozono.
 CS Nebezpečný pro ozonovou vrstvu.
 DA Farlig for ozonlaget.
 DE Die Ozonschicht schädigend.
 ET Ohtlik osoonikihile.
 EL Επικίνδυνο για τη στιβάδα του όζοντος.
 EN Hazardous to the ozone layer.
 FR Dangereux pour la couche d'ozone.
 GA Guaiseach don chiseal ózóin.
 IT Pericoloso per lo strato di ozono.
 LV Bīstams ozona slānim.
 LT Pavojinga ozono sluoksniui.
 HU Veszélyes az ózonrétegre.
 MT Perikoluż għas-saff ta' l-ożonu.
 NL Gevaarlijk voor de ozonlaag.
 PL Stwarza zagrożenie dla warstwy ozonowej.
 PT Perigoso para a camada de ozono.
 RO Periculos pentru stratul de ozon.
 SK Nebezpečný pre ozónovú vrstvu.
 SL Nevarno za ozonski plašč.
 FI Vaarallista otsonikerrokselle.
 SV Farligt för ozonskiktet.

3. 

EUH 201/ 201A Language 
201201A BG Съдържа олово. Да не се използва върху повърхност, която евентуално може да се дъвче или смуче от деца.Внимание! Съдържа олово.
201201A ES Contiene plomo. No utilizar en objetos que los niños puedan masticar o chupar.¡Atención! Contiene plomo.
201201A CS Obsahuje olovo. Nemá se používat na povrchy, které mohou okusovat nebo olizovat děti.Pozor! Obsahuje olovo.
201201A DA Indeholder bly. Må ikke anvendes på genstande, som børn vil kunne tygge eller sutte på.Advarsel! Indeholder bly.
201201A DE Enthält Blei. Nicht für den Anstrich von Gegenständen verwenden, die von Kindern gekaut oder gelutscht werden könnten.Achtung! Enthält Blei.
201201A ET Sisaldab pliid. Mitte kasutada pindadel, mida lapsed võivad närida või imeda.Ettevaatust! Sisaldab pliid.
201201A EL Περιέχει μόλυβδο. Να μη χρησιμοποιείται σε επιφάνειες που είναι πιθανόν να μασήσουν ή να πιπιλίσουν τα παιδιά.Προσοχή! Περιέχει μόλυβδο.
201201A EN Contains lead. Should not be used on surfaces liable to be chewed or sucked by children.Warning! Contains lead.
201201A FR Contient du plomb. Ne pas utiliser sur les objets susceptibles d'être mâchés ou sucés par des enfants.Attention! Contient du plomb.
201201A GA Luaidhe ann. Níor chóir a úsáid ar dhromchlaí a d'fhéadfadh a bheith á gcogaint nó á sú ag leanaí.Rabhadh! Luaidhe ann.
201201A IT Contiene piombo. Non utilizzare su oggetti che possono essere masticati o succhiati dai bambini.Attenzione! Contiene piombo.
201201A LV Satur svinu. Nedrīkst lietot uz virsmām, kuras var nonākt bērnam mutē.Brīdinājums! Satur svinu.
201201A LT Sudėtyje yra švino. Nenaudoti paviršiams, kurie gali būti vaikų kramtomi arba čiulpiami.Atsargiai! Sudėtyje yra švino.
201201A HU Ólmot tartalmaz. Tilos olyan felületeken használni, amelyeket gyermekek szájukba vehetnek.Figyelem! Ólmot tartalmaz.
201201A MT Fih iċ-ċomb. M'għandux jintuża' fuq uċuh li x'aktarx jomogħduhom jew jerdgħuhom it-tfal.Twissija! Fih iċ-ċomb.
201201A NL Bevat lood. Mag niet worden gebruikt voor voorwerpen waarin kinderen kunnen bijten of waaraan kinderen kunnen zuigen.Let op! Bevat lood.
201201A PL Zawiera ołów. Nie należy stosować na powierzchniach, które mogą być gryzione lub ssane przez dzieci.Uwaga! Zawiera ołów.
201201A PT Contém chumbo. Não utilizar em superfícies que possam ser mordidas ou chupadas por crianças.Atenção! Contém chumbo.
201201A RO Conţine plumb. A nu se utiliza pe obiecte care pot fi mestecate sau supte de copii.Atenţie! Conţine plumb.
201201A SK Obsahuje olovo. Nepoužívajte na povrchy, ktoré by mohli žuť alebo oblizovať deti.Pozor! Obsahuje olovo.
201201A SL Vsebuje svinec. Ne sme se nanašati na površine, ki bi jih lahko žvečili ali sesali otroci.Pozor! Vsebuje svinec.
201201A FI Sisältää lyijyä. Ei saa käyttää pintoihin, joita lapset voivat pureskella tai imeä.Varoitus! Sisältää lyijyä.
201201A SV Innehåller bly. Bör inte användas på ytor där barn kan komma åt att tugga eller suga.Varning! Innehåller bly.


EUH 202 Language 
 BG Цианокрилат. Опасно. Залепва кожата и очите за секунди. Да се съхранява извън обсега на деца.
 ES Cianoacrilato. Peligro. Se adhiere a la piel y a los ojos en pocos segundos. Mantener fuera del alcance de los niños.
 CS Kyanoakrylát. Nebezpečí. Okamžitě slepuje kůži a oči. Uchovávejte mimo dosah dětí.
 DA Cyanoacrylat. Farligt. Klæber til huden og øjnene på få sekunder. Opbevares utilgængeligt for børn.
 DE Cyanacrylat. Gefahr. Klebt innerhalb von Sekunden Haut und Augenlider zusammen. Darf nicht in die Hände von Kindern gelangen.
 ET Tsüanoakrülaat. Ohtlik. Liimib naha ja silmad hetkega. Hoida lastele kättesaamatus kohas.
 EL Κυανοακρυλική ένωση. Κίνδυνος. Κολλάει στην επιδερμίδα και στα μάτια μέσα σε λίγα δευτερόλεπτα. Να φυλάσσεται μακριά από παιδιά.
 EN Cyanoacrylate. Danger. Bonds skin and eyes in seconds. Keep out of the reach of children.
 FR Cyanoacrylate. Danger. Colle à la peau et aux yeux en quelques secondes. À conserver hors de portée des enfants.
 GA Cianaicrioláit. Contúirt. Nascann craiceann agus súile laistigh de shoicindí. Coimeád as aimsiú leanaí.
 IT Cianoacrilato. Pericolo. Incolla la pelle e gli occhi in pochi secondi. Tenere fuori dalla portata dei bambini.
 LV Ciānakrilāts. Bīstami. Iedarbība uz acīm un ādu tūlītēja. Sargāt no bērniem.
 LT Cianakrilatas. Pavojinga. Staigiai suklijuoja odą ir akis. Laikyti vaikams neprieinamoje vietoje.
 HU Cianoakrilát. Veszély! Néhány másodperc alatt a bőrre és a szembe ragad. Gyermekektől elzárva tartandó.
 MT Cyanoacrylate. Periklu. Iwaħħal il-ġilda u l-għajnejn fi ftit sekondi. Żomm ‘il bogħod minn fejn jistgħu jilħquh it-tfal.
 NL Cyanoacrylaat. Gevaarlijk. Kleeft binnen enkele seconden aan huid en oogleden. Buiten het bereik van kinderen houden.
 PL Cyjanoakrylany. Niebezpieczeństwo. Skleja skórę i powieki w ciągu kilku sekund. Chronić przed dziećmi.
 PT Cianoacrilato. Perigo. Cola à pele e aos olhos em poucos segundos. Manter fora do alcance das crianças.
 RO Cianoacrilat. Pericol. Se lipeşte de piele şi ochi în câteva secunde. A nu se lăsa la îndemâna copiilor.
 SK Kyanoakrylát. Nebezpečenstvo. V priebehu niekoľkých sekúnd zlepí pokožku a oči. Uchovávajte mimo dosahu detí.
 SL Cianoakrilat. Nevarno. Kožo in oči zlepi v nekaj sekundah. Hraniti zunaj dosega otrok.
 FI Syanoakrylaattia. Vaara. Liimaa ihon ja silmät hetkessä. Säilytettävä lasten ulottumattomissa.
 SV Cyanoakrylat. Fara. Fäster snabbt på hud och ögon. Förvaras oåtkomligt för barn.


EUH 203 Language 
 BG Съдържа хром (VI). Може да причини алергична реакция.
 ES Contiene cromo (VI). Puede provocar una reacción alérgica.
 CS Obsahuje chrom (VI). Může vyvolat alergickou reakci.
 DA Indeholder krom (VI). Kan udløse allergisk reaktion.
 DE Enthält Chrom (VI). Kann allergische Reaktionen hervorrufen.
 ET Sisaldab kroomi (VI). Võib esile kutsuda allergilise reaktsiooni.
 EL Περιέχει χρώμιο (VI). Μπορεί να προκαλέσει αλλεργική αντίδραση.
 EN Contains chromium (VI). May produce an allergic reaction.
 FR Contient du chrome (VI). Peut produire une réaction allergique.
 GA Cróimiam (VI) ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
 IT Contiene cromo (VI). Può provocare una reazione allergica.
 LV Satur hromu (VI). Var izraisīt alerģisku reakciju.
 LT Sudėtyje yra chromo (VI). Gali sukelti alerginę reakciją.
 HU Krómot (VI) tartalmaz. Allergiás reakciót válthat ki.
 MT Fih il-kromju (VI). Jista’ joħloq reazzjoni allerġika.
 NL Bevat zeswaardig chroom. Kan een allergische reactie veroorzaken.
 PL Zawiera chrom (VI). Może powodować wystąpienie reakcji alergicznej.
 PT Contém crómio (VI). Pode provocar uma reacção alérgica.
 RO Conţine crom (VI). Poate provoca o reacţie alergică.
 SK Obsahuje chróm (VI). Môže vyvolať alergickú reakciu.
 SL Vsebuje krom (VI). Lahko povzroči alergijski odziv.
 FI Sisältää kromi(VI)-yhdisteitä. Voi aiheuttaa allergisen reaktion.
 SV Innehåller krom (VI). Kan orsaka en allergisk reaktion.


EUH 204 Language 
 BG Съдържа изоцианати. Може да причини алергична реакция.
 ES Contiene isocianatos. Puede provocar una reacción alérgica.
 CS Obsahuje isokyanáty. Může vyvolat alergickou reakci.
 DA Indeholder isocyanater. Kan udløse allergisk reaktion.
 DE Enthält Isocyanate. Kann allergische Reaktionen hervorrufen.
 ET Sisaldab isotsüanaate. Võib esile kutsuda allergilise reaktsiooni.
 EL Περιέχει ισοκυανικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.
 EN Contains isocyanates. May produce an allergic reaction.
 FR Contient des isocyanates. Peut produire une réaction allergique.
 GA Isicianaítí ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
 IT Contiene isocianati. Può provocare una reazione allergica.
 LV Satur izocianātus. Var izraisīt alerģisku reakciju.
 LT Sudėtyje yra izocianatų. Gali sukelti alerginę reakciją.
 HU Izocianátokat tartalmaz. Allergiás reakciót válthat ki.
 MT Fih l-isocyanates. Jista’ jagħmel reazzjoni allerġika.
 NL Bevat isocyanaten. Kan een allergische reactie veroorzaken.
 PL Zawiera izocyjaniany. Może powodować wystąpienie reakcji alergicznej.
 PT Contém isocianatos. Pode provocar uma reacção alérgica.
 RO Conţine izocianaţi. Poate provoca o reacţie alergică.
 SK Obsahuje izokyanáty. Môže vyvolať alergickú reakciu.
 SL Vsebuje izocianate. Lahko povzroči alergijski odziv.
 FI Sisältää isosyanaatteja. Voi aiheuttaa allergisen reaktion.
 SV Innehåller isocyanater. Kan orsaka en allergisk reaktion.


EUH 205 Language 
 BG Съдържа епоксидни съставки. Може да причини алергична реакция.
 ES Contiene componentes epoxídicos. Puede provocar una reacción alérgica.
 CS Obsahuje epoxidové složky. Může vyvolat alergickou reakci.
 DA Indeholder epoxyforbindelser. Kan udløse allergisk reaktion.
 DE Enthält epoxidhaltige Verbindungen. Kann allergische Reaktionen hervorrufen.
 ET Sisaldab epoksükomponente. Võib esile kutsuda allergilise reaktsiooni.
 EL Περιέχει εποξειδικές ενώσεις. Μπορεί να προκαλέσει αλλεργική αντίδραση.
 EN Contains epoxy constituents. May produce an allergic reaction.
 FR Contient des composés époxydiques. Peut produire une réaction allergique.
 GA Comhábhair eapocsacha ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
 IT Contiene componenti epossidici. Può provocare una reazione allergica.
 LV Satur epoksīda sastāvdaļas. Var izraisīt alerģisku reakciju.
 LT Sudėtyje yra epoksidinių komponentų. Gali sukelti alerginę reakciją.
 HU Epoxid tartalmú vegyületeket tartalmaz. Allergiás reakciót válthat ki.
 MT Fih kostitwenti ta’ l-eposside. Jista’ jagħmel reazzjoni allerġika.
 NL Bevat epoxyverbindingen. Kan een allergische reactie veroorzaken.
 PL Zawiera składniki epoksydowe. Może powodować wystąpienie reakcji alergicznej.
 PT Contém componentes epoxídicos. Pode provocar uma reacção alérgica.
 RO Conţine componenţi epoxidici. Poate provoca o reacţie alergică.
 SK Obsahuje epoxidové zložky. Môže vyvolať alergickú reakciu.
 SL Vsebuje epoksidne sestavine. Lahko povzroči alergijski odziv.
 FI Sisältää epoksihartseja. Voi aiheuttaa allergisen reaktion.
 SV Innehåller epoxiförening. Kan orsaka en allergisk reaktion.


EUH 206 Language 
 BG Внимание! Да не се използва заедно с други продукти. Може да отдели опасни газове (хлор).
 ES ¡Atención! No utilizar junto con otros productos. Puede desprender gases peligrosos (cloro).
 CS Pozor! Nepoužívejte společně s jinými výrobky. Může uvolňovat nebezpečné plyny (chlor).
 DA Advarsel! Må ikke anvendes i forbindelse med andre produkter. Farlige luftarter (chlor) kan frigøres.
 DE Achtung! Nicht zusammen mit anderen Produkten verwenden, da gefährliche Gase (Chlor) freigesetzt werden können.
 ET Ettevaatust! Mitte kasutada koos teiste toodetega. Segust võib eralduda ohtlikke gaase (kloori).
 EL Προσοχή! Να μην χρησιμοποιείται σε συνδυασμό με άλλα προϊόντα. Μπορεί να ελευθερωθούν επικίνδυνα αέρια (χλώριο).
 EN Warning! Do not use together with other products. May release dangerous gases (chlorine).
 FR Attention! Ne pas utiliser en combinaison avec d'autres produits. Peut libérer des gaz dangereux (chlore).
 GA Rabhadh! Ná húsáid in éineacht le táirgí eile. D'fhéadfadh sé go scaoilfí gáis chontúirteacha (clóirín).
 IT Attenzione! Non utilizzare in combinazione con altri prodotti. Possono liberarsi gas pericolosi (cloro).
 LV Brīdinājums! Nelietot kopā ar citiem produktiem. Var izdalīt bīstamas gāzes (hloru).
 LT Atsargiai! Nenaudoti kartu su kitais produktais. Gali išskirti pavojingas dujas (chlorą).
 HU Figyelem! Tilos más termékekkel együtt használni. Veszélyes gázok (klór) szabadulhatnak fel.
 MT Twissija! Tużahx flimkien ma’ prodotti oħra. Jista’ jerħi gassijiet perikolużi (kloru).
 NL Let op! Niet in combinatie met andere producten gebruiken. Er kunnen gevaarlijke gassen (chloor) vrijkomen.
 PL Uwaga! Nie stosować razem z innymi produktami. Może wydzielać niebezpieczne gazy (chlor).
 PT Atenção! Não utilizar juntamente com outros produtos. Podem libertar-se gases perigosos (cloro).
 RO Atenţie! A nu se folosi împreună cu alte produse. Poate elibera gaze periculoase (clor).
 SK Pozor! Nepoužívajte spolu s inými výrobkami. Môžu uvoľňovať nebezpečné plyny (chlór).
 SL Pozor! Ne uporabljajte skupaj z drugimi izdelki. Lahko se sproščajo nevarni plini (klor).
 FI Varoitus! Älä käytä yhdessä muiden tuotteiden kanssa. Tuotteesta voi vapautua vaarallista kaasua (klooria).
 SV Varning! Får ej användas tillsammans med andra produkter. Kan avge farliga gaser (klor).


EUH 207 Language 
 BG Внимание! Съдържа кадмий. При употреба се образуват опасни пари. Вижте информацията, предоставена от производителя. Спазвайте инструкциите за безопасност.
 ES ¡Atención! Contiene cadmio. Durante su utilización se desprenden vapores peligrosos. Ver la información facilitada por el fabricante. Seguir las instrucciones de seguridad.
 CS Pozor! Obsahuje kadmium. Při používání vznikají nebezpečné výpary. Viz informace dodané výrobcem. Dodržujte bezpečnostní pokyny.
 DA Advarsel! Indeholder cadmium. Der udvikles farlige dampe under anvendelsen. Se producentens oplysninger. Overhold sikkerhedsforskrifterne.
 DE Achtung! Enthält Cadmium. Bei der Verwendung entstehen gefährliche Dämpfe. Hinweise des Herstellers beachten. Sicherheitsanweisungen einhalten.
 ET Ettevaatust! Sisaldab kaadmiumi. Kasutamisel moodustuvad ohtlikud aurud. Vt tootja esitatud teavet. Järgida ohutuseeskirju.
 EL Προσοχή! Περιέχει κάδμιο. Κατά τη χρήση αναπτύσσονται επικίνδυνες αναθυμιάσεις. Βλέπετε πληροφορίες του κατασκευαστή. Τηρείτε τις οδηγίες ασφαλείας.
 EN Warning! Contains cadmium. Dangerous fumes are formed during use. See information supplied by the manufacturer. Comply with the safety instructions.
 FR Attention! Contient du cadmium. Des fumées dangereuses se développent pendant l'utilisation. Voir les informations fournies par le fabricant. Respectez les consignes de sécurité.
 GA Rabhadh! Caidmiam ann. Cruthaítear múch chontúirteach le linn a úsáide. Féach an fhaisnéis atá curtha ar fáil ag an monaróir. Cloígh leis na treoracha sábháilteachta.
 IT Attenzione! Contiene cadmio. Durante l'uso si sviluppano fumi pericolosi. Leggere le informazioni fornite dal fabbricante. Rispettare le disposizioni di sicurezza.
 LV Brīdinājums! Satur kadmiju. Lietojot veidojas bīstami izgarojumi. Sk. ražotāja sniegto informāciju. Ievērot drošības instrukcijas.
 LT Atsargiai! Sudėtyje yra kadmio. Naudojant susidaro pavojingi garai. Žiūrėti gamintojo pateiktą informaciją. Vykdyti saugos instrukcijas.
 HU Figyelem! Kadmiumot tartalmaz! A használat során veszélyes füstök képződnek. Lásd a gyártó által közölt információt. Be kell tartani a biztonsági előírásokat.
 MT Twissija! Fih il-kadmju. Waqt li jintuża jiffurmaw dħaħen perikolużi. Ara l-informazzjoni mogħtija mill-fabbrikant. Ħares l-istruzzjonijiet dwar is-sigurtà.
 NL Let op! Bevat cadmium. Bij het gebruik ontwikkelen zich gevaarlijke dampen. Zie de aanwijzingen van de fabrikant. Neem de veiligheidsvoorschriften in acht.
 PL Uwaga! Zawiera kadm. Podczas stosowania wydziela niebezpieczne pary. Zapoznaj się z informacją dostarczoną przez producenta. Przestrzegaj instrukcji bezpiecznego stosowania.
 PT Atenção! Contém cádmio. Libertam-se fumos perigosos durante a utilização. Ver as informações fornecidas pelo fabricante. Respeitar as instruções de segurança.
 RO Atenţie! Conţine cadmiu. În timpul utilizării se degajă un fum periculos. A se vedea informaţiile furnizate de producător. A se respecta instrucţiunile privind siguranţa.
 SK Pozor! Obsahuje kadmium. Pri používaní sa tvorí nebezpečný dym. Pozri informácie od výrobcu. Dodržiavajte bezpečnostné pokyny.
 SL Pozor! Vsebuje kadmij. Med uporabo nastajajo nevarni dimi. Preberite informacije proizvajalca. Upoštevajte navodila za varno uporabo.
 FI Varoitus! Sisältää kadmiumia. Käytettäessä muodostuu vaarallisia huuruja. Noudata valmistajan antamia ohjeita. Noudata turvallisuusohjeita.
 SV Varning! Innehåller kadmium. Farliga ångor bildas vid användning. Se information från tillverkaren. Följ skyddsanvisningarna.


EUH 208 Language 
 BG Съдържа < наименование на сенсибилизиращото вещество>. Може да предизвика алергична реакция.
 ES Contiene <nombre de la sustancia sensibilizante>. Puede provocar una reacción alérgica.
 CS Obsahuje <název senzibilizující látky>. Může vyvolat alergickou reakci.
 DA Indeholder <navn på det sensibiliserende stof>. Kan udløse allergisk reaktion.
 DE Enthält <Name des sensibilisierenden Stoffes>. Kann allergische Reaktionen hervorrufen.
 ET Sisaldab <sensibiliseeriva aine nimetus>. Võib esile kutsuda allergilise reaktsiooni.
 EL Περιέχει <όνομα της ευαισθητοποιητικής ουσίας>. Μπορεί να προκαλέσει αλλεργική αντίδραση.
 EN Contains <name of sensitising substance>. May produce an allergic reaction.
 FR Contient <nom de la substance sensibilisante>. Peut produire une réaction allergique.
 GA <Ainm na substainte íograithe> ann. D'fhéadfadh sé a bheith ina chúis le frithghníomh ailléirgeach.
 IT Contiene <denominazione della sostanza sensibilizzante>. Può provocare una reazione allergica.
 LV Satur <sensibilizējošās vielas nosaukums>. Var izraisīt alerģisku reakciju.
 LT Sudėtyje yra <jautrinančios medžiagos pavadinimas>. Gali sukelti alerginę reakciją.
 HU <Allergén anyag neve>-t tartalmaz. Allergiás reakciót válthat ki.
 MT Fih <l-isem tas-sustanza sensibbli>. Jista’ jagħmel reazzjoni allerġika.
 NL Bevat <naam van de sensibiliserende stof>. Kan een allergische reactie veroorzaken.
 PL Zawiera <nazwa substancji uczulającej>. Może powodować wystąpienie reakcji alergicznej.
 PT Contém <nome da substância sensibilizante em questão>. Pode provocar uma reacção alérgica.
 RO Conţine <denumirea substanţei sensibilizante>. Poate provoca o reacţie alergică.
 SK Obsahuje <názov senzibilizujúcej látky>. Môže vyvolať alergickú reakciu.
 SL Vsebuje <ime snovi, ki povzroča preobčutljivost>. Lahko povzroči alergijski odziv.
 FI Sisältää <herkistävän aineen nimi>. Voi aiheuttaa allergisen reaktion.
 SV Innehåller <namnet på det sensibiliserande ämnet>. Kan orsaka en allergisk reaktion.


EUH 209/ 209A Language 
209209A BG При употреба може да стане силно запалимо.При употреба може да стане запалимо.
209209A ES Puede inflamarse fácilmente al usarloPuede inflamarse al usarlo.
209209A CS Při používání se může stát vysoce hořlavým.Při používání se může stát hořlavým.
209209A DA Kan blive meget brandfarlig ved brug.Kan blive brandfarlig ved brug.
209209A DE Kann bei Verwendung leicht entzündbar werden.Kann bei Verwendung entzündbar werden.
209209A ET Kasutamisel võib muutuda väga tuleohtlikuks.Kasutamisel võib muutuda tuleohtlikuks.
209209A EL Μπορεί να γίνει πολύ εύφλεκτο κατά τη χρήση.Mπορεί να γίνει εύφλεκτο κατά τη χρήση.
209209A EN Can become highly flammable in use.Can become flammable in use.
209209A FR Peut devenir facilement inflammable en cours d'utilisation.Peut devenir inflammable en cours d'utilisation.
209209A GA D'fhéadfadh sé éirí an-inadhainte agus é á úsáid.D'fhéadfadh sé éirí inadhainte agus é á úsáid.
209209A IT Può diventare facilmente infiammabile durante l'uso.Può diventare infiammabile durante l'uso.
209209A LV Lietojot var viegli uzliesmot.Kļūt uzliesmojošs.
209209A LT Naudojama gali tapti labai degi.Naudojama gali tapti degi.
209209A HU A használat során fokozottan tűzveszélyessé válhat.A használat során tűzveszélyessé válhat.
209209A MT Jista’ jieħu n-nar faċilment meta jintuża.Jista’ jieħu n-nar meta jintuża.
209209A NL Kan bij gebruik licht ontvlambaar worden.Kan bij gebruik ontvlambaar worden.
209209A PL Podczas stosowania może przekształcić się w substancję wysoce łatwopalną.Podczas stosowania może przekształcić się w substancję łatwopalną.
209209A PT Pode tornar-se facilmente inflamável durante o uso.Pode tornar-se inflamável durante o uso.
209209A RO Poate deveni foarte inflamabil în timpul utilizării.Poate deveni inflamabil în timpul utilizării.
209209A SK Pri používaní sa môže stať veľmi horľavou.Pri používaní sa môže stať horľavou.
209209A SL Med uporabo utegne postati lahko vnetljivo.Med uporabo utegne postati vnetljivo.
209209A FI Voi muuttua helposti syttyväksi käytössä.Voi muuttua syttyväksi käytössä.
209209A SV Kan bli mycket brandfarligt vid användning.Kan bli brandfarligt vid användning.


EUH 210 Language 
 BG Информационен лист за безопасност ще бъде представен при поискване.
 ES Puede solicitarse la ficha de datos de seguridad.
 CS Na vyžádání je kodispozici bezpečnostní list.
 DA Sikkerhedsdatablad kan på anmodning rekvireres.
 DE Sicherheitsdatenblatt auf Anfrage erhältlich.
 ET Ohutuskaart nõudmisel kättesaadav.
 EL Δελτίο δεδομένων ασφαλείας παρέχεται εφόσον ζητηθεί.
 EN Safety data sheet available on request.
 FR Fiche de données de sécurité disponible sur demande.
 GA Bileog sonraí sábháilteachta ar fáil arna iarraidh sin.
 IT Scheda dati di sicurezza disponibile su richiesta.
 LV Drošības datu lapa ir pieejama pēc pieprasījuma.
 LT Saugos duomenų lapą galima gauti paprašius.
 HU Kérésre biztonsági adatlap kapható.
 MT Il-karta tad-data dwar is-sikurezza hija disponibbli meta tintalab.
 NL Veiligheidsinformatieblad op verzoek verkrijgbaar.
 PL Karta charakterystyki dostępna na żądanie.
 PT Ficha de segurança fornecida a pedido.
 RO Fişa cu date de securitate disponibilă la cerere.
 SK Na požiadanie možno poskytnúť kartu bezpečnostných údajov.
 SL Varnosti list na voljo na zahtevo.
 FI Käyttöturvallisuustiedote toimitetaan pyynnöstä.
 SV Säkerhetsdatablad finns att rekvirera.


EUH 401 Language 
 BG За да се избегнат рискове за човешкото здраве и околната среда, спазвайте инструкциите за употреба.
 ES A fin de evitar riesgos para las personas y el medio ambiente, siga las instrucciones de uso.
 CS Dodržujte pokyny pro používání, abyste se vyvarovali rizik pro lidské zdraví a životní prostředí.
 DA Brugsanvisningen skal følges for ikke at bringe menneskers sundhed og miljøet i fare.
 DE Zur Vermeidung von Risiken für Mensch und Umwelt die Gebrauchsanleitung einhalten.
 ET Inimeste tervise ja keskkonna ohustamise vältimiseks järgida kasutusjuhendit.
 EL Για να αποφύγετε τους κινδύνους για την ανθρώπινη υγεία και το περιβάλλον, ακολουθήστε τις οδηγίες χρήσης.
 EN To avoid risks to human health and the environment, comply with the instructions for use.
 FR Respectez les instructions d'utilisation pour éviter les risques pour la santé humaine et l'environnement.
 GA Chun priacail do shláinte an duine agus don chomhshaol a sheachaint, cloígh leis na treoracha maidir le húsáid.
 IT Per evitare rischi per la salute umana e per l'ambiente, seguire le istruzioni per l'uso.
 LT Siekiant išvengti žmonių sveikatai ir aplinkai keliamos rizikos, būtina vykdyti naudojimo instrukcijos nurodymus.
 LV Lai izvairītos no riska cilvēku veselībai un videi, ievērojiet lietošanas pamācību.
 HU Az emberi egészség és a környezet veszélyeztetésének elkerülése érdekében be kell tartani a használati utasítás előírásait.
 MT Biex jiġu evitati r-riskji għal saħħet il-bniedem u għall-ambjent, ħares l-istruzzjonijiet dwar l-użu.
 NL Volg de gebruiksaanwijzing om gevaar voor de menselijke gezondheid en het milieu te voorkomen.
 PL W celu uniknięcia zagrożeń dla zdrowia ludzi i środowiska, należy postępować zgodnie z instrukcją użycia.
 PT Para evitar riscos para a saúde humana e para o ambiente, respeitar as instruções de utilização.
 RO Pentru a evita riscurile pentru sănătatea umană şi mediu, a se respecta instrucţiunile de utilizare.
 SK Dodržiavajte návod na používanie, aby ste zabránili vzniku rizík pre zdravie ľudí a životné prostredie.
 SL Da bi se izognili tveganjem za ljudi in okolje, ravnajte v skladu z navodili za uporabo.
 FI Noudata käyttöohjeita ihmisen terveydelle ja ympäristölle aiheutuvien vaarojen välttämiseksi.
 SV För att undvika risker för människors hälsa och för miljön, följ bruksanvisningen.

ANNEX IV
In selecting the precautionary statements in accordance with Articles 22 and 28(3), suppliers may combine the Precautionary Statements in the table below, having regard to clarity and comprehensibility of the precautionary advice.

1. 

Code General precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P101 If medical advice is needed, have product container or label at hand. as appropriate  Consumer products
P102 Keep out of reach of children. as appropriate  Consumer products
P103 Read label before use. as appropriate  Consumer products


Code Prevention precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P201 Obtain special instructions before use. Explosives (section 2.1) Unstable explosive 
Germ cell mutagenicity (section 3.5) 1A, 1B, 2
  Carcinogenicity (section 3.6) 1A, 1B, 2 
  Reproductive toxicity (section 3.7) 1A, 1B, 2 
  Reproductive toxicity — effects on or via lactation (section 3.7) Additional category 
P202 Do not handle until all safety precautions have been read and understood. Explosives (section 2.1) Unstable explosive 
Germ cell mutagenicity (section 3.5) 1A, 1B, 2
  Carcinogenicity (section 3.6) 1A, 1B, 2 
  Reproductive toxicity (section 3.7) 1A, 1B, 2 
P210 Keep away from heat/sparks/open flames/hot surfaces. — No smoking. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 Manufacturer/supplier to specify applicable ignition source(s).
Flammable gases (section 2.2) 1, 2
Flammable aerosols (section 2.3) 1, 2
  Flammable liquids (section 2.6) 1, 2, 3 
  Flammable solids (section 2.7) 1, 2 
  Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F 
  Pyrophoric liquids (section 2.9) 1 
  Pyrophoric solids (section 2.10) 1 
  Organic peroxides (section 2.15) Types A, B, C, D, E, F 
  Oxidising liquids (section 2.13) 1, 2, 3 
— Specify to keep away from heat.
  Oxidising solids (section 2.14) 1, 2, 3
P211 Do not spray on an open flame or other ignition source. Flammable aerosols (section 2.3) 1, 2 
P220 Keep/Store away from clothing/…/combustible materials. Oxidising gases (section 2.4) 1 … Manufacturer/supplier to specify incompatible materials.
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
  Oxidising liquids (section 2.13) 1 … Manufacturer/supplier to specify incompatible materials.
— specify to keep away from clothing as well as other incompatible materials.
2, 3 … Manufacturer/supplier to specify incompatible materials.
  Oxidising solids (section 2.14) 1 … Manufacturer/supplier to specify incompatible materials.
— specify to keep away from clothing as well as other incompatible materials.
2, 3 … Manufacturer/supplier to specify incompatible materials.
  Organic peroxides (section 2.15) Types A, B, C, D, E, F
P221 Take any precaution to avoid mixing with combustibles/… Oxidising liquids (section 2.13) 1, 2, 3 … Manufacturer/supplier to specify incompatible materials.
Oxidising solids (section 2.14) 1, 2, 3
P222 Do not allow contact with air. Pyrophoric liquids (section 2.9) 1 
Pyrophoric solids (section 2.10) 1
P223 Keep away from any possible contact with water, because of violent reaction and possible flash fire. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2 
P230 Keep wetted with … Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.5 … Manufacturer/supplier to specify appropriate material.
— if drying out increases explosion hazard, except as needed for manufacturing or operating processes (e.g. nitrocellulose).
P231 Handle under inert gas. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
P232 Protect from moisture. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
P233 Keep container tightly closed. Flammable liquids (section 2.6) 1, 2, 3 
Acute toxicity — inhalation (section 3.1) 1, 2, 3 
— if product is volatile so as to generate hazardous atmosphere.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P234 Keep only in original container. Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F 
Organic peroxides (section 2.15) Types A, B, C, D, E, F
Corrosive to metals (section 2.16) 1
P235 Keep cool. Flammable liquids (section 2.6) 1, 2, 3 
Self-reactive substances and mixtures (Section 2.8) Types A, B, C, D, E, F
Self-heating substances and mixtures (section 2.11) 1, 2
Organic peroxides (section 2.15) Types A, B, C, D, E, F
P240 Ground/bond container and receiving equipment. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 
— if the explosive is electrostatically sensitive.
  Flammable liquids (section 2.6) 1, 2, 3 
— if electrostatically sensitive material is for reloading.
— if product is volatile so as to generate hazardous atmosphere.
  Flammable solids (section 2.7) 1, 2 
— if electrostatically sensitive material is for reloading.
P241 Use explosion-proof electrical/ventilating/lighting/…/equipment. Flammable liquids (section 2.6) 1, 2, 3 … Manufacturer/supplier to specify other equipment.
Flammable solids (section 2.7) 1, 2 … Manufacturer/supplier to specify other equipment.
— if dust clouds can occur.
P242 Use only non-sparking tools. Flammable liquids (section 2.6) 1, 2, 3 
P243 Take precautionary measures against static discharge. Flammable liquids (section 2.6) 1, 2, 3 
P244 Keep reduction valves free from grease and oil. Oxidising gases (section 2.4) 1 
P250 Do not subject to grinding/shock/…/friction. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 … Manufacturer/supplier to specify applicable rough handling.
P251 Pressurized container: Do not pierce or burn, even after use. Flammable aerosols (section 2.3) 1, 2 
P260 Do not breathe dust/fume/gas/mist/vapours/spray. Acute toxicity — inhalation (section 3.1) 1, 2 Manufacturer/supplier to specify applicable conditions.
Specific target organ toxicity — single exposure (section 3.8) 1, 2
Specific target organ toxicity — repeated exposure (section 3.9) 1, 2
  Skin corrosion (section 3.2) 1A, 1B, 1C 
— Specify do not breathe dusts or mists.
— if inhalable particles of dusts or mists may occur during use.
Reproductive toxicity — effects on or via lactation (section 3.7) Additional category
P261 Avoid breathing dust/fume/gas/mist/vapours/spray. Acute toxicity — inhalation (section 3.1) 3, 4 Manufacturer/supplier to specify applicable conditions.
Respiratory sensitisation (section 3.4) 1
Skin sensitisation (section 3.4) 1
  Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 
  Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 
P262 Do not get in eyes, on skin, or on clothing. Acute toxicity — dermal (section 3.1) 1, 2 
P263 Avoid contact during pregnancy/while nursing. Reproductive toxicity — effects on or via lactation (section 3.7) Additional category 
P264 Wash … thoroughly after handling. Acute toxicity — oral (section 3.1) 1, 2, 3, 4 Manufacturer/supplier to specify parts of the body to be washed after handling.
Acute toxicity — dermal (section 3.1) 1, 2
Skin corrosion (section 3.2) 1A, 1B, 1C
  Skin irritation (section 3.2) 2 
  Eye irritation (section 3.3) 2 
  Reproductive toxicity — effects on or via lactation (section 3.7) Additional category 
  Specific target organ toxicity — single exposure (section 3.8) 1, 2 
  Specific target organ toxicity — repeated exposure (section 3.9) 1 
P270 Do not eat, drink or smoke when using this product. Acute toxicity — oral (section 3.1) 1, 2, 3, 4 
Acute toxicity — dermal (section 3.1) 1, 2
  Reproductive toxicity — effects on or via lactation (section 3.7) Additional category 
  Specific target organ toxicity — single exposure (section 3.8) 1, 2 
  Specific target organ toxicity — repeated exposure (section 3.9) 1 
P271 Use only outdoors or in a well-ventilated area. Acute toxicity — inhalation (section 3.1) 1, 2, 3, 4 
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P272 Contaminated work clothing should not be allowed out of the workplace. Skin sensitisation (section 3.4) 1 
P273 Avoid release to the environment. Hazardous to the aquatic environment — acute aquatic hazard (section 4.1) 1 
— if this is not the intended use.
Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1) 1, 2, 3, 4
  Hazardous to the ozone layer (section 5.1) 1 
P280 Wear protective gloves/protective clothing/eye protection/face protection. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 Manufacturer/supplier to specify type of equipment.
— Specify face protection.
  Flammable liquids (section 2.6) 1, 2, 3 Manufacturer/supplier to specify type of equipment.
— Specify protective gloves and eye/face protection.
Flammable solids (section 2.7) 1, 2
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9) 1
Pyrophoric solids (section 2.10) 1
  Self-heating substances and mixtures (section 2.11) 1, 2 
  Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
  Oxidising liquids (section 2.13) 1, 2, 3 
  Oxidising solids (section 2.14) 1, 2, 3 
  Organic peroxides (section 2.15) Types A, B, C, D, E, F 
  Acute toxicity — dermal (section 3.1) 1, 2, 3, 4 Manufacturer/supplier to specify type of equipment.
— Specify protective gloves/clothing.
  Skin corrosion (section 3.2) 1A, 1B, 1C Manufacturer/supplier to specify type of equipment.
— Specify protective gloves/clothing and eye/face protection.
  Skin irritation (section 3.2) 2 Manufacturer/supplier to specify type of equipment.
— Specify protective gloves.
Skin sensitisation (section 3.4) 1
  Serious eye damage/eye irritation (section 3.3) 1 Manufacturer/supplier to specify type of equipment.
— Specify eye/face protection.
Eye irritation (section 3.3) 2
P281 Use personal protective equipment as required. Explosives (section 2.1) Unstable explosive 
Germ cell mutagenicity (section 3.5) 1A, 1B, 2
  Carcinogenicity (section 3.6) 1A, 1B, 2 
  Reproductive toxicity (section 3.7) 1A, 1B, 2 
P282 Wear cold insulating gloves/face shield/eye protection. Gases under pressure (section 2.5) Refrigerated liquefied gas 
P283 Wear fire/flame resistant/retardant clothing. Oxidising liquids (section 2.13) 1 
Oxidising solids (section 2.14) 1
P284 Wear respiratory protection. Acute toxicity — inhalation (section 3.1) 1, 2 Manufacturer/supplier to specify equipment.
P285 In case of inadequate ventilation wear respiratory protection. Respiratory sensitisation (section 3.4) 1 Manufacturer/supplier to specify equipment.
P231 + P232 Handle under inert gas. Protect from moisture. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
P235 + P410 Keep cool. Protect from sunlight. Self-heating substances and mixtures (section 2.11) 1, 2 


Code Response precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P301 IF SWALLOWED: Acute toxicity — oral (section 3.1) 1, 2, 3, 4 
Skin corrosion (section 3.2) 1A, 1B, 1C
Aspiration Hazard (section 3.10) 1
P302 IF ON SKIN: Pyrophoric liquids (section 2.9) 1 
Acute toxicity — dermal (section 3.1) 1, 2, 3, 4
  Skin irritation (section 3.2) 2 
  Skin sensitisation (section 3.4) 1 
P303 IF ON SKIN (or hair): Flammable liquids (section 2.6) 1, 2, 3 
Skin corrosion (section 3.2) 1A, 1B, 1C
P304 IF INHALED: Acute toxicity — inhalation (section 3.1) 1, 2, 3, 4 
Skin corrosion (section 3.2) 1A, 1B, 1C
  Respiratory sensitisation (section 3.4) 1 
  Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 
  Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 
P305 IF IN EYES: Skin corrosion (section 3.2) 1A, 1B, 1C 
Serious eye damage/eye irritation (section 3.3) 1
Eye irritation (section 3.3) 2
P306 IF ON CLOTHING: Oxidising liquids (section 2.13) 1 
Oxidising solids (section 2.14) 1
P307 IF exposed: Specific target organ toxicity — single exposure (section 3.8) 1 
P308 IF exposed or concerned: Germ cell mutagenicity (section 3.5) 1A, 1B, 2 
Carcinogenicity (section 3.6) 1A, 1B, 2
Reproductive toxicity (section 3.7) 1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7) Additional category
P309 IF exposed or if you feel unwell: Specific target organ toxicity — single exposure (section 3.8) 2 
P310 Immediately call a POISON CENTER or doctor/physician. Acute toxicity — oral (section 3.1) 1, 2, 3 
Acute toxicity — dermal (section 3.1) 1, 2
  Acute toxicity — inhalation (section 3.1) 1, 2 
  Skin corrosion (section 3.2) 1A, 1B, 1C 
  Serious eye damage/eye irritation (section 3.3) 1 
  Aspiration hazard (section 3.10) 1 
P311 Call a POISON CENTER or doctor/physician. Acute toxicity — inhalation (section 3.1) 3 
Respiratory sensitisation (section 3.4) 1
Specific target organ toxicity — single exposure (section 3.8) 1, 2
P312 Call a POISON CENTER or doctor/physician if you feel unwell. Acute toxicity — oral (section 3.1) 4 
Acute toxicity — dermal (section 3.1) 3, 4
  Acute toxicity — inhalation (section 3.1) 4 
  Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 
  Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 
P313 Get medical advice/attention. Skin irritation (section 3.2) 2, 3 
Eye irritation (section 3.3) 2
  Skin sensitisation (section 3.4) 1 
  Germ cell mutagenicity (section 3.5) 1A, 1B, 2 
  Carcinogenicity (section 3.6) 1A, 1B, 2 
  Reproductive toxicity (section 3.7) 1A, 1B, 2 
  Reproductive toxicity — effects on or via lactation (section 3.7) Additional category 
P314 Get medical advice/attention if you feel unwell. Specific target organ toxicity — repeated exposure (section 3.9) 1, 2 
P315 Get immediate medical advice/attention. Gases under pressure (section 2.5) Refrigerated liquefied gas 
P320 Specific treatment is urgent (see … on this label). Acute toxicity — inhalation (section 3.1) 1, 2 … Reference to supplemental first aid instruction.
— if immediate administration of antidote is required.
P321 Specific treatment (see … on this label). Acute toxicity — oral (section 3.1) 1, 2, 3 … Reference to supplemental first aid instruction.
— if immediate administration of antidote is required.
  Acute toxicity — inhalation (section 3.1) 3 … Reference to supplemental first aid instruction.
— if immediate specific measures are required.
  Specific target organ toxicity — single exposure (section 3.8) 1 … Reference to supplemental first aid instruction.
— if immediate measures are required.
  Skin sensitisation (section 3.4) 1 … Reference to supplemental first aid instruction.
— manufacturer/supplier may specify a cleansing agent if appropriate.
  Skin corrosion (section 3.2) 1A, 1B, 1C
  Skin irritation (section 3.2) 2
P322 Specific measures (see … on this label). Acute toxicity — dermal (section 3.1) 1, 2 … Reference to supplemental first aid instruction.
— if immediate measures such as specific cleansing agent is advised.
  Acute toxicity — dermal (section 3.1) 3, 4 … Reference to supplemental first aid instruction.
— if measures such as specific cleansing agent is advised.
P330 Rinse mouth. Acute toxicity — oral (section 3.1) 1, 2, 3, 4 
Skin corrosion (section 3.2) 1A, 1B, 1C
P331 Do NOT induce vomiting. Skin corrosion (section 3.2) 1A, 1B, 1C 
Aspiration hazard (section 3.10) 1
P332 If skin irritation occurs: Skin irritation (section 3.2) 2, 3 
P333 If skin irritation or rash occurs: Skin sensitisation (section 3.4) 1 
P334 Immerse in cool water/wrap in wet bandages. Pyrophoric liquids (section 2.9) 1 
Pyrophoric solids (section 2.10) 1
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2
P335 Brush off loose particles from skin. Pyrophoric solids (section 2.10) 1 
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2
P336 Thaw frosted parts with lukewarm water. Do not rub affected area. Gases under pressure (section 2.5) Refrigerated liquefied gas 
P337 If eye irritation persists: Eye irritation (section 3.3) 2 
P338 Remove contact lenses, if present and easy to do. Continue rinsing. Skin corrosion (section 3.2) 1A, 1B, 1C 
Serious eye damage/eye irritation (section 3.3) 1
Eye irritation (section 3.3) 2
P340 Remove victim to fresh air and keep at rest in a position comfortable for breathing. Acute toxicity — inhalation (section 3.1) 1, 2, 3, 4 
Skin corrosion (section 3.2) 1A, 1B, 1C
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P341 If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. Respiratory sensitisation (section 3.4) 1 
P342 If experiencing respiratory symptoms: Respiratory sensitisation (section 3.4) 1 
P350 Gently wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 1, 2 
P351 Rinse cautiously with water for several minutes. Skin corrosion (section 3.2) 1A, 1B, 1C 
Serious eye damage/eye irritation (section 3.3) 1
Eye irritation (section 3.3) 2
P352 Wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 3, 4 
Skin irritation (section 3.2) 2
Skin sensitisation (section 3.4) 1
P353 Rinse skin with water/shower. Flammable liquids (section 2.6) 1, 2, 3 
Skin corrosion (section 3.2) 1A, 1B, 1C
P360 Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. Oxidising liquids (section 2.13) 1 
Oxidising solids (section 2.14) 1
P361 Remove/Take off immediately all contaminated clothing. Flammable liquids (section 2.6) 1, 2, 3 
Acute toxicity — dermal (section 3.1) 1, 2, 3
Skin corrosion (section 3.2) 1A, 1B, 1C
P362 Take off contaminated clothing and wash before reuse. Skin irritation (section 3.2) 2 
P363 Wash contaminated clothing before reuse. Acute toxicity — dermal (section 3.1) 1, 2, 3, 4 
Skin corrosion (section 3.2) 1A, 1B, 1C
Skin sensitisation (section 3.4) 1
P370 In case of fire: Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 
Oxidising gases (section 2.4) 1
  Flammable liquids (section 2.6) 1, 2, 3 
  Flammable solids (section 2.7) 1, 2 
  Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F 
  Pyrophoric liquids (section 2.9) 1 
  Pyrophoric solids (section 2.10) 1 
  Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
  Oxidising liquids (section 2.13) 1, 2, 3 
  Oxidising solids (section 2.14) 1, 2, 3 
P371 In case of major fire and large quantities: Oxidising liquids (section 2.13) 1 
Oxidising solids (section 2.14) 1
P372 Explosion risk in case of fire. Explosives (section 2.1) Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5 
— except if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.
P373 DO NOT fight fire when fire reaches explosives. Explosives (section 2.1) Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5 
P374 Fight fire with normal precautions from a reasonable distance. Explosives (section 2.1) Division 1.4 
— if explosives are 1.4S AMMUNITION AND COMPONENTS THEREOF.
P375 Fight fire remotely due to the risk of explosion. Self-reactive substances and mixtures (section 2.8) Types A, B 
Oxidising liquids (section 2.13) 1
Oxidising solids (section 2.14) 1
P376 Stop leak if safe to do so. Oxidising gases (section 2.4) 1 
P377 Leaking gas fire:Do not extinguish, unless leak can be stopped safely. Flammable gases (section 2.2) 1, 2 
P378 Use … for extinction. Flammable liquids (section 2.6) 1, 2, 3 … Manufacturer/supplier to specify appropriate media
— if water increases risk.
Flammable solids (section 2.7) 1, 2
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9) 1
Pyrophoric solids (section 2.10) 1
  Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
  Oxidising liquids (section 2.13) 1, 2, 3 
  Oxidising solids (section 2.14) 1, 2, 3 
P380 Evacuate area. Explosives (section 2.1) Unstable explosives 
Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5
  Self-reactive substances and mixtures (section 2.8) Types A, B 
  Oxidising liquids (section 2.13) 1 
  Oxidising solids (section 2.14) 1 
P381 Eliminate all ignition sources if safe to do so. Flammable gases (section 2.2) 1, 2 
P390 Absorb spillage to prevent material damage. Corrosive to metals (section 2.16) 1 
P391 Collect spillage. Hazardous to the aquatic environment – acute aquatic hazard (section 4.1) 1 
Hazardous to the aquatic environment – chronic aquatic hazard (section 4.1) 1, 2
P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. Acute toxicity — oral (section 3.1) 1, 2, 3 
Aspiration hazard (section 3.10) 1
P301 + P312 IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. Acute toxicity — oral (section 3.1) 4 
P301 + P330 + P331 IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. Skin corrosion (section 3.2) 1A, 1B, 1C 
P302 + P334 IF ON SKIN: Immerse in cool water/wrap in wet bandages. Pyrophoric liquids (section 2.9) 1 
P302 + P350 IF ON SKIN: Gently wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 1, 2 
P302 + P352 IF ON SKIN: Wash with plenty of soap and water. Acute toxicity — dermal (section 3.1) 3, 4 
Skin irritation (section 3.2) 2
Skin sensitisation (section 3.4) 1
P303 + P361 + P353 IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. Flammable liquids (section 2.6) 1, 2, 3 
Skin corrosion (section 3.2) 1A, 1B, 1C
P304 + P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Acute toxicity — inhalation (section 3.1) 1, 2, 3, 4 
Skin corrosion (section 3.2) 1A, 1B, 1C
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P304 + P341 IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. Respiratory sensitisation (section 3.4) 1 
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Skin corrosion (section 3.2) 1A, 1B, 1C 
Serious eye damage/eye irritation (section 3.3) 1
Eye irritation (section 3.3) 2
P306 + P360 IF ON CLOTHING: Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. Oxidising liquids (section 2.13) 1 
Oxidising solids (section 2.14) 1
P307 + P311 IF exposed: Call a POISON CENTER or doctor/physician. Specific target organ toxicity — single exposure (section 3.8) 1 
P308 + P313 IF exposed or concerned: Get medical advice/attention. Germ cell mutagenicity (section 3.5) 1A, 1B, 2 
Carcinogenicity (section 3.6) 1A, 1B, 2
Reproductive toxicity (section 3.7) 1A, 1B, 2
Reproductive toxicity — effects on or via lactation (section 3.7) Additional category
P309 + P311 IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician. Specific target organ toxicity — single exposure (section 3.8) 2 
P332 + P313 If skin irritation occurs: Get medical advice/attention. Skin irritation (section 3.2) 2 
P333 + P313 If skin irritation or rash occurs: Get medical advice/attention. Skin sensitisation (section 3.4) 1 
P335 + P334 Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. Pyrophoric solids (section 2.10) 1 
Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2
P337 + P313 If eye irritation persists: Get medical advice/attention. Eye irritation (section 3.3) 2 
P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Respiratory sensitisation (section 3.4) 1 
P370 + P376 In case of fire: Stop leak if safe to do so. Oxidizing gases (section 2.4) 1 
P370 + P378 In case of fire: Use … for extinction. Flammable liquids (section 2.6) 1, 2, 3 … Manufacturer/supplier to specify appropriate media.
— if water increases risk.
Flammable solids (section 2.7) 1, 2
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
Pyrophoric liquids (section 2.9) 1
Pyrophoric solids (section 2.10) 1
  Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
  Oxidising liquids (section 2.13) 1, 2, 3 
  Oxidising solids (section 2.14) 1, 2, 3 
P370 + P380 In case of fire: Evacuate area. Explosives (section 2.1) Divisions 1.1, 1.2, 1.3, 1.4, 1.5 
P370 + P380 + P375 In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. Self-reactive substances and mixtures (section 2.8) Types A, B 
P371 + P380 + P375 In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. Oxidising liquids (section 2.13) 1 
Oxidising solids (section 2.14) 1


Code Storage precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P401 Store … Explosives (section 2.1) Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5 … in accordance with local/regional/national/international regulations (to be specified).
P402 Store in a dry place. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
P403 Store in a well-ventilated place. Flammable gases (section 2.2) 1, 2 
— if product is volatile so as to generate hazardous atmosphere.
Oxidising gases (section 2.4) 1
Gases under pressure (section 2.5) Compressed gas
Liquefied gas
Refrigerated Liquefied gas
Dissolved gas
  Flammable liquids (section 2.6) 1, 2, 3 
  Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F 
  Acute toxicity — inhalation (section 3.1) 1, 2, 3 
  Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 
  Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 
P404 Store in a closed container. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
P405 Store locked up. Acute toxicity — oral (section 3.1) 1, 2, 3 
Acute toxicity — dermal (section 3.1) 1, 2, 3
  Acute toxicity — inhalation (section 3.1) 1, 2, 3 
  Skin corrosion (section 3.2) 1A, 1B, 1C 
  Germ cell mutagenicity (section 3.5) 1A, 1B, 2 
  Carcinogenicity (section 3.6) 1A, 1B, 2 
  Reproductive toxicity (section 3.7) 1A, 1B, 2 
  Specific target organ toxicity — single exposure (section 3.8) 1, 2 
  Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 
  Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 
  Aspiration hazard (section 3.10) 1 
P406 Store in corrosive resistant/… container with a resistant inner liner. Corrosive to metals (section 2.16) 1 … Manufacturer/supplier to specify other compatible materials.
P407 Maintain air gap between stacks/pallets. Self-heating substances and mixtures (section 2.11) 1, 2 
P410 Protect from sunlight. Flammable aerosols (section 2.3) 1, 2 
Gases under pressure (section 2.5) Compressed gas
Liquefied gas
Dissolved gas
  Self-heating substances and mixtures (section 2.11) 1, 2 
  Organic peroxides (section 2.15) Types A, B, C, D, E, F 
P411 Store at temperatures not exceeding … oC/…oF. Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F … Manufacturer/supplier to specify temperature
Organic peroxides (section 2.15) Types A, B, C, D, E, F
P412 Do not expose to temperatures exceeding 50 oC/122 oF. Flammable aerosols (section 2.3) 1, 2 
P413 Store bulk masses greater than … kg/…lbs at temperatures not exceeding … oC/…oF. Self-heating substances and mixtures (section 2.11) 1, 2 … Manufacturer/supplier to specify mass and temperature.
P420 Store away from other materials. Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F 
Self-heating substances and mixtures (section 2.11) 1, 2
Organic peroxides (section 2.15) Types A, B, C, D, E, F
P422 Store contents under … Pyrophoric liquids (section 2.9) 1 … Manufacturer/supplier to specify appropriate liquid or inert gas.
Pyrophoric solids (section 2.10) 1
P402 + P404 Store in a dry place. Store in a closed container. Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
P403 + P233 Store in a well-ventilated place. Keep container tightly closed. Acute toxicity — inhalation (section 3.1) 1, 2, 3 
— if product is volatile so as to generate hazardous atmosphere.
Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3
Specific target organ toxicity — single exposure; narcosis (section 3.8) 3
P403 + P235 Store in a well-ventilated place. Keep cool. Flammable liquids (section 2.6) 1, 2, 3 
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
P410 + P403 Protect from sunlight. Store in a well-ventilated place. Gases under pressure (section 2.5) Compressed gas 
Liquefied gas
Dissolved gas
P410 + P412 Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. Flammable aerosols (section 2.3) 1, 2 
P411 + P235 Store at temperatures not exceeding … oC/…oF. Keep cool. Organic peroxides (section 2.15) Types A, B, C, D, E, F … Manufacturer/supplier to specify temperature.


Code Disposal precautionary statements Hazard class Hazard category Conditions for use
(1) (2) (3) (4) (5)
P501 Dispose of contents/container to … Explosives (section 2.1) Unstable explosives and Divisions 1.1, 1.2, 1.3, 1.4, 1.5 … in accordance with local/regional/national/international regulation (to be specified).
Flammable liquids (section 2.6) 1, 2, 3
Self-reactive substances and mixtures (section 2.8) Types A, B, C, D, E, F
  Substances and mixtures which, in contact with water, emit flammable gases (section 2.12) 1, 2, 3 
  Oxidising liquids (section 2.13) 1, 2, 3 
  Oxidising solids (section 2.14) 1, 2, 3 
  Organic peroxides (section 2.15) Types A, B, C, D, E, F 
  Acute toxicity — oral (section 3.1) 1, 2, 3, 4 
  Acute toxicity — dermal (section 3.1) 1, 2, 3, 4 
  Acute toxicity — inhalation (section 3.1) 1, 2 
  Skin corrosion (section 3.2) 1A, 1B, 1C 
  Respiratory sensitisation (section 3.4) 1 
Skin sensitisation (section 3.4) 1
  Germ cell mutagenicity (section 3.5) 1A, 1B, 2 
  Carcinogenicity (section 3.6) 1A, 1B, 2 
  Reproductive toxicity (section 3.7) 1A, 1B, 2 
  Specific target organ toxicity — single exposure (section 3.8) 1, 2 
  Specific target organ toxicity — single exposure; respiratory tract irritation (section 3.8) 3 
  Specific target organ toxicity — single exposure; narcosis (section 3.8) 3 
  Specific target organ toxicity — repeated exposure (section 3.9) 1, 2 
  Aspiration hazard (section 3.10) 1 
  Hazardous to the aquatic environment — acute aquatic hazard (section 4.1) 1 
  Hazardous to the aquatic environment — chronic aquatic hazard (section 4.1) 1, 2, 3, 4 
  Hazardous to the ozone layer (section 5.1) 1 

2. 
The precautionary statements shall be taken from this part of Annex IV and selected in accordance with Part 1.


P101 Language 
 BG При необходимост от медицинска помощ, носете опаковката или етикета на продукта.
 ES Si se necesita consejo médico, tener a mano el envase o la etiqueta.
 CS Je-li nutná lékařská pomoc, mějte po ruce obal nebo štítek výrobku.
 DA Hvis der er brug for lægehjælp, medbring da beholderen eller etiketten.
 DE Ist ärztlicher Rat erforderlich, Verpackung oder Kennzeichnungsetikett bereithalten.
 ET Arsti poole pöördudes võtta kaasa toote pakend või etikett.
 EL Εάν ζητήσετε ιατρική συμβουλή, να έχετε μαζί σας τον περιέκτη του προϊόντος ή την ετικέτα.
 EN If medical advice is needed, have product container or label at hand.
 FR En cas de consultation d’un médecin, garder à disposition le récipient ou l’étiquette.
 GA Más gá comhairle liachta, bíodh coimeádán nó lipéad an táirge ina aice láimhe.
 IT In caso di consultazione di un medico, tenere a disposizione il contenitore o l'etichetta del prodotto.
 LV Medicīniska padoma nepieciešamības gadījumā attiecīgā informācija ir norādīta uz iepakojuma vai etiķetes.
 LT Jei reikalinga gydytojo konsultacija, su savimi turėkite produkto talpyklą ar jo etiketę.
 HU Orvosi tanácsadás esetén tartsa kéznél a termék edényét vagy címkéjét.
 MT Jekk ikun meħtieġ parir mediku, ara li jkollok il-kontenitur jew it-tikketta tal-prodott fil-qrib.
 NL Bij het inwinnen van medisch advies, de verpakking of het etiket ter beschikking houden.
 PL W razie konieczności zasięgnięcia porady lekarza należy pokazać pojemnik lub etykietę.
 PT Se for necessário consultar um médico, mostre-lhe a embalagem ou o rótulo.
 RO Dacă este necesară consultarea medicului, țineți la îndemână recipientul sau eticheta produsului.
 SK Ak je potrebná lekárska pomoc, majte k dispozícii obal alebo etiketu výrobku.
 SL Če je potreben zdravniški nasvet, mora biti na voljo posoda ali etiketa proizvoda.
 FI Jos tarvitaan lääkinnällistä apua, näytä pakkaus tai varoitusetiketti.
 SV Ha förpackningen eller etiketten till hands om du måste söka läkarvård.


P102 Language 
 BG Да се съхранява извън обсега на деца.
 ES Mantener fuera del alcance de los niños.
 CS Uchovávejte mimo dosah dětí.
 DA Opbevares utilgængeligt for børn.
 DE Darf nicht in die Hände von Kindern gelangen.
 ET Hoida lastele kättesaamatus kohas.
 EL Μακριά από παιδιά.
 EN Keep out of reach of children.
 FR Tenir hors de portée des enfants.
 GA Coimeád as aimsiú leanaí.
 IT Tenere fuori dalla portata dei bambini.
 LV Sargāt no bērniem.
 LT Laikyti vaikams neprieinamoje vietoje.
 HU Gyermekektől elzárva tartandó.
 MT Żommu ‘l bogħod minn fejn jistgħu jilħquh it-tfal.
 NL Buiten het bereik van kinderen houden.
 PL Chronić przed dziećmi.
 PT Manter fora do alcance das crianças.
 RO A nu se lăsa la îndemâna copiilor.
 SK Uchovávajte mimo dosahu detí.
 SL Hraniti zunaj dosega otrok.
 FI Säilytä lasten ulottumattomissa.
 SV Förvaras oåtkomligt för barn.


P103 Language 
 BG Преди употреба прочетете етикета.
 ES Leer la etiqueta antes del uso.
 CS Před použitím si přečtěte údaje na štítku.
 DA Læs etiketten før brug.
 DE Vor Gebrauch Kennzeichnungsetikett lesen.
 ET Enne kasutamist tutvuda etiketil oleva infoga.
 EL Διαβάστε την ετικέτα πριν από τη χρήση.
 EN Read label before use.
 FR Lire l’étiquette avant utilisation.
 GA Léigh an lipéad roimh úsáid.
 IT Leggere l’etichetta prima dell’uso.
 LV Pirms izmantošanas izlasīt etiķeti.
 LT Prieš naudojimą perskaityti etiketę.
 HU Használat előtt olvassa el a címkén közölt információkat.
 MT Aqra t-tikketta qabel l-użu.
 NL Alvorens te gebruiken, het etiket lezen.
 PL Przed użyciem przeczytać etykietę.
 PT Ler o rótulo antes da utilização.
 RO Citiţi eticheta înainte de utilizare.
 SK Pred použitím si prečítajte etiketu.
 SL Pred uporabo preberite etiketo.
 FI Lue merkinnät ennen käyttöä.
 SV Läs etiketten före användning.


P201 Language 
 BG Преди употреба се снабдете със специални инструкции.
 ES Pedir instrucciones especiales antes del uso.
 CS Před použitím si obstarejte speciální instrukce.
 DA Indhent særlige anvisninger før brug.
 DE Vor Gebrauch besondere Anweisungen einholen.
 ET Enne kasutamist tutvuda erijuhistega.
 EL Εφοδιαστείτε με τις ειδικές οδηγίες πριν από τη χρήση.
 EN Obtain special instructions before use.
 FR Se procurer les instructions avant utilisation.
 GA Faigh treoracha speisialta roimh úsáid.
 IT Procurarsi istruzioni specifiche prima dell’uso.
 LV Pirms lietošanas saņemt speciālu instruktāžu.
 LT Prieš naudojimą gauti specialias instrukcijas.
 HU Használat előtt ismerje meg az anyagra vonatkozó különleges utasításokat.
 MT Ikseb struzzjonijiet speċjali qabel l-użu.
 NL Alvorens te gebruiken de speciale aanwijzingen raadplegen.
 PL Przed użyciem zapoznać się ze specjalnymi środkami ostrożności.
 PT Pedir instruções específicas antes da utilização.
 RO Procuraţi instrucţiuni speciale înainte de utilizare.
 SK Pred použitím sa oboznámte s osobitnými pokynmi.
 SL Pred uporabo pridobiti posebna navodila.
 FI Lue erityisohjeet ennen käyttöä.
 SV Inhämta särskilda instruktioner före användning.


P202 Language 
 BG Не използвайте преди да сте прочели и разбрали всички предпазни мерки за безопасност.
 ES No manipular la sustancia antes de haber leído y comprendido todas las instrucciones de seguridad.
 CS Nepoužívejte, dokud jste si nepřečetli všechny bezpečnostní pokyny a neporozuměli jim.
 DA Anvend ikke produktet, før alle advarsler er læst og forstået.
 DE Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
 ET Mitte käidelda enne ohutusnõuetega tutvumist ja nendest arusaamist.
 EL Μην το χρησιμοποιήσετε πριν διαβάσετε και κατανοήσετε τις οδηγίες προφύλαξης.
 EN Do not handle until all safety precautions have been read and understood.
 FR Ne pas manipuler avant d’avoir lu et compris toutes les précautions de sécurité.
 GA Ná láimhsigh go dtí go léifear agus go dtuigfear gach ráiteas réamhchúraim sábháilteachta.
 IT Non manipolare prima di avere letto e compreso tutte le avvertenze.
 LV Neizmantot pirms nav izlasīti un saprasti visi apzīmējumi.
 LT Nenaudoti, jeigu neperskaityti ar nesuprasti visi saugos įspėjimai.
 HU Ne használja addig, amíg az összes biztonsági óvintézkedést el nem olvasta és meg nem értette.
 MT Tmissux qabel ma tkun qrajt u fhimt l-istruzzjonijiet kollha ta' prekawzjoni.
 NL Pas gebruiken nadat u alle veiligheidsvoorschriften gelezen en begrepen heeft
 PL Nie używać przed zapoznaniem się i zrozumieniem wszystkich środków bezpieczeństwa.
 PT Não manuseie o produto antes de ter lido e percebido todas as precauções de segurança.
 RO A nu se manipula decât după ce au fost citite şi înţelese toate măsurile de securitate.
 SK Nepoužívajte, kým si neprečítate a nepochopíte všetky bezpečnostné opatrenia.
 SL Ne uporabljajte, dokler se ne seznanite z vsemi varnostnimi ukrepi.
 FI Lue varoitukset huolellisesti ennen käsittelyä.
 SV Använd inte produkten innan du har läst och förstått säkerhetsanvisningarna


P210 Language 
 BG Да се пази от топлина/искри/открит пламък/нагорещени повърхности. — Тютюнопушенето забранено.
 ES Mantener alejado de fuentes de calor, chispas, llama abierta o superficies calientes. — No fumar.
 CS Chraňte před teplem/jiskrami/otevřeným plamenem/horkými povrchy. — Zákaz kouření.
 DA Holdes væk fra varme/gnister/åben ild/varme overflader. Rygning forbudt.
 DE Von Hitze/Funken/offener Flamme/heißen Oberflächen fernhalten. Nicht rauchen.
 ET Hoida eemal soojusallikast/sädemetest/leekidest/kuumadest pindadest. — Mitte suitsetada.
 EL Μακριά από θερμότητα/σπινθήρες/γυμνές φλόγες/θερμές επιφάνειες. — Μην καπνίζετε.
 EN Keep away from heat/sparks/open flames/hot surfaces. — No smoking.
 FR Tenir à l’écart de la chaleur/des étincelles/des flammes nues/des surfaces chaudes. — Ne pas fumer.
 GA Coimeád ó theas/splancacha/lasair gan chosaint/dromchlaí te. — Ná caitear tobac.
 IT Tenere lontano da fonti di calore/scintille/fiamme libere/superfici riscaldate. — Non fumare.
 LV Nelietot vietās, kur ir sastopams karstums/dzirksteles/atklāta uguns/…/karstas virsmas. Nesmēķēt.
 LT Laikyti atokiau nuo šilumos šaltinių/žiežirbų/atviros liepsnos/karštų paviršių. — Nerūkyti.
 HU Hőtől/szikrától/nyílt lángtól/…/forró felületektől távol tartandó. Tilos a dohányzás.
 MT Żomm ‘il bogħod mis-sħana/xrar tan-nar/fjammiet mikxufa/uċuħ jaħarqu. — Tpejjipx.
 NL Verwijderd houden van warmte/vonken/open vuur/hete oppervlakken. — Niet roken.
 PL Przechowywać z dala od źródeł ciepła/iskrzenia/otwartego ognia/gorących powierzchni. Palenie wzbronione.
 PT Manter afastado do calor/faísca/chama aberta/superfícies quentes. — Não fumar.
 RO A se păstra departe de surse de căldură/scântei/flăcări deschise/suprafeţe încinse. — Fumatul interzis.
 SK Uchovávajte mimo dosahu tepla/iskier/otvoreného ohňa/horúcich povrchov. Nefajčite.
 SL Hraniti ločeno od vročine/isker/odprtega ognja/vročih površin. — Kajenje prepovedano.
 FI Suojaa lämmöltä/kipinöiltä/avotulelta/kuumilta pinnoilta. — Tupakointi kielletty.
 SV Får inte utsättas för värme/gnistor/öppen låga/heta ytor. — Rökning förbjuden.


P211 Language 
 BG Да не се пръска към открит пламък или друг източник на запалване.
 ES No pulverizar sobre una llama abierta u otra fuente de ignición.
 CS Nestříkejte do otevřeného ohně nebo jiných zdrojů zapálení.
 DA Spray ikke mod åben ild eller andre antændelseskilder.
 DE Nicht gegen offene Flamme oder andere Zündquelle sprühen.
 ET Mitte pihustada leekidesse või muusse süüteallikasse.
 EL Μην ψεκάζετε κοντά σε γυμνή φλόγα ή άλλη πηγή ανάφλεξης.
 EN Do not spray on an open flame or other ignition source.
 FR Ne pas vaporiser sur une flamme nue ou sur toute autre source d’ignition.
 GA Ná spraeáil ar lasair gan chosaint ná ar fhoinse eile adhainte.
 IT Non vaporizzare su una fiamma libera o altra fonte di accensione.
 LV Neizsmidzināt uz atklātas uguns vai citiem aizdegšanās avotiem.
 LT Nepurkšti į atvirą liepsną arba kitus degimo šaltinius.
 HU Tilos nyílt lángra vagy más gyújtóforrásra permetezni.
 MT Tisprejjax fuq fjamma mikxufa jew sors ieħor li jaqbad.
 NL Niet in een open vuur of op andere ontstekingsbronnen spuiten.
 PL Nie rozpylać nad otwartym ogniem lub innym źródłem zapłonu.
 PT Não pulverizar sobre chama aberta ou outra fonte de ignição.
 RO Nu pulverizaţi deasupra unei flăcări deschise sau unei alte surse de aprindere.
 SK Nestriekajte na otvorený oheň ani iný zdroj zapálenia.
 SL Ne pršiti proti odprtemu ognju ali drugemu viru vžiga.
 FI Ei saa suihkuttaa avotuleen tai muuhun sytytyslähteeseen.
 SV Spreja inte över öppen låga eller andra antändningskällor.


P220 Language 
 BG Да се държи/съхранява далеч от облекло/…/горими материали
 ES Mantener o almacenar alejado de la ropa/…/materiales combustibles.
 CS Uchovávejte/skladujte odděleně od oděvů/…/hořlavých materiálů.
 DA Må ikke anvendes/opbevares i nærheden af tøj/…/brændbare materialer.
 DE Von Kleidung/…/brennbaren Materialien fernhalten/entfernt aufbewahren.
 ET Hoida eemal rõivastest/…/süttivast materjalist.
 EL Διατηρείται/Φυλάσσεται μακριά από ενδύματα/…/καύσιμα υλικά.
 EN Keep/Store away from clothing/…/combustible materials.
 FR Tenir/stocker à l’écart des vêtements/…/matières combustibles
 GA Coimeád/Stóráil glan ar éadaí/…/ábhair indóite.
 IT Tenere/conservare lontano da indumenti/…/materiali combustibili.
 LV Turēt/uzglabāt vietās, kur nav piekļuves drēbēm/…/uzliesmojošiem materiāliem.
 LT Laikyti/sandėliuoti atokiau nuo drabužių/…/degių medžiagų.
 HU Ruhától/…/éghető anyagtól távol tartandó/tárolandó.
 MT Żomm/Aħżen ‘il bogħod mill-ħwejjeġ/…/materjali li jaqbdu.
 NL Van kleding/…/brandbare stoffen verwijderd houden/bewaren.
 PL Trzymać/przechowywać z dala od odzieży/…/materiałów zapalnych.
 PT Manter/guardar afastado de roupa/…/matérias combustíveis.
 RO A se păstra/depozita departe de îmbrăcăminte/…/materiale combustibile.
 SK Uchovávajte/skladujte mimo odevov/…/horľavých materiálov.
 SL Hraniti ločeno od oblačil/…/vnetljivih materialov.
 FI Pidä/Varastoi erillään vaatetuksesta/…/syttyvistä materiaaleista.
 SV Hålls/förvarad åtskilt från kläder/…/brännbara material.


P221 Language 
 BG Вземете всички предпазни мерки за избягване на смесването с горими материали…
 ES Tomar todas las precauciones necesarias para no mezclar con materias combustibles…
 CS Proveďte preventivní opatření proti smíchání s hořlavými materiály…
 DA Undgå at blande med brændbare materialer…
 DE Mischen mit brennbaren Stoffen/… unbedingt verhindern.
 ET Rakendada ettevaatusabinõusid, et vältida segunemist põlevainetega…
 EL Λάβετε κάθε προφύλαξη ώστε να μην αναμειχθεί με καύσιμα…
 EN Take any precaution to avoid mixing with combustibles…
 FR Prendre toutes précautions pour éviter de mélanger avec des matières combustibles…
 GA Déan gach réamhchúram chun meascadh le hábhair indóite a sheachaint…
 IT Prendere ogni precauzione per evitare di miscelare con sostanze combustibili…
 LV Nekādā gadījumā nemaisīt ar viegli uzliesmojošām vielām…
 LT Imtis visų atsargumo priemonių, kad nebūtų sumaišyta su degiomis medžiagomis…
 HU Minden óvintézkedést meg kell tenni, hogy ne keveredjen éghető anyagokkal.
 MT Ħu kull prekawzjoni biex tevita li jitħallat mal-kombustibbli…
 NL Vermenging met brandbare stoffen… absoluut vermijden.
 PL Zastosować wszelkie środki ostrożności w celu uniknięcia mieszania z innymi materiałami zapalnymi …
 PT Tomar todas as precauções para não misturar com combustíveis…
 RO Luaţi toate măsurile de precauţie pentru a evita amestecul cu combustibili…
 SK Prijmite opatrenia na zabránenie zmiešania s horľavými materiálmi…
 SL Preprečiti mešanje z vnetljivimi snovmi …
 FI Varo sekoittamasta syttyvien materiaalien… kanssa.
 SV Undvik att blanda med med brännbara ämnen…


P222 Language 
 BG Не допускайте конктакт с въздух.
 ES No dejar que entre en contacto con el aire.
 CS Zabraňte styku se vzduchem.
 DA Undgå kontakt med luft.
 DE Kontakt mit Luft nicht zulassen.
 ET Hoida õhuga kokkupuute eest.
 EL Να μην έρθει σε επαφή με τον αέρα.
 EN Do not allow contact with air.
 FR Ne pas laisser au contact de l’air.
 GA Ná ceadaigh teagmháil le haer.
 IT Evitare il contatto con l’aria.
 LV Nepieļaut kontaktu ar gaisu.
 LT Saugoti nuo kontakto su oru.
 HU Nem érintkezhet levegővel.
 MT Tħallix li jkun hemm kuntatt ma' l-arja.
 NL Contact met de lucht vermijden.
 PL Nie dopuszczać do kontaktu z powietrzem.
 PT Não deixar entrar em contacto com o ar.
 RO A nu se lăsa în contact cu aerul.
 SK Zabráňte kontaktu so vzduchom.
 SL Preprečiti stik z zrakom.
 FI Ei saa joutua kosketuksiin ilman kanssa.
 SV Undvik kontakt med luft.


P223 Language 
 BG Да се избягва всякакъв възможен контакт с вода поради бурна реакция и възможно внезапно запалване.
 ES Mantener alejado de cualquier posible contacto con el agua, pues reacciona violentamente y puede provocar una llamarada.
 CS Chraňte před možným stykem s vodou kvůli prudké reakci a možnému náhlému vzplanutí.
 DA Undgå enhver kontakt med vand, da dette kan fremkalde voldsom reaktion og risiko for eksplosionsagtig brand.
 DE Kontakt mit Wasser wegen heftiger Reaktion und möglichem Aufflammen unbedingt verhindern.
 ET Hoida igasuguse kokkupuute eest veega, vastasel juhul reageerib ägedalt ja võib põhjustada hetkpõlemise.
 EL Αποφύγετε κάθε πιθανή επαφή με το νερό, διότι αντιδρά βίαια και μπορεί να προκληθεί ανάφλεξη.
 EN Keep away from any possible contact with water, because of violent reaction and possible flash fire.
 FR Éviter tout contact avec l’eau, à cause du risque de réaction violente et d’inflammation spontanée.
 GA Ná ceadaigh teagmháil de shaghas ar bith le huisce, mar gheall ar imoibriú foirtil agus splancthine a d’fhéadfadh a bheith ann.
 IT Evitare qualsiasi contatto con l’acqua: pericolo di reazione violenta e di infiammazione spontanea.
 LV Nepieļaut kontaktu ar ūdeni īpaši stipras reakcijas un iespējamas eksplozijas dēļ.
 LT Saugoti nuo bet kokio galimo kontakto su vandeniu, nes smarkiai reaguoja ir gali susidaryti ugnies pliūpsnis.
 HU Vízzel semmilyen formában nem érintkezhet, ellenkező esetben heves reakció és belobbanás fordulhat elő.
 MT Żomm ‘il bogħod minn kull kuntatt possibbli ma' l-ilma, minħabba li jirreaġġixxi bil-qawwa u jista’ jkun hemm fjamma nar.
 NL Contact met water vermijden in verband met een heftige reactie en een mogelijke wolkbrand.
 PL Chronić przed wszelkim kontaktem z wodą z powodu gwałtownej reakcji i możliwości wystąpienia błyskawicznego pożaru.
 PT Não deixar entrar em contacto com a água: risco de reacção violenta e possibilidade de formação de chama súbita.
 RO A se evita orice contact cu apa, din cauza reacţiei violente şi a riscului de aprindere spontană.
 SK Zabráňte akémukoľvek kontaktu s vodou, aby nedošlo k prudkej reakcii a prípadnému zapáleniu.
 SL Hraniti ločeno od možnega stika z vodo zaradi burne reakcije in možnega bliskovitega požara.
 FI Ei saa joutua kosketuksiin veden kanssa voimakkaan reaktion ja mahdollisen leimahduksen takia.
 SV Undvik all kontakt med vatten eftersom det kan framkalla en våldsam reaktion och explosionsartad brand.


P230 Language 
 BG Да се държи навлажнен с…
 ES Mantener humedecido con…
 CS Uchovávejte ve zvlhčeném stavu…
 DA Holdes befugtet med…
 DE Feucht halten mit …
 ET Niisutada …-ga.
 EL Να διατηρείται υγρό με …
 EN Keep wetted with…
 FR Maintenir humidifié avec…
 GA Coimeád fliuchta le…
 IT Mantenere umido con…
 LV Vienmēr samitrināt ar …
 LT Laikyti sudrėkintą (kuo)
 HU …-val/-vel nedvesítve tartandó.
 MT Żommu mxarrab bi …
 NL Vochtig houden met…
 PL Przechowywać produkt zwilżony…
 PT Manter húmido com…
 RO A se păstra umezit cu…
 SK Uchovávajte zvlhčené …
 SL Hraniti prepojeno z …
 FI Säilytä kostutettuna …
 SV Ska hållas fuktigt med…


P231 Language 
 BG Да се използва под инертен газ.
 ES Manipular en gas inerte.
 CS Manipulace pod inertním plynem.
 DA Håndteres under inaktiv gas.
 DE Unter inertem Gas handhaben.
 ET Käidelda inertgaasis.
 EL Χειρισμός σε αδρανή ατμόσφαιρα.
 EN Handle under inert gas.
 FR Manipuler sous gaz inerte.
 GA Láimhsigh faoi thriathghás.
 IT Manipolare in atmosfera di gas inerte.
 LV Rīkoties tikai inertas gāzes apstākļos.
 LT Tvarkyti inertinėse dujose.
 HU Inert gázban használandó.
 MT Immaniġġja taħt gass inerti.
 NL Onder inert gas werken.
 PL Używać w atmosferze obojętnego gazu.
 PT Manusear em atmosfera de gás inerte.
 RO A se manipula sub un gaz inert.
 SK Manipulujte v prostredí s inertným plynom.
 SL Hraniti v ustreznem inertnem plinu.
 FI Käsittele inertissä kaasussa.
 SV Hanteras under inert gas.


P232 Language 
 BG Да се пази от влага.
 ES Proteger de la humedad.
 CS Chraňte před vlhkem.
 DA Beskyttes mod fugt.
 DE Vor Feuchtigkeit schützen.
 ET Hoida niiskuse eest.
 EL Προστετέψτε από την υγρασία.
 EN Protect from moisture.
 FR Protéger de l’humidité.
 GA Cosain ar thaise.
 IT Proteggere dall’umidità.
 LV Aizsargāt no mitruma.
 LT Saugoti nuo drėgmės.
 HU Nedvességtől védendő.
 MT Ipproteġi mill-umdità.
 NL Tegen vocht beschermen.
 PL Chronić przed wilgocią.
 PT Manter ao abrigo da humidade.
 RO A se proteja de umiditate.
 SK Chráňte pred vlhkosťou.
 SL Zaščititi pred vlago.
 FI Suojaa kosteudelta.
 SV Skyddas från fukt.


P233 Language 
 BG Съдът да се съхранява плътно затворен.
 ES Mantener el recipiente herméticamente cerrado.
 CS Uchovávejte obal těsně uzavřený.
 DA Hold beholderen tæt lukket.
 DE Behälter dicht verschlossen halten.
 ET Hoida pakend tihedalt suletuna.
 EL Να διατηρείται ο περιέκτης ερμητικά κλειστός.
 EN Keep container tightly closed.
 FR Maintenir le récipient fermé de manière étanche.
 GA Coimeád an coimeádán dúnta go docht.
 IT Tenere il recipiente ben chiuso.
 LV Tvertni stingri noslēgt.
 LT Talpyklą laikyti sandariai uždarytą.
 HU Az edény szorosan lezárva tartandó.
 MT Żomm il-kontenitur magħluq sew.
 NL In goed gesloten verpakking bewaren.
 PL Przechowywać pojemnik szczelnie zamknięty.
 PT Manter o recipiente bem fechado.
 RO Păstraţi recipientul închis etanş.
 SK Nádobu uchovávajte tesne uzavretú.
 SL Hraniti v tesno zaprti posodi.
 FI Säilytä tiiviisti suljettuna.
 SV Behållaren ska vara väl tillsluten.


P234 Language 
 BG Да се съхранява само в оригиналната опаковка.
 ES Conservar únicamente en el recipiente original.
 CS Uchovávejte pouze v původním obalu.
 DA Opbevares kun i den originale beholder.
 DE Nur im Originalbehälter aufbewahren.
 ET Hoida üksnes originaalpakendis.
 EL Να διατηρείται μόνο στον αρχικό περιέκτη.
 EN Keep only in original container.
 FR Conserver uniquement dans le récipient d’origine.
 GA Coimeád sa choimeádán bunaidh amháin.
 IT Conservare soltanto nel contenitore originale.
 LV Turēt tikai oriģinālā iepakojumā.
 LT Laikyti tik originalioje talpykloje.
 HU Az eredeti edényben tartandó.
 MT Żomm biss fil-kontenitur oriġinali.
 NL Uitsluitend in de oorspronkelijke verpakking bewaren.
 PL Przechowywać wyłącznie w oryginalnym pojemniku.
 PT Conservar unicamente no recipiente de origem.
 RO Păstraţi numai în recipientul original.
 SK Uchovávajte iba v pôvodnej nádobe.
 SL Hraniti samo v originalni posodi.
 FI Säilytä alkuperäispakkauksessa.
 SV Förvaras endast i originalbehållaren.


P235 Language 
 BG Да се държи на хладно.
 ES Mantener en lugar fresco.
 CS Uchovávejte v chladu.
 DA Opbevares køligt.
 DE Kühl halten.
 ET Hoida jahedas.
 EL Να διατηρείται δροσερό.
 EN Keep cool.
 FR Tenir au frais.
 GA Coimeád fionnuar é
 IT Conservare in luogo fresco.
 LV Turēt vēsumā.
 LT Laikyti vėsioje vietoje.
 HU Hűvös helyen tartandó.
 MT Żomm frisk.
 NL Koel bewaren.
 PL Przechowywać w chłodnym miejscu.
 PT Conservar em ambiente fresco.
 RO A se păstra la rece.
 SK Uchovávajte v chlade.
 SL Hraniti na hladnem.
 FI Säilytä viileässä.
 SV Förvaras svalt.


P240 Language 
 BG Заземяване/еквипотенциална връзка на съда и приемателното устройство.
 ES Conectar a tierra/enlace equipotencial del recipiente y del equipo de recepción.
 CS Uzemněte obal a odběrové zařízení.
 DA Beholder og modtageudstyr jordforbindes/potentialudlignes.
 DE Behälter und zu befüllende Anlage erden.
 ET Mahuti ja vastuvõtuseade maandada/ühendada.
 EL Γείωση/ισοδυναμική σύνδεση του περιέκτη και του εξοπλισμού δέκτη.
 EN Ground/bond container and receiving equipment.
 FR Mise à la terre/liaison équipotentielle du récipient et du matériel de réception.
 GA Nasc an coimeádán agus an trealamh glactha leis an talamh.
 IT Mettere a terra/massa il contenitore e il dispositivo ricevente.
 LV Tvertnes un iekārtas saņemšanai ievietot zemē/sasaistīt
 LT Įžeminti/įtvirtinti talpyklą ir priėmimo įrangą.
 HU A tárolóedényt és a fogadóedényt le kell földelni/át kell kötni.
 MT Poġġi ma' l-art/waħħal il-kontenitur u t-tagħmir li jirċievi.
 NL Opslag- en opvangreservoir aarden.
 PL Uziemić/połączyć pojemnik i sprzęt odbiorczy.
 PT Ligação à terra/equipotencial do recipiente e do equipamento receptor.
 RO Legătură la pământ/conexiune echipotenţială cu recipientul şi cu echipamentul de recepţie.
 SK Uzemnite/upevnite nádobu a plniace zariadenie.
 SL Ozemljiti posodo in opremo za sprejem tekočine.
 FI Säiliö ja vastaanottavat laitteet on maadoitettava/yhdistettävä.
 SV Jorda/potentialförbind behållare och mottagarutrustning.


P241 Language 
 BG Използвайте електрическо/проветряващо/осветително/…/оборудване, обезопасено срещу експлозия
 ES Utilizar un material eléctrico, de ventilación o de iluminación/…/antideflagrante.
 CS Používejte elektrické/ventilační/osvětlovací/…/zařízení do výbušného prostředí.
 DA Anvend eksplosionssikkert elektrisk/ventilations-/lys-/…/udstyr.
 DE Explosionsgeschützte elektrische Betriebsmittel/Lüftungsanlagen/Beleuchtung/… verwenden.
 ET Kasutada plahvatuskindlaid elektri-/ventilatsiooni-/valgustus-/…/seadmeid.
 EL Να χρησιμοποιείται αντιεκρηκτικός ηλεκτρολογικός/εξαερισμού/φωτιστικός/…/εξοπλισμός.
 EN Use explosion-proof electrical/ventilating/lighting/…/equipment.
 FR Utiliser du matériel électrique/de ventilation/d’éclairage/…/antidéflagrant.
 GA Bain úsáid as trealamh pléascdhíonach leictreach/aerála/soilsiúcháin/…
 IT Utilizzare impianti elettrici/di ventilazione/d’illuminazione/…/a prova di esplosione.
 LV Izmantot sprādziendrošas elektriskas/ar ventilāciju/izgaismotas/…/iekārtas
 LT Naudoti sprogimui atsparią elektros/ventiliacijos/apšvietimo/…/įrangą.
 HU Robbanásbiztos elektromos/szellőztető/világító/…/berendezés használandó.
 MT Uża’ tagħmir elettriku/ta’ ventilazzjoni/ta' dawl/…/li jiflaħ għal splużjoni.
 NL Explosieveilige elektrische/ventilatie-/verlichtings-/…apparatuur gebruiken.
 PL Używać elektrycznego/wentylującego/oświetleniowego/…/. przeciwwybuchowego sprzętu.
 PT Utilizar equipamento eléctrico/de ventilação/de iluminação/…/à prova de explosão.
 RO Utilizaţi echipamente electrice/de ventilare/de iluminat/…/antideflagrante.
 SK Používajte elektrické/ventilačné/osvetľovacie/…/zariadenie do výbušného prostredia.
 SL Uporabiti električno/prezračevalno opremo, opremo za razsvetljavo/…/, odporno proti eksplozijam.
 FI Käytä räjähdysturvallisia sähkö/ilmanvaihto/valaisin/…/laitteita.
 SV Använd explosionssäker elektrisk/ventilations-/belysnings-/…/utrustning.


P242 Language 
 BG Използвайте само инструменти, които не предизвикват искри.
 ES Utilizar únicamente herramientas que no produzcan chispas.
 CS Používejte pouze nářadí z nejiskřícího kovu.
 DA Anvend kun værktøj, som ikke frembringer gnister.
 DE Nur funkenfreies Werkzeug verwenden.
 ET Mitte kasutada seadmeid, mis võivad tekitada sädemeid.
 EL Να χρησιμοποιούνται μόνο εργαλεία που δεν παράγουν σπινθήρες.
 EN Use only non-sparking tools.
 FR Ne pas utiliser d'outils produisant des étincelles.
 GA Bain úsáid as uirlisí neamhspréachta amháin.
 IT Utilizzare solo utensili antiscintillamento.
 LV Izmantot instrumentus, kas nerada dzirksteles.
 LT Naudoti tik kibirkščių nekeliančius įrankius.
 HU Szikramentes eszközök használandók.
 MT Uża’ biss għodda li ma jtajrux żnied.
 NL Uitsluitend vonkvrij gereedschap gebruiken.
 PL Używać wyłącznie nieiskrzących narzędzi.
 PT Utilizar apenas ferramentas antichispa.
 RO Nu utilizaţi unelte care produc scântei.
 SK Používajte iba neiskriace prístroje.
 SL Uporabiti le orodje, ki ne povzroča isker.
 FI Käytä ainoastaan kipinöimättömiä työkaluja.
 SV Använd endast verktyg som inte ger upphov till gnistor.


P243 Language 
 BG Вземете предпазни мерки срещу освобождаване на статично електричество.
 ES Tomar medidas de precaución contra descargas electrostáticas.
 CS Proveďte preventivní opatření proti výbojům statické elektřiny.
 DA Træf foranstaltninger mod statisk elektricitet.
 DE Maßnahmen gegen elektrostatische Aufladungen treffen.
 ET Rakendada ettevaatusabinõusid staatilise elektri vastu.
 EL Λάβετε προστατευτικά μέτρα έναντι ηλεκτροστατικών εκκενώσεων.
 EN Take precautionary measures against static discharge.
 FR Prendre des mesures de précaution contre les décharges électrostatiques.
 GA Déan bearta réamhchúraim in aghaidh díluchtú statach.
 IT Prendere precauzioni contro le scariche elettrostatiche.
 LV Nodrošināties pret statiskās enerģijas izlādi.
 LT Imtis atsargumo priemonių statinei iškrovai išvengti.
 HU Az elektrosztatikus kisülés megakadályozására óvintézkedéseket kell tenni.
 MT Ħu miżuri ta' prekawzjoni kontra l-ħruġ ta' elettriku statiku.
 NL Voorzorgsmaatregelen treffen tegen ontladingen van statische elektriciteit.
 PL Przedsięwziąć środki ostrożności zapobiegające statycznemu rozładowaniu.
 PT Evitar acumulação de cargas electrostáticas.
 RO Luaţi măsuri de precauţie împotriva descărcărilor electrostatice.
 SK Urobte preventívne opatrenia proti výbojom statickej elektriny.
 SL Preprečiti statično naelektrenje.
 FI Estä staattisen sähkön aiheuttama kipinöinti.
 SV Vidta åtgärder mot statisk elektricitet.


P244 Language 
 BG Почиствайте редуциращите вентили от смазка и масло
 ES Mantener las válvulas de reducción limpias de grasa y aceite.
 CS Udržujte redukční ventily bez maziva a oleje.
 DA Reduktionsventilerne holdes fri for fedt og olie.
 DE Druckminderer frei von Fett und Öl halten.
 ET Hoida reduktsiooniklapid rasvast ja õlist puhtad.
 EL Να διατηρούνται καθαρές από γράσα και λάδια οι βαλβίδες μείωσης.
 EN Keep reduction valves free from grease and oil.
 FR S’assurer de l’absence de graisse ou d’huile sur les soupapes de réduction.
 GA Coimeád comhlaí brúlaghdaithe saor ó ghréisc agus ó ola.
 IT Mantenere le valvole di riduzione libere da grasso e olio.
 LV Turēt reducēšanās vārstus tīrus no taukiem un eļļas.
 LT Saugoti, kad ant redukcinių vožtuvų nepatektų riebalų ir tepalų.
 HU A nyomáscsökkentő szelepeket zsírtól és olajtól mentesen kell tartani.
 MT Żomm il-valvs ta' tnaqqis ħielsa mill-griż u ż-żejt.
 NL Reduceerventielen vrij van olie en vet houden.
 PL Chronić zawory redukcyjne przed tłuszczem i olejem.
 PT Manter as válvulas de redução isentas de óleo e massa lubrificantes.
 RO Protejaţi supapele reductoare de grăsimi și ulei.
 SK Redukčné ventily udržiavajte bez mazadiel a oleja.
 SL Preprečiti stik reducirnih ventilov z mastjo in oljem.
 FI Pidä paineenalennusventtiilit vapaana rasvasta ja öljystä.
 SV Reducerventilerna ska hållas fria från fett och olja.


P250 Language 
 BG Да не се подлага на стържене/удар/…/триене
 ES Evitar la abrasión/el choque/…/la fricción.
 CS Nevystavujte obrušování/nárazům/…/tření.
 DA Må ikke udsættes for slibning/stød/…/gnidning.
 DE Nicht schleifen/stoßen/…/reiben.
 ET Hoida kriimustamise/põrutuse/…/hõõrdumise eest.
 EL Να αποφεύγεται άλεση/κρούση/…/τριβή.
 EN Do not subject to grinding/shock/…/friction.
 FR Éviter les abrasions/les chocs/…/les frottements.
 GA Ná nocht do mheilt/do thurraing/…/do fhrithchuimilt.
 IT Evitare le abrasioni/gli urti/…/gli attriti.
 LV Nepakļaut drupināšanai/triecienam/…/berzei
 LT Nešlifuoti/netrankyti/…/netrinti.
 HU Tilos csiszolásnak/ütésnek/…/súrlódásnak kitenni.
 MT Tissottoponihomx għal brix/xokk/…/frizzjoni.
 NL Malen/schokken/…/wrijving vermijden.
 PL Nie poddawać szlifowaniu/wstrząsom/…/tarciu.
 PT Não submeter a trituração/choque/…/fricção.
 RO A nu supune la abraziuni/şocuri/…/frecare.
 SK Nevystavujte brúseniu/nárazu/…/treniu.
 SL Ne izpostavljati drgnjenju/udarcem/…/trenju.
 FI Suojele rasitukselta/iskuilta/…/hankaukselta.
 SV Får inte utsättas för gnidning/stötar/…/friktion.


P251 Language 
 BG Съд под налягане: да не се пробива и изгаря дори след употреба.
 ES Recipiente a presión: no perforar ni quemar, aun después del uso.
 CS Tlakový obal: nepropichujte nebo nespalujte ani po použití.
 DA Beholder under tryk: Må ikke punkteres eller brændes, heller ikke efter brug.
 DE Behälter steht unter Druck: Nicht durchstechen oder verbrennen, auch nicht nach der Verwendung.
 ET Mahuti on rõhu all: mitte purustada ega põletada isegi pärast kasutamist.
 EL Περιέκτης υπό πίεση. Να μην τρυπηθεί ή καεί ακόμη και μετά τη χρήση.
 EN Pressurized container: Do not pierce or burn, even after use.
 FR Récipient sous pression: ne pas perforer, ni brûler, même après usage.
 GA Coimeádán brúchóirithe: Ná toll agus ná dóigh, fiú tar éis úsáide.
 IT Recipiente sotto pressione: non perforare né bruciare, neppure dopo l’uso.
 LV Tvertne zem spiediena: nedurt vai nededzināt, arī pēc izlietošanas.
 LT Slėginis indas. Nepradurti ir nedeginti net panaudoto.
 HU Nyomás alatti edény: ne lyukassza ki vagy égesse el, még használat után sem.
 MT Kontenitur taħt pressjoni: Ittaqqbux jew taħarqux, anki wara li tużah.
 NL Houder onder druk: ook na gebruik niet doorboren of verbranden.
 PL Pojemnik pod ciśnieniem. Nie przekłuwać ani nie spalać, nawet po zużyciu.
 PT Recipiente sob pressão. Não furar nem queimar, mesmo após utilização.
 RO Recipient sub presiune. Nu perforaţi sau ardeţi, chiar şi după utilizare.
 SK Nádoba je pod tlakom: neprepichujte alebo nespaľujte ju, a to ani po spotrebovaní obsahu.
 SL Posoda je pod tlakom: ne preluknjajte ali sežigajte je niti, ko je prazna.
 FI Painesäiliö: Ei saa puhkaista tai polttaa edes tyhjänä.
 SV Tryckbehållare: Får inte punkteras eller brännas, gäller även tömd behållare.


P260 Language 
 BG Не вдишвайте прах/пушек/газ/дим/изпарения/аерозоли
 ES No respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.
 CS Nevdechujte prach/dým/plyn/mlhu/páry/aerosoly.
 DA Indånd ikke pulver/røg/gas/tåge/damp/spray.
 DE Staub/Rauch/Gas/Nebel/Dampf/Aerosol nicht einatmen.
 ET Tolmu/suitsu/gaasi/udu/auru/pihustatud ainet mitte sisse hingata.
 EL Μην αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα
 EN Do not breathe dust/fume/gas/mist/vapours/spray.
 FR Ne pas respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.
 GA Ná hanálaigh deannach/múch/gás/ceo/gala/sprae.
 IT Non respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.
 LV Neieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.
 LT Neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.
 HU A por/füst/gáz/köd/gőzök/permet belélegzése tilos.
 MT Tiblax bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.
 NL Stof/rook/gas/nevel/damp/spuitnevel niet inademen.
 PL Nie wdychać pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.
 PT Não respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.
 RO Nu inspiraţi praful/fumul/gazul/ceața/vaporii/spray-ul.
 SK Nevdychujte prach/dym/plyn/hmlu/pary/aerosóly.
 SL Ne vdihavati prahu/dima/plina/meglice/hlapov/razpršila.
 FI Älä hengitä pölyä/savua/kaasua/sumua/höyryä/suihketta.
 SV Inandas inte damm/rök/gaser/dimma/ångor/sprej.


P261 Language 
 BG Избягвайте вдишване на прах/пушек/газ/дим/изпарения/аерозоли
 ES Evitar respirar el polvo/el humo/el gas/la niebla/los vapores/el aerosol.
 CS Zamezte vdechování prachu/dýmu/plynu/mlhy/par/aerosolů.
 DA Undgå indånding af pulver/røg/gas/tåge/damp/spray.
 DE Einatmen von Staub/Rauch/Gas/Nebel/Dampf/Aerosol vermeiden.
 ET Vältida tolmu/suitsu/gaasi/udu/auru/pihustatud aine sissehingamist.
 EL Aποφεύγετε να αναπνέετε σκόνη/αναθυμιάσεις/αέρια/σταγονίδια/ατμούς/εκνεφώματα.
 EN Avoid breathing dust/fume/gas/mist/vapours/spray.
 FR Éviter de respirer les poussières/fumées/gaz/brouillards/vapeurs/aérosols.
 GA Seachain deannach/múch/gás/ceo/gala/sprae a análú.
 IT Evitare di respirare la polvere/i fumi/i gas/la nebbia/i vapori/gli aerosol.
 LV Izvairīties ieelpot putekļus/tvaikus/gāzi/dūmus/izgarojumus/smidzinājumu.
 LT Stengtis neįkvėpti dulkių/dūmų/dujų/rūko/garų/aerozolio.
 HU Kerülje a por/füst/gáz/köd/gőzök/permet belélegzését.
 MT Evita li tibla' bin-nifs trabijiet/dħaħen/gass/raxx/fwar/sprej.
 NL Inademing van stof/rook/gas/nevel/damp/spuitnevel vermijden.
 PL Unikać wdychania pyłu/dymu/gazu/mgły/par/rozpylonej cieczy.
 PT Evitar respirar as poeiras/fumos/gases/névoas/vapores/aerossóis.
 RO Evitaţi să inspirați praful/fumul/gazul/ceața/vaporii/spray-ul.
 SK Zabráňte vdychovaniu prachu/dymu/plynu/hmly/pár/aerosólov.
 SL Ne vdihavati prahu/dima/plina/meglice/hlapov/razpršila.
 FI Vältä pölyn/savun/kaasun/sumun/höyryn/suihkeen hengittämistä.
 SV Undvik att inandas damm/rök/gaser/dimma/ångor/sprej.


P262 Language 
 BG Да се избягва контакт с очите, кожата или облеклото.
 ES Evitar el contacto con los ojos, la piel o la ropa.
 CS Zabraňte styku s očima, kůží nebo oděvem.
 DA Må ikke komme i kontakt med øjne, hud eller tøj.
 DE Nicht in die Augen, auf die Haut oder auf die Kleidung gelangen lassen.
 ET Vältida silma, nahale või rõivastele sattumist.
 EL Να μην έρθει σε επαφή με τα μάτια, με το δέρμα ή με τα ρούχα.
 EN Do not get in eyes, on skin, or on clothing.
 FR Éviter tout contact avec les yeux, la peau ou les vêtements.
 GA Ná lig sna súile, ar an gcraiceann, ná ar éadaí.
 IT Evitare il contatto con gli occhi, la pelle o gli indumenti.
 LV Nepieļaut nokļūšanu acīs, uz ādas vai uz drēbēm.
 LT Saugotis, kad nepatektų į akis, ant odos ar drabužių.
 HU Szembe, bőrre vagy ruhára nem kerülhet.
 MT Iddaħħalx fl-għajnejn, fuq il-ġilda, jew fuq il-ħwejjeġ.
 NL Contact met de ogen, de huid of de kleding vermijden.
 PL Nie wprowadzać do oczu, na skórę lub na odzież.
 PT Não pode entrar em contacto com os olhos, a pele ou a roupa.
 RO Evitaţi orice contact cu ochii, pielea sau îmbrăcămintea.
 SK Zabráňte kontaktu s očami, pokožkou alebo odevom.
 SL Preprečiti stik z očmi, kožo ali oblačili.
 FI Varo kemikaalin joutumista silmiin, iholle tai vaatteisiin.
 SV Får inte komma i kontakt med ögonen, huden eller kläderna.


P263 Language 
 BG Да се избягва контакт по време на бременност/при кърмене.
 ES Evitar el contacto durante el embarazo/la lactancia.
 CS Zabraňte styku během těhotenství/kojení.
 DA Undgå kontakt under graviditet/amning.
 DE Kontakt während der Schwangerschaft/und der Stillzeit vermeiden.
 ET Vältida kokkupuudet raseduse/imetamise ajal.
 EL Aποφεύγετε την επαφή στη διάρκεια της εγκυμοσύνης/γαλουχίας.
 EN Avoid contact during pregnancy/while nursing.
 FR Éviter tout contact avec la substance au cours de la grossesse/pendant l’allaitement.
 GA Seachain teagmháil le linn toirchis/agus an chíoch á tabhairt.
 IT Evitare il contatto durante la gravidanza/l’allattamento.
 LV Izvairīties no saskares grūtniecības laikā/barojot bērnu ar krūti.
 LT Vengti kontakto nėštumo metu/maitinant krūtimi.
 HU A terhesség/szoptatás alatt kerülni kell az anyaggal való érintkezést.
 MT Evita l-kuntatt waqt it-tqala/waqt it-treddigħ.
 NL Bij zwangerschap of borstvoeding aanraking vermijden.
 PL Unikać kontaktu w czasie ciąży/karmienia piersią.
 PT Evitar o contacto durante a gravidez/o aleitamento.
 RO Evitaţi contactul în timpul sarcinii/alăptării.
 SK Zabráňte kontaktu počas tehotenstva a dojčenia.
 SL Preprečiti stik med nosečnostjo/dojenjem.
 FI Vältä kosketusta raskauden tai imetyksen aikana.
 SV Undvik kontakt under graviditet eller amning.


P264 Language 
 BG Да се измие… старателно след употреба.
 ES Lavarse … concienzudamente tras la manipulación.
 CS Po manipulaci důkladně omyjte …
 DA Vask … grundigt efter brug.
 DE Nach Gebrauch … gründlich waschen.
 ET Pärast käitlemist pesta hoolega …
 EL Πλύνετε … σχολαστικά μετά το χειρισμό.
 EN Wash … thoroughly after handling.
 FR Se laver … soigneusement après manipulation.
 GA Nigh … go lánchúramach tar éis láimhsithe.
 IT Lavare accuratamente … dopo l’uso.
 LV Pēc izmantošanas … kārtīgi nomazgāt.
 LT Po naudojimo kruopščiai nuplauti …
 HU A használatot követően a(z) … -t alaposan meg kell mosni.
 MT Aħsel … sew wara li timmaniġġjah.
 NL Na het werken met dit product … grondig wassen.
 PL Dokładnie umyć … po użyciu.
 PT Lavar … cuidadosamente após manuseamento.
 RO Spălaţi-vă … bine după utilizare.
 SK Po manipulácii starostlivo umyte…
 SL Po uporabi temeljito umiti …
 FI Pese … huolellisesti käsittelyn jälkeen.
 SV Tvätta … grundligt efter användning.


P270 Language 
 BG Да не се яде, пие или пуши при употреба на продукта.
 ES No comer, beber ni fumar durante su utilización.
 CS Při používání tohoto výrobku nejezte, nepijte ani nekuřte.
 DA Der må ikke spises, drikkes eller ryges under brugen af dette produkt.
 DE Bei Gebrauch nicht essen, trinken oder rauchen.
 ET Toote käitlemise ajal mitte süüa, juua ega suitsetada.
 EL Μην τρώτε, πίνετεή καπνίζετε, όταν χρησιμοποιείτε αυτό το προϊόν.
 EN Do no eat, drink or smoke when using this product.
 FR Ne pas manger, boire ou fumer en manipulant ce produit.
 GA Ná hith, ná hól agus ná caitear tobac agus an táirge seo á úsáid.
 IT Non mangiare, né bere, né fumare durante l’uso.
 LV Neēst, nedzert un nesmēķēt produkta izmantošanas laikā.
 LT Naudojant šį produktą, nevalgyti, negerti ir nerūkyti.
 HU A termék használata közben tilos enni, inni vagy dohányozni.
 MT Tikolx, tixrobx u tpejjipx waqt li tuża’ dan il-prodott.
 NL Niet eten, drinken of roken tijdens het gebruik van dit product.
 PL Nie jeść, nie pić i nie palić podczas używania produktu.
 PT Não comer, beber ou fumar durante a utilização deste produto.
 RO A nu mânca, bea sau fuma în timpul utilizării produsului.
 SK Pri používaní výrobku nejedzte, nepite ani nefajčite.
 SL Ne jesti, piti ali kaditi med uporabo tega izdelka.
 FI Syöminen, juominen ja tupakointi kielletty kemikaalia käytettäessä.
 SV Ät inte, drick inte och rök inte när du använder produkten.


P271 Language 
 BG Да се използва само на открито или на добре проветривомясто.
 ES Utilizar únicamente en exteriores o en un lugar bien ventilado.
 CS Používejte pouze venku nebo v dobře větraných prostorách.
 DA Brug kun udendørs eller i et rum med god udluftning.
 DE Nur im Freien oder in gut belüfteten Räumen verwenden.
 ET Käidelda üksnes välitingimustes või hästi ventileeritavas kohas.
 EL Να χρησιμοποιείται μόνο σε ανοικτό ή καλά αεριζόμενο χώρο.
 EN Use only outdoors or in a well-ventilated area.
 FR Utiliser seulement en plein air ou dans un endroit bien ventilé.
 GA Úsáid amuigh faoin aer nó i limistéar dea-aerálaithe amháin.
 IT Utilizzare soltanto all’aperto o in luogo ben ventilato.
 LV Izmantot tikai ārā vai labi vēdināmās telpās.
 LT Naudoti tik lauke arba gerai vėdinamoje patalpoje.
 HU Kizárólag szabadban vagy jól szellőző helyiségben használható.
 MT Uża biss barra jew f’post ventilat sew.
 NL Alleen buiten of in een goed geventileerde ruimte gebruiken.
 PL Stosować wyłącznie na zewnątrz lub w dobrze wentylowanym pomieszczeniu
 PT Utilizar apenas ao ar livre ou em locais bem ventilados.
 RO A se utiliza numai în aer liber sau în spaţii bine ventilate.
 SK Používajte iba na voľnom priestranstve alebo v dobre vetranom priestore.
 SL Uporabljati le zunaj ali v dobro prezračevanem prostoru.
 FI Käytä ainoastaan ulkona tai tiloissa, joissa on hyvä ilmanvaihto.
 SV Används endast utomhus eller i väl ventilerade utrymmen.


P272 Language 
 BG Да не се изнася замърсено работно облекло извън работното помещение.
 ES Las prendas de trabajo contaminadas no podrán sacarse del lugar de trabajo.
 CS Kontaminovaný pracovní oděv neodnášejte z pracoviště.
 DA Tilsmudset arbejdstøj bør ikke fjernes fra arbejdspladsen.
 DE Kontaminierte Arbeitskleidung nicht außerhalb des Arbeitsplatzes tragen.
 ET Saastunud töörõivaid töökohast mitte välja viia.
 EL Τα μολυσμένα ενδύματα εργασίας δεν πρέπει να βγαίνουν από το χώρο εργασίας.
 EN Contaminated work clothing should not be allowed out of the workplace.
 FR Les vêtements de travail contaminés ne devraient pas sortir du lieu de travail.
 GA Níor chóir éadaí éillithe oibre a ligean amach as an láthair oibre.
 IT Gli indumenti da lavoro contaminati non devono essere portati fuori dal luogo di lavoro.
 LV Piesārņoto darba apģērbu neiznest ārpus darba telpām.
 LT Užterštų darbo drabužių negalima išnešti iš darbo vietos.
 HU Szennyezett munkaruhát tilos kivinni a munkahely területéről.
 MT Ilbies tax-xogħol kontaminat m’għandux jitħalla joħroġ mill-post tax-xogħol.
 NL Verontreinigde werkkleding mag de werkruimte niet verlaten.
 PL Zanieczyszczonej odzieży ochronnej nie wynosić poza miejsce pracy.
 PT A roupa de trabalho contaminada não pode sair do local de trabalho.
 RO Nu scoateţi îmbrăcămintea de lucru contaminată în afara locului de muncă.
 SK Je zakázané vyniesť kontaminovaný pracovný odev z pracoviska.
 SL Kontaminirana delovna oblačila niso dovoljena zunaj delovnega mesta.
 FI Saastuneita työvaatteita ei saa viedä työpaikalta.
 SV Nedstänkta arbetskläder får inte avlägsnas från arbetsplatsen.


P273 Language 
 BG Да се избягва изпускане в околната среда.
 ES Evitar su liberación al medio ambiente.
 CS Zabraňte uvolnění do životního prostředí.
 DA Undgå udledning til miljøet.
 DE Freisetzung in die Umwelt vermeiden.
 ET Vältida sattumist keskkonda.
 EL Να αποφεύγεται η ελευθέρωση στο περιβάλλον.
 EN Avoid release to the environment.
 FR Éviter le rejet dans l’environnement.
 GA Ná scaoiltear amach sa chomhshaol.
 IT Non disperdere nell’ambiente.
 LV Izvairīties no izplatīšanas apkārtējā vidē.
 LT Saugoti, kad nepatektų į aplinką.
 HU Kerülni kell az anyagnak a környezetbe való kijutását.
 MT Evita r-rilaxx fl-ambjent.
 NL Voorkom lozing in het milieu.
 PL Unikać uwolnienia do środowiska.
 PT Evitar a libertação para o ambiente.
 RO Evitaţi dispersarea în mediu.
 SK Zabráňte uvoľneniu do životného prostredia.
 SL Preprečiti sproščanje v okolje.
 FI Vältettävä päästämistä ympäristöön.
 SV Undvik utsläpp till miljön.


P280 Language 
 BG Използвайте предпазни ръкавици/предпазно облекло/предпазни очила/предпазна маска за лице.
 ES Llevar guantes/prendas/gafas/máscara de protección.
 CS Používejte ochranné rukavice/ochranný oděv/ochranné brýle/obličejový štít.
 DA Bær beskyttelseshandsker/beskyttelsestøj/øjenbeskyttelse/ansigtsbeskyttelse
 DE Schutzhandschuhe/Schutzkleidung/Augenschutz/Gesichtsschutz tragen.
 ET Kanda kaitsekindaid/kaitserõivastust/kaitseprille/kaitsemaski.
 EL Να φοράτε προστατευτικά γάντια/προστατευτικά ενδύματα/μέσα ατομικής προστασίας για τα μάτια/πρόσωπο.
 EN Wear protective gloves/protective clothing/eye protection/face protection.
 FR Porter des gants de protection/des vêtements de protection/un équipement de protection des yeux/du visage.
 GA Caith lámhainní cosanta/éadaí cosanta/cosaint súile/cosaint aghaidhe.
 IT Indossare guanti/indumenti protettivi/Proteggere gli occhi/il viso.
 LV Izmantot aizsargcimdus/aizsargdrēbes/acu aizsargus/sejas aizsargus.
 LT Mūvėti apsaugines pirštines/dėvėti apsauginius drabužius/naudoti akių (veido) apsaugos priemones.
 HU Védőkesztyű/védőruha/szemvédő/arcvédő használata kötelező.
 MT Ilbes ingwanti protettivi/ilbies protettiv/protezzjoni għall-għajnejn/protezzjoni għall-wiċċ.
 NL Beschermende handschoenen/beschermende kleding/oogbescherming/gelaatsbescherming dragen.
 PL Stosować rękawice ochronne/odzież ochronną/ochronę oczu/ochronę twarzy.
 PT Usar luvas de protecção/vestuário de protecção/protecção ocular/protecção facial.
 RO Purtaţi mănuşi de protecţie/îmbrăcăminte de protecţie/echipament de protecţie a ochilor/echipament de protecţie a feţei.
 SK Noste ochranné rukavice/ochranný odev/ochranné okuliare/ochranu tváre.
 SL Nositi zaščitne rokavice/zaščitno obleko/zaščito za oči/zaščito za obraz.
 FI Käytä suojakäsineitä/suojavaatetusta/silmiensuojainta/kasvonsuojainta.
 SV Använd skyddshandskar/skyddskläder/ögonskydd/ansiktsskydd.


P281 Language 
 BG Използвайте предписаните лични предпазни средства.
 ES Utilizar el equipo de protección individual obligatorio.
 CS Používejte požadované osobní ochranné prostředky.
 DA Anvend de påkrævede personlige værnemidler.
 DE Vorgeschriebene persönliche Schutzausrüstung verwenden.
 ET Kasutada vajalikke isikukaitsevahendeid.
 EL Χρησιμοποιείτε μέσα ατομικής προστασίας όταν απαιτείται.
 EN Use personal protective equipment as required.
 FR Utiliser l’équipement de protection individuel requis.
 GA Bain úsáid as an trealamh cosanta pearsanta faoi mar a éilítear.
 IT Utilizzare il dispositivo di protezione individuale richiesto.
 LV Izmantot personisko aizsargaprīkojumu atbilstoši prasībām.
 LT Naudoti reikalaujamas asmenines apsaugos priemones.
 HU Az előírt egyéni védőfelszerelés használata kötelező.
 MT Uża’ t-tagħmir personali protettiv kif meħtieġ.
 NL De nodige persoonlijke beschermingsuitrusting gebruiken.
 PL Stosować wymagane środki ochrony indywidualnej.
 PT Usar o equipamento de protecção individual exigido.
 RO Utilizaţi echipamentul de protecţie individuală conform cerinţelor.
 SK Používajte predpísané osobné ochranné prostriedky.
 SL Uporabiti predpisano osebno zaščitno opremo.
 FI Käytä vaadittuja henkilönsuojaimia.
 SV Använd föreskriven personlig skyddsutrustning.


P282 Language 
 BG Носете предпазващи от студ ръкавици/маска за лице/защитни очила.
 ES Llevar guantes que aíslen del frío/gafas/máscara.
 CS Používejte ochranné rukavice proti chladu/obličejový štít/ochranné brýle.
 DA Bær kuldeisolerende handsker/ansigtsskærm/øjenbeskyttelse.
 DE Schutzhandschuhe/Gesichtsschild/Augenschutz mit Kälteisolierung tragen.
 ET Kanda külmakaitsekindaid/kaitsemaski/kaitseprille.
 EL Φοράτε μονωτικά γάντια προστασίας από το ψύχος/προστατευτική μάσκα/προστατευτικά γυαλιά.
 EN Wear cold insulating gloves/face shield/eye protection.
 FR Porter des gants isolants contre le froid/un équipement de protection du visage/des yeux.
 GA Caith lámhainní inslithe fuachta/aghaidhsciath/cosaint súile.
 IT Utilizzare guanti termici/schermo facciale/Proteggere gli occhi.
 LV Izmantot aizsargcimdus/sejas aizsargus/acu aizsargus ar aukstuma izolāciju.
 LT Mūvėti nuo šalčio izoliuojančias pirštines/naudoti veido skydelį/akių apsaugos priemones.
 HU Hidegszigetelő kesztyű/arcvédő/szemvédő használata kötelező.
 MT Ilbies ingwanti kiesħa li ma jinfedx minnhom/ilqugħ għall-wiċċ/protezzjoni għall-għajnejn.
 NL Koude-isolerende handschoenen/gelaatsbescherming/oogbescherming dragen.
 PL Nosić rękawice izolujące od zimna/maski na twarz/ochronę oczu.
 PT Usar luvas de protecção contra o frio/escudo facial/protecção ocular.
 RO Purtaţi mănuşi izolante împotriva frigului/echipament de protecţie a feţei/ochilor.
 SK Používajte termostabilné rukavice/ochranný štít/ochranné okuliare.
 SL Nositi hladne izolirne rokavice/zaščito za obraz/zaščito za oči.
 FI Käytä kylmäeristäviä suojakäsineitä/kasvonsuojainta/silmiensuojainta.
 SV Använd köldisolerande handskar/visir/ögonskydd.


P283 Language 
 BG Носете огнеупорно/огнезащитно облекло.
 ES Llevar prendas ignífugas/resistentes al fuego/resistentes a las llamas.
 CS Používejte ohnivzdorný/nehořlavý oděv.
 DA Bær brandbestandig/brandhæmmende beklædning.
 DE Schwer entflammbare/flammhemmende Kleidung tragen.
 ET Kanda tule-/leegikindlat/tule levikut aeglustavat rõivastust.
 EL Φοράτε αντιπυρικά/αλεξίφλογα πυράντοχα/βραδυφλεγή ενδύματα.
 EN Wear fire/flame resistant/retardant clothing.
 FR Porter des vêtements résistant au feu/aux flammes/ignifuges.
 GA Caith éadaí dódhíonacha/lasairdhíonacha nó dómhoillitheacha/lasairmhoillitheacha.
 IT Indossare indumenti completamente ignifughi o in tessuti ritardanti di fiamma.
 LV Izmantot aizsargapģērbu pret uguni/liesmām.
 LT Dėvėti ugniai/liepsnai atsparius/antipireninius drabužius.
 HU Tűz-/lángálló/-késleltető ruházat viselése kötelező.
 MT Ilbies ħwejjeġ reżistenti għan-nar/fjammi.
 NL Vuur/vlambestendige/brandwerende kleding dragen.
 PL Nosić odzież ognioodporną/płomienioodporną/opóźniającą zapalenie.
 PT Usar vestuário ignífugo/retardador de fogo/chamas.
 RO Purtaţi îmbrăcăminte rezistentă la foc/flacără/ignifugă.
 SK Noste ohňovzdorný odev/odev so zníženou horľavosťou.
 SL Nositi negorljiva oblačila in oblačila, odporna proti ognju.
 FI Käytä palosuojattua/paloturvallista vaatetusta.
 SV Använd brand-/flamsäkra eller brand-/flamhämmande kläder.


P284 Language 
 BG Носете респираторни предпазни средства.
 ES Llevar equipo de protección respiratoria.
 CS Používejte vybavení pro ochranu dýchacích cest.
 DA Anvend åndedrætsværn.
 DE Atemschutz tragen.
 ET Kanda hingamisteede kaitsevahendeid.
 EL Φοράτε μέσα ατομικής προστασίας της αναπνοής.
 EN Wear respiratory protection.
 FR Porter un équipement de protection respiratoire.
 GA Caith cosaint riospráide.
 IT Utilizzare un apparecchio respiratorio.
 LV Izmantot gāzmasku.
 LT Naudoti kvėpavimo takų apsaugos priemones.
 HU Légzésvédelem használata kötelező.
 MT Ilbes protezzjoni respiratorja.
 NL Adembescherming dragen.
 PL Stosować indywidualne środki ochrony dróg oddechowych.
 PT Usar protecção respiratória.
 RO Purtaţi echipament de protecţie respiratorie.
 SK Používajte ochranu dýchacích ciest.
 SL Nositi opremo za zaščito dihal.
 FI Käytä hengityksensuojainta.
 SV Använd andningsskydd.


P285 Language 
 BG В случай на лоша вентилация носете респираторни предпазни средства.
 ES En caso de ventilación insuficiente, llevar equipo de protección respiratoria.
 CS V případě nedostatečného větrání používejte vybavení pro ochranu dýchacích cest.
 DA Ved utilstrækkelig udluftning anvendes åndedrætsværn.
 DE Bei unzureichender Belüfung Atemschutz tragen.
 ET Ebapiisava ventilatsiooni korral kanda hingamisteede kaitsevahendeid.
 EL Σε περίπτωση ανεπαρκούς αερισμού, να φοράτε μέσα ατομικής προστασίας της αναπνοής.
 EN In case of inadequate ventilation wear respiratory protection.
 FR Lorsque la ventilation du local est insuffisante, porter un équipement de protection respiratoire.
 GA I gcás aerála uireasaigh caith cosaint riospráide.
 IT In caso di ventilazione insufficiente utilizzare un apparecchio respiratorio.
 LV Neatbilstošas ventilācijas gadījumā izmantot gāzmasku.
 LT Esant nepakankamam vėdinimui, naudoti kvėpavimo takų apsaugos priemones.
 HU Nem megfelelő szellőzés esetén légzésvédelem kötelező.
 MT F’każ ta' ventilazzjoni inadegwata ilbes protezzjoni respiratorja.
 NL Bij ontoereikende ventilatie een geschikte adembescherming dragen.
 PL W przypadku niedostatecznej wentylacji stosować indywidualne środki ochrony dróg oddechowych.
 PT Em caso de ventilação inadequada, usar protecção respiratória.
 RO În cazul în care ventilarea este insuficientă, purtaţi echipament de protecţie respiratorie.
 SK V prípade nedostatočného vetrania, používajte ochranu dýchacích ciest.
 SL Ob nezadostnem prezračevanju nositi opremo za zaščito dihal.
 FI Käytä hengityksensuojainta, jos ilmanvaihto on riittämätön.
 SV Använd andningsskydd vid otillräcklig ventilation.


P231 + P232 Language 
 BG Да се използва под инертен газ. Да се пази от влага.
 ES Manipular en gas inerte. Proteger de la humedad.
 CS Manipulace pod inertním plynem. Chraňte před vlhkem.
 DA Anvendes under inaktiv gas. Beskyttes mod fugt.
 DE Unter inertem Gas handhaben. Vor Feuchtigkeit schützen.
 ET Käidelda inertgaasis. Hoida niiskuse eest.
 EL Χειρισμός σε αδρανή ατμόσφαιρα. Προστατέψτε από την υγρασία.
 EN Handle under inert gas. Protect from moisture.
 FR Manipuler sous gaz inerte. Protéger de l’humidité.
 GA Láimhsigh faoi thriathghás. Cosain ó thaise.
 IT Manipolare in atmosfera di gas inerte. Tenere al riparo dall’umidità.
 LV Izmantot tikai inertas gāzes apstākļos. Aizsargāt no mitruma.
 LT Tvarkyti inertinėse dujose. Saugoti nuo drėgmės.
 HU Inert gázban használandó. Nedvességtől védendő.
 MT Uża’ taħt gass inerti. Ipproteġi mill-umdità.
 NL Onder inert gas werken. Tegen vocht beschermen.
 PL Używać w atmosferze obojętnego gazu Chronić przed wilgocią.
 PT Manusear em atmosfera de gás inerte. Manter ao abrigo da humidade.
 RO A se manipula sub un gaz inert. A se proteja de umiditate.
 SK Manipulujte v prostredí s inertným plynom. Chráňte pred vlhkosťou.
 SL Hraniti v ustreznem inertnem plinu. Zaščititi pred vlago.
 FI Käsittele inertissä kaasussa. Suojaa kosteudelta.
 SV Hanteras under inert gas. Skyddas från fukt.


P235 + P410 Language 
 BG Да се държи на хладно. Да се пази от пряка слънчева светлина.
 ES Conservar en un lugar fresco. Proteger de la luz del sol.
 CS Uchovávejte v chladu. Chraňte před slunečním zářením.
 DA Opbevares køligt. Beskyttes mod sollys.
 DE Kühl halten. Vor Sonnenbestrahlung schützen.
 ET Hoida jahedas. Hoida päikesevalguse eest.
 EL Να διατηρείται δροσερό. Να προστατεύεται από τις ηλιακές ακτίνες.
 EN Keep cool. Protect from sunlight.
 FR Tenir au frais. Protéger du rayonnement solaire.
 GA Coimeád fionnuar. Cosain ó sholas na gréine.
 IT Tenere in luogo fresco. Proteggere dai raggi solari.
 LV Turēt vēsumā. Aizsargāt no saules gaismas.
 LT Laikyti vėsioje vietoje. Saugoti nuo saulės šviesos.
 HU Hűvös helyen tartandó. Napfénytől védendő.
 MT Żomm frisk. Ipproteġi mir-raġġi tax-xemx.
 NL Koel bewaren. Tegen zonlicht beschermen.
 PL Przechowywać w chłodnym miejscu. Chronić przed światłem słonecznym.
 PT Conservar em ambiente fresco. Manter ao abrigo da luz solar.
 RO A se păstra la rece. A se proteja de lumina solară.
 SK Uchovávajte v chlade. Chráňte pred slnečným žiarením.
 SL Hraniti na hladnem. Zaščititi pred sončno svetlobo.
 FI Säilytä viileässä. Suojaa auringonvalolta.
 SV Förvaras svalt. Skyddas från solljus.


P301 Language 
 BG ПРИ ПОГЛЪЩАНЕ:
 ES EN CASO DE INGESTIÓN:
 CS PŘI POŽITÍ:
 DA I TILFÆLDE AF INDTAGELSE:
 DE BEI VERSCHLUCKEN:
 ET ALLANEELAMISE KORRAL:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ:
 EN IF SWALLOWED:
 FR EN CAS D’INGESTION:
 GA MÁ SHLOGTAR:
 IT IN CASO DI INGESTIONE:
 LV NORĪŠANAS GADĪJUMĀ:
 LT PRARIJUS:
 HU LENYELÉS ESETÉN:
 MT JEKK JINBELA’:
 NL NA INSLIKKEN:
 PL W PRZYPADKU POŁKNIĘCIA:
 PT EM CASO DE INGESTÃO:
 RO ÎN CAZ DE ÎNGHIŢIRE:
 SK PO POŽITÍ:
 SL PRI ZAUŽITJU:
 FI JOS KEMIKAALIA ON NIELTY:
 SV VID FÖRTÄRING:


P302 Language 
 BG ПРИ КОНТАКТ С КОЖАТА:
 ES EN CASO DE CONTACTO CON LA PIEL:
 CS PŘI STYKU S KŮŽÍ:
 DA VED KONTAKT MED HUDEN:
 DE BEI BERÜHRUNG MIT DER HAUT:
 ET NAHALE SATTUMISE KORRAL:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ:
 EN IF ON SKIN:
 FR EN CAS DE CONTACT AVEC LA PEAU:
 GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN:
 IT IN CASO DI CONTATTO CON LA PELLE:
 LV SASKARĒ AR ĀDU:
 LT PATEKUS ANT ODOS:
 HU HA BŐRRE KERÜL:
 MT F'KAŻ TA' KUNTATT MAL-ĠILDA:
 NL BIJ CONTACT MET DE HUID:
 PL W PRZYPADKU KONTAKTU ZE SKÓRĄ:
 PT SE ENTRAR EM CONTACTO COM A PELE:
 RO ÎN CAZ DE CONTACT CU PIELEA:
 SK PRI KONTAKTE S POKOŽKOU:
 SL PRI STIKU S KOŽO:
 FI JOS KEMIKAALIA JOUTUU IHOLLE:
 SV VID HUDKONTAKT:


P303 Language 
 BG ПРИ КОНТАКТ С КОЖАТА (или косата):
 ES EN CASO DE CONTACTO CON LA PIEL (o el pelo):
 CS PŘI STYKU S KŮŽÍ (nebo s vlasy):
 DA VED KONTAKT MED HUDEN (eller håret):
 DE BEI BERÜHRUNG MIT DER HAUT (oder dem Haar):
 ET NAHALE (või juustele) SATTUMISE KORRAL:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά):
 EN IF ON SKIN (or hair):
 FR EN CAS DE CONTACT AVEC LA PEAU (ou les cheveux):
 GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN (nó le gruaig):
 IT IN CASO DI CONTATTO CON LA PELLE (o con i capelli):
 LV SASKARĒ AR ĀDU (vai matiem):
 LT PATEKUS ANT ODOS (arba plaukų):
 HU HA BŐRRE (vagy hajra) KERÜL:
 MT F'KAŻ TA' KUNTATT MAL-ĠILDA (jew ix-xagħar):
 NL BIJ CONTACT MET DE HUID (of het haar):
 PL W PRZYPADKU KONTAKTU ZE SKÓRĄ (lub z włosami):
 PT SE ENTRAR EM CONTACTO COM A PELE (ou o cabelo):
 RO ÎN CAZ DE CONTACT CU PIELEA (sau părul):
 SK PRI KONTAKTE S POKOŽKOU (alebo vlasmi):
 SL PRI STIKU S KOŽO (ali lasmi):
 FI JOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin):
 SV VID HUDKONTAKT (även håret):


P304 Language 
 BG ПРИ ВДИШВАНЕ:
 ES EN CASO DE INHALACIÓN:
 CS PŘI VDECHNUTÍ:
 DA VED INDÅNDING:
 DE BEI EINATMEN:
 ET SISSEHINGAMISE KORRAL:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ:
 EN IF INHALED:
 FR EN CAS D’INHALATION:
 GA MÁ IONANÁLAÍTEAR:
 IT IN CASO DI INALAZIONE:
 LV IEELPOJOT:
 LT ĮKVĖPUS:
 HU BELÉLEGZÉS ESETÉN:
 MT JEKK JINĠIBED MAN-NIFS:
 NL NA INADEMING:
 PL W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH:
 PT EM CASO DE INALAÇÃO:
 RO ÎN CAZ DE INHALARE:
 SK PO VDÝCHNUTÍ:
 SL PRI VDIHAVANJU:
 FI JOS KEMIKAALIA ON HENGITETTY:
 SV VID INANDNING:


P305 Language 
 BG ПРИ КОНТАКТ С ОЧИТЕ:
 ES EN CASO DE CONTACTO CON LOS OJOS:
 CS PŘI ZASAŽENÍ OČÍ:
 DA VED KONTAKT MED ØJNENE:
 DE BEI KONTAKT MIT DEN AUGEN:
 ET SILMA SATTUMISE KORRAL:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ:
 EN IF IN EYES:
 FR EN CAS DE CONTACT AVEC LES YEUX:
 GA I gCÁS TEAGMHÁLA LEIS NA SÚILE:
 IT IN CASO DI CONTATTO CON GLI OCCHI:
 LV IEKĻŪSTOT ACĪS:
 LT PATEKUS Į AKIS:
 HU SZEMBE KERÜLÉS ESETÉN:
 MT JEKK JIDĦOL FL-GĦAJNEJN:
 NL BIJ CONTACT MET DE OGEN:
 PL W PRZYPADKU DOSTANIA SIĘ DO OCZU:
 PT SE ENTRAR EM CONTACTO COM OS OLHOS:
 RO ÎN CAZ DE CONTACT CU OCHII:
 SK PO ZASIAHNUTÍ OČÍ:
 SL PRI STIKU Z OČMI:
 FI JOS KEMIKAALIA JOUTUU SILMIIN:
 SV VID KONTAKT MED ÖGONEN:


P306 Language 
 BG ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО:
 ES EN CASO DE CONTACTO CON LA ROPA:
 CS PŘI STYKU S ODĚVEM:
 DA VED KONTAKT MED TØJET:
 DE BEI KONTAMINIERTER KLEIDUNG:
 ET RÕIVASTELE SATTUMISE KORRAL:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ:
 EN IF ON CLOTHING:
 FR EN CAS DE CONTACT AVEC LES VÊTEMENTS:
 GA I gCÁS TEAGMHÁLA LE hÉADAÍ:
 IT IN CASO DI CONTATTO CON GLI INDUMENTI:
 LV SASKARĒ AR APĢĒRBU:
 LT PATEKUS ANT DRABUŽIŲ:
 HU HA RUHÁRA KERÜL:
 MT F'KAŻ TA' KUNTATT MA' L-ILBIES:
 NL NA MORSEN OP KLEDING:
 PL W PRZYPADKU KONTAKTU Z ODZIEŻĄ:
 PT SE ENTRAR EM CONTACTO COM A ROUPA:
 RO ÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA:
 SK PRI KONTAKTE S ODEVOM:
 SL PRI STIKU Z OBLAČILI:
 FI JOS KEMIKAALIA JOUTUU VAATTEISIIN:
 SV VID KONTAKT MED KLÄDERNA:


P307 Language 
 BG ПРИ експозиция:
 ES EN CASO DE exposición:
 CS PŘI expozici:
 DA VED eksponering:
 DE BEI Exposition:
 ET Kokkupuute korral:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης:
 EN IF exposed:
 FR EN CAS d’exposition:
 GA I gCÁS nochta:
 IT IN CASO di esposizione:
 LV JA saskaras:
 LT Esant sąlyčiui:
 HU Expozíció esetén:
 MT JEKK espost:
 NL NA blootstelling:
 PL W PRZYPADKU narażenia:
 PT EM CASO DE exposição:
 RO ÎN CAZ DE expunere:
 SK PO expozícii:
 SL PRI izpostavljenosti:
 FI Altistumisen tapahduttua:
 SV Om du exponerats:


P308 Language 
 BG ПРИ явна или предполагаема експозиция:
 ES EN CASO DE exposición manifiesta o presunta:
 CS PŘI expozici nebo podezření na ni:
 DA VED eksponering eller mistanke om eksponering:
 DE BEI Exposition oder falls betroffen
 ET Kokkupuute või kokkupuutekahtluse korral:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανής έκθεσης:
 EN IF exposed or concerned:
 FR EN CAS d’exposition prouvée ou suspectée:
 GA I gCÁS nochta nó má mheastar a bheith nochtaithe:
 IT IN CASO di esposizione o di possibile esposizione:
 LV Ja saskaras vai saistīts ar:
 LT Esant sąlyčiui arba jeigu numanomas sąlytis:
 HU Expozíció vagy annak gyanúja esetén:
 MT JEKK espost jew konċernat:
 NL NA (mogelijke) blootstelling:
 PL W PRZYPADKU narażenia lub styczności:
 PT EM CASO DE exposição ou suspeita de exposição:
 RO ÎN CAZ DE expunere sau de posibilă expunere:
 SK Po expozícii alebo podozrení z nej:
 SL PRI izpostavljenosti ali sumu izpostavljenosti:
 FI Altistumisen tapahduttua tai jos epäillään altistumista:
 SV Vid exponering eller misstanke om exponering:


P309 Language 
 BG ПРИ експозиция или при неразположение:
 ES EN CASO DE exposición o malestar:
 CS PŘI expozici nebo necítíte-li se dobře:
 DA VED eksponering eller ubehag:
 DE BEI Exposition oder Unwohlsein:
 ET Kokkupuute või halva enesetunde korral:
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας:
 EN IF exposed or if you feel unwell:
 FR EN CAS d’exposition ou d'un malaise:
 GA I gCÁS nochta nó má bhraitear tinn:
 IT IN CASO di esposizione o di malessere:
 LV JA saskaras vai ja jums ir slikta pašsajūta:
 LT Esant sąlyčiui arba blogai pasijutus:
 HU Expozíció vagy rosszullét esetén:
 MT JEKK espost jew tħossok ma tiflaħx:
 NL NA blootstelling of bij onwel voelen:
 PL W PRZYPADKU narażenia lub złego samopoczucia:
 PT EM CASO DE exposição ou de indisposição:
 RO ÎN CAZ DE expunere sau dacă nu vă simţiţi bine:
 SK Po expozícii alebo pri zdravotných problémoch.
 SL PRI izpostavljenosti ali slabem počutju:
 FI Altistumisen tapahduttua tai jos ilmenee pahoinvointia:
 SV Vid exponering eller obehag:


P310 Language 
 BG Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
 ES Llamar inmediatamente a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.
 CS Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
 DA Ring omgående til en GIFTINFORMATION eller en læge.
 DE Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
 ET Võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
 EL Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
 EN Immediately call a POISON CENTER or doctor/physician.
 FR Appeler immédiatement un CENTRE ANTIPOISON ou un médecin.
 GA Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.
 IT Contattare immediatamente un CENTRO ANTIVELENI o un medico.
 LV Nekavējoties sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
 LT Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
 HU Azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
 MT Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
 NL Onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.
 PL Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.
 PT Contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
 RO Sunaţi imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
 SK Okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
 SL Takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
 FI Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
 SV Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.


P311 Language 
 BG Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
 ES Llamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico.
 CS Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
 DA Ring til en GIFTINFORMATION eller en læge.
 DE GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
 ET Võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
 EL Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
 EN Call a POISON CENTER or doctor/physician.
 FR Appeler un CENTRE ANTIPOISON ou un médecin.
 GA Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
 IT Contattare un CENTRO ANTIVELENI o un medico.
 LV Sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
 LT Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
 HU Forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
 MT Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
 NL Een ANTIGIFCENTRUM of een arts raadplegen.
 PL Skontaktować się z OŚRODKIEM ZATRUĆ lub lekarzem.
 PT Contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
 RO Sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
 SK Volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
 SL Pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
 FI Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
 SV Kontakta GIFTINFORMATIONSCENTRAL eller läkare.


P312 Language 
 BG При неразположение се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
 ES Llamar a un CENTRO DE INFORMACION TOXICOLOGICA o a un médico en caso de malestar.
 CS Necítíte-li se dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
 DA I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.
 DE Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
 ET Halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
 EL Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό εάν αισθανθείτε αδιαθεσία.
 EN Call a POISON CENTER or doctor/physician if you feel unwell.
 FR Appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.
 GA Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.
 IT In caso di malessere, contattare un CENTRO ANTIVELENI o un medico.
 LV Sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.
 LT Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
 HU Rosszullét esetén forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
 MT Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.
 NL Bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.
 PL W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
 PT Caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
 RO Sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simţiţi bine.
 SK Pri zdravotných problémoch, volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
 SL Ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
 FI Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.
 SV Vid obehag, kontakta GIFTINFORMATIONSCENTRAL eller läkare.


P313 Language 
 BG Потърсете медицински съвет/помощ.
 ES Consultar a un médico.
 CS Vyhledejte lékařskou pomoc/ošetření.
 DA Søg lægehjælp.
 DE Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
 ET Pöörduda arsti poole.
 EL Συμβουλευθείτε/Επισκεφθείτε γιατρό.
 EN Get medical advice/attention.
 FR Consulter un médecin.
 GA Faigh comhairle/cúram liachta.
 IT Consultare un medico.
 LV Lūdziet palīdzību mediķiem.
 LT Kreiptis į gydytoją.
 HU Orvosi ellátást kell kérni.
 MT Ikkonsulta tabib.
 NL Een arts raadplegen.
 PL Zasięgnąć porady/zgłosić się pod opiekę lekarza.
 PT Consulte um médico.
 RO Consultaţi medicul.
 SK Vyhľadajte lekársku pomoc/starostlivosť.
 SL Poiščite zdravniško pomoč/oskrbo.
 FI Hakeudu lääkäriin.
 SV Sök läkarhjälp.


P314 Language 
 BG При неразположение потърсете медицински съвет/помощ.
 ES Consultar a un médico en caso de malestar.
 CS Necítíte-li se dobře, vyhledejte lékařskou pomoc/ošetření.
 DA Søg lægehjælp ved ubehag.
 DE Bei Unwohlsein ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
 ET Halva enesetunde korral pöörduda arsti poole.
 EL Συμβουλευθείτε/Επισκεφθείτε γιατρό εάν αισθανθείτε αδιαθεσία.
 EN Get medical advice/attention if you feel unwell.
 FR Consulter un médecin en cas de malaise.
 GA Faigh comhairle/cúram liachta má bhraitheann tú tinn.
 IT In caso di malessere, consultare un medico.
 LV Lūdziet palīdzību mediķiem, ja jums ir slikta pašsajūta.
 LT Pasijutus blogai, kreiptis į gydytoją.
 HU Rosszullét esetén orvosi ellátást kell kérni.
 MT Ikkonsulta tabib jekk tħossok ma tiflaħx.
 NL Bij onwel voelen een arts raadplegen.
 PL W przypadku złego samopoczucia zasięgnąć porady/zgłosić się pod opiekę lekarza.
 PT Em caso de indisposição, consulte um médico.
 RO Consultaţi medicul, dacă nu vă simţiţi bine.
 SK Ak pociťujete zdravotné problémy, vyhľadajte lekársku pomoc/starostlivosť.
 SL Ob slabem počutju poiščite zdravniško pomoč/oskrbo.
 FI Hakeudu lääkäriin, jos ilmenee pahoinvointia.
 SV Sök läkarhjälp vid obehag.


P315 Language 
 BG Незабавно потърсете медицински съвет/помощ.
 ES Consultar a un médico inmediatamente.
 CS Okamžitě vyhledejte lékařskou pomoc/ošetření.
 DA Søg omgående lægehjælp.
 DE Sofort ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
 ET Pöörduda viivitamata arsti poole.
 EL Συμβουλευθείτε/Επισκεφθείτε αμέσως γιατρό.
 EN Get immediate medical advice/attention.
 FR Consulter immédiatement un médecin.
 GA Faigh comhairle/cúram liachta láithreach.
 IT Consultare immediatamente un medico.
 LV Nekavējoties lūdziet palīdzību mediķiem.
 LT Nedelsiant kreiptis į gydytoją.
 HU Azonnal orvosi ellátást kell kérni.
 MT Ikkonsulta tabib minnufih.
 NL Onmiddellijk een arts raadplegen.
 PL Natychmiast zasięgnąć porady/zgłosić się pod opiekę lekarza.
 PT Consulte imediatamente um médico.
 RO Consultaţi imediat medicul.
 SK Okamžite vyhľadajte lekársku pomoc/starostlivosť.
 SL Takoj poiščite zdravniško pomoč/oskrbo.
 FI Hakeudu välittömästi lääkäriin.
 SV Sök omedelbart läkarhjälp.


P320 Language 
 BG Спешна нужда от специализирано лечение (вж… на този етикет).
 ES Se necesita urgentemente un tratamiento específico (ver … en esta etiqueta).
 CS Je nutné odborné ošetření (viz … na tomto štítku).
 DA Særlig behandling straks påkrævet (se … på denne etiket).
 DE Besondere Behandlung dringend erforderlich (siehe … auf diesem Kennzeichnungsetikett).
 ET Nõuab viivitamatut eriravi (vt … käesoleval etiketil).
 EL Χρειάζεται επειγόντως ειδική αγωγή (βλέπε … στην ετικέτα).
 EN Specific treatment is urgent (see … on this label).
 FR Un traitement spécifique est urgent (voir … sur cette étiquette).
 GA Tá sé práinneach go bhfaightear cóir leighis ar leith (féach … ar an lipéad seo).
 IT Trattamento specifico urgente (vedere… su questa etichetta).
 LV Steidzami nepieciešama īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).
 LT Būtinas skubus specialus gydymas (žr. … šioje etiketėje).
 HU Sürgős szakellátás szükséges (lásd … a címkén).
 MT Trattament speċifiku hu urġenti (ara … fuq din it-tikketta).
 NL Specifieke behandeling dringend vereist (zie … op dit etiket).
 PL Pilnie zastosować określone leczenie (patrz … na etykiecie).
 PT É urgente um tratamento específico (ver … no presente rótulo).
 RO Un tratament specific este urgent (a se vedea … de pe această etichetă).
 SK Odborné ošetrenie je naliehavé (pozri … na etikete).
 SL Posebno zdravljenje je nujno (glejte … na tej etiketi).
 FI Erityishoitoa tarvitaan välittömästi (katso … pakkauksen merkinnöissä).
 SV Särskild behandling krävs omedelbart (se … på etiketten).


P321 Language 
 BG Специализирано лечение (вж… на този етикет).
 ES Se necesita un tratamiento específico (ver … en esta etiqueta).
 CS Odborné ošetření (viz … na tomto štítku).
 DA Særlig behandling (se … på denne etiket).
 DE Besondere Behandlung (siehe … auf diesem Kennzeichnungsetikett).
 ET Nõuab eriravi (vt … käesoleval etiketil).
 EL Χρειάζεται ειδική αγωγή (βλέπε … στην ετικέτα).
 EN Specific treatment (see … on this label).
 FR Traitement spécifique (voir … sur cette étiquette).
 GA Cóir liachta ar leith (féach … ar an lipéad seo).
 IT Trattamento specifico (vedere …su questa etichetta).
 LV Īpaša medicīniskā palīdzība (skat. … uz šīs etiķetes).
 LT Specialus gydymas (žr. … šioje etiketėje).
 HU Szakellátás (lásd … a címkén).
 MT Trattament speċifiku (ara … fuq din it-tikketta).
 NL Specifieke behandeling vereist (zie … op dit etiket).
 PL Zastosować określone leczenie (patrz … na etykiecie).
 PT Tratamento específico (ver … no presente rótulo).
 RO Tratament specific (a se vedea … de pe această etichetă).
 SK Odborné ošetrenie (pozri … na etikete).
 SL Posebno zdravljenje (glejte … na tej etiketi).
 FI Erityishoitoa tarvitaan (katso … pakkauksen merkinnöissä).
 SV Särskild behandling (se … på etiketten).


P322 Language 
 BG Специални мерки (вж… на този етикет).
 ES Se necesitan medidas específicas (ver … en esta etiqueta).
 CS Specifické opatření (viz … na tomto štítku).
 DA Særlige foranstaltninger (se … på denne etiket).
 DE Gezielte Maßnahmen (siehe … auf diesem Kennzeichnungsetikett).
 ET Nõuab erimeetmeid (vt … käesoleval etiketil).
 EL Χρειάζονται ειδικά μέτρα (βλέπε … στην ετικέτα).
 EN Specific measures (see … on this label).
 FR Mesures spécifiques (voir … sur cette étiquette).
 GA Bearta ar leith (féach … ar an lipéad seo).
 IT Misure specifiche (vedere …su questa etichetta).
 LV Īpaši pasākumi (skat. … uz šīs etiķetes).
 LT Specialios priemonės (žr. … šioje etiketėje).
 HU Különleges intézkedések (lásd … a címkén).
 MT Miżuri speċifiċi (ara … fuq din it-tikketta).
 NL Specifieke maatregelen (zie … op dit etiket).
 PL Środki szczególne (patrz … na etykiecie).
 PT Medidas específicas (ver … no presente rótulo).
 RO Măsuri specifice (a se vedea … de pe această etichetă).
 SK Osobitné opatrenia (pozri … na etikete).
 SL Posebni ukrepi (glejte … na tej etiketi).
 FI Erityistoimenpiteitä tarvitaan (katso … pakkauksen merkinnöissä).
 SV Särskilda åtgärder (se … på etiketten).


P330 Language 
 BG Изплакнете устата.
 ES Enjuagarse la boca.
 CS Vypláchněte ústa.
 DA Skyl munden.
 DE Mund ausspülen.
 ET Loputada suud.
 EL Ξεπλύνετε το στόμα.
 EN Rinse mouth.
 FR Rincer la bouche.
 GA Sruthlaítear an béal.
 IT Sciacquare la bocca.
 LV Izskalot muti.
 LT Išskalauti burną.
 HU A szájat ki kell öblíteni.
 MT Laħlaħ ħalqek.
 NL De mond spoelen.
 PL Wypłukać usta.
 PT Enxaguar a boca.
 RO Clătiţi gura.
 SK Vypláchnite ústa.
 SL Izprati usta.
 FI Huuhdo suu.
 SV Skölj munnen.


P331 Language 
 BG НЕ предизвиквайте повръщане.
 ES NO provocar el vómito.
 CS NEVYVOLÁVEJTE zvracení.
 DA Fremkald IKKE opkastning.
 DE KEIN Erbrechen herbeiführen.
 ET MITTE kutsuda esile oksendamist.
 EL ΜΗΝ προκαλέσετε εμετό.
 EN Do NOT induce vomiting.
 FR NE PAS faire vomir.
 GA NÁ spreagtar urlacan.
 IT NON provocare il vomito.
 LV NEIZRAISĪT vemšanu.
 LT NESKATINTI vėmimo.
 HU TILOS hánytatni.
 MT TIPPROVOKAX ir-remettar.
 NL GEEN braken opwekken.
 PL NIE wywoływać wymiotów.
 PT NÃO provocar o vómito.
 RO NU provocaţi voma.
 SK Nevyvolávajte zvracanie.
 SL NE izzvati bruhanja.
 FI EI saa oksennuttaa.
 SV Framkalla INTE kräkning.


P332 Language 
 BG При поява на кожно дразнене:
 ES En caso de irritación cutánea:
 CS Při podráždění kůže:
 DA Ved hudirritation:
 DE Bei Hautreizung:
 ET Nahaärrituse korral:
 EL Εάν παρατηρηθεί ερεθισμός του δέρματος:
 EN If skin irritation occurs:
 FR En cas d’irritation cutanée:
 GA I gcás greannú craicinn:
 IT In caso di irritazione della pelle:
 LV Ja rodas ādas iekaisums:
 LT Jeigu sudirginama oda:
 HU Bőrirritáció esetén:
 MT Jekk ikun hemm irritazzjoni tal-ġilda:
 NL Bij huidirritatie:
 PL W przypadku wystąpienia podrażnienia skóry:
 PT Em caso de irritação cutânea:
 RO În caz de iritare a pielii:
 SK Ak sa prejaví podráždenie pokožky:
 SL Če nastopi draženje kože:
 FI Jos ilmenee ihoärsytystä:
 SV Vid hudirritation:


P333 Language 
 BG При поява на кожно дразнене или обрив на кожата:
 ES En caso de irritación o erupción cutánea:
 CS Při podráždění kůže nebo vyrážce:
 DA Ved hudirritation eller udslet:
 DE Bei Hautreizung oder -ausschlag:
 ET Nahaärrituse või _obe korral:
 EL Εάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα:
 EN If skin irritation or rash occurs:
 FR En cas d’irritation ou d’éruption cutanée:
 GA I gcás greannú nó grís craicinn:
 IT In caso di irritazione o eruzione della pelle:
 LV Ja rodas ādas iekaisums vai izsitumi:
 LT Jeigu sudirginama oda arba ją išberia.
 HU Bőrirritáció vagy kiütések megjelenése esetén:
 MT Jekk ikun hemm irritazzjoni jew raxx tal-ġilda:
 NL Bij huidirritatie of uitslag:
 PL W przypadku wystąpienia podrażnienia skóry lub wysypki:
 PT Em caso de irritação ou erupção cutânea:
 RO În caz de iritare a pielii sau de erupţie cutanată:
 SK Ak sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky:
 SL Če nastopi draženje kože ali se pojavi izpuščaj:
 FI Jos ilmenee ihoärsytystä tai ihottumaa:
 SV Vid hudirritation eller utslag:


P334 Language 
 BG Потопете в хладка вода/сложете мокри компреси.
 ES Sumergir en agua fresca/aplicar compresas húmedas.
 CS Ponořte do studené vody/zabalte do vlhkého obvazu.
 DA Skyl under koldt vand/anvend våde omslag.
 DE In kaltes Wasser tauchen/nassen Verband anlegen.
 ET Hoida jahedas vees/panna peale niiske kompress.
 EL Βυθίστε σε δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
 EN Immerse in cool water/wrap in wet bandages.
 FR Rincer à l’eau fraîche/poser une compresse humide.
 GA Tum in uisce fionnuar/cuir bréid fliuch air.
 IT Immergere in acqua fredda/avvolgere con un bendaggio umido.
 LV Iegremdēt vēsā ūdenī/ietīt mitros apsējos.
 LT Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
 HU Hideg vízzel/nedves kötéssel kell hűteni.
 MT Daħħal fl-ilma kiesaħ/kebbeb f’faxex imxarrbin.
 NL In koud water onderdompelen/nat verband aanbrengen.
 PL Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.
 PT Mergulhar em água fria/aplicar compressas húmidas.
 RO Introduceţi în apă rece/acoperiţi cu o compresă umedă.
 SK Ponorte do studenej vody/obviažte mokrými obväzmi.
 SL Potopiti v hladno vodo/zaviti v mokre povoje.
 FI Upota kylmään veteen/kääri märkiin siteisiin.
 SV Skölj under kallt vatten/använd våta omslag.


P335 Language 
 BG Отстранете от кожата посипаните частици.
 ES Sacudir las partículas que se hayan depositado en la piel.
 CS Volné částice odstraňte z kůže.
 DA Børst løse partikler bort fra huden.
 DE Lose Partikel von der Haut abbürsten.
 ET Pühkida lahtised osakesed nahalt maha.
 EL Αφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα.
 EN Brush off loose particles from skin.
 FR Enlever avec précaution les particules déposées sur la peau.
 GA Glan cáithníní scaoilte den chraiceann.
 IT Rimuovere le particelle depositate sulla pelle.
 LV Noberzt no ādas nepiestiprinātās daļiņas.
 LT Neprilipusias daleles nuvalyti nuo odos.
 HU A bőrre lazán tapadó szemcséket óvatosan le kell kefélni.
 MT Farfar il-frak mhux imwaħħla minn fuq il-ġilda.
 NL Losse deeltjes van de huid afvegen.
 PL Nie związaną pozostałość strzepnąć ze skóry.
 PT Sacudir da pele as partículas soltas.
 RO Îndepărtaţi particulele depuse pe piele.
 SK Z pokožky oprášte sypké čiastočky.
 SL S krtačo odstraniti razsute delce s kože.
 FI Poista irtohiukkaset iholta.
 SV Borsta bort lösa partiklar från huden.


P336 Language 
 BG Размразете замръзналите части в хладка вода. Не разтривайте засегнатото място.
 ES Descongelar las partes heladas con agua tibia. No frotar la zona afectada.
 CS Omrzlá místa ošetřete vlažnou vodou. Postižené místo netřete.
 DA Forsigtig opvarmning af frostskadede legemsdele i lunkent vand. Gnid ikke det angrebne område.
 DE Vereiste Bereiche mit lauwarmem Wasser auftauen. Betroffenen Bereich nicht reiben.
 ET Sulatada külmunud piirkonnad leige veega. Kannatada saanud piirkonda mitte hõõruda.
 EL Ξεπαγώστε τα παγωμένα μέρη με χλιαρό νερό. Μην τρίβετε την περιοχή που πάγωσε.
 EN Thaw frosted parts with lukewarm water. Do no rub affected area.
 FR Dégeler les parties gelées avec de l’eau tiède. Ne pas frotter les zones touchées.
 GA Leáigh codanna sioctha le huisce alabhog. Ná cuimil an réimse lena mbaineann.
 IT Sgelare le parti congelate usando acqua tiepida. Non sfregare la parte interessata.
 LV Atkausēt sasalušās daļas ar remdenu ūdeni. Skarto zonu neberzt.
 LT Prišalusias daleles atitirpinti drungnu vandeniu. Netrinti paveiktos zonos.
 HU A fagyott részeket langyos vízzel fel kell melegíteni. Tilos az érintett terület dörzsölése.
 MT Ħoll il-partijiet kiesħa bl-ilma fietel. Togħrokx il-parti affettwata.
 NL Bevroren lichaamsdelen met lauw water ontdooien. Niet wrijven op de betrokken plaatsen.
 PL Rozmrozić oszronione obszary letnią wodą. Nie trzeć oszronionego obszaru.
 PT Derreter as zonas congeladas com água morna. Não friccionar a zona afectada.
 RO Dezgheţaţi părţile degerate cu apă călduţă. Nu frecaţi zona afectată.
 SK Zmrznuté časti ošetrite vlažnou vodou. Postihnuté miesto netrite.
 SL Zamrznjene dele odtaliti z mlačno vodo. Ne drgniti prizadetega mesta.
 FI Sulata jäätyneet alueet haalealla vedellä. Vahingoittunutta aluetta ei saa hangata.
 SV Värm det köldskadade området med ljummet vatten. Gnid inte det skadade området.


P337 Language 
 BG При продължително дразнене на очите:
 ES Si persiste la irritación ocular:
 CS Přetrvává-li podráždění očí:
 DA Ved vedvarende øjenirritation:
 DE Bei anhaltender Augenreizung:
 ET Kui silmade ärritus ei möödu:
 EL Εάν δεν υποχωρεί ο οφθαλμικός ερεθισμός:
 EN If eye irritation persists:
 FR Si l’irritation oculaire persiste:
 GA Má mhaireann an greannú súile:
 IT Se l’irritazione degli occhi persiste:
 LV Ja acu iekaisums nepāriet:
 LT Jei akių dirginimas nepraeina:
 HU Ha a szemirritáció nem múlik el:
 MT Jekk l-irritazzjoni ta' l-għajnejn tibqa’:
 NL Bij aanhoudende oogirritatie:
 PL W przypadku utrzymywania się działania drażniącego na oczy:
 PT Caso a irritação ocular persista:
 RO Dacă iritarea ochilor persistă:
 SK Ak podráždenie očí pretrváva:
 SL Če draženje oči ne preneha:
 FI Jos silmä-ärsytys jatkuu:
 SV Vid bestående ögonirritation:


P338 Language 
 BG Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължете с изплакването.
 ES Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.
 CS Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.
 DA Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.
 DE Eventuell Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter ausspülen.
 ET Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.
 EL Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.
 EN Remove contact lenses, if present and easy to do. Continue rinsing.
 FR Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.
 GA Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta é sin a dhéanamh. Lean den sruthlú.
 IT Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.
 LV Izņemiet kontaktlēcas, ja tās ir ievietotas un to ir viegli izdarīt. Turpiniet skalot.
 LT Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.
 HU Adott esetben kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.
 MT Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.
 NL Contactlenzen verwijderen, indien mogelijk. Blijven spoelen.
 PL Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.
 PT Se usar lentes de contacto, retire-as, se tal lhe for possível. Continue a enxaguar.
 RO Scoateţi lentilele de contact, dacă este cazul şi dacă acest lucru se poate face cu uşurinţă. Continuaţi să clătiţi.
 SK Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.
 SL Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.
 FI Poista piilolinssit, jos sen voi tehdä helposti. Jatka huuhtomista.
 SV Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.


P340 Language 
 BG Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
 ES Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
 CS Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
 DA Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
 DE Die betroffene Person an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
 ET Toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
 EL Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
 EN Remove victim to fresh air and keep at rest in a position comfortable for breathing.
 FR Transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
 GA Tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
 IT Trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
 LV Izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
 LT Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
 HU Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
 MT Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
 NL Het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
 PL Wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
 PT Retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
 RO Transportaţi victima la aer liber şi menţineţi-o în stare de repaus într-o poziţie confortabilă pentru respiraţie.
 SK Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
 SL Prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
 FI Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
 SV Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen


P341 Language 
 BG При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
 ES Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
 CS Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
 DA Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
 DE Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
 ET Hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
 EL Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
 EN If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
 FR S'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
 GA Más deacair don duine análú, tabhair amach faoin aer é agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
 IT Se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
 LV Ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
 LT Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
 HU Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
 MT Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista' tieħu n-nifs.
 NL Bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
 PL W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
 PT Em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
 RO Dacă respiraţia este dificilă, transportaţi victima la aer liber şi menţineţi-o în stare de repaus într-o poziţie confortabilă pentru respiraţie.
 SK Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
 SL Pri oteženem dihanju prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
 FI Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
 SV Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.


P342 Language 
 BG При симптоми на затруднено дишане:
 ES En caso de síntomas respiratorios:
 CS Při dýchacích potížích:
 DA Ved luftvejssymptomer:
 DE Bei Symptomen der Atemwege:
 ET Hingamisteede probleemide ilmnemise korral:
 EL Εάν παρουσιάζονται αναπνευστικά συμπτώματα:
 EN If experiencing respiratory symptoms:
 FR En cas de symptômes respiratoires:
 GA I gcás siomptóm riospráide:
 IT In caso di sintomi respiratori:
 LV Ja rodas elpošanas traucējumu simptomi:
 LT Jeigu pasireiškia respiraciniai simptomai:
 HU Légzési problémák esetén:
 MT Jekk tkun qed tbati minn sintomi respiratorji:
 NL Bij ademhalingssymptomen:
 PL W przypadku wystąpienia objawów ze strony układu oddechowego:
 PT Em caso de sintomas respiratórios:
 RO În caz de simptome respiratorii:
 SK Pri sťaženom dýchaní:
 SL Pri respiratornih simptomih:
 FI Jos ilmenee hengitysoireita:
 SV Vid besvär i luftvägarna:


P350 Language 
 BG Измийте внимателно и обилно със сапун и вода.
 ES Lavar suavemente con agua y jabón abundantes.
 CS Jemně omyjte velkým množstvím vody a mýdla.
 DA Vask forsigtigt med rigeligt sæbe og vand.
 DE Behutsam mit viel Wasser und Seife waschen.
 ET Pesta õrnalt rohke vee ja seebiga.
 EL Πλύνετε απαλά με άφθονο νερό και σαπούνι.
 EN Gently wash with plenty of soap and water.
 FR Laver avec précaution et abondamment à l’eau et au savon.
 GA Nigh go bog le neart gallúnaí agus uisce.
 IT Lavare delicatamente e abbondantemente con acqua e sapone.
 LV Maigi izskalot ar lielu daudzumu ziepēm un ūdeni.
 LT Atsargiai nuplauti dideliu kiekiu muilo ir vandens.
 HU Óvatos lemosás bő szappanos vízzel.
 MT Aħsel bil-mod b’ħafna sapun u ilma.
 NL Voorzichtig wassen met veel water en zeep.
 PL Delikatnie umyć dużą ilością wody z mydłem.
 PT Lavar suavemente com sabonete e água abundantes.
 RO Spălaţi uşor cu multă apă și săpun.
 SK Opatrne umyte veľkým množstvom vody a mydla.
 SL Nežno umiti z veliko mila in vode.
 FI Pese varovasti runsaalla vedellä ja saippualla.
 SV Tvätta försiktigt med mycket tvål och vatten.


P351 Language 
 BG Промивайте внимателно с вода в продължение на няколко минути.
 ES Aclarar cuidadosamente con agua durante varios minutos.
 CS Několik minut opatrně oplachujte vodou.
 DA Skyl forsigtigt med vand i flere minutter.
 DE Einige Minuten lang behutsam mit Wasser ausspülen.
 ET Loputada mitme minuti jooksul ettevaatlikult veega.
 EL Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά.
 EN Rinse cautiously with water for several minutes.
 FR Rincer avec précaution à l’eau pendant plusieurs minutes.
 GA Sruthlaítear go faichilleach le huisce ar feadh roinnt nóiméad.
 IT Sciacquare accuratamente per parecchi minuti.
 LV Uzmanīgi skalot ar ūdeni vairākas minūtes.
 LT Atsargiai plauti vandeniu kelias minutes.
 HU Óvatos öblítés vízzel több percen keresztül.
 MT Laħlaħ b'attenzjoni bl-ilma għal diversi minuti.
 NL Voorzichtig afspoelen met water gedurende een aantal minuten.
 PL Ostrożnie płukać wodą przez kilka minut.
 PT Enxaguar cuidadosamente com água durante vários minutos.
 RO Clătiţi cu atenţie cu apă, timp de mai multe minute.
 SK Opatrne niekoľko minút oplachujte vodou.
 SL Previdno izpirati z vodo nekaj minut.
 FI Huuhdo huolellisesti vedellä usean minuutin ajan.
 SV Skölj försiktigt med vatten i flera minuter.


P352 Language 
 BG Измийте обилно със сапун и вода.
 ES Lavar con agua y jabón abundantes.
 CS Omyjte velkým množstvím vody a mýdla.
 DA Vask med rigeligt sæbe og vand.
 DE Mit viel Wasser und Seife waschen.
 ET Pesta rohke vee ja seebiga.
 EL Πλύνετε με άφθονο σαπούνι και νερό.
 EN Wash with plenty of soap and water.
 FR Laver abondamment à l’eau et au savon.
 GA Nigh le neart gallúnaí agus uisce.
 IT Lavare abbondantemente con acqua e sapone.
 LV Mazgāt ar lielu daudzmu ziepēm un ūdeni.
 LT Plauti dideliu kiekiu muilo ir vandens.
 HU Lemosás bő szappanos vízzel.
 MT Aħsel b’ħafna sapun u ilma.
 NL Met veel water en zeep wassen.
 PL Umyć dużą ilością wody z mydłem.
 PT Lavar com sabonete e água abundantes.
 RO Spălaţi cu multă apă și săpun.
 SK Umyte veľkým množstvom vody a mydla.
 SL Umiti z veliko mila in vode.
 FI Pese runsaalla vedellä ja saippualla.
 SV Tvätta med mycket tvål och vatten.


P353 Language 
 BG Облейте кожата с вода/вземете душ.
 ES Aclararse la piel con agua/ducharse.
 CS Opláchněte kůži vodou/osprchujte.
 DA Skyl/brus huden med vand.
 DE Haut mit Wasser abwaschen/duschen.
 ET Loputada nahka veega/loputada duši all.
 EL Ξεπλύνετε την επιδερμίδα με νερό/στο ντους.
 EN Rinse skin with water/shower.
 FR Rincer la peau à l’eau/se doucher.
 GA Sruthlaítear an craiceann le huisce/glac cithfholcadh.
 IT Sciacquare la pelle/fare una doccia.
 LV Noskalot ādu ar ūdeni/dušā.
 LT Odą nuplauti vandeniu/čiurkšle.
 HU A bőrt le kell öblíteni vízzel/zuhanyozás.
 MT Laħlaħ il-ġilda bl-ilma/bix-xawer.
 NL Huid met water afspoelen/afdouchen.
 PL Spłukać skórę pod strumieniem wody/prysznicem.
 PT Enxaguar a pele com água/tomar um duche.
 RO Clătiţi pielea cu apă/faceţi duş.
 SK Pokožku opláchnite vodou/sprchou.
 SL Kožo izprati z vodo/prho.
 FI Huuhdo/suihkuta iho vedellä.
 SV Skölj huden med vatten/duscha.


P360 Language 
 BG Незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.
 ES Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.
 CS Kontaminovaný oděv a kůži okamžitě omyjte velkým množstvím vody a potom oděv odložte.
 DA Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.
 DE Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.
 ET Saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.
 EL Ξεπλύνετε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.
 EN Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
 FR Rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.
 GA Sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula mbaineann an duine na héadaí de.
 IT Sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.
 LV Nekavējoties noskalot piesārņoto apģērbu un skarto ādu ar lielu daudzumu ūdens pirms apģērba novilkšanas.
 LT Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.
 HU A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.
 MT Laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.
 NL Verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.
 PL Natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.
 PT Enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.
 RO Clătiţi imediat îmbrăcămintea contaminată şi pielea cu multă apă, înainte de scoaterea îmbrăcămintei.
 SK Kontaminovaný odev a pokožku ihneď opláchnite veľkým množstvom vody a potom odev odstráňte.
 SL Takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.
 FI Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.
 SV Skölj genast nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.


P361 Language 
 BG Незабавно свалете цялото замърсено облекло.
 ES Quitarse inmediatamente las prendas contaminadas.
 CS Veškeré kontaminované části oděvu okamžitě svlékněte.
 DA Tilsmudset tøj tages straks af/fjernes.
 DE Alle kontaminierten Kleidungsstücke sofort ausziehen.
 ET Kõik saastunud rõivad viivitamata seljast võtta.
 EL Αφαιρέστε/Βγάλτε αμέσως όλα τα μολυσμένα ρούχα.
 EN Remove/Take off immediately all contaminated clothing.
 FR Enlever immédiatement les vêtements contaminés.
 GA Bain díot láithreach na héadaí éillithe go léir.
 IT Togliersi di dosso immediatamente tutti gli indumenti contaminati.
 LV Noņemt/Novilkt nekavējoties visu piesārņoto apģērbu.
 LT Nedelsiant nuvilkti/pašalinti visus užterštus drabužius.
 HU Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni.
 MT Neħħi/Inża’ mall-ewwel l-ilbies ikkontaminat.
 NL Verontreinigde kleding onmiddellijk uittrekken.
 PL Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież.
 PT Despir/retirar imediatamente toda a roupa contaminada.
 RO Scoateţi imediat toată îmbrăcămintea contaminată.
 SK Ihneď odstráňte/vyzlečte všetky kontaminované časti odevu.
 SL Takoj odstraniti/sleči vsa kontaminirana oblačila.
 FI Riisu saastunut vaatetus välittömästi.
 SV Ta omedelbart av alla nedstänkta kläder.


P362 Language 
 BG Свалете замърсеното облекло и го изперете преди повторна употреба.
 ES Quitarse las prendas contaminadas y lavarlas antes de volver a usarlas.
 CS Kontaminovaný oděv svlékněte a před opětovným použitím ho vyperte.
 DA Forurenet tøj tages af og vaskes, før det bruges igen.
 DE Kontaminierte Kleidung ausziehen und vor erneutem Tragen waschen.
 ET Võtta saastunud rõivad seljast ja pesta neid enne järgmist kasutamist.
 EL Βγάλτε τα μολυσμένα ρούχα και πλύνετέ τα πριν τα ξαναχρησιμοποιήσετε.
 EN Take off contaminated clothing and wash before reuse.
 FR Enlever les vêtements contaminés et les laver avant réutilisation
 GA Bain díot láithreach na héadaí éillithe go léir agus nigh iad sula ndéanfar iad a athúsáid.
 IT Togliersi di dosso gli indumenti contaminati e lavarli prima di indossarli nuovamente.
 LV Novilkt piesārņoto apģērbu un pirms atkārtotas lietošanas izmazgāt.
 LT Nusivilkti užterštus drabužius ir išskalbti prieš vėl juos apsivelkant.
 HU A szennyezett ruhát le kell vetni és az újbóli használat előtt ki kell mosni.
 MT Inża' l-ħwejjeġ kontaminati u aħsilhom qabel ma terġa' tużahom.
 NL Verontreinigde kleding uittrekken en wassen alvorens deze opnieuw te gebruiken.
 PL Zanieczyszczoną odzież zdjąć i wyprać przed ponownym użyciem.
 PT Retirar a roupa contaminada e lavá-la antes de a voltar a usar.
 RO Scoateţi îmbrăcămintea contaminată şi spălaţi-o înainte de reutilizare.
 SK Kontaminovaný odev vyzlečte a pred ďalším použitím vyperte.
 SL Sleči kontaminirana oblačila in jih oprati pred ponovno uporabo.
 FI Riisu ja pese saastunut vaatetus ennen uudelleenkäyttöä.
 SV Nedstänkta kläder tas av och tvättas innan de används igen.


P363 Language 
 BG Изперете замърсеното облекло преди повторна употреба.
 ES Lavar las prendas contaminadas antes de volver a usarlas.
 CS Kontaminovaný oděv před opětovným použitím vyperte.
 DA Tilsmudset tøj skal vaskes, før det kan anvendes igen.
 DE Kontaminierte Kleidung vor erneutem Tragen waschen.
 ET Saastunud rõivad enne järgmist kasutamist pesta.
 EL Πλύνετε τα μολυσμένα ενδύματα πριν τα ξαναχρησιμοποιήσετε.
 EN Wash contaminated clothing before reuse.
 FR Laver les vêtements contaminés avant réutilisation.
 GA Nigh éadaí éillithe sula ndéanfar iad a athúsáid.
 IT Lavare gli indumenti contaminati prima di indossarli nuovamente.
 LV Pirms atkārtotas lietošanas piesārņoto apģērbu izmazgāt.
 LT Užterštus drabužius išskalbti prieš vėl juos apsivelkant.
 HU A szennyezett ruhát újbóli használat előtt ki kell mosni.
 MT Aħsel il-ħwejjeġ kontaminati qabel terġa’ tużahom.
 NL Verontreinigde kleding wassen alvorens deze opnieuw te gebruiken.
 PL Wyprać zanieczyszczoną odzież przed ponownym użyciem.
 PT Lavar a roupa contaminada antes de a voltar a usar.
 RO Spălaţi îmbracămintea contaminată, înainte de reutilizare.
 SK Kontaminovaný odev pred ďalším použitím vyperte.
 SL Kontaminirana oblačila oprati pred ponovno uporabo.
 FI Pese saastunut vaatetus ennen uudelleenkäyttöä.
 SV Nedstänkta kläder ska tvättas innan de används igen.


P370 Language 
 BG При пожар:
 ES En caso de incendio:
 CS V případě požáru:
 DA Ved brand:
 DE Bei Brand:
 ET Tulekahju korral:
 EL Σε περίπτωση πυρκαγιάς:
 EN In case of fire:
 FR En cas d’incendie:
 GA I gcás dóiteáin:
 IT In caso di incendio:
 LV Ugunsgrēka gadījumā:
 LT Gaisro atveju:
 HU Tűz esetén:
 MT F’każ ta' nar:
 NL In geval van brand:
 PL W przypadku pożaru:
 PT Em caso de incêndio:
 RO În caz de incendiu:
 SK V prípade požiaru:
 SL Ob požaru:
 FI Tulipalon sattuessa:
 SV Vid brand:


P371 Language 
 BG При голям пожар и значителни количества:
 ES En caso de incendio importante y en grandes cantidades:
 CS V případě velkého požáru a velkého množství:
 DA Ved større brand og store mængder:
 DE Bei Großbrand und großen Mengen:
 ET Suure tulekahju korral ning kui on tegemist suurte kogustega:
 EL Σε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες:
 EN In case of major fire and large quantities:
 FR En cas d’incendie important et s’il s’agit de grandes quantités:
 GA I gcás mórdhóiteáin agus má tá cainníochtaí móra i gceist:
 IT In caso di incendio grave e di quantità rilevanti:
 LV Ugunsgrēka un lielu apjomu gadījumā:
 LT Didelio gaisro ir didelių kiekių atveju:
 HU Nagyobb tűz és nagy mennyiség esetén:
 MT F’każ ta' nar kbir u kwantitajiet kbar:
 NL In geval van grote brand en grote hoeveelheden:
 PL W przypadku poważnego pożaru i dużych ilości:
 PT Em caso de incêndio importante e de grandes quantidades:
 RO În caz de incendiu de proporţii şi de cantităţi mari de produs:
 SK V prípade veľkého požiaru a veľkého množstva:
 SL Ob velikem požaru in velikih količinah:
 FI Jos tulipalo ja ainemäärät ovat suuret:
 SV Vid större brand och stora mängder:


P372 Language 
 BG Опасност от експлозия при пожар.
 ES Riesgo de explosión en caso de incendio.
 CS Nebezpečí výbuchu v případě požáru.
 DA Eksplosionsfare ved brand.
 DE Explosionsgefahr bei Brand.
 ET Tulekahju korral plahvatusoht.
 EL Κίνδυνος έκρηξης σε περίπτωση πυρκαγιάς.
 EN Explosion risk in case of fire.
 FR Risque d’explosion en cas d’incendie.
 GA Baol pléasctha i gcás dóiteáin.
 IT Rischio di esplosione in caso di incendio.
 LV Eksplozijas risks ugunsgrēka gadījumā:
 LT Sprogimo pavojus gaisro atveju.
 HU Tűz esetén robbanásveszély.
 MT Riskju ta' splużjoni f’każ ta' nar.
 NL Ontploffingsgevaar in geval van brand.
 PL Ryzyko wybuchu w razie pożaru.
 PT Risco de explosão em caso de incêndio.
 RO Risc de explozie în caz de incendiu.
 SK V prípade požiaru hrozí riziko výbuchu.
 SL Nevarnost eksplozije ob požaru.
 FI Tulipalon sattuessa räjähdysvaara.
 SV Explosionsrisk vid brand.


P373 Language 
 BG НЕ се опитвайте да гасите пожара, ако огънят наближи експлозиви.
 ES NO luchar contra el incendio cuando el fuego llega a los explosivos.
 CS Požár NEHASTE, dostane-li se k výbušninám.
 DA BEKÆMP IKKE branden, hvis denne når eksplosiverne.
 DE KEINE Brandbekämpfung, wenn das Feuer explosive Stoffe/Gemische/Erzeugnisse erreicht.
 ET Kui tuli jõuab lõhkeaineteni, MITTE teha kustutustöid.
 EL ΜΗΝ προσπαθείτε να σβήσετε την πυρκαγιά, όταν η φωτιά πλησιάζει σε εκρηκτικά.
 EN DO NOT fight fire when fire reaches explosives.
 FR NE PAS combattre l’incendie lorsque le feu atteint les explosifs.
 GA NÁ DÉAN an dóiteán a chomhrac má shroicheann sé pléascáin.
 IT NON utilizzare mezzi estinguenti se l’incendio raggiunge materiali esplosivi.
 LV NECENSTIES dzēst ugunsgrēku, ja uguns piekļūst sprādzienbīstamām vielām.
 LT NEGESINTI gaisro, jeigu ugnis pasiekia sprogmenis.
 HU TILOS a tűz oltása, ha az robbanóanyagra átterjedt.
 MT TIPPRUVAX TITFI n-nar meta n-nar jilħaq l-isplussivi.
 NL NIET blussen wanneer het vuur de ontplofbare stoffen bereikt.
 PL NIE gasić pożaru, jeżeli ogień dosięgnie materiały wybuchowe
 PT Se o fogo atingir os explosivos, NÃO tentar combatê-lo.
 RO NU încercaţi să stingeţi incendiul atunci când focul a ajuns la explozivi.
 SK Požiar NEHASTE, ak sa oheň priblížil k výbušninám.
 SL NE gasiti, ko ogenj doseže eksploziv.
 FI Tulta EI SAA yrittää sammuttaa sen saavutettua räjähteet.
 SV Försök INTE bekämpa branden när den når explosiva varor.


P374 Language 
 BG Гасете пожара с обичайните предпазни мерки от разумно разстояние.
 ES Luchar contra el incendio desde una distancia razonable, tomando las precauciones habituales.
 CS Haste z přiměřené vzdálenosti a dodržujte běžná opatření.
 DA Træf normale foranstaltninger mod brand og bekæmp den på en fornuftig afstand.
 DE Brandbekämpfung mit üblichen Vorsichtsmaßnahmen aus angemessener Entfernung.
 ET Kustutustöid teha tavaliste ettevaatusabinõudega ja mõistlikust kaugusest.
 EL Προσπαθήστε να σβήσετε την πυρκαγιά λαμβάνοντας τις κατάλληλες προφυλάξεις και από εύλογη απόσταση.
 EN Fight fire with normal precautions from a reasonable distance.
 FR Combattre l’incendie à distance en prenant les précautions normales.
 GA Déan na gnáth-réamhchúraimí chun an dóiteán a chomhrac gan a bheith níos gaire dó ná mar atá réasúnta.
 IT Utilizzare i mezzi estinguenti con le precauzioni abituali a distanza ragionevole.
 LV Dzēst ugunsgrēku, ņemot vērā parastos drošības nosacījumus un no saprātīga attāluma.
 LT Gaisrą gesinti laikantis įprastinio atsargumo pakankamu atstumu.
 HU Tűzoltás megfelelő távolságból a szokásos óvintézkedések betartásával.
 MT Itfi n-nar bil-prekawzjonijiet normali minn distanza raġonevoli.
 NL Met normale voorzorgen vanaf een redelijke afstand blussen.
 PL Gasić pożar z rozsądnej odległości z zachowaniem zwykłych środków ostrożności.
 PT Combater o incêndio tomando as precauções normais e a partir de uma distância razoável.
 RO Stingeţi incendiul de la o distanţă rezonabilă, luând măsuri normale de precauţie.
 SK Požiar haste z primeranej vzdialenosti pri dodržiavaní bežných bezpečnostných opatrení.
 SL Gasiti z običajno previdnostjo in s primerne razdalje.
 FI Sammuta palo kohtuullisen välimatkan päästä tavanomaisin varotoimin.
 SV Bekämpa branden på vanligt sätt på behörigt avstånd.


P375 Language 
 BG Гасете пожара от разстояние поради опасност от експлозия.
 ES Luchar contra el incendio a distancia, dado el riesgo de explosión.
 CS Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
 DA Bekæmp branden på afstand på grund af eksplosionsfare.
 DE Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
 ET Plahvatusohu tõttu teha kustutustöid eemalt.
 EL Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
 EN Fight fire remotely due to the risk of explosion.
 FR Combattre l’incendie à distance à cause du risque d’explosion.
 GA Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
 IT Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
 LV Dzēst ugunsgrēku no attāluma eksplozijas riska dēļ.
 LT Gaisrą gesinti iš toli dėl sprogimo pavojaus.
 HU A tűz oltását robbanásveszély miatt távolból kell végezni.
 MT Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
 NL Op afstand blussen omwille van ontploffingsgevaar.
 PL Z powodu ryzyka wybuchu gasić pożar z odległości.
 PT Combater o incêndio à distância, devido ao risco de explosão.
 RO Stingeţi incendiul de la distanţă din cauza pericolului de explozie.
 SK Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
 SL Gasiti z večje razdalje zaradi nevarnosti eksplozije.
 FI Sammuta palo etäältä räjähdysvaaran takia.
 SV Bekämpa branden på avstånd på grund av explosionsrisken.


P376 Language 
 BG Спрете теча, ако е безопасно.
 ES Detener la fuga, si no hay peligro en hacerlo.
 CS Zastavte únik, můžete-li tak učinit bez rizika.
 DA Stands lækagen, hvis dette er sikkert.
 DE Undichtigkeit beseitigen, wenn gefahrlos möglich.
 ET Leke peatada, kui seda on võimalik teha ohutult.
 EL Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.
 EN Stop leak if safe to do so.
 FR Obturer la fuite si cela peut se faire sans danger.
 GA Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.
 IT Bloccare la perdita se non c’è pericolo.
 LV Apstādināt noplūdi, ja to var izdarīt drošā veidā.
 LT Sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.
 HU Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.
 MT Waqqaf it-tnixxija jekk ma jkunx hemm periklu.
 NL Het lek dichten als dat veilig gedaan kan worden.
 PL Jeżeli jest to bezpieczne zahamować wyciek.
 PT Deter a fuga se tal puder ser feito em segurança.
 RO Opriţi scurgerea, dacă acest lucru se poate face în siguranţă.
 SK Zastavte únik, ak je to bezpečné.
 SL Zaustaviti puščanje, če je varno.
 FI Sulje vuoto, jos sen voi tehdä turvallisesti.
 SV Stoppa läckan om det kan göras på ett säkert sätt.


P377 Language 
 BG Пожар от изтекъл газ:Не гасете освен при възможност за безопасно отстраняване на теча.
 ES Fuga de gas en llamas:No apagar, salvo si la fuga puede detenerse sin peligro.
 CS Požár unikajícího plynu:Nehaste, nelze-li únik bezpečně zastavit.
 DA Brand fra udsivende gas:Sluk ikke, medmindre det er sikkert at stoppe lækagen.
 DE Brand von ausströmendem Gas:Nicht löschen, bis Undichtigkeit gefahrlos beseitigt werden kann.
 ET Lekkiva gaasi põlemise korral mitte kustutada, välja arvatud juhul, kui leket on võimalik ohutult peatada.
 EL Διαρροή φλεγόμενου αερίου:Μην την σβήσετε, εκτός εάν μπορείτε να σταματήσετε τη διαρροή χωρίς κίνδυνο.
 EN Leaking gas fire:Do not extinguish, unless leak can be stopped safely.
 FR Fuite de gaz enflammé:Ne pas éteindre si la fuite ne peut pas être arrêtée sans danger.
 GA Tine gháis ag sceitheadh:Ná múch, mura i ndán agus gur féidir stop a chur leis an sceitheadh go sábháilte.
 IT In caso d’incendio dovuto a perdita di gas, non estinguere a meno che non sia possibile bloccare la perdita senza pericolo.
 LV Degšanas gāzes noplūde:Nedzēst, ja vien noplūdi var apstādināt drošā veidā.
 LT Dujų nuotėkio sukeltas gaisras:Negesinti, nebent nuotėkį būtų galima saugiai sustabdyti.
 HU Égő szivárgó gáz:Csak akkor szabad a tüzet oltani, ha a szivárgás biztonságosan megszüntethető.
 MT Tnixxija ta' gass tan-nar:Tippruvax titfiha, sakemm it-tnixxija ma tkunx tista' titwaqqaf bla periklu.
 NL Brand door lekkend gas:niet blussen, tenzij het lek veilig gedicht kan worden.
 PL W przypadku płonięcia wyciekającego gazu:Nie gasić, jeżeli nie można bezpiecznie zahamować wycieku.
 PT Incêndio por fuga de gás: não apagar, a menos que se possa deter a fuga em segurança.
 RO Incendiu cauzat de o scurgere de gaz: nu încercaţi să stingeţi, decât dacă scurgerea poate fi oprită în siguranţă.
 SK Požiar unikajúceho plynu: Nehaste, pokiaľ únik nemožno bezpečne zastaviť.
 SL Požar zaradi uhajanja plina:Ne gasiti, če puščanja ni mogoče varno zaustaviti.
 FI Vuotavasta kaasusta johtuva palo:Ei saa sammuttaa, jollei vuotoa voida pysäyttää turvallisesti.
 SV Läckande gas som brinner:Försök inte släcka branden om inte läckan kan stoppas på ett säkert sätt.


P378 Language 
 BG Използвайте … за гасене.
 ES Utilizar … para apagarlo.
 CS K hašení použijte …
 DA Anvend … til brandslukning.
 DE … zum Löschen verwenden.
 ET Kustutamiseks kasutada …
 EL Χρησιμοποιήστε … για την κατάσβεση.
 EN Use … for extinction.
 FR Utiliser … pour l’extinction.
 GA Úsáid … le haghaidh múchta.
 IT Estinguere con…
 LV Nodzēšanai izmantot…
 LT Gesinimui naudoti …
 HU Az oltáshoz … használandó.
 MT Uża’ … biex titfi.
 NL Blussen met …
 PL Użyć … do gaszenia.
 PT Para a extinção utilizar …
 RO Utilizați… pentru stingere.
 SK Na hasenie použite …
 SL Za gašenje uporabiti …
 FI Käytä palon sammuttamiseen …
 SV Släck branden med …


P380 Language 
 BG Евакуирайте зоната.
 ES Evacuar la zona.
 CS Vykliďte _roctor.
 DA Evakuer området.
 DE Umgebung räumen.
 ET Ala evakueerida.
 EL Εκκενώστε την περιοχή.
 EN Evacuate area.
 FR Évacuer la zone.
 GA Aslonnaigh gach duine as an limistéar.
 IT Evacuare la zona.
 LV Evakuēt zonu.
 LT Evakuoti zoną.
 HU A területet ki kell üríteni.
 MT Evakwa ż-żona.
 NL Evacueren.
 PL Ewakuować teren.
 PT Evacuar a zona.
 RO Evacuaţi zona.
 SK Priestory evakuujte.
 SL Izprazniti območje.
 FI Evakuoi alue.
 SV Utrym området.


P381 Language 
 BG Премахнете всички източници на запалване, ако е безопасно.
 ES Eliminar todas las fuentes de ignición si no hay peligro en hacerlo.
 CS Odstraňte všechny zdroje zapálení, můžete-li tak učinit bez rizika.
 DA Fjern alle antændelseskilder, hvis dette kan gøres sikkert.
 DE Alle Zündquellen entfernen, wenn gefahrlos möglich.
 ET Eemaldada kõik süüteallikad, kui seda on võimalik teha ohutult.
 EL Απομακρύνετε τις πηγές ανάφλεξης, εάν αυτό μπορεί να γίνει χωρίς κίνδυνο.
 EN Eliminate all ignition sources if safe to do so.
 FR Éliminer toutes les sources d’ignition si cela est faisable sans danger.
 GA Díothaigh gach foinse adhainte, má tá sé sábháilte é sin a dhéanamh.
 IT Eliminare ogni fonte di accensione se non c’è pericolo.
 LV Novērst visus uzliesmošanas avotus, ja to var izdarīt droši.
 LT Pašalinti visus uždegimo šaltinius, jeigu galima saugiai tai padaryti.
 HU Meg kell szüntetni az összes gyújtóforrást, ha ez biztonságosan megtehető.
 MT Elimina s-sorsi kollha li jqabbdu sakemm ma jkunx perikoluż li tagħmel dan.
 NL Alle ontstekingsbronnen wegnemen als dat veilig gedaan kan worden.
 PL Wyeliminować wszystkie źródła zapłonu, jeżeli jest to bezpieczne.
 PT Eliminar todas as fontes de ignição se tal puder ser feito em segurança.
 RO Eliminaţi toate sursele de aprindere, dacă acest lucru se poate face în siguranţă.
 SK Ak je to bezpečné, odstráňte všetky zdroje zapálenia.
 SL Odstraniti vse vire vžiga, če je varno.
 FI Poista kaikki sytytyslähteet, jos sen voi tehdä turvallisesti.
 SV Avlägsna alla antändningskällor om det kan göras på ett säkert sätt.


P390 Language 
 BG Попийте разлятото, за да се предотвратят материални вреди.
 ES Absorber el vertido para que no dañe otros materiales.
 CS Uniklý produkt absorbujte, aby se zabránilo materiálním škodám.
 DA Absorber udslip for at undgå materielskade.
 DE Verschüttete Mengen aufnehmen, um Materialschäden zu vermeiden.
 ET Mahavoolanud toode absorbeerida, et see ei kahjustaks teisi materjale.
 EL Σκουπίστε τη χυμένη ποσότητα για να προλάβετε υλικές ζημιές.
 EN Absorb spillage to prevent material damage.
 FR Absorber toute substance répandue pour éviter qu’elle attaque les matériaux environnants.
 GA Ionsúigh doirteadh chun damáiste d’ábhar a chosc.
 IT Assorbire la fuoriuscita per evitare danni materiali.
 LV Uzsūkt izšļakstījumus, lai novērstu materiālus zaudējumus.
 LT Absorbuoti išsiliejusią medžiagą, siekiant išvengti materialinės žalos.
 HU A kiömlött anyagot fel kell itatni a körülvevő anyagok károsodásának megelőzése érdekében.
 MT Assorbi t-tixrid biex tipprevjeni ħsara fil-materjal.
 NL Gelekte/gemorste stof opnemen om materiële schade te vermijden.
 PL Usunąć wyciek, aby zapobiec szkodom materialnym.
 PT Absorver o produto derramado a fim de evitar danos materiais.
 RO Absorbiţi scurgerile de produs, pentru a nu afecta materialele din apropiere.
 SK Absorbujte uniknutý produkt, aby sa zabránilo materiálnym škodám.
 SL Odpraviti razlitje, da se prepreči materialna škoda.
 FI Imeytä valumat vahinkojen estämiseksi.
 SV Sug upp spill för att undvika materiella skador.


P391 Language 
 BG Съберете разлятото.
 ES Recoger el vertido.
 CS Uniklý produkt seberte.
 DA Udslip opsamles.
 DE Verschüttete Mengen aufnehmen.
 ET Mahavoolanud toode kokku koguda.
 EL Μαζέψτε τη χυμένη ποσότητα.
 EN Collect spillage.
 FR Recueillir le produit répandu.
 GA Bailigh doirteadh.
 IT Raccogliere il materiale fuoriuscito.
 LV Savākt izšļakstīto šķidrumu.
 LT Surinkti ištekėjusią medžiagą.
 HU A kiömlött anyagot össze kell gyűjteni.
 MT Iġbor it-tixrid.
 NL Gelekte/gemorste stof opruimen.
 PL Zebrać wyciek.
 PT Recolher o produto derramado.
 RO Colectaţi scurgerile de produs.
 SK Zozbierajte uniknutý produkt.
 SL Prestreči razlito tekočino.
 FI Valumat on kerättävä.
 SV Samla upp spill.


P301 + P310 Language 
 BG ПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
 ES EN CASO DE INGESTIÓN: Llamar inmediatamente a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
 CS PŘI POŽITÍ: Okamžitě volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
 DA I TILFÆLDE AF INDTAGELSE: Ring omgående til en GIFTINFORMATION eller en læge.
 DE BEI VERSCHLUCKEN: Sofort GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
 ET ALLANEELAMISE KORRAL: võtta viivitamata ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
 EN IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
 FR EN CAS D’INGESTION: appeler immédiatement un CENTRE ANTIPOISON ou un médecin.
 GA MÁ SHLOGTAR: Cuir glao láithreach ar IONAD NIMHE nó ar dhoctúir/lia.
 IT IN CASO DI INGESTIONE: contattare immediatamente un CENTRO ANTIVELENI o un medico
 LV NORĪŠANAS GADĪJUMĀ: Nekavējoties sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.
 LT PRARIJUS: Nedelsiant skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
 HU LENYELÉS ESETÉN: azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
 MT JEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
 NL NA INSLIKKEN: onmiddellijk een ANTIGIFCENTRUM of een arts raadplegen.
 PL W PRZYPADKU POŁKNIĘCIA: Natychmiast skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
 PT EM CASO DE INGESTÃO: contacte imediatamente um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
 RO ÎN CAZ DE ÎNGHIŢIRE: sunaţi imediat la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
 SK PO POŽITÍ: okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
 SL PRI ZAUŽITJU: takoj pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
 FI JOS KEMIKAALIA ON NIELTY: Ota välittömästi yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
 SV VID FÖRTÄRING: Kontakta genast GIFTINFORMATIONSCENTRAL eller läkare.


P301 + P312 Language 
 BG ПРИ ПОГЛЪЩАНЕ: Незабавно се обадете в ЦЕНТЪР ПО ТОСКИКОЛОГИЯ или на лекар при неразположение.
 ES EN CASO DE INGESTIÓN: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico si se encuentra mal.
 CS PŘI POŽITÍ: Necítíte-li s dobře, volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
 DA I TILFÆLDE AF INDTAGELSE: I tilfælde af ubehag ring til en GIFTINFORMATION eller en læge.
 DE BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
 ET ALLANEELAMISE KORRAL: halva enesetunde korral võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Καλέστε αμέσως το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό, εάν αισθανθείτε αδιαθεσία.
 EN IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
 FR EN CAS D’INGESTION: appeler un CENTRE ANTIPOISON ou un médecin en cas de malaise.
 GA MÁ SHLOGTAR: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia má bhraitheann tú tinn.
 IT IN CASO DI INGESTIONE accompagnata da malessere: contattare un CENTRO ANTIVELENI o un medico.
 LV NORĪŠANAS GADĪJUMĀ: sazināties ar SAINDĒŠANĀS CENTRU vai ārstu, ja jums ir slikta pašsajūta.
 LT PRARIJUS: Pasijutus blogai, skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
 HU LENYELÉS ESETÉN: rosszullét esetén azonnal forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
 MT JEKK JINBELA’: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib jekk tħossok ma tiflaħx.
 NL NA INSLIKKEN: bij onwel voelen een ANTIGIFCENTRUM of een arts raadplegen.
 PL W PRZYPADKU POŁKNIĘCIA: W przypadku złego samopoczucia skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
 PT EM CASO DE INGESTÃO: caso sinta indisposição, contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
 RO ÎN CAZ DE ÎNGHIŢIRE: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic, dacă nu vă simţiţi bine.
 SK PO POŽITÍ: ak máte zdravotné problémy, okamžite volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
 SL PRI ZAUŽITJU: ob slabem počutju pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
 FI JOS KEMIKAALIA ON NIELTY: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin, jos ilmenee pahoinvointia.
 SV VID FÖRTÄRING: Kontakta GIFTINFORMATIONSCENTRAL eller läkare om du mår dåligt.


P301 + P330 + P331 Language 
 BG ПРИ ПОГЛЪЩАНЕ: изплакнете устата. НЕ предизвиквайте повръщане.
 ES EN CASO DE INGESTIÓN: Enjuagarse la boca. NO provocar el vómito.
 CS PŘI POŽITÍ: Vypláchněte ústa. NEVYVOLÁVEJTE zvracení.
 DA I TILFÆLDE AF INDTAGELSE: Skyl munden. Fremkald IKKE opkastning.
 DE BEI VERSCHLUCKEN: Mund ausspülen. KEIN Erbrechen herbeiführen.
 ET ALLANEELAMISE KORRAL: loputada suud. MITTE kutsuda esile oksendamist.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΚΑΤΑΠΟΣΗΣ: Ξεπλύνετε το στόμα. ΜΗΝ προκαλέσετε εμετό.
 EN IF SWALLOWED: rinse mouth. Do NOT induce vomiting.
 FR EN CAS D’INGESTION: rincer la bouche. NE PAS faire vomir.
 GA MÁ SHLOGTAR: sruthlaítear an béal. NÁ déan urlacan a spreagadh.
 IT IN CASO DI INGESTIONE: sciacquare la bocca. NON provocare il vomito.
 LV NORĪŠANAS GADĪJUMĀ: izskalot muti. NEIZRAISĪT vemšanu.
 LT PRARIJUS: išskalauti burną. NESKATINTI vėmimo.
 HU LENYELÉS ESETÉN: a szájat ki kell öblíteni. TILOS hánytatni.
 MT JEKK JINBELA’: laħlaħ il-ħalq. TIPPROVOKAX ir-remettar.
 NL NA INSLIKKEN: de mond spoelen — GEEN braken opwekken.
 PL W PRZYPADKU POŁKNIĘCIA: wypłukać usta. NIE wywoływać wymiotów.
 PT EM CASO DE INGESTÃO: enxaguar a boca. NÃO provocar o vómito.
 RO ÎN CAZ DE ÎNGHIŢIRE: clătiţi gura. NU provocaţi voma.
 SK PO POŽITÍ: vypláchnite ústa. Nevyvolávajte zvracanie.
 SL PRI ZAUŽITJU: izprati usta. NE izzvati bruhanja.
 FI JOS KEMIKAALIA ON NIELTY: Huuhdo suu. EI saa oksennuttaa.
 SV VID FÖRTÄRING: Skölj munnen. Framkalla INTE kräkning.


P302 + P334 Language 
 BG ПРИ КОНТАКТ С КОЖАТА: Потопете в студена вода/сложете мокри компреси.
 ES EN CASO DE CONTACTO CON LA PIEL: Sumergir en agua fresca/aplicar compresas húmedas.
 CS PŘI STYKU S KŮŽÍ: Ponořte do studené vody/zabalte do vlhkého obvazu.
 DA VED KONTAKT MED HUDEN: Skyl under koldt vand/anvend våde omslag.
 DE BEI KONTAKT MIT DER HAUT: In kaltes Wasser tauchen/nassen Verband anlegen.
 ET NAHALE SATTUMISE KORRAL: hoida jahedas vees/panna peale niiske kompress.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
 EN IF ON SKIN: Immerse in cool water/wrap in wet bandages.
 FR EN CAS DE CONTACT AVEC LA PEAU: rincer à l’eau fraîche/poser une compresse humide.
 GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Tum in uisce fionnuar/cuir bréid fliuch air.
 IT IN CASO DI CONTATTO CON LA PELLE: immergere in acqua fredda/avvolgere con un bendaggio umido.
 LV SASKARĒ AR ĀDU: iegremdēt vēsā ūdenī/ietīt mitros apsējos.
 LT PATEKUS ANT ODOS: Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
 HU HA BŐRRE KERÜL: Hideg vízzel/nedves kötéssel kell hűteni.
 MT JEKK FUQ IL-ĠILDA: Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.
 NL BIJ CONTACT MET DE HUID: in koud water onderdompelen/nat verband aanbrengen.
 PL W PRZYPADKU KONTAKTU ZE SKÓRĄ: Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.
 PT SE ENTRAR EM CONTACTO COM A PELE: mergulhar em água fria/aplicar compressas húmidas.
 RO ÎN CAZ DE CONTACT CU PIELEA: introduceţi în apă rece/acoperiţi cu o compresă umedă.
 SK PRI KONTAKTE S POKOŽKOU: Ponorte do studenej vody/obviažte mokrými obväzmi.
 SL PRI STIKU S KOŽO: potopiti v hladno vodo/zaviti v mokre povoje.
 FI JOS KEMIKAALIA JOUTUU IHOLLE: Upota kylmään veteen/kääri märkiin siteisiin.
 SV VID HUDKONTAKT: Skölj under kallt vatten/använd våta omslag.


P302 + P350 Language 
 BG ПРИ КОНТАКТ С КОЖАТА: Измийте внимателно и обилно със сапун и вода.
 ES EN CASO DE CONTACTO CON LA PIEL: Lavar suavemente con agua y jabón abundantes.
 CS PŘI STYKU S KŮŽÍ: Jemně omyjte velkým množstvím vody a mýdla.
 DA VED KONTAKT MED HUDEN: Vask forsigtigt med rigeligt sæbe og vand.
 DE BEI KONTAKT MIT DER HAUT: Behutsam mit viel Wasser und Seife waschen.
 ET NAHALE SATTUMISE KORRAL: pesta õrnalt rohke vee ja seebiga.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύντε απαλά με άφθονο νερό και σαπούνι.
 EN IF ON SKIN: Gently wash with plenty of soap and water.
 FR EN CAS DE CONTACT AVEC LA PEAU: laver avec précaution et abondamment à l’eau et au savon.
 GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh go bog le neart gallúnaí agus uisce.
 IT IN CASO DI CONTATTO CON LA PELLE: lavare delicatamente e abbondantemente con acqua e sapone.
 LV SASKARĒ AR ĀDU: maigi nomazgāt ar lielu ziepju un ūdens daudzumu.
 LT PATEKUS ANT ODOS: Atsargiai nuplauti dideliu kiekiu muilo ir vandens.
 HU HA BŐRRE KERÜL: Óvatos lemosás bő szappanos vízzel.
 MT JEKK FUQ IL-ĠILDA: Aħsel bil-mod b’ħafna sapun u ilma.
 NL BIJ CONTACT MET DE HUID: voorzichtig wassen met veel water en zeep.
 PL W PRZYPADKU DOSTANIA SIĘ NA SKÓRĘ: Delikatnie umyć dużą iloścą wody z mydłem.
 PT SE ENTRAR EM CONTACTO COM A PELE: lavar suavemente com sabonete e água abundantes.
 RO ÎN CAZ DE CONTACT CU PIELEA: spălaţi uşor cu multă apă şi săpun.
 SK PRI KONTAKTE S POKOŽKOU: Opatrne umyte veľkým množstvom vody a mydla.
 SL PRI STIKU S KOŽO: nežno umiti z veliko mila in vode.
 FI JOS KEMIKAALIA JOUTUU IHOLLE: Pese varovasti runsaalla vedellä ja saippualla.
 SV VID HUDKONTAKT: Tvätta försiktigt med mycket tvål och vatten.


P302 + P352 Language 
 BG ПРИ КОНТАКТ С КОЖАТА: Измийте обилно със сапун и вода.
 ES EN CASO DE CONTACTO CON LA PIEL: Lavar con agua y jabón abundantes.
 CS PŘI STYKU S KŮŽÍ: Omyjte velkým množstvím vody a mýdla.
 DA VED KONTAKT MED HUDEN: Vask med rigeligt sæbe og vand.
 DE BEI KONTAKT MIT DER HAUT: Mit viel Wasser und Seife waschen.
 ET NAHALE SATTUMISE KORRAL: pesta rohke vee ja seebiga.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ: Πλύνετε με άφθονο νερό και σαπούνι.
 EN IF ON SKIN: Wash with plenty of soap and water.
 FR EN CAS DE CONTACT AVEC LA PEAU: laver abondamment à l’eau et au savon.
 GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN: Nigh le neart gallúnaí agus uisce.
 IT IN CASO DI CONTATTO CON LA PELLE: lavare abbondantemente con acqua e sapone.
 LV SASKARĒ AR ĀDU: nomazgāt ar lielu ziepju un ūdens daudzumu.
 LT PATEKUS ANT ODOS: Nuplauti dideliu kiekiu muilo ir vandens.
 HU HA BŐRRE KERÜL: Lemosás bő szappanos vízzel.
 MT JEKK FUQ IL-ĠILDA: Aħsel b’ħafna sapun u ilma.
 NL BIJ CONTACT MET DE HUID: met veel water en zeep wassen.
 PL W PRZYPADKU KONTAKTU ZE SKÓRĄ: Umyć dużą ilością wody z mydłem.
 PT SE ENTRAR EM CONTACTO COM A PELE: lavar com sabonete e água abundantes.
 RO ÎN CAZ DE CONTACT CU PIELEA: spălaţi cu multă apă şi săpun.
 SK PRI KONTAKTE S POKOŽKOU: Umyte veľkým množstvom vody a mydla.
 SL PRI STIKU S KOŽO: umiti z veliko mila in vode.
 FI JOS KEMIKAALIA JOUTUU IHOLLE: Pese runsaalla vedellä ja saippualla.
 SV VID HUDKONTAKT: Tvätta med mycket tvål och vatten.


P303 + P361 + P353 Language 
 BG ПРИ КОНТАКТ С КОЖАТА (или косата): Незабавно свалете цялото замърсено облекло. Облейте кожата с вода/вземете душ
 ES EN CASO DE CONTACTO CON LA PIEL (o el pelo): Quitarse inmediatamente las prendas contaminadas. Aclararse la piel con agua o ducharse.
 CS PŘI STYKU S KŮŽÍ (nebo s vlasy): Veškeré kontaminované části oděvu okamžitě svlékněte. Opláchněte kůži vodou/osprchujte.
 DA VED KONTAKT MED HUDEN (eller håret): Tilsmudset tøj tages straks af/fjernes. Skyl/brus huden med vand.
 DE BEI KONTAKT MIT DER HAUT (oder dem Haar): Alle beschmutzten, getränkten Kleidungsstücke sofort ausziehen. Haut mit Wasser abwaschen/duschen.
 ET NAHALE (või juustele) SATTUMISE KORRAL: võtta viivitamata kõik saastunud rõivad seljast. Loputada nahka veega/loputada duši all.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΟ ΔΕΡΜΑ (ή με τα μαλλιά): Αφαιρέστε αμέσως όλα τα μολυσμένα ενδύματα. Ξεπλύνετε το δέρμα με νερό/στο ντους.
 EN IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower.
 FR EN CAS DE CONTACT AVEC LA PEAU (ou les cheveux): enlever immédiatement les vêtements contaminés. Rincer la peau à l’eau/se doucher.
 GA I gCÁS TEAGMHÁLA LEIS AN gCRAICEANN(nó le gruaig): Bain díot láithreach na héadaí éillithe go léir. Sruthlaítear an craiceann le huisce/glac cithfholcadh.
 IT IN CASO DI CONTATTO CON LA PELLE (o con i capelli): togliersi di dosso immediatamente tutti gli indumenti contaminati. Sciacquare la pelle/fare una doccia.
 LV SASKARĒ AR ĀDU (vai matiem): noģērbt visu piesārņoto apģērbu. Noskalot ādu ar ūdeni/dušā.
 LT PATEKUS ANT ODOS (arba plaukų): Nedelsiant nuvilkti/pašalinti visus užterštus drabužius. Odą nuplauti vandeniu/čiurkšle.
 HU HA BŐRRE (vagy hajra) KERÜL: Az összes szennyezett ruhadarabot azonnal el kell távolítani/le kell vetni. A bőrt le kell öblíteni vízzel/zuhanyozás.
 MT JEKK FUQ IL-ĠILDA (jew xagħar): Neħħi/inża’ minnufih l-ilbies kontaminat. Laħlaħ il-ġilda bl-ilma/bix-xawer.
 NL BIJ CONTACT MET DE HUID (of het haar): verontreinigde kleding onmiddellijk uittrekken — huid met water afspoelen/afdouchen.
 PL W PRZYPADKU KONTATKU ZE SKÓRĄ (lub z włosami): Natychmiast usunąć/zdjąć całą zanieczyszczoną odzież. Spłukać skórę pod strumieniem wody/prysznicem.
 PT SE ENTRAR EM CONTACTO COM A PELE (ou o cabelo): despir/retirar imediatamente toda a roupa contaminada. Enxaguar a pele com água/tomar um duche.
 RO ÎN CAZ DE CONTACT CU PIELEA (sau părul): scoateţi imediat toată îmbrăcămintea contaminată. Clătiţi pielea cu apă/faceţi duş.
 SK PRI KONTAKTE S POKOŽKOU (alebo vlasmi): Odstráňte/vyzlečte všetky kontaminované časti odevu. Pokožku ihneď opláchnite vodou/sprchou.
 SL PRI STIKU S KOŽO (ali lasmi): takoj odstraniti/sleči vsa kontaminirana oblačila. Izprati kožo z vodo/prho.
 FI JOS KEMIKAALIA JOUTUU IHOLLE (tai hiuksiin): Riisu saastunut vaatetus välittömästi. Huuhdo/suihkuta iho vedellä.
 SV VID HUDKONTAKT (även håret): Ta omedelbart av alla nedstänkta kläder. Skölj huden med vatten/duscha.


P304 + P340 Language 
 BG ПРИ ВДИШВАНЕ: Изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
 ES EN CASO DE INHALACIÓN: Transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
 CS PŘI VDECHNUTÍ: Přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
 DA VED INDÅNDING: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
 DE BEI EINATMEN: An die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
 ET SISSEHINGAMISE KORRAL: toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Μεταφέρετε τον παθόντα στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
 EN IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
 FR EN CAS D’INHALATION: transporter la victime à l’extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
 GA MÁ IONÁLAÍTEAR, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
 IT IN CASO DI INALAZIONE: trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
 LV IEELPOŠANAS GADĪJUMĀ: izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
 LT ĮKVĖPUS: Išnešti nukentėjusįjį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
 HU BELÉLEGZÉS ESETÉN: Az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
 MT JEKK JITTIEĦED FIN-NIFS: Esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
 NL NA INADEMING: het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
 PL W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
 PT EM CASO DE INALAÇÃO: retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
 RO ÎN CAZ DE INHALARE: transportaţi victima la aer liber şi menţineţi-o în stare de repaus, într-o poziţie confortabilă pentru respiraţie.
 SK PO VDÝCHNUTÍ: Presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
 SL PRI VDIHAVANJU: prenesti žrtev na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
 FI JOS KEMIKAALIA ON HENGITETTY: Siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
 SV VID INANDNING: Flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.


P304 + P341 Language 
 BG ПРИ ВДИШВАНЕ: При затруднено дишане изведете пострадалия на чист въздух и го поставете в позиция, улесняваща дишането.
 ES EN CASO DE INHALACIÓN: Si respira con dificultad, transportar a la víctima al exterior y mantenerla en reposo en una posición confortable para respirar.
 CS PŘI VDECHNUTÍ: Při obtížném dýchání přeneste postiženého na čerstvý vzduch a ponechte jej v klidu v poloze usnadňující dýchání.
 DA VED INDÅNDING: Ved vejrtrækningsbesvær: Flyt personen til et sted med frisk luft og sørg for, at vedkommende hviler i en stilling, som letter vejrtrækningen.
 DE BEI EINATMEN: Bei Atembeschwerden an die frische Luft bringen und in einer Position ruhigstellen, die das Atmen erleichtert.
 ET SISSEHINGAMISE KORRAL: hingamisraskuste korral toimetada kannatanu värske õhu kätte ja asetada mugavasse puhkeasendisse, mis võimaldab kergesti hingata.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΙΣΠΝΟΗΣ: Εάν ο παθών έχει δύσπνοια, μεταφέρετέ τον στον καθαρό αέρα και αφήστε τον να ξεκουραστεί σε στάση που διευκολύνει την αναπνοή.
 EN IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
 FR EN CAS D’INHALATION: s'il y a difficulté à respirer, transporter la victime à l'extérieur et la maintenir au repos dans une position où elle peut confortablement respirer.
 GA MÁ THÉANN AN TÁIRGE SEO LE hANÁIL DUINE, tabhair amach faoin aer an duine agus coimeád socair é, i riocht ina bhféadfaidh sé anáil a tharraingt go réidh.
 IT IN CASO DI INALAZIONE: se la respirazione è difficile, trasportare l'infortunato all’aria aperta e mantenerlo a riposo in posizione che favorisca la respirazione.
 LV IEELPOŠANAS GADĪJUMĀ: ja elpošana ir apgrūtināta, izvest cietušo svaigā gaisā un turēt miera stāvoklī, lai būtu ērti elpot.
 LT ĮKVĖPUS: Jeigu nukentėjusiajam sunku kvėpuoti, išnešti jį į gryną orą; jam būtina ramybė ir padėtis, leidžianti laisvai kvėpuoti.
 HU BELÉLEGZÉS ESETÉN: Légzési nehézségek esetén az érintett személyt friss levegőre kell vinni és olyan nyugalmi testhelyzetbe kell helyezni, hogy könnyen tudjon lélegezni.
 MT JEKK JITTIEĦED FIN-NIFS: Jekk in-nifs ikun diffiċli, esponi lill-vittma għall-arja friska u żommha mistrieħa f’pożizzjoni komda biex tkun tista’ tieħu n-nifs.
 NL NA INADEMING: bij ademhalingsmoeilijkheden het slachtoffer in de frisse lucht brengen en laten rusten in een houding die het ademen vergemakkelijkt.
 PL W PRZYPADKU DOSTANIA SIĘ DO DRÓG ODDECHOWYCH: W przypadku trudności z oddychaniem, wyprowadzić lub wynieść poszkodowanego na świeże powietrze i zapewnić warunki do odpoczynku w pozycji umożliwiającej swobodne oddychanie.
 PT EM CASO DE INALAÇÃO: em caso de dificuldade respiratória, retirar a vítima para uma zona ao ar livre e mantê-la em repouso numa posição que não dificulte a respiração.
 RO ÎN CAZ DE INHALARE: dacă respiraţia este dificilă, transportaţi victima la aer liber şi menţineţi-o în stare de repaus, într-o poziţie confortabilă pentru respiraţie.
 SK PO VDÝCHNUTÍ: Ak nastanú ťažkosti s dýchaním, presuňte postihnutého na čerstvý vzduch a nechajte ho oddychovať v polohe, ktorá mu umožní pohodlné dýchanie.
 SL PRI VDIHAVANJU: prenesti žrtev pri oteženem dihanju na svež zrak in jo pustiti počivati v položaju, ki olajša dihanje.
 FI JOS KEMIKAALIA ON HENGITETTY: Jos hengitysvaikeuksia, siirrä henkilö raittiiseen ilmaan ja pidä lepoasennossa, jossa on helppo hengittää.
 SV VID INANDNING: Vid andningsbesvär, flytta personen till frisk luft och se till att han eller hon vilar i en ställning som underlättar andningen.


P305 + P351 + P338 Language 
 BG ПРИ КОНТАКТ С ОЧИТЕ: Промивайте внимателно с вода в продължение на няколко минути. Свалете контактните лещи, ако има такива и доколкото това е възможно. Продължавайте да промивате.
 ES EN CASO DE CONTACTO CON LOS OJOS: Aclarar cuidadosamente con agua durante varios minutos. Quitar las lentes de contacto, si lleva y resulta fácil. Seguir aclarando.
 CS PŘI ZASAŽENÍ OČÍ: Několik minut opatrně vyplachujte vodou. Vyjměte kontaktní čočky, jsou-li nasazeny a pokud je lze vyjmout snadno. Pokračujte ve vyplachování.
 DA VED KONTAKT MED ØJNENE: Skyl forsigtigt med vand i flere minutter. Fjern eventuelle kontaktlinser, hvis dette kan gøres let. Fortsæt skylning.
 DE BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Vorhandene Kontaktlinsen nach Möglichkeit entfernen. Weiter spülen.
 ET SILMA SATTUMISE KORRAL: loputada mitme minuti jooksul ettevaatlikult veega. Eemaldada kontaktläätsed, kui neid kasutatakse ja kui neid on kerge eemaldada. Loputada veel kord.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΜΑΤΙΑ: Ξεπλύνετε προσεκτικά με νερό για αρκετά λεπτά. Εάν υπάρχουν φακοί επαφής, αφαιρέστε τους, εφόσον είναι εύκολο. Συνεχίστε να ξεπλένετε.
 EN IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
 FR EN CAS DE CONTACT AVEC LES YEUX: rincer avec précaution à l’eau pendant plusieurs minutes. Enlever les lentilles de contact si la victime en porte et si elles peuvent être facilement enlevées. Continuer à rincer.
 GA I gCÁS TEAGMHÁLA LEIS NA SÚILE: Sruthlaigh go cúramach le huisce ar feadh roinnt nóiméad. Tóg amach na tadhall-lionsaí, más ann dóibh agus más furasta. Lean den sruthlú.
 IT IN CASO DI CONTATTO CON GLI OCCHI: sciacquare accuratamente per parecchi minuti. Togliere le eventuali lenti a contatto se è agevole farlo. Continuare a sciacquare.
 LV SASKARĒ AR ACĪM: uzmanīgi izskalot ar ūdeni vairākas minūtes. Izņemt kontaktlēcas, ja tās ir ievietotas un ja to ir viegli izdarīt. Turpināt skalot.
 LT PATEKUS Į AKIS: Kelias minutes atsargiai plauti vandeniu. Išimti kontaktinius lęšius, jeigu jie yra ir jeigu lengvai galima tai padaryti. Toliau plauti akis.
 HU SZEMBE KERÜLÉS esetén: Több percig tartó óvatos öblítés vízzel. Adott esetben a kontaktlencsék eltávolítása, ha könnyen megoldható. Az öblítés folytatása.
 MT JEKK JIDĦOL FL-GĦAJNEJN: Laħlaħ b'attenzjoni bl-ilma għal diversi minuti. Neħħi l-lentijiet tal-kuntatt, jekk ikun hemm u jkunu faċli biex tneħħihom. Kompli laħlaħ.
 NL BIJ CONTACT MET DE OGEN: voorzichtig afspoelen met water gedurende een aantal minuten; contactlenzen verwijderen, indien mogelijk; blijven spoelen.
 PL W PRZYPADKU DOSTANIA SIĘ DO OCZU: Ostrożnie płukać wodą przez kilka minut. Wyjąć soczewki kontaktowe, jeżeli są i można je łatwo usunąć. Nadal płukać.
 PT SE ENTRAR EM CONTACTO COM OS OLHOS: enxaguar cuidadosamente com água durante vários minutos. Se usar lentes de contacto, retire-as, se tal lhe for possível. Continuar a enxaguar.
 RO ÎN CAZ DE CONTACT CU OCHII: clătiţi cu atenţie cu apă timp de mai multe minute. Scoateţi lentilele de contact, dacă este cazul şi dacă acest lucru se poate face cu uşurinţă. Continuaţi să clătiţi.
 SK PO ZASIAHNUTÍ OČÍ: Niekoľko minút ich opatrne vyplachujte vodou. Ak používate kontaktné šošovky a ak je to možné, odstráňte ich. Pokračujte vo vyplachovaní.
 SL PRI STIKU Z OČMI: previdno izpirajte z vodo nekaj minut. Odstranite kontaktne leče, če jih imate in če to lahko storite brez težav. Nadaljujte z izpiranjem.
 FI JOS KEMIKAALIA JOUTUU SILMIIN: Huuhdo huolellisesti vedellä usean minuutin ajan. Poista piilolinssit, _edical voi tehdä helposti. Jatka huuhtomista.
 SV VID KONTAKT MED ÖGONEN: Skölj försiktigt med vatten i flera minuter. Ta ur eventuella kontaktlinser om det går lätt. Fortsätt att skölja.


P306 + P360 Language 
 BG ПРИ ПОПАДАНЕ ВЪРХУ ОБЛЕКЛОТО: незабавно облейте замърсеното облекло и кожата обилно с вода, преди да свалите дрехите.
 ES EN CASO DE CONTACTO CON LA ROPA: Aclarar inmediatamente con agua abundante las prendas y la piel contaminadas antes de quitarse la ropa.
 CS PŘI STYKU S ODĚVEM: Kontaminovaný oděv a kůži oklamžitě omyjte velkým množstvím vody a potom oděv odložte.
 DA VED KONTAKT MED TØJET: Skyl omgående tilsmudset tøj og hud med rigeligt vand, før tøjet fjernes.
 DE BEI KONTAKT MIT DER KLEIDUNG: Kontaminierte Kleidung und Haut sofort mit viel Wasser abwaschen und danach Kleidung ausziehen.
 ET RÕIVASTELE SATTUMISE KORRAL: saastunud rõivad ja nahk loputada viivitamata rohke veega ning alles seejärel rõivad eemaldada.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ ΕΠΑΦΗΣ ΜΕ ΤΑ ΡΟΥΧΑ: Ξεπλύντε αμέσως τα μολυσμένα ρούχα και την επιδερμίδα με άφθονο νερό πριν αφαιρέσετε τα ρούχα.
 EN IF ON CLOTHING: rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
 FR EN CAS DE CONTACT AVEC LES VÊTEMENTS: rincer immédiatement et abondamment avec de l’eau les vêtements contaminés et la peau avant de les enlever.
 GA I gCÁS TEAGMHÁLA LE hÉADAÍ: sruthlaítear éadaí éillithe agus an craiceann láithreach le neart uisce sula ndéantar na héadaí a bhaint den duine.
 IT IN CASO DI CONTATTO CON GLI INDUMENTI: sciacquare immediatamente e abbondantemente gli indumenti contaminati e la pelle prima di togliersi gli indumenti.
 LV SASKARĒ AR APĢĒRBU: nekavējoties izskalot piesārņoto apģērbu un ādu ar lielu daudzumu ūdeni, pirms apģērba novilkšanas.
 LT PATEKUS ANT DRABUŽIŲ: Prieš nuvelkant užterštus drabužius, nedelsiant juos ir odą nuplauti dideliu kiekiu vandens.
 HU HA RUHÁRA KERÜL: A ruhák levetése előtt a szennyezett ruházatot és a bőrt bő vízzel azonnal le kell öblíteni.
 MT JEKK FUQ L-ILBIES: laħlaħ mall-ewwel l-ilbies ikkontaminat u l-ġilda b’ħafna ilma qabel ma tneħħi l-ilbies.
 NL NA MORSEN OP KLEDING: verontreinigde kleding en huid onmiddellijk met veel water afspoelen en pas daarna kleding uittrekken.
 PL W PRZYPADKU KONTAKTU Z ODZIEŻĄ: natychmiast spłukać zanieczyszczoną odzież i skórę dużą ilością wody przed zdjęciem odzieży.
 PT SE ENTRAR EM CONTACTO COM A ROUPA: enxaguar imediatamente com muita água a roupa e a pele contaminadas antes de se despir.
 RO ÎN CAZ DE CONTACT CU ÎMBRĂCĂMINTEA: clătiţi imediat îmbrăcămintea contaminată şi pielea cu multă apă, înainte de scoaterea îmbrăcămintei.
 SK PRI KONTAKTE S ODEVOM: kontaminovaný odev a pokožku opláchnite veľkým množstvom vody a potom odev odstráňte.
 SL PRI STIKU Z OBLAČILI: takoj izprati kontaminirana oblačila in kožo z veliko vode pred odstranitvijo oblačil.
 FI JOS KEMIKAALIA JOUTUU VAATTEISIIN: Huuhdo saastunut vaatetus ja iho välittömästi runsaalla vedellä ennen vaatetuksen riisumista.
 SV VID KONTAKT MED KLÄDERNA: Skölj omedelbart nedstänkta kläder och hud med mycket vatten innan du tar av dig kläderna.


P307 + P311 Language 
 BG ПРИ експозиция: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
 ES EN CASO DE exposición: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
 CS PŘI expozici: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
 DA VED eksponering: Ring til en GIFTINFORMATION eller en læge.
 DE BEI Exposition: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
 ET Kokkupuute korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
 EN IF exposed: Call a POISON CENTER or doctor/physician.
 FR EN CAS d’exposition: appeler un CENTRE ANTIPOISON ou un médecin.
 GA I gCÁS nochta: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
 IT IN CASO di esposizione, contattare un CENTRO ANTIVELENI o un medico.
 LV Ja ir saskarē: Sazināties ar SAINDĒŠANĀS CENTRU vai ārstu.
 LT Esant sąlyčiui: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
 HU Expozíció esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
 MT Jekk espost: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
 NL NA blootstelling: een ANTIGIFCENTRUM of een arts raadplegen.
 PL W przypadku narażenia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
 PT EM CASO DE exposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
 RO ÎN CAZ DE expunere: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
 SK Po expozícii: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
 SL PRI izpostavljenosti: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
 FI Altistumisen tapahduttua: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
 SV Om du exponerats: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.


P308 + P313 Language 
 BG ПРИ явна или предполагаема експозиция: Потърсете медицински съвет/помощ.
 ES EN CASO DE exposición manifiesta o presunta: Consultar a un médico.
 CS PŘI expozici nebo podezření na ni: Vyhledejte lékařskou pomoc/ošetření.
 DA VED eksponering eller mistanke om eksponering: Søg lægehjælp.
 DE BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
 ET Kokkupuute või kokkupuutekahtluse korral: pöörduda arsti poole.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή πιθανότητας έκθεσης: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
 EN IF exposed or concerned: Get medical advice/attention.
 FR EN CAS d’exposition prouvée ou suspectée: consulter un médecin.
 GA I gCÀS nochta nó má mheastar a bheith nochtaithe: Faigh comhairle/cúram liachta.
 IT IN CASO di esposizione o di possibile esposizione, consultare un medico.
 LV Ja nokļūst saskarē vai saistīts ar to: lūdziet mediķu palīdzību.
 LT Esant sąlyčiui arba jeigu numanomas sąlytis: kreiptis į gydytoją.
 HU Expozíció vagy annak gyanúja esetén: orvosi ellátást kell kérni.
 MT Jekk espost jew konċernat: Ikkonsulta tabib.
 NL NA (mogelijke) blootstelling: een arts raadplegen.
 PL W przypadku narażenia lub styczności: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
 PT EM CASO DE exposição ou suspeita de exposição: consulte um médico.
 RO ÎN CAZ DE expunere sau de posibilă expunere: consultaţi medicul.
 SK Po expozícii alebo podozrení z nej: Vyhľadajte lekársku pomoc/starostlivosť.
 SL PRI izpostavljenosti ali sumu izpostavljenosti: poiščite zdravniško pomoč/oskrbo.
 FI Altistumisen tapahduttua tai jos epäillään altistumista: Hakeudu lääkäriin.
 SV Vid exponering eller misstanke om exponering Sök läkarhjälp.


P309 + P311 Language 
 BG ПРИ експозиция или неразположение: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
 ES EN CASO DE exposición o si se encuentra mal: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
 CS PŘI expozici nebo necítíte-li se dobře: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
 DA VED eksponering eller ubehag: Ring til en GIFTINFORMATION eller en læge.
 DE BEI Exposition oder Unwohlsein: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
 ET Kokkupuute või halva enesetunde korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
 EL ΣΕ ΠΕΡΙΠΤΩΣΗ έκθεσης ή αδιαθεσίας: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
 EN IF exposed or if you feel unwell: Call a POISON CENTER or doctor/physician.
 FR EN CAS d’exposition ou de malaise: appeler un CENTRE ANTIPOISON ou un médecin.
 GA I gCÀS nochta nó má bhraitear tinn: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
 IT IN CASO di esposizione o di malessere, contattare un CENTRO ANTIVELENI o un medico.
 LV Ja nokļūst saskarē vai jums ir slikta pašsajūta: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
 LT Esant sąlyčiui arba pasijutus blogai: Skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
 HU Expozíció vagy rosszullét esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
 MT JEKK espost jew tħossok ma tiflaħx: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
 NL NA blootstelling of bij onwel voelen: een ANTIGIFCENTRUM of een arts raadplegen.
 PL W przypadku narażenia lub złego samopoczucia: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
 PT EM CASO DE exposição ou de indisposição: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
 RO ÎN CAZ DE expunere sau dacă nu vă simţiţi bine: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
 SK Po expozícii alebo pri zdravotných problémoch: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
 SL PRI izpostavljenosti ali slabem počutju: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
 FI Altistumisen tapahduttua tai jos ilmenee pahoinvointia: Ota yhteys MYRKYTYSTIETOSKESKUKSEEN tai lääkäriin.
 SV Vid exponering eller obehag: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.


P332 + P313 Language 
 BG При поява на кожно дразнене: Потърсете медицински съвет/помощ.
 ES En caso de irritación cutánea: Consultar a un médico.
 CS Při podráždění kůže: Vyhledejte lékařskou pomoc/ošetření.
 DA Ved hudirritation: Søg lægehjælp.
 DE Bei Hautreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
 ET Nahaärrituse korral: pöörduda arsti poole.
 EL Εάν παρατηρηθεί ερεθισμός του δέρματος: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
 EN If skin irritation occurs: Get medical advice/attention.
 FR En cas d’irritation cutanée: consulter un médecin.
 GA I gcás greannú craicinn: Faigh comhairle/cúram liachta.
 IT In caso di irritazione della pelle: consultare un medico.
 LV Ja rodas ādas iekaisums: lūdziet mediķu palīdzību.
 LT Jeigu sudirginama oda: kreiptis į gydytoją.
 HU Bőrirritáció esetén: orvosi ellátást kell kérni.
 MT Jekk ikun hemm irritazzjoni tal-ġilda: Ikkonsulta tabib.
 NL Bij huidirritatie: een arts raadplegen.
 PL W przypadku wystąpienia podrażnienia skóry: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
 PT Em caso de irritação cutânea: consulte um médico.
 RO În caz de iritare a pielii: consultaţi medicul.
 SK Ak sa objaví podráždenie pokožky, vyhľadajte lekársku pomoc/starostlivosť.
 SL Če nastopi draženje kože: poiščite zdravniško pomoč/oskrbo.
 FI Jos ilmenee ihoärsytystä: Hakeudu lääkäriin.
 SV Vid hudirritation: Sök läkarhjälp.


P333 + P313 Language 
 BG При поява на кожно дразнене или обрив на кожата: Потърсете медицински съвет/помощ.
 ES En caso de irritación o erupción cutánea: Consultar a un médico.
 CS Při podráždění kůže nebo vyrážce: Vyhledejte lékařskou pomoc/ošetření.
 DA Ved hudirritation eller udslet: Søg lægehjælp.
 DE Bei Hautreizung oder -ausschlag: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
 ET Nahaärrituse või _obe korral: pöörduda arsti poole.
 EL Εάν παρατηρηθεί ερεθισμός του δέρματος ή εμφανιστεί εξάνθημα: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
 EN If skin irritation or rash occurs: Get medical advice/attention.
 FR En cas d’irritation ou d'éruption cutanée: consulter un médecin.
 GA Má tharlaíonn greannú nó gríos craicinn: Faigh comhairle/cúram liachta.
 IT In caso di irritazione o eruzione della pelle: consultare un medico.
 LV Ja rodas ādas iekaisums vai izsitumi: lūdziet mediķu palīdzību.
 LT Jeigu sudirginama oda arba ją išberia: kreiptis į gydytoją.
 HU Bőrirritáció vagy kiütések megjelenése esetén: orvosi ellátást kell kérni.
 MT Jekk ikun hemm irritazzjoni jew raxx tal-ġilda: Ikkonsulta tabib.
 NL Bij huidirritatie of uitslag: een arts raadplegen.
 PL W przypadku wystąpienia podrażnienia skóry lub wysypki: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
 PT Em caso de irritação ou erupção cutânea: consulte um médico.
 RO În caz de iritare a pielii sau de erupţie cutanată: consultaţi medicul.
 SK Ak sa prejaví podráždenie pokožky alebo sa vytvoria vyrážky: vyhľadajte lekársku pomoc/starostlivosť.
 SL Če nastopi draženje kože ali se pojavi izpuščaj: poiščite zdravniško pomoč/oskrbo.
 FI Jos ilmenee ihoärsytystä tai ihottumaa: Hakeudu lääkäriin.
 SV Vid hudirritation eller utslag: Sök läkarhjälp.


P335 + P334 Language 
 BG Отстранете посипаните частици от кожата. Потопете в хладка вода/сложете мокри компреси.
 ES Sacudir las partículas que se hayan depositado en la piel. Sumergir en agua fresca/aplicar compresas húmedas.
 CS Volné částice odstraňte z kůže. Ponořte do studené vody/zabalte do vlhkého obvazu.
 DA Børst løse partikler bort fra huden. Skyl under koldt vand/anvend våde omslag.
 DE Lose Partikel von der Haut abbürsten. In kaltes Wasser tauchen/nassen Verband anlegen.
 ET Pühkida lahtised osakesed nahalt maha. Hoida jahedas vees / panna peale niiske kompress.
 EL Αφαιρέστε προσεκτικά τα σωματίδια που έχουν μείνει στο δέρμα. Πλύντε με άφθονο δροσερό νερό/τυλίξτε με βρεγμένους επιδέσμους.
 EN Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
 FR Enlever avec précaution les particules déposées sur la peau. Rincer à l’eau fraîche/poser une compresse humide.
 GA Scuab cáithníní scaoilte den chraiceann. Tum in uisce fionnuar/cuir bréid fliuch air.
 IT Rimuovere le particelle depositate sulla pelle. Immergere in acqua fredda/avvolgere con un bendaggio umido.
 LV Noberziet brīvās daļiņas no ādas. Iegremdējiet vēsā ūdenī/ietiniet mitros apsējos.
 LT Neprilipusias daleles nuvalyti nuo odos. Įmerkti į vėsų vandenį/apvynioti šlapiais tvarsčiais.
 HU A bőrre tapadó szemcséket óvatosan le kell kefélni. Hideg vízzel/nedves kötéssel kell hűteni.
 MT Farfar il-frak mhux imwaħħal minn mal-ġilda. Daħħal fl-ilma frisk/kebbeb f’faxex imxarrbin.
 NL Losse deeltjes van de huid afvegen. In koud water onderdompelen/nat verband aanbrengen.
 PL Nie związaną pozostałość strzepnąć ze skóry. Zanurzyć w zimnej wodzie/owinąć mokrym bandażem.
 PT Sacudir da pele as partículas soltas. Mergulhar em água fria/aplicar compressas húmidas.
 RO Îndepărtaţi particulele depuse pe piele. Introduceţi în apă rece/acoperiţi cu o compresă umedă.
 SK Z pokožky oprášte sypké čiastočky. Ponorte do studenej vody/obviažte mokrými obväzmi.
 SL S krtačo odstraniti razsute delce s kože. Potopiti v hladno vodo/zaviti v mokre povoje.
 FI Poista irtohiukkaset iholta. Upota kylmään veteen/kääri märkiin siteisiin.
 SV Borsta bort lösa partiklar från huden. Skölj under kallt vatten/använd våta omslag.


P337 + P313 Language 
 BG При продължително дразнене на очите: Потърсете медицински съвет/помощ.
 ES Si persiste la irritación ocular: Consultar a un médico.
 CS Přetrvává-li podráždění očí: Vyhledejte lékařskou pomoc/ošetření.
 DA Ved vedvarende øjenirritation: Søg lægehjælp.
 DE Bei anhaltender Augenreizung: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.
 ET Kui silmade ärritus ei möödu: pöörduda arsti poole.
 EL Εάν δεν υποχωρεί ο οφθαλμικός ερεθισμός: Συμβουλευθείτε/Επισκεφθείτε γιατρό.
 EN If eye irritation persists: Get medical advice/attention.
 FR Si l’irritation oculaire persiste: consulter un médecin.
 GA Má mhaireann an greannú súile: Faigh comhairle/cúram liachta.
 IT Se l’irritazione degli occhi persiste, consultare un medico.
 LV Ja acu iekaisums nepāriet: lūdziet mediķu palīdzību.
 LT Jei akių dirginimas nepraeina: kreiptis į gydytoją.
 HU Ha a szemirritáció nem múlik el: orvosi ellátást kell kérni.
 MT Jekk l-irritazzjoni ta' l-għajnejn tippersisti: Ikkonsulta tabib.
 NL Bij aanhoudende oogirritatie: een arts raadplegen.
 PL W przypadku utrzymywania się działania drażniącego na oczy: Zasięgnąć porady/zgłosić się pod opiekę lekarza.
 PT Caso a irritação ocular persista: consulte um médico.
 RO Dacă iritarea ochilor persistă: consultaţi medicul.
 SK Ak podráždenie očí pretrváva: vyhľadajte lekársku pomoc/starostlivosť.
 SL Če draženje oči ne preneha: poiščite zdravniško pomoč/oskrbo.
 FI Jos silmä-ärsytys jatkuu: Hakeudu lääkäriin.
 SV Vid bestående ögonirritation: Sök läkarhjälp.


P342 + P311 Language 
 BG При симптоми на затруднено дишане: Обадете се в ЦЕНТЪР ПО ТОКСИКОЛОГИЯ или на лекар.
 ES En caso de síntomas respiratorios: Llamar a un CENTRO DE INFORMACIÓN TOXICOLÓGICA o a un médico.
 CS Při dýchacích potížích: Volejte TOXIKOLOGICKÉ INFORMAČNÍ STŘEDISKO nebo lékaře.
 DA Ved luftvejssymptomer: Ring til en GIFTINFORMATION eller en læge.
 DE Bei Symptomen der Atemwege: GIFTINFORMATIONSZENTRUM oder Arzt anrufen.
 ET Hingamisteede probleemide ilmnemise korral: võtta ühendust MÜRGISTUSTEABEKESKUSE või arstiga.
 EL Εάν παρουσιάζονται αναπνευστικά συμπτώματα: Καλέστε το ΚΕΝΤΡΟ ΔΗΛΗΤΗΡΙΑΣΕΩΝ ή ένα γιατρό.
 EN If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician.
 FR En cas de symptômes respiratoires: appeler un CENTRE ANTIPOISON ou un médecin.
 GA I gcás siomptóm riospráide: Cuir glao ar IONAD NIMHE nó ar dhoctúir/lia.
 IT In caso di sintomi respiratori: contattare un CENTRO ANTIVELENI o un medico.
 LV Ja rodas elpas trūkuma simptomi: sazinieties ar SAINDĒŠANĀS CENTRU vai ārstu.
 LT Jeigu pasireiškia respiraciniai simptomai: skambinti į APSINUODIJIMŲ KONTROLĖS IR INFORMACIJOS BIURĄ arba kreiptis į gydytoją.
 HU Légzési problémák esetén: forduljon TOXIKOLÓGIAI KÖZPONTHOZ vagy orvoshoz.
 MT Jekk ikollok sintomi respiratorji: Ikkuntattja ĊENTRU TA' L-AVVELENAMENT jew tabib.
 NL Bij ademhalingssymptomen: een ANTIGIFCENTRUM of een arts raadplegen.
 PL W przypadku wystąpienia objawów ze strony układu oddechowego: Skontaktować się z OŚRODKIEM ZATRUĆ lub z lekarzem.
 PT Em caso de sintomas respiratórios: contacte um CENTRO DE INFORMAÇÃO ANTIVENENOS ou um médico.
 RO În caz de simptome respiratorii: sunaţi la un CENTRU DE INFORMARE TOXICOLOGICĂ sau un medic.
 SK Pri ťažkostiach s dýchaním: volajte NÁRODNÉ TOXIKOLOGICKÉ INFORMAČNÉ CENTRUM alebo lekára.
 SL Pri respiratornih simptomih: pokličite CENTER ZA ZASTRUPITVE ali zdravnika.
 FI Jos ilmenee hengitysoireita: Ota yhteys MYRKYTYSTIETOKESKUKSEEN tai lääkäriin.
 SV Vid besvär i luftvägarna: Kontakta GIFTINFORMATIONSCENTRAL eller läkare.


P370 + P376 Language 
 BG При пожар: Спрете теча, ако е безопасно.
 ES En caso de incendio: Detener la fuga, si no hay peligro en hacerlo.
 CS V případě požáru: Zastavte únik, můžete-li tak učinit bez rizika.
 DA Ved brand: Stands lækagen, hvis dette er sikkert.
 DE Bei Brand: Undichtigkeit beseitigen, wenn gefahrlos möglich.
 ET Tulekahju korral: leke peatada, kui seda on võimalik teha ohutult.
 EL Σε περίπτωση πυρκαγιάς: Σταματήστε τη διαρροή, εφόσον δεν υπάρχει κίνδυνος.
 EN In case of fire: Stop leak if safe to do so.
 FR En cas d’incendie: obturer la fuite si cela peut se faire sans danger.
 GA I gcás dóiteáin: Cuir stop leis an sceitheadh má tá sé sábháilte é sin a dhéanamh.
 IT In caso di incendio: bloccare la perdita se non c’è pericolo.
 LV Ugunsgrēka gadījumā: apturiet noplūdi, ja to darīt ir droši.
 LT Gaisro atveju: sustabdyti nuotėkį, jeigu galima saugiai tai padaryti.
 HU Tűz esetén: Meg kell szüntetni a szivárgást, ha ez biztonságosan megtehető.
 MT F’każ ta' nar: Waqqaf it-tnixxija sakemm ma jkunx ta' periklu.
 NL In geval van brand: het lek dichten als dat veilig gedaan kan worden.
 PL W przypadku pożaru: Jeżeli jest to bezpieczne zahamować wyciek.
 PT Em caso de incêndio: deter a fuga se tal puder ser feito em segurança.
 RO În caz de incendiu: opriţi scurgerea, dacă acest lucru se poate face în siguranţă.
 SK V prípade požiaru: ak je to bezpečné, zastavte únik.
 SL Ob požaru: zaustaviti puščanje, če je varno.
 FI Tulipalon sattuessa: Sulje vuoto, jos sen voi tehdä turvallisesti.
 SV Vid brand: Stoppa läckan om det kan göras på ett säkert sätt.


P370 + P378 Language 
 BG При пожар: Използвайте … за гасене.
 ES En caso de incendio: Utilizar … para apagarlo.
 CS V případě požáru: K hašení použijte …
 DA Ved brand: Anvend … til brandslukning.
 DE Bei Brand: … zum Löschen verwenden.
 ET Tulekahju korral: kasutada kustutamiseks …
 EL Σε περίπτωση πυρκαγιάς: Χρησιμοποιήστε … για την κατάσβεση.
 EN In case of fire: Use … for extinction.
 FR En cas d’incendie: utiliser … pour l’extinction.
 GA I gcás dóiteáin: Úsáid … le haghaidh múchta.
 IT In caso di incendio: estinguere con…
 LV Ugunsgrēka gadījumā: dzēšanai izmantojiet …
 LT Gaisro atveju: gesinimui naudoti …
 HU Tűz esetén: az oltáshoz …használandó.
 MT F’każ ta' nar: Uża’ … għat-tifi.
 NL In geval van brand: blussen met …
 PL W przypadku pożaru: Użyć … do gaszenia.
 PT Em caso de incêndio: para a extinção utilizar …
 RO În caz de incendiu: utilizaţi… pentru stingere.
 SK V prípade požiaru: na hasenie použite …
 SL Ob požaru: za gašenje uporabiti …
 FI Tulipalon sattuessa: Käytä palon sammuttamiseen …
 SV Vid brand: Släck branden med …


P370 + P380 Language 
 BG При пожар: Евакуирайте зоната.
 ES En caso de incendio: Evacuar la zona.
 CS V případě požáru: Vykliďte prostor.
 DA Ved brand: Evakuer området.
 DE Bei Brand: Umgebung räumen.
 ET Tulekahju korral: ala evakueerida.
 EL Σε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή.
 EN In case of fire: Evacuate area.
 FR En cas d’incendie: évacuer la zone.
 GA I gcás dóiteáin: Aslonnaigh gach duine as an limistéar.
 IT Evacuare la zona in caso di incendio.
 LV Ugunsgrēka gadījumā: evakuēt zonu.
 LT Gaisro atveju: evakuoti zoną.
 HU Tűz esetén: Ki kell üríteni a területet.
 MT F’każ ta' nar: Evakwa ż-żona.
 NL In geval van brand: evacueren.
 PL W przypadku pożaru: Ewakuować teren.
 PT Em caso de incêndio: evacuar a zona.
 RO În caz de incendiu: evacuaţi zona.
 SK V prípade požiaru: priestory evakuujte.
 SL Ob požaru: izprazniti območje.
 FI Tulipalon sattuessa: Evakuoi alue.
 SV Vid brand: Utrym området.


P370 + P380 + P375 Language 
 BG При пожар: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.
 ES En caso de incendio: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.
 CS V případě požáru: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
 DA Ved brand: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.
 DE Bei Brand: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
 ET Tulekahju korral: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.
 EL Σε περίπτωση πυρκαγιάς: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
 EN In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
 FR En cas d’incendie: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.
 GA I gcás dóiteáin: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
 IT In caso di incendio: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
 LV Ugunsgrēka gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.
 LT Gaisro atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.
 HU Tűz esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.
 MT F’każ ta' nar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
 NL In geval van brand: evacueren. Op afstand blussen omwille van ontploffingsgevaar.
 PL W przypadku pożaru: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.
 PT Em caso de incêndio: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.
 RO În caz de incendiu: evacuaţi zona. Stingeţi incendiul de la distanţă din cauza pericolului de explozie.
 SK V prípade požiaru: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
 SL Ob požaru: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.
 FI Tulipalon sattuessa: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.
 SV Vid brand: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.


P371 + P380 + P375 Language 
 BG При голям пожар и значителни количества: Евакуирайте зоната. Гасете пожара от разстояние поради опасност от експлозия.
 ES En caso de incendio importante y en grandes cantidades: Evacuar la zona. Luchar contra el incendio a distancia, dado el riesgo de explosión.
 CS V případě velkého požáru a velkého množství: Vykliďte prostor. Kvůli nebezpečí výbuchu haste z dostatečné vzdálenosti.
 DA Ved større brand og store mængder: Evakuer området. Bekæmp branden på afstand på grund af eksplosionsfare.
 DE Bei Großbrand und großen Mengen: Umgebung räumen. Wegen Explosionsgefahr Brand aus der Entfernung bekämpfen.
 ET Suure tulekahju korral ning kui on tegemist suurte kogustega: ala evakueerida. Plahvatusohu tõttu teha kustutustöid eemalt.
 EL Σε περίπτωση σοβαρής πυρκαγιάς και εάν πρόκειται για μεγάλες ποσότητες: Εκκενώστε την περιοχή. Προσπαθήστε να σβήσετε την πυρκαγιά από απόσταση, επειδή υπάρχει κίνδυνος έκρηξης.
 EN In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
 FR En cas d’incendie important et s’il s’agit de grandes quantités: évacuer la zone. Combattre l’incendie à distance à cause du risque d’explosion.
 GA I gcás mórdhóiteáin agus mórchainníochtaí: Aslonnaigh gach duine as an limistéar. Téigh i gcianghleic leis an dóiteán mar gheall ar an mbaol pléasctha.
 IT In caso di incendio grave e di grandi quantità: evacuare la zona. Rischio di esplosione. Utilizzare i mezzi estinguenti a grande distanza.
 LV Ugunsgrēka vai liela apjoma gadījumā: evakuēt zonu. Dzēst uguni no attāluma eksplozijas riska dēļ.
 LT Didelio gaisro ir didelių kiekių atveju: evakuoti zoną. Gaisrą gesinti iš toli dėl sprogimo pavojaus.
 HU Nagyobb tűz és nagy mennyiség esetén: Ki kell üríteni a területet. A tűz oltását robbanásveszély miatt távolból kell végezni.
 MT F’każ ta' nar kbir u kwantitajiet kbar: Evakwa ż-żona. Itfi n-nar mill-bogħod minħabba r-riskju ta' splużjoni.
 NL In geval van grote brand en grote hoeveelheden: evacueren. Op afstand blussen omwille van ontploffingsgevaar.
 PL W przypadku poważnego pożaru i dużych ilości: Ewakuować teren. Z powodu ryzyka wybuchu gasić pożar z odległości.
 PT Em caso de incêndio importante e de grandes quantidades: evacuar a zona. Combater o incêndio à distância, devido ao risco de explosão.
 RO În caz de incendiu de proporţii şi de cantităţi mari de produs: evacuaţi zona. Stingeţi incendiul de la distanţă din cauza pericolului de explozie.
 SK V prípade veľkého požiaru a značného množstva: priestory evakuujte. Z dôvodu nebezpečenstva výbuchu požiar haste z diaľky.
 SL Ob velikem požaru in velikih količinah: izprazniti območje. Gasiti z večje razdalje zaradi nevarnosti eksplozije.
 FI Jos tulipalo ja ainemäärät ovat suuret: Evakuoi alue. Sammuta palo etäältä räjähdysvaaran takia.
 SV Vid större brand och stora mängder: Utrym området. Bekämpa branden på avstånd på grund av explosionsrisken.


P401 Language 
 BG Да се съхранява…
 ES Almacenar …
 CS Skladujte …
 DA Opbevares …
 DE … aufbewahren.
 ET Hoida …
 EL Αποθηκεύεται …
 EN Store …
 FR Stocker …
 GA Stóráil …
 IT Conservare…
 LV Glabāt…
 LT Laikyti…
 HU Tárolás: … .
 MT Aħżen …
 NL … bewaren.
 PL Przechowywać …
 PT Armazenar …
 RO A se depozita…
 SK Uchovávajte …
 SL Hraniti …
 FI Varastoi …
 SV Förvaras …


P402 Language 
 BG Да се съхранява на сухо място.
 ES Almacenar en un lugar seco.
 CS Skladujte na suchém místě.
 DA Opbevares et tørt sted.
 DE An einem trockenen Ort aufbewahren.
 ET Hoida kuivas.
 EL Αποθηκεύεται σε στεγνό μέρος.
 EN Store in a dry place.
 FR Stocker dans un endroit sec.
 GA Stóráil in áit thirim.
 IT Conservare in luogo asciutto.
 LV Glabāt sausā vietā.
 LT Laikyti sausoje vietoje.
 HU Száraz helyen tárolandó.
 MT Aħżen f’post niexef.
 NL Op een droge plaats bewaren.
 PL Przechowywać w suchym miejscu.
 PT Armazenar em local seco.
 RO A se depozita într-un loc uscat.
 SK Uchovávajte na suchom mieste.
 SL Hraniti na suhem.
 FI Varastoi kuivassa paikassa.
 SV Förvaras torrt.


P403 Language 
 BG Да се съхранява на добре проветриво място.
 ES Almacenar en un lugar bien ventilado.
 CS Skladujte na dobře větraném místě.
 DA Opbevares på et godt ventileret sted.
 DE An einem gut belüfteten Ort aufbewahren.
 ET Hoida hästi ventileeritavas kohas.
 EL Αποθηκεύεται σε καλά αεριζόμενο χώρο.
 EN Store in a well-ventilated place.
 FR Stocker dans un endroit bien ventilé.
 GA Stóráil in áit dhea-aeráilte.
 IT Conservare in luogo ben ventilato.
 LV Glabāt labi vēdināmā vietā.
 LT Laikyti gerai vėdinamoje vietoje.
 HU Jól szellőző helyen tárolandó.
 MT Aħżen f’post b'ventilazzjoni tajba.
 NL Op een goed geventileerde plaats bewaren.
 PL Przechowywać w dobrze wentylowanym miejscu.
 PT Armazenar em local bem ventilado.
 RO A se depozita într-un spaţiu bine ventilat.
 SK Uchovávajte na dobre vetranom mieste.
 SL Hraniti na dobro prezračevanem mestu.
 FI Varastoi paikassa, jossa on hyvä ilmanvaihto.
 SV Förvaras på väl ventilerad plats.


P404 Language 
 BG Да се съхранява в затворен съд.
 ES Almacenar en un recipiente cerrado.
 CS Skladujte v uzavřeném obalu.
 DA Opbevares i en lukket beholder.
 DE In einem geschlossenen Behälter aufbewahren.
 ET Hoida suletud mahutis.
 EL Φυλάσσεται σε κλειστό περιέκτη.
 EN Store in a closed container.
 FR Stocker dans un récipient fermé.
 GA Stóráil i gcoimeádán iata.
 IT Conservare in un recipiente chiuso.
 LV Glabāt slēgtā tvertnē.
 LT Laikyti uždaroje talpykloje.
 HU Zárt edényben tárolandó.
 MT Aħżen f’kontenitur magħluq.
 NL In gesloten verpakking bewaren.
 PL Przechowywać w zamkniętym pojemniku.
 PT Armazenar em recipiente fechado.
 RO A se depozita într-un recipient închis.
 SK Uchovávajte v uzavretej nádobe.
 SL Hraniti v zaprti posodi.
 FI Varastoi suljettuna.
 SV Förvaras i sluten behållare.


P405 Language 
 BG Да се съхранява под ключ.
 ES Guardar bajo llave.
 CS Skladujte uzamčené.
 DA Opbevares under lås.
 DE Unter Verschluss aufbewahren.
 ET Hoida lukustatult.
 EL Φυλάσσεται κλειδωμένο.
 EN Store locked up.
 FR Garder sous clef.
 GA Stóráil faoi ghlas.
 IT Conservare sotto chiave.
 LV Glabāt slēgtā veidā.
 LT Laikyti užrakintą.
 HU Elzárva tárolandó.
 MT Aħżen f'post imsakkar.
 NL Achter slot bewaren.
 PL Przechowywać pod zamknięciem.
 PT Armazenar em local fechado à chave.
 RO A se depozita sub cheie.
 SK Uchovávajte uzamknuté.
 SL Hraniti zaklenjeno.
 FI Varastoi lukitussa tilassa.
 SV Förvaras inlåst.


P406 Language 
 BG Да се съхранява в устойчив на разяждане съд/… съд с устойчива вътрешна облицовка.
 ES Almacenar en un recipiente resistente a la corrosión/… con revestimiento interior resistente.
 CS Skladujte v obalu odolném proti korozi/… obalu s odolnou vnitřní vrstvou.
 DA Opbevares i ætsningsbestandig/…beholder med modstandsdygtig indvendig belægning.
 DE In korrosionsbeständigem/… Behälter mit korrosionsbeständiger Auskleidung aufbewahren.
 ET Hoida sööbekindlas/…sööbekindla sisevooderdisega mahutis.
 EL Αποθηκεύεται σε ανθεκτικό στη διάβρωση/… περιέκτη με ανθεκτική εσωτερική επένδυση.
 EN Store in corrosive resistant/… container with a resistant inner liner.
 FR Stocker dans un récipient résistant à la corrosion/récipient en … avec doublure intérieure résistant à la corrosion.
 GA Stóráil i gcoimeádán … frithchreimneach/… le líneáil frithchreimneach laistigh.
 IT Conservare in recipiente resistente alla corrosione/… provvisto di rivestimento interno resistente.
 LV Glabāt tvertnē, kas aizsargā pret koroziju/… tvertnes ar iekšējo pretkorozijas izolāciju.
 LT Laikyti korozijai atsparioje talpykloje/…, turinčioje atsparią vidinę dangą.
 HU Saválló/saválló bélésű … edényben tárolandó.
 MT Aħżen f'post reżistenti għall-korrużjoni/… kontenitur li huwa infurrat minn ġewwa b'materjal reżistenti.
 NL In corrosiebestendige/… houder met corrosiebestendige binnenbekleding bewaren.
 PL Przechowywać w pojemniku odpornym na korozję / … o odpornej powłoce wewnętrznej.
 PT Armazenar num recipiente resistente à corrosão/… com um revestimento interior resistente.
 RO Depozitaţi într-un recipient rezistent la coroziune/recipient din… cu dublură interioară rezistentă la coroziune.
 SK Uchovávajte v nádobe odolnej proti korózii/… nádobe s odolnou vnútornou vrstvou.
 SL Hraniti v posodi, odporni proti koroziji/…, z odporno notranjo oblogo.
 FI Varastoi syöpymättömässä/… säiliössä, jossa on kestävä sisävuoraus.
 SV Förvaras i korrosionsbeständig/… behållare med beständigt innerhölje.


P407 Language 
 BG Да се остави въздушно пространство между купчините/палетите.
 ES Dejar una separación entre los bloques/los palés de carga.
 CS Mezi stohy/paletami ponechte vzduchovou mezeru.
 DA Obevares med luftmellemrum mellem stakkene/pallerne.
 DE Luftspalt zwischen Stapeln/Paletten lassen.
 ET Jätta virnade/kaubaaluste vahele õhuvahe.
 EL Να υπάρχει κενό αέρος μεταξύ των σωρών/παλετών.
 EN Maintain air gap between stacks/pallets.
 FR Maintenir un intervalle d’air entre les piles/palettes.
 GA Coimeád bearna aeir idir chruacha/phailléid.
 IT Mantenere uno spazio libero tra gli scaffali/i pallet.
 LV Saglabāt gaisa spraugu starp krāvumiem/paletēm.
 LT Palikti oro tarpą tarp eilių/palečių.
 HU A rakatok/raklapok között térközt kell hagyni.
 MT Ħalli l-arja tgħaddi bejn l-imniezel/il-palits.
 NL Ruimte laten tussen stapels/pallets.
 PL Zachować szczelinę powietrzną pomiędzy stosami/paletami.
 PT Respeitar as distâncias mínimas entre pilhas/paletes.
 RO Păstraţi un spaţiu gol între stive/paleți.
 SK Medzi regálmi/paletami ponechajte vzduchovú medzeru.
 SL Ohraniti zračno režo med skladi/paletami.
 FI Jätä pinojen/kuormalavojen väliin ilmarako.
 SV Se till att det finns luft mellan staplar/pallar.


P410 Language 
 BG Да се пази от пряка слънчева светлина.
 ES Proteger de la luz del sol.
 CS Chraňte před slunečním zářením.
 DA Beskyttes mod sollys.
 DE Vor Sonnenbestrahlung schützen.
 ET Hoida päikesevalguse eest.
 EL Να προστατεύεται από τις ηλιακές ακτίνες.
 EN Protect from sunlight.
 FR Protéger du rayonnement solaire.
 GA Cosain ó sholas na gréine.
 IT Proteggere dai raggi solari.
 LV Aizsargāt no saules gaismas.
 LT Saugoti nuo saulės šviesos.
 HU Napfénytől védendő.
 MT Ipproteġi mid-dawl tax-xemx.
 NL Tegen zonlicht beschermen.
 PL Chronić przed światłem słonecznym.
 PT Manter ao abrigo da luz solar.
 RO A se proteja de lumina solară.
 SK Chráňte pred slnečným žiarením.
 SL Zaščititi pred sončno svetlobo.
 FI Suojaa auringonvalolta.
 SV Skyddas från solljus.


P411 Language 
 BG Да се съхранява при температури, не по-високи от … oC/…oF.
 ES Almacenar a temperaturas no superiores a … oC/…oF.
 CS Skladujte při teplotě nepřesahující … oC/…oF.
 DA Opbevares ved en temperatur, som ikke overstiger … oC/…oF.
 DE Bei Temperaturen von nicht mehr als … oC/…aufbewahren.
 ET Hoida temperatuuril mitte üle … oC/… oF.
 EL Αποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.
 EN Store at temperatures not exceeding … oC/…oF.
 FR Stocker à une température ne dépassant pas … oC/… oF.
 GA Stóráil ag teocht nach airde ná … oC/…oF.
 IT Conservare a temperature non superiori a … oC/…oF.
 LV Uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.
 LT Laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.
 HU A tárolási hőmérséklet legfeljebb … oC/…oF lehet.
 MT Aħżen f’temperaturi li ma jeċċedux … oC/…oF.
 NL Bij maximaal … oC/…oF bewaren.
 PL Przechowywać w temperaturze nieprzekraczającej … oC/…oF.
 PT Armazenar a uma temperatura não superior a … oC/…oF.
 RO A se depozita la temperaturi care să nu depăşească … oC/…oF.
 SK Uchovávajte pri teplotách do … oC/…oF
 SL Hraniti pri temperaturi do … oC/… oF.
 FI Varastoi alle … oC/…oF lämpötilassa.
 SV Förvaras vid högst … oC/…oF.


P412 Language 
 BG Да не се излага на температури, по-високи от 50 oC/122oF.
 ES No exponer a temperaturas superiores a 50 oC/122oF.
 CS Nevystavujte teplotě přesahující 50 oC/122 oF.
 DA Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.
 DE Nicht Temperaturen von mehr als 50 oC aussetzen.
 ET Mitte hoida temperatuuril üle 50 oC/122 oF.
 EL Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.
 EN Do not expose to temperatures exceeding 50 oC/122oF.
 FR Ne pas exposer à une température supérieure à 50 oC/122 oF.
 GA Ná nocht do theocht níos airde ná 50 oC/122oF.
 IT Non esporre a temperature superiori a 50 oC/122oF.
 LV Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.
 LT Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.
 HU Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.
 MT Tesponix għal temperaturi li jeċċedu l-50 oC/122oF.
 NL Niet blootstellen aan temperaturen boven 50 oC/122oF.
 PL Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.
 PT Não expor a temperaturas superiores a 50 oC/122oF.
 RO Nu expuneţi la temperaturi care depăşesc 50 oC/122 oF.
 SK Nevystavujte teplotám nad 50 oC/122 oF.
 SL Ne izpostavljati temperaturam nad 50 oC/122 oF.
 FI Ei saa altistaa yli 50 oC/122 oF lämpötiloille.
 SV Får inte utsättas för temperaturer över 50 oC/122 oF.


P413 Language 
 BG При насипни количества, по-големи от … kg/… фунта, да се съхранява при температури, не по-високи от … oC/…oF.
 ES Almacenar las cantidades a granel superiores a … kg/… lbs a temperaturas no superiores a … oC/…oF.
 CS Množství větší než … kg/… liber skladujte při teplotě nepřesahující … oC/…oF.
 DA Bulkmængder på over … kg/…lbs opbevares ved en temperatur, som ikke overstiger … oC/…oF.
 DE Schüttgut in Mengen von mehr als … kg bei Temperaturen von nicht mehr als … oC aufbewahren
 ET Kogust, mis on suurem kui … kg/… naela, hoida temperatuuril mitte üle … oC/… oF.
 EL Οι σωροί χύδην με βάρος άνω των … kg/… lbs αποθηκεύονται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF.
 EN Store bulk masses greater than … kg/… lbs at temperatures not exceeding … oC/…oF.
 FR Stocker les quantités en vrac de plus de … kg/… lb à une température ne dépassant pas … oC/… oF.
 GA Stóráil bulcmhaiseanna os cionn … kg/… lb ag teocht nach airde ná … oC/…oF.
 IT Conservare le rinfuse di peso superiore a …kg/…lb a temperature non superiori a … oC/oF.
 LV Lielus apjomus, kas pārsniedz … kg/… lbs, uzglabāt temperatūrā, kas nepārsniedz … oC/…oF.
 LT Didesnius kaip … kg/… lbs medžiagos kiekius laikyti ne aukštesnėje kaip … oC/…oF temperatūroje.
 HU A … kg/… lb tömeget meghaladó ömlesztett anyag tárolási hőmérséklete legfeljebb … oC/…oF lehet.
 MT Aħżen il-kwantitajiet f’massa ta' akbar minn … kg/… lbs f’temperaturi ta' mhux aktar minn … oC/…oF.
 NL Bulkmateriaal, indien meer dan … kg/… lbs, bij temperaturen van maximaal … oC bewaren.
 PL Przechowywać luzem masy przekraczające … kg/… funtów w temperaturze nieprzekraczającej … oC/…oF.
 PT Armazenar quantidades a granel superiores a … kg/… lbs a uma temperatura não superior a … oC/…oF.
 RO Depozitaţi cantităţile în vrac mai mari de … kg/… lbs la temperaturi care să nu depăşească … oC/…oF.
 SK Veľké množstvo s hmotnosťou nad … kg/… lbs uchovávajte pri teplote do … oC/…oF.
 SL Razsute količine, večje od … kg/… lbs, hraniti pri temperaturi do … oC/… oF.
 FI Säilytä yli … kg/…lbs painoinen irtotavara enintään … oC/…oF lämpötilassa.
 SV Bulkprodukter som väger mer än … kg/… lbs förvaras vid högst … oC/…oF.


P420 Language 
 BG Да се съхранява на разстояние от други материали.
 ES Almacenar alejado de otros materiales.
 CS Skladujte odděleně od ostatních materiálů.
 DA Må ikke opbevares i nærheden af andre materialer.
 DE Von anderen Materialien entfernt aufbewahren.
 ET Hoida eemal teistest materjalidest.
 EL Αποθηκεύεται μακριά από άλλα υλικά.
 EN Store away from other materials.
 FR Stocker à l’écart des autres matières.
 GA Stóráil glan ar ábhair eile.
 IT Conservare lontano da altri materiali.
 LV Glabāt atsevišķi no citiem materiāliem.
 LT Laikyti atokiau nuo kitų medžiagų.
 HU Más anyagoktól távol tárolandó.
 MT Aħżen ‘l bogħod minn materjal ieħor.
 NL Gescheiden van ander materiaal bewaren.
 PL Przechowywać z dala od innych materiałów.
 PT Armazenar afastado de outros materiais.
 RO Depozitaţi departe de alte materiale.
 SK Uchovávajte oddelene od iných materiálov.
 SL Hraniti ločeno od drugih materialov.
 FI Varastoi erillään muista materiaaleista.
 SV Förvaras åtskilt från andra material.


P422 Language 
 BG Съдържанието да се съхранява при…
 ES Almacenar el contenido en …
 CS Skladujte pod …
 DA Indholdet skal opbevares under …
 DE Inhalt in/unter … aufbewahren
 ET Hoida sisu …
 EL Το περιεχόμενο αποθηκεύεται σε …
 EN Store contents under …
 FR Stocker le contenu sous …
 GA Stóráil an t-ábhar faoi …
 IT Conservare sotto…
 LV Saturu uzglabāt zem…
 LT Turinį laikyti …
 HU Tartalma … -ban/-ben tárolandó.
 MT Aħżen il-kontenut taħt …
 NL Onder … bewaren.
 PL Zawartość przechowywać w …
 PT Armazenar o conteúdo em …
 RO Depozitaţi conţinutul sub …
 SK Obsah uchovávajte v …
 SL Vsebino hraniti v …
 FI Varastoi sisältö …
 SV Förvara innehållet i…


P402 + P404 Language 
 BG Да се съхранява на сухо място. Да се съхранява в затворен съд.
 ES Almacenar en un lugar seco. Almacenar en un recipiente cerrado.
 CS Skladujte na suchém místě. Skladujte v uzavřeném obalu.
 DA Opbevares et tørt sted. Opbevares i en lukket beholder.
 DE In einem geschlossenen Behälter an einem trockenen Ort aufbewahren.
 ET Hoida kuivas. Hoida suletud mahutis.
 EL Αποθηκεύεται σε στεγνό μέρος. Φυλάσσεται σε κλειστό περιέκτη.
 EN Store in a dry place. Store in a closed container.
 FR Stocker dans un endroit sec. Stocker dans un récipient fermé.
 GA Stóráil in áit thirim. Stóráil i gcoimeádán iata.
 IT Conservare in luogo asciutto e in recipiente chiuso.
 LV Glabāt sausā vietā. Glabāt aizvērtā tvertnē.
 LT Laikyti sausoje vietoje. Laikyti uždaroje talpykloje.
 HU Száraz helyen tárolandó. Zárt edényben tárolandó.
 MT Aħżen f’post niexef. Aħżen f’kontenitur magħluq.
 NL Op een droge plaats bewaren. In gesloten verpakking bewaren.
 PL Przechowywać w suchym miejscu. Przechowywać w zamkniętym pojemniku.
 PT Armazenar em local seco. Armazenar em recipiente fechado.
 RO A se depozita într-un loc uscat, într-un recipient închis.
 SK Uchovávajte na suchom mieste. Uchovávajte v uzavretej nádobe.
 SL Hraniti na suhem. Hraniti v zaprti posodi.
 FI Varastoi kuivassa paikassa. Varastoi suljettuna.
 SV Förvaras torrt. Förvaras i sluten behållare.


P403 + P233 Language 
 BG Да се съхранява на добре проветриво място. Съдът да се съхранява плътно затворен.
 ES Almacenar en un lugar bien ventilado. Mantener el recipiente cerrado herméticamente.
 CS Skladujte na dobře větraném místě. Uchovávejte obal těsně uzavřený.
 DA Opbevares på et godt ventileret sted. Hold beholderen tæt lukket.
 DE Behälter dicht verschlossen an einem gut belüfteten Ort aufbewahren.
 ET Hoida hästi ventileeritavas kohas. Hoida mahuti tihedalt suletuna.
 EL Αποθηκεύεται σε καλά αεριζόμενο χώρο. Ο περιέκτης διατηρείται ερμητικά κλειστός.
 EN Store in a well-ventilated place. Keep container tightly closed.
 FR Stocker dans un endroit bien ventilé. Maintenir le récipient fermé de manière étanche.
 GA Stóráil in áit dhea-aeráilte. Coimeád an coimeádán dúnta go docht.
 IT Tenere il recipiente ben chiuso e in luogo ben ventilato.
 LV Glabāt labi vēdināmās telpās. Tvertni turēt cieši noslēgtu.
 LT Laikyti gerai vėdinamoje vietoje. Talpyklą laikyti sandariai uždarytą.
 HU Jól szellőző helyen tárolandó. Az edény szorosan lezárva tartandó.
 MT Aħżen f'post b'ventilazzjoni tajba. Żomm il-kontenitur magħluq sew.
 NL Op een goed geventileerde plaats bewaren. In goed gesloten verpakking bewaren.
 PL Przechowywać w dobrze wentylowanym miejscu. Przechowywać pojemnik szczelnie zamknięty.
 PT Armazenar em local bem ventilado. Manter o recipiente bem fechado.
 RO A se depozita într-un spaţiu bine ventilat. Păstraţi recipientul închis etanş.
 SK Uchovávajte na dobre vetranom mieste. Nádobu uchovávajte tesne uzavretú.
 SL Hraniti na dobro prezračevanem mestu. Hraniti v tesno zaprti posodi.
 FI Varastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä tiiviisti suljettuna.
 SV Förvaras på väl ventilerad plats. Förpackningen ska förvaras väl tillsluten.


P403 + P235 Language 
 BG Да се съхранява на добре проветриво място. Да се съхранява на хладно.
 ES Almacenar en un lugar bien ventilado. Mantener en lugar fresco.
 CS Skladujte na dobře větraném místě. Uchovávejte v chladu.
 DA Opbevares på et godt ventileret sted. Opbevares køligt.
 DE Kühl an einem gut belüfteten Ort aufgewahren.
 ET Hoida hästi ventileeritavas kohas. Hoida jahedas.
 EL Αποθηκεύεται σε καλά αεριζόμενο χώρο. Διατηρείται δροσερό.
 EN Store in a well-ventilated place. Keep cool.
 FR Stocker dans un endroit bien ventilé. Tenir au frais.
 GA Stóráil in áit dhea-aeráilte. Coimeád fionnuar.
 IT Conservare in luogo fresco e ben ventilato.
 LV Glabāt labi vēdināmās telpās. Turēt vēsumā.
 LT Laikyti gerai vėdinamoje vietoje. Laikyti vėsioje vietoje.
 HU Jól szellőző helyen tárolandó. Hűvös helyen tartandó.
 MT Aħżen f'post b'ventilazzjoni tajba. Żomm frisk.
 NL Op een goed geventileerde plaats bewaren. Koel bewaren.
 PL Przechowywać w dobrze wentylowanym miejscu. Przechowywać w chłodnym miejscu.
 PT Armazenar em local bem ventilado. Conservar em ambiente fresco.
 RO A se depozita într-un spaţiu bine ventilat. A se păstra la rece.
 SK Uchovávajte na dobre vetranom mieste. Uchovávajte v chlade.
 SL Hraniti na dobro prezračevanem mestu. Hraniti na hladnem.
 FI Varastoi paikassa, jossa on hyvä ilmanvaihto. Säilytä viileässä.
 SV Förvaras på väl ventilerad plats. Förvaras svalt.


P410 + P403 Language 
 BG Да се пази от пряка слънчева светлина. Да се съхранява на добре проветриво място.
 ES Proteger de la luz del sol. Almacenar en un lugar bien ventilado.
 CS Chraňte před slunečním zářením. Skladujte na dobře větraném místě.
 DA Beskyttes mod sollys. Opbevares på et godt ventileret sted.
 DE Vor Sonnenbestrahlung geschützt an einem gut belüfteten Ort aufbewahren.
 ET Hoida päikesevalguse eest. Hoida hästi ventileeritavas kohas.
 EL Να προστατεύεται από τις ηλιακές ακτίνες. Αποθηκεύεται σε καλά αεριζόμενο χώρο.
 EN Protect from sunlight. Store in a well-ventilated place.
 FR Protéger du rayonnement solaire. Stocker dans un endroit bien ventilé.
 GA Cosain ó sholas na gréine. Stóráil in áit dhea-aeráilte.
 IT Proteggere dai raggi solari. Conservare in luogo ben ventilato.
 LV Aizsargāt no saules gaismas. Glabāt labi vēdināmās telpās.
 LT Saugoti nuo saulės šviesos. Laikyti gerai vėdinamoje vietoje.
 HU Napfénytől védendő. Jól szellőző helyen tárolandó.
 MT Ipproteġi mid-dawl tax-xemx. Aħżen f'post b'ventilazzjoni tajba.
 NL Tegen zonlicht beschermen. Op een goed geventileerde plaats bewaren.
 PL Chronić przed światłem słonecznym. Przechowywać w dobrze wentylowanym miejscu.
 PT Manter ao abrigo da luz solar. Armazenar em local bem ventilado.
 RO A se proteja de lumina solară. A se depozita într-un spaţiu bine ventilat.
 SK Chráňte pred slnečným žiarením. Uchovávajte na dobre vetranom mieste.
 SL Zaščititi pred sončno svetlobo. Hraniti na dobro prezračevanem mestu.
 FI Suojaa auringonvalolta. Varastoi paikassa, jossa on hyvä ilmanvaihto.
 SV Skyddas från solljus. Förvaras på väl ventilerad plats.


P410 + P412 Language 
 BG Да се пази от пряка слънчева светлина. Да не се излага на температури, по-високи от 50 oC/122oF.
 ES Proteger de la luz del sol. No exponer a temperaturas superiores a 50 oC/122oF.
 CS Chraňte před slunečním zářením. Nevystavujte teplotě přesahující 50 oC/122oF.
 DA Beskyttes mod sollys. Må ikke udsættes for en temperatur, som overstiger 50 oC/122oF.
 DE Vor Sonnenbestrahlung schützen und nicht Temperaturen von mehr als 50 oC aussetzen.
 ET Hoida päikesevalguse eest. Mitte hoida temperatuuril üle 50 oC/122 oF.
 EL Να προστατεύεται από τις ηλιακές ακτίνες. Να μην εκτίθεται σε θερμοκρασίες που υπερβαίνουν τους 50 oC/122oF.
 EN Protect from sunlight. Do no expose to temperatures exceeding 50 oC/122oF.
 FR Protéger du rayonnement solaire. Ne pas exposer à une température supérieure à 50 oC/122 oF.
 GA Cosain ó sholas na gréine. Ná nocht do theocht níos airde ná 50 oC/122oF.
 IT Proteggere dai raggi solari. Non esporre a temperature superiori a 50 oC/122oF.
 LV Aizsargāt no saules gaismas. Nepakļaut temperatūrai, kas pārsniedz 50 oC/122oF.
 LT Saugoti nuo saulės šviesos. Nelaikyti aukštesnėje kaip 50 oC/122oF temperatūroje.
 HU Napfénytől védendő. Nem érheti 50 oC/122oF hőmérsékletet meghaladó hő.
 MT Ipproteġi mid-dawl tax-xemx. Tesponix għal temperatura li teċċedi l-50 oC/122oF.
 NL Tegen zonlicht beschermen. Niet blootstellen aan temperaturen boven 50 oC/122oF.
 PL Chronić przed światłem słonecznym. Nie wystawiać na działanie temperatury przekraczającej 50 oC/122 oF.
 PT Manter ao abrigo da luz solar. Não expor a temperaturas superiores a 50 oC/122oF.
 RO A se proteja de lumina solară. Nu expuneţi la temperaturi care depăşesc 50 oC/122 oF.
 SK Chráňte pred slnečným žiarením. Nevystavujte teplotám nad 50 oC/122 oF.
 SL Zaščititi pred sončno svetlobo. Ne izpostavljati temperaturam nad 50 oC/122 oF.
 FI Suojaa auringonvalolta. Ei saa altistaa yli 50 oC/122 oF lämpötiloille.
 SV Skyddas från solljus. Får inte utsättas för temperaturer över 50 oC/122 oF.


P411 + P235 Language 
 BG Да се съхранява при температури, не по-високи от … oC/…oF. Да се държи на хладно.
 ES Almacenar a temperaturas no superiores a … oC/…oF. Mantener en lugar fresco.
 CS Skladujte při teplotě nepřesahující … oC/…oF. Uchovávejte v chladu.
 DA Opbevares ved en temperatur, som ikke overstiger … oC/…oF. Opbevares køligt.
 DE Kühl und bei Temperaturen von nicht mehr als … oC aufbewahren.
 ET Hoida temperatuuril mitte üle … oC/… oF. Hoida jahedas.
 EL Αποθηκεύεται σε θερμοκρασίες που δεν υπερβαίνουν τους … oC/…oF. Διατηρείται δροσερό.
 EN Store at temperatures not exceeding … oC/…oF. Keep cool.
 FR Stocker à une température ne dépassant pas … oC/… oF. Tenir au frais.
 GA Stóráil ag teocht nach airde ná … oC/…oF. Coimeád fionnuar.
 IT Conservare in luogo fresco a temperature non superiori a … oC/…oF.
 LV Glabāt temperatūrā, kas nepārsniedz … oC/…oF. Turēt vēsumā.
 LT Laikyti ne aukštesnėje kaip … oC/…oF temperatūroje. Laikyti vėsioje vietoje.
 HU A tárolási hőmérséklet legfeljebb … oC/…oF lehet. Hűvös helyen tartandó.
 MT Aħżen f’temperaturi li ma jeċċedux … oC/…oF. Żomm frisk.
 NL Bij maximaal … oC/…oF bewaren. Koel bewaren.
 PL Przechowywać w temperaturze nieprzekraczającej … oC/…oF. Przechowywać w chłodnym miejscu.
 PT Armazenar a uma temperatura não superior a … oC/…oF. Conservar em ambiente fresco.
 RO A se depozita la temperaturi care să nu depăşească … oC/…oF. A se păstra la rece.
 SK Uchovávajte pri teplotách do … oC/…oF. Uchovávajte v chlade.
 SL Hraniti pri temperaturi do … oC/… oF. Hraniti na hladnem.
 FI Varastoi alle … oC/…oF lämpötilassa. Säilytä viileässä.
 SV Förvaras vid högst … oC/…oF. Förvaras svalt.


P501 Language 
 BG Съдържанието/съдът да се изхвърли в …
 ES Eliminar el contenido/el recipiente en …
 CS Odstraňte obsah/obal …
 DA Indholdet/beholderen bortskaffes i …
 DE Inhalt/Behälter … zuführen.
 ET Sisu/mahuti kõrvaldada …
 EL Διάθεση του περιεχομένου/περιέκτη σε …
 EN Dispose of contents/container to …
 FR Éliminer le contenu/récipient dans …
 GA Diúscair an t-ábhar/an coimeádán i …
 IT Smaltire il prodotto/recipiente in …
 LV Atbrīvoties no satura/tvertnes…
 LT Turinį/talpyklą išpilti (išmesti) į …
 HU A tartalom/edény elhelyezése hulladékként: …
 MT Armi l-kontenut/il-kontenitur fi …
 NL Inhoud/verpakking afvoeren naar …
 PL Zawartość/pojemnik usuwać do …
 PT Eliminar o conteúdo/recipiente em …
 RO Aruncaţi conţinutul/recipientul la …
 SK Zneškodnite obsah/nádobu …
 SL Odstraniti vsebino/posodo …
 FI Hävitä sisältö/pakkaus …
 SV Innehållet/behållaren lämnas till…

ANNEX V
The hazard pictograms for each hazard class, differentiation of a hazard class and hazard category shall satisfy the provisions of this Annex and Annex I, section 1.2 and conform, in terms of colour, symbols and general format, to the specimens shown.
 1.  1.1. 

Pictogram(1) Hazard class and hazard category(2)
GHS01 Section 2.1Unstable explosivesExplosives of Divisions 1.1, 1.2, 1.3, 1.4Section 2.8Self reactive substances and mixtures, Types A, BSection 2.15Organic peroxides, Types A, B
 1.2. 

Pictogram(1) Hazard class and hazard category(2)
GHS02 Section 2.2Flammable gases, hazard category 1Section 2.3Flammable aerosols, hazard categories 1, 2Section 2.6Flammable liquids, hazard categories 1, 2, 3Section 2.7Flammable solids, hazard categories 1, 2Section 2.8Self-reactive substances and mixtures, Types B, C, D, E, FSection 2.9Pyrophoric liquids, hazard category 1Section 2.10Pyrophoric solids, hazard category 1Section 2.11Self-heating substances and mixtures, hazard categories 1, 2Section 2.12Substances and mixtures, which in contact with water, emit flammable gases, hazard categories 1, 2, 3Section 2.15Organic peroxides, Types B, C, D, E, F
 1.3. 

Pictogram(1) Hazard class and hazard category(2)
GHS03 Section 2.4Oxidising gases, hazard category 1Section 2.13Oxidising liquids, hazard categories 1, 2, 3Section 2.14Oxidising solids, hazard categories 1, 2, 3
 1.4. 

Pictogram(1) Hazard class and hazard category(2)
GHS04 Section 2.5Gases under pressure:Compressed gases;Liquefied gases;Refrigerated liquefied gases;Dissolved gases
 1.5. 

Pictogram(1) Hazard class and hazard category(2)
GHS05 Section 2.16Corrosive to metals, hazard category 1
 1.6. 
Section 2.1: Explosives of Division 1.5

Section 2.1: Explosives of Division 1.6

Section 2.2: Flammable gases, hazard Category 2

Section 2.8: Self-reactive substances and mixtures, Type G

Section 2.15: Organic peroxides, Type G
 2.  2.1. 

Pictogram(1) Hazard class and hazard category(2)
GHS06 Section 3.1Acute toxicity (oral, dermal, inhalation), hazard categories 1, 2, 3
 2.2. 

Pictogram(1) Hazard class and hazard category(2)
GHS05 Section 3.2Skin corrosion, hazard categories 1A, 1B, 1CSection 3.3Serious eye damage, hazard category 1
 2.3. 

Pictogram(1) Hazard class and hazard category(2)
GHS07 Section 3.1Acute toxicity (oral, dermal, inhalation), hazard category 4Section 3.2Skin irritation, hazard category 2Section 3.3Eye irritation, hazard category 2Section 3.4Skin sensitisation, hazard category 1Section 3.8Specific Target Organ Toxicity — Single exposure, hazard category 3Respiratory tract irritationNarcotic effects
 2.4. 

Pictogram(1) Hazard class and hazard category(2)
GHS08 Section 3.4Respiratory sensitisation, hazard category 1Section 3.5Germ cell mutagenicity, hazard categories 1A, 1B, 2Section 3.6Carcinogenicity, hazard categories 1A, 1B, 2Section 3.7Reproductive toxicity, hazard categories 1A, 1B, 2Section 3.8Specific Target Organ Toxicity — Single exposure, hazard categories 1, 2Section 3.9Specific Target Organ Toxicity — Repeated exposure, hazard categories 1, 2Section 3.10Aspiration hazard, hazard category 1
 2.5. 
Section 3.7: Reproductive toxicity, Effects on or via lactation, additional hazard category
 3.  3.1. 

Pictogram(1) Hazard class and hazard category(2)
GHS09 Section 4.1Hazardous to the aquatic environment
— Acute hazard category 1
— Chronic hazard categories 1, 2

A pictogram is not required for the following environmental hazard classes and hazard categories:

Section 4.1: Hazardous to the aquatic environment — Chronic hazard categories 3, 4

ANNEX VI
Part 1 of this Annex provides an introduction to the list of harmonised classification and labelling, including information listed for each entry and related classifications and hazard statements in Table 3.1, subject to certain considerations arising from translating the classifications listed in Annex I to Directive 67/548/EEC.
Part 2 of this Annex lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling of substances at Community level.
Part 3 of this Annex lists hazardous substances for which harmonised classification and labelling have been established at Community level. In Table 3.1 the classification and labelling are based on the criteria in Annex I to this Regulation. In Table 3.2 classification and labelling are based on the criteria in Annex VI to Directive 67/548/EEC.

1.  1.1.  1.1.1.  1.1.1.1. 
Entries in Part 3 are listed according to the atomic number of the element most characteristic of the properties of the substance. Organic substances, because of their variety, have been placed in classes. The Index number for each substance is in the form of a digit sequence of the type ABC-RST-VW-Y. ABC corresponds to the atomic number of the most characteristic element or the most characteristic organic group in the molecule. RST is the consecutive number of the substance in the series ABC. VW denotes the form in which the substance is produced or placed on the market. Y is the check-digit calculated in accordance with the 10-digit ISBN method. This number is indicated in the column entitled ‘Index No’.
 1.1.1.2. 
The EC number, i.e. EINECS, ELINCS or NLP, is the official number of the substance within the European Union. The EINECS number can be obtained from the European Inventory of Existing Commercial Chemical Substance (EINECS). The ELINCS number can be obtained from the European List of Notified Substances (as amended) (EUR 22543 EN, Office for Official Publications of the European Communities, 2006, ISSN 1018-5593). The NLP number can be obtained from the list of ‘No-longer-polymers’ (as amended) (Document, Office for Official Publications of the European Communities, 1997, ISBN 92-827-8995-0). The EC number is a seven-digit system of the type XXX-XXX-X which starts at 200-001-8 (EINECS), at 400-010-9 (ELINCS) and at 500-001-0 (NLP). This number is indicated in the column entitled ‘EC No’.
 1.1.1.3. 
The Chemical Abstracts Service (CAS) number is also included to assist identification of the entry. It should be noted that the EINECS number includes both anhydrous and hydrated forms of a substance, and there are frequently different CAS numbers for anhydrous and hydrated forms. The CAS number included is for the anhydrous form only, and therefore the CAS number shown does not always describe the entry as accurately as the EINECS number. This number is indicated in the column entitled ‘CAS No’.
 1.1.1.4. 
Wherever possible, hazardous substances are designated by their IUPAC names. Substances listed in EINECS, ELINCS or the list of ‘No-longer-polymers’ are designated using the names in these lists. Other names, such as usual or common names, are included in some cases. Whenever possible, plant protection products and biocides are designated by their ISO names.

Impurities, additives and minor components are normally not mentioned unless they contribute significantly to the classification of the substance.

Some substances are described with a specific percentage of purity. Substances containing a higher content of active material (e.g. organic peroxide) than this percentage are not included in the entry in Part 3 and may have other hazardous properties (e.g. explosive) and should be classified and labelled accordingly.

Where specific concentration limits are shown, these apply to the substance or substances shown in the entry. In particular, in the case of entries which are mixtures of substances or substances described with a specific percentage of purity, the limits apply to the substance as described in Part 3 and not the pure substance.

Without prejudice to Article 17(2), for substances appearing in Part 3, the name of the substance to be used on the label shall be one of the designations given there. For certain substances, additional information has been added in square brackets in order to help identify the substance. This additional information need not be included on the label.

Certain entries contain a reference to impurities; in these cases the name of the substance is followed by the text: ‘(containing ≥ xx % impurity)’. The reference in brackets is then to be considered as a part of the name, and must be included on the label.
 1.1.1.5. 
A number of group entries are included in Part 3. In these cases, the classification and labelling requirements will apply to all substances covered by the description.

In some cases, there are classification and labelling requirements for specific substances that would be covered by the group entry. In such cases a specific entry is included in Part 3 for the substance and the group entry will be annotated with the phrase ‘except those specified elsewhere in this Annex’.

In some cases, individual substances may be covered by more than one group entry. In these cases, the classification of the substance reflects the classification for each of the two group entries. In cases where different classifications for the same hazard are given, the most severe classification shall be applied.

Entries in Part 3 for salts (under any denomination) cover both anhydrous and hydrous forms, unless specified otherwise.

EC or CAS numbers are not usually included for entries which comprise more than four individual substances.
 1.1.2.  1.1.2.1.  1.1.2.1.1. 
The classification for each entry is based on the criteria set out in Annex I, in accordance with Article 13(a) and is presented in the form of a code representing the hazard class and the category or categories/divisions/types within this hazard class.

The Hazard class and category codes used for each of the hazard categories/divisions/types included in a class are shown in Table 1.1.


Hazard Class Hazard Class and Category Code
Explosive Unst. Expl.Expl. 1.1Expl. 1.2Expl. 1.3Expl. 1.4Expl. 1.5Expl. 1.6
Flammable gas Flam. Gas 1Flam. Gas 2
Flammable aerosol Flam. Aerosol 1Flam. Aerosol 2
Oxidising gas Ox. Gas 1
Gases under pressure Press. Gas
Flammable liquid Flam. Liq. 1Flam. Liq. 2Flam. Liq. 3
Flammable solid Flam. Sol. 1Flam. Sol. 2
Self-reactive substance or mixture Self-react. ASelf-react. BSelf-react. CDSelf-react. EFSelf-react. G
Pyrophoric liquid Pyr. Liq. 1
Pyrophoric solid Pyr. Sol. 1
Self-heating substance or mixture Self-heat. 1Self-heat. 2
Substance or mixture which in contact with water emits flammable gas Water-react. 1Water-react. 2Water-react. 3
Oxidising liquid Ox. Liq. 1Ox. Liq. 2Ox. Liq. 3
Oxidising solid Ox. Sol. 1Ox. Sol. 2Ox. Sol. 3
Organic peroxide Org. Perox. AOrg. Perox. BOrg. Perox. CDOrg. Perox. EFOrg. Perox. G
Substance or mixture corrosive to metals Met. Corr. 1
Acute toxicity Acute Tox. 1Acute Tox. 2Acute Tox. 3Acute Tox. 4
Skin corrosion/irritation Skin Corr. 1ASkin Corr. 1BSkin Corr. 1CSkin Irrit. 2
Serious eye damage/eye irritation Eye Dam. 1Eye Irrit. 2
Respiratory/skin sensitization Resp. Sens. 1Skin Sens. 1
Germ cell mutagenicity Muta. 1AMuta. 1BMuta. 2
Carcinogenicity Carc. 1ACarc. 1BCarc. 2
Reproductive toxicity Repr. 1ARepr. 1BRepr. 2Lact.
Specific target organ toxicity — single exposure STOT SE 1STOT SE 2STOT SE 3
Specific target organ toxicity — repeated exposure STOT RE 1STOT RE 2
Aspiration hazard Asp. Tox. 1
Hazardous to the aquatic environment Aquatic Acute 1Aquatic Chronic 1Aquatic Chronic 2Aquatic Chronic 3Aquatic Chronic 4
Hazardous for the ozone layer Ozone

 1.1.2.1.2. 
The hazard statements assigned in accordance with Article 13(b), are indicated in accordance with Annex III. In addition, for certain hazard statements letters are added to the 3-digit code. The following additional codes are used:


H350i May cause cancer by inhalation.
H360F May damage fertility.
H360D May damage the unborn child.
H361f Suspected of damaging fertility.
H361d Suspected of damaging the unborn child.
H360FD May damage fertility. May damage the unborn child.
H361fd Suspected of damaging fertility. Suspected of damaging the unborn child.
H360Fd May damage fertility. Suspected of damaging the unborn child.
H360Df May damage the unborn child. Suspected of damaging fertility.
 1.1.2.2. 
In the labelling column, the following elements are listed:


((i)) the hazard pictogram codes as specified in Annex V, in accordance with the precedence rules in Article 26;
((ii)) the signal word code ‘Dgr’ for ‘Danger’or ‘Wng’ for ‘Warning’, in accordance with the precedence rule in Article 20(3);
((iii)) the hazard statement codes as specified in Annex III, in accordance with the classification;
((iv)) the codes for the supplemental statements assigned in accordance with Article 25(1) and the rules specified in Annex II, part 1.
 1.1.2.3. 
Specific concentration limits, where different from the generic concentration limits given in Annex I for a certain category, are given in a separate column together with the classification concerned using the same codes as under 1.1.2.1.1. Where no specific concentration limits are given in this Annex for a certain category, the generic concentration limits given in Annex I must be applied for the classification of substances containing impurities, additives or individual constituents or for mixtures. An asterisk (*) in this column indicates that the entry has specific concentration limits for acute toxicity under Directive 67/548/EEC (Table 3.2): see also section 1.2.1.

Unless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.

In case an M-factor has been harmonised for substances classified as hazardous to the aquatic environment in the categories Aquatic Acute 1 or Aquatic Chronic 1, this M-factor is given in the same column as the specific concentration limits. Where an M-factor is not given in Table 3.1, an M-factor based on available data for the substance shall be set by the manufacturer, importer or downstream user. When a mixture including the substance is classified by the manufacturer, importer or downstream user using the summation method, this M-factor shall be used. For the setting of M-factors, see paragraph 4.1.3.5.5.5 of Annex I.
 1.1.3. 
The note(s) assigned to an entry are listed in the column entitled ‘Notes’. The meaning of the notes is as follows:
 1.1.3.1. 
Without prejudice to Article 17(2), the name of the substance must appear on the label in the form of one of the designations given in Part 3.

In Part 3, use is sometimes made of a general description such as ‘... compounds’ or ‘... salts’. In this case, the supplier is required to state on the label the correct name, due account being taken of section 1.1.1.4.

Some substances (acids, bases, etc.) are placed on the market in aqueous solutions at various concentrations and, therefore, these solutions require different classification and labelling since the hazards vary at different concentrations.

In Part 3 entries with Note B have a general designation of the following type: ‘nitric acid … %’.

In this case the supplier must state the percentage concentration of the solution on the label. Unless otherwise stated, it is assumed that the percentage concentration is calculated on a weight/weight basis.

Some organic substances may be marketed either in a specific isomeric form or as a mixture of several isomers.

In this case the supplier must state on the label whether the substance is a specific isomer or a mixture of isomers.

Certain substances which are susceptible to spontaneous polymerisation or decomposition are generally placed on the market in a stabilised form. It is in this form that they are listed in Part 3.

However, such substances are sometimes placed on the market in a non-stabilised form. In this case, the supplier must state on the label the name of the substance followed by the words ‘non-stabilised’.

Substances with specific effects on human health (see Chapter 4 of Annex VI to Directive 67/548/EEC) that are classified as carcinogenic, mutagenic and/or toxic for reproduction in categories 1 or 2 are ascribed Note E if they are also classified as very toxic (T+), toxic (T) or harmful (Xn). For these substances, the risk phrases R20, R21, R22, R23, R24, R25, R26, R27, R28, R39, R68 (harmful), R48 and R65 and all combinations of these risk phrases shall be preceded by the word ‘Also’.

This substance may contain a stabiliser. If the stabiliser changes the hazardous properties of the substance, as indicated by the classification in Part 3, classification and labelling should be provided in accordance with the rules for classification and labelling of hazardous mixtures.

This substance may be marketed in an explosive form in which case it must be evaluated using the appropriate test methods. The classification and labelling provided shall reflect the explosive properties.

The classification and labelling shown for this substance applies to the hazardous property(ies) indicated by the hazard statement(s) in combination with the hazard class(es) and category(ies) shown. The requirements of Article 4 for manufacturers, importers or downstream users of this substance apply to all other hazard classes and categories. For hazard classes where the route of exposure or the nature of the effects leads to a differentiation of the classification of the hazard class, the manufacturer, importer or downstream user is required to consider the routes of exposure or the nature of the effects not already considered.

The final label shall follow the requirements of Article 17 and of section 1.2 of Annex I.

The classification and label shown for this substance applies to the dangerous property(ies) indicated by the risk phrase(s) in combination with the category(ies) of danger shown. Manufacturers, importers and downstream users of this substance shall be obliged to carry out an investigation to make themselves aware of the relevant and accessible data which exists for all other properties to classify and label the substance. The final label shall follow the requirements of section 7 of Annex VI to Directive 67/548/EEC.

The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7). This note applies only to certain complex coal- and oil-derived substances in Part 3.

The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w 1,3-butadiene (EINECS No 203-450-8). If the substance is not classified as a carcinogen or mutagen, at least the precautionary statements (P102-)P210-P403 (Table 3.1) or the S-phrases (2-)9-16 (Table 3.2) should apply. This note applies only to certain complex oil-derived substances in Part 3.

The classification as a carcinogen need not apply if it can be shown that the substance contains less than 3 % DMSO extract as measured by IP 346 ‘Determination of polycyclic aromatics in unused lubricating base oils and asphaltene free petroleum fractions — Dimethyl sulphoxide extraction refractive index method’, Institute of Petroleum, London. This note applies only to certain complex oil-derived substances in Part 3.

The classification as a carcinogen need not apply if it can be shown that the substance contains less than 0,005 % w/w benzo[a]-pyrene (EINECS No 200-028-5). This note applies only to certain complex coal-derived substances in Part 3.

The classification as a carcinogen need not apply if the full refining history is known and it can be shown that the substance from which it is produced is not a carcinogen. This note applies only to certain complex oil-derived substances in Part 3.

The classification as a carcinogen or mutagen need not apply if it can be shown that the substance contains less than 0,1 % w/w benzene (EINECS No 200-753-7).

When the substance is not classified as a carcinogen at least the precautionary statements (P102-)P260-P262-P301 + P310-P331 (Table 3.1) or the S-phrases (2-)23-24-62 (Table 3.2) shall apply.

This note applies only to certain complex oil-derived substances in Part 3.

The classification as a carcinogen need not apply if it can be shown that the substance fulfils one of the following conditions:


— a short term biopersistence test by inhalation has shown that the fibres longer than 20 μm have a weighted half-life less than 10 days; or
— a short term biopersistence test by intratracheal instillation has shown that the fibres longer than 20 μm have a weighted half-life less than 40 days; or
— an appropriate intra-peritoneal test has shown no evidence of excess carcinogenicity; or
— absence of relevant pathogenicity or neoplastic changes in a suitable long term inhalation test.

The classification as a carcinogen need not apply to fibres with a length weighted geometric mean diameter less two standard geometric errors greater than 6 μm.

This substance may not require a label according to Article 17 (see section 1.3 of Annex I) (Table 3.1).

This substance may not require a label according to Article 23 of Directive 67/548/EEC (see section 8 of Annex VI to that Directive) (Table 3.2).

This substance may be marketed in a form which does not have the physical hazards as indicated by the classification in the entry in Part 3. If the results of the relevant method or methods in accordance with Part 2 of Annex I of this Regulation show that the specific form of substance marketed does not exhibit this physical property or these physical hazards, the substance shall be classified in accordance with the result or results of this test or these tests. Relevant information, including reference to the relevant test method(s) shall be included in the safety data sheet.

When put on the market gases have to be classified as ‘Gases under pressure’, in one of the groups compressed gas, liquefied gas, refrigerated liquefied gas or dissolved gas. The group depends on the physical state in which the gas is packaged and therefore has to be assigned case by case.
 1.1.3.2. 
The concentration stated or, in the absence of such concentrations, the generic concentrations of this Regulation (Table 3.1) or the generic concentrations of Directive 1999/45/EC (Table 3.2), are the percentages by weight of the metallic element calculated with reference to the total weight of the mixture.

The concentration of isocyanate stated is the percentage by weight of the free monomer calculated with reference to the total weight of the mixture.

The concentration stated is the percentage by weight of chromate ions dissolved in water calculated with reference to the total weight of the mixture.

The concentration limits for gaseous mixtures are expressed as volume per volume percentage.

Alloys containing nickel are classified for skin sensitisation when the release rate of 0,5 μg Ni/cm2/week, as measured by the European Standard reference test method EN 1811, is exceeded.
 1.1.4.  1.1.4.1. 
The classification for each category of danger (as defined in Article 2(2) of Directive 67/548/EEC) is normally presented in the form of an abbreviation representing the category of danger together with the appropriate risk phrase or phrases. However, in some cases (i.e. substances classified as flammable, sensitising and some substances classified as dangerous for the environment) the risk phrase alone is used;

The abbreviation for each of the categories of danger is shown below:


— explosive: E
— oxidising: O
— extremely flammable: F+
— highly flammable: F
— flammable: R10
— very toxic: T+
— Toxic: T
— harmful: Xn
— corrosive: C
— irritant: Xi
— sensitising: R42 and/or R43
— carcinogenic: Carc. Cat. (1, 2 or 3)
— mutagenic: Muta. Cat. (1, 2 or 3)
— toxic for reproduction: Repr. Cat. (1, 2 or 3)
— dangerous for the environment: N or R52 and/or R53;
 1.1.4.2. 

((i)) the letter assigned to the substance in accordance with Annex II to Directive 67/548/EEC (see Article 23(2)(c) Directive 67/548/EEC). This acts as an abbreviation for the symbol and for the indication of danger (if these are assigned);
((ii)) the risk phrases, denoted as a series of numbers preceded by the letter R indicating the nature of the special risks, in accordance with Annex III to Directive 67/548/EEC (see Article 23(2)(d) Directive 67/548/EEC). The numbers are separated by either a dash (-) to denote separate statements concerning special risks (R), or an oblique stroke (/) to denote a combined statement, in a single sentence, of the special risks as set out in Annex III to Directive 67/548/EEC;
((iii)) the safety phrases denoted as a series of numbers preceded by the letter S indicating the recommended safety precautions, in accordance with Annex IV to Directive 67/548/EEC (see Article 23(2)(e) Directive 67/548/EEC). Again the numbers are separated by either a dash or an oblique stroke; the significance of recommended safety precautions is set out in Annex IV to Directive 67/548/EEC. The safety phrases shown apply only to substances; for mixtures, phrases are selected according to the usual rules.
Note that for certain dangerous substances and mixtures sold to the general public certain S-phrases are mandatory.
S1, S2 and S45 are obligatory for all very toxic, toxic and corrosive substances and mixtures sold to the general public.
S2 and S46 are obligatory for all other dangerous substances and mixtures sold to the general public other than those that have only been classified as dangerous for the environment.
Safety phrases S1 and S2 are shown in brackets in Annex I and can only be omitted from the label when the substance or mixture is sold for industrial use only.
 1.1.4.3. 
The concentration limits and associated classifications are necessary to classify dangerous mixtures containing the substance in accordance with Directive 1999/45/EC.

Unless otherwise shown, the concentration limits are a percentage by weight of the substance calculated with reference to the total weight of the mixture.

Where no concentration limits are given, the concentration limits to be used when applying the conventional method of assessing health hazards are those in Annex II, and when applying the conventional method of assessing environmental hazards are those in Annex III to Directive 1999/45/EC.
 1.1.4.4. 
It is recommended to update the physical hazards of some entries in Table 3.2 in a forthcoming adaptation to technical progress.

Until these entries are updated, the physical hazards of the corresponding entries in both tables will not be in conformity. These entries are indicated with reference ⊗ in Table 3.2.
 1.2.  1.2.1. 
For certain hazard classes, including acute toxicity and STOT repeated exposure, the classification according to the criteria in Directive 67/548/EEC does not correspond directly to the classification in a hazard class and category under this Regulation. In these cases the classification in this Annex shall be considered as a minimum classification. This classification shall be applied if none of the following conditions are fulfilled:


— the manufacturer or importer has access to data or other information as specified in Part 1 of Annex I that lead to classification in a more severe category compared to the minimum classification. Classification in the more severe category must then be applied;
— the minimum classification can be further refined based on the translation table in Annex VII when the physical state of the substance used in the acute inhalation toxicity test is known to the manufacturer or importer. The classification as obtained from Annex VII shall then substitute the minimum classification indicated in this Annex if it differs from it.

Minimum classification for a category is indicated by the reference * in the column ‘Classification’ in Table 3.1.

The reference * can also be found in the column ‘Specific concentration Limits and M-factors’ where it indicates that the entry concerned has specific concentration limits under Directive 67/548/EEC (Table 3.2) for acute toxicity. These concentration limits cannot be ‘translated’ into concentration limits under this Regulation, especially when a minimum classification is given. However, when the reference * is shown, the classification for acute toxicity for this entry may be of special concern.
 1.2.2. 
For certain hazard classes, e.g. STOT, the route of exposure should be indicated in the hazard statement only if it is conclusively proven that no other route of exposure can cause the hazard in accordance to the criteria in Annex I. Under Directive 67/548/EEC the route of exposure is indicated for classifications with R48 when there was data justifying the classification for this route of exposure. The classification under 67/548/EEC indicating the route of exposure has been translated into the corresponding class and category according to this Regulation, but with a general hazard statement not specifying the route of exposure as the necessary information is not available.

These hazard statements are indicated by the reference ** in Table 3.1.
 1.2.3. 
Hazard statements H360 and H361 indicate a general concern for effects on both fertility and development: ‘May damage/Suspected of damaging fertility or the unborn child’. According to the criteria, the general hazard statement can be replaced by the hazard statement indicating only the property of concern, where either fertility or developmental effects are proven to be not relevant.

In order not to lose information from the harmonised classifications for fertility and developmental effects under Directive 67/548/EEC, the classifications have been translated only for those effects classified under that Directive.

These hazard statements are indicated by the reference *** in Table 3.1.
 1.2.4. 
For some entries the correct classification for physical hazards could not be established because sufficient data are not available for the application of the classification criteria in this Regulation. The entry might be assigned to a different (also higher) category or even another hazard class than indicated. The correct classification shall be confirmed by testing.

The entries with physical hazards that need to be confirmed by testing are indicated by the reference **** in Table 3.1.

2. 
This Part lays down general principles for preparing dossiers to propose and justify harmonised classification and labelling.

The relevant parts of sections 1, 2 and 3 of Annex I to Regulation (EC) No 1907/2006 shall be used for the methodology and format of any dossier.

For all dossiers any relevant information from registration dossiers shall be considered and other available information may be used. For hazard information which has not been previously submitted to the Agency, a robust study summary shall be included in the dossier.

A dossier for harmonised classification and labelling shall contain the following:


— Proposal
The proposal shall include the identity of the substance or substances concerned and the harmonised classification and labelling proposed.
— Justification for the proposed harmonised classification and labelling
A comparison of the available information with the criteria contained in Parts 2 to 5, taking into account the general principles in Part 1, of Annex I to this Regulation shall be completed and documented in the format set out in Part B of the Chemical Safety Report in Annex I to Regulation (EC) No 1907/2006.
— Justification for other effects at Community level
For other effects than carcinogenity, mutagenicity, reprotoxicity and respiratory sensitisation a justification shall be provided that there is a need for action demonstrated at Community level. This does not apply for an active substance in the meaning of Directive 91/414/EEC or Directive 98/8/EC.

3. 
Table 3.1: List of harmonised classification and labelling of hazardous substances is listed in the separate Volume IIIa.

Table 3.2: The list of harmonised classification and labelling of hazardous substances from Annex I to Directive 67/548/EEC is listed in the separate Volume IIIb.


Index No International Chemical Identification EC No CAS No Classification Labelling Specific Conc. Limits, M-factors Notes
Hazard Class and Category Code(s) Hazard statement Code(s) Pictogram, Signal Word Code(s) Hazard statement Code(s) Suppl. Hazard statement Code(s)  
001-001-00-9 hydrogen 215-605-7 1333-74-0 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   U
001-002-00-4 aluminium lithium hydride 240-877-9 16853-85-3 Water-react. 1 H260 GHS02Dgr H260   
001-003-00-X sodium hydride 231-587-3 7646-69-7 Water-react. 1 H260 GHS02Dgr H260   
001-004-00-5 calcium hydride 232-189-2 7789-78-8 Water-react. 1 H260 GHS02Dgr H260   
003-001-00-4 lithium 231-102-5 7439-93-2 Water-react. 1Skin Corr. 1B H260H314 GHS02GHS05Dgr H260H314 EUH014  
003-002-00-X n-hexyllithium 404-950-0 21369-64-2 Water-react. 1Pyr. Sol. 1Skin Corr. 1A H260H250H314 GHS02GHS05Dgr H260H250H314 EUH014  
004-001-00-7 beryllium 231-150-7 7440-41-7 Carc. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H350iH330H301H372 **H319H335H315H317 GHS06GHS08Dgr H350iH330H301H372 **H319H335H315H317   
004-002-00-2 beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex — — Carc. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H350iH330H301H372 **H319H335H315H317H411 GHS06GHS08GHS09Dgr H350iH330H301H372 **H319H335H315H317H411   A
004-003-00-8 beryllium oxide 215-133-1 1304-56-9 Carc. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H350iH330H301H372 **H319H335H315H317 GHS06GHS08Dgr H350iH330H301H372 **H319H335H315H317   
005-001-00-X boron trifluoride 231-569-5 7637-07-2 Press. GasAcute Tox. 2 *Skin Corr. 1A H330H314 GHS04GHS06GHS05Dgr H330H314 EUH014  U
005-002-00-5 boron trichloride 233-658-4 10294-34-5 Press. GasAcute Tox. 2 *Acute Tox. 2 *Skin Corr. 1B H330H300H314 GHS04GHS06GHS05Dgr H330H300H314 EUH014  U
005-003-00-0 boron tribromide 233-657-9 10294-33-4 Acute Tox. 2 *Acute Tox. 2 *Skin Corr. 1A H330H300H314 GHS06GHS05Dgr H330H300H314 EUH014  
005-004-00-6 trialkylboranes, solid — — Pyr. Sol. 1Skin Corr. 1B H250H314 GHS02GHS05Dgr H250H314   A
005-004-01-3 trialkylboranes, liquid — — Pyr. Liq. 1Skin Corr. 1B H250H314 GHS02GHS05Dgr H250H314   A
005-005-00-1 trimethyl borate 204-468-9 121-43-7 Flam. Liq. 3Acute Tox. 4 * H226H312 GHS02GHS07Wng H226H312   
005-006-00-7 dibutyltin hydrogen borate 401-040-5 75113-37-0 STOT RE 1Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H372 **H312H302H318H317H400H410 GHS08GHS05GHS07GHS09Dgr H372 **H312H302H318H317H410   
005-009-00-3 tetrabutylammonium butyltriphenylborate 418-080-4 120307-06-4 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
005-010-00-9 N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate 422-050-6 118612-00-3 Carc. 2Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1 H351H302H315H318 GHS08GHS05GHS07Dgr H351H302H315H318   
005-012-00-X diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate 418-070-1 141714-54-7 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
006-001-00-2 carbon monoxide 211-128-3 630-08-0 Flam. Gas 1Press. GasRepr. 1AAcute Tox. 3 *STOT RE 1 H220H360D ***H331H372 ** GHS02GHS04GHS06GHS08Dgr H220H360D ***H331H372 **   U
006-002-00-8 phosgene;carbonyl chloride 200-870-3 75-44-5 Press. GasAcute Tox. 2 *Skin Corr. 1B H330H314 GHS04GHS06GHS05Dgr H330H314   U
006-003-00-3 carbon disulphide 200-843-6 75-15-0 Flam. Liq. 2Repr. 2STOT RE 1Eye Irrit. 2Skin Irrit. 2 H225H361fdH372 **H319H315 GHS02GHS08GHS07Dgr H225H361fdH372 **H319H315  Repr. 2; H361fd: C ≥ 1 %STOT RE 1; H372: C ≥ 1 %STOT RE 2; H373: 0,2 % ≤C < 1 % 
006-004-00-9 calcium carbide 200-848-3 75-20-7 Water-react. 1 H260 GHS02Dgr H260   T
006-005-00-4 thiram (ISO);tetramethylthiuram disulphide 205-286-2 137-26-8 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H332H302H373 **H319H315H317H400H410 GHS08GHS07GHS09Wng H332H302H373 **H319H315H317H410  M = 10 
006-006-00-X hydrogen cyanide;hydrocyanic acid 200-821-6 74-90-8 Flam. Liq. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H224H330H400H410 GHS02GHS06GHS09Dgr H224H330H410   
006-006-01-7 hydrogen cyanide … %;hydrocyanic acid … % 200-821-6 74-90-8 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H400H410 GHS06GHS09Dgr H330H310H300H410   B
006-007-00-5 salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide — — Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H400H410 GHS06GHS09Dgr H330H310H300H410 EUH032  A
006-008-00-0 antu (ISO);1-(1-naphthyl)-2-thiourea 201-706-3 86-88-4 Acute Tox. 2 *Carc. 2 H300H351 GHS06GHS08Dgr H300H351   
006-009-00-6 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;isolan 204-318-2 119-38-0 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
006-010-00-1 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;dimetan 204-525-8 122-15-6 Acute Tox. 3 * H301 GHS06Dgr H301   
006-011-00-7 carbaryl (ISO);1-naphthyl methylcarbamate 200-555-0 63-25-2 Carc. 2Acute Tox. 4 *Aquatic Acute 1 H351H302H400 GHS08GHS07GHS09Wng H351H302H400   
006-012-00-2 ziram (ISO);zinc bis dimethyldithiocarbamate 205-288-3 137-30-4 Acute Tox. 2 *Acute Tox. 4 *STOT RE 2 *STOT SE 3Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H302H373 **H335H318H317H400H410 GHS06GHS08GHS05GHS09Dgr H330H302H373 **H335H318H317H410  M = 100 
006-013-00-8 metam-sodium (ISO);sodium methyldithiocarbamate 205-293-0 137-42-8 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H314H317H400H410 GHS05GHS07GHS09Dgr H302H314H317H410 EUH031  
006-014-00-3 nabam (ISO);disodium ethylenebis(N,N'-dithiocarbamate) 205-547-0 142-59-6 Acute Tox. 4 *STOT SE 3Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H335H317H410 GHS07GHS09Wng H302H335H317H410   
006-015-00-9 diuron (ISO);3-(3,4-dichlorophenyl)-1,1-dimethylurea 206-354-4 330-54-1 Carc. 2Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H351H302H373 **H400H410 GHS08GHS07GHS09Wng H351H302H373 **H410   
006-016-00-4 propoxur (ISO);2-isopropyloxyphenyl N-methylcarbamate;2-isopropoxyphenyl methylcarbamate 204-043-8 114-26-1 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410   
006-017-00-X aldicarb (ISO);2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime 204-123-2 116-06-3 Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H330H300H311H400H410 GHS06GHS09Dgr H330H300H311H410   
006-018-00-5 aminocarb (ISO);4-dimethylamino-3-tolyl methylcarbamate 217-990-7 2032-59-9 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H410   
006-019-00-0 di-allate (ISO);S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate 218-961-1 2303-16-4 Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H302H400H410 GHS08GHS07GHS09Wng H351H302H410   
006-020-00-6 barban (ISO);4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate 202-930-4 101-27-9 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
006-021-00-1 linuron (ISO);3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea 206-356-5 330-55-2 Repr. 1BCarc. 2Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H360DfH351H302H373 **H400H410 GHS08GHS07GHS09Dgr H360DfH351H302H373 **H410   
006-022-00-7 decarbofuran (ISO);2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate — 1563-67-3 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301   
006-023-00-2 mercaptodimethur (ISO);methiocarb (ISO);3,5-dimethyl-4-methylthiophenyl N-methylcarbamate 217-991-2 2032-65-7 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410   
006-024-00-8 proxan-sodium (ISO);sodium O-isopropyldithiocarbonate 205-443-5 140-93-2 Acute Tox. 4 *Skin Irrit. 2Aquatic Chronic 2 H302H315H411 GHS07GHS09Wng H302H315H411   
006-025-00-3 allethrin;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;bioallethrin;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]S-bioallethrin;(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]esbiothrin;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3] 209-542-4 [1]249-013-5 [2]-[3] 584-79-2 [1]28434-00-6 [2]84030-86-4 [3] Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H302H400H410 GHS07GHS09Wng H332H302H410   C
006-026-00-9 carbofuran (ISO);2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate 216-353-0 1563-66-2 Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H300H400H410 GHS06GHS09Dgr H330H300H410   
006-028-00-X dinobuton (ISO);2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate 213-546-1 973-21-7 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410   
006-029-00-5 dioxacarb (ISO);2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate 230-253-4 6988-21-2 Acute Tox. 3 *Aquatic Chronic 2 H301H411 GHS06GHS09Dgr H301H411   
006-030-00-0 EPTC (ISO);S-ethyl dipropylthiocarbamate 212-073-8 759-94-4 Acute Tox. 4 * H302 GHS07Wng H302   
006-031-00-6 formetanate (ISO);3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate 244-879-0 22259-30-9 Acute Tox. 2 *Acute Tox. 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H300H317H400H410 GHS06GHS09Dgr H330H300H317H410   
006-032-00-1 monolinuron (ISO);3-(4-chlorophenyl)-1-methoxy-1-methylurea 217-129-5 1746-81-2 Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H302H373 **H400H410 GHS08GHS07GHS09Wng H302H373 **H410   
006-033-00-7 metoxuron (ISO);3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea 243-433-2 19937-59-8 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
006-034-00-2 pebulate (ISO);N-butyl-N-ethyl-S-propylthiocarbamate 214-215-4 1114-71-2 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
006-035-00-8 pirimicarb (ISO);5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate 245-430-1 23103-98-2 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410   
006-036-00-3 benzthiazuron (ISO);1-benzothiazol-2-yl-3-methylurea 217-685-9 1929-88-0 Acute Tox. 4 * H302 GHS07Wng H302   
006-037-00-9 promecarb (ISO);3-isopropyl-5-methylphenyl N-methylcarbamate 220-113-0 2631-37-0 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410   
006-038-00-4 sulfallate (ISO);2-chloroallyl N,N-dimethyldithiocarbamate 202-388-9 95-06-7 Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H302H400H410 GHS08GHS07GHS09Dgr H350H302H410   
006-039-00-X tri-allate (ISO);S-2,3,3-trichloroallyl diisopropylthiocarbamate 218-962-7 2303-17-5 Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H373 **H317H400H410 GHS08GHS07GHS09Wng H302H373 **H317H410   
006-040-00-5 3-methylpyrazol-5-yl-dimethylcarbamate;monometilan — 2532-43-6 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301   
006-041-00-0 dimethylcarbamoyl chloride 201-208-6 79-44-7 Carc. 1BAcute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H350H331H302H319H335H315 GHS06GHS08Dgr H350H331H302H319H335H315  Carc. 1B; H350: C ≥ 0,001 % 
006-042-00-6 monuron (ISO);3-(4-chlorophenyl)-1,1-dimethylurea 205-766-1 150-68-5 Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H302H400H410 GHS08GHS07GHS09Wng H351H302H410   
006-043-00-1 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;monuron-TCA — 140-41-0 Carc. 2Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H351H319H315H400H410 GHS08GHS07GHS09Wng H351H319H315H410   
006-044-00-7 isoproturon (ISO);3-(4-isopropylphenyl)-1,1-dimethylurea 251-835-4 34123-59-6 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410  M = 10 
006-045-00-2 methomyl (ISO);1-(methylthio)ethylideneamino N-methylcarbamate 240-815-0 16752-77-5 Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H300H400H410 GHS06GHS09Dgr H300H410   
006-046-00-8 bendiocarb (ISO);2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate 245-216-8 22781-23-3 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H331H301H312H410 GHS06GHS09Dgr H331H301H312H410   
006-047-00-3 bufencarb (ISO);reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate — 8065-36-9 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H410   
006-048-00-9 ethiofencarb (ISO);2-(ethylthiomethyl)phenyl N-methylcarbamate 249-981-9 29973-13-5 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
006-049-00-4 dixanthogen;O,O-diethyl dithiobis(thioformate) 207-944-4 502-55-6 Acute Tox. 4 * H302 GHS07Wng H302   
006-050-00-X 1,1-dimethyl-3-phenyluronium trichloroacetate;fenuron-TCA — 4482-55-7 Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H315H400H410 GHS07GHS09Wng H315H410   
006-051-00-5 ferbam (ISO);iron tris(dimethyldithiocarbamate) 238-484-2 14484-64-1 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H335H315H400H410 GHS07GHS09Wng H319H335H315H410   
006-052-00-0 formetanate hydrochloride;3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate 245-656-0 23422-53-9 Acute Tox. 2 *Acute Tox. 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H300H317H400H410 GHS06GHS09Dgr H330H300H317H410   
006-053-00-6 isoprocarb (ISO);2-isopropylphenyl N-methylcarbamate 220-114-6 2631-40-5 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
006-054-00-1 mexacarbate (ISO);3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate 206-249-3 315-18-4 Acute Tox. 2 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H300H312H400H410 GHS06GHS09Dgr H300H312H410   
006-055-00-7 xylylcarb (ISO);3,4-dimethylphenyl N-methylcarbamate;3,4-xylyl methylcarbamate;MPMC 219-364-9 2425-10-7 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
006-056-00-2 metolcarb (ISO);m-tolyl methylcarbamate;MTMC 214-446-0 1129-41-5 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
006-057-00-8 nitrapyrin (ISO);2-chloro-6-trichloromethylpyridine 217-682-2 1929-82-4 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
006-058-00-3 noruron (ISO);1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea — 2163-79-3 Acute Tox. 4 * H302 GHS07Wng H302   
006-059-00-9 oxamyl (ISO);N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate; 245-445-3 23135-22-0 Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 4 *Aquatic Chronic 2 H330H300H312H411 GHS06GHS09Dgr H330H300H312H411   
006-060-00-4 oxycarboxin (ISO);2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide 226-066-2 5259-88-1 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
006-061-00-X S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;prothiocarb hydrochloride 243-193-9 19622-19-6 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
006-062-00-5 methyl 3,4-dichlorophenylcarbanilate;SWEP. — 1918-18-9 Acute Tox. 4 * H302 GHS07Wng H302   
006-063-00-0 thiobencarb (ISO);S-4-chlorobenzyl diethylthiocarbamate 248-924-5 28249-77-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
006-064-00-6 thiofanox (ISO);3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime 254-346-4 39196-18-4 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410   
006-065-00-1 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;triamid — 15271-41-7 Acute Tox. 2 *Acute Tox. 3 *Aquatic Chronic 2 H300H311H411 GHS06GHS09Dgr H300H311H411   
006-066-00-7 vernolate (ISO);S-propyl dipropylthiocarbamate 217-681-7 1929-77-7 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
006-067-00-2 XMC;3,5-xylyl methylcarbamate — 2655-14-3 Acute Tox. 4 * H302 GHS07Wng H302   
006-068-00-8 diazomethane 206-382-7 334-88-3 Carc. 1B H350 GHS08Dgr H350   
006-069-00-3 thiophanate-methyl (ISO);1,2-di-(3-methoxycarbonyl-2-thioureido)benzene 245-740-7 23564-05-8 Muta. 2Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H341H332H317H400H410 GHS08GHS07GHS09Wng H341H332H317H410   
006-070-00-9 furmecyclox (ISO);N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide 262-302-0 60568-05-0 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410   
006-071-00-4 cyclooct-4-en-1-yl methyl carbonate 401-620-8 87731-18-8 Skin Sens. 1 H317 GHS07Wng H317   
006-072-00-X prosulfocarb (ISO);S-benzyl N,N-dipropylthiocarbamate 401-730-6 52888-80-9 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H302H317H411 GHS07GHS09Wng H302H317H411   
006-073-00-5 3-(dimethylamino)propylurea 401-950-2 31506-43-1 Eye Dam. 1 H318 GHS05Dgr H318   
006-074-00-0 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate 402-440-2 2094-99-7 Acute Tox. 2 *Skin Corr. 1BSTOT RE 2 *Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H314H373 **H334H317H400H410 GHS06GHS08GHS05GHS09Dgr H330H314H373 **H334H317H410   
006-076-00-1 mancozeb (ISO) — 8018-01-7 STOT SE 3Skin Sens. 1 H335H317 GHS07Wng H335H317   
006-077-00-7 maneb (ISO) 235-654-8 12427-38-2 STOT SE 3Skin Sens. 1 H335H317 GHS07Wng H335H317   
006-078-00-2 zineb (ISO);zinc ethylenebis(dithiocarbamate) (polymeric) 235-180-1 12122-67-7 STOT SE 3Skin Sens. 1 H335H317 GHS07Wng H335H317   
006-079-00-8 disulfiram;tetraethylthiuramdisulfide 202-607-8 97-77-8 Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H373 **H317H400H410 GHS08GHS07GHS09Wng H302H373 **H317H410   
006-080-00-3 tetramethylthiuram monosulphide 202-605-7 97-74-5 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H302H317H411 GHS07GHS09Wng H302H317H411   
006-081-00-9 zinc bis(dibutyldithiocarbamate) 205-232-8 136-23-2 Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H319H335H315H317H400H410 GHS07GHS09Wng H319H335H315H317H410   
006-082-00-4 zinc bis(diethyldithiocarbamate) 238-270-9 14324-55-1 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H319H335H315H317H400H410 GHS07GHS09Wng H302H319H335H315H317H410   
006-083-00-X butocarboxim (ISO);3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime 252-139-3 34681-10-2 Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H226H331H311H301H319H400H410 GHS02GHS06GHS09Dgr H226H331H311H301H319H410   
006-084-00-5 carbosulfan (ISO);2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate 259-565-9 55285-14-8 Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H301H317H400H410 GHS06GHS09Dgr H331H301H317H410   
006-085-00-0 fenobucarb (ISO);2-butylphenyl methylcarbamate 223-188-8 3766-81-2 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
006-086-00-6 ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;fenoxycarb 276-696-7 72490-01-8 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
006-087-00-1 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate;furathiocarb 265-974-3 65907-30-4 Acute Tox. 2 *Acute Tox. 3 *STOT RE 2 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H301H373 **H319H315H317H400H410 GHS06GHS08GHS09Dgr H330H301H373 **H319H315H317H410   
006-088-00-7 benfuracarb;ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate — 82560-54-1 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H301H400H410 GHS06GHS09Dgr H331H301H410   
006-089-00-2 chlorine dioxide 233-162-8 10049-04-4 Ox. Gas 1Press. GasAcute Tox. 2 *Skin Corr. 1BAquatic Acute 1 H270H330H314H400 GHS03GHS04GHS06GHS05GHS09Dgr H270H330H314H400 EUH006 M = 1000 U
006-089-01-X chlorine dioxide . . . % 233-162-8 10049-04-4 Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1 H301H314H400 GHS06GHS05GHS09Dgr H301H314H400  Skin Corr. 1B; H314: C ≥ 10 %Skin Irrit. 2; H315: 3 % ≤ C < 10 %Eye Irrit. 2; H319: 0,3 % ≤ C < 10 %STOT SE 3; H335: C ≥ 3 %M = 10 B
006-090-00-8 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate 408-010-0 88558-41-2 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3 H332H318H412 GHS05GHS07Dgr H332H318H412   
007-001-00-5 ammonia, anhydrous 231-635-3 7664-41-7 Flam. Gas 2Press. GasAcute Tox. 3 *Skin Corr. 1BAquatic Acute 1 H221H331H314H400 GHS04GHS06GHS05GHS09Dgr H221H331H314H400   U
007-001-01-2 ammonia ….% 215-647-6 1336-21-6 Skin Corr. 1BAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400  STOT SE 3; H335: C ≥ 5 % B
007-002-00-0 nitrogen dioxide; [1]dinitrogen tetraoxide [2] 233-272-6 [1]234-126-4 [2] 10102-44-0 [1]10544-72-6 [2] Press. GasAcute Tox. 2 *Skin Corr. 1B H330H314 GHS04GHS06GHS05Dgr H330H314  * U5
007-003-00-6 chlormequat chloride (ISO);2-chloroethyltrimethylammonium chloride 213-666-4 999-81-5 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
007-004-00-1 nitric acid … % 231-714-2 7697-37-2 Ox. Liq. 3Skin Corr. 1A H272H314 GHS03GHS05Dgr H272H314  Skin Corr. 1A; H314: C ≥ 20 %Skin Corr. 1B; H314: 5 % ≤ C < 20 %Ox. Liq. 3; H272: C ≥ 65 % B
007-006-00-2 ethyl nitrite 203-722-6 109-95-5 Flam. Gas 1Press. GasAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H220H332H312H302 GHS02GHS04GHS07Dgr H220H332H312H302   U
007-007-00-8 ethyl nitrate 210-903-3 625-58-1 Unst. Expl. H200 GHS01Dgr H200   
007-008-00-3 hydrazine 206-114-9 302-01-2 Flam. Liq. 3Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H226H350H331H311H301H314H317H400H410 GHS02GHS06GHS08GHS05GHS09Dgr H226H350H331H311H301H314H317H410  Skin Corr. 1B; H314: C ≥ 10 %Skin Irrit. 2; H315: 3 % ≤ C < 10 %Eye Irrit. 2; H319: 3 % ≤ C < 10 % 
007-009-00-9 dicyclohexylammonium nitrite 221-515-9 3129-91-7 Acute Tox. 4 *Acute Tox. 4 * H332H302 GHS07Wng H332H302  * 
007-010-00-4 sodium nitrite 231-555-9 7632-00-0 Ox. Sol. 3Acute Tox. 3 *Aquatic Acute 1 H272H301H400 GHS03GHS06GHS09Dgr H272H301H400  * 
007-011-00-X potassium nitrite 231-832-4 7758-09-0 Ox. Sol. 2Acute Tox. 3 *Aquatic Acute 1 H272H301H400 GHS03GHS06GHS09Dgr H272H301H400  * 
007-012-00-5 N,N-dimethylhydrazine 200-316-0 57-14-7 Flam. Liq. 2Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Chronic 2 H225H350H331H301H314H411 GHS02GHS06GHS08GHS05GHS09Dgr H225H350H331H301H314H411   
007-013-00-0 1,2-dimethylhydrazine — 540-73-8 Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H350H331H311H301H411 GHS06GHS08GHS09Dgr H350H331H311H301H411  Carc. 1B; H350: C ≥ 0,01 % 
007-014-00-6 salts of hydrazine — — Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H331H311H301H317H400H410 GHS06GHS08GHS09Dgr H350H331H311H301H317H410   A
007-015-00-1 O-ethylhydroxylamine 402-030-3 624-86-2 Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Eye Irrit. 2Skin Sens. 1Aquatic Acute 1 H225H331H311H301H372 **H319H317H400 GHS02GHS06GHS08GHS09Dgr H225H331H311H301H372 **H319H317H400   
007-016-00-7 butyl nitrite 208-862-1 544-16-1 Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 * H225H331H301 GHS02GHS06Dgr H225H331H301   
007-017-00-2 isobutyl nitrite 208-819-7 542-56-3 Flam. Liq. 2Carc. 1BMuta. 2Acute Tox. 4 *Acute Tox. 4 * H225H350H341H332H302 GHS02GHS08GHS07Dgr H225H350H341H332H302   
007-018-00-8 sec-butyl nitrite 213-104-8 924-43-6 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 * H225H332H302 GHS02GHS07Dgr H225H332H302   
007-019-00-3 tert-butyl nitrite 208-757-0 540-80-7 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 * H225H332H302 GHS02GHS07Dgr H225H332H302   
007-020-00-9 pentyl nitrite; [1]‘amyl nitrite’, mixed isomers [2] 207-332-7 [1]203-770-8 [2] 463-04-7 [1]110-46-3 [2] Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 * H225H332H302 GHS02GHS07Dgr H225H332H302   
007-021-00-4 hydrazobenzene;1,2-diphenylhydrazine 204-563-5 122-66-7 Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H302H400H410 GHS08GHS07GHS09Dgr H350H302H410   
007-022-00-X hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) 405-030-1 — Carc. 1BAcute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3 H350H302H314H317H412 GHS08GHS05GHS07Dgr H350H302H314H317H412   
007-023-00-5 sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate 405-510-0 — Skin Irrit. 2Skin Sens. 1 H315H317 GHS07Wng H315H317   
007-024-00-0 2-(decylthio)ethylammonium chloride 405-640-8 36362-09-1 STOT RE 2 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H373 **H315H318H400H410 GHS08GHS05GHS09Dgr H373 **H315H318H410   
007-025-00-6 (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride 406-090-1 81880-96-8 Muta. 2Acute Tox. 3 *STOT RE 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H341H301H372 **H317H400H410 GHS06GHS08GHS09Dgr H341H301H372 **H317H410   
007-026-00-1 oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide 413-230-5 122035-71-6 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
007-027-00-7 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane 420-190-2 771478-66-1 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H312H302H373 **H314H317H400H410 GHS08GHS05GHS07GHS09Dgr H312H302H373 **H314H317H410   
008-001-00-8 oxygen 231-956-9 7782-44-7 Ox. Gas 1Press. Gas H270 GHS03GHS04Dgr H270   U
008-003-00-9 hydrogen peroxide solution … % 231-765-0 7722-84-1 Ox. Liq. 1Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H271H332H302H314 GHS03GHS05GHS07Dgr H271H332H302H314  Ox. Liq. 1; H271: C ≥ 70 %****Ox. Liq. 2; H272: 50 % ≤ C < 70 % *****Skin Corr. 1A; H314: C ≥ 70 %Skin Corr. 1B; H314: 50 % ≤ C < 70 %Skin Irrit. 2; H315: 35 % ≤ C < 50 %Eye Dam. 1; H318: 8 % ≤ C < 50 %Eye Irrit. 2; H319: 5 % ≤ C < 8 %STOT SE 3; H335; C ≥ 35 % B
009-001-00-0 fluorine 231-954-8 7782-41-4 Ox. Gas 1Press. GasAcute Tox. 2 *Skin Corr. 1A H270H330H314 GHS03GHS04GHS06GHS05Dgr H270H330H314   U
009-002-00-6 hydrogen fluoride 231-634-8 7664-39-3 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Skin Corr. 1A H330H310H300H314 GHS06GHS05Dgr H330H310H300H314   
009-003-00-1 hydrofluoric acid … % 231-634-8 7664-39-3 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Skin Corr. 1A H330H310H300H314 GHS06GHS05Dgr H330H310H300H314  Skin Corr. 1A; H314: C ≥ 7 %Skin Corr. 1B; H314: 1 % ≤ C < 7 %Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % B
009-004-00-7 sodium fluoride 231-667-8 7681-49-4 Acute Tox. 3 *Eye Irrit. 2Skin Irrit. 2 H301H319H315 GHS06Dgr H301H319H315 EUH032  
009-005-00-2 potassium fluoride 232-151-5 7789-23-3 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301   
009-006-00-8 ammonium fluoride 235-185-9 12125-01-8 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301   
009-007-00-3 sodium bifluoride;sodium hydrogen difluoride 215-608-3 1333-83-1 Acute Tox. 3 *Skin Corr. 1B H301H314 GHS06GHS05Dgr H301H314  *Skin Corr. 1B; H314: C ≥ 1 %Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 
009-008-00-9 potassium bifluoride;potassium hydrogen difluoride 232-156-2 7789-29-9 Acute Tox. 3 *Skin Corr. 1B H301H314 GHS06GHS05Dgr H301H314  *Skin Corr. 1B; H314: C ≥ 1 %Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 
009-009-00-4 ammonium bifluoride;ammonium hydrogen difluoride 215-676-4 1341-49-7 Acute Tox. 3 *Skin Corr. 1B H301H314 GHS06GHS05Dgr H301H314  *Skin Corr. 1B; H314: C ≥ 1 %Skin Irrit. 2; H315: 0,1 % ≤ C < 1 %Eye Irrit. 2; H319: 0,1 % ≤ C < 1 % 
009-010-00-X fluoroboric acid ... % 240-898-3 16872-11-0 Skin Corr. 1B H314 GHS05Dgr H314  Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H315: 10 % ≤ C < 25 %Eye Irrit. 2; H319: 10 % ≤ C < 25 % B
009-011-00-5 fluorosilicic acid ... % 241-034-8 16961-83-4 Skin Corr. 1B H314 GHS05Dgr H314   B
009-012-00-0 alkali fluorosilicates(Na); [1]alkali fluorosilicates(K); [2]alkali fluorosilicates(NH4) [3] 240-934-8 [1]240-896-2 [2]240-968-3 [3] 16893-85-9 [1]16871-90-2 [2]16919-19-0 [3] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301  * A
009-013-00-6 fluorosilicates, with the exception of those specified elsewhere in this Annex — — Acute Tox. 4 * H302 GHS07Wng H302  * A
009-014-00-1 lead hexafluorosilicate 247-278-1 25808-74-6 Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H360DfH332H302H373 **H400H410 GHS08GHS07GHS09Dgr H360DfH332H302H373 **H410   1
009-015-00-7 sulphuryl difluoride 220-281-5 2699-79-8 Press. GasAcute Tox. 3 *STOT RE 2 *Aquatic Acute 1 H331H373 **H400 GHS04GHS06GHS08GHS09Dgr H331H373 **H400   U
009-016-00-2 trisodium hexafluoroaluminate;cryolite 237-410-6239-148-8 13775-53-615096-52-3 STOT RE 1Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H372 **H332H302H411 GHS08GHS07GHS09Dgr H372 **H332H302H411   C
009-017-00-8 potassium mu-fluoro-bis(triethylaluminium) 400-040-2 12091-08-6 Flam. Sol. 1Water-react. 1Skin Corr. 1AAcute Tox. 4 * H228H270H314H332 GHS02GHS05GHS07Dgr H228H270H314H332 EUH014  T
009-018-00-3 magnesium hexafluorosilicate 241-022-2 16949-65-8 Acute Tox. 3 * H301 GHS06Dgr H301  * 
011-001-00-0 sodium 231-132-9 7440-23-5 Water-react. 1Skin Corr. 1B H260H314 GHS02GHS05Dgr H260H314 EUH014  
011-002-00-6 sodium hydroxide;caustic soda 215-185-5 1310-73-2 Skin Corr. 1A H314 GHS05Dgr H314  Skin Corr. 1A; H314: C ≥ 5 %Skin Corr. 1B; H314: 2 % ≤ C < 5 %Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % 
011-003-00-1 sodium peroxide 215-209-4 1313-60-6 Ox. Sol. 1Skin Corr. 1A H271H314 GHS03GHS05Dgr H271H314   
011-004-00-7 sodium azide 247-852-1 26628-22-8 Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H300H400H410 GHS06GHS09Dgr H300H400H410 EUH032  
011-005-00-2 sodium carbonate 207-838-8 497-19-8 Eye Irrit. 2 H319 GHS07Wng H319   
011-006-00-8 sodium cyanate 213-030-6 917-61-3 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
011-007-00-3 propoxycarbazone-sodium — 181274-15-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410  M = 10 
012-001-00-3 magnesium powder (pyrophoric) 231-104-6 7439-95-4 Water-react. 1Pyr. Sol. 1 H260H250 GHS02Dgr H260H250   T
012-002-00-9 magnesium, powder or turnings 231-104-6 — Flam. Sol. 1Water-react. 2Self-heat. 1 H228H261H252 GHS02Dgr H228H261H252   T
012-003-00-4 magnesium alkyls — — Pyr. Liq. 1Water-react. 1Skin Corr. 1B H250H260H314 GHS02GHS05Dgr H250H260H314 EUH014  A
013-001-00-6 aluminium powder (pyrophoric) 231-072-3 7429-90-5 Water-react. 2Pyr. Sol. 1 H261H250 GHS02Dgr H261H250   T
013-002-00-1 aluminium powder (stabilised) 231-072-3 — Water-react. 2Flam.Sol. 3 H261H228 GHS02Dgr H261H228   T
013-003-00-7 aluminium chloride, anhydrous 231-208-1 7446-70-0 Skin Corr. 1B H314 GHS05Dgr H314   
013-004-00-2 aluminium alkyls — — Pyr. Liq. 1Water-react. 1Skin Corr. 1B H250H260H314 GHS02GHS05Dgr H250H260H314 EUH014  A
013-005-00-8 diethyl(ethyldimethylsilanolato)aluminium 401-160-8 55426-95-4 Water-react. 1Pyr. Liq. 1Skin Corr. 1A H260H250H314 GHS02GHS05Dgr H260H250H314 EUH014  
013-006-00-3 (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised 402-370-2 — Flam. Liq. 3Eye Dam. 1 H226H318 GHS02GHS05Dgr H226H318   
013-007-00-9 poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) 403-430-0 — Eye Dam. 1 H318 GHS05Dgr H318   
013-008-00-4 di-n-octylaluminium iodide 408-190-0 7585-14-0 Pyr. Liq. 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H250H314H400H410 GHS02GHS05GHS09Dgr H250H314H410 EUH014  
013-009-00-X sodium (n-butyl)x(ethyl)y-1,5-dihydro)aluminate x = 0,5 y = 1,5 418-720-2 — Flam. Sol. 1Water-react. 1Pyr. Sol. 1Acute Tox. 4 *Skin Corr. 1A H228H260H250H332H314 GHS02GHS05GHS07Dgr H228H260H250H332H314 EUH014  T
014-001-00-9 trichlorosilane 233-042-5 10025-78-2 Flam. Liq. 1Pyr. Liq. 1Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H224H250H332H302H314 GHS02GHS05GHS07Dgr H224H250H332H302H314 EUH014EUH029 *STOT SE 3; H335: C ≥ 1 % T
014-002-00-4 silicon tetrachloride 233-054-0 10026-04-7 Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315 EUH014  
014-003-00-X dimethyldichlorosilane 200-901-0 75-78-5 Flam. Liq. 2Eye Irrit. 2STOT SE 3Skin Irrit. 2 H225H319H335H315 GHS02GHS07Dgr H225H319H335H315   
014-004-00-5 trichloro(methyl)silane;methyltrichlorosilane 200-902-6 75-79-6 Flam. Liq. 2Eye Irrit. 2STOT SE 3Skin Irrit. 2 H225H319H335H315 GHS02GHS07Dgr H225H319H335H315 EUH014 Skin Irrit. 2; H315: C ≥ 1 %Eye Irrit. 2; H319: C ≥ 1 %STOT SE 3; H335: C ≥ 1 % 
014-005-00-0 tetraethyl silicate;ethyl silicate 201-083-8 78-10-4 Flam. Liq. 3Acute Tox. 4 *Eye Irrit. 2STOT SE 3 H226H332H319H335 GHS02GHS07Wng H226H332H319H335   
014-006-00-6 bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride 401-380-4 — Eye Irrit. 2Aquatic Chronic 2 H319H411 GHS07GHS09Wng H319H411   
014-007-00-1 triethoxyisobutylsilane 402-810-3 17980-47-1 Skin Irrit. 2 H315 GHS07Wng H315   
014-008-00-7 (chloromethyl)bis(4-fluorophenyl)methylsilane 401-200-4 85491-26-5 Aquatic Chronic 2 H411 GHS09 H411   
014-009-00-2 isobutylisopropyldimethoxysilane 402-580-4 111439-76-0 Flam. Liq. 3Acute Tox. 4 *Skin Irrit. 2 H226H332H315 GHS02GHS07Wng H226H332H315   
014-010-00-8 disodium metasilicate 229-912-9 6834-92-0 Skin Corr. 1BSTOT SE 3 H314H335 GHS05GHS07Dgr H314H335   
014-011-00-3 cyclohexyldimethoxymethylsilane 402-140-1 17865-32-6 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
014-012-00-9 bis(3-(trimethoxysilyl)propyl)amine 403-480-3 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
014-013-00-4 α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) 404-920-7 — Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2 H312H302H314H411 GHS05GHS07GHS09Dgr H312H302H314H411   
014-014-00-X etacelasil (ISO);6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane 253-704-7 37894-46-5 Repr. 1BAcute Tox. 4 *STOT RE 2 * H360D ***H302H373 ** GHS08GHS07Dgr H360D ***H302H373 **   
014-015-00-5 α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]- co-oxy(dimethylsilane)) 406-420-4 69430-40-6 Aquatic Chronic 4 H413 — H413   
014-016-00-0 reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane 406-490-6 — Aquatic Chronic 2 H411 GHS09 H411   
014-017-00-6 flusilazole (ISO);bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane — 85509-19-9 Carc. 2Repr. 1BAcute Tox. 4 *Aquatic Chronic 2 H351H360D ***H302H411 GHS08GHS07GHS09Dgr H351H360D ***H302H411   
014-018-00-1 octamethylcyclotetrasiloxane 209-136-7 556-67-2 Repr. 2Aquatic Chronic 4 H361f ***H413 GHS08Wng H361f ***H413   
014-019-00-7 reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole 403-250-2 — Carc. 2Repr. 1BAcute Tox. 4 *Aquatic Chronic 2 H351H360D ***H302H411 GHS08GHS07GHS09Dgr H351H360D ***H302H411   
014-020-00-2 bis(1,1-dimethyl-2-propynyloxy)dimethylsilane 414-960-7 53863-99-3 Acute Tox. 4 * H332 GHS07Wng H332   
014-021-00-8 tris(isopropenyloxy)phenyl silane 411-340-8 52301-18-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H400H410   
014-022-00-3 reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) 401-530-9 — Flam. Sol. 1STOT SE 1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H228H370 **H332H312H302 GHS02GHS08GHS07Dgr H228H370 **H332H312H302   T
014-023-00-9 α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole 408-160-7 125613-45-8 Aquatic Chronic 2 H411 GHS09 H411   
014-024-00-4 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene 412-620-2 121626-74-2 Aquatic Chronic 2 H411 GHS09 H411   
014-025-00-X 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine 411-400-3 102089-33-8 Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3 H302H373 **H315H318H412 GHS08GHS05GHS07Dgr H302H373 **H315H318H412   
014-026-00-5 dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane 407-180-3 770722-36-6 Skin Corr. 1A H314 GHS05Dgr H314   
014-027-00-0 chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane 410-270-5 770722-46-8 Skin Corr. 1A H314 GHS05Dgr H314   
014-028-00-6 α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) 415-290-8 193159-06-7 Skin Sens. 1 H317 GHS07Wng H317   
014-029-00-1 O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] 421-870-1 156145-66-3 Repr. 2Acute Tox. 4 *STOT RE 2 * H361f ***H302H373 ** GHS08GHS07Wng H361f ***H302H373 **   
014-030-00-7 [(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium 422-060-0 137390-08-0 Acute Tox. 2 * H300 GHS06Dgr H300   
014-031-00-2 bis(1-methylethyl)-dimethoxysilane 421-540-7 18230-61-0 Flam. Liq. 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3 H226H315H317H412 GHS02GHS07Wng H226H315H317H412   
014-032-00-8 dicyclopentyldimethoxysilane 404-370-8 126990-35-0 Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H400H410 GHS05GHS09Dgr H315H318H410   
015-001-00-1 white phosphorus 231-768-7 12185-10-3 Pyr. Sol. 1Acute Tox. 2 *Acute Tox. 2 *Skin Corr. 1AAquatic Acute 1 H250H330H300H314H400 GHS02GHS06GHS05GHS09Dgr H250H330H300H314H400   
015-002-00-7 red phosphorus 231-768-7 7723-14-0 Flam. Sol. 1Aquatic Chronic 3 H228H412 GHS02Dgr H228H412   
015-003-00-2 calcium phosphide;tricalcium diphosphide 215-142-0 1305-99-3 Water-react. 1Acute Tox. 2 *Aquatic Acute 1 H260H300H400 GHS02GHS06GHS09Dgr H260H300H400 EUH029  T
015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 Water-react. 1Acute Tox. 2 *Aquatic Acute 1 H260H300H400 GHS02GHS06GHS09Dgr H260H300H400 EUH029EUH032  T
015-005-00-3 magnesium phosphide;trimagnesium diphosphide 235-023-7 12057-74-8 Water-react. 1Acute Tox. 2 *Aquatic Acute 1 H260H300H400 GHS02GHS06GHS09Dgr H260H300H400 EUH029  T
015-006-00-9 trizinc diphosphide;zinc phosphide 215-244-5 1314-84-7 Water-react. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H260H300H400H410 GHS02GHS06GHS09Dgr H260H300H410 EUH029EUH032  T
015-007-00-4 phosphorus trichloride 231-749-3 7719-12-2 Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Skin Corr. 1A H330H300H373 **H314 GHS06GHS08GHS05Dgr H330H300H373 **H314 EUH014EUH029  
015-008-00-X phosphorus pentachloride 233-060-3 10026-13-8 Acute Tox. 2 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1B H330H302H373 **H314 GHS06GHS08GHS05Dgr H330H302H373 **H314 EUH014EUH029  
015-009-00-5 phosphoryl trichloride 233-046-7 10025-87-3 Acute Tox. 2 *STOT RE 1Acute Tox. 4 *Skin Corr. 1A H330H372 **H302H314 GHS06GHS08GHS05Dgr H330H372 **H302H314 EUH014EUH029  
015-010-00-0 phosphorus pentoxide 215-236-1 1314-56-3 Skin Corr. 1A H314 GHS05Dgr H314   
015-011-00-6 phosphoric acid ... %, orthophosphoric acid ... % 231-633-2 7664-38-2 Skin Corr. 1B H314 GHS05Dgr H314  Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H315: 10 % ≤ C < 25 %Eye Irrit. 2; H319: 10 % ≤ C < 25 % B
015-012-00-1 tetraphosphorus trisulphide;phosphorus sesquisulphid 215-245-0 1314-85-8 Flam. Sol. 2Water-react. 1Acute Tox. 4 *Aquatic Acute 1 H228H260H302H400 GHS02GHS07GHS09Dgr H228H260H302H400   T
015-013-00-7 triethyl phosphate 201-114-5 78-40-0 Acute Tox. 4 * H302 GHS07Wng H302   
015-014-00-2 tributyl phosphate 204-800-2 126-73-8 Carc. 2Acute Tox. 4 *Skin Irrit. 2 H351H302H315 GHS08GHS07Wng H351H302H315   
015-015-00-8 tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); 201-103-5 78-30-8 STOT SE 1Aquatic Chronic 2 H370 **H411 GHS08GHS09Dgr H370 **H411  STOT SE 1; H370: C ≥ 1 %STOT SE 2; H371: 0,2 % ≤ C < 1 % C
015-016-00-3 tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); 201-105-6 78-32-0 Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H312H302H411 GHS07GHS09Wng H312H302H411  * C
015-019-00-X dichlorvos (ISO);2,2-dichlorovinyl dimethyl phosphate 200-547-7 62-73-7 Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1 H330H311H301H317H400 GHS06GHS09Dgr H330H311H301H317H400   
015-020-00-5 mevinphos (ISO);2-methoxycarbonyl-1-methylvinyl dimethyl phosphate 232-095-1 7786-34-7 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410  M = 10000 
015-021-00-0 trichlorfon (ISO);dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate 200-149-3 52-68-6 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H400H410  M = 1000 
015-022-00-6 phosphamidon (ISO);2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate 236-116-5 13171-21-6 Muta. 2Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H341H300H311H400H410 GHS06GHS08GHS09Dgr H341H300H311H410   
015-023-00-1 pyrazoxon;diethyl 3-methylpyrazol-5-yl phosphate — 108-34-9 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 * H330H310H300 GHS06Dgr H330H310H300   
015-024-00-7 triamiphos (ISO);5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide — 1031-47-6 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
015-025-00-2 TEPP (ISO);tetraethyl pyrophosphate 203-495-3 107-49-3 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1 H310H300H400 GHS06GHS09Dgr H310H300H400   
015-026-00-8 schradan (ISO);octamethylpyrophosphoramide 205-801-0 152-16-9 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
015-027-00-3 sulfotep (ISO);O,O,O,O-tetraethyl dithiopyrophosphate 222-995-2 3689-24-5 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410  M = 1000 
015-028-00-9 demeton-O (ISO);O,O-diethyl-O-2-ethylthioethyl phosphorothioate 206-053-8 298-03-3 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1 H310H300H400 GHS06GHS09Dgr H310H300H400   
015-029-00-4 demeton-S (ISO);diethyl-S-2-ethylthioethyl phosphorothioate 204-801-8 126-75-0 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
015-030-00-X demeton-O-methyl (ISO);O-2-ethylthioethyl O,O-dimethyl phosphorothioate 212-758-1 867-27-6 Acute Tox. 3 * H301 GHS06Dgr H301   
015-031-00-5 demeton-S-methyl (ISO);S-2-ethylthioethyl dimethyl phosphorothioate 213-052-6 919-86-8 Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H311H301H411 GHS06GHS09Dgr H311H301H411   
015-032-00-0 prothoate (ISO);O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate 218-893-2 2275-18-5 Acute Tox. 1Acute Tox. 2 *Aquatic Chronic 3 H310H300H412 GHS06Dgr H310H300H412   
015-033-00-6 phorate (ISO);O,O-diethyl ethylthiomethyl phosphorodithioate 206-052-2 298-02-2 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410  M = 1000 
015-034-00-1 parathion (ISO);O,O-diethyl O-4-nitrophenyl phosphorothioate 200-271-7 56-38-2 Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H330H300H311H372 **H400H410 GHS06GHS08GHS09Dgr H330H300H311H372 **H410  M = 100 
015-035-00-7 parathion — methyl (ISO);O,O-dimethyl O-4-nitrophenyl phosphorothioate 206-050-1 298-00-0 Flam. Liq. 3Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H226H330H300H311H373 **H400H410 GHS02GHS06GHS08GHS09Dgr H226H330H300H311H373 **H410  M = 100 
015-036-00-2 O-ethyl O-4-nitrophenyl phenylphosphonothioate;EPN 218-276-8 2104-64-5 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410   
015-037-00-8 phenkapton (ISO);S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate 218-892-7 2275-14-1 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410   
015-038-00-3 coumaphos (ISO);O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate 200-285-3 56-72-4 Acute Tox. 2 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H300H312H400H410 GHS06GHS09Dgr H300H312H410   
015-039-00-9 azinphos-methyl (ISO);O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate 201-676-1 86-50-0 Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H300H311H317H400H410 GHS06GHS09Dgr H330H300H311H317H410   
015-040-00-4 diazinon (ISO);O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate 206-373-8 333-41-5 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H400H410   
015-041-00-X malathion (ISO);1,2-bis (ethoxycarbonyl) ethyl O,O-dimethyl phosphorodithioate 204-497-7 121-75-5 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H400H410  M = 100 
015-042-00-5 chlorthionO-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate 207-902-5 500-28-7 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410  M = 100 
015-043-00-0 phosnichlor (ISO);O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate — 5826-76-6 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302   
015-044-00-6 carbophenothion (ISO);4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate 212-324-1 786-19-6 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H410   
015-045-00-1 mecarbam (ISO);N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate 219-993-9 2595-54-2 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H400H410   
015-046-00-7 oxydemeton-methyl;S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate 206-110-7 301-12-2 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1 H311H301H400 GHS06GHS09Dgr H311H301H400   
015-047-00-2 ethion (ISO);O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);diethion 209-242-3 563-12-2 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H312H400H410 GHS06GHS09Dgr H301H312H410  M = 10000 
015-048-00-8 fenthion (ISO);O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate 200-231-9 55-38-9 Muta. 2Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H341H331H372 **H312H302H400H410 GHS06GHS08GHS09Dgr H341H331H372 **H312H302H410   
015-049-00-3 endothion (ISO);S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate 220-472-3 2778-04-3 Acute Tox. 3 *Acute Tox. 3 * H311H301 GHS06Dgr H311H301   
015-050-00-9 thiometon (ISO);S-2-ethylthioethyl O,O-dimethyl phosphorodithioate 211-362-6 640-15-3 Acute Tox. 3 *Acute Tox. 4 * H301H312 GHS06Dgr H301H312   
015-051-00-4 dimethoate (ISO);O,O-dimethyl methylcarbamoylmethyl phosphorodithioate 200-480-3 60-51-5 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
015-052-00-X fenchlorphos (ISO);O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate 206-082-6 299-84-3 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
015-053-00-5 menazon (ISO);S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate 201-123-4 78-57-9 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
015-054-00-0 fenitrothion (ISO);O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate 204-524-2 122-14-5 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
015-055-00-6 naled (ISO);1,2-dibromo-2,2-dichloroethyl dimethyl phosphate 206-098-3 300-76-5 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1 H312H302H319H315H400 GHS07GHS09Wng H312H302H319H315H400  M = 1000 
015-056-00-1 azinphos-ethyl (ISO);O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate 220-147-6 2642-71-9 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H410   
015-057-00-7 formothion (ISO);N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate 219-818-6 2540-82-1 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
015-058-00-2 morphothion (ISO);O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate 205-628-0 144-41-2 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410   
015-059-00-8 vamidothion (ISO);O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate 218-894-8 2275-23-2 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1 H301H312H400 GHS06GHS09Dgr H301H312H400   
015-060-00-3 disulfoton (ISO);O,O-diethyl 2-ethylthioethyl phosphorodithioate 206-054-3 298-04-4 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410   
015-061-00-9 dimefox (ISO);tetramethylphosphorodiamidic fluoride 204-076-8 115-26-4 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
015-062-00-4 mipafox (ISO);N,N'- di-isopropylphosphorodiamidic fluoride 206-742-3 371-86-8 STOT SE 1 H370 ** GHS08Dgr H370 **   
015-063-00-X dioxathion (ISO);1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) 201-107-7 78-34-2 Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H330H300H311H400H410 GHS06GHS09Dgr H330H300H311H410  M = 1000 
015-064-00-5 bromophos-ethyl (ISO);O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate 225-399-0 4824-78-6 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H312H400H410 GHS06GHS09Dgr H301H312H410   
015-065-00-0 S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate — 2703-37-9 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Chronic 2 H330H310H300H411 GHS06GHS09Dgr H330H310H300H411   
015-066-00-6 omethoate (ISO);O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate 214-197-8 1113-02-6 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1 H301H312H400 GHS06GHS09Dgr H301H312H400   
015-067-00-1 phosalone (ISO);S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate 218-996-2 2310-17-0 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H312H400H410 GHS06GHS09Dgr H301H312H410   
015-068-00-7 dichlofenthion (ISO);O—2,4-dichlorophenyl O,O-diethyl phosphorothioate 202-564-5 97-17-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H400H410   
015-069-00-2 methidathion (ISO);2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate 213-449-4 950-37-8 Acute Tox. 2 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H300H312H400H410 GHS06GHS09Dgr H300H312H410   
015-070-00-8 cyanthoate (ISO);S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate 223-099-4 3734-95-0 Acute Tox. 2 *Acute Tox. 3 * H300H311 GHS06Dgr H300H311   
015-071-00-3 chlorfenvinphos (ISO);2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate 207-432-0 470-90-6 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H410   
015-072-00-9 monocrotophos (ISO);dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate 230-042-7 6923-22-4 Muta. 2Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H341H330H300H311H400H410 GHS06GHS08GHS09Dgr H341H330H300H311H410   
015-073-00-4 dicrotophos (ISO);(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate 205-494-3 141-66-2 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H410   
015-074-00-X crufomate (ISO);4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate 206-083-1 299-86-5 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
015-075-00-5 S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate — 2635-50-9 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301   
015-076-00-0 potasan;O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate — 299-45-6 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H400H410 GHS06GHS09Dgr H330H310H300H410  M = 1000 
015-077-00-6 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate — 7076-53-1 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301   
015-078-00-1 demeton-S-methylsulphon (ISO);S-2-ethylsulphonylethyl dimethyl phosphorothioate 241-109-5 17040-19-6 Acute Tox. 3 *Acute Tox. 4 *Aquatic Chronic 2 H301H312H411 GHS06GHS09Dgr H301H312H411   
015-079-00-7 acephate (ISO);O,S-dimethyl acetylphosphoramidothioate 250-241-2 30560-19-1 Acute Tox. 4 * H302 GHS07Wng H302   
015-080-00-2 amidithion (ISO);2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate — 919-76-6 Acute Tox. 4 * H302 GHS07Wng H302   
015-081-00-8 O,O,O',O'-tetrapropyl dithiopyrophosphate 221-817-0 3244-90-4 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
015-082-00-3 azothoate (ISO);O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate 227-419-3 5834-96-8 Acute Tox. 4 *Acute Tox. 4 * H332H302 GHS07Wng H332H302   
015-083-00-9 bensulide (ISO);O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate 212-010-4 741-58-2 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
015-084-00-4 chlorpyrifos (ISO);O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 220-864-4 2921-88-2 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H400H410  M = 10000 
015-085-00-X chlorphonium chloride (ISO);tributyl (2,4-dichlorobenzyl) phosphonium chloride 204-105-4 115-78-6 Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2 H301H312H319H315 GHS06Dgr H301H312H319H315   
015-086-00-5 coumithoate (ISO);O,O-diethyl O-7,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate — 572-48-5 Acute Tox. 3 * H301 GHS06Dgr H301   
015-087-00-0 cyanophos (ISO);O-4-cyanophenyl O,O-dimethyl phosphorothioate 220-130-3 2636-26-2 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
015-088-00-6 dialifos (ISO);2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate 233-689-3 10311-84-9 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H400H410   
015-089-00-1 ethoate-methyl (ISO);ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate 204-121-1 116-01-8 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
015-090-00-7 fensulfothion (ISO);O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate 204-114-3 115-90-2 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410   
015-091-00-2 fonofos (ISO);O-ethyl phenyl ethylphosphonodithioate 213-408-0 944-22-9 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410   
015-092-00-8 phosacetim (ISO);O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate 223-874-7 4104-14-7 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410   
015-093-00-3 leptophos (ISO);O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate 244-472-8 21609-90-5 Acute Tox. 3 *STOT SE 1Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H370 **H312H400H410 GHS06GHS08GHS09Dgr H301H370 **H312H410   
015-094-00-9 mephosfolan (ISO);diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate 213-447-3 950-10-7 Acute Tox. 1Acute Tox. 2 *Aquatic Chronic 2 H310H300H411 GHS06GHS09Dgr H310H300H411   
015-095-00-4 methamidophos (ISO);O,S-dimethyl phosphoramidothioate 233-606-0 10265-92-6 Acute Tox. 2 *Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1 H330H300H311H400 GHS06GHS09Dgr H330H300H311H400   
015-096-00-X oxydisulfoton (ISO);O,O-diethyl S-2-ethylsulphinylethyl phosphorodithioate 219-679-1 2497-07-6 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H410  M = 10 
015-097-00-5 phenthoate (ISO);ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate 219-997-0 2597-03-7 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410  M = 100 
015-098-00-0 trichloronate (ISO);O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate 206-326-1 327-98-0 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H410   
015-099-00-6 pirimiphos-ethyl (ISO);O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate 245-704-0 23505-41-1 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H312H400H410 GHS06GHS09Dgr H301H312H410   
015-100-00-X phoxim (ISO);α-(diethoxyphosphinothioylimino) phenylacetonitrile 238-887-3 14816-18-3 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410  M = 1000 
015-101-00-5 phosmet (ISO);O,O-dimethyl phthalimidomethyl S-phosphorodithioate 211-987-4 732-11-6 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410  M = 100 
015-102-00-0 tris(2-chloroethyl) phosphate 204-118-5 115-96-8 Carc. 2Acute Tox. 4 *Aquatic Chronic 2 H351H302H411 GHS08GHS07GHS09Wng H351H302H411   
015-103-00-6 phosphorus tribromide 232-178-2 7789-60-8 Skin Corr. 1BSTOT SE 3 H314H335 GHS05GHS07Dgr H314H335 EUH014  
015-104-00-1 diphosphorus pentasulphide;phosphorus pentasulphide 215-242-4 1314-80-3 Flam. Sol. 1Water-react. 1Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1 H228H260H332H302H400 GHS02GHS07GHS09Dgr H228H260H332H302H400 EUH029  T
015-105-00-7 triphenyl phosphite 202-908-4 101-02-0 Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H315H400H410 GHS07GHS09Wng H319H315H410  Skin Irrit. 2; H315: C ≥ 5 %Eye Irrit. 2; H319: C ≥ 5 % 
015-106-00-2 hexamethylphosphoric triamide;hexamethylphosphoramide 211-653-8 680-31-9 Carc. 1BMuta. 1B H350H340 GHS08Dgr H350H340  Carc. 1B; H350: C ≥ 0,01 % 
015-107-00-8 ethoprophos (ISO);ethyl-S,S-dipropyl phosphorodithioate 236-152-1 13194-48-4 Acute Tox. 2 *Acute Tox. 1Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H310H301H317H400H410 GHS06GHS09Dgr H330H310H301H317H410   
015-108-00-3 bromophos (ISO);O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate 218-277-3 2104-96-3 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410  M = 100 
015-109-00-9 crotoxyphos (ISO);1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate 231-720-5 7700-17-6 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H410  M = 10 
015-110-00-4 cyanofenphos (ISO);O-4-cyanophenyl O-ethyl phenylphosphonothioate — 13067-93-1 Acute Tox. 3 *STOT SE 1Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2 H301H370 **H312H319H411 GHS06GHS08GHS09Dgr H301H370 **H312H319H411   
015-111-00-X phosfolan (ISO);diethyl 1,3-dithiolan-2-ylidenephosphoramidate 213-423-2 947-02-4 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
015-112-00-5 thionazin (ISO);O,O-diethyl O-pyrazin-2-yl phosphorothioate; 206-049-6 297-97-2 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
015-114-00-6 chlormephos (ISO);S-chloromethyl O,O-diethyl phosphorodithioate 246-538-1 24934-91-6 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410   
015-115-00-1 chlorthiophos (ISO) 244-663-6 21923-23-9 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H410   
015-116-00-7 demephion-O (ISO);O,O-dimethyl O-2-methylthioethyl phosphorothioate 211-666-9 682-80-4 Acute Tox. 2 *Acute Tox. 3 * H300H311 GHS06Dgr H300H311   
015-117-00-2 demephion-S (ISO);O,O-dimethyl S-2-methylthioethyl phosphorothioate 219-971-9 2587-90-8 Acute Tox. 2 *Acute Tox. 3 * H300H311 GHS06Dgr H300H311   
015-118-00-8 demeton — 8065-48-3 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1 H310H300H400 GHS06GHS09Dgr H310H300H400   
015-119-00-3 dimethyl 4-(methylthio)phenyl phosphate — 3254-63-5 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
015-120-00-9 ditalimfos (ISO);O,O-diethyl phthalimidophosphonothioate 225-875-8 5131-24-8 Skin Irrit. 2Skin Sens. 1 H315H317 GHS07Wng H315H317   
015-121-00-4 edifenphos (ISO);O-ethyl S,S-diphenyl phosphorodithioate 241-178-1 17109-49-8 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H301H312H317H400H410 GHS06GHS09Dgr H331H301H312H317H410   
015-122-00-X etrimfos (ISO);O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate 253-855-9 38260-54-7 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410  M = 10 
015-123-00-5 fenamiphos (ISO);ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate 244-848-1 22224-92-6 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H410  M = 100 
015-124-00-0 fosthietan (ISO);diethyl 1,3-dithietan-2-ylidenephosphoramidate 244-437-7 21548-32-3 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
015-125-00-6 glyphosine (ISO);N,N-bis(phosphonomethyl)glycine 219-468-4 2439-99-8 Eye Dam. 1 H318 GHS05Dgr H318   
015-126-00-1 heptenophos (ISO);7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate 245-737-0 23560-59-0 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410  M = 100 
015-127-00-7 iprobenfos(ISO);S-benzyl diisopropyl phosphorothioate 247-449-0 26087-47-8 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
015-128-00-2 IPSP;S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate — 5827-05-4 Acute Tox. 1Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H310H301H400H410 GHS06GHS09Dgr H310H301H410  M = 100 
015-129-00-8 isofenphos (ISO);O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate 246-814-1 25311-71-1 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H410  M = 100 
015-130-00-3 isothioate (ISO);S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate; — 36614-38-7 Acute Tox. 3 *Acute Tox. 3 * H311H301 GHS06Dgr H311H301   
015-131-00-9 isoxathion (ISO);O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate 242-624-8 18854-01-8 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H410   
015-132-00-4 S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;methylcarbophenothione — 953-17-3 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H410  M = 1000 
015-133-00-X piperophos (ISO);S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate — 24151-93-7 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410  M = 10 
015-134-00-5 pirimiphos-methyl (ISO);O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate 249-528-5 29232-93-7 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
015-135-00-0 profenofos (ISO)O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate; 255-255-2 41198-08-7 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410  M = 1000 
015-136-00-6 trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;propetamphos (ISO) 250-517-2 31218-83-4 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410  M = 100 
015-137-00-1 pyrazophos (ISO);O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate 236-656-1 13457-18-6 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H302H400H410 GHS07GHS09Wng H332H302H410   
015-138-00-7 quinalphos (ISO);O,O-diethyl-O-quinoxalin-2-yl phosphorothioate 237-031-6 13593-03-8 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H312H400H410 GHS06GHS09Dgr H301H312H410  M = 1000 
015-139-00-2 terbufos (ISO);S-tert-butylthiomethyl O,O-diethylphosphorodithioate; 235-963-8 13071-79-9 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410  M = 1000 
015-140-00-8 triazophos (ISO);O,O-diethyl-O-1-phenyl-1H,2,4-triazol-3-yl phosphorothioate 245-986-5 24017-47-8 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H331H301H312H400H410 GHS06GHS09Dgr H331H301H312H410   
015-141-00-3 ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers 400-520-1 — Skin Corr. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H314H302H400H410 GHS05GHS07GHS09Dgr H314H302H410   
015-142-00-9 butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate 401-100-0 — Flam. Liq. 2Eye Irrit. 2Aquatic Chronic 2 H225H319H411 GHS02GHS07GHS09Dgr H225H319H411   T
015-143-00-4 reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate,reaction mass of isomers 401-740-0 — Acute Tox. 4 * H302 GHS07Wng H302   
015-144-00-X reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate 402-090-0 87025-52-3 Skin Corr. 1B H314 GHS05Dgr H314   
015-145-00-5 reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate 401-520-4 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
015-146-00-0 S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate 401-850-9 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
015-147-00-6 reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) 400-930-0 — Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H315H318H317H411 GHS05GHS07GHS09Dgr H315H318H317H411   
015-148-00-1 2-(diphosphonomethyl)succinic acid 403-070-4 51395-42-7 Skin Corr. 1BSkin Sens. 1 H314H317 GHS05GHS07Dgr H314H317   
015-149-00-7 reaction mass of: hexyldioctylphosphineoxide;dihexyloctylphosphineoxide;trioctylphosphineoxide 403-470-9 — Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H314H400H410 GHS05GHS09Dgr H314H410   
015-150-00-2 (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide 404-940-6 86608-70-0 Acute Tox. 4 *Eye Dam. 1STOT RE 2 *Aquatic Chronic 3 H302H318H373 **H412 GHS08GHS05GHS07Dgr H302H318H373 **H412   
015-151-00-8 tris(isopropyl/tert-butylphenyl) phosphate 405-010-2 — Aquatic Chronic 2 H411 GHS09 H411   
015-152-00-3 dioxabenzofos (ISO);2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide 223-292-3 3811-49-2 Acute Tox. 3 *Acute Tox. 3 *STOT SE 1Aquatic Chronic 2 H311H301H370 **H411 GHS06GHS08GHS09Dgr H311H301H370 **H411   
015-153-00-9 isazofos (ISO);O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate 255-863-8 42509-80-8 Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H311H301H373 **H317H400H410 GHS06GHS08GHS09Dgr H330H311H301H373 **H317H410   
015-154-00-4 2-chloroethylphosphonic acid;ethephon 240-718-3 16672-87-0 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3 H332H312H314H412 GHS05GHS07Dgr H332H312H314H412  STOT SE 3; H335: C ≥ 5 % 
015-155-00-X ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate;glufosinate ammonium 278-636-5 77182-82-2 Acute Tox. 4 * H302 GHS07Wng H302   
015-156-00-5 methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]methacrifos (ISO);methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] 250-366-9 [1]-[2] 30864-28-9 [1]62610-77-9 [2] Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
015-157-00-0 phosphonic acid; [1]phosphorous acid [2] 237-066-7 [1]233-663-1[2] 13598-36-2 [1]10294-56-1 [2] Acute Tox. 4 *Skin Corr. 1A H302H314 GHS05GHS07Dgr H302H314   
015-158-00-6 (η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-) 402-340-9 32760-80-8 Aquatic Chronic 3 H412 — H412   
015-159-00-1 hydroxyphosphonoacetic acid 405-710-8 23783-26-8 Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1 H302H373 **H314H317 GHS08GHS05GHS07Dgr H302H373 **H314H317   
015-160-00-7 vanadyl pyrophosphate 406-260-5 58834-75-6 Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3 H319H317H412 GHS07Wng H319H317H412   
015-161-00-2 divanadyl pyrophosphate 407-130-0 65232-89-5 Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H318H317H411 GHS05GHS07GHS09Dgr H302H318H317H411   
015-162-00-8 vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped 407-350-7 — Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Aquatic Chronic 2 H332H373 **H318H411 GHS08GHS05GHS07GHS09Dgr H332H373 **H318H411   
015-163-00-3 bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide 412-010-6 145052-34-2 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
015-164-00-9 calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate 400-480-5 36669-85-9 Aquatic Chronic 3 H412 — H412   
015-165-00-4 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate 404-986-7 — Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
015-166-00-X 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 410-290-4 80693-00-1 Aquatic Chronic 4 H413 — H413   
015-167-00-5 3-(hydroxyphenylphosphinyl)propanoic acid 411-200-6 14657-64-8 Eye Dam. 1 H318 GHS05Dgr H318   
015-168-00-0 fosthiazate (ISO);(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate — 98886-44-3 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H301H312H317H400H410 GHS06GHS09Dgr H331H301H312H317H410 EUH070  
015-169-00-6 tributyltetradecylphosphonium tetrafluoroborate 413-520-1 — Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H373 **H314H317H400H410 GHS08GHS05GHS07GHS09Dgr H302H373 **H314H317H410   
015-170-00-1 reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;1-octane-N,N,N-trimethylammonium di-octylphosphate;1-octane-N,N,N-trimethylammonium octylphosphate 407-490-9 — Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H312H302H314 GHS05GHS07Dgr H312H302H314   
015-171-00-7 O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate 406-940-1 — Aquatic Chronic 2 H411 GHS09 H411   
015-172-00-2 reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate 406-240-6 — Flam. Liq. 3Skin Corr. 1BAquatic Chronic 2 H226H314H411 GHS02GHS05GHS09Dgr H226H314H411   
015-173-00-8 methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate 414-080-3 117291-73-3 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
015-174-00-3 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine 411-370-1 82857-68-9 Acute Tox. 3 *Eye Dam. 1Aquatic Chronic 2 H301H318H411 GHS06GHS05GHS09Dgr H301H318H411   
015-175-00-9 tert-butyl (triphenylphosphoranylidene) acetate 412-880-7 35000-38-5 Acute Tox. 3 *STOT RE 2 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2 H301H373 **H319H317H411 GHS06GHS08GHS09Dgr H301H373 **H319H317H411   
015-176-00-4 P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine 413-430-2 116163-96-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
015-177-00-X ((4-phenylbutyl)hydroxyphosphoryl)acetic acid 412-170-7 83623-61-4 STOT RE 2 *Eye Dam. 1Skin Sens. 1 H373 **H318H317 GHS08GHS05Dgr H373 **H318H317   
015-178-00-5 (R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate 418-570-8 25383-07-7 Repr. 2Aquatic Chronic 2 H361f ***H411 GHS08GHS09Wng H361f ***H411   
015-179-00-0 UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine 422-720-8 166242-53-1 Carc. 2Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H302H373 **H314H317H400H410 GHS08GHS05GHS07GHS09Dgr H351H302H373 **H314H317H410   
015-180-00-6 [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt 415-820-8 137590-32-0 Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   
015-181-00-1 phosphine 232-260-8 7803-51-2 Flam. Gas 1Press. GasAcute Tox. 2 *Skin Corr. 1BAquatic Acute 1 H220H330H314H400 GHS02GHS04GHS06GHS05GHS09Dgr H220H330H314H400   U
015-184-00-8 Salts of glyphosate, with the exception of those specified elsewhere in this Annex — — Aquatic Chronic 2 H411 GHS09 H411   A
015-186-00-9 chlorpyrifos-methyl (ISO)O,O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 227-011-5 5598-13-0 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410  M = 10000 
015-187-00-4 reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide 417-540-1 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 423-340-5 162881-26-7 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
016-001-00-4 hydrogen sulphide 231-977-3 7783-06-4 Flam. Gas 1Press. GasAcute Tox. 2 *Aquatic Acute 1 H220H330H400 GHS02GHS04GHS06GHS09Dgr H220H330H400   U
016-002-00-X barium sulphide 244-214-4 21109-95-5 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1 H332H302H400 GHS07GHS09Wng H332H302H400 EUH031  
016-003-00-5 barium polysulphides 256-814-3 50864-67-0 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1 H319H335H315H400 GHS07GHS09Wng H319H335H315H400 EUH031  
016-004-00-0 calcium sulphide 243-873-5 20548-54-3 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1 H319H335H315H400 GHS07GHS09Wng H319H335H315H400 EUH031  
016-005-00-6 calcium polysulphides 215-709-2 1344-81-6 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1 H319H335H315H400 GHS07GHS09Wng H319H335H315H400 EUH031  
016-006-00-1 dipotassium sulphide;potassium sulphide 215-197-0 1312-73-8 Skin Corr. 1BAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400 EUH031  
016-007-00-7 potassium polysulphides 253-390-1 37199-66-9 Skin Corr. 1BAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400 EUH031  
016-008-00-2 ammonium polysulphides 232-989-1 9080-17-5 Skin Corr. 1BAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400 EUH031 EUH031: C ≥ 1 % 
016-009-00-8 disodium sulphide;sodium sulphide 215-211-5 1313-82-2 Skin Corr. 1BAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400 EUH031  
016-010-00-3 sodium polysulphides 215-686-9 1344-08-7 Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1 H301H314H400 GHS06GHS05GHS09Dgr H301H314H400 EUH031  
016-011-00-9 sulphur dioxide 231-195-2 7446-09-5 Press. GasAcute Tox. 3 *Skin Corr. 1B H331H314 GHS04GHS06GHS05Dgr H331H314  * U5
016-012-00-4 disulphur dichloride;sulfur monochloride 233-036-2 10025-67-9 Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1 H301H332H314H400 GHS06GHS05GHS09Dgr H301H332H314H400 EUH014EUH029 STOT SE 3; H335: C ≥ 1 % 
016-013-00-X sulphur dichloride 234-129-0 10545-99-0 Skin Corr. 1BSTOT SE 3Aquatic Acute 1 H314H335H400 GHS05GHS07GHS09Dgr H314H335H400 EUH014 STOT SE 3; H335: C ≥ 5 % 
016-014-00-5 sulphur tetrachloride — 13451-08-6 Skin Corr. 1BAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400 EUH014 STOT SE 3; H335: C ≥ 5 % 
016-015-00-0 thionyl dichloride;thionyl chloride 231-748-8 7719-09-7 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H332H302H314 GHS05GHS07Dgr H332H302H314 EUH014EUH029 STOT SE 3; H335: C ≥ 1 % 
016-016-00-6 sulphuryl chloride 232-245-6 7791-25-5 Skin Corr. 1BSTOT SE 3 H314H335 GHS05GHS07Dgr H314H335 EUH014  
016-017-00-1 chlorosulphonic acid 232-234-6 7790-94-5 Skin Corr. 1ASTOT SE 3 H314H335 GHS05GHS07Dgr H314H335 EUH014  
016-018-00-7 fluorosulphonic acid 232-149-4 7789-21-1 Acute Tox. 4 *Skin Corr. 1A H332H314 GHS05GHS07Dgr H332H314   
016-019-00-2 oleum ... % SO3 — — Skin Corr. 1ASTOT SE 3 H314H335 GHS05GHS07Dgr H314H335 EUH014  B
016-020-00-8 sulphuric acid ... % 231-639-5 7664-93-9 Skin Corr. 1A H314 GHS05Dgr H314  Skin Corr. 1A; H314: C ≥ 15 %Skin Irrit. 2; H315: 5 % ≤ C < 15 %Eye Irrit. 2; H319: 5 % ≤ C < 15 % B
016-021-00-3 methanethiol;methyl mercaptan 200-822-1 74-93-1 Flam. Gas. 1Press. GasAcute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H220H331H400H410 GHS02GHS04GHS06GHS09Dgr H220H331H410   U
016-022-00-9 ethanethiol;ethyl mercaptan 200-837-3 75-08-1 Flam. Liq. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H225H332H400H410 GHS02GHS07GHS09Dgr H225H332H410   
016-023-00-4 dimethyl sulphate 201-058-1 77-78-1 Carc. 1BMuta. 2Acute Tox. 2 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1 H350H341H330H301H314H317 GHS06GHS08GHS05Dgr H350H341H330H301H314H317  Carc. 1B; H350: C ≥ 0,01 %Muta. 2; H341: C ≥ 0,01 %STOT SE 3; H335: C ≥ 5 % 
016-024-00-X dimexano(ISO);bis(methoxythiocarbonyl) disulphide 215-993-8 1468-37-7 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
016-025-00-5 disul (ISO);2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;2,4-DES 205-259-5 149-26-8 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1 H302H315H318 GHS05GHS07Dgr H302H315H318   
016-026-00-0 sulphamidic acid;sulphamic acid;sulfamic acid 226-218-8 5329-14-6 Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 3 H319H315H412 GHS07Wng H319H315H412   
016-027-00-6 diethyl sulphate 200-589-6 64-67-5 Carc. 1BMuta. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H350H340H332H312H302H314 GHS05GHS08GHS07Dgr H350H340H332H312H302H314   
016-028-00-1 sodium dithionite;sodium hydrosulphite 231-890-0 7775-14-6 Self-heat. 1Acute Tox. 4 * H251H302 GHS02GHS07Dgr H251H302 EUH031  
016-029-00-7 p-toluenesulphonic acid, containing more than 5 % H2SO4 — — Skin Corr. 1B H314 GHS05Dgr H314  Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H315: 10 % ≤ C < 25 %Eye Irrit. 2; H319: 10 % ≤ C < 25 % 
016-030-00-2 p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) 203-180-0 104-15-4 Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315  STOT SE 3; H335: C ≥ 20 % 
016-031-00-8 tetrahydrothiophene-1,1-dioxide;sulpholane 204-783-1 126-33-0 Acute Tox. 4 * H302 GHS07Wng H302   
016-032-00-3 1,3-propanesultone;1,2-oxathiolane 2,2-dioxide 214-317-9 1120-71-4 Carc. 1BAcute Tox. 4 *Acute Tox. 4 * H350H312H302 GHS08GHS07Dgr H350H312H302  Carc. 1B; H350: C ≥ 0,01 % 
016-033-00-9 dimethylsulfamoylchloride 236-412-4 13360-57-1 Carc. 1BAcute Tox. 2 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H350H330H312H302H314 GHS06GHS05GHS08Dgr H350H330H312H302H314   
016-034-00-4 tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) 400-010-9 81898-60-4 Skin Sens. 1 H317 GHS07Wng H317   
016-035-00-X pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate 400-120-7 — Eye Irrit. 2 H319 GHS07Wng H319   
016-036-00-5 tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate 400-130-1 — Resp. Sens. 1Aquatic Chronic 2 H334H411 GHS08GHS09Dgr H334H411   
016-037-00-0 disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate 400-350-8 85153-93-1 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
016-038-00-6 disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate 400-380-1 86393-35-3 Skin Sens. 1 H317 GHS07Wng H317   
016-039-00-1 tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate 400-430-2 — Skin Sens. 1 H317 GHS07Wng H317   
016-040-00-7 reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate 400-570-4 — Eye Irrit. 2 H319 GHS07Wng H319   
016-041-00-2 calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate 400-710-4 — Acute Tox. 4 * H332 GHS07Wng H332   
016-042-00-8 tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate 400-790-0 85665-97-0 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   
016-043-00-3 dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate 401-010-1 — Skin Sens. 1 H317 GHS07Wng H317   
016-044-00-9 disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate 401-320-7 — Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
016-045-00-4 lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate 401-560-2 108624-00-6 Skin Sens. 1 H317 GHS07Wng H317   
016-046-00-X sodium hydrogensulphate 231-665-7 7681-38-1 Eye Dam. 1 H318 GHS05Dgr H318   
016-047-00-5 hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate 401-650-1 85665-96-9 Skin Sens. 1 H317 GHS07Wng H317   
016-048-00-0 sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate 401-870-8 — Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
016-049-00-6 calcium octadecylxylenesulphonate 402-040-8 — Skin Corr. 1BAquatic Chronic 2 H314H411 GHS05GHS09Dgr H314H411   
016-050-00-1 potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat 402-150-6 — Eye Irrit. 2Skin Sens. 1 H319H317 GHS07Wng H319H317   
016-051-00-7 trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate 402-170-5 106359-91-5 Skin Sens. 1 H317 GHS07Wng H317   
016-052-00-2 benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate 402-240-5 102561-46-6 Acute Tox. 4 *Aquatic Chronic 2 H332H411 GHS07GHS09Wng H332H411   
016-053-00-8 (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate 402-460-1 — Skin Irrit. 2Skin Sens. 1Aquatic Chronic 4 H315H317H413 GHS07Wng H315H317H413   
016-054-00-3 sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate 400-030-8 — Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Sens. 1 H331H372 **H302H319H335H317 GHS06GHS08Dgr H331H372 **H302H319H335H317   
016-055-00-9 tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) 400-510-7 — Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
016-056-00-4 potassium hydrogensulphate 231-594-1 7646-93-7 Skin Corr. 1BSTOT SE 3 H314H335 GHS05GHS07Dgr H314H335   
016-057-00-X styrene-4-sulfonyl chloride 404-770-2 2633-67-2 Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H315H318H317 GHS05GHS07Dgr H315H318H317   
016-058-00-5 thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine 404-820-3 — Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3 H315H317H412 GHS07Wng H315H317H412   
016-059-00-0 N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride 405-300-9 17339-60-5 Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H319H317H400H410 GHS07GHS09Wng H302H319H317H410   
016-060-00-6 diammonium peroxodisulphate;ammonium persulphate 231-786-5 7727-54-0 Ox. Sol. 3Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1Skin Sens. 1 H272H302H319H335H315H334H317 GHS03GHS08GHS07Dgr H272H302H319H335H315H334H317   
016-061-00-1 dipotassium peroxodisulphate;potassium persulphate 231-781-8 7727-21-1 Ox. Sol. 3Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1Skin Sens. 1 H272H302H319H335H315H334H317 GHS03GHS08GHS07Dgr H272H302H319H335H315H334H317   
016-062-00-7 bensultap (ISO);1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane — 17606-31-4 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
016-063-00-2 sodium metabisulphite 231-673-0 7681-57-4 Acute Tox. 4 *Eye Dam. 1 H302H318 GHS05GHS07Dgr H302H318 EUH031  
016-064-00-8 sodium hydrogensulphite . . . %;sodium bisulphite . . . % 231-548-0 7631-90-5 Acute Tox. 4 * H302 GHS07Wng H302 EUH031  B
016-065-00-3 sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate 400-100-8 84057-97-6 Aquatic Chronic 2 H411 GHS09 H411   
016-066-00-9 tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II) 404-070-7 116912-62-0 Aquatic Chronic 3 H412 — H412   
016-067-00-4 (4-methylphenyl)mesitylene sulfonate 407-530-5 67811-06-7 Aquatic Chronic 4 H413 — H413   
016-068-00-X sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate 407-720-8 155160-86-4 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
016-069-00-5 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid 407-990-7 141915-64-2 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
016-070-00-0 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone 408-220-2 — Aquatic Chronic 4 H413 — H413   
016-071-00-6 trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate 410-130-3 136248-03-8 Skin Sens. 1 H317 GHS07Wng H317   
016-072-00-1 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide 411-520-6 112195-27-4 Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
016-073-00-7 tetrakis(phenylmethyl)thioperoxydi(carbothioamide) 404-310-0 10591-85-2 Aquatic Chronic 4 H413 — H413   
016-074-00-2 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene 405-410-7 — Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H315H318H317H411 GHS05GHS07GHS09Dgr H315H318H317H411   
016-075-00-8 2,2'-diallyl-4,4'-sulfonyldiphenol 411-570-9 41481-66-7 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
016-076-00-3 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol 411-290-7 131538-00-6 Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H302H373 **H400H410 GHS08GHS07GHS09Wng H302H373 **H410   
016-077-00-9 2-chloro-p-toluenesulfochloride 412-890-1 42413-03-6 Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3 H314H317H412 GHS05GHS07Dgr H314H317H412   
016-078-00-4 4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide 413-300-5 56187-04-3 Aquatic Chronic 4 H413 —    
016-079-00-X N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide 412-920-3 16695-22-0 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
016-080-00-5 sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate 412-320-1 31361-99-6 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
016-081-00-0 hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide 418-350-1 — Muta. 2Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2 H341H302H319H317H411 GHS08GHS07GHS09Wng H341H302H319H317H411   
016-082-00-6 ethoxysulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea — 126801-58-9 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
016-083-00-1 acibenzolar-S-methyl;benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester 420-050-0 135158-54-2 Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H319H335H315H317H400H410 GHS07GHS09Wng H319H335H315H317H410   
016-084-00-7 prosulfuron;1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea — 94125-34-5 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
016-085-00-2 flazasulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea — 104040-78-0 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
016-086-00-8 tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 402-590-9 109125-56-6 Eye Dam. 1 H318 GHS05Dgr H318   
016-087-00-3 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;propylene carbonate 403-490-8 104558-95-4 Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H319H317H400H410 GHS07GHS09Wng H319H317H410   
016-088-00-9 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid 407-280-7 71297-11-5 Aquatic Chronic 3 H412 — H412   
016-089-00-4 reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene 413-840-1 — Self-react. C ****Aquatic Chronic 4 H242H413 GHS02Dgr H242H413   
016-090-00-X 4-methyl-N-(methylsulfonyl)benzenesulfonamide 415-040-8 14653-91-9 Acute Tox. 4 *STOT SE 3Eye Dam. 1 H302H335H318 GHS05GHS07Dgr H302H335H318   
016-091-00-5 C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate 414-110-5 — Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
016-093-00-6 reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) 414-770-4 140698-96-0 Self-react. C ****Carc. 2 H242H351 GHS02GHS08Dgr H242H351   
016-095-00-7 reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) 417-980-4 — Self-react. C ****Carc. 2 H242H351 GHS02GHS08Dgr H242H351   
016-096-00-2 thifensulfuron-methyl (ISO);methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate — 79277-27-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
017-001-00-7 chlorine 231-959-5 7782-50-5 Ox. Gas 1Press. GasAcute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1 H270H331H319H335H315H400 GHS03GHS04GHS06GHS09Dgr H270H331H319H335H315H400   U
017-002-00-2 hydrogen chloride 231-595-7 7647-01-0 Press. GasAcute Tox. 3 *Skin Corr. 1A H331H314 GHS04GHS06GHS05Dgr H331H314   U5
017-002-01-X hydrochloric acid ... % 231-595-7 — Skin Corr. 1BSTOT SE 3 H314H335 GHS05GHS07Dgr H314H335  Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H315: 10 % ≤ C < 25 %Eye Irrit. 2; H319: 10 % ≤ C < 25 %STOT SE 3; H335: C ≥ 10 % B
017-003-00-8 barium chlorate 236-760-7 13477-00-4 Ox. Sol. 1Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H271H332H302H411 GHS03GHS07GHS09Dgr H271H332H302H411   
017-004-00-3 potassium chlorate 223-289-7 3811-04-9 Ox. Sol. 1Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H271H332H302H411 GHS03GHS07GHS09Dgr H271H332H302H411   
017-005-00-9 sodium chlorate 231-887-4 7775-09-9 Ox. Sol. 1Acute Tox. 4 *Aquatic Chronic 2 H271H302H411 GHS03GHS07GHS09Dgr H271H302H411   
017-006-00-4 perchloric acid ... % 231-512-4 7601-90-3 Ox. Liq. 1Skin Corr. 1A H271H314 GHS03GHS05Dgr H271H314  Skin Corr. 1A; H314: C ≥ 50 %Skin Corr. 1B; H314: 10 % ≤ C < 50 %Skin Irrit. 2; H315: 1 % ≤ C < 10 %Eye Irrit. 2; H319: 1 % ≤ C < 10 %Ox. Liq. 1; H271: C > 50 %:Ox. Liq. 2; H272: C ≤ 50 %: B
017-007-00-X barium perchlorate 236-710-4 13465-95-7 Ox. Sol. 1Acute Tox. 4 *Acute Tox. 4 * H271H332H302 GHS03GHS07Dgr H271H332H302   
017-008-00-5 potassium perchlorate 231-912-9 7778-74-7 Ox. Sol. 1Acute Tox. 4 * H271H302 GHS03GHS07Dgr H271H302   
017-009-00-0 ammonium perchlorate 232-235-1 7790-98-9 Expl. 1.1Ox. Sol. 1 H201H271 GHS01Dgr H201H271 EUH044  T
017-010-00-6 sodium perchlorate 231-511-9 7601-89-0 Ox. Sol. 1Acute Tox. 4 * H271H302 GHS03GHS07Dgr H271H302   
017-011-00-1 sodium hypochlorite, solution ... % Cl active 231-668-3 7681-52-9 Skin Corr. 1BAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400 EUH031 EUH031: C ≥ 5 % B
017-012-00-7 calcium hypochlorite 231-908-7 7778-54-3 Ox. Sol. 2Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1 H272H302H314H400 GHS03GHS05GHS07GHS09Dgr H272H302H314H400 EUH031 Skin Corr. 1B; H314: C ≥ 10 %Skin Irrit. 2; H315: 3 % ≤ C < 10 %Eye Dam. 1; H31: 3 % ≤ C < 10 %Eye Irrit. 2; H319: 0,5 % ≤ C < 3 %STOT SE 3; H335: C ≥ 3 % T
017-013-00-2 calcium chloride 233-140-8 10043-52-4 Eye Irrit. 2 H319 GHS07Wng H319   
017-014-00-8 ammonium chloride 235-186-4 12125-02-9 Acute Tox. 4 *Eye Irrit. 2 H302H319 GHS07Wng H302H319   
017-015-00-3 (2-(aminomethyl)phenyl)acetylchloride hydrochloride 417-410-4 61807-67-8 Acute Tox. 4 *Skin Corr. 1ASkin Sens. 1 H302H314H317 GHS05GHS07Dgr H302H314H317   
017-016-00-9 methyltriphenylphosphonium chloride 418-400-2 1031-15-8 Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2 H312H302H315H318H411 GHS05GHS07GHS09Dgr H312H302H315H318H411   
017-017-00-4 (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride 426-210-6 120086-58-0 Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H314H400H410 GHS05GHS09Dgr H314H410   
017-018-00-X N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride 405-660-7 — Aquatic Chronic 2 H411 GHS09 H411   
017-019-00-5 (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride 415-110-8 54417-53-7 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
017-020-00-0 ethyl propoxy aluminium chloride 421-790-7 13014-29-4 Water-react. 1Skin Corr. 1A H260H314 GHS02GHS05Dgr H260H314 EUH014  
017-021-00-6 behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride 423-420-1 136920-10-0 Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H318H317H400H410 GHS05GHS07GHS09Dgr H318H317H410   
019-001-00-2 potassium 231-119-8 7440-09-7 Water-react. 1Skin Corr. 1B H260H314 GHS02GHS05Dgr H260H314 EUH014  
019-002-00-8 potassium hydroxide;caustic potash 215-181-3 1310-58-3 Acute Tox. 4 *Skin Corr. 1A H302H314 GHS05GHS07Dgr H302H314  Skin Corr. 1A; H314: C ≥ 5 %Skin Corr. 1B; H314: 2 % ≤ C < 5 %Skin Irrit. 2; H315: 0,5 % ≤ C < 2 %Eye Irrit. 2; H319: 0,5 % ≤ C < 2 % 
020-001-00-X calcium 231-179-5 7440-70-2 Water-react. 2 H261 GHS02Dgr H261   
020-002-00-5 calcium cyanide 209-740-0 592-01-8 Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H300H400H410 GHS06GHS09Dgr H300H410 EUH032  
020-003-00-0 reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] 420-470-4 — Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   
022-001-00-5 titanium tetrachloride 231-441-9 7550-45-0 Skin Corr. 1B H314 GHS05Dgr H314 EUH014  
022-002-00-0 titanium(4+) oxalate 403-260-7 — Eye Dam. 1 H318 GHS05Dgr H318   
022-003-00-6 bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium 412-000-1 125051-32-3 Flam. Sol. 1Repr. 2STOT RE 2 *Aquatic Chronic 2 H228H361f ***H373 **H411 GHS02GHS08GHS09Dgr H228H361f ***H373 **H411   T
023-001-00-8 divanadium pentaoxide;vanadium pentoxide 215-239-8 1314-62-1 Muta. 2Repr. 2STOT RE 1Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Aquatic Chronic 2 H341H361d ***H372 **H332H302H335H411 GHS08GHS07GHS09Dgr H341H361d ***H372 **H332H302H335H411   
024-001-00-0 chromium (VI) trioxide 215-607-8 1333-82-0 Ox. Sol. 1Carc. 1AMuta. 1BRepr. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Skin Corr. 1AResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H271H350H340H361f ***H330H311H301H372 **H314H334H317H400H410 GHS03GHS06GHS08GHS05GHS09Dgr H271H350H340H361f ***H330H311H301H372 **H314H334H317H410  STOT SE 3; H335: C ≥ 1 % 
024-002-00-6 potassium dichromate 231-906-6 7778-50-9 Ox. Sol. 2Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H272H350H340H360FDH330H301H372 **H312H314H334H317H400H410 GHS03GHS06GHS08GHS05GHS09Dgr H272H350H340H360FDH330H301H372 **H312H314H334H317H410  STOT SE 3; H335: C ≥ 5 % 3
024-003-00-1 ammonium dichromate 232-143-1 7789-09-5 Ox. Sol. 2 ****Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H272H350H340H360FDH330H301H372 **H312H314H334H317H400H410 GHS03GHS06GHS08GHS05GHS09Dgr H272H350H340H360FDH330H301H372 **H312H314H334H317H410  STOT SE 3; H335: C ≥ 5 %Resp. Sens.; H334: C ≥ 0,2 %Skin Sens.; H317: C ≥ 0,2 % G3
024-004-00-7 sodium dichromate anhydrate 234-190-3 10588-01-9 Ox. Sol. 2Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H272H350H340H360FDH330H301H372 **H312H314H334H317H400H410 GHS03GHS06GHS08GHS05GHS09Dgr H272H350H340H360FDH330H301H372 **H312H314H334H317H410  STOT SE 3; H335: C ≥ 5 %Resp. Sens.; H334: C ≥ 0,2 %Skin Sens.; H317: C ≥ 0,2 % 3
024-004-01-4 sodium dichromate, dihydrate 234-190-3 7789-12-0 Ox. Sol. 2Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H272H350H340H360FDH330H301H372 **H312H314H334H317H400H410 GHS03GHS06GHS08GHS05GHS09Dgr H272H350H340H360FDH330H301H372 **H312H314H334H317H410  STOT SE 3; H335: C ≥ 5 %Resp. Sens.; H334: C ≥ 0,2 %Skin Sens.; H317: C ≥ 0,2 % 3
024-005-00-2 chromyl dichloride;chromic oxychloride 239-056-8 14977-61-8 Ox. Liq. 1Carc. 1BMuta. 1BSkin Corr. 1ASkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H271H350iH340H314H317H400H410 GHS03GHS08GHS05GHS07GHS09Dgr H271H350iH340H314H317H410  Skin Corr. 1A; H314: C ≥ 10 %Skin Corr. 1B; H314: 5 % ≤ C < 10 %Skin Irrit. 2; H315: 0,5 % ≤ C < 5 %Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %STOT SE 3; H335: 0,5 % ≤ C < 5 %Skin Sens. 1; H317: C ≥ 0,5 % T3
024-006-00-8 potassium chromate 232-140-5 7789-00-6 Carc. 1BMuta. 1BEye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350iH340H319H335H315H317H400H410 GHS08GHS07GHS09Dgr H350iH340H319H335H315H317H410  Skin Sens. 1; H317: C ≥ 0,5 % 3
024-007-00-3 zinc chromates including zinc potassium chromate — — Carc. 1AAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H302H317H400H410 GHS08GHS07GHS09Dgr H350H302H317H410   A
024-008-00-9 calcium chromate 237-366-8 13765-19-0 Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H302H400H410 GHS08GHS07GHS09Dgr H350H302H410   
024-009-00-4 strontium chromate 232-142-6 7789-06-2 Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H302H400H410 GHS08GHS07GHS09Dgr H350H302H400H410   
024-010-00-X dichromium tris(chromate);chromium III chromate;chromic chromate 246-356-2 24613-89-6 Ox. Sol. 1Carc. 1BSkin Corr. 1ASkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H271H350H314H317H400H410 GHS03GHS08GHS05GHS07GHS09Dgr H271H350H314H317H410   T
024-011-00-5 ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) 400-110-2 109125-51-1 Self-react. C ****Aquatic Acute 1Aquatic Chronic 1 H242H400H410 GHS02GHS09Dgr H242H410   
024-012-00-0 trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) 400-810-8 — Muta. 2 H341 GHS08Wng H341   
024-013-00-6 trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) 402-500-8 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
024-014-00-1 trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) 402-870-0 93952-24-0 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
024-015-00-7 disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) 404-930-1 — Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H332H318H411 GHS05GHS07GHS09Dgr H332H318H411   
024-016-00-2 tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) 405-110-6 88377-66-6 STOT RE 2 *Aquatic Chronic 4 H373 **H413 GHS08Wng H373 **H413   
024-017-00-8 Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex — — Carc. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350iH317H400H410 GHS08GHS07GHS09Dgr H350iH317H410   A
024-018-00-3 sodium chromate 231-889-5 7775-11-3 Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H340H360FDH330H301H372 **H312H314H334H317H400H410 GHS06GHS08GHS05GHS09Dgr H350H340H360FDH330H301H372 **H312H314H334H317H410  Resp. Sens.; H334: C ≥ 0,2 %Skin Sens.; H317: C ≥ 0,2 % 3
024-019-00-9 Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) 419-230-1 — Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
024-020-00-4 trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate(III) 418-220-4 — Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
025-001-00-3 manganese dioxide 215-202-6 1313-13-9 Acute Tox. 4 *Acute Tox. 4 * H332H302 GHS07Wng H332H302   
025-002-00-9 potassium permanganate 231-760-3 7722-64-7 Ox. Sol. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H272H302H400H410 GHS03GHS07GHS09Dgr H272H302H410   
025-003-00-4 manganese sulphate 232-089-9 7785-87-7 STOT RE 2 *Aquatic Chronic 2 H373 **H411 GHS08GHS09Wng H373 **H411   
025-004-00-X bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate 411-760-1 116633-53-5 Aquatic Chronic 2 H411 GHS09 H411   
025-005-00-5 reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-) 417-660-4 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
026-001-00-6 (η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate 407-840-0 100011-37-8 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3 H302H318H412 GHS05GHS07Dgr H302H318H412   
026-002-00-1 (η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate 407-880-9 117549-13-0 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
027-001-00-9 cobalt 231-158-0 7440-48-4 Resp. Sens. 1Skin Sens. 1Aquatic Chronic 4 H334H317H413 GHS08Dgr H334H317H413   
027-002-00-4 cobalt oxide 215-154-6 1307-96-6 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
027-003-00-X cobalt sulphide 215-273-3 1317-42-6 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
027-004-00-5 cobalt dichloride 231-589-4 7646-79-9 Carc. 1BAcute Tox. 4 *Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350iH302H334H317H400H410 GHS08GHS07GHS09Dgr H350iH302H334H317H410  Carc. 1B; H350i: C ≥ 0,01 %* 1
027-005-00-0 cobalt sulphate 233-334-2 10124-43-3 Carc. 1BAcute Tox. 4 *Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350iH302H334H317H400H410 GHS08GHS07GHS09Dgr H350iH302H334H317H410  Carc. 1B; H350i: C ≥ 0,01 % 1
028-001-00-1 tetracarbonylnickel;nickel tetracarbonyl 236-669-2 13463-39-3 Flam. Liq. 2Carc. 2Repr. 1BAcute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H225H351H360D ***H330H400H410 GHS02GHS06GHS08GHS09Dgr H225H351H360D ***H330H410   
028-002-00-7 nickel 231-111-4 7440-02-0 Carc. 2Skin Sens. 1 H351H317 GHS08GHS07Wng H351H317   
028-003-00-2 nickel monoxide 215-215-7 1313-99-1 Carc. 1AiSkin Sens. 1Aquatic Chronic 4 H350iH317H413 GHS08GHS07Dgr H350iH317H413   
028-004-00-8 nickel dioxide 234-823-3 12035-36-8 Carc. 1AiSkin Sens. 1Aquatic Chronic 4 H350iH317H413 GHS08GHS07Dgr H350iH317H413   
028-005-00-3 dinickel trioxide 215-217-8 1314-06-3 Carc. 1AiSkin Sens. 1Aquatic Chronic 4 H350iH317H413 GHS08GHS07Dgr H350iH317H413   
028-006-00-9 nickel sulphide 240-841-2 16812-54-7 Carc. 1AiSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350iH317H400H410 GHS08GHS07GHS07GHS09Dgr H350iH317H410   
028-007-00-4 nickel subsulphide;trinickel disulphide 234-829-6 12035-72-2 Carc. 1AiSkin Sens. 1Aquatic Chronic 2 H350iH317H411 GHS08GHS07GHS09Dgr H350iH317H411   
028-008-00-X nickel dihydroxide 235-008-5 12054-48-7 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H332H302H317H400H410 GHS08GHS07GHS09Wng H351H332H302H317H410   
028-009-00-5 nickel sulphate 232-104-9 7786-81-4 Carc. 2Acute Tox. 4 *Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H302H334H317H400H410 GHS08GHS07GHS09Dgr H351H302H334H317H410   
028-010-00-0 nickel carbonate 222-068-2 3333-67-3 Carc. 2Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H302H317H400H410 GHS08GHS07GHS09Wng H351H302H317H410   
029-001-00-4 copper chloride;copper (I) chloride;cuprous chloride 231-842-9 7758-89-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H400H410   
029-002-00-X dicopper oxide;copper (I) oxide 215-270-7 1317-39-1 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
029-003-00-5 Naphthenic acids, copper salts;copper naphthenate 215-657-0 1338-02-9 Flam. Liq. 3Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H226H302H400H410 GHS02GHS07GHS09Wng H226H302H410   
029-004-00-0 copper sulphate 231-847-6 7758-98-7 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H315H400H410 GHS07GHS09Wng H302H319H315H410   
029-005-00-6 (tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid 401-260-1 — Eye Irrit. 2 H319 GHS07Wng H319   
029-006-00-1 tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) 403-210-4 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
029-007-00-7 (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide 404-670-9 89797-01-3 Skin Sens. 1 H317 GHS07Wng H317   G
029-008-00-2 copper(II) methanesulfonate 405-400-2 54253-62-2 Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H302H318H400H410 GHS05GHS07GHS09Dgr H302H318H410   
029-009-00-8 phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex 413-650-9 93971-95-0 Aquatic Chronic 3 H412 — H412   
029-010-00-3 reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) 407-700-9 101408-30-4 Skin Sens. 1 H317 GHS07Wng H317   
029-011-00-9 sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex 412-730-0 150522-10-4 Skin Corr. 1B H314 GHS05Dgr H314   
029-012-00-4 sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) 407-340-2 124719-24-0 Eye Dam. 1 H318 GHS05Dgr H318   
029-013-00-X trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) 407-580-8 130201-51-3 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
030-001-00-1 zinc powder — zinc dust (pyrophoric) 231-175-3 7440-66-6 Water-react. 1Pyr. Sol. 1Aquatic Acute 1Aquatic Chronic 1 H260H250H400H410 GHS02GHS09Dgr H260H250H410   T
030-001-01-9 zinc powder — zinc dust (stabilised) 231-175-3 7440-66-6 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
030-003-00-2 zinc chloride 231-592-0 7646-85-7 Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H302H314H400H410 GHS05GHS07GHS09Dgr H302H314H410  STOT SE 3; H335: C ≥ 5 % 
030-004-00-8 dimethylzinc; [1]diethylzinc [2] 208-884-1 [1]209-161-3 [2] 544-97-8 [1]557-20-0 [2] Pyr. Liq. 1Water-react. 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H250H260H314H400H410 GHS02GHS05GHS09Dgr H250H260H314H410 EUH014  
030-005-00-3 diamminediisocyanatozinc 401-610-3 — Acute Tox. 4 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1 H302H318H334H317H400 GHS05GHS08GHS07GHS09Dgr H302H318H334H317H400   
030-006-00-9 zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]zinc sulphate (anhydrous) [2] 231-793-3 [1]231-793-3 [2] 7446-19-7 [1]7733-02-0 [2] Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H302H318H400H410 GHS05GHS07GHS09Dgr H302H318H410   
030-007-00-4 bis(3,5-di-tert-butylsalicylato-O1,O2)zinc 403-360-0 42405-40-3 Flam. Sol. 1Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H228H302H400H410 GHS02GHS07GHS09Dgr H228H302H410   T
030-008-00-X hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) 403-750-0 113036-91-2 Acute Tox. 4 *Aquatic Chronic 2 H332H411 GHS07GHS09Wng H332H411   
030-011-00-6 trizinc bis(orthophosphate) 231-944-3 7779-90-0 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
030-013-00-7 zinc oxide 215-222-5 1314-13-2 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
033-001-00-X arsenic 231-148-6 7440-38-2 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H301H400H410 GHS06GHS09Dgr H331H301H410   
033-002-00-5 arsenic compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H301H400H410 GHS06GHS09Dgr H331H301H410  * A1
033-003-00-0 diarsenic trioxide;arsenic trioxide 215-481-4 1327-53-3 Carc. 1AAcute Tox. 2 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H350H300H314H400H410 GHS06GHS08GHS05GHS09Dgr H350H300H314H410   
033-004-00-6 diarsenic pentaoxide;arsenic pentoxide;arsenic oxide 215-116-9 1303-28-2 Carc. 1AAcute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H350H331H301H400H410 GHS06GHS08GHS09Dgr H350H331H301H410   
033-005-00-1 arsenic acid and its salts — — Carc. 1AAcute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H350H331H301H400H410 GHS06GHS08GHS09Dgr H350H331H301H410   A
033-006-00-7 arsine 232-066-3 7784-42-1 Flam. Gas 1Press. GasAcute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H220H330H373 **H400H410 GHS02GHS04GHS06GHS08GHS09Dgr H220H330H373 **H410   U
033-007-00-2 tert-butylarsine 423-320-6 4262-43-5 Pyr. Liq. 1Acute Tox. 2 * H250H330 GHS02GHS06Dgr H250H330   
034-001-00-2 selenium 231-957-4 7782-49-2 Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 4 H331H301H373 **H413 GHS06GHS08Dgr H331H301H373 **H413   
034-002-00-8 selenium compounds except cadmium sulphoselenide — — Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H301H373 **H400H410 GHS06GHS08GHS09Dgr H331H301H373 **H410   A
034-003-00-3 sodium selenite 233-267-9 10102-18-8 Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Chronic 2 H300H331H317H411 GHS06GHS09Dgr H300H331H317H411 EUH031  
035-001-00-5 bromine 231-778-1 7726-95-6 Acute Tox. 2 *Skin Corr. 1AAquatic Acute 1 H330H314H400 GHS06GHS05GHS09Dgr H330H314H400   
035-002-00-0 hydrogen bromide 233-113-0 10035-10-6 Press. GasSkin Corr. 1ASTOT SE 3 H314H335 GHS04GHS05GHS07Dgr H314H335   U
035-002-01-8 hydrobromic acid ... % — — Skin Corr. 1BSTOT SE 3 H314H335 GHS05GHS07Dgr H314H335  Skin Corr. 1B; H314: C ≥ 40 %Skin Irrit. 2; H315: 10 % ≤ C < 40 %Eye Irrit. 2; H319: 10 % ≤ C < 40 %STOT SE 3; H335: C ≥ 10 % B
035-003-00-6 potassium bromate 231-829-8 7758-01-2 Ox. Sol. 1Carc. 1BAcute Tox. 3 * H271H350H301 GHS03GHS06GHS08Dgr H271H350H301   
035-004-00-1 2-hydroxyethylammonium perbromide 407-440-6 — Ox. Sol. 2 ****Acute Tox. 4 *Skin Corr. 1ASkin Sens. 1Aquatic Acute 1 H272H302H314H317H400 GHS03GHS05GHS07GHS09Dgr H272H302H314H317H400   
040-001-00-3 zirconium powder (pyrophoric) 231-176-9 7440-67-7 Water-react. 1Pyr. Sol. 1 H260H250 GHS02Dgr H260H250   T
040-002-00-9 zirconium powder, dry (non pyrophoric) — — Self-heat. 1 H251 GHS02Dgr H251   T
042-001-00-9 molybdenum trioxide 215-204-7 1313-27-5 STOT RE 2 *Eye Irrit. 2STOT SE 3 H373 **H319H335 GHS08GHS07Wng H373 **H319H335   
042-002-00-4 tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-) 404-760-8 117342-25-3 Acute Tox. 3 *Eye Dam. 1Aquatic Chronic 4 H331H318H413 GHS06GHS05Dgr H331H318H413   
042-003-00-X tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) 404-860-1 116810-46-9 Flam. Sol. 1Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H228H318H400H410 GHS02GHS05GHS09Dgr H228H318H410   T
042-004-00-5 Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) 412-780-3 — Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H315H317H411 GHS07GHS09Wng H315H317H411   
047-001-00-2 silver nitrate 231-853-9 7761-88-8 Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H314H400H410 GHS05GHS09Dgr H314H410   
048-001-00-5 cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe),reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex — — Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410  * A1
048-002-00-0 cadmium (non-pyrophoric); [1]cadmium oxide (non-pyrophoric) [2] 231-152-8 [1]215-146-2 [2] 7440-43-9 [1]1306-19-0 [2] Carc. 1BMuta. 2Repr. 2Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H350H341H361fdH330H372 **H400H410 GHS06GHS08GHS09Dgr H350H341H361fdH330H372 **H410   
048-003-00-6 cadmium diformate;cadmiumformate 224-729-0 4464-23-7 Acute Tox. 3 *Acute Tox. 3 *Carc. 2STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H301H351H373 **H400H410 GHS06GHS08GHS09Dgr H331H301H351H373 **H410  *STOT RE 2; H373: C ≥ 0,25 % 
048-004-00-1 cadmium cyanide 208-829-1 542-83-6 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Carc. 2STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H351H373 **H400H410 GHS06GHS08GHS09Dgr H330H310H300H351H373 **H410 EUH032 STOT RE 2; H373: C ≥ 0,1 %EUH032: C ≥ 1 % 
048-005-00-7 cadmiumhexafluorosilicate(2-);cadmium fluorosilica 241-084-0 17010-21-8 Acute Tox. 3 *Acute Tox. 3 *Carc. 2STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H301H351H373 **H400H410 GHS06GHS08GHS09Dgr H331H301H351H373 **H410  *STOT RE 2; H373: C ≥ 0,1 % 
048-006-00-2 cadmium fluoride 232-222-0 7790-79-6 Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H350H340H360FDH330H301H372 **H400H410 GHS06GHS08GHS09Dgr H350H340H360FDH330H301H372 **H410  Carc. 1B; H350: C ≥ 0,01 %* oralSTOT RE 1; H372: C ≥ 7 %STOT RE 2: 0,1 % ≤ C < 7 % 
048-007-00-8 cadmium iodide 232-223-6 7790-80-9 Acute Tox. 3 *Acute Tox. 3 *Carc. 2STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H301H351H373 **H400H410 GHS06GHS08GHS09Dgr H331H301H351H373 **H410  *STOT RE 2; H373: C ≥ 0,1 % 
048-008-00-3 cadmium chloride 233-296-7 10108-64-2 Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H350H340H360FDH330H301H372 **H400H410 GHS06GHS08GHS09Dgr H350H340H360FDH330H301H372 **H410  Carc. 1B; H350: C ≥ 0,01 %* oralSTOT RE 1; H372: C ≥ 7 %STOT RE 2; H373: 0,1 % ≤ C < 7 % 
048-009-00-9 cadmium sulphate 233-331-6 10124-36-4 Carc. 1BMuta. 1BRepr. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H350H340H360FDH330H301H372 **H400H410 GHS06GHS08GHS09Dgr H350H340H360FDH330H301H372 **H410  Carc. 1B; H350: C ≥ 0,01 %* oralSTOT RE 1; H372: C ≥ 7 %STOT RE 2; H373: 0,1 % ≤ C < 7 % 
048-010-00-4 cadmium sulphide 215-147-8 1306-23-6 Carc. 1BMuta. 2Repr. 2STOT RE 1Acute Tox. 4 *Aquatic Chronic 4 H350H341H361fdH372 **H302H413 GHS08GHS07Dgr H350H341H361fdH372 **H302H413  *STOT RE 1; H372: C ≥ 10 %STOT RE 2; H373: 0,1 % ≤ C < 10 % 1
048-011-00-X cadmium (pyrophoric) 231-152-8 7440-43-9 Pyr. Sol. 1Carc. 1BMuta. 2Repr. 2Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H250H350H341H361fdH330H372 **H400H410 GHS02GHS06GHS08GHS09Dgr H250H350H341H361fdH330H372 **H410   
050-001-00-5 tin tetrachloride;stannic chloride 231-588-9 7646-78-8 Skin Corr. 1BAquatic Chronic 3 H314H412 GHS05Dgr H314H412  STOT SE 3; H335: C ≥ 5 % 
050-002-00-0 cyhexatin (ISO);hydroxytricyclohexylstannane;tri(cyclohexyl)tin hydroxide 236-049-1 13121-70-5 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410   
050-003-00-6 fentin acetate (ISO);triphenyltin acetate 212-984-0 900-95-8 Carc. 2Repr. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H351H361d ***H330H311H301H372 **H335H315H318H400H410 GHS06GHS08GHS05GHS09Dgr H351H361d ***H330H311H301H372 **H335H315H318H410   
050-004-00-1 fentin hydroxide (ISO);triphenyltin hydroxide 200-990-6 76-87-9 Carc. 2Repr. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H351H361d ***H330H311H301H372 **H335H315H318H400H410 GHS06GHS08GHS05GHS09Dgr H351H361d ***H330H311H301H372 **H335H315H318H410   
050-005-00-7 trimethyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H400H410 GHS06GHS09Dgr H330H310H300H410  * A1
050-006-00-2 triethyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H400H410 GHS06GHS09Dgr H330H310H300H410  * A1
050-007-00-8 tripropyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410  * A1
050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H301H372 **H312H319H315H400H410 GHS06GHS08GHS09Dgr H301H372 **H312H319H315H410  * oralSTOT RE 1; H372: C ≥ 1 %STOT RE 2; H373: 0,25 % ≤ C < 1 %* dermalEye Irrit. 2; H319: C ≥ 1 %Skin Irrit. 2; H315: C ≥ 1 % A1
050-009-00-9 fluorotripentylstannane; [1]hexapentyldistannoxane [2] 243-546-7 [1]247-143-7 [2] 20153-49-5 [1]25637-27-8 [2] Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410  * 1
050-010-00-4 fluorotrihexylstannane 243-547-2 20153-50-8 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410  * 1
050-011-00-X triphenyltin compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410  * A1
050-012-00-5 tetracyclohexylstannane; [1]chlorotricyclohexylstannane; [2]butyltricyclohexylstannane [3] 215-910-5 [1]221-437-5 [2]230-358-5 [3] 1449-55-4 [1]3091-32-5 [2]7067-44-9 [3] Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410  * A1
050-013-00-0 trioctyltin compounds, with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 4 H319H335H315H413 GHS07Wng H319H335H315H413  Skin Irrit. 2; H315: C ≥ 1 %Eye Irrit. 2; H319: C ≥ 1 %STOT SE 3; H335: C ≥ 1 % A1
050-017-00-2 fenbutatin oxide (ISO);bis(tris(2-methyl-2-phenylpropyl)tin)oxide 236-407-7 13356-08-6 Acute Tox. 2 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H330H319H315H400H410 GHS06GHS09Dgr H330H319H315H410   
050-018-00-8 tin(II) methanesulphonate 401-640-7 53408-94-9 Skin Corr. 1BAcute Tox. 4 *Skin Sens. 1 H314H302H317 GHS05GHS07Dgr H314H302H317   
050-019-00-3 azocyclotin (ISO);1-(tricyclohexylstannyl)-1H-1,2,4-triazole 255-209-1 41083-11-8 Acute Tox. 2 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H330H301H335H315H318H400H410 GHS06GHS05GHS09Dgr H330H301H335H315H318H410   
050-020-00-9 trioctylstannane 413-320-4 869-59-0 STOT RE 1Skin Irrit. 2Aquatic Chronic 4 H372 **H315H413 GHS08GHS07Dgr H372 **H315H413   
051-001-00-8 antimony trichloride 233-047-2 10025-91-9 Skin Corr. 1BAquatic Chronic 2 H314H411 GHS05GHS09Dgr H314H411  STOT SE 3; H335: C ≥ 5 % 
051-002-00-3 antimony pentachloride 231-601-8 7647-18-9 Skin Corr. 1BAquatic Chronic 2 H314H411 GHS05GHS09Dgr H314H411  STOT SE 3; H335: C ≥ 5 % 
051-003-00-9 antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex — — Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H332H302H411 GHS07GHS09Wng H332H302H411  * A1
051-004-00-4 antimony trifluoride 232-009-2 7783-56-4 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H331H311H301H411 GHS06GHS09Dgr H331H311H301H411   
051-005-00-X antimony trioxide 215-175-0 1309-64-4 Carc. 2 H351 GHS08Wng H351   
051-006-00-5 diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate 403-500-0 — Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
051-007-00-0 bis(4-dodecylphenyl)iodonium hexafluoroantimonate 404-420-9 71786-70-4 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
053-001-00-3 iodine 231-442-4 7553-56-2 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1 H332H312H400 GHS07GHS09Wng H332H312H400   
053-002-00-9 hydrogen iodide 233-109-9 10034-85-2 Press. GasSkin Corr. 1A H314 GHS04GHS05Dgr H314  Skin Corr. 1A; H314: C ≥ 10 %Skin Corr. 1B; H314: 0,2 % ≤ C < 10 %Skin Irrit. 2; H315: 0,02 % ≤ C < 0,2 %Eye Irrit. 2; H319: 0,02 % ≤ C < 0,2 %STOT SE 3; H335: C ≥ 0,02 % U5
053-002-01-6 hydriodic acid ... % — — Skin Corr. 1B H314 GHS05Dgr   Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H315: 10 % ≤ C < 25 %Eye Irrit. 2; H319: 10 % ≤ C < 25 % B
053-005-00-5 (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-) 422-960-3 178233-72-2 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H312H302H373 **H400H410 GHS08GHS07GHS09Wng H312H302H373 **H410   
056-001-00-1 barium peroxide 215-128-4 1304-29-6 Ox. Sol. 2Acute Tox. 4 *Acute Tox. 4 * H272H332H302 GHS03GHS07Dgr H272H332H302   
056-002-00-7 barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex — — Acute Tox. 4 *Acute Tox. 4 * H332H302 GHS07Wng H332H302  * A1
056-003-00-2 barium carbonate 208-167-3 513-77-9 Acute Tox. 4 * H302 GHS07Wng H302   
056-004-00-8 barium chloride 233-788-1 10361-37-2 Acute Tox. 3 *Acute Tox. 4 * H301H332 GHS06Dgr H301H332   
072-001-00-4 hafnium tetra-n-butoxide 411-740-2 22411-22-9 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
074-001-00-X hexasodium tungstate hydrate 412-770-9 12141-67-2 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3 H302H318H412 GHS05GHS07Dgr H302H318H412   
074-002-00-5 Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione 408-250-6 — Flam. Liq. 2Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H225H332H314H317H400H410 GHS02GHS05GHS07GHS09Dgr H225H332H314H317H410   
076-001-00-5 osmium tetraoxide;osmic acid 244-058-7 20816-12-0 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Skin Corr. 1B H330H310H300H314 GHS06GHS05Dgr H330H310H300H314   
078-001-00-0 tetrachloroplatinates with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H301H318H334H317 GHS06GHS05GHS08Dgr H301H318H334H317   A
078-002-00-6 diammonium tetrachloroplatinate 237-499-1 13820-41-2 Acute Tox. 3 *Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H301H315H318H334H317 GHS06GHS05GHS08Dgr H301H315H318H334H317   
078-003-00-1 disodium tetrachloroplatinate 233-051-4 10026-00-3 Acute Tox. 3 *Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H301H315H318H334H317 GHS06GHS05GHS08Dgr H301H315H318H334H317   
078-004-00-7 dipotassium tetrachloroplatinate 233-050-9 10025-99-7 Acute Tox. 3 *Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H301H315H318H334H317 GHS06GHS05GHS08Dgr H301H315H318H334H317   
078-005-00-2 hexachloroplatinates with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H301H318H334H317 GHS06GHS05GHS08Dgr H301H318H334H317   A
078-006-00-8 disodium hexachloroplatinate 240-983-5 16923-58-3 Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H301H318H334H317 GHS06GHS05GHS08Dgr H301H318H334H317   
078-007-00-3 dipotassium hexachloroplatinate 240-979-3 16921-30-5 Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H301H318H334H317 GHS06GHS05GHS08Dgr H301H318H334H317   
078-008-00-9 diammonium hexachloroplatinate 240-973-0 16919-58-7 Acute Tox. 3 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H301H318H334H317 GHS06GHS05GHS08Dgr H301H318H334H317   
078-009-00-4 hexachloroplatinic acid 241-010-7 16941-12-1 Acute Tox. 3 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1 H301H314H334H317 GHS06GHS05GHS08Dgr H301H314H334H317   
080-001-00-0 mercury 231-106-7 7439-97-6 Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H373 **H400H410 GHS06GHS08GHS09Dgr H331H373 **H410   
080-002-00-6 inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex — — Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H373 **H400H410 GHS06GHS08GHS09Dgr H330H310H300H373 **H410  *STOT RE 2; H373: C ≥ 0,1 % A1
080-003-00-1 dimercury dichloride;mercurous chloride;calomel 233-307-5 10112-91-1 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H335H315H400H410 GHS07GHS09Wng H302H319H335H315H410   
080-004-00-7 organic compounds of mercury with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H373 **H400H410 GHS06GHS08GHS09Dgr H330H310H300H373 **H410  *STOT RE 2; H373: C ≥ 0,1 % A1
080-005-00-2 mercury difulminate;mercuric fulminate;fulminate of mercury 211-057-8 628-86-4 Unst. Expl.Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H200H331H311H301H373 **H400H410 GHS01GHS06GHS08GHS09Dgr H200H331H311H301H373 **H400H410   
080-005-01-X mercury difulminate;mercuric fulminate;fulminate of mercury [≥ 20 % phlegmatiser] 211-057-8 628-86-4 Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H201H331H311H301H373 **H400H410 GHS01GHS06GHS08GHS09Dgr H201H331H311H301H373 **H400H410   
080-006-00-8 dimercury dicyanide oxide;mercuric oxycyanide 215-629-8 1335-31-5 Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H201H331H311H301H373 **H400H410 GHS01GHS06GHS08GHS09Dgr H201H331H311H301H373 **H410   T
080-007-00-3 dimethylmercury; [1]diethylmercury [2] 209-805-3 [1]211-000-7 [2] 593-74-8 [1]627-44-1 [2] Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H373 **H400H410 GHS06GHS08GHS09Dgr H330H310H300H373 **H410  *STOT RE 2; H373: C ≥ 0,05 % 1
080-008-00-9 phenylmercury nitrate; [1]phenylmercury hydroxide; [2]basic phenylmercury nitrate [3] 200-242-9 [1]202-866-7 [2]-[3] 55-68-5 [1]100-57-2 [2]8003-05-2 [3] Acute Tox. 3 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H301H372 **H314H400H410 GHS06GHS08GHS05GHS09Dgr H301H372 **H314H410   
080-009-00-4 2-methoxyethylmercury chloride 204-659-7 123-88-6 Acute Tox. 3 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H301H372 **H314H400H410 GHS06GHS08GHS05GHS09Dgr H301H372 **H314H410   
080-010-00-X mercury dichloride;mercuric chloride 231-299-8 7487-94-7 Acute Tox. 2 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H300H372 **H314H400H410 GHS06GHS08GHS05GHS09Dgr H300H372 **H314H410   
080-011-00-5 phenylmercury acetate 200-532-5 62-38-4 Acute Tox. 3 *STOT RE 1Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H301H372 **H314H400H410 GHS06GHS08GHS05GHS09Dgr H301H372 **H314H410   
081-001-00-3 thallium 231-138-1 7440-28-0 Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 4 H330H300H373 **H413 GHS06GHS08Dgr H330H300H373 **H413   
081-002-00-9 thallium compounds, with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2 H330H300H373 **H411 GHS06GHS08GHS09Dgr H330H300H373 **H411   A
081-003-00-4 dithallium sulphate;thallic sulphate 231-201-3 7446-18-6 Acute Tox. 2 *STOT RE 1Skin Irrit. 2Aquatic Chronic 2 H300H372 **H315H411 GHS06GHS08GHS09Dgr H300H372 **H315H411   
082-001-00-6 lead compounds with the exception of those specified elsewhere in this Annex — — Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H360DfH332H302H373 **H400H410 GHS08GHS07GHS09Dgr H360DfH332H302H373 **H410  Repr. 2; H361f: C ≥ 2,5 %*STOT RE 2; H373: C ≥ 0,5 % A1
082-002-00-1 lead alkyls — — Repr. 1AAcute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H360DfH330H310H300H373 **H400H410 GHS06GHS08GHS09Dgr H360DfH330H310H300H373 **H410  Repr. 1A; H360D: C ≥ 0,1 %*STOT RE 2; H373: C ≥ 0,05 % A1
082-003-00-7 lead diazide;lead azide 236-542-1 13424-46-9 Unst. Expl.Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H200H360DfH332H302H373 **H400H410 GHS01GHS08GHS07GHS09Dgr H200H360DfH332H302H373 **H410   1
082-003-01-4 lead diazide;lead azide [≥ 20 % phlegmatiser] 236-542-1 13424-46-9 Expl. 1.1Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H201H360DfH332H302H373 **H400H410 GHS01GHS08GHS07GHS09Dgr H201H360DfH332H302H373 **H410   1
082-004-00-2 lead chromate 231-846-0 7758-97-6 Carc. 2Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H351H360DfH373 **H400H410 GHS08GHS09Dgr H351H360DfH373 **H410   1
082-005-00-8 lead di(acetate) 206-104-4 301-04-2 Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H360DfH373 **H400H410 GHS08GHS09Dgr H360DfH373 **H410   1
082-006-00-3 trilead bis(orthophosphate) 231-205-5 7446-27-7 Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H360DfH373 **H400H410 GHS08GHS09Dgr H360DfH373 **H410   1
082-007-00-9 lead acetate, basic 215-630-3 1335-32-6 Carc. 2Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H351H360DfH373 **H400H410 GHS08GHS09Dgr H351H360DfH373 **H410   1
082-008-00-4 lead(II) methanesulphonate 401-750-5 17570-76-2 Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1 H360DfH332H302H373 **H315H318 GHS08GHS05GHS07Dgr H360DfH332H302H373 **H315H318   1
082-009-00-X Lead sulfochromate yellow;C.I. Pigment Yellow 34;[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] 215-693-7 1344-37-2 Carc. 2Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H351H360DfH373 **H400H410 GHS08GHS09Dgr H351H360DfH373 **H410   1
082-010-00-5 Lead chromate molybdate sulfate red;C.I. Pigment Red 104;[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] 235-759-9 12656-85-8 Carc. 2Repr. 1ASTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H351H360DfH373 **H400H410 GHS08GHS09Dgr H351H360DfH373 **H410   1
082-011-00-0 lead hydrogen arsenate 232-064-2 7784-40-9 Carc. 1ARepr. 1AAcute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H350H360DfH331H301H373 **H400H410 GHS06GHS08GHS09Dgr H350H360DfH331H301H373 **H410   1
092-001-00-8 uranium 231-170-6 7440-61-1 Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 4 H330H300H373 **H413 GHS06GHS08Dgr H330H300H373 **H413   
092-002-00-3 uranium compounds — — Acute Tox. 2 *Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2 H330H300H373 **H411 GHS06GHS08GHS09Dgr H330H300H373 **H411   A
601-001-00-4 methane 200-812-7 74-82-8 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   U
601-002-00-X ethane 200-814-8 74-84-0 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   U
601-003-00-5 propane 200-827-9 74-98-6 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   U
601-004-00-0 butane; [1]and isobutane [2] 203-448-7 [1]200-857-2 [2] 106-97-8 [1]75-28-5 [2] Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   C U
601-004-01-8 butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2] 203-448-7 [1]200-857-2 [2] 106-97-8 [1]75-28-5 [2] Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   C S U
601-005-00-6 2,2-dimethylpropane;neopentane 207-343-7 463-82-1 Flam. Gas 1Press. GasAquatic Chronic 2 H220H411 GHS02GHS04GHS09Dgr H220H411   U
601-006-00-1 pentane 203-692-4 109-66-0 Flam. Liq. 2Asp. Tox. 1STOT SE 3Aquatic Chronic 2 H225H304H336H411 GHS02GHS08GHS07GHS09Dgr H225H304H336H411 EUH066  C
601-007-00-7 hexane, reaction mass of isomers (containing < 5 % n-hexane (203-777-6)) — — Flam. Liq. 2Asp. Tox. 1Skin Irrit. 2STOT SE 3Aquatic Chronic 2 H225H304H315H336H411 GHS02GHS08GHS07GHS09Dgr H225H304H315H336H411   C
601-008-00-2 heptane [and isomers] [1] 205-563-8 [1]203-548-0 [2]207-346-3 [3]209-230-8 [4]209-280-0 [5]209-643-3 [6]209-680-5 [7]209-730-6 [8]210-529-0 [9]250-610-8 [10] 142-82-5 [1]108-08-7 [2]464-06-2 [3]562-49-2 [4]565-59-3 [5]589-34-4 [6]590-35-2 [7]591-76-4 [8]617-78-7 [9]31394-54-4 [10] Flam. Liq. 2Asp. Tox. 1Skin Irrit. 2STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H225H304H315H336H400H410 GHS02GHS08GHS07GHS09Dgr H225H304H315H336H410   C
601-009-00-8 octane [and isomers] [1] 203-892-1 [1]208-759-1 [2]209-207-2 [3]209-243-9 [4]209-266-4 [5]209-292-6 [6]209-504-7 [7]209-547-1 [8]209-649-6 [9]209-650-1 [10]209-660-6 [11]209-689-4 [12]209-745-8 [13]209-747-9 [14]209-855-6 [15]210-187-2 [16]210-621-0 [17]213-923-0 [18]247-861-0 [19] 111-65-9 [1]540-84-1 [2]560-21-4 [3]563-16-6 [4]564-02-3 [5]565-75-3 [6]583-48-2 [7]584-94-1 [8]589-43-5 [9]589-53-7 [10]589-81-1 [11]590-73-8 [12]592-13-2 [13]592-27-8 [14]594-82-1 [15]609-26-7 [16]619-99-8 [17]1067-08-9 [18]26635-64-3 [19] Flam. Liq. 2Asp. Tox. 1Skin Irrit. 2STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H225H304H315H336H400H410 GHS02GHS08GHS07GHS09Dgr H225H304H315H336H410   C
601-010-00-3 ethylene 200-815-3 74-85-1 Flam. Gas 1Press. GasSTOT SE 3 H220H336 GHS02GHS04GHS07Dgr H220H336   U
601-011-00-9 propene;propylene 204-062-1 115-07-1 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   U
601-012-00-4 but-1-ene; [1]butene, mixed-1-and-2-isomers; [2]2-methylpropene; [3](Z)-but-2-ene; [4](E)-but-2-ene [5] 203-449-2 [1]203-452-9 [2]204-066-3 [3]209-673-7 [4]210-855-3 [5] 106-98-9 [1]107-01-7 [2]115-11-7 [3]590-18-1 [4]624-64-6 [5] Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   C U
601-013-00-X 1,3-butadiene;buta-1,3-diene 203-450-8 106-99-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   D U
601-014-00-5 isoprene (stabilised)2-methyl-1,3-butadiene 201-143-3 78-79-5 Flam. Liq. 1Carc. 1BMuta. 2Aquatic Chronic 3 H224H350H341H412 GHS02GHS08Dgr H224H350H341H412   D
601-015-00-0 acetylene;ethyne 200-816-9 74-86-2 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220 EUH006  U
601-016-00-6 cyclopropane 200-847-8 75-19-4 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   U
601-017-00-1 cyclohexane 203-806-2 110-82-7 Flam. Liq. 2Asp. Tox. 1Skin Irrit. 2STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H225H304H315H336H400H410 GHS02GHS08GHS07GHS09Dgr H225H304H315H336H410   
601-018-00-7 methylcyclohexane 203-624-3 108-87-2 Flam. Liq. 2Asp. Tox. 1Skin Irrit. 2STOT SE 3Aquatic Chronic 2 H225H304H315H336H411 GHS02GHS08GHS07GHS09Dgr H225H304H315H336H411   
601-019-00-2 1,4-dimethylcyclohexane 209-663-2 589-90-2 Flam. Liq. 2Asp. Tox. 1Skin Irrit. 2STOT SE 3Aquatic Chronic 2 H225H304H315H336H411 GHS02GHS08GHS07GHS09Dgr H225H304H315H336H411   
601-020-00-8 benzene 200-753-7 71-43-2 Flam. Liq. 2Carc. 1AMuta. 1BSTOT RE 1Asp. Tox. 1Eye Irrit. 2Skin Irrit. 2 H225H350H340H372 **H304H319H315 GHS02GHS08GHS07Dgr H225H350H340H372 **H304H319H315   E
601-021-00-3 toluene 203-625-9 108-88-3 Flam. Liq. 2Repr. 2Asp. Tox. 1STOT RE 2 *Skin Irrit. 2STOT SE 3 H225H361d ***H304H373 **H315H336 GHS02GHS08GHS07Dgr H225H361d ***H304H373 **H315H336   
601-022-00-9 o-xylene; [1]p-xylene; [2]m-xylene; [3]xylene [4] 202-422-2 [1]203-396-5 [2]203-576-3 [3]215-535-7 [4] 95-47-6 [1]106-42-3 [2]108-38-3 [3]1330-20-7 [4] Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2 H226H332H312H315 GHS02GHS07Wng H226H332H312H315  * C
601-023-00-4 ethylbenzene 202-849-4 100-41-4 Flam. Liq. 2Acute Tox. 4 * H225H332 GHS02GHS07Dgr H225H332   
601-024-00-X cumene; [1]propylbenzene [2] 202-704-5 [1]203-132-9 [2] 98-82-8 [1]103-65-1 [2] Flam. Liq. 3Asp. Tox. 1STOT SE 3Aquatic Chronic 2 H226H304H335H411 GHS02GHS08GHS07GHS09Dgr H226H304H335H411   C
601-025-00-5 mesitylene;1,3,5-trimethylbenzene 203-604-4 108-67-8 Flam. Liq. 3STOT SE 3Aquatic Chronic 2 H226H335H411 GHS02GHS07GHS09Wng H226H335H411  STOT SE 3; H335: C ≥ 25 % 
601-026-00-0 styrene 202-851-5 100-42-5 Flam. Liq. 3Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2 H226H332H319H315 GHS02GHS07Wng H226H332H319H315  * D
601-027-00-6 2-phenylpropene;α-methylstyrene 202-705-0 98-83-9 Flam. Liq. 3Eye Irrit. 2STOT SE 3Aquatic Chronic 2 H226H319H335H411 GHS02GHS07GHS09Wng H226H319H335H411  STOT SE 3; H335: C ≥ 25 % 
601-028-00-1 2-methylstyrene;2-vinyltoluene 210-256-7 611-15-4 Acute Tox. 4 *Aquatic Chronic 2 H332H411 GHS07GHS09Wng H332H411   
601-029-00-7 dipentene;limonene; [1](R)-p-mentha-1,8-diene;d-limonene; [2](S)-p-mentha-1,8-diene;l-limonene; [3]trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4](±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] 205-341-0 [1]227-813-5 [2]227-815-6 [3]229-977-3 [4]231-732-0 [5] 138-86-3 [1]5989-27-5 [2]5989-54-8 [3]6876-12-6 [4]7705-14-8 [5] Flam. Liq. 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H226H315H317H400H410 GHS02GHS07GHS09Wng H226H315H317H410   C
601-030-00-2 cyclopentane 206-016-6 287-92-3 Flam. Liq. 2Aquatic Chronic 3 H225H412 GHS02Dgr H225H412   
601-031-00-8 2,4,4-trimethylpent-1-ene 203-486-4 107-39-1 Flam. Liq. 2Aquatic Chronic 2 H225H411 GHS02GHS09Dgr H225H411   
601-032-00-3 benzo[a]pyrene;benzo[def]chrysene 200-028-5 50-32-8 Carc. 1BMuta. 1BRepr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H340H360FDH317H400H410 GHS08GHS07GHS09Dgr H350H340H360FDH317H410  Carc. 1B; H350: C ≥ 0,01 % 
601-033-00-9 benz[a]anthracene 200-280-6 56-55-3 Carc. 1BAquatic Acute 1Aquatic Chronic 1 H350H400H410 GHS08GHS09Dgr H350H410   
601-034-00-4 benz[e]acephenanthrylene 205-911-9 205-99-2 Carc. 1BAquatic Acute 1Aquatic Chronic 1 H350H400H410 GHS08GHS09Dgr H350H410   
601-035-00-X benzo[j]fluoranthene 205-910-3 205-82-3 Carc. 1BAquatic Acute 1Aquatic Chronic 1 H350H400H410 GHS08GHS09Dgr H350H410   
601-036-00-5 benzo[k]fluoranthene 205-916-6 207-08-9 Carc. 1BAquatic Acute 1Aquatic Chronic 1 H350H400H410 GHS08GHS09Dgr H350H410   
601-037-00-0 n-hexane 203-777-6 110-54-3 Flam. Liq. 2Repr. 2Asp. Tox. 1STOT RE 2 *Skin Irrit. 2STOT SE 3Aquatic Chronic 2 H225H361f ***H304H373 **H315H336H411 GHS02GHS08GHS07GHS09Dgr H225H361f ***H304H373 **H315H336H411  STOT RE 2; H373: C ≥ 5 % 
601-041-00-2 dibenz[a,h]anthracene 200-181-8 53-70-3 Carc. 1BAquatic Acute 1Aquatic Chronic 1 H350H400H410 GHS08GHS09Dgr H350H410  Carc. 1B; H350: C ≥ 0,01 % 
601-042-00-8 biphenyl;diphenyl 202-163-5 92-52-4 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H335H315H400H410 GHS07GHS09Wng H319H335H315H410   
601-043-00-3 1,2,4-trimethylbenzene 202-436-9 95-63-6 Flam. Liq. 3Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 2 H226H332H319H335H315H411 GHS02GHS07GHS09Wng H226H332H319H335H315H411   
601-044-00-9 3a,4,7,7a-tetrahydro-4,7-methanoindene 201-052-9 77-73-6 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 2 H225H332H302H319H335H315H411 GHS02GHS07GHS09Dgr H225H332H302H319H335H315H411   
601-045-00-4 1,2,3,4-tetrahydronaphthalene 204-340-2 119-64-2 Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H319H315H411 GHS07GHS09Wng H319H315H411 EUH019  
601-046-00-X 7-methylocta-1,6-diene 404-210-7 42152-47-6 Flam. Liq. 3Aquatic Acute 1Aquatic Chronic 1 H226H400H410 GHS02GHS09Wng H226H410   
601-047-00-5 m-mentha-1,3(8)-diene 404-150-1 17092-80-7 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
601-048-00-0 chrysene 205-923-4 218-01-9 Carc. 1BMuta. 2Aquatic Acute 1Aquatic Chronic 1 H350H341H400H410 GHS08GHS09Dgr H350H341H410   
601-049-00-6 benzo[e]pyrene 205-892-7 192-97-2 Carc. 1BAquatic Acute 1Aquatic Chronic 1 H350H400H410 GHS08GHS09Dgr H350H410   
601-051-00-7 4-phenylbut-1-ene 405-980-7 768-56-9 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
601-052-00-2 naphthalene 202-049-5 91-20-3 Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H302H400H410 GHS07GHS08GHS09Wng H351H302H410   
601-053-00-8 nonylphenol; [1]4-nonylphenol, branched [2] 246-672-0 [1]284-325-5 [2] 25154-52-3 [1]84852-15-3 [2] Repr. 2Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H361fdH302H314H400H410 GHS08GHS05GHS07GHS09Dgr H361fdH302H314H410   
601-054-00-3 reaction mass of isomers of: dibenzylbenzene;dibenzyl(methyl)benzene;dibenzyl(dimethyl)benzene;dibenzyl(trimethyl)benzene 405-570-8 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
601-055-00-9 reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;di-(2-tetradecyl)naphthalenes;tri-(2-tetradecyl)naphthalenes 410-190-0 132983-41-6 Eye Irrit. 2Aquatic Chronic 4 H319H413 GHS07Wng H319H413   
601-056-00-4 reaction mass of isomers of: methyldiphenylmethane;dimethyldiphenylmethane 405-470-4 73807-39-3 Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H315H400H410 GHS07GHS09Wng H315H410   
601-057-00-X N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate 421-130-8 156679-41-3 Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H318H317H400H410 GHS05GHS07GHS09Dgr H318H317H410   
601-058-00-5 di-L-para-menthene 417-870-6 83648-84-4 Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H317H400H410 GHS07GHS09Wng H315H317H410   
601-059-00-0 methyl 2-benzylidene-3-oxobutyrate 420-940-9 15768-07-7 Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H319H315H411 GHS07GHS09Wng H319H315H411   
601-060-00-6 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245 417-610-1 155522-09-1 Skin Sens. 1 H317 GHS07Wng H317   
601-061-00-1 (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) 418-960-8 — Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H314H317H411 GHS05GHS07GHS09Dgr H314H317H411   
601-062-00-7 reaction mass of: branched triacontane;branched dotriacontane;branched tetratriacontane;branched hexatriacontane 417-030-9 151006-59-6 Aquatic Chronic 4 H413 — H413   
601-063-00-2 reaction mass of isomers of branched tetracosane 417-060-2 151006-61-0 Acute Tox. 4 *Aquatic Chronic 4 H332H413 GHS07Wng H332H413   
601-064-00-8 branched hexatriacontane 417-070-7 151006-62-1 Aquatic Chronic 4 H413 — H413   
601-065-00-3 reaction mass of: (1'-α,3'-α,6'-α-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) 416-930-9 — STOT RE 2 *Eye Dam. 1Aquatic Chronic 2 H373 **H318H411 GHS08GHS05GHS09Dgr H373 **H318H411   
601-066-00-9 1-(4-(trans-4-heptylcyclohexyl)phenyl) ethanone 426-820-2 78531-60-9 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
601-067-00-4 triethyl arsenate 427-700-2 15606-95-8 Carc. 1AAcute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H350H331H301H400H410 GHS06GHS08GHS09Dgr H350H331H301H410   
601-068-00-X 1,2-diacetoxybut-3-ene 421-720-5 18085-02-4 Acute Tox. 4 * H302 GHS07Wng H302   
601-069-00-5 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide 422-680-1 287933-44-2 Aquatic Chronic 3 H412 — H412   
601-071-00-6 1-dimethoxymethyl-2-nitro-benzene 423-830-9 20627-73-0 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
601-073-00-7 1-bromo-3,5-difluorobenzene 416-710-2 461-96-1 Flam. Liq. 3Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H226H302H373 **H315H317H400H410 GHS02GHS08GHS07GHS09Wng H226H302H373 **H315H317H410   
601-074-00-2 reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] 422-040-1 — Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H319H315H411 GHS07GHS09Wng H319H315H411   
601-085-00-2 isopentane;2-methylbutane 201-142-8 78-78-4 Flam. Liq. 1Asp. Tox. 1STOT SE 3Aquatic Chronic 2 H224H304H336H411 GHS02GHS08GHS07GHS09Dgr H224H304H336H411 EUH066  
602-001-00-7 chloromethane;methyl chloride 200-817-4 74-87-3 Flam. Gas 1Press. GasCarc. 2STOT RE 2 * H220H351H373 ** GHS02GHS04GHS08Dgr H220H351H373 **   U
602-002-00-2 bromomethane;methylbromide 200-813-2 74-83-9 Press. GasMuta. 2Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Ozone H341H331H301H373 **H319H335H315H400EUH059 GHS04GHS06GHS08GHS09Dgr H341H331H301H373 **H319H335H315H400 EUH059  U
602-003-00-8 dibromomethane 200-824-2 74-95-3 Acute Tox. 4 *Aquatic Chronic 3 H332H412 GHS07Wng H332H412  * 
602-004-00-3 dichloromethane;methylene chloride 200-838-9 75-09-2 Carc. 2 H351 GHS08Wng H351   
602-005-00-9 methyl iodide;iodomethane 200-819-5 74-88-4 Carc. 2Acute Tox. 4 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2 H351H312H331H301H335H315 GHS06GHS08Dgr H351H312H331H301H335H315   
602-006-00-4 trichloromethane;chloroform 200-663-8 67-66-3 Carc. 2Acute Tox. 4 *STOT RE 2 *STOT RE 2 *Skin Irrit. 2 H351H302H373 **H373 **H315 GHS07GHS08Wng H351H302H373 **H373 **H315  *STOT RE 2; H373: C ≥ 5 % 
602-007-00-X bromoform;tribromomethane 200-854-6 75-25-2 Acute Tox. 3 *Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H331H319H315H411 GHS06GHS09Dgr H331H319H315H411   
602-008-00-5 carbon tetrachloride;tetrachloromethane 200-262-8 56-23-5 Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Aquatic Chronic 3Ozone H351H331H311H301H372 **H412EUH059 GHS06GHS08Dgr H351H331H311H301H372 **H412 EUH059 *STOT RE 1; H372: C ≥ 1 %STOT RE 2; H373: 0,2 % ≤ C < 1 % 
602-009-00-0 chloroethane 200-830-5 75-00-3 Flam. Gas 1Press. GasCarc. 2Aquatic Chronic 3 H220H351H412 GHS02GHS04GHS08Dgr H220H351H412   U
602-010-00-6 1,2-dibromoethane 203-444-5 106-93-4 Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 2 H350H331H311H301H319H335H315H411 GHS06GHS08GHS09Dgr H350H331H311H301H319H335H315H411  * 
602-011-00-1 1,1-dichloroethane 200-863-5 75-34-3 Flam. Liq. 2Acute Tox. 4 *Eye Irrit. 2STOT SE 3Aquatic Chronic 3 H225H302H319H335H412 GHS02GHS07Dgr H225H302H319H335H412  * 
602-012-00-7 1,2-dichloroethane;ethylene dichloride 203-458-1 107-06-2 Flam. Liq. 2Carc. 1BAcute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H225H350H302H319H335H315 GHS02GHS08GHS07Dgr H225H350H302H319H335H315   
602-013-00-2 1,1,1-trichloroethane;methyl chloroform 200-756-3 71-55-6 Acute Tox. 4 *Ozone H332EUH059 GHS07Wng H332 EUH059  F
602-014-00-8 1,1,2-trichloroethane 201-166-9 79-00-5 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H351H332H312H302 GHS08GHS07Wng H351H332H312H302 EUH066 * 
602-015-00-3 1,1,2,2-tetrachloroethane 201-197-8 79-34-5 Acute Tox. 2 *Acute Tox. 1Aquatic Chronic 2 H330H310H411 GHS06GHS09Dgr H330H310H411   
602-016-00-9 1,1,2,2-tetrabromoethane 201-191-5 79-27-6 Acute Tox. 2 *Eye Irrit. 2Aquatic Chronic 3 H330H319H412 GHS06Dgr H330H319H412   
602-017-00-4 pentachloroethane 200-925-1 76-01-7 Carc. 2STOT RE 1Aquatic Chronic 2 H351H372 **H411 GHS08GHS09Dgr H351H372 **H411  STOT RE 1; H372: C ≥ 1 %STOT RE 2; H373: 0,2 % ≤ C < 1 % 
602-018-00-X 1-chloropropane; [1]2-chloropropane [2] 208-749-7 [1]200-858-8 [2] 540-54-5 [1]75-29-6 [2] Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H225H332H312H302 GHS02GHS07Dgr H225H332H312H302   C
602-019-00-5 1-bromopropane;n-propyl bromide 203-445-0 106-94-5 Flam. Liq. 2Repr. 1BSTOT RE 2 *Eye Irrit. 2STOT SE 3Skin Irrit. 2STOT SE 3 H225H360FDH373 **H319H335H315H336 GHS02GHS08GHS07Dgr H225H360FDH373 **H319H335H315H336   
602-020-00-0 1,2-dichloropropane;propylene dichloride 201-152-2 78-87-5 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 * H225H332H302 GHS02GHS07Dgr H225H332H302   
602-021-00-6 1,2-dibromo-3-chloropropane 202-479-3 96-12-8 Carc. 1BMuta. 1BRepr. 1AAcute Tox. 3 *STOT RE 2 *Aquatic Chronic 3 H350H340H360F ***H301H373 **H412 GHS06GHS08Dgr H350H340H360F ***H301H373 **H412   
602-022-00-1 1-chloropentane; [1]2-chloropentane; [2]3-chloropentane [3] 208-846-4 [1]210-885-7 [2]210-467-4 [3] 543-59-9 [1]625-29-6 [2]616-20-6 [3] Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H225H332H312H302 GHS02GHS07Dgr H225H332H312H302   C
602-023-00-7 vinyl chloride;chloroethylene 200-831-0 75-01-4 Press. GasFlam. Gas 1Carc. 1A H220H350 GHS02GHS08Dgr H220H350   D U
602-024-00-2 bromoethylene 209-800-6 593-60-2 Press. GasFlam. Gas 1Carc. 1B H220H350 GHS02GHS08Dgr H220H350   U
602-025-00-8 1,1-dichloroethylene;vinylidene chloride 200-864-0 75-35-4 Flam. Liq. 1Carc. 2Acute Tox. 4 * H224H351H332 GHS02GHS08GHS07Dgr H224H351H332  * D
602-026-00-3 1,2-dichloroethylene; [1]cis-dichloroethylene; [2]trans-dichloroethylene [3] 208-750-2 [1]205-859-7 [2]205-860-2 [3] 540-59-0 [1]156-59-2 [2]156-60-5 [3] Flam. Liq. 2Acute Tox. 4 *Aquatic Chronic 3 H225H332H412 GHS02GHS07Dgr H225H332H412  * C
602-027-00-9 trichloroethylene;trichloroethene 201-167-4 79-01-6 Carc. 1BMuta. 2Eye Irrit. 2Skin Irrit. 2STOT SE 3Aquatic Chronic 3 H350H341H319H315H336H412 GHS08GHS07Dgr H350H341H319H315H336H412   
602-028-00-4 tetrachloroethylene 204-825-9 127-18-4 Carc. 2Aquatic Chronic 2 H351H411 GHS08GHS09Wng H351H411   
602-029-00-X 3-chloropropene;allyl chloride 203-457-6 107-05-1 Flam. Liq. 2Carc. 2Muta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1 H225H351H341H332H312H302H373 **H319H335H315H400 GHS02GHS08GHS07GHS09Dgr H225H351H341H332H312H302H373 **H319H335H315H400   D
602-030-00-5 1,3-dichloropropene; [1](Z)-1,3-dichloropropene [2] 208-826-5 [1]233-195-8 [2] 542-75-6 [1]10061-01-5 [2] Flam. Liq. 3Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H226H301H332H312H319H335H315H317H400H410 GHS02GHS06GHS09Dgr H226H301H332H312H319H335H315H317H410   C D
602-031-00-0 1,1-dichloropropene 209-253-3 563-58-6 Flam. Liq. 2Acute Tox. 3 *Aquatic Chronic 3 H225H301H412 GHS02GHS06Dgr H225H301H412   
602-032-00-6 3-chloro-2-methylpropene 209-251-2 563-47-3 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H225H332H302H314H317H411 GHS02GHS05GHS07GHS09Dgr H225H332H302H314H317H411   
602-033-00-1 chlorobenzene 203-628-5 108-90-7 Flam. Liq. 3Acute Tox. 4 *Aquatic Chronic 2 H226H332H411 GHS02GHS07GHS09Wng H226H332H411  * 
602-034-00-7 1,2-dichlorobenzene;o-dichlorobenzene 202-425-9 95-50-1 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H335H315H400H410 GHS07GHS09Wng H302H319H335H315H410  * 
602-035-00-2 1,4-dichlorobenzene;p-dichlorobenzene 203-400-5 106-46-7 Carc. 2Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H351H319H400H410 GHS08GHS09Wng H351H319H410   
602-036-00-8 chloroprene (stabilised);2-chlorobuta-1,3-diene (stabilised) 204-818-0 126-99-8 Flam. Liq. 2Carc. 1BAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H225H350H332H302H373 **H319H335H315 GHS02GHS08GHS07Dgr H225H350H332H302H373 **H319H335H315   D
602-037-00-3 α-chlorotoluene;benzyl chloride 202-853-6 100-44-7 Carc. 1BAcute Tox. 3 *Acute Tox. 4 *STOT RE 2 *STOT SE 3Skin Irrit. 2Eye Dam. 1 H350H331H302H373 **H335H315H318 GHS06GHS08GHS05Dgr H350H331H302H373 **H335H315H318   
602-038-00-9 α, α,α-trichlorotoluene;benzotrichloride 202-634-5 98-07-7 Carc. 1BAcute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1 H350H331H302H335H315H318 GHS06GHS08GHS05Dgr H350H331H302H335H315H318   
602-039-00-4 polychlorobiphenyls;PCB 215-648-1 1336-36-3 STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H373 **H400H410 GHS08GHS09Wng H373 **H410  STOT RE 2; H373: C ≥ 0,005 % C
602-040-00-X 2-chlorotoluene; [1]3-chlorotoluene; [2]4-chlorotoluene; [3]chlorotoluene [4] 202-424-3 [1]203-580-5 [2]203-397-0 [3]246-698-2 [4] 95-49-8 [1]108-41-8 [2]106-43-4 [3]25168-05-2 [4] Acute Tox. 4 *Aquatic Chronic 2 H332H411 GHS07GHS09Wng H332H411   C
602-041-00-5 penthachloronaphthalene 215-320-8 1321-64-8 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H312H302H319H315H400H410 GHS07GHS09Wng H312H302H319H315H410   C
602-042-00-0 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex — — Carc. 2Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H301H312H400H410 GHS06GHS08GHS09Dgr H351H301H312H410   A C
602-043-00-6 lindane (ISO);γ-HCH or γ-BHC;γ-1,2,3,4,5,6-hexachlorocyclohexane 200-401-2 58-89-9 Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Lact.Aquatic Acute 1Aquatic Chronic 1 H301H332H312H373 **H362H400H410 GHS06GHS08GHS09Dgr H301H332H312H373 **H362H410  M=10 
602-044-00-1 camphechlor (ISO);toxaphene; 232-283-3 8001-35-2 Carc. 2Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H351H301H312H335H315H400H410 GHS06GHS08GHS09Dgr H351H301H312H335H315H410   
602-045-00-7 DDT (ISO);clofenotane (INN);dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;dichlorodiphenyltrichloroethane 200-024-3 50-29-3 Carc. 2Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H351H301H372 **H400H410 GHS06GHS08GHS09Dgr H351H301H372 **H410   
602-046-00-2 heptachlor (ISO);1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene 200-962-3 76-44-8 Carc. 2Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H351H311H301H373 **H400H410 GHS06GHS08GHS09Dgr H351H311H301H373 **H410   
602-047-00-8 chlordane (ISO);1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan 200-349-0 57-74-9 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H312H302H400H410 GHS08GHS07GHS09Wng H351H312H302H410   
602-048-00-3 aldrin (ISO) 206-215-8 309-00-2 Carc. 2Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H351H311H301H372 **H400H410 GHS06GHS08GHS09Dgr H351H311H301H372 **H410   
602-049-00-9 dieldrin (ISO) 200-484-5 60-57-1 Carc. 2Acute Tox. 1Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H351H310H301H372 **H400H410 GHS06GHS08GHS09Dgr H351H310H301H372 **H410   
602-050-00-4 (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphfthalene;isodrin 207-366-2 465-73-6 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H400H410 GHS06GHS09Dgr H330H310H300H410   
602-051-00-X endrin (ISO);1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene 200-775-7 72-20-8 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H311H400H410 GHS06GHS09Dgr H300H311H410   
602-052-00-5 endosulfan (ISO);1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethyl sulphite 204-079-4 115-29-7 Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H311H301H319H400H410 GHS06GHS09Dgr H311H301H319H410   
602-053-00-0 isobenzan (ISO);1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran 206-045-4 297-78-9 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1 H310H300H400 GHS06GHS09Dgr H310H300H400   
602-054-00-6 3-iodpropene;allyl iodide 209-130-4 556-56-9 Flam. Liq. 2Skin Corr. 1B H226H314 GHS02GHS05Dgr H226H314   
602-055-00-1 bromoethane;ethyl bromide 200-825-8 74-96-4 Flam. Liq. 2Carc. 2Acute Tox. 4 *Acute Tox. 4 * H225H351H332H302 GHS02GHS08GHS07Dgr H225H351H332H302   
602-056-00-7 α, α,α-trifluorotoluene;benzotrifluoride 202-635-0 98-08-8 Flam. Liq. 2Aquatic Chronic 2 H225H411 GHS02GHS09Dgr H225H411   
602-057-00-2 α-bromotoluene;benzyl bromide 202-847-3 100-39-0 Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315   
602-058-00-8 α, α-dichlorotoluene;benzylidene chloride;benzal chloride 202-709-2 98-87-3 Carc. 2Acute Tox. 3 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1 H351H331H302H335H315H318 GHS06GHS08GHS05Dgr H351H331H302H335H315H318   
602-059-00-3 1-chlorobutane;butyl chloride 203-696-6 109-69-3 Flam. Liq. 2 H225 GHS02Dgr H225   
602-060-00-9 bromobenzene 203-623-8 108-86-1 Flam. Liq. 3Skin Irrit. 2Aquatic Chronic 2 H226H315H411 GHS02GHS07GHS09Wng H226H315H411   
602-061-00-4 hexafluoropropene;hexafluoropropylene 204-127-4 116-15-4 Press. GasAcute Tox. 4 *STOT SE 3 H332H335 GHS07Wng H332H335   U
602-062-00-X 1,2,3-trichloropropane 202-486-1 96-18-4 Carc. 1BRepr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H350H360F ***H332H312H302 GHS08GHS07Dgr H350H360F ***H332H312H302   D
602-063-00-5 heptachlor epoxide;2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane 213-831-0 1024-57-3 Carc. 2Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H351H301H373 **H400H410 GHS06GHS08GHS09Dgr H351H301H373 **H410   
602-064-00-0 1,3-dichloro-2-propanol 202-491-9 96-23-1 Carc. 1BAcute Tox. 3 *Acute Tox. 4 * H350H301H312 GHS06GHS08Dgr H350H301H312   
602-065-00-6 hexachlorobenzene 204-273-9 118-74-1 Carc. 1BSTOT RE 1Aquatic Acute 1Aquatic Chronic 1 H350H372 **H400H410 GHS08GHS09Dgr H350H372 **H410   
602-066-00-1 tetrachloro-p-benzoquinone 204-274-4 118-75-2 Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H315H400H410 GHS07GHS09Wng H319H315H410   
602-067-00-7 1,3-dichlorbenzene 208-792-1 541-73-1 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
602-068-00-2 ethylene bis(trichloroacetate) 219-732-9 2514-53-6 Skin Irrit. 2 H315 GHS07Wng H315   
602-069-00-8 dichloroacetylene — 7572-29-4 Unst. Expl.Carc. 2STOT RE 2 * H200H351H373 ** GHS01GHS08Wng H200H351H373 **   
602-070-00-3 3-chloro-4,5,α, α,α-pentafluorotoluene 401-930-3 77227-99-7 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1 H226H332H302H400 GHS02GHS07GHS09Wng H226H332H302H400   
602-071-00-9 bromobenzylbromotoluene, reaction mass of isomers 402-210-1 99688-47-8 STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H373 **H317H400H410 GHS08GHS07GHS09Wng H373 **H317H410   
602-072-00-4 dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC) 278-404-3 76253-60-6 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
602-073-00-X 1,4-dichlorobut-2-ene 212-121-8 764-41-0 Carc. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H350H330H311H301H314H400H410 GHS06GHS08GHS05GHS09Dgr H350H330H311H301H314H410  Carc. 1B; H350: C ≥ 0,01 %STOT SE 3; H335: C ≥ 5 % 
602-074-00-5 pentachlorobenzene 210-172-0 608-93-5 Flam. Sol. 1Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H228H302H400H410 GHS02GHS07GHS09Dgr H228H302H410   T
602-075-00-0 4,4,5,5-tetrachloro-1,3-dioxolan-2-one 404-060-2 22432-68-4 Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1B H330H302H314 GHS06GHS05Dgr H330H302H314   
602-076-00-6 2,3,4-trichlorobut-1-ene 219-397-9 2431-50-7 Carc. 2Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H351H331H302H319H335H315H400H410 GHS06GHS08GHS09Dgr H351H331H302H319H335H315H410  Carc. 2; H351: C ≥ 0,1 % 
602-077-00-1 dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;mirex 219-196-6 2385-85-5 Carc. 2Repr. 2Lact.Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H361fdH362H312H302H400H410 GHS08GHS07GHS09Wng H351H361fdH362H312H302H410   
602-078-00-7 hexachlorocyclopentadiene 201-029-3 77-47-4 Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H330H311H302H314H400H410 GHS06GHS05GHS09Dgr H330H311H302H314H410   
602-079-00-2 2,3-dichloropropene;2,3-dichloropropylene 201-153-8 78-88-6 Flam. Liq. 2Muta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3 H225H341H332H312H302H335H315H318H412 GHS02GHS08GHS05GHS07Dgr H225H341H332H312H302H335H315H318H412   
602-080-00-8 alkanes, C10-13, chloro 287-476-5 85535-84-8 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410   
602-081-00-3 2-chloro-4,5-difluorobenzoic acid 405-380-5 — Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1 H312H302H318H317 GHS05GHS07Dgr H312H302H318H317   
602-082-00-9 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol 408-020-5 109678-33-3 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
602-083-00-4 diphenyl ether, pentabromo derivative pentabromodiphenyl ether 251-084-2 32534-81-9 STOT RE 2 *Lact.Aquatic Acute 1Aquatic Chronic 1 H373 **H362H400H410 GHS08GHS09Wng H373 **H362H410   
602-084-00-X 1,1-dichloro-1-fluoroethane 404-080-1 1717-00-6 Aquatic Chronic 3Ozone H412EUH059 — H412 EUH059  
602-085-00-5 2-bromopropane 200-855-1 75-26-3 Flam. Liq. 2Repr. 1ASTOT RE 2 * H225H360F ***H373 ** GHS02GHS08Dgr H225H360F ***H373 ** EUH066  
602-086-00-0 trifluoroiodomethane;trifluoromethyl iodide 219-014-5 2314-97-8 Muta. 2 H341 GHS08Wng H341   
602-087-00-6 1,2,4-trichlorobenzene 204-428-0 120-82-1 Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H315H400H410 GHS07GHS09Wng H302H315H410   
602-088-00-1 2,3-dibromopropan-1-ol;2,3-dibromo-1-propanol 202-480-9 96-13-9 Carc. 1BRepr. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H350H361f ***H311H332H302H412 GHS08GHS07Dgr H350H361f ***H311H332H302H412   
602-089-00-7 4-bromo-2-chlorofluorobenzene 405-580-2 60811-21-4 Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H315H400H410 GHS07GHS09Wng H302H315H410   
602-090-00-2 1-allyl-3-chloro-4-fluorobenzene 406-630-6 121626-73-1 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
602-091-00-8 1,3-dichloro-4-fluorobenzene 406-160-1 1435-48-9 Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2 H302H373 **H315H411 GHS08GHS07Wng H302H373 **H315H411   
602-092-00-3 1-bromo-3,4,5-trifluorobenzene 418-480-9 138526-69-9 Flam. Liq. 3Carc. 2Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2 H226H351H315H318H411 GHS02GHS08GHS05GHS09Dgr H226H351H315H318H411   
602-093-00-9 α, α,α,4-tetrachlorotoluene;p-chlorobenzotrichloride 226-009-1 5216-25-1 Carc. 1BRepr. 2STOT RE 1Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2 H350H361f ***H372 **H312H302H335H315 GHS08GHS07Dgr H350H361f ***H372 **H312H302H335H315   
602-094-00-4 diphenylether; octabromo derivate 251-087-9 32536-52-0 Repr. 1B H360Df GHS08Dgr H360Df   
602-096-00-5 malachite green hydrochloride; [1]malachite green oxalate [2] 209-322-8 [1]219-441-7 [2] 569-64-2 [1]2437-29-8 [2] Repr. 2Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H361d ***H302H318H400H410 GHS08GHS05GHS07GHS09Dgr H361d ***H302H318H410   
602-097-00-0 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane 422-850-5 148757-89-5 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
603-001-00-X methanol 200-659-6 67-56-1 Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 1 H225H331H311H301H370 ** GHS02GHS06GHS08Dgr H225H331H311H301H370 **  *STOT SE 1; H370: C ≥ 10 %STOT SE 2; H371: 3 % ≤ C < 10 % 
603-002-00-5 ethanol;ethyl alcohol 200-578-6 64-17-5 Flam. Liq. 2 H225 GHS02Dgr H225   
603-003-00-0 propan-1-ol;n-propanol 200-746-9 71-23-8 Flam. Liq. 2Eye Dam. 1STOT SE 3 H225H318H336 GHS02GHS05GHS07Dgr H225H318H336   
603-004-00-6 butan-1-ol;n-butanol 200-751-6 71-36-3 Flam. Liq. 3Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1STOT SE 3 H226H302H335H315H318H336 GHS02GHS05GHS07Dgr H226H302H335H315H318H336   
603-005-00-1 2-methylpropan-2-ol;tert-butyl alcohol 200-889-7 75-65-0 Flam. Liq. 2Acute Tox. 4 * H225H332 GHS02GHS07Dgr H225H332   
603-006-00-7 pentanol isomers, with the exception fo those specified elsewhere in this Annex 250-378-8  Flam. Liq. 3Acute Tox. 4 *STOT SE 3 H226H332H335 GHS02GHS07Wng H226H332H335 EUH066  C
603-007-00-2 2-methylbutan-2-ol;tert-pentanol 200-908-9 75-85-4 Flam. Liq. 2Acute Tox. 4 *STOT SE 3Skin Irrit. 2 H225H332H335H315 GHS02GHS07Dgr H225H332H335H315   
603-008-00-8 4-methylpentan-2-ol;methyl isobutyl carbinol 203-551-7 108-11-2 Flam. Liq. 3STOT SE 3 H226H335 GHS02GHS07Wng H226H335  STOT SE 3; H335: C ≥ 25 % 
603-009-00-3 cyclohexanol 203-630-6 108-93-0 Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2 H332H302H335H315 GHS07Wng H332H302H335H315   
603-010-00-9 2-methylcyclohexanol, mixed isomers; [1]cis-2-methylcyclohexanol; [2]trans-2-methylcyclohexanol [3] 209-512-0 [1]231-187-9 [2]231-186-3 [3] 583-59-5 [1]7443-70-1 [2]7443-52-9 [3] Acute Tox. 4 * H332 GHS07Wng H332   C
603-011-00-4 2-methoxyethanol;ethylene glycol monomethyl ether 203-713-7 109-86-4 Flam. Liq. 3Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H226H360FDH332H312H302 GHS02GHS08GHS07Dgr H226H360FDH332H312H302   
603-012-00-X 2-ethoxyethanol;ethylene glycol monoethyl ether 203-804-1 110-80-5 Flam. Liq. 3Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H226H360FDH332H312H302 GHS02GHS08GHS07Dgr H226H360FDH332H312H302   
603-013-00-5 2-isopropoxyethanol;ethylene glycol monoisopropyl ether 203-685-6 109-59-1 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2 H332H312H319 GHS07Wng H332H312H319   
603-014-00-0 2-butoxyethanol;ethylene glycol monobutyl ether;butyl cellosolve 203-905-0 111-76-2 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2 H332H312H302H319H315 GHS07Wng H332H312H302H319H315   
603-015-00-6 allyl alcohol 203-470-7 107-18-6 Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1 H225H331H311H301H319H335H315H400 GHS02GHS06GHS09Dgr H225H331H311H301H319H335H315H400   
603-016-00-1 4-hydroxy-4-methylpentan-2-one;diacetone alcohol 204-626-7 123-42-2 Eye Irrit. 2 H319 GHS07Wng H319  Eye Irrit. 2; H319: C ≥ 10 % 
603-018-00-2 furfuryl alcohol 202-626-1 98-00-0 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302  * 
603-019-00-8 dimethyl ether 204-065-8 115-10-6 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   U
603-020-00-3 ethyl methyl ether — 540-67-0 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   U
603-021-00-9 methyl vinyl ether 203-475-4 107-25-5 Flam. Gas 1Press. Gas H220 GHS02GHS04Dgr H220   D U
603-022-00-4 diethyl ether;ether 200-467-2 60-29-7 Flam. Liq. 1Acute Tox. 4 *STOT SE 3 H224H302H336 GHS02GHS07Dgr H224H302H336 EUH019EUH066  
603-023-00-X ethylene oxide;oxirane 200-849-9 75-21-8 Flam. Gas 1Press. GasCarc. 1BMuta. 1BAcute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H220H350H340H331H319H335H315 GHS02GHS04GHS06GHS08Dgr H220H350H340H331H319H335H315   U
603-024-00-5 1,4-dioxane 204-661-8 123-91-1 Flam. Liq. 2Carc. 2Eye Irrit. 2STOT SE 3 H225H351H319H335 GHS02GHS08GHS07Dgr H225H351H319H335 EUH019EUH066  D
603-025-00-0 tetrahydrofuran 203-726-8 109-99-9 Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H335 GHS02GHS07Dgr H225H319H335 EUH019 Eye Irrit. 2; H319: C ≥ 25 %STOT SE 3; H335: C ≥ 25 % 
603-026-00-6 1-chloro-2,3-epoxypropane;epichlorhydrin 203-439-8 106-89-8 Flam. Liq. 3Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1 H226H350H331H311H301H314H317 GHS02GHS06GHS08GHS05Dgr H226H350H331H311H301H314H317  * 
603-027-00-1 ethanediol;ethylene glycol 203-473-3 107-21-1 Acute Tox. 4 * H302 GHS07Wng H302   
603-028-00-7 2-chloroethanol;ethylene chlorohydrin 203-459-7 107-07-3 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 * H330H310H300 GHS06Dgr H330H310H300   
603-029-00-2 bis(2-chloroethyl) ether 203-870-1 111-44-4 Carc. 2Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 * H351H330H310H300 GHS06GHS08Dgr H351H330H310H300   
603-030-00-8 2-aminoethanol;ethanolamine 205-483-3 141-43-5 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H332H312H302H314 GHS05GHS07Dgr H332H312H302H314  STOT SE 3; H335: C ≥ 5 % 
603-031-00-3 1,2-dimethoxyethane;ethylene glycol dimethyl ether;EGDME 203-794-9 110-71-4 Flam. Liq. 2Repr. 1BAcute Tox. 4 * H225H360FDH332 GHS02GHS08GHS07Dgr H225H360FDH332 EUH019  
603-032-00-9 ethylene dinitrate;ethylene glycol dinitrate 211-063-0 628-96-6 Unst. Expl.Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 * H200H330H310H300H373 ** GHS01GHS06GHS08Dgr H200H330H310H300H373 **   
603-033-00-4 oxydiethylene dinitrate;diethylene glycol dinitrate;digol dinitrate 211-745-8 693-21-0 Unst. ExplAcute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 3 H200H330H310H300H373 **H412 GHS01GHS06GHS08Dgr H200H330H310H300H373 **H412   
603-033-01-1 oxydiethylene dinitrate;diethylene glycol dinitrate;digol dinitrate;[>25 % phlegmatiser] 211-745-8 693-21-0 Expl. 1.1Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 3 H201H330H310H300H373 **H412 GHS01GHS06GHS08Dgr H201H330H310H300H373 **H412   
603-034-00-X glycerol trinitrate;nitroglycerine 200-240-8 55-63-0 Unst. Expl.Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2 H200H330H310H300H373 **H411 GHS01GHS06GHS08GHS09Dgr H200H330H310H300H373 **H411   
603-034-01-7 glycerol trinitrate;nitroglycerine;[>40 % phlegmatiser] 200-240-8 55-63-0 Expl. 1.1Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2 H201H330H310H300H373 **H411 GHS01GHS06GHS08GHS09Dgr H201H330H310H300H373 **H411   
603-035-00-5 pentaerythritol tetranitrate; pentaerythrite tetranitrate;P.E.T.N. 201-084-3 78-11-5 Unst. Expl. H200 GHS01Dgr H200   
603-035-01-2 pentaerythritol tetranitrate; pentaerythrite tetranitrate;P.E.T.N.;[>20 % phlegmatiser] 201-084-3 78-11-5 Expl. 1.1 H201 GHS01Dgr H201   T
603-036-00-0 mannitol hexanitrate;nitromannite 239-924-6 15825-70-4 Unst. Expl. H200 GHS01Dgr H200   
603-036-01-8 mannitol hexanitrate;nitromannite;[>40 % phlegmatiser] 239-924-6 15825-70-4 Expl. 1.1 H201 GHS01Dgr H201   
603-037-00-6 cellulose nitrate; — — Expl. 1.1 H201 GHS01Dgr H201 EUH001  T
603-038-00-1 allyl glycidyl ether;allyl 2,3-epoxypropyl ether;prop-2-en-1-yl 2,3-epoxypropyl ether 203-442-4 106-92-3 Flam. Liq. 3Carc. 2Muta. 2Repr. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H226H351H341H361f ***H332H302H335H315H318H317H412 GHS02GHS08GHS05GHS07Dgr H226H351H341H361f ***H332H302H335H315H318H317H412   
603-039-00-7 butyl glycidyl ether;butyl 2,3-epoxypropyl ether 219-376-4 2426-08-6 Flam. Liq. 3Carc. 2Muta. 2Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Sens. 1Aquatic Chronic 3 H226H351H341H332H302H335H317H412 GHS02GHS08GHS07Wng H226H351H341H332H302H335H317H412   
603-040-00-2 sodium methanolate;sodium methoxide; [1]potassium methanolate;potassium methoxide; [2]lithium methanolate;lithium methoxide [3] 204-699-5 [1]212-736-1 [2]212-737-7 [3] 124-41-4 [1]865-33-8 [2]865-34-9 [3] Self-heat 1Skin Corr. 1B H251H314 GHS02GHS05Dgr H251H314 EUH014  T
603-041-00-8 potassium ethanolate;potassium ethoxide; [1]sodium ethanolate;sodium ethoxide [2] 213-029-0 [1]205-487-5 [2] 917-58-8 [1]141-52-6 [2] Self-heat 1Skin Corr. 1B H251H314 GHS02GHS05Dgr H251H314 EUH014  T
603-042-00-3 aluminium-tri-isopropoxide 209-090-8 555-31-7 Flam. Sol. 1 H228 GHS02Dgr H228   T
603-043-00-9 triarimol (ISO);2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol — 26766-27-8 Acute Tox. 4 * H302 GHS07Wng H302   
603-044-00-4 dicofol (ISO);2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol 204-082-0 115-32-2 Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H312H302H315H317H400H410 GHS07GHS09Wng H312H302H315H317H410   
603-045-00-X diisopropyl ether; [1]dipropyl ether [2] 203-560-6 [1]203-869-6 [2] 108-20-3 [1]111-43-3 [2] Flam. Liq. 2STOT SE 3 H225H336 GHS02GHS07Dgr H225H336 EUH019EUH066  C
603-046-00-5 bis (chloromethyl) ether;oxybis(chloromethane) 208-832-8 542-88-1 Flam. Liq. 2Carc. 1AAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 * H225H350H330H311H302 GHS02GHS06GHS08Dgr H225H350H330H311H302  Carc. 1A; H350: C ≥ 0,001 % 
603-047-00-0 2-dimethylaminoethanol;N,N-dimethylethanolamine 203-542-8 108-01-0 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H226H332H312H302H314 GHS02GHS05GHS07Dgr H226H332H312H302H314  STOT SE 3; H335: C ≥ 5 % 
603-048-00-6 2-diethylaminoethanol;N,N-diethylethanolamine 202-845-2 100-37-8 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H226H332H312H302H314 GHS02GHS05GHS07 GHS09Dgr H226H332H312H302H314  STOT SE 3; H335: C ≥ 5 % 
603-049-00-1 chlorfenethol (ISO);1,1-bis (4-chlorophenyl) ethanol 201-246-3 80-06-8 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
603-050-00-7 1-(2-butoxypropoxy)propan-2-ol 246-011-6 24083-03-2 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
603-051-00-2 2-ethylbutan-1-ol 202-621-4 97-95-0 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
603-052-00-8 3-butoxypropan-2-ol;propylene glycol monobutyl ether 225-878-4 5131-66-8 Eye Irrit. 2Skin Irrit. 2 H319H315 GHS07Wng H319H315   
603-053-00-3 2-methylpentane-2,4-diol 203-489-0 107-41-5 Eye Irrit. 2Skin Irrit. 2 H319H315 GHS07Wng H319H315   
603-054-00-9 di-n-butyl ether;dibutyl ether 205-575-3 142-96-1 Flam. Liq. 3Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 3 H226H319H335H315H412 GHS02GHS07Wng H226H319H335H315H412  STOT SE 3; H335: C ≥ 10 % 
603-055-00-4 propylene oxide;1,2-epoxypropane;methyloxirane 200-879-2 75-56-9 Flam. Liq. 1Carc. 1BMuta. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H224H350H340H332H312H302H319H335H315 GHS02GHS08GHS07Dgr H224H350H340H332H312H302H319H335H315   
603-056-00-X [(p-tolyloxy)methyl]oxirane; [1][(m-tolyloxy)methyl]oxirane; [2]2,3-epoxypropyl o-tolyl ether; [3][(tolyloxy)methyl]oxirane;cresyl glycidyl ether [4] 218-574-8 [1]218-575-3 [2]218-645-3 [3]247-711-4 [4] 2186-24-5 [1]2186-25-6 [2]2210-79-9 [3]26447-14-3 [4] Muta. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H341H315H317H411 GHS08GHS07GHS09Wng H341H315H317H411   C
603-057-00-5 benzyl alcohol 202-859-9 100-51-6 Acute Tox. 4 *Acute Tox. 4 * H332H302 GHS07Wng H332H302   
603-058-00-0 1,3-propylene oxide 207-964-3 503-30-0 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H225H332H312H302 GHS02GHS07Dgr H225H332H312H302   
603-059-00-6 hexan-1-ol 203-852-3 111-27-3 Acute Tox. 4 * H302 GHS07Wng H302   
603-060-00-1 2,2'-bioxirane;1,2:3,4-diepoxybutane 215-979-1 1464-53-5 Carc. 1BMuta. 1BAcute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B H350H340H330H311H301H314 GHS06GHS08GHS05Dgr H350H340H330H311H301H314   
603-061-00-7 tetrahydro-2-furylmethanol;tetrahydrofurfuryl alcohol 202-625-6 97-99-4 Eye Irrit. 2 H319 GHS07Wng H319   
603-062-00-2 tetrahydrofuran-2,5-diyldimethanol 203-239-0 104-80-3 Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315  STOT SE 3; H335: C ≥ 10 % 
603-063-00-8 2,3-epoxypropan-1-ol;glycidol;oxiranemethanol 209-128-3 556-52-5 Carc. 1BMuta. 2Repr. 1BAcute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H350H341H360F ***H331H312H302H319H335H315 GHS06GHS08Dgr H350H341H360F ***H331H312H302H319H335H315   
603-064-00-3 1-methoxy-2-propanol;monopropylene glycol methyl ether 203-539-1 107-98-2 Flam. Liq. 3 H226 GHS02Wng H226   
603-065-00-9 resorcinol diglycidyl ether;1,3-bis(2,3-epoxypropoxy)benzene 202-987-5 101-90-6 Carc. 2Muta. 2Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3 H351H341H312H302H319H315H317H412 GHS08GHS07Wng H351H341H312H302H319H315H317H412   
603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane;vinylcyclohexane diepoxide 203-437-7 106-87-6 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Carc. 2 H331H311H301H351 GHS06GHS08Dgr H331H311H301H351  * 
603-067-00-X phenyl glycidyl ether;2,3-epoxypropyl phenyl ether;1,2-epoxy-3-phenoxypropane 204-557-2 122-60-1 Carc. 1BMuta. 2Acute Tox. 4 *STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3 H350H341H332H335H315H317H412 GHS08GHS07Dgr H350H341H332H335H315H317H412   
603-068-00-5 2,3-epoxypropyl-2-ethylcyclohexyl ether;ethylcyclohexylglycidyl ether — 130014-35-6 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   
603-069-00-0 2,4,6-tris(dimethylaminomethyl)phenol 202-013-9 90-72-2 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2 H302H319H315 GHS07Wng H302H319H315   
603-070-00-6 2-amino-2-methylpropanol 204-709-8 124-68-5 Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 3 H319H315H412 GHS07Wng H319H315H412   
603-071-00-1 2,2'-iminodiethanol;diethanolamine 203-868-0 111-42-2 Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1 H302H373 **H315H318 GHS08GHS05GHS07Dgr H302H373 **H315H318   
603-072-00-7 1,4-bis(2,3 epoxypropoxy)butane;butanedioldiglycidyl ether 219-371-7 2425-79-8 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H332H312H319H315H317 GHS07Wng H332H312H319H315H317   
603-073-00-2 bis-[4-(2,3-epoxipropoxi)phenyl]propane 216-823-5 1675-54-3 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317  Eye Irrit. 2; H319: C ≥ 5 %Skin Irrit. 2; H315: C ≥ 5 % 
603-074-00-8 reaction product: bisphenol-A-(epichlorhydrin);epoxy resin (number average molecular weight ≤ 700) 500-033-5 25068-38-6 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H319H315H317H411 GHS07GHS09Wng H319H315H317H411  Eye Irrit. 2; H319: C ≥ 5 %Skin Irrit. 2; H315: C ≥ 5 % 
603-075-00-3 chlormethyl methyl ether;chlorodimethyl ether 203-480-1 107-30-2 Flam. Liq. 2Carc. 1AAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H225H350H332H312H302 GHS02GHS08GHS07Dgr H225H350H332H312H302   
603-076-00-9 but-2-yne-1,4-diol;2-butyne-1,4-diol 203-788-6 110-65-6 Skin Corr. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Sens. 1 H314H331H301H312H373 **H317 GHS06GHS05GHS08Dgr H314H331H301H312H373 **H317  Skin Corr. 1B; H314: C ≥ 50 %Skin Irrit. 2; H315: 25 % ≤ C < 50 %Eye Irrit. 2; H319: 25 % ≤ C < 50 % D
603-077-00-4 1-dimethylaminopropan-2-ol;dimepranol (INN) 203-556-4 108-16-7 Flam. Liq. 3Acute Tox. 4 *Skin Corr. 1B H226H302H314 GHS02GHS05GHS07Dgr H226H302H314   
603-078-00-X prop-2-yn-1-ol;propargyl alcohol 203-471-2 107-19-7 Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Chronic 2 H226H331H311H301H314H411 GHS02GHS06GHS05GHS09Dgr H226H331H311H301H314H411   
603-079-00-5 2,2'-(methylimino)diethanol;N-methyldiethanolamine 203-312-7 105-59-9 Eye Irrit. 2 H319 GHS07Wng H319   
603-080-00-0 2-methylaminoethanol;N-methylethanolamine;N-methyl-2-ethanolamine;N-methyl-2-amino ethanol;2-(methylamino)ethanol 203-710-0 109-83-1 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H312H302H314 GHS05 GHS07Dgr H312H302H314  STOT SE 3; H335: C ≥ 5 % 
603-081-00-6 2,2'-thiodiethanol;thiodiglycol 203-874-3 111-48-8 Eye Irrit. 2 H319 GHS07Wng H319   
603-082-00-1 1-aminopropan-2-ol;isopropanolamine 201-162-7 78-96-6 Skin Corr. 1B H314 GHS05Dgr H314   
603-083-00-7 1,1'-iminodipropan-2-ol;di-isopropanolamine 203-820-9 110-97-4 Eye Irrit. 2 H319 GHS07Wng H319   
603-084-00-2 styrene oxide;(epoxyethyl)benzene;phenyloxirane 202-476-7 96-09-3 Carc. 1BAcute Tox. 4 *Eye Irrit. 2 H350H312H319 GHS08GHS07Dgr H350H312H319   
603-085-00-8 bronopol (INN);2-bromo-2-nitropropane-1,3-diol 200-143-0 52-51-7 Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1 H312H302H335H315H318H400 GHS05GHS07GHS09Dgr H312H302H335H315H318H400   
603-086-00-3 ethirimol (ISO);5-butyl-2-ethylamino-6-methylpyrimidin-4-ol 245-949-3 23947-60-6 Acute Tox. 4 * H312 GHS07Wng H312   
603-087-00-9 2-ethylhexane-1,3-diol;octylene glycol;ethoexadiol 202-377-9 94-96-2 Eye Dam. 1 H318 GHS05Dgr H318   
603-088-00-4 2-(octylthio)ethanol;2-hydroxyethyl octyl sulphide 222-598-4 3547-33-9 Eye Dam. 1 H318 GHS05Dgr H318   
603-089-00-X 7,7-dimethyl-3-oxa-6-azaoctan-1-ol 400-390-6 — Skin Corr. 1AAcute Tox. 4 * H314H302 GHS05GHS07Dgr H314H302   
603-090-00-5 2-(2-bromoethoxy)anisole 402-010-4 4463-59-6 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
603-091-00-0 exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol 402-470-6 87172-89-2 Acute Tox. 4 *Eye Dam. 1 H302H318 GHS05GHS07Dgr H302H318   
603-092-00-6 2-methyl-4-phenylpentanol 402-770-7 92585-24-5 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
603-093-00-1 cinmethylin (ISO);exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane 402-410-9 87818-31-3 Acute Tox. 4 *Aquatic Chronic 2 H332H411 GHS07GHS09Dgr H332H411   
603-094-00-7 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane 241-536-7 17557-23-2 Skin Irrit. 2Skin Sens. 1 H315H317 GHS07Wng H315H317   
603-095-00-2 2-(propyloxy)ethanol;EGPE 220-548-6 2807-30-9 Acute Tox. 4 *Eye Irrit. 2 H312H319 GHS07Wng H312H319   
603-096-00-8 2-(2-butoxyethoxy)ethanol;diethylene glycol monobutyl ether 203-961-6 112-34-5 Eye Irrit. 2 H319 GHS07Wng H319   
603-097-00-3 1,1',1''-nitrilotripropan-2-ol;triisopropanolamine 204-528-4 122-20-3 Eye Irrit. 2Aquatic Chronic 3 H319H412 GHS07Wng H319H412   
603-098-00-9 2-phenoxyethanol 204-589-7 122-99-6 Acute Tox. 4 *Eye Irrit. 2 H302H319 GHS07Wng H302H319   
603-099-00-4 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride 403-440-5 93633-79-5 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
603-100-00-8 1,2-dimethoxypropane 404-630-0 7778-85-0 Flam. Liq. 2 H225 GHS02Dgr H225 EUH019  
603-101-00-3 tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) 405-040-6 — Eye Irrit. 2 H319 GHS07Wng H319   
603-102-00-9 1,2-epoxybutane 203-438-2 106-88-7 Flam. Liq. 2Carc. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 3 H225H351H332H312H302H319H335H315H412 GHS02GHS08GHS07Dgr H225H351H332H312H302H319H335H315H412   
603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Skin Irrit. 2Skin Sens. 1 H315H317 GHS07Wng H315H317   
603-104-00-X fenarimol (ISO);2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol 262-095-7 60168-88-9 Repr. 2Lact.Aquatic Chronic 2 H361fdH362H411 GHS08 GHS09Wng H361fdH362H411   
603-105-00-5 furan 203-727-3 110-00-9 Flam. Liq. 1Carc. 1BMuta. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Aquatic Chronic 3 H224H350H341H332H302H373 **H315H412 GHS02GHS08GHS07Dgr H224H350H341H332H302H373 **H315H412 EUH019  
603-106-00-0 2-methoxypropanol 216-455-5 1589-47-5 Flam. Liq. 3Repr. 1BSTOT SE 3Skin Irrit. 2Eye Dam. 1 H226H360D ***H335H315H318 GHS02GHS08GHS05GHS07Dgr H226H360D ***H335H315H318   
603-107-00-6 2-(2-methoxyethoxy)ethanol;diethylene glycol monomethyl ether 203-906-6 111-77-3 Repr. 2 H361d *** GHS08Wng H361d ***   
603-108-00-1 2-methylpropan-1-ol;iso-butanol 201-148-0 78-83-1 Flam. Liq. 3STOT SE 3Skin Irrit. 2Eye Dam. 1STOT SE 3 H226H335H315H318H336 GHS02GHS05GHS07Dgr H226H335H315H318H336   
603-117-00-0 propan-2-ol;isopropyl alcohol;isopropanol 200-661-7 67-63-0 Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H336 GHS02GHS07Dgr H225H319H336   
603-118-00-6 6-dimethylaminohexan-1-ol 404-680-3 1862-07-3 Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3 H302H314H412 GHS05GHS07Dgr H302H314H412   
603-119-00-1 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) 405-840-5 — Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
603-120-00-7 2-methyl-5-phenylpentanol 405-890-8 25634-93-9 Eye Irrit. 2Skin Irrit. 2 H319H315 GHS07Wng H319H315   
603-121-00-2 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone 406-057-1 114565-66-1 Carc. 2Skin Sens. 1Aquatic Chronic 4 H351H317H413 GHS08GHS07Wng H351H317H413   
603-122-00-8 sodium 2-ethylhexanolate 406-150-7 38411-13-1 Flam. Sol. 1Skin Corr. 1BAquatic Chronic 3 H228H314H412 GHS02GHS05Dgr H228H314H412   T
603-123-00-3 4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol 406-330-5 122760-84-3 Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H315H317H411 GHS07GHS09Wng H315H317H411   
603-124-00-9 1,4-bis[2-(vinyloxy)ethoxy]benzene 406-900-3 84563-49-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
603-125-00-4 2-(2,4-dichlorophenyl)-1-(1H—1,2,4-triazol-1-yl)pent-4-en-2-ol 407-850-5 89544-40-1 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H302H318H411 GHS05GHS07GHS09Dgr H302H318H411   
603-126-00-X 2-((4-methyl-2-nitrophenyl)amino)ethanol 408-090-7 100418-33-5 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3 H302H317H412 GHS07Wng H302H317H412   
603-127-00-5 butan-2-ol; [1](S)-butan-2-ol; [2](R)-butan-2-ol; [3](±)-butan-2-ol [4] 201-158-5 [1]224-168-1 [2]238-967-8 [3]240-029-8 [4] 78-92-2 [1]4221-99-2 [2]14898-79-4 [3]15892-23-6 [4] Flam. Liq. 3Eye Irrit. 2STOT SE 3STOT SE 3 H226H319H335H336 GHS02GHS07Wng H226H319H335H336   C
603-128-00-0 2-(phenylmethoxy)naphthalene 405-490-3 613-62-7 Aquatic Chronic 4 H413 — H413   
603-129-00-6 1-tert-butoxypropan-2-ol 406-180-0 57018-52-7 Flam. Liq. 3Eye Dam. 1 H226H318 GHS02GHS05Dgr H226H318   
603-130-00-1 reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) 406-325-8 — Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
603-131-00-7 reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) 407-290-1 — Eye Dam. 1 H318 GHS05Dgr H318   
603-132-00-2 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane 408-200-3 63187-91-7 Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3 H315H318H412 GHS05Dgr H315H318H412   
603-133-00-8 reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) 408-240-1 — Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
603-134-00-3 reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used. 410-450-3 — Aquatic Chronic 4 H413 — H413   
603-135-00-9 bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium 410-500-4 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
603-136-00-4 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol 410-910-3 104226-19-9 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
603-137-00-X reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol 411-130-6 — Eye Dam. 1 H318 GHS05Dgr H318   
603-138-00-5 3-(2,2-dimethyl-3-hydroxypropyl)toluene;(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol 403-140-4 103694-68-4 Aquatic Chronic 3 H412 — H412   
603-139-00-0 bis(2-methoxyethyl) ether 203-924-4 111-96-6 Flam. Liq. 3Repr. 1B H226H360FD GHS02GHS08Dgr H226H360FD EUH019  
603-140-00-6 2,2' -oxybisethanol;diethylene glycol 203-872-2 111-46-6 Acute Tox. 4 * H302 GHS07Wng H302   
603-141-00-1 reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane 413-780-6 — Aquatic Chronic 3 H412 — H412   
603-142-00-7 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane 407-360-1 116230-20-7 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1 H312H302H373 **H315H318 GHS06GHS08GHS05Dgr H312H302H373 **H315H318   
603-143-00-2 R—2,3-epoxy-1-propanol 404-660-4 57044-25-4 Self-react. C ****Carc. 1BMuta. 2Repr. 1BAcute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H242H350H341H360F ***H331H312H302H314 GHS02GHS06GHS08GHS05Dgr H242H350H341H360F ***H331H312H302H314   
603-144-00-8 reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol 413-530-6 111850-00-1 Aquatic Chronic 2 H411 GHS09 H411   
603-145-00-3 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane 406-970-5 129228-11-1 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
603-146-00-9 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol 406-080-7 83016-70-0 Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3 H302H314H412 GHS05GHS07Dgr H302H314H412   
603-147-00-4 (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 406-030-4 105812-81-5 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H302H318H411 GHS05GHS07GHS09Dgr H302H318H411   
603-148-00-X 1,4-bis[(vinyloxy)methyl]cyclohexane 413-370-7 17351-75-6 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07 GHS09Wng H317H411   
603-149-00-5 reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane 407-640-3 63767-86-2 Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H319H315H411 GHS07 GHS09Wng H319H315H411   
603-150-00-0 (±) trans—3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol 411-580-3 107898-54-4 Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H315H400H410 GHS07GHS09Wng H315H410   
603-151-00-6 (±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol 413-570-4 — Aquatic Chronic 3 H412 — H412   
603-152-00-1 2-(4-tert-butylphenyl)ethanol 410-020-5 5406-86-0 Repr. 2STOT RE 2 *Eye Dam. 1Aquatic Chronic 2 H361f ***H373 **H318H411 GHS08GHS05GHS09Dgr H361f ***H373 **H318H411   
603-153-00-7 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol 410-010-0 104333-00-8 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
603-154-00-2 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol 412-300-2 139504-68-0 Aquatic Chronic 2 H411 GHS09 H411   
603-155-00-8 Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane 410-560-1 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
603-156-00-3 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane 411-210-0 89544-48-9 Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H317H400H410 GHS07GHS09Wng H315H317H410   
603-157-00-9 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol 411-450-6 143747-72-2 Aquatic Chronic 4 H413 — H413   
603-158-00-4 reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene 412-460-3 — Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07 GHS09Wng H315H411   
603-159-00-X 2-cyclododecylpropan-1-ol 411-410-8 118562-73-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
603-160-00-5 1,2-diethoxypropane 412-180-1 10221-57-5 Flam. Liq. 2 H225 GHS02Dgr H225 EUH019  
603-161-00-0 1,3-diethoxypropane 413-140-6 3459-83-4 Flam. Liq. 3 H226 GHS02Wng H226   
603-162-00-6 α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]- ω nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] 413-420-8 144736-29-8 Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H314H317H411 GHS05GHS07GHS09Dgr H314H317H411   
603-163-00-1 2-phenyl-1,3-propanediol 411-810-2 1570-95-2 Eye Dam. 1 H318 GHS05Dgr H318   
603-164-00-7 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole 412-420-5 133909-99-6 Aquatic Chronic 4 H413 — H413   
603-165-00-2 reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol 417-470-1 — Muta. 2Skin Sens. 1 H341H317 GHS08GHS07Wng H341H317   
603-166-00-8 R-1-chloro-2,3-epoxypropane 424-280-2 51594-55-9 Flam. Liq. 3Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1 H226H350H331H311H301H314H317 GHS02GHS06GHS08GHS05Dgr H226H350H331H311H301H314H317   
603-167-00-3 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol 407-920-5 6390-69-8 Aquatic Chronic 4 H413 GHS05Dgr H413   
603-168-00-9 3-(2-ethylhexyloxy)propane-1,2-diol 408-080-2 70445-33-9 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
603-169-00-4 (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 415-550-0 109887-53-8 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H302H318H411 GHS05GHS07GHS09Dgr H302H318H411   
603-170-00-X reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol 415-990-3 67739-11-1 Eye Irrit. 2Aquatic Chronic 2 H319H411 GHS07GHS09Wng H319H411   
603-171-00-5 5-thiazolylmethanol 414-780-9 38585-74-9 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
603-172-00-0 mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate 415-180-1 773058-82-5 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H302H318H411 GHS05GHS07GHS09Dgr H302H318H411   
603-173-00-6 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane 421-750-9 57280-22-5 Eye Irrit. 2Skin Sens. 1 H319H317 GHS07Wng H319H317   
603-174-00-1 4-cyclohexyl-2-methyl-2-butanol 420-630-3 83926-73-2 Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
603-175-00-7 2-(2-hexyloxyethoxy)ethanol;DEGHE;diethylene glycol monohexyl ether;3,6-dioxa-1-dodecanol;hexyl carbitol;3,6-dioxadodecan-1-ol 203-988-3 112-59-4 Acute Tox. 4 *Eye Dam. 1 H312H318 GHS05GHS07Dgr H312H318   
603-176-00-2 1,2-bis(2-methoxyethoxy)ethane;TEGDME;triethylene glycol dimethyl ether;triglyme 203-977-3 112-49-2 Repr. 1B H360Df GHS08Dgr H360Df EUH019  
603-177-00-8 1-ethoxypropan-2-ol;2PG1EE;1-ethoxy-2-propanol;propylene glycol monoethyl ether; [1]2-ethoxy-1-methylethyl acetate;2PG1EEA [2] 216-374-5 [1]259-370-9 [2] 1569-02-4 [1]54839-24-6 [2] Flam. Liq. 3STOT SE 3 H226H336 GHS02GHS07Wng H226H336   
603-178-00-3 2-hexyloxyethanol;ethylene glycol monohexyl ether;n-hexylglycol 203-951-1 112-25-4 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H312H302H314 GHS05GHS07Dgr H312H302H314   
603-179-00-9 ergocalciferol (ISO);Vitamin D2 200-014-9 50-14-6 Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1 H330H311H301H372 ** GHS06GHS08Dgr H330H311H301H372 **   
603-180-00-4 colecalciferol;Vitamin D3 200-673-2 67-97-0 Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1 H330H311H301H372 ** GHS06GHS08Dgr H330H311H301H372 **   
603-181-00-X tert-butyl methyl ether;MTBE;2-methoxy-2-methylpropane 216-653-1 1634-04-4 Flam. Liq. 2Skin Irrit. 2 H225H315 GHS02GHS07Dgr H225H315   
603-183-00-0 2-[2-(2-butoxyethoxy)ethoxy]ethanol;TEGBE;triethylene glycol monobutyl ether;butoxytriethylene glycol 205-592-6 143-22-6 Eye Dam. 1 H318 GHS05Dgr H318  Eye Dam. 1; H318: C ≥ 30 %Eye Irrit. 2; H319: 20 % ≤ C < 30 % 
603-184-00-6 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol 416-380-1 146925-83-9 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
603-185-00-1 2,4-dichloro-3-ethyl-6-nitrophenol 420-740-1 99817-36-4 Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H301H318H317H400H410 GHS06GHS05GHS09Dgr H301H318H317H410   
603-186-00-7 trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol 419-050-3 79944-37-9 Skin Sens. 1 H317 GHS07Wng H317   
603-187-00-2 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride 419-360-9 163661-77-6 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
603-189-00-3 reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol 405-250-8 — Aquatic Chronic 2 H411 GHS09 H411   
603-191-00-4 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol 419-740-4 137658-79-8 Aquatic Chronic 4 H413 — H413   
603-195-00-6 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol 430-810-3 154825-62-4 Aquatic Chronic 3 H412 — H412   
603-196-00-1 2-(7-ethyl-1H-indol-3-yl)ethanol 431-020-1 41340-36-7 Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 2 H302H373 **H411 GHS08GHS07GHS09Wng H302H373 **H411   
603-197-00-7 tebuconazole (ISO);1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. 2Acute Tox. 4 *Aquatic Chronic 2 H361d ***H302H411 GHS08GHS07GHS09Wng H361d ***H302H411   
603-199-00-8 etoxazol (ISO);(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole — 153233-91-1 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410  M = 100 
604-001-00-2 phenol;carbolic acid;monohydroxybenzene;phenylalcohol 203-632-7 108-95-2 Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Skin Corr. 1B H341H331H311H301H373 **H314 GHS06GHS08 GHS05Dgr H341H331H311H301H373 **H314  *Skin Corr. 1B; H314: C ≥ 3 %Skin Irrit. 2; H315: 1 % ≤ C < 3 %Eye Irrit. 2; H319: 1 % ≤ C < 3 % 
604-002-00-8 pentachlorophenol 201-778-6 87-86-5 Carc. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H351H330H311H301H319H335H315H400H410 GHS06GHS08GHS09Dgr H351H330H311H301H319H335H315H410   
604-003-00-3 sodium pentachlorophenolate; [1]potassium pentachlorophenolate [2] 205-025-2 [1]231-911-3 [2] 131-52-2 [1]7778-73-6 [2] Carc. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H351H330H311H301H319H335H315H400H410 GHS06GHS08GHS09Dgr H351H330H311H301H319H335H315H410   
604-004-00-9 m-cresol; [1]o-cresol; [2]p-cresol; [3]mix-cresol [4] 203-577-9 [1]202-423-8 [2]203-398-6 [3]215-293-2 [4] 108-39-4 [1]95-48-7 [2]106-44-5 [3]1319-77-3 [4] Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B H311H301H314 GHS06GHS05Dgr H311H301H314  * C
604-005-00-4 1,4-dihydroxybenzene;hydroquinone;quinol 204-617-8 123-31-9 Carc. 2Muta. 2Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1 H351H341H302H318H317H400 GHS08GHS05GHS07GHS09Dgr H351H341H302H318H317H400   
604-006-00-X 3,4-xylenol; [1]2,5-xylenol; [2]2,4-xylenol; [3]2,3-xylenol; [4]2,6-xylenol; [5]xylenol; [6]2,4(or 2,5)-xylenol [7] 202-439-5 [1]202-461-5 [2]203-321-6 [3]208-395-3 [4]209-400-1 [5]215-089-3 [6]276-245-4 [7] 95-65-8 [1]95-87-4 [2]105-67-9 [3]526-75-0 [4]576-26-1 [5]1300-71-6 [6]71975-58-1 [7] Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Chronic 2 H311H301H314H411 GHS06GHS05GHS09Dgr H311H301H314H411   C
604-007-00-5 2-naphthol 205-182-7 135-19-3 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1 H332H302H400 GHS07GHS09Wng H332H302H400   
604-008-00-0 2-chlorophenol; [1]4-chlorophenol; [2]3-chlorophenol; [3]chlorophenol [4] 202-433-2 [1]203-402-6 [2]203-582-6 [3]246-691-4 [4] 95-57-8 [1]106-48-9 [2]108-43-0 [3]25167-80-0 [4] Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H332H312H302H411 GHS07 GHS09Wng H332H312H302H411   C
604-009-00-6 pyrogallol;1,2,3-trihydroxybenzene 201-762-9 87-66-1 Muta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H341H332H312H302H412 GHS08GHS07Wng H341H332H312H302H412  * 
604-010-00-1 resorcinol;1,3-benzenediol 203-585-2 108-46-3 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1 H302H319H315H400 GHS07GHS09Wng H302H319H315H400  * 
604-011-00-7 2,4-dichlorophenol 204-429-6 120-83-2 Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2 H311H302H314H411 GHS06GHS05GHS09Dgr H311H302H314H411   
604-012-00-2 4-chloro-o-cresol;4-chloro-2-methyl phenol 216-381-3 1570-64-5 Acute Tox. 3 *Skin Corr. 1AAquatic Acute 1 H331H314H400 GHS06GHS05GHS09Dgr H331H314H400  STOT SE 3; H335: C ≥ 1 % 
604-013-00-8 2,3,4,6-tetrachlorophenol 200-402-8 58-90-2 Acute Tox. 3 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H301H319H315H400H410 GHS06GHS09Dgr H301H319H315H410  *Eye Irrit. 2; H319: C ≥ 5 %Skin Irrit. 2; H315: C ≥ 5 % 
604-014-00-3 chlorocresol;4-chloro-m-cresol;4-chloro-3-methylphenol 200-431-6 59-50-7 Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1 H312H302H318H317H400 GHS05GHS07GHS09Dgr H312H302H318H317H400  * 
604-015-00-9 2,2'-methylenebis-(3,4,6-trichlorophenol);hexachlorophene 200-733-8 70-30-4 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H311H301H400H410 GHS06GHS09Dgr H311H301H410  * 
604-016-00-4 1,2-dihydroxybenzene;pyrocatechol 204-427-5 120-80-9 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2 H312H302H319H315 GHS07Wng H312H302H319H315   
604-017-00-X 2,4,5-trichlorophenol 202-467-8 95-95-4 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H315H400H410 GHS07GHS09Wng H302H319H315H410  *Eye Irrit. 2; H319: C ≥ 5 %Skin Irrit. 2; H315: C ≥ 5 % 
604-018-00-5 2,4,6-trichlorophenol 201-795-9 88-06-2 Carc. 2Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H351H302H319H315H400H410 GHS08GHS07GHS09Wng H351H302H319H315H410   
604-019-00-0 dichlorophen (ISO) 202-567-1 97-23-4 Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H400H410 GHS07GHS09Wng H302H319H410   
604-020-00-6 2-phenylphenol (ISO)biphenyl-2-ol;2-hydroxybiphenyl; 201-993-5 90-43-7 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1 H319H335H315H400 GHS07GHS09Wng H319H335H315H400   
604-021-00-1 sodium 2-biphenylate;2-phenylphenol, sodium salt 205-055-6 132-27-4 Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1 H302H335H315H318H400 GHS05GHS07GHS09Wng H302H335H315H318H400   
604-022-00-7 2,2-dimethyl-1,3-benzodioxol-4-ol 400-900-7 22961-82-6 Eye Dam. 1 H318 GHS05Dgr H318   
604-023-00-2 2,4-dichloro-3-ethylphenol 401-060-4 — Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H314H400H410 GHS05GHS09Dgr H314H410   
604-024-00-8 4,4-isobutylethylidenediphenol 401-720-1 6807-17-6 Repr. 1BEye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H360F ***H319H400H410 GHS08GHS09Dgr H360F ***H319H410   
604-025-00-3 2,5-bis(1,1-dimethylbutyl)hydroquinone 400-220-0 — Aquatic Chronic 2 H411 GHS09 H411   
604-026-00-9 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) 400-270-3 — Aquatic Chronic 2 H411 GHS09 H411   
604-027-00-4 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone 400-530-6 — Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
604-028-00-X 4-amino-3-fluorophenol 402-230-0 399-95-1 Carc. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H350H302H317H411 GHS08GHS07GHS09Dgr H350H302H317H411   
604-029-00-5 1-naphtol 201-969-4 90-15-3 Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1 H312H302H335H315H318 GHS05GHS07Dgr H312H302H335H315H318   
604-030-00-0 bisphenol A;4,4'-isopropylidenediphenol 201-245-8 80-05-7 Repr. 2STOT SE 3Eye Dam. 1Skin Sens. 1 H361f ***H335H318H317 GHS08GHS05 GHS07Dgr H361f ***H335H318H317   
604-031-00-6 guaiacol 201-964-7 90-05-1 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2 H302H319H315 GHS07Wng H302H319H315   
604-032-00-1 thymol 201-944-8 89-83-8 Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2 H302H314H411 GHS05GHS07GHS09Dgr H302H314H411   
604-033-00-7 isobutyl but-3-enoate 401-170-2 24342-03-8 Flam. Liq. 3 H226 GHS02Wng H226   
604-034-00-2 4,4'-thiodi-o-cresol 403-330-7 24197-34-0 Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
604-035-00-8 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol 404-160-6 — Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
604-036-00-3 4,4'-oxybis(ethylenethio)diphenol 404-590-4 90884-29-0 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
604-037-00-9 3,5-xylenol;3,5-dimethylphenol 203-606-5 108-68-9 Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B H311H301H314 GHS06GHS05Dgr H311H301H314   
604-038-00-4 4-chloro-3,5-dimethylphenol; [1]chloroxylenol [2] 201-793-8 [1]215-316-6 [2] 88-04-0 [1]1321-23-9 [2] Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H302H319H315H317 GHS07Wng H302H319H315H317   
604-039-00-X ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;fenoxaprop-ethyl 266-362-9 66441-23-4 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
604-040-00-5 fomesafen (ISO);5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide 276-439-9 72178-02-0 Acute Tox. 4 * H302 GHS07Wng H302   
604-041-00-0 acifluorfen (ISO);5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;acifluorfen-sodium [2] 256-634-5 [1]263-560-7 [2] 50594-66-6 [1]62476-59-9 [2] Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H302H315H318H400H410 GHS05GHS07GHS09Dgr H302H315H318H410   
604-042-00-6 4-nitrosophenol 203-251-6 104-91-6 Muta. 2Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H341H302H318H411 GHS08GHS05GHS07GHS09Dgr H341H302H318H411   
604-043-00-1 monobenzone;4-hydroxyphenyl benzyl ether;hydroquinone monobenzyl ether 203-083-3 103-16-2 Eye Irrit. 2Skin Sens. 1 H319H317 GHS07Wng H319H317   
604-044-00-7 mequinol;4-methoxyphenol;hydroquinone monomethyl ether 205-769-8 150-76-5 Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1 H302H319H317 GHS07Wng H302H319H317   
604-045-00-2 2,3,5-trimethylhydroquinone 211-838-3 700-13-0 Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H332H335H315H318H317H400H410 GHS05GHS07GHS09Dgr H332H335H315H318H317H410   
604-046-00-8 4-(4-isopropoxyphenylsulfonyl)phenol 405-520-5 95235-30-6 Aquatic Chronic 2 H411 GHS09 H411   
604-047-00-3 4-(4-tolyloxy)biphenyl 405-730-7 51601-57-1 STOT RE 2 *Aquatic Chronic 4 H373 **H413 GHS08Wng H373 **H413   
604-048-00-9 4,4',4''-(ethan-1,1,1-triyl)triphenol 405-800-7 27955-94-8 Aquatic Chronic 2 H411 GHS09 H411   
604-049-00-4 4-4'-methylenebis(oxyethylenethio)diphenol 407-480-4 93589-69-6 Aquatic Chronic 2 H411 GHS09 H411   
604-051-00-5 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol 401-110-5 87113-78-8 Aquatic Chronic 3 H412 — H412   
604-052-00-0 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) 403-800-1 103597-45-1 Aquatic Chronic 4 H413 — H413   
604-053-00-6 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol 410-760-9 157661-93-3 Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H317H400H410 GHS07GHS09Wng H315H317H410   
604-054-00-1 reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol 412-020-0 — Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
604-055-00-7 2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane 413-900-7 85954-11-6 Muta. 2 H341 GHS08Wng H341   
604-056-00-2 2-(2-hydroxy-3,5-dinitroanilino)ethanol 412-520-9 99610-72-7 Flam. Sol. 2Repr. 2Acute Tox. 4 * H228H361f ***H302 GHS02GHS07GHS08Dgr H228H361f ***H302   
604-057-00-8 reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6 401-680-5 — Aquatic Chronic 2 H411 GHS09 H411   
604-058-00-3 1,2-bis(3-methylphenoxy)ethane 402-730-9 54914-85-1 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
604-059-00-9 2-n-hexadecylhydroquinone 406-400-5 — STOT RE 2 *Skin Irrit. 2Skin Sens. 1Aquatic Chronic 4 H373 **H315H317H413 GHS08GHS07Wng H373 **H315H317H413   
604-060-00-4 9,9-bis(4-hydroxyphenyl)fluorene 406-950-6 3236-71-3 Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H315H400H410 GHS07GHS09Wng H319H315H410   
604-061-00-X reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;1-ethyldodecyl;1-propylundecyl;1-butyldecyl;1-pentylnonyl;1-hexyloctyl 407-740-7 — Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3 H315H317H412 GHS07Wng H315H317H412   
604-062-00-5 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol 411-220-5 — Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H317H400H410 GHS07GHS09Wng H315H317H410   
604-063-00-0 5,6-dihydroxyindole 412-130-9 3131-52-0 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H302H318H411 GHS05 GHS07GHS09Dgr H302H318H411   
604-064-00-6 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol 411-380-6 147315-50-2 Aquatic Chronic 4 H413 — H413   
604-065-00-1 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) 407-460-5 111850-25-0 Aquatic Chronic 2 H411 GHS09 H411   
604-066-00-7 reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol 414-550-8 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
604-067-00-2 reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) 414-520-4 — Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H400H410 GHS05GHS09Dgr H315H318H410   
604-068-00-8 (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride 415-170-5 90274-24-1 Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1 H332H302H317 GHS07Wng H332H302H317   
604-069-00-3 2-(1-methylpropyl)-4-tert-butylphenol 421-740-4 51390-14-8 Skin Corr. 1BAquatic Chronic 2 H314H411 GHS05GHS09Dgr H314H411   
604-070-00-9 triclosan;2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;5-chloro-2-(2,4-dichlorophenoxy)phenol 222-182-2 3380-34-5 Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H315H400H410 GHS07GHS09Wng H319H315H410  M = 100 
605-001-00-5 formaldehyde ...% 200-001-8 50-00-0 Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1 H351H331H311H301H314H317 GHS06GHS08GHS05Dgr H351H331H311H301H314H317  *Skin Corr. 1B; H314: C ≥25 %Skin Irrit. 2; H315: 5 % ≤ C < 25 %Eye Irrit. 2; H319: 5 % ≤ C < 25 %STOT SE 3; H335: C ≥ 5 %Skin Sens. 1; H317: C ≥ 0,2 % B D
605-002-00-0 1,3,5-trioxan;trioxymethylene 203-812-5 110-88-3 Flam. Sol. 1Repr. 2STOT SE 3 H228H361d ***H335 GHS02GHS08GHS07Dgr H228H361d ***H335   T
605-003-00-6 acetaldehyde;ethanal 200-836-8 75-07-0 Flam. Liq. 1Carc. 2Eye Irrit. 2STOT SE 3 H224H351H319H335 GHS02GHS08GHS07Dgr H224H351H319H335   
605-004-00-1 2,4,6-trimethyl-1,3,5-trioxan;paraldehyde 204-639-8 123-63-7 Flam. Liq. 3 H226 GHS02Dgr H226   
605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;metaldehyde 203-600-2 108-62-3 Flam. Sol. 2Acute Tox. 4 * H228H302 GHS02GHS07Wng H228H302   
605-006-00-2 butyraldehyde 204-646-6 123-72-8 Flam. Liq. 2 H225 GHS02Dgr H225   
605-007-00-8 1,1-dimethoxyethane;dimethyl acetal 208-589-8 534-15-6 Flam. Liq. 2 H225 GHS02Dgr H225   
605-008-00-3 acrylaldehyde;acrolein;prop-2-enal 203-453-4 107-02-8 Flam. Liq. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1 H225H330H311H301H314H400 GHS02GHS06GHS05GHS09Dgr H225H330H311H301H314H400   D
605-009-00-9 crotonaldehyde;2-butenal; [1](E)-2-butenal;(E)-crotonaldehyde [2] 224-030-0 [1]204-647-1 [2] 4170-30-3 [1]123-73-9 [2] Flam. Liq. 2Muta. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1 H225H341H330H311H301H373 **H335H315H318H400 GHS02GHS06GHS08GHS05GHS09Dgr H225H341H330H311H301H373 **H335H315H318H400   
605-010-00-4 2-furaldehyde 202-627-7 98-01-1 Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3 H351H331H301H312H319H335 GHS06GHS08Dgr H351H331H301H312H319H335  * 
605-011-00-X 2-chlorobenzaldehyde;o-chlorobenzaldehyde 201-956-3 89-98-5 Skin Corr. 1B H314 GHS05Dgr H314   
605-012-00-5 benzaldehyde 202-860-4 100-52-7 Acute Tox. 4 * H302 GHS07Wng H302   
605-013-00-0 chloralose (INN);(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;glucochloralose;anhydroglucochloral 240-016-7 15879-93-3 Acute Tox. 4 *Acute Tox. 4 * H332H302 GHS07Wng H332H302   
605-014-00-6 chloral hydrate;2,2,2-trichloroethane-1,1-diol 206-117-5 302-17-0 Acute Tox. 3 *Eye Irrit. 2Skin Irrit. 2 H301H319H315 GHS06Dgr H301H319H315   
605-015-00-1 1,1-diethoxyethane;acetal 203-310-6 105-57-7 Flam. Liq. 2Eye Irrit. 2Skin Irrit. 2 H225H319H315 GHS02GHS07Dgr H225H319H315   
605-016-00-7 glyoxal...%;ethandial...% 203-474-9 107-22-2 Muta. 2Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H341H332H319H315H317 GHS07GHS08Wng H341H332H319H315H317  * B
605-017-00-2 1,3-dioxolane 211-463-5 646-06-0 Flam. Liq. 2 H225 GHS02Dgr H225   
605-018-00-8 propanal;propionaldehyde 204-623-0 123-38-6 Flam. Liq. 2Eye Irrit. 2STOT SE 3Skin Irrit. 2 H225H319H335H315 GHS02GHS07Dgr H225H319H335H315   
605-019-00-3 citral 226-394-6 5392-40-5 Skin Irrit. 2Skin Sens. 1 H315H317 GHS07Wng H315H317   
605-020-00-9 safrole;5-allyl-1,3-benzodioxole 202-345-4 94-59-7 Carc. 1BMuta. 2Acute Tox. 4 * H350H341H302 GHS08GHS07Dgr H350H341H302   
605-021-00-4 formaldehyde, reaction products with butylphenol 294-145-9 91673-30-2 Skin Sens. 1 H317 GHS07Wng H317   
605-022-00-X glutaral;glutaraldehyde;1,5-pentanedial 203-856-5 111-30-8 Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Acute 1 H331H301H314H334H317H400 GHS06GHS08GHS05GHS09Dgr H331H301H314H334H317H400  *Skin Corr. 1B; H314: C ≥ 10 %Skin Irrit. 2; H315: 0,5 % ≤ C < 10 %Eye Dam. ; H318: 2 % ≤ C < 10 %Eye Irrit. 2; H319: 0,5 % ≤ C < 2 %STOT SE; H335: C ≥ 0,5 %Skin Sens. 1; H317: C ≥ 0,5 % 
605-025-00-6 chloroacetaldehyde 203-472-8 107-20-0 Carc. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1 H351H330H311H301H314H400 GHS06GHS08GHS05GHS09Dgr H351H330H311H301H314H400  STOT SE 3; H335: C ≥ 5 % 
605-026-00-1 2,5,7,7-tetramethyloctanal 405-690-0 114119-97-0 Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H315H317H411 GHS07 GHS09Wng H315H317H411   
605-027-00-7 reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde 410-480-7 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
605-028-00-2 β-methyl-3-(1-methylethyl)-benzenepropanal 412-050-4 125109-85-5 Aquatic Chronic 2 H411 GHS09 H411   
605-029-00-8 2-cyclohexylpropanal 412-270-0 2109-22-0 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
605-030-00-3 1-(p-methoxyphenyl)acetaldehyde oxime 411-510-1 3353-51-3 Skin Sens. 1 H317 GHS07Wng H317   
605-031-00-9 reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70,4 % hydrate;water(Including free water and water in hydrated 2,2-dimethoxyethanal)] 421-890-0 — Skin Sens. 1 H317 GHS07Wng H317   
606-001-00-8 acetone;propan-2-one;propanone 200-662-2 67-64-1 Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H336 GHS02GHS07Dgr H225H319H336 EUH066  
606-002-00-3 butanone;ethyl methyl ketone 201-159-0 78-93-3 Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H336 GHS02GHS07Dgr H225H319H336 EUH066  
606-003-00-9 heptan-3-one;butyl ethyl ketone 203-388-1 106-35-4 Flam. Liq. 3Acute Tox. 4 *Eye Irrit. 2 H226H332H319 GHS02GHS07Wng H226H332H319   
606-004-00-4 4-methylpentan-2-one;isobutyl methyl ketone 203-550-1 108-10-1 Flam. Liq. 2Acute Tox. 4 *Eye Irrit. 2STOT SE 3 H225H332H319H335 GHS02GHS07Dgr H225H332H319H335 EUH066  
606-005-00-X 2,6-dimethylheptan-4-one;di-isobutyl ketone 203-620-1 108-83-8 Flam. Liq. 3STOT SE 3 H226H335 GHS02GHS07Wng H226H335  STOT SE 3; H335: C ≥ 10 % 
606-006-00-5 pentan-3-one;diethyl ketone 202-490-3 96-22-0 Flam. Liq. 2STOT SE 3STOT SE 3 H225H335H336 GHS02GHS07Dgr H225H335H336 EUH066  
606-007-00-0 3-methylbutan-2-one;methyl isopropyl ketone 209-264-3 563-80-4 Flam. Liq. 2 H225 GHS02Dgr H225   
606-009-00-1 4-methylpent-3-en-2-one;mesityl oxide 205-502-5 141-79-7 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H226H332H312H302 GHS02GHS07Wng H226H332H312H302  * 
606-010-00-7 cyclohexanone 203-631-1 108-94-1 Flam. Liq. 3Acute Tox. 4 * H226H332 GHS02GHS07Wng H226H332   
606-011-00-2 2-methylcyclohexanone 209-513-6 583-60-8 Flam. Liq. 3Acute Tox. 4 * H226H332 GHS02GHS07Wng H226H332   
606-012-00-8 3,5,5-trimethylcyclohex-2-enone;isophorone 201-126-0 78-59-1 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3 H351H312H302H319H335 GHS08GHS07Wng H351H312H302H319H335  STOT SE 3; H335: C ≥ 10 % 
606-013-00-3 p-benzoquinone;quinone 203-405-2 106-51-4 Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1 H331H301H319H335H315H400 GHS06GHS09Dgr H331H301H319H335H315H400   
606-014-00-9 chlorophacinone (ISO);2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione 223-003-0 3691-35-8 Acute Tox. 1Acute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H310H300H331H372 **H400H410 GHS06GHS08GHS09Dgr H310H300H331H372 **H410   
606-016-00-X pindone (ISO);2-pivaloylindan-1,3-dione 201-462-8 83-26-1 Acute Tox. 3 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H301H372 **H400H410 GHS06GHS08GHS09Dgr H301H372 **H410   
606-017-00-5 diketene;diketen 211-617-1 674-82-8 Flam. Liq. 3Acute Tox. 4 * H226H332 GHS02GHS07Wng H226H332   D
606-018-00-0 dichlone (ISO);2,3-dichloro-1,4-naphthoquinone 204-210-5 117-80-6 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H315H400H410 GHS07GHS09Wng H302H319H315H410   
606-019-00-6 chlordecone (ISO);perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one 205-601-3 143-50-0 Carc. 2Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H351H311H301H400H410 GHS06GHS08GHS09Dgr H351H311H301H410   
606-020-00-1 5-methylheptan-3-one 208-793-7 541-85-5 Flam. Liq. 3Eye Irrit. 2STOT SE 3 H226H319H335 GHS02GHS07Wng H226H319H335  STOT SE 3; H335: C ≥ 10 % 
606-021-00-7 N-methyl-2-pyrrolidone 212-828-1 872-50-4 Eye Irrit. 2Skin Irrit. 2 H319H315 GHS07Wng H319H315   
606-022-00-2 1-phenyl-3-pyrazolidone 202-155-1 92-43-3 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
606-023-00-8 4-methoxy-4-methylpentan-2-one 203-512-4 107-70-0 Flam. Liq. 3Acute Tox. 4 * H226H332 GHS02GHS07Wng H226H332   
606-024-00-3 heptan-2-one;methyl amyl ketone 203-767-1 110-43-0 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 * H226H332H302 GHS02GHS07Wng H226H332H302   
606-025-00-9 cyclopentanone 204-435-9 120-92-3 Flam. Liq. 3Eye Irrit. 2Skin Irrit. 2 H226H319H315 GHS02GHS07Wng H226H319H315   
606-026-00-4 5-methylhexan-2-one;isoamyl methyl ketone 203-737-8 110-12-3 Flam. Liq. 3Acute Tox. 4 * H226H332 GHS02GHS07Wng H226H332   
606-027-00-X heptan-4-one;di-n-propyl ketone 204-608-9 123-19-3 Flam. Liq. 3Acute Tox. 4 * H226H332 GHS02GHS07Wng H226H332   
606-028-00-5 2,4-dimethylpentan-3-one;di-isopropyl ketone 209-294-7 565-80-0 Flam. Liq. 2Acute Tox. 4 * H225H332 GHS02GHS07Dgr H225H332   
606-029-00-0 pentane-2,4-dione;acetylacetone 204-634-0 123-54-6 Flam. Liq. 3Acute Tox. 4 * H226H302 GHS02GHS07Wng H226H302   
606-030-00-6 hexan-2-one;methyl butyl ketone;butyl methyl ketone;methyl-n-butyl ketone 209-731-1 591-78-6 Flam. Liq. 3Repr. 2STOT RE 1STOT SE 3 H226H361f ***H372 **H336 GHS02GHS08GHS07Dgr H226H361f ***H372 **H336   
606-031-00-1 3-propanolide;1,3-propiolactone 200-340-1 57-57-8 Carc. 1BAcute Tox. 2 *Eye Irrit. 2Skin Irrit. 2 H350H330H319H315 GHS06GHS08Dgr H350H330H319H315   
606-032-00-7 hexachloroacetone 204-129-5 116-16-5 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
606-033-00-2 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;methazole 243-761-6 20354-26-1 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H312H302H319H315H411 GHS07GHS09Wng H312H302H319H315H411   
606-034-00-8 metribuzin (ISO);4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one 244-209-7 21087-64-9 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
606-035-00-3 chloridazon (ISO);5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;pyrazon 216-920-2 1698-60-8 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
606-036-00-9 quinomethionate;chinomethionat (ISO);6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one 219-455-3 2439-01-2 Repr. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361f ***H332H312H302H373 **H319H317H400H410 GHS08GHS07GHS09Wng H361f ***H332H312H302H373 **H319H317H410   
606-037-00-4 triadimefon (ISO);1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone 256-103-8 43121-43-3 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H302H317H411 GHS07GHS09Wng H302H317H411   
606-038-00-X diphacinone (ISO);2-diphenylacetylindan-1,3-dione 201-434-5 82-66-6 Acute Tox. 2 *STOT RE 1 H300H372 ** GHS06GHS08Dgr H300H372 **   
606-039-00-5 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one 400-680-2 — Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H400H410 GHS07GHS09Wng H332H410   
606-040-00-0 (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride 401-840-4 55845-90-4 Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
606-041-00-6 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 400-600-6 71868-10-5 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
606-042-00-1 acetophenone 202-708-7 98-86-2 Acute Tox. 4 *Eye Irrit. 2 H302H319 GHS07Wng H302H319   
606-043-00-7 2,4-di-tert-butylcyclohexanone 405-340-7 13019-04-0 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
606-044-00-2 2,4,6-trimethylbenzophenone 403-150-9 954-16-5 Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H400H410 GHS07GHS09Wng H302H319H410   
606-045-00-8 oxadiazon (ISO);3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one 243-215-7 19666-30-9 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-046-00-3 reaction mass of cis- and trans-cyclohexadec-8-en-1-one 401-700-2 3100-36-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-047-00-9 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone 404-360-3 119313-12-1 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-048-00-4 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one 406-480-1 — Aquatic Chronic 4 H413 — H413   
606-049-00-X 4-(trans-4-propylcyclohexyl)acetophenone 406-700-6 78531-61-0 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
606-050-00-5 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione 412-480-2 72453-58-8 Aquatic Chronic 2 H411 GHS09 H411   
606-051-00-0 4-pentylcyclohexanone 406-670-4 61203-83-6 Aquatic Chronic 2 H411 GHS09 H411   
606-052-00-6 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone 410-410-5 54574-82-2 Aquatic Chronic 3 H412 — H412   
606-053-00-1 flurtamone (ISO);(RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one — 96525-23-4 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-054-00-7 isoxaflutole (ISO);5-cyclopropyl-1,2-oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone — 141112-29-0 Repr. 2Aquatic Acute 1Aquatic Chronic 1 H361d ***H400H410 GHS08GHS09Wng H361d ***H410   
606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 2 H302H373 **H411 GHS08GHS07GHS09Wng H302H373 **H411   
606-056-00-8 4-chloro-3',4'-dimethoxybenzophenone 404-610-1 116412-83-0 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-057-00-3 4-propylcyclohexanone 406-810-4 40649-36-3 Skin Irrit. 2Aquatic Chronic 3 H315H412 GHS07Wng H315H412   
606-058-00-9 4'-fluoro-2,2-dimethoxyacetophenone 407-500-1 21983-80-2 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
606-059-00-4 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride 412-390-3 86386-75-6 Acute Tox. 4 *Eye Dam. 1Skin Sens. 1 H302H318H317 GHS05GHS07Dgr H302H318H317   
606-060-00-X reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane 412-950-7 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-061-00-5 (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone 423-290-4 66938-41-8 Muta. 2Aquatic Acute 1Aquatic Chronic 1 H341H400H410 GHS08GHS09Wng H341H410   
606-062-00-0 tetrahydrothiopyran-3-carboxaldehyde 407-330-8 61571-06-0 Repr. 1BEye Dam. 1Aquatic Chronic 3 H360D ***H318H412 GHS08GHS05Dgr H360D ***H318H412   
606-063-00-6 (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal 410-980-5 112704-51-5 Eye Irrit. 2Skin Sens. 1 H319H317 GHS07Wng H319H317   
606-064-00-1 pregn-5-ene-3,20-dione bis(ethylene ketal) 407-450-0 7093-55-2 Aquatic Chronic 4 H413 — H413   
606-065-00-7 1-(4-morpholinophenyl)butan-1-one 413-790-0 — Aquatic Chronic 2 H411 GHS09 H411   
606-066-00-2 (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone 410-440-9 164058-20-2 Aquatic Chronic 2 H411 GHS09 H411   
606-067-00-8 reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone 414-870-8 96792-67-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-068-00-3 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al 415-770-7 1638-05-7 STOT RE 2 *Skin Sens. 1Aquatic Chronic 3 H373 **H317H412 GHS08GHS07Wng H373 **H317H412   
606-069-00-9 spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] 415-460-1 154171-76-3 Aquatic Chronic 2 H411 GHS09 H411   
606-070-00-4 butroxydim (ISO);5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one 414-790-3 138164-12-2 Repr. 2Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H361fdH302H315H400H410 GHS08GHS07GHS09Wng H361fdH302H315H410   
606-071-00-X 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one 421-050-3 13258-43-0 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-072-00-5 3-acetyl-1-phenyl-pyrrolidine-2,4-dione 421-600-2 719-86-8 STOT RE 2 *Aquatic Chronic 2 H373 **H411 GHS08GHS09Wng H373 **H411   
606-073-00-0 4,4'-bis(dimethylamino)benzophenone;Michler's ketone 202-027-5 90-94-8 Carc. 1BMuta. 2Eye Dam. 1 H350H341H318 GHS08GHS05Dgr H350H341H318   
606-075-00-1 1-benzyl-5-ethoxyimidazolidine-2,4-dione 417-340-4 65855-02-9 Acute Tox. 4 * H302 GHS07Wng H302   
606-076-00-7 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione 418-630-3 136465-99-1 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
606-077-00-2 (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 418-650-2 104872-06-2 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-078-00-8 1-octylazepin-2-one 420-040-6 59227-88-2 Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H314H317H411 GHS05GHS07GHS09Dgr H314H317H411   
606-079-00-3 2-n-butyl-benzo[d]isothiazol-3-one 420-590-7 4299-07-4 Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H314H317H400H410 GHS05GHS07GHS09Dgr H314H317H410   
606-080-00-9 Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene 417-100-9 — Aquatic Chronic 4 H413  H413   
606-081-00-4 (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one 419-790-7 4229-69-0 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
606-082-00-X reaction mass of: butan-2-one oxime;syn-O,O'-di(butan-2-one oxime)diethoxysilane 406-930-7  STOT RE 1Skin Sens. 1Aquatic Chronic 3 H372 **H317H412 GHS08GHS07Dgr H372 **H317H412   
606-083-00-5 2-chloro-5-sec-hexadecylhydroquinone 407-750-1 137193-60-3 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3 H319H315H317H412 GHS07Wng H319H315H317H412   
606-084-00-0 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione 414-540-3 484-33-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-085-00-6 (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one 418-530-1 79200-56-9 Acute Tox. 4 *Eye Dam. 1Skin Sens. 1 H302H318H317 GHS05GHS07Dgr H302H318H317   
606-086-00-1 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one 422-330-8 56973-87-6 Aquatic Chronic 2 H411 GHS09 H411   
606-087-00-7 6-ethyl-5-fluoro-4(3H)-pyrimidone 422-460-5 137234-87-8 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
606-088-00-2 2,4,4,7-tetramethyl-6-octen-3-one 422-520-0 74338-72-0 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
606-089-00-8 reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;1,4-diamino-2,3-bis-phenoxyanthraquinone 423-220-2 12223-77-7 Aquatic Chronic 4 H413 — H413   
606-091-00-9 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one 421-320-0 118289-55-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
606-092-00-4 reaction mass of: (E)-oxacyclohexadec-12-en-2-one;(E)-oxacyclohexadec-13-en-2-one;a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one 422-320-3  Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-001-00-0 formic acid ... % 200-579-1 64-18-6 Skin Corr. 1A H314 GHS05Dgr H314  Skin Corr. 1A; H314: C ≥ 90 %Skin Corr. 1B; H314: 10 % ≤ C < 90 %Skin Irrit. 2; H315: 2 % ≤ C < 10 %Eye Irrit. 2; H319: 2 % ≤ C < 10 % B
607-002-00-6 acetic acid ... % 200-580-7 64-19-7 Flam. Liq. 3Skin Corr. 1A H226H314 GHS02GHS05Dgr H226H314  Skin Corr. 1A; H314: C ≥ 90 %Skin Corr. 1B; H314: 25 % ≤ C < 90 %Skin Irrit. 2; H315: 10 % ≤ C < 25 %Eye Irrit. 2; H319: 10 % ≤ C < 25 % B
607-003-00-1 chloroacetic acid 201-178-4 79-11-8 Acute Tox. 3 *Skin Corr. 1BAquatic Acute 1 H301H314H400 GHS06GHS05GHS09Dgr H301H314H400   
607-004-00-7 TCA (ISO);trichloroacetic acid 200-927-2 76-03-9 Skin Corr. 1AAquatic Acute 1Aquatic Chronic 1 H314H400H410 GHS05GHS09Dgr H314H410  STOT SE 3; H335: C ≥ 1 % 
607-005-00-2 TCA-sodium (ISO);sodium trichloroacetate 211-479-2 650-51-1 STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H335H400H410 GHS07GHS09Wng H335H410   
607-006-00-8 oxalic acid 205-634-3 144-62-7 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302  * 
607-007-00-3 salts of oxalic acid — — Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302  * A
607-008-00-9 acetic anhydride 203-564-8 108-24-7 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H226H332H302H314 GHS02GHS05GHS07Dgr H226H332H302H314  Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H315: 5 % ≤ C < 25 %Eye Dam. 1; H318: 5 % ≤ C < 25 %Eye Irrit. 2; H319: 1 % ≤ C < 5 %STOT SE 3; H335: C ≥ 5 % 
607-009-00-4 phthalic anhydride 201-607-5 85-44-9 Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H302H335H315H318H334H317 GHS08GHS05GHS07Dgr H302H335H315H318H334H317   
607-010-00-X propionic anhydride 204-638-2 123-62-6 Skin Corr. 1B H314 GHS05Dgr H314  Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H315: 10 % ≤ C < 25 %Eye Irrit. 2; H319: 10 % ≤ C < 25 % 
607-011-00-5 acetyl chloride 200-865-6 75-36-5 Flam. Liq. 2Skin Corr. 1B H225H314 GHS02GHS05Dgr H225H314 EUH014  
607-012-00-0 benzoyl chloride 202-710-8 98-88-4 Skin Corr. 1B H314 GHS05Dgr H314   
607-013-00-6 dimethyl carbonate 210-478-4 616-38-6 Flam. Liq. 2 H225 GHS02Dgr H225   
607-014-00-1 methyl formate 203-481-7 107-31-3 Flam. Liq. 1Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3 H224H332H302H319H335 GHS02GHS07Dgr H224H332H302H319H335   
607-015-00-7 ethyl formate 203-721-0 109-94-4 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3 H225H332H302H319H335 GHS02GHS07Dgr H225H332H302H319H335   
607-016-00-2 propyl formate; [1]isopropyl formate [2] 203-798-0 [1]210-901-2 [2] 110-74-7 [1]625-55-8 [2] Flam. Liq. 2Eye Irrit. 2STOT SE 3STOT SE 3 H225H319H335H336 GHS02GHS07Dgr H225H319H335H336   C
607-017-00-8 butyl formate; [1]tert-butyl formate; [2]isobutyl formate [3] 209-772-5 [1]212-105-0 [2]208-818-1 [3] 592-84-7 [1]762-75-4 [2]542-55-2 [3] Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H335 GHS02GHS07Dgr H225H319H335   C
607-018-00-3 isopentyl formate; [1]2-methylbutyl formate [2] 203-769-2 [1]252-343-2 [2] 110-45-2 [1]35073-27-9 [2] Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H335 GHS02GHS07Dgr H225H319H335   C
607-019-00-9 methyl chloroformate 201-187-3 79-22-1 Flam. Liq. 2Acute Tox. 2 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H225H330H312H302H314 GHS02GHS06GHS05Dgr H225H330H312H302H314   
607-020-00-4 ethyl chloroformate 208-778-5 541-41-3 Flam. Liq. 2Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1B H225H330H302H314 GHS02GHS06GHS05Dgr H225H330H302H314   
607-021-00-X methyl acetate 201-185-2 79-20-9 Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H336 GHS02GHS07Dgr H225H319H336 EUH066  
607-022-00-5 ethyl acetate 205-500-4 141-78-6 Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H336 GHS02GHS07Dgr H225H319H336 EUH066  
607-023-00-0 vinyl acetate 203-545-4 108-05-4 Flam. Liq. 2 H225 GHS02Dgr H225   D
607-024-00-6 propyl acetate; [1]isopropyl acetate [2] 203-686-1 [1]203-561-1 [2] 109-60-4 [1]108-21-4 [2] Flam. Liq. 2Eye Irrit. 2STOT SE 3 H225H319H336 GHS02GHS07Dgr H225H319H336 EUH066  C
607-025-00-1 n-butyl acetate 204-658-1 123-86-4 Flam. Liq. 3STOT SE 3 H226H336 GHS02GHS07Wng H226H336 EUH066  
607-026-00-7 sec-butyl acetate; [1]isobutyl acetate; [2]tert-butyl acetate [3] 203-300-1 [1]203-745-1 [2]208-760-7 [3] 105-46-4 [1]110-19-0 [2]540-88-5 [3] Flam. Liq. 2 H225 GHS02Dgr H225 EUH066  C
607-027-00-2 methyl propionate 209-060-4 554-12-1 Flam. Liq. 2Acute Tox. 4 * H225H332 GHS02GHS07Dgr H225H332   
607-028-00-8 ethyl propionate 203-291-4 105-37-3 Flam. Liq. 2 H225 GHS02Dgr H225   
607-029-00-3 n-butyl propionate; [1]sec-butyl propionate; [2]iso-butyl propionate [3] 209-669-5 [1]- [2]208-746-0 [3] 590-01-2 [1]591-34-4 [2]540-42-1 [3] Flam. Liq. 3 H226 GHS02Wng H226   C
607-030-00-9 propyl propionate 203-389-7 106-36-5 Flam. Liq. 3Acute Tox. 4 * H226H332 GHS02GHS07Wng H226H332   
607-031-00-4 butyl butyrate 203-656-8 109-21-7 Flam. Liq. 3 H226 GHS02Wng H226   C
607-032-00-X ethyl acrylate 205-438-8 140-88-5 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H225H332H312H302H319H335H315H317 GHS02GHS07Dgr H225H332H312H302H319H335H315H317  Skin Irrit. 2; H315: C ≥ 5 %Eye Irrit. 2; H319: C ≥ 5 %STOT SE 3; H335: C ≥ 5 % D
607-033-00-5 n-butyl methacrylate 202-615-1 97-88-1 Flam. Liq. 3Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H226H319H335H315H317 GHS02GHS07Wng H226H319H335H315H317   D
607-034-00-0 methyl acrylate;methyl propenoate 202-500-6 96-33-3 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H225H332H312H302H319H335H315H317 GHS02GHS07Dgr H225H332H312H302H319H335H315H317   D
607-035-00-6 methyl methacrylate;methyl 2-methylprop-2-enoate;methyl 2-methylpropenoate 201-297-1 80-62-6 Flam. Liq. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H225H335H315H317 GHS02GHS07Dgr H225H335H315H317   D
607-036-00-1 2-methoxyethyl acetate;methylglycol acetate 203-772-9 110-49-6 Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H360FDH332H312H302 GHS08GHS07Dgr H360FDH332H312H302   
607-037-00-7 2-ethoxyethyl acetate;ethylglycol acetate 203-839-2 111-15-9 Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H360FDH332H312H302 GHS08GHS07Dgr H360FDH332H312H302   
607-038-00-2 2-butoxyethyl acetate;butylglycol acetate 203-933-3 112-07-2 Acute Tox. 4 *Acute Tox. 4 * H332H312 GHS07Wng H332H312   
607-039-00-8 2,4-D (ISO);2,4-dichlorophenoxyacetic acid 202-361-1 94-75-7 Acute Tox. 4 *STOT SE 3Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H302H335H318H317H412 GHS05GHS07Dgr H302H335H318H317H412   
607-040-00-3 salts of 2,4-D — — Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H318H317H411 GHS05GHS07GHS09Dgr H302H318H317H411   A
607-041-00-9 2,4,5-T (ISO);2,4,5-trichlorophenoxy acetic acid 202-273-3 93-76-5 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H335H315H400H410 GHS07GHS09Wng H302H319H335H315H410   
607-042-00-4 salts and esters of 2,4,5-T;salts and esters of 2,4,5-trichlorophenoxy acetic acid — — Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H335H315H400H410 GHS07GHS09Wng H302H319H335H315H410   A
607-043-00-X dicamba (ISO);2,5-dichloro-6-methoxybenzoic acid;3,6-dichloro-2-methoxybenzoic acid 217-635-6 1918-00-9 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3 H302H318H412 GHS05GHS07Dgr H302H318H412   
607-044-00-5 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]potassium 3,6-dichloro-o-anisate [2] 218-951-7 [1]233-002-7 [2] 2300-66-5 [1]10007-85-9 [2] Eye Irrit. 2Aquatic Chronic 3 H319H412 GHS07Wng H319H412   
607-045-00-0 dichlorprop (ISO);2-(2,4-dichlorophenoxy) propionic acid 204-390-5 120-36-5 Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1 H312H302H315H318 GHS05GHS07Dgr H312H302H315H318   
607-046-00-6 salts of dichlorprop — — Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302   A
607-047-00-1 fenoprop (ISO);2-(2,4,5-trichlorophenoxy)propionic acid 202-271-2 93-72-1 Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H315H400H410 GHS07GHS09Wng H302H315H410   
607-048-00-7 salts of fenoprop;salts of 2-(2,4,5-trichlorophenoxy)propionic acid — — Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410   A
607-049-00-2 mecoprop (ISO);2-(4-chloro-o-tolyloxy) propionic acid;(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]2-(4-chloro-2-methylphenoxy)propionic acid [2] 230-386-8 [1]202-264-4 [2] 7085-19-0 [1]708519-0 [2] Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H302H315H318H400H410 GHS05GHS07GHS09Dgr H302H315H318H410  M=100 
607-050-00-8 salts of mecoprop — — Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H302H315H318H400H410 GHS05GHS07GHS09Dgr H302H315H318H410   A
607-051-00-3 MCPA (ISO);4-chloro-o-tolyloxyacetic acid 202-360-6 94-74-6 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1 H302H315H318 GHS05GHS07Dgr H302H315H318   
607-052-00-9 salts and esters of MCPA — — Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302   A
607-053-00-4 MCPB (ISO);4-(4-chloro-o-tolyloxy) butyric acid 202-365-3 94-81-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-054-00-X salts and esters of MCPB — — Acute Tox. 4 * H302 GHS07Wng H302   A
607-055-00-5 endothal-sodium (ISO);disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate 204-959-8 129-67-9 Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H301H312H319H335H315 GHS06Dgr H301H312H319H335H315   
607-056-00-0 warfarin (ISO); [1](S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2](R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3] 201-377-6 [1]226-907-3 [2]226-908-9 [3] 81-81-2 [1]5543-57-7 [2]5543-58-8 [3] Repr. 1ASTOT RE 1Aquatic Chronic 3 H360D ***H372 **H412 GHS08Dgr H360D ***H372 **H412   
607-057-00-6 coumachlor (ISO);3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin 201-378-1 81-82-3 STOT RE 2 *Aquatic Chronic 3 H373 **H412 GHS08Wng H373 **H412   
607-058-00-1 coumafuryl (ISO);fumarin;(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin 204-195-5 117-52-2 Acute Tox. 3 *STOT RE 1Aquatic Chronic 3 H301H372 **H412 GHS06GHS08Dgr H301H372 **H412   
607-059-00-7 coumatetralyl;4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin 227-424-0 5836-29-3 Acute Tox. 1Acute Tox. 2 *STOT RE 1Aquatic Chronic 3 H310H300H372 **H412 GHS06GHS08Dgr H310H300H372 **H412   
607-060-00-2 dicoumarol;4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) 200-632-9 66-76-2 STOT RE 1Acute Tox. 4 *Aquatic Chronic 2 H372 **H302H411 GHS08GHS07GHS09Dgr H372 **H302H411   
607-061-00-8 acrylic acid;prop-2-enoic acid 201-177-9 79-10-7 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1 H226H332H312H302H314H400 GHS02GHS05GHS07GHS09Dgr H226H332H312H302H314H400  STOT SE 3; H335: C ≥ 1 % D
607-062-00-3 n-butyl acrylate 205-480-7 141-32-2 Flam. Liq. 3Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H226H319H335H315H317 GHS02GHS07Wng H226H319H335H315H317   D
607-063-00-9 isobutyric acid 201-195-7 79-31-2 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
607-064-00-4 benzyl chloroformate 207-925-0 501-53-1 Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H314H400H410 GHS05GHS09Dgr H314H410  STOT SE 3; H335: C ≥ 5 % 
607-065-00-X bromoacetic acid 201-175-8 79-08-3 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1AAquatic Acute 1 H331H311H301H314H400 GHS06GHS05GHS09Dgr H331H311H301H314H400   
607-066-00-5 dichloroacetic acid 201-207-0 79-43-6 Skin Corr. 1AAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400   
607-067-00-0 dichloroacetyl chloride 201-199-9 79-36-7 Skin Corr. 1AAquatic Acute 1 H314H400 GHS05GHS09Dgr H314H400   
607-068-00-6 iodoacetic acid 200-590-1 64-69-7 Acute Tox. 3 *Skin Corr. 1A H301H314 GHS06GHS05Dgr H301H314   
607-069-00-1 ethyl bromoacetate 203-290-9 105-36-2 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 * H330H310H300 GHS06Dgr H330H310H300   
607-070-00-7 ethyl chloroacetate 203-294-0 105-39-5 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1 H331H311H301H400 GHS06GHS09Dgr H331H311H301H400   
607-071-00-2 ethyl methacrylate 202-597-5 97-63-2 Flam. Liq. 2Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H225H319H335H315H317 GHS02GHS07Dgr H225H319H335H315H317   D
607-072-00-8 2-hydroxyethyl acrylate 212-454-9 818-61-1 Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1 H311H314H317H400 GHS06GHS05GHS09Dgr H311H314H317H400  *Skin Sens. 1; H317: C ≥ 0,2 % D
607-073-00-3 4-CPA (ISO);4-chlorophenoxyacetic acid 204-581-3 122-88-3 Acute Tox. 4 * H302 GHS07Wng H302   
607-074-00-9 chlorfenac(ISO);2,3,6-trichlorophenylacetic acid 201-599-3 85-34-7 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
607-075-00-4 chlorfenprop-methyl;methyl 2-chloro-3-(4-chlorophenyl)propionate 238-413-5 14437-17-3 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
607-076-00-X dodine(ISO);dodecylguanidinium acetate 219-459-5 2439-10-3 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H315H400H410 GHS07GHS09Wng H302H319H315H410   
607-077-00-5 erbon (ISO);2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate — 136-25-4 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
607-078-00-0 fluenetil (ISO);2-fluoroethyl biphenyl-4-ylacetate — 4301-50-2 Acute Tox. 1Acute Tox. 2 * H310H300 GHS06Dgr H310H300   
607-079-00-6 kelevan (ISO);ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate — 4234-79-1 Acute Tox. 3 *Acute Tox. 4 *Aquatic Chronic 2 H311H302H411 GHS06GHS09Dgr H311H302H411   
607-080-00-1 chloroacetyl chloride 201-171-6 79-04-9 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Skin Corr. 1AAquatic Acute 1 H331H311H301H372 **H314H400 GHS06GHS08GHS05GHS09Dgr H331H311H301H372 **H314H400 EUH014EUH029  
607-081-00-7 fluoroacetic acid 205-631-7 144-49-0 Acute Tox. 2 *Aquatic Acute 1 H300H400 GHS06GHS09Dgr H300H400   
607-082-00-2 fluoroacetates, soluble — — Acute Tox. 2 *Aquatic Acute 1 H300H400 GHS06GHS09Dgr H300H400   A
607-083-00-8 2,4-DB (ISO);4-(2,4-dichlorophenoxy)butyric acid 202-366-9 94-82-6 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
607-084-00-3 salts of 2,4-DB — — Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H302H318H411 GHS05GHS07GHS09Dgr H302H318H411   A
607-085-00-9 benzyl benzoate 204-402-9 120-51-4 Acute Tox. 4 * H302 GHS07Wng H302   
607-086-00-4 diallyl phthalate 205-016-3 131-17-9 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
607-088-00-5 methacrylic acid;2-methylpropenoic acid 201-204-4 79-41-4 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H312H302H314 GHS05GHS07Dgr H312H302H314  STOT SE 3; H335: C ≥ 1 % D
607-089-00-0 propionic acid ... % 201-176-3 79-09-4 Skin Corr. 1B H314 GHS05Dgr H314  Skin Corr. 1B; H314: C ≥ 25 %Skin Irrit. 2; H319: 10 % ≤ C < 25 %Eye Irrit. 2; H319: 10 % ≤ C < 25 %STOT SE 3; H335: C ≥ 10 % B
607-090-00-6 thioglycolic acid 200-677-4 68-11-1 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B H331H311H301H314 GHS06GHS05Dgr H331H311H301H314  * 
607-091-00-1 trifluoroacetic acid . . . % 200-929-3 76-05-1 Acute Tox. 4 * H332 GHS05 H332  * B
    Skin Corr. 1AAquatic Chronic 3 H314H412 GHS07Dgr H314H412   
607-092-00-7 methyl lactate; [1]methyl (±)-lactate; [2]methyl (R)-lactate; [3]methyl (S)-(-)-lactate [4] 208-930-0 [1]218-449-8 [2]241-420-6 [3]248-704-9 [4] 547-64-8 [1]2155-30-8 [2]17392-83-5 [3]27871-49-4 [4] Flam. Liq. 3Eye Irrit. 2STOT SE 3 H226H319H335 GHS02GHS07Wng H226H319H335   C
607-093-00-2 propionyl chloride 201-170-0 79-03-8 Flam. Liq. 2Skin Corr. 1B H225H314 GHS02GHS05Dgr H225H314 EUH014  B D
607-094-00-8 peracetic acid . . . % 201-186-8 79-21-0 Flam. Liq. 3Org. Perox. D ****Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1 H226H242H332H312H302H314H400 GHS02GHS05GHS07GHS09Dgr H226H242H332H312H302H314H400  *STOT SE 3; H335: C ≥ 1 % B D
607-095-00-3 maleic acid 203-742-5 110-16-7 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H302H319H335H315 GHS07Wng H302H319H335H315   
607-096-00-9 maleic anhydride 203-571-6 108-31-6 Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1 H302H314H334H317 GHS08GHS05GHS07Dgr H302H314H334H317   
607-097-00-4 benzene-1,2,4-tricarboxylic acid 1,2-anhydride;trimellitic anhydride 209-008-0 552-30-7 STOT SE 3Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H335H318H334H317 GHS08GHS05GHS07Dgr H335H318H334H317   
607-098-00-X benzene-1,2:4,5-tetracarboxylic dianhydride;benzene-1,2:4,5-tetracarboxylic dianhydride;pyromellitic dianhydride 201-898-9 89-32-7 Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H318H334H317 GHS08GHS05Dgr H318H334H317   
607-099-00-5 1,2,3,6-tetrahydrophthalic anhydride; [1]cis-1,2,3,6-tetrahydrophthalic anhydride; [2]3,4,5,6-tetrahydrophthalic anhydride; [3]tetrahydrophthalic anhydride [4] 201-605-4 [1]213-308-7 [2]219-374-3 [3]247-570-9 [4] 85-43-8 [1]935-79-5 [2]2426-02-0 [3]26266-63-7 [4] Eye Dam. 1Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3 H318H334H317H412 GHS08GHS05Dgr H318H334H317H412   C
607-100-00-9 benzophenone-3,3',4,4'-tetracarboxylic dianhydride;4,4'-carbonyldi(phthalic anhydride) 219-348-1 2421-28-5 Eye Irrit. 2STOT SE 3 H319H335 GHS07Wng H319H335  Eye Irrit. 2; H319: C ≥ 1 %STOT SE 3; H335: C ≥ 1 % 
607-101-00-4 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride 204-077-3 115-27-5 Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315  Skin Irrit. 2; H315: C ≥ 1 %Eye Irrit. 2; H319: C ≥ 1 %STOT SE 3; H335: C ≥ 1 % 
607-102-00-X cyclohexane-1,2-dicarboxylic anhydride; [1]cis-cyclohexane-1,2-dicarboxylic anhydride; [2]trans-cyclohexane-1,2-dicarboxylic anhydride [3] 201-604-9 [1]236-086-3 [2]238-009-9 [3] 85-42-7 [1]13149-00-3 [2]14166-21-3 [3] Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H318H334H317 GHS08GHS05Dgr H318H334H317   C
607-103-00-5 succinic anhydride 203-570-0 108-30-5 Eye Irrit. 2STOT SE 3 H319H335 GHS07Wng H319H335  Eye Irrit. 2; H319: C ≥ 1 %STOT SE 3; H335: C ≥ 1 % 
607-104-00-0 cyclopentane-1,2,3,4-tetracarboxylic dianhydride 227-964-7 6053-68-5 Eye Irrit. 2STOT SE 3 H319H335 GHS07Wng H319H335  Eye Irrit. 2; H319: C ≥ 1 %STOT SE 3; H335: C ≥ 1 % 
607-105-00-6 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2](1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] 204-957-7 [1]212-557-9 [2]220-384-5 [3] 129-64-6 [1]826-62-0 [2]2746-19-2 [3] Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H318H334H317 GHS08GHS05Dgr H318H334H317   C
607-106-00-1 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride — 123748-85-6 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H302H319H335H315H334 GHS08GHS07Dgr H302H319H335H315H334  STOT SE 3; H335: C ≥ 10 % C
607-107-00-7 2-ethylhexyl acrylate 203-080-7 103-11-7 STOT SE 3Skin Irrit. 2Skin Sens. 1 H335H315H317 GHS07Wng H335H315H317   D
607-108-00-2 2-hydroxy-1-methylethylacrylate; [1]2-hydroxypropylacrylate; [2]acrylic acid, monoester with propane-1,2-diol [3] 220-852-9 [1]213-663-8 [2]247-118-0 [3] 2918-23-2 [1]999-61-1 [2]25584-83-2 [3] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1 H331H311H301H314H317 GHS06GHS05Dgr H331H311H301H314H317  *Skin Sens. 1; H317: C ≥ 0,2 % C D
607-109-00-8 hexamethylene diacrylate;hexane-1,6-diol diacrylate 235-921-9 13048-33-4 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   D
607-110-00-3 pentaerythritol triacrylate 222-540-8 3524-68-3 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   D
607-111-00-9 2,2-bis(acryloyloxymethyl)butyl acrylate;trimethylolpropane triacrylate 239-701-3 15625-89-5 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   D
607-112-00-4 2,2-dimethyltrimethylene diacrylate;neopentyl glycol diacrylate 218-741-5 2223-82-7 Acute Tox. 3 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H311H319H315H317 GHS06Dgr H311H319H315H317  * D
607-113-00-X isobutyl methacrylate 202-613-0 97-86-9 Flam. Liq. 3Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1 H226H319H335H315H317H400 GHS02GHS07GHS09Wng H226H319H335H315H317H400   D
607-114-00-5 ethylene dimethacrylate 202-617-2 97-90-5 STOT SE 3Skin Sens. 1 H335H317 GHS07Wng H335H317  STOT SE 3; H335: C ≥ 10 % D
607-115-00-0 isobutyl acrylate 203-417-8 106-63-8 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1 H226H332H312H315H317 GHS02GHS07Wng H226H332H312H315H317   D
607-116-00-6 cyclohexyl acrylate 221-319-3 3066-71-5 STOT SE 3Skin Irrit. 2Aquatic Chronic 2 H335H315H411 GHS07GHS09Wng H335H315H411  STOT SE 3; H335: C ≥ 10 % D
607-117-00-1 2,3-epoxypropyl acrylate;glycidyl acrylate 203-440-3 106-90-1 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1 H331H311H301H314H317 GHS06GHS05Dgr H331H311H301H314H317  *Skin Sens. 1; H317: C ≥ 0,2 % D
607-118-00-7 1-methyltrimethylene diacrylate;1,3-butylene glycol diacrylate 243-105-9 19485-03-1 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1 H312H314H317 GHS05GHS07Dgr H312H314H317   D
607-119-00-2 tetramethylene diacrylate;1,4-butyleneglycol diacrylate 213-979-6 1070-70-8 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1 H312H314H317 GHS05GHS07Dgr H312H314H317   D
607-120-00-8 2,2'-oxydiethyl diacrylate;diethylene glycol diacrylate 223-791-6 4074-88-8 Acute Tox. 3 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H311H319H315H317 GHS06Dgr H311H319H315H317  *Skin Sens. 1; H317: C ≥ 0,2 % D
607-121-00-3 8,9,10-trinorborn-2-yl acrylate — 10027-06-2 Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1 H312H315H317 GHS07Wng H312H315H317   D
607-122-00-9 pentaerythritol tetraacrylate 225-644-1 4986-89-4 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   D
607-123-00-4 2,3-epoxypropyl methacrylate;glycidyl methacrylate 203-441-9 106-91-2 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H332H312H302H319H315H317 GHS07Wng H332H312H302H319H315H317   D
607-124-00-X 2-hydroxyethyl methacrylate 212-782-2 868-77-9 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   D
607-125-00-5 2-hydroxypropyl methacrylate; [1]3-hydroxypropyl methacrylate [2] 213-090-3 [1]220-426-2 [2] 923-26-2 [1]2761-09-3 [2] Eye Irrit. 2Skin Sens. 1 H319H317 GHS07Wng H319H317   C D
607-126-00-0 2,2'-(ethylenedioxy)diethyl diacrylate;triethylene glycol diacrylate 216-853-9 1680-21-3 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   D
607-127-00-6 2-diethylaminoethyl methacrylate 203-275-7 105-16-8 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H332H319H315H317 GHS07Wng H332H319H315H317   D
607-128-00-1 2-tert-butylaminoethyl methacrylate 223-228-4 3775-90-4 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   D
607-129-00-7 ethyl lactate;ethyl DL-lactate; [1]ethyl (S)-2-hydroxypropionate;ethyl L-lactate;ethyl-(S)-lactate [2] 202-598-0 [1]211-694-1 [2] 97-64-3 [1]687-47-8 [2] Flam. Liq. 3STOT SE 3Eye Dam. 1 H226H335H318 GHS02GHS05GHS07Dgr H226H335H318   C
607-130-00-2 pentyl acetate; [1]isopentyl acetate; [2]1-methylbutyl acetate; [3]2-methylbutyl acetat; [4]2(or 3)-methylbutyl acetate [5] 211-047-3 [1]204-662-3 [2]210-946-8 [3]210-843-8 [4]282-263-3 [5] 628-63-7 [1]123-92-2 [2]626-38-0 [3]624-41-9 [4]84145-37-9 [5] Flam. Liq. 3 H226 GHS02Wng H226 EUH066  C
607-131-00-8 isopentyl propionate; [1]pentyl propionate; [2]2-methylbutyl propionate [3] 203-322-1 [1]210-852-7 [2]219-449-0 [3] 105-68-0 [1]624-54-4 [2]2438-20-2 [3] Flam. Liq. 3 H226 GHS02Wng H226   C
607-132-00-3 2-dimethylaminoethyl methacrylate 220-688-8 2867-47-2 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H312H302H319H315H317 GHS07Wng H312H302H319H315H317   D
607-133-00-9 monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 2 H319H335H315H411 GHS07GHS09Wng H319H335H315H411  STOT SE 3; H335: C ≥ 10 % A
607-134-00-4 monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315  STOT SE 3; H335: C ≥ 10 % A
607-135-00-X butyric acid 203-532-3 107-92-6 Skin Corr. 1B H314 GHS05Dgr H314   
607-136-00-5 butyryl chloride 205-498-5 141-75-3 Flam. Liq. 2Skin Corr. 1B H225H314 GHS02GHS05Dgr H225H314   
607-137-00-0 methyl acetoacetate 203-299-8 105-45-3 Eye Irrit. 2 H319 GHS07Wng H319   
607-138-00-6 butyl chloroformate;chloroformic acid butyl ester 209-750-5 592-34-7 Flam. Liq. 3Acute Tox. 3 *Skin Corr. 1B H226H331H314 GHS02GHS06GHS05Dgr H226H331H314   
607-139-00-1 2-chloropropionic acid 209-952-3 598-78-7 Acute Tox. 4 *Skin Corr. 1A H302H314 GHS05GHS07Dgr H302H314   
607-140-00-7 isobutyryl chloride 201-194-1 79-30-1 Flam. Liq. 2Skin Corr. 1A H225H314 GHS02GHS05Dgr H225H314   
607-141-00-2 oxydiethylene bis(chloroformate) 203-430-9 106-75-2 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2 H302H315H318H411 GHS05GHS07GHS09Dgr H302H315H318H411   
607-142-00-8 propyl chloroformate;chloroformic acid propylester;n-propyl chloroformate 203-687-7 109-61-5 Flam. Liq. 2Acute Tox. 3 *Skin Corr. 1B H225H331H314 GHS02GHS06GHS05Dgr H225H331H314   
607-143-00-3 valeric acid 203-677-2 109-52-4 Skin Corr. 1BAquatic Chronic 3 H314H412 GHS05Dgr H314H412   
607-144-00-9 adipic acid 204-673-3 124-04-9 Eye Irrit. 2 H319 GHS07Wng H319   
607-145-00-4 methanesulphonic acid 200-898-6 75-75-2 Skin Corr. 1B H314 GHS05Dgr H314   
607-146-00-X fumaric acid 203-743-0 110-17-8 Eye Irrit. 2 H319 GHS07Wng H319   
607-147-00-5 oxalic acid diethylester;diethyl oxalate 202-464-1 95-92-1 Acute Tox. 4 *Eye Irrit. 2 H302H319 GHS07Wng H302H319   
607-148-00-0 guanidinium chloride;guanadine hydrochloride 200-002-3 50-01-1 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2 H302H319H315 GHS07Wng H302H319H315   
607-149-00-6 urethane (INN);ethyl carbamate 200-123-1 51-79-6 Carc. 1B H350 GHS08Dgr H350   
607-150-00-1 endothal (ISO);7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid 205-660-5 145-73-3 Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H301H312H319H335H315 GHS06Dgr H301H312H319H335H315   
607-151-00-7 propargite (ISO);2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite 219-006-1 2312-35-8 Carc. 2Acute Tox. 3 *Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H351H331H315H318H400H410 GHS06GHS08GHS05GHS09Dgr H351H331H315H318H410  M = 10 
607-152-00-2 2,3,6-TBA (ISO);2,3,6-trichlorobenzoic acid 200-026-4 50-31-7 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
607-153-00-8 benazolin (ISO);4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid 223-297-0 3813-05-6 Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 3 H319H315H412 GHS07Wng H319H315H412   
607-154-00-3 ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;benzoylprop-ethyl (ISO) 244-845-5 22212-55-1 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
607-155-00-9 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;blasticidin-s — 2079-00-7 Acute Tox. 2 * H300 GHS06Dgr H300   
607-156-00-4 chlorfenson (ISO);4-chlorophenyl 4-chlorobenzenesulfonate 201-270-4 80-33-1 Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H315H400H410 GHS07GHS09Wng H302H315H410   
607-157-00-X 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;difenacoum 259-978-4 56073-07-5 Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H300H372 **H400H410 GHS06GHS08GHS09Dgr H300H372 **H410   
607-158-00-5 sodium salt of chloroacetic acid;sodium chloroacetate 223-498-3 3926-62-3 Acute Tox. 3 *Skin Irrit. 2Aquatic Acute 1 H301H315H400 GHS06GHS09Dgr H301H315H400   
607-159-00-0 chlorobenzilate (ISO);ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;ethyl 4,4'-dichlorobenzilate 208-110-2 510-15-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
607-160-00-6 isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;clofop-isobutyl (ISO) — 51337-71-4 Acute Tox. 4 * H302 GHS07Wng H302   
607-161-00-1 diethanolamine salt of 4-CPA — — Acute Tox. 4 * H302 GHS07Wng H302   
607-162-00-7 2,2-dichloropropionic acid;dalapon 200-923-0 75-99-0 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3 H302H315H318H412 GHS05GHS07Dgr H302H315H318H412   
607-163-00-2 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;dehydracetic acid 208-293-9 520-45-6 Acute Tox. 4 * H302 GHS07Wng H302   
607-164-00-8 sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;sodium dehydracetate 224-580-1 4418-26-2 Acute Tox. 4 * H302 GHS07Wng H302   
607-165-00-3 diclofop-methyl (ISO)methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; 257-141-8 51338-27-3 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
607-166-00-9 medinoterb acetate (ISO);6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate 219-634-6 2487-01-6 Acute Tox. 3 *Acute Tox. 4 * H301H312 GHS06Dgr H301H312   
607-167-00-4 sodium 3-chloroacrylate — 4312-97-4 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
607-168-00-X dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;propylisome — 83-59-0 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H311H302H400H410 GHS06GHS09Dgr H311H302H410   
607-169-00-5 sodium fluoroacetate 200-548-2 62-74-8 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1 H330H310H300H400 GHS06GHS09Dgr H330H310H300H400   
607-170-00-0 bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;thiocyclam-oxalate 250-859-2 31895-22-4 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
607-172-00-1 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;brodifacoum 259-980-5 56073-10-0 Acute Tox. 1Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H310H300H372 **H400H410 GHS06GHS08GHS09Dgr H310H300H372 **H410   
607-173-00-7 dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate 400-460-6 — Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
607-174-00-2 reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate 400-580-9 — Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
607-175-00-8 methyl 2-(2-nitrobenzylidene)acetoacetate 400-650-9 39562-27-1 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-176-00-3 reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) 400-830-7 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-177-00-9 methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulphonyl)benzoate 401-190-1 101200-48-0 Skin Sens. 1 H317 GHS07Wng H317   
607-178-00-4 methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate 401-340-6 83055-99-6 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-179-00-X (benzothiazol-2-ylthio)succinic acid 401-450-4 95154-01-1 Skin Sens. 1 H317 GHS07Wng H317   
607-180-00-5 potassium 2-hydroxycarbazole-1-carboxylate 401-630-2 96566-70-0 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Aquatic Chronic 3 H302H319H335H412 GHS07Wng H302H319H335H412   
607-181-00-0 3,5-dichloro-2,4-difluorobenzoyl fluoride 401-800-6 101513-70-6 Acute Tox. 3 *Skin Corr. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Chronic 3 H331H314H302H317H412 GHS06GHS05Dgr H331H314H302H317H412 EUH029  
607-182-00-6 methyl 3-sulphamoyl-2-thenoate 402-050-2 — Skin Sens. 1 H317 GHS07Wng H317   
607-183-00-1 zinc 2-hydroxy-5-C13-18alkylbenzoate 402-280-3 — Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H319H315H411 GHS07GHS09Wng H319H315H411   
607-184-00-7 S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate 402-290-8 85702-90-5 Flam. Liq. 3Resp. Sens. 1Skin Sens. 1 H226H334H317 GHS02GHS08Dgr H226H334H317   
607-185-00-2 ethyl trans-3-dimethylaminoacrylate 402-650-4 1117-37-9 Skin Sens. 1 H317 GHS07Wng H317   
607-186-00-8 quinclorac (ISO);3,7-dichloroquinoline-8-carboxylic acid 402-780-1 84087-01-4 Skin Sens. 1 H317 GHS07Wng H317   
607-187-00-3 bis(2,2,6,6-tetramethyl-4-piperidyl) succinate 402-940-0 62782-03-0 Eye Irrit. 2Aquatic Chronic 3 H319H412 GHS07Wng H319H412   
607-188-00-9 hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate 402-970-4 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-189-00-4 trimethylenediaminetetraacetic acid 400-400-9 1939-36-2 Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H302H318H400H410 GHS05GHS07GHS09Dgr H302H318H410   
607-190-00-X methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) 401-890-7 77402-03-0 Carc. 1BMuta. 1BAcute Tox. 4 *Eye Irrit. 2 H350H340H302H319 GHS08GHS07Dgr H350H340H302H319   
607-191-00-5 isobutyl 3,4-epoxybutyrate 401-920-9 100181-71-3 Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H317H400H410 GHS07GHS09Wng H315H317H410   
607-192-00-0 disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate 402-360-8 92511-22-3 Eye Dam. 1 H318 GHS05Dgr H318   
607-194-00-1 propylene carbonate 203-572-1 108-32-7 Eye Irrit. 2 H319 GHS07Wng H319   
607-195-00-7 2-methoxy-1-methylethyl acetate 203-603-9 108-65-6 Flam. Liq. 3Eye Irrit. 2 H226H319 GHS02GHS07Wng H226H319   
607-196-00-2 heptanoic acid 203-838-7 111-14-8 Skin Corr. 1B H314 GHS05Dgr H314   
607-197-00-8 nonanoic acid 203-931-2 112-05-0 Skin Corr. 1B H314 GHS05Dgr H314   
607-198-00-3 propyl 3,4,5-trihydroxybenzoate 204-498-2 121-79-9 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317   
607-199-00-9 octyl 3,4,5-trihydroxybenzoate 213-853-0 1034-01-1 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317   
607-200-00-2 dodecyl 3,4,5-trihydroxybenzoate 214-620-6 1166-52-5 Skin Sens. 1 H317 GHS07Wng H317   
607-201-00-8 thiocarbonyl chloride 207-341-6 463-71-8 Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H331H302H319H335H315 GHS06Dgr H331H302H319H335H315   
607-203-00-9 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate 279-452-8 80387-97-9 Repr. 1BSkin Sens. 1Aquatic Chronic 3 H360D ***H317H412 GHS08GHS07Dgr H360D ***H317H412   
607-204-00-4 (chlorophenyl)(chlorotolyl)methane, mixed isomers 400-140-6 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-205-00-X methyl chloroacetate 202-501-1 96-34-4 Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Dam. 1 H226H331H301H335H315H318 GHS02GHS06GHS05Dgr H226H331H301H335H315H318   
607-206-00-5 isopropyl chloroacetate 203-301-7 105-48-6 Flam. Liq. 3Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H226H301H319H335H315 GHS02GHS06Dgr H226H301H319H335H315   
607-207-00-0 haloxyfop-etotyl (ISO);2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;haloxyfop-(2-ethoxyethyl) 402-560-5 87237-48-7 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
607-208-00-6 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers 403-000-2 91853-67-7 Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H315H400H410 GHS07GHS09Wng H315H410   
607-209-00-1 reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate 403-030-6 — Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
607-210-00-7 methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) 403-230-3 77402-05-2 Carc. 1BMuta. 1BSkin Corr. 1BSkin Sens. 1 H350H340H314H317 GHS08GHS05GHS07Dgr H350H340H314H317   
607-211-00-2 methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate 403-270-1 6386-39-6 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
607-212-00-8 poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate 403-300-3 — Skin Sens. 1 H317 GHS07Wng H317   
607-213-00-3 ethyl 3,3-bis(tert-pentylperoxy)butyrate 403-320-2 67567-23-1 Org. Perox. D ****Flam. Liq. 3Aquatic Chronic 2 H242H226H411 GHS02GHS09Dgr H242H226H411   
607-214-00-9 N,N-hydrazinodiacetic acid 403-510-5 19247-05-3 Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 3 H301H373 **H317H412 GHS06GHS08Dgr H301H373 **H317H412   
607-215-00-4 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid 403-920-4 107551-67-7 Acute Tox. 4 *Eye Irrit. 2 H302H319 GHS07Wng H302H319   
607-216-00-X glutamic acid, reaction products with N-(C12-14alkyl)propylenediamine 403-950-8 — Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H330H302H314H400H410 GHS06GHS05GHS09Dgr H330H302H314H410   
607-217-00-5 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate 403-960-2 — Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
607-218-00-0 dichlorprop-P (ISO);(+)-R-2-(2,4-dichlorophenoxy)propionic acid 403-980-1 15165-67-0 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H302H315H318H317 GHS05GHS07Dgr H302H315H318H317   
607-219-00-6 bis(2-ethylhexyl) dithiodiacetate 404-510-8 62268-47-7 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H302H317H411 GHS07GHS09Wng H302H317H411   
607-221-00-7 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid 404-550-6 — Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
607-222-00-2 6-(2,3-dimethylmaleimido)hexyl methacrylate 404-870-6 63740-41-0 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-223-00-8 transfluthrin (ISO);2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate 405-060-5 118712-89-3 Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H315H400H410 GHS07GHS09Wng H315H410   
607-224-00-3 methyl 2-(3-nitrobenzylidene)acetoacetate 405-270-7 39562-17-9 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
607-225-00-9 3-azidosulfonylbenzoic acid 405-310-3 15980-11-7 Self-React. C ****STOT RE 2 *Eye Dam. 1Skin Sens. 1 H241H373 **H318H317 GHS02GHS08GHS05GHS07Dgr H241H373 **H318H317   
607-226-00-4 reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate 405-360-6 — Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H315H318H317H412 GHS05GHS07Dgr H315H318H317H412   
607-227-00-X potassium 2-amino-2-methylpropionate octahydrate 405-560-3 120447-91-8 Acute Tox. 4 *Skin Corr. 1A H302H314 GHS05GHS07Dgr H302H314   
607-228-00-5 bis(2-methoxyethyl) phthalate 204-212-6 117-82-8 Repr. 1B H360Df GHS08Dgr H360Df   
607-229-00-0 diethylcarbamoyl chloride 201-798-5 88-10-8 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H351H332H302H319H335H315 GHS08GHS07Wng H351H332H302H319H335H315   
607-230-00-6 2-ethylhexanoic acid 205-743-6 149-57-5 Repr. 2 H361d *** GHS08Wng H361d ***   
607-231-00-1 3,6-dichloropyridine-2-carboxylic acid;clopyralid 216-935-4 1702-17-6 Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
607-232-00-7 pyridate (ISO);O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate 259-686-7 55512-33-9 Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H317H400H410 GHS07GHS09Wng H315H317H410   
607-233-00-2 hexyl acrylate 219-698-5 2499-95-8 Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H319H335H315H317H411 GHS07GHS09Wng H319H335H315H317H411   
607-234-00-8 flurenol (ISO);9-hydroxy-9H-fluorene-9-carboxylic acid 207-397-1 467-69-6 Aquatic Chronic 2 H411 GHS09 H411   
607-235-00-3 mecrilate;methyl 2-cyanoacrylate 205-275-2 137-05-3 Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315  STOT SE 3; H335: C ≥ 10 % 
607-236-00-9 ethyl 2-cyanoacrylate 230-391-5 7085-85-0 Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315  STOT SE 3; H335: C ≥ 10 % 
607-237-00-4 benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;flurazole 276-942-3 72850-64-7 Aquatic Chronic 2 H411 GHS09 H411   
607-238-00-X tau-fluvalinate (ISO);cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate — 102851-06-9 Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H315H400H410 GHS07GHS09Wng H302H315H410   
607-239-00-5 fenpropathrin (ISO);α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate 254-485-0 39515-41-8 Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H330H301H312H400H410 GHS06GHS09Dgr H330H301H312H410   
607-240-00-0 cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]tetrahydromethylphthalic anhydride; [4]1,2,3,6-tetrahydromethylphthalic anhydride; [5]tetrahydro-4-methylphthalic anhydride; [6]2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] 216-906-6 [1]222-323-8 [2]226-247-6 [3]234-290-7 [4]247-830-1 [5]251-823-9 [6]255-853-3 [7] 1694-82-2 [1]3425-89-6 [2]5333-84-6 [3]11070-44-3 [4]26590-20-5 [5]34090-76-1 [6]42498-58-8 [7] Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H318H334H317 GHS08GHS05Dgr H318H334H317   C
607-241-00-6 hexahydro-4-methylphthalic anhydride; [1]hexahydromethylphthalic anhydride; [2]hexahydro-1-methylphthalic anhydride; [3]hexahydro-3-methylphthalic anhydride [4] 243-072-0 [1]247-094-1 [2]256-356-4 [3]260-566-1 [4] 19438-60-9 [1]25550-51-0 [2]48122-14-1 [3]57110-29-9 [4] Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H318H334H317 GHS08GHS05Dgr H318H334H317   C
607-242-00-1 tetrachlorophthalic anhydride 204-171-4 117-08-8 Eye Dam. 1Resp. Sens. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H318H334H317H400H410 GHS08GHS05GHS09Dgr H318H334H317H410   
607-243-00-7 sodium 3,6-dichloro-o-anisate; [1]3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] 217-846-3 [1]246-590-5 [2]258-527-9 [3] 1982-69-0 [1]25059-78-3 [2]53404-28-7 [3] Aquatic Chronic 3 H412 — H412   
607-244-00-2 isooctyl acrylate 249-707-8 29590-42-9 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H335H315H400H410 GHS07GHS09Wng H319H335H315H410  STOT SE 3; H335: C ≥ 10 % 
607-245-00-8 tert-butyl acrylate 216-768-7 1663-39-4 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3 H225H332H312H302H335H315H317H412 GHS02GHS07Dgr H225H332H312H302H335H315H317H412   D
607-246-00-3 allyl methacrylate;2-methyl-2-propenoic acid 2-propenyl ester 202-473-0 96-05-9 Flam. Liq. 3Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1 H226H331H312H302H400 GHS02GHS06GHS09Dgr H226H331H312H302H400   
607-247-00-9 dodecyl methacrylate 205-570-6 142-90-5 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H335H315H400H410 GHS07GHS09Wng H319H335H315H410  STOT SE 3; H335: C ≥ 10 % 
607-248-00-4 naptalam-sodium (ISO);sodium N-naphth-1-ylphthalamate 205-073-4 132-67-2 Acute Tox. 4 * H302 GHS07Wng H302   
607-249-00-X (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate 256-032-2 42978-66-5 Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H319H335H315H317H411 GHS07GHS09Wng H319H335H315H317H411  STOT SE 3; H335: C ≥ 10 % 
607-250-00-5 4H-3,1-benzoxazine-2,4(1H)-dione 204-255-0 118-48-9 Eye Irrit. 2Skin Sens. 1 H319H317 GHS07Wng H319H317   
607-251-00-0 2-methoxypropyl acetate 274-724-2 70657-70-4 Flam. Liq. 3Repr. 1BSTOT SE 3 H226H360D ***H335 GHS02GHS08GHS07Dgr H226H360D ***H335   
607-252-00-6 lambda-cyhalothrin (ISO);reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) 415-130-7 91465-08-6 Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H330H301H312H400H410 GHS06GHS09Dgr H330H301H312H410   
607-253-00-1 α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;cyfluthrin 269-855-7 68359-37-5 Acute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H300H331H400H410 GHS06GHS09Dgr H300H331H410   
607-254-00-7 α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;beta-cyfluthrin 269-855-7 68359-37-5 Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H300H400H410 GHS06GHS09Dgr H330H300H410   
607-255-00-2 fluroxypyr (ISO);4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid — 69377-81-7 Aquatic Chronic 3 H412 — H412   
607-256-00-8 azoxystrobin (ISO);methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate — 131860-33-8 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H400H410 GHS06GHS09Dgr H331H410   
607-257-00-3 isopropyl propionate 211-300-8 637-78-5 Flam. Liq. 2 H225 GHS02Dgr H225   
607-258-00-9 dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate 403-990-6 70950-45-7 Aquatic Chronic 4 H413 — H413   
607-259-00-4 methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate 404-130-2 105560-93-8 Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   
607-260-00-X ethyl 2-(3-nitrobenzylidene)acetoacetate 404-490-0 39562-16-8 Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   
607-261-00-5 iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate 404-800-4 118832-72-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-262-00-0 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 405-050-0 86393-33-1 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
607-263-00-6 potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate 405-680-6 — Self-heat. 2 ****Aquatic Chronic 2 H252H411 GHS02GHS09Wng H252H411   
607-264-00-1 2-chloro-4-(methylsulfonyl)benzoic acid 406-520-8 53250-83-2 Eye Dam. 1 H318 GHS05Dgr H318   
607-265-00-7 ethyl-2-chloro-2,2-diphenylacetate 406-580-5 52460-86-3 Skin Irrit. 2Aquatic Chronic 3 H315H412 GHS07Wng H315H412   
607-266-00-2 reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];3,5-di-tert-butyl-salicylic acid 406-890-0 130296-87-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
607-267-00-8 tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate 407-620-4 33610-13-8 Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3 H334H317H412 GHS08Dgr H334H317H412   
607-268-00-3 2-methylpropyl (R)-2-hydroxypropanoate 407-770-0 61597-96-4 Eye Irrit. 2 H319 GHS07Wng H319   
607-269-00-9 (R)-2-(4-hydroxyphenoxy)propanoic acid 407-960-3 94050-90-5 Eye Dam. 1 H318 GHS05Dgr H318   
607-270-00-4 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane 410-730-5 90498-90-1 Acute Tox. 4 * H312 GHS07Wng H312   
607-271-00-X 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane 417-420-9 156324-82-2 Eye Irrit. 2Aquatic Chronic 2 H319H411 GHS07GHS09Wng H319H411   
607-272-00-5 fluroxypyr-meptyl (ISO);methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]fluroxypyr-butometyl (ISO);2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] 279-752-9 [1]- [2] 81406-37-3 [1]154486-27-8 [2] Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-273-00-0 ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate 404-520-2 — Aquatic Chronic 3 H412 — H412   
607-274-00-6 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate 405-350-1 54527-73-0 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-275-00-1 sodium benzoyloxybenzene-4-sulfonate 405-450-5 66531-87-1 Skin Sens. 1 H317 GHS07Wng H317   
607-276-00-7 bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex 405-635-0 — Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H400H410 GHS05GHS09Dgr H315H318H410   
607-277-00-2 reaction mass of: 2-(hexylthio)ethylamine hydrochloride;sodium propionate 405-720-2 — Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H318H317H411 GHS05GHS07GHS09Dgr H302H318H317H411   
607-278-00-8 reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;sodium naphthylethylbenzenesulfonate 405-760-0 — Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   
607-279-00-3 reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate 405-960-8 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-280-00-9 sodium 4-chloro-1-hydroxybutane-1-sulfonate 406-190-5 54322-20-2 Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1 H302H319H317 GHS07Wng H302H319H317   
607-281-00-4 reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates 407-000-3 127519-17-9 Aquatic Chronic 2 H411 GHS09 H411   
607-282-00-X 2-acetoxymethyl-4-benzyloxybut-1-yl acetate 407-140-5 131266-10-9 Aquatic Chronic 3 H412 — H412   
607-283-00-5 E-ethyl-4-oxo-4-phenylcrotonate 408-040-4 15121-89-8 Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H312H302H315H318H317H400H410 GHS05GHS07GHS09Dgr H312H302H315H318H317H410   
607-284-00-0 reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) 410-040-4 136213-76-8 Aquatic Chronic 2 H411 GHS09 H411   
607-285-00-6 reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate 410-065-0 — Skin Sens. 1 H317 GHS07Wng    
607-286-00-1 reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate 410-070-8 141880-36-6 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
607-287-00-7 O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate 410-140-8 — Aquatic Chronic 3 H412 — H412   
607-288-00-2 tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively 410-160-7 148732-74-5 Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3 H319H317H412 GHS07Wng H319H317H412   
607-289-00-8 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid 410-370-9 105488-33-3 Aquatic Chronic 4 H413 — H413   
607-290-00-3 reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate 410-540-2 — Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H317H400H410 GHS07GHS09Wng H315H317H410   
607-291-00-9 dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate 410-630-1 104051-92-5 Aquatic Chronic 4 H413 — H413   
607-292-00-4 reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid 410-640-6 — Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H400H410 GHS05GHS09Dgr H315H318H410   
607-293-00-X reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate 410-650-0 — Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
607-294-00-5 sodium 2-benzoyloxy-1-hydroxyethane-sulfonate 410-680-4 — Skin Sens. 1 H317 GHS07Wng H317   
607-295-00-0 reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;hexasodium phosphonobutane-1,2,3,4-tetracarboxylate 410-800-5 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-296-00-6 reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid 410-830-9 — Aquatic Chronic 4 H413 — H413   
607-297-00-1 (E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) 410-960-6 92761-26-7 Eye Dam. 1 H318 GHS05Dgr H318   
607-298-00-7 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate 411-010-3 — Skin Sens. 1 H317 GHS07Wng H317   
607-299-00-2 methyl 3-(acetylthio)-2-methyl-propanoate 411-040-7 97101-46-7 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
607-300-00-6 trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25 411-430-7 — Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
607-301-00-1 reaction mass of: dodecanoic acid;poly(1-7)lactate esters of dodecanoic acid 411-860-5 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-302-00-7 reaction mass of: tetradecanoic acid;poly(1-7)lactate esters of tetradecanoic acid 411-910-6 — Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H315H318H317H411 GHS05GHS07GHS09Dgr H315H318H317H411   
607-303-00-2 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 413-760-7 93107-30-3 Repr. 2Aquatic Chronic 3 H361f ***H412 GHS08Wng H361f ***H412   
607-304-00-8 fluazifop-butyl (ISO);butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate 274-125-6 69806-50-4 Repr. 1BAquatic Acute 1Aquatic Chronic 1 H360D ***H400H410 GHS08GHS09Dgr H360D ***H410   
607-305-00-3 fluazifop-P-butyl (ISO);butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate — 79241-46-6 Repr. 2Aquatic Acute 1Aquatic Chronic 1 H361d ***H400H410 GHS08GHS09Wng H361d ***H410   
607-306-00-9 chlozolinate (ISO);ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate 282-714-4 84332-86-5 Carc. 2Aquatic Chronic 2 H351H411 GHS08GHS09Wng H351H411   
607-307-00-4 vinclozolin (ISO);N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione 256-599-6 50471-44-8 Carc. 2Repr. 1BSkin Sens. 1Aquatic Chronic 2 H351H360FDH317H411 GHS08GHS07GHS09Dgr H351H360FDH317H411   
607-308-00-X esters of 2,4-D — — Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   A
607-309-00-5 carfentrazone-ethyl (ISO);ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate — 128639-02-1 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-310-00-0 kresoxim-methyl (ISO);methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate — 143390-89-0 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410   
607-311-00-6 benazolin-ethyl;ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate 246-591-0 25059-80-7 Aquatic Chronic 2 H411 GHS09 H411   
607-312-00-1 methoxyacetic acid 210-894-6 625-45-6 Repr. 1BAcute Tox. 4 *Skin Corr. 1B H360FDH302H314 GHS08GHS05GHS07Dgr H360FDH302H314  STOT SE 3; H335: C ≥ 5 % 
607-313-00-7 neodecanoyl chloride 254-875-0 40292-82-8 Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1B H330H302H314 GHS06GHS06Dgr H330H302H314  STOT SE 3; H335: C ≥ 5 % 
607-314-00-2 ethofumesate (ISO);(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate 247-525-3 26225-79-6 Aquatic Chronic 2 H411 GHS09 H411   
607-315-00-8 glyphosate (ISO);N-(phosphonomethyl)glycine 213-997-4 1071-83-6 Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
607-316-00-3 glyphosate-trimesium;glyphosate-trimethylsulfonium — 81591-81-3 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07 GHS09Wng H302H411   
607-317-00-9 bis(2-ethylhexyl) phthalate;di-(2-ethylhexyl) phthalate;DEHP 204-211-0 117-81-7 Repr. 1B H360FD GHS08Dgr H360FD   
607-318-00-4 dibutyl phthalate;DBP 201-557-4 84-74-2 Repr. 1BAquatic Acute 1 H360DfH400 GHS08GHS09Dgr H360DfH400   
607-319-00-X deltamethrin (ISO);(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate 258-256-6 52918-63-5 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H301H400H410 GHS06GHS09Dgr H331H301H410   
607-320-00-5 bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate 413-930-0 130066-57-8 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
607-321-00-0 (S)-methyl-2-chloropropionate 412-470-8 73246-45-4 Flam. Liq. 3STOT RE 2 *Eye Irrit. 2 H226H373 **H319 GHS02GHS08Wng H226H373 **H319   
607-322-00-6 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid 413-120-7 107144-30-9 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
607-323-00-1 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate 413-850-6 123968-25-2 Aquatic Chronic 4 H413 — H413   
607-324-00-7 reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;dihydrogenated alkyl (C14-C18)amine 413-800-3 — Aquatic Chronic 4 H413 — H413   
607-325-00-2 (S)-2-chloropropionic acid 411-150-5 29617-66-1 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H312H302H314 GHS05GHS07Dgr H312H302H314   
607-326-00-8 reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate 410-720-0 141847-13-4 Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
607-327-00-3 2-(2-iodoethyl)-1,3-propanediol diacetate 411-780-0 127047-77-2 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
607-328-00-9 methyl 4-bromomethyl-3-methoxybenzoate 410-310-1 70264-94-7 Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H317H400H410 GHS05GHS07GHS09Dgr H315H318H317H410   
607-329-00-4 reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;sodium 2-octadecenyl-amino-1,4-butandioate 411-250-9 — Skin Sens. 1 H317 GHS07Wng H317   
607-330-00-X (S)-2,3-dihydro-1H-indole-2-carboxylic acid 410-860-2 79815-20-6 Repr. 2STOT RE 2 *Skin Sens. 1 H361f ***H373 **H317 GHS08GHS07Wng H361f ***H373 **H317   
607-331-00-5 reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane 406-750-9 — Aquatic Chronic 4 H413 — H413   
607-332-00-0 cyclopentyl chloroformate 411-460-0 50715-28-1 Flam. Liq. 3Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1 H226H331H302H373 **H318H317 GHS02GHS06GHS08GHS05Dgr H226H331H302H373 **H318H317   
607-333-00-6 reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate 405-670-1 — Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H302H373 **H314H400H410 GHS08GHS05GHS07GHS09Dgr H302H373 **H314H410   
607-334-00-1 ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate 405-880-3 100501-62-0 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
607-335-00-7 methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate 406-250-0 72619-32-0 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
607-336-00-2 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate 406-560-6 122760-85-4 Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H315H317H411 GHS07GHS09Wng H315H317H411   
607-337-00-8 di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate 406-052-4 125078-60-6 Flam. Liq. 3Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2 H226H302H315H318H411 GHS02GHS05GHS07GHS09Dgr H226H302H315H318H411   
607-338-00-3 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate 406-235-9 72531-53-4 Eye Irrit. 2Skin Irrit. 2 H319H315 GHS07Wng H319H315   
607-339-00-9 2,3,4,5-tetrachlorobenzoylchloride 406-760-3 42221-52-3 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1 H302H314H317 GHS05GHS07Dgr H302H314H317   
607-340-00-4 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate 406-990-4 — Aquatic Chronic 2 H411 GHS09 H411   
607-341-00-X (9S)-9-amino-9-deoxyerythromycin 406-790-7 26116-56-3 Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
607-342-00-5 4-chlorobutyl veratrate 410-950-1 69788-75-6 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-343-00-0 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) 407-410-2 — Aquatic Chronic 4 H413 — H413   
607-344-00-6 reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate 407-810-7 — STOT RE 2 * H373 ** GHS08Wng H373 **   
607-345-00-1 potassium 2-(2,4-dichlorophenoxy)-(R)-propionate 413-580-9 113963-87-4 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H302H315H318H317 GHS05GHS07Dgr H302H315H318H317   
607-346-00-7 3-icosyl-4-henicosylidene-2-oxetanone 401-210-9 83708-14-9 Aquatic Chronic 4 H413 — H413   
607-347-00-2 sodium (R)-2-(2,4-dichlorophenoxy)propionate 413-340-3 119299-10-4 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H302H315H318H317 GHS05GHS07Dgr H302H315H318H317   
607-348-00-8 magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) 413-360-2 — Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H302H315H318H317 GHS05GHS07Dgr H302H315H318H317   
607-349-00-3 mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate 411-270-8 — Aquatic Chronic 3 H412  H412   
607-350-00-9 bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane 412-060-9 136210-32-7 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
607-351-00-4 methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate 407-550-4 69184-17-4 Aquatic Chronic 2 H411 GHS09 H411   
607-352-00-X 4,4'-oxydiphthalic anhydride 412-830-4 1823-59-2 Aquatic Chronic 3 H412 — H412   
607-353-00-5 reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate 407-520-0 80657-64-3 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
607-354-00-0 ethyl 2-cyclohexylpropionate 412-280-5 2511-00-4 Aquatic Chronic 2 H411 GHS09 H411   
607-355-00-6 p-tolyl 4-chlorobenzoate 411-530-0 15024-10-9 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
607-356-00-1 ethyl trans-2,2,6-trimethylcyclohexanecarboxylate 412-540-8 — Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
607-357-00-7 reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran 412-450-9 131766-73-9 Skin Sens. 1 H317 GHS07Wng H317   
607-358-00-2 (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate 412-670-5 54275-93-3 Resp. Sens. 1 H334 GHS08Dgr H334   
607-359-00-8 (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate 412-800-0 76109-32-5 Resp. Sens. 1 H334 GHS08Dgr H334   
607-360-00-3 sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate 411-680-7 133167-77-8 Skin Sens. 1 H317 GHS07Wng H317   
607-361-00-9 methyl (R)-2-(4-hydroxyphenoxy)propionate 411-950-4 96562-58-2 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
607-362-00-4 reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate 413-500-2 — Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2 H315H318H411 GHS05GHS09Dgr H315H318H411   
607-363-00-X methyl-3-methoxyacrylate 412-900-4 5788-17-0 Skin Sens. 1 H317 GHS07Wng H317   
607-364-00-5 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione 413-330-9 134724-55-3 Aquatic Chronic 4 H413  H413   
607-365-00-0 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride 410-620-7 119154-86-8 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1 H302H314H317 GHS05GHS07Dgr H302H314H317   
607-366-00-6 3,5-dimethylbenzoyl chloride 413-010-9 6613-44-1 Skin Corr. 1BSkin Sens. 1 H314H317 GHS05GHS07Dgr H314H317   
607-367-00-1 potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate 411-640-9 153352-59-1 Acute Tox. 4 * H302 GHS07Wng H302   
607-368-00-7 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole 411-650-3 110895-43-7 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H301H400H410 GHS06GHS09Dgr H331H301H410   
607-369-00-2 reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid 411-660-8 147027-04-1 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H302H315H318H317 GHS05GHS07Dgr H302H315H318H317   
607-370-00-8 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol 412-210-3 41620-33-1 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-371-00-3 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate 413-410-3 88150-62-3 Aquatic Chronic 4 H413 — H413   
607-372-00-9 ethoxylated bis phenol A di-(norbornene carboxylate) 412-410-0 — Aquatic Chronic 3 H412 — H412   
607-373-00-4 (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate 414-200-4 119738-06-6 Muta. 2Repr. 1BAcute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H341H360DfH302H373 **H400H410 GHS08GHS07GHS09Dgr H341H360DfH302H373 **H410   
607-374-00-X 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride 417-220-1 37441-29-5 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-375-00-5 reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin 421-960-0 90035-08-8 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 1Aquatic Acute 1Aquatic Chronic 1 H330H310H300H372 **H400H410 GHS06GHS08GHS09Dgr H330H310H300H372 **H410   
607-376-00-0 benzyl 2,4-dibromobutanoate 420-710-8 23085-60-1 Repr. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361f ***H315H317H400H410 GHS08GHS07GHS09Wng H361f ***H315H317H410   
607-377-00-6 trans-4-cyclohexyl-L-proline monohydrochloride 419-160-1 90657-55-9 Repr. 2Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H361f ***H302H315H318H317 GHS08GHS05GHS07Dgr H361f ***H302H315H318H317   
607-378-00-1 ammonium (Z)-α-methoxyimino-2-furylacetate 405-990-1 97148-39-5 Flam. Sol. 2 H228 GHS02Dgr H228   T
607-379-00-7 reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;sodium [bis(2-hydroxyethyl)amino]methylsulfonate;N,N-bis(2-hydroxyethyl)stearamide 401-230-8  Aquatic Chronic 3 H412 — H412   
607-380-00-2 reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate 407-320-3 — Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3 H315H318H412 GHS05Dgr H315H318H412   
607-381-00-8 reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid 413-710-4 — Aquatic Chronic 4 H413 — H413   
607-382-00-3 2-((4-amino-2-nitrophenyl)amino)benzoic acid 411-260-3 117907-43-4 Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   
607-383-00-9 reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate 415-430-8 86403-32-9 Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H318H317H400H410 GHS05GHS07GHS09Dgr H318H317H410   
607-384-00-4 reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate 413-750-2 171090-93-0 Aquatic Chronic 4 H413 — H413   
607-385-00-X Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate 414-590-6 125229-74-5 Aquatic Chronic 2 H411 GHS09 H411   
607-386-00-5 reaction mass of: tetradecanoic acid (42,5-47,5 %);poly(1-7)lactate esters of tetradecanoic acid (52,5-57,5 %) 412-580-6 174591-51-6 Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H317H400H410 GHS05GHS07GHS09Dgr H315H318H317H410   
607-387-00-0 reaction mass of: dodecanoic acid (35-40 %);poly(1-7)lactate esters of dodecanoic acid (60-65 %) 412-590-0 58856-63-6 Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H317H400H410 GHS05GHS07GHS09Dgr H315H318H317H410   
607-388-00-6 4-ethylamino-3-nitrobenzoic acid 412-090-2 2788-74-1 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3 H302H317H412 GHS07Wng H302H317H412   
607-389-00-1 trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate 414-130-4 119710-96-2 Acute Tox. 4 * H302 GHS07Wng H302   
607-390-00-7 1,2,3,4-tetrahydro-6-nitro-quinoxaline 414-270-6 41959-35-7 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
607-391-00-2 dimethylcyclopropane-1,1-dicarboxylate 414-240-2 6914-71-2 Aquatic Chronic 3 H412 — H412   
607-392-00-8 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate 414-260-1 88938-37-8 Aquatic Chronic 4 H413 — H413   
607-393-00-3 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 415-750-8 106447-44-3 Skin Sens. 1 H317 GHS07Wng H317   
607-394-00-9 5-methylpyrazine-2-carboxylic acid 413-260-9 5521-55-1 Eye Dam. 1 H318 GHS05Dgr H318   
607-395-00-4 reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate 410-230-7 — Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H314H317H411 GHS05GHS07GHS09Dgr H314H317H411   
607-396-00-X bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate 414-840-4 147783-69-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-397-00-5 reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);Ca phenates (branched C10-14 and C18-30 alkylated);Ca sulfurized phenates (branched C10-14 and C18-30 alkylated) 415-930-6 — Skin Sens. 1 H317 GHS07Wng H317   
607-398-00-0 ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate 414-820-5 125630-94-6 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-399-00-6 2,2-dimethyl 3-methyl-3-butenyl propanoate 415-610-6 104468-21-5 Skin Irrit. 2Aquatic Chronic 3 H315H412 GHS07Wng H315H412   
607-400-00-X methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate 414-400-1 32750-89-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-401-00-5 ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate 414-450-4 88805-65-6 Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H315H318H317 GHS05GHS07Dgr H315H318H317   
607-402-00-0 methyl N-(phenoxycarbonyl)-L-valinate 414-500-5 153441-77-1 Aquatic Chronic 3 H412 — H412   
607-403-00-6 reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;isopropyl alcohol 414-810-0 — STOT RE 2 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H373 **H318H400H410 GHS08GHS05GHS09Dgr H373 **H318H410   
607-404-00-1 reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;(Z)-3,7-dimethyl-2,6-octadienyl butandioate;((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid 415-190-4 — Skin Sens. 1 H317 GHS07Wng H317   
607-405-00-7 2-hexyldecyl-p-hydroxybenzoate 415-380-7 148348-12-3 Aquatic Chronic 2 H411 GHS09 H411   
607-406-00-2 potassium 2,5-dichlorobenzoate 415-700-5 184637-62-5 Acute Tox. 4 *Eye Dam. 1 H302H318 GHS05GHS07Dgr H302H318   
607-407-00-8 ethyl 2-carboxy-3-(2-thienyl)propionate 415-680-8 143468-96-6 Skin Irrit. 2Eye Dam. 1Skin Sens. 1 H315H318H317 GHS05GHS07Dgr H315H318H317   
607-408-00-3 potassium N-(4-fluorophenyl)glycinate 415-710-1 184637-63-6 STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H373 **H318H317H412 GHS08GHS05GHS07Dgr H373 **H318H317H412   
607-409-00-9 reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;inert biomass from Aspergillus terreus 415-840-7 — Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
607-410-00-4 mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate 415-880-5 779343-34-9 Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H317H400H410 GHS05GHS07GHS09Dgr H315H318H317H410   
607-411-00-X oxiranemethanol, 4-methylbenzene-sulfonate, (S)- 417-210-7 70987-78-9 Carc. 1BMuta. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H350H341H318H317H411 GHS08GHS05GHS07GHS09Dgr H350H341H318H317H411   
607-412-00-5 ethyl 2-(1-cyanocyclohexyl)acetate 415-970-4 133481-10-4 Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 3 H302H373 **H412 GHS08GHS07Wng H302H373 **H412   
607-413-00-0 trans-4-phenyl-L-proline 416-020-1 96314-26-0 Repr. 2Skin Sens. 1 H361f ***H317 GHS08GHS07Wng H361f ***H317   
607-414-00-6 tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate 402-070-1 88122-99-0 Aquatic Chronic 4 H413 — H413   
607-415-00-1 poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride) 419-590-1 — Flam. Sol. 1Skin Sens. 1 H228H317 GHS02GHS07Dgr H228H317   T
607-416-00-7 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide 420-730-7 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-418-00-8 2-ethylhexyl 4-aminobenzoate 420-170-3 26218-04-2 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-419-00-3 (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid 422-240-9 166596-68-5 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
607-420-00-9 2,2-bis(hydroxymethyl)butanoic acid 424-090-1 10097-02-6 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
607-421-00-4 cypermethrin cis/trans +/- 40/60;(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 257-842-9 52315-07-8 Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H332H302H335H400H410 GHS07GHS09Wng H332H302H335H410   
607-422-00-X α-cypermethrin 257-842-9 67375-30-8 Acute Tox. 3 *STOT RE 2 *STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H301H373 **H335H400H410 GHS06GHS08GHS09Dgr H301H373 **H335H410   
607-423-00-5 esters of mecoprop and of mecoprop-P — — Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   A
607-424-00-0 trifloxystrobin (ISO);(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester — 141517-21-7 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
607-425-00-6 metalaxyl (ISO);methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate 260-979-7 57837-19-1 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3 H302H317H412 GHS07Wng H302H317H412   
607-426-00-1 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]n-pentyl-isopentylphthalate; [2]di-n-pentyl phthalate; [3]diisopentylphthalate [4] 284-032-2 [1]- [2]205-017-9 [3]210-088-4 [4] 84777-06-0 [1]- [2]131-18-0 [3]605-50-5 [4] Repr. 1BAquatic Acute 1 H360FDH400 GHS08GHS09Dgr H360FDH400   
607-427-00-7 bromoxynil heptanoate (ISO);2,6-dibromo-4-cyanophenyl heptanoate 260-300-4 56634-95-8 Repr. 2Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361d ***H332H302H317H400H410 GHS08GHS07GHS09Wng H361d ***H332H302H317H410   
607-430-00-3 BBP;benzyl butyl phthalate e 201-622-7 85-68-7 Repr. 1BAquatic Acute 1Aquatic Chronic 1 H360DfH400H410 GHS08GHS09Dgr H360DfH410   
607-431-00-9 prallethrin (ISO);ETOC;2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 245-387-9 23031-36-9 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H331H302H400H410 GHS06GHS09Dgr H331H302H410   
607-432-00-4 S-metolachlor;reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1] (R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] - [1]- [2] 87392-12-9 [1]178961-20-1 [2] Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
607-433-00-X cypermethrin cis/trans +/- 80/20;(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 257-842-9 52315-07-8 Acute Tox. 4 *STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H335H315H317H400H410 GHS07GHS09Wng H302H335H315H317H410   
607-434-00-5 mecoprop-P [1] and its salts;(R)-2-(4-chloro-2-methylphenoxy)propionic acid 240-539-0 16484-77-8 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H302H318H411 GHS05GHS07GHS09Dgr H302H318H411   
607-435-00-0 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate 416-810-6 111969-64-3 STOT RE 2 *Eye Dam. 1Aquatic Chronic 2 H373 **H318H411 GHS08GHS05GHS09Dgr H373 **H318H411   
607-436-00-6 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate 417-350-9 — Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H400H410 GHS05GHS09Dgr H315H318H410   
607-437-00-1 3-(4-aminophenyl)-2-cyano-2-propenoic acid 417-480-6 252977-62-1 Skin Sens. 1 H317 GHS07Wng H317   
607-438-00-7 methyl-2-[(aminosulfonyl)methyl]benzoate 419-010-5 112941-26-1 Acute Tox. 4 *Eye Irrit. 2 H302H319 GHS07Wng H302H319   
607-439-00-2 methyl tetrahydro-2-furancarboxylate 420-670-1 37443-42-8 Eye Dam. 1 H318 GHS05Dgr H318   
607-440-00-8 methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate 421-220-7 144740-59-0 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
607-441-00-3 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid 421-490-6 167684-63-1 Aquatic Chronic 4 H413 — H413   
607-442-00-9 benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate 416-050-5 87460-09-1 Eye Dam. 1 H318 GHS05Dgr H318   
607-443-00-4 bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate 416-140-4 145650-60-8 Aquatic Chronic 4 H413 — H413   
607-444-00-X reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;trans-1,4-dimethylcyclohexyl dibenzoate 416-230-3 35541-81-2 Aquatic Chronic 4 H413 — H413   
607-445-00-5 Iron (III) tris(4-methylbenzenesulfonate) 420-960-8 77214-82-5 Eye Dam. 1 H318 GHS05Dgr H318   
607-446-00-0 methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate 416-240-8 155522-12-6 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
607-447-00-6 sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate 416-370-5 156738-27-1 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
607-448-00-1 2,3,5,6-tetrafluorobenzoic acid 416-800-1 652-18-6 Skin Irrit. 2Eye Dam. 1 H315H318 GHS05Dgr H315H318   
607-449-00-7 reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] 417-080-1 — Self-react. D ****Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H242H317H400H410 GHS02GHS07GHS09Dgr H242H317H410   
607-450-00-2 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate 419-040-9 89604-92-2 Aquatic Chronic 4 H413 — H413   
607-451-00-8 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt 417-640-5 161935-19-9 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
607-453-00-9 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) 418-100-1 172964-15-7 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
607-454-00-4 reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid 418-170-3 116193-72-7 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
607-455-00-X 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt 419-520-8 172890-93-6 Skin Sens. 1 H317 GHS07Wng H317   
607-456-00-5 3-amino-4-chlorobenzoic acid, hexadecyl ester 419-700-6 143269-74-3 Aquatic Chronic 2 H411 GHS09 H411   
607-457-00-0 tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) 420-350-1 172277-97-3 Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
607-458-00-6 reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] 420-850-1 — Aquatic Chronic 2 H411 GHS09 H411   
607-459-00-1 isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate 418-930-4 — Aquatic Chronic 4 H413 — H413   
607-460-00-7 3-tridecyloxy-propyl-ammonium 9-octadecenoate 418-990-1 778577-53-0 STOT RE 2 *Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H373 **H319H315H400H410 GHS08GHS07GHS09Wng H373 **H319H315H410   
607-461-00-2 reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate 421-160-1 — Aquatic Chronic 3 H412 — H412   
607-462-00-8 reaction mass of: 1-hexyl acetate;2-methyl-1-pentyl acetate;3-methyl-1-pentyl acetate;4-methyl-1-pentyl acetate;other mixed linear and branched C6-alkyl acetates 421-230-1 88230-35-7 Aquatic Chronic 2 H411 GHS09 H411   
607-463-00-3 3-(phenothiazin-10-yl)propionic acid 421-260-5 362-03-8 Aquatic Chronic 2 H411 GHS09 H411   
607-464-00-9 reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid 421-280-4  Aquatic Chronic 3 H412 — H412   
607-465-00-4 tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate 421-440-3 778583-04-3 Aquatic Chronic 3 H412 — H412   
607-466-00-X reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate 421-480-1 — Aquatic Chronic 2 H411 GHS09 H411   
607-467-00-5 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate 419-430-9 56533-00-7 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H312H302H373 **H314H400H410 GHS08GHS05GHS07GHS09Dgr H312H302H373 **H314H410   
607-468-00-0 reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate 419-450-8 — Skin Sens. 1 H317 GHS07Wng H317   
607-469-00-6 disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate 419-460-2 120029-06-3 Aquatic Chronic 3 H412 — H412   
607-470-00-1 potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 414-100-0 154336-20-6 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
607-472-00-2 ammonium iron(III) trimethylenediaminetetraacetate hemihydrate 400-660-3 111687-36-6 Aquatic Chronic 2 H411 GHS09 H411   
607-474-00-3 (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid 410-430-4 117573-89-4 Aquatic Chronic 4 H413 — H413   
607-475-00-9 reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) 412-940-2 148878-18-6 Skin Sens. 1 H317 GHS07Wng H317   
607-476-00-4 trisodium N,N-bis(carboxymethyl)-β-alanine 414-070-9 129050-62-0 Skin Corr. 1BAquatic Chronic 3 H314H412 GHS05Dgr H314H412   
607-478-00-5 tetramethylammonium hydrogen phthalate 416-900-5 79723-02-7 Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1 H301H373 **H400 GHS06GHS08GHS09Dgr H301H373 **H400   
607-479-00-0 hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate 418-550-9 168689-49-4 Aquatic Chronic 4 H413 — H413   
607-480-00-6 1,2-benzenedicarboxylic acid;di-C7-11-branched and linear alkylesters 271-084-6 68515-42-4 Repr. 1B H360Df GHS08Dgr H360Df   
607-487-00-4 reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate 402-660-9 — Repr. 1BAquatic Chronic 3 H360D ***H412 GHS08Dgr H360D ***H412   
607-488-00-X ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate 414-210-9 147379-38-2 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-489-00-5 reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;2-ethylhexyl epoxyoleate;2-ethylhexyl diepoxylinoleate;2-ethylhexyl triepoxylinolenate 414-890-7 71302-79-9 Skin Sens. 1 H317 GHS07Wng H317   
607-490-00-0 N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate 415-060-7 — Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
607-492-00-1 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate 415-490-5 141773-73-1 Aquatic Chronic 2 H411 GHS09 H411   
607-493-00-7 methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate 415-670-3 78850-37-0 Eye Dam. 1 H318 GHS05Dgr H318   
607-494-00-2 bis(2-ethylhexyl)octylphosphonate 417-170-0 52894-02-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-495-00-8 sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate 417-550-6 168151-92-6 Skin Sens. 1 H317 GHS07Wng H317   
607-496-00-3 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite 418-310-3 126050-54-2 Aquatic Chronic 4 H413 — H413   
607-497-00-9 cerium oxide isostearate 419-760-3 — Aquatic Chronic 4 H413 — H413   
607-498-00-4 (E)-3,7-dimethyl-2,6-octadienylhexadecanoate 421-370-3 3681-73-0 Skin Irrit. 2Aquatic Chronic 4 H315H413 GHS07Wng H315H413   
607-499-00-X bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) 421-660-1 — Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
607-500-00-3 calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate 421-670-4 — Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H315H400H410 GHS07GHS09Wng H315H410   
607-501-00-9 reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives 421-820-9 192268-65-8 Aquatic Chronic 4 H413 — H413   
607-502-00-4 (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate 422-200-0 178277-55-9 Skin Corr. 1BAcute Tox. 4 *Aquatic Chronic 2 H314H302H411 GHS05GHS07GHS09Dgr H314H302H411   
607-503-00-X 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane 422-210-5 68957-94-8 Skin Corr. 1B H314 GHS05Dgr H314   
607-505-00-0 pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate 422-930-1  Aquatic Chronic 3 H412 — H412   
607-506-00-6 reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate 422-970-8  Aquatic Chronic 2 H411 GHS09 H411   
607-507-00-1 potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate 422-980-2 187026-95-5 Eye Dam. 1 H318 GHS05Dgr H318   
607-508-00-7 disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] 423-110-4 — Eye Dam. 1 H318 GHS05Dgr H318   
607-512-00-9 trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate 423-970-0 182926-43-8 Aquatic Chronic 3 H412 — H412   
607-513-00-4 reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid 423-200-3 — Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   
607-515-00-5 reaction mass of: disodium hexyldiphenyl ether disulphonate;disodium dihexyldiphenyl ether disulphonate 429-650-7 147732-60-3 Eye Irrit. 2Aquatic Chronic 2 H319H411 GHS07GHS09Wng H319H411   
607-516-00-0 N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine 429-670-6 105996-54-1 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
607-517-00-6 (S)-α-(acetylthio)benzenepropanoic acid 430-300-0 76932-17-7 Acute Tox. 4 *Eye Dam. 1Skin Sens. 1 H302H318H317 GHS05GHS07Dgr H302H318H317   
607-526-00-5 cartap (ISO);1,3-bis(carbamoylthio)-2-(dimethylamino)propane — 15263-53-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
607-527-00-0 reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate 423-180-6 — STOT RE 2 * H373 ** GHS08Wng H373 **   
607-696-00-0 pentyl formate 211-340-6 638-49-3 Flam. Liq. 3Eye Irrit. 2STOT SE 3 H226H319H335 GHS02GHS07Dgr H226H319H335   C
607-697-00-6 tert-butyl propionate — 20487-40-5 Flam. Liq. 2 H225 GHS02Dgr H225   C
608-001-00-3 acetonitrile;cyanomethane 200-835-2 75-05-8 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2 H225H332H312H302H319 GHS02GHS07Dgr H225H332H312H302H319   
608-002-00-9 trichloroacetonitrile 208-885-7 545-06-2 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H331H311H301H411 GHS06GHS09Dgr H331H311H301H411   
608-003-00-4 acrylonitrile 203-466-5 107-13-1 Flam. Liq. 2Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H225H350H331H311H301H335H315H318H317H411 GHS02GHS06GHS08GHS05GHS09Dgr H225H350H331H311H301H335H315H318H317H411  * D
608-004-00-X 2-hydroxy-2-methylpropionitrile;2-cyanopropan-2-ol;acetone cyanohydrin 200-909-4 75-86-5 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H400H410 GHS06GHS09Dgr H330H310H300H410   
608-005-00-5 n-butyronitrile 203-700-6 109-74-0 Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H225H331H311H301 GHS02GHS06Dgr H225H331H311H301   
608-006-00-0 bromoxynil (ISO)3,5-dibromo-4-hydroxybenzonitrile;bromoxynil phenol 216-882-7 1689-84-5 Repr. 2Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361d ***H330H301H317H400H410 GHS06GHS08GHS09Dgr H361d ***H330H301H317H410  M = 10 
608-007-00-6 ioxynil (ISO)4-hydroxy-3,5-diiodobenzonitrile 216-881-1 1689-83-4 Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H361d ***H331H301H312H373 **H319H400H410 GHS06GHS08GHS09Dgr H361d ***H331H301H312H373 **H319H410  M = 10 
608-008-00-1 chloroacetonitrile 203-467-0 107-14-2 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H331H311H301H411 GHS06GHS09Dgr H331H311H301H411   
608-009-00-7 malononitrile 203-703-2 109-77-3 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410   
608-010-00-2 methacrylonitrile;2-methyl-2-propene nitrile 204-817-5 126-98-7 Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1 H225H331H311H301H317 GHS02GHS06Dgr H225H331H311H301H317  *Skin Sens. 1; H317: C ≥ 0,2 % D
608-011-00-8 oxalonitrile;cyanogen 207-306-5 460-19-5 Flam. Gas 1Press. GasAcute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H220H331H400H410 GHS02GHS04GHS06GHS09Dgr H220H331H410   U
608-012-00-3 benzonitrile 202-855-7 100-47-0 Acute Tox. 4 *Acute Tox. 4 * H312H302 GHS07Wng H312H302   
608-013-00-9 2-chlorobenzonitrile 212-836-5 873-32-5 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2 H312H302H319 GHS07Wng H312H302H319   
608-014-00-4 chlorothalonil (ISO);tetrachloroisophthalonitrile 217-588-1 1897-45-6 Carc. 2Acute Tox. 2 *Eye Dam. 1STOT SE 3Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H330H318H335H317H400H410 GHS06GHS08GHS05GHS09Dgr H351H330H318H335H317H410  M = 10 
608-015-00-X dichlobenil (ISO);2,6-dichlorobenzonitrile 214-787-5 1194-65-6 Acute Tox. 4 *Aquatic Chronic 2 H312H411 GHS07GHS09Wng H312H411   
608-016-00-5 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene 401-550-8 1897-41-2 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
608-017-00-0 bromoxynil octanoate (ISO);2,6-dibromo-4-cyanophenyl octanoate 216-885-3 1689-99-2 Repr. 2Acute Tox. 3 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361d ***H331H302H317H400H410 GHS06GHS08GHS09Dgr H361d ***H331H302H317H410  M = 10 
608-018-00-6 ioxynil octanoate (ISO);4-cyano-2,6-diiodophenyl octanoate 223-375-4 3861-47-0 Repr. 2Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361d ***H301H319H317H400H410 GHS06GHS08GHS09Dgr H361d ***H301H319H317H410  M = 10 
608-019-00-1 2,2'-dimethyl-2,2'-azodipropiononitrile;ADZN 201-132-3 78-67-1 Self-react. CAcute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H242H332H302H412 GHS02GHS07Dgr H242H332H302H412   T
608-021-00-2 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile 403-710-2 76823-93-3 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317   
608-022-00-8 3,7-dimethyloctanenitrile 403-620-3 40188-41-8 Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H315H317H411 GHS07GHS09Wng H315H317H411   
608-023-00-3 fenbuconazole (ISO);4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile 406-140-2 114369-43-6 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
608-024-00-9 2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile 407-650-8 97460-76-9 Aquatic Chronic 4 H413 — H413   
608-025-00-4 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile 410-970-0 117568-27-1 Aquatic Chronic 4 H413 — H413   
608-026-00-X 3-cyano-3,5,5-trimethylcyclohexanone 411-490-4 7027-11-4 Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 3 H302H373 **H317H412 GHS08GHS07Wng H302H373 **H317H412   
608-027-00-5 reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;3-(3-ethylphenyl)-2,2-dimethylpropanenitrile 412-660-0 — Aquatic Chronic 2 H411 GHS09 H411   
608-028-00-0 4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate 413-510-7 147374-67-2 STOT RE 2 *Skin Sens. 1Aquatic Chronic 2 H373 **H317H411 GHS08GHS09Wng H373 **H317H411   
608-029-00-6 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile 411-990-2 68612-94-2 Skin Sens. 1 H317 GHS07Wng H317   
608-030-00-1 N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide 412-340-0 147741-93-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
608-031-00-7 2-benzyl-2-methyl-3-butenitrile 407-870-4 97384-48-0 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
608-033-00-8 N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide 407-970-8 75511-91-0 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
608-034-00-3 chlorfenapyr;4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile — 122453-73-0 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H331H302H400H410 GHS06GHS09Dgr H331H302H410   
608-035-00-9 (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile 419-290-9 — Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
608-036-00-4 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile 419-060-8 79026-02-1 Aquatic Chronic 4 H413 — H413   
608-037-00-X reaction mass of: (E)-2,12-tridecadiennitrile;(E)-3,12-tridecadiennitrile;(Z)-3,12-tridecadiennitrile 422-190-8  Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
608-038-00-5 2,2,4-trimethyl-4-phenyl-butane-nitrile 422-580-8 75490-39-0 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
608-039-00-0 2-phenylhexanenitrile 423-460-8 3508-98-3 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
608-040-00-6 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) 423-490-1 130755-46-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
608-041-00-1 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile 423-500-4 138401-24-8 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
608-043-00-2 3-(cis-3-hexenyloxy)propanenitril 415-220-6 142653-61-0 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H331H302H400H410 GHS06GHS09Dgr H331H302H410   
608-065-00-2 salts of bromoxynil with the exception of those specified elsewhere in this Annex — — Repr. 2Acute Tox. 2 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361d ***H330H301H317H400H410 GHS06GHS08GHS09Dgr H361d ***H330H301H317H410  M = 10 A
608-066-00-8 salts of ioxynil with the exception of those specified elsewhere in this Annex — — Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H361d ***H331H301H312H373 **H319H400H410 GHS06GHS08GHS09Dgr H361d ***H331H301H312H373 **H319H410  M = 10 A
609-001-00-6 1-nitropropane 203-544-9 108-03-2 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H226H332H312H302 GHS02GHS07Wng H226H332H312H302  * 
609-002-00-1 2-nitropropane 201-209-1 79-46-9 Flam. Liq. 3Carc. 1BAcute Tox. 4 *Acute Tox. 4 * H226H350H332H302 GHS02GHS08GHS07Dgr H226H350H332H302   
609-003-00-7 nitrobenzene 202-716-0 98-95-3 Carc. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Aquatic Chronic 2 H351H361f ***H331H311H301H372 **H411 GHS06GHS08GHS09Dgr H351H361f ***H331H311H301H372 **H411   
609-004-00-2 dinitrobenzene; [1]1,4-dinitrobenzene; [2]1,3-dinitrobenzene; [3]1,2-dinitrobenzene [4] 246-673-6 [1]202-833-7 [2]202-776-8 [3]208-431-8 [4] 25154-54-5 [1]100-25-4 [2]99-65-0 [3]528-29-0 [4] Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H373 **H400H410 GHS06GHS08GHS09Dgr H330H310H300H373 **H410   
609-005-00-8 1,3,5-trinitrobenzene 202-752-7 99-35-4 Expl. 1.1Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H201H330H310H300H373 **H400H410 GHS01GHS06GHS08GHS09Dgr H201H330H310H300H373 **H410   
609-006-00-3 4-nitrotoluene 202-808-0 99-99-0 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H331H311H301H373 **H411   
609-007-00-9 2,4-dinitrotoluene;dinitrotoluene, technical grade; [1]dinitrotoluene [2] 204-450-0 [1]246-836-1 [2] 121-14-2 [1]25321-14-6 [2] Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H350H341H361f ***H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H350H341H361f ***H331H311H301H373 **H411   
609-008-00-4 2,4,6-trinitrotoluene;TNT 204-289-6 118-96-7 Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H201H331H311H301H373 **H411 GHS01GHS06GHS08GHS09Dgr H201H331H311H301H373 **H411   
609-009-00-X 2,4,6-trinitrophenol;picric acid 201-865-9 88-89-1 Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H201H331H311H301 GHS01GHS06Dgr H201H331H311H301   
609-010-00-5 salts of picric acid — — Unst. ExplAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H201H331H311H301 GHS01GHS06Dgr H201H331H311H301   T
609-011-00-0 2,4,6-trinitroanisole — 606-35-9 Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H201H332H312H302H411 GHS01GHS07GHS09Wng H201H332H312H302H411   
609-012-00-6 2,4,6-trinitro-m-cresol 210-027-1 602-99-3 Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H201H332H312H302 GHS01GHS07Wng H201H332H312H302   
609-013-00-1 2,4,6-trinitro-m-xylene 211-187-5 632-92-8 Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 * H201H332H312H302H373 ** GHS01GHS08GHS07Wng H201H332H312H302H373 **   
609-015-00-2 4-nitrophenol;p-nitrophenol 202-811-7 100-02-7 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 * H332H312H302H373 ** GHS08GHS07Wng H332H312H302H373 **   
609-016-00-8 dinitrophenol (reaction mass of isomers); [1]2,4(or 2,6)-dinitrophenol [2] 247-096-2 [1]275-732-9 [2] 25550-58-7 [1]71629-74-8 [2] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H373 **H400H410 GHS06GHS08GHS09Dgr H331H311H301H373 **H410   
609-018-00-9 2,4,6-trinitroresorcinol;styphnic acid 201-436-6 82-71-3 Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H201H332H312H302 GHS01GHS07Wng H201H332H312H302   T
609-019-00-4 lead 2,4,6-trinitro-m-phenylene dioxide;lead 2,4,6-trinitroresorcinoxide;lead styphnate 239-290-0 15245-44-0 Unst. ExplRepr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H200H360DfH332H302H373 **H400H410 GHS01GHS08GHS07GHS09Dgr H200H360DfH332H302H373 **H410   1
609-019-01-1 lead 2,4,6-trinitro-m-phenylene dioxide;lead 2,4,6-trinitroresorcinoxide;lead styphnate (≥ 20 % phlegmatiser) 239-290-0 15245-44-0 Expl. 1.1Repr. 1AAcute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H201H360DfH332H302H373 **H400H410 GHS01GHS08GHS07GHS09Dgr H201H360DfH332H302H373 **H410   1
609-020-00-X DNOC (ISO);4,6-dinitro-o-cresol 208-601-1 534-52-1 Muta. 2Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H341H330H310H300H315H318H317H400H410 GHS06GHS08GHS05GHS07GHS09Dgr H341H330H310H300H315H318H317H410 EUH044  
609-021-00-5 sodium salt of DNOC;sodium 4,6-dinitro-o-cresolate; [1]potassium salt of DNOC;potassium 4,6-dinitro-o-cresolate [2] 219-007-7 [1]- [2] 2312-76-7 [1]5787-96-2 [2] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H373 **H400H410 GHS06GHS08GHS09Dgr H331H311H301H373 **H410   
609-022-00-0 ammonium salt of DNOC;ammonium 4,6-dinitro-o-tolyl oxide 221-037-0 2980-64-5 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H330H310H300H373 **H400H410 GHS06GHS08GHS09Dgr H330H310H300H373 **H410   
609-023-00-6 dinocap (ISO) 254-408-0 39300-45-3 Repr. 1BAcute Tox. 4 *STOT RE 2 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H360D ***H332H373 **H315H317H400H410 GHS08GHS07GHS09Dgr H360D ***H332H373 **H315H317H410   
609-024-00-1 binapacryl (ISO);2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate 207-612-9 485-31-4 Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H360D ***H312H302H400H410 GHS08GHS07GHS09Dgr H360D ***H312H302H410   
609-025-00-7 dinoseb(ISO);6-sec-butyl-2,4-dinitrophenol 201-861-7 88-85-7 Repr. 1BAcute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H360DfH311H301H319H400H410 GHS06GHS08GHS09Dgr H360DfH311H301H319H410 EUH044  
609-026-00-2 salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex — — Repr. 1BAcute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H360DfH311H301H319H400H410 GHS06GHS08GHS09Dgr H360DfH311H301H319H410 EUH044  A
609-027-00-8 dinocton;reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate — 63919-26-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
609-028-00-3 dinex (ISO);2-cyclohexyl-4,6-dinitrophenol 205-042-5 131-89-5 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410   
609-029-00-9 salts and esters of dinex — — Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410   A
609-030-00-4 dinoterb (ISO);2-tert-butyl-4,6-dinitrophenol 215-813-8 1420-07-1 Repr. 1BAcute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H360D ***H300H311H400H410 GHS06GHS08GHS09Dgr H360D ***H300H311H410 EUH044  
609-031-00-X salts and esters of dinoterb — — Repr. 1BAcute Tox. 2 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H360D ***H300H311H400H410 GHS06GHS08GHS09Dgr H360D ***H300H311H410   A
609-032-00-5 bromofenoxim (ISO);3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime 236-129-6 13181-17-4 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
609-033-00-0 dinosam (ISO);2-(1-methylbutyl)-4,6-dinitrophenol — 4097-36-3 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410   
609-034-00-6 salts and esters of dinosam — — Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H400H410 GHS06GHS09Dgr H331H311H301H410   A
609-035-00-1 nitroethane 201-188-9 79-24-3 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 * H226H332H302 GHS02GHS07Wng H226H332H302  * 
609-036-00-7 nitromethane 200-876-6 75-52-5 Flam. Liq. 3Acute Tox. 4 * H226H302 GHS02GHS07Wng H226H302  * 
609-037-00-2 5-nitroacenaphthene 210-025-0 602-87-9 Carc. 1B H350 GHS08Dgr H350   
609-038-00-8 2-nitronaphthalene 209-474-5 581-89-5 Carc. 1BAquatic Chronic 2 H350H411 GHS08GHS09Dgr H350H411   
609-039-00-3 4-nitrobiphenyl 202-204-7 92-93-3 Carc. 1BAquatic Chronic 2 H350H411 GHS08GHS09Dgr H350H411   
609-040-00-9 nitrofen (ISO);2,4-dichlorophenyl 4-nitrophenyl ether 217-406-0 1836-75-5 Carc. 1BRepr. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H360D ***H302H400H410 GHS08GHS07GHS09Dgr H350H360D ***H302H410   
609-041-00-4 2,4-dinitrophenol 200-087-7 51-28-5 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1 H331H311H301H373 **H400 GHS06GHS08GHS09Dgr H331H311H301H373 **H400   
609-042-00-X pendimethalin (ISO);N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine 254-938-2 40487-42-1 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
609-043-00-5 quintozene (ISO);pentachloronitrobenzene 201-435-0 82-68-8 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
609-044-00-0 tecnazene (ISO);1,2,4,5-tetrachloro-3-nitrobenzene 204-178-2 117-18-0 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
609-045-00-6 reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;dinocton-6 — 8069-76-9 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
609-046-00-1 trifluralin (ISO) (containing < 0.5 ppm NPDA);α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA);N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA) 216-428-8 1582-09-8 Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H319H317H400H410 GHS07GHS09Wng H319H317H410   
609-047-00-7 2-nitroanisole 202-052-1 91-23-6 Carc. 1BAcute Tox. 4 * H350H302 GHS08GHS07Dgr H350H302   
609-048-00-2 sodium 3-nitrobenzenesulphonate 204-857-3 127-68-4 Eye Irrit. 2Skin Sens. 1 H319H317 GHS07Wng H319H317   
609-049-00-8 2,6-dinitrotoluene 210-106-0 606-20-2 Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3 H350H341H361f ***H331H311H301H373 **H412 GHS06GHS08Dgr H350H341H361f ***H331H311H301H373 **H412   
609-050-00-3 2,3-dinitrotoluene 210-013-5 602-01-7 Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H350H341H361f ***H331H311H301H373 **H400H410 GHS06GHS08GHS09Dgr H350H341H361f ***H331H311H301H373 **H410   
609-051-00-9 3,4-dinitrotoluene 210-222-1 610-39-9 Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H350H341H361f ***H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H350H341H361f ***H331H311H301H373 **H411   
609-052-00-4 3,5-dinitrotoluene 210-566-2 618-85-9 Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3 H350H341H361f ***H331H311H301H373 **H412 GHS06GHS08Dgr H350H341H361f ***H331H311H301H373 **H412   
609-053-00-X hydrazine-trinitromethane 414-850-9 — Expl. 1.1 ****Self-react. ACarc. 1BAcute Tox. 3 *Acute Tox. 3 *Skin Sens. 1 H201H240H350H331H301H317 GHS01GHS06GHS08Dgr H201H240H350H331H301H317   
609-054-00-5 2,3-dinitrophenol; [1]2,5-dinitrophenol; [2]2,6-dinitrophenol; [3]3,4-dinitrophenol; [4]salts of dinitrophenol [5] 200-628-7 [1]206-348-1 [2]209-357-9 [3]209-415-3 [4]- [5] 66-56-8 [1]329-71-5 [2]573-56-8 [3]577-71-9 [4]- [5] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H331H311H301H373 **H411   
609-055-00-0 2,5-dinitrotoluene 210-581-4 619-15-8 Carc. 1BMuta. 2Repr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H350H341H361f ***H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H350H341H361f ***H331H311H301H373 **H411   
609-056-00-6 2,2-dibromo-2-nitroethanol 412-380-9 69094-18-4 Expl. 1.1Carc. 2Acute Tox. 4 *STOT RE 2 *Skin Corr. 1ASkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H201H351H302H373 **H314H317H400H410 GHS01GHS08GHS05GHS07GHS09Dgr H201H351H302H373 **H314H317H410  *STOT SE 3; H335: C ≥ 1 % T
609-057-00-1 3-chloro-2,4-difluoronitrobenzene 411-980-8 3847-58-3 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H314H317H400H410 GHS05GHS07GHS09Dgr H302H314H317H410   
609-058-00-7 2-nitro-2-phenyl-1,3-propanediol 410-360-4 5428-02-4 STOT RE 1Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H372 **H312H302H317H411 GHS08GHS07GHS09Dgr H372 **H312H302H317H411 EUH070  
609-059-00-2 2-chloro-6-(ethylamino)-4-nitrophenol 411-440-1 131657-78-8 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H302H317H411 GHS07GHS09Wng H302H317H411   
609-060-00-8 4-[(3-hydroxypropyl)amino]-3-nitrophenol 406-305-9 92952-81-3 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
609-061-00-3 (E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime 406-100-4 94097-88-8 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
609-062-00-9 2-bromo-2-nitropropanol 407-030-7 24403-04-1 Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H311H302H373 **H314H317H400H410 GHS06GHS08GHS05GHS09Dgr H311H302H373 **H314H317H410   
609-063-00-4 2-[(4-chloro-2-nitrophenyl)amino]ethanol 413-280-8 59320-13-7 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
609-064-00-X mesotrione(ISO);2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione — 104206-82-8 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
609-065-00-5 2-nitrotoluene 201-853-3 88-72-2 Carc. 1BMuta. 1BRepr. 2Acute Tox. 4 *Aquatic Chronic 2 H350H340H361f ***H302H411 GHS08GHS07GHS09Dgr H350H340H361f ***H302H411   
609-066-00-0 lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 418-870-9 154212-58-5 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 2 ** H332H312H302H371 ** GHS08GHS07Dgr H332H312H302H371 **   
609-067-00-6 sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine 416-280-6 156769-97-0 Skin Sens. 1 H317 GHS07Wng H317   
609-068-00-1 musk xylene;5-tert-butyl-2,4,6-trinitro-m-xylene 201-329-4 81-15-2 Expl. 1.1Carc. 2Aquatic Acute 1Aquatic Chronic 1 H201H351H400H410 GHS01GHS08GHS09Wng H201H351H410   T
609-070-00-2 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene 415-580-4 130841-23-5 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
609-071-00-8 reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol 423-520-3 156137-33-6 Skin Sens. 1 H317 GHS07Wng H317   
610-001-00-3 trichloronitromethane;chloropicrin 200-930-9 76-06-2 Acute Tox. 2 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H330H302H319H335H315 GHS06Dgr H330H302H319H335H315   
610-002-00-9 1,1-dichloro-1-nitroethane 209-854-0 594-72-9 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301   
610-003-00-4 chlorodinitrobenzene — — Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H373 **H400H410 GHS06GHS08GHS09Dgr H331H311H301H373 **H410   C
610-004-00-X 2-chloro-1,3,5-trinitrobenzene 201-864-3 88-88-0 Expl. 1.1Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H201H330H310H300H400H410 GHS01GHS06GHS09Dgr H201H330H310H300H410   
610-005-00-5 1-chloro-4-nitrobenzene 202-809-6 100-00-5 Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H351H341H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H351H341H331H311H301H373 **H411   
610-006-00-0 chloronitroanilines with the exception of those specified elsewhere in this Annex — — Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2 H330H310H300H373 **H411 GHS06GHS08GHS09Dgr H330H310H300H373 **H411   A C
610-007-00-6 1-chloro-1-nitropropane 209-990-0 600-25-9 Acute Tox. 4 *Acute Tox. 4 * H332H302 GHS07Wng H332H302  * 
610-008-00-1 2,6-dichloro-4-nitroanisole 403-350-6 17742-69-7 Acute Tox. 3 *Aquatic Chronic 2 H301H411 GHS06GHS09Dgr H301H411   
610-009-00-7 2-chloro-4-nitroaniline 204-502-2 121-87-9 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
610-010-00-2 2-bromo-1-(2-furyl)-2-nitroethylene 406-110-9 35950-52-8 Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H373 **H314H317H400H410 GHS08GHS05GHS07GHS09Dgr H302H373 **H314H317H410   
611-001-00-6 azobenzene 203-102-5 103-33-3 Carc. 1BMuta. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H350H341H332H302H373 **H400H410 GHS08GHS07GHS09Dgr H350H341H332H302H373 **H410   
611-002-00-1 azoxybenzene 207-802-1 495-48-7 Acute Tox. 4 *Acute Tox. 4 * H332H302 GHS07Wng H332H302   
611-003-00-7 fenaminosulf (ISO);sodium 4-dimethylaminobenzenediazosulphonate 205-419-4 140-56-7 Acute Tox. 3 *Acute Tox. 4 *Aquatic Chronic 3 H301H312H412 GHS06Dgr H301H312H412   
611-004-00-2 methyl-ONN-azoxymethyl acetate;methyl azoxy methyl acetate 209-765-7 592-62-1 Carc. 1BRepr. 1B H350H360D *** GHS08Dgr H350H360D ***   
611-005-00-8 disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);CI Direct Brown 95 240-221-1 16071-86-6 Carc. 1B H350 GHS08Dgr H350   
611-006-00-3 4-o-tolylazo-o-toluidine;4-amino-2',3-dimethylazobenzene;fast garnet GBC base;AAT;o-aminoazotoluene 202-591-2 97-56-3 Carc. 1BSkin Sens. 1 H350H317 GHS08Dgr H350H317   
611-007-00-9 tricyclazole (ISO);5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole; 255-559-5 41814-78-2 Acute Tox. 4 * H302 GHS07Wng H302   
611-008-00-4 4-aminoazobenzene;4-phenylazoaniline 200-453-6 60-09-3 Carc. 1BAquatic Acute 1Aquatic Chronic 1 H350H400H410 GHS08GHS09Dgr H350H410   
611-009-00-X sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II) 401-220-3 — Acute Tox. 4 *Aquatic Chronic 3 H332H412 GHS07Wng H332H412   
611-010-00-5 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide 403-010-7 106359-94-8 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
611-011-00-0 N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate 403-340-1 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dg H318H411   
611-012-00-6 reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate 403-410-1 114565-65-0 Skin Sens. 1 H317 GHS07Wng H317   
611-013-00-1 trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate 403-650-7 117409-78-6 Expl. 1.3 ****Aquatic Chronic 2 H203H411 GHS01GHS09Dgr H203H411   
611-014-00-7 (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide 404-250-5 115099-55-3 Skin Sens. 1 H317 GHS07Wng H317   
611-015-00-2 tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate 404-320-5 116889-78-2 Skin Sens. 1 H317 GHS07Wng H317   
611-016-00-8 reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride 404-540-1 — Skin Sens. 1 H317 GHS07Wng H317   
611-017-00-3 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide 404-910-2 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-018-00-9 tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate 405-130-5 — Skin Sens. 1 H317 GHS07Wng H317   
611-019-00-4 tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-150-4 106028-58-4 Skin Sens. 1 H317 GHS07Wng H317   
611-020-00-X tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-170-3 116340-05-7 Acute Tox. 3 *Skin Sens. 1Aquatic Chronic 3 H301H317H412 GHS06Dgr H301H317H412   
611-021-00-5 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate 405-480-9 — Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Aquatic Chronic 4 H302H373 **H315H413 GHS08GHS07Wng H302H373 **H315H413   
611-022-00-0 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate 404-980-4 — Self-react. CAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H242H331H301H312H373 **H318H317H400H410 GHS02GHS06GHS08GHS05GHS09Dgr H242H331H301H312H373 **H318H317H410   T
611-023-00-6 disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate 404-600-7 — Skin Sens. 1 H317 GHS07Wng H317   
611-024-00-1 Benzidine based azo dyes;4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex — — Carc. 1B H350 GHS08Dgr H350   A
611-025-00-7 disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;C.I. Direct Black 38 217-710-3 1937-37-7 Carc. 1BRepr. 2 H350H361d *** GHS08Dgr H350H361d ***   
611-026-00-2 tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];C.I. Direct Blue 6 220-012-1 2602-46-2 Carc. 1BRepr. 2 H350H361d *** GHS08Dgr H350H361d ***   
611-027-00-8 disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);C.I. Direct Red 28 209-358-4 573-58-0 Carc. 1BRepr. 2 H350H361d *** GHS08Dgr H350H361d ***   
611-028-00-3 C,C'-azodi(formamide) 204-650-8 123-77-3 Resp. Sens. 1 H334 GHS08Dgr H334   G
611-029-00-9 o-dianisidine based azo dyes;4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex — — Carc. 1B H350 GHS08Dgr H350   A H
611-030-00-4 o-tolidine based dyes;4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex — — Carc. 1B H350 GHS08Dgr H350   A H
611-031-00-X 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;C.I. Basic Red 9 209-321-2 569-61-9 Carc. 1B H350 GHS08Dgr H350   
611-032-00-5 1,4,5,8-tetraaminoanthraquinone;C.I. Disperse Blue 1 219-603-7 2475-45-8 Carc. 1BSkin Irrit. 2Eye Dam. 1Skin Sens. 1 H350H315H318H317 GHS08GHS05GHS07Dgr H350H315H318H317   
611-033-00-0 hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II) 400-020-3 82027-60-9 Aquatic Chronic 2 H411 GHS09 H411   
611-034-00-6 N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide 402-430-8 105076-77-5 Aquatic Chronic 4 H413 — H413   
611-035-00-1 tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate 403-660-1 107246-80-0 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-036-00-7 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate 405-440-0 — Skin Sens. 1 H317 GHS07Wng H317   
611-037-00-2 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate 406-055-0 124584-00-5 Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H318H317H411 GHS05GHS07GHS09Dgr H302H318H317H411   
611-038-00-8 trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate 406-820-9 — Eye Irrit. 2 H319 GHS07Wng H319   
611-039-00-3 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid 407-050-6 117715-57-8 Skin Sens. 1 H317 GHS07Wng H317   
611-040-00-9 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid 407-670-7 115099-58-6 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
611-041-00-4 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide 407-680-1 98809-11-1 Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
611-042-00-X trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate 411-770-6 136213-71-3 Aquatic Chronic 3 H412 — H412   
611-043-00-5 reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) 402-850-1 — Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
611-044-00-0 reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-) 403-720-7 117527-94-3 Aquatic Chronic 2 H411 GHS09 H411   
611-045-00-6 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene 404-830-8 — Aquatic Chronic 4 H413 — H413   
611-046-00-1 4,4'-diamino-2-methylazobenzene 407-590-2 43151-99-1 Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H301H373 **H317H400H410 GHS06GHS08GHS09Dgr H301H373 **H317H410   
611-047-00-7 reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 407-890-3 111381-11-4 Aquatic Chronic 4 H413 — H413   
611-048-00-2 reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 407-900-6 111381-12-5 Aquatic Chronic 4 H413 — H413   
611-049-00-8 reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) 408-000-6 118658-98-3 STOT RE 2 *Skin Sens. 1Aquatic Chronic 3 H373 **H317H412 GHS08Wng H373 **H317H412   
611-051-00-9 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride 411-110-7 136213-74-6 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
611-052-00-4 monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex 400-720-9 — Aquatic Chronic 3 H412 — H412   
611-053-00-X 2,2'-azobis[2-methylpropionamidine] dihydrochloride 221-070-0 2997-92-4 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317   
611-055-00-0 C.I. Disperse Yellow 3;N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide 220-600-8 2832-40-8 Carc. 2Skin Sens. 1 H351H317 GHS08GHS07Wng H351H317   
611-056-00-6 C.I. Solvent Yellow 14;1-phenylazo-2-naphthol 212-668-2 842-07-9 Carc. 2Muta. 2Skin Sens. 1Aquatic Chronic 4 H351H341H317H413 GHS08GHS07Wng H351H341H317H413   
611-057-00-1 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile 400-340-3 85136-74-9 Carc. 1BAquatic Chronic 4 H350H413 GHS08Wng H350H413   
611-058-00-7 (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate 402-060-7 108225-03-2 Carc. 1BEye Dam. 1Aquatic Chronic 2 H350H318H411 GHS08GHS05GHS09Dgr H350H318H411   
611-059-00-2 octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate 412-960-1 148878-21-1 Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   
611-060-00-8 reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid 413-180-4 187285-15-0 Eye Dam. 1 H318 GHS05Dgr H318   
611-061-00-3 disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate 412-530-3 — Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
611-062-00-9 octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate 413-550-5 — Skin Irrit. 2Eye Dam. 1 H315H318 GHS05Dgr H315H318   
611-063-00-4 trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) 413-590-3 164058-22-4 Carc. 1B H350 GHS08Dgr H350   
611-064-00-X 4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol 410-600-8 124719-26-2 STOT RE 2 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H373 **H315H400H410 GHS08GHS07GHS09Wng H373 **H315H410   
611-065-00-5 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol 410-610-2 111850-24-9 STOT RE 2 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H373 **H319H315H317H400H410 GHS08GHS07GHS09Wng H373 **H319H315H317H410   
611-066-00-0 tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 411-540-5 130201-57-9 Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
611-067-00-6 reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate 406-910-8 — Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3 H302H318H412 GHS05GHS07Dgr H302H318H412   
611-068-00-1 tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 400-690-7 85665-98-1 Aquatic Chronic 2 H411 GHS09 H411   
611-069-00-7 N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline 413-380-1 — Aquatic Chronic 2 H411 GHS09 H411   
611-070-00-2 reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) 405-665-4 — Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
611-071-00-8 tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate 406-073-9 131013-81-5 Acute Tox. 3 *Aquatic Chronic 3 H301H412 GHS06Dgr H301H412   
611-072-00-3 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride 407-010-8 118208-02-9 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 2 H302H318H411 GHS05GHS07GHS09Dgr H302H318H411   
611-073-00-9 dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate 407-310-9 122630-55-1 Aquatic Chronic 4 H413 — H413   
611-074-00-4 reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II) 407-100-7 — Skin Sens. 1 H317 GHS07Wng H317   
611-075-00-X reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1) 406-000-0 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
611-076-00-5 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole 406-280-4 117584-16-4 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
611-077-00-0 dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) 407-230-4 126637-70-5 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317   
611-078-00-6 (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate 407-240-9 159604-94-1 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-079-00-1 disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate 410-390-8 147703-64-8 Eye Dam. 1 H318 GHS05Dgr H318   
611-080-00-7 sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate 410-150-2 147703-65-9 Skin Sens. 1 H317 GHS07Wng H317   
611-081-00-2 tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) 411-470-5 141048-13-7 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
611-082-00-8 reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-) 407-570-3 — Aquatic Chronic 2 H411 GHS09 H411   
611-083-00-3 reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) 411-560-4 — STOT RE 1Skin Sens. 1Aquatic Chronic 2 H372 **H317H411 GHS08GHS07GHS09Dgr H372 **H317H411   
611-084-00-9 reaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide 412-550-2 — Aquatic Chronic 4 H413 — H413   
611-085-00-4 reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine 411-880-4 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-086-00-X monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate 411-360-7 — Aquatic Chronic 3 H412 — H412   
611-087-00-5 reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) 411-710-9 — Aquatic Chronic 4 H413 — H413   
611-088-00-0 reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate 411-890-9 — Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3 H302H318H412 GHS05GHS07Dgr H302H318H412   
611-089-00-6 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate 411-100-2 136213-73-5 STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H373 **H317H400H410 GHS08GHS07GHS09Wng H373 **H317H410   
611-090-00-1 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate 413-290-2 93672-52-7 Self-react. CAcute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H242H302H318H317H412 GHS02GHS05GHS07Dgr H242H302H318H317H412   T
611-091-00-7 sodium (1,0-1,95)/lithium (0,05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate 413-470-0 134595-59-8 Skin Sens. 1 H317 GHS07Wng H317   
611-092-00-2 tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate 413-210-6 — Aquatic Chronic 2 H411 GHS09 H411   
611-093-00-8 sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate 410-770-3 146177-84-6 Skin Sens. 1 H317 GHS07Wng H317   
611-094-00-3 reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) 411-600-0 143145-93-1 Aquatic Chronic 4 H413 — H413   
611-095-00-9 hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide 412-240-7 89797-03-5 Aquatic Chronic 2 H411 GHS09 H411   
611-096-00-4 methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate 413-040-2 149850-30-6 Skin Sens. 1 H317 GHS07Wng H317   
611-097-00-X reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) 414-150-3 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-098-00-5 tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate 405-950-3 131013-83-7 Acute Tox. 3 *Aquatic Chronic 3 H301H412 GHS06Dgr H301H412   
611-099-00-0 (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride 401-500-5 118658-99-4 Carc. 1BAquatic Chronic 2 H350H411 GHS08GHS09Dgr H350H411   
611-100-00-4 potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate 403-810-6 140876-13-7 Eye Dam. 1 H318 GHS05Dgr H318   
611-101-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide 405-200-5 104366-25-8 Skin Sens. 1 H317 GHS07Wng H317   
611-103-00-0 trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) 407-110-1 — Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
611-104-00-6 reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate 406-870-1 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-105-00-1 sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate 407-800-2 136213-75-7 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-106-00-7 hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate 410-180-6 157627-99-1 Eye Dam. 1 H318 GHS05Dgr H318   
611-107-00-2 potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate 412-490-7 — Skin Sens. 1 H317 GHS07Wng H317   
611-108-00-8 disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate 413-600-6 6527-62-4 Aquatic Chronic 3 H412 — H412   
611-109-00-3 reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) 407-710-3 — Aquatic Chronic 2 H411 GHS09 H411   
611-110-00-9 tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene 408-210-8 124605-82-9 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-111-00-4 disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-) 414-230-8 — Skin Sens. 1 H317 GHS07Wng H317   
611-112-00-X tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate 413-070-6 — Skin Sens. 1 H317 GHS07Wng H317   
611-113-00-5 lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) 414-280-0 149626-00-6 Aquatic Chronic 2 H411 GHS09 H411   
611-114-00-0 lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) 414-250-7 149564-66-9 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3 H302H318H412 GHS05GHS07Dgr H302H318H412   
611-115-00-6 trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) 414-290-5 149564-65-8 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
611-116-00-1 reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 414-620-8 — Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
611-117-00-7 1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt 415-100-3 149850-29-3 Skin Sens. 1 H317 GHS07Wng H317   
611-118-00-2 sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt 413-990-8  Skin Sens. 1 H317 GHS07Wng H317   
611-119-00-8 tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 415-400-4 148878-22-2 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
611-120-00-3 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt 418-340-7 157707-94-3 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
611-121-00-9 main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol 417-280-9 30785-74-1 Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
611-122-00-4 hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel 417-250-5 151436-99-6 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
611-123-00-X 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate 424-310-4 178452-66-9 Eye Dam. 1 H318 GHS05Dgr H318   
611-124-00-5 reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate 424-320-9  Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
611-125-00-0 reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex 423-940-7 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
611-126-00-6 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride 424-120-1 174514-06-8 Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
611-127-00-1 pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate 423-790-2 — Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   G
611-128-00-7 N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt 419-500-9 171599-85-2 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
611-129-00-2 reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid 418-230-9 163879-69-4 Expl. 1.3 ****Repr. 2STOT RE 2 *Skin Sens. 1Aquatic Chronic 2 H203H361f ***H373 **H317H411 GHS01GHS08GHS07GHS09Dgr H203H361f ***H373 **H317H411   
611-130-00-8 tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate 418-520-5 183130-96-3 Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H400H410 GHS07GHS09Wng H319H410   
611-131-00-3 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one 420-580-2 151798-26-4 Repr. 1BAquatic Chronic 4 H360D ***H413 GHS08Dgr H360D ***H413   
611-132-00-9 pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) 419-210-2 178452-71-6 Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
611-133-00-4 Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt 419-260-5 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
611-134-00-X trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex 423-770-3 — Eye Dam. 1Aquatic Chronic 2 H318H411 GHS05GHS09Dgr H318H411   
611-135-00-5 reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative, mixed potassium/sodium salt 424-250-9 — Eye Dam. 1Aquatic Chronic 3 H318H412 GHS05Dgr H318H412   
611-136-00-0 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate 424-260-3 — Repr. 2Eye Dam. 1Aquatic Chronic 2 H361f ***H318H411 GHS05GHS08GHS09Dgr H361f ***H318H411   
611-137-00-6 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole 419-870-1 159038-16-1 Aquatic Chronic 4 H413 — H413   
611-138-00-1 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole 415-910-7 152828-25-6 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
611-140-00-2 azafenidin (ISO);2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one — 68049-83-2 Repr. 1BSTOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H360DfH373 **H400H410 GHS08GHS09Dgr H360DfH373 **H410  M = 1 000 
612-001-00-9 mono-methylamine; [1]di-methylamine; [2]tri-methylamine [3] 200-820-0 [1]204-697-4 [2]200-875-0 [3] 74-89-5 [1]124-40-3 [2]75-50-3 [3] Flam. Gas 1Press. GasAcute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1 H220H332H335H315H318 GHS02GHS04GHS05GHS07Dgr H220H332H335H315H318  *Skin Irrit. 2; H315: C ≥ 5 %Eye Dam. 1; H318: C ≥ 5 %Eye Irrit. 2; H319: 0,5 % ≤ C < 5 %STOT SE 3; H335: C ≥ 5 % U5
612-001-01-6 mono-methylamine ... %; [1]di-methylamine ... %; [2]tri-methylamine ... % [3] 200-820-0 [1]204-697-4 [2]200-875-0 [3] 74-89-5 [1]124-40-3 [2]75-50-3 [3] Flam. Liq. 1Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H224H332H302H314 GHS02GHS05GHS07Dgr H224H332H302H314  *STOT SE 3; H335: C ≥ 5 % B
612-002-00-4 ethylamine 200-834-7 75-04-7 Flam. Gas 1Press. GasEye Irrit. 2STOT SE 3 H220H319H335 GHS02GHS04GHS07Dgr H220H319H335   U
612-003-00-X diethylamine 203-716-3 109-89-7 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H225H332H312H302H314 GHS02GHS05GHS07Dgr H225H332H312H302H314  STOT SE 3; H335: C ≥ 1 % 
612-004-00-5 triethylamine 204-469-4 121-44-8 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H225H332H312H302H314 GHS02GHS05GHS07Dgr H225H332H312H302H314  STOT SE 3; H335: C ≥ 1 % 
612-005-00-0 butylamine 203-699-2 109-73-9 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H225H332H312H302H314 GHS02GHS05GHS07Dgr H225H332H312H302H314  STOT SE 3; H335: C ≥ 1 % 
612-006-00-6 ethylenediamine;1,2-diaminoethane 203-468-6 107-15-3 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1 H226H312H302H314H334H317 GHS02GHS08GHS05GHS07Dgr H226H312H302H314H334H317   
612-007-00-1 2-aminopropane;isopropylamine 200-860-9 75-31-0 Flam. Liq. 1Eye Irrit. 2STOT SE 3Skin Irrit. 2 H224H319H335H315 GHS02GHS07Dgr H224H319H335H315   
612-008-00-7 aniline 200-539-3 62-53-3 Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1 H351H341H331H311H301H372 **H318H317H400 GHS06GHS08GHS05GHS09Dgr H351H341H331H311H301H372 **H318H317H400  *STOT RE 1; H372: C ≥ 1 %STOT RE 2; H373: 0,2 % ≤ C < 1 % 
612-009-00-2 salts of aniline — — Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Eye Dam. 1Skin Sens. 1Aquatic Acute 1 H351H341H331H311H301H372 **H318H317H400 GHS06GHS08GHS05GHS09Dgr H351H341H331H311H301H372 **H318H317H400  *STOT RE 1; H372: C ≥ 1 %STOT RE 2; H373: 0,2 % ≤ C < 1 % A
612-010-00-8 chloroanilines (with exception of those specified elsewhere in this Annex) — — Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H373 **H400H410 GHS06GHS08GHS09Dgr H331H311H301H373 **H410   C
612-011-00-3 4-nitrosoaniline 211-535-6 659-49-4 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302   
612-012-00-9 o-nitroaniline; [1]m-nitroaniline; [2]p-nitroaniline [3] 201-855-4 [1]202-729-1 [2]202-810-1 [3] 88-74-4 [1]99-09-2 [2]100-01-6 [3] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3 H331H311H301H373 **H412 GHS06GHS08Dgr H331H311H301H373 **H412   C
612-013-00-4 3-aminobenzene sulphonic acid;metanilic acid 204-473-6 121-47-1 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302   
612-014-00-X sulphanilic acid;4-aminobenzenesulphonic acid 204-482-5 121-57-3 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H319H315H317 GHS07Wng H319H315H317   
612-015-00-5 N-methylaniline 202-870-9 100-61-8 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H373 **H400H410 GHS06GHS08GHS09Dgr H331H311H301H373 **H410   
612-016-00-0 N,N-dimethylaniline 204-493-5 121-69-7 Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H351H331H311H301H411 GHS06GHS08GHS09Dgr H351H331H311H301H411   
612-017-00-6 N-methyl-N,2,4,6-tetranitroaniline;tetryl 207-531-9 479-45-8 Expl. 1.1Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 * H201H331H311H301H373 ** GHS01GHS06GHS08Dgr H201H331H311H301H373 **   
612-018-00-1 bis(2,4,6-trinitrophenyl)amine;hexyl 205-037-8 131-73-7 Expl. 1.1Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2 H201H330H310H300H373 **H411 GHS01GHS06GHS08GHS09Dgr H201H330H310H300H373 **H411   
612-019-00-7 dipicrylamine, ammonium salt 220-639-0 2844-92-0 Expl. 1.1Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2 H201H330H310H300H373 **H411 GHS01GHS06GHS08GHS09Dgr H201H330H310H300H373 **H411 EUH001  
612-020-00-2 1-naphthylamine 205-138-7 134-32-7 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
612-022-00-3 2-naphthylamine 202-080-4 91-59-8 Carc. 1AAcute Tox. 4 *Aquatic Chronic 2 H350H302H411 GHS08GHS07GHS09Dgr H350H302H411  Carc. 1A; H350: C ≥ 0,01 % 
612-023-00-9 phenylhydrazine; [1]phenylhydrazinium chloride; [2]phenylhydrazine hydrochloride; [3]phenylhydrazinium sulphate (2:1) [4] 202-873-5 [1]200-444-7 [2]248-259-0 [3]257-622-2 [4] 100-63-0 [1]59-88-1 [2]27140-08-5 [3]52033-74-6 [4] Carc. 1BMuta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1 H350H341H331H311H301H372 **H319H315H317H400 GHS06GHS08GHS09Dgr H350H341H331H311H301H372 **H319H315H317H400   
612-024-00-4 m-toluidine;3-aminotoluene 203-583-1 108-44-1 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1 H331H311H301H373 **H400 GHS06GHS08GHS09Dgr H331H311H301H373 **H400   
612-025-00-X nitrotoluidines, with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H331H311H301H373 **H411   C
612-026-00-5 diphenylamine 204-539-4 122-39-4 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H331H311H301H373 **H400H410 GHS06GHS08GHS09Dgr H331H311H301H373 **H410   
612-027-00-0 xylidines with the exception of those specified elsewhere in this Annex;dimethyl anilines with the exception of those specified elsewhere in this Annex — — Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H331H311H301H373 **H411   C
612-028-00-6 p-phenylenediamine 203-404-7 106-50-3 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H311H301H319H317H400H410 GHS06GHS09Dgr H331H311H301H319H317H410   
612-029-00-1 benzene-1,4-diamine dihydrochloride;p-phenylenediamine dihydrochloride 210-834-9 624-18-0 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H311H301H319H317H400H410 GHS06GHS09Dgr H331H311H301H319H317H410   
612-030-00-7 2-methyl-p-phenylenediamine sulphate [1] 210-431-8 [1]228-871-4 [2] 615-50-9 [1]6369-59-1 [2] Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H301H332H312H317H411 GHS06GHS09Dgr H301H332H312H317H411   
612-031-00-2 N,N-dimethylbenzene-1,3-diamine; [1]4-amino-N,N-dimethylaniline;3-amino-N,N'-dimethylaniline [2] 220-623-3 [1]202-807-5 [2] 2836-04-6 [1]99-98-9 [2] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H331H311H301 GHS06Dgr H331H311H301   C
612-032-00-8 N,N,N',N'-tetramethyl-p-phenylenediamine 202-831-6 100-22-1 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302   
612-033-00-3 2-aminophenol 202-431-1 95-55-6 Muta. 2Acute Tox. 4 *Acute Tox. 4 * H341H332H302 GHS08GHS07Wng H341H332H302   
612-034-00-9 2-amino-4,6-dinitrophenol;picramic acid (< 20 % water) 202-544-6 96-91-3 Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H201H332H312H302H412 GHS01GHS07Wng H201H332H312H302H412   T
612-034-01-6 2-amino-4,6-dinitrophenol;picramic acid;[≥ 20 % water] 202-544-6 96-91-3 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H332H312H302H412 GHS07Wng H332H312H302H412   G
612-035-00-4 2-methoxyaniline;o-anisidine 201-963-1 90-04-0 Carc. 1BMuta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 * H350H341H331H311H301 GHS06GHS08Dgr H350H341H331H311H301   
612-036-00-X 3,3'-dimethoxybenzidine;o-dianisidine 204-355-4 119-90-4 Carc. 1BAcute Tox. 4 * H350H302 GHS08GHS07Dgr H350H302   
612-037-00-5 salts of 3,3'-dimethoxybenzidine;salts of o-dianisidine — — Carc. 1BAcute Tox. 4 * H350H302 GHS08GHS07Dgr H350H302   A
612-038-00-0 2-nitro-p-anisidine;4-methoxy-2-nitroaniline 202-547-2 96-96-8 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 3 H330H310H300H373 **H412 GHS06GHS08Dgr H330H310H300H373 **H412   
612-039-00-6 2-ethoxyaniline;o-phenetidine 202-356-4 94-70-2 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 * H331H311H301H373 ** GHS06GHS08Dgr H331H311H301H373 **   
612-040-00-1 2,4-dinitroaniline 202-553-5 97-02-9 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Chronic 2 H330H310H300H373 **H411 GHS06GHS08GHS09Dgr H330H310H300H373 **H411   
612-041-00-7 4,4'-bi-o-toluidine 204-358-0 119-93-7 Carc. 1BAcute Tox. 4 *Aquatic Chronic 2 H350H302H411 GHS08GHS07GHS09Dgr H350H302H411   
612-042-00-2 benzidine;1,1'-biphenyl-4,4'-diamine;4,4'-diaminobiphenyl;biphenyl-4,4'-ylenediamine 202-199-1 92-87-5 Carc. 1AAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H302H400H410 GHS08GHS07GHS09Dgr H350H302H410  Carc. 1A; H350: C ≥ 0,01 % 
612-043-00-8 N,N'-dimethylbenzidine — 2810-74-4 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302   
612-044-00-3 N,N'-diacetylbenzidine 210-338-2 613-35-4 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H332H312H302 GHS07Wng H332H312H302   
612-046-00-4 allylamine 203-463-9 107-11-9 Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H225H331H311H301H411 GHS02GHS06GHS09Dgr H225H331H311H301H411   
612-047-00-X benzylamine 202-854-1 100-46-9 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H312H302H314 GHS05GHS07Dgr H312H302H314   
612-048-00-5 dipropylamine 205-565-9 142-84-7 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H225H332H312H302H314 GHS02GHS05GHS07Dgr H225H332H312H302H314  STOT SE 3; H335: C ≥ 1 % 
612-049-00-0 di-n-butylamine; [1]di-sec-butylamine [2] 203-921-8 [1]210-937-9 [2] 111-92-2 [1]626-23-3 [2] Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H226H332H312H302 GHS02GHS07Wng H226H332H312H302   
612-050-00-6 cyclohexylamine 203-629-0 108-91-8 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H226H312H302H314 GHS02GHS05GHS07Dgr H226H312H302H314   
612-051-00-1 4,4'-diaminodiphenylmethane;4,4'-methylenedianiline 202-974-4 101-77-9 Carc. 1BMuta. 2STOT SE 1STOT RE 2 *Skin Sens. 1Aquatic Chronic 2 H350H341H370 **H373 **H317H411 GHS08GHS07GHS09Dgr H350H341H370 **H373 **H317H411   
612-052-00-7 (S)-sec-butylamine;(S)-2-aminobutane; [1](R)-sec-butylamine;(R)-2-aminobutane; [2]sec-butylamine;2-aminobutane [3] 208-164-7 [1]236-232-6 [2]237-732-7 [3] 513-49-5 [1]13250-12-9 [2]13952-84-6 [3] Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1 H225H332H302H314H400 GHS02GHS05GHS07GHS09Dgr H225H332H302H314H400   C
612-053-00-2 N-ethylaniline 203-135-5 103-69-5 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 * H331H311H301H373 ** GHS06GHS08Dgr H331H311H301H373 **   
612-054-00-8 N,N-diethylaniline 202-088-8 91-66-7 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H331H311H301H373 **H411  * 
612-055-00-3 N-methyl-o-toluidine; [1]N-methyl-m-toluidine; [2]N-methyl-p-toluidine [3] 210-260-9 [1]211-795-0 [2]210-769-6 [3] 611-21-2 [1]696-44-6 [2]623-08-5 [3] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3 H331H311H301H373 **H412 GHS06GHS08Dgr H331H311H301H373 **H412   C
612-056-00-9 N,N-dimethyl-p-toluidine; [1]N,N-dimethyl-m-toluidine; [2]N,N-dimethyl-o-toluidine [3] 202-805-4 [1]204-495-6 [2]210-199-8 [3] 99-97-8 [1]121-72-2 [2]609-72-3 [3] Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 3 H331H311H301H373 **H412 GHS06GHS08Dgr H331H311H301H373 **H412  * C
612-057-00-4 piperazine 203-808-3 110-85-0 Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Chronic 3 H314H334H317H412 GHS08GHS05Dgr H314H334H317H412   
612-058-00-X 2,2'-iminodiethylamine;diethylenetriamine 203-865-4 111-40-0 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1 H312H302H314H317 GHS05GHS07Dgr H312H302H314H317   
612-059-00-5 3,6-diazaoctanethylenediamin;triethylenetetramine 203-950-6 112-24-3 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3 H312H314H317H412 GHS05GHS07Dgr H312H314H317H412   
612-060-00-0 3,6,9-triazaundecamethylenediamine;tetraethylenepentamine 203-986-2 112-57-2 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H312H302H314H317H411 GHS05GHS07GHS09Dgr H312H302H314H317H411   
612-061-00-6 3-aminopropyldimethylamine;N,N-dimethyl-1,3-diaminopropane 203-680-9 109-55-7 Flam. Liq. 3Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1 H226H302H314H317 GHS02GHS05GHS07Dgr H226H302H314H317   
612-062-00-1 3-aminopropyldiethylamine;N,N-diethyl-1,3-diaminopropane 203-236-4 104-78-9 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1 H226H312H302H314H317 GHS02GHS05GHS07Dgr H226H312H302H314H317   
612-063-00-7 3,3'-iminodi(propylamine);dipropylenetriamine 200-261-2 56-18-8 Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1ASkin Sens. 1 H330H311H302H314H317 GHS06GHS05Dgr H330H311H302H314H317   
612-064-00-2 3,6,9,12-tetra-azatetradecamethylenediamine;pentacthylenehexamine 223-775-9 4067-16-7 Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H314H317H400H410 GHS05GHS07GHS09Dgr H314H317H410   
612-065-00-8 polyethlyenepolyamines with the exception of those specified elsewhere in this Annex — — Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H312H302H314H317H400H410 GHS05GHS07GHS09Dgr H312H302H314H317H410   
612-066-00-3 dicyclohexylamine 202-980-7 101-83-7 Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H302H314H400H410 GHS05GHS07GHS09Dgr H302H314H410   
612-067-00-9 3-aminomethyl-3,5,5-trimethylcyclohexylamine 220-666-8 2855-13-2 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3 H312H302H314H317H412 GHS05GHS07Dgr H312H302H314H317H412   
612-068-00-4 3,3'-dichlorobenzidine;3,3'-dichlorobiphenyl-4,4'-ylenediamine 202-109-0 91-94-1 Carc. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H312H317H400H410 GHS08GHS07GHS09Dgr H350H312H317H410   
612-069-00-X salts of 3,3'-dichlorobenzidine;salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine — — Carc. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H312H317H400H410 GHS08GHS07GHS09Dgr H350H312H317H410   A
612-070-00-5 salts of benzidine 208-519-6208-520-1244-236-4252-984-8 531-85-1531-86-221136-70-936341-27-2 Carc. 1AAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H302H400H410 GHS08GHS07GHS09Dgr H350H302H410   A
612-071-00-0 salts of 2-naphthylamine 209-030-0210-313-6 553-00-4612-52-2 Carc. 1AAcute Tox. 4 *Aquatic Chronic 2 H350H302H411 GHS08GHS07GHS09Dgr H350H302H411   A
612-072-00-6 biphenyl-4-ylamine;xenylamine;4-aminobiphenyl 202-177-1 92-67-1 Carc. 1AAcute Tox. 4 * H350H302 GHS08GHS07Dgr H350H302   
612-073-00-1 salts of biphenyl-4-ylamine;salts of xenylamine;salts of 4-aminobiphenyl — — Carc. 1AAcute Tox. 4 * H350H302 GHS08GHS07Dgr H350H302   A
612-074-00-7 benzyldimethylamine 203-149-1 103-83-3 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 3 H226H332H312H302H314H412 GHS02GHS05GHS07Dgr H226H332H312H302H314H412   
612-075-00-2 2-aminoethyldimethylamine;2-dimethylaminoethylamine 203-541-2 108-00-9 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H225H312H302H314 GHS02GHS05GHS07Dgr H225H312H302H314   
612-076-00-8 ethyldimethylamine 209-940-8 598-56-1 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H225H332H302H314 GHS02GHS05GHS07Dgr H225H332H302H314   
612-077-00-3 dimethylnitrosoamine;N-nitrosodimethylamine 200-549-8 62-75-9 Carc. 1BAcute Tox. 2 *Acute Tox. 3 *STOT RE 1Aquatic Chronic 2 H350H330H301H372 **H411 GHS06GHS08GHS09Dgr H350H330H301H372 **H411  Carc. 1B; H350: C ≥ 0,001 % 
612-078-00-9 2,2'-dichloro-4,4'-methylenedianiline;4,4'-methylene bis(2-chloroaniline) 202-918-9 101-14-4 Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H302H400H410 GHS08GHS07GHS09Dgr H350H302H410   
612-079-00-4 salts of 2,2'-dichloro-4,4'-methylenedianiline;salts of 4,4'-methylenebis(2-chloroaniline) — — Carc. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H350H302H400H410 GHS08GHS07GHS09Dgr H350H302H410   A
612-080-00-X 4-amino-N,N-diethylaniline;N,N-diethyl-p-phenylendiamine 202-214-1 93-05-0 Acute Tox. 3 *Skin Corr. 1B H301H314 GHS06GHS05Dgr H301H314   
612-081-00-5 salts of 4,4'-bi-o-toluidine;salts of 3,3'-dimethylbenzidine;salts of o-tolidine 210-322-5265-294-7277-985-0 612-82-864969-36-474753-18-7 Carc. 1BAcute Tox. 4 *Aquatic Chronic 2 H350H302H411 GHS08GHS07GHS09Dgr H350H302H411   A
612-082-00-0 thiourea;thiocarbamide 200-543-5 62-56-6 Carc. 2Repr. 2Acute Tox. 4 *Aquatic Chronic 2 H351H361d ***H302H411 GHS08GHS07GHS09Wng H351H361d ***H302H411   
612-083-00-6 1-methyl-3-nitro-1-nitrosoguanidine 200-730-1 70-25-7 Carc. 1BAcute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H350H332H319H315H411 GHS08GHS07GHS09Dgr H350H332H319H315H411  Carc. 1B; H350: C ≥ 0,01 % 
612-084-00-1 dapsone;4,4'-diamino diphenyl sulfone 201-248-4 80-08-0 Acute Tox. 4 * H302 GHS07Wng H302   
612-085-00-7 4,4'-methylenedi-o-toluidine 212-658-8 838-88-0 Carc. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H302H317H400H410 GHS08GHS07GHS09Dgr H350H302H317H410   
612-086-00-2 amitraz (ISO);N,N-bis(2,4-xylyliminomethyl) methylamine 251-375-4 33089-61-1 Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H373 **H317H400H410 GHS08GHS07GHS09Wng H302H373 **H317H410  M = 10 
612-087-00-8 guazatine (ISO)  108173-90-6 Acute Tox. 2 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H330H312H302H335H315H318H400H410 GHS06GHS05GHS09Dgr H330H312H302H335H315H318H410   
612-088-00-3 simazine (ISO);6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine 204-535-2 122-34-9 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410   
612-089-00-9 1,5-naphthylenediamine 218-817-8 2243-62-1 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410   
612-090-00-4 2,2'-(nitrosoimino)bisethanol 214-237-4 1116-54-7 Carc. 1B H350 GHS08Dgr H350   
612-091-00-X o-toluidine;2-aminotoluene 202-429-0 95-53-4 Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Aquatic Acute 1 H350H331H301H319H400 GHS06GHS08GHS09Dgr H350H331H301H319H400   
612-092-00-5 N,N'-(2,2-dimethylpropylidene)hexamethylenediamine 401-660-6 1000-78-8 Skin Irrit. 2Skin Sens. 1 H315H317 GHS07Wng H315H317   
612-093-00-0 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline 401-790-3 104147-32-2 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
612-094-00-6 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride 402-190-4 — STOT RE 1Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H372 **H302H318H317H400H410 GHS08GHS05GHS07GHS09Dgr H372 **H302H318H317H410   
612-095-00-1 benzyl-2-hydroxydodecyldimethylammonium benzoate 402-610-6 113694-52-3 Skin Corr. 1BAcute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H314H302H400H410 GHS05GHS07GHS09Dgr H314H302H410   
612-096-00-7 4,4'-carbonimidoylbis[N,N-dimethylaniline] 207-762-5 492-80-8 Carc. 2Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2 H351H302H319H411 GHS08GHS07GHS09Wng H351H302H319H411   
612-097-00-2 salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline] — — Carc. 2Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2 H351H302H319H411 GHS08GHS07GHS09Wng H351H302H319H411   A
612-098-00-8 nitrosodipropylamine 210-698-0 621-64-7 Carc. 1BAcute Tox. 4 *Aquatic Chronic 2 H350H302H411 GHS08GHS07GHS09Dgr H350H302H411  Carc. 1B; H350: C ≥ 0,001 % 
612-099-00-3 4-methyl-m-phenylenediamine;2,4-toluenediamine 202-453-1 95-80-7 Carc. 1BAcute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2 H350H301H312H319H317H411 GHS06GHS08GHS09Dgr H350H301H312H319H317H411   
612-100-00-7 propylenediamine 201-155-9 78-90-0 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1A H226H312H302H314 GHS02GHS05GHS07Dgr H226H312H302H314   
612-101-00-2 methenamine;hexamethylenetetramine 202-905-8 100-97-0 Flam. Sol. 2Resp. Sens. 1Skin Sens. 1 H228H334H317 GHS02GHS08Dgr H228H334H317   
612-102-00-8 N,N-bis(3-aminopropyl)methylamine 203-336-8 105-83-9 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1B H331H311H302H314 GHS06GHS05Dgr H331H311H302H314   
612-103-00-3 N,N,N',N'-tetramethylethylenediamine 203-744-6 110-18-9 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H225H332H302H314 GHS02GHS05GHS07Dgr H225H332H302H314   
612-104-00-9 hexamethylenediamine 204-679-6 124-09-4 Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Corr. 1B H312H302H335H314 GHS05GHS07Dgr H312H302H335H314   
612-105-00-4 2-piperazin-1-ylethylamine 205-411-0 140-31-8 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3 H312H302H314H317H412 GHS05GHS07Dgr H312H302H314H317H412   
612-106-00-X 2,6-diethylaniline 209-445-7 579-66-8 Acute Tox. 4 * H302 — H302   
612-107-00-5 1-phenylethylamine; [1]DL-α-methylbenzylamine [2] 202-706-6 [1]210-545-8 [2] 98-84-0 [1]618-36-0 [2] Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H312H302H314 GHS05GHS07Dgr H312H302H314   
612-108-00-0 3-aminopropyltriethoxysilane 213-048-4 919-30-2 Acute Tox. 4 *Skin Corr. 1B H302H314 GHS05GHS07Dgr H302H314   
612-109-00-6 bis(2-dimethylaminoethyl)(methyl)amine 221-201-1 3030-47-5 Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1B H311H302H314 GHS06GHS05Dgr H311H302H314   
612-110-00-1 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) 229-962-1 6864-37-5 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1AAquatic Chronic 2 H331H311H302H314H411 GHS06GHS05GHS09Dgr H331H311H302H314H411   
612-111-00-7 2-methyl-m-phenylenediamine;2,6-toluenediamine 212-513-9 823-40-5 Muta. 2Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H341H312H302H317H411 GHS08GHS07GHS09Wng H341H312H302H317H411   
612-112-00-2 p-anisidine;4-methoxyaniline 203-254-2 104-94-9 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *STOT RE 2 *Aquatic Acute 1 H330H310H300H373 **H400 GHS06GHS08GHS09Dgr H330H310H300H373 **H400   
612-113-00-8 6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine 403-240-8 106264-79-3 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
612-114-00-3 R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate 404-390-7 — Flam. Sol. 1Skin Sens. 1Aquatic Chronic 3 H228H317H412 GHS02GHS07Wng H228H317H412   
612-115-00-9 dimethyldioctadecylammonium hydrogen sulfate 404-050-8 123312-54-9 Eye Irrit. 2Aquatic Chronic 4 H319H413 GHS07Wng H319H413   
612-116-00-4 C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate 404-690-8 68132-19-4 Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H314H317H400H410 GHS06GHS05GHS09Dgr H331H314H317H410   
612-117-00-X C12-14-tert-alkylamine, methylphosphonic acid salt 404-750-3 119415-07-5 Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2 H302H314H411 GHS05GHS07GHS09Dgr H302H314H411   
612-118-00-5 A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate;(1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide 405-080-4 — Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
612-119-00-0 benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate 405-330-2 — Skin Irrit. 2Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H400H410 GHS05GHS09Dgr H315H318H410   
612-120-00-6 aclonifen (ISO);2-chloro-6-nitro-3-phenoxyaniline 277-704-1 74070-46-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
612-121-00-1 amines, polyethylenepoly-;HEPA 268-626-9 68131-73-7 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H312H302H314H317H400H410 GHS05GHS07GHS09Dgr H312H302H314H317H410   
612-122-00-7 hydroxylamine 232-259-2 7803-49-8 Unst. Expl.Met. Corr. 1Acute Tox. 4 *STOT RE 2 *STOT SE 3Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1 H200H290H302H373 **H335H315H318H317H400 GHS01GHS08GHS05GHS07GHS09Dgr H200H290H302H373 **H335H315H318H317H400   T
612-123-00-2 hydroxylammonium chloride;hydroxylamine hydrochloride; [1]bis(hydroxylammonium) sulphate;hydroxylamine sulphate (2:1); [2]hydroxylammonium hydrogensulphate;hydroxylamine sulphate (1:1) [3] 226-798-2 [1]233-118-8 [2]233-154-4 [3] 5470-11-1 [1]10039-54-0 [2]10046-00-1 [3] Met. Corr. 1Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1 H290H302H373 **H319H315H317H400 GHS08GHS05GHS07GHS09Wng H290H302H373 **H319H315H317H400   G T
612-124-00-8 N,N,N-trimethylanilinium chloride 205-319-0 138-24-9 Acute Tox. 3 *Acute Tox. 3 * H311H301 GHS06Dgr H311H301   
612-125-00-3 2-methyl-p-phenylenediamine;2,5-toluenediamine 202-442-1 95-70-5 Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H301H332H312H317H411 GHS06GHS09Dgr H301H332H312H317H411   
612-126-00-9 toluene-2,4-diammonium sulphate;4-methyl-m-phenylenediamine sulfate 265-697-8 65321-67-7 Carc. 1BAcute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2 H350H301H312H319H317H411 GHS06GHS08GHS09Dgr H350H301H312H319H317H411   
612-127-00-4 3-aminophenol 209-711-2 591-27-5 Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H332H302H411 GHS07GHS09Wng H332H302H411   
612-128-00-X 4-aminophenol 204-616-2 123-30-8 Muta. 2Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H341H332H302H400H410 GHS08GHS07GHS09Wng H341H332H302H410   
612-129-00-5 diisopropylamine 203-558-5 108-18-9 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H225H332H302H314 GHS02GHS05GHS07Dgr H225H332H302H314  STOT SE 3; H335: C ≥ 5 % 
612-130-00-0 2,6-diamino-3,5-diethyltoluene;4,6-diethyl-2-methyl-1,3-benzenediamine; [1]2,4-diamino-3,5-diethyltoluene;2,4-diethyl-6-methyl-1,3-benzenediamine; [2]diethylmethylbenzenediamine [3] 218-255-3 [1]218-256-9 [2]270-877-4 [3] 2095-01-4 [1]2095-02-5 [2]68479-98-1 [3] Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H312H302H373 **H319H400H410 GHS08GHS07GHS09Wng H312H302H373 **H319H410   C
612-131-00-6 didecyldimethylammonium chloride 230-525-2 7173-51-5 Acute Tox. 4 *Skin Corr. 1B H302H314 GHS05GHS07Dgr H302H314   
612-132-00-1 N,N'-diphenyl-p-phenylenediamine;N,N'-diphenyl-1,4-benzenediamine 200-806-4 74-31-7 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
612-133-00-7 (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate 247-162-0 25646-77-9 Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H301H373 **H317H400H410 GHS06GHS08GHS09Dgr H301H373 **H317H410   
612-134-00-2 N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate 247-161-5 25646-71-3 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
612-135-00-8 N-2-naphthylaniline;N-phenyl-2-naphthylamine 205-223-9 135-88-6 Carc. 2Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H351H319H315H317H411 GHS08GHS07GHS09Wng H351H319H315H317H411   
612-136-00-3 N-isopropyl-N'-phenyl-p-phenylenediamine 202-969-7 101-72-4 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410  Skin Sens. 1; H317: C ≥ 0,1 % 
612-137-00-9 4-chloroaniline 203-401-0 106-47-8 Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H331H311H301H317H400H410 GHS06GHS08GHS09Dgr H350H331H311H301H317H410   
612-138-00-4 furalaxyl (ISO);methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-DL-alaninate 260-875-1 57646-30-7 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
612-139-00-X mefenacet (ISO);2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide 277-328-8 73250-68-7 Aquatic Chronic 2 H411 GHS09 H411   
612-140-00-5 quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides 264-151-6 63449-41-2 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1 H312H302H314H400 GHS05GHS07GHS09Dgr H312H302H314H400   
612-141-00-0 4,4'-methylenebis(2-ethylaniline);4,4'-methylenebis(2-ethylbenzeneamine) 243-420-1 19900-65-3 Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H302H400H410 GHS08GHS07GHS09Wng H351H302H410   
612-142-00-6 biphenyl-2-ylamine 201-990-9 90-41-5 Carc. 2Acute Tox. 4 *Aquatic Chronic 3 H351H302H412 GHS08GHS07Wng H351H302H412   
612-143-00-1 N5,N5-diethyltoluene-2,5-diamine monohydrochloride;4-diethylamino-2-methylaniline monohydrochloride 218-130-3 2051-79-8 Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H301H319H317H400H410 GHS06GHS09Dgr H301H319H317H410   
612-144-00-7 flumetralin (ISO);N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine — 62924-70-3 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H319H315H317H400H410 GHS07GHS09Wng H319H315H317H410   
612-145-00-2 o-phenylenediamine 202-430-6 95-54-5 Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H341H301H332H312H319H317H400H410 GHS06GHS08GHS09Dgr H351H341H301H332H312H319H317H410   
612-146-00-8 o-phenylenediamine dihydrochloride 210-418-7 615-28-1 Carc. 2Muta. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H341H301H332H312H319H317H400H410 GHS06GHS08GHS09Dgr H351H341H301H332H312H319H317H410   
612-147-00-3 m-phenylenediamine 203-584-7 108-45-2 Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H341H331H311H301H319H317H400H410 GHS06GHS08GHS09Dgr H341H331H311H301H319H317H410   
612-148-00-9 m-phenylenediamine dihydrochloride 208-790-0 541-69-5 Muta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H341H331H311H301H319H317H400H410 GHS06GHS08GHS09Dgr H341H331H311H301H319H317H410   
612-149-00-4 1,3-diphenylguanidine 203-002-1 102-06-7 Repr. 2Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 2 H361f ***H302H319H335H315H411 GHS08GHS07GHS09Wng H361f ***H302H319H335H315H411   
612-150-00-X spiroxamine (ISO);8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine — 118134-30-8 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H332H312H302H315H317H400H410 GHS07GHS09Wng H332H312H302H315H317H410   
612-151-00-5 diaminotoluene, technical product - reaction mass of [2] and [3];methyl-phenylenediamine; [1]4-methyl-m-phenylene diamine; [2]2-methyl-m-phenylene diamine [3] 246-910-3 [1]202-453-1 [2]212-513-9 [3] 25376-45-8 [1]95-80-7 [2]823-40-5 [3] Carc. 1BAcute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2 H350H301H332H312H319H317H411 GHS06GHS08GHS09Dgr H350H301H332H312H319H317H411   
612-152-00-0 N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine 406-610-7 62478-82-4 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1AAquatic Chronic 3 H226H332H302H373 **H314H412 GHS02GHS08GHS05GHS07Dgr H226H332H302H373 **H314H412   
612-153-00-6 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride 407-020-2 132885-85-9 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3 H302H317H412 GHS07Wng H302H317H412   
612-154-00-1 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene] 410-890-6 95235-29-3 Aquatic Chronic 4 H413 — H413   
612-155-00-7 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene 411-730-8 93071-94-4 Aquatic Chronic 4 H413 — H413   
612-156-00-2 reaction mass of: trihexadecylmethylammonium chloride;dihexadecyldimethylammonium chloride 405-620-9 — Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
612-157-00-8 (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride 410-780-8 — Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H373 **H318H317H411 GHS08GHS05GHS07GHS09Dgr H302H373 **H318H317H411   
612-158-00-3 reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;4-dodecylsalicylaldoxime 410-820-4 — Aquatic Chronic 4 H413 — H413   
612-159-00-9 Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid 410-880-1 — Acute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H302H314H400H410 GHS05GHS07GHS09Dgr H302H314H410   
612-160-00-4 p-toluidine;4-aminotoluene; [1]toluidinium chloride; [2]toluidine sulphate (1:1) [3] 203-403-1 [1]208-740-8 [2]208-741-3 [3] 106-49-0 [1]540-23-8 [2]540-25-0 [3] Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1 H351H331H311H301H319H317H400 GHS06GHS08GHS09Dgr H351H331H311H301H319H317H400   
612-161-00-X 2,6-xylidine;2,6-dimethylaniline 201-758-7 87-62-7 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT SE 3Skin Irrit. 2Aquatic Chronic 2 H351H332H312H302H335H315H411 GHS08GHS07GHS09Wng H351H332H312H302H335H315H411   
612-162-00-5 dimethyldioctadecylammonium chloride;DODMAC 203-508-2 107-64-2 Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
612-163-00-0 metalaxyl-M (ISO);mefenoxam;(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester — 70630-17-0 Acute Tox. 4 *Eye Dam. 1 H302H318 GHS05GHS07Dgr H302H318   
612-164-00-6 2-butyl-2-ethyl-1,5-diaminopentane 412-700-7 137605-95-9 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3 H312H302H373 **H314H317H412 GHS08GHS05GHS07Dgr H312H302H373 **H314H317H412   
612-165-00-1 N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine 413-810-8 65181-78-4 Aquatic Chronic 2 H411 GHS09 H411   
612-166-00-7 reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) 411-830-1 114765-88-7 Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H318H317H412 GHS05GHS07Dgr H318H317H412   
612-167-00-2 5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride 410-490-1 — Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H373 **H318H317H411 GHS08GHS05GHS07GHS09Dgr H302H373 **H318H317H411   
612-168-00-8 3,5-dichloro-2,6-difluoropyrdine-4-amine 220-630-1 2840-00-8 Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H312H302H411 GHS07GHS09Wng H312H302H411   
612-170-00-9 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime 405-260-2 — Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
612-171-00-4 N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane 410-060-3 130728-76-6 Muta. 2Skin Sens. 1Aquatic Chronic 2 H341H317H411 GHS08GHS09Wng H341H317H411   
612-172-00-X 4,4'-methylenebis(N,N'-dimethylcyclohexanamine 412-840-9 13474-64-1 Acute Tox. 4 *STOT RE 2 *Skin Corr. 1AAquatic Chronic 3 H302H373 **H314H412 GHS08GHS05GHS07Dgr H302H373 **H314H412   
612-173-00-5 lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate 411-140-0 125328-86-1 Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
612-174-00-0 4,4-dimethoxybutylamine 407-690-6 19060-15-2 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 3 H302H314H317H412 GHS05GHS07Dgr H302H314H317H412   
612-175-00-6 2-(O-aminooxy)ethylamine dihydrochloride 412-310-7 37866-45-8 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
612-176-00-1 polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine 410-570-6 143747-73-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
612-177-00-7 2-naphthylamino-6-sulfomethylamide 412-120-4 104295-55-8 STOT RE 2 *Skin Sens. 1Aquatic Chronic 2 H373 **H317H411 GHS08GHS09Wng H373 **H317H411   
612-178-00-2 1,4,7,10-tetraazacyclododecane disulfate 412-080-8 112193-77-8 Acute Tox. 4 *STOT SE 3Eye Dam. 1Aquatic Chronic 3 H302H335H318H412 GHS05GHS07Dgr H302H335H318H412   
612-179-00-8 1-(2-propenyl)pyridinium chloride 412-740-5 25965-81-5 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317   
612-180-00-3 3-aminobenzylamine 412-230-2 4403-70-7 Acute Tox. 4 *Skin Corr. 1BAquatic Chronic 2 H302H314H411 GHS05GHS07GHS09Dgr H302H314H411   
612-181-00-9 2-phenylthioaniline 413-030-8 1134-94-7 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
612-182-00-4 1-ethyl-1-methylmorpholinium bromide 418-210-1 65756-41-4 Muta. 2 H341 GHS08Wng H341   
612-183-00-X 1-ethyl-1-methylpyrrolidinium bromide 418-200-5 69227-51-6 Muta. 2 H341 GHS08Wng H341   
612-184-00-5 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one 403-830-5 89331-94-2 Aquatic Chronic 3 H412 — H412   
612-185-00-0 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide 407-400-8 59493-72-0 Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
612-186-00-6 bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate 406-770-8 149057-64-7 STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H373 **H318H317H400H410 GHS08GHS05GHS07GHS09Dgr H373 **H318H317H410   
612-187-00-1 2,3,4-trifluoroaniline 407-170-9 3862-73-5 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2 H312H302H373 **H315H318H411 GHS08GHS05GHS07GHS09Dgr H312H302H373 **H315H318H411   
612-188-00-7 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) 407-560-9 107934-68-9 Aquatic Chronic 2 H411 GHS09 H411   
612-189-00-2 4-amino-2-(aminomethyl)phenol dihydrochloride 412-510-4 135043-64-0 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
612-190-00-8 4,4'-methylenebis(2-isopropyl-6-methylaniline) 415-150-6 16298-38-7 STOT RE 2 *Aquatic Chronic 2 H373 **H411 GHS08GHS09Wng H373 **H411   
612-191-00-3 polymer of allylamine hydrochloride 415-050-2 71550-12-4 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317   
612-192-00-9 2-isopropyl-4-(N-methyl)aminomethylthiazole 414-800-6 154212-60-9 Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2 H312H302H315H318H411 GHS05GHS07GHS09Dgr H312H302H315H318H411   
612-193-00-4 3-methylaminomethylphenylamine 414-570-7 18759-96-1 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H312H302H314H317H400H410 GHS05GHS07GHS09Dgr H312H302H314H317H410   
612-194-00-X 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride 414-670-0 141890-30-4 Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H302H318H400H410 GHS05GHS07GHS09Dgr H302H318H410   
612-195-00-5 bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate 415-210-1 160236-81-7 Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H332H302H318H400H410 GHS05GHS07GHS09Dgr H332H302H318H410   
612-196-00-0 4-chloro-o-toluidine; [1]4-chloro-o-toluidine hydrochloride [2] 202-441-6 [1]221-627-8 [2] 95-69-2 [1]3165-93-3 [2] Carc. 1BMuta. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H350H341H331H311H301H400H410 GHS06GHS08GHS09Dgr H350H341H331H311H301H410   
612-197-00-6 2,4,5-trimethylaniline; [1]2,4,5-trimethylaniline hydrochloride [2] 205-282-0 [1] - [2] 137-17-7 [1]21436-97-5 [2] Carc. 1BAcute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H350H331H311H301H411 GHS06GHS08GHS09Dgr H350H331H311H301H411   
612-198-00-1 4,4'-thiodianiline and its salts 205-370-9 139-65-1 Carc. 1BAcute Tox. 4 *Aquatic Chronic 2 H350H302H411 GHS08GHS07GHS09Dgr H350H302H411   
612-199-00-7 4,4'-oxydianiline and its salts;p-aminophenyl ether 202-977-0 101-80-4 Carc. 1BMuta. 1BRepr. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 2 H350H340H361f ***H331H311H301H411 GHS06GHS08GHS09Dgr H350H340H361f ***H331H311H301H411   
612-200-00-0 2,4-diaminoanisole;4-methoxy-m-phenylenediamine; [1]2,4-diaminoanisole sulphate [2] 210-406-1 [1]254-323-9 [2] 615-05-4 [1]39156-41-7 [2] Carc. 1BMuta. 2Acute Tox. 4 *Aquatic Chronic 2 H350H341H302H411 GHS08GHS07GHS09Dgr H350H341H302H411   
612-201-00-6 N,N,N',N'-tetramethyl-4,4'-methylendianiline 202-959-2 101-61-1 Carc. 1BAquatic Acute 1Aquatic Chronic 1 H350H400H410 GHS08GHS09Dgr H350H410   
612-202-00-1 3,4-dichloroaniline 202-448-4 95-76-1 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H311H301H318H317H400H410 GHS06GHS05GHS09Dgr H331H311H301H318H317H410   
612-204-00-2 C.I. Basic Violet 3;4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride 208-953-6 548-62-9 Carc. 2Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H351H302H318H400H410 GHS08GHS05GHS07GHS09Dgr H351H302H318H410   
612-205-00-8 C.I. Basic Violet 3 with ≥ 0,1 % of Michler's ketone (EC no. 202-027-5) 208-953-6 548-62-9 Carc. 1BAcute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H350H302H318H400H410 GHS08GHS05GHS07GHS09Dgr H350H302H318H410   
612-206-00-3 famoxadone (ISO);3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione — 131807-57-3 STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H373 **H400H410 GHS08GHS09Wng H373 **H410   
612-207-00-9 4-ethoxyaniline;p-phenetidine 205-855-5 156-43-4 Muta. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1 H341H332H312H302H319H317 GHS08GHS07Wng H341H332H312H302H319H317   
612-209-00-X 6-methoxy-m-toluidine;p-cresidine 204-419-1 120-71-8 Carc. 1BAcute Tox. 4 * H350H302 GHS08GHS07Dgr H350H302   
612-210-00-5 5-nitro-o-toluidine; [1]5-nitro-o-toluidine hydrochloride [2] 202-765-8 [1]256-960-8 [2] 99-55-8 [1]51085-52-0 [2] Carc. 2Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Aquatic Chronic 3 H351H331H311H301H412 GHS06GHS08Dgr H351H331H311H301H412   
612-211-00-0 N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide 416-470-9 170292-97-4 Eye Irrit. 2Aquatic Chronic 2 H319H411 GHS07GHS09Wng H319H411   
612-212-00-6 2,6-dichloro-4-trifluoromethylaniline 416-430-0 24279-39-8 Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H332H302H315H317H400H410 GHS07GHS09Wng H332H302H315H317H410   
612-213-00-1 isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine 419-850-2 148348-13-4 Skin Corr. 1BAquatic Chronic 3 H314H412 GHS05Dgr H314H412   
612-214-00-7 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine 421-390-2 89114-90-9 Aquatic Chronic 4 H413 — H413   
612-215-00-2 3-chloro-2-(isopropylthio)aniline 421-700-6 179104-32-6 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
612-217-00-3 1-methoxy-2-propylamine 422-550-4 37143-54-7 Flam. Liq. 2Skin Corr. 1BAcute Tox. 4 *Aquatic Chronic 3 H225H314H302H412 GHS02GHS05GHS07Dgr H225H314H302H412   
613-001-00-1 ethyleneimine;aziridine 205-793-9 151-56-4 Flam. Liq. 2Carc. 1BMuta. 1BAcute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Skin Corr. 1BAquatic Chronic 2 H225H350H340H330H310H300H314H411 GHS02GHS06GHS08GHS05GHS09Dgr H225H350H340H330H310H300H314H411   D
613-002-00-7 pyridine 203-809-9 110-86-1 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H225H332H312H302 GHS02GHS07Dgr H225H332H312H302  * 
613-003-00-2 1,2,3,4-tetranitrocarbazole — 6202-15-9 Expl. 1.1Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 * H201H332H312H302 GHS01GHS07Wng H201H332H312H302   
613-004-00-8 crimidine (ISO);2-chloro-6-methylpyrimidin-4-yldimethylamine 208-622-6 535-89-7 Acute Tox. 2 * H300 GHS06Dgr H300   
613-007-00-4 desmetryne (ISO);6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine 213-800-1 1014-69-3 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
613-008-00-X dazomet (ISO);tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione 208-576-7 533-74-4 Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H400H410 GHS07GHS09Wng H302H319H410   
613-009-00-5 2,4,6-trichloro-1,3,5-triazine;cyanuric chloride 203-614-9 108-77-0 Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1 H330H302H314H317 GHS06GHS05Dgr H330H302H314H317 EUH014 STOT SE 3; H335: C ≥ 5 % 
613-010-00-0 ametryn (ISO);2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine 212-634-7 834-12-8 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-011-00-6 amitrole (ISO);1,2,4-triazol-3-ylamine 200-521-5 61-82-5 Repr. 2STOT RE 2 *Aquatic Chronic 2 H361d ***H373 **H411 GHS08GHS09Wng H361d ***H373 **H411   
613-012-00-1 bentazone (ISO);3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide 246-585-8 25057-89-0 Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3 H302H319H317H412 GHS07Wng H302H319H317H412   
613-013-00-7 cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile 244-544-9 21725-46-2 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-014-00-2 ethoxyquin(ISO);6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline 202-075-7 91-53-2 Acute Tox. 4 * H302 GHS07Wng H302   
613-015-00-8 fenazaflor (ISO);phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate 238-134-9 14255-88-0 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
613-016-00-3 fuberidazole(ISO);2-(2-furyl)benzimidazole 223-404-0 3878-19-1 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-017-00-9 bis (8-hydroxyquinolinium) sulphate 205-137-1 134-31-6 Acute Tox. 4 * H302 GHS07Wng H302   
613-018-00-4 morfamquat (ISO);1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion — 7411-47-4 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 3 H302H319H335H315H412 GHS07Wng H302H319H335H315H412   
613-019-00-X thioquinox(ISO);2-thio-1,3-dithiolo(4,5,b)quinoxaline 202-272-8 93-75-4 Acute Tox. 4 * H302 GHS07Wng H302   
613-020-00-5 tridemorph (ISO);2,6-dimethyl-4-tridecylmorpholine 246-347-3 24602-86-6 Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H360D ***H332H302H315H400H410 GHS08GHS07GHS09Dgr H360D ***H332H302H315H410   
613-021-00-0 dithianon (ISO);5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile 222-098-6 3347-22-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-022-00-6 pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex — — Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410   A
613-023-00-1 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;pyrethrin I 204-455-8 121-21-1 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410   
613-024-00-7 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;pyrethrin II 204-462-6 121-29-9 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410   
613-025-00-2 cinerin I;3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 246-948-0 25402-06-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-026-00-8 cinerin II;3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate 204-454-2 121-20-0 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-027-00-3 piperidine 203-813-0 110-89-4 Flam. Liq. 2Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1B H225H331H311H314 GHS02GHS06GHS05Dgr H225H331H311H314  * 
613-028-00-9 morpholine 203-815-1 110-91-8 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H226H332H312H302H314 GHS02GHS05GHS07Dg H226H332H312H302H314   
613-029-00-4 dichloro-1,3,5-triazinetrione;dichloroisocyanuric acid 220-487-5 2782-57-2 Ox. Sol. 2Acute Tox. 4 *Eye Irrit. 2STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H272H302H319H335H400H410 GHS03GHS07GHS09Dgr H272H302H319H335H410 EUH031  T
613-030-00-X troclosene potassium; [1]troclosene sodium [2] 218-828-8 [1]220-767-7 [2] 2244-21-5 [1]2893-78-9 [2] Ox. Sol. 2Acute Tox. 4 *Eye Irrit. 2STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H272H302H319H335H400H410 GHS03GHS07GHS09Dgr H272H302H319H335H410 EUH031 *STOT SE 3; H335: C ≥ 10 %EUH031: C ≥ 10 % 
613-030-01-7 troclosene sodium, dihydrate 220-767-7 51580-86-0 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H302H319H335H400H410 GHS07GHS09Wng H302H319H335H410 EUH031  
613-031-00-5 symclosene;trichloroisocyanuric acid;trichloro-1,3,5-triazinetrion 201-782-8 87-90-1 Ox. Sol. 2Acute Tox. 4 *Eye Irrit. 2STOT SE 3Aquatic Acute 1Aquatic Chronic 1 H272H302H319H335H400H410 GHS03GHS07GHS09Dgr H272H302H319H335H410 EUH031  
613-032-00-0 methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine 236-035-5 13108-52-6 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1 H312H302H319H317 GHS07Wng H312H302H319H317   
613-033-00-6 2-methylaziridine;propyleneimine 200-878-7 75-55-8 Flam. Liq. 2Carc. 1BAcute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Eye Dam. 1Aquatic Chronic 2 H225H350H330H310H300H318H411 GHS02GHS06GHS08GHS05GHS09Dgr H225H350H330H310H300H318H411  Carc. 1B; H350: C ≥ 0,01 % 
613-034-00-1 1,2-dimethylimidazole 217-101-2 1739-84-0 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1 H302H315H318 GHS05GHS07Dgr H302H315H318   
613-035-00-7 1-methylimidazole 210-484-7 616-47-7 Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1B H312H302H314 GHS05GHS07Dgr H312H302H314   
613-036-00-2 2-methylpyridine;2-picoline 203-643-7 109-06-8 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3 H226H332H312H302H319H335 GHS02GHS07Wng H226H332H312H302H319H335   
613-037-00-8 4-methylpyridine;4-picoline 203-626-4 108-89-4 Flam. Liq. 3Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H226H311H332H302H319H335H315 GHS02GHS06Dgr H226H311H332H302H319H335H315   
613-038-00-3 6-phenyl-1,3,5-triazine-2,4-diyldiamine;6-phenyl-1,3,5-triazine-2,4-diamine;benzoguanamine 202-095-6 91-76-9 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
613-039-00-9 ethylene thiourea;imidazolidine-2-thione;2-imidazoline-2-thiol 202-506-9 96-45-7 Repr. 1BAcute Tox. 4 * H360D ***H302 GHS08GHS07Dgr H360D ***H302   
613-040-00-4 azaconazole (ISO);1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole 262-102-3 60207-31-0 Acute Tox. 4 * H302 GHS07Wng H302   
613-041-00-X morpholine-4-carbonyl chloride 239-213-0 15159-40-7 Carc. 2Eye Irrit. 2Skin Irrit. 2 H351H319H315 GHS08Wng H351H319H315 EUH014  
613-042-00-5 imazalil (ISO);1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 252-615-0 35554-44-0 Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H332H302H318H400H410 GHS05GHS07GHS09Dgr H332H302H318H410   
613-043-00-0 imazalil sulphate (ISO) powder;1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1](±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1]281-291-3 [2] 58594-72-2 [1]83918-57-4 [2] Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
613-043-01-8 imazalil sulphate (ISO), aqueous solution;1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1](±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1]281-291-3 [2] 58594-72-2 [1]83918-57-4 [2] Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H314H317H400H410 GHS05GHS07GHS09Wng H302H314H317H410  Skin Corr. 1B; H314: C ≥ 50 %Skin Irrit. 2; H315: 30 % ≤ C < 50 %Eye Dam. 1; H318: 15 % ≤ C < 50 %Eye Irrit. 2; H319: 5 % ≤ C < 15 % 
613-044-00-6 captan (ISO);1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide 205-087-0 133-06-2 Carc. 2Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1 H351H331H318H317H400 GHS06GHS08GHS05GHS09Dgr H351H331H318H317H400   
613-045-00-1 folpet (ISO);N-(trichloromethylthio)phthalimide 205-088-6 133-07-3 Carc. 2Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1 H351H332H319H317H400 GHS08GHS07GHS09Wng H351H332H319H317H400   
613-046-00-7 captafol (ISO);1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide 219-363-3 2425-06-1 Carc. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H350H317H400H410 GHS08GHS09Dgr H350H317H410   
613-047-00-2 1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;dimetilan (ISO) 211-420-0 644-64-4 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H312H400H410 GHS06GHS09Dgr H301H312H410   
613-048-00-8 carbendazim (ISO);methyl benzimidazol-2-ylcarbamate 234-232-0 10605-21-7 Muta. 1BRepr. 1BAquatic Acute 1Aquatic Chronic 1 H340H360FDH400H410 GHS08GHS09Dgr H340H360FDH410   
613-049-00-3 benomyl (ISO);methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate 241-775-7 17804-35-2 Muta. 1BRepr. 1BSTOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H340H360FDH335H315H317H400H410 GHS08GHS07GHS09Dgr H340H360FDH335H315H317H410  M = 10 
613-050-00-9 carbadox (INN);methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide 229-879-0 6804-07-5 Flam. Sol. 1Carc. 1BAcute Tox. 4 * H228H350H302 GHS02GHS08GHS07Dgr H228H350H302   T
613-051-00-4 molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate;S-ethyl perhydroazepine-1-carbothioate 218-661-0 2212-67-1 Carc. 2Repr. 2Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H361f ***H332H302H373 **H317H400H410 GHS08GHS07GHS09Wng H351H361f ***H332H302H373 **H317H410  M = 100 
613-052-00-X trifenmorph (ISO);4-tritylmorpholine 215-812-2 1420-06-0 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-053-00-5 anilazine (ISO);2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline 202-910-5 101-05-3 Eye Irrit. 2Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H315H400H410 GHS07GHS09Wng H319H315H410   
613-054-00-0 thiabendazol (ISO);2-(thiazole-4-yl)benzimidazole 205-725-8 148-79-8 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-056-00-1 1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;difenzoquat methyl sulfate 256-152-5 43222-48-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS09Wng H302H410   
613-057-00-7 dodemorph (ISO);4-cyclododecyl-2,6-dimethylmorpholine 216-474-9 1593-77-7 Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 2 H319H335H315H411 GHS07GHS09Wng H319H335H315H411   
613-058-00-2 permethrin (ISO);m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 258-067-9 52645-53-1 Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H332H302H317H400H410 GHS07GHS09Wng H332H302H317H410  M = 1 000 
613-059-00-8 profluralin (ISO);N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine 247-656-6 26399-36-0 Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H400H410 GHS07GHS09Wng H319H410   
613-060-00-3 resmethrin (ISO);5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate 233-940-7 10453-86-8 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-061-00-9 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;ryania 239-732-2 15662-33-6 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
613-062-00-4 sabadilla (ISO);veratrine — 8051-02-3 Eye Irrit. 2STOT SE 3Skin Irrit. 2 H319H335H315 GHS07Wng H319H335H315   
613-063-00-X secbumeton (ISO);2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 247-554-1 26259-45-0 Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H400H410 GHS07GHS09Wng H302H319H410   
613-064-00-5 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;sesamex — 51-14-9 Acute Tox. 4 * H302 GHS07Wng H302   
613-065-00-0 simetryn (ISO);2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine 213-801-7 1014-70-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-066-00-6 terbumeton (ISO);2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 251-637-8 33693-04-8 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-067-00-1 propazine(ISO);2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine 205-359-9 139-40-2 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410   
613-068-00-7 atrazine (ISO);2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine 217-617-8 1912-24-9 STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H373 **H317H400H410 GHS08GHS09Wng H373 **H317H410   
613-069-00-2 ε-caprolactam 203-313-2 105-60-2 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2 H332H302H319H335H315 GHS07Wng H332H302H319H335H315   
613-070-00-8 propylenethiourea — 2122-19-2 Repr. 2Acute Tox. 4 *Aquatic Chronic 3 H361d ***H302H412 GHS08GHS07Wng H361d ***H302H412   
613-071-00-3 2-fluoro-5-trifluoromethylpyridine 400-290-2 69045-82-5 Flam. Liq. 3Skin Sens. 1Aquatic Chronic 3 H226H317H412 GHS02GHS07Wng H226H317H412   
613-072-00-9 N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine 401-280-0 91273-04-0 Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H314H317H411 GHS05GHS07GHS09Dgr H314H317H411   
613-073-00-4 N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine 401-410-6 10357-99-0 STOT RE 2 *Skin Sens. 1Aquatic Chronic 2 H373 **H317H411 GHS08GHS09Wng H373 **H317H411   
613-074-00-X 3-(3-methylpent-3-yl)isoxazol-5-ylamine 401-460-9 82560-06-3 Acute Tox. 3 *Acute Tox. 3 *Eye Dam. 1Aquatic Chronic 3 H331H301H318H412 GHS06GHS05Dgr H331H301H318H412   
613-075-00-5 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione 401-570-7 89415-87-2 Ox. Sol. 1 ****Acute Tox. 3 *Skin Corr. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1 H271H331H314H302H317H400 GHS03GHS06GHS05GHS09Dgr H271H331H314H302H317H400   
613-076-00-0 3-chloro-5-trifluoromethyl-2-pyridylamine 401-670-0 79456-26-1 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
613-077-00-6 reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine 401-940-8 — Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2 H302H319H411 GHS07GHS09Wng H302H319H411   
613-078-00-1 N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine 401-990-0 106990-43-6 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
613-079-00-7 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers 402-520-7 — Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H312H302H315H317H400H410 GHS07GHS09Wng H312H302H315H317H410   
613-080-00-2 3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione 402-540-6 105254-85-1 Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H314H317H400H410 GHS05GHS07GHS09Dgr H314H317H410   
613-081-00-8 1-butyl-2-methylpyridinium bromide 402-680-8 26576-84-1 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
613-082-00-3 2-methyl-1-pentylpyridinium bromide 402-690-2 — Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H312H302H412 GHS07Wng H312H302H412   
613-083-00-9 2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate 402-120-2 — Skin Corr. 1BSTOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H314H373 **H317H400H410 GHS08GHS05GHS07GHS09Dgr H314H373 **H317H410   
613-084-00-4 2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate 402-490-5 106359-93-7 Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H400H410 GHS07GHS09Wng H319H410   
613-085-00-X reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione 401-970-1 — Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
613-086-00-5 caffeine 200-362-1 58-08-2 Acute Tox. 4 * H302 GHS07Wng H302   
613-087-00-0 tetrahydrothiophene 203-728-9 110-01-0 Flam. Liq. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 3 H225H332H312H302H319H315H412 GHS02GHS07Dgr H225H332H312H302H319H315H412   
613-088-00-6 1,2-benzisothiazol-3(2H)-one;1,2-benzisothiazolin-3-one 220-120-9 2634-33-5 Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1 H302H315H318H317H400 GHS05GHS07GHS09Dgr H302H315H318H317H400  Skin Sens. 1; H317: C ≥ 0,05 % 
613-089-00-1 diquat dibromide; [1]diquat dichloride; [2]6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3] 201-579-4 [1]223-714-6 [2]301-467-6 [3] 85-00-7 [1]4032-26-2 [2]94021-76-8 [3] Acute Tox. 2 *STOT RE 1Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H372 **H302H319H335H315H317H400H410 GHS06GHS08GHS09Dgr H330H372 **H302H319H335H315H317H410   
613-090-00-7 paraquat dichloride;1,1-dimethyl-4,4'-bipyridinium dichloride; [1]paraquat dimethylsulfate;1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] 217-615-7 [1]218-196-3 [2] 1910-42-5 [1]2074-50-2 [2] Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H330H311H301H372 **H319H335H315H400H410 GHS06GHS08GHS09Dgr H330H311H301H372 **H319H335H315H410   
613-091-00-2 morfamquat dichloride; [1]morfamquat sulfate [2] 225-062-8 [1][2] 4636-83-3 [1]29873-36-7 [2] Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Chronic 3 H302H319H335H315H412 GHS07Wng H302H319H335H315H412   
613-092-00-8 1,10-phenanthroline 200-629-2 66-71-7 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410   
613-093-00-3 hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 400-050-7 85153-92-0 Resp. Sens. 1Skin Sens. 1 H334H317 GHS08Dgr H334H317   
613-094-00-9 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine 401-360-5 5248-39-5 Acute Tox. 4 *STOT RE 2 * H302H373 ** GHS08GHS07Wng H302H373 **   
613-095-00-4 sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate 403-080-9 92484-48-5 Eye Dam. 1 H318 GHS05Dgr H318   
613-096-00-X 2-amino-6-ethoxy-4-methylamino-1,3,5-triazine 403-580-7 62096-63-3 Acute Tox. 4 * H302 GHS07Wng H302   
613-097-00-5 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 403-690-5 111298-82-9 Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3 H334H317H412 GHS08Dgr H334H317H412   
613-098-00-0 N-(n-octyl)-2-pyrrolidone 403-700-8 2687-94-7 Skin Corr. 1BAquatic Chronic 2 H314H411 GHS05GHS09Dgr H314H411   
613-099-00-6 1-dodecyl-2-pyrrolidone 403-730-1 2687-96-9 Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H314H317H400H410 GHS05GHS07GHS09Dgr H314H317H410   
613-100-00-X 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione 404-230-6 — Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
613-101-00-5 N—tert-pentyl-2-benzothiazolesulfenamide 404-380-2 110799-28-5 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
613-102-00-0 dimethomorph (ISO);4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine 404-200-2 110488-70-5 Aquatic Chronic 2 H411 GHS09 H411   
613-103-00-6 sodium 5-n-butylbenzotriazole 404-450-2 118685-34-0 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H302H314H317H411 GHS05GHS07GHS09Dgr H302H314H317H411   
613-104-00-1 5-tert-butyl-3-isoxazolylamine hydrochloride 404-840-2 — Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Aquatic Chronic 3 H302H373 **H318H412 GHS08GHS05GHS07Dgr H302H373 **H318H412   
613-105-00-7 hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate) 405-160-9 124537-30-0 Acute Tox. 3 *Skin Sens. 1Aquatic Chronic 3 H301H317H412 GHS06Dgr H301H317H412   
613-106-00-2 tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate 405-240-3 — Skin Sens. 1 H317 GHS07Wng H317   
613-107-00-8 hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate 405-280-1 76508-02-6 Eye Irrit. 2 H319 GHS07Wng H319   
613-108-00-3 benzothiazole-2-thiol 205-736-8 149-30-4 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
613-109-00-9 bis(piperidinothiocarbonyl) disulphide 202-328-1 94-37-1 Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1 H319H335H315H317 GHS07Wng H319H335H315H317   
613-110-00-4 dimepiperate (ISO);S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate 262-784-2 61432-55-1 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
613-111-00-X 1,2,4-triazole 206-022-9 288-88-0 Repr. 2Acute Tox. 4 *Eye Irrit. 2 H361d ***H302H319 GHS08GHS07Wng H361d ***H302H319   
613-112-00-5 octhilinone (ISO);2-octyl-2H-isothiazol-3-one 247-761-7 26530-20-1 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H311H302H314H317H400H410 GHS06GHS05GHS09Dgr H331H311H302H314H317H410  Skin Sens. 1; H317: C ≥ 0,05 % 
613-113-00-0 2-(morpholinothio)benzothiazole 203-052-4 102-77-2 Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H319H315H317H411 GHS07GHS09Wng H319H315H317H411   
613-114-00-6 2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine 225-208-0 4719-04-4 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317  Skin Sens. 1; H317: C ≥ 0,1 % 
613-115-00-1 hymexazol (ISO);3-hydroxy-5-methylisoxazole 233-000-6 10004-44-1 Acute Tox. 4 *Eye Dam. 1Aquatic Chronic 3 H302H318H412 GHS05GHS07Dgr H302H318H412   
613-116-00-7 tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide 211-986-9 731-27-1 Acute Tox. 3 *STOT RE 2 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H373 **H319H335H315H317H400H410 GHS06GHS08GHS09Dgr H331H373 **H319H335H315H317H410   
613-117-00-2 diniconazole (ISO);(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H—1,2,4-triazol-1-ethanol;(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1-yl)pent-1-en-3-ol — 76714-88-0 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-118-00-8 flubenzimine (ISO);N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline 253-703-1 37893-02-0 Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H319H400H410 GHS07GHS09Wng H319H410   
613-119-00-3 (benzothiazol-2-ylthio)methyl thiocyanate;TCMTB 244-445-0 21564-17-0 Acute Tox. 2 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H330H302H319H315H317H400H410 GHS06GHS09Dgr H330H302H319H315H317H410   
613-120-00-9 bioresmethrin;(5-bezylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboylate 249-014-0 28434-01-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-121-00-4 chlorsulfuron (ISO);2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide 265-268-5 64902-72-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-122-00-X diclobutrazole (ISO);(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H—1,2,4-triazol-1yl)pentan-3-ol — 75736-33-3 Eye Irrit. 2Aquatic Chronic 2 H319H411 GHS07GHS09Wng H319H411   
613-123-00-5 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;etem 251-684-4 33813-20-6 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-124-00-0 fenpropimorph (ISO);cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine 266-719-9 67564-91-4 Repr. 2Acute Tox. 4 *Skin Irrit. 2Aquatic Chronic 2 H361d ***H302H315H411 GHS08GHS07GHS09Wng H361d ***H302H315H411   
613-125-00-6 hexythiazox(ISO);trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide — 78587-05-0 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-126-00-1 imazapyr (ISO);2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate — 81334-34-1 Eye Irrit. 2Aquatic Chronic 3 H319H412 GHS07Wng H319H412   
613-127-00-7 1,1-dimethylpiperidinium chloride;mepiquat chloride 246-147-6 24307-26-4 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
613-128-00-2 prochloraz (ISO);N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide 266-994-5 67747-09-5 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-129-00-8 metamitron (ISO);4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one 255-349-3 41394-05-2 Acute Tox. 4 *Aquatic Acute 1 H302H400 GHS07GHS09Wng H302H400   
613-131-00-9 pyroquilon (ISO);1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one — 57369-32-1 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
613-132-00-4 hexazinone (ISO);3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione 257-074-4 51235-04-2 Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H302H319H400H410 GHS07GHS09Wng H302H319H410   
613-133-00-X etridiazole (ISO);5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole 219-991-8 2593-15-9 Carc. 2Acute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H331H312H302H400H410 GHS06GHS08GHS09Dgr H351H331H312H302H410   
613-134-00-5 myclobutanil(ISO);2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile — 88671-89-0 Repr. 2Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2 H361d ***H302H319H411 GHS08GHS07GHS09Wng H361d ***H302H319H411   
613-135-00-0 di(benzothiazol-2-yl) disulphide 204-424-9 120-78-5 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410 EUH031  
613-136-00-6 N-cyclohexylbenzothiazole-2-sulphenamide 202-411-2 95-33-0 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
613-137-00-1 methabenzthiazuron (ISO);1-(1,3-benzothiazol-2-yl)1,3-dimethylurea 242-505-0 18691-97-9 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-138-00-7 quinoxyfen (ISO);5,7-dichloro-4-(4-fluorophenoxy)quinoline — 124495-18-7 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
613-139-00-2 metsulfuron-methyl;2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid — 74223-64-6 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-140-00-8 cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione 200-636-0 66-81-9 Muta. 2Repr. 1BAcute Tox. 2 *Aquatic Chronic 2 H341H360D ***H300H411 GHS06GHS08GHS09Dgr H341H360D ***H300H411   
613-141-00-3 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone 401-470-3 93686-63-6 Aquatic Chronic 4 H413 — H413   
613-142-00-9 trans—N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate 405-860-4 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
613-143-00-4 1-(3-phenylpropyl)-2-methylpyridinium bromide 405-930-4 10551-42-5 Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 3 H302H319H412 GHS07Wng H302H319H412   
613-144-00-X reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate 406-460-2 125139-08-4 Aquatic Chronic 3 H412 — H412   
613-145-00-5 (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate 406-960-0 77497-97-3 Aquatic Chronic 2 H411 GHS09 H411   
613-146-00-0 N-ethyl-N-methylpiperidinium iodide 407-780-5 4186-71-4 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
613-147-00-6 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine 407-940-4 111681-72-2 Eye Dam. 1 H318 GHS05Dgr H318   
613-148-00-1 tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane 411-240-4 143683-23-2 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
613-149-00-7 pyridaben (ISO);2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 405-700-3 96489-71-3 Acute Tox. 3 *Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H331H301H400H410 GHS06GHS09Dgr H331H301H410   
613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1—b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione 406-295-6 — Aquatic Chronic 4 H413 — H413   
613-151-00-8 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine 406-360-9 104218-44-2 Aquatic Chronic 4 H413 — H413   
613-152-00-3 phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate 406-600-2 89392-03-0 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
613-153-00-9 2,3,5-trichloropyridine 407-270-2 16063-70-0 Aquatic Chronic 3 H412 — H412   
613-154-00-4 2-amino-4-chloro-6-methoxypyrimidine 410-050-9 5734-64-5 Acute Tox. 4 * H302 GHS07Wng H302   
613-155-00-X 5-chloro-2,3-difluoropyridine 410-090-7 89402-43-7 Flam. Liq. 3Acute Tox. 4 *Aquatic Chronic 3 H226H302H412 GHS02GHS07Wng H226H302H412   
613-156-00-5 2-butyl-4-chloro-5-formylimidazole 410-260-0 83857-96-9 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
613-157-00-0 2,4-diamino-5-methoxymethylpyrimidine 410-330-0 54236-98-5 Acute Tox. 4 *STOT RE 2 *Eye Irrit. 2 H302H373 **H319 GHS08GHS07Wng H302H373 **H319   
613-158-00-6 2,3-dichloro-5-trifluoromethyl-pyridine 410-340-5 69045-84-7 Acute Tox. 4 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H332H302H318H317H411 GHS05GHS07GHS09Dgr H332H302H318H317H411   
613-159-00-1 fenazaquin (ISO);4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline 410-580-0 120928-09-8 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H332H400H410 GHS06GHS09Dgr H301H332H410   
613-160-00-7 (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide 411-000-9 125224-62-6 Skin Sens. 1 H317 GHS07Wng H317   
613-163-00-3 azimsulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea — 120162-55-2 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-164-00-9 flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide — 142459-58-3 Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H373 **H317H400H410 GHS08GHS07GHS09Wng H302H373 **H317H410   
613-165-00-4 flupyrsulfuron-methyl-sodium (ISO);methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt — 144740-54-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-166-00-X flumioxazin (ISO);N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H—1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide — 103361-09-7 Repr. 1BAquatic Acute 1Aquatic Chronic 1 H360D ***H400H410 GHS08GHS09Dgr H360D ***H410   
613-167-00-5 reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1) — 55965-84-9 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H311H301H314H317H400H410 GHS06GHS05GHS09Dgr H331H311H301H314H317H410  Skin Corr. 1B; H314: C ≥ 0,6 %Skin Irrit. 2; H315: 0,06 % ≤ C < 0,6 %Eye Irrit. 2; H319: 0,06 % ≤ C < 0,6 %Skin Sens. 1; H317: C ≥ 0,0015 % 
613-168-00-0 1-vinyl-2-pyrrolidone 201-800-4 88-12-0 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *STOT SE 3Eye Dam. 1 H351H332H312H302H373 **H335H318 GHS06GHS05GHS09Dgr H351H332H312H302H373 **H335H318   D
613-169-00-6 9-vinylcarbazole 216-055-0 1484-13-5 Muta. 2Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H341H312H302H315H317H400H410 GHS08GHS07GHS09Wng H341H312H302H315H317H410   
613-170-00-1 2,2-ethylmethylthiazolidine 404-500-3 694-64-4 Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H318H317H411 GHS05GHS07GHS09Dgr H302H318H317H411   
613-171-00-7 hexaconazole (ISO);(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol 413-050-7 79983-71-4 Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H302H317H411 GHS07GHS09Wng H302H317H411   
613-172-00-2 5-chloro-1,3-dihydro-2H-indol-2-one 412-200-9 17630-75-0 Repr. 2Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 3 H361f ***H302H317H412 GHS08GHS07Wng H361f ***H302H317H412   
613-173-00-8 fluquinconazole (ISO);3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one 411-960-9 136426-54-5 Acute Tox. 3 *Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H331H301H372 **H312H315H400H410 GHS06GHS08GHS09Dgr H331H301H372 **H312H315H410   
613-174-00-3 (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether 407-760-6 112281-77-3 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H351H332H302H411 GHS08GHS07GHS09Wng H351H332H302H411   
613-175-00-9 epoxiconazole(ISO);(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane 406-850-2 133855-98-8 Carc. 2Repr. 2Aquatic Chronic 2 H351H361fdH411 GHS08GHS09Wng H351H361fdH411   
613-176-00-4 2-methyl-2-azabicyclo[2.2.1]heptane 404-810-9 4524-95-2 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1B H226H312H302H373 **H314 GHS02GHS08GHS05GHS07Dgr H226H312H302H373 **H314   
613-177-00-X 8-amino-7-methylquinoline 412-760-4 5470-82-6 Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Chronic 2 H312H302H317H411 GHS07GHS09Wng H312H302H317H411   
613-178-00-5 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine 410-470-2 137796-06-6 Skin Corr. 1BSkin Sens. 1 H314H317 GHS05GHS07Dgr H314H317  STOT SE 3; H335: C ≥ 5 % 
613-179-00-0 lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide 411-690-1 111337-53-2 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Chronic 2 H302H314H317H411 GHS05GHS07Dgr H302H314H317H411   
613-180-00-6 N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide 407-430-1 3741-80-8 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-181-00-1 5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone 405-090-9 67485-29-4 STOT RE 1Acute Tox. 4 *Eye Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H372 **H302H319H400H410 GHS08GHS07GHS09Dgr H372 **H302H319H410   
613-182-00-7 1-(1-naphthylmethyl)quinolinium chloride 406-220-7 65322-65-8 Carc. 2Muta. 2Acute Tox. 4 *Skin Irrit. 2Eye Dam. 1Aquatic Chronic 3 H351H341H302H315H318H412 GHS08GHS05GHS07Dgr H351H341H302H315H318H412   
613-183-00-2 reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one 413-640-4 — STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H373 **H400H410 GHS08GHS09Wng H373 **H410   
613-184-00-8 nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate 413-670-8 — Eye Irrit. 2Skin Sens. 1 H319H317 GHS07Wng H319H317   
613-185-00-3 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one 407-630-9 82633-79-2 Acute Tox. 3 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H301H318H317H400H410 GHS06GHS05GHS09Dgr H301H318H317H410   
613-186-00-9 (2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate 408-050-9 76855-69-1 Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2 H319H317H411 GHS07GHS09Wng H319H317H411   
613-188-00-X 1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone 411-500-7 116256-11-2 Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H318H317H411 GHS05GHS07GHS09Dgr H302H318H317H411   
613-189-00-5 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane 414-030-0 52667-88-6 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
613-190-00-0 disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate 414-040-5 149530-93-8 Acute Tox. 4 *Skin Sens. 1 H302H317 GHS07Wng H302H317   
613-191-00-6 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine 421-150-7 143860-04-2 Repr. 1BSkin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H360F ***H314H400H410 GHS08GHS05GHS09Dgr H360F ***H314H410   
613-193-00-7 pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate 414-930-3 — Aquatic Chronic 2 H411 GHS09 H411   
613-194-00-2 6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt 418-000-8 163062-28-0 Eye Dam. 1 H318 GHS05Dgr H318   
613-195-00-8 2,2-(1,4-phenylene)bis((4H—3,1-benzoxazine-4-one) 418-280-1 18600-59-4 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
613-196-00-3 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt 418-380-5 168113-78-8 Eye Dam. 1 H318 GHS05Dgr H318   
613-197-00-9 reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine 420-390-1 187547-46-2 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
613-199-00-X reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione 421-550-1 — Carc. 1BRepr. 1BSkin Sens. 1Aquatic Chronic 3 H350H360D ***H317H412 GHS08Dgr H350H360D ***H317H412   
613-200-00-3 Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts 420-980-7 — Eye Dam. 1 H318 GHS05Dgr H318   
613-201-00-9 (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole 422-390-5 143322-57-0 Repr. 2STOT RE 1Acute Tox. 4 *Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361f ***H372 **H332H302H317H400H410 GHS08GHS07GHS09Dgr H361f ***H372 **H332H302H317H410 EUH070  
613-202-00-4 pymetrozine (ISO);(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one — 123312-89-0 Carc. 2Aquatic Chronic 3 H351H412 GHS08Wng H351H412   
613-203-00-X pyraflufen-ethyl; [1]pyraflufen [2] -[1]-[2] 129630-19-9 [1]129630-17-7 [2] Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-204-00-5 oxadiargyl (ISO);3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one 254-637-6 39807-15-3 Repr. 2STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H361d ***H373 **H400H410 GHS08GHS09Wng H361d ***H373 **H410   
613-205-00-0 propiconazole(ISO);(±) 1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H—1,2,4-triazole 262-104-4 60207-90-1 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
613-206-00-6 fenamidone (ISO);(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one — 161326-34-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-208-00-7 imazamox (ISO);(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid — 114311-32-9 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-209-00-2 cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride 417-430-3 63645-17-0 Acute Tox. 3 *STOT RE 2 *Skin Sens. 1Aquatic Chronic 2 H301H373 **H317H411 GHS06GHS08GHS09Dgr H301H373 **H317H411   
613-210-00-8 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane 417-650-1 88128-57-8 STOT RE 2 *Aquatic Chronic 3 H373 **H412 GHS08Wng H373 **H412   
613-211-00-3 N-methyl-4-(p-formylstyryl)pyridinium methylsulfate 418-240-3 74401-04-0 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
613-212-00-9 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) 418-320-8 133467-41-1 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
613-213-00-4 cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline 416-040-0 120807-02-5 Aquatic Chronic 3 H412 — H412   
613-214-00-X N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide 416-260-7 147613-95-4 Aquatic Chronic 4 H413 — H413   
613-215-00-5 2-chloromethyl-3,4-dimethoxypyridinium chloride 416-440-5 72830-09-2 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H312H302H373 **H315H318H317H411 GHS08GHS05GHS07GHS09Dgr H312H302H373 **H315H318H317H411   
613-216-00-0 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole 416-490-8 162208-01-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-217-00-6 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine 416-770-1 73754-27-5 Aquatic Chronic 4 H413 — H413   
613-218-00-1 6-hydroxyindole 417-020-4 2380-86-1 Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H302H318H317H411 GHS05GHS07GHS09Dgr H302H318H317H411   
613-219-00-7 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole 417-140-7 79185-77-6 Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
613-220-00-2 trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide 417-290-3 147086-81-5 Acute Tox. 4 * H302 GHS07Wng H302   
613-221-00-8 2-chloro-5-methyl-pyridine 418-050-0 18368-64-4 Acute Tox. 4 *Acute Tox. 4 *Skin Irrit. 2Aquatic Chronic 3 H312H302H315H412 GHS07Wng H312H302H315H412   
613-222-00-3 4-(1-oxo-2-propenyl)-morpholine 418-140-1 5117-12-4 Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1 H302H373 **H318H317 GHS08GHS05GHS07Dgr H302H373 **H318H317   
613-223-00-9 N-isopropyl-3-(4-fluorophenyl)-1H-indole 418-790-4 93957-49-4 Aquatic Chronic 4 H413 — H413   
613-224-00-4 2,5-dimercaptomethyl-1,4-dithiane 419-770-8 136122-15-1 Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H314H317H400H410 GHS05GHS07GHS09Dgr H302H314H317H410   
613-225-00-X reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. 421-290-9 — STOT RE 2 *Aquatic Chronic 4 H373 **H413 GHS08Wng H373 **H413   
613-226-00-5 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride 420-950-3 163831-67-2 Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H318H400H410 GHS05GHS09Dgr H318H410   
613-227-00-0 (±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 419-600-2 99199-90-3 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
613-228-00-6 (±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 419-630-6 793669-26-8 Aquatic Chronic 2 H411 GHS09 H411   
613-230-00-7 florasulam (ISO);2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];pyrimidine-2-sulfonanilide — 145701-23-1 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
613-233-00-3 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane 423-230-7 56552-15-9 Eye Dam. 1 H318 GHS05Dgr H318   
614-001-00-4 nicotine (ISO);3-(N-methyl-2-pyrrolidinyl)pyridine 200-193-3 54-11-5 Acute Tox. 1Acute Tox. 3 *Aquatic Chronic 2 H310H301H411 GHS06GHS09Dgr H310H301H411   
614-002-00-X salts of nicotine — — Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 *Aquatic Chronic 2 H330H310H300H411 GHS06GHS09Dgr H330H310H300H411   A
614-003-00-5 strychnine 200-319-7 57-24-9 Acute Tox. 1Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H310H300H400H410 GHS06GHS09Dgr H310H300H410   
614-004-00-0 salts of strychnine — — Acute Tox. 2 *Acute Tox. 2 *Aquatic Acute 1Aquatic Chronic 1 H330H300H400H410 GHS06GHS09Dgr H330H300H410   A
614-005-00-6 colchicine 200-598-5 64-86-8 Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   
614-006-00-1 brucine;2,3-dimethoxystrychnine 206-614-7 357-57-3 Acute Tox. 2 *Acute Tox. 2 *Aquatic Chronic 3 H330H300H412 GHS06Dgr H330H300H412   
614-007-00-7 brucine sulphate; [1]brucine nitrate; [2]strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] 225-432-9 [1]227-317-9 [2]269-439-5 [3]269-710-8 [4] 4845-99-2 [1]5786-97-0 [2]68239-26-9 [3]68310-42-9 [4] Acute Tox. 2 *Acute Tox. 2 *Aquatic Chronic 3 H330H300H412 GHS06Dgr H330H300H412   A
614-008-00-2 aconitine 206-121-7 302-27-2 Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   
614-009-00-8 salts of aconitine — — Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   A
614-010-00-3 atropine 200-104-8 51-55-8 Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   
614-011-00-9 salts of atropine — — Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   A
614-012-00-4 hyoscyamine 202-933-0 101-31-5 Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   
614-013-00-X salts of hyoscyamine — — Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   A
614-014-00-5 hyoscine 200-090-3 51-34-3 Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 * H330H310H300 GHS06Dgr H330H310H300   
614-015-00-0 salts of hyoscine — — Acute Tox. 2 *Acute Tox. 1Acute Tox. 2 * H330H310H300 GHS06Dgr H330H310H300   A
614-016-00-6 pilocarpine 202-128-4 92-13-7 Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   
614-017-00-1 salts of pilocarpine — — Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   A
614-018-00-7 papaverine 200-397-2 58-74-2 Acute Tox. 4 * H302 GHS07Wng H302   
614-019-00-2 salts of papaverine — — Acute Tox. 4 * H302 GHS07Wng H302   A
614-020-00-8 physostigmine 200-332-8 57-47-6 Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   
614-021-00-3 salts of physostigmine — — Acute Tox. 2 *Acute Tox. 2 * H330H300 GHS06Dgr H330H300   A
614-022-00-9 digitoxin 200-760-5 71-63-6 Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 * H331H301H373 ** GHS06GHS08Dgr H331H301H373 **   
614-023-00-4 ephedrine 206-080-5 299-42-3 Acute Tox. 4 * H302 GHS07Wng H302   
614-024-00-X salts of ephedrine — — Acute Tox. 4 * H302 GHS07Wng H302   A
614-025-00-5 ouabain 211-139-3 630-60-4 Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 * H331H301H373 ** GHS06GHS08Dgr H331H301H373 **   
614-026-00-0 strophantin-K 234-239-9 11005-63-3 Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 * H331H301H373 ** GHS06GHS08Dgr H331H301H373 **   
614-027-00-6 bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;red squill;scilliroside 208-077-4 507-60-8 Acute Tox. 2 * H300 GHS06Dgr H300   
614-028-00-1 reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;2-ethylhexyl di-D-glucopyranoside 414-420-0 — Eye Dam. 1 H318 GHS05Dgr H318   
614-029-00-7 constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside 419-640-0 68784-14-5 Acute Tox. 4 * H302 GHS07Wng H302   
615-001-00-7 methyl isocyanate 210-866-3 624-83-9 Flam. Liq. 2Repr. 2Acute Tox. 2 *Acute Tox. 3 *Acute Tox. 3 *STOT SE 3Skin Irrit. 2Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H225H361d ***H330H311H301H335H315H318H334H317 GHS02GHS06GHS06GHS08GHS05Dgr H225H361d ***H330H311H301H335H315H318H334H317   
615-002-00-2 methyl isothiocyanate 209-132-5 556-61-6 Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H301H314H317H400H410 GHS06GHS05GHS09Dgr H331H301H314H317H410   
615-003-00-8 thiocyanic acid 207-337-4 463-56-9 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H332H312H302H412 GHS07Wng H332H312H302H412 EUH032  
615-004-00-3 salts of thiocyanic acid — — Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H332H312H302H412 GHS07Wng H332H312H302H412 EUH032  A
615-005-00-9 4,4'-methylenediphenyl diisocyanate;diphenylmethane-4,4'-diisocyanate; [1]2,2'-methylenediphenyl diisocyanate;diphenylmethane-2,2'-diisocyanate; [2]o-(p-isocyanatobenzyl)phenyl isocyanate;diphenylmethane-2,4'-diisocyanate; [3]methylenediphenyl diisocyanate [4] 202-966-0 [1]219-799-4 [2]227-534-9 [3]247-714-0 [4] 101-68-8 [1]2536-05-2 [2]5873-54-1 [3]26447-40-5 [4] Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1Skin Sens. 1 H332H319H335H315H334H317 GHS08GHS07Dgr H332H319H335H315H334H317  Eye Irrit.; H319: C ≥ 5 %STOT SE 3; H335: C ≥ 5 %Skin Irrit. 2; H315: C ≥ 5 %Resp. Sens. 1; H334: C ≥ 0,1 % C2
615-006-00-4 2-methyl-m-phenylene diisocyanate;toluene-2,4-di-isocyanate; [1]4-methyl-m-phenylene diisocyanate;toluene-2,6-di-isocyanate; [2]m-tolylidene diisocyanate;toluene-diisocyanate [3] 202-039-0 [1]209-544-5 [2]247-722-4 [3] 91-08-7 [1]584-84-9 [2]26471-62-5 [3] Carc. 2Acute Tox. 2 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Chronic 3 H351H330H319H335H315H334H317H412 GHS06GHS08Dgr H351H330H319H335H315H334H317H412  Resp. Sens. 1; H334: C ≥ 0,1 % C
615-007-00-X 1,5-naphthylene diisocyanate 221-641-4 3173-72-6 Acute Tox. 4 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1Aquatic Chronic 3 H332H319H335H315H334H412 GHS08GHS07Dgr H332H319H335H315H334H412   
615-008-00-5 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;isophorone di-isocyanate 223-861-6 4098-71-9 Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1Skin Sens. 1Aquatic Chronic 2 H331H319H335H315H334H317H411 GHS06GHS08GHS09Dgr H331H319H335H315H334H317H411  *Resp. Sens. 1; H334: C ≥ 0,5 %Skin Sens.1; H317: C ≥ 0,5 % 2
615-009-00-0 4,4'-methylenedi(cyclohexyl isocyanate);dicyclohexylmethane-4,4'-di-isocyanate 225-863-2 5124-30-1 Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1Skin Sens. 1 H331H319H335H315H334H317 GHS06GHS08Dgr H331H319H335H315H334H317  *Resp. Sens. 1; H334: C ≥ 0,5 %Skin Sens. 1; H317: C ≥ 0,5 % 2
615-010-00-6 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] 241-001-8 [1]239-714-4 [2] 16938-22-0 [1]15646-96-5 [2] Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H331H319H335H315H334 GHS06GHS08Dgr H331H319H335H315H334  *Resp. Sens. 1; H334: C ≥ 0,5 %Skin Sens. 1; H317: C ≥ 0,5 % C2
615-011-00-1 hexamethylene-di-isocyanate 212-485-8 822-06-0 Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1Skin Sens. 1 H331H319H335H315H334H317 GHS06GHS08Dgr H331H319H335H315H334H317  *Resp. Sens. 1; H334: C ≥ 0,5 %Skin Sens. 1; H317: C ≥ 0,5 % 2
615-012-00-7 4-isocyanatosulphonyltoluene;tosyl isocyanate 223-810-8 4083-64-1 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334 EUH014 Eye Irrit.; H319: C ≥ 5 %STOT SE 3; H335: C ≥ 5 %Skin Irrit. 2; H315: C ≥ 5 % 
615-013-00-2 cyanamide;carbanonitril 206-992-3 420-04-2 Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H301H312H319H315H317 GHS06Dgr H301H312H319H315H317   
615-014-00-8 tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate — 7276-58-6 Acute Tox. 4 * H302 GHS07Wng H302   
615-015-00-3 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;isobornyl thiocyanoacetate 204-081-5 115-31-1 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
615-016-00-9 potassium cyanate 209-676-3 590-28-3 Acute Tox. 4 * H302 GHS07Wng H302   
615-017-00-4 calcium cyanamide 205-861-8 156-62-7 Acute Tox. 4 *STOT SE 3Eye Dam. 1 H302H335H318 GHS05GHS07Dgr H302H335H318   
615-018-00-X 2-(2-butoxyethoxy)ethyl thiocyanate 203-985-7 112-56-1 Flam. Liq. 3Acute Tox. 3 *Acute Tox. 3 * H226H311H301 GHS02GHS06Dgr H226H311H301   
615-019-00-5 dicyclohexylcarbodiimide 208-704-1 538-75-0 Acute Tox. 3 *Acute Tox. 4 *Eye Dam. 1Skin Sens. 1 H311H302H318H317 GHS06GHS05Dgr H311H302H318H317   
615-020-00-0 methylene dithiocyanate 228-652-3 6317-18-6 Acute Tox. 2 *Acute Tox. 3 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1 H330H301H314H317H400 GHS06GHS05GHS09Dgr H330H301H314H317H400   
615-021-00-6 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;TGIC 219-514-3 2451-62-9 Muta. 1BAcute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H340H331H301H373 **H318H317H412 GHS06GHS08GHS05Dgr H340H331H301H373 **H318H317H412   
615-022-00-1 methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate 410-550-7 79277-18-2 STOT RE 2 *Resp. Sens. 1Skin Sens. 1 H373 **H334H317 GHS08Dgr E; R2H373 **H334H317 EUH014  
615-023-00-7 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate 410-900-9 83056-32-0 Flam. Liq. 3Muta. 2Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Resp. Sens. 1 H226H341H332H373 **H318H334 GHS02GHS08GHS05GHS07Dgr H226H341H332H373 **H318H334 EUH014  
615-024-00-2 2-phenylethylisocyanate 413-080-0 1943-82-4 Acute Tox. 3 *Acute Tox. 4 *Skin Corr. 1AResp. Sens. 1Skin Sens. 1Aquatic Chronic 2 H331H302H314H334H317H411 GHS06GHS08GHS05GHS09Dgr H331H302H314H334H317H411   
615-025-00-8 4,4'-ethylidenediphenyl dicyanate 405-740-1 47073-92-7 Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H332H302H373 **H318H400H410 GHS08GHS05GHS07GHS09Dgr H332H302H373 **H318H410   
615-026-00-3 4,4'-methylenebis(2,6-dimethylphenyl cyanate) 405-790-4 101657-77-6 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
615-028-00-4 ethyl 2-(isocyanatosulfonyl)benzoate 410-220-2 77375-79-2 ****Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Resp. Sens. 1Skin Sens. 1 H302H373 **H318H334H317 GHS08GHS05GHS07Dgr E; R2H302H373 **H318H334H317 EUH014  
615-029-00-X 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane 411-280-2 — Acute Tox. 2 *Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1Skin Sens. 1Aquatic Chronic 3 H330H302H314H334H317H412 GHS06GHS08GHS05Dgr H330H302H314H334H317H412   
615-030-00-5 alkali salts, alkali earth salts and other salts of thiocyanic acid not mentioned elsewhere in this Annex — — Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 3 H332H312H302H412 GHS07Wng H332H312H302H412 EUH032  A
615-031-00-0 thallium salt of thiocyanic acid 222-571-7 3535-84-0 Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Chronic 2 H332H312H302H411 GHS07GHS09Wng H332H312H302H411 EUH032  A
615-032-00-6 metal salts of thiocyanic acid not mentioned elsewhere in this Annex — — Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H332H312H302H400H410 GHS07GHS09Wng H332H312H302H410 EUH032  A
616-001-00-X N,N-dimethylformamide;dimethyl formamide 200-679-5 68-12-2 Repr. 1BAcute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2 H360D ***H332H312H319 GHS08GHS07Dgr H360D ***H332H312H319   
616-002-00-5 2-fluoroacetamide 211-363-1 640-19-7 Acute Tox. 2 *Acute Tox. 3 * H300H311 GHS06Dgr H300H311   
616-003-00-0 acrylamide;prop-2-enamide 201-173-7 79-06-1 Carc. 1BMuta. 1BRepr. 2Acute Tox. 3 *STOT RE 1Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Skin Sens. 1 H350H340H361f ***H301H372 **H332H312H319H315H317 GHS06GHS08Dgr H350H340H361f ***H301H372 **H332H312H319H315H317   D
616-004-00-6 allidochlor (ISO);N,N-diallylchloroacetamide 202-270-7 93-71-0 Acute Tox. 4 *Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H312H302H319H315H411 GHS07GHS09Wng H312H302H319H315H411   
616-005-00-1 chlorthiamid (ISO);2,6-dichloro (thiobenzamide) 217-637-7 1918-13-4 Acute Tox. 4 * H302 GHS07Wng H302   
616-006-00-7 dichlofluanid (ISO);N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulphamide 214-118-7 1085-98-9 Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H332H319H317H400H410 GHS07GHS09Wng H332H319H317H410   
616-007-00-2 diphenamid (ISO);N,N-dimethyl-2,2-diphenylacetamide 213-482-4 957-51-7 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
616-008-00-8 propachlor (ISO);2-chloro-N-isopropylacetanilide;α-chloro-N-isopropylacetanilide 217-638-2 1918-16-7 Acute Tox. 4 *Eye Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H319H317H400H410 GHS07GHS09Wng H302H319H317H410   
616-009-00-3 propanil (ISO);3',4'-dichloropropionanilide 211-914-6 709-98-8 Acute Tox. 4 *Aquatic Acute 1 H302H400 GHS07GHS09Wng H302H400   
616-010-00-9 tosylchloramide sodium 204-854-7 127-65-1 Acute Tox. 4 *Skin Corr. 1BResp. Sens. 1 H302H314H334 GHS08GHS05GHS07Dg H302H314H334 EUH031  
616-011-00-4 N,N-dimethylacetamide 204-826-4 127-19-5 Repr. 1BAcute Tox. 4 *Acute Tox. 4 * H360D ***H332H312 GHS08GHS07Dgr H360D ***H332H312  Repr. 1B; H360D: C ≥ 5 % 
616-012-00-X N-(dichlorofluoromethylthio)phthalimide;N-(fluorodichloromethylthio)phthalimide 211-952-3 719-96-0 Skin Irrit. 2 H315 GHS07Wng H315   
616-013-00-5 butyraldehyde oxime 203-792-8 110-69-0 Acute Tox. 3 *Acute Tox. 4 *Eye Irrit. 2 H311H302H319 GHS06Dgr H311H302H319   
616-014-00-0 2-butanone oxime;ethyl methyl ketoxime;ethyl methyl ketone oxime 202-496-6 96-29-7 Carc. 2Acute Tox. 4 *Eye Dam. 1Skin Sens. 1 H351H312H318H317 GHS08GHS05GHS07Dgr H351H312H318H317   
616-015-00-6 alachlor (ISO);2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide 240-110-8 15972-60-8 Carc. 2Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H351H302H317H400H410 GHS08GHS07GHS09Wng H351H302H317H410  M=10 
616-016-00-1 1-(3,4-dichlorophenylimino) thiosemicarbazide — 5836-73-7 Acute Tox. 2 * H300 GHS06Dgr H300   
616-017-00-7 cartap hydrochloride 239-309-2 15263-52-2 Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H312H302H400H410 GHS07GHS09Wng H312H302H410   
616-018-00-2 N,N-diethyl-m-toluamide;deet 205-149-7 134-62-3 Acute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 3 H302H319H315H412 GHS07Wng H302H319H315H412   
616-019-00-8 perfluidone (ISO);1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide; 253-718-3 37924-13-3 Acute Tox. 4 *Eye Irrit. 2 H302H319 GHS07Wng H302H319   
616-020-00-3 tebuthiuron (ISO);1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 251-793-7 34014-18-1 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
616-021-00-9 thiazafluron (ISO);1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea 246-901-4 25366-23-8 Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
616-022-00-4 acetamide 200-473-5 60-35-5 Carc. 2 H351 GHS08Wng H351   
616-023-00-X N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide 401-980-6 — Skin Irrit. 2Skin Sens. 1 H315H317 GHS07Wng H315H317   
616-024-00-5 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide 402-260-4 54942-74-4 Aquatic Chronic 4 H413 — H413   
616-025-00-0 valinamide 402-840-7 20108-78-5 Repr. 2Eye Irrit. 2Skin Sens. 1 H361f ***H319H317 GHS08Wng H361f ***H319H317   
616-026-00-6 thioacetamide 200-541-4 62-55-5 Carc. 1BAcute Tox. 4 *Eye Irrit. 2Skin Irrit. 2Aquatic Chronic 3 H350H302H319H315H412 GHS08GHS07Dgr H350H302H319H315H412   
616-027-00-1 tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate 403-760-5 — Skin Sens. 1 H317 GHS07Wng H317   
616-028-00-7 N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 403-790-9 108673-51-4 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
616-029-00-2 N,N'-ethylenebis(vinylsulfonylacetamide) 404-790-1 66710-66-5 Eye Dam. 1Skin Sens. 1 H318H317 GHS05GHS07Dgr H318H317   
616-030-00-8 ethidimuron (ISO);1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 250-010-6 30043-49-3 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
616-031-00-3 dimethachlor (ISO);2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide; 256-625-6 50563-36-5 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
616-032-00-9 diflufenican (ISO);N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide — 83164-33-4 Aquatic Chronic 3 H412 — H412   
616-033-00-4 cyprofuram (ISO);N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide 274-050-9 69581-33-5 Acute Tox. 3 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H301H312H400H410 GHS06GHS09Dgr H301H312H410   
616-034-00-X pyracarbolid; (ISO);3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide 246-419-4 24691-76-7 Aquatic Chronic 3 H412 — H412   
616-035-00-5 cymoxanil (ISO);2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-0 57966-95-7 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
616-036-00-0 2-chloracetamide 201-174-2 79-07-2 Repr. 2Acute Tox. 3 *Skin Sens. 1 H361f ***H301H317 GHS06GHS08Dgr H361f ***H301H317  Skin Sens. 1; H317: C ≥ 0,1 % 
616-037-00-6 acetochlor (ISO);2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide 251-899-3 34256-82-1 Acute Tox. 4 *STOT SE 3Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H332H335H315H317H400H410 GHS07GHS09Wng H332H335H315H317H410   
616-038-00-1 (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride 406-010-5 88918-84-7 Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H318H317H411 GHS05GHS07GHS09Dgr H318H317H411   
616-039-00-7 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide 406-200-8 117827-06-2 Skin Sens. 1 H317 GHS07Wng H317   
616-040-00-2 potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide 406-650-5 97888-41-0 Eye Dam. 1 H318 GHS05Dgr H318   
616-041-00-8 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide 406-840-8 101664-25-9 Aquatic Chronic 4 H413 — H413   
616-042-00-3 N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide 407-070-5 142859-67-4 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
616-043-00-9 isoxaben (ISO);N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide 407-190-8 82558-50-7 Aquatic Chronic 4 H413 — H413   
616-044-00-4 N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide 402-510-2 — Aquatic Chronic 2 H411 GHS09 H411   
616-045-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide 405-190-2 122371-93-1 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
616-046-00-5 N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 406-390-2 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-047-00-0 reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide 406-640-0 — Skin Sens. 1 H317 GHS07Wng H317   
616-048-00-6 3'-trifluoromethylisobutyranilide 406-740-4 1939-27-1 STOT RE 2 *Aquatic Chronic 2 H373 **H411 GHS08GHS09Wng H373 **H411   
616-049-00-1 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide 408-150-2 99141-89-6 Aquatic Chronic 4 H413 — H413   
616-050-00-7 lufenuron (ISO);N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide 410-690-9 103055-07-8 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
616-051-00-2 reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene 411-070-0 — Aquatic Chronic 4 H413 — H413   
616-052-00-8 formamide 200-842-0 75-12-7 Repr. 1B H360D *** GHS08Dgr H360D ***   
616-053-00-3 N-methylacetamide 201-182-6 79-16-3 Repr. 1B H360D *** GHS08Dgr H360D ***   
616-054-00-9 iprodione (ISO);3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide 253-178-9 36734-19-7 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410   
616-055-00-4 propyzamide (ISO);3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide 245-951-4 23950-58-5 Carc. 2Aquatic Acute 1Aquatic Chronic 1 H351H400H410 GHS08GHS09Wng H351H410   
616-056-00-X N-methylformamide 204-624-6 123-39-7 Repr. 1BAcute Tox. 4 * H360D ***H312 GHS08GHS07Dg H360D ***H312   
616-057-00-5 reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;methacrylamide;2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide 412-790-8 — Carc. 1BMuta. 2STOT RE 2 * H350H341H373 ** GHS08Dgr H350H341H373 **   
616-058-00-0 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene 412-570-1 119462-56-5 STOT RE 2 *Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H373 **H318H317H400H410 GHS08GHS05GHS07GHS09Dgr H373 **H318H317H410   
616-059-00-6 4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide 412-650-6 121487-83-0 Aquatic Chronic 4 H413 — H413   
616-060-00-1 Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) 413-770-1 — Acute Tox. 4 *Skin Corr. 1BSkin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H314H317H400H410 GHS05GHS07GHS09Dgr H302H314H317H410   
616-061-00-7 N,N'—1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide 413-610-0 124172-53-8 Eye Irrit. 2Aquatic Chronic 3 H319H412 GHS07Wng H319H412   
616-062-00-2 N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide 411-590-8 70693-57-1 Skin Corr. 1BAquatic Chronic 3 H314H412 GHS05Dgr H314H412   
616-063-00-8 3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione 411-920-0 106917-30-0 Acute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1AAquatic Acute 1Aquatic Chronic 1 H331H302H373 **H314H400H410 GHS06GHS08GHS05GHS09Dgr H331H302H373 **H314H410   
616-064-00-3 N—tert-butyl-3-methylpicolinamide 406-720-5 32998-95-1 Aquatic Chronic 3 H412 — H412   
616-065-00-9 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea 411-970-3 79881-89-3 Acute Tox. 4 *STOT RE 2 * H302H373 ** GHS08GHS07Wng H302H373 **   
616-066-00-4 5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone 405-100-1 115662-06-1 Repr. 2 H361f *** GHS08Wng H361f ***   
616-067-00-X dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate 407-300-4 92683-20-0 Aquatic Chronic 4 H413 — H413   
616-068-00-5 potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate 406-500-9 174393-75-0 Skin Sens. 1 H317 GHS07Wng H317   
616-069-00-0 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide 406-210-2 110560-22-0 Aquatic Chronic 4 H413 — H413   
616-070-00-6 reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-530-2 — Aquatic Chronic 4 H413 — H413   
616-071-00-1 reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;bis(N-octadecyl-N'-phenyleneureido)methylene;bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) 406-550-1 — Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
616-072-00-7 1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine 407-120-6 55612-11-8 Aquatic Chronic 4 H413 — H413   
616-073-00-2 4'-ethoxy-2-benzimidazoleanilide 407-600-5 120187-29-3 Muta. 2Aquatic Chronic 4 H341H413 GHS08Wng H341H413   
616-074-00-8 N-butyl-2-(4-morpholinylcarbonyl)benzamide 407-730-2 104958-67-0 Eye Irrit. 2Skin Sens. 1Aquatic Chronic 3 H319H317H412 GHS07Wng H319H317H412   
616-075-00-3 D, L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) 408-120-9 65197-96-8 Acute Tox. 4 *Eye Dam. 1 H302H318 GHS05GHS07Dgr H302H318   
616-076-00-9 tebufenozide (ISO);N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide 412-850-3 112410-23-8 Aquatic Chronic 2 H411 GHS09 H411   
616-077-00-4 reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate 411-310-4 — Eye Dam. 1 H318 GHS05Dgr H318   
616-078-00-X 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide 411-330-3 104541-33-5 Aquatic Chronic 4 H413 — H413   
616-079-00-5 1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate 411-700-4 140921-24-0 Skin Sens. 1 H317 GHS07Wng H317   
616-080-00-0 4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide) 411-850-0 119018-29-0 Aquatic Chronic 3 H412 — H412   
616-081-00-6 5-bromo-8-naphtholactam 413-480-5 24856-00-6 Acute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H317H400H410 GHS07GHS09Wng H302H317H410   
616-082-00-1 N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide 413-200-1 129604-78-0 Skin Sens. 1 H317 GHS07Wng H317   
616-083-00-7 [2-[(4-nitrophenyl)amino]ethyl]urea 410-700-1 27080-42-8 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
616-084-00-2 2,4-bis[N'-(4-methylphenyl)ureido]toluene 411-790-5 — Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-085-00-8 3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione 412-190-6 168900-02-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-086-00-3 2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene 412-250-1 102387-48-4 Aquatic Chronic 4 H413 — H413   
616-087-00-9 reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate 412-260-6 52658-19-2 Eye Irrit. 2Skin Sens. 1Aquatic Chronic 2 H319H317H411 GHS07GHS09Wng H319H317H411   
616-088-00-4 2-aminosulfonyl-N,N-dimethylnicotinamide 413-440-7 112006-75-4 Skin Sens. 1Aquatic Chronic 3 H317H412 GHS07Wng H317H412   
616-089-00-X 5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran 415-360-8 41107-56-6 Muta. 2 H341 GHS08Wng H341   
616-090-00-5 1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride 415-660-9 70918-74-0 Acute Tox. 3 *Acute Tox. 3 *Acute Tox. 3 *STOT RE 2 *Aquatic Chronic 2 H331H311H301H373 **H411 GHS06GHS08GHS09Dgr H331H311H301H373 **H411   
616-091-00-0 1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione 423-400-0 59653-74-6 Muta. 1BAcute Tox. 3 *Acute Tox. 4 *STOT RE 2 *Eye Dam. 1Skin Sens. 1 H340H331H302H373 **H318H317 GHS06GHS08GHS05Dgr H340H331H302H373 **H318H317   
616-092-00-6 Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide 404-035-6 — Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
616-093-00-1 Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride 406-620-1 129217-90-9 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
616-094-00-7 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea 406-370-3 58890-25-8 Skin Sens. 1Aquatic Chronic 4 H317H413 GHS07Wng H317H413   
616-095-00-2 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-690-3 43136-14-7 Aquatic Chronic 4 H413 — H413   
616-096-00-8 N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide 408-110-4 110483-07-3 Aquatic Chronic 4 H413 — H413   
616-097-00-3 N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide 411-840-6 83372-55-8 Aquatic Chronic 4 H413 — H413   
616-098-00-9 1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide 411-750-7 119126-15-7 Aquatic Chronic 2 H411 GHS09 H411   
616-099-00-4 2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide 414-170-2 135937-20-1 Aquatic Chronic 4 H413 — H413   
616-100-00-8 1,3-dimethyl-1,3-bis(trimethylsilyl)urea 414-180-7 10218-17-4 Acute Tox. 4 *Skin Irrit. 2 H302H315 GHS07Wng H302H315   
616-101-00-3 (S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide 414-600-9 149182-72-9 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
616-102-00-9 reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane] 415-870-0 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
616-103-00-4 (S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide 415-030-3 120298-38-6 Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H317H400H410 GHS07GHS09Wng H317H410   
616-104-00-X benalaxyl (ISO);methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate 275-728-7 71626-11-4 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-105-00-5 chlorotoluron (ISO);3-(3-chloro-p-tolyl)-1,1-dimethylurea 239-592-2 15545-48-9 Carc. 2Repr. 2Aquatic Acute 1Aquatic Chronic 1 H351H361d ***H400H410 GHS08GHS09Wng H351H361d ***H410   
616-106-00-0 phenmedipham (ISO);methyl 3-(3-methylcarbaniloyloxy)carbanilate 237-199-0 13684-63-4 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-108-00-1 iodosulfuron-methyl-sodium;sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide — 144550-36-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-109-00-7 sulfosulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea — 141776-32-1 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-110-00-2 cyclanilide (ISO);1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid 419-150-7 113136-77-9 Acute Tox. 4 *Aquatic Chronic 2 H302H411 GHS07GHS09Wng H302H411   
616-111-00-8 fenhexamid (ISO);N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid 422-530-5 126833-17-8 Aquatic Chronic 2 H411 GHS09 H411   
616-112-00-3 oxasulfuron (ISO);oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate — 144651-06-9 STOT RE 2 *Aquatic Acute 1Aquatic Chronic 1 H373 **H400H410 GHS08GHS09Wng H373 **H410   
616-113-00-9 desmedipham (ISO);ethyl 3-phenylcarbamoyloxyphenylcarbamate 237-198-5 13684-56-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410  M=10 
616-114-00-4 dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis- 418-010-2 136897-58-0 Aquatic Chronic 4 H413 — H413   
616-115-00-X N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide 416-150-9 136450-06-1 Aquatic Chronic 4 H413 — H413   
616-116-00-5 N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate 416-790-9 143052-96-4 Aquatic Chronic 4 H413 — H413   
616-117-00-0 N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide 416-860-9 777891-21-1 Repr. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H361f ***H317H400H410 GHS08GHS09Wng H361f ***H317H410   
616-118-00-6 N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride 417-950-0 65797-42-4 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
616-119-00-1 2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide 418-060-5 118020-93-2 Aquatic Chronic 4 H413 — H413   
616-120-00-7 reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;N-(3-dimethylamino-2-methyl-phenyl)-benzamide;N-(3-dimethylamino-3-methyl-phenyl)-benzamide 420-600-1 — STOT RE 2 *Aquatic Chronic 2 H373 **H411 GHS08GHS09Wng H373 **H411   
616-121-00-2 2,4-dihydroxy-N-(2-methoxyphenyl)benzamide 419-090-1 129205-19-2 Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
616-123-00-3 N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide 414-740-0 96141-86-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-124-00-9 lithium bis(trifluoromethylsulfonyl)imide 415-300-0 90076-65-6 Acute Tox. 3 *Acute Tox. 3 *Skin Corr. 1BAquatic Chronic 3 H311H301H314H412 GHS06GHS05Dgr H311H301H314H412   
616-125-00-4 3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide 415-730-9 151338-11-3 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng 410   
616-127-00-5 reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide) 430-050-2 — Skin Sens. 1Aquatic Chronic 2 H317H411 GHS07GHS09Wng H317H411   
616-128-00-0 N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide 417-530-7 123590-00-1 Aquatic Chronic 4 H413 — H413   
616-129-00-6 N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide 419-710-0 42774-15-2 Acute Tox. 4 *Eye Irrit. 2 H302H319 GHS07Wng H302H319   
616-130-00-1 N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide 421-780-2 150919-56-5 Aquatic Chronic 4 H413 — H413   
616-132-00-2 N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide 423-250-6 130016-98-7 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
616-133-00-8 N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide 423-990-1 149118-66-1 Acute Tox. 4 *Eye Dam. 1Aquatic Acute 1Aquatic Chronic 1 H302H318H400H410 GHS05GHS07GHS09Dgr H302H318H410   
616-134-00-3 3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide 401-820-5 793710-14-2 Aquatic Chronic 3 H412 — H412   
616-135-00-9 (3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide 430-230-0 136522-17-3 Acute Tox. 4 *Aquatic Chronic 3 H302H412 GHS07Wng H302H412   
616-142-00-7 1,3-Bis(vinylsulfonylacetamido)propane 428-350-3 93629-90-4 Muta. 2Eye Dam. 1Skin Sens. 1Aquatic Chronic 3 H341H318H317H412 GHS08GHS05GHS07Dgr H341H318H317H412   
616-143-00-2 N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide 422-560-9 149591-38-8 Repr. 2Eye Irrit. 2Aquatic Chronic 4 H361f ***H319H413 GHS08Wng H361f ***H319H413   
617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 Org. Perox. EFlam. Liq. 2 H242H225 GHS02Dgr H242H225   
617-002-00-8 α, α-dimethylbenzyl hydroperoxide;cumene hydroperoxide 201-254-7 80-15-9 Org. Perox. EAcute Tox. 3 *Acute Tox. 4 *Acute Tox. 4 *STOT RE 2 *Skin Corr. 1BAquatic Chronic 2 H242H331H312H302H373 **H314H411 GHS02GHS06GHS08GHS05GHS09Dgr H242H331H312H302H373 **H314H411  Skin Corr. 1B; H314: C ≥ 10 %Skin Irrit. 2; H315: 3 % ≤ C < 10 %Eye Dam. 1; H318: 3 % ≤ C < 10 %Eye Irrit. 2; H319: 1 % ≤ C < 3 %STOT SE 3; H335: C < 10 % 
617-003-00-3 dilauroyl peroxide 203-326-3 105-74-8 Org. Perox. D H242 GHS02Dgr H242   
617-004-00-9 1,2,3,4-tetrahydro-1-naphthyl hydroperoxide 212-230-0 771-29-9 Org. Perox. DAcute Tox. 4 *Skin Corr. 1BAquatic Acute 1Aquatic Chronic 1 H242H302H314H400H410 GHS02GHS05GHS07GHS09Dgr H242H302H314H410  STOT SE 3; H335: C ≥ 5 % 
617-006-00-X bis(α, α-dimethylbenzyl) peroxide 201-279-3 80-43-3 Org. Perox. FEye Irrit. 2Skin Irrit. 2Aquatic Chronic 2 H242H319H315H411 GHS02GHS07GHS09Wng H242H319H315H411   
617-007-00-5 tert-butyl α, α-dimethylbenzyl peroxide 222-389-8 3457-61-2 Org. Perox. E Skin Irrit. 2Aquatic Chronic 2 H242H315H411 GHS02GHS07GHS09Wng H242H315H411   
617-008-00-0 dibenzoyl peroxide;benzoyl peroxide 202-327-6 94-36-0 Org. Perox. BEye Irrit. 2Skin Sens. 1 H241H319H317 GHS01GHS02GHS07Wng H241H319H317   T
617-010-00-1 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]1,1'-dioxybiscyclohexan-1-ol; [2]cyclohexylidene hydroperoxide; [3]cyclohexanone, peroxide [4][> 91 % solution] 201-091-1 [1]219-306-2 [2]220-279-4 [3]235-527-7 [4] 78-18-2 [1]2407-94-5 [2]2699-11-8 [3]12262-58-7 [4] Org. Perox. AAcute Tox. 4 *Skin Corr. 1B H240H302H314 GHS01GHS05GHS07Dgr H240H302H314  STOT SE 3; H335: C ≥ 5 % C T
617-010-01-9 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]1,1'-dioxybiscyclohexan-1-ol; [2]cyclohexylidene hydroperoxide; [3]cyclohexanone, peroxide [4][≤ 91 % solution] 201-091-1 [1]219-306-2 [2]220-279-4 [3]235-527-7 [4] 78-18-2 [1]2407-94-5 [2]2699-11-8 [3]12262-58-7 [4] Org. Perox. CAcute Tox. 4 *Skin Corr. 1B H242H302H314 GHS02GHS05GHS07Dgr H242H302H314  STOT SE 3; H335: C ≥ 5 % C T
617-012-00-2 8-p-menthyl hydroperoxide;p-menthane hydroperoxide 201-281-4 80-47-7 Org. Perox. DSkin Corr. 1BAcute Tox. 4 * H242H314H332 GHS02GHS05GHS07Dgr H242H314H332  STOT SE 3; H335: C ≥ 5 % 
617-013-00-8 O,O-tert-butyl O-docosyl monoperoxyoxalate 404-300-6 116753-76-5 Org. Perox. C ****Aquatic Acute 1Aquatic Chronic 1 H242H400H410 GHS02GHS09Dgr H242H410   
617-014-00-3 6-(nonylamino)-6-oxo-peroxyhexanoic acid 406-680-9 104788-63-8 Org. Perox. C ****Eye Dam. 1Skin Sens. 1Aquatic Acute 1 H242H318H317H400 GHS02GHS05GHS07GHS09Dgr H242H318H317H400   
617-015-00-9 bis(4-methylbenzoyl)peroxide 407-950-9 895-85-2 Org. Perox. B ****Aquatic Acute 1Aquatic Chronic 1 H241H400H410 GHS01GHS02GHS09Dgr H241H410   
617-016-00-4 3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate 413-910-1 — Org. Perox. C ****Flam. Liq. 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H242H226H315H400H410 GHS02GHS07GHS09Dgr H242H226H315H410   
617-017-00-X reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene 412-140-3 32144-25-5 Org. Perox. D ****Aquatic Chronic 4 H242H413 GHS02Dgr H242H413   T
617-018-00-5 reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight 410-840-3 71566-50-2 Org. Perox. C ****Aquatic Chronic 2 H242H411 GHS02GHS09Dgr H242H411   T
617-019-00-0 6-(phthalimido)peroxyhexanoic acid 410-850-8 128275-31-0 Org. Perox. DEye Dam. 1Aquatic Acute 1 H242H318H400 GHS02GHS05GHS09DgDgr H242H318H400   T
617-020-00-6 1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide) 420-060-5 117663-11-3 Flam. Liq. 3Org. Perox. D ****Aquatic Chronic 2 H226H242H411 GHS02GHS09Dgr H226H242H411   
647-001-00-8 glucosidase, β- 232-589-7 9001-22-3 Resp. Sens. 1 H334 GHS08Dgr H334   
647-002-00-3 cellulase 232-734-4 9012-54-8 Resp. Sens. 1 H334 GHS08Dgr H334   
647-003-00-9 cellobiohydrolase, exo- 253-465-9 37329-65-0 Resp. Sens. 1 H334 GHS08Dgr H334   
647-004-00-4 cellulases with the exception of those specified elsewhere in this Annex — — Resp. Sens. 1 H334 GHS08Dgr H334   A
647-005-00-X bromelain, juice 232-572-4 9001-00-7 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-006-00-5 ficin 232-599-1 9001-33-6 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-007-00-0 papain 232-627-2 9001-73-4 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-008-00-6 pepsin A 232-629-3 9001-75-6 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-009-00-1 rennin 232-645-0 9001-98-3 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-010-00-7 trypsin 232-650-8 9002-07-7 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-011-00-2 chymotrypsin 232-671-2 9004-07-3 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-012-00-8 subtilisin 232-752-2 9014-01-1 STOT SE 3Skin Irrit. 2Eye Dam. 1Resp. Sens. 1 H335H315H318H334 GHS08GHS05 GHS07Dgr H335H315H318H334   
647-013-00-3 proteinase, microbial neutral 232-966-6 9068-59-1 Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-014-00-9 proteases with the exception of those specified elsewhere in this Annex — — Eye Irrit. 2STOT SE 3Skin Irrit. 2Resp. Sens. 1 H319H335H315H334 GHS08GHS07Dgr H319H335H315H334   
647-015-00-4 amylase, α- 232-565-6 9000-90-2 Resp. Sens. 1 H334 GHS08Dgr H334   
647-016-00-X amylases with the exception of those specified elsewhere in this Annex — — Resp. Sens. 1 H334 GHS08Dgr H334   
648-001-00-0 Distillates (coal tar), benzole fraction;Light Oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).] 283-482-7 84650-02-2 Carc. 1B H350 GHS08Dgr H350   H
648-002-00-6 Tar oils, brown-coal;Light Oil;[The distillate from lignite tar boiling in the range of approximately 80 oC to 250 oC (176 oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.] 302-674-4 94114-40-6 Carc. 1B H350 GHS08Dgr H350   H J
648-003-00-1 Benzol forerunnings (coal);Light Oil Redistillate, low boiling;[The distillate from coke oven light oil having an approximate distillation range below 100 oC (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.] 266-023-5 65996-88-5 Carc. 1B H350 GHS08Dgr H350   H J
648-004-00-7 Distillates (coal tar), benzole fraction, BTX-rich;Light Oil Redistillate, low boiling;[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).] 309-984-9 101896-26-8 Carc. 1B H350 GHS08Dgr H350   H J
648-005-00-2 Aromatic hydrocarbons, C6-10, C8-rich;Light Oil Redistillate, low boiling 292-697-5 90989-41-6 Carc. 1B H350 GHS08Dgr H350   H J
648-006-00-8 Solvent naphtha (coal), light;Light Oil Redistillate, low boiling 287-498-5 85536-17-0 Carc. 1B H350 GHS08Dgr H350   H J
648-007-00-3 Solvent naphtha (coal), xylene-styrene cut;Light Oil Redistillate, intermediate boiling 287-502-5 85536-20-5 Carc. 1B H350 GHS08Dgr H350   H J
648-008-00-9 Solvent naphtha (coal), coumarone-styrene contg.;Light Oil Redistillate, intermediate boiling 287-500-4 85536-19-2 Carc. 1B H350 GHS08Dgr H350   H J
648-009-00-4 Naphtha (coal), distn. residues;Light Oil Redistillate, high boiling;[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.] 292-636-2 90641-12-6 Carc. 1B H350 GHS08Dgr H350   H J
648-010-00-X Aromatic hydrocarbons, C8;Light Oil Redistillate, high boiling 292-694-9 90989-38-1 Carc. 1B H350 GHS08Dgr H350   H J
648-012-00-0 Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;Light Oil Redistillate, high boiling;[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 oC to 215 oC (248 oF to 419 oF).] 295-281-1 91995-20-9 Carc. 1B H350 GHS08Dgr H350   H J
648-013-00-6 Aromatic hydrocarbons, C9-12, benzene distn.;Light Oil Redistillate, high boiling 295-551-9 92062-36-7 Carc. 1B H350 GHS08Dgr H350   H J
648-014-00-1 Extract residues (coal), benzole fraction alk., acid ext.;Light Oil Extract Residues, low boiling;[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 oC to 160 oC (194 oF to 320 oF). It consists predominantly of benzene, toluene and xylenes.] 295-323-9 91995-61-8 Carc. 1B H350 GHS08Dgr H350   H J
648-015-00-7 Extract residues (coal tar), benzole fraction alk., acid ext.;Light Oil Extract Residues, low boiling;[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC-195 oC (185 oF-383 oF).] 309-868-8 101316-63-6 Carc. 1B H350 GHS08Dgr H350   H J
648-016-00-2 Extract residues (coal), benzole fraction acid;Light Oil Extract Residues, low boiling;[An acid sludge by-product of the sulphuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.] 298-725-2 93821-38-6 Carc. 1B H350 GHS08Dgr H350   H J
648-017-00-8 Extract residues (coal), light oil alk., distn. overheads;Light Oil Extract Residues, low boiling;[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefactionator bottoms or washed carbolic oil boiling substantially below 145 oC (293 oF). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.] 292-625-2 90641-02-4 Carc. 1B H350 GHS08Dgr H350   H J
648-018-00-3 Extract residues (coal), light oil alk., acid ext., indene fraction;Light Oil Extract Residues, intermediate boiling 309-867-2 101316-62-5 Carc. 1B H350 GHS08Dgr H350   H J
648-019-00-9 Extract residues (coal), light oil alk., indene naphtha fraction;Light Oil Extract Residues, high boiling;[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 oC to 180 oC (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.] 292-626-8 90641-03-5 Carc. 1B H350 GHS08Dgr H350   H J
648-020-00-4 Solvent naphtha (coal);Light Oil Extract Residues, high boiling;[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 oC to 210 oC (266 oF to 410 oF) Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.] 266-013-0 65996-79-4 Carc. 1B H350 GHS08Dgr H350   H J
648-021-00-X Distillates (coal tar), light oils, neutral fraction;Light Oil Extract Residues, high boiling;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF). May also include unsaturated hydrocarbons such as indene and coumarone.] 309-971-8 101794-90-5 Carc. 1B H350 GHS08Dgr H350   H J
648-022-00-5 Distillates (coal tar), light oils, acid exts.;Light Oil Extract Residues, high boiling;[This oil is a complex mixture of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 oC to 215 oC (284 oF to 419 oF).] 292-609-5 90640-87-2 Carc. 1B H350 GHS08Dgr H350   H J
648-023-00-0 Distillates (coal tar), light oils;Carbolic Oil;[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 oC to 210 oC (302 oF to 410 oF).] 283-483-2 84650-03-3 Carc. 1B H350 GHS08Dgr H350   H J
648-024-00-6 Tar oils, coal;Carbolic Oil;[The distillate from high temperature coal tar having an approximate distillation range of 130 oC to 250 oC (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.] 266-016-7 65996-82-9 Carc. 1B H350 GHS08Dgr H350   H J
648-026-00-7 Extract residues (coal), light oil alk., acid ext.;Carbolic Oil Extract Residue;[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.] 292-624-7 90641-01-3 Carc. 1B H350 GHS08Dgr H350   H J
648-027-00-2 Extract residues (coal), tar oil alk.;Carbolic Oil Extract Residue;[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.] 266-021-4 65996-87-4 Carc. 1B H350 GHS08Dgr H350   H J
648-028-00-8 Extract oils (coal), light oil;Acid Extract;[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-622-6 90640-99-6 Carc. 1B H350 GHS08Dgr H350   H J
648-029-00-3 Pyridine, alkyl derivs.;Crude Tar Bases;[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 oC (302 oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.] 269-929-9 68391-11-7 Carc. 1B H350 GHS08Dgr H350   H J
648-030-00-9 Tar bases, coal, picoline fraction;Distillate Bases;[Pyridine bases boiling in the range of approximately 125 oC to 160 oC (257 oF 320 oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.] 295-548-2 92062-33-4 Carc. 1B H350 GHS08Dgr H350   H J
648-031-00-4 Tar bases, coal, lutidine fraction;Distillate Bases 293-766-2 91082-52-9 Carc. 1B H350 GHS08Dgr H350   H J
648-032-00-X Extract oils (coal), tar base, collidine fraction;Distillate Bases;[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.] 273-077-3 68937-63-3 Carc. 1B H350 GHS08Dgr H350   H J
648-033-00-5 Tar bases, coal, collidine fraction;Distillate Bases;[The distillation fraction boiling in the range of approximately 181 oC to 186 oC (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.] 295-543-5 92062-28-7 Carc. 1B H350 GHS08Dgr H350   H J
648-034-00-0 Tar bases, coal, aniline fraction;Distillate Bases;[The distillation fraction boiling in the range of approximately 180 oC to 200 oC (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.] 295-541-4 92062-27-6 Carc. 1B H350 GHS08Dgr H350   H J
648-035-00-6 Tar bases, coal, toluidine fraction;Distillate Bases 293-767-8 91082-53-0 Carc. 1B H350 GHS08Dgr H350   H J
648-036-00-1 Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;Redistillates;[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 oC to 190 oC (320 oF to 374 oF).] 295-292-1 91995-31-2 Carc. 1B H350 GHS08Dgr H350   H J
648-037-00-7 Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;Redistillates;[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 oC to 270 oC (374 oF to 518 oF). Composed primarily of substituted dinuclear aromatics.] 295-295-8 91995-35-6 Carc. 1B H350 GHS08Dgr H350   H J
648-038-00-2 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;Redistillates;[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 oC to 230 oC (428 oF to 446 oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.] 295-329-1 91995-66-3 Carc. 1B H350 GHS08Dgr H350   H J
648-039-00-8 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;Redistillates;[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residuel oils which has a boiling range of 225 oC to 255 oC (437 oF to 491 oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.] 310-170-0 122070-79-5 Carc. 1B H350 GHS08Dgr H350   H J
648-040-00-3 Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;Redistillates;[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 oC to 260 oC (464 oF to 500 oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.] 310-171-6 122070-80-8 Carc. 1B H350 GHS08Dgr H350   H J
648-041-00-9 Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).] 309-851-5 101316-45-4 Carc. 1B H350 GHS08Dgr H350   H M
648-042-00-4 Distillates (coal tar), upper, fluorene-rich;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.] 284-900-0 84989-11-7 Carc. 1B H350 GHS08Dgr H350   H M
648-043-00-X Creosote oil, acenaphthene fraction, acenaphthene-free;Wash Oil Redistillate;[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] 292-606-9 90640-85-0 Carc. 1B H350 GHS08Dgr H350   H
648-044-00-5 Distillates (coal tar), heavy oils;Heavy Anthracene Oil;[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.] 292-607-4 90640-86-1 Carc. 1B H350 GHS08Dgr H350   H
648-045-00-0 Distillates (coal tar), upper;Heavy Anthracene Oil;[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.] 266-026-1 65996-91-0 Carc. 1B H350 GHS08Dgr H350   H M
648-046-00-6 Anthracene oil, acid ext.;Anthracene Oil Extract Residue;[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.] 295-274-3 91995-14-1 Carc. 1B H350 GHS08Dgr H350   H M
648-047-00-1 Distillates (coal tar);Heavy Anthracene Oil;[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.] 266-027-7 65996-92-1 Carc. 1B H350 GHS08Dgr H350   H M
648-048-00-7 Distillates (coal tar), pitch, heavy oils;Heavy Anthracene Oil;[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.] 295-312-9 91995-51-6 Carc. 1B H350 GHS08Dgr H350   H M
648-049-00-2 Distillates (coal tar), pitch;Heavy Anthracene Oil;[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).] 309-855-7 101316-49-8 Carc. 1B H350 GHS08Dgr H350   H M
648-050-00-8 Distillates (coal tar), heavy oils, pyrene fraction;Heavy Anthracene Oil Redistillate;[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.] 295-304-5 91995-42-5 Carc. 1B H350 GHS08Dgr H350   H M
648-051-00-3 Distillates (coal tar), pitch, pyrene fraction;Heavy Anthracene Oil Redistillate;[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.] 295-313-4 91995-52-7 Carc. 1B H350 GHS08Dgr H350   H M
648-052-00-9 Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;Coal Tar Extract;[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-296-6 97926-76-6 Carc. 1B H350 GHS08Dgr H350   H M
648-053-00-4 Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;Coal Tar Extract;[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-297-1 97926-77-7 Carc. 1B H350 GHS08Dgr H350   H M
648-054-00-X Pitch;Pitch 263-072-4 61789-60-4 Carc. 1B H350 GHS08Dgr H350   H M
648-055-00-5 Pitch, coal tar, high-temp.;Pitch;[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 266-028-2 65996-93-2 Carc. 1B H350 GHS08Dgr H350   H
648-056-00-0 Pitch, coal tar, high-temp., heat-treated;Pitch;[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 310-162-7 121575-60-8 Carc. 1B H350 GHS08Dgr H350   H M
648-057-00-6 Pitch, coal tar, high-temp., secondary;Pitch Redistillate;[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.] 302-650-3 94114-13-3 Carc. 1B H350 GHS08Dgr H350   H M
648-058-00-1 Residues (coal tar), pitch distn.;Pitch Redistillate;[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.] 295-507-9 92061-94-4 Carc. 1B H350 GHS08Dgr H350   H M
648-059-00-7 Tar, coal, high-temp., distn. and storage residues;Coal Tar Solids Residue;[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.] 295-535-1 92062-20-9 Carc. 1B H350 GHS08Dgr H350   H M
648-060-00-2 Tar, coal, storage residues;Coal Tar Solids Residue;[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.] 293-764-1 91082-50-7 Carc. 1B H350 GHS08Dgr H350   H M
648-061-00-8 Tar, coal, high-temp., residues;Coal Tar Solids Residue;[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.] 309-726-5 100684-51-3 Carc. 1B H350 GHS08Dgr H350   H M
648-062-00-3 Tar, coal, high-temp., high-solids;Coal Tar Solids Residue;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.] 273-615-7 68990-61-4 Carc. 1B H350 GHS08Dgr H350   H M
648-063-00-9 Waste solids, coal-tar pitch coking;Coal Tar Solids Residue;[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.] 295-549-8 92062-34-5 Carc. 1B H350 GHS08Dgr H350   H M
648-064-00-4 Extract residues (coal), brown;Coal Tar Extract;[The residue from extraction of dried coal.] 294-285-0 91697-23-3 Carc. 1B H350 GHS08Dgr H350   H M
648-065-00-X Paraffin waxes (coal), brown-coal-high-temp. tar;Coal Tar Extract;[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-454-1 92045-71-1 Carc. 1B H350 GHS08Dgr H350   H M
648-066-00-5 Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;Coal Tar Extract;[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-455-7 92045-72-2 Carc. 1B H350 GHS08Dgr H350   H M
648-067-00-0 Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;Coal Tar Extract;[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-298-7 97926-78-8 Carc. 1B H350 GHS08Dgr H350   H M
648-068-00-6 Tar, coal, low-temp., distn. residues;Tar Oil, intermediate boiling;[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.] 309-887-1 101316-85-2 Carc. 1B H350 GHS08Dgr H350   H M
648-069-00-1 Pitch, coal tar, low-temp;Pitch Residue;[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-651-4 90669-57-1 Carc. 1B H350 GHS08Dgr H350   H M
648-070-00-7 Pitch, coal tar, low-temp., oxidized;Pitch Residue, oxidised;[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-654-0 90669-59-3 Carc. 1B H350 GHS08Dgr H350   H M
648-071-00-2 Pitch, coal tar, low-temp., heat-treated;Pitch Residue, oxidised;Pitch Residue, heat-treated;[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.] 292-653-5 90669-58-2 Carc. 1B H350 GHS08Dgr H350   H M
648-072-00-8 Distillates (coal-petroleum), condensed-ring arom;Distillates;[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.] 269-159-3 68188-48-7 Carc. 1B H350 GHS08Dgr H350   H M
648-073-00-3 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;Pyrolysis Products;[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-956-6 101794-74-5 Carc. 1B H350 GHS08Dgr H350   H M
648-074-00-9 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;Pyrolysis Products;[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-957-1 101794-75-6 Carc. 1B H350 GHS08Dgr H350   H M
648-075-00-4 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;Pyrolysis Products;[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-958-7 101794-76-7 Carc. 1B H350 GHS08Dgr H350   H M
648-076-00-X Pitch, coal tar-petroleum;Pitch Residues;[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.] 269-109-0 68187-57-5 Carc. 1B H350 GHS08Dgr H350   H M
648-077-00-5 Phenanthrene, distn. residues;Heavy Anthracene Oil Redistillate;[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.] 310-169-5 122070-78-4 Carc. 1B H350 GHS08Dgr H350   H M
648-078-00-0 Distillates (coal tar), upper, fluorene-free;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.] 284-899-7 84989-10-6 Carc. 1B H350 GHS08Dgr H350   H M
648-079-00-6 Anthracene oil;Anthracene oil;[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.] 292-602-7 90640-80-5 Carc. 1B H350 GHS08Dgr H350   H M
648-080-00-1 Residues (coal tar), creosote oil distn.;Wash Oil Redistillate;[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 oC to 330 oC (518 oF to 626 oF). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.] 295-506-3 92061-93-3 Carc. 1B H350 GHS08Dgr H350   H
648-081-00-7 Tar, coal;Coal tar;[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.] 232-361-7 8007-45-2 Carc. 1A H350 GHS08Dgr H350   H
648-082-00-2 Tar, coal, high-temp.;Coal tar;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.] 266-024-0 65996-89-6 Carc. 1A H350 GHS08Dgr H350   H
648-083-00-8 Tar, coal, low-temp.;Coal oil;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.] 266-025-6 65996-90-9 Carc. 1A H350 GHS08Dgr H350   H
648-084-00-3 Distillates (coal), coke-oven light oil, naphthalene cut;Naphthalene Oil;[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298 oF).] 285-076-5 85029-51-2 Carc. 1B H350 GHS08Dgr H350   HJM
648-085-00-9 Distillates (coal tar), naphthalene oils;Naphthalene Oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392 oF to 482 oF).] 283-484-8 84650-04-4 Carc. 1B H350 GHS08Dgr H350   HJM
648-086-00-4 Distillates (coal tar), naphthalene oils, naphthalene-low;Naphthalene Oil Redistillate;[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.] 284-898-1 84989-09-3 Carc. 1B H350 GHS08Dgr H350   HJM
648-087-00-X Distillates (coal tar), naphthalene oil crystn. mother liquor;Naphthalene Oil Redistillate;[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.] 295-310-8 91995-49-2 Carc. 1B H350 GHS08Dgr H350   HJM
648-088-00-5 Extract residues (coal), naphthalene oil, alk.;Naphthalene Oil Extract Residue;[A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.] 310-166-9 121620-47-1 Carc. 1B H350 GHS08Dgr H350   HJM
648-089-00-0 Extract residues (coal), naphthalene oil, alk., naphthalene-low;Naphthalene Oil Extract Residue;[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.] 310-167-4 121620-48-2 Carc. 1B H350 GHS08Dgr H350   HJM
648-090-00-6 Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;Naphthalene Oil Extract Residue;[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.] 292-612-1 90640-90-7 Carc. 1B H350 GHS08Dgr H350   HJM
648-091-00-1 Extract residues (coal), naphthalene oil alk., distn. overheads;Naphthalene Oil Extract Residue;[The distillation from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356 oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.] 292-627-3 90641-04-6 Carc. 1B H350 GHS08Dgr H350   HJM
648-092-00-7 Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;Methylnaphthalene Oil;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437 oF to 491 oF).] 309-985-4 101896-27-9 Carc. 1B H350 GHS08Dgr H350   HJM
648-093-00-2 Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;Methylnaphthalene Oil;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).] 309-972-3 101794-91-6 Carc. 1B H350 GHS08Dgr H350   HJM
648-094-00-8 Distillates (coal tar), naphthalene oils, acid exts.;Methylnaphthalene Oil Extract Residue;[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446 oF to 491 oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.] 295-309-2 91995-48-1 Carc. 1B H350 GHS08Dgr H350   HJM
648-095-00-3 Extract residues (coal), naphthalene oil alk., distn. residues;Methylnaphthalene Oil Extract Residue;[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428 oF to 572 oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.] 292-628-9 90641-05-7 Carc. 1B H350 GHS08Dgr H350   HJM
648-096-00-9 Extract oils (coal), acidic, tar-base free;Methylnaphthalene Oil Extract Residue;[The extract oil boiling in the range of approximately 220 oC to 265 oC (428 oF to 509 oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.] 284-901-6 84989-12-8 Carc. 1B H350 GHS08Dgr H350   HJM
648-097-00-4 Distillates (coal tar), benzole fraction, distn. residues;Wash Oil;[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 oC to 300 oC (302 oF to 572 oF) or a semi-solid or solid with a melting point up to 70 oC (158 oF). It is composed primarily of naphthalene and alkyl naphthalenes.] 310-165-3 121620-46-0 Carc. 1B H350 GHS08Dgr H350   HJM
648-098-00-X Creosote oil, acenaphthene fraction;Wash Oil;[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 oC to 280 oC (464 oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] 292-605-3 90640-84-9 Carc. 1B H350 GHS08Dgr H350   H
648-099-00-5 Creosote oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392 oF to 617 oF).] 263-047-8 61789-28-4 Carc. 1B H350 GHS08Dgr H350   H
648-100-00-9 Creosote oil, high-boiling distillate;Wash Oil;[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41 oF).] 274-565-9 70321-79-8 Carc. 1B H350 GHS08Dgr H350   H
648-101-00-4 Creosote;[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] 232-287-5 8001-58-9 Carc. 1B H350 GHS08Dgr H350   H
648-102-00-X Extract residues (coal), creosote oil acid;Wash Oil Extract Residue;[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482 oF to 536 oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.] 310-189-4 122384-77-4 Carc. 1B H350 GHS08Dgr H350   H
648-103-00-5 Anthracene oil, anthracene paste;Anthracene Oil Fraction;[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.] 292-603-2 90640-81-6 Carc. 1B H350 GHS08Dgr H350   HJM
648-104-00-0 Anthracene oil, anthracene-low;Anthracene Oil Fraction;[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.] 292-604-8 90640-82-7 Carc. 1B H350 GHS08Dgr H350   HJM
648-105-00-6 Residues (coal tar), anthracene oil distn.;Anthracene Oil Fraction;[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644 oF to 752 oF). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.] 295-505-8 92061-92-2 Carc. 1B H350 GHS08Dgr H350   HJM
648-106-00-1 Anthracene oil, anthracene paste, anthracene fraction;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626 oF to 662 oF). It contains chiefly anthracene, carbazole and phenanthrene.] 295-275-9 91995-15-2 Carc. 1B H350 GHS08Dgr H350   HJM
648-107-00-7 Anthracene oil, anthracene paste, carbazole fraction;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthrancene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662 oF to 680 oF). It contains chiefly anthacene, carbazole and phenanthrene.] 295-276-4 91995-16-3 Carc. 1B H350 GHS08Dgr H350   HJM
648-108-00-2 Anthracene oil, anthracene paste, distn. lights;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous light temperature tar and boiling in the range of approximately 290 oC to 340 oC (554 oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.] 295-278-5 91995-17-4 Carc. 1B H350 GHS08Dgr H350   HJM
648-109-00-8 Tar oils, coal, low-temp.;Tar Oil, high boiling;[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320 oF to 644 oF).] 309-889-2 101316-87-4 Carc. 1B H350 GHS08Dgr H350   HJM
648-110-00-3 Extract residues (coal), low temp. coal atar alk.;[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.] 310-191-5 122384-78-5 Carc. 1B H350 GHS08Dgr H350   HJM
648-111-00-9 Phenols, ammonia liquor ext.;Alkaline Extract;[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292 oF)) destructive distillation of coal. It consists predominantly of a mixture of monohydric and dihydric phenols.] 284-881-9 84988-93-2 Carc. 1B H350 GHS08Dgr H350   HJM
648-112-00-4 Distillates (coal tar), light oils, alk. exts.;Alkaline Extract;[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 292-610-0 90640-88-3 Carc. 1B H350 GHS08Dgr H350   HJM
648-113-00-X Extracts, coal tar oil alk.;Alkaline Extract;[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 266-017-2 65996-83-0 Carc. 1B H350 GHS08Dgr H350   HJM
648-114-00-5 Distillates (coal tar), naphthalene oils, alk. exts.;Alkaline Extract;[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxid. Composed primarily of the alkali salts of various phenolic compounds.] 292-611-6 90640-89-4 Carc. 1B H350 GHS08Dgr H350   HJM
648-115-00-0 Extract residues (coal), tar oil alk., carbonated, limed;Crude Phenols;[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.] 292-629-4 90641-06-8 Carc. 1B H350 GHS08Dgr H350   HJM
648-116-00-6 Tar acids, coal, crude;Crude Phenols;[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.] 266-019-3 65996-85-2 Carc. 1B H350 GHS08Dgr H350   HJM
648-117-00-1 Tar acids, brown-coal, crude;Crude Phenols;[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.] 309-888-7 101316-86-3 Carc. 1B H350 GHS08Dgr H350   HJM
648-118-00-7 Tar acids, brown-coal gasification;Crude Phenols;[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.] 295-536-7 92062-22-1 Carc. 1B H350 GHS08Dgr H350   HJM
648-119-00-2 Tar acids, distn. residues;Distillate Phenols;[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140 oF to 176 oF).] 306-251-5 96690-55-0 Carc. 1B H350 GHS08Dgr H350   HJM
648-120-00-8 Tar acids, methylphenol fraction;Distillate Phenols;[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-892-9 84989-04-8 Carc. 1B H350 GHS08Dgr H350   HJM
648-121-00-3 Tar acids, polyalkylphenol fraction;Distillate Phenols;[The fraction of tar aicds, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437 oF to 608 oF). Composed primarily of polyalkylphenols.] 284-893-4 84989-05-9 Carc. 1B H350 GHS08Dgr H350   HJM
648-122-00-9 Tar acids, xylenol fraction;Distillate Phenols;[The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-895-5 84989-06-0 Carc. 1B H350 GHS08Dgr H350   HJM
648-123-00-4 Tar acids, ethylphenol fraction;Distillate Phenols;[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-891-3 84989-03-7 Carc. 1B H350 GHS08Dgr H350   HJM
648-124-00-X Tar acids, 3,5-xylenol fraction;Distillate Phenols;[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.] 284-896-0 84989-07-1 Carc. 1B H350 GHS08Dgr H350   HJM
648-125-00-5 Tar acids, residues, distillates, first-cut;Distillate Phenols;[The residue from the distillation in the range of 235 oC to 355 oC (481 oF to 697 oF) of light carbolic oil.] 270-713-1 68477-23-6 Carc. 1B H350 GHS08Dgr H350   HJM
648-126-00-0 Tar acids, cresylic, residues;Distillate Phenols;[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176 oF). Composed primarily of polyalkyphenols, resin gums, and inorganic salts.] 271-418-0 68555-24-8 Carc. 1B H350 GHS08Dgr H350   HJM
648-127-00-6 Phenols, C9-11;Distillate Phenols 293-435-2 91079-47-9 Carc. 1B H350 GHS08Dgr H350   HJM
648-128-00-1 Tar acids, cresylic;Distillate Phenols;[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). It contains chiefly phenols and pyridine bases.] 295-540-9 92062-26-5 Carc. 1B H350 GHS08Dgr H350   HJM
648-129-00-7 Tar acids, brown-coal, C2-alkylphenol fraction;Distillate Phenols;[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Composed primarily of m- and p-ethylphenol as well as cresols and xylenols.] 302-662-9 94114-29-1 Carc. 1B H350 GHS08Dgr H350   HJM
648-130-00-2 Extract oils (coal), naphthalene oils;Acid Extract;[The aqueous extract produced by an acidic wash of alkali-washed napthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-623-1 90641-00-2 Carc. 1B H350 GHS08Dgr H350   HJM
648-131-00-8 Tar bases, quinoline derivs.;Distillate Bases 271-020-7 68513-87-1 Carc. 1B H350 GHS08Dgr H350   HJM
648-132-00-3 Tar bases, coal, quinoline derivs. fraction;Distillate Bases 274-560-1 70321-67-4 Carc. 1B H350 GHS08Dgr H350   HJM
648-133-00-9 Tar bases, coal, distn. residues;Distillate Bases;[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.] 295-544-0 92062-29-8 Carc. 1B H350 GHS08Dgr H350   HJM
648-134-00-4 Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).] 309-745-9 100801-63-6 Carc. 1B H350 GHS08Dgr H350   HJM
648-135-00-X Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158 oF to 248 oF).] 309-748-5 100801-65-8 Carc. 1B H350 GHS08Dgr H350   HJM
648-136-00-5 Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410 oF).] 309-749-0 100801-66-9 Carc. 1B H350 GHS08Dgr H350   HJM
648-137-00-0 Extract residues (coal), tar oil alk., naphthalene distn. residues;Naphthalene Oil Extract Residue;[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.] 277-567-8 73665-18-6 Carc. 1B H350 GHS08Dgr H350   HJM
648-138-00-6 Creosote oil, low-boiling distillate;Wash Oil;[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 oC (100 oF).] 274-566-4 70321-80-1 Carc. 1B H350 GHS08Dgr H350   H
648-139-00-1 Tar acids, cresylic, sodium salts, caustic solns.;Alkaline Extract 272-361-4 68815-21-4 Carc. 1B H350 GHS08Dgr H350   HJM
648-140-00-7 Extract oils (coal), tar base;Acid Extract;[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillatin to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.] 266-020-9 65996-86-3 Carc. 1B H350 GHS08Dgr H350   HJM
648-141-00-2 Tar bases, coal, crude;Crude Tar Bases;[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.] 266-018-8 65996-84-1 Carc. 1B H350 GHS08Dgr H350   HJM
648-142-00-8 Residues (coal), liq. solvent extn.;[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.] 302-681-2 94114-46-2 Carc. 1B H350 GHS08Dgr H350   H M
648-143-00-3 Coal liquids, liq. solvent extn. soln.;[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] 302-682-8 94114-47-3 Carc. 1B H350 GHS08Dgr H350   H M
648-144-00-9 Coal liquids, liq. solvent extn.;[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.] 302-683-3 94114-48-4 Carc. 1B H350 GHS08Dgr H350   H M
648-145-00-4 Tar brown-coal;[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).] 309-885-0 101316-83-0 Carc. 1A H350 GHS08Dgr H350   H
648-146-00-X Tar, brown-coal, low-temp.;[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.] 309-886-6 101316-84-1 Carc. 1A H350 GHS08Dgr H350   H
648-147-00-5 Light oil (coal), coke-oven;Crude benzole;[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.] 266-012-5 65996-78-3 Carc. 1B H350 GHS08Dgr H350   H J
648-148-00-0 Distillates (coal), liq. solvent extn., primary;[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.] 302-688-0 94114-52-0 Carc. 1B H350 GHS08Dgr H350   H J
648-149-00-6 Distillates (coal), solvent extn., hydrocracked;[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction process and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-689-6 94114-53-1 Carc. 1B H350 GHS08Dgr H350   H J
648-150-00-1 Naphtha (coal), solvent extn., hydrocracked;[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-690-1 94114-54-2 Carc. 1B H350 GHS08Dgr H350   H J
648-151-00-7 Gasoline, coal solvent extn., hydrocracked naphtha;[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.] 302-691-7 94114-55-3 Carc. 1B H350 GHS08Dgr H350   H
648-152-00-2 Distillates (coal), solvent extn., hydrocracked middle;[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 300 oC (356 oF to 572 oF). Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.] 302-692-2 94114-56-4 Carc. 1B H350 GHS08Dgr H350   H J
648-153-00-8 Distillates (coal), solvent extn., hydrocracked hydrogenated middle;[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 oF to 536 oF). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.] 302-693-8 94114-57-5 Carc. 1B H350 GHS08Dgr H350   H J
648-154-00-3 Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] 302-694-3 94114-58-6 Carc. 2 H351 GHS08Wng H350   H
648-155-00-9 Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.] 302-695-9 94114-59-7 Carc. 2 H351 GHS08Wng H350   H
648-156-00-4 Light oil (coal), semi-coking process;Fresh oil;[The volatile organic liquid condensed from the gas evolved in the low temperature (less than 700 oC (1292 oF) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.] 292-635-7 90641-11-5 Carc. 1B H350 GHS08Dgr H350   H J
649-001-00-3 Extracts (petroleum), light naphthenic distillate solvent 265-102-1 64742-03-6 Carc. 1B H350 GHS08Dgr H350   H
649-002-00-9 Extracts (petroleum), heavy paraffinic distillate solvent 265-103-7 64742-04-7 Carc. 1B H350 GHS08Dgr H350   H
649-003-00-4 Extracts (petroleum), light paraffinic distillate solvent 265-104-2 64742-05-8 Carc. 1B H350 GHS08Dgr H350   H
649-004-00-X Extracts (petroleum), heavy naphthenic distillate solvent 265-111-0 64742-11-6 Carc. 1B H350 GHS08Dgr H350   H
649-005-00-5 Extracts (petroleum), light vacuum gas oil solvent 295-341-7 91995-78-7 Carc. 1B H350 GHS08Dgr H350   H
649-006-00-0 hydrocarbons C26-55, arom-rich 307-753-7 97722-04-8 Carc. 1B H350 GHS08Dgr H350   H
649-007-00-6 fatty acids, tall-oil, reaction products with iminodiethanol and boric acid 400-160-5 — Skin Irrit. 2Aquatic Chronic 2 H315H411 GHS07GHS09Wng H315H411   
649-008-00-1 Residues (petroleum), atm. tower;Heavy Fuel oil;[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-045-2 64741-45-3 Carc. 1B H350 GHS08Dgr H350   H
649-009-00-7 Gas oils (petroleum), heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-058-3 64741-57-7 Carc. 1B H350 GHS08Dgr H350   H
649-010-00-2 Distillates (petroleum), heavy catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-063-0 64741-61-3 Carc. 1B H350 GHS08Dgr H350   H
649-011-00-8 Clarified oils (petroleum), catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-064-6 64741-62-4 Carc. 1B H350 GHS08Dgr H350   H
649-012-00-3 Residues (petroleum), hydrocracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).] 265-076-1 64741-75-9 Carc. 1B H350 GHS08Dgr H350   H
649-013-00-9 Residues (petroleum), thermal cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-081-9 64741-80-6 Carc. 1B H350 GHS08Dgr H350   H
649-014-00-4 Distillates (petroleum), heavy thermal cracked;Heavy Fuel oil;[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-082-4 64741-81-7 Carc. 1B H350 GHS08Dgr H350   H
649-015-00-X Gas oils (petroleum), hydrotreated vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-162-9 64742-59-2 Carc. 1B H350 GHS08Dgr H350   H
649-016-00-5 Residues (petroleum), hydrodesulfurized atmospheric tower;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-181-2 64742-78-5 Carc. 1B H350 GHS08Dgr H350   H
649-017-00-0 Gas oils (petroleum), hydrodesulfurized heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-189-6 64742-86-5 Carc. 1B H350 GHS08Dgr H350   H
649-018-00-6 Residues (petroleum), steam-cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-193-8 64742-90-1 Carc. 1B H350 GHS08Dgr H350   H
649-019-00-1 Residues (petroleum), atmospheric;Heavy Fuel oil;[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-777-3 68333-22-2 Carc. 1B H350 GHS08Dgr H350   H
649-020-00-7 Clarified oils (petroleum), hydrodesulfurized catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-782-0 68333-26-6 Carc. 1B H350 GHS08Dgr H350   H
649-021-00-2 Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 269-783-6 68333-27-7 Carc. 1B H350 GHS08Dgr H350   H
649-022-00-8 Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 269-784-1 68333-28-8 Carc. 1B H350 GHS08Dgr H350   H
649-023-00-3 Fuel oil, residues-straight-run gas oils, high-sulfur;Heavy Fuel oil 270-674-0 68476-32-4 Carc. 1B H350 GHS08Dgr H350   H
649-024-00-9 Fuel oil, residual;Heavy Fuel oil;[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.] 270-675-6 68476-33-5 Carc. 1B H350 GHS08Dgr H350   H
649-025-00-4 Residues (petroleum), catalytic reformer fractionator residue distn.;Heavy Fuel oil;[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).] 270-792-2 68478-13-7 Carc. 1B H350 GHS08Dgr H350   H
649-026-00-X Residues (petroleum), heavy coker gas oil and vacuum gas oil;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-796-4 68478-17-1 Carc. 1B H350 GHS08Dgr H350   H
649-027-00-5 Residues (petroleum), heavy coker and light vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-983-0 68512-61-8 Carc. 1B H350 GHS08Dgr H350   H
649-028-00-0 Residues (petroleum), light vacuum;Heavy Fuel oil;[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-984-6 68512-62-9 Carc. 1B H350 GHS08Dgr H350   H
649-029-00-6 Residues (petroleum), steam-cracked light;Heavy Fuel oil;[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).] 271-013-9 68513-69-9 Carc. 1B H350 GHS08Dgr H350   H
649-030-00-1 Fuel oil, No 6;Heavy Fuel oil;[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).] 271-384-7 68553-00-4 Carc. 1B H350 GHS08Dgr H350   H
649-031-00-7 Residues (petroleum), topping plant, low-sulfur;Heavy Fuel oil;[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.] 271-763-7 68607-30-7 Carc. 1B H350 GHS08Dgr H350   H
649-032-00-2 Gas oils (petroleum), heavy atmospheric;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).] 272-184-2 68783-08-4 Carc. 1B H350 GHS08Dgr H350   H
649-033-00-8 Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;Heavy Fuel oil;[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.] 272-187-9 68783-13-1 Carc. 1B H350 GHS08Dgr H350   H
649-034-00-3 Distillates (petroleum), petroleum residues vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.] 273-263-4 68955-27-1 Carc. 1B H350 GHS08Dgr H350   H
649-035-00-9 Residues (petroleum), steam-cracked, resinous;Heavy Fuel oil;[A complex residuum from the distillation of steam-cracked petroleum residues.] 273-272-3 68955-36-2 Carc. 1B H350 GHS08Dgr H350   H
649-036-00-4 Distillates (petroleum), intermediate vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 274-683-0 70592-76-6 Carc. 1B H350 GHS08Dgr H350   H
649-037-00-X Distillates (petroleum), light vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).] 274-684-6 70592-77-7 Carc. 1B H350 GHS08Dgr H350   H
649-038-00-5 Distillates (petroleum), vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 274-685-1 70592-78-8 Carc. 1B H350 GHS08Dgr H350   H
649-039-00-0 Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 285-555-9 85117-03-9 Carc. 1B H350 GHS08Dgr H350   H
649-040-00-6 Residues (petroleum), steam-cracked, distillates;Heavy Fuel oil;[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.] 292-657-7 90669-75-3 Carc. 1B H350 GHS08Dgr H350   H
649-041-00-1 Residues (petroleum), vacuum, light;Heavy Fuel oil;[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).] 292-658-2 90669-76-4 Carc. 1B H350 GHS08Dgr H350   H
649-042-00-7 Fuel oil, heavy, high-sulfur;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 295-396-7 92045-14-2 Carc. 1B H350 GHS08Dgr H350   H
649-043-00-2 Residues (petroleum), catalytic cracking;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).] 295-511-0 92061-97-7 Carc. 1B H350 GHS08Dgr H350   H
649-044-00-8 Distillates (petroleum), intermediate catalytic cracked, thermally degraded;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.] 295-990-6 92201-59-7 Carc. 1B H350 GHS08Dgr H350   H
649-045-00-3 Residual oils (petroleum);Heavy Fuel oil;[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.] 298-754-0 93821-66-0 Carc. 1B H350 GHS08Dgr H350   H
649-046-00-9 Residues, steam cracked, thermally treated;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).] 308-733-0 98219-64-8 Carc. 1B H350 GHS08Dgr H350   H
649-047-00-4 Distillates (petroleum), hydrodesulfurized full-range middle;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).] 309-863-0 101316-57-8 Carc. 1B H350 GHS08Dgr H350   H
649-048-00-X Residues (petroleum), catalytic reformer fractionator;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.] 265-069-3 64741-67-9 Carc. 1B H350 GHS08Dgr H350   H
649-049-00-5 Petroleum;Crude oil;[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] 232-298-5 8002-05-9 Carc. 1B H350 GHS08Dgr H350   H
649-050-00-0 Distillates (petroleum), light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.] 265-051-5 64741-50-0 Carc. 1A H350 GHS08Dgr H350   H
649-051-00-6 Distillates (petroleum), heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.] 265-052-0 64741-51-1 Carc. 1A H350 GHS08Dgr H350   H
649-052-00-1 Distillates (petroleum), light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-053-6 64741-52-2 Carc. 1A H350 GHS08Dgr H350   H
649-053-00-7 Distillates (petroleum), heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-054-1 64741-53-3 Carc. 1A H350 GHS08Dgr H350   H
649-054-00-2 Distillates (petroleum), acid-treated heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-117-3 64742-18-3 Carc. 1A H350 GHS08Dgr H350   H
649-055-00-8 Distillates (petroleum), acid-treated light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-118-9 64742-19-4 Carc. 1A H350 GHS08Dgr H350   H
649-056-00-3 Distillates (petroleum), acid-treated heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).] 265-119-4 64742-20-7 Carc. 1A H350 GHS08Dgr H350   H
649-057-00-9 Distillates (petroleum), acid-treated light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-121-5 64742-21-8 Carc. 1A H350 GHS08Dgr H350   H
649-058-00-4 Distillates (petroleum), chemically neutralized heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.] 265-127-8 64742-27-4 Carc. 1A H350 GHS08Dgr H350   H
649-059-00-X Distillates (petroleum), chemically neutralized light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-128-3 64742-28-5 Carc. 1A H350 GHS08Dgr H350   H
649-060-00-5 Distillates (petroleum), chemically neutralized heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-135-1 64742-34-3 Carc. 1A H350 GHS08Dgr H350   H
649-061-00-0 Distillates (petroleum), chemically neutralized light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-136-7 64742-35-4 Carc. 1A H350 GHS08Dgr H350   H
649-062-00-6 Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.] 270-755-0 68477-73-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-063-00-1 Gases (petroleum), catalytic cracker;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-756-6 68477-74-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-064-00-7 Gases (petroleum), catalytic cracker, C1-5-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.] 270-757-1 68477-75-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-065-00-2 Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.] 270-758-7 68477-76-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-066-00-8 Gases (petroleum), catalytic reformer, C1-4-rich;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.] 270-760-8 68477-79-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-067-00-3 Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;Petroleum gas;[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.] 270-765-5 68477-83-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-068-00-9 Gases (petroleum), C4-rich;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-767-6 68477-85-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-069-00-4 Gases (petroleum), deethanizer overheads;Petroleum gas;[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.] 270-768-1 68477-86-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-070-00-X Gases (petroleum), deisobutanizer tower overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-769-7 68477-87-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-071-00-5 Gases (petroleum), depropanizer dry, propene-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.] 270-772-3 68477-90-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-072-00-0 Gases (petroleum), depropanizer overheads;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-773-9 68477-91-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-073-00-6 Gases (petroleum), gas recovery plant depropanizer overheads;Petroleum gas;[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.] 270-777-0 68477-94-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-074-00-1 Gases (petroleum), Girbatol unit feed;Petroleum gas;[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-778-6 68477-95-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-075-00-7 Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;Petroleum gas 270-782-8 68477-99-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-076-00-2 Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-802-5 68478-21-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-077-00-8 Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;Petroleum gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-803-0 68478-22-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-078-00-3 Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.] 270-804-6 68478-24-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-079-00-9 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-806-7 68478-26-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-080-00-4 Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.] 270-813-5 68478-32-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-081-00-X Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.] 270-814-0 68478-33-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-082-00-5 Tail gas (petroleum), vacuum residues thermal cracker;Petroleum gas;[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-815-6 68478-34-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-083-00-0 Hydrocarbons, C3-4-rich, petroleum distillate;Petroleum gas;[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.] 270-990-9 68512-91-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-084-00-6 Gases (petroleum), full-range straight-run naphtha dehexanizer off;petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-000-8 68513-15-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-085-00-1 Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;Petroleum gas;[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.] 271-001-3 68513-16-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-086-00-7 Gases (petroleum), light straight-run naphtha stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-002-9 68513-17-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-087-00-2 Residues (petroleum), alkylation splitter, C4-rich;Petroleum gas;[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 oC to 27.8 oC (11 oF to 82 oF).] 271-010-2 68513-66-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-088-00-8 Hydrocarbons, C1-4;Petroleum gas;[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 oC to minus 0.5 oC (- 263 oF to 31 oF).] 271-032-2 68514-31-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-089-00-3 Hydrocarbons, C1-4, sweetened;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 164 oC to - 0.5 oC (-263 oF to 31 oF).] 271-038-5 68514-36-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-090-00-9 Hydrocarbons, C1-3;Petroleum gas;[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 oC to minus 42 oC (- 263 oF to - 44 oF).] 271-259-7 68527-16-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-091-00-4 Hydrocarbons, C1-4, debutanizer fraction;Petroleum gas 271-261-8 68527-19-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-092-00-X Gases (petroleum), C1-5, wet;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 271-624-0 68602-83-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-093-00-5 Hydrocarbons, C2-4;Petroleum gas 271-734-9 68606-25-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-094-00-0 Hydrocarbons, C3;Petroleum gas 271-735-4 68606-26-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-095-00-6 Gases (petroleum), alkylation feed;Petroleum gas;[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 271-737-5 68606-27-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-096-00-1 Gases (petroleum), depropanizer bottoms fractionation off;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.] 271-742-2 68606-34-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-097-00-7 Gases (petroleum), refinery blend;Petroleum gas;[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-183-7 68783-07-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-098-00-2 Gases (petroleum), catalytic cracking;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 272-203-4 68783-64-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-099-00-8 Gases (petroleum), C2-4, sweetened;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (-60 oF to - 30 oF).] 272-205-5 68783-65-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-100-00-1 Gases (petroleum), crude oil fractionation off;Petroleum gas;[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-871-7 68918-99-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-101-00-7 Gases (petroleum), dehexanizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-872-2 68919-00-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-102-00-2 Gases (petroleum), light straight run gasoline fractionation stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-878-5 68919-05-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-103-00-8 Gases (petroleum), naphtha unifiner desulfurization stripper off;Petroleum gas;[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-879-0 68919-06-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-104-00-3 Gases (petroleum), straight-run naphtha catalytic reforming off;Petroleum gas;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.] 272-882-7 68919-09-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-105-00-9 Gases (petroleum), fluidized catalytic cracker splitter overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.] 272-893-7 68919-20-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-106-00-4 Gases (petroleum), straight-run stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-883-2 68919-10-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-107-00-X Gases (petroleum), catalytic cracked naphtha debutanizer;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-169-3 68952-76-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-108-00-5 Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-170-9 68952-77-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-109-00-0 Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;petroleum gas;[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-175-6 68952-81-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-110-00-6 Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-176-1 68952-82-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-111-00-1 Gases (petroleum, light steam-cracked, butadiene conc.;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process, It consists of hydrocarbons having a carbon number predominantly of C4.] 273-265-5 68955-28-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-112-00-7 Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;Petroleum gas;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 273-270-2 68955-34-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-113-00-2 Hydrocarbons, C4;Petroleum gas 289-339-5 87741-01-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-114-00-8 Alkanes, C1-4, C3-rich;Petroleum gas 292-456-4 90622-55-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-115-00-3 Gases (petroleum), steam-cracker C3-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (- 94 oF to 32 oF).] 295-404-9 92045-22-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-116-00-9 Hydrocarbons, C4, steam-cracker distillate;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 oC to 5 oC (10.4 oF to 41 oF).] 295-405-4 92045-23-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-117-00-4 Petroleum gases, liquefied, sweetened, C4 fraction;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.] 295-463-0 92045-80-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   HKSU
649-118-00-X Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;Petroleum gas 306-004-1 95465-89-7 Flam. Gas 1Press. GasCarc. 1B H220H350 GHS02GHS04GHS08Dgr H220H350   H K U
649-119-00-5 Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;Petroleum gas 307-769-4 97722-19-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-120-00-0 Gases (petroleum), amine system feed;Refinery gas;[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.] 270-746-1 68477-65-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-121-00-6 Gases (petroleum), benzene unit hydrodesulfurizer off;Refinery gas;[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.] 270-747-7 68477-66-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-122-00-1 Gases (petroleum), benzene unit recycle, hydrogen-rich;Refinery gas;[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.] 270-748-2 68477-67-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-123-00-7 Gases (petroleum), blend oil, hydrogen-nitrogen-rich;Refinery gas;[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-749-8 68477-68-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-124-00-2 Gases (petroleum), catalytic reformed naphtha stripper overheads;Refinery gas;[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-759-2 68477-77-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-125-00-8 Gases (petroleum), C6-8 catalytic reformer recycle;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-761-3 68477-80-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-126-00-3 Gases (petroleum), C6-8 catalytic reformer;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.] 270-762-9 68477-81-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-127-00-9 Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;Refinery gas 270-763-4 68477-82-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-128-00-4 Gases (petroleum), C2-return stream;Refinery gas;[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.] 270-766-0 68477-84-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-129-00-X Gases (petroleum), dry sour, gas-concn.-unit-off;Refinery gas;[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-774-4 68477-92-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-130-00-5 Gases (petroleum), gas concn. reabsorber distn.;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.] 270-776-5 68477-93-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-131-00-0 Gases (petroleum), hydrogen absorber off;Refinery gas;[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.] 270-779-1 68477-96-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-132-00-6 Gases (petroleum), hydrogen-rich;Refinery gas;[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.] 270-780-7 68477-97-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-133-00-1 Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;Refinery gas;[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-781-2 68477-98-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-134-00-7 Gases (petroleum), recycle, hydrogen-rich;Refinery gas;[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 270-783-3 68478-00-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-135-00-2 Gases (petroleum), reformer make-up, hydrogen-rich;Refinery gas;[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-784-9 68478-01-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-136-00-8 Gases (petroleum), reforming hydrotreater;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 thorugh C5.] 270-785-4 68478-02-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-137-00-3 Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.] 270-787-5 68478-03-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-138-00-9 Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-788-0 68478-04-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-139-00-4 Gases (petroleum), thermal cracking distn.;Refinery gas;[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-789-6 68478-05-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-140-00-X Tail gas (petroleum), catalytic cracker refractionation absorber;Refinery gas;[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-805-1 68478-25-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-141-00-5 Tail gas (petroleum), catalytic reformed naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-807-2 68478-27-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-142-00-0 Tail gas (petroleum), catalytic reformed naphtha stabilizer;Refinery gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-808-8 68478-28-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-143-00-6 Tail gas (petroleum), cracked distillate hydrotreater separator;Refinery gas;[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-809-3 68478-29-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-144-00-1 Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-810-9 68478-30-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-145-00-7 Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;Refinery gas;[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.] 270-999-8 68513-14-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-146-00-2 Gases (petroleum), reformer effluent high-pressure flash drum off;Refinery gas;[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-003-4 68513-18-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-147-00-8 Gases (petroleum), reformer effluent low-pressure flash drum off;Refinery gas;[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-005-5 68513-19-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-148-00-3 Gases (petroleum), oil refinery gas distn. off;Refinery gas;[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.] 271-258-1 68527-15-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-149-00-9 Gases (petroleum), benzene unit hydrotreater depentanizer overheads;Refinery gas;[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.] 271-623-5 68602-82-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-150-00-4 Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;Refinery gas;[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 271-625-6 68602-84-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-151-00-X Petroleum products, refinery gases;Refinery gas;[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-750-6 68607-11-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-152-00-5 Gases (petroleum), hydrocracking low-pressure separator;Refinery gas;[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-182-1 68783-06-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-153-00-0 Gases (petroleum), refinery;Refinery gas;[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-338-9 68814-67-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-154-00-6 Gases (petroleum), platformer products separator off;Refinery gas;[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 272-343-6 68814-90-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-155-00-1 Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;Refinery gas;[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.] 272-775-5 68911-58-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-156-00-7 Gases (petroleum), hydrotreated sour kerosine flash drum;Refinery gas;[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydro-carbons having carbon numbers predominantly in the range of C2 through C5.] 272-776-0 68911-59-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-157-00-2 Gases (petroleum), distillate unifiner desulfurization stripper off;Refinery gas;[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.] 272-873-8 68919-01-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-158-00-8 Gases (petroleum), fluidized catalytic cracker fractionation off;Refinery gas;[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-874-3 68919-02-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-159-00-3 Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;Refinery gas;[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.] 272-875-9 68919-03-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-160-00-9 Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;Refinery gas;[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5]. 272-876-4 68919-04-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-161-00-4 Gases (petroleum), platformer stabilizer off, light ends fractionation;Refinery gas;[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the plattformer unit. It consists of hydrogen, methane, ethane and propane.] 272-880-6 68919-07-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-162-00-X Gases (petroleum), preflash tower off, crude distn.;Refinery gas;[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-881-1 68919-08-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-163-00-5 Gases (petroleum), tar stripper off;Refinery gas;[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-884-8 68919-11-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-164-00-0 Gases (petroleum), unifiner stripper off;Refinery gas;[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.] 272-885-3 68919-12-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-165-00-6 Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.] 273-173-5 68952-79-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-166-00-1 Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;Refinery gas;[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 273-174-0 68952-80-7 Press. GasFlam. Gas 1Carc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-167-00-7 Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;Refinery gas;[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-269-7 68955-33-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-168-00-2 Gases (petroleum), crude distn. and catalytic cracking;Refinery gas;[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-563-5 68989-88-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-169-00-8 Gases (petroleum), gas oil diethanolamine scrubber off;Refinery gas;[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 295-397-2 92045-15-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-170-00-3 Gases (petroleum), gas oil hydrodesulfurization effluent;Refinery gas;[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 295-398-8 92045-16-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-171-00-9 Gases (petroleum), gas oil hydrodesulfurization purge;Refinery gas;[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 295-399-3 92045-17-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-172-00-4 Gases (petroleum), hydrogenator effluent flash drum off;Refinery gas;[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 295-400-7 92045-18-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-173-00-X Gases (petroleum), naphtha steam cracking high-pressure residual;Refinery gas;[A complex combination obtained as a mixture of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.] 295-401-2 92045-19-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-174-00-5 Gases (petroleum), residue visbaking off;Refinery gas;[A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 295-402-8 92045-20-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-175-00-0 Foots oil (petroleum), acid-treated;Foots oil;[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-225-7 93924-31-3 Flam. Gas 1Press. GasCarc. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-176-00-6 Foots oil (petroleum), clay-treated;Foots oil;[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-226-2 93924-32-4 Flam. Gas 1Press. GasCarc. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-177-00-1 Gases (petroleum), C3-4;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (-60oF to 30 oF.)] 268-629-5 68131-75-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-178-00-7 Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;Petroleum gas;[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-617-2 68307-98-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-179-00-2 Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-618-8 68307-99-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-180-00-8 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-619-3 68308-00-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-181-00-3 Tail gas (petroleum), cracked distillate hydrotreater stripper;Petroleum gas;[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-620-9 68308-01-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-182-00-9 Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-630-3 68308-10-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-183-00-4 Tail gas (petroleum), gas oil catalytic cracking absorber;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-623-5 68308-03-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-184-00-X Tail gas (petroleum), gas recovery plant;Petroleum gas;[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-624-0 68308-04-3 Press. GasFlam. Gas 1Carc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-185-00-5 Tail gas (petroleum), gas recovery plant deethanizer;Petroleum gas;[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbon having carbon numbers predominantly in the range of C1 through C4.] 269-625-6 68308-05-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-186-00-0 Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-626-1 68308-06-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-187-00-6 Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-627-7 68308-07-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-188-00-1 Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-629-8 68308-09-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-189-00-7 Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-631-9 68308-11-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-190-00-2 Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-632-4 68308-12-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-191-00-8 Gases (petroleum), catalytic cracked overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately - 48 oC to 32 oC (- 54 oF to 90 oF).] 270-071-2 68409-99-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-193-00-9 Alkanes, C1-2;Petroleum gas 270-651-5 68475-57-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-194-00-4 Alkanes, C2-3;Petroleum gas 270-652-0 68475-58-1 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-195-00-X Alkanes, C3-4;Petroleum gas 270-653-6 68475-59-2 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-196-00-5 Alkanes, C4-5;Petroleum gas 270-654-1 68475-60-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-197-00-0 Fuel gases;Petroleum gas;[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.] 270-667-2 68476-26-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-198-00-6 Fuel gases, crude oil of distillates;Petroleum gas;[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217 oC to - 12 oC (- 423 oF to 10 oF).] 270-670-9 68476-29-9 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-199-00-1 Hydrocarbons, C3-4;Petroleum gas 270-681-9 68476-40-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-200-00-5 Hydrocarbons, C4-5;Petroleum gas 270-682-4 68476-42-6 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-201-00-0 Hydrocarbons, C2-4, C3-rich;Petroleum gas 270-689-2 68476-49-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-202-00-6 Petroleum gases, liquefied;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).] 270-704-2 68476-85-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   HKSU
649-203-00-1 Petroleum gases, liquefied, sweetened;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).] 270-705-8 68476-86-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   HKSU
649-204-00-7 Gases (petroleum), C3-4, isobutane-rich;Petroleum gas;[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.] 270-724-1 68477-33-8 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-205-00-2 Distillates (petroleum), C3-6, piperylene-rich;Petroleum gas;[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.] 270-726-2 68477-35-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-206-00-8 Gases (petroleum), butane splitter overheads;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-750-3 68477-69-0 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-207-00-3 Gases (petroleum), C2-;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.] 270-751-9 68477-70-3 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-208-00-9 Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-752-4 68477-71-4 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-209-00-4 Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 270-754-5 68477-72-5 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-210-00-X Tail gas (petroleum), isomerized naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-628-2 68308-08-7 Flam. Gas 1Press. GasCarc. 1AMuta. 1B H220H350H340 GHS02GHS04GHS08Dgr H220H350H340   H K U
649-211-00-5 Foots oil (petroleum), carbon-treated;Foots oil;[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-126-0 97862-76-5 Carc. 1B H350 GHS08Dgr H350   H L
649-212-00-0 Distillates (petroleum), sweetened middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-088-7 64741-86-2 Carc. 1B H350 GHS08Dgr H350   H N
649-213-00-6 Gas oils (petroleum), solvent-refined;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-092-9 64741-90-8 Carc. 1B H350 GHS08Dgr H350   H N
649-214-00-1 Distillates (petroleum), solvent-refined middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-093-4 64741-91-9 Carc. 1B H350 GHS08Dgr H350   H N
649-215-00-7 Gas oils (petroleum), acid-treated;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-112-6 64742-12-7 Carc. 1B H350 GHS08Dgr H350   H N
649-216-00-2 Distillates (petroleum), acid-treated middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-113-1 64742-13-8 Carc. 1B H350 GHS08Dgr H350   H N
649-217-00-8 Distillates (petroleum), acid-treated light;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-114-7 64742-14-9 Carc. 1B H350 GHS08Dgr H350   H N
649-218-00-3 Gas oils (petroleum), chemically neutralized;Gasoil — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-129-9 64742-29-6 Carc. 1B H350 GHS08Dgr H350   H N
649-219-00-9 Distillates (petroleum), chemically neutralized middle;Gasoil — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-130-4 64742-30-9 Carc. 1B H350 GHS08Dgr H350   H N
649-220-00-4 Distillates (petroleum), clay-treated middle;Gasoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-139-3 64742-38-7 Carc. 1B H350 GHS08Dgr H350   H N
649-221-00-X Distillates (petroleum), hydrotreated middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-148-2 64742-46-7 Carc. 1B H350 GHS08Dgr H350   H N
649-222-00-5 Gas oils (petroleum), hydrodesulfurized;Gasoil — unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-182-8 64742-79-6 Carc. 1B H350 GHS08Dgr H350   H N
649-223-00-0 Distillates (petroleum), hydrodesulfurized middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-183-3 64742-80-9 Carc. 1B H350 GHS08Dgr H350   H N
649-224-00-6 Fuels, diesel;Gasoil — unspecified;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).] 269-822-7 68334-30-5 Carc. 2 H351 GHS08Wng H351   H N
649-225-00-1 Fuel oil, No 2;Gasoil — unspecified;[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).] 270-671-4 68476-30-2 Carc. 2 H351 GHS08Wng H351   H
649-226-00-7 Fuel oil, No 4;Gasoil — unspecified;[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).] 270-673-5 68476-31-3 Carc. 2 H351 GHS08Wng H351   H
649-227-00-2 Fuels, diesel, No 2;Gasoil — unspecified;[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).] 270-676-1 68476-34-6 Carc. 2 H351 GHS08Wng H351   H
649-228-00-8 Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;Gasoil — unspecified;[A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).] 270-719-4 68477-29-2 Carc. 1B H350 GHS08Dgr H350   H N
649-229-00-3 Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;Gasoil — unspecified;[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).] 270-721-5 68477-30-5 Carc. 1B H350 GHS08Dgr H350   H N
649-230-00-9 Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;Gasoil — unspecified;[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).] 270-722-0 68477-31-6 Carc. 1B H350 GHS08Dgr H350   H N
649-231-00-4 Distillates (petroleum), highly refined middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.] 292-615-8 90640-93-0 Carc. 1B H350 GHS08Dgr H350   H N
649-232-00-X Distillates (petroleum) catalytic reformer, heavy arom. conc.;Gasoil — unspecified;[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).] 295-294-2 91995-34-5 Carc. 1B H350 GHS08Dgr H350   H N
649-233-00-5 Gas oils, paraffinic;Gasoil — unspecified;[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).] 300-227-8 93924-33-5 Carc. 1B H350 GHS08Dgr H350   H N
649-234-00-0 Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;Gasoil — unspecified 307-035-3 97488-96-5 Carc. 1B H350 GHS08Dgr H350   H N
649-235-00-6 Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-659-6 97675-85-9 Carc. 1B H350 GHS08Dgr H350   H N
649-236-00-1 Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-660-1 97675-86-0 Carc. 1B H350 GHS08Dgr H350   H N
649-237-00-7 Hydrocarbons, C11-17, solvent-extd. light naphthenic;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).] 307-757-9 97722-08-2 Carc. 1B H350 GHS08Dgr H350   H N
649-238-00-2 Gas oils, hydrotreated;Gasoil — unspecified;[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).] 308-128-1 97862-78-7 Carc. 1B H350 GHS08Dgr H350   H N
649-239-00-8 Distillates (petroleum), carbon-treated light paraffinic;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.] 309-667-5 100683-97-4 Carc. 1B H350 GHS08Dgr H350   H N
649-240-00-3 Distillates (petroleum), intermediate paraffinic, carbon-treated;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-668-0 100683-98-5 Carc. 1B H350 GHS08Dgr H350   H N
649-241-00-9 Distillates (petroleum), intermediate paraffinic, clay-treated;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-669-6 100683-99-6 Carc. 1B H350 GHS08Dgr H350   H N
649-242-00-4 Alkanes, C12-26-branched and linear 292-454-3 90622-53-0 Carc. 1B H350 GHS08Dgr H350   H N
649-243-00-X Lubricating greases;Grease;[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.] 278-011-7 74869-21-9 Carc. 1B H350 GHS08Dgr H350   H N
649-244-00-5 Slack wax (petroleum);Slack wax;[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 265-165-5 64742-61-6 Carc. 1B H350 GHS08Dgr H350   H N
649-245-00-0 Slack wax (petroleum), acid-treated;Slack wax;[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 292-659-8 90669-77-5 Carc. 1B H350 GHS08Dgr H350   H N
649-246-00-6 Slack wax (petroleum), clay-treated;Slack wax;[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.] 292-660-3 90669-78-6 Carc. 1B H350 GHS08Dgr H350   H N
649-247-00-1 Slack wax (petroleum), hydrotreated;Slack wax;[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 295-523-6 92062-09-4 Carc. 1B H350 GHS08Dgr H350   H N
649-248-00-7 Slack wax (petroleum), low-melting;Slack wax;[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-524-1 92062-10-7 Carc. 1B H350 GHS08Dgr H350   H N
649-249-00-2 Slack wax (petroleum), low-melting, hydrotreated;Slack wax;[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-525-7 92062-11-8 Carc. 1B H350 GHS08Dgr H350   H N
649-250-00-8 Slack wax (petroleum), low-melting, carbon-treated;Slack wax;[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-155-9 97863-04-2 Carc. 1B H350 GHS08Dgr H350   H N
649-251-00-3 Slack wax (petroleum), low-melting, clay-treated;Slack wax;[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-156-4 97863-05-3 Carc. 1B H350 GHS08Dgr H350   H N
649-252-00-9 Slack wax (petroleum), low-melting, silicic acid-treated;Slack wax;[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-158-5 97863-06-4 Carc. 1B H350 GHS08Dgr H350   H N
649-253-00-4 Slack wax (petroleum), carbon-treated;Slack wax;[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.] 309-723-9 100684-49-9 Carc. 1B H350 GHS08Dgr H350   H N
649-254-00-X Petrolatum;Petrolatum;[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 232-373-2 8009-03-8 Carc. 1B H350 GHS08Dgr H350   H N
649-255-00-5 Petrolatum (petroleum), oxidized;Petrolatum;[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.] 265-206-7 64743-01-7 Carc. 1B H350 GHS08Dgr H350   H N
649-256-00-0 Petrolatum (petroleum), alumina-treated;Petrolatum;[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 285-098-5 85029-74-9 Carc. 1B H350 GHS08Dgr H350   H N
649-257-00-6 Petrolatum (petroleum), hydrotreated;Petrolatum;[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.] 295-459-9 92045-77-7 Carc. 1B H350 GHS08Dgr H350   H N
649-258-00-1 Petrolatum (petroleum), carbon-treated;Petrolatum;[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-149-6 97862-97-0 Carc. 1B H350 GHS08Dgr H350   H N
649-259-00-7 Petrolatum (petroleum), silicic acid-treated;Petrolatum;[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-150-1 97862-98-1 Carc. 1B H350 GHS08Dgr H350   H N
649-260-00-2 Petrolatum (petroleum), clay-treated;Petrolatum;[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.] 309-706-6 100684-33-1 Carc. 1B H350 GHS08Dgr H350   H N
649-261-00-8 Gasoline, natural;Low boiling point naphtha;[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (- 4 oF to 248 oF).] 232-349-1 8006-61-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-262-00-3 Naphtha;Low boiling point naphtha;[Refined, partly refined, or unrefined petroleum products by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).]] 232-443-2 8030-30-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-263-00-9 Ligroine;Low boiling point naphtha;[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58 oF to 275 oF).] 232-453-7 8032-32-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-264-00-4 Naphtha (petroleum), heavy straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-041-0 64741-41-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-265-00-X Naphtha (petroleum), full-range straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 220 oC (- 4 oF to 428 oF).] 265-042-6 64741-42-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-266-00-5 Naphtha (petroleum), light straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).] 265-046-8 64741-46-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-267-00-0 Solvent naphtha (petroleum), light aliph.;Low boiling point naphtha;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 oC to 160 oC (95 oF to 320 oF).] 265-192-2 64742-89-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-268-00-6 Distillates (petroleum), straight-run light;Low boiling point naphtha;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately - 88 oC to 99 oC (- 127 oF to 210 oF).] 270-077-5 68410-05-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-269-00-1 Gasoline, vapor-recovery;Low boiling point naphtha;[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (-4 oF to 384 oF).] 271-025-4 68514-15-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-270-00-7 Gasoline, straight-run, topping-plant;Low boiling point naphtha;[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97 oF to 380 oF).] 271-727-0 68606-11-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-271-00-2 Naphtha (petroleum), unsweetened;Low boiling point naphtha;[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25 oF to 446 oF).] 272-186-3 68783-12-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-272-00-8 Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;Low boiling point naphtha;[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C3 through C6..] 272-931-2 68921-08-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-273-00-3 Naphtha (petroleum), heavy straight run, arom.-contg.;Low boiling point naphtha;[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).] 309-945-6 101631-20-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-274-00-9 Naphtha (petroleum), full-range alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consist of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).] 265-066-7 64741-64-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-275-00-4 Naphtha (petroleum), heavy alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302 oF to 428 oF).] 265-067-2 64741-65-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-276-00-X Naphtha (petroleum), light alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of aproximately 90 oC to 160 oC (194 oF to 320 oF).] 265-068-8 64741-66-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-277-00-5 Naphtha (petroleum), isomerization;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.] 265-073-5 64741-70-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-278-00-0 Naphtha (petroleum), solvent-refined light;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).] 265-086-6 64741-84-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-279-00-6 Naphtha (petroleum), solvent-refined heavy;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-095-5 64741-92-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-280-00-1 Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.] 270-088-5 68410-71-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-281-00-7 Raffinates (petroleum), reformer, Lurgi unit-sepd.;Low boiling point modified naphtha;[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.] 270-349-3 68425-35-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-282-00-2 Naphtha (petroleum), full-range alkylate, butane-contg.;Low boiling point modified naphta;[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).] 271-267-0 68527-27-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-283-00-8 Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.] 295-315-5 91995-53-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-284-00-3 Naphtha (petroleum), C4-12 butane-alkylate, isooctane-rich;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95 oF to 410 oF).] 295-430-0 92045-49-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-285-00-9 Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;Low boiling point modified naphtha;[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 oC to 99 oC (201 oF to 210 oF).] 295-436-3 92045-55-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-286-00-4 Naphtha (petroleum), isomerization, C6-fraction;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140 oF to 151 oF).] 295-440-5 92045-58-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-287-00-X Hydrocarbons, C6-7, naphtha-cracking, solvent-refined;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158 oF to 212 oF).] 295-446-8 92045-64-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-288-00-5 Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 oC to 70 oC (149 oF to 158 oF).] 309-871-4 101316-67-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-289-00-0 Naphtha (petroleum), heavy catalytic cracked;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-055-7 64741-54-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-290-00-6 Naphtha (petroleum), light catalytic cracked;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-056-2 64741-55-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-291-00-1 Hydrocarbons, C3-11, catalytic cracker distillates;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400 oF).] 270-686-6 68476-46-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-292-00-7 Naphtha (petroleum), catalytic cracked light distd.;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-185-8 68783-09-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-293-00-2 Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;Low boiling point cat-cracked naphtha.;[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predom-inantly of aromatic hydrocarbons.] 295-311-3 91995-50-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-294-00-8 Naphtha (petroleum), heavy catalytic cracked, sweetened;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to 200 oC (140 oF to 392 oF).] 295-431-6 92045-50-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-295-00-3 Naphtha (petroleum), light catalytic cracked sweetened;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approximately 35 oC to 210 oC (95 oF to 410 oF).] 295-441-0 92045-59-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-296-00-9 Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).] 295-794-0 92128-94-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-297-00-4 Hydrocarbons, C8-12, catalytic cracker distillates;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists pre-dominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 oC to 210 oC (284 oF to 410 oF).] 309-974-4 101794-97-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-298-00-X Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;Low boiling point cat-cracked naphtha 309-987-5 101896-28-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-299-00-5 Naphtha (petroleum), light catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.]] 265-065-1 64741-63-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-300-00-9 Naphtha (petroleum), heavy catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-070-9 64741-68-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-301-00-4 Distillates (petroleum), catalytic reformed depentanizer;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC - 57 oF to 145 oF).] 270-660-4 68475-79-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-302-00-X Hydrocarbons, C2-6, C6-8 catalytic reformer;Low boiling point cat-reformed naphtha 270-687-1 68476-47-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-303-00-5 Residues (petroleum), C6-8 catalytic reformer;Low boiling point cat-reformed naphtha';[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 270-794-3 68478-15-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-304-00-0 Naphtha (petroleum), light catalytic reformed, arom.-free;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 oC to 120 oC (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.] 270-993-5 68513-03-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-305-00-6 Distillates (petroleum), catalytic reformed straight-run naphtha overheads;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-008-1 68513-63-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-306-00-1 Petroleum products, hydrofiner-powerformer reformates;Low boiling point cat-reformed naphtha;[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80 oF to 410 oF).] 271-058-4 68514-79-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-307-00-7 Naphtha (petroleum, full-range reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).] 272-895-8 68919-37-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-308-00-2 Naphtha (petroleum), catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90 oF to 430 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol.% or more benzene.] 273-271-8 68955-35-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-309-00-8 Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;Low boiling point cat-reformed naphtha;[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320 oF to 356 oF).] 285-509-8 85116-58-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-310-00-3 Aromatic hydrocarbons, C8, catalytic reforming-derived;Low boiling point cat-reformed naphtha 295-279-0 91995-18-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-311-00-9 Aromatic hydrocarbons, C7-12, C8-rich;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266 oF to 392 oF).] 297-401-8 93571-75-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-312-00-4 Gasoline, C5-11, high-octane stabilized reformed;Low boiling point cat-reformed naphtha;[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 oC to 185 oC (113 oF to 365 oF).] 297-458-9 93572-29-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-313-00-X Hydrocarbons, C7-12, C >9-arom.-rich, reforming heavy fraction;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248 oF to 380 oF) and C9 and higher aromatic hydrocarbons.] 297-465-7 93572-35-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-314-00-5 Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 35 oC to 125 oC (94 oF to 257 oF), benzene and toluene.] 297-466-2 93572-36-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-315-00-0 Foots oil (petroleum), silicic acid-treated;Foots oil;[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-127-6 97862-77-6 Carc. 1B H350H304 GHS08Dgr H350H304   H L
649-316-00-6 Naphtha (petroleum), light thermal cracked;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 10 oC to 130 oC (14 oF to 266 oF).] 265-075-6 64741-74-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-317-00-1 Naphtha (petroleum), heavy thermal cracked;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 220 oC (148 oF to 428 oF).] 265-085-0 64741-83-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-318-00-7 Distillates (petroleum), heavy arom.;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.] 267-563-4 67891-79-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-319-00-2 Distillates (petroleum), light arom.;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.] 267-565-5 67891-80-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-320-00-8 Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400 oF).] 270-344-6 68425-29-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-321-00-3 Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;Low boiling point thermally cracked naphtha;A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.] 270-658-3 68475-70-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-322-00-9 Distillates (petroleum), thermal cracked naphtha and gas oil;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 oC to 60 oC (91 oF to 140 oF).] 271-631-9 68603-00-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-323-00-4 Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 oC to 184 oC (91 oF to 363 oF).] 271-632-4 68603-01-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-324-00-X Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 oC to 40 oC (88 oF to 104 oF).] 271-634-5 68603-03-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-325-00-5 Distillates (petroleum), light thermal cracked, debutanized arom.;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.] 273-266-0 68955-29-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-326-00-0 Naphtha (petroleum), light thermal cracked, sweetened;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 oC (68 oF to 212 oF).] 295-447-3 92045-65-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-327-00-6 Naphtha (petroleum), hydrotreated heavy;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-150-3 64742-48-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-328-00-1 Naphtha (petroleum), hydrotreated light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-151-9 64742-49-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-329-00-7 Naphtha (petroleum), hydrodesulfurized light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-178-6 64742-73-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-330-00-2 Naphtha (petroleum), hydrodesulfurized heavy;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-185-4 64742-82-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-331-00-8 Distillates (petroleum), hydrotreated middle, intermediate boiling;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 oC to 188 oC (262 oF to 370 oF).] 270-092-7 68410-96-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-332-00-3 Distillates (petroleum), light distillate hydrotreating process, low-boiling;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 oC to 194 oC (37 oF to 382 oF).] 270-093-2 68410-97-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-333-00-9 Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (- 57 oF to 155 oF).] 270-094-8 68410-98-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-334-00-4 Solvent naphtha (petroleum), light arom., hydrotreated;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).] 270-988-8 68512-78-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-335-00-X Naphtha (petroleum), hydrodesulfurized thermal cracked light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73 oF to 383 oF).] 285-511-9 85116-60-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-336-00-5 Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 285-512-4 85116-61-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-337-00-0 Naphtha (petroleum), heavy steam-cracked, hydrogenated;Low boiling point hydrogen treated naphtha 295-432-1 92045-51-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-338-00-6 Naphtha (petroleum), hydrodesulfurized full-range;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86 oF to 482 oF).] 295-433-7 92045-52-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-339-00-1 Naphtha (petroleum), hydrotreated light steam-cracked;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).] 295-438-4 92045-57-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-340-00-7 Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230 oC (86 oF to 446 oF).] 295-443-1 92045-61-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-341-00-2 Solvent naphtha (petroleum), hydrotreated light naphthenic;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 oC to 85 oC (163 oF to 185 oF).] 295-529-9 92062-15-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-342-00-8 Naphtha (petroleum), light steam-cracked, hydrogenated;Low boiling point hydrogen treated naphtha;[A complex comination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 oC to 200 oC (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulphur and oxygenated compounds.] 296-942-7 93165-55-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-343-00-3 Hydrocarbons, C6-11, hydrotreated, dearomatized;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-852-0 93763-33-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-344-00-9 Hydrocarbons, C9-12, hydrotreated, dearomatized;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-853-6 93763-34-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-345-00-4 Stoddard solvent;Low boiling point naphtha — unspecified;[A colourless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 300 oF to 400 oF.] 232-489-3 8052-41-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-346-00-X Natural gas condensates (petroleum);Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.] 265-047-3 64741-47-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-347-00-5 Natural gas (petroleum), raw liq. mix;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.] 265-048-9 64741-48-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-348-00-0 Naphtha (petroleum), light hydrocracked;Low boiling naphtha — unspecified;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).] 265-071-4 64741-69-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-349-00-6 Naphtha (petroleum), heavy hydrocracked;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF).] 265-079-8 64741-78-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-350-00-1 Naphtha (petroleum), sweetened;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately minus 10 oC to 230 oC (14 oF to 446 oF).] 265-089-2 64741-87-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-351-00-7 Naphtha (petroleum), acid-treated;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-115-2 64742-15-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-352-00-2 Naphtha (petroleum), chemically neutralized heavy;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-122-0 64742-22-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-353-00-8 Naphtha (petroleum), chemically neutralized light;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-123-6 64742-23-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-354-00-3 Naphtha (petroleum), catalytic dewaxed;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).] 265-170-2 64742-66-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-355-00-9 Naphtha (petroleum), light steam-cracked;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). This stream is likely to contain 10 vol.% or more benzene.] 265-187-5 64742-83-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-356-00-4 Solvent naphtha (petroleum), light arom.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).] 265-199-0 64742-95-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-357-00-X Aromatic hydrocarbons, C6-10, acid-treated, neutralized;Low boiling point naphtha — unspecified 268-618-5 68131-49-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-358-00-5 Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.] 270-725-7 68477-34-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-359-00-0 Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.]] 270-735-1 68477-50-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-360-00-6 Distillates (petroleum), steam-cracked, C5-12 fraction;Low boiling point naphtha — unspecified;[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] 270-736-7 68477-53-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-361-00-1 Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;Low boiling point naphtha — unspecified 270-738-8 68477-55-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-362-00-7 Extracts (petroleum), cold-acid, C4-6;Low boiling point naphtha — unspecified;[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 270-741-4 68477-61-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-363-00-2 Distillates (petroleum), depentanizer overheads;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-771-8 68477-89-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-364-00-8 Residues (petroleum), butane splitter bottoms;Low boiling point naphtha — unspecified;[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-791-7 68478-12-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-365-00-3 Residual oils (petroleum), deisobutanizer tower;Low boiling point naphtha — unspecified;[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-795-9 68478-16-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-366-00-9 Naphtha (petroleum), full-range coker;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 oC to 250 oC (110 oF to 500 oF).] 270-991-4 68513-02-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-367-00-4 Naphtha (petroleum), steam-cracked middle arom.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 oC to 220 oC (266 oF to 428 oF).]] 271-138-9 68516-20-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-368-00-X Naphtha (petroleum), clay-treated full-range straight-run;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (- 4 oF to 429 oF).] 271-262-3 68527-21-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-369-00-5 Naphtha (petroleum), clay-treated light straight-run;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities, present. It consists of hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200 oF to 356 oF.] 271-263-9 68527-22-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-370-00-0 Naphtha (petroleum), light steam-cracked arom.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 oC to 165 oC (230 oF to 329 oF).] 271-264-4 68527-23-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-371-00-6 Naphtha (petroleum), light steam-cracked, debenzenized;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 oC to 218 oC (176 oF to 424 oF).] 271-266-5 68527-26-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-372-00-1 Naphtha (petroleum), arom.-contg.;Low boiling point naphtha — unspecified 271-635-0 68603-08-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-373-00-7 Gasoline, pyrolysis, debutanizer bottoms;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.] 271-726-5 68606-10-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-374-00-2 Naphtha (petroleum), light, sweetened;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20 oC to 100 oC (- 4 oF to 212 oF).] 272-206-0 68783-66-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-375-00-8 Natural gas condensates;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.] 272-896-3 68919-39-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H J
649-376-00-3 Distillates (petroleum), naphtha unifiner stripper;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 272-932-8 68921-09-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-377-00-9 Naphtha (petroleum), catalytic reformed light, arom.-free fraction;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 oC to 121 oC (151 oF to 250 oF).] 285-510-3 85116-59-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-378-00-4 Gasoline;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260 oC (86 oF to 500 oF).] 289-220-8 86290-81-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-379-00-X Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues;Low boiling point naphtha — unspecified 292-698-0 90989-42-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-380-00-5 Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 oC to 40 oC (77 oF to 104 oF).] 295-298-4 91995-38-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-381-00-0 Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 295-302-4 91995-41-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-382-00-6 Extracts (petroleum), catalytic reformed light naphtha solvent;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).] 295-331-2 91995-68-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-383-00-1 Naphtha (petroleum), hydrodesulfurized light, dearomatized;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 oC to 100 oC (194 oF to 212 oF).] 295-434-2 92045-53-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-384-00-7 Naphtha (petroleum), light, C5-rich, sweetened;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35 oC (14 oF to 95 oF).] 295-442-6 92045-60-8 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-385-00-2 Hydrocarbons, C8-11, naphtha-cracking, toluene cut;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 oC to 205 oC (266 oF to 401 oF).] 295-444-7 92045-62-0 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-386-00-8 Hydrocarbons, C4-11, naphtha-cracking, arom.-free;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C4 through C11 and boiling in the range of approximately 30 oC to 205 oC (86 oF to 401 oF).] 295-445-2 92045-63-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-387-00-3 Naphtha (petroleum), light heat-soaked, steam-cracked;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon numbers predominantly in the range of C4 through C6 and boiling in the range of approximately 0 oC to 80 oC (32 oF to 176 oF.] 296-028-8 92201-97-3 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-388-00-9 Distillates (petroleum), C6-rich;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 oC to 70 oC (140 oF to 158 oF).] 296-903-4 93165-19-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-389-00-4 Gasoline, pyrolysis, hydrogenated;Low boiling point naphtha — unspecified;[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 oC to 200 oC (68 oF to 392 oF).] 302-639-3 94114-03-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-390-00-X Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 305-750-5 95009-23-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-391-00-5 Extracts (petroleum) heavy naphtha solvent, clay-treated;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C18 and boiling in the range of approximately 80 oC to 180 oC (175 oF to 356 oF).] 308-261-5 97926-43-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-392-00-0 Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200 oC (203 oF to 392 oF).] 308-713-1 98219-46-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-393-00-6 Naphtha (petroleum), light steam-cracked, thermally treated;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 oC to 80 oC (95 oF to 176 oF).] 308-714-7 98219-47-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-394-00-1 Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 oC to 130 oC (248 oF to 266 oF).] 309-862-5 101316-56-7 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-395-00-7 Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 oC to 135 oC (176 oF to 275 oF).] 309-870-9 101316-66-9 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-396-00-2 Naphtha (petroleum), hydrodesulfurized full-range coker;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 oC (73 oF to 385 oF).] 309-879-8 101316-76-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-397-00-8 Naphtha (petroleum), sweetened light;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 oC to 130 oC (68 oF to 266 oF).] 309-976-5 101795-01-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-398-00-3 Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.] 310-012-0 102110-14-5 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-399-00-9 Hydrocarbons, C5-rich, dicyclopentadiene-contg.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of the products from a stream-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 oC to 170 oC (86 oF to 338 oF).] 310-013-6 102110-15-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-400-00-2 Residues (petroleum), steam-cracked light, arom.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 oC (104 oF).] 310-057-6 102110-55-4 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-401-00-8 Hydrocarbons, C≥ 5, C5-6-rich;Low boiling point naphtha — unspecified 270-690-8 68476-50-6 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-402-00-3 Hydrocarbons, C5-rich;Low boiling point naphtha — unspecified 270-695-5 68476-55-1 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-403-00-9 Aromatic hydrocarbons, C8-10;Low boiling point naphtha — unspecified 292-695-4 90989-39-2 Carc. 1BAsp. Tox. 1 H350H304 GHS08Dgr H350H304   H P
649-404-00-4 Kerosine (petroleum);Straight run kerosine;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).] 232-366-4 8008-20-6 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-405-00-X Solvent naphtha (petroleum), medium aliph.;Straight run kerosine;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).] 265-191-7 64742-88-7 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-406-00-5 Solvent naphtha (petroleum) heavy aliph.;Straight run kerosine;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).] 265-200-4 64742-96-7 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-407-00-0 Kerosine (petroleum), straight-run wide-cut;Straight run kerosine;[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).] 295-418-5 92045-37-9 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-408-00-6 Distillates (petroleum), steam-cracked;Cracked kerosine;[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).] 265-194-3 64742-91-2 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-409-00-1 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;Cracked kerosine;[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).] 270-728-3 68477-39-4 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-410-00-7 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;Cracked kerosine;[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.] 270-729-9 68477-40-7 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-411-00-2 Distillates (petroleum), steam-cracked, C8-12 fraction;Cracked kerosine;[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 270-737-2 68477-54-3 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-412-00-8 Kerosine (petroleum), hydrodesulfurized thermal cracked;Cracked kerosine;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).] 285-507-7 85116-55-8 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-413-00-3 Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;Cracked kerosine;[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).] 292-621-0 90640-98-5 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-414-00-9 Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;Cracked kerosine;[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).] 292-637-8 90641-13-7 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-415-00-4 Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.] 309-866-7 101316-61-4 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-416-00-X Distillates (petroleum), catalytic cracked heavy tar light;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-938-8 101631-13-4 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-417-00-5 Solvent naphtha (petroleum), hydrocracked heavy arom.;Cracked kerosine;[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).] 309-881-9 101316-80-7 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-418-00-0 Distillates (petroleum), steam-cracked heavy tar light;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-940-9 101631-15-6 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-419-00-6 Distillates (petroleum), alkylate;Kerosine — unspecified;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).] 265-074-0 64741-73-7 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-420-00-1 Extracts (petroleum), heavy naphtha solvent;Kerosine — unspecified;[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).] 265-099-7 64741-98-6 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-421-00-7 Distillates (petroleum), chemically neutralized light;Kerosine — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-132-5 64742-31-0 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-422-00-2 Distillates (petroleum), hydrotreated light;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-149-8 64742-47-8 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-423-00-8 Kerosine (petroleum), hydrodesulfurized;Kerosine — unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-184-9 64742-81-0 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-424-00-3 Solvent naphtha (petroleum), heavy arom.;Kerosine — unspecified;[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).] 265-198-5 64742-94-5 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-425-00-9 Naphtha (petroleum), heavy coker;Kerosine — unspecified;[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).] 269-778-9 68333-23-3 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-426-00-4 Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;Kerosine — unspecified;[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).] 285-508-2 85116-57-0 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-427-00-X Kerosine (petroleum), sweetened;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).] 294-799-5 91770-15-9 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-428-00-5 Kerosine (petroleum), solvent-refined sweetened;Kerosine — unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).] 295-416-4 92045-36-8 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-429-00-0 Hydrocarbons, C9-16, hydrotreated, dearomatized;Kerosine — unspecified;[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-854-1 93763-35-0 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-430-00-6 Kerosine (petroleum), solvent-refined hydrodesulfurized;Kerosine — unspecified 307-033-2 97488-94-3 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-431-00-1 Distillates (petroleum), hydrodesulfurized full-range middle coker;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).] 309-864-6 101316-58-9 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-432-00-7 Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).] 309-882-4 101316-81-8 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-433-00-2 Solvent naphtha (petroleum), hydrodesulfurized medium;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).] 309-884-5 101316-82-9 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-434-00-8 Kerosine (petroleum), hydrotreated;Kerosine — unspecified;[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).] 309-944-0 101631-19-0 Asp. Tox. 1 H304 GHS08Dgr H304   H
649-435-00-3 Distillates (petroleum), light catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 265-060-4 64741-59-9 Carc. 1B H350 GHS08Dgr H350   H
649-436-00-9 Distillates (petroleum), intermediate catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 265-062-5 64741-60-2 Carc. 1B H350 GHS08Dgr H350   H
649-437-00-4 Distillates (petroleum), light hydrocracked;Cracked gasoil;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).] 265-078-2 64741-77-1 Carc. 2 H351 GHS08Wng H351   H
649-438-00-X Distillates (petroleum), light thermal cracked;Cracked gasoil;[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).] 265-084-5 64741-82-8 Carc. 1B H350 GHS08Dgr H350   H
649-439-00-5 Distillates (petroleum), hydrodesulfurized light catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 269-781-5 68333-25-5 Carc. 1B H350 GHS08Dgr H350   H
649-440-00-0 Distillates (petroleum), light steam-cracked naphtha;Cracked gasoil;[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.] 270-662-5 68475-80-9 Carc. 1B H350 GHS08Dgr H350   H
649-441-00-6 Distillates (petroleum), cracked steam-cracked petroleum distillates;Cracked gasoil;[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.] 270-727-8 68477-38-3 Carc. 1B H350 GHS08Dgr H350   H
649-442-00-1 Gas oils (petroleum), steam-cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).] 271-260-2 68527-18-4 Carc. 1B H350 GHS08Dgr H350   H
649-443-00-7 Distillates (petroleum), hydrodesulfurized thermal cracked middle;Cracked gasoil;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 285-505-6 85116-53-6 Carc. 1B H350 GHS08Dgr H350   H
649-444-00-2 Gas oils (petroleum), thermal-cracked, hydrodesulfurized;Cracked gasoil 295-411-7 92045-29-9 Carc. 1B H350 GHS08Dgr H350   H
649-445-00-8 Residues (petroleum), hydrogenated steam-cracked naphtha;Cracked gasoil;[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).] 295-514-7 92062-00-5 Carc. 1B H350 GHS08Dgr H350   H
649-446-00-3 Residues (petroleum), steam-cracked naphtha distn.;Cracked gasoil;[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.] 295-517-3 92062-04-9 Carc. 1B H350 GHS08Dgr H350   H
649-447-00-9 Distillates (petroleum), light catalytic cracked, thermally degraded;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.] 295-991-1 92201-60-0 Carc. 1B H350 GHS08Dgr H350   H
649-448-00-4 Residues (petroleum), steam-cracked heat-soaked naphtha;Cracked gasoil;[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).] 297-905-8 93763-85-0 Carc. 1B H350 GHS08Dgr H350   H
649-449-00-X Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;Cracked gasoil;[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).] 307-662-2 97675-88-2 Carc. 2 H351 GHS08Wng H351   H
649-450-00-5 Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;Cracked gasoil;[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).] 308-278-8 97926-59-5 Carc. 1B H350 GHS08Dgr H350   H
649-451-00-0 Distillates (petroleum), hydrodesulfurized middle coker;Cracked gasoil;[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).] 309-865-1 101316-59-0 Carc. 1B H350 GHS08Dgr H350   H
649-452-00-6 Distillates (petroleum), heavy steam-cracked;Cracked gasoil;[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).] 309-939-3 101631-14-5 Carc. 1B H350 GHS08Dgr H350   H
649-453-00-1 Distillates (petroleum), heavy hydrocracked;Baseoil — unspecified;[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).] 265-077-7 64741-76-0 Carc. 1B H350 GHS08Dgr H350   H L
649-454-00-7 Distillates (petroleum), solvent-refined heavy paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-090-8 64741-88-4 Carc. 1B H350 GHS08Dgr H350   H L
649-455-00-2 Distillates (petroleum), solvent-refined light paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-091-3 64741-89-5 Carc. 1B H350 GHS08Dgr H350   H L
649-456-00-8 Residual oils (petroleum), solvent deasphalted;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-096-0 64741-95-3 Carc. 1B H350 GHS08Dgr H350   H L
649-457-00-3 Distillates (petroleum), solvent-refined heavy naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.] 265-097-6 64741-96-4 Carc. 1B H350 GHS08Dgr H350   H L
649-458-00-9 Distillates (petroleum), solvent-refined light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-098-1 64741-97-5 Carc. 1B H350 GHS08Dgr H350   H L
649-459-00-4 Residual oils (petroleum,) solvent-refined;Baseoil — unspecified;[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-101-6 64742-01-4 Carc. 1B H350 GHS08Dgr H350   H L
649-460-00-X Distillates (petroleum), clay-treated paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-137-2 64742-36-5 Carc. 1B H350 GHS08Dgr H350   H L
649-461-00-5 Distillates (petroleum), clay-treated light paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-138-8 64742-37-6 Carc. 1B H350 GHS08Dgr H350   H L
649-462-00-0 Residual oils (petroleum), clay-treated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-143-5 64742-41-2 Carc. 1B H350 GHS08Dgr H350   H L
649-463-00-6 Distillates (petroleum), clay-treated heavy naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-146-1 64742-44-5 Carc. 1B H350 GHS08Dgr H350   H L
649-464-00-1 Distillates (petroleum), clay-treated light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-147-7 64742-45-6 Carc. 1B H350 GHS08Dgr H350   H L
649-465-00-7 Distillates (petroleum), hydrotreated heavy naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-155-0 64742-52-5 Carc. 1B H350 GHS08Dgr H350   H L
649-466-00-2 Distillates (petroleum), hydrotreated light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-156-6 64742-53-6 Carc. 1B H350 GHS08Dgr H350   H L
649-467-00-8 Distillates (petroleum), hydrotreated heavy paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-157-1 64742-54-7 Carc. 1B H350 GHS08Dgr H350   H L
649-468-00-3 Distillates (petroleum), hydrotreated light paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-158-7 64742-55-8 Carc. 1B H350 GHS08Dgr H350   H L
649-469-00-9 Distillates (petroleum), solvent-dewaxed light paraffinic;Baseoil — unspecified;[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-159-2 64742-56-9 Carc. 1B H350 GHS08Dgr H350   H L
649-470-00-4 Residual oils (petroleum), hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-160-8 64742-57-0 Carc. 1B H350 GHS08Dgr H350   H L
649-471-00-X Residual oils (petroleum), solvent-dewaxed;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-166-0 64742-62-7 Carc. 1B H350 GHS08Dgr H350   H L
649-472-00-5 Distillates (petroleum), solvent-dewaxed heavy naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-167-6 64742-63-8 Carc. 1B H350 GHS08Dgr H350   H L
649-473-00-0 Distillates (petroleum), solvent-dewaxed light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-168-1 64742-64-9 Carc. 1B H350 GHS08Dgr H350   H L
649-474-00-6 Distillates (petroleum), solvent-dewaxed heavy paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-169-7 64742-65-0 Carc. 1B H350 GHS08Dgr H350   H L
649-475-00-1 Naphthenic oils (petroleum), catalytic dewaxed heavy;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-172-3 64742-68-3 Carc. 1B H350 GHS08Dgr H350   H L
649-476-00-7 Naphthenic oils (petroleum), catalytic dewaxed light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-173-9 64742-69-4 Carc. 1B H350 GHS08Dgr H350   H L
649-477-00-2 Paraffin oils (petroleum), catalytic dewaxed heavy;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-174-4 64742-70-7 Carc. 1B H350 GHS08Dgr H350   H L
649-478-00-8 Paraffin oils (petroleum), catalytic dewaxed light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-176-5 64742-71-8 Carc. 1B H350 GHS08Dgr H350   H L
649-479-00-3 Naphthenic oils (petroleum), complex dewaxed heavy;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-179-1 64742-75-2 Carc. 1B H350 GHS08Dgr H350   H L
649-480-00-9 Naphthenic oils (petroleum), complex dewaxed light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-180-7 64742-76-3 Carc. 1B H350 GHS08Dgr H350   H L
649-481-00-4 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-736-3 72623-85-9 Carc. 1B H350 GHS08Dgr H350   H L
649-482-00-X Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.] 276-737-9 72623-86-0 Carc. 1B H350 GHS08Dgr H350   H L
649-483-00-5 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-738-4 72623-87-1 Carc. 1B H350 GHS08Dgr H350   H L
649-484-00-0 Lubricating oils;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.] 278-012-2 74869-22-0 Carc. 1B H350 GHS08Dgr H350   H L
649-485-00-6 Distillates (petroleum), complex dewaxed heavy paraffinci;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-613-7 90640-91-8 Carc. 1B H350 GHS08Dgr H350   H L
649-486-00-1 Distillates (petroleum), complex dewaxed light paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-614-2 90640-92-9 Carc. 1B H350 GHS08Dgr H350   H L
649-487-00-7 Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-616-3 90640-94-1 Carc. 1B H350 GHS08Dgr H350   H L
649-488-00-2 Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-617-9 90640-95-2 Carc. 1B H350 GHS08Dgr H350   H L
649-489-00-8 Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-618-4 90640-96-3 Carc. 1B H350 GHS08Dgr H350   H L
649-490-00-3 Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-620-5 90640-97-4 Carc. 1B H350 GHS08Dgr H350   H L
649-491-00-9 Residual oils (petroleum), hydrotreated solvent dewaxed;Baseoil — unspecified 292-656-1 90669-74-2 Carc. 1B H350 GHS08Dgr H350   H L
649-492-00-4 Residual oils (petroleum), catalytic dewaxed;Baseoil — unspecified 294-843-3 91770-57-9 Carc. 1B H350 GHS08Dgr H350   H L
649-493-00-X Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.] 295-300-3 91995-39-0 Carc. 1B H350 GHS08Dgr H350   H L
649-494-00-5 Distillates (petroleum), dewaxed light paraffinic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.] 295-301-9 91995-40-3 Carc. 1B H350 GHS08Dgr H350   H L
649-495-00-0 Distillates (petroleum), hydrocracked solvent-refined, dewaxed;Baseoil — unspecified;[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.] 295-306-6 91995-45-8 Carc. 1B H350 GHS08Dgr H350   H L
649-496-00-6 Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.] 295-316-0 91995-54-9 Carc. 1B H350 GHS08Dgr H350   H L
649-497-00-1 Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;Baseoil — unspecified 295-423-2 92045-42-6 Carc. 1B H350 GHS08Dgr H350   H L
649-498-00-7 Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;Baseoil — unspecified 295-424-8 92045-43-7 Carc. 1B H350 GHS08Dgr H350   H L
649-499-00-2 Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;Baseoil — unspecified;[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).] 295-499-7 92061-86-4 Carc. 1B H350 GHS08Dgr H350   H L
649-500-00-6 Paraffin oils (petroleum), solvent-refined dewaxed heavy;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.] 295-810-6 92129-09-4 Carc. 1B H350 GHS08Dgr H350   H L
649-501-00-1 Lubricating oils (petroleum), base oils, paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).] 297-474-6 93572-43-1 Carc. 1B H350 GHS08Dgr H350   H L
649-502-00-7 Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;Baseoil — unspecified 297-857-8 93763-38-3 Carc. 1B H350 GHS08Dgr H350   H L
649-503-00-2 Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;Baseoil — unspecified 300-257-1 93924-61-9 Carc. 1B H350 GHS08Dgr H350   H L
649-504-00-8 Distillates (petroleum), solvent-refined hydrotreated heavy;hydrogenated;Baseoil — unspecified 305-588-5 94733-08-1 Carc. 1B H350 GHS08Dgr H350   H L
649-505-00-3 Distillates (petroleum), solvent-refined hydrocracked light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).] 305-589-0 94733-09-2 Carc. 1B H350 GHS08Dgr H350   H L
649-506-00-9 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-594-8 94733-15-0 Carc. 1B H350 GHS08Dgr H350   H L
649-507-00-4 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-595-3 94733-16-1 Carc. 1B H350 GHS08Dgr H350   H L
649-508-00-X Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;Baseoil — unspecified 305-971-7 95371-04-3 Carc. 1B H350 GHS08Dgr H350   H L
649-509-00-5 Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;Baseoil — unspecified 305-972-2 95371-05-4 Carc. 1B H350 GHS08Dgr H350   H L
649-510-00-0 Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;Baseoil — unspecified 305-974-3 95371-07-6 Carc. 1B H350 GHS08Dgr H350   H L
649-511-00-6 Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;Baseoil — unspecified 305-975-9 95371-08-7 Carc. 1B H350 GHS08Dgr H350   H L
649-512-00-1 Distillates (petroleum), hydrocracked solvent-refined light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.] 307-010-7 97488-73-8 Carc. 1B H350 GHS08Dgr H350   H L
649-513-00-7 Distillates (petroleum), solvent-refined hydrogenated heavy;Baseoil — unspecified;[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).] 307-011-2 97488-74-9 Carc. 1B H350 GHS08Dgr H350   H L
649-514-00-2 Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;Baseoil — unspecified 307-034-8 97488-95-4 Carc. 1B H350 GHS08Dgr H350   H L
649-515-00-8 Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).] 307-661-7 97675-87-1 Carc. 1B H350 GHS08Dgr H350   H L
649-516-00-3 Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).] 307-755-8 97722-06-0 Carc. 1B H350 GHS08Dgr H350   H L
649-517-00-9 Hydrocarbons, C13-27, solvent-extd. light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF).] 307-758-4 97722-09-3 Carc. 1B H350 GHS08Dgr H350   H L
649-518-00-4 Hydrocarbons, C14-29, solvent-extd. light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).] 307-760-5 97722-10-6 Carc. 1B H350 GHS08Dgr H350   H L
649-519-00-X Hydrocarbons, C27-42, dearomatized;Baseoil — unspecified 308-131-8 97862-81-2 Carc. 1B H350 GHS08Dgr H350   H L
649-520-00-5 Hydrocarbons, C17-30, hydrotreated distillates, distn. lights;Baseoil — unspecified 308-132-3 97862-82-3 Carc. 1B H350 GHS08Dgr H350   H L
649-521-00-0 Hydrocarbons, C27-45, naphthenic vacuum distn.;Baseoil — unspecified 308-133-9 97862-83-4 Carc. 1B H350 GHS08Dgr H350   H L
649-522-00-6 Hydrocarbons, C27-45, dearomatized;Baseoil — unspecified 308-287-7 97926-68-6 Carc. 1B H350 GHS08Dgr H350   H L
649-523-00-1 Hydrocarbons, C20-58, hydrotreated;Baseoil — unspecified 308-289-8 97926-70-0 Carc. 1B H350 GHS08Dgr H350   H L
649-524-00-7 Hydrocarbons, C27-42, naphthenic;Baseoil — unspecified 308-290-3 97926-71-1 Carc. 1B H350 GHS08Dgr H350   H L
649-525-00-2 Residual oils (petroleum), carbon-treated solvent-dewaxed;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.] 309-710-8 100684-37-5 Carc. 1B H350 GHS08Dgr H350   H L
649-526-00-8 Residual oils (petroleum), clay-treated solvent-dewaxed;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.] 309-711-3 100684-38-6 Carc. 1B H350 GHS08Dgr H350   H L
649-527-00-3 Lubricating oils (petroleum), C>25, solvent-extd., deasphalted, dewaxed, hydrogenated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).] 309-874-0 101316-69-2 Carc. 1B H350 GHS08Dgr H350   H L
649-528-00-9 Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.] 309-875-6 101316-70-5 Carc. 1B H350 GHS08Dgr H350   H L
649-529-00-4 Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).] 309-876-1 101316-71-6 Carc. 1B H350 GHS08Dgr H350   H L
649-530-00-X Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).] 309-877-7 101316-72-7 Carc. 1B H350 GHS08Dgr H350   H L
649-531-00-5 Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;Distillate aromatic extract (treated);[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.] 272-175-3 68783-00-6 Carc. 1B H350 GHS08Dgr H350   H L
649-532-00-0 Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 272-180-0 68783-04-0 Carc. 1B H350 GHS08Dgr H350   H L
649-533-00-6 Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.] 272-342-0 68814-89-1 Carc. 1B H350 GHS08Dgr H350   H L
649-534-00-1 Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).] 292-631-5 90641-07-9 Carc. 1B H350 GHS08Dgr H350   H L
649-535-00-7 Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF). 292-632-0 90641-08-0 Carc. 1B H350 GHS08Dgr H350   H L
649-536-00-2 Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).] 292-633-6 90641-09-1 Carc. 1B H350 GHS08Dgr H350   H L
649-537-00-8 Extracts (petroleum), hydrotreated light paraffinic distillate solvent;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 295-335-4 91995-73-2 Carc. 1B H350 GHS08Dgr H350   H L
649-538-00-3 Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 295-338-0 91995-75-4 Carc. 1B H350 GHS08Dgr H350   H L
649-539-00-9 Extracts (petroleum), light paraffinic distillate solvent, acid-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 295-339-6 91995-76-5 Carc. 1B H350 GHS08Dgr H350   H L
649-540-00-4 Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.] 295-340-1 91995-77-6 Carc. 1B H350 GHS08Dgr H350   H L
649-541-00-X Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 295-342-2 91995-79-8 Carc. 1B H350 GHS08Dgr H350   H L
649-542-00-5 Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.] 296-437-1 92704-08-0 Carc. 1B H350 GHS08Dgr H350   H L
649-543-00-0 Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-827-4 93763-10-1 Carc. 1B H350 GHS08Dgr H350   H L
649-544-00-6 Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-829-5 93763-11-2 Carc. 1B H350 GHS08Dgr H350   H L
649-545-00-1 Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-672-2 100684-02-4 Carc. 1B H350 GHS08Dgr H350   H L
649-546-00-7 Extracts (petroleum), light paraffinic distillate solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-673-8 100684-03-5 Carc. 1B H350 GHS08Dgr H350   H L
649-547-00-2 Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-674-3 100684-04-6 Carc. 1B H350 GHS08Dgr H350   H L
649-548-00-8 Extracts (petroleum), light vacuum gas oil solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-675-9 100684-05-7 Carc. 1B H350 GHS08Dgr H350   H L
649-549-00-3 Foots oil (petroleum);Foots oil;[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 265-171-8 64742-67-2 Carc. 1B H350 GHS08Dgr H350   H L
649-550-00-9 Foots oil (petroleum), hydrotreated;Foots oil 295-394-6 92045-12-0 Carc. 1B H350 GHS08Dgr H350   H L
650-002-00-6 turpentine, oil 232-350-7 8006-64-2 Flam. Liq. 3Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Asp. Tox. 1Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 2 H226H332H312H302H304H319H315H317H411 GHS02GHS08GHS07GHS09Dgr H226H332H312H302H304H319H315H317H411   
650-003-00-1 fenson (ISO);4-chlorophenyl benzenesulphonate; 201-274-6 80-38-6 Acute Tox. 4 *Eye Irrit. 2Aquatic Chronic 2 H302H319H411 GHS07GHS09Wng H302H319H411   
650-004-00-7 norbormide (ISO);5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide 213-589-6 991-42-4 Acute Tox. 4 * H302 GHS07Wng H302   
650-005-00-2 (2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone 201-501-9 83-79-4 Acute Tox. 3 *Eye Irrit. 2STOT SE 3Skin Irrit. 2Aquatic Acute 1Aquatic Chronic 1 H301H319H335H315H400H410 GHS06GHS09Dgr H301H319H335H315H410   
650-006-00-8 benquinox (ISO);p-benzoquinone 1-benzoylhydrazone 4-oxime 207-807-9 495-73-8 Acute Tox. 3 *Acute Tox. 4 * H301H312 GHS06Dgr H301H312   
650-007-00-3 chlordimeform (ISO);N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine 228-200-5 6164-98-3 Carc. 2Acute Tox. 4 *Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H312H302H400H410 GHS08GHS07GHS09Wng H351H312H302H410   
650-008-00-9 drazoxolon (ISO);4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone 227-197-8 5707-69-7 Acute Tox. 3 *Aquatic Acute 1Aquatic Chronic 1 H301H400H410 GHS06GHS09Dgr H301H410   
650-009-00-4 chlordimeform hydrochloride;N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride 243-269-1 19750-95-9 Carc. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H351H302H400H410 GHS08GHS07GHS09Wng H351H302H410   
650-010-00-X benzyl violet 4B;α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate 216-901-9 1694-09-3 Carc. 2 H351 GHS08Wng H351   
650-012-00-0 erionite — 12510-42-8 Carc. 1A H350 GHS08Dgr H350   
650-013-00-6 asbestos ——————— 12001-28-4132207-32-012172-73-577536-66-477536-68-677536-67-512001-29-5 Carc. 1ASTOT RE 1 H350H372 ** GHS08Dgr H350H372 **   
650-014-00-1 diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate 401-770-4 — Skin Corr. 1BAcute Tox. 4 * H314H302 GHS05GHS07Dgr H314H302   
650-015-00-7 rosin;colophony 232-475-7232-484-6277-299-1 8050-09-78052-10-673138-82-6 Skin Sens. 1 H317 GHS07Wng H317   
650-016-00-2 Mineral wool, with the exception of those specified elsewhere in this Annex;[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] — — Carc. 2Skin Irrit. 2 H351H315 GHS08GHS07Wng H351H315   AQR
650-017-00-8 Refractory Ceramic Fibres;Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] — — Carc. 1BSkin Irrit. 2 H350iH315 GHS08GHS07Dgr H350iH315   A R
650-018-00-3 Reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid 406-230-1 — Flam. Liq. 3Carc. 2Skin Corr. 1BAcute Tox. 4 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H226H351H314H332H317H400H410 GHS02GHS08GHS05 GHS07GHS09Dgr H226H351H314H332H317H410   
650-031-00-4 bis(4-hydroxy-N-methylanilinium) sulphate 200-237-1 55-55-0 Acute Tox. 4 *STOT RE 2 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H302H373 **H317H400H410 GHS08GHS07GHS09Wng H302H373 **H317H410   
650-032-00-X cyproconazole (ISO);(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H—1,2,4-triazol-1-yl)butan-2-ol — 94361-06-5 Repr. 2Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H361d ***H302H400H410 GHS08GHS07 GHS09Wng H361d ***H302H410   
650-033-00-5 (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate;esfenvalerate — 66230-04-4 Acute Tox. 3 *Acute Tox. 3 *Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H331H301H317H400H410 GHS06GHS09Dgr H331H301H317H410   
650-041-00-9 triasulfuron (ISO);1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea — 82097-50-5 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   
650-042-00-4 reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates 417-450-2 — Eye Irrit. 2Skin Irrit. 2Skin Sens. 1Aquatic Chronic 3 H319H315H317H412 GHS07Wng H319H315H317H412   
650-043-00-X reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate 420-310-3 — Acute Tox. 4 *Aquatic Acute 1Aquatic Chronic 1 H302H400H410 GHS07GHS09Wng H302H410   
650-044-00-5 mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin 420-480-9 158570-99-1 Skin Irrit. 2Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H317H400H410 GHS07GHS09Wng H315H317H410   
650-045-00-0 reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate 417-110-3 — Flam. Liq. 2Skin Irrit. 2Eye Dam. 1Aquatic Chronic 2 H225H315H318H411 GHS02GHS05GHS09Dgr H225H315H318H411   
650-046-00-6 di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates 416-180-2 12222-04-7 Acute Tox. 4 *STOT RE 2 *Aquatic Chronic 2 H302H373 **H411 GHS08GHS07GHS09Wng H302H373 **H411   
650-047-00-1 dibenzylphenylsulfonium hexafluoroantimonate 417-760-8 134164-24-2 STOT RE 1Acute Tox. 4 *Eye Dam. 1Skin Sens. 1Aquatic Chronic 2 H372 **H302H318H317H411 GHS08GHS05 GHS07GHS09Dgr H372 **H302H318H317H411   
650-048-00-7 reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid 420-070-1 — Org. Perox. D ****Acute Tox. 4 *Acute Tox. 4 *Acute Tox. 4 *Skin Corr. 1AAquatic Acute 1 H242H332H312H302H314H400 GHS02GHS05 GHS07GHS09Dgr H242H332H312H302H314H400   
650-049-00-2 2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl 417-960-5 — Skin Irrit. 2Eye Dam. 1Skin Sens. 1Aquatic Acute 1Aquatic Chronic 1 H315H318H317H400H410 GHS05 GHS07GHS09Dgr H315H318H317H410   
650-050-00-8 reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers 423-600-8 — Aquatic Chronic 2 H411 GHS09 H411   
650-055-00-5 silver sodium zirconium hydrogenphosphate 422-570-3 155925-27-2 Aquatic Acute 1Aquatic Chronic 1 H400H410 GHS09Wng H410   


Index No International Chemical Identification EC No CAS No Classification Labelling Concentration Limits Notes
001-001-00-9 hydrogen 215-605-7 1333-74-0 F+; R12 F+R: 12S: (2-)9-16-33  
001-002-00-4 aluminium lithium hydride 240-877-9 16853-85-3 F; R15 FR: 15S: (2-)7/8-24/25-43  
001-003-00-X sodium hydride 231-587-3 7646-69-7 F; R15 FR: 15S: (2-)7/8-24/25-43  
001-004-00-5 calcium hydride 232-189-2 7789-78-8 F; R15 FR: 15S: (2-)7/8-24/25-43  
003-001-00-4 lithium 231-102-5 7439-93-2 F; R15R14C; R34 F; CR: 14/15-34S: (1/2-)8-43-45  
003-002-00-X n-hexyllithium 404-950-0 21369-64-2 F; R15-17R14C; R35 F; CR: 14/15-17-35S: (1/2-)6-16-26-30-36/37/39-43-45  
004-001-00-7 beryllium 231-150-7 7440-41-7 Carc. Cat. 2; R49T+; R26T; R25-48/23Xi; R36/37/38R43 T+R: 49-25-26-36/37/38-43-48/23S: 53-45  E
004-002-00-2 beryllium compounds with the exception of aluminium beryllium silicates, and with those specified elsewhere in this Annex — — Carc. Cat. 2; R49T+; R26T; R25-48/23Xi; R36/37/38R43N; R51-53 T+; NR: 49-25-26-36/37/38-43-48/23-51/53S: 53-45-61  AE
004-003-00-8 beryllium oxide 215-133-1 1304-56-9 Carc. Cat. 2; R49T+; R26T; R25-48/23Xi; R36/37/38R43 T+R: 49-25-26-36/37/38-43-48/23S: 53-45  E
005-001-00-X boron trifluoride 231-569-5 7637-07-2 R14T+; R26C; R35 T+; CR: 14-26-35S: (1/2-)9-26-28-36/37/39-45  
005-002-00-5 boron trichloride 233-658-4 10294-34-5 R14T+; R26/28C; R34 T+R: 14-26/28-34S: (1/2-)9-26-28-36/37/39-45  
005-003-00-0 boron tribromide 233-657-9 10294-33-4 R14T+; R26/28C; R35 T+; CR: 14-26/28-35S: (1/2-)9-26-28-36/37/39-45  
005-004-00-6 trialkylboranes — — F; R17C; R34 F; CR: 17-34S: (1/2-)7-23-26-36/37/39-43-45  A
005-005-00-1 trimethyl borate 204-468-9 121-43-7 R10Xn; R21 XnR: 10-21S: (2-)23-25  
005-006-00-7 dibutyltin hydrogen borate 401-040-5 75113-37-0 T; R48/25Xn; R21/22Xi; R41R43N; R50-53 T; NR: 21/22-41-43-48/25-50/53S: (1/2-)22-26-36/37-45-60-61  
005-009-00-3 tetrabutylammonium butyltriphenylborate 418-080-4 120307-06-4 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-56-61  
005-010-00-9 N,N-dimethylanilinium tetrakis(pentafluorophenyl)borate 422-050-6 118612-00-3 Carc. Cat. 3; R40Xn; R22Xi; R38-41 XnR: 22-38-40-41S: (2-)22-26-36/37/39  
005-012-00-X diethyl{4-[1,5,5-tris(4-diethylaminophenyl)penta-2,4-dienylidene]cyclohexa-2,5-dienylidene}ammonium butyltriphenylborate 418-070-1 141714-54-7 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
006-001-00-2 carbon monoxide 211-128-3 630-08-0 F+; R12Repr. Cat. 1; R61T; R23-48/23 F+; TR: 61-12-23-48/23S: 53-45  E
006-002-00-8 phosgene;carbonyl chloride 200-870-3 75-44-5 T+; R26C; R34 T+R: 26-34S: (1/2-)9-26-36/37/39-45  
006-003-00-3 carbon disulphide 200-843-6 75-15-0 F; R11Repr. Cat. 3; R62-63T; R48/23Xi; R36/38 F; TR: 11-36/38-48/23-62-63S: (1/2-)16-33-36/37-45 Repr. Cat. 3; R62-63: C ≥ 1 %T; R48/23: C ≥ 1 %Xn; R48/20: 0,2 % ≤ C < 1 % 
006-004-00-9 calcium carbide 200-848-3 75-20-7 F; R15 FR: 15S: (2-)8-43  
006-005-00-4 thiram (ISO);tetramethylthiuram disulphide 205-286-2 137-26-8 Xn; R20/22-48/22Xi; R36/38R43N; R50-53 Xn; NR: 20/22-36/38-43-48/22-50/53S: (2-)26-36/37-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
006-006-00-X hydrogen cyanide;hydrocyanic acid 200-821-6 74-90-8 F+; R12T+; R26N; R50-53 F+; T+; NR: 12-26-50/53S: (1/2-)7/9-16-36/37-38-45-60-61  
006-006-01-7 hydrogen cyanide ...%;hydrocyanic acid ...% 200-821-6 74-90-8 T+; R26/27/28N; R50-53 T+; NR: 26/27/28-50/53S: (1/2-)7/9-36/37-38-45-60-61  B
006-007-00-5 salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide — — T+; R26/27/28R32N; R50-53 T+; NR: 26/27/28-32-50/53S: (1/2-)7-28-29-45-60-61  A
006-008-00-0 antu (ISO);1-(1-naphthyl)-2-thiourea 201-706-3 86-88-4 T+; R28Carc. Cat. 3; R40 T+R: 28-40S: (1/2-)25-36/37-45  
006-009-00-6 1-isopropyl-3-methylpyrazol-5-yl dimethylcarbamate;isolan 204-318-2 119-38-0 T+; R27/28 T+R: 27/28S: (1/2-)28-36/37/39-45  
006-010-00-1 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate 5,5-dimethyldihydroresorcinol dimethylcarbamate;dimetan 204-525-8 122-15-6 T; R25 TR: 25S: (1/2-)36/37-45  
006-011-00-7 carbaryl (ISO);1-naphthyl methylcarbamate 200-555-0 63-25-2 Carc. Cat. 3; R40Xn; R22N; R50 Xn; NR: 22-40-50S: (2-)22-24-36/37-46-61  
006-012-00-2 ziram (ISO);zinc bis dimethyldithiocarbamate 205-288-3 137-30-4 T+; R26Xn; R22-48/22Xi; R37-41R43N; R50-53 T+; NR: 22-26-37-41-43-48/22-50/53S: (1/2-)22-26-28-36/37/39-45-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
006-013-00-8 metam-sodium (ISO);sodium methyldithiocarbamate 205-293-0 137-42-8 Xn; R22R31C; R34R43N; R50-53 C; NR: 22-31-34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
006-014-00-3 nabam (ISO);disodium ethylenebis(N,N'-dithiocarbamate) 205-547-0 142-59-6 Xn; R22Xi; R37R43N; R50-53 Xn; NR: 22-37-43-50/53S: (2-)8-24/25-46-60-61  
006-015-00-9 diuron (ISO);3-(3,4-dichlorophenyl)-1,1-dimethylurea 206-354-4 330-54-1 Carc. Cat. 3; R40Xn; R22-48/22N; R50-53 Xn; NR: 22-40-48/22-50/53S: (2-)13-22-23-37-46-60-61  
006-016-00-4 propoxur (ISO);2-isopropyloxyphenyl N-methylcarbamate;2-isopropoxyphenyl methylcarbamate 204-043-8 114-26-1 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)37-45-60-61  
006-017-00-X aldicarb (ISO);2-methyl-2-(methylthio)propanal-O-(N-methylcarbamoyl)oxime 204-123-2 116-06-3 T+; R26/28T; R24N; R50-53 T+; NR: 24-26/28-50/53S: (1/2-)22-36/37-45-60-61  
006-018-00-5 aminocarb (ISO);4-dimethylamino-3-tolyl methylcarbamate 217-990-7 2032-59-9 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)28-36/37-45-60-61  
006-019-00-0 di-allate (ISO);S-(2,3-dichloroallyl)-N,N-diisopropylthiocarbamate 218-961-1 2303-16-4 Carc. Cat. 3; R40Xn; R22N; R50-53 Xn; NR: 22-40-50/53S: (2-)25-36/37-60-61  
006-020-00-6 barban (ISO);4-chlorbut-2-ynyl N-(3-chlorophenyl)carbamate 202-930-4 101-27-9 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-36/37-60-61  
006-021-00-1 linuron (ISO);3-(3,4-dichlorophenyl)-1-methoxy-1-methylurea 206-356-5 330-55-2 Repr. Cat. 2; R61Repr. Cat. 3; R62Carc. Cat. 3; R40Xn; R22-48/22N; R50-53 T; NR: 61-22-40-48/22-62-50/53S: 53-45-60-61  E
006-022-00-7 decarbofuran (ISO);2,3-dihydro-2-methylbenzofuran-7-yl methylcarbamate — 1563-67-3 T; R23/24/25 TR: 23/24/25S: (1/2-)13-36/37-45  
006-023-00-2 mercaptodimethur (ISO);methiocarb (ISO);3,5-dimethyl-4-methylthiophenyl N-methylcarbamate 217-991-2 2032-65-7 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)22-37-45-60-61  
006-024-00-8 proxan-sodium (ISO);sodium O-isopropyldithiocarbonate 205-443-5 140-93-2 Xn; R22Xi; R38N; R51-53 Xn; NR: 22-38-51/53S: (2-)13-61  
006-025-00-3 allethrin;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1RS,3RS;1RS,3SR)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate;bioallethrin;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [1]S-bioallethrin;(S)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate; [2]esbiothrin;(RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate [3] 209-542-4 [1]249-013-5 [2]- [3] 584-79-2 [1]28434-00-6 [2]84030-86-4 [3] Xn; R20/22N; R50-53 Xn; NR: 20/22-50/53S: (2-)36-60-61  C
006-026-00-9 carbofuran (ISO);2,3-dihydro-2,2-dimethylbenzofuran-7-yl N-methylcarbamate 216-353-0 1563-66-2 T+; R26/28N; R50-53 T+; NR: 26/28-50/53S: (1/2-)36/37-45-60-61  
006-028-00-X dinobuton (ISO);2-(1-methylpropyl)-4,6-dinitrophenyl isopropyl carbonate 213-546-1 973-21-7 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)37-45-60-61  
006-029-00-5 dioxacarb (ISO);2-(1,3-dioxolan-2-yl)phenyl N-methylcarbamate 230-253-4 6988-21-2 T; R25N; R51-53 T; NR: 25-51/53S: (1/2-)37-45-61  
006-030-00-0 EPTC (ISO);S-ethyl dipropylthiocarbamate 212-073-8 759-94-4 Xn; R22 XnR: 22S: (2-)23  
006-031-00-6 formetanate (ISO);3-[(EZ)-dimethylaminomethyleneamino]phenyl methylcarbamate 244-879-0 22259-30-9 T+; R26/28R43N; R50-53 T+; NR: 26/28-43-50/53S: (1/2-)24-28-37/39-45-60-61  
006-032-00-1 monolinuron (ISO);3-(4-chlorophenyl)-1-methoxy-1-methylurea 217-129-5 1746-81-2 Xn; R22-48/22N; R50-53 Xn; NR: 22-48/22-50/53S: (2-)22-60-61  
006-033-00-7 metoxuron (ISO);3-(3-chloro-4-methoxyphenyl)-1,1-dimethylurea 243-433-2 19937-59-8 N; R50-53 NR: 50/53S: 60-61  
006-034-00-2 pebulate (ISO);N-butyl-N-ethyl-S-propylthiocarbamate 214-215-4 1114-71-2 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)23-61  
006-035-00-8 pirimicarb (ISO);5,6-dimethyl-2-dimethylamino-pyrimidin-4-yl N,N-dimethylcarbamate 245-430-1 23103-98-2 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)22-37-45-60-61  
006-036-00-3 benzthiazuron (ISO);1-benzothiazol-2-yl-3-methylurea 217-685-9 1929-88-0 Xn; R22 XnR: 22S: (2-)24/25  
006-037-00-9 promecarb (ISO);3-isopropyl-5-methylphenyl N-methylcarbamate 220-113-0 2631-37-0 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)24-37-45-60-61  
006-038-00-4 sulfallate (ISO);2-chloroallyl N,N-dimethyldithiocarbamate 202-388-9 95-06-7 Carc. Cat. 2; R45Xn; R22N; R50-53 T; NR: 45-22-50/53S: 53-45-60-61  E
006-039-00-X tri-allate (ISO);S-2,3,3-trichloroallyl diisopropylthiocarbamate 218-962-7 2303-17-5 Xn; R22-48/22R43N; R50-53 Xn; NR: 22-43-48/22-50/53S: (2-)24-37-60-61  
006-040-00-5 3-methylpyrazol-5-yl-dimethylcarbamate;monometilan — 2532-43-6 T; R23/24/25 TR: 23/24/25S: (1/2-)13-45  
006-041-00-0 dimethylcarbamoyl chloride 201-208-6 79-44-7 Carc. Cat. 2; R45T; R23Xn; R22Xi; R36/37/38 TR: 45-22-23-36/37/38S: 53-45 Carc. Cat. 2; R45: C ≥ 0,001 % E
006-042-00-6 monuron (ISO);3-(4-chlorophenyl)-1,1-dimethylurea 205-766-1 150-68-5 Carc. Cat. 3; R40Xn; R22N; R50-53 Xn; NR: 22-40-50/53S: (2-)36/37-60-61  
006-043-00-1 3-(4-chlorophenyl)-1,1-dimethyluronium trichloroacetate;monuron-TCA — 140-41-0 Xi; R36/38Carc. Cat. 3; R40N; R50-53 Xn; NR: 36/38-40-50/53S: (2-)36/37-60-61  
006-044-00-7 isoproturon (ISO);3-(4-isopropylphenyl)-1,1-dimethylurea 251-835-4 34123-59-6 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
006-045-00-2 methomyl (ISO);1-(methylthio)ethylideneamino N-methylcarbamate 240-815-0 16752-77-5 T+;R28N; R50-53 T+; NR: 28-50/53S: (1/2-)22-36/37-45-60-61  
006-046-00-8 bendiocarb (ISO);2,2-dimethyl-1,3-benzodioxol-4-yl N-methylcarbamate 245-216-8 22781-23-3 T; R23/25Xn; R21N; R50-53 T; NR: 21-23/25-50/53S: (1/2-)22-36/37-45-60-61  
006-047-00-3 bufencarb (ISO);reaction mass of 3-(1-methylbutyl)phenyl N-methylcarbamate and 3-(1-ethylpropyl)phenyl N-methylcarbamate — 8065-36-9 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)28-36/37-45-60-61  
006-048-00-9 ethiofencarb (ISO);2-(ethylthiomethyl)phenyl N-methylcarbamate 249-981-9 29973-13-5 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
006-049-00-4 dixanthogen;O,O-diethyl dithiobis(thioformate) 207-944-4 502-55-6 Xn; R22 XnR: 22S: (2-)24  
006-050-00-X 1,1-dimethyl-3-phenyluronium trichloroacetate;fenuron-TCA — 4482-55-7 Xi; R38N; R50-53 Xi; NR: 38-50/53S: (2-)60-61  
006-051-00-5 ferbam (ISO);iron tris(dimethyldithiocarbamate) 238-484-2 14484-64-1 Xi; R36/37/38N; R50-53 Xi; NR: 36/37/38-50/53S: (2-)60-61  
006-052-00-0 formetanate hydrochloride;3-(N,N-dimethylaminomethyleneamino)phenyl N-methylcarbamate 245-656-0 23422-53-9 T+; R26/28R43N; R50-53 T+; NR: 26/28-43-50/53S: (1/2-)24-28-37/39-45-60-61  
006-053-00-6 isoprocarb (ISO);2-isopropylphenyl N-methylcarbamate 220-114-6 2631-40-5 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
006-054-00-1 mexacarbate (ISO);3,5-dimethyl-4-dimethylaminophenyl N-methylcarbamate 206-249-3 315-18-4 T+; R28Xn; R21N; R50-53 T+; NR: 21-28-50/53S: (1/2-)36/37-45-60-61  
006-055-00-7 xylylcarb (ISO);3,4-dimethylphenyl N-methylcarbamate;3,4-xylyl methylcarbamate;MPMC 219-364-9 2425-10-7 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
006-056-00-2 metolcarb (ISO);m-tolyl methylcarbamate;MTMC 214-446-0 1129-41-5 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
006-057-00-8 nitrapyrin (ISO);2-chloro-6-trichloromethylpyridine 217-682-2 1929-82-4 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)24-61  
006-058-00-3 noruron (ISO);1,1-dimethyl-3-(perhydro-4,7-methanoinden-5-yl)urea — 2163-79-3 Xn; R22 XnR: 22S: (2-)  
006-059-00-9 oxamyl (ISO);N',N'-dimethylcarbamoyl(methylthio)methylenamine N-methylcarbamate; 245-445-3 23135-22-0 T+; R26/28Xn; R21N; R51-53 T+; NR: 21-26/28-51/53S: (1/2-)36/37-45-61  
006-060-00-4 oxycarboxin (ISO);2,3-dihydro-6-methyl-5-(N-phenylcarbamoyl)-1,4-oxothiine 4,4-dioxide 226-066-2 5259-88-1 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
006-061-00-X S-ethyl N-(dimethylaminopropyl)thiocarbamatehydrochloride;prothiocarb hydrochloride 243-193-9 19622-19-6 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
006-062-00-5 methyl 3,4-dichlorophenylcarbanilate;SWEP. — 1918-18-9 Xn; R22 XnR: 22S: (2-)  
006-063-00-0 thiobencarb (ISO);S-4-chlorobenzyl diethylthiocarbamate; 248-924-5 28249-77-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
006-064-00-6 thiofanox (ISO);3,3-dimethyl-1-(methylthio)butanone-O-(N-methylcarbamoyl)oxime; 254-346-4 39196-18-4 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)27-36/37-45-60-61  
006-065-00-1 3-chloro-6-cyano-bicyclo(2,2,1)heptan-2-one-O-(N-methylcarbamoyl)oxime;triamid — 15271-41-7 T+; R28T; R24N; R51-53 T+; NR: 24-28-51/53S: (1/2-)28-36/37-45-61  
006-066-00-7 vernolate (ISO);S-propyl dipropylthiocarbamate; 217-681-7 1929-77-7 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
006-067-00-2 XMC;3,5-xylyl methylcarbamate — 2655-14-3 Xn; R22 XnR: 22S: (2-)  
006-068-00-8 diazomethane 206-382-7 334-88-3 Carc. Cat. 2; R45 TR: 45S: 53-45  
006-069-00-3 thiophanate-methyl (ISO);1,2-di-(3-methoxycarbonyl-2-thioureido)benzene 245-740-7 23564-05-8 Muta. Cat. 3; R68Xn; R20R43N; R50-53 Xn; NR: 20-43-50/53-68S: (2-)36/37-46-60-61  
006-070-00-9 furmecyclox (ISO);N-cyclohexyl-N-methoxy-2,5-dimethyl-3-furamide; 262-302-0 60568-05-0 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-60-61  
006-071-00-4 cyclooct-4-en-1-yl methyl carbonate 401-620-8 87731-18-8 R43 XiR: 43S: (2-)24-37  
006-072-00-X prosulfocarb(ISO);S-benzyl N,N-dipropylthiocarbamate; 401-730-6 52888-80-9 Xn; R22R43N; R51-53 Xn; NR: 22-43-51/53S: (2-)24-37-61  
006-073-00-5 3-(dimethylamino)propylurea 401-950-2 31506-43-1 Xi; R41 XiR: 41S: (2-)26-39  
006-074-00-0 2-(3-(prop-1-en-2-yl)phenyl)prop-2-yl isocyanate 402-440-2 2094-99-7 T+; R26C; R34Xn; R48/20R42/43N; R50-53 T+; NR: 26-34-42/43-48/20-50/53S: (1/2-)7-15-28-36/37/39-38-45-60-61  
006-076-00-1 mancozeb (ISO) — 8018-01-7 Xi; R37R43 XiR: 37-43S: (2-)8-24/25-46  
006-077-00-7 maneb (ISO) 235-654-8 12427-38-2 Xi; R37R43 XiR: 37-43S: (2-)8-24/25-46  
006-078-00-2 zineb (ISO);zinc ethylenebis(dithiocarbamate) (polymeric) 235-180-1 12122-67-7 Xi; R37R43 XiR: 37-43S: (2-)8-24/25-46  
006-079-00-8 disulfiram;tetraethylthiuramdisulfide 202-607-8 97-77-8 Xn; R22-48/22R43N; R50-53 Xn; NR: 22-43-48/22-50/53S: (2-)24-37-60-61  
006-080-00-3 tetramethylthiuram monosulphide 202-605-7 97-74-5 Xn; R22R43N; R51-53 Xn; NR: 22-43-51/53S: (2-)24-26-37-61  
006-081-00-9 zinc bis(dibutyldithiocarbamate) 205-232-8 136-23-2 Xi; R36/37/38R43N; R50-53 Xi; NR: 36/37/38-43-50/53S: (2-)24-37-60-61  
006-082-00-4 zinc bis(diethyldithiocarbamate) 238-270-9 14324-55-1 Xn; R22Xi; R36/37/38R43N; R50-53 Xn; NR: 22-36/37/38-43-50/53S: (2-)24-37-60-61  
006-083-00-X butocarboxim (ISO);3-(methylthio)-2-butanone O-[(methylamino)carbonyl]oxime 252-139-3 34681-10-2 R10T; R23/24/25Xi; R36N; R50-53 T; NR: 10-23/24/25-36-50/53S: (1/2-)36/37-45-60-61  
006-084-00-5 carbosulfan (ISO);2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate; 259-565-9 55285-14-8 T; R23/25R43N; R50-53 T; NR: 23/25-43-50/53S: (1/2-)24-37-38-45-60-61  
006-085-00-0 fenobucarb (ISO);2-butylphenyl methylcarbamate; 223-188-8 3766-81-2 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
006-086-00-6 ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate;fenoxycarb 276-696-7 72490-01-8 N; R50-53 NR: 50/53S: 60-61  
006-087-00-1 2,3-dihydro-2,2-dimethyl-7-benzofuryl 2,4-dimethyl-6-oxa-5-oxo-3-thia-2,4-diazadecanoate;furathiocarb 265-974-3 65907-30-4 T+; R26T; R25Xn; R48/22Xi; R36/38R43N; R50-53 T+; NR: 25-26-36/38-43-48/22-50/53S: (1/2-)28-36/37-38-45-60-61  
006-088-00-7 benfuracarb;ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl- β-alaninate — 82560-54-1 T; R23/25N; R50-53 T; NR: 23/25-50/53S: (1/2-)36/37-45-60-61  
006-089-00-2 chlorine dioxide 233-162-8 10049-04-4 O; R8R6T+; R26C; R34N; R50 O; T+; NR: 6-8-26-34-50S: (1/2-)23-26-28-36/37/39-38-45-61 N; R50: C ≥ 0,02 % 5
006-089-01-X chlorine dioxide … % 233-162-8 10049-04-4 T; R25C; R34N; R50 T; NR: 25-34-50S: (1/2-)23-26-28-36/37/39-45-61 C; R34: C ≥ 10 %Xi; R36/37/38: 3 % ≤ C < 10 %Xi; R36: 0,3 % ≤ C < 3 %N; R50: C ≥ 3 % B
006-090-00-8 2-(3-iodoprop-2-yn-1-yloxy)ethyl phenylcarbamate 408-010-0 88558-41-2 Xn; R20Xi; R41R52-53 XnR: 20-41-52/53S: (2-)22-26-39-61  
007-001-00-5 ammonia, anhydrous 231-635-3 7664-41-7 R10 ⊗T; R23C; R34N; R50 T; NR: 10-23-34-50S: (1/2-)9-16-26-36/37/39-45-61  
007-001-01-2 ammonia ....% 215-647-6 1336-21-6 C; R34N; R50 C; NR: 34-50S: (1/2-)26-36/37/39-45-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % B
007-002-00-0 nitrogen dioxide; [1]dinitrogen tetraoxide [2] 233-272-6 [1]234-126-4 [2] 10102-44-0 [1]10544-72-6 [2] T+; R26C; R34 T+R: 26-34S: (1/2-)9-26-28-36/37/39-45 T+; R26: C ≥ 10 %T; R23: 1 % ≤ C < 10 %Xn; R20: 0,1 % ≤ C < 1 % 5
007-003-00-6 chlormequat chloride (ISO);2-chloroethyltrimethylammonium chloride 213-666-4 999-81-5 Xn; R21/22 XnR: 21/22S: (2-)36/37  
007-004-00-1 nitric acid ... % 231-714-2 7697-37-2 O; R8C; R35 O; CR: 8-35S: (1/2-)23-26-36-45 C; R35: C ≥ 20 %C; R34: 5 % ≤ C < 20 %Footnote:O; R8: C ≥ 70 % B
007-006-00-2 ethyl nitrite 203-722-6 109-95-5 E; R2Xn; R20/21/22 E; XnR: 2-20/21/22S: (2-)  
007-007-00-8 ethyl nitrate 210-903-3 625-58-1 E; R2 ⊗ ER: 2S: (2-)23-24/25  
007-008-00-3 hydrazine 206-114-9 302-01-2 R10Carc. Cat. 2; R45T; R23/24/25C; R34R43N; R50-53 T; NR: 45-10-23/24/25-34-43-50/53S: 53-45-60-61 C; R34: C ≥ 10 %Xi; R36/38: 3 % ≤ C < 10 % E
007-009-00-9 dicyclohexylammonium nitrite 221-515-9 3129-91-7 Xn; R20/22 XnR: 20/22S: (2-)15-41 Xn; R20/22: C ≥ 10 % 
007-010-00-4 sodium nitrite 231-555-9 7632-00-0 O; R8T; R25N; R50 O; T; NR: 8-25-50S: (1/2-)45-61 T; R25: C ≥ 5 %Xn; R22: 1 % ≤ C < 5 % 
007-011-00-X potassium nitrite 231-832-4 7758-09-0 O; R8T; R25N; R50 O; T; NR: 8-25-50S: (1/2-)45-61 T; R25: C ≥ 5 %Xn; R22: 1 % ≤ C < 5 % 
007-012-00-5 N,N-dimethylhydrazine 200-316-0 57-14-7 F; R11Carc. Cat. 2; R45T; R23/25C; R34N; R51-53 F; T; NR: 45-11-23/25-34-51/53S: 53-45-61  E
007-013-00-0 1,2-dimethylhydrazine — 540-73-8 Carc. Cat. 2; R45T; R23/24/25N; R51-53 T; NR: 45-23/24/25-51/53S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,01 % E
007-014-00-6 salts of hydrazine — — Carc. Cat. 2; R45T; R23/24/25R43N; R50-53 T; NR: 45-23/24/25-43-50/53S: 53-45-60-61  AE
007-015-00-1 O-ethylhydroxylamine 402-030-3 624-86-2 F; R11T; R23/24/25-48/23Xi; R36R43N; R50 F; T; NR: 11-23/24/25-36-43-48/23-50S: (1/2-)16-26-36/37/39-45-60-61  
007-016-00-7 butyl nitrite 208-862-1 544-16-1 F; R11T; R23/25 F; TR: 11-23/25S: (1/2-)16-24-45  
007-017-00-2 isobutyl nitrite 208-819-7 542-56-3 F; R11Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R20/22 F; TR: 11-20/22-45-68S: 53-45  E
007-018-00-8 sec-butyl nitrite 213-104-8 924-43-6 F; R11Xn; R20/22 F; XnR: 11-20/22S: (2-)16-24-46  
007-019-00-3 tert-butyl nitrite 208-757-0 540-80-7 F; R11Xn; R20/22 F; XnR: 11-20/22S: (2-)16-24-46  
007-020-00-9 pentyl nitrite; [1]‘amyl nitrite’, mixed isomers [2] 207-332-7 [1]203-770-8 [2] 463-04-7 [1]110-46-3 [2] F; R11Xn; R20/22 F; XnR: 11-20/22S: (2-)16-24-46  
007-021-00-4 hydrazobenzene;1,2-diphenylhydrazine 204-563-5 122-66-7 Carc. Cat. 2; R45Xn; R22N; R50-53 T; NR: 45-22-50/53S: 53-45-60-61  E
007-022-00-X hydrazine bis(3-carboxy-4-hydroxybenzensulfonate) 405-030-1 — Carc. Cat. 2; R45Xn; R22C; R34R43R52-53 TR: 45-22-34-43-52/53S: 53-45-61  E
007-023-00-5 sodium 3,5-bis(3-(2,4-di-tert-pentylphenoxy)propylcarbamoyl)benzenesulfonate 405-510-0 — Xi; R38R43 XiR: 38-43S: (2-)24-37  
007-024-00-0 2-(decylthio)ethylammonium chloride 405-640-8 36362-09-1 Xn; R48/22Xi; R38-41N; R50-53 Xn; NR: 38-41-48/22-50/53S: (2-)26-36/37/39-60-61  
007-025-00-6 (4-hydrazinophenyl)-N-methylmethanesulfonamide hydrochloride 406-090-1 81880-96-8 Muta. Cat. 3; R68T; R25-48/25R43N; R50-53 T; NR: 25-43-48/25-68-50/53S: (1/2-)22-36/37/39-45-60-61  
007-026-00-1 oxo-((2,2,6,6-tetramethylpiperidin-4-yl)amino)carbonylacetohydrazide 413-230-5 122035-71-6 Xi; R41R43 XiR: 41-43S: (2-)8-22-24-26-30-37/39  
007-027-00-7 1,6-bis(3,3-bis((1-methylpentylidenimino)propyl)ureido)hexane 420-190-2 771478-66-1 C; R34Xn; R21/22-48/21R43N; R50-53 C; NR: 21/22-34-43-48/21-50/53S: (1/2-)7-26-36/37/39-45-60-61  
008-001-00-8 oxygen 231-956-9 7782-44-7 O; R8 OR: 8S: (2-)17  
008-003-00-9 hydrogen peroxide solution ... % 231-765-0 7722-84-1 R5O; R8C; R35Xn; R20/22 O; CR: 5-8-20/22-35S: (1/2-)17-26-28-36/37/39-45 Xn; R20: C ≥ 50 %Xn; R22: C ≥ 8 %C; R35: C ≥ 70 %C; R34: 50 % ≤ C < 70 %Xi; R37/38: 35 % ≤ C < 50 %Xi; R41: 8 % ≤ C < 50 %Xi; R36: 5 % ≤ C < 8 %Footnote:O; R8: C ≥ 50 %R5: C ≥ 70 % B
009-001-00-0 fluorine 231-954-8 7782-41-4 R7 ⊗T+; R26C; R35 T+; CR: 7-26-35S: (1/2-)9-26-36/37/39-45  
009-002-00-6 hydrogen fluoride 231-634-8 7664-39-3 T+; R26/27/28C; R35 T+; CR: 26/27/28-35S: (1/2-)7/9-26-36/37/39-45  
009-003-00-1 hydrofluoric acid ... % 231-634-8 7664-39-3 T+; R26/27/28C; R35 T+; CR: 26/27/28-35S: (1/2-)7/9-26-36/37-45 C; R35: C ≥ 7 %C; R34: 1 % ≤ C < 7 %Xi; R36: 0,1 % ≤ C < 1 % B
009-004-00-7 sodium fluoride 231-667-8 7681-49-4 T; R25Xi; R36/38R32 TR: 25-32-36/38S: (1/2-)22-36-45  
009-005-00-2 potassium fluoride 232-151-5 7789-23-3 T; R23/24/25 TR: 23/24/25S: (1/2-)26-45  
009-006-00-8 ammonium fluoride 235-185-9 12125-01-8 T; R23/24/25 TR: 23/24/25S: (1/2-)26-45  
009-007-00-3 sodium bifluoride;sodium hydrogen difluoride 215-608-3 1333-83-1 T; R25C; R34 T; CR: 25-34S: (1/2-)22-26-37-45 T; R25: C ≥ 10 %Xn; R22: 1 % ≤ C < 10 %C; R34: C ≥ 1 %Xi; R36/38: 0,1 % ≤ C < 1 % 
009-008-00-9 potassium bifluoride;potassium hydrogen difluoride 232-156-2 7789-29-9 T; R25C; R34 T; CR: 25-34S: (1/2-)22-26-37-45 T; R25: C ≥ 10 %Xn; R22: 1 % ≤ C < 10 %C; R34: C ≥ 1 %Xi; R36/38: 0,1 % ≤ C < 1 % 
009-009-00-4 ammonium bifluoride;ammonium hydrogen difluoride 215-676-4 1341-49-7 T; R25C; R34 T; CR: 25-34S: (1/2-)22-26-37-45 T; R25: C ≥ 10 %Xn; R22: 1 % ≤ C < 10 %C; R34: C ≥ 1 %Xi; R36/38: 0,1 % ≤ C < 1 % 
009-010-00-X fluoroboric acid ... % 240-898-3 16872-11-0 C; R34 CR: 34S: (1/2-)26-27-45 C; R34: C ≥ 25 %Xi; R36/38: 10 % ≤ C < 25 % B
009-011-00-5 fluorosilicic acid ... % 241-034-8 16961-83-4 C; R34 CR: 34S: (1/2-)26-27-45  B
009-012-00-0 alkali fluorosilicates(Na); [1]alkali fluorosilicates(K); [2]alkali fluorosilicates(NH4) [3] 240-934-8 [1]240-896-2 [2]240-968-3 [3] 16893-85-9 [1]16871-90-2 [2]16919-19-0 [3] T; R23/24/25 TR: 23/24/25S: (1/2-)26-45 T; R23/24/25: C ≥ 10 %Xn; R20/21/22: 1 % ≤ C < 10 % A
009-013-00-6 fluorosilicates, with the exception of those specified elsewhere in this annex — — Xn; R22 XnR: 22S: (2-)13-24/25 Xn; R22: C ≥ 10 % A
009-014-00-1 lead hexafluorosilicate 247-278-1 25808-74-6 Repr. Cat. 1; R61Repr. Cat. 3; R62Xn; R20/22R33N; R50-53 T; NR: 61-62-20/22-33-50/53S: 53-45-60-61  E1
009-015-00-7 sulphuryl difluoride 220-281-5 2699-79-8 T; R23Xn; R48/20N; R50 T; NR: 23-48/20-50S: (1/2-)45-63-60-61  
009-016-00-2 trisodium hexafluoroaluminate;cryolite 237-410-6239-148-8 13775-53-615096-52-3 T; R48/23/25Xn; R20/22N; R51-53 T; NR: 20/22-48/23/25-51/53S: (1/2-)22-37-45-61  C
009-017-00-8 potassium mu-fluoro-bis(triethylaluminium) 400-040-2 12091-08-6 F; R11-14/15C; R35Xn; R20 F; CR: 11-14/15-20-35S: (1/2-)16-30-36/39-43-45  
009-018-00-3 magnesium hexafluorosilicate 241-022-2 16949-65-8 T; R25 TR: 25S: (1/2-)24/25-45 T; R25: C ≥ 10 %Xn; R22: 1 % ≤ C < 10 % 
011-001-00-0 sodium 231-132-9 7440-23-5 F; 15R14C; R34 F; CR: 14/15-34S: (1/2-)5-8-43-45  
011-002-00-6 sodium hydroxide;caustic soda 215-185-5 1310-73-2 C; R35 CR: 35S: (1/2-)26-37/39-45 C; R35: C ≥ 5 %C; R34: 2 % ≤ C < 5 %Xi; R36/38: 0,5 % ≤ C < 2 % 
011-003-00-1 sodium peroxide 215-209-4 1313-60-6 O; R8C; R35 O; CR: 8-35S: (1/2-)8-27-39-45  
011-004-00-7 sodium azide 247-852-1 26628-22-8 T+; R28R32N; R50-53 T+; NR: 28-32-50/53S: (1/2-)28-45-60-61  
011-005-00-2 sodium carbonate 207-838-8 497-19-8 Xi; R36 XiR: 36S: (2-)22-26  
011-006-00-8 sodium cyanate 213-030-6 917-61-3 Xn; R22R52-53 XnR: 22-52/53S: (2-)24/25-61  
011-007-00-3 propoxycarbazone-sodium — 181274-15-7 N; R50-53 NR: 50/53S: 60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
012-001-00-3 magnesium powder (pyrophoric) 231-104-6 7439-95-4 F; R15-17 FR: 15-17S: (2-)7/8-43  
012-002-00-9 magnesium, powder or turnings 231-104-6 — F; R11-15 FR: 11-15S: (2-)7/8-43  
012-003-00-4 magnesium alkyls — — R14F; R17C; R34 F; CR: 14-17-34S: (1/2-)16-43-45  A
013-001-00-6 aluminium powder (pyrophoric) 231-072-3 7429-90-5 F; R15-17 FR: 15-17S: (2-)7/8-43  
013-002-00-1 aluminium powder (stabilised) 231-072-3 — F; R15R10 ⊗ FR: 10-15S: (2-)7/8-43  
013-003-00-7 aluminium chloride, anhydrous 231-208-1 7446-70-0 C; R34 CR: 34S: (1/2-)7/8-28-45  
013-004-00-2 aluminium alkyls — — R14F; R17C; R34 F; CR: 14-17-34S: (1/2-)16-43-45  A
013-005-00-8 diethyl(ethyldimethylsilanolato)aluminium 401-160-8 55426-95-4 F; R 15-17R14C; R35 F; CR: 14/15-17-35S: (1/2-)6-16-30-36/39-43-45  
013-006-00-3 (ethyl-3-oxobutanoato-O'1,O'3)(2-dimethylaminoethanolato)(1-methoxypropan-2-olato)aluminium(III), dimerised 402-370-2 — R10Xi; R41 XiR: 10-41S: (2-)26-39  
013-007-00-9 poly(oxo(2-butoxyethyl-3-oxobutanoato-O'1,O'3)aluminium) 403-430-0 — Xi; R41 XiR: 41S: (2-)26-39  
013-008-00-4 di-n-octylaluminium iodide 408-190-0 7585-14-0 R14F; R17C; R34N; R50-53 F; C; NR: 14-17-34-50/53S: (1/2-)6-16-26-36/37/39-43-45-60-61  
013-009-00-X sodium((n-butyl)x(ethyl)y-1,5-dihydro)aluminate) x = 0,5, y = 1,5 418-720-2 — F; R11-15-17R14Xn; R20C; R35 F; CR: 11-14/15-17-20-35S: (1/2-)6-16-26-30-36/37/39-43-45  
014-001-00-9 trichlorosilane 233-042-5 10025-78-2 F+; R12R14F; R17Xn; R20/22R29C; R35 F+; CR: 12-14-17-20/22-29-35S: (2-)7/9-16-26-36/37/39-43-45 Xn; R20/22: C ≥ 10 %C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
014-002-00-4 silicon tetrachloride 233-054-0 10026-04-7 R14Xi; R36/37/38 XiR: 14-36/37/38S: (2-)7/8-26  
014-003-00-X dimethyldichlorosilane 200-901-0 75-78-5 F; R11Xi; R36/37/38 F; XiR: 11-36/37/38S: (2-)  
014-004-00-5 trichloro(methyl)silane;methyltrichlorosilane 200-902-6 75-79-6 R14F; R11Xi; R36/37/38 F; XiR: 11-14-36/37/38S: (2-)26-39 Xi; R36/37/38: C ≥ 1 % 
014-005-00-0 tetraethyl silicate;ethyl silicate 201-083-8 78-10-4 R10Xn; R20Xi; R36/37 XnR: 10-20-36/37S: (2-)  
014-006-00-6 bis(4-fluorophenyl)-methyl-(1,2,4-triazol-4-ylmethyl)silane hydrochloride 401-380-4 — Xi; R36N; R51-53 Xi; NR: 36-51/53S: (2-)26-61  
014-007-00-1 triethoxyisobutylsilane 402-810-3 17980-47-1 Xi; R38 XiR: 38S: (2-)24  
014-008-00-7 (chloromethyl)bis(4-fluorophenyl)methylsilane 401-200-4 85491-26-5 N; R51-53 NR: 51/53S: 61  
014-009-00-2 isobutylisopropyldimethoxysilane 402-580-4 111439-76-0 R10Xn; R20Xi; R38 XnR: 10-20-38S: (2-)25-26-36/37  
014-010-00-8 disodium metasilicate 229-912-9 6834-92-0 C; R34Xi; R37 CR: 34-37S: (1/2-)13-24/25-36/37/39-45  
014-011-00-3 cyclohexyldimethoxymethylsilane 402-140-1 17865-32-6 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)24-61  
014-012-00-9 bis(3-(trimethoxysilyl)propyl)amine 403-480-3 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)24-26-39-61  
014-013-00-4 α-hydroxypoly(methyl-(3-(2,2,6,6-tetramethylpiperidin-4-yloxy)propyl)siloxane) 404-920-7 — Xn; R21/22C; R34N; R51-53 C; NR: 21/22-34-51/53S: (1/2-)26-36/37/39-45-61  
014-014-00-X etacelasil (ISO);6-(2-chloroethyl)-6-(2-methoxyethoxy)-2,5,7,10-tetraoxa-6-silaundecane; 253-704-7 37894-46-5 Repr. Cat. 2; R61Xn; R22-48/22 TR: 61-22-48/22S: 53-45  E
014-015-00-5 α-trimethylsilanyl-ω-trimethylsiloxypoly[oxy(methyl-3-(2-(2-methoxypropoxy)propoxy)propylsilanediyl]-co-oxy(dimethylsilane)) 406-420-4 69430-40-6 R53 R: 53S: 61  
014-016-00-0 reaction mass of: 1,3-dihex-5-en-1-yl-1,1,3,3-tetramethyldisiloxane;1,3-dihex-n-en-1-yl-1,1,3,3-tetramethyldisiloxane 406-490-6 — N; R51-53 NR: 51/53S: 61  
014-017-00-6 flusilazole (ISO);bis(4-fluorophenyl)(methyl)(1H-1,2,4-triazol-1-ylmethyl)silane — 85509-19-9 Carc. Cat. 3; R40Repr. Cat. 2; R61Xn; R22N; R51-53 T; NR: 61-22-40-51/53S: 53-45-61  E
014-018-00-1 octamethylcyclotetrasiloxane 209-136-7 556-67-2 Repr. Cat. 3; R62R53 XnR: 53-62S: (2-)36/37-46-51-61  
014-019-00-7 reaction mass of: 4-[[bis-(4-fluorophenyl)methylsilyl]methyl]-4H-1,2,4-triazole;1-[[bis-(4-fluorophenyl)methylsilyl]methyl]-1H-1,2,4-triazole 403-250-2 — Carc. Cat. 3; R40Repr. Cat. 2; R61Xn; R22N; R51-53 T; NR: 61-22-40-51/53S: 53-45-61  E
014-020-00-2 bis(1,1-dimethyl-2-propynyloxy)dimethylsilane 414-960-7 53863-99-3 Xn; R20 XnR: 20S: (2)  
014-021-00-8 tris(isopropenyloxy)phenyl silane 411-340-8 52301-18-5 N; R50-53 NR: 50/53S: 60-61  
014-022-00-3 reaction product of: (2-hydroxy-4-(3-propenoxy)benzophenone and triethoxysilane) with (hydrolysis product of silica and methyltrimethoxysilane) 401-530-9 — F; R11T; R39/23/24/25Xn; R20/21/22 F; TR: 11-20/21/22-39/23/24/25S: (1/2-)16-29-36/37-45  
014-023-00-9 α, ω-dihydroxypoly(hex-5-en-1-ylmethylsiloxane)hoxysilane with (hydrolysis product of silica and methyltrimethoxysilane)iazole 408-160-7 125613-45-8 N; R51-53 NR: 51/53S: 61  
014-024-00-4 1-((3-(3-chloro-4-fluorophenyl)propyl)dimethylsilanyl)-4-ethoxybenzene 412-620-2 121626-74-2 N; R51-53 NR: 51/53S: 61  
014-025-00-X 4-[3-(diethoxymethylsilylpropoxy)-2,2,6,6-tetramethyl]piperidine 411-400-3 102089-33-8 Xn; R22-48/21Xi; R38-41R52-53 XnR: 22-38-41-48/21-52/53S: (2-)26-36/37/39-61  
014-026-00-5 dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane 407-180-3 770722-36-6 C; R35 CR: 35S: (1/2-)26-36/37/39-45  
014-027-00-0 chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane 410-270-5 770722-46-8 C; R35 CR: 35S: (1/2-)8-26-28-36/37/39-45  
014-028-00-6 α-[3-(1-oxoprop-2-eny)l-1-oxypropyl]dimethoxysilyloxy-ω-[3(1-oxoprop-2-enyl)-1-oxypropyl]dimethoxysilyl poly(dimethylsiloxane) 415-290-8 193159-06-7 R43 XiR: 43S: (2-)24-37  
014-029-00-1 O,O'-(ethenylmethylsilylene)di[(4-methylpentan-2-one)oxime] 421-870-1 156145-66-3 Repr. Cat. 3; R62Xn; R22-48/22 XnR: 22-48/22-62S: (2-)36/37  
014-030-00-7 [(dimethylsilylene)bis((1,2,3,3a,7a-η)-1H-inden-1-ylidene)dimethyl]hafnium 422-060-0 137390-08-0 T+; R28 T+R: 28S: (1/2-)6-22-28-36/37-45  
014-031-00-2 bis(1-methylethyl)-dimethoxysilane 421-540-7 18230-61-0 R10Xi; R38R43R52-53 XiR: 10-38-43-52/53S: (2-)24-37-61  
014-032-00-8 dicyclopentyldimethoxysilane 404-370-8 126990-35-0 Xi; R38-41N; R50-53 Xi; NR: 38-41-50/53S: (2-)26-37/39-60-61  
015-001-00-1 white phosphorus 231-768-7 12185-10-3 F; R17T+; R26/28C; R35N; R50 F; T+; C; NR: 17-26/28-35-50S: (1/2-)5-26-38-45-61  
015-002-00-7 red phosphorus 231-768-7 7723-14-0 F; R11R16R52-53 FR: 11-16-52/53S: (2-)7-43-61  
015-003-00-2 calcium phosphide;tricalcium diphosphide 215-142-0 1305-99-3 F; R15/29T+; R28N; R50 F; T+; NR: 15/29-28-50S: (1/2-)22-43-45-61  
015-004-00-8 aluminium phosphide 244-088-0 20859-73-8 F; R15/29T+; R28R32N; R50 F; T+; NR: 15/29-28-32-50S: (1/2-)3/9/14-30-36/37-45-61  
015-005-00-3 magnesium phosphide;trimagnesium diphosphide 235-023-7 12057-74-8 F; R15/29T+; R28N; R50 F; T+; NR: 15/29-28-50S: (1/2-)22-43-45-61  
015-006-00-9 trizinc diphosphide;zinc phosphide 215-244-5 1314-84-7 F; R15/29T+; R28R32N; R50-53 F; T+; NR: 15/29-28-32-50/53S: (1/2-)3/9/14-30-36/37-45-60-61  
015-007-00-4 phosphorus trichloride 231-749-3 7719-12-2 R14T+; R26/28Xn; R48/20C; R35R29 T+; CR: 14-26/28-35-48/20S: (1/2-)7/8-26-36/37/39-45  
015-008-00-X phosphorus pentachloride 233-060-3 10026-13-8 R14T+; R26Xn; R22-48/20C; R34R29 T+R: 14-22-26-34-48/20S: (1/2-)7/8-26-36/37/39-45  
015-009-00-5 phosphoryl trichloride 233-046-7 10025-87-3 R14T+; R26T; R48/23Xn; R22C; R35R29 T+; CR: 14-22-26-35-48/23S: (1/2-)7/8-26-36/37/39-45  
015-010-00-0 phosphorus pentoxide 215-236-1 1314-56-3 C; R35 CR: 35S: (1/2-)22-26-45  
015-011-00-6 phosphoric acid ... %, orthophosphoric acid ... % 231-633-2 7664-38-2 C; R34 CR: 34S: (1/2-)26-45 C; R34: C ≥ 25 %Xi; R36/38: 10 % ≤ C < 25 % B
015-012-00-1 tetraphosphorus trisulphide;phosphorus sesquisulphid 215-245-0 1314-85-8 F; R11Xn; R22N; R50 F; Xn; NR: 11-22-50S: (2-)7-16-24/25-61  
015-013-00-7 triethyl phosphate 201-114-5 78-40-0 Xn; R22 XnR: 22S: (2-)25  
015-014-00-2 tributyl phosphate 204-800-2 126-73-8 Carc. Cat. 3; R40Xn; R22Xi; R38 XnR: 22-38-40S: (2-)36/37-46  
015-015-00-8 tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-);tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); 201-103-5 78-30-8 T; R39/23/24/25N; R51-53 T; NR: 39/23/24/25-51/53S: (1/2-)20/21-28-45-61 T; R39/23/24/25: C ≥ 1 %Xn; R68/20/21/22: 0,2 % ≤ C < 1 % C
015-016-00-3 tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); 201-105-6 78-32-0 Xn; R21/22N; R51-53 Xn; NR: 21/22-51/53S: (2-)28-61 Xn; R21/22: C ≥ 5 % C
015-019-00-X dichlorvos (ISO);2,2-dichlorovinyl dimethyl phosphate 200-547-7 62-73-7 T+; R26T; R24/25R43N; R50 T+; NR: 24/25-26-43-50S: (1/2-)28-36/37-45-61  
015-020-00-5 mevinphos (ISO);2-methoxycarbonyl-1-methylvinyl dimethyl phosphate 232-095-1 7786-34-7 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)23-28-36/37-45-60-61 N; R50-53: C ≥ 0,0025 %N; R51-53: 0,00025 % ≤ C < 0,0025 %R52-53: 0,000025 % ≤ C < 0,00025 % 
015-021-00-0 trichlorfon (ISO);dimethyl 2,2,2-trichloro-1-hydroxyethylphosphonate 200-149-3 52-68-6 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-022-00-6 phosphamidon (ISO);2-chloro-2-diethylcarbamoyl-1-methylvinyl dimethyl phosphate 236-116-5 13171-21-6 T+; R28T; R24Muta. Cat. 3; R68N; R50-53 T+; NR: 24-28-50/53-68S: (1/2-)23-36/37-45-60-61  
015-023-00-1 pyrazoxon;diethyl 3-methylpyrazol-5-yl phosphate — 108-34-9 T+; R26/27/28 T+R: 26/27/28S: (1/2-)13-28-45  
015-024-00-7 triamiphos (ISO);5-amino-3-phenyl-1,2,4-triazol-1-yl-N,N,N',N'-tetramethylphosphonic diamide — 1031-47-6 T+; R27/28 T+R: 27/28S: (1/2-)22-28-36/37-45  
015-025-00-2 TEPP (ISO);tetraethyl pyrophosphate 203-495-3 107-49-3 T+; R27/28N; R50 T+; NR: 27/28-50S: (1/2-)36/37/39-38-45-61  
015-026-00-8 schradan (ISO);octamethylpyrophosphoramide 205-801-0 152-16-9 T+; R27/28 T+R: 27/28S: (1/2-)36/37-38-45  
015-027-00-3 sulfotep (ISO);O,O,O,O-tetraethyl dithiopyrophosphate 222-995-2 3689-24-5 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)23-28-36/37-45-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-028-00-9 demeton-O (ISO);O,O-diethyl-O-2-ethylthioethyl phosphorothioate 206-053-8 298-03-3 T+; R27/28N; R50 T+; NR: 27/28-50S: (1/2-)28-36/37-45-61  
015-029-00-4 demeton-S (ISO);diethyl-S-2-ethylthioethyl phosphorothioate 204-801-8 126-75-0 T+; R27/28 T+R: 27/28S: (1/2-)28-36/37-45  
015-030-00-X demeton-O-methyl (ISO);O-2-ethylthioethyl O,O-dimethyl phosphorothioate 212-758-1 867-27-6 T; R25 TR: 25S: (1/2-)24-36/37-45  
015-031-00-5 demeton-S-methyl (ISO);S-2-ethylthioethyl dimethyl phosphorothioate 213-052-6 919-86-8 T; R24/25N; R51-53 T; NR: 24/25-51/53S: (1/2-)28-36/37-45-61  
015-032-00-0 prothoate (ISO);O,O-diethyl isopropylcarbamoylmethyl phosphorodithioate 218-893-2 2275-18-5 T+; R27/28R52-53 T+R: 27/28-52/53S: (1/2-)28-36/37-45-61  
015-033-00-6 phorate (ISO);O,O-diethyl ethylthiomethyl phosphorodithioate 206-052-2 298-02-2 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-034-00-1 parathion (ISO);O,O-diethyl O-4-nitrophenyl phosphorothioate 200-271-7 56-38-2 T+; R26/28T; R24-48/25N; R50-53 T+; NR: 24-26/28-48/25-50/53S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-035-00-7 parathion — methyl (ISO);O,O-dimethyl O-4-nitrophenyl phosphorothioate 206-050-1 298-00-0 R5R10T+; R26/28T; R24Xn; R48/22N; R50-53 T+; NR: 5-10-24-26/28-48/22-50/53S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-036-00-2 O-ethyl O-4-nitrophenyl phenylphosphonothioate;EPN 218-276-8 2104-64-5 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)22-36/37-45-60-61  
015-037-00-8 phenkapton (ISO);S-(2,5-dichlorophenylthiomethyl) O,O-diethyl phosphorodithioate 218-892-7 2275-14-1 T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)13-45-60-61  
015-038-00-3 coumaphos (ISO);O-3-chloro-4-methylcoumarin-7-yl O,O-diethyl phosphorothioate 200-285-3 56-72-4 T+; R28Xn; R21N; R50-53 T+; NR: 21-28-50/53S: (1/2-)28-36/37-45-60-61  
015-039-00-9 azinphos-methyl (ISO);O,O-dimethyl-4-oxobenzotriazin-3-ylmethyl phosphorodithioate 201-676-1 86-50-0 T+; R26/28T; R24R43N; R50-53 T+; NR: 24-26/28-43-50/53S: (1/2-)28-36/37-45-60-61  
015-040-00-4 diazinon (ISO);O,O-diethyl O-2-isopropyl-6-methylpyrimidin-4-yl phosphorothioate 206-373-8 333-41-5 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)24/25-60-61  
015-041-00-X malathion (ISO);1,2-bis (ethoxycarbonyl) ethyl O,O-dimethyl phosphorodithioate 204-497-7 121-75-5 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)24-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-042-00-5 chlorthionO-(3-chloro-4-nitrophenyl) O,O-dimethyl phosphorothioate 207-902-5 500-28-7 Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)13-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-043-00-0 phosnichlor (ISO);O-4-chloro-3-nitrophenyl O,O-dimethyl phosphorothioate — 5826-76-6 Xn; R20/21/22 XnR: 20/21/22S: (2-)13  
015-044-00-6 carbophenothion (ISO);4-chlorophenylthiomethyl O,O-diethyl phosphorodithioate 212-324-1 786-19-6 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)28-36/37-45-60-61  
015-045-00-1 mecarbam (ISO);N-ethoxycarbonyl-N-methylcarbamoylmethyl O,O-diethyl phosphorodithioate 219-993-9 2595-54-2 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)36/37-45-60-61  
015-046-00-7 oxydemeton-methyl;S-2-(ethylsulphinyl)ethyl O,O-dimethyl phosphorothioate 206-110-7 301-12-2 T; R24/25N; R50 T; NR: 24/25-50S: (1/2-)23-36/37-45-61  
015-047-00-2 ethion (ISO);O,O,O',O'-tetraethyl S,S'-methylenedi (phosphorodithioate);diethion 209-242-3 563-12-2 T; R25Xn; R21N; R50-53 T; NR: 21-25-50/53S: (1/2-)25-36/37-45-60-61 N; R50-53: C ≥ 0,0025 %N; R51-53: 0,00025 % ≤ C < 0,0025 %R52-53: 0,000025 % ≤ C < 0,00025 % 
015-048-00-8 fenthion (ISO);O,O-dimethyl-O-(4-methylthion-m-tolyl) phosphorothioate 200-231-9 55-38-9 Muta. Cat. 3; R68T; R23-48/25Xn; R21/22N; R50-53 T; NR: 21/22-23-48/25-50/53-68S: (1/2-)36/37-45-60-61  
015-049-00-3 endothion (ISO);S-5-methoxy-4-oxopyran-2-ylmethyl dimethyl phosphorothioate 220-472-3 2778-04-3 T; R24/25 TR: 24/25S: (1/2-)36/37-45  
015-050-00-9 thiometon (ISO);S-2-ethylthioethyl O,O-dimethyl phosphorodithioate 211-362-6 640-15-3 T; R25Xn; R21 TR: 21-25S: (1/2-)36/37-45  
015-051-00-4 dimethoate (ISO);O,O-dimethyl methylcarbamoylmethyl phosphorodithioate 200-480-3 60-51-5 Xn; R21/22 XnR: 21/22S: (2-)36/37  
015-052-00-X fenchlorphos (ISO);O,O-dimethyl O-2,4,5-trichlorophenyl phosphorothioate 206-082-6 299-84-3 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)25-36/37-60-61  
015-053-00-5 menazon (ISO);S-[(4,6-diamino-1,3,5-triazin-2-yl)methyl] O,O-dimethyl phosphorodithioate 201-123-4 78-57-9 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
015-054-00-0 fenitrothion (ISO);O,O-dimethyl O-4-nitro-m-tolyl phosphorothioate 204-524-2 122-14-5 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
015-055-00-6 naled (ISO);1,2-dibromo-2,2-dichloroethyl dimethyl phosphate 206-098-3 300-76-5 Xn; R21/22Xi; R36/38N; R50 Xn; NR: 21/22-36/38-50S: (2-)36/37-61 N; R50: C ≥ 0,025 % 
015-056-00-1 azinphos-ethyl (ISO);O,O-diethyl 4-oxobenzotriazin-3-ylmethyl phosphorodithioate 220-147-6 2642-71-9 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)28-36/37-45-60-61  
015-057-00-7 formothion (ISO);N-formyl-N-methylcarbamoylmethyl O,O-dimethyl phosphorodithioate 219-818-6 2540-82-1 Xn; R21/22 XnR: 21/22S: (2-)36/37  
015-058-00-2 morphothion (ISO);O,O-dimethyl-S-(morpholinocarbonylmethyl) phosphorodithioate 205-628-0 144-41-2 T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)13-45-60-61  
015-059-00-8 vamidothion (ISO);O,O-dimethyl S-2-(1-methylcarbamoylethylthio) ethyl phosphorothioate 218-894-8 2275-23-2 T; R25Xn; R21N; R50 T; NR: 21-25-50S: (1/2-)36/37-45-61  
015-060-00-3 disulfoton (ISO);O,O-diethyl 2-ethylthioethyl phosphorodithioate 206-054-3 298-04-4 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)28-36/37-45-60-61  
015-061-00-9 dimefox (ISO);tetramethylphosphorodiamidic fluoride 204-076-8 115-26-4 T+; R27/28 T+R: 27/28S: (1/2-)23-28-36/37-38-45  
015-062-00-4 mipafox (ISO);N,N'- di-isopropylphosphorodiamidic fluoride 206-742-3 371-86-8 T+; R39/26/27/28 T+R: 39/26/27/28S: (1/2-)13-45  
015-063-00-X dioxathion (ISO);1,4-dioxan-2,3-diyl-O,O,O',O'-tetraethyl di(phosphorodithioate) 201-107-7 78-34-2 T+; R26/28T; R24N; R50-53 T+; NR: 24-26/28-50/53S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-064-00-5 bromophos-ethyl (ISO);O-4-bromo-2,5-dichlorophenyl O,O-diethyl phosphorothioate 225-399-0 4824-78-6 T; R25Xn; R21N; R50-53 T; NR: 21-25-50/53S: (1/2-)28-36/37-45-60-61  
015-065-00-0 S-[2-(ethylsulphinyl)ethyl] O,O-dimethyl phosphorodithioate — 2703-37-9 T+; R26/27/28N; R51-53 T+; NR: 26/27/28-51/53S: (1/2-)13-28-45-61  
015-066-00-6 omethoate (ISO);O,O-dimethyl S-methylcarbamoylmethyl phosphorothioate 214-197-8 1113-02-6 T; R25Xn; R21N; R50 T; NR: 21-25-50S: (1/2-)23-36/37-45-61  
015-067-00-1 phosalone (ISO);S-(6-chloro-2-oxobenzoxazolin-3-ylmethyl) O,O-diethyl phosphorodithioate 218-996-2 2310-17-0 T; R25Xn; R21N; R50-53 T; NR: 21-25-50/53S: (1/2-)36/37-45-60-61  
015-068-00-7 dichlofenthion (ISO);O-,4-dichlorophenyl O,O-diethyl phosphorothioate 202-564-5 97-17-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
015-069-00-2 methidathion (ISO);2,3-dihydro-5-methoxy-2-oxo-1,3,4-thiadiazol-3-ylmethyl-O,O-dimethylphosphorodithioate 213-449-4 950-37-8 T+; R28Xn; R21N; R50-53 T+; NR: 21-28-50/53S: (1/2-)22-28-36/37-45-60-61  
015-070-00-8 cyanthoate (ISO);S-(N-(1-cyano-1-methylethyl)carbamoylmethyl) O,O-diethyl phosphorothioate 223-099-4 3734-95-0 T+; R28T; R24 T+R: 24-28S: (1/2-)36/37-45  
015-071-00-3 chlorfenvinphos (ISO);2-chloro-1-(2,4 dichlorophenyl) vinyl diethyl phosphate 207-432-0 470-90-6 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)28-36/37-45-60-61  
015-072-00-9 monocrotophos (ISO);dimethyl-1-methyl-2-(methylcarbamoyl)vinyl phosphate 230-042-7 6923-22-4 Muta. Cat. 3; R68T+; R26/28T; R24N; R50-53 T+; NR: 24-26/28-50/53-68S: (1/2-)36/37-45-60-61  
015-073-00-4 dicrotophos (ISO);(Z)-2-dimethylcarbamoyl-1-methylvinyl dimethyl phosphate 205-494-3 141-66-2 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)28-36/37-45-60-61  
015-074-00-X crufomate (ISO);4-tert-butyl-2-chlorophenyl methyl methylphosphoramidate 206-083-1 299-86-5 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-60-61  
015-075-00-5 S-[2-(isopropylsulphinyl)ethyl] O,O-dimethyl phosphorothioate — 2635-50-9 T; R23/24/25 TR: 23/24/25S: (1/2-)13-45  
015-076-00-0 potasan;O,O-diethyl O-(4-methylcoumarin-7-yl) phosphorothioate — 299-45-6 T+; R26/27/28N; R50-53 T+; NR: 26/27/28-50/53S: (1/2-)13-28-45-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-077-00-6 2,2-dichlorovinyl 2-ethylsulphinylethyl methyl phosphate — 7076-53-1 T; R23/24/25 TR: 23/24/25S: (1/2-)13-45  
015-078-00-1 demeton-S-methylsulphon (ISO);S-2-ethylsulphonylethyl dimethyl phosphorothioate 241-109-5 17040-19-6 T; R25Xn; R21N; R51-53 T; NR: 21-25-51/53S: (1/2-)22-28-36/37-45-61  
015-079-00-7 acephate (ISO);O,S-dimethyl acetylphosphoramidothioate 250-241-2 30560-19-1 Xn; R22 XnR: 22S: (2-)36  
015-080-00-2 amidithion (ISO);2-methoxyethylcarbamoylmethyl O,O-dimethyl phosphorodithioate — 919-76-6 Xn; R22 XnR: 22S: (2-)24-36  
015-081-00-8 O,O,O',O'-tetrapropyl dithiopyrophosphate 221-817-0 3244-90-4 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-60-61  
015-082-00-3 azothoate (ISO);O-4-(4-chlorophenylazo)phenyl O,O-dimethyl phosphorothioate 227-419-3 5834-96-8 Xn; R20/22 XnR: 20/22S: (2-)13  
015-083-00-9 bensulide (ISO);O,O-diisopropyl 2-phenylsulphonylaminoethyl phosphorodithioate 212-010-4 741-58-2 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)24-36-60-61  
015-084-00-4 chlorpyrifos (ISO);O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 220-864-4 2921-88-2 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)45-60-61 N; R50-53: C ≥ 0,0025 %N; R51-53: 0,00025 % ≤ C < 0,0025 %R52-53: 0,000025 % ≤ C < 0,00025 % 
015-085-00-X chlorphonium chloride (ISO);tributyl (2,4-dichlorobenzyl) phosphonium chloride 204-105-4 115-78-6 T; R25Xn; R21Xi; R36/38 TR: 21-25-36/38S: (1/2-)36/37/39-45  
015-086-00-5 coumithoate (ISO);O,O-diethyl O-,8,9,10-tetrahydro-6-oxo-benzo(c)chromen-3-yl phosphorothioate — 572-48-5 T; R25 TR: 25S: (1/2-)28-36/37-45  
015-087-00-0 cyanophos (ISO);O-4-cyanophenyl O,O-dimethyl phosphorothioate 220-130-3 2636-26-2 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-60-61  
015-088-00-6 dialifos (ISO);2-chloro-1-phthalimidoethyl O,O-diethyl phosphorodithioate 233-689-3 10311-84-9 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)28-36/37-45-60-61  
015-089-00-1 ethoate-methyl (ISO);ethylcarbamoylmethyl O,O-dimethyl phosphorodithioate 204-121-1 116-01-8 Xn; R21/22 XnR: 21/22S: (2-)36/37  
015-090-00-7 fensulfothion (ISO);O,O-diethyl O-4-methylsulfinylphenyl phosphorothioate 204-114-3 115-90-2 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)23-28-36/37-45-60-61  
015-091-00-2 fonofos (ISO);O-ethyl phenyl ethylphosphonodithioate 213-408-0 944-22-9 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)28-36/37-45-60-61  
015-092-00-8 phosacetim (ISO);O,O-bis(4-chlorophenyl) N-acetimidoylphosphoramidothioate 223-874-7 4104-14-7 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)28-36/37-45-60-61  
015-093-00-3 leptophos (ISO);O-4-bromo-2,5-dichlorophenyl O-methyl phenylphosphorothioate 244-472-8 21609-90-5 T; R25-39/25Xn; R21N; R50-53 T; NR: 21-25-39/25-50/53S: (1/2-)25-36/37/39-45-60-61  
015-094-00-9 mephosfolan (ISO);diethyl 4-methyl-1,3-dithiolan-2-ylidenephosphoramidate 213-447-3 950-10-7 T+; R27/28N; R51-53 T+; NR: 27/28-51/53S: (1/2-)36/37/39-45-61  
015-095-00-4 methamidophos (ISO);O,S-dimethyl phosphoramidothioate 233-606-0 10265-92-6 T+; R26/28T; R24N; R50 T+; NR: 24-26/28-50S: (1/2-)28-36/37-45-61  
015-096-00-X oxydisulfoton (ISO);O, O-diethyl S-2-ethylsulphinylethyl phosphorodithioate 219-679-1 2497-07-6 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
015-097-00-5 phenthoate (ISO);ethyl 2-(dimethoxyphosphinothioylthio)-2-phenylacetate 219-997-0 2597-03-7 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)22-36/37-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-098-00-0 trichloronate (ISO);O-ethyl O-2,4,5-trichlorophenyl ethylphosphonothioate 206-326-1 327-98-0 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)23-28-36/37-45-60-61  
015-099-00-6 pirimiphos-ethyl (ISO);O,O-diethyl O-2-diethylamino-6-methylpyrimidin-4-yl phosphorothioate 245-704-0 23505-41-1 T; R25Xn; R21N; R50-53 T; NR: 21-25-50/53S: (1/2-)23-36/37-45-60-61  
015-100-00-X phoxim (ISO);α-(diethoxyphosphinothioylimino) phenylacetonitrile 238-887-3 14816-18-3 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)36-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-101-00-5 phosmet (ISO);O,O-dimethyl phthalimidomethyl S-phosphorodithioate 211-987-4 732-11-6 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)22-36/37-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-102-00-0 tris(2-chloroethyl) phosphate 204-118-5 115-96-8 Carc. Cat. 3; R40Xn; R22N; R51-53 Xn; NR: 22-40-51/53S: (2-)36/37-61  
015-103-00-6 phosphorus tribromide 232-178-2 7789-60-8 R14C; R34Xi; R37 CR: 14-34-37S: (1/2-)26-45  
015-104-00-1 diphosphorus pentasulphide;phosphorus pentasulphide 215-242-4 1314-80-3 F; R11R29Xn; R20/22N; R50 F; Xn; NR: 11-20/22-29-50S: (2-)61  
015-105-00-7 triphenyl phosphite 202-908-4 101-02-0 Xi; R36/38N; R50-53 Xi; NR: 36/38-50/53S: (2-)28-60-61 Xi; R36/38: C ≥ 5 % 
015-106-00-2 hexamethylphosphoric triamide;hexamethylphosphoramide 211-653-8 680-31-9 Carc. Cat. 2; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45 Carc. Cat. 2; R45: C ≥ 0,01 % 
015-107-00-8 ethoprophos (ISO);ethyl-S,S-dipropyl phosphorodithioate 236-152-1 13194-48-4 T+; R26/27T; R25R43N; R50-53 T+; NR: 25-26/27-43-50/53S: (1/2-)27/28-36/37/39-45-60-61  
015-108-00-3 bromophos (ISO);O-4-bromo-2,5-dichlorophenyl O,O-dimethyl phosphorothioate 218-277-3 2104-96-3 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-) 46-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-109-00-9 crotoxyphos (ISO);1-phenylethyl 3-(dimethoxyphosphinyloxy) isocrotonate 231-720-5 7700-17-6 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
015-110-00-4 cyanofenphos (ISO);O-4-cyanophenyl O-ethyl phenylphosphonothioate — 13067-93-1 T; R25-39/25Xn; R21Xi; R36N; R51-53 T; NR: 21-25-36-39/25-51/53S: (1/2-)36/37-45-61  
015-111-00-X phosfolan (ISO);diethyl 1,3-dithiolan-2-ylidenephosphoramidate 213-423-2 947-02-4 T+; R27/28 T+R: 27/28S: (1/2-)28-36/37-45  
015-112-00-5 thionazin (ISO);O,O-diethyl O-pyrazin-2-yl phosphorothioate; 206-049-6 297-97-2 T+; R27/28 T+R: 27/28S: (1/2-)36/37/39-38-45  
015-114-00-6 chlormephos (ISO);S-chloromethyl O,O-diethyl phosphorodithioate 246-538-1 24934-91-6 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)28-36/37-45-60-61  
015-115-00-1 chlorthiophos (ISO) 244-663-6 21923-23-9 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)28-36/37-45-60-61  
015-116-00-7 demephion-O (ISO);O,O-dimethyl O-2-methylthioethyl phosphorothioate 211-666-9 682-80-4 T+; R28T; R24 T+R: 24-28S: (1/2-)28-36/37-45  
015-117-00-2 demephion-S (ISO);O,O-dimethyl S-2-methylthioethyl phosphorothioate 219-971-9 2587-90-8 T+; R28T; R24 T+R: 24-28S: (1/2-)28-36/37-45  
015-118-00-8 demeton — 8065-48-3 T+; R27/28N; R50 T+; NR: 27/28-50S: (1/2-)28-36/37-45-61  
015-119-00-3 dimethyl 4-(methylthio)phenyl phosphate — 3254-63-5 T+; R27/28 T+R: 27/28S: (1/2-)28-36/37-45  
015-120-00-9 ditalimfos (ISO);O,O-diethyl phthalimidophosphonothioate; 225-875-8 5131-24-8 Xi; R38R43 XiR: 38-43S: (2-)36/37  
015-121-00-4 edifenphos (ISO);O-ethyl S,S-diphenyl phosphorodithioate 241-178-1 17109-49-8 T; R23/25Xn; R21R43N; R50-53 T; NR: 21-23/25-43-50/53S: (1/2-)36/37-45-60-61  
015-122-00-X etrimfos (ISO);O-6-ethoxy-2-ethylpyrimidin-4-yl O,O-dimethylphosphorothioate; 253-855-9 38260-54-7 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
015-123-00-5 fenamiphos (ISO);ethyl-4-methylthio-m-tolyl isopropyl phosphoramidate 244-848-1 22224-92-6 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)23-28-36/37-45-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-124-00-0 fosthietan (ISO);diethyl 1,3-dithietan-2-ylidenephosphoramidate; 244-437-7 21548-32-3 T+; R27/28 T+R: 27/28S: (1/2-)36/37-45  
015-125-00-6 glyphosine (ISO);N,N-bis(phosphonomethyl)glycine 219-468-4 2439-99-8 Xi; R41 XiR: 41S: (2-)26  
015-126-00-1 heptenophos (ISO);7-chlorobicyclo(3.2.0)hepta-2,6-dien-6-yl dimethyl phosphate 245-737-0 23560-59-0 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)23-28-37-45-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-127-00-7 iprobenfos (ISO);S-benzyl diisopropyl phosphorothioate 247-449-0 26087-47-8 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
015-128-00-2 IPSP;S-ethylsulphinylmethyl O,O-diisopropylphosphorodithioate — 5827-05-4 T+; R27T; R25N; R50-53 T+; NR: 25-27-50/53S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-129-00-8 isofenphos (ISO);O-ethyl O-2-isopropoxycarbonylphenyl-isopropylphosphoramidothioate 246-814-1 25311-71-1 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)36/37-45-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-130-00-3 isothioate (ISO)S-2-isopropylthioethyl O,O-dimethyl phosphorodithioate; — 36614-38-7 T; R24/25 TR: 24/25S: (1/2-)28-36/37-45  
015-131-00-9 isoxathion (ISO);O,O-diethyl O-5-phenylisoxazol-3-ylphosphorothioate 242-624-8 18854-01-8 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)28-36/37-45-60-61  
015-132-00-4 S-(chlorophenylthiomethyl) O,O-dimethylphosphorodithioate;methylcarbophenothione — 953-17-3 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)28-36/37-45-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-133-00-X piperophos (ISO);S-2-methylpiperidinocarbonylmethyl-O,O-dipropyl phosphorodithioate — 24151-93-7 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
015-134-00-5 pirimiphos-methyl (ISO);O-(2-diethylamino-6-methylpyrimidin-4-yl) O,O-dimethyl phosphorothioate 249-528-5 29232-93-7 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
015-135-00-0 profenofos (ISO);O-(4-bromo-2-chlorophenyl) O-ethyl S-propyl phosphorothioate 255-255-2 41198-08-7 Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)36/37-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-136-00-6 trans-isopropyl-3-[[(ethylamino)methoxyfosfinothioyl]oxy]crotonate;isopropyl 3-[[(ethylamino)methoxyphosphinothioyl]oxy]isocrotonate;propetamphos (ISO) 250-517-2 31218-83-4 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)37-45-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
015-137-00-1 pyrazophos (ISO);O,O-diethyl O-(6-ethoxycarbonyl-5-methylpyrazolo[2,3-a]pyrimidin-2-yl) phosphorothioate 236-656-1 13457-18-6 Xn; R20/22N; R50-53 Xn; NR: 20/22-50/53S: (2-)36/37-46-60-61  
015-138-00-7 quinalphos (ISO);O,O-diethyl-O-quinoxalin-2-yl phosphorothioate 237-031-6 13593-03-8 T; R25Xn; R21N; R50-53 T; NR: 21-25-50/53S: (1/2-)22-36/37-45-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-139-00-2 terbufos (ISO)S-tert-butylthiomethyl O,O-diethylphosphorodithioate; 235-963-8 13071-79-9 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)36/37-45-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
015-140-00-8 triazophos (ISO);O,O-diethyl-O-1-phenyl-1H,2,4-triazol-3-yl phosphorothioate 245-986-5 24017-47-8 T; R23/25Xn; R21N; R50-53 T; NR: 21-23/25-50/53S: (1/2-)36/37-45-60-61  
015-141-00-3 ethylenediammonium O,O-bis(octyl) phosphorodithioate, mixed isomers 400-520-1 — C; R34Xn; R22N; R50-53 C; NR: 22-34-50/53S: (1/2-)24/25-26-28-39-45-60-61  
015-142-00-9 butyl (dialkyloxy(dibutoxyphosphoryloxy))titanium (trialkyloxy)titanium phosphate 401-100-0 — F; R11Xi; R36N; R51-53 F; Xi; NR: 11-36-51/53S: (2-)7/9-16-26-43-61  
015-143-00-4 reaction mass of 2-chloroethyl chloropropyl 2-chloroethylphosphonate, mixture reaction mass of isomers and 2-chloroethyl chloropropyl 2-chloropropylphosphonate, reaction mass of isomers 401-740-0 — Xn; R22 XnR: 22S: (2-)  
015-144-00-X reaction mass of pentyl methylphosphinate and 2-methylbutyl methylphosphinate 402-090-0 87025-52-3 C; R34 CR: 34S: (1/2-)26-36/37/39-45  
015-145-00-5 reaction mass of copper(I) O,O-diisopropyl phosphorodithioate and copper(I) O-isopropyl O-(4-methylpent-2-yl) phosphorodithioate and copper(I) O,O-bis(4-methylpent-2-yl) phosphorodithioate 401-520-4 — N; R50-53 NR: 50/53S: 60-61  
015-146-00-0 S-(tricyclo(5.2.1.02,6)deca-3-en-8(or 9)-yl O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate 401-850-9 — N; R50-53 NR: 50/53S: 60-61  
015-147-00-6 reaction mass of C12-14-tert-alkylammonium diphenyl phosphorothioate and dinonyl sulphide (or disulphide) 400-930-0 — Xi; R38-41N; R51-53R43 Xi; NR: 38-41-43-51/53S: (2-)24-26-37/39-61  
015-148-00-1 2-(diphosphonomethyl)succinic acid 403-070-4 51395-42-7 C; R34R43 CR: 34-43S: (1/2-)26-36/37/39-45  
015-149-00-7 reaction mass of: hexyldioctylphosphineoxide;dihexyloctylphosphineoxide;trioctylphosphineoxide 403-470-9 — C; R34N; R50-53 C; NR: 34-50/53S: (1/2-)26-36/37/39-45-60-61  
015-150-00-2 (2-(1,3-dioxolan-2-yl)ethyl)triphenylphosphonium bromide 404-940-6 86608-70-0 Xn; R22Xi; R41R33R52-53 XnR: 22-33-41-52/53S: (2-)22-26-39-61  
015-151-00-8 tris(isopropyl/tert-butylphenyl) phosphate 405-010-2 — N; R51-53 NR: 51/53S: 61  
015-152-00-3 dioxabenzofos (ISO);2-methoxy-4H-1,3,2-benzodioxaphosphorin 2-sulphide; 223-292-3 3811-49-2 T; R24/25-39/25N; R51-53 T; NR: 24/25-39/25-51/53S: (1/2-)36/37-38-45-61  
015-153-00-9 isazofos (ISO);O-(5-chloro-1-isopropyl-1,2,4-triazol-3-yl) O,O-diethyl phosphorothioate; 255-863-8 42509-80-8 T+; R26T; R24/25Xn; R48/20R43N; R50-53 T+; NR: 24/25-26-43-48/20-50/53S: (1/2-)28-36/37-38-45-59-61  
015-154-00-4 2-chloroethylphosphonic acid;ethephon 240-718-3 16672-87-0 Xn; R20/21C; R34R52-53 CR: 20/21-34-52/53S: (1/2-)26-28-36/37/39-45-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
015-155-00-X ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate;glufosinate ammonium 278-636-5 77182-82-2 Xn; R22 XnR: 22S: (2-)  
015-156-00-5 methyl 3-[(dimethoxyphosphinothioyl)oxy]methacrylate; [1]methacrifos (ISO);methyl (E)-3-[(dimethoxyphosphinothioyl)oxy]methacrylate [2] 250-366-9 [1]- [2] 30864-28-9 [1]62610-77-9 [2] Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)36/37-60-61  
015-157-00-0 phosphonic acid; [1]phosphorous acid [2] 237-066-7 [1]233-663-1 [2] 13598-36-2 [1]10294-56-1 [2] Xn; R22C; R35 CR: 22-35S: (1/2-)26-36/37/39-45  
015-158-00-6 (η-cyclopentadienyl)(η-cumenyl)iron(1+)hexafluorophosphate(1-) 402-340-9 32760-80-8 R52-53 R: 52/53S: 61  
015-159-00-1 hydroxyphosphonoacetic acid 405-710-8 23783-26-8 Xn; R22-48/22C; R34R43 CR: 22-34-43-48/22S: (1/2-)22-26-36/37/39-45  
015-160-00-7 vanadyl pyrophosphate 406-260-5 58834-75-6 Xi; R36R43R52-53 XiR: 36-43-52/53S: (2-)24-26-37-61  
015-161-00-2 divanadyl pyrophosphate 407-130-0 65232-89-5 Xn; R22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-51/53S: (2-)24-26-37/39-61  
015-162-00-8 vanadium(IV) oxide hydrogen phosphate hemihydrate, lithium, zinc, molybdenum, iron and chlorine-doped 407-350-7 — Xn; R20-48/22Xi; R41N; R51-53 Xn; NR: 20-41-48/22-51/53S: (2-)22-26-36/39-61  
015-163-00-3 bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphinoxide 412-010-6 145052-34-2 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
015-164-00-9 calcium P,P'-(1-hydroxyethylene)bis(hydrogen phosphonate)dihydrate 400-480-5 36669-85-9 R52-53 R: 52/53S: 61  
015-165-00-4 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate 404-986-7 — Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)15-26-39-60-61  
015-166-00-X 3,9-bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane 410-290-4 80693-00-1 R53 R: 53S: 61  
015-167-00-5 3-(hydroxyphenylphosphinyl)propanoic acid 411-200-6 14657-64-8 Xi; R41 XiR: 41S: (2-)26-39  
015-168-00-0 fosthiazate (ISO);(RS)-S-sec-butyl-O-ethyl-2-oxo-1,3-thiazolidin-3-ylphosphonothioate — 98886-44-3 T; R23/25-39Xn; R21Xi; R41R43N; R50-53 T; NR: 21-23/25-39-41-43-50/53S: (1/2-)53-45-25-26-39-60-61  
015-169-00-6 tributyltetradecylphosphonium tetrafluoroborate 413-520-1 — Xn; R22-48/22C; R34R43N; R50-53 C; NR: 22-34-43-48/22-50/53S: (1/2-)26-28-36/37/39-45-60-61  
015-170-00-1 reaction mass of: di-(1-octane-N,N,N-trimethylammonium) octylphosphate;1-octane-N,N,N-trimethylammonium di-octylphosphate;1-octane-N,N,N-trimethylammonium octylphosphate 407-490-9 — Xn; R21/22C; R34 CR: 21/22-34S: (1/2-)26-36/37/39-45  
015-171-00-7 O,O,O-tris(2(or 4)-C9-10-isoalkylphenyl) phosphorothioate 406-940-1 — N; R51-53 NR: 51/53S: 61  
015-172-00-2 reaction mass of: bis(isotridecylammonium)mono(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate;isotridecylammonium bis(di-(4-methylpent-2-yloxy)thiophosphorothionylisopropyl)phosphate 406-240-6 — R10C; R34N; R51-53 C; NR: 10-34-51/53S: (1/2-)23-26-28-36/37/39-45-61  
015-173-00-8 methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4-yl]ethylphosphonothioate 414-080-3 117291-73-3 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)23-36-60-61  
015-174-00-3 1-chloro-N,N-diethyl-1,1-diphenyl-1-(phenylmethyl)phosphoramine 411-370-1 82857-68-9 T; R25Xi; R41N; R51-53 T; NR: 25-41-51/53S: (1/2-)26-37/39-41-45-61  
015-175-00-9 tert-butyl (triphenylphosphoranylidene) acetate 412-880-7 35000-38-5 T; R25Xn; R48/22Xi; R36R43N; R51-53 T; NR: 25-36-43-48/22-51/53S: (1/2-)26-36/37/39-45-61  
015-176-00-4 P,P,P',P'-tetrakis-(o-methoxyphenyl)propane-1,3-diphosphine 413-430-2 116163-96-3 N; R50-53 NR: 50/53S: 60-61  
015-177-00-X ((4-phenylbutyl)hydroxyphosphoryl)acetic acid 412-170-7 83623-61-4 Xn; R48/22Xi; R41R43 XnR: 41-43-48/22S: (2-)22-26-36/37/39  
015-178-00-5 (R)-α-phenylethylammonium (-)-(1R, 2S)-(1,2-epoxypropyl)phosphonate monohydrate 418-570-8 25383-07-7 Repr. Cat. 3; R62N; R51-53 Xn; NR: 62-51/53S: (2-)22-36/37-61  
015-179-00-0 UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrogenated C16-18 tallow alkylamine 422-720-8 166242-53-1 Carc. Cat. 3; R40Xn; R22-48/22C; R34R43N; R50-53 C; NR: 22-34-40-43-48/22-50/53S: (1/2-)26-36/37/39-45-60-61  
015-180-00-6 [R-(R*,S*)]-[[2-methyl-1-(1-oxopropoxy)propoxy]-(4-phenylbutyl)phosphinyl] acetic acid, (-)-cinchonidine (1:1) salt 415-820-8 137590-32-0 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)24-26-37/39-61  
015-181-00-1 phosphine 232-260-8 7803-51-2 F+; R12R17T+; R26C; R34N; R50 F+; T+; NR: 12-17-26-34-50S: (1/2-)28-36/37-45-61-63  
015-184-00-8 Salts of glyphosate, with the exception of those specified elsewhere in this Annex — — N; R51-53 NR: 51/53S: 61  A
015-186-00-9 chlorpyrifos-methyl (ISO),O, O-dimethyl O-3,5,6-trichloro-2-pyridyl phosphorothioate 227-011-5 5598-13-0 R43N; R50-53 Xi; NR: 43-50/53S: (2-)36/37-60-61 N; R50-53: C ≥ 0,0025 %N; R51-53: 0,00025 % ≤ C < 0,0025 %R52-53: 0,000025 % ≤ C < 0,00025 % 
015-187-00-4 reaction mass of: tetrasodium(((2-hydroxyethyl)imino)bis(methylene))bisphosphonate, N-oxide;trisodium ((tetrahydro-2-hydroxy-4H-1,4,2-oxazaphosphorin-4-yl)-methyl)phosphonate, N-oxide, P-oxide 417-540-1 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
015-189-00-5 phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide 423-340-5 162881-26-7 R43R53 XiR: 43-53S: (2-)22-24-37-61  
016-001-00-4 hydrogen sulphide 231-977-3 7783-06-4 F+; R12T+; R26N; R50 F+; T+; NR: 12-26-50S: (1/2-)9-16-36-38-45-61  
016-002-00-X barium sulphide 244-214-4 21109-95-5 R31Xn; R20/22N; R50 Xn; NR: 20/22-31-50S: (2-)28-61  
016-003-00-5 barium polysulphides 256-814-3 50864-67-0 R31Xi; R36/37/38N; R50 Xi; NR: 31-36/37/38-50S: (2-)28-61  
016-004-00-0 calcium sulphide 243-873-5 20548-54-3 R31Xi; R36/37/38N; R50 Xi; NR: 31-36/37/38-50S: (2-)28-61  
016-005-00-6 calcium polysulphides 215-709-2 1344-81-6 R31Xi; R36/37/38N; R50 Xi; NR: 31-36/37/38-50S: (2-)28-61  
016-006-00-1 dipotassium sulphide;potassium sulphide 215-197-0 1312-73-8 R31C; R34N; R50 C; NR: 31-34-50S: (1/2-)26-45-61  
016-007-00-7 potassium polysulphides 253-390-1 37199-66-9 R31C; R34N; R50 C; NR: 31-34-50S: (1/2-)26-45-61  
016-008-00-2 ammonium polysulphides 232-989-1 9080-17-5 R31C; R34N; R50 C; NR: 31-34-50S: (1/2-)26-45-61 C; R34: C ≥ 5 %Xi; R36/38: 1 % ≤ C < 5 %R31: C ≥ 1 % 
016-009-00-8 disodium sulphide;sodium sulphide 215-211-5 1313-82-2 R31C; R34N; R50 C; NR: 31-34-50S: (1/2-)26-45-61  
016-010-00-3 sodium polysulphides 215-686-9 1344-08-7 T; R25R31C; R34N; R50 T; NR: 25-31-34-50S: (1/2-)26-36/37/39-45-61  
016-011-00-9 sulphur dioxide 231-195-2 7446-09-5 T; R23C; R34 TR: 23-34S: (1/2-)9-26-36/37/39-45 T; R23: C ≥ 20 %Xn; R20: 5 % ≤ C < 20 % 5
016-012-00-4 disulphur dichloride;sulfur monochloride 233-036-2 10025-67-9 R14T; R25Xn; R20R29C; R35N; R50 T; C; NR: 14-20-25-29-35-50S: (1/2-)26-36/37/39-45-61 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
016-013-00-X sulphur dichloride 234-129-0 10545-99-0 R14C; R34Xi; R37N; R50 C; NR: 14-34-37-50S: (1/2-)26-45-61  
016-014-00-5 sulphur tetrachloride — 13451-08-6 R14C; R34N; R50 C; NR: 14-34-50S: (1/2-)26-45-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
016-015-00-0 thionyl dichloride;thionyl chloride 231-748-8 7719-09-7 R14Xn; R20/22R29C; R35 CR: 14-20/22-29-35S: (1/2-)26-36/37/39-45 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
016-016-00-6 sulphuryl chloride 232-245-6 7791-25-5 R14C; R34Xi; R37 CR: 14-34-37S: (1/2-)26-45  
016-017-00-1 chlorosulphonic acid 232-234-6 7790-94-5 R14C; R35Xi; R37 CR: 14-35-37S: (1/2-)26-45  
016-018-00-7 fluorosulphonic acid 232-149-4 7789-21-1 Xn; R20C; R35 CR: 20-35S: (1/2-)26-45  
016-019-00-2 oleum ... % SO3 — — R14C; R35Xi; R37 CR: 14-35-37S: (1/2-)26-30-45  B
016-020-00-8 sulphuric acid ... % 231-639-5 7664-93-9 C; R35 CR: 35S: (1/2-)26-30-45 C; R35: C ≥ 15 %Xi; R36/38: 5 % ≤ C < 15 % B
016-021-00-3 methanethiol;methyl mercaptan 200-822-1 74-93-1 F+; R12T; R23N; R50-53 F+; T; NR: 12-23-50/53S: (2-)16-25-60-61  
016-022-00-9 ethanethiol;ethyl mercaptan 200-837-3 75-08-1 F; R11Xn; R20N; R50-53 F; Xn; NR: 11-20-50/53S: (2-)16-25-60-61  
016-023-00-4 dimethyl sulphate 201-058-1 77-78-1 Carc. Cat. 2; R45Muta. Cat. 3; R68T+; R26T; R25C; R34R43 T+R: 45-25-26-34-43-68S: 53-45 Car. Cat. 2; R45: C ≥ 0,01 %Muta. Cat. 3, R68: C ≥ 0,01 %C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % E
016-024-00-X dimexano (ISO);bis(methoxythiocarbonyl) disulphide 215-993-8 1468-37-7 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
016-025-00-5 disul (ISO);2-(2,4-dichlorophenoxy)ethyl hydrogensulphate;2,4-DES 205-259-5 149-26-8 Xn; R22Xi; R38-41 XnR: 22-38-41S: (2-)26  
016-026-00-0 sulphamidic acid;sulphamic acid;sulfamic acid 226-218-8 5329-14-6 Xi; R36/38R52-53 XiR: 36/38-52/53S: (2-)26-28-61  
016-027-00-6 diethyl sulphate 200-589-6 64-67-5 Carc. Cat. 2; R45Muta. Cat. 2; R46Xn; R20/21/22C; R34 TR: 45-46-20/21/22-34S: 53-45  E
016-028-00-1 sodium dithionite;sodium hydrosulphite 231-890-0 7775-14-6 R7R31Xn; R22 XnR: 7-22-31S: (2-)7/8-26-28-43  
016-029-00-7 p-toluenesulphonic acid, containing more than 5 % H2SO4 — — C; R34 CR: 34S: (1/2-)26-37/39-45 C; R34: C ≥ 25 %Xi; R36/38: 10 % ≤ C < 25 % 
016-030-00-2 p-toluenesulphonic acid (containing a maximum of 5 % H2SO4) 203-180-0 104-15-4 Xi; R36/37/38 XiR: 36/37/38S: (2-)26-37  
016-031-00-8 tetrahydrothiophene-1,1-dioxide;sulpholane 204-783-1 126-33-0 Xn; R22 XnR: 22S: (2-)25  
016-032-00-3 1,3-propanesultone;1,2-oxathiolane 2,2-dioxide 214-317-9 1120-71-4 Carc. Cat. 2; R45Xn; R21/22 TR: 45-21/22S: 53-45 Carc. Cat. 2; R45: C ≥ 0,01 % E
016-033-00-9 dimethylsulfamoylchloride 236-412-4 13360-57-1 Carc. Cat. 2; R45T+; R26Xn; R21/22C; R34 T+R: 45-21/22-26-34S: 53-45  E
016-034-00-4 tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-1,3,5-triazine-2,4-diyl)imino(2-acetamido)-4,1-phenyleneazo))bis(naphthalene-1,5-disulphonate) 400-010-9 81898-60-4 R43 XiR: 43S: (2-)22-24-37  
016-035-00-X pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-dimethylphenylazo)-2,5-disulphonatophenylazo)-4-hydroxynaphthalene-2,7-disulphonate 400-120-7 — Xi; R36 XiR: 36S: (2-)22-26  
016-036-00-5 tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate 400-130-1 — R42N; R51-53 Xn; NR: 42-51/53S: (2-)22-61  
016-037-00-0 disodium 1-amino-4-(4-benzenesulphonamido-3-sulphonatoanilino)anthraquinone-2-sulphonate 400-350-8 85153-93-1 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
016-038-00-6 disodium 6-((4-chloro-6-(N-methyl)-2-toluidino)-1,3,5-triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2-sulphonatophenylazo)naphthalene-3-sulphonate 400-380-1 86393-35-3 R43 XiR: 43S: (2-)22-24-37  
016-039-00-1 tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-disulphonatophenylazo)phenylazo)-3-ureidoanilino)-1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate 400-430-2 — R43 XiR: 43S: (2-)22-24-37  
016-040-00-7 reaction mass of disodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(2,4-dihydroxyphenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and disodium 6-(2,4-diaminophenylazo)-3-(4-(4-(2,4-diaminophenylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate and trisodium 6-(2,4-dihydroxyphenylazo)-3-(4-(4-(7-(2,4-dihydroxyphenylazo)-1-hydroxy-3-sulphonato-2-naphthylazo)anilino)-3-sulphonatophenylazo)-4-hydroxynaphthalene-2-sulphonate 400-570-4 — Xi; R36 XiR: 36S: (2-)26  
016-041-00-2 calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1-yl)benzenesulphonate 400-710-4 — Xn; R20 XnR: 20S: (2-)  
016-042-00-8 tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- disulphonate 400-790-0 85665-97-0 Xi; R36/38R43 XiR: 36/38-43S: (2-)22-24/25-37  
016-043-00-3 dilithium 6-acetamido-4-hydroxy-3-(4-((2-sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2-sulphonate 401-010-1 — R43 XiR: 43S: (2-)24-37  
016-044-00-9 disodium S,S-hexane-1,6-diyldi(thiosulphate) dihydrate 401-320-7 — R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
016-045-00-4 lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulphonatophenylazo)-5-hydroxy-3-(4-(2-(sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene-2,7-disulphonate 401-560-2 108624-00-6 R43 XiR: 43S: (2-)22-24-37  
016-046-00-X sodium hydrogensulphate 231-665-7 7681-38-1 Xi; R41 XiR: 41S: (2-)24-26  
016-047-00-5 hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-sulphonatonaphthylazo)naphthalene-1,3,5- trisulphonate 401-650-1 85665-96-9 R43 XiR: 43S: (2-)22-24-37  
016-048-00-0 sodium 3,5-dichloro-2-(5-cyano-2,6-bis(3-hydroxypropylamino)-4-methylpyridin-3-ylazo)benzenesulphonate 401-870-8 — Xi; R41R52-53 XiR: 41-52/53S: (2-)26-61  
016-049-00-6 calcium octadecylxylenesulphonate 402-040-8 — C; R34N; R51-53 C; NR: 34-51/53S: (1/2-)26-28-36/37/39-45-61  
016-050-00-1 potassium sodium 5-(4-chloro-6-(N-(4-(4-chloro-6-(5-hydroxy-2,7-disulphonato-6-(2-sulphonatophenylazo)-4-naphthylamino)-1,3,5-triazin-2-ylamino) phenyl-N-methyl)amino)-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(2-sulphonatophenylazo)naphthalene-2,7-disulphonat 402-150-6 — Xi; R36R43 XiR: 36-43S: (2-)22-24-26-37  
016-051-00-7 trisodium 7-(4-(6-fluoro-4-(2-(2-vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6- trisulphonate 402-170-5 106359-91-5 R43 XiR: 43S: (2-)22-24-37  
016-052-00-2 benzyltributylammonium 4-hydroxynaphthalene-1-sulphonate 402-240-5 102561-46-6 Xn; R20N; R51-53 Xn; NR: 20-51/53S: (2-)22-61  
016-053-00-8 (C16 or C18-n-alkyl)(C16 or C18-n-alkyl)ammonium 2-((C16 or C18-n-alkyl)(C16 or C18-n-alkyl)carbamoyl)benzenesulphonate 402-460-1 — Xi; R38R43R53 XiR: 38-43-53S: (2-)24-37-61  
016-054-00-3 sodium 4-(2,4,4-trimethylpentylcarbonyloxy)benzenesulfonate 400-030-8 — T; R23-48/23Xn; R22Xi; R36/37R43 TR: 22-23-36/37-43-48/23S: (1/2-)22-24-36-45  
016-055-00-9 tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-sulfonate (containing > 35 % sodium chloride and sodium acetate) 400-510-7 — Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
016-056-00-4 potassium hydrogensulphate 231-594-1 7646-93-7 C; R34Xi; R37 CR: 34-37S: (1/2-)26-36/37/39-45  
016-057-00-X styrene-4-sulfonyl chloride 404-770-2 2633-67-2 Xi; R38-41R43 XiR: 38-41-43S: (2-)24-26-37/39  
016-058-00-5 thionyl chloride, reaction products with 1,3,4-thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert-alkylamine 404-820-3 — Xi; R38R43R52-53 XiR: 38-43-52/53S: (2-)36/37-61  
016-059-00-0 N,N,N',N'-tetramethyldithiobis(ethylene)diamine dihydrochloride 405-300-9 17339-60-5 Xn; R22Xi; R36R43N; R50-53 Xn; NR: 22-36-43-50/53S: (2-)26-36/37-60-61  
016-060-00-6 diammonium peroxodisulphate;ammonium persulphate 231-786-5 7727-54-0 O; R8Xn; R22Xi; R36/37/38R42/43 O; XnR: 8-22-36/37/38-42/43S: (2-)22-24-26-37  
016-061-00-1 dipotassium peroxodisulphate;potassium persulphate 231-781-8 7727-21-1 O; R8Xn; R22Xi; R36/37/38R42/43 O; XnR: 8-22-36/37/38-42/43S: (2-)22-24-26-37  
016-062-00-7 bensultap (ISO);1,3-bis(phenylsulfonylthio)-2-(N,N-dimethylamino)propane — 17606-31-4 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
016-063-00-2 sodium metabisulphite 231-673-0 7681-57-4 Xn; R22Xi; R41R31 XnR: 22-31-41S: (2-)26-39-46  
016-064-00-8 sodium hydrogensulphite … %;sodium bisulphite … % 231-548-0 7631-90-5 Xn; R22R31 XnR: 22-31S: (2-)25-46  B
016-065-00-3 sodium 1-amino-4-[2-methyl-5-(4-methylphenylsulfonylamino)phenylamino]anthraquinone-2-sulfonate 400-100-8 84057-97-6 N; R51-53 NR: 51/53S: 61  
016-066-00-9 tetrasodium [5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-2-((2-hydroxy-3,5-disulfonatophenylazo)-2- sulfonatobenzylidenehydrazino)benzoate]copper(II) 404-070-7 116912-62-0 R52-53 R: 52/53S: 61  
016-067-00-4 (4-methylphenyl)mesitylene sulfonate 407-530-5 67811-06-7 R53 R: 53S: 61  
016-068-00-X sodium 3,5-bis(tetradecyloxycarbonyl)benzenesulfinate 407-720-8 155160-86-4 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
016-069-00-5 3,5-bis-(tetradecyloxycarbonyl)benzenesulfinic acid 407-990-7 141915-64-2 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
016-070-00-0 4-benzyloxy-4'-(2,3-epoxy-2-methylprop-1-yloxy)diphenylsulfone 408-220-2 — R53 R: 53S: 61  
016-071-00-6 trisodium 3-amino-6,13-dichloro-10-((3-((4-chloro-6-(2-sulfophenylamino)-1,3,5-triazin-2-yl)amino)propyl) amino)-4,11-triphenoxydioxazinedisulfonate 410-130-3 136248-03-8 R43 XiR: - 43S: (2-)22-24-37  
016-072-00-1 3-amino-4-hydroxy-N-(2-methoxyethyl)-benzenesulfonamide 411-520-6 112195-27-4 Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)24-26-37/39-61  
016-073-00-7 tetrakis(phenylmethyl)thioperoxydi(carbothioamide) 404-310-0 10591-85-2 R53 R: 53S: 61  
016-074-00-2 6-fluoro-2-methyl-3-(4-methylthiobenzyl)indene 405-410-7 — Xi; R38-41R43N; R51-53 Xi; NR: 38-41-43-51/53S: (2-)26-36/37/39-61  
016-075-00-8 2,2'-diallyl-4,4'-sulfonyldiphenol 411-570-9 41481-66-7 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
016-076-00-3 2,3-bis((2-mercaptoethyl)thio)-1-propanethiol 411-290-7 131538-00-6 Xn; R22-48/22N; R50-53 Xn; NR: 22-48/22-50/53S: (2-)23-24/25-36-60-61  
016-077-00-9 2-chloro-p-toluenesulfochloride 412-890-1 42413-03-6 C; R34R43R52-53 CR: 34-43-52/53S: (1/2-)23-26-36/37/39-45-61  
016-078-00-4 4-methyl-N,N-bis(2-(((4-methylphenyl)sulfonyl)amino)ethyl)benzenesulfonamide 413-300-5 56187-04-3 R53 R: 53S: 61  
016-079-00-X N,N-bis(2-(p-toluenesulfonyloxy)ethyl)-p-toluenesulfonamide 412-920-3 16695-22-0 R43R53 XiR: 43-53S: (2-)24-37-61  
016-080-00-5 sodium 2-anilino-5-(2-nitro-4-(N-phenylsulfamoyl))anilinobenzenesulfonate 412-320-1 31361-99-6 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
016-081-00-0 hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N-ethoxycarbonyl-N-(p-tolylsulfonyl)azanide 418-350-1 — Muta. Cat. 3; R68Xn; R22Xi; R36R43N; R51-53 Xn; NR: 22-36-43-68-51/53S: (2-)26-36/37-61  
016-082-00-6 ethoxysulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea — 126801-58-9 N; R50-53 NR: 50/53S: 60-61  
016-083-00-1 acibenzolar-S-methyl;benzo[1,2,3]thiadiazole-7-carbothioic acid S-methyl ester 420-050-0 135158-54-2 Xi; R36/37/38R43N; R50-53 Xi; NR: 36/37/38-43-50/53S: (2-)24/25-37-46-59-60-61  
016-084-00-7 prosulfuron;1-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3-[2-(3,3,3-trifluoropropyl)phenylsulfonyl]urea — 94125-34-5 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
016-085-00-2 flazasulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(3-trifluoromethyl-2-pyridylsulfonyl)urea — 104040-78-0 N; R50-53 NR: 50/53S: 60-61  
016-086-00-8 tetrasodium 10-amino-6,13-dichloro-3-(3-(4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 402-590-9 109125-56-6 Xi; R41 XiR: 41S: (2-)22-26-39  
016-087-00-3 reaction mass of: thiobis(4,1-phenylene)-S,S,S',S'-tetraphenyldisulfonium bishexafluorophosphate;diphenyl(4-phenylthiophenyl)sulfonium hexafluorophosphate;propylene carbonate 403-490-8 104558-95-4 Xi; R36R43N; R50-53 Xi; NR: 36-43-50/53S: (2-)24-26-37-60-61  
016-088-00-9 4-(bis(4-(diethylamino)phenyl)methyl)benzene-1,2-dimethanesulfonic acid 407-280-7 71297-11-5 R52-53 R: 52/53S: 61  
016-089-00-4 reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene 413-840-1 — E; R2F; R11R53 ER: 2-11-53S: (2-)33-35-40-61  
016-090-00-X 4-methyl-N-(methylsulfonyl)benzenesulfonamide 415-040-8 14653-91-9 Xn; R22Xi; R37-41 XnR: 22-37-41S: (2-)26-39  
016-091-00-5 C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro-9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2-sulfonate 414-110-5 — Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
016-093-00-6 reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate);4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) 414-770-4 140698-96-0 F; R11Carc. Cat. 3; R40 F; XnR: 11-40S: (2-)7-36/37  
016-095-00-7 reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2);Reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) 417-980-4 — F; R11Carc. Cat. 3; R40 F; XnR: 11-40S: (2-)7-36/37  
016-096-00-2 thifensulfuron-methyl (ISO);methyl 3-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl)thiophene-2-carboxylate — 79277-27-3 N; R50-53 NR: 50/53S: 60-61  
017-001-00-7 chlorine 231-959-5 7782-50-5 T; R23Xi; R36/37/38N; R50 T; NR: 23-36/37/38-50S: (1/2-)9-45-61  
017-002-00-2 hydrogen chloride 231-595-7 7647-01-0 T; R23C; R35 T; CR: 23-35S: (1/2-)9-26-36/37/39-45  5
017-002-01-X hydrochloric acid ... % 231-595-7 — C; R34Xi; R37 CR: 34-37S: (1/2-)26-45 C; R34-37: C ≥ 25 %Xi; R36/37/38: 10 % ≤ C < 25 % B
017-003-00-8 barium chlorate 236-760-7 13477-00-4 O; R9Xn; R20/22N; R51-53 O; Xn; NR: 9-20/22-51/53S: (2-)13-27-61  
017-004-00-3 potassium chlorate 223-289-7 3811-04-9 O; R9Xn; R20/22N; R51-53 O; Xn; NR: 9-20/22-51/53S: (2-)13-16-27-61  
017-005-00-9 sodium chlorate 231-887-4 7775-09-9 O; R9Xn; R22N; R51-53 O; Xn; NR: 9-22-51/53S: (2-)13-17-46-61  
017-006-00-4 perchloric acid ... % 231-512-4 7601-90-3 R5O; R8C; R35 O; CR: 5-8-35S: (1/2-)23-26-36-45 C; R35: C ≥ 50 %C; R34: 10 % ≤ C < 50 %Xi; R36/38: 1 % ≤ C < 10 %FootnoteO; R5-8: C > 50 % B
017-007-00-X barium perchlorate 236-710-4 13465-95-7 O; R9Xn; R20/22 O; XnR: 9-20/22S: (2-)27  
017-008-00-5 potassium perchlorate 231-912-9 7778-74-7 O; R9Xn; R22 O; XnR: 9-22S: (2-)13-22-27  
017-009-00-0 ammonium perchlorate 232-235-1 7790-98-9 O; R9R44 ⊗ OR: 9-44S: (2-)14-16-27-36/37  G
017-010-00-6 sodium perchlorate 231-511-9 7601-89-0 O; R9Xn; R22 O; XnR: 9-22S: (2-)13-22-27  
017-011-00-1 sodium hypochlorite, solution ... % Cl active 231-668-3 7681-52-9 C; R34R31N; R50 C; NR: 31-34-50S: (1/2-)28-45-50-61 R31: C ≥ 5 % B
017-012-00-7 calcium hypochlorite 231-908-7 7778-54-3 O; R8 ⊗Xn; R22R31C; R34N; R50 O; C; NR: 8-22-31-34-50S: (1/2-)26-36/37/39-45-61 C; R34: C ≥ 10 %Xi; R37/38-41: 3 % ≤ C < 10 %Xi; R36: 0,5 % ≤ C < 3 % 
017-013-00-2 calcium chloride 233-140-8 10043-52-4 Xi; R36 XiR: 36S: (2-)22-24  
017-014-00-8 ammonium chloride 235-186-4 12125-02-9 Xn; R22Xi; R36 XnR: 22-36S: (2-)22  
017-015-00-3 (2-(aminomethyl)phenyl)acetylchloride hydrochloride 417-410-4 61807-67-8 Xn; R22C; R35R43 CR: 22-35-43S: (1/2-)26-36/37/39-45  
017-016-00-9 methyltriphenylphosphonium chloride 418-400-2 1031-15-8 Xn; R21/22Xi; R38-41N; R51-53 Xn; NR: 21/22-38-41-51/53S: (2-)22-26-36/37/39-61  
017-017-00-4 (Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride 426-210-6 120086-58-0 C; R34N; R50-53 C; NR: 34-50/53S: (2-)26-36/37/39-45-60-61  
017-018-00-X N,N,N-trimethyl-2,3-bis(stearoyloxy)propylammonium chloride 405-660-7 — N; R51-53 NR: 51/53S: 61  
017-019-00-5 (R)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratrylisoquinoline hydrochloride 415-110-8 54417-53-7 Xn; R22R52-53 XnR: 22-52/53S: (2-)22-61  
017-020-00-0 ethyl propoxy aluminium chloride 421-790-7 13014-29-4 F; R15R 14C; R35 F; CR: 14/15-35S: (1/2-)16-23-26-30-36/37/39-43-45  
017-021-00-6 behenamidopropyl-dimethyl-(dihydroxypropyl) ammonium chloride 423-420-1 136920-10-0 Xi; R41R43N; R50-53 Xi; NR: 41-43-50/53S: (2-)26-36/37/39-60-61  
019-001-00-2 potassium 231-119-8 7440-09-7 F; R15R14C; R34 F; CR: 14/15-34S: (1/2-)5-8-45  
019-002-00-8 potassium hydroxide;caustic potash 215-181-3 1310-58-3 Xn; R22C; R35 CR: 22-35S: (1/2-)26-36/37/39-45 C; R35: C ≥ 5 %C; R34: 2 % ≤ C < 5 %Xi; R36/38: 0.5 % ≤ C < 2 % 
020-001-00-X calcium 231-179-5 7440-70-2 F; R15 FR: 15S: (2-)8-24/25-43  
020-002-00-5 calcium cyanide 209-740-0 592-01-8 T+; R28R32N; R50-53 T+; NR: 28-32-50/53S: (1/2-)7/8-23-36/37-45-60-61  
020-003-00-0 reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide;tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide;poly[calcium ((2-hydroxy-5-tetra-propenyl-phenylmethyl)methylamine)hydroxide] 420-470-4 — Xi; R36/38R43 XiR: 36/38-43S: (2-)24-26-37  
022-001-00-5 titanium tetrachloride 231-441-9 7550-45-0 R14C; R34 CR: 14-34S: (1/2-)7/8-26-36/37/39-45  
022-002-00-0 titanium(4+) oxalate 403-260-7 — Xi; R41 XiR: 41S: (2-)26-39  
022-003-00-6 bis(η5-cyclopentadienyl)-bis(2,6-difluoro-3-[pyrrol-1-yl]-phenyl)titanium 412-000-1 125051-32-3 F; R11Repr. Cat. 3; R62Xn; R48/22N; R51-53 F; Xn; NR: 11-48/22-62-51/53S: (2-)7-22-33-36/37-61  
023-001-00-8 divanadium pentaoxide;vanadium pentoxide 215-239-8 1314-62-1 Muta. Cat. 3; R68Repr. Cat. 3; R63T; R48/23Xn; R20/22Xi; R37N; R51-53 T; NR: 20/22-37-48/23-51/53-63-68S: (1/2-)36/37-38-45-61  
024-001-00-0 chromium (VI) trioxide 215-607-8 1333-82-0 O; R9Carc. Cat. 1; R45Muta. Cat. 2; R46Repr. Cat. 3; R62T+; R26T; R24/25-48/23C; R35R42/43N; R50-53 O; T+; NR: 45-46-9-24/25-26-35-42/43-48/23-62-50/53S: 53-45-60-61 C: R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % E
024-002-00-6 potassium dichromate 231-906-6 7778-50-9 O; R8Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23Xn; R21C; R34R42/43N; R50-53 T+; N; OR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53S: 53-45-60-61 C; R34: C ≥ 10 %:Xi; R36/37/38: 5 % ≤ C < 10 % E3
024-003-00-1 ammonium dichromate 232-143-1 7789-09-5 E; R2O; R8Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23Xn; R21C; R34R42/43N; R50-53 E; T+; NR: 45-46-60-61-2-8-21-25-26-34-42/43-48/23-50/53S: 53-45-60-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 %R42/43: C ≥ 0,2 % E3
024-004-00-7 sodium dichromate anhydrate 234-190-3 10588-01-9 O; R8Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23Xn; R21C; R34R42/43N; 50-53 T+; N; OR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53S: 53-45-60-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 %R42/43: C ≥ 0,2 % E3
024-004-01-4 sodium dichromate, dihydrate 234-190-3 7789-12-0 O; R8Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23Xn; R21C; R34R42/43N; R50-53 T+; N; OR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53S: 53-45-60-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 %R42/43: C ≥ 0,2 % E3
024-005-00-2 chromyl dichloride;chromic oxychloride 239-056-8 14977-61-8 O; R8Carc. Cat. 2; R49Muta. Cat. 2; R46C; R35R43N; R50-53 O; T; C; NR: 49-46-8-35-43-50/53S: 53-45-60-61 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 0,5 % ≤ C < 5 %R43: C ≥ 0,5 % 3
024-006-00-8 potassium chromate 232-140-5 7789-00-6 Carc. Cat. 2; R49Muta. Cat. 2; R46Xi; R36/37/38R43N; R50-53 T; NR: 49-46-36/37/38-43-50/53S: 53-45-60-61 R43: C ≥ 0,5 % 3
024-007-00-3 zinc chromates including zinc potassium chromate — — Carc. Cat. 1; R45Xn; R22R43N; R50-53 T; NR: 45-22-43-50/53S: 53-45-60-61  AE
024-008-00-9 calcium chromate 237-366-8 13765-19-0 Carc. Cat. 2; R45Xn; R22N; R50-53 T; NR: 45-22-50/53S: 53-45-60-61  E
024-009-00-4 strontium chromate 232-142-6 7789-06-2 Carc. Cat. 2; R45Xn; R22N; R50-53 T; NR: 45-22-50/53S: 53-45-60-61  E
024-010-00-X dichromium tris(chromate);chromium III chromate;chromic chromate 246-356-2 24613-89-6 O; R8Carc. Cat. 2; R45C; R35R43N; R50-53 O; T; C; NR: 45-8-35-43-50/53S: 53-45-60-61  
024-011-00-5 ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) 400-110-2 109125-51-1 F; R11N; R50-53 F; NR: 11-50/53S: (2-)33-60-61  
024-012-00-0 trisodium bis(7-acetamido-2-(4-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)chromate(1-) 400-810-8 — Muta. Cat. 3; R68 XnR: 68S: (2-)22-36/37  
024-013-00-6 trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi-2,2'naphtholato)chromate(1-) 402-500-8 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
024-014-00-1 trisodium bis(2-(5-chloro-4-nitro-2-oxidophenylazo)-5-sulphonato-1-naphtholato)chromate(1-) 402-870-0 93952-24-0 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
024-015-00-7 disodium (3-methyl-4-(5-nitro-2-oxidophenylazo)-1-phenylpyrazololato)(1-(3-nitro-2-oxido-5-sulfonatophenylazo)-2-naphtholato)chromate(1-) 404-930-1 — Xn; R20Xi; R41N; R51-53 Xn; NR: 20-41-51/53S: (2-)26-39-61  
024-016-00-2 tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) 405-110-6 88377-66-6 Xn; R48/22R53 XnR: 48/22-53S: (2-)22-36-61  
024-017-00-8 Chromium (VI) compounds, with the exception of barium chromate and of compounds specified elsewhere in this Annex — — Carc. Cat. 2; R49R43N; R50-53 T; NR: 49-43-50/53S: 53-45-60-61  A
024-018-00-3 sodium chromate 231-889-5 7775-11-3 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23Xn; R21C; R34R42/43N; R50-53 T+; NR: 45-46-60-61-21-25-26-34-42/43-48/23-50/53S: 53-45-60-61 R42/43: C ≥ 0,2 % E3
024-019-00-9 Main component: acetoacetic acid anilide/3-amino-1-hydroxybenzene (ATAN-MAP): trisodium {6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}-{6''-[1-(phenylcarbamoyl)ethylazo]-5'''-(phenylsulfamoyl)-3''-sulfonatonaphthalene-2''-azobenzene-1'',2'''-diolato}chromate (III);by-product 1: acetoacetic acid anilide/acetoacetic acid anilide (ATAN-ATAN): trisodium bis{6-[1-(phenylcarbamoyl)ethylazo]-5'-(phenylsulfonyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato}chromate (III);by-product 2: 3-amino-1-hydroxybenzene/3-amino-1-hydroxybenzene (MAP-MAP): trisodium bis{6-[(2 or 3 or 4)-amino-(4 or 5 or 6)-hydroxyphenylazo]-5'-(phenylsulfamoyl)-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) 419-230-1 — R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
024-020-00-4 trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2-hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin-5-azo)benzene-2',4-diolato)]chromate (III) 418-220-4 — R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
025-001-00-3 manganese dioxide 215-202-6 1313-13-9 Xn; R20/22 XnR: 20/22S: (2-)25  
025-002-00-9 potassium permanganate 231-760-3 7722-64-7 O; R8Xn; R22N; R50-53 O; Xn; NR: 8-22-50/53S: (2-)60-61  
025-003-00-4 manganese sulphate 232-089-9 7785-87-7 Xn; R48/20/22N; R51-53 Xn; NR: 48/20/22-51/53S: (2-)22-61  
025-004-00-X bis(N,N',N''-trimethyl-1,4,7-triazacyclononane)-trioxo-dimanganese (IV) di(hexafluorophosphate) monohydrate 411-760-1 116633-53-5 N; R51-53 NR: 51/53S: 61  
025-005-00-5 reaction mass of: tri-sodium [29H, 31H-phthalocyanine-C,C,C-trisulfonato (6-)-N29,N30,N31,N32] manganate (3-);tetrasodium [29H,31H-phthalocyanine-C,C,C,C-tetrasulfonato (6-)-N29,N30,N31,N32], manganate (3-);pentasodium [29H,31H-phthalocyanine-C,C,C,C,C-pentasulfonato (6-)-N29,N30,N31,N32] manganate (3-) 417-660-4 — N; R50-53 NR: 50/53S: 60-61  
026-001-00-6 (η-cumene)-(η-cyclopentadienyl)iron(II) hexafluoroantimonate 407-840-0 100011-37-8 Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)22-26-39-61  
026-002-00-1 (η-cumene)-(η-cyclopentadienyl)iron(II) trifluoromethane-sulfonate 407-880-9 117549-13-0 Xn; R22R52-53 XnR: 22-52/53S: (2-)26-61  
027-001-00-9 cobalt 231-158-0 7440-48-4 R42/43R53 XnR: 42/43-53S: (2-)22-24-37-61  
027-002-00-4 cobalt oxide 215-154-6 1307-96-6 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61  
027-003-00-X cobalt sulphide 215-273-3 1317-42-6 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
027-004-00-5 cobalt dichloride 231-589-4 7646-79-9 Carc. Cat. 2; R49Xn; R22R42/43N; R50-53 T; NR: 49-22-42/43-50/53S: (2-)22-53-45-60-61 Carc. Cat. 2; R49: C ≥ 0,01 %Xn; R22: C ≥ 2,5 % E1
027-005-00-0 cobalt sulphate 233-334-2 10124-43-3 Carc. Cat. 2; R49Xn; R22R42/43N; R50-53 T; NR: 49-22-42/43-50/53S: (2-)22-53-45-60-61 Carc. Cat. 2; R49: C ≥ 0,01 % E1
028-001-00-1 tetracarbonylnickel;nickel tetracarbonyl 236-669-2 13463-39-3 F; R11Carc. Cat. 3; R40Repr. Cat. 2; R61T+; R26N; R50-53 F; T+; NR: 61-11-26-40-50/53S: 53-45-60-61  E
028-002-00-7 nickel 231-111-4 7440-02-0 Carc. Cat. 3; R40R43 XnR: 40-43S: (2-)22-36  
028-003-00-2 nickel monoxide 215-215-7 1313-99-1 Carc. Cat. 1; R49R43R53 TR: 49-43-53S: 53-45-61  
028-004-00-8 nickel dioxide 234-823-3 12035-36-8 Carc. Cat. 1; R49R43R53 TR: 49-43-53S: 53-45-61  
028-005-00-3 dinickel trioxide 215-217-8 1314-06-3 Carc. Cat. 1; R49R43R53 TR: 49-43-53S: 53-45-61  
028-006-00-9 nickel sulphide 240-841-2 16812-54-7 Carc. Cat. 1; R49R43N; R50-53 T; NR: 49-43-50/53S: 53-45-60-61  
028-007-00-4 nickel subsulphide;trinickel disulphide 234-829-6 12035-72-2 Carc. Cat. 1; R49R43N; R51-53 T; NR: 49-43-51/53S: 53-45-61  
028-008-00-X nickel dihydroxide 235-008-5 12054-48-7 Carc. Cat. 3; R40Xn; R20/22R43N; R50-53 Xn; NR: 20/22-40-43-50/53S: (2-)22-36-60-61  
028-009-00-5 nickel sulphate 232-104-9 7786-81-4 Carc. Cat. 3; R40Xn; R22R42/43N; R50-53 Xn; NR: 22-40-42/43-50/53S: (2-)22-36/37-60-61  
028-010-00-0 nickel carbonate 222-068-2 3333-67-3 Carc. Cat. 3; R40Xn; R22R43N; R50-53 Xn; NR: 22-40-43-50/53S: (2-)22-36/37-60-61  
029-001-00-4 copper chloride;copper (I) chloride;cuprous chloride 231-842-9 7758-89-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)22-60-61  
029-002-00-X dicopper oxide;copper (I) oxide 215-270-7 1317-39-1 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)22-60-61  
029-003-00-5 Naphthenic acids, copper salts;copper naphthenate 215-657-0 1338-02-9 R10Xn; R22N; R50-53 Xn; NR: 10-22-50/53S: (2-)60-61  
029-004-00-0 copper sulphate 231-847-6 7758-98-7 Xn; R22Xi; R36/38N; R50-53 Xn; NR: 22-36/38-50/53S: (2-)22-60-61  
029-005-00-6 (tris(chloromethyl)phthalocyaninato)copper(II), reaction products with N-methylpiperazine and methoxyacetic acid 401-260-1 — Xi; R36 XiR: 36S: (2-)26  
029-006-00-1 tris(octadec-9-enylammonium) (trisulfonatophthalocyaninato)copper(II) 403-210-4 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)22-26-39-61  
029-007-00-7 (trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)phenylmethylazo)-4-sulfonatobenzoato)copper(3-)) hydroxide 404-670-9 89797-01-3 E; R2R43 E; XiR: 2-43S: (2-)22-24-35-37  
029-008-00-2 copper(II) methanesulfonate 405-400-2 54253-62-2 Xn; R22Xi; R41N; R50-53 Xn; NR: 22-41-50/53S: (2-)26-36/37/39-60-61  
029-009-00-8 phthalocyanine-N-[3-(diethylamino)propyl]sulfonamide copper complex 413-650-9 93971-95-0 R52-53 R: 52/53S: 61  
029-010-00-3 reaction mass of compounds from (dodecakis(p-tolylthio)phthalocyaninato)copper(II) to (hexadecakis(p-tolylthio)phthalocyaninato)copper(II) 407-700-9 101408-30-4 R43 XiR: 43S: (2-)24-37  
029-011-00-9 sodium [29H,31H-phthalocyaninato-(2-)-N29,N30,N31,N32]-((3-(N-methyl-N-(2-hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, copper complex 412-730-0 150522-10-4 C; R34 CR: 34S: (1/2-)22-26-36/37/39-45  
029-012-00-4 sodium ((N-(3-trimethylammoniopropyl)sulfamoyl)methylsulfonatophthalocyaninato)copper(II) 407-340-2 124719-24-0 Xi; R41 XiR: 41S: (2-)26-39  
029-013-00-X trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) 407-580-8 130201-51-3 Xi; R41R52-53 XiR: 41-52/53S: (2-)24-37-61  
030-001-00-1 zinc powder — zinc dust (pyrophoric) 231-175-3 7440-66-6 F; R15-17N; R50-53 F; NR: 15-17-50/53S: (2-)43-46-60-61  
030-001-01-9 zinc powder — zinc dust (stabilised) 231-175-3 7440-66-6 N; R50-53 NR: 50/53S: 60-61  
030-003-00-2 zinc chloride 231-592-0 7646-85-7 C; R34Xn; R22N; R50-53 C; NR: 22-34-50/53S: (1/2-)26-36/37/39-45-60-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
030-004-00-8 dimethylzinc; [1]diethylzinc [2] 208-884-1 [1]209-161-3 [2] 544-97-8 [1]557-20-0 [2] F; R17R14C; R34N; R50-53 F; C; NR: 14-17-34-50/53S: (1/2-)16-43-45-60-61  
030-005-00-3 diamminediisocyanatozinc 401-610-3 — Xn; R22Xi; R41R42/43N; R50 Xn; NR: 22-41-42/43-50S: (2-)22-26-36/37/39-41-61  
030-006-00-9 zinc sulphate (hydrous) (mono-, hexa- and hepta hydrate); [1]zinc sulphate (anhydrous) [2] 231-793-3 [1]231-793-3 [2] 7446-19-7 [1]7733-02-0 [2] Xn; R22Xi; R41N; R50-53 Xn; NR: 22-41-50/53S: (2-)22-26-39-46-60-61  
030-007-00-4 bis(3,5-di-tert-butylsalicylato-O1,O2)zinc 403-360-0 42405-40-3 F; R11Xn; R22N; R50-53 F; Xn; NR: 11-22-50/53S: (2-)7-22-60-61  
030-008-00-X hydroxo(2-(benzenesulfonamido)benzoato)zinc(II) 403-750-0 113036-91-2 Xn; R20N; R51-53 Xn; NR: 20-51/53S: (2-)22-57-61  
030-011-00-6 trizinc bis(orthophosphate) 231-944-3 7779-90-0 N; R50-53 NR: 50/53S: 60-61  
030-013-00-7 zinc oxide 215-222-5 1314-13-2 N; R50-53 NR: 50/53S: 60-61  
033-001-00-X arsenic 231-148-6 7440-38-2 T; R23/25N; R50-53 T; NR: 23/25-50/53S: (1/2-)20/21-28-45-60-61  
033-002-00-5 arsenic compounds, with the exception of those specified elsewhere in this Annex — — T; R23/25N; R50-53 T; NR: 23/25-50/53S: (1/2-)20/21-28-45-60-61 T; R23/25: C ≥ 0,2 %Xn; R20/22: 0,1 % ≤ C < 0,2 % A1
033-003-00-0 diarsenic trioxide;arsenic trioxide 215-481-4 1327-53-3 Carc. Cat. 1; R45T+; R28C; R34N; R50-53 T+; NR: 45-28-34-50/53S: 53-45-60-61  E
033-004-00-6 diarsenic pentaoxide;arsenic pentoxide;arsenic oxide 215-116-9 1303-28-2 Carc. Cat. 1; R45T; R23/25N; R50-53 T; NR: 45-23/25-50/53S: 53-45-60-61  E
033-005-00-1 arsenic acid and its salts — — Carc. Cat. 1; R45T; R23/25N; R50-53 T; NR: 45-23/25-50/53S: 53-45-60-61  AE
033-006-00-7 arsine 232-066-3 7784-42-1 F+; R12T+; R26Xn; R48/20N; R50-53 F+; T+; NR: 12-26-48/20-50/53S: (1/2-)9-16-28-33-36/37-45-60-61  
033-007-00-2 tert-butylarsine 423-320-6 4262-43-5 F; R17T+; R26 F; T+R: 17-26S: (1/2-)9-28-36/37-43-45  
034-001-00-2 selenium 231-957-4 7782-49-2 T; R23/25R33R53 TR: 23/25-33-53S: (1/2-)20/21-28-45-61  
034-002-00-8 selenium compounds except cadmium sulphoselenide — — T; R23/25R33N; R50-53 T; NR: 23/25-33-50/53S: (1/2-)20/21-28-45-60-61  A
034-003-00-3 sodium selenite 233-267-9 10102-18-8 T+; R28T; R23R31R43N; R51-53 T+; NR: 23-28-31-43-51/53S: (1/2-)28-36/37-45-61  
035-001-00-5 bromine 231-778-1 7726-95-6 T+; R26C; R35N; R50 T+; C; NR: 26-35-50S: (1/2-)7/9-26-45-61  
035-002-00-0 hydrogen bromide 233-113-0 10035-10-6 C; R35Xi; R37 CR: 35-37S: (1/2-)7/9-26-45  
035-002-01-8 hydrobromic acid ... % — — C; R34Xi; R37 CR: 34-37S: (1/2-)7/9-26-45 C; R34: C ≥ 40 %Xi; R36/38: 10 % ≤ C < 40 %Xi; R37: C ≥ 10 % B
035-003-00-6 potassium bromate 231-829-8 7758-01-2 O; R9Carc. Cat. 2; R45T; R25 T; OR: 45-9-25S: 53-45  E
035-004-00-1 2-hydroxyethylammonium perbromide 407-440-6 — O; R8Xn; R22C; R35R43N; R50 O; C; NR: 8-22-35-43-50S: (1/2-)3/7-14-26-36/37/39-45-60-61  
040-001-00-3 zirconium powder (pyrophoric) 231-176-9 7440-67-7 F; R15-17 FR: 15-17S: (2-)7/8-43  
040-002-00-9 zirconium powder (non pyrophoric) — — F; R15 FR: 15S: (2-)7/8-43  
042-001-00-9 molybdenum trioxide 215-204-7 1313-27-5 Xn; R48/20/22Xi; R36/37 XnR: 36/37-48/20/22S: (2-)22-25  
042-002-00-4 tetrakis(dimethylditetradecylammonium) hexa-μ-oxotetra-μ3-oxodi-μ5-oxotetradecaoxooctamolybdate(4-) 404-760-8 117342-25-3 T; R23Xi; R41R53 TR: 23-41-53S: (1/2-)26-37/39-45-61  
042-003-00-X tetrakis(trimethylhexadecylammonium) hexa-mu-oxotetra-mu3-oxodi-mu5-oxotetradecaoxooctamolybdate(4-) 404-860-1 116810-46-9 F; R11Xi; R41N; R50-53 F; Xi; NR: 11-41-50/53S: (2-)26-39-60-61  
042-004-00-5 Reaction product of ammonium molybdate and C12-C24-diethoxylated alkylamine (1:5-1:3) 412-780-3 — Xi; R38R43N; R51-53 Xi; NR: 38-43-51/53S: 24/25-37-61  
047-001-00-2 silver nitrate 231-853-9 7761-88-8 ⊗ C; R34N; R50-53 C; NR: 34-50/53S: (1/2-)26-45-60-61  
048-001-00-5 cadmium compounds, with the exception of cadmium sulphoselenide (xCdS.yCdSe), reaction mass of cadmium sulphide with zinc sulphide (xCdS.yZnS), reaction mass of cadmium sulphide with mercury sulphide (xCdS.yHgS), and those specified elsewhere in this Annex — — Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)60-61 Xn; R20/21/22: C ≥ 0,1 % A1
048-002-00-0 cadmium (non-pyrophoric); [1]cadmium oxide (non-pyrophoric) [2] 231-152-8 [1]215-146-2 [2] 7440-43-9 [1]1306-19-0 [2] Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62-63T+; R26T; R48/23/25N; R50-53 T+; NR: 45-26-48/23/25-62-63-68-50/53S: 53-45-60-61  E
048-003-00-6 cadmium diformate;cadmiumformate 224-729-0 4464-23-7 T; R23/25R33Xn; R68N; R50-53 T; NR: 23/25-33-68-50/53S: (1/2-)22-45-60-61 T; R23/25: C ≥ 10 %Xn; R20/22: 0,25 % ≤ C < 10 %R33: C ≥ 0,25 % 
048-004-00-1 cadmium cyanide 208-829-1 542-83-6 T+; R26/27/28R32R33Xn; R68N; R50-53 T+; NR: 26/27/28-32-33-68-50/53S: (1/2-)7-28-29-45-60-61 R32: C ≥ 1 %R33: C ≥ 0,1 % 
048-005-00-7 cadmiumhexafluorosilicate(2-);cadmium fluorosilica 241-084-0 17010-21-8 T; R23/25R33Xn; R68N; R50-53 T; NR: 23/25-33-68-50/53S: (1/2-)22-45-60-61 T; R23/25: C ≥ 10 %Xn; R20/22: 0,1 % ≤ C < 10 %R33: C ≥ 0,1 % 
048-006-00-2 cadmium fluoride 232-222-0 7790-79-6 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23/25N; R50-53 T+; NR: 45-46-60-61-25-26-48/23/25-50/53S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 %T; R25: C ≥ 10 %Xn; R22: 0,1 % ≤ C < 10 %T; R48/23/25: C ≥ 7 %Xn; R48/20/22: 0,1 % ≤ C < 7 % E
048-007-00-8 cadmium iodide 232-223-6 7790-80-9 T; R23/25R33Xn; R68N; R50-53 T; NR: 23/25-33-68-50/53S: (1/2-)22-45-60-61 T; R23/25: C ≥ 10 %Xn; R20/22: 0,1 % ≤ C < 10 %R33: C ≥ 0,1 % 
048-008-00-3 cadmium chloride 233-296-7 10108-64-2 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23/25N; R50-53 T+; NR: 45-46-60-61-25-26-48/23/25-50/53S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 %T; R25: C ≥ 10 %Xn; R22: 0,1 % ≤ C < 10 %T; R48/23/25: C ≥ 7 %Xn; R48/20/22: 0,1 % ≤ C < 7 % E
048-009-00-9 cadmium sulphate 233-331-6 10124-36-4 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23/25N; R50-53 T+; NR: 45-46-60-61-25-26-48/23/25-50/53S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 %T; R25: C ≥ 10 %Xn; R22: 0,1 % ≤ C < 10 %T; R48/23/25: C ≥ 7 %Xn; R48/20/22: 0,1 % ≤ C < 7 % E
048-010-00-4 cadmium sulphide 215-147-8 1306-23-6 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62-63T; R48/23/25Xn; R22R53 T;R: 45-22-48/23/25-62-63-68-53S: 53-45-61 Xn; R22: C ≥ 10 %T; R48/23/25: C ≥ 10 %Xn; R48/20/22: 0,1 % ≤ C < 10 % E1
048-011-00-X cadmium (pyrophoric) 231-152-8 7440-43-9 F; R17Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62-63T+; R26T; R48/23/25N; R50-53 F; T+; NR: 45-17-26-48/23/25-62-63-68-50/53S: 53-45-7/8-43-60-61  E
050-001-00-5 tin tetrachloride;stannic chloride 231-588-9 7646-78-8 C; R34R52-53 CR: 34-52/53S: (1/2-)7/8-26-45-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
050-002-00-0 cyhexatin (ISO);hydroxytricyclohexylstannane;tri(cyclohexyl)tin hydroxide 236-049-1 13121-70-5 Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)13-60-61  
050-003-00-6 fentin acetate (ISO);triphenyltin acetate 212-984-0 900-95-8 Carc. Cat. 3; R40Repr. Cat. 3; R63T+; R26T; R24/25-48/23Xi; R37/38-41N; R50-53 T+; NR: 24/25-26-37/38-40-41-48/23-50/53-63S: (1/2-)26-28-36/37/39-45-60-61  
050-004-00-1 fentin hydroxide (ISO);triphenyltin hydroxide 200-990-6 76-87-9 Carc. Cat. 3; R40Repr. Cat. 3; R63T+; R26T; R24/25-48/23Xi; R37/38-41N; R50-53 T+; NR: 24/25-26-37/38-40-41-48/23-50/53-63S: (1/2-)26-28-36/37/39-45-60-61  
050-005-00-7 trimethyltin compounds, with the exception of those specified elsewhere in this Annex — — T+; R26/27/28N; R50-53 T+; NR: 26/27/28-50/53S: (1/2-)26-27-28-45-60-61 T+; R26/27/28: C ≥ 0,5 %T; R23/24/25: 0,1 % ≤ C < 0,5 %Xn; R20/21/22: 0,05 % ≤ C < 0,1 % A1
050-006-00-2 triethyltin compounds, with the exception of those specified elsewhere in this Annex — — T+; R26/27/28N; R50-53 T+; NR: 26/27/28-50/53S: (1/2-)26-27-28-45-60-61 T+; R26/27/28: C ≥ 0,5 %T; R23/24/25: 0,1 % ≤ C < 0,5 %Xn; R20/21/22: 0,05 % ≤ C < 0,1 % A1
050-007-00-8 tripropyltin compounds, with the exception of those specified elsewhere in this Annex — — T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)26-27-28-45-60-61 T; R23/24/25: C ≥ 0,5 %Xn; R20/21/22: 0,1 % ≤ C < 0,5 % A1
050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex — — T; R25-48/23/25Xn; R21Xi; R36/38N; R50-53 T; NR: 21-25-36/38-48/23/25-50/53S: (1/2-)35-36/37/39-45-60-61 T; R25: C ≥ 1 %Xn; R22: 0,25 % ≤ C < 1 %T; R48/23/25: C ≥ 1 %Xn; R48/20/22: 0,25 % ≤ C < 1 %Xn; R21: C ≥ 1 %Xi; R36/38: C ≥ 1 % A1
050-009-00-9 fluorotripentylstannane; [1]hexapentyldistannoxane [2] 243-546-7 [1]247-143-7 [2] 20153-49-5 [1]25637-27-8 [2] Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)26-28-60-61 Xn; R20/21/22: C ≥ 1 % 1
050-010-00-4 fluorotrihexylstannane 243-547-2 20153-50-8 Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)26-28-60-61 Xn; R20/21/22: C ≥ 1 % 1
050-011-00-X triphenyltin compounds, with the exception of those specified elsewhere in this Annex — — T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)26-27-28-45-60-61 T; R23/24/25: C ≥ 1 %Xn; R20/21/22: 0,25 % ≤ C < 1 % A1
050-012-00-5 tetracyclohexylstannane; [1]chlorotricyclohexylstannane; [2]butyltricyclohexylstannane [3] 215-910-5 [1]221-437-5 [2]230-358-5 [3] 1449-55-4 [1]3091-32-5 [2]7067-44-9 [3] Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)26-28-60-61 Xn; R20/21/22: C ≥ 1 % A1
050-013-00-0 trioctyltin compounds, with the exception of those specified elsewhere in this Annex — — Xi; R36/37/38R53 XiR: 36/37/38-53S: (2-)61 Xi; R36/37/38: C ≥ 1 % A1
050-017-00-2 fenbutatin oxide (ISO);bis(tris(2-methyl-2-phenylpropyl)tin)oxide 236-407-7 13356-08-6 T+; R26Xi; R36/38N; R50-53 T+; NR: 26-36/38-50/53S: (1/2-)28-36/37-45-60-61  
050-018-00-8 tin(II) methanesulphonate 401-640-7 53408-94-9 C; R34Xn; R22R43 CR: 22-34-43S: (1/2-)22-26-36/37/39-45  
050-019-00-3 azocyclotin (ISO);1-(tricyclohexylstannyl)-1H-1,2,4-triazole; 255-209-1 41083-11-8 T+; R26T; R25Xi; R37/38-41N; R50-53 T+; NR: 25-26-37/38-41-50/53S: (1/2-)26-28-36/37/39-38-45-60-61  
050-020-00-9 trioctylstannane 413-320-4 869-59-0 T; R48/25Xi; R38R53 TR: 38-48/25-53S: (1/2-)23-36/37-45-61  
051-001-00-8 antimony trichloride 233-047-2 10025-91-9 C; R34N; R51-53 C; NR: 34-51/53S: (1/2-)26-45-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
051-002-00-3 antimony pentachloride 231-601-8 7647-18-9 C; R34N; R51-53 C; NR: 34-51/53S: (1/2-)26-45-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
051-003-00-9 antimony compounds, with the exception of the tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide (Sb2S3), pentasulphide (Sb2S5) and those specified elsewhere in this Annex — — Xn; R20/22N; R51-53 Xn; NR: 20/22-51/53S: (2-)61 Xn; R20/22: C ≥ 0,25 % A1
051-004-00-4 antimony trifluoride 232-009-2 7783-56-4 T; R23/24/25N; R51-53 T; NR: 23/24/25-51/53S: (1/2-)7-26-45-61  
051-005-00-X antimony trioxide 215-175-0 1309-64-4 Carc. Cat. 3; R40 XnR: 40S: (2-)22-36/37  
051-006-00-5 diphenyl(4-phenylthiophenyl)sulfonium hexafluoroantimonate 403-500-0 — R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
051-007-00-0 bis(4-dodecylphenyl)iodonium hexafluoroantimonate 404-420-9 71786-70-4 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
053-001-00-3 iodine 231-442-4 7553-56-2 Xn; R20/21N; R50 Xn; NR: 20/21-50S: (2-)23-25-61  
053-002-00-9 hydrogen iodide 233-109-9 10034-85-2 C; R35 CR: 35S: (1/2-)9-26-36/37/39-45 C; R35: C ≥ 10 %C; R34: 0,2 % ≤ C < 10 %Xi; R36/37/38: 0,02 % ≤ C < 0,2 % 5
053-002-01-6 hydriodic acid ... % — — C; R34 CR: 34S: (1/2-)26-45 C; R34: C ≥ 25 %Xi; R36/38: 10 % ≤ C < 25 % B
053-003-00-4 iodoxybenzene — 696-33-3 E; R1 ⊗ ER: 1S: (2-)35  
053-004-00-X calcium iodoxybenzoate — — E; R1 ⊗ ER: 1S: (2-)35  C
053-005-00-5 (4-(1-methylethyl)phenyl)-(4-methylphenyl)iodonium tetrakis(pentafluorophenyl)borate (1-) 422-960-3 178233-72-2 Xn; R21/22-48/22N; R50-53 Xn; NR: 21/22-48/22-50/53S: (2-)22-36/37-60-61  
056-001-00-1 barium peroxide 215-128-4 1304-29-6 O; R8Xn; R20/22 O; XnR: 8-20/22S: (2-)13-27  
056-002-00-7 barium salts, with the exception of barium sulphate, salts of 1-azo-2-hydroxynaphthalenyl aryl sulphonic acid, and of salts specified elsewhere in this Annex — — Xn; R20/22 XnR: 20/22S: (2-)28 Xn; R20/22: C ≥ 1 % A1
056-003-00-2 barium carbonate 208-167-3 513-77-9 Xn; R22 XnR: 22S: (2-)24/25  
056-004-00-8 barium chloride 233-788-1 10361-37-2 T; R25Xn; R20 TR: 20-25S: (1/2-)45  
072-001-00-4 hafnium tetra-n-butoxide 411-740-2 22411-22-9 Xi; R41R43 XiR: 41-43S: (2-)24/25-26-37/39  
074-001-00-X hexasodium tungstate hydrate 412-770-9 12141-67-2 Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)22-26-39-61  
074-002-00-5 Reaction products of tungsten hexachloride with 2-methylpropan-2-ol, nonylphenol and pentane-2,4-dione 408-250-6 — F; R11Xn; R20C; R34R43N; R50-53 F; C; NR: 11-20-34-43-50/53S: (1/2-)16-26-29-33-36/37/39-45-60-61  
076-001-00-5 osmium tetraoxide;osmic acid 244-058-7 20816-12-0 T+; R26/27/28C; R34 T+R: 26/27/28-34S: (1/2-)7/9-26-45  
078-001-00-0 tetrachloroplatinates with the exception of those specified elsewhere in this Annex — — T; R25Xi; R41R42/43 TR: 25-41-42/43S: (2-)22-26-36/37/39-45  A
078-002-00-6 diammonium tetrachloroplatinate 237-499-1 13820-41-2 T; R25Xi; R38-41R42/43 TR: 25-38-41-42/43S: (2-)22-26-36/37/39-45  
078-003-00-1 disodium tetrachloroplatinate 233-051-4 10026-00-3 T; R25Xi; R38-41R42/43 TR: 25-38-41-42/43S: (2-)22-26-36/37/39-45  
078-004-00-7 dipotassium tetrachloroplatinate 233-050-9 10025-99-7 T; R25Xi; R38-41R42/43 TR: 25-38-41-42/43S: (2-)22-26-36/37/39-45  
078-005-00-2 hexachloroplatinates with the exception of those specified elsewhere in this Annex — — T; R25Xi; R41R42/43 TR: 25-41-42/43S: (1/2-)22-26-36/37/39-45  A
078-006-00-8 disodium hexachloroplatinate 240-983-5 16923-58-3 T; R25Xi; R41R42/43 TR: 25-41-42/43S: (1/2-)22-26-36/37/39-45  
078-007-00-3 dipotassium hexachloroplatinate 240-979-3 16921-30-5 T; R25Xi; R41R42/43 TR: 25-41-42/43S: (1/2-)22-26-36/37/39-45  
078-008-00-9 diammonium hexachloroplatinate 240-973-0 16919-58-7 T; R25Xi; R41R42/43 TR: 25-41-42/43S: (1/2-)22-26-36/37/39-45  
078-009-00-4 hexachloroplatinic acid 241-010-7 16941-12-1 T; R25C; R34R42/43 TR: 25-34-42/43S: (1/2-)22-26-36/37/39-45  
080-001-00-0 mercury 231-106-7 7439-97-6 T; R23R33N; R50-53 T; NR: 23-33-50/53S: (1/2-)7-45-60-61  
080-002-00-6 inorganic compounds of mercury with the exception of mercuric sulphide and those specified elsewhere in this Annex — — T+; R26/27/28R33N; R50-53 T+; NR: 26/27/28-33-50/53S: (1/2-)13-28-45-60-61 T+; R26/27/28: C ≥ 2 %T; R23/24/25: 0,5 % ≤ C < 2 %Xn; R20/21/22: 0,1 % ≤ C < 0,5 %R33: C ≥ 0,1 % A1
080-003-00-1 dimercury dichloride;mercurous chloride;calomel 233-307-5 10112-91-1 Xn; R22Xi; R36/37/38N; R50-53 Xn; NR: 22-36/37/38-50/53S: (2-)13-24/25-46-60-61  
080-004-00-7 organic compounds of mercury with the exception of those specified elsewhere in this Annex — — T+; R26/27/28R33N; R50-53 T+; NR: 26/27/28-33-50/53S: (1/2-)13-28-36-45-60-61 T+; R26/27/28: C ≥ 2 %T; R23/24/25: 0,5 % ≤ C < 2 %Xn; R20/21/22: 0,05 % ≤ C < 0,5 %R33: C ≥ 0,05 % A1
080-005-00-2 mercury difulminate;mercuric fulminate;fulminate of mercury 211-057-8 628-86-4 E; R3T; R23/24/25R33N; R50-53 E; T; NR: 3-23/24/25-33-50/53S: (1/2-)3-45-60-61  
080-006-00-8 dimercury dicyanide oxide;mercuric oxycyanide 215-629-8 1335-31-5 E; R3 ⊗T; R23/24/25R33N; R50-53 E; T; NR: 3-23/24/25-33-50/53S: (1/2-)28-35-45-60-61  
080-007-00-3 dimethylmercury; [1]diethylmercury [2] 209-805-3 [1]211-000-7 [2] 593-74-8 [1]627-44-1 [2] T+; R26/27/28R33N; R50-53 T+; NR: 26/27/28-33-50/53S: (1/2-)13-28-36-45-60-61 T+; R26/27/28: C ≥ 0,5 %T; R23/24/25: 0,1 % ≤ C < 0,5 %Xn; R20/21/22: 0,05 % ≤ C < 0,1 %R33: C ≥ 0,05 % 1
080-008-00-9 phenylmercury nitrate; [1]phenylmercury hydroxide; [2]basic phenylmercury nitrate [3] 200-242-9 [1]202-866-7 [2]- [3] 55-68-5 [1]100-57-2 [2]8003-05-2 [3] T; R25-48/24/25C; R34N; R50-53 T; NR: 25-34-48/24/25-50/53S: (1/2-)23-24/25-37-45-60-61  
080-009-00-4 2-methoxyethylmercury chloride 204-659-7 123-88-6 T; R25-48/25C; R34N; R50-53 T; NR: 25-34-48/25-50/53S: (1/2-)36/37/39-45-60-61  
080-010-00-X mercury dichloride;mercuric chloride 231-299-8 7487-94-7 T+; R28T; R48/24/25C; R34N; R50-53 T+; NR: 28-34-48/24/25-50/53S: (1/2-)36/37/39-45-60-61  
080-011-00-5 phenylmercury acetate 200-532-5 62-38-4 T; R25-48/24/25C; R34N; R50-53 T; NR: 25-34-48/24/25-50/53S: (1/2-)23-24/25-37-45-60-61  
081-001-00-3 thallium 231-138-1 7440-28-0 T+; R26/28R33R53 T+R: 26/28-33-53S: (1/2-)13-28-45-61  
081-002-00-9 thallium compounds, with the exception of those specified elsewhere in this Annex — — T+; R26/28R33N; R51-53 T+; NR: 26/28-33-51/53S: (1/2-)13-28-45-61  A
081-003-00-4 dithallium sulphate;thallic sulphate 231-201-3 7446-18-6 T+; R28T; R48/25Xi; R38N; R51-53 T+; NR: 28-38-48/25-51/53S: (1/2-)13-36/37-45-61  
082-001-00-6 lead compounds with the exception of those specified elsewhere in this Annex — — Repr. Cat. 1; R61Repr. Cat. 3; R62Xn; R20/22R33N; R50-53 T; NR: 61-20/22-33-62-50/53S: 53-45-60-61 Repr. Cat. 3; R62: C ≥ 2,5 %Xn; R20/22: C ≥ 1 %R33: C ≥ 0,5 % AE1
082-002-00-1 lead alkyls — — Repr. Cat. 1; R61Repr. Cat. 3; R62T+; R26/27/28R33N; R50-53 T+; NR: 61-26/27/28-33-62-50/53S: 53-45-60-61 Repr. Cat. 1; R61: C ≥ 0,1 %T+; R26/27/28: C ≥ 0,25 %T; R23/24/25: 0,1 % ≤ C < 0,25 %Xn; R20/21/22: 0,05 % ≤ C < 0,1 %R33: C ≥ 0,05 % AE1
082-003-00-7 lead diazide;lead azide 236-542-1 13424-46-9 E; R3Repr. Cat. 1; R61Repr. Cat. 3; R62Xn; R20/22R33N; R50-53 E; T; NR: 61-3-20/22-33-50/53-62S: 53-45-60-61  E1
082-004-00-2 lead chromate 231-846-0 7758-97-6 Carc. Cat. 3; R40Repr. Cat. 1; R61Repr. Cat. 3; R62R33N; R50-53 T; NR: 61-33-40-50/53-62S: 53-45-60-61  1
082-005-00-8 lead di(acetate) 206-104-4 301-04-2 Repr. Cat. 1; R61Repr. Cat. 3; R62Xn; R48/22R33N; R50-53 T; NR: 61-33-48/22-50/53-62S: 53-45-60-61  E1
082-006-00-3 trilead bis(orthophosphate) 231-205-5 7446-27-7 Repr. Cat. 1; R61Repr. Cat. 3; R62Xn; R48/22R33N; R50-53 T; NR: 61-33-48/22-50/53-62S: 53-45-60-61  E1
082-007-00-9 lead acetate, basic; 215-630-3 1335-32-6 Carc. Cat. 3; R40Repr. Cat. 1; R61Repr. Cat. 3; R62Xn; R48/22R33N; R50-53 T; NR: 61-33-40-48/22-50/53-62S: 53-45-60-61  E1
082-008-00-4 lead(II) methanesulphonate 401-750-5 17570-76-2 Repr. Cat. 1; R61Repr. Cat. 3; R62Xn; R20/22-48/20/22Xi; R38-41N; R58R33 T; NR: 61-62-20/22-33-38-41-48/20/22-58S: 53-45-57-61  E1
082-009-00-X Lead sulfochromate yellow;C.I. Pigment Yellow 34;[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77603.] 215-693-7 1344-37-2 Carc. Cat. 3; R40Repr. Cat. 1; R61Repr. Cat. 3; R62R33N; R50-53 T; NR: 61-33-40-50/53-62S: 53-45-60-61  1
082-010-00-5 Lead chromate molybdate sulfate red;C.I. Pigment Red 104;[This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77605.] 235-759-9 12656-85-8 Carc. Cat. 3; R40Repr. Cat. 1; R61Repr. Cat. 3; R62R33N; R50-53 T; NR: 61-33-40-50/53-62S: 53-45-60-61  1
082-011-00-0 lead hydrogen arsenate 232-064-2 7784-40-9 Carc. Cat. 1; R45Repr. Cat. 1; R61Repr. Cat. 3; R62T; R23/25R33N; R50-53 T; NR: 45-61-23/25-33-50/53-62S: 53-45-60-61  E1
092-001-00-8 uranium 231-170-6 7440-61-1 T+; R26/28R33R53 T+R: 26/28-33-53S: (1/2-)20/21-45-61  
092-002-00-3 uranium compounds — — T+; R26/28R33N; R51-53 T+; NR: 26/28-33-51/53S: (1/2-)20/21-45-61  A
601-001-00-4 methane 200-812-7 74-82-8 F+; R12 F+R: 12S: (2-)9-16-33  
601-002-00-X ethane 200-814-8 74-84-0 F+; R12 F+R: 12S: (2-)9-16-33  
601-003-00-5 propane 200-827-9 74-98-6 F+; R12 F+R: 12S: (2-)9-16  
601-004-00-0 butane; [1]and isobutane [2] 203-448-7 [1]200-857-2 [2] 106-97-8 [1]75-28-5 [2] F+; R12 F+R: 12S: (2-)9-16  C
601-004-01-8 butane (containing ≥ 0,1 % butadiene (203-450-8)); [1]isobutane (containing ≥ 0,1 % butadiene (203-450-8)) [2] 203-448-7 [1]200-857-2 [2] 106-97-8 [1]75-28-5 [2] F+; R12Carc. Cat. 1; R45Muta. Cat. 2; R46 F+; TR: 45-46-12S: 53-45  CS
601-005-00-6 2,2-dimethylpropane;neopentane 207-343-7 463-82-1 F+; R12N; R51-53 F+; NR: 12-51/53S: (2-)9-16-33-61  
601-006-00-1 pentane; [1]isopentane;2-methylbutane [2] 203-692-4 [1]201-142-8 [2] 109-66-0 [1]78-78-4 [2] F+; R12Xn; R65R66R67N; R51-53 F+; Xn; NR: 12-51/53-65-66-67S: (2-)9-16-29-33-61-62  C
601-007-00-7 hexane, reaction mass of isomers (containing < 5 % n-hexane (203-777-6)) — — F; R11Xn; R65Xi; R38R67N; R51-53 F; Xn; NR: 11-38-51/53-65-67S: (2-)9-16-29-33-61-62  C
601-008-00-2 heptane [and isomers] [1] 205-563-8 [1]203-548-0 [2]207-346-3 [3]209-230-8 [4]209-280-0 [5]209-643-3 [6]209-680-5 [7]209-730-6 [8]210-529-0 [9]250-610-8 [10] 142-82-5 [1]108-08-7 [2]464-06-2 [3]562-49-2 [4]565-59-3 [5]589-34-4 [6]590-35-2 [7]591-76-4 [8]617-78-7 [9]31394-54-4 [10] F; R11Xn; R65Xi; R38R67N; R50-53 F; Xn; NR: 11-38-50/53-65-67S: (2-)9-16-29-33-60-61-62  C
601-009-00-8 octane [and isomers] [1] 203-892-1 [1]208-759-1 [2]209-207-2 [3]209-243-9 [4]209-266-4 [5]209-292-6 [6]209-504-7 [7]209-547-1 [8]209-649-6 [9]209-650-1 [10]209-660-6 [11]209-689-4 [12] 111-65-9 [1]540-84-1 [2]560-21-4 [3]563-16-6 [4]564-02-3 [5]565-75-3 [6]583-48-2 [7]584-94-1 [8]589-43-5 [9]589-53-7 [10]589-81-1 [11]590-73-8 [12]592-13-2 [13]592-27-8 [14]594-82-1 [15]609-26-7 [16]619-99-8 [17]1067-08-9 [18]26635-64-3 [19] F; R11Xn; R65Xi; R38R67N; R50-53 F; Xn; NR: 11-38-50/53-65-67S: (2-)9-16-29-33-60-61-62  C
  209-745-8 [13]209-747-9 [14]209-855-6 [15]210-187-2 [16]210-621-0 [17]213-923-0 [18]247-861-0 [19]     
601-010-00-3 ethylene 200-815-3 74-85-1 F+; R12R67 F+R: 12-67S: (2-)9-16-33-45  
601-011-00-9 propene;propylene 204-062-1 115-07-1 F+; R12 F+R: 12S: (2-)9-16-33  
601-012-00-4 but-1-ene; [1]butene, mixed-1-and-2-isomers; [2]2-methylpropene; [3](Z)-but-2-ene; [4](E)-but-2-ene [5] 203-449-2 [1]203-452-9 [2]204-066-3 [3]209-673-7 [4]210-855-3 [5] 106-98-9 [1]107-01-7 [2]115-11-7 [3]590-18-1 [4]624-64-6 [5] F+; R12 F+R: 12S: (2-)9-16-33  C
601-013-00-X 1,3-butadiene;buta-1,3-diene 203-450-8 106-99-0 F+; R12Carc. Cat. 1; R45Muta. Cat. 2; R46 F+; TR: 45-46-12S: 53-45  D
601-014-00-5 isoprene (stabilised)2-methyl-1,3-butadiene 201-143-3 78-79-5 F+; R12Carc. Cat. 2; R45Muta. Cat. 3; R68R52-53 F+; TR: 45-12-68-52/53S: 53-45-61  D
601-015-00-0 acetylene;ethyne 200-816-9 74-86-2 R5R6F+; R12 F+R: 5-6-12S: (2-)9-16-33  
601-016-00-6 cyclopropane 200-847-8 75-19-4 F+; R12 F+R: 12S: (2-)9-16-33  
601-017-00-1 cyclohexane 203-806-2 110-82-7 F; R11Xn; R65Xi; R38R67N; R50-53 F; Xn; NR: 11-38-65-67-50/53S: (2-)9-16-25-33-60-61-62  
601-018-00-7 methylcyclohexane 203-624-3 108-87-2 F; R11Xn; R65Xi; R38R67N; R51-53 F; Xn; NR: 11-38-51/53-65-67S: (2-)9-16-33-61-62  
601-019-00-2 1,4-dimethylcyclohexane 209-663-2 589-90-2 F; R11Xn; R65Xi; R38R67N; R51-53 F; Xn; NR: 11-38-51/53-65-67S: (2-)9-16-33-61-62  
601-020-00-8 benzene 200-753-7 71-43-2 F; R11Carc. Cat. 1; R45Muta. Cat. 2; R46T; R48/23/24/25Xn; R65Xi; R36/38 F; TR: 45-46-11-36/38-48/23/24/25-65S: 53-45  E
601-021-00-3 toluene 203-625-9 108-88-3 F; R11Repr. Cat. 3; R63Xn; R48/20-65Xi; R38R67 F; XnR: 11-38-48/20-63-65-67S: (2-)36/37-46-62  
601-022-00-9 o-xylene; [1]p-xylene; [2]m-xylene; [3]xylene [4] 202-422-2 [1]203-396-5 [2]203-576-3 [3]215-535-7 [4] 95-47-6 [1]106-42-3 [2]108-38-3 [3]1330-20-7 [4] R10Xn; R20/21Xi; R38 XnR: 10-20/21-38S: (2-)25 Xn; R20/21: C ≥ 12,5 % C
601-023-00-4 ethylbenzene 202-849-4 100-41-4 F; R11Xn; R20 F; XnR: 11-20S: (2-)16-24/25-29  
601-024-00-X cumene; [1]propylbenzene [2] 202-704-5 [1]203-132-9 [2] 98-82-8 [1]103-65-1 [2] R10Xn; R65Xi; R37N; R51-53 Xn; NR: 10-37-51/53-65S: (2-)24-37-61-62  C
601-025-00-5 mesitylene;1,3,5-trimethylbenzene 203-604-4 108-67-8 R10Xi; R37N; R51-53 Xi; NR: 10-37-51/53S: (2-)61 Xi; R37: C ≥ 25 % 
601-026-00-0 styrene 202-851-5 100-42-5 R10Xn; R20Xi; R36/38 XnR: 10-20-36/38S: (2-)23 Xn; R20: C ≥ 12,5 %Xi; R36/38: C ≥ 12,5 % D
601-027-00-6 2-phenylpropene;α-methylstyrene 202-705-0 98-83-9 R10Xi; R36/37N; R51-53 Xi; NR: 10-36/37-51/53S: (2-)61 Xi; R36/37: C ≥ 25 % 
601-028-00-1 2-methylstyrene;2-vinyltoluene 210-256-7 611-15-4 Xn; R20N; R51-53 Xn; NR: 20-51/53S: (2-)24-61  
601-029-00-7 dipentene;limonene; [1](R)-p-mentha-1,8-diene;d-limonene; [2](S)-p-mentha-1,8-diene;l-limonene; [3]trans-1-methyl-4-(1-methylvinyl)cyclohexene; [4](±)-1-methyl-4-(1-methylvinyl)cyclohexene [5] 205-341-0 [1]227-813-5 [2]227-815-6 [3]229-977-3 [4]231-732-0 [5] 138-86-3 [1]5989-27-5 [2]5989-54-8 [3]6876-12-6 [4]7705-14-8 [5] R10Xi; R38R43N; R50-53 Xi; NR: 10-38-43-50/53S: (2-)24-37-60-61  C
601-030-00-2 cyclopentane 206-016-6 287-92-3 F; R11R52-53 FR: 11-52/53S: (2-)9-16-29-33-61  
601-031-00-8 2,4,4-trimethylpent-1-ene 203-486-4 107-39-1 F; R11N; R51-53 F; NR: 11-51/53S: (2-)9-16-29-33-61  
601-032-00-3 benzo[a]pyrene;benzo[def]chrysene 200-028-5 50-32-8 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61R43N; R50-53 T; NR: 45-46-60-61-43-50/53S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 % 
601-033-00-9 benz[a]anthracene 200-280-6 56-55-3 Carc. Cat. 2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61  
601-034-00-4 benz[e]acephenanthrylene 205-911-9 205-99-2 Carc. Cat. 2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61  
601-035-00-X benzo[j]fluoranthene 205-910-3 205-82-3 Carc. Cat. 2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61  
601-036-00-5 benzo[k]fluoranthene 205-916-6 207-08-9 Carc. Cat. 2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61  
601-037-00-0 n-hexane 203-777-6 110-54-3 F; R11Repr. Cat. 3; R62Xn; R65-48/20Xi; R38R67N; R51-53 F; Xn; NR: 11-38-48/20-62-65-67-51/53S: (2-)9-16-29-33-36/37-61-62 Xn; R48/20: C ≥ 5 % 
601-041-00-2 dibenz[a,h]anthracene 200-181-8 53-70-3 Carc. Cat. 2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 % 
601-042-00-8 biphenyl;diphenyl 202-163-5 92-52-4 Xi; R36/37/38N; R50-53 Xi; NR: 36/37/38-50/53S: (2-)23-60-61  
601-043-00-3 1,2,4-trimethylbenzene 202-436-9 95-63-6 R10Xn; R20Xi; R36/37/38N; R51-53 Xn; NR: 10-20-36/37/38-51/53S: (2-)26-61  
601-044-00-9 3a,4,7,7a-tetrahydro-4,7-methanoindene 201-052-9 77-73-6 F; R11Xn; R20/22Xi; R36/37/38N; R51-53 F; Xn; NR: 11-20/22-36/37/38-51/53S: (2-)36/37-61  
601-045-00-4 1,2,3,4-tetrahydronaphthalene 204-340-2 119-64-2 R19Xi; R36/38N; R51-53 Xi; NR: 19-36/38-51/53S: (2-)26-28-61  
601-046-00-X 7-methylocta-1,6-diene 404-210-7 42152-47-6 R10N; R50-53 NR: 10-50/53S: (2-)60-61  
601-047-00-5 m-mentha-1,3(8)-diene 404-150-1 17092-80-7 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
601-048-00-0 chrysene 205-923-4 218-01-9 Carc. Cat. 2; R45Muta. Cat. 3; R68N; R50-53 T; NR: 45-68-50/53S: 53-45-60-61  
601-049-00-6 benzo[e]pyrene 205-892-7 192-97-2 Carc. Cat. 2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61  
601-051-00-7 4-phenylbut-1-ene 405-980-7 768-56-9 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
601-052-00-2 naphthalene 202-049-5 91-20-3 Carc. Cat. 3; R40Xn; R22N; R50-53 Xn; NR: 22-40-50/53S: (2-)36/37-46-60-61  
601-053-00-8 nonylphenol; [1]4-nonylphenol, branched [2] 246-672-0 [1]284-325-5 [2] 25154-52-3 [1]84852-15-3 [2] Repr. Cat. 3; R62-63Xn; R22C; R34N; R50-53 C; NR: 22-34-62-63-50/53S: (1/2-)26-36/37/39-45-46-60-61  
601-054-00-3 reaction mass of isomers of: dibenzylbenzene;dibenzyl(methyl)benzene;dibenzyl(dimethyl)benzene;dibenzyl(trimethyl)benzene 405-570-8 — N; R50-53 NR: 50/53S: 60-61  
601-055-00-9 reaction mass of isomers of: mono-(2-tetradecyl)naphthalenes;di-(2-tetradecyl)naphthalenes;tri-(2-tetradecyl)naphthalenes 410-190-0 132983-41-6 Xi; R36R53 XiR: 36-53S: (2-)26-61  
601-056-00-4 reaction mass of isomers of: methyldiphenylmethane;dimethyldiphenylmethane 405-470-4 73807-39-3 Xi; R38N; R50-53 Xi; NR: 38-50/53S: (2-)37-60-61  
601-057-00-X N-dodecyl-[3-(4-(dimethylamino)benzamido)-propyl]dimethylammonium tosylate 421-130-8 156679-41-3 Xi; R41R43N; R50-53 Xi; NR: 41-43-50/53S: (2-)24-26-37/39-60-61  
601-058-00-5 di-L-para-menthene 417-870-6 83648-84-4 Xi; R38R43N; R50-53 Xi; NR: 38-43-50/53S: (2-)23-24-37-60-61  
601-059-00-0 methyl 2-benzylidene-3-oxobutyrate 420-940-9 15768-07-7 Xi; R36/38N; R51-53 Xi; NR: 36/38-51/53S: (2-)26-37/39-61  
601-060-00-6 1,2-bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7-ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane; x-sodium, y-potassium salts x = 7,755 y = 0,245 417-610-1 155522-09-1 R43 XiR: 43S: (2-)22-24-37  
601-061-00-1 (ethyl-1,2-ethanediyl)[-2-[[[(2-hydroxyethyl)methylamino]acetyl]-propyl]ω-(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) 418-960-8 — C; R34R43N; R51-53 C; NR: 34-43-51/53S: (1/2-)26-28-36/37/39-45-61  
601-062-00-7 reaction mass of: branched triacontane;branched dotriacontane;branched tetratriacontane;branched hexatriacontane 417-030-9 151006-59-6 R53 R: 53S: 61  
601-063-00-2 reaction mass of isomers of branched tetracosane 417-060-2 151006-61-0 Xn; R20R53 XnR: 20-53S: (2-)61  
601-064-00-8 branched hexatriacontane 417-070-7 151006-62-1 R53 R: 53S: 61  
601-065-00-3 reaction mass of: (1'-α,3'-α,6'-α-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane);(1'α,3'β,6'α)-2,2,3',7',7'-pentamethylspiro(1,3-dioxane-5,2'-norcarane) 416-930-9 — Xn; R48/22Xi; R41N; R51-53 Xn; NR: 41-48/22-51/53S: (2-)22-26-37/39-61  
601-066-00-9 1-(4-(trans-4-heptylcyclohexyl)phenyl)ethanone 426-820-2 78531-60-9 R43R53 XiR: 43-53S: (2-)24-37-61  
601-067-00-4 triethyl arsenate 427-700-2 15606-95-8 Carc. Cat. 1; R45T; R23/25N; R50-53 T; NR: 45-23/25-50/53S: 53-45-60-61  E
601-068-00-X 1,2-diacetoxybut-3-ene 421-720-5 18085-02-4 Xn; R22 XnR: 22S: (2-)  
601-069-00-5 2-ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide 422-680-1 287933-44-2 R52-53 R: 52/53S: 61  
601-071-00-6 1-dimethoxymethyl-2-nitro-benzene 423-830-9 20627-73-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
601-073-00-7 1-bromo-3,5-difluorobenzene 416-710-2 461-96-1 R10Xn; R22-48/22Xi; R38R43N; R50-53 Xn; NR: 10-22-38-43-48/22-50/53S: (2-)24-36/37-60-61  
601-074-00-2 reaction mass of: 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-1-methyl-2-oxabicyclo[2.2.2]octane;1-(2,2,3-trimethylcyclopent-3-en-1-yl)-5-methyl-6-oxabicyclo[3.2.1]octane;spiro[cyclohex-3-en-1-yl-[(4,5,6,6a-tetrahydro-3,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]furan];spiro[cyclohex-3-en-1-yl-[4,5,6,6a-tetrahydro-4,6',6',6'a-tetramethyl)-1,3'(3'aH)-[2H]cyclopenta[b]]furan] 422-040-1 — Xi; R36/38N; R51-53 Xi; NR: 36/38-51/53S: (2-)26-37-61  
602-001-00-7 chloromethane;methyl chloride 200-817-4 74-87-3 F+; R12Carc. Cat. 3; R40Xn; R48/20 F+; XnR: 12-40-48/20S: (2-)9-16-33  
602-002-00-2 bromomethane;methylbromide 200-813-2 74-83-9 Muta. Cat. 3; R68T; R23/25Xn; R48/20Xi; R36/37/38N; R50N; R59 T; NR: 23/25-36/37/38-48/20-50-59-68S: (1/2-)15-27-36/39-38-45-59-61  
602-003-00-8 dibromomethane 200-824-2 74-95-3 Xn; R20R52-53 XnR: 20-52/53S: (2-)24-61 Xn; R20: C ≥ 12,5 % 
602-004-00-3 dichloromethane;methylene chloride 200-838-9 75-09-2 Carc. Cat. 3; R40 XnR: 40S: (2-)23-24/25-36/37  
602-005-00-9 methyl iodide;iodomethane 200-819-5 74-88-4 Carc. Cat. 3; R40Xn; R21T; R23/25Xi; R37/38 TR: 21-23/25-37/38-40S: (1/2-)36/37-38-45  
602-006-00-4 trichloromethane;chloroform 200-663-8 67-66-3 Xn; R22-48/20/22Xi; R38Carc. Cat. 3; R40 XnR: 22-38-40-48/20/22S: (2-)36/37 Xn; R22: C ≥ 5 %Xn; R48/20/22: C ≥ 5 % 
602-007-00-X bromoform;tribromomethane 200-854-6 75-25-2 T; R23Xi; R36/38N; R51-53 T; NR: 23-36/38-51/53S: (1/2-)28-45-61  
602-008-00-5 carbon tetrachloride;tetrachloromethane 200-262-8 56-23-5 Carc. Cat. 3; R40T; R23/24/25-48/23N; R59R52-53 T; NR: 23/24/25-40-48/23-59-52/53S: (1/2-)23-36/37-45-59-61 T; R23/24/25: C ≥ 1 %Xn; R20/21/22: 0,2 % ≤ C < 1 %T; R48/23: C ≥ 1 %Xn; R48/20: 0,2 % ≤ C < 1 % 
602-009-00-0 chloroethane 200-830-5 75-00-3 F+; R12Carc. Cat. 3; R40R52-53 F+; XnR: 12-40-52/53S: (2-)9-16-33-36/37-61  
602-010-00-6 1,2-dibromoethane 203-444-5 106-93-4 Carc. Cat. 2; R45T; R23/24/25Xi; R36/37/38N; R51-53 T; NR: 45-23/24/25-36/37/38-51/53S: 53-45-61 T; R23/24/25: C ≥ 1 %Xn; R20/21/22: 0,1 % ≤ C < 1 % E
602-011-00-1 1,1-dichloroethane 200-863-5 75-34-3 F; R11Xn; R22Xi; R36/37R52-53 F; XnR: 11-22-36/37-52/53S: (2-)16-23-61 Xn; R22: C ≥ 12,5 % 
602-012-00-7 1,2-dichloroethane;ethylene dichloride 203-458-1 107-06-2 F; R11Carc. Cat. 2; R45Xn; R22Xi; R36/37/38 F; TR: 45-11-22-36/37/38S: 53-45  E
602-013-00-2 1,1,1-trichloroethane;methyl chloroform 200-756-3 71-55-6 Xn; R20N; R59 Xn; NR: 20-59S: (2-)24/25-59-61  F
602-014-00-8 1,1,2-trichloroethane 201-166-9 79-00-5 Carc. Cat. 3; R40Xn; R20/21/22R66 XnR: 20/21/22-40-66S: (2-)9-36/37-46 Xn; R20/21/22: C ≥ 5 % 
602-015-00-3 1,1,2,2-tetrachloroethane 201-197-8 79-34-5 T+; R26/27N; R51-53 T+; NR: 26/27-51/53S: (1/2-)38-45-61  
602-016-00-9 1,1,2,2-tetrabromoethane 201-191-5 79-27-6 T+; R26Xi; R36R52-53 T+R: 26-36-52/53S: (1/2-)24-27-45-61  
602-017-00-4 pentachloroethane 200-925-1 76-01-7 Carc. Cat. 3; R40T; R48/23N; R51-53 T; NR: 40-48/23-51/53S: (1/2-)23-36/37-45-61 T; R48/23: C ≥ 1 %Xn; R48/20: 0,2 % ≤ C < 1 % 
602-018-00-X 1-chloropropane; [1]2-chloropropane [2] 208-749-7 [1]200-858-8 [2] 540-54-5 [1]75-29-6 [2] F; R11Xn; R20/21/22 F; XnR: 11-20/21/22S: (2-)9-29  C
602-019-00-5 1-bromopropane;n-propyl bromide 203-445-0 106-94-5 F; R11Repr. Cat. 2; R60Repr. Cat. 3; R63Xn; R48/20Xi; R36/37/38R67 F; TR: 60-11-36/37/38-48/20-63-67S: 53-45  E
602-020-00-0 1,2-dichloropropane;propylene dichloride 201-152-2 78-87-5 F; R11Xn; R20/22 F; XnR: 11-20/22S: (2-)16-24  
602-021-00-6 1,2-dibromo-3-chloropropane 202-479-3 96-12-8 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 1; R60T; R25Xn; R48/20/22R52-53 TR: 45-46-60-25-48/20/22-52/53S: 53-45-61  E
602-022-00-1 1-chloropentane; [1]2-chloropentane; [2]3-chloropentane [3] 208-846-4 [1]210-885-7 [2]210-467-4 [3] 543-59-9 [1]625-29-6 [2]616-20-6 [3] F; R11Xn; R20/21/22 F; XnR: 11-20/21/22S: (2-)9-29  C
602-023-00-7 vinyl chloride;chloroethylene 200-831-0 75-01-4 F+; R12Carc. Cat. 1; R45 F+; TR: 45-12S: 53-45  D
602-024-00-2 bromoethylene 209-800-6 593-60-2 F+; R12Carc. Cat. 2; R45 F+; TR: 45-12S: 53-45  
602-025-00-8 1,1-dichloroethylene;vinylidene chloride 200-864-0 75-35-4 F+; R12Carc. Cat. 3; R40Xn; R20 F+; XnR: 12-20-40S: (2-)7-16-29-36/37-46 Xn; R20: C ≥ 12,5 % D
602-026-00-3 1,2-dichloroethylene; [1]cis-dichloroethylene; [2]trans-dichloroethylene [3] 208-750-2 [1]205-859-7 [2]205-860-2 [3] 540-59-0 [1]156-59-2 [2]156-60-5 [3] F; R11Xn; R20R52-53 F; XnR: 11-20-52/53S: (2-)7-16-29-61 Xn; R20: C ≥ 12,5 % C
602-027-00-9 trichloroethylene;trichloroethene 201-167-4 79-01-6 Carc. Cat. 2; R45Muta. Cat. 3; R68R67Xi; R36/38R52-53 TR: 45-36/38-52/53-67S: 53-45-61  
602-028-00-4 tetrachloroethylene 204-825-9 127-18-4 Carc. Cat. 3; R40N; R51-53 Xn; NR: 40-51/53S: (2-)23-36/37-61  
602-029-00-X 3-chloropropene;allyl chloride 203-457-6 107-05-1 F; R11Carc. Cat. 3; R40Muta. Cat. 3; R68Xn; R20/21/22-48/20Xi; R36/37/38N; R50 F; Xn; NR: 11-20/21/22-36/37/38-40-48/20-68-50S: (2-)16-25-26-36/37-46-61  D
602-030-00-5 1,3-dichloropropene; [1](Z)-1,3-dichloropropene [2] 208-826-5 [1]233-195-8 [2] 542-75-6 [1]10061-01-5 [2] R10T; R25Xn; R20/21Xi; R36/37/38R43N; R50-53 T; NR: 10-20/21-25-36/37/38-43-50/53S: (1/2-)36/37-45-60-61  DC
602-031-00-0 1,1-dichloropropene 209-253-3 563-58-6 F; R11T; R25R52-53 F; TR: 11-25-52/53S: (1/2-)16-29-33-45-61  
602-032-00-6 3-chloro-2-methylpropene 209-251-2 563-47-3 F; R11Xn; R20/22C; R34R43N; R51-53 F; C; NR: 11-20/22-34-43-51/53S: (2-)9-16-26-29-36/37/39-45-61  
602-033-00-1 chlorobenzene 203-628-5 108-90-7 R10Xn; R20N; R51-53 Xn; NR: 10-20-51/53S: (2-)24/25-61 Xn; R20: C ≥ 5 % 
602-034-00-7 1,2-dichlorobenzene;o-dichlorobenzene 202-425-9 95-50-1 Xn; R22Xi; R36/37/38N; R50-53 Xn; NR: 22-36/37/38-50/53S: (2-)23-60-61 Xn; R22: C ≥ 5 % 
602-035-00-2 1,4-dichlorobenzene;p-dichlorobenzene 203-400-5 106-46-7 Carc. Cat. 3; R40Xi; R36N; R50-53 Xn; NR: 36-40-50/53S: (2-)36/37-46-60-61  
602-036-00-8 chloroprene (stabilised);2-chlorobuta-1,3-diene (stabilised) 204-818-0 126-99-8 F; R11Carc. Cat. 2; R45Xn; R20/22-48/20Xi; R36/37/38 F; TR: 45-11-20/22-36/37/38-48/20S: 53-45  D E
602-037-00-3 α-chlorotoluene;benzyl chloride 202-853-6 100-44-7 Carc. Cat. 2; R45T; R23Xn; R22-48/22Xi; R37/38-41 TR: 45-22-23-37/38-41-48/22S: 53-45  E
602-038-00-9 α,α,α-trichlorotoluene;benzotrichloride 202-634-5 98-07-7 Carc. Cat. 2; R45T; R23Xn; R22Xi; R37/38-41 TR: 45-22-23-37/38-41S: 53-45  E
602-039-00-4 polychlorobiphenyls;PCB 215-648-1 1336-36-3 R33N; R50-53 NR: 33-50/53S: (2-)-60-61 R33: C ≥ 0,005 % C
602-040-00-X 2-chlorotoluene; [1]3-chlorotoluene; [2]4-chlorotoluene; [3]chlorotoluene [4] 202-424-3 [1]203-580-5 [2]203-397-0 [3]246-698-2 [4] 95-49-8 [1]108-41-8 [2]106-43-4 [3]25168-05-2 [4] Xn; R20N; R51-53 Xn; NR: 20-51/53S: (2-)24/25-61  C
602-041-00-5 penthachloronaphthalene 215-320-8 1321-64-8 Xn; R21/22Xi; R36/38N; R50-53 Xn; NR: 21/22-36/38-50/53S: (2-)-60-61  C
602-042-00-0 1,2,3,4,5,6-hexachlorcyclohexanes with the exception of those specified elsewhere in this Annex — — Carc. Cat. 3; R40T; R25Xn; R21N; R50-53 T; NR: 21-25-40-50/53S: (1/2-)22-36/37-45-60-61  A C
602-043-00-6 lindane (ISO)γ-HCH or γ-BHC;γ-1,2,3,4,5,6-hexachlorocyclohexane; 200-401-2 58-89-9 T; R25Xn; R20/21-48/22R64N; R50-53 T; NR: 20/21-25-48/22-64-50/53S: (1/2-)36/37-45-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
602-044-00-1 camphechlor (ISO)toxaphene; 232-283-3 8001-35-2 Carc. Cat. 3; R40T; R25Xn; R21Xi; R37/38N; R50-53 T; NR: 21-25-37/38-40-50/53S: (1/2-)36/37-45-60-61  
602-045-00-7 DDT (ISO);clofenotane (INN);dicophane;1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane;dichlorodiphenyltrichloroethane 200-024-3 50-29-3 T; R25-48/25Carc. Cat. 3; R40N; R50-53 T; NR: 25-40-48/25-50/53S: (1/2-)22-36/37-45-60-61  
602-046-00-2 heptachlor (ISO);1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene 200-962-3 76-44-8 T; R24/25Carc. Cat. 3; R40R33N; R50-53 T; NR: 24/25-33-40-50/53S: (1/2-)36/37-45-60-61  
602-047-00-8 chlordane (ISO);1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-4,7-methanoindan 200-349-0 57-74-9 Carc. Cat. 3; R40Xn; R21/22N; R50-53 Xn; NR: 21/22-40-50/53S: (2-)36/37-60-61  
602-048-00-3 aldrin (ISO) 206-215-8 309-00-2 T; R24/25-48/24/25Carc. Cat. 3; R40N; R50-53 T; NR: 24/25-40-48/24/25-50/53S: (1/2-)22-36/37-45-60-61  
602-049-00-9 dieldrin (ISO) 200-484-5 60-57-1 T+; R27T; R25-48/25Carc. Cat. 3; R40N; R50-53 T+; NR: 25-27-40-48/25-50/53S: (1/2-)22-36/37-45-60-61  
602-050-00-4 (1α,4α,4aβ,5β,8β,8aβ)-1,2,3,4,10,10-hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphfthalene;isodrin 207-366-2 465-73-6 T+; R26/27/28N; R50-53 T+; NR: 26/27/28-50/53S: (1/2-)13-28-45-60-61  
602-051-00-X endrin (ISO);1,2,3,4,10,10-hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene 200-775-7 72-20-8 T+; R28T; R24N; R50-53 T+; NR: 24-28-50/53S: (1/2-)22-36/37-45-60-61  
602-052-00-5 endosulfan (ISO);1,2,3,4,7,7-hexachloro-8,9,10-trinorborn-2-en-5,6-ylenedimethyl sulphite 204-079-4 115-29-7 T; R24/25Xi; R36N; R50-53 T; NR: 24/25-36-50/53S: (1/2-)28-36/37-45-60-61  
602-053-00-0 isobenzan (ISO);1,3,4,5,6,7,8,8-octachloro-1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran 206-045-4 297-78-9 T+; R27/28N; R50 T+; NR: 27/28-50S: (1/2-)28-36/37-45-61  
602-054-00-6 3-iodpropene;allyl iodide 209-130-4 556-56-9 R10C; R34 CR: 10-34S: (1/2-)7-26-45  
602-055-00-1 bromoethane;ethyl bromide 200-825-8 74-96-4 F; R11Carc. Cat. 3; R40Xn; R20/22 F; XnR: 11-20/22-40S: (2-)36/37  
602-056-00-7 α,α,α-trifluorotoluene;benzotrifluoride 202-635-0 98-08-8 F; R11N; R51-53 F; NR: 11-51/53S: (2-)16-23-61  
602-057-00-2 α-bromotoluene;benzyl bromide 202-847-3 100-39-0 Xi; R36/37/38 XiR: 36/37/38S: (2-)39  
602-058-00-8 α,α-dichlorotoluene;benzylidene chloride;benzal chloride 202-709-2 98-87-3 Carc. Cat. 3; R40T; R23Xn; R22Xi; R37/38-41 TR: 22-23-37/38-40-41S: (1/2-)36/37-38-45  
602-059-00-3 1-chlorobutane;butyl chloride 203-696-6 109-69-3 F; R11 FR: 11S: (2-)9-16-29  
602-060-00-9 bromobenzene 203-623-8 108-86-1 R10Xi; R38N; R51-53 Xi; NR: 10-38-51/53S: (2-)61  
602-061-00-4 hexafluoropropene;hexafluoropropylene 204-127-4 116-15-4 Xn; R20Xi; R37 XnR: 20-37S: (2-)41  
602-062-00-X 1,2,3-trichloropropane 202-486-1 96-18-4 Carc. Cat. 2; R45Repr. Cat. 2; R60Xn; R20/21/22 TR: 45-60-20/21/22S: 53-45  E D
602-063-00-5 heptachlor epoxide;2,3-epoxy-1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindane 213-831-0 1024-57-3 T; R25Carc. Cat. 3; R40R33N; R50-53 T; NR: 25-33-40-50/53S: (1/2-)36/37-45-60-61  
602-064-00-0 1,3-dichloro-2-propanol 202-491-9 96-23-1 Carc. Cat. 2; R45T; R25Xn; R21 TR: 45-21-25S: 53-45  E
602-065-00-6 hexachlorobenzene 204-273-9 118-74-1 Carc. Cat. 2; R45T; R48/25N; R50-53 T; NR: 45-48/25-50/53S: 53-45-60-61  E
602-066-00-1 tetrachloro-p-benzoquinone 204-274-4 118-75-2 Xi; R36/38N; R50-53 Xi; NR: 36/38-50/53S: (2-)37-60-61  
602-067-00-7 1,3-dichlorbenzene 208-792-1 541-73-1 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
602-068-00-2 ethylene bis(trichloroacetate) 219-732-9 2514-53-6 Xi; R38 XiR: 38S: (2-)  
602-069-00-8 dichloroacetylene — 7572-29-4 E; R2Carc. Cat. 3; R40Xn; R48/20 E; XnR: 2-40-48/20S: (2-)36/37  
602-070-00-3 3-chloro-4,5,α, α,α-pentafluorotoluene 401-930-3 77227-99-7 R10Xn; R20/22N; R50-58 Xn; NR: 10-20/22-50-58S: (2-)51-60-61  
602-071-00-9 bromobenzylbromotoluene, reaction mass of isomers 402-210-1 99688-47-8 Xn; R48/22R43N; R50-53 Xn; NR: 43-48/22-50/53S: (2-)24-37-41-60-61  
602-072-00-4 dichloro [(dichlorophenyl)methyl]methylbenzene, reaction mass of isomers;(dichlorophenyl)(dichlorotolyl)methane, reaction mass of isomers (IUPAC) 278-404-3 76253-60-6 N; R50-53 NR: 50/53S: 60-61  
602-073-00-X 1,4-dichlorobut-2-ene 212-121-8 764-41-0 Carc. Cat. 2; R45T+; R26T; R24/25C; R34N; R50-53 T+; NR: 45-24/25-26-34-50/53S: 53-45-60-61 Carc. Cat. 2; R45: C ≥ 0,01 %C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % E
602-074-00-5 pentachlorobenzene 210-172-0 608-93-5 F; R11Xn; R22N; R50-53 F; Xn; NR: 11-22-50/53S: (2-)41-46-50-60-61  
602-075-00-0 4,4,5,5-tetrachloro-1,3-dioxolan-2-one 404-060-2 22432-68-4 T+; R26Xn; R22C; R34 T+R: 22-26-34S: (1/2-)9-26-28-36/37/39-45  
602-076-00-6 2,3,4-trichlorobut-1-ene 219-397-9 2431-50-7 Carc. Cat. 3; R40T; R23Xn; R22Xi; R36/37/38N; R50-53 T; NR: 22-23-36/37/38-40-50/53S: (1/2-)36/37-45-60-61 Carc. Cat. 3; R40: C ≥ 0,1 % 
602-077-00-1 dodecachloropentacyclo[5.2.1.02,6.03,9.05,8]decane;mirex 219-196-6 2385-85-5 Carc. Cat. 3; R40Repr. Cat. 3; R62-63R64Xn; R21/22N; R50/53 Xn; NR: 21/22-40-50/53-62-63-64S: (2-)13-36/37-46-60-61  
602-078-00-7 hexachlorocyclopentadiene 201-029-3 77-47-4 T+; R26T; R24Xn; R22C; R34N; R50-53 T+; NR: 22-24-26-34-50/53S: (1/2-)25-39-45-53-60-61  
602-079-00-2 2,3-dichloropropene;2,3-dichloropropylene 201-153-8 78-88-6 F; R11Muta. Cat. 3; R68Xn; R20/21/22Xi; R37/38-41R52-53 F; XnR: 11-20/21/22-37/38-41-52/53-68S: (2-)9-16-23-26-36/37/39-61  
602-080-00-8 alkanes, C10-13, chloro 287-476-5 85535-84-8 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)24-36/37-60-61  
602-081-00-3 2-chloro-4,5-difluorobenzoic acid 405-380-5 — Xn; R21/22Xi; R41R43 XnR: 21/22-41-43S: (2-)26-36/37/39  
602-082-00-9 2,2,6,6-tetrakis(bromomethyl)-4-oxaheptane-1,7-diol 408-020-5 109678-33-3 R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-41-61  
602-083-00-4 diphenyl ether, pentabromo derivative pentabromodiphenyl ether 251-084-2 32534-81-9 Xn; R48/21/22R64N; R50-53 Xn; NR: 48/21/22-50/53-64S: (1/2-)36/37-45-60-61  
602-084-00-X 1,1-dichloro-1-fluoroethane 404-080-1 1717-00-6 R52-53N; R59 NR: 52/53-59S: 59-61  
602-085-00-5 2-bromopropane 200-855-1 75-26-3 F; R11Repr. Cat. 1; R60Xn; R48/20R66 F; TR: 60-11-48/20-66S: 53-45  E
602-086-00-0 trifluoroiodomethane;trifluoromethyl iodide 219-014-5 2314-97-8 Muta. Cat. 3; R68 XnR: 68S: (2-)36/37  
602-087-00-6 1,2,4-trichlorobenzene 204-428-0 120-82-1 Xn; R22Xi; R38N; R50-53 Xn; NR: 22-38-50/53S: (2-)23-37/39-60-61  
602-088-00-1 2,3-dibromopropan-1-ol;2,3-dibromo-1-propanol 202-480-9 96-13-9 Carc. Cat. 2; R45Repr. Cat. 3; R62T; R24Xn; R20/22R52-53 TR: 45-20/22-24-52/53-62S: 53-45-61  E
602-089-00-7 4-bromo-2-chlorofluorobenzene 405-580-2 60811-21-4 Xn; R22Xi; R38N; R50-53 Xn; NR: 22-38-50/53S: (2-)26-36/37-60-61  
602-090-00-2 1-allyl-3-chloro-4-fluorobenzene 406-630-6 121626-73-1 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)23-37-61  
602-091-00-8 1,3-dichloro-4-fluorobenzene 406-160-1 1435-48-9 Xn; R22-48/20/22Xi; R38N; R51-53 Xn; NR: 22-38-48/20/22-51/53S: (2-)36/37-61  
602-092-00-3 1-bromo-3,4,5-trifluorobenzene 418-480-9 138526-69-9 R10Carc. Cat. 3; R40Xi; R38-41N; R51-53 Xn; NR: 10-38-40-41-51/53S: (2-)23-26-36/37/39-61  
602-093-00-9 α, α,α,4-tetrachlorotoluene;p-chlorobenzotrichloride 226-009-1 5216-25-1 Carc. Cat. 2; R45Repr. Cat. 3; R62T; R48/23Xn; R21/22Xi; R37/38 TR: 45-21/22-37/38-48/23-62S: 53-45  E
602-094-00-4 diphenylether; octabromo derivate 251-087-9 32536-52-0 Repr. Cat. 2; R61Repr. Cat. 3; R62 TR: 61-62S: 53-45  
602-096-00-5 malachite green hydrochloride; [1]malachite green oxalate [2] 209-322-8 [1]219-441-7 [2] 569-64-2 [1]2437-29-8 [2] Repr. Cat. 3; R63Xn; R22Xi; R41N; R50-53 Xn; NR: 22-41-63-50/53S: (2-)26-36/37-39-46-60-61  
602-097-00-0 1-bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane 422-850-5 148757-89-5 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
603-001-00-X methanol 200-659-6 67-56-1 F; R11T; R23/24/25-39/23/24/25 F; TR: 11-23/24/25-39/23/24/25S: (1/2-)7-16-36/37-45 T; R23/24/25: C ≥ 20 %Xn; R20/21/22: 3 % ≤ C < 20 %T; R39/23/24/25: C ≥ 10 %Xn; R68/20/21/22: 3 % ≤ C < 10 % 
603-002-00-5 ethanol;ethyl alcohol 200-578-6 64-17-5 F; R11 FR: 11S: (2-)7-16  
603-003-00-0 propan-1-ol;n-propanol 200-746-9 71-23-8 F; R11Xi; R41R67 F; XiR: 11-41-67S: (2-)7-16-24-26-39  
603-004-00-6 butan-1-ol;n-butanol 200-751-6 71-36-3 R10Xn; R22Xi; R37/38-41R67 XnR: 10-22-37/38-41-67S: (2-)7/9-13-26-37/39-46  
603-005-00-1 2-methylpropan-2-ol;tert-butyl alcohol 200-889-7 75-65-0 F; R11Xn; R20 F; XnR: 11-20S: (2-)9-16  
603-006-00-7 pentanol isomers, with the exception fo those specified elsewhere in this Annex 250-378-8  R10Xn; R20Xi; R37R66 XnR: 10-20-37-66S: (2-)46  C
603-007-00-2 2-methylbutan-2-ol;tert-pentanol 200-908-9 75-85-4 F; R11Xn; R20Xi; R37/38 F; XnR: 11-20-37/38S: (2-)46  
603-008-00-8 4-methylpentan-2-ol;methyl isobutyl carbinol 203-551-7 108-11-2 R10Xi; R37 XiR: 10-37S: (2-)24/25 Xi; R37: C ≥ 25 % 
603-009-00-3 cyclohexanol 203-630-6 108-93-0 Xn; R20/22Xi; R37/38 XnR: 20/22-37/38S: (2-)24/25  
603-010-00-9 2-methylcyclohexanol, mixed isomers; [1]cis-2-methylcyclohexanol; [2]trans-2-methylcyclohexanol [3] 209-512-0 [1]231-187-9 [2]231-186-3 [3] 583-59-5 [1]7443-70-1 [2]7443-52-9 [3] Xn; R20 XnR: 20S: (2-)24/25  C
603-011-00-4 2-methoxyethanol;ethylene glycol monomethyl ether 203-713-7 109-86-4 R10Repr. Cat. 2; R60-61Xn; R20/21/22 TR: 60-61-10-20/21/22S: 53-45  E
603-012-00-X 2-ethoxyethanol;ethylene glycol monoethyl ether 203-804-1 110-80-5 R10Repr. Cat. 2; R60-61Xn; R20/21/22 TR: 60-61-10-20/21/22S: 53-45  E
603-013-00-5 2-isopropoxyethanol;ethylene glycol monoisopropyl ether 203-685-6 109-59-1 Xn; R20/21Xi; R36 XnR: 20/21-36S: (2-)24/25  
603-014-00-0 2-butoxyethanol;ethylene glycol monobutyl ether;butyl cellosolve 203-905-0 111-76-2 Xn; R20/21/22Xi; R36/38 XnR: 20/21/22-36/38S: (2-)36/37-46  
603-015-00-6 allyl alcohol 203-470-7 107-18-6 R10T; R23/24/25Xi; R36/37/38N; R50 T; NR: 10-23/24/25-36/37/38-50S: (1/2-)36/37/39-38-45-61  
603-016-00-1 4-hydroxy-4-methylpentan-2-one;diacetone alcohol 204-626-7 123-42-2 Xi; R36 XiR: 36S: (2-)24/25 Xi; R36: C ≥ 10 % 
603-018-00-2 furfuryl alcohol 202-626-1 98-00-0 Xn; R20/21/22 XnR: 20/21/22S: (2-) Xn; R20/21/22: C ≥ 5 % 
603-019-00-8 dimethyl ether 204-065-8 115-10-6 F+; R12 F+R: 12S: (2-)9-16-33  
603-020-00-3 ethyl methyl ether — 540-67-0 F+; R12 F+R: 12S: (2-)9-16-33  
603-021-00-9 methyl vinyl ether 203-475-4 107-25-5 F+; R12 F+R: 12S: (2-)9-16-33  D
603-022-00-4 diethyl ether;ether 200-467-2 60-29-7 F+; R12R19Xn; R22R66R67 F+; XnR: 12-19-22-66-67S: (2-)9-16-29-33  
603-023-00-X ethylene oxide;oxirane 200-849-9 75-21-8 F+; R12 ⊗Carc. Cat. 2; R45Muta. Cat. 2; R46T; R23Xi; R36/37/38 F+; TR: 45-46-12-23-36/37/38S: 53-45  E
603-024-00-5 1,4-dioxane 204-661-8 123-91-1 F; R11-19Carc. Cat. 3; R40Xi; R36/37R66 F; XnR: 11-19-36/37-40-66S: (2-)9-16-36/37-46  D
603-025-00-0 tetrahydrofuran 203-726-8 109-99-9 F; R11-19Xi; R36/37 F; XiR: 11-19-36/37S: (2-)16-29-33 Xi; R36/37: C ≥ 25 % 
603-026-00-6 1-chloro-2,3-epoxypropane;epichlorhydrin 203-439-8 106-89-8 R10Carc. Cat. 2; R45T; R23/24/25C; R34R43 TR: 45-10-23/24/25-34-43S: 53-45 T; R23/24/25: C ≥ 1 %Xn; R20/21/22: 0,1 % ≤ C < 1 % E
603-027-00-1 ethanediol;ethylene glycol 203-473-3 107-21-1 Xn; R22 XnR: 22S: (2-)  
603-028-00-7 2-chloroethanol;ethylene chlorohydrin 203-459-7 107-07-3 T+; R26/27/28 T+R: 26/27/28S: (1/2-)7/9-28-45  
603-029-00-2 bis(2-chloroethyl) ether 203-870-1 111-44-4 R10 ⊗Carc. Cat. 3; R40T+; R26/27/28 T+R: 10-26/27/28-40S: (1/2-)7/9-27-28-36/37-45  
603-030-00-8 2-aminoethanol;ethanolamine 205-483-3 141-43-5 Xn; R20/21/22C; R34 CR: 20/21/22-34S: (1/2-)26-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
603-031-00-3 1,2-dimethoxyethane;ethylene glycol dimethyl ether;EGDME 203-794-9 110-71-4 F; R11R19Repr. Cat. 2; R60Repr. Cat. 2; R61Xn; R20 F; TR: 60-61-11-19-20S: 53-45  E
603-032-00-9 ethylene dinitrate;ethylene glycol dinitrate 211-063-0 628-96-6 E; R2 $T+; R26/27/28R33 E; T+R: 2-26/27/28-33S: (1/2-)33-35-36/37-45  
603-033-00-4 oxydiethylene dinitrate;diethylene glycol dinitrate;digol dinitrate 211-745-8 693-21-0 E; R3T+; R26/27/28R33R52-53 E; T+R: 3-26/27/28-33-52/53S: (1/2-)33-35-36/37-45-61  
603-034-00-X glycerol trinitrate;nitroglycerine 200-240-8 55-63-0 E; R3T+; R26/27/28R33N; R51-53 E; T+; NR: 3-26/27/28-33-51/53S: (1/2-)33-35-36/37-45-61  
603-035-00-5 pentaerythritol tetranitrate;P.E.T.N. 201-084-3 78-11-5 E; R3 ER: 3S: (2-)35  
603-036-00-0 mannitol hexanitrate;nitromannite 239-924-6 15825-70-4 E; R3 ER: 3S: (2-)35  
603-037-00-6 cellulose nitrate;nitrocellulose, containing more than 12,6 % nitrogen — — E; R3 $R1 ER: 1-3S: (2-)35  
603-037-01-3 cellulose nitrate;nitrocellulose, containing a maximum of 12,6 % nitrogen — — F; R11 $ FR: 11S: (2-)16-33-37/39  
603-038-00-1 allyl glycidyl ether;allyl 2,3-epoxypropyl ether;prop-2-en-1-yl 2,3-epoxypropyl ether 203-442-4 106-92-3 R10Carc. Cat. 3; R40Muta. Cat. 3; R68Repr. Cat. 3; R62Xn; R20/22Xi; R37/38-41R43R52-53 XnR: 10-20/22-37/38-40-41-43-52/53-62-68S: (2-)24/25-26-36/37/39-61  
603-039-00-7 butyl glycidyl ether;butyl 2,3-epoxypropyl ether 219-376-4 2426-08-6 R10Carc. Cat. 3; R40Muta. Cat. 3; R68Xn; R20/22Xi; R37R43R52-53 XnR: 10-20/22-37-40-43-52/53-68S: (2-)24/25-36/37-61  
603-040-00-2 sodium methanolate;sodium methoxide; [1]potassium methanolate;potassium methoxide; [2]lithium methanolate;lithium methoxide [3] 204-699-5 [1]212-736-1 [2]212-737-7 [3] 124-41-4 [1]865-33-8 [2]865-34-9 [3] F; R11C; R34R14 F; CR: 11-14-34S: (1/2-)8-16-26-43-45  
603-041-00-8 potassium ethanolate;potassium ethoxide; [1]sodium ethanolate;sodium ethoxide [2] 213-029-0 [1]205-487-5 [2] 917-58-8 [1]141-52-6 [2] F; R11C; R34R14 F; CR: 11-14-34S: (1/2-)8-16-26-43-45  
603-042-00-3 aluminium-tri-isopropoxide 209-090-8 555-31-7 F; R11 FR: 11S: (2-)8-16  
603-043-00-9 triarimol (ISO);2,4-dichloro-α-(pyrimidin-5-yl) benzhydryl alcohol — 26766-27-8 Xn; R22 XnR: 22S: (2-)  
603-044-00-4 dicofol (ISO);2,2,2-trichloro-1,1-bis(4-chlorophenyl)ethanol 204-082-0 115-32-2 Xn; R21/22Xi; R38R43N; R50-53 Xn; NR: 21/22-38-43-50/53S: (2-)36/37-60-61  
603-045-00-X diisopropyl ether; [1]dipropyl ether [2] 203-560-6 [1]203-869-6 [2] 108-20-3 [1]111-43-3 [2] F; R11R19R66R67 FR: 11-19-66-67S: (2-)9-16-29-33  C
603-046-00-5 bis (chloromethyl) ether;oxybis(chloromethane) 208-832-8 542-88-1 R10 $Carc. Cat. 1; R45T+; R26T; R24Xn; R22 T+R: 45-10-22-24-26S: 53-45 Carc. Cat. 1; R45: C ≥ 0,001 % E
603-047-00-0 2-dimethylaminoethanol;N,N-dimethylethanolamine 203-542-8 108-01-0 R10Xn; R20/21/22C; R34 CR: 10-20/21/22-34S: (1/2-)25-26-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
603-048-00-6 2-diethylaminoethanol;N,N-diethylethanolamine 202-845-2 100-37-8 R10Xn; R20/21/22C; R34 CR: 10-20/21/22-34S: (1/2-)25-26-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
603-049-00-1 chlorfenethol (ISO);1,1-bis (4-chlorophenyl) ethanol 201-246-3 80-06-8 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)36-61  
603-050-00-7 1-(2-Butoxypropoxy)propan-2-ol 246-011-6 24083-03-2 Xn; R21/22 XnR: 21/22S: (2-)  
603-051-00-2 2-ethylbutan-1-ol 202-621-4 97-95-0 Xn; R21/22 XnR: 21/22S: (2-)  
603-052-00-8 3-butoxypropan-2-ol;propylene glycol monobutyl ether 225-878-4 5131-66-8 Xi; R36/38 XiR: 36/38S: (2-)  
603-053-00-3 2-methylpentane-2,4-diol 203-489-0 107-41-5 Xi; R36/38 XiR: 36/38S: (2-) Xi; R36/38: C ≥ 10 % 
603-054-00-9 di-n-butyl ether;dibutyl ether 205-575-3 142-96-1 R10Xi; R36/37/38R52-53 XiR: 10-36/37/38-52/53S: (2-)61 Xi; R36/37/38: C ≥ 10 % 
603-055-00-4 propylene oxide;1,2-epoxypropane;methyloxirane 200-879-2 75-56-9 F+; R12Carc. Cat. 2; R45Muta. Cat. 2; R46Xn; R20/21/22Xi; R36/37/38 F+; TR: 45-46-12-20/21/22-36/37/38S: 53-45  E
603-056-00-X [(p-tolyloxy)methyl]oxirane; [1][(m-tolyloxy)methyl]oxirane; [2]2,3-epoxypropyl o-tolyl ether; [3][(tolyloxy)methyl]oxirane;cresyl glycidyl ether [4] 218-574-8 [1]218-575-3 [2]218-645-3 [3]247-711-4 [4] 2186-24-5 [1]2186-25-6 [2]2210-79-9 [3]26447-14-3 [4] Muta. Cat. 3; R68Xi; R38R43N; R51-53 Xn; NR: 38-43-51/53-68S: (2-)36/37-61  C
603-057-00-5 benzyl alcohol 202-859-9 100-51-6 Xn; R20/22 XnR: 20/22S: (2-)26  
603-058-00-0 1,3-propylene oxide 207-964-3 503-30-0 F; R11Xn; R20/21/22 F; XnR: 11-20/21/22S: (2-)9-16-26-29  
603-059-00-6 hexan-1-ol 203-852-3 111-27-3 Xn; R22 XnR: 22S: (2-)24/25  
603-060-00-1 2,2'-bioxirane;1,2:3,4-diepoxybutane 215-979-1 1464-53-5 Carc. Cat. 2; R45Muta. Cat. 2; R46T+; R26T; R24/25C; R34 T+R: 45-46-24/25-26-34S: 53-45  E
603-061-00-7 tetrahydro-2-furylmethanol;tetrahydrofurfuryl alcohol 202-625-6 97-99-4 Xi; R36 XiR: 36S: (2-)39 Xi; R36: C ≥ 10 % 
603-062-00-2 tetrahydrofuran-2,5-diyldimethanol 203-239-0 104-80-3 Xi; R36/37/38 XiR: 36/37/38S: (2-)39 Xi; R36/37/38: C ≥ 10 % 
603-063-00-8 2,3-epoxypropan-1-ol;glycidol;oxiranemethanol 209-128-3 556-52-5 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 2; R60T; R23Xn; R21/22Xi; R36/37/38 TR: 45-60-21/22-23-36/37/38-68S: 53-45  E
603-064-00-3 1-methoxy-2-propanol;monopropylene glycol methyl ether 203-539-1 107-98-2 R10 R: 10S: (2-)24  
603-065-00-9 resorcinol diglycidyl ether;1,3-bis(2,3-epoxypropoxy)benzene 202-987-5 101-90-6 Carc. Cat. 3; R40Muta. Cat. 3; R68Xn; R21/22Xi; R36/38R43R52-53 XnR: 21/22-36/38-40-43-52/53-68S: (2-)23-36/37-61  
603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane;vinylcyclohexane diepoxide 203-437-7 106-87-6 T; R23/24/25Xn; R68 TR: 23/24/25-68S: (1/2-)23-24-45 T; R23/24/25: C ≥ 1 %:Xn; R20/21/22: 0,1 % ≤ C < 1 % 
603-067-00-X phenyl glycidyl ether;2,3-epoxypropyl phenyl ether;1,2-epoxy-3-phenoxypropane 204-557-2 122-60-1 Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R20Xi; R37/38R43R52-53 TR: 45-20-37/38-43-68-52/53S: 53-45-61  E
603-068-00-5 2,3-epoxypropyl-2-ethylcyclohexyl ether;ethylcyclohexylglycidyl ether — 130014-35-6 Xi; R36/38R43 XiR: 36/38-43S: (2-)26-28-37/39  
603-069-00-0 2,4,6-tris(dimethylaminomethyl)phenol 202-013-9 90-72-2 Xn; R22Xi; R36/38 XnR: 22-36/38S: (2-)26-28  
603-070-00-6 2-amino-2-methylpropanol 204-709-8 124-68-5 Xi; R36/38R52-53 XiR: 36/38-52/53S: (2-)61 Xi; R36/38: C ≥ 10 % 
603-071-00-1 2,2'-iminodiethanol;diethanolamine 203-868-0 111-42-2 Xn; R22-48/22Xi; R38-41 XnR: 22-38-41-48/22S: (2-)26-36/37/39-46  
603-072-00-7 1,4-bis(2,3 epoxypropoxy)butane;butanedioldiglycidyl ether 219-371-7 2425-79-8 Xn; R20/21Xi; R36/38R43 XnR: 20/21-36/38-43S: (2-)26-28-37/39  
603-073-00-2 bis-[4-(2,3-epoxipropoxi)phenyl]propane 216-823-5 1675-54-3 Xi; R36/38R43 XiR: 36/38-43S: (2-)28-37/39 Xi; R36/38: C ≥ 5 % 
603-074-00-8 reaction product: bisphenol-A-(epichlorhydrin);epoxy resin (number average molecular weight ≤ 700) 500-033-5 25068-38-6 Xi; R36/38R43N; R51-53 Xi; NR: 36/38-43-51/53S: (2-)28-37/39-61 Xi; R36/38: C ≥ 5 % 
603-075-00-3 chlormethyl methyl ether;chlorodimethyl ether 203-480-1 107-30-2 F; R11Carc. Cat. 1; R45Xn; R20/21/22 F; TR: 45-11-20/21/22S: 53-45  E
603-076-00-9 but-2-yne-1,4-diol;2-butyne-1,4-diol 203-788-6 110-65-6 C; R34T; R23/25Xn; R21-48/22R43 C; TR: 21-23/25-34-43-48/22S: (1/2-)25-26-36/37/39-45-46 C; R34: C ≥ 50 %Xi; R36/38: 25 % ≤ C < 50 % D
603-077-00-4 1-dimethylaminopropan-2-ol;dimepranol (INN) 203-556-4 108-16-7 R10Xn; R22C; R34 CR: 10-22-34S: (1/2-)23-26-36-45  
603-078-00-X prop-2-yn-1-ol;propargyl alcohol 203-471-2 107-19-7 R10T; R23/24/25C; R34N; R51-53 T; NR: 10-23/24/25-34-51/53S: (1/2-)26-28-36-45-61  
603-079-00-5 2,2'-(methylimino)diethanol;N-methyldiethanolamine 203-312-7 105-59-9 Xi; R36 XiR: 36S: (2-)24  
603-080-00-0 2-methylaminoethanol;N-methylethanolamine;N-methyl-2-ethanolamine;N-methyl-2-amino ethanol;2-(methylamino)ethanol 203-710-0 109-83-1 Xn; R21/22C; R34 CR: 21/22-34S: (1/2-)26-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
603-081-00-6 2,2'-thiodiethanol;thiodiglycol 203-874-3 111-48-8 Xi; R36 XiR: 36S: (2-)  
603-082-00-1 1-aminopropan-2-ol;isopropanolamine 201-162-7 78-96-6 C; R34 CR: 34S: (1/2-)23-26-36-45  
603-083-00-7 1,1'-iminodipropan-2-ol;di-isopropanolamine 203-820-9 110-97-4 Xi; R36 XiR: 36S: (2-)26  
603-084-00-2 styrene oxide;(epoxyethyl)benzene;phenyloxirane 202-476-7 96-09-3 Carc. Cat. 2; R45Xn; R21Xi; R36 TR: 45-21-36S: 53-45  E
603-085-00-8 bronopol (INN);2-bromo-2-nitropropane-1,3-diol 200-143-0 52-51-7 Xn; R21/22Xi; R37/38-41N; R50 Xn; NR: 21/22-37/38-41-50S: (2-)26-37/39-61  
603-086-00-3 ethirimol (ISO);5-butyl-2-ethylamino-6-methylpyrimidin-4-ol 245-949-3 23947-60-6 Xn; R21 XnR: 21S: (2-)36/37  
603-087-00-9 2-ethylhexane-1,3-diol;octylene glycol;ethoexadiol 202-377-9 94-96-2 Xi; R41 XiR: 41S: (2-)25-26-39-46  
603-088-00-4 2-(octylthio)ethanol;2-hydroxyethyl octyl sulphide 222-598-4 3547-33-9 Xi; R41 XiR: 41S: (2-)26  
603-089-00-X 7,7-dimethyl-3-oxa-6-azaoctan-1-ol 400-390-6 — C; R35Xn; R22 CR: 22-35S: (1/2-)26-28-36/37/39-45  
603-090-00-5 2-(2-bromoethoxy)anisole 402-010-4 4463-59-6 Xn; R22R52-53 XnR: 22-52/53S: (2-)22-61  
603-091-00-0 exo-1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptan-2-ol 402-470-6 87172-89-2 Xn; R22Xi; R41 XnR: 22-41S: (2-)26-39  
603-092-00-6 2-methyl-4-phenylpentanol 402-770-7 92585-24-5 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
603-093-00-1 cinmethylin (ISO)exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane 402-410-9 87818-31-3 Xn; R20N; R51-53 Xn; NR: 20-51/53S: (2-)23-61  
603-094-00-7 1,3-bis(2,3-epoxypropoxy)-2,2-dimethylpropane 241-536-7 17557-23-2 Xi; R38R43 XiR: 38-43S: (2-)24-37  
603-095-00-2 2-(propyloxy)ethanol;EGPE 220-548-6 2807-30-9 Xn; R21Xi; R36 XnR: 21-36S: (2-)26-36/37-46  
603-096-00-8 2-(2-butoxyethoxy)ethanol;diethylene glycol monobutyl ether 203-961-6 112-34-5 Xi; R36 XiR: 36S: (2-)24-26  
603-097-00-3 1,1',1''-nitrilotripropan-2-ol;triisopropanolamine 204-528-4 122-20-3 Xi; R36R52-53 XiR: 36-52/53S: (2-)26-61  
603-098-00-9 2-phenoxyethanol 204-589-7 122-99-6 Xn; R22Xi; R36 XnR: 22-36S: (2-)26  
603-099-00-4 3-(N-methyl-N-(4-methylamino-3-nitrophenyl)amino)propane-1,2-diol hydrochloride 403-440-5 93633-79-5 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
603-100-00-8 1,2-dimethoxypropane 404-630-0 7778-85-0 F; R11-19 FR: 11-19S: (2-)9-16-24/25-33  
603-101-00-3 tetrahydro-2-isobutyl-4-methylpyran-4-ol, mixed isomers (cis and trans) 405-040-6 — Xi; R36 XiR: 36S: (2-)25-26  
603-102-00-9 1,2-epoxybutane 203-438-2 106-88-7 F; R11Carc. Cat. 3; R40Xn; R20/21/22Xi; R36/37/38R52-53 F; XnR: 11-20/21/22-36/37/38-40-52/53S: (2-)9-16-29-36/37-61  
603-103-00-4 oxirane, mono[(C12-14-alkyloxy)methyl] derivs. 271-846-8 68609-97-2 Xi; R38R43 XiR: 38-43S: (2-)24-37  
603-104-00-X fenarimol (ISO);2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol 262-095-7 60168-88-9 Repr. Cat. 3; R62-63R64N; R51-53 Xn; NR: 51/53-62-63-64S: (2-)36/37-61  
603-105-00-5 furan 203-727-3 110-00-9 F+; R12R19Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R20/22-48/22Xi; R38R52-53 F+; TR: 45-12-19-20/22-38-48/22-68-52/53S: 53-45-61  E
603-106-00-0 2-methoxypropanol 216-455-5 1589-47-5 R10Repr. Cat. 2; R61Xi; R37/38-41 TR: 61-10-37/38-41S: 53-45  
603-107-00-6 2-(2-methoxyethoxy)ethanol;diethylene glycol monomethyl ether 203-906-6 111-77-3 Repr. Cat. 3; R63 XnR: 63S: (2-)36/37  
603-108-00-1 2-methylpropan-1-ol;iso-butanol 201-148-0 78-83-1 R10Xi; R37/38-41R67 XiR: 10-37/38-41-67S: (2-)7/9-13-26-37/39-46  
603-117-00-0 propan-2-ol;isopropyl alcohol;isopropanol 200-661-7 67-63-0 F; R11Xi; R36R67 F; XiR: 11-36-67S: (2-)7-16-24/25-26  
603-118-00-6 6-dimethylaminohexan-1-ol 404-680-3 1862-07-3 Xn; R22C; R34R52-53 CR: 22-34-52/53S: (1/2-)26-36/37/39-45-61  
603-119-00-1 1,1'-(1,3-phenylenedioxy)bis(3-(2-(prop-2-enyl)phenoxy)propan-2-ol) 405-840-5 — R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
603-120-00-7 2-methyl-5-phenylpentanol 405-890-8 25634-93-9 Xi; R36/38 XiR: 36/38S: (2-)26-37  
603-121-00-2 4-[4-(1,3-dihydroxyprop-2-yl)phenylamino]-1,8-dihydroxy-5-nitroanthraquinone 406-057-1 114565-66-1 Carc. Cat. 3; R40R43R53 XnR: 40-43-53S: (2-)36/37-61  
603-122-00-8 sodium 2-ethylhexanolate 406-150-7 38411-13-1 F; R11C; R34R52-53 F; CR: 11-34-52/53S: (1/2-)7-26-36/37/39-45-61  
603-123-00-3 4-methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol 406-330-5 122760-84-3 Xi; R38R43N; R51-53 Xi; NR: 38-43-51/53S: (2-)24-37-61  
603-124-00-9 1,4-bis[2-(vinyloxy)ethoxy]benzene 406-900-3 84563-49-5 N; R50-53 NR: 50/53S: 60-61  
603-125-00-4 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4-en-2-ol 407-850-5 89544-40-1 Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)26-39-61  
603-126-00-X 2-((4-methyl-2-nitrophenyl)amino)ethanol 408-090-7 100418-33-5 Xn; R22R43R52-53 XnR: 22-43-52/53S: (2-)36/37-61  
603-127-00-5 butan-2-ol; [1](S)-butan-2-ol; [2](R)-butan-2-ol; [3](±)-butan-2-ol [4] 201-158-5 [1]224-168-1 [2]238-967-8 [3]240-029-8 [4] 78-92-2 [1]4221-99-2 [2]14898-79-4 [3]15892-23-6 [4] R10Xi; R36/37R67 XiR: 10-36/37-67S: (2-)7/9-13-24/25-26-46  C
603-128-00-0 2-(phenylmethoxy)naphthalene 405-490-3 613-62-7 R53 R: 53S: 61  
603-129-00-6 1-tert-butoxypropan-2-ol 406-180-0 57018-52-7 R10Xi; R41 XiR: 10-41S: (2-)26-39  
603-130-00-1 reaction mass of isomers of: α-((dimethyl)biphenyl)-ω-hydroxypoly(oxyethylene) 406-325-8 — Xn; R22R52-53 XnR: 22-52/53S: (2-)39-61  
603-131-00-7 reaction mass of: 1-deoxy-1-[methyl-(1-oxododecyl)amino]-D-glucitol;1-deoxy-1-[methyl-(1-oxotetradecyl)amino]-D-glucitol (3:1) 407-290-1 — Xi; R41 XiR: 41S: (2-)26-39  
603-132-00-2 2-hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4-dioxaspiro[4.5]decane 408-200-3 63187-91-7 Xi; R38-41R52-53 XiR: 38-41-52/53S: (2-)26-37/39-61  
603-133-00-8 reaction mass of: 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-propane-1,2-diol;3,3'-(2-chloro-5-nitro-1,4-phenylenediimino)bis(propan-1,2-diol) 408-240-1 — Xn; R22R52-53 XnR: 22-52/53S: (2-)22-36-61  
603-134-00-3 reaction mass of substituted dodecyl and/or tetradecyl, diphenyl ethers. The substance is produced by the Friedel Crafts reaction. The catalyst is removed from the reaction product. Diphenyl ether is substituted by C1-C10 alkyl groups. The alkyl groups are bonded randomly between C1 and C6. Linear C12 and C14, 50/50 used. 410-450-3 — R53 R: 53S: 61  
603-135-00-9 bis[[2,2',2''-nitrilotris-[ethanolato]]-1-N,O]-bis[2-(2-methoxyethoxy)ethoxy]-titanium 410-500-4 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
603-136-00-4 3-((4-(bis(2-hydroxyethyl)amino)-2-nitrophenyl)amino)-1-propanol 410-910-3 104226-19-9 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
603-137-00-X reaction mass of: 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-D-glucitol;1-deoxy-1-[methyl-(1-oxooctadecyl)amino]-D-glucitol 411-130-6 — Xi; R41 XiR: 41S: (2-)26-39  
603-138-00-5 3-(2,2-dimethyl-3-hydroxypropyl)toluene;(alt.): 2,2-dimethyl-3-(3-methylphenyl)propanol 403-140-4 103694-68-4 R52-53 R: 52/53S: 61  
603-139-00-0 bis(2-methoxyethyl) ether 203-924-4 111-96-6 R10R19Repr. Cat. 2; R60-61 TR: 60-61-10-19S: 53-45  
603-140-00-6 2,2' -oxybisethanol;diethylene glycol 203-872-2 111-46-6 Xn; R22 XnR: 22S: (2-)46  
603-141-00-1 reaction mass of: dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]pentadecane;dodecyloxy-1-methyl-1-[oxy-poly-(2-hydroxymethylethanoxy)]heptadecane 413-780-6 — R52-53 R: 52/53S: 61  
603-142-00-7 2-(2-(2-hydroxyethoxy)ethyl)-2-aza-bicyclo[2.2.1]heptane 407-360-1 116230-20-7 Xn; R21/22-48/20Xi; R38-41 XnR: 21/22-38-41-48/20S: (2-)26-36/37/39  
603-143-00-2 R-2,3-epoxy-1-propanol 404-660-4 57044-25-4 E; R2Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 2; R60T; R23Xn; R21/22C; R34 E; TR: 45-60-2-21/22-23-34-68S: 53-45  E
603-144-00-8 reaction mass of: 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol;6,9-dimethyl-2-methylen-5,9-cyclododecadien-1-ol 413-530-6 111850-00-1 N; R51-53 NR: 51/53S: 61  
603-145-00-3 2-isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane 406-970-5 129228-11-1 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)36/37-61  
603-146-00-9 2-[(2-[2-(dimethylamino)ethoxy]ethyl)methylamino]ethanol 406-080-7 83016-70-0 Xn; R22C; R34R52-53 CR: 22-34-52/53S: (1/2-)23-26-36/37/39-45-61  
603-147-00-4 (-)-trans-4-(4'-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 406-030-4 105812-81-5 Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)22-24-26-37/39-61  
603-148-00-X 1,4-bis[(vinyloxy)methyl]cyclohexane 413-370-7 17351-75-6 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
603-149-00-5 reaction mass of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-methylethyl)cyclohexane 407-640-3 63767-86-2 Xi; R36/38N; R51-53 Xi; NR: 36/38-51/53S: (2-)26-37-61  
603-150-00-0 (±) trans-3,3-dimethyl-5-(2,2,3-trimethyl-cyclopent-3-en-1-yl)-pent-4-en-2-ol 411-580-3 107898-54-4 Xi; R38N; R50-53 Xi; NR: 38-50/53S: (2-)24/25-37-60-61  
603-151-00-6 (±)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1-ol 413-570-4 — R52-53 R: 52/53S: 61  
603-152-00-1 2-(4-tert-butylphenyl)ethanol 410-020-5 5406-86-0 Repr. Cat. 3; R62Xn; R48/22Xi; R41N; R51-53 Xn; NR: 41-48/22-62-51/53S: (2-)26-36/37/39-61  
603-153-00-7 3-((2-nitro-4-(trifluoromethyl)phenyl)amino)propane-1,2-diol 410-010-0 104333-00-8 Xn; R22R52-53 XnR: 22-52/53S: (2-)22-61  
603-154-00-2 1-[(2-tert-butyl)cyclohexyloxy]-2-butanol 412-300-2 139504-68-0 N; R51-53 NR: 51/53S: 61  
603-155-00-8 Reaction products of 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-hydroxyphenol with ((C10-16, rich in C12-13 alkyloxy)methyl)oxyrane 410-560-1 — N; R50-53 NR: 50/53S: 60-61  
603-156-00-3 2-(2,4-dichlorophenyl)-2-(2-propenyl)oxirane 411-210-0 89544-48-9 Xi; R38R43N; R50-53 Xi; NR: 38-43-50/53S: (2-)24-37-60-61  
603-157-00-9 6,9-bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9-triol 411-450-6 143747-72-2 R53 R: 53S: 61  
603-158-00-4 reaction mass of 4 diastereoisomers of 2,7-dimethyl-10-(1-methylethyl)-1-oxaspiro[4.5]deca-3,6-diene 412-460-3 — Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
603-159-00-X 2-cyclododecylpropan-1-ol 411-410-8 118562-73-5 N; R50-53 NR: 50/53S: 60-61  
603-160-00-5 1,2-diethoxypropane 412-180-1 10221-57-5 F; R11R19 FR: 11-19S: (2-)9-16-24-33  
603-161-00-0 1,3-diethoxypropane 413-140-6 3459-83-4 R10 R: 10S: (2-)9-24  
603-162-00-6 α[2-[[[(2-hydroxyethyl)methylamino]acetyl]amino]propyl]-ω-(nonylphenoxy)poly[oxo(methyl-1,2-ethanediyl)] 413-420-8 144736-29-8 C; R34R43N; R51-53 C; NR: 34-43-51/53S: (1/2-)26-28-36/37/39-45-61  
603-163-00-1 2-phenyl-1,3-propanediol 411-810-2 1570-95-2 Xi; R41 XiR: 41S: (2-)26-39  
603-164-00-7 2-butyl-4-chloro-4,5-dihydro-5-hydroxymethyl-1-[2'-(2-triphenylmethyl-1,2,3,4-2H-tetrazol-5-yl)-1,1'-biphenyl-4-methyl]-1H-imidazole 412-420-5 133909-99-6 R53 R: 53S: 61  
603-165-00-2 reaction mass of: 4-allyl-2,6-bis(2,3-epoxypropyl)phenol;4-allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;4-allyl-6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol;4-allyl-6-[3-[6-[3-(4-allyl-2,6-bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-epoxypropyl)phenol 417-470-1 — Muta. Cat. 3; R68R43 XnR: 43-68S: (2-)36/37  
603-166-00-8 R-1-chloro-2,3-epoxypropane 424-280-2 51594-55-9 R10Carc. Cat. 2; R45T; R23/24/25C; R34R43 TR: 45-10-23/24/25-34-43S: 53-45  E
603-167-00-3 3,3',5,5'-tetra-tert-butylbiphenyl-2,2'-diol 407-920-5 6390-69-8 R53 R: 53S: 61  
603-168-00-9 3-(2-ethylhexyloxy)propane-1,2-diol 408-080-2 70445-33-9 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
603-169-00-4 (±)-trans-4-(4-fluorophenyl)-3-hydroxymethyl-N-methylpiperidine 415-550-0 109887-53-8 Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)22-26-39-61  
603-170-00-X reaction mass of: 2-methyl-1-(6-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol;2-methyl-1-(1-methylbicyclo[2.2.1]hept-5-en-2-yl)-pent-1-en-3-ol;2-methyl-1-(5-methylbicyclo[2.2.1]hept-5-en-2-yl)pent-1-en-3-ol 415-990-3 67739-11-1 Xi; R36N; R51-53 Xi; NR: 36-51/53S: (2-)26-61  
603-171-00-5 5-thiazolylmethanol 414-780-9 38585-74-9 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
603-172-00-0 mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazinium-1-yl]ethoxy)ethanol trans-butenedioate 415-180-1 773058-82-5 Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)22-26-39-61  
603-173-00-6 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]octane 421-750-9 57280-22-5 Xi; R36R43 XiR: 36-43S: (2-)26-36/37  
603-174-00-1 4-cyclohexyl-2-methyl-2-butanol 420-630-3 83926-73-2 Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
603-175-00-7 2-(2-hexyloxyethoxy)ethanol;DEGHE;diethylene glycol monohexyl ether;3,6-dioxa-1-dodecanol;hexyl carbitol;3,6-dioxadodecan-1-ol 203-988-3 112-59-4 Xn; R21Xi; R41 XnR: 21-41S: (2-)26-36/37/39-46  
603-176-00-2 1,2-bis(2-methoxyethoxy)ethane;TEGDME;triethylene glycol dimethyl ether;triglyme 203-977-3 112-49-2 R19Repr. Cat. 2; R61Repr. Cat. 3; R62 TR: 61-19-62S: 53-45  
603-177-00-8 1-ethoxypropan-2-ol;2PG1EE;1-ethoxy-2-propanol;propylene glycol monoethyl ether; [1]2-ethoxy-1-methylethyl acetate;2PG1EEA [2] 216-374-5 [1]259-370-9 [2] 1569-02-4 [1]54839-24-6 [2] R10R67 R: 10-67S: (2-)24  
603-178-00-3 2-hexyloxyethanol;ethylene glycol monohexyl ether;n-hexylglycol 203-951-1 112-25-4 Xn; R21/22C; R34 CR: 21/22-34S: (1/2-)26-36/37/39-45  
603-179-00-9 ergocalciferol (ISO);Vitamin D2 200-014-9 50-14-6 T+; R26T; R24/25-48/25 T+R: 24/25-26-48/25S: (1/2-)28-36/37-45  
603-180-00-4 colecalciferol;Vitamin D3 200-673-2 67-97-0 T+; R26T; R24/25-48/25 T+R: 24/25-26-48/25S: (1/2-)28-36/37-45  
603-181-00-X tert-butyl methyl ether;MTBE;2-methoxy-2-methylpropane 216-653-1 1634-04-4 F; R11Xi; R38 F; XiR: 11-38S: (2-)9-16-24  
603-183-00-0 2-[2-(2-butoxyethoxy)ethoxy]ethanol;TEGBE;triethylene glycol monobutyl ether;butoxytriethylene glycol 205-592-6 143-22-6 Xi; R41 XiR: 41S: (2-)26-39-46 Xi; R41: C ≥ 30 %Xi; R36: 20 % ≤ C < 30 % 
603-184-00-6 2-(hydroxymethyl)-2-[[2-hydroxy-3-(isooctadecyloxy)propoxy]methyl]-1,3-propanediol 416-380-1 146925-83-9 N; R50-53 NR: 50/53S: 60-61  
603-185-00-1 2,4-dichloro-3-ethyl-6-nitrophenol 420-740-1 99817-36-4 T; R25Xi; R41R43N; R50-53 T; NR: 25-41-43-50/53S: (1/2-)26-36/37/39-45-60-61  
603-186-00-7 trans-(5RS,6SR)-6-amino-2,2-dimethyl-1,3-dioxepan-5-ol 419-050-3 79944-37-9 R43 XiR: 43S: (2-)22-24/25-26-37  
603-187-00-2 2-((4,6-bis(4-(2-(1-methylpyridinium-4-yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2-hydroxyethyl)amino)ethanol dichloride 419-360-9 163661-77-6 N; R50-53 NR: 50/53S: 60-61  
603-189-00-3 reaction mass of complexes of: titanium, 2,2'-oxydiethanol, ammonium lactate, nitrilotris(2-propanol) and ethylene glycol 405-250-8 — N; R51-53 NR: 51/53S: 61  
603-191-00-4 2-(4,6-bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3-((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol 419-740-4 137658-79-8 R53 R: 53S: 61  
603-195-00-6 2-[4-(4-methoxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-phenol 430-810-3 154825-62-4 R52-53 R: 52/53S: 61  
603-196-00-1 2-(7-ethyl-1H-indol-3-yl)ethanol 431-020-1 41340-36-7 Xn; 22-48/22N; R51-53 Xn; NR: 22-48/22-51/53S: (2-)36/37/39-61  
603-197-00-7 tebuconazole (ISO);1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol 403-640-2 107534-96-3 Repr. Cat. 3; R63Xn; R22N; R51-53 Xn; NR: 22-51/53-63S: (2-)22-36/37-61  
603-199-00-8 etoxazol (ISO);(RS)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl]phenetole — 153233-91-1 N; R50-53 NR: 50/53S: 60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
604-001-00-2 phenol;carbolic acid;monohydroxybenzene;phenylalcohol 203-632-7 108-95-2 Muta. Cat. 3; R68T; R23/24/25Xn; R48/20/21/22C; R34 T;R: 23/24/25-34-48/20/21/22-68S: (1/2-)24/25-26-28-36/37/39-45 T; R23/24/25: C ≥ 10 %Xn; R20/21/22: 3 % ≤ C < 10 %C; R34: C ≥ 3 %Xi; R36/38: 1 % ≤ C < 3 % 
604-002-00-8 pentachlorophenol 201-778-6 87-86-5 Carc. Cat. 3; R40T+; R26T; R24/25Xi; R36/37/38N; R50-53 T+; NR: 24/25-26-36/37/38-40-50/53S: (1/2-)22-36/37-45-52-60-61  
604-003-00-3 sodium pentachlorophenolate; [1]potassium pentachlorophenolate [2] 205-025-2 [1]231-911-3 [2] 131-52-2 [1]7778-73-6 [2] Carc. Cat. 3; R40T+; R26T; R24/25Xi; R36/37/38N; R50-53 T+; NR: 24/25-26-36/37/38-40-50/53S: (1/2-)22-28-36/37-45-52-60-61  
604-004-00-9 m-cresol; [1]o-cresol; [2]p-cresol; [3]mix-cresol [4] 203-577-9 [1]202-423-8 [2]203-398-6 [3]215-293-2 [4] 108-39-4 [1]95-48-7 [2]106-44-5 [3]1319-77-3 [4] T; R24/25C; R34 TR: 24/25-34S: (1/2-)36/37/39-45 T; R24/25: C ≥ 5 %Xn; R21/22: 1 % ≤ C < 5 %C; R34: C ≥ 5 %Xi; R36/38: 1 % ≤ C < 5 % C
604-005-00-4 1,4-dihydroxybenzene;hydroquinone;quinol 204-617-8 123-31-9 Carc. Cat. 3; R40Muta. Cat. 3; R68Xn; R22Xi; R41R43N; R50 Xn; NR: 22-40-41-43-50-68S: (2-)26-36/37/39-61  
604-006-00-X 3,4-xylenol; [1]2,5-xylenol; [2]2,4-xylenol; [3]2,3-xylenol; [4]2,6-xylenol; [5]xylenol; [6]2,4(or 2,5)-xylenol [7] 202-439-5 [1]202-461-5 [2]203-321-6 [3]208-395-3 [4]209-400-1 [5]215-089-3 [6]276-245-4 [7] 95-65-8 [1]95-87-4 [2]105-67-9 [3]526-75-0 [4]576-26-1 [5]1300-71-6 [6]71975-58-1 [7] T; R24/25C; R34N; R51-53 T; NR: 24/25-34-51/53S: (1/2-)26-36/37/39-45-61  C
604-007-00-5 2-naphthol 205-182-7 135-19-3 Xn; R20/22N; R50 Xn; NR: 20/22-50S: (2-)24/25-61  
604-008-00-0 2-chlorophenol; [1]4-chlorophenol; [2]3-chlorophenol; [3]chlorophenol [4] 202-433-2 [1]203-402-6 [2]203-582-6 [3]246-691-4 [4] 95-57-8 [1]106-48-9 [2]108-43-0 [3]25167-80-0 [4] Xn; R20/21/22N; R51-53 Xn; NR: 20/21/22-51/53S: (2-)28-61  C
604-009-00-6 pyrogallol;1,2,3-trihydroxybenzene 201-762-9 87-66-1 Muta. Cat. 3; R68Xn; R20/21/22R52-53 XnR: 20/21/22-68-52/53S: (2-)36/37-61 Xn; R20/21/22: C ≥ 10 % 
604-010-00-1 resorcinol;1,3-benzenediol 203-585-2 108-46-3 Xn; R22Xi; R36/38N; R50 Xn; NR: 22-36/38-50S: (2-)26-61 Xn; R22: C ≥ 10 % 
604-011-00-7 2,4-dichlorophenol 204-429-6 120-83-2 T; R24Xn; R22C; R34N; R51-53 T; NR: 22-24-34-51/53S: (1/2-)26-36/37/39-45-61  
604-012-00-2 4-chloro-o-cresol;4-chloro-2-methyl phenol 216-381-3 1570-64-5 T; R23C; R35N; R50 T; C; NR: 23-35-50S: (1/2-)26-36/37/39-45-61 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
604-013-00-8 2,3,4,6-tetrachlorophenol 200-402-8 58-90-2 T; R25Xi; R36/38N; R50-53 T; NR: 25-36/38-50/53S: (1/2-)26-28-37-45-60-61 T; R25: C ≥ 5 %Xn; R22: 0,5 % ≤ C < 5 %Xi; R36/38: C ≥ 5 % 
604-014-00-3 chlorocresol;4-chloro-m-cresol;4-chloro-3-methylphenol 200-431-6 59-50-7 Xn; R21/22Xi; R41R43N; R50 Xn; NR: 21/22-41-43-50S: (2-)26-36/37/39-61 Xn; R21/22: C ≥ 10 % 
604-015-00-9 2,2'-methylenebis-(3,4,6-trichlorophenol);hexachlorophene 200-733-8 70-30-4 T; R24/25N; R50-53 T; NR: 24/25-50/53S: (1/2-)20-37-45-60-61 T; R24/25: C ≥ 2 %Xn; R21/22: 0,2 % ≤ C < 2 % 
604-016-00-4 1,2-dihydroxybenzene;pyrocatechol 204-427-5 120-80-9 Xn; R21/22Xi; R36/38 XnR: 21/22-36/38S: (2-)22-26-37  
604-017-00-X 2,4,5-trichlorophenol 202-467-8 95-95-4 Xn; R22Xi; R36/38N; R50-53 Xn; NR: 22-36/38-50/53S: (2-)26-28-60-61 Xn; R22: C ≥ 20 %Xi; R36/38: C ≥ 5 % 
604-018-00-5 2,4,6-trichlorophenol 201-795-9 88-06-2 Carc. Cat. 3; R40Xn; R22Xi; R36/38N; R50-53 Xn; NR: 22-36/38-40-50/53S: (2-)36/37-60-61  
604-019-00-0 dichlorophen (ISO) 202-567-1 97-23-4 Xn; R22Xi; R36N; R50-53 Xn; NR: 22-36-50/53S: (2-)26-60-61  
604-020-00-6 2-phenylphenol (ISO);biphenyl-2-ol;2-hydroxybiphenyl; 201-993-5 90-43-7 Xi; R36/37/38N; R50 Xi; NR: 36/37/38-50S: (2-)22-61  
604-021-00-1 sodium 2-biphenylate;2-phenylphenol, sodium salt 205-055-6 132-27-4 Xn; R22Xi; R37/38-41N; R50 Xn; NR: 22-37/38-41-50S: (2-)22-26-61  
604-022-00-7 2,2-dimethyl-1,3-benzodioxol-4-ol 400-900-7 22961-82-6 Xi; R41 XiR: 41S: (2-)24-26-39  
604-023-00-2 2,4-dichloro-3-ethylphenol 401-060-4 — C; R34N; R50-53 C; NR: 34-50/53S: (1/2-)26-36/39-45-60-61  
604-024-00-8 4,4-isobutylethylidenediphenol 401-720-1 6807-17-6 Repr. Cat. 2; R60Xi; R36N; R50-53 T; NR: 60-36-50/53S: 53-45-60-61  
604-025-00-3 2,5-bis(1,1-dimethylbutyl)hydroquinone 400-220-0 — N; R51-53 NR: 51/53S: 61  
604-026-00-9 2,2-spirobi(6-hydroxy-4,4,7-trimethylchromane) 400-270-3 — N; R51-53 NR: 51/53S: 61  
604-027-00-4 2-methyl-5-(1,1,3,3-tetramethylbutyl)hydroquinone 400-530-6 — Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)24/25-26-37-61  
604-028-00-X 4-amino-3-fluorophenol 402-230-0 399-95-1 Carc. Cat. 2; R45Xn; R22R43N; R51-53 T; NR: 45-22-43-51/53S: 53-45-61  E
604-029-00-5 1-naphtol 201-969-4 90-15-3 Xn; R21/22Xi; R37/38-41 XnR: 21/22-37/38-41S: (2-)22-26-37/39  
604-030-00-0 bisphenol A;4,4'-isopropylidenediphenol 201-245-8 80-05-7 Repr. Cat. 3; R62Xi; R37-41R43 XnR: 37-41-43-62S: (2-)26-36/37-39-46  
604-031-00-6 guaiacol 201-964-7 90-05-1 Xn; R22Xi; R36/38 XnR: 22-36/38S: (2-)26  
604-032-00-1 thymol 201-944-8 89-83-8 Xn; R22C; R34N; R51-53 C; NR: 22-34-51/53S: (1/2-)26-28-36/37/39-45-61  
604-033-00-7 isobutyl but-3-enoate 401-170-2 24342-03-8 R10 R: 10S: (2-)  
604-034-00-2 4,4'-thiodi-o-cresol 403-330-7 24197-34-0 Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
604-035-00-8 4-nonylphenol, reaction products with formaldehyde and dodecane-1-thiol 404-160-6 — R43R53 XR: 43-53S: (2-)24-37-61  
604-036-00-3 4,4'-oxybis(ethylenethio)diphenol 404-590-4 90884-29-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
604-037-00-9 3,5-xylenol;3,5-dimethylphenol 203-606-5 108-68-9 T; R24/25C; R34 TR: 24/25-34S: (1/2-)26-28-36/37/39-45  
604-038-00-4 4-chloro-3,5-dimethylphenol; [1]chloroxylenol [2] 201-793-8 [1]215-316-6 [2] 88-04-0 [1]1321-23-9 [2] Xn; R22Xi; R36/38R43 XnR: 22-36/38-43S: (2-)24-37  
604-039-00-X ethyl 2-[4-[(6-chlorobenzoxazol-2-yl)oxy]phenoxy]propionate;fenoxaprop-ethyl 266-362-9 66441-23-4 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
604-040-00-5 fomesafen (ISO);5-[2-chloro-4-(trifluoromethyl)phenoxy]-N-(methylsulphonyl)-2-nitrobenzamide 276-439-9 72178-02-0 Xn; R22 XnR: 22S: (2-)  
604-041-00-0 acifluorfen (ISO);5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoic acid [1]sodium 5-[2-chloro-4-(trifluoromethyl) phenoxy]-2-nitrobenzoate;acifluorfen-sodium [2] 256-634-5 [1]263-560-7 [2] 50594-66-6 [1]62476-59-9 [2] Xn; R22Xi; R38-41N; R50-53 Xn; NR: 22-38-41-50/53S: (2-)24-39-60-61  
604-042-00-6 4-nitrosophenol 203-251-6 104-91-6 Muta. Cat. 3; R68Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53-68S: (2-)26-36/37/39-47-49-61  
604-043-00-1 monobenzone;4-hydroxyphenyl benzyl ether;hydroquinone monobenzyl ether 203-083-3 103-16-2 Xi; R36R43 XiR: 36-43S: (2-)24/25-26-37  
604-044-00-7 mequinol;4-methoxyphenol;hydroquinone monomethyl ether 205-769-8 150-76-5 Xn; R22Xi; R36R43 XnR: 22-36-43S: (2-)24/25-26-37/39-46  
604-045-00-2 2,3,5-trimethylhydroquinone 211-838-3 700-13-0 Xn; R20Xi; R37/38-41R43N; R50-53 Xn; NR: 20-37/38-41-43-50/53S: (2-)24-26-37/39-60-61  
604-046-00-8 4-(4-isopropoxyphenylsulfonyl)phenol 405-520-5 95235-30-6 N; R51-53 NR: 51/53S: 61  
604-047-00-3 4-(4-tolyloxy)biphenyl 405-730-7 51601-57-1 Xn; R48/22R53 XnR: 48/22-53S: (2-)22-36-61  
604-048-00-9 4,4',4''-(ethan-1,1,1-triyl)triphenol 405-800-7 27955-94-8 N; R51-53 NR: 51/53S: 61  
604-049-00-4 4-4'-methylenebis(oxyethylenethio)diphenol 407-480-4 93589-69-6 N; R51-53 NR: 51/53S: 61  
604-051-00-5 3,5-bis((3,5-di-tert-butyl-4-hydroxy)benzyl)-2,4,6-trimethylphenol 401-110-5 87113-78-8 R52-53 R: 52/53S: 61  
604-052-00-0 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) 403-800-1 103597-45-1 R53 R: 53S: 61  
604-053-00-6 2-methyl-4-(1,1-dimethylethyl)-6-(1-methyl-pentadecyl)-phenol 410-760-9 157661-93-3 Xi; R38R43N; R50-53 Xi; NR: 38-43-50/53S: (2-)24-37-60-61  
604-054-00-1 reaction mass of: 2-methoxy-4-(tetrahydro-4-methylene-2H-pyran-2-yl)-phenol;4-(3,6-dihydro-4-methyl-2H-pyran-2-yl)-2-methoxyphenol 412-020-0 — R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
604-055-00-7 2,2'-((3,3',5,5'-tetramethyl-(1,1'-biphenyl)-4,4'-diyl)-bis(oxymethylene))-bis-oxirane 413-900-7 85954-11-6 Muta. Cat. 3; R68 XnR: 68S: (2-)22-36-37  
604-056-00-2 2-(2-hydroxy-3,5-dinitroanilino)ethanol 412-520-9 99610-72-7 F; R11Repr. Cat. 3; R62Xn; R22 F; XnR: 11-22-62S: (2-)22-33-36/37  
604-057-00-8 reaction mass of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol;isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol;isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n = 5 or 6 401-680-5 — N; R51-53 NR: 51/53S: 61  
604-058-00-3 1,2-bis(3-methylphenoxy)ethane 402-730-9 54914-85-1 N; R50-53 NR: 50/53S: 60-61  
604-059-00-9 2-n-hexadecylhydroquinone 406-400-5 — Xn; R48/22Xi; R38R43R53 XnR: 38-43-48/22-53S: (2-)22-36/37-61  
604-060-00-4 9,9-bis(4-hydroxyphenyl)fluorene 406-950-6 3236-71-3 Xi; R36-38N; R50-53 Xi; NR: 36/38-50/53S: (2-)26-37-60-61  
604-061-00-X reaction mass of: 2-chloro-5-sec-tetradecylhydroquinones where sec-tetradecyl = 1-methyltridecyl;1-ethyldodecyl;1-propylundecyl;1-butyldecyl;1-pentylnonyl;1-hexyloctyl 407-740-7 — Xi; R38R43R52-53 XiR: 38-43-52/53S: (2-)24-37-61  
604-062-00-5 2,4-dimethyl-6-(1-methyl-pentadecyl)phenol 411-220-5 — Xi; R38R43N; R50-53 Xi; NR: 38-43-50/53S: (2-)24-37-60-61  
604-063-00-0 5,6-dihydroxyindole 412-130-9 3131-52-0 Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)22-26-36/37/39-61  
604-064-00-6 2-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-((hexyl)oxy)-phenol 411-380-6 147315-50-2 R53 R: 53S: 61  
604-065-00-1 4,4',4''-(1-methylpropan-1-yl-3-ylidene)tris(2-cyclohexyl-5-methylphenol) 407-460-5 111850-25-0 N; R51-53 NR: 51/53S: 61  
604-066-00-7 reaction mass of: phenol, 6-(1,1-dimethylethyl)-4-tetrapropyl-2-[(2-hydroxy-5-tetra-propylphenyl)methyl (C41-compound) and methane, 2,2'-bis[6-(1,1-dimethyl-ethyl)-1-hydroxy-4-tetrapropyl-phenyl)]- (C45-compound);2,6-bis(1,1-dimethylethyl)-4-tetra-propyl-phenol and 2-(1,1-dimethylethyl)-4-tetrapropyl-phenol;2,6-bis[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol and 2-[(6-(1,1-dimethylethyl)-1-hydroxy-4-tetrapropylphenylmethyl]-6-[1-hydroxy-4-tetrapropylphenyl)methyl]-4-(tetrapropyl)phenol 414-550-8 — N; R50-53 NR: 50/53S: 60-61  
604-067-00-2 reaction mass of: 2,2'-[[(2-hydroxyethyl)imino]bis(methylene)bis[4-dodecylphenol];formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 2);formaldehyde, oligomer with 4-dodecyl phenol and 2-aminoethanol(n = 3, 4 and higher) 414-520-4 — Xi; R38-41N; R50-53 Xi; NR: 38-41-50/53S: (2-)26-37/39-60-61  
604-068-00-8 (±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride 415-170-5 90274-24-1 Xn; R20/22R43 XnR: 20/22-43S: (2-)24-26-37  
604-069-00-3 2-(1-methylpropyl)-4-tert-butylphenol 421-740-4 51390-14-8 C; R34N; R51-53 C; NR: 34-51/53S: (1/2-)26-36/37/39-45-61  
604-070-00-9 triclosan;2,4,4'-trichloro-2'-hydroxy-diphenyl-ether;5-chloro-2-(2,4-dichlorophenoxy)phenol 222-182-2 3380-34-5 Xi; R36/38N; R50-53 Xi; NR: 36/38-50/53S: 26-39-46-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
605-001-00-5 formaldehyde … % 200-001-8 50-00-0 Carc. Cat. 3; R40T; R23/24/25C; R34R43 TR: 23/24/25-34-40-43S: (1/2-)26-36/37/39-45-51 T; R23/24/25: C ≥25 %Xn; R20/21/22: 5 % ≤ C < 25 %C; R34: C ≥25 %Xi; R36/37/38: 5 % ≤ C < 25 %R43: C ≥ 0,2 % B D
605-002-00-0 1,3,5-trioxan;trioxymethylene 203-812-5 110-88-3 F; R11Repr. Cat. 3; R63Xi; R37 F; XnR: 11-37-63S: (2-)36/37-46  
605-003-00-6 acetaldehyde;ethanal 200-836-8 75-07-0 F+; R12Carc. Cat. 3; R40Xi; R36/37 F+; XnR: 12-36/37-40S: (2-)16-33-36/37  
605-004-00-1 2,4,6-trimethyl-1,3,5-trioxan;paraldehyde 204-639-8 123-63-7 F; R11 $ FR: 11S: (2-)9-16-29-33  
605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;metaldehyde 203-600-2 108-62-3 R10 $Xn; R22 XnR: 10-22S: (2-)13-25-46  
605-006-00-2 butyraldehyde 204-646-6 123-72-8 F; R11 FR: 11S: (2-)9-29-33  
605-007-00-8 1,1-dimethoxyethane;dimethyl acetal 208-589-8 534-15-6 F; R11 FR: 11S: (2-)9-16-33  
605-008-00-3 acrylaldehyde;acrolein;prop-2-enal 203-453-4 107-02-8 F; R11T+; R26T; R24/25C; R34N; R50 F; T+; NR: 11-24/25-26-34-50S: 23-26-28-36/37/39-45-61  D
605-009-00-9 crotonaldehyde;2-butenal; [1](E)-2-butenal;(E)-crotonaldehyde [2] 224-030-0 [1]204-647-1 [2] 4170-30-3 [1]123-73-9 [2] F; R11Muta. Cat. 3; R68T+; R26T; R24/25Xn; R48/22Xi; R37/38-41N; R50 F; T+; NR: 11-24/25-26-37/38-41-48/22-50-68S: (1/2-)26-28-36/37/39-45-61  
605-010-00-4 2-furaldehyde 202-627-7 98-01-1 Carc. Cat. 3; R40T; R23/25Xn; R21Xi; R36/37 TR: 21-23/25-36/37-40S: (1/2-)26-36/37/39-45 T; R23/25: C ≥ 5 %Xn; R20/22: 1 % ≤ C < 5 % 
605-011-00-X 2-chlorobenzaldehyde;o-chlorobenzaldehyde 201-956-3 89-98-5 C; R34 CR: 34S: (1/2-)26-45  
605-012-00-5 benzaldehyde 202-860-4 100-52-7 Xn; R22 XnR: 22S: (2-)24  
605-013-00-0 chloralose (INN);(R)-1,2-O-(2,2,2-trichloroethylidene)-α-D-glucofuranose;glucochloralose;anhydroglucochloral 240-016-7 15879-93-3 Xn; R20/22 XnR: 20/22S: (2-)16-24/25-28  
605-014-00-6 chloral hydrate;2,2,2-trichloroethane-1,1-diol 206-117-5 302-17-0 T; R25Xi; R36/38 TR: 25-36/38S: (1/2-)25-45  
605-015-00-1 1,1-diethoxyethane;acetal 203-310-6 105-57-7 F; R11Xi; R36/38 F; XiR: 11-36/38S: (2-)9-16-33 Xi; R36/38: C ≥ 10 % 
605-016-00-7 glyoxal … %;ethandial … % 203-474-9 107-22-2 Muta. Cat. 3; R68Xn; R20Xi; R36/38R43 XnR: 20-36/38-43-68S: (2-)36/37 Xn; R20: C ≥ 10 %Xi; R36/38: C ≥ 10 % B
605-017-00-2 1,3-dioxolane 211-463-5 646-06-0 F; R11 FR: 11S: (2-)16  
605-018-00-8 propanal;propionaldehyde 204-623-0 123-38-6 F; R11Xi; R36/37/38 F; XiR: 11-36/37/38S: (2-)9-16-29  
605-019-00-3 citral 226-394-6 5392-40-5 Xi; R38R43 XiR: 38-43S: (2-)24/25-37  
605-020-00-9 safrole;5-allyl-1,3-benzodioxole 202-345-4 94-59-7 Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R22 TR: 45-22-68S: 53-45  E
605-021-00-4 formaldehyde, reaction products with butylphenol 294-145-9 91673-30-2 R43 XiR: 43S: (2-)24-37  
605-022-00-X glutaral;glutaraldehyde;1,5-pentanedial 203-856-5 111-30-8 T; R23/25C; R34R42/43N; R50 T; NR: 23/25-34-42/43-50S: (1/2-)26-36/37/39-45-61 T; R25: C ≥ 50 %Xn; R22: 2 % ≤ C < 50 %T; R23: C ≥ 25 %Xn; R20: 2 % ≤ C < 25 %C; R34: C ≥ 10 %Xi; R37/38-41: 2 % ≤ C < 10 %Xi; R36/37/38: 0,5 % ≤ C < 2 %R43: C ≥ 0,5 % 
605-025-00-6 chloroacetaldehyde 203-472-8 107-20-0 Carc. Cat. 3; R40T+; R26T; R24/25C; R34N; R50 T+; NR: 24/25-26-34-40-50S: (1/2-)26-28-36/37/39-45-61  
605-026-00-1 2,5,7,7-tetramethyloctanal 405-690-0 114119-97-0 Xi; R38R43N; R51-53 Xi; NR: 38-43-51/53S: (2-)24-37-61  
605-027-00-7 reaction mass of: 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-6-carboxaldehyde;3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene-5-carboxaldehyde 410-480-7 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
605-028-00-2 β-methyl-3-(1-methylethyl)-benzenepropanal 412-050-4 125109-85-5 N; R51-53 NR: 51/53S: 61  
605-029-00-8 2-cyclohexylpropanal 412-270-0 2109-22-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
605-030-00-3 1-(p-methoxyphenyl)acetaldehyde oxime 411-510-1 3353-51-3 R43 XiR: 43S: (2-)24-37  
605-031-00-9 reaction mass of: 2,2-dimethoxyethanal [(this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate;water(Including free water and water in hydrated 2,2-dimethoxyethanal)] 421-890-0 — R43 XiR: 43S: (2-)24-37  
606-001-00-8 acetone;propan-2-one;propanone 200-662-2 67-64-1 F; R11Xi; R36R66R67 F; XiR: 11-36-66-67S: (2-)9-16-26  
606-002-00-3 butanone;ethyl methyl ketone 201-159-0 78-93-3 F; R11Xi; R36R66R67 F; XiR: 11-36-66-67S: (2-)9-16  
606-003-00-9 heptan-3-one;butyl ethyl ketone 203-388-1 106-35-4 R10Xn; R20Xi; R36 XnR: 10-20-36S: (2-)24  
606-004-00-4 4-methylpentan-2-one;isobutyl methyl ketone 203-550-1 108-10-1 F; R11Xn; R20Xi; R36/37R66 F; XnR: 11-20-36/37-66S: (2-)9-16-29  
606-005-00-X 2,6-dimethylheptan-4-one;di-isobutyl ketone 203-620-1 108-83-8 R10Xi; R37 XiR: 10-37S: (2-)24 Xi; R37: C ≥ 10 % 
606-006-00-5 pentan-3-one;diethyl ketone 202-490-3 96-22-0 F; R11Xi; R37R66R67 F; XiR: 11-37-66-67S: (2-)9-16-25-33  
606-007-00-0 3-methylbutan-2-one;methyl isopropyl ketone 209-264-3 563-80-4 F; R11 FR: 11S: (2-)9-16-33  
606-009-00-1 4-methylpent-3-en-2-one;mesityl oxide 205-502-5 141-79-7 R10Xn; R20/21/22 XnR: 10-20/21/22S: (2-)25 Xn; R20/21/22: C ≥ 5 % 
606-010-00-7 cyclohexanone 203-631-1 108-94-1 R10Xn; R20 XnR: 10-20S: (2-)25  
606-011-00-2 2-methylcyclohexanone 209-513-6 583-60-8 R10Xn; R20 XnR: 10-20S: (2-)25  
606-012-00-8 3,5,5-trimethylcyclohex-2-enone;isophorone 201-126-0 78-59-1 Carc. Cat. 3; R40Xn; R21/22Xi; R36/37 XnR: 21/22-36/37-40S: (2-)13-23-36/37/39-46 Xi; R36/37: C ≥ 10 % 
606-013-00-3 p-benzoquinone;quinone 203-405-2 106-51-4 T; R23/25Xi; R36/37/38N; R50 T; NR: 23/25-36/37/38-50S: (1/2-)26-28-45-61  
606-014-00-9 chlorophacinone (ISO);2-(2-(4-chlorophenyl)phenylacetyl)indan-1,3-dione 223-003-0 3691-35-8 T+; R27/28T; R23-48/24/25N; R50-53 T+; NR: 23-27/28-48/24/25-50/53S: (1/2-)36/37-45-60-61  
606-016-00-X pindone (ISO);2-pivaloylindan-1,3-dione 201-462-8 83-26-1 T; R25-48/25N; R50-53 T; NR: 25-48/25-50/53S: (1/2-)37-45-60-61  
606-017-00-5 diketene;diketen 211-617-1 674-82-8 R10Xn; R20 XnR: 10-20S: (2-)3  D
606-018-00-0 dichlone (ISO);2,3-dichloro-1,4-naphthoquinone 204-210-5 117-80-6 Xn; R22Xi; R36/38N; R50-53 Xn; NR: 22-36/38-50/53S: (2-)26-60-61  
606-019-00-6 chlordecone (ISO);perchloropentacyclo[5,3,0,02,6,03,9,04,8]decan-5-one;decachloropentacyclo[5,2,1,02,6,03,9,05,8]decan-4-one 205-601-3 143-50-0 Carc. Cat. 3; R40T; R24/25N; R50-53 T; NR: 24/25-40-50/53S: (1/2-)22-36/37-45-60-61  
606-020-00-1 5-methylheptan-3-one 208-793-7 541-85-5 R10Xi; R36/37 XiR: 10-36/37S: (2-)23 Xi; R36/37: C ≥ 10 % 
606-021-00-7 N-methyl-2-pyrrolidone 212-828-1 872-50-4 Xi; R36/38 XiR: 36/38S: (2-)41 Xi; R36/38: C ≥ 10 % 
606-022-00-2 1-phenyl-3-pyrazolidone 202-155-1 92-43-3 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
606-023-00-8 4-methoxy-4-methylpentan-2-one 203-512-4 107-70-0 R10Xn; R20 XnR: 10-20S: (2-)23-24/25  
606-024-00-3 heptan-2-one;methyl amyl ketone 203-767-1 110-43-0 R10Xn; R20/22 XnR: 10-20/22S: (2-)24/25  
606-025-00-9 cyclopentanone 204-435-9 120-92-3 R10Xi; R36/38 XiR: 10-36/38S: (2-)23  
606-026-00-4 5-methylhexan-2-one;isoamyl methyl ketone 203-737-8 110-12-3 R10Xn; R20 XnR: 10-20S: (2-)23-24/25  
606-027-00-X heptan-4-one;di-n-propyl ketone 204-608-9 123-19-3 R10Xn; R20 XnR: 10-20S: (2-)24/25  
606-028-00-5 2,4-dimethylpentan-3-one;di-isopropyl ketone 209-294-7 565-80-0 F; R11Xn; R20 F; XnR: 11-20S: (2-)9-16-24/25  
606-029-00-0 pentane-2,4-dione;acetylacetone 204-634-0 123-54-6 R10Xn; R22 XnR: 10-22S: (2-)21-23-24/25  
606-030-00-6 hexan-2-one;methyl butyl ketone;butyl methyl ketone;methyl-n-butyl ketone 209-731-1 591-78-6 R10Repr. Cat. 3; R62T; R48/23R67 TR: 10-48/23-62-67S: (1/2-)36/37-45  
606-031-00-1 3-propanolide;1,3-propiolactone 200-340-1 57-57-8 Carc. Cat. 2; R45T+; R26Xi; R36/38 T+R: 45-26-36/38S: 53-45  E
606-032-00-7 hexachloroacetone 204-129-5 116-16-5 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)24/25-61  
606-033-00-2 2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;methazole 243-761-6 20354-26-1 Xn; R21/22Xi; R36/38N; R51-53 Xn; NR: 21/22-36/38-51/53S: (2-)36/37-61  
606-034-00-8 metribuzin (ISO);4-amino-6-tert-butyl-3-methylthio-1,2,4-triazin-5(4H)-one;4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-methylthio-1,2,4-triazin-5-one 244-209-7 21087-64-9 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
606-035-00-3 chloridazon (ISO);5-amino-4-chloro-2-phenylpyridazine-3-(2H)-one;pyrazon 216-920-2 1698-60-8 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
606-036-00-9 quinomethionate;chinomethionat (ISO);6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one 219-455-3 2439-01-2 Repr. Cat. 3; R62Xn; R20/21/22-48/22Xi; R36R43N; R50-53 Xn; NR: 20/21/22-36-43-48/22-50/53-62S: (2-)24-37-60-61  
606-037-00-4 triadimefon (ISO);1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone 256-103-8 43121-43-3 Xn; R22R43N; R51-53 Xn; NR: 22-43-51/53S: (2-)24-37-61  
606-038-00-X diphacinone (ISO);2-diphenylacetylindan-1,3-dione 201-434-5 82-66-6 T+; R28T; R48/23/24/25 T+R: 28-48/23/24/25S: (1/2-)36/37-45  
606-039-00-5 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino-3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one 400-680-2 — Xn; R20N; R50-53 Xn; NR: 20-50/53S: (2-)60-61  
606-040-00-0 (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride 401-840-4 55845-90-4 Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
606-041-00-6 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one 400-600-6 71868-10-5 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)22-61  
606-042-00-1 acetophenone 202-708-7 98-86-2 Xn; R22Xi; R36 XnR: 22-36S: (2-)26  
606-043-00-7 2,4-di-tert-butylcyclohexanone 405-340-7 13019-04-0 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
606-044-00-2 2,4,6-trimethylbenzophenone 403-150-9 954-16-5 Xn; R22Xi; R36N; R50-53 Xn; NR: 22-36-50/53S: (2-)26-60-61  
606-045-00-8 oxadiazon (ISO);3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one 243-215-7 19666-30-9 N; R50-53 NR: 50/53S: 60-61  
606-046-00-3 reaction mass of cis- and trans-cyclohexadec-8-en-1-one 401-700-2 3100-36-5 N; R50-53 NR: 50/53S: 60-61  
606-047-00-9 2-benzyl-2-dimethylamino-4-morpholinobutyrophenone 404-360-3 119313-12-1 N; R50-53 NR: 50/53S: 60-61  
606-048-00-4 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one 406-480-1 — R53 R: 53S: 61  
606-049-00-X 4-(trans-4-propylcyclohexyl)acetophenone 406-700-6 78531-61-0 R43R53 XiR: 43-53S: (2-)24-37-61  
606-050-00-5 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione 412-480-2 72453-58-8 N; R51-53 NR: 51/53S: 61  
606-051-00-0 4-pentylcyclohexanone 406-670-4 61203-83-6 N; R51-53 NR: 51/53S: 61  
606-052-00-6 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone 410-410-5 54574-82-2 R52-53 R: 52/53S: 61  
606-053-00-1 flurtamone (ISO);(RS)-5-methylamino-2-phenyl-4-(α, α,α-trifluoro-m-tolyl)furan-3(2H)-one — 96525-23-4 N; R50-53 NR: 50/53S: 60-61  
606-054-00-7 isoxaflutole (ISO);5-cyclopropyl-1,2-oxazol-4-yl α, α,α-trifluoro-2-mesyl-p-tolyl ketone — 141112-29-0 Repr. Cat. 3; R63N; R50-53 Xn; NR: 50/53-63S: (2-)36/37-60-61  
606-055-00-2 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone 411-180-9 92836-10-7 Xn; R22-48/22N; R51-53 Xn; NR: 22-48/22-51/53S: (2-)24-36-61  
606-056-00-8 4-chloro-3',4'-dimethoxybenzophenone 404-610-1 116412-83-0 N; R50-53 NR: 50/53S: 60-61  
606-057-00-3 4-propylcyclohexanone 406-810-4 40649-36-3 Xi; R38R52-53 XiR: 38-52/53S: (2-)25-37-61  
606-058-00-9 4'-fluoro-2,2-dimethoxyacetophenone 407-500-1 21983-80-2 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
606-059-00-4 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride 412-390-3 86386-75-6 Xn; R22Xi; R41R43 XnR: 22-41-43S: (2-)22-26-36/37/39  
606-060-00-X reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane;cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane 412-950-7 — N; R50-53 NR: 50/53S: 60-61  
606-061-00-5 (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone 423-290-4 66938-41-8 Muta. Cat. 3; R68N; R50-53 Xn; NR: 68-50/53S: (2-)22-36/37-60-61  
606-062-00-0 tetrahydrothiopyran-3-carboxaldehyde 407-330-8 61571-06-0 Repr. Cat. 2; R61Xi; R41R52-53 TR: 61-41-52/53S: 53-45-61  
606-063-00-6 (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal 410-980-5 112704-51-5 Xi; R36R43 XiR: 36-43S: (2-)24-26-37  
606-064-00-1 pregn-5-ene-3,20-dione bis(ethylene ketal) 407-450-0 7093-55-2 R53 R: 53S: 61  
606-065-00-7 1-(4-morpholinophenyl)butan-1-one 413-790-0 — N; R51-53 NR: 51/53S: 61  
606-066-00-2 (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone 410-440-9 164058-20-2 N; R51-53 NR: 51/53S: 61  
606-067-00-8 reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone;1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1H-benz(f)inden-4-yl)ethanone;1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-5-yl)ethanone;1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1H-benz(g)inden-5-yl)ethanone 414-870-8 96792-67-5 N; R50-53 NR: 50/53S: 60-61  
606-068-00-3 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al 415-770-7 1638-05-7 Xn; R48/22R43R52-53 XnR: 43-48/22-52/53S: (2-)22-36/37-61  
606-069-00-9 spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] 415-460-1 154171-76-3 N; R51-53 NR: 51/53S: 24-61  
606-070-00-4 butroxydim (ISO);5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one 414-790-3 138164-12-2 Repr. Cat. 3; R62-63Xn; R22Xi; R38N; R50-53 Xn; NR: 22-38-62-63-50/53S: (2-)22-36/37-60-61  
606-071-00-X 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one 421-050-3 13258-43-0 N; R50-53 NR: 50/53S: 22-60-61  
606-072-00-5 3-acetyl-1-phenyl-pyrrolidine-2,4-dione 421-600-2 719-86-8 Xn; R48/22N; R51-53 Xn; NR: 48/22-51/53S: (2-)22-36/37-61  
606-073-00-0 4,4'-bis(dimethylamino)benzophenone;Michler's ketone 202-027-5 90-94-8 Carc. Cat. 2; R45Muta. Cat. 3; R68Xi; R41 TR: 45-41-68S: 53-45  
606-075-00-1 1-benzyl-5-ethoxyimidazolidine-2,4-dione 417-340-4 65855-02-9 Xn; R22 XnR: 22S: (2-)22  
606-076-00-7 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione 418-630-3 136465-99-1 Xi; R41R43 XiR: 41-43S: (2-)24-26-37/39  
606-077-00-2 (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone 418-650-2 104872-06-2 N; R50-53 NR: 50/53S: 60-61  
606-078-00-8 1-octylazepin-2-one 420-040-6 59227-88-2 C; R34R43N; R51-53 C; NR: 34-43-51/53S: (1/2-)26-36/37/39-45-61  
606-079-00-3 2-n-butyl-benzo[d]isothiazol-3-one 420-590-7 4299-07-4 C; R34R43N; R50-53 C; NR: 34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
606-080-00-9 Reaction product of: 3-hydroxy-5,7-di-tert-butylbenzofuran-2-one with o-xylene 417-100-9 — R53 R: 53S: 61  
606-081-00-4 (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one 419-790-7 4229-69-0 R43R52-53 XiR: 43-52/53S: (2-)22-36/37-61  
606-082-00-X reaction mass of: butan-2-one oxime;syn-O,O'-di(butan-2-one oxime)diethoxysilane 406-930-7  T; R48/25R43R52-53 TR: 43-48/25-52/53S: (1/2-)25-36/37-45-61  
606-083-00-5 2-chloro-5-sec-hexadecylhydroquinone 407-750-1 137193-60-3 Xi; R36/38R43R52-53 XiR: 36/38-43-52/53S: (2-)24-26-37-61  
606-084-00-0 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione 414-540-3 484-33-3 N; R50-53 NR: 50/53S: 60-61  
606-085-00-6 (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one 418-530-1 79200-56-9 Xn; R22Xi; R41R43 XnR: 22-41-43S: (2-)24-26-37/39  
606-086-00-1 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one 422-330-8 56973-87-6 N; R51-53 NR: 51/53S: 61  
606-087-00-7 6-ethyl-5-fluoro-4(3H)-pyrimidone 422-460-5 137234-87-8 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
606-088-00-2 2,4,4,7-tetramethyl-6-octen-3-one 422-520-0 74338-72-0 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
606-089-00-8 reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone;1,4-diamino-2,3-bis-phenoxyanthraquinone 423-220-2 12223-77-7 R53 R: 53S: 61  
606-091-00-9 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one 421-320-0 118289-55-7 N; R50-53 NR: 50/53S: 60-61  
606-092-00-4 reaction mass of: (E)-oxacyclohexadec-12-en-2-one;(E)-oxacyclohexadec-13-en-2-one;a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one 422-320-3  N; R50-53 NR: 50/53S: 60-61  
607-001-00-0 formic acid … % 200-579-1 64-18-6 C; R35 CR: 35S: (1/2-)23-26-45 C; R35: C ≥ 90 %C; R34: 10 % ≤ C < 90 %Xi; R36/38: 2 % ≤ C < 10 % B
607-002-00-6 acetic acid … % 200-580-7 64-19-7 R10C; R35 CR: 10-35S: (1/2-)23-26-45 C; R35: C ≥ 90 %C; R34: 25 % ≤ C < 90 %Xi; R36/38: 10 % ≤ C < 25 % B
607-003-00-1 chloroacetic acid 201-178-4 79-11-8 T; R25C; R34N; R50 T; NR: 25-34-50S: (1/2-)23-37-45-61  
607-004-00-7 TCA (ISO);trichloroacetic acid 200-927-2 76-03-9 C; R35N; R50-53 C; NR: 35-50/53S: (1/2-)26-36/37/39-45-60-61 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
607-005-00-2 TCA-sodium (ISO);sodium trichloroacetate 211-479-2 650-51-1 Xi; R37N; R50-53 Xi; NR: 37-50/53S: (2-)46-60-61  
607-006-00-8 oxalic acid 205-634-3 144-62-7 Xn; R21/22 XnR: 21/22S: (2-)24/25 Xn; R21/22: C ≥ 5 % 
607-007-00-3 salts of oxalic acid — — Xn; R21/22 XnR: 21/22S: (2-)24/25 Xn; R21/22: C ≥ 5 % A
607-008-00-9 acetic anhydride 203-564-8 108-24-7 R10Xn; R20/22C; R34 CR: 10-20/22-34S: (1/2-)26-36/37/39-45 C; R34: C ≥ 25 %Xi; R37/38-41: 5 % ≤ C < 25 %Xi; R36: 1 % ≤ C < 5 % 
607-009-00-4 phthalic anhydride 201-607-5 85-44-9 Xn; R22Xi; R37/38-41R42/43 XnR: 22-37/38-41-42/43S: (2-)23-24/25-26-37/39-46  
607-010-00-X propionic anhydride 204-638-2 123-62-6 C; R34 CR: 34S: (1/2-)26-45 C; R34: C ≥ 25 %Xi; R36/38: 10 % ≤ C < 25 % 
607-011-00-5 acetyl chloride 200-865-6 75-36-5 F; R11R14C; R34 F; CR: 11-14-34S: (1/2-)9-16-26-45  
607-012-00-0 benzoyl chloride 202-710-8 98-88-4 C; R34 CR: 34S: (1/2-)26-45  
607-013-00-6 dimethyl carbonate 210-478-4 616-38-6 F; R11 FR: 11S: (2-)9-16  
607-014-00-1 methyl formate 203-481-7 107-31-3 F+; R12Xn; R20/22Xi; R36/37 F+; XnR: 12-20/22-36/37S: (2-)9-16-24-26-33  
607-015-00-7 ethyl formate 203-721-0 109-94-4 F; R11Xn; R20/22Xi; R36/37 F; XnR: 11-20/22-36/37S: (2-)9-16-24-26-33  
607-016-00-2 propyl formate; [1]isopropyl formate [2] 203-798-0 [1]210-901-2 [2] 110-74-7 [1]625-55-8 [2] F; R11Xi; R36/37R67 F; XiR: 11-36/37-67S: (2-)9-16-24-33  C
607-017-00-8 butyl formate; [1]tert-butyl formate; [2]isobutyl formate [3] 209-772-5 [1]212-105-0 [2]208-818-1 [3] 592-84-7 [1]762-75-4 [2]542-55-2 [3] F; R11Xi; R36/37 F; XiR: 11-36/37S: (2-)9-16-24-33  C
607-018-00-3 isopentyl formate; [1]pentyl formate; [2]2-methylbutyl formate [3] 203-769-2 [1]211-340-6 [2]252-343-2 [3] 110-45-2 [1]638-49-3 [2]35073-27-9 [3] R10Xi; R36/37 XiR: 10-36/37S: (2-)24  C
607-019-00-9 methyl chloroformate 201-187-3 79-22-1 F; R11T+; R26Xn; R21/22C; R34 F; T+R: 11-21/22-26-34S: (1/2-)14-26-28-36/37/39-45-46-63  
607-020-00-4 ethyl chloroformate 208-778-5 541-41-3 F; R11T+; R26Xn; R22C; R34 F; T+R: 11-22-26-34S: (1/2-)9-16-26-28-33-36/37/39-45  
607-021-00-X methyl acetate 201-185-2 79-20-9 F; R11Xi; R36R66R67 F; XiR: 11-36-66-67S: (2-)16-26-29-33  
607-022-00-5 ethyl acetate 205-500-4 141-78-6 F; R11Xi; R36R66R67 F; XiR: 11-36-66-67S: (2-)16-26-33  
607-023-00-0 vinyl acetate 203-545-4 108-05-4 F; R11 FR: 11S: (2-)16-23-29-33  D
607-024-00-6 propyl acetate; [1]isopropyl acetate [2] 203-686-1 [1]203-561-1 [2] 109-60-4 [1]108-21-4 [2] F; R11Xi; R36R66R67 F; XiR: 11-36-66-67S: (2-)16-26-29-33  C
607-025-00-1 n-butyl acetate 204-658-1 123-86-4 R10R66R67 R: 10-66-67S: (2-)25  
607-026-00-7 sec-butyl acetate; [1]isobutyl acetate; [2]tert-butyl acetate [3] 203-300-1 [1]203-745-1 [2]208-760-7 [3] 105-46-4 [1]110-19-0 [2]540-88-5 [3] F; R11R66 FR: 11-66S: (2-)16-23-25-29-33  C
607-027-00-2 methyl propionate 209-060-4 554-12-1 F; R11Xn; R20 F; XnR: 11-20S: (2-)16-24-29-33  
607-028-00-8 ethyl propionate 203-291-4 105-37-3 F; R11 FR: 11S: (2-)16-23-24-29-33  
607-029-00-3 n-butyl propionate; [1]sec-butyl propionate; [2]tert-butyl propionate; [3]iso-butyl propionate [4] 209-669-5 [1]- [2]- [3]208-746-0 [4] 590-01-2 [1]591-34-4 [2]20487-40-5 [3]540-42-1 [4] R10 R: 10S: (2-)  C
607-030-00-9 propyl propionate 203-389-7 106-36-5 R10Xn; R20 XnR: 10-20S: (2-)24  
607-031-00-4 butyl butyrate 203-656-8 109-21-7 R10 R: 10S: (2-)  C
607-032-00-X ethyl acrylate 205-438-8 140-88-5 F; R11Xn; R20/21/22Xi; R36/37/38R43 F; XnR: 11-20/21/22-36/37/38-43S: (2-)9-16-33-36/37 Xi; 36/37/38: C ≥ 5 % D
607-033-00-5 n-butyl methacrylate 202-615-1 97-88-1 R10Xi; R36/37/38R43 XiR: 10-36/37/38-43S: (2-)  D
607-034-00-0 methyl acrylate;methyl propenoate 202-500-6 96-33-3 F; R11Xn; R20/21/22Xi; R36/37/38R43 F; XnR: 11-20/21/22-36/37/38-43S: (2-)9-25-26-33-36/37-43  D
607-035-00-6 methyl methacrylate;methyl 2-methylprop-2-enoate;methyl 2-methylpropenoate 201-297-1 80-62-6 F; R11Xi; R37/38R43 F; XiR: 11-37/38-43S: (2-)24-37-46  D
607-036-00-1 2-methoxyethyl acetate;methylglycol acetate 203-772-9 110-49-6 Repr. Cat. 2; R60-61Xn; R20/21/22 TR: 60-61-20/21/22S: 53-45  E
607-037-00-7 2-ethoxyethyl acetate;ethylglycol acetate 203-839-2 111-15-9 $ Repr. Cat. 2; R60-61Xn; R20/21/22 TR: 60-61-20/21/22S: 53-45  E
607-038-00-2 2-butoxyethyl acetate;butylglycol acetate 203-933-3 112-07-2 Xn; R20/21 XnR: 20/21S: (2-)24  
607-039-00-8 2,4-D (ISO);2,4-dichlorophenoxyacetic acid 202-361-1 94-75-7 Xn; R22Xi; R37-41R43R52-53 XnR: 22-37-41-43-52/53S: (2-)24/25-26-36/37/39-46-61  
607-040-00-3 salts of 2,4-D — — Xn; R22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-51/53S: (2-)24/25-26-36/37/39-46-61  A
607-041-00-9 2,4,5-T (ISO);2,4,5-trichlorophenoxy acetic acid 202-273-3 93-76-5 Xn; R22Xi; R36/37/38N; R50-53 Xn; NR: 22-36/37/38-50/53S: (2-)24-60-61  
607-042-00-4 salts and esters of 2,4,5-T;salts and esters of 2,4,5-trichlorophenoxy acetic acid — — Xn; R22Xi; R36/37/38N; R50-53 Xn; NR: 22-36/37/38-50/53S: (2-)24-60-61  A
607-043-00-X dicamba (ISO);2,5-dichloro-6-methoxybenzoic acid;3,6-dichloro-2-methoxybenzoic acid 217-635-6 1918-00-9 Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)26-61  
607-044-00-5 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1]potassium 3,6-dichloro-o-anisate [2] 218-951-7 [1]233-002-7 [2] 2300-66-5 [1]10007-85-9 [2] Xi; R36R52-53 XiR: 36-52/53S: (2-)26-61  
607-045-00-0 dichlorprop (ISO);2-(2,4-dichlorophenoxy) propionic acid 204-390-5 120-36-5 Xn; R21/22Xi; R38-41 XnR: 21/22-38-41S: (2-)26-36/37  
607-046-00-6 salts of dichlorprop — — Xn; R20/21/22 XnR: 20/21/22S: (2-)13  A
607-047-00-1 fenoprop (ISO);2-(2,4,5-trichlorophenoxy)propionic acid 202-271-2 93-72-1 Xn; R22Xi; R38N; R50-53 Xn; NR: 22-38-50/53S: (2-)37-60-61  
607-048-00-7 salts of fenoprop;salts of 2-(2,4,5-trichlorophenoxy)propionic acid — — Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)13-60-61  A
607-049-00-2 mecoprop (ISO);2-(4-chloro-o-tolyloxy) propionic acid;(RS)-2-(4-chloro-o-tolyloxy)propionic acid; [1]2-(4-chloro-2-methylphenoxy)propionic acid [2] 230-386-8 [1]202-264-4 [2] 7085-19-0 [1]7085-19-0 [2] Xn; R22Xi; R38-41N; R50-53 Xn; NR: 22-38-41-50/53S: (2-)13-26-37/39-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
607-050-00-8 salts of mecoprop — — Xn; R22Xi; R38-41N; R50-53 Xn; NR: 22-38-41-50/53S: (2-)13-26-37/39-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % A
607-051-00-3 MCPA (ISO);4-chloro-o-tolyloxyacetic acid 202-360-6 94-74-6 Xn; R22Xi; R38-41 XnR: 22-38-41S: (2-)26-37-39  
607-052-00-9 salts and esters of MCPA — — Xn; R20/21/22 XnR: 20/21/22S: (2-)13  A
607-053-00-4 MCPB (ISO);4-(4-chloro-o-tolyloxy) butyric acid 202-365-3 94-81-5 N; R50-53 NR: 50/53S: 60-61  
607-054-00-X salts and esters of MCPB — — Xn; R22 XnR: 22S: (2-)24/25  A
607-055-00-5 endothal-sodium (ISO);disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate 204-959-8 129-67-9 T; R25Xn; R21Xi; R36/37/38 TR: 21-25-36/37/38S: (1/2-)36/37/39-45  
607-056-00-0 warfarin (ISO); [1](S)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone; [2](R)-4-hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone [3] 201-377-6 [1]226-907-3 [2]226-908-9 [3] 81-81-2 [1]5543-57-7 [2]5543-58-8 [3] Repr. Cat. 1; R61T; R48/25R52-53 TR: 61-48/25-52/53S: 53-45-61  E
607-057-00-6 coumachlor (ISO);3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin 201-378-1 81-82-3 Xn; R48/22R52-53 XnR: 48/22-52/53S: (2-)37-61  
607-058-00-1 coumafuryl (ISO);fumarin;(RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin;4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin 204-195-5 117-52-2 T; R25-48/25R52-53 TR: 25-48/25-52/53S: (1/2-)37-45-61  
607-059-00-7 coumatetralyl;4-hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl)coumarin 227-424-0 5836-29-3 T+; R27/28T; R48/24/25R52-53 T+R: 27/28-48/24/25-52/53S: (1/2-)28-36/37-45-61  
607-060-00-2 dicoumarol;4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) 200-632-9 66-76-2 T; R48/25Xn; R22N; R51-53 T; NR: 22-48/25-51/53S: (1/2-)37-45-61  
607-061-00-8 acrylic acid;prop-2-enoic acid 201-177-9 79-10-7 R10Xn; R20/21/22C; R35N; R50 C; NR: 10-20/21/22-35-50S: (1/2-)26-36/37/39-45-61 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % D
607-062-00-3 n-butyl acrylate 205-480-7 141-32-2 R10Xi; R36/37/38R43 XiR: 10-36/37/38-43S: (2-)9  D
607-063-00-9 isobutyric acid 201-195-7 79-31-2 Xn; R21/22 XnR: 21/22S: (2-)  
607-064-00-4 benzyl chloroformate 207-925-0 501-53-1 C; R34N; R50-53 C; NR: 34-50/53S: (1/2-)26-45-60-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
607-065-00-X bromoacetic acid 201-175-8 79-08-3 T; R23/24/25C; R35N; R50 T; C; NR: 23/24/25-35-50S: (1/2-)26-36/37/39-45-61  
607-066-00-5 dichloroacetic acid 201-207-0 79-43-6 C; R35N; R50 C; NR: 35-50S: (1/2-)26-45-61  
607-067-00-0 dichloroacetyl chloride 201-199-9 79-36-7 C; R35N; R50 C; NR: 35-50S: (1/2-)9-26-45-61  
607-068-00-6 iodoacetic acid 200-590-1 64-69-7 T; R25C; R35 T; CR: 25-35S: (1/2-)22-36/37/39-45  
607-069-00-1 ethyl bromoacetate 203-290-9 105-36-2 T+; R26/27/28 T+R: 26/27/28S: (1/2-)7/9-26-45  
607-070-00-7 ethyl chloroacetate 203-294-0 105-39-5 T; R23/24/25N; R50 T; NR: 23/24/25-50S: (1/2-)7/9-45-61  
607-071-00-2 ethyl methacrylate 202-597-5 97-63-2 F; R11Xi; R36/37/38R43 F; XiR: 11-36/37/38-43S: (2-)9-16-29-33  D
607-072-00-8 2-hydroxyethyl acrylate 212-454-9 818-61-1 T; R24C; R34R43N; R50 T; NR: 24-34-43-50S: (1/2-)26-36/39-45-61 T; R24: C ≥ 2 %Xn; R21: 0,2 % ≤ C < 2 %R43: C ≥ 0,2 % D
607-073-00-3 4-CPA (ISO);4-chlorophenoxyacetic acid 204-581-3 122-88-3 Xn; R22 XnR: 22S: (2-)  
607-074-00-9 chlorfenac (ISO);2,3,6-trichlorophenylacetic acid 201-599-3 85-34-7 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)36-61  
607-075-00-4 chlorfenprop-methyl;methyl 2-chloro-3-(4-chlorophenyl)propionate 238-413-5 14437-17-3 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-60-61  
607-076-00-X dodine (ISO);dodecylguanidinium acetate 219-459-5 2439-10-3 Xn; R22Xi; R36/38N; R50-53 Xn; NR: 22-36/38-50/53S: (2-)26-60-61  
607-077-00-5 erbon (ISO);2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate — 136-25-4 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
607-078-00-0 fluenetil (ISO);2-fluoroethyl biphenyl-4-ylacetate — 4301-50-2 T+; R27/28 T+R: 27/28S: (1/2-)28-36/37-45  
607-079-00-6 kelevan (ISO);ethyl 5-(perchloro-5-hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate;ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate — 4234-79-1 T; R24Xn; R22N; R51-53 T; NR: 22-24-51/53S: (1/2-)36/37-45-61  
607-080-00-1 chloroacetyl chloride 201-171-6 79-04-9 R14R29T; R23/24/25-48/23C; R35N; R50 T; C; NR: 14-23/24/25-29-35-48/23-50S: (1/2-)7/8-9-26-36/37/39-45-61  
607-081-00-7 fluoroacetic acid 205-631-7 144-49-0 T+; R28N; R50 T+; NR: 28-50S: (1/2-)20-22-26-45-61  
607-082-00-2 fluoroacetates, soluble — — T+; R28N; R50 T+; NR: 28-50S: (1/2-)20-22-26-45-61  A
607-083-00-8 2,4-DB (ISO);4-(2,4-dichlorophenoxy)butyric acid 202-366-9 94-82-6 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)25-29-46-61  
607-084-00-3 salts of 2,4-DB — — Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)26-29-39-46-61  A
607-085-00-9 benzyl benzoate 204-402-9 120-51-4 Xn; R22 XnR: 22S: (2-)25  
607-086-00-4 diallyl phthalate 205-016-3 131-17-9 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)24/25-60-61  
607-088-00-5 methacrylic acid;2-methylpropenoic acid 201-204-4 79-41-4 Xn; R21/22C; R35 CR: 21/22-35S: (1/2-)26-36/37/39-45 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % D
607-089-00-0 propionic acid … % 201-176-3 79-09-4 C; R34 CR: 34S: (1/2-)23-36-45 C; R34: C ≥ 25 %Xi; R36/37/38: 10 % ≤ C < 25 % B
607-090-00-6 thioglycolic acid 200-677-4 68-11-1 T; R23/24/25C; R34 TR: 23/24/25-34S: (1/2-)25-27-28-45 T; R23/24/25: C ≥ 2 %Xn; R20/21/22: 0,2 % ≤ C < 2 % 
607-091-00-1 trifluoroacetic acid . . . % 200-929-3 76-05-1 Xn; R20C; R35R52-53 CR: 20-35-52/53S: (1/2-)9-26-27-28-45-61 Xn; R20: C ≥ 10 % B
607-092-00-7 methyl lactate; [1]methyl (±)-lactate; [2]methyl (R)-lactate; [3]methyl (S)-(-)-lactate [4] 208-930-0 [1]218-449-8 [2]241-420-6 [3]248-704-9 [4] 547-64-8 [1]2155-30-8 [2]17392-83-5 [3]27871-49-4 [4] R10Xi; R36/37 XiR: 10-36/37S: (2-)24  C
607-093-00-2 propionyl chloride 201-170-0 79-03-8 F; R11R14C; R34 F; CR: 11-14-34S: (1/2-)9-16-26-45  B D
607-094-00-8 peracetic acid . . . % 201-186-8 79-21-0 R10O; R7Xn; R20/21/22C; R35N; R50 O; C; NR: 7-10-20/21/22-35-50S: (1/2-)3/7-14-36/37/39-45-61 Xn; R20/21/22: C ≥ 10 %C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % B D
607-095-00-3 maleic acid 203-742-5 110-16-7 Xn; R22Xi; R36/37/38 XnR: 22-36/37/38S: (2-)26-28-37  
607-096-00-9 maleic anhydride 203-571-6 108-31-6 Xn; R22C; R34R42/43 CR: 22-34-42/43S: (2-)22-26-36/37/39-45  
607-097-00-4 benzene-1,2,4-tricarboxylic acid 1,2-anhydride;trimellitic anhydride 209-008-0 552-30-7 Xi; R37-41R42/43 XnR: 37-41-42/43S: (2-)22-26-36/37/39  
607-098-00-X benzene-1,2:4,5-tetracarboxylic dianhydride;benzene-1,2:4,5-tetracarboxylic dianhydride;pyromellitic dianhydride 201-898-9 89-32-7 Xi; R41R42/43 XnR: 41-42/43S: (2-)22-24-26-37/39  
607-099-00-5 1,2,3,6-tetrahydrophthalic anhydride; [1]cis-1,2,3,6-tetrahydrophthalic anhydride; [2]3,4,5,6-tetrahydrophthalic anhydride; [3]tetrahydrophthalic anhydride [4] 201-605-4 [1]213-308-7 [2]219-374-3 [3]247-570-9 [4] 85-43-8 [1]935-79-5 [2]2426-02-0 [3]26266-63-7 [4] Xi; R41R42/43R52-53 XnR: 41-42/43-52/53S: (2-)22-24-26-37/39-61  C
607-100-00-9 benzophenone-3,3',4,4'-tetracarboxylic dianhydride;4,4'-carbonyldi(phthalic anhydride) 219-348-1 2421-28-5 Xi; R36/37 XiR: 36/37S: (2-)25 Xi; R36/37: C ≥ 1 % 
607-101-00-4 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride 204-077-3 115-27-5 Xi; R36/37/38 XiR: 36/37/38S: (2-)25 Xi; R36/37/38: C ≥ 1 % 
607-102-00-X cyclohexane-1,2-dicarboxylic anhydride; [1]cis-cyclohexane-1,2-dicarboxylic anhydride; [2]trans-cyclohexane-1,2-dicarboxylic anhydride [3] 201-604-9 [1]236-086-3 [2]238-009-9 [3] 85-42-7 [1]13149-00-3 [2]14166-21-3 [3] Xi; R41R42/43 XnR: 41-42/43S: (2-)23-24-26-37/39  C
607-103-00-5 succinic anhydride 203-570-0 108-30-5 Xi; R36/37 XiR: 36/37S: (2-)25 Xi; R36/37: C ≥ 1 % 
607-104-00-0 cyclopentane-1,2,3,4-tetracarboxylic dianhydride 227-964-7 6053-68-5 Xi; R36/37 XiR: 36/37S: (2-)25 Xi; R36/37: C ≥ 1 % 
607-105-00-6 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1]1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2](1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] 204-957-7 [1]212-557-9 [2]220-384-5 [3] 129-64-6 [1]826-62-0 [2]2746-19-2 [3] Xi; R41R42/43 XnR: 41-42/43S: (2-)22-24-26-37/39  C
607-106-00-1 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride — 123748-85-6 Xn; R22Xi; R36/37/38R42 XnR: 22-36/37/38-42S: (2-)39 Xi; R36/37/38: C ≥ 10 % C
607-107-00-7 2-ethylhexyl acrylate 203-080-7 103-11-7 Xi; R37/38R43 XiR: 37/38-43S: (2-)36/37-46  D
607-108-00-2 2-hydroxy-1-methylethylacrylate; [1]2-hydroxypropylacrylate; [2]acrylic acid, monoester with propane-1,2-diol [3] 220-852-9 [1]213-663-8 [2]247-118-0 [3] 2918-23-2 [1]999-61-1 [2]25584-83-2 [3] T; R23/24/25C; R34R43 TR: 23/24/25-34-43S: (1/2-)26-36/37/39-45 T; R23/24/25: C ≥ 2 %Xn; R20/21/22: 0,2 % ≤ C < 2 %R43: C ≥ 0,2 % C D
607-109-00-8 hexamethylene diacrylate;hexane-1,6-diol diacrylate 235-921-9 13048-33-4 Xi; R36/38R43 XiR: 36/38-43S: (2-)39  D
607-110-00-3 pentaerythritol triacrylate 222-540-8 3524-68-3 Xi; R36/38R43 XiR: 36/38-43S: (2-)39  D
607-111-00-9 2,2-bis(acryloyloxymethyl)butyl acrylate;trimethylolpropane triacrylate 239-701-3 15625-89-5 Xi; R36/38R43 XiR: 36/38-43S: (2-)39  D
607-112-00-4 2,2-dimethyltrimethylene diacrylate;neopentyl glycol diacrylate 218-741-5 2223-82-7 T; R24Xi; R36/38R43 TR: 24-36/38-43S: (1/2-)28-39-45 T; R24: C ≥ 5 %Xn; R21: 0,2 % ≤ C < 5 % D
607-113-00-X isobutyl methacrylate 202-613-0 97-86-9 R10Xi; R36/37/38R43N; R50 Xi; NR: 10-36/37/38-43-50S: (2-)24-37-61  D
607-114-00-5 ethylene dimethacrylate 202-617-2 97-90-5 Xi; R37R43 XiR: 37-43S: (2-)24-37 Xi; R37: C ≥ 10 % D
607-115-00-0 isobutyl acrylate 203-417-8 106-63-8 R10Xn; R20/21Xi; R38R43 XnR: 10-20/21-38-43S: (2-)9-24-37 Xi; R38: C ≥ 10 % D
607-116-00-6 cyclohexyl acrylate 221-319-3 3066-71-5 Xi; R37/38N; R51-53 Xi; NR: 37/38-51/53S: (2-)61 Xi; R37/38: C ≥ 10 % D
607-117-00-1 2,3-epoxypropyl acrylate;glycidyl acrylate 203-440-3 106-90-1 T; R23/24/25C; R34R43 TR: 23/24/25-34-43S: (1/2-)26-36/37/39-45 T; R23/24/25: C ≥ 2 %Xn; R20/21/22: 0,2 % ≤ C < 2 %R43: C ≥ 0,2 % D
607-118-00-7 1-methyltrimethylene diacrylate;1,3-butylene glycol diacrylate 243-105-9 19485-03-1 Xn; R21C; R34R43 CR: 21-34-43S: (1/2-)26-36/37/39-45  D
607-119-00-2 tetramethylene diacrylate;1,4-butyleneglycol diacrylate 213-979-6 1070-70-8 Xn; R21C; R34R43 CR: 21-34-43S: (1/2-)26-36/37/39-45  D
607-120-00-8 2,2'-oxydiethyl diacrylate;diethylene glycol diacrylate 223-791-6 4074-88-8 T; R24Xi; R36/38R43 TR: 24-36/38-43S: (1/2-)28-39-45 T; R24: C ≥ 2 %Xn; R21: 0,2 % ≤ C < 2 %R43: C ≥ 0,2 % D
607-121-00-3 8,9,10-trinorborn-2-yl acrylate — 10027-06-2 Xn; R21Xi; R38R43 XnR: 21-38-43S: (2-)28 Xi; R38: C ≥ 10 % D
607-122-00-9 pentaerythritol tetraacrylate 225-644-1 4986-89-4 Xi; R36/38R43 XiR: 36/38-43S: (2-)26-39  D
607-123-00-4 2,3-epoxypropyl methacrylate;glycidyl methacrylate 203-441-9 106-91-2 Xn; R20/21/22Xi; R36/38R43 XnR: 20/21/22-36/38-43S: (2-)26-28 Xi; R36/38: C ≥ 10 % D
607-124-00-X 2-hydroxyethyl methacrylate 212-782-2 868-77-9 Xi; R36/38R43 XiR: 36/38-43S: (2-)26-28  D
607-125-00-5 2-hydroxypropyl methacrylate; [1]3-hydroxypropyl methacrylate [2] 213-090-3 [1]220-426-2 [2] 923-26-2 [1]2761-09-3 [2] Xi; R36R43 XiR: 36-43S: (2-)24/25-26-37/39  C D
607-126-00-0 2,2'-(ethylenedioxy)diethyl diacrylate;triethylene glycol diacrylate 216-853-9 1680-21-3 Xi; R36/38R43 XiR: 36/38-43S: (2-)26-28  D
607-127-00-6 2-diethylaminoethyl methacrylate 203-275-7 105-16-8 Xn; R20Xi; R36/38R43 XnR: 20-36/38-43S: (2-)26 Xi; R36/38: C ≥ 10 % D
607-128-00-1 2-tert-butylaminoethyl methacrylate 223-228-4 3775-90-4 Xi; R36/38R43 XiR: 36/38-43S: (2-)26  D
607-129-00-7 ethyl lactate;ethyl DL-lactate; [1]ethyl (S)-2-hydroxypropionate;ethyl L-lactate;ethyl-(S)-lactate [2] 202-598-0 [1]211-694-1 [2] 97-64-3 [1]687-47-8 [2] R10Xi; R37-41 XiR: 10-37-41S: (2-)24-26-39  C
607-130-00-2 pentyl acetate; [1]isopentyl acetate; [2]1-methylbutyl acetate; [3]2-methylbutyl acetat; [4]2(or 3)-methylbutyl acetate [5] 211-047-3 [1]204-662-3 [2]210-946-8 [3]210-843-8 [4]282-263-3 [5] 628-63-7 [1]123-92-2 [2]626-38-0 [3]624-41-9 [4]84145-37-9 [5] R10R66 R: 10-66S: (2-)23-25  C
607-131-00-8 isopentyl propionate; [1]pentyl propionate; [2]2-methylbutyl propionate [3] 203-322-1 [1]210-852-7 [2]219-449-0 [3] 105-68-0 [1]624-54-4 [2]2438-20-2 [3] R10 R: 10S: (2-)23-24  C
607-132-00-3 2-dimethylaminoethyl methacrylate 220-688-8 2867-47-2 Xn; R21/22Xi; R36/38R43 XnR: 21/22-36/38-43S: (2-)26-28 Xi; R36/38: C ≥ 10 % D
607-133-00-9 monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex — — Xi; R36/37/38N; R51-53 Xi; NR: 36/37/38-51/53S: (2-)26-28-61 Xi; R36/37/38: C ≥ 10 % A
607-134-00-4 monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex — — Xi; R36/37/38 XiR: 36/37/38S: (2-)26-28 Xi; R36/37/38: C ≥ 10 % A
607-135-00-X butyric acid 203-532-3 107-92-6 C; R34 CR: 34S: (1/2-)26-36-45  
607-136-00-5 butyryl chloride 205-498-5 141-75-3 F; R11C; R34 F; CR: 11-34S: (1/2-)16-23-26-36-45  
607-137-00-0 methyl acetoacetate 203-299-8 105-45-3 Xi; R36 XiR: 36S: (2-)26  
607-138-00-6 butyl chloroformate;chloroformic acid butyl ester 209-750-5 592-34-7 R10T; R23C; R34 TR: 10-23-34S: (1/2-)26-36-45  
607-139-00-1 2-chloropropionic acid 209-952-3 598-78-7 Xn; R22C; R35 CR: 22-35S: (1/2-)23-26-28-36-45  
607-140-00-7 isobutyryl chloride 201-194-1 79-30-1 F; R11C; R35 F; CR: 11-35S: (1/2-)16-23-26-36-45  
607-141-00-2 oxydiethylene bis(chloroformate) 203-430-9 106-75-2 Xn; R22Xi; R38-41N; R51-53 Xn; NR: 22-38-41-51/53S: (2-)23-26-61  
607-142-00-8 propyl chloroformate;chloroformic acid propylester;n-propyl chloroformate 203-687-7 109-61-5 R10 $T; R23C; R34 TR: 10-23-34S: (1/2-)26-36-45  
607-143-00-3 valeric acid 203-677-2 109-52-4 C; R34R52-53 CR: 34-52/53S: (1/2-)26-36-45-61  
607-144-00-9 adipic acid 204-673-3 124-04-9 Xi; R36 XiR: 36S: (2-)  
607-145-00-4 methanesulphonic acid 200-898-6 75-75-2 C; R34 CR: 34S: (1/2-)26-36-45  
607-146-00-X fumaric acid 203-743-0 110-17-8 Xi; R36 XiR: 36S: (2-)26  
607-147-00-5 oxalic acid diethylester;diethyl oxalate 202-464-1 95-92-1 Xn; R22Xi; R36 XnR: 22-36S: (2-)23  
607-148-00-0 guanidinium chloride;guanadine hydrochloride 200-002-3 50-01-1 Xn; R22Xi; R36/38 XnR: 22-36/38S: (2-)22  
607-149-00-6 urethane (INN);ethyl carbamate 200-123-1 51-79-6 Carc. Cat. 2; R45 TR: 45S: 53-45  
607-150-00-1 endothal (ISO);7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid 205-660-5 145-73-3 T; R25Xn; R21Xi; R36/37/38 TR: 21-25-36/37/38S: (1/2-)36/37/39-45  
607-151-00-7 propargite (ISO);2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite 219-006-1 2312-35-8 Carc. Cat. 3; R40T; R23Xi; R38-41N; R50-53 T; NR: 23-38-40-41-50/53S: (1/2-)26-36/37/39-45-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
607-152-00-2 2,3,6-TBA (ISO);2,3,6-trichlorobenzoic acid 200-026-4 50-31-7 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
607-153-00-8 benazolin (ISO);4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid 223-297-0 3813-05-6 Xi; R36/38R52-53 XiR: 36/38-52/53S: (2-)22-61  
607-154-00-3 ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DL-alaninate;benzoylprop-ethyl (ISO) 244-845-5 22212-55-1 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)24-60-61  
607-155-00-9 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-(6H)-pyran-2-carboxylic acid;blasticidin-s — 2079-00-7 T+; R28 T+R: 28S: (1/2-)24/25-36/37-45  
607-156-00-4 chlorfenson (ISO);4-chlorophenyl 4-chlorobenzenesulfonate 201-270-4 80-33-1 Xn; R22Xi; R38N; R50-53 Xn; NR: 22-38-50/53S: (2-)37-60-61  
607-157-00-X 3-(3-biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4-hydroxycoumarin;difenacoum 259-978-4 56073-07-5 T+; R28T; R48/25N; R50-53 T+; NR: 28-48/25-50/53S: (1/2-)36/37-45-60-61  
607-158-00-5 sodium salt of chloroacetic acid;sodium chloroacetate 223-498-3 3926-62-3 T; R25Xi; R38N; R50 T; NR: 25-38-50S: (1/2-)22-37-45-61  
607-159-00-0 chlorobenzilate (ISO);ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate;ethyl 4,4'-dichlorobenzilate 208-110-2 510-15-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
607-160-00-6 isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate;clofop-isobutyl (ISO) — 51337-71-4 Xn; R22 XnR: 22S: (2-)  
607-161-00-1 diethanolamine salt of 4-CPA — — Xn; R22 XnR: 22S: (2-)  
607-162-00-7 2,2-dichloropropionic acid;dalapon 200-923-0 75-99-0 Xn; R22Xi; R38-41R52-53 XnR: 22-38-41-52/53S: (2-)26-39-61  
607-163-00-2 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione;dehydracetic acid 208-293-9 520-45-6 Xn; R22 XnR: 22S: (2-)  
607-164-00-8 sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate;sodium dehydracetate 224-580-1 4418-26-2 Xn; R22 XnR: 22S: (2-)  
607-165-00-3 diclofop-methyl (ISO);methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate;methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; 257-141-8 51338-27-3 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61  
607-166-00-9 medinoterb acetate (ISO);6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate 219-634-6 2487-01-6 T; R25Xn; R21 TR: 21-25S: (1/2-)36/37-45  
607-167-00-4 sodium 3-chloroacrylate — 4312-97-4 Xn; R21/22 XnR: 21/22S: (2-)36/37  
607-168-00-X dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate;propylisome — 83-59-0 T; R24Xn; R22N; R50-53 T; NR: 22-24-50/53S: (1/2-)36/37-45-60-61  
607-169-00-5 sodium fluoroacetate 200-548-2 62-74-8 T+; R26/27/28N; R50 T+; NR: 26/27/28-50S: (1/2-)13-22-36/37-45-61  
607-170-00-0 bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate;thiocyclam-oxalate 250-859-2 31895-22-4 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-46-60-61  
607-172-00-1 4-hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4-tetrahydro-1-naphthyl)coumarin;brodifacoum 259-980-5 56073-10-0 T+; R27/28T; R48/24/25N; R50-53 T+; NR: 27/28-48/24/25-50/53S: (1/2-)36/37-45-60-61  
607-173-00-7 dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate 400-460-6 — R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
607-174-00-2 reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate 400-580-9 — Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)28-61  
607-175-00-8 methyl 2-(2-nitrobenzylidene)acetoacetate 400-650-9 39562-27-1 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-176-00-3 reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly(oxyethylene) 400-830-7 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)36/37-61  
607-177-00-9 methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)3-methylureidosulphonyl)benzoate 401-190-1 101200-48-0 R43 XiR: 43S: (2-)22-24-37  
607-178-00-4 methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate 401-340-6 83055-99-6 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-179-00-X (benzothiazol-2-ylthio)succinic acid 401-450-4 95154-01-1 R43 XiR: 43S: (2-)24-37  
607-180-00-5 potassium 2-hydroxycarbazole-1-carboxylate 401-630-2 96566-70-0 Xn; R22Xi; R36/37R52-53 XnR: 22-36/37-52/53S: (2-)22-26-61  
607-181-00-0 3,5-dichloro-2,4-difluorobenzoyl fluoride 401-800-6 101513-70-6 T; R23C; R34Xn; R22R29R43R52-53 T; CR: 22-23-29-34-43-52/53S: (1/2-)26-36/37/39-45-61  
607-182-00-6 methyl 3-sulphamoyl-2-thenoate 402-050-2 — R43 XiR: 43S: (2-)24-37  
607-183-00-1 zinc 2-hydroxy-5-C13-18alkylbenzoate 402-280-3 — Xi; R36/38N; R51-53 Xi; NR: 36/38-51/53S: (2-)26-61  
607-184-00-7 S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate 402-290-8 85702-90-5 R10R42/43 XnR: 10-42/43S: (2-)23-24-37  
607-185-00-2 ethyl trans-3-dimethylaminoacrylate 402-650-4 1117-37-9 R43 XiR: 43S: (2-)24-37  
607-186-00-8 quinclorac (ISO);3,7-dichloroquinoline-8-carboxylic acid 402-780-1 84087-01-4 R43 XiR: 43S: (2-)24-37  
607-187-00-3 bis(2,2,6,6-tetramethyl-4-piperidyl) succinate 402-940-0 62782-03-0 Xi; R36R52-53 XiR: 36-52/53S: (2-)26-61  
607-188-00-9 hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate 402-970-4 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-189-00-4 trimethylenediaminetetraacetic acid 400-400-9 1939-36-2 Xn; R22Xi; R41N; R50-53 Xn; NR: 22-41-50/53S: (2-)22-26-39-60-61  
607-190-00-X methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) 401-890-7 77402-03-0 Carc. Cat. 2; R45Muta. Cat. 2; R46Xn; R22Xi; R36 TR: 45-46-22-36S: 53-45  E
607-191-00-5 isobutyl 3,4-epoxybutyrate 401-920-9 100181-71-3 Xi; R38R43N; R50-53 Xi; NR: 38-43-50/53S: (2-)24-28-36/37-60-61  
607-192-00-0 disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate 402-360-8 92511-22-3 Xi; R41 XiR: 41S: (2-)26-39  
607-194-00-1 propylene carbonate 203-572-1 108-32-7 Xi; R36 XiR: 36S: (2-)  
607-195-00-7 2-methoxy-1-methylethyl acetate 203-603-9 108-65-6 R10Xi; R36 XiR: 10-36S: (2-)25  
607-196-00-2 heptanoic acid 203-838-7 111-14-8 C; R34 CR: 34S: (1/2-)26-28-36/37/39-45  
607-197-00-8 nonanoic acid 203-931-2 112-05-0 C; R34 CR: 34S: (1/2-)26-28-36/37/39-45  
607-198-00-3 propyl 3,4,5-trihydroxybenzoate 204-498-2 121-79-9 Xn; R22R43 XnR: 22-43S: (2-)24-37  
607-199-00-9 octyl 3,4,5-trihydroxybenzoate 213-853-0 1034-01-1 Xn; R22R43 XnR: 22-43S: (2-)24-37  
607-200-00-2 dodecyl 3,4,5-trihydroxybenzoate 214-620-6 1166-52-5 R43 XiR: 43S: (2-)24-37  
607-201-00-8 thiocarbonyl chloride 207-341-6 463-71-8 T; R23Xn; R22Xi; R36/37/38 TR: 22-23-36/37/38S: (1/2-)7-9-36/37-45  
607-203-00-9 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate 279-452-8 80387-97-9 Repr. Cat. 2; R61R43R52-53 TR: 61-43-52/53S: 53-45-61  
607-204-00-4 (chlorophenyl)(chlorotolyl)methane, mixed isomers 400-140-6 — N; R50-53 NR: 50/53S: 60-61  
607-205-00-X methyl chloroacetate 202-501-1 96-34-4 R10T; R23/25Xi; R37/38-41 TR: 10-23/25-37/38-41S: (1/2-)26-37/39-45  
607-206-00-5 isopropyl chloroacetate 203-301-7 105-48-6 R10T; R25Xi; R36/37/38 TR: 10-25-36/37/38S: (1/2-)26-37/39-45  
607-207-00-0 haloxyfop-etotyl (ISO)2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate;haloxyfop-(2-ethoxyethyl) 402-560-5 87237-48-7 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)22-36-60-61  
607-208-00-6 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers 403-000-2 91853-67-7 Xi; R38N; R50-53 Xi; NR: 38-50/53S: (2-)37/39-60-61  
607-209-00-1 reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate 403-030-6 — Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)36/37-60-61  
607-210-00-7 methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) 403-230-3 77402-05-2 Carc. Cat. 2; R45Muta. Cat. 2; R46C; R34R43 TR: 45-46-34-43S: 53-45  
607-211-00-2 methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate 403-270-1 6386-39-6 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)36-61  
607-212-00-8 poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate 403-300-3 — R43 XiR: 43S: (2-)24-37  
607-213-00-3 ethyl 3,3-bis(tert-pentylperoxy)butyrate 403-320-2 67567-23-1 E; R2 $O; R7R10N; R51-53 E; NR: 2-7-10-51/53S: (2-)3/7-14-33-36/37/39-61  
607-214-00-9 N,N-hydrazinodiacetic acid 403-510-5 19247-05-3 T; R25Xn; R48/22R43R52-53 TR: 25-43-48/22-52/53S: (1/2-)26-36/37/39-45-61  
607-215-00-4 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid 403-920-4 107551-67-7 Xn; R22Xi; R36 XnR: 22-36S: (2-)25-26-36  
607-216-00-X glutamic acid, reaction products with N-(C12-14alkyl)propylenediamine 403-950-8 — T+; R26Xn; R22C; R34N; R50-53 T+; NR: 22-26-34-50/53S: (1/2-)26-36/37/39-38-45-60-61  
607-217-00-5 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate 403-960-2 — R43R53 XiR: 43-53S: (2-)24-37-61  
607-218-00-0 dichlorprop-P (ISO);(+)-R-2-(2,4-dichlorophenoxy)propionic acid 403-980-1 15165-67-0 Xn; R22Xi; R38-41R43 XnR: 22-38-41-43S: (2-)24-26-37/39  
607-219-00-6 bis(2-ethylhexyl) dithiodiacetate 404-510-8 62268-47-7 Xn; R22R43N; R51-53 Xn; NR: 22-43-51/53S: (2-)24/25-37-61  
607-221-00-7 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid 404-550-6 — R43R53 XiR: 43-53S: (2-)24-37-61  
607-222-00-2 6-(2,3-dimethylmaleimido)hexyl methacrylate 404-870-6 63740-41-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-223-00-8 transfluthrin (ISO);2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate 405-060-5 118712-89-3 Xi; R38N; R50-53 Xi; NR: 38-50/53S: (2-)36/37-60-61  
607-224-00-3 methyl 2-(3-nitrobenzylidene)acetoacetate 405-270-7 39562-17-9 Xi; R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
607-225-00-9 3-azidosulfonylbenzoic acid 405-310-3 15980-11-7 E; R2Xn; R48/22Xi; R41R43 E; XnR: 2-41-43-48/22S: (2-)22-26-35-36/37/39  
607-226-00-4 reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate 405-360-6 — Xi; R38-41R43R52-53 XiR: 38-41-43-52/53S: (2-)24-26-37/39-61  
607-227-00-X potassium 2-amino-2-methylpropionate octahydrate 405-560-3 120447-91-8 Xn; R22C; R35 CR: 22-35S: (1/2-)26-28-36/37/39-45  
607-228-00-5 bis(2-methoxyethyl) phthalate 204-212-6 117-82-8 Repr. Cat. 2; R61Repr. Cat. 3; R62 TR: 61-62S: 53-45  
607-229-00-0 diethylcarbamoyl chloride 201-798-5 88-10-8 Carc. Cat. 3; R40Xn; R20/22Xi; R36/37/38 XnR: 20/22-36/37/38-40S: (2-)26-36/37  
607-230-00-6 2-ethylhexanoic acid 205-743-6 149-57-5 Repr. Cat. 3; R63 XnR: 63S: (2-)36/37  
607-231-00-1 3,6-dichloropyridine-2-carboxylic acid;clopyralid 216-935-4 1702-17-6 Xi; R41N; R51-53 X; NR: 41-51/53S: (2-)26-39-61  
607-232-00-7 pyridate (ISO);O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate 259-686-7 55512-33-9 Xi; R38R43N; R50-53 Xi; NR: 38-43-50/53S: (2-)24-37-60-61  
607-233-00-2 hexyl acrylate 219-698-5 2499-95-8 Xi; R36/37/38R43N; R51-53 Xi; NR: 36/37/38-43-51/53S: (2-)24-26-37-61  
607-234-00-8 flurenol (ISO);9-hydroxy-9H-fluorene-9-carboxylic acid 207-397-1 467-69-6 N; R51-53 NR: 51/53S: 61  
607-235-00-3 mecrilate;methyl 2-cyanoacrylate 205-275-2 137-05-3 Xi; R36/37/38 XiR: 36/37/38S: (2-)23-24/25-26 Xi; R36/37/38: C ≥ 10 % 
607-236-00-9 ethyl 2-cyanoacrylate 230-391-5 7085-85-0 Xi; R36/37/38 XiR: 36/37/38S: (2-)23-24/25-26 Xi; R36/37/38: C ≥ 10 % 
607-237-00-4 benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate;flurazole 276-942-3 72850-64-7 N; R51-53 NR: 51/53S: 61  
607-238-00-X tau-fluvalinate (ISO);cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate — 102851-06-9 Xn; R22Xi; R38N; R50-53 Xn; NR: 22-38-50/53S: (2-)24-59-61  
607-239-00-5 fenpropathrin (ISO);α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate; 254-485-0 39515-41-8 T+; R26T; R25Xn; R21N; R50-53 T+; NR: 21-25-26-50/53S: (1/2-)28-36/37-38-45-60-61  
607-240-00-0 cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1]1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2]1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3]tetrahydromethylphthalic anhydride; [4]1,2,3,6-tetrahydromethylphthalic anhydride; [5]tetrahydro-4-methylphthalic anhydride; [6]2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] 216-906-6 [1]222-323-8 [2]226-247-6 [3]234-290-7 [4]247-830-1 [5]251-823-9 [6]255-853-3 [7] 1694-82-2 [1]3425-89-6 [2]5333-84-6 [3]11070-44-3 [4]26590-20-5 [5]34090-76-1 [6]42498-58-8 [7] Xi; R41R42/43 XnR: 41-42/43S: (2-)22-24-26-37/39  C
607-241-00-6 hexahydro-4-methylphthalic anhydride; [1]hexahydromethylphthalic anhydride; [2]hexahydro-1-methylphthalic anhydride; [3]hexahydro-3-methylphthalic anhydride [4] 243-072-0 [1]247-094-1 [2]256-356-4 [3]260-566-1 [4] 19438-60-9 [1]25550-51-0 [2]48122-14-1 [3]57110-29-9 [4] Xi; R41R42/43 XnR: 41-42/43S: (2-)22-24-26-37/39  C
607-242-00-1 tetrachlorophthalic anhydride 204-171-4 117-08-8 Xi; R41R42/43N; R50-53 Xn; NR: 41-42/43-50/53S: (2-)22-24-26-37/39-60-61  
607-243-00-7 sodium 3,6-dichloro-o-anisate; [1]3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2]3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] 217-846-3 [1]246-590-5 [2]258-527-9 [3] 1982-69-0 [1]25059-78-3 [2]53404-28-7 [3] R52-53 R: 52/53S: 61  
607-244-00-2 isooctyl acrylate 249-707-8 29590-42-9 Xi; R36/37/38N; R50-53 Xi; NR: 36/37/38-50/53S: (2-)26-28-60-61 Xi; R36/37/38: C ≥ 10 % 
607-245-00-8 tert-butyl acrylate 216-768-7 1663-39-4 F; R11Xn; R20/21/22Xi; R37/38R43N; R52-53 F; XnR: 11-20/21/22-37/38-43-52/53S: (2-)16-25-37-61  D
607-246-00-3 allyl methacrylate;2-methyl-2-propenoic acid 2-propenyl ester 202-473-0 96-05-9 R10T; R23Xn; R21/22N; R50 T; NR: 10-21/22-23-50S: (1/2-)36/37-45-61  
607-247-00-9 dodecyl methacrylate 205-570-6 142-90-5 Xi; 36/37/38N; R50-53 Xi; NR: 36/37/38-50/53S: (2-)26-28-60-61 Xi; R36/37/38: C ≥ 10 % 
607-248-00-4 naptalam-sodium (ISO);sodium N-naphth-1-ylphthalamate 205-073-4 132-67-2 Xn; R22 XnR: 22S: (2-)  
607-249-00-X (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate 256-032-2 42978-66-5 Xi; R36/37/38R43N; R51-53 Xi; NR: 36/37/38-43-51/53S: (2-)24-37-61 Xi; R36/37/38: C ≥ 10 % 
607-250-00-5 4H-3,1-benzoxazine-2,4(1H)-dione 204-255-0 118-48-9 Xi; R36R43 XiR: 36-43S: (2-)24-26-37  
607-251-00-0 2-methoxypropyl acetate 274-724-2 70657-70-4 R10Repr. Cat. 2; R61Xi; R37 TR: 61-10-37S: 53-45  
607-252-00-6 lambda-cyhalothrin (ISO);reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) 415-130-7 91465-08-6 T+; R26T; R25Xn; R21N; R50-53 T+; NR: 21-25-26-50/53S: (1/2-)28-36/37/39-38-45-60-61  
607-253-00-1 α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;cyfluthrin 269-855-7 68359-37-5 T+; R28T; R23N; R50-53 T+; NR: 23-28-50/53S: (1/2-)36/37/39-45-60-61  
607-254-00-7 α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate;beta-cyfluthrin 269-855-7 68359-37-5 T+; R26/28N; R50-53 T+; NR: 26/28-50/53S: (1/2-)36/37/39-45-60-61  
607-255-00-2 fluroxypyr (ISO);4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid — 69377-81-7 R52-53 R: 52/53S: 61  
607-256-00-8 azoxystrobin (ISO);methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate — 131860-33-8 T; R23N; 50-53 T; NR: 23-50/53S: (1/2-)22-45-60-61  
607-257-00-3 isopropyl propionate 211-300-8 637-78-5 F; R11 FR: 11S: (2-)16-23-24-29-33  
607-258-00-9 dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl)acetamido)-4-chlorobenzoate 403-990-6 70950-45-7 R53 R: 53S: 61  
607-259-00-4 methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate 404-130-2 105560-93-8 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)24-26-37/39-61  
607-260-00-X ethyl 2-(3-nitrobenzylidene)acetoacetate 404-490-0 39562-16-8 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)24-26-37/39-61  
607-261-00-5 iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate 404-800-4 118832-72-7 N; R50-53 NR: 50/53S: 60-61  
607-262-00-0 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 405-050-0 86393-33-1 Xn; R22R52-53 XnR: 22-52/53S: (2-)22-61  
607-263-00-6 potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate 405-680-6 — E; R2N; R51-53 E; NR: 2-51/53S: (2-)35-61  
607-264-00-1 2-chloro-4-(methylsulfonyl)benzoic acid 406-520-8 53250-83-2 Xi; R41 XiR: 41S: (2-)26-39  
607-265-00-7 ethyl-2-chloro-2,2-diphenylacetate 406-580-5 52460-86-3 Xi; R38R52-53 XiR: 38-52/53S: (2-)37-61  
607-266-00-2 reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate];3,5-di-tert-butyl-salicylic acid 406-890-0 130296-87-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)22-60-61  
607-267-00-8 tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate 407-620-4 33610-13-8 R42/43R52-53 XnR: 42/43-52/53S: (2-)22-24-37-61  
607-268-00-3 2-methylpropyl (R)-2-hydroxypropanoate 407-770-0 61597-96-4 Xi; R36 XiR: 36S: (2-)26  
607-269-00-9 (R)-2-(4-hydroxyphenoxy)propanoic acid 407-960-3 94050-90-5 Xi; R41 XiR: 41S: (2-)26-39  
607-270-00-4 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane 410-730-5 90498-90-1 Xn; R21 XnR: 21S: (2-)36/37  
607-271-00-X 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane 417-420-9 156324-82-2 Xi; R36N; R51-53 Xi; NR: 36-51/53S: (2-)26-61  
607-272-00-5 fluroxypyr-meptyl (ISO);methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1]fluroxypyr-butometyl (ISO);2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] 279-752-9 [1]- [2] 81406-37-3 [1]154486-27-8 [2] N; R50-53 NR: 50/53S: 60-61  
607-273-00-0 ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate 404-520-2 — R52-53 R: 52/53S: 61  
607-274-00-6 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate 405-350-1 54527-73-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-275-00-1 sodium benzoyloxybenzene-4-sulfonate 405-450-5 66531-87-1 R43 XiR: 43S: (2-)24-37  
607-276-00-7 bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex 405-635-0 — Xi; R38-41N; R50-53 Xi; NR: 38-41-50/53S: (2-)26-37/39-60-61  
607-277-00-2 reaction mass of: 2-(hexylthio)ethylamine hydrochloride;sodium propionate 405-720-2 — Xn; R22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-51/53S: (2-)24-26-37/39-61  
607-278-00-8 reaction mass of isomers of: sodium phenethylnaphthalenesulfonate;sodium naphthylethylbenzenesulfonate 405-760-0 — Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)24-26-37/39-61  
607-279-00-3 reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate);n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate 405-960-8 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-280-00-9 sodium 4-chloro-1-hydroxybutane-1-sulfonate 406-190-5 54322-20-2 Xn; R22Xi; R36R43 XnR: 22-36-43S: (2-)22-26-36/37  
607-281-00-4 reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates 407-000-3 127519-17-9 N; R51-53 NR: 51/53S: 61  
607-282-00-X 2-acetoxymethyl-4-benzyloxybut-1-yl acetate 407-140-5 131266-10-9 R52-53 R: 52/53S: 61  
607-283-00-5 E-ethyl-4-oxo-4-phenylcrotonate 408-040-4 15121-89-8 Xn; R21/22Xi; R38-41R43N; R50-53 Xn; NR: 21/22-38-41-43-50/53S: (2-)26-36/37/39-60-61  
607-284-00-0 reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-triphenodioxazinedisulfonate);lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) 410-040-4 136213-76-8 N; R51-53 NR: 51/53S: 61  
607-285-00-6 reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid;sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate;potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate 410-065-0 — R43 XiR: 43S: (2-)22-24-37  
607-286-00-1 reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate 410-070-8 141880-36-6 R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
607-287-00-7 O'-methyl O-(1-methyl-2-methacryloyloxy-ethyl)-1,2,3,6-tetrahydrophthalate 410-140-8 — R52-53 R: 52/53S: 61  
607-288-00-2 Tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)-4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II, where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively 410-160-7 148732-74-5 Xi; R36R43R52-53 XiR: 36-43-52/53S: (2-)22-26-36/37-61  
607-289-00-8 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid 410-370-9 105488-33-3 R53 R: 53S: 61  
607-290-00-3 reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate;ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate 410-540-2 — Xi; R38R43N; R50-53 Xi; NR: 38-43-50/53S: (2-)24-37-60-61  
607-291-00-9 dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate 410-630-1 104051-92-5 R53 R: 53S: 61  
607-292-00-4 reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid;[1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid 410-640-6 — Xi; R38-41N; R50-53 Xi; NR: 38-41-50/53S: (2-)26-37/39-60-61  
607-293-00-X reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate;N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate 410-650-0 — Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)26-36/37/39-61  
607-294-00-5 sodium 2-benzoyloxy-1-hydroxyethane-sulfonate 410-680-4 — R43 XiR: 43S: (2-)24-37  
607-295-00-0 reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate;hexasodium phosphonobutane-1,2,3,4-tetracarboxylate 410-800-5 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-296-00-6 reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid 410-830-9 — R53 R: 53S: 61  
607-297-00-1 (E-E)-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) 410-960-6 92761-26-7 Xi; R41 XiR: 41S: (2-)26-39  
607-298-00-7 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate 411-010-3 — R43 XiR: 43S: (2-)22-36/37  
607-299-00-2 methyl 3-(acetylthio)-2-methyl-propanoate 411-040-7 97101-46-7 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61  
607-300-00-6 trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c, d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5-)]cuprate(II) where a = 1,2,3,4 b = 8,9,10,11 c = 15,16,17,18 d = 22,23,24,25 411-430-7 — Xi; R41R43 XiR: 41-43S: (2-)26-36/37/39  
607-301-00-1 reaction mass of: dodecanoic acid;poly(1-7)lactate esters of dodecanoic acid 411-860-5 — R43N; R51-53 Xi; NR: 38-41-43-51/53S: (2-)24-26-37/39-61  
607-302-00-7 reaction mass of: tetradecanoic acid;poly(1-7)lactate esters of tetradecanoic acid 411-910-6 — Xi; R38-41R43N; R51-53 Xi; NR: 38-41-43-51/53S: (2-)24-26-37/39-61  
607-303-00-2 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid 413-760-7 93107-30-3 Repr. Cat. 3; R62R52-53 XnR: 62-52/53S: (2-)22-36/37-61  
607-304-00-8 fluazifop-butyl (ISO);butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate 274-125-6 69806-50-4 Repr. Cat. 2; R61N; R50-53 T; NR: 61-50/53S: 53-45-60-61  
607-305-00-3 fluazifop-P-butyl (ISO);butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate — 79241-46-6 Repr. Cat. 3; R63N; R50-53 Xn; NR: 50/53-63S: (2-)29-36/37-46-60-61  
607-306-00-9 chlozolinate (ISO);ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate 282-714-4 84332-86-5 Carc. Cat. 3; R40N; R51-53 Xn; NR: 40-51/53S: (2-)36/37-61  
607-307-00-4 vinclozolin (ISO);N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione 256-599-6 50471-44-8 Carc. Cat. 3; R40Repr. Cat. 2; R60-61R43N; R51-53 T; NR: 60-61-40-43-51/53S: 53-45-61  
607-308-00-X esters of 2,4-D — — Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)26-29-36/37-46-60-61  A
607-309-00-5 carfentrazone-ethyl (ISO);ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate — 128639-02-1 N; R50-53 NR: 50/53S: 60-61  
607-310-00-0 kresoxim-methyl (ISO);methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate — 143390-89-0 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-60-61  
607-311-00-6 benazolin-ethyl;ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate 246-591-0 25059-80-7 N; R51-53 NR: 51/53S: 61  
607-312-00-1 methoxyacetic acid 210-894-6 625-45-6 Repr. Cat. 2; R60-61Xn; R22C; R34 TR: 60-61-22-34S: 53-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % E
607-313-00-7 neodecanoyl chloride 254-875-0 40292-82-8 T+; R26Xn; R22C; R34 T+R: 22-26-34S: (1/2-)26-28-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
607-314-00-2 ethofumesate (ISO);(±)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate 247-525-3 26225-79-6 N; R51-53 NR: 51/53S: 61  
607-315-00-8 glyphosate (ISO);N-(phosphonomethyl)glycine 213-997-4 1071-83-6 Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
607-316-00-3 glyphosate-trimesium;glyphosate-trimethylsulfonium — 81591-81-3 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)36/37-46-61  
607-317-00-9 bis(2-ethylhexyl) phthalate;di-(2-ethylhexyl) phthalate;DEHP 204-211-0 117-81-7 Repr. Cat. 2; R60-61 TR: 60-61S: 53-45  
607-318-00-4 dibutyl phthalate;DBP 201-557-4 84-74-2 Repr. Cat. 2; R61Repr. Cat. 3; R62N; R50 T; NR: 61-50-62S: 53-45-61  
607-319-00-X deltamethrin (ISO);(S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate 258-256-6 52918-63-5 T; R23/25N; R50-53 T; NR: 23/25-50/53S: (1/2-)24-28-36/37/39-38-45-60-61  
607-320-00-5 bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate 413-930-0 130066-57-8 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
607-321-00-0 (S)-methyl-2-chloropropionate 412-470-8 73246-45-4 R10Xn; R48/22Xi; R36 XnR: 10-36-48/22S: (2-)23-26-36  
607-322-00-6 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid 413-120-7 107144-30-9 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)22-61  
607-323-00-1 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate 413-850-6 123968-25-2 R53 R: 53S: 61  
607-324-00-7 reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid;dihydrogenated alkyl (C14-C18)amine 413-800-3 — R53 R: 53S: 61  
607-325-00-2 (S)-2-chloropropionic acid 411-150-5 29617-66-1 Xn; R21/22C; R35 CR: 21/22-35S: (1/2-)23-26-28-36/37/39-45  
607-326-00-8 reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate;isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate 410-720-0 141847-13-4 Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
607-327-00-3 2-(2-iodoethyl)-1,3-propanediol diacetate 411-780-0 127047-77-2 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)36-61  
607-328-00-9 methyl 4-bromomethyl-3-methoxybenzoate 410-310-1 70264-94-7 Xi; R38-41R43N; R50-53 Xi; NR: 38-41-43-50/53S: (2-)26-36/37/39-60-61  
607-329-00-4 reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate;sodium 2-octadecenyl-amino-1,4-butandioate 411-250-9 — R43 XiR: 43S: (2-)24-26-37/39  
607-330-00-X (S)-2,3-dihydro-1H-indole-2-carboxylic acid 410-860-2 79815-20-6 Repr. Cat. 3; R62Xn; R48/22R43 XnR: 43-48/22-62S: (2-)22-25-26-36/37  
607-331-00-5 reaction mass of: bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-1,10-decanedioate;1,8-bis[(2,2,6,6-tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin-4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane 406-750-9 — R53 R: 53S: 23-61  
607-332-00-0 cyclopentyl chloroformate 411-460-0 50715-28-1 R10T; R23Xn; R22-48/22Xi; R41R43 TR: 10-22-23-41-43-48/22S: (1/2-)26-36/37/39-45  
607-333-00-6 reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate;tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate 405-670-1 — Xn; R22-48/22C; R34N; R50-53 C; NR: 22-34-48/22-50/53S: (1/2-)26-36/37/39-45-60-61  
607-334-00-1 ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate 405-880-3 100501-62-0 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
607-335-00-7 methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate 406-250-0 72619-32-0 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
607-336-00-2 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate 406-560-6 122760-85-4 Xi; R38R43N; R51-53 Xi; NR: 38-43-51/53S: (2-)36/37-61  
607-337-00-8 di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate 406-052-4 125078-60-6 R10Xn; R22Xi; R38-41N; R51-53 Xn; NR: 10-22-38-41-51/53S: (2-)26-37/39-61  
607-338-00-3 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate 406-235-9 72531-53-4 Xi; R36/38 XiR: 36/38S: (2-)26-37  
607-339-00-9 2,3,4,5-tetrachlorobenzoylchloride 406-760-3 42221-52-3 Xn; R22C; R34R43 CR: 22-34-43S: (1/2-)26-36/37/39-45  
607-340-00-4 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate 406-990-4 — N; R51-53 NR: 51/53S: 61  
607-341-00-X (9S)-9-amino-9-deoxyerythromycin 406-790-7 26116-56-3 Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
607-342-00-5 4-chlorobutyl veratrate 410-950-1 69788-75-6 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-343-00-0 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) 407-410-2 — R53 R: 53S: 61  
607-344-00-6 reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid;N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate;3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate 407-810-7 — Xn; R48/22 XnR: 48/22S: (2-)21-22-36/37  
607-345-00-1 potassium 2-(2,4-dichlorophenoxy)-(R)-propionate 413-580-9 113963-87-4 Xn; R22Xi; R38-41R43 XnR: 22-38-41-43S: (2-)24-26-37/39  
607-346-00-7 3-icosyl-4-henicosylidene-2-oxetanone 401-210-9 83708-14-9 R53 R: 53S: 61  
607-347-00-2 sodium (R)-2-(2,4-dichlorophenoxy)propionate 413-340-3 119299-10-4 Xn; R22Xi; R38-41R43 XnR: 22-38-41-43S: (2-)22-26-36/37/39  
607-348-00-8 magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) 413-360-2 — Xn; R22Xi; R38-41R43 XnR: 22-38-41-43S: (2-)22-26-36/37/39  
607-349-00-3 mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate 411-270-8 — R52-53 R: 52/53S: 61  
607-350-00-9 bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane 412-060-9 136210-32-7 R43R52-53 XiR: 43-52/53S: (2-)36/37-61  
607-351-00-4 methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate 407-550-4 69184-17-4 N; R51-53 NR: 51/53S: 20/21-61  
607-352-00-X 4,4'-oxydiphthalic anhydride 412-830-4 1823-59-2 R52-53 R: 52/53S: 61  
607-353-00-5 reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate;ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate 407-520-0 80657-64-3 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
607-354-00-0 ethyl 2-cyclohexylpropionate 412-280-5 2511-00-4 N; R51-53 NR: 51/53S: 61  
607-355-00-6 p-tolyl 4-chlorobenzoate 411-530-0 15024-10-9 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
607-356-00-1 ethyl trans-2,2,6-trimethylcyclohexanecarboxylate 412-540-8 — Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
607-357-00-7 reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran;cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran 412-450-9 131766-73-9 R43 XiR: 43S: (2-)24-37  
607-358-00-2 (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate 412-670-5 54275-93-3 R42 XnR: 42S: (2-)22  
607-359-00-8 (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate 412-800-0 76109-32-5 R42 XnR: 42S: (2-)22  
607-360-00-3 sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate 411-680-7 133167-77-8 R43 XiR: 43S: (2-)24-37  
607-361-00-9 methyl (R)-2-(4-hydroxyphenoxy)propionate 411-950-4 96562-58-2 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
607-362-00-4 reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate;(3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate 413-500-2 — Xi; R38-41N; R51-53 Xi; NR: 38-41-51/53S: (2-)26-37/39-61  
607-363-00-X methyl-3-methoxyacrylate 412-900-4 5788-17-0 R43 XiR: 43S: (2-)24-37  
607-364-00-5 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione 413-330-9 134724-55-3 R53 R: 53S: 61  
607-365-00-0 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride 410-620-7 119154-86-8 Xn; R22C; R34R43 CR: 22-34-43S: (1/2-)22-26-36/37/39-45  
607-366-00-6 3,5-dimethylbenzoyl chloride 413-010-9 6613-44-1 C; R34R43 CR: 34-43S: (1/2-)26-36/37/39-45  
607-367-00-1 potassium bis(N-carboxymethyl)-N-methyl-glycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate 411-640-9 153352-59-1 Xn; R22 XnR: 22S: (2-)37  
607-368-00-7 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole 411-650-3 110895-43-7 T; R23/25N; R50-53 T; NR: 23/25-50/53S: (1/2-)37-38-45-60-61  
607-369-00-2 reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid;cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid 411-660-8 147027-04-1 Xn; R22Xi; R38-41R43 XnR: 22-38-41-43S: (2-)22-24-26-37/39  
607-370-00-8 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol 412-210-3 41620-33-1 N; R50-53 NR: 50/53S: 60-61  
607-371-00-3 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate 413-410-3 88150-62-3 R53 R: 53S: 61  
607-372-00-9 ethoxylated bis phenol A di-(norbornene carboxylate) 412-410-0 — R52-53 R: 52/53S: 61  
607-373-00-4 (±) tetrahydrofurfuryl (R)-2-[4-(6-chloroquinoxalin-2-yloxy)phenyloxy]propionate 414-200-4 119738-06-6 Muta. Cat. 3; R68Repr. Cat. 2; R61Repr. Cat. 3; R62Xn; R22-48/22N; R50-53 T; NR: 61-22-48/22-62-68-50/53S: 53-45-60-61  E
607-374-00-X 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride 417-220-1 37441-29-5 R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-36/37-61  
607-375-00-5 reaction mass of: cis-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin;trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin 421-960-0 90035-08-8 T+; R26/27/28T; R48/23/24/25N; R50-53 T+; NR: 26/27/28-48/23/24/25-50/53S: (1/2-)28-36/37/39-45-60-61  
607-376-00-0 benzyl 2,4-dibromobutanoate 420-710-8 23085-60-1 Repr. Cat. 3; R62Xi; R38R43N; R50-53 Xn; NR: 38-43-62-50/53S: (2-)23-36/37-41-60-61  
607-377-00-6 trans-4-cyclohexyl-L-proline monohydrochloride 419-160-1 90657-55-9 Repr. Cat. 3; R62Xn; R22Xi; R38-41R43 XnR: 22-38-41-43-62S: (2-)22-26-36/37/39  
607-378-00-1 ammonium (Z)-α-methoxyimino-2-furylacetate 405-990-1 97148-39-5 F; R11 FR: 11S: (2-)22-43  
607-379-00-7 reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate;sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate;sodium [bis(2-hydroxyethyl)amino]methylsulfonate;N,N-bis(2-hydroxyethyl)stearamide 401-230-8  R52-53 R: 52/53S: 61  
607-380-00-2 reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate;ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate;ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate 407-320-3 — Xi; R38-41R52-53 XiR: 38-41-52/53S: (2-)26-37/39-61  
607-381-00-8 reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid 413-710-4 — R53 R: 53S: 61  
607-382-00-3 2-((4-amino-2-nitrophenyl)amino)benzoic acid 411-260-3 117907-43-4 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)24-26-37/39-61  
607-383-00-9 reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate;2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate 415-430-8 86403-32-9 Xi; R41R43N; R50-53 Xi; NR: 41-43-50/53S: (2-)24-26-37/39-60-61  
607-384-00-4 reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid;C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate;C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate 413-750-2 171090-93-0 R53 R: 53S: 61  
607-385-00-X Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate 414-590-6 125229-74-5 N; R51-53 NR: 51/53S: 61  
607-386-00-5 reaction mass of: tetradecanoic acid (42.5-47.5 %);poly(1-7)lactate esters of tetradecanoic acid (52.5-57.5 %) 412-580-6 174591-51-6 Xi; R38-41R43N; R50-53 Xi; NR: 38-41-43-50/53S: (2-)24-26-37/39-60-61  
607-387-00-0 reaction mass of: dodecanoic acid (35-40 %);poly(1-7)lactate esters of dodecanoic acid (60-65 %) 412-590-0 58856-63-6 Xi; R38-41R43N; R50-53 Xi; NR: 38-41-43-50/53S: (2-)24-26-37/39-60-61  
607-388-00-6 4-ethylamino-3-nitrobenzoic acid 412-090-2 2788-74-1 Xn; R22R43R52-53 XnR: 22-43-52/53S: (2-)22-24-37-61  
607-389-00-1 trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate 414-130-4 119710-96-2 Xn; R22 XnR: 22S: (2-)22  
607-390-00-7 1,2,3,4-tetrahydro-6-nitro-quinoxaline 414-270-6 41959-35-7 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)22-61  
607-391-00-2 dimethylcyclopropane-1,1-dicarboxylate 414-240-2 6914-71-2 R52-53 R: 52/53S: 61  
607-392-00-8 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate 414-260-1 88938-37-8 R53 R: 53S: 61  
607-393-00-3 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 415-750-8 106447-44-3 R43 XiR: 43S: (2-)22-24-37  
607-394-00-9 5-methylpyrazine-2-carboxylic acid 413-260-9 5521-55-1 Xi; R41 XiR: 41S: (2-)26-39  
607-395-00-4 reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate;sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate 410-230-7 — C; R34R43N; R51-53 C; NR: 34-43-51/53S: (1/2-)26-36/37/39-45-61  
607-396-00-X bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate 414-840-4 147783-69-5 N; R50-53 NR: 50/53S: 22-60-61  
607-397-00-5 reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated);Ca phenates (branched C10-14 and C18-30 alkylated);Ca sulfurized phenates (branched C10-14 and C18-30 alkylated) 415-930-6 — R43 XiR: 43S: (2-)36/37  
607-398-00-0 ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate 414-820-5 125630-94-6 N; R50-53 NR: 50/53S: 60-61  
607-399-00-6 2,2-dimethyl 3-methyl-3-butenyl propanoate 415-610-6 104468-21-5 Xi; R38R52-53 XiR: 38-52/53S: (2-)37-61  
607-400-00-X methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate 414-400-1 32750-89-3 N; R50-53 NR: 50/53S: 60-61  
607-401-00-5 ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate 414-450-4 88805-65-6 Xi; R38-41R43 XiR: 38-41-43S: (2-)24-26-37/39  
607-402-00-0 methyl N-(phenoxycarbonyl)-L-valinate 414-500-5 153441-77-1 R52-53 R: 52/53S: 61  
607-403-00-6 reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate;isopropyl alcohol 414-810-0 — Xn; R48/22Xi; R41N; R50-53 Xn; NR: 41-48/22-50/53S: (2-)22-26-36/39-60-61  
607-404-00-1 reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid;di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate;di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate;(Z)-3,7-dimethyl-2,6-octadienyl butandioate;((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid 415-190-4 — R43 XiR: 43S: (2-)24-37  
607-405-00-7 2-hexyldecyl-p-hydroxybenzoate 415-380-7 148348-12-3 N; R51-53 NR: 51/53S: 61  
607-406-00-2 potassium 2,5-dichlorobenzoate 415-700-5 184637-62-5 Xn; R22Xi; R41 XnR: 22-41S: (2-)26-39  
607-407-00-8 ethyl 2-carboxy-3-(2-thienyl)propionate 415-680-8 143468-96-6 Xi; R38-41R43 XiR: 38-41-43S: (2-)24-26-37/39  
607-408-00-3 potassium N-(4-fluorophenyl)glycinate 415-710-1 184637-63-6 Xn; R48/22Xi; R41R43R52-53 XnR: 41-43-48/22-52/53S: (2-)22-26-36/37/39-61  
607-409-00-9 reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid;inert biomass from Aspergillus terreus 415-840-7 — R43R52-53 XiR: 43-52/53S: (2-)36/37-61  
607-410-00-4 mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen-3-(hexadec-2-enyl)butanedioate 415-880-5 779343-34-9 Xi; R38-41R43N; R50-53 Xi; NR: 38-41-43-50/53S: (2-)24-26-37/39-60-61  
607-411-00-X oxiranemethanol, 4-methylbenzene-sulfonate, (S)- 417-210-7 70987-78-9 Carc. Cat. 2; R45Muta. Cat. 3; R68Xi; R41R43N; R51-53 T; NR: 45-41-43-68-51/53S: 53-45-61  
607-412-00-5 ethyl 2-(1-cyanocyclohexyl)acetate 415-970-4 133481-10-4 Xn; R22-48/22R52-53 XnR: 22-48/22-52/53S: (2-)36/37-61  
607-413-00-0 trans-4-phenyl-L-proline 416-020-1 96314-26-0 Repr. Cat. 3; R62R43 XnR: 43-62S: (2-)22-36/37  
607-414-00-6 tris(2-ethylhexyl)-4,4',4''-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate 402-070-1 88122-99-0 R53 R: 53S: 61  
607-415-00-1 poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α, α-dimethylbenzyl carbamate)-co-(maleicanhydride) 419-590-1 — F; R11R43 F; XiR: 11-43S: (2-)24-37-43  
607-416-00-7 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide 420-730-7 — N; R50-53 NR: 50/53S: 60-61  
607-418-00-8 2-ethylhexyl 4-aminobenzoate 420-170-3 26218-04-2 N; R50-53 NR: 50/53S: 60-61  
607-419-00-3 (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid 422-240-9 166596-68-5 Xi; R41R43 XiR: 41-43S: (2-)26-36/37/39  
607-420-00-9 2,2-bis(hydroxymethyl)butanoic acid 424-090-1 10097-02-6 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
607-421-00-4 cypermethrin cis/trans +/- 40/60;(RS)-α-cyano-3-phenoxybenzyl (1RS,3RS;1RS,3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 257-842-9 52315-07-8 Xn; R20/22Xi; R37N; R50-53 Xn; NR: 20/22-37-50/53S: (2-)24-36/37/39-60-61  
607-422-00-X α-cypermethrin 257-842-9 67375-30-8 T; R25Xn; R48/22Xi; R37N; R50-53 T; NR: 25-37-48/22-50/53S: (2-)36/37/39-45-60-61  
607-423-00-5 esters of mecoprop and of mecoprop-P — — Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)13-36/37-60-61  A
607-424-00-0 trifloxystrobin (ISO);(E,E)-α-methoxyimino-{2-[[[[1-[3-(trifluoromethyl)phenyl]ethylidene]amino]oxy]methyl]benzeneacetic acid methyl ester — 141517-21-7 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-46-60-61  
607-425-00-6 metalaxyl (ISO);methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate 260-979-7 57837-19-1 Xn; R22R43R52-53 XnR: 22-43-52/53S: (2-)13-24-37-46-61  
607-426-00-1 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1]n-pentyl-isopentylphthalate; [2]di-n-pentyl phthalate; [3]diisopentylphthalate [4] 284-032-2 [1]- [2]205-017-9 [3]210-088-4 [4] 84777-06-0 [1]- [2]131-18-0 [3]605-50-5 [4] Repr. Cat. 2; R60-61N; R50 T; NR: 60-61-50S: 53-45-61  
607-427-00-7 bromoxynil heptanoate (ISO);2,6-dibromo-4-cyanophenyl heptanoate 260-300-4 56634-95-8 Repr. Cat. 3; R63Xn; R20/22R43N; R50-53 Xn; NR: 20/22-43-63-50/53S: (2-)36/37-46-60-61  
607-430-00-3 BBP;benzyl butyl phthalate 201-622-7 85-68-7 Repr. Cat. 2; R61Repr. Cat. 3; R62N; R50-53 T; NR: 61-62-50/53S: 53-45-60-61  
607-431-00-9 prallethrin (ISO);ETOC;2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 245-387-9 23031-36-9 T; R23Xn; R22N; R50-53 T; NR: 22-23-50/53S: (1/2-)45-60-61  
607-432-00-4 S-metolachlor;reaction mass of (S)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (80-100 %); [1](R)-2-chloro-N-(2-ethyl-6-methyl-phenyl)-N-(2-methoxy-1-methyl-ethyl)-acetamide (0-20 %) [2] - [1]- [2] 87392-12-9 [1]178961-20-1 [2] R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
607-433-00-X cypermethrin cis/trans +/- 80/20;(RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 257-842-9 52315-07-8 Xn; R22Xi; R37/38R43N; R50-53 Xn; NR: 22-37/38-43-50/53S: (2-)36/37/39-60-61  
607-434-00-5 mecoprop-P [1] and its salts;(R)-2-(4-chloro-2-methylphenoxy)propionic acid 240-539-0 16484-77-8 Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)13-26-37/39-46-61  
607-435-00-0 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate 416-810-6 111969-64-3 Xn; R48/22Xi; R41N; R51-53 Xn; NR: 41-48/22-51/53S: (2-)22-26-36/39-61  
607-436-00-6 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate 417-350-9 — Xi; R38-41N; R50-53 Xi; NR: 38-41-50/53S: (2-)26-28-37/39-60-61  
607-437-00-1 3-(4-aminophenyl)-2-cyano-2-propenoic acid 417-480-6 252977-62-1 R43 XiR: 43S: (2-)22-24-37  
607-438-00-7 methyl-2-[(aminosulfonyl)methyl]benzoate 419-010-5 112941-26-1 Xn; R22Xi; R36 XnR: 22-36S: (2-)22-26  
607-439-00-2 methyl tetrahydro-2-furancarboxylate 420-670-1 37443-42-8 Xi; R41 XiR: 41S: (2-)26-39  
607-440-00-8 methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate 421-220-7 144740-59-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-61  
607-441-00-3 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid 421-490-6 167684-63-1 R53 R: 53S: 57-61  
607-442-00-9 benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate 416-050-5 87460-09-1 Xi; R41 XiR: 41S: (2-)26-36/39  
607-443-00-4 bis(2,4-di-tert-butyl-6-methylphenyl)ethyl phosphate 416-140-4 145650-60-8 R53 R: 53S: 61  
607-444-00-X reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate;trans-1,4-dimethylcyclohexyl dibenzoate 416-230-3 35541-81-2 R53 R: 53S: 61  
607-445-00-5 Iron (III) tris(4-methylbenzenesulfonate) 420-960-8 77214-82-5 Xi; R41 XiR: 41S: (2-)24-26-39  
607-446-00-0 methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate 416-240-8 155522-12-6 R43R53 XiR: 43-53S: (2-)22-24-37-61  
607-447-00-6 sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate 416-370-5 156738-27-1 R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
607-448-00-1 2,3,5,6-tetrafluorobenzoic acid 416-800-1 652-18-6 Xi; R38-41 XiR: 38-41S: (2-)22-26-37/39  
607-449-00-7 reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] 417-080-1 — E; R2R43N; R50-53 E; Xi; NR: 2-43-50/53S: (2-)24-37-60-61  
607-450-00-2 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate 419-040-9 89604-92-2 R53 R: 53S: 61  
607-451-00-8 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt 417-640-5 161935-19-9 Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
607-453-00-9 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) 418-100-1 172964-15-7 R43R53 XiR: 43-53S: (2-)24-37-61  
607-454-00-4 reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid;cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid 418-170-3 116193-72-7 Xi; R41R52-53 XiR: 41-52/53S: (2-)25-26-39-61  
607-455-00-X 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithiumsalt 419-520-8 172890-93-6 R43 XiR: 43S: (2-)22-24-37  
607-456-00-5 3-amino-4-chlorobenzoic acid, hexadecyl ester 419-700-6 143269-74-3 N; R51-53 NR: 51/53S: 61  
607-457-00-0 tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) 420-350-1 172277-97-3 Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
607-458-00-6 reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate;2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate;2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] 420-850-1 — N; R51-53 NR: 51/53S: 61  
607-459-00-1 isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino}benzoate 418-930-4 — R53 R: 53S: 61  
607-460-00-7 3-tridecyloxy-propyl-ammonium 9-octadecenoate 418-990-1 778577-53-0 Xn; R48/22Xi; R36/38N; R50-53 Xn; NR: 36/38-48/22-50/53S: (2-)23-26-37/39-60-61  
607-461-00-2 reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate;pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate 421-160-1 — R52-53 R: 52/53S: 61  
607-462-00-8 reaction mass of: 1-hexyl acetate;2-methyl-1-pentyl acetate;3-methyl-1-pentyl acetate;4-methyl-1-pentyl acetate;other mixed linear and branched C6-alkyl acetates 421-230-1 88230-35-7 N; R51-53 NR: 51/53S: 61  
607-463-00-3 3-(phenothiazin-10-yl)propionic acid 421-260-5 362-03-8 N; R51-53 NR: 51/53S: 24/25-61  
607-464-00-9 reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid;5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid 421-280-4  R52-53 R: 52/53S: 61  
607-465-00-4 tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo}naphthalene-1,3-disulfonate 421-440-3 778583-04-3 R52-53 R: 52/53S: 61  
607-466-00-X reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate;phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate 421-480-1 — N; R51-53 NR: 51/53S: 37/39-61  
607-467-00-5 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate 419-430-9 56533-00-7 Xn; R21/22-48/22C; R34N; R50-53 C; NR: 21/22-34-48/22-50/53S: (1/2-)26-36/37/39-45-60-61  
607-468-00-0 reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate;tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate 419-450-8 — R43 XiR: 43S: (2-)22-24-37  
607-469-00-6 disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)-2-naphthalene sulfonate 419-460-2 120029-06-3 R52-53 R: 52/53S: 61  
607-470-00-1 potassium sodium 6,13-dichloro-3,10-bis{2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 414-100-0 154336-20-6 Xi; R41R52-53 XiR: 41-52/53S: (2-)39-22-26-61  
607-472-00-2 ammonium iron(III) trimethylenediaminetetraacetate hemihydrate 400-660-3 111687-36-6 N; R51-53 NR: 51/53S: 61  
607-474-00-3 (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid 410-430-4 117573-89-4 R53 R: 53S: 61  
607-475-00-9 reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) 412-940-2 148878-18-6 R43 XiR: 43S: (2-)22-24-37  
607-476-00-4 trisodium N,N-bis(carboxymethyl)-β-alanine 414-070-9 129050-62-0 C; R34R52-53 CR: 34-52/53S: (1/2-)26-36/37/39-45-61  
607-478-00-5 tetramethylammonium hydrogen phthalate 416-900-5 79723-02-7 T; R25Xn; R48/22N; R50 T; NR: 25-48/22-50S: (1/2-)25-36-45-61  
607-479-00-0 hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate 418-550-9 168689-49-4 R53 R: 53S: 61  
607-480-00-6 1,2-benzenedicarboxylic acid;di-C7-11-branched and linear alkylesters 271-084-6 68515-42-4 Repr. Cat. 2; R61Repr. Cat. 3; R62 TR: 61-62S: 53-45  
607-487-00-4 reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate;trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate 402-660-9 — Repr. Cat. 2; R61R52-53 TR: 61-52/53S: 53-45-61  
607-488-00-X ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate 414-210-9 147379-38-2 N; R50-53 NR: 50/53S: 60-61  
607-489-00-5 reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate;2-ethylhexyl epoxyoleate;2-ethylhexyl diepoxylinoleate;2-ethylhexyl triepoxylinolenate 414-890-7 71302-79-9 R43 XiR: 43S: (2-)24-37  
607-490-00-0 N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate 415-060-7 — Xi; R41R43 XiR: 41-43S: (2-)24-26-37/39  
607-492-00-1 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate 415-490-5 141773-73-1 N; R51-53 NR: 51/53S: 61  
607-493-00-7 methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano[3,4-d]oxazole-6-carboxylate 415-670-3 78850-37-0 Xi; R41 XiR: 41S: (2-)26-39  
607-494-00-2 bis(2-ethylhexyl)octylphosphonate 417-170-0 52894-02-7 N; R50-53 NR: 50/53S: 60-61  
607-495-00-8 sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate 417-550-6 168151-92-6 R43 XiR: 43S: (2-)24-37  
607-496-00-3 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite 418-310-3 126050-54-2 R53 R: 53S: 61  
607-497-00-9 cerium oxide isostearate 419-760-3 — R53 R: 53S: 61  
607-498-00-4 (E)-3,7-dimethyl-2,6-octadienylhexadecanoate 421-370-3 3681-73-0 Xi; R38R53 XiR: 38-53S: (2-)37-61  
607-499-00-X bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) 421-660-1 — Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)24-26-37/39-61  
607-500-00-3 calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate 421-670-4 — Xi; R38N; R50-53 Xi; NR: 38-50/53S: (2-)37-60-61  
607-501-00-9 reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives 421-820-9 192268-65-8 R53 R: 53S: 61  
607-502-00-4 (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate 422-200-0 178277-55-9 C; R34Xn; R22N; R51-53 C; NR: 22-34-51/53S: (1/2-)26-36/37/39-45-61  
607-503-00-X 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane 422-210-5 68957-94-8 C; R34 CR: 34S: (1/2-)26-36/37/39-45  
607-505-00-0 pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate 422-930-1  R52-53 R: 52/53S: 22-61  
607-506-00-6 reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate;disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl)benzenesulfonate 422-970-8  N; R51-53 NR: 51/53S: 22-61  
607-507-00-1 potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate 422-980-2 187026-95-5 Xi; R41 XiR: 41S: (2-)22-26-39  
607-508-00-7 disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] 423-110-4 — Xi; R41 XiR: 41S: (2-)22-26-39  
607-512-00-9 trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate 423-970-0 182926-43-8 R52-53 R: 52/53S: 22-61  
607-513-00-4 reaction mass of: Trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfato-naphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate;5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt;5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid 423-200-3 — Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)22-26-36/37/39-61  
607-515-00-5 reaction mass of: disodium hexyldiphenyl ether disulphonate;disodium dihexyldiphenyl ether disulphonate 429-650-7 147732-60-3 Xi; R36N; R51-53 Xi; NR: 36-51/53S: (2-)26-61  
607-516-00-0 N,N'-bis(trifluoroacetyl)-S,S'-bis L-homocysteine 429-670-6 105996-54-1 Xi; R41R43 XiR: 41-43S: (2-)24-26-37/39  
607-517-00-6 (S)-α-(acetylthio)benzenepropanoic acid 430-300-0 76932-17-7 Xn; R22Xi; R41R43 XnR: 22-41-43S: (2-)22-26-36/37/39  
607-526-00-5 cartap (ISO);1,3-bis(carbamoylthio)-2-(dimethylamino)propane — 15263-53-3 N; R50-53 NR: 50/53S: 60-61  
607-527-00-0 reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate;1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate 423-180-6 — Xn; R48/22 XnR: 48/22S: (2-)36  
608-001-00-3 acetonitrile;cyanomethane 200-835-2 75-05-8 F; R11Xn; R20/21/22Xi; R36 F; XnR: 11-20/21/22-36S: (2-)16-36/37  
608-002-00-9 trichloroacetonitrile 208-885-7 545-06-2 T; R23/24/25N; R51-53 T; NR: 23/24/25-51/53S: (1/2-)45-61  
608-003-00-4 acrylonitrile 203-466-5 107-13-1 F; R11Carc. Cat. 2; R45T; R23/24/25Xi; R37/38-41R43N; R51-53 F; T; NR: 45-11-23/24/25-37/38-41-43-51/53S: - 53-45-61 T; R23/24/25: C ≥ 1 %Xn; R20/21/22: 0,2 % ≤ C < 1 % D E
608-004-00-X 2-hydroxy-2-methylpropionitrile;2-cyanopropan-2-ol;acetone cyanohydrin 200-909-4 75-86-5 T+; R26/27/28N; R50-53 T+; NR: 26/27/28-50/53S: (1/2-)7/9-27-45-60-61  
608-005-00-5 n-butyronitrile 203-700-6 109-74-0 R10 ⊗T; R23/24/25 TR: 10-23/24/25S: (1/2-)45  
608-006-00-0 bromoxynil (ISO)3,5-dibromo-4-hydroxybenzonitrile;bromoxynil phenol 216-882-7 1689-84-5 Repr. Cat. 3; R63T+; R26T; R25R43N; R50-53 T+; NR: 25-26-43-63-50/53S: (1/2-)27/28-36/37-45-63-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
608-007-00-6 ioxynil (ISO)4-hydroxy-3,5-diiodobenzonitrile 216-881-1 1689-83-4 Repr. Cat. 3; R63T; R23/25Xn; R21-48/22Xi; R36N; R50-53 T; NR: 21-23/25-36-48/22-63-50/53S: (1/2-)36/37-45-60-61-63 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
608-008-00-1 chloroacetonitrile 203-467-0 107-14-2 T; R23/24/25N; R51-53 T; NR: 23/24/25-51/53S: (1/2-)45-61  
608-009-00-7 malononitrile 203-703-2 109-77-3 T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)23-27-45-60-61  
608-010-00-2 methacrylonitrile;2-methyl-2-propene nitrile 204-817-5 126-98-7 F; R11T; R23/24/25R43 F; TR: 11-23/24/25-43S: (1/2-)9-16-18-29-45 T; R23/24/25: C ≥ 1 %Xn; R20/21/22: 0,2 % ≤ C < 1 %R43: C ≥ 0,2 % D
608-011-00-8 oxalonitrile;cyanogen 207-306-5 460-19-5 F; R11 ⊗T; R23N; R50-53 F; T; NR: 11-23-50/53S: (1/2-)23-45-60-61  
608-012-00-3 benzonitrile 202-855-7 100-47-0 Xn; R21/22 XnR: 21/22S: (2-)23  
608-013-00-9 2-chlorobenzonitrile 212-836-5 873-32-5 Xn; R21/22Xi; R36 XnR: 21/22-36S: (2-)23  
608-014-00-4 chlorothalonil (ISO);tetrachloroisophthalonitrile 217-588-1 1897-45-6 Carc. Cat. 3; R40T+; R26Xi; R41Xi; R37R43N; R50-53 T+; NR: 26-37-40-41-43-50/53S: (2-)28-36/37/39-45-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
608-015-00-X dichlobenil (ISO);2,6-dichlorobenzonitrile 214-787-5 1194-65-6 Xn; R21N; R51-53 Xn; NR: 21-51/53S: (2-)36/37-61  
608-016-00-5 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene 401-550-8 1897-41-2 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
608-017-00-0 bromoxynil octanoate (ISO);2,6-dibromo-4-cyanophenyl octanoate 216-885-3 1689-99-2 Repr. Cat. 3; R63T; R23Xn; R22R43N; R50-53 T; NR: 22-23-43-63-50/53S: (1/2-)36/37-45-63-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
608-018-00-6 ioxynil octanoate (ISO);4-cyano-2,6-diiodophenyl octanoate 223-375-4 3861-47-0 Repr. Cat. 3; R63T; R25Xi; R36R43N; R50-53 T; NR: 25-36-43-63-50/53S: (1/2-)26-36/37-45-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
608-019-00-1 2,2'-dimethyl-2,2'-azodipropiononitrile;ADZN 201-132-3 78-67-1 E; R2F; R11Xn; R20/22R52-53 E; XnR: 2-11-20/22-52/53S: (2-)39-41-47-61  
608-021-00-2 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile 403-710-2 76823-93-3 Xn; R22R43 XnR: 22-43S: (2-)22-24-37  
608-022-00-8 3,7-dimethyloctanenitrile 403-620-3 40188-41-8 Xi; R38R43N; R51-53 Xi; NR: 38-43-51/53S: (2-)36/37-61  
608-023-00-3 fenbuconazole (ISO)4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile 406-140-2 114369-43-6 N; R50-53 NR: 50/53S: 60-61  
608-024-00-9 2-(4-(N-butyl-N-phenethylamino)phenyl)ethylene-1,1,2-tricarbonitrile 407-650-8 97460-76-9 R53 R: 53S: 61  
608-025-00-4 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile 410-970-0 117568-27-1 R53 R: 53S: 61  
608-026-00-X 3-cyano-3,5,5-trimethylcyclohexanone 411-490-4 7027-11-4 Xn; R22-48/22R43R52-53 XnR: 22-43-48/22-52/53S: (2-)36/37-61  
608-027-00-5 reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile;3-(2-ethylphenyl)-2,2-dimethylpropanenitrile;3-(3-ethylphenyl)-2,2-dimethylpropanenitrile 412-660-0 — N; R51-53 NR: 51/53S: 61  
608-028-00-0 4-(2-cyano-3-phenylamino-acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate 413-510-7 147374-67-2 Xn; R48/20/21R43N; R51-53 Xn; NR: 43-48/20/21-51/53S: (2-)36/37-61  
608-029-00-6 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile 411-990-2 68612-94-2 R43 XiR: 43S: (2-)24-37  
608-030-00-1 N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide 412-340-0 147741-93-3 N; R50-53 NR: 50/53S: 60-61  
608-031-00-7 2-benzyl-2-methyl-3-butenitrile 407-870-4 97384-48-0 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
608-033-00-8 N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide 407-970-8 75511-91-0 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
608-034-00-3 chlorfenapyr;4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile — 122453-73-0 T; R23Xn; R22N; R50-53 T; NR: 22-23-50/53S: (1/2-)13-36/37-45-60-61  
608-035-00-9 (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile 419-290-9 — R43R53 XiR: 43-53S: (2-)24-37-61  
608-036-00-4 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl}vinyl)benzonitrile 419-060-8 79026-02-1 R53 R: 53S: 61  
608-037-00-X reaction mass of: (E)-2,12-tridecadiennitrile;(E)-3,12-tridecadiennitrile;(Z)-3,12-tridecadiennitrile 422-190-8  N; R50-53 NR: 50/53S: 60-61  
608-038-00-5 2,2,4-trimethyl-4-phenyl-butane-nitrile 422-580-8 75490-39-0 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
608-039-00-0 2-phenylhexanenitrile 423-460-8 3508-98-3 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)23-60-61  
608-040-00-6 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) 423-490-1 130755-46-3 N; R50-53 NR: 50/53S: 60-61  
608-041-00-1 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile 423-500-4 138401-24-8 N; R50-53 NR: 50/53S: 60-61  
608-043-00-2 3-(cis-3-hexenyloxy)propanenitril 415-220-6 142653-61-0 T; R23Xn; R22N; R50-53 T; NR: 22-23-50/53S: (1/2-)13-36/37-45-60-61  
608-065-00-2 salts of bromoxynil with the exception of those specified elsewhere in this Annex — — Repr. Cat. 3; R63T+; R26T; R25R43N; R50-53 T+; NR: 25-26-43-50/53S: (1/2-)27/28-36/37-45-63-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % A
608-066-00-8 salts of ioxynil with the exception of those specified elsewhere in this Annex — — Repr. Cat. 3; R63T; R23/25Xn; R21-48/22Xi; R36N; R50-53 T; NR: 21-23/25-36-48/22-63-50/53S: (1/2-)36/37-45-63-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % A
609-001-00-6 1-nitropropane 203-544-9 108-03-2 R10Xn; R20/21/22 XnR: 10-20/21/22S: (2-)9 Xn; R20/21/22: C ≥ 5 % 
609-002-00-1 2-nitropropane 201-209-1 79-46-9 R10Carc. Cat. 2; R45Xn; R20/22 TR: 45-10-20/22S: 53-45  E
609-003-00-7 nitrobenzene 202-716-0 98-95-3 Carc. Cat. 3; R40Repr. Cat. 3; R62T; R23/24/25-48/23/24N; R51-53 T; NR: 23/24/25-40-48/23/24-51/53-62S: (1/2-)28-36/37-45-61  
609-004-00-2 dinitrobenzene; [1]1,4-dinitrobenzene; [2]1,3-dinitrobenzene; [3]1,2-dinitrobenzene [4] 246-673-6 [1]202-833-7 [2]202-776-8 [3]208-431-8 [4] 25154-54-5 [1]100-25-4 [2]99-65-0 [3]528-29-0 [4] T+; R26/27/28R33N; R50-53 T+; NR: 26/27/28-33-50/53S: (1/2-)28-36/37-45-60-61  
609-005-00-8 1,3,5-trinitrobenzene 202-752-7 99-35-4 E; R2 ⊗T+; R26/27/28R33N; R50-53 E; T+; NR: 2-26/27/28-33-50/53S: (1/2-)35-45-60-61  
609-006-00-3 4-nitrotoluene 202-808-0 99-99-0 T; R23/24/25R33N; R51-53 T; NR: 23/24/25-33-51/53S: (1/2-)28-37-45-61  
609-007-00-9 2,4-dinitrotoluene;dinitrotoluene, technical grade; [1]dinitrotoluene [2] 204-450-0 [1]246-836-1 [2] 121-14-2 [1]25321-14-6 [2] Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R23/24/25Xn; R48/22N; R51-53 T; NR: 45-23/24/25-48/22-62-68-51/53S: 53-45-61  E
609-008-00-4 2,4,6-trinitrotoluene;TNT 204-289-6 118-96-7 E; R2T; R23/24/25R33N; R51-53 E; T; NR: 2-23/24/25-33-51/53S: (1/2-)35-45-61  
609-009-00-X 2,4,6-trinitrophenol;picric acid 201-865-9 88-89-1 E; R2 ⊗R4T; R23/24/25 E; TR: 2-4-23/24/25S: (1/2-)28-35-37-45  
609-010-00-5 salts of picric acid — — E; R3T; R23/24/25 E; TR: 3-23/24/25S: (1/2-)28-35-37-45  A
609-011-00-0 2,4,6-trinitroanisole — 606-35-9 E; R2Xn; R20/21/22N; R51-53 E; Xn; NR: 2-20/21/22-51/53S: (2-)35-61  
609-012-00-6 2,4,6-trinitro-m-cresol 210-027-1 602-99-3 E; R2R4Xn; R20/21/22 E; XnR: 2-4-20/21/22S: (2-)35  
609-013-00-1 2,4,6-trinitro-m-xylene 211-187-5 632-92-8 E; R2Xn; R20/21/22R33 E; XnR: 2-20/21/22-33S: (2-)35  
609-015-00-2 4-nitrophenol;p-nitrophenol 202-811-7 100-02-7 Xn; R20/21/22R33 XnR: 20/21/22-33S: (2-)28  
609-016-00-8 dinitrophenol (reaction mass of isomers); [1]2,4(or 2,6)-dinitrophenol [2] 247-096-2 [1]275-732-9 [2] 25550-58-7 [1]71629-74-8 [2] T; R23/24/25R33N; R50-53 T; NR: 23/24/25-33-50/53S: (1/2-)28-37-45-60-61  
609-018-00-9 2,4,6-trinitroresorcinol;styphnic acid 201-436-6 82-71-3 E; R2 ⊗R4Xn; R20/21/22 E; XnR: 2-4-20/21/22S: (2-)35  
609-019-00-4 lead 2,4,6-trinitro-m-phenylene dioxide;lead 2,4,6-trinitroresorcinoxide;lead styphnate 239-290-0 15245-44-0 E; R3Repr. Cat. 1; R61Repr. Cat. 3; R62Xn; R20/22R33N; R50-53 E; T; NR: 61-3-20/22-33-50/53-62S: 53-45-60-61  E1
609-020-00-X DNOC (ISO);4,6-dinitro-o-cresol 208-601-1 534-52-1 Muta. Cat. 3; R68T+; R26/27/28Xi; R38-41R43R44N; R50-53 T+; NR: 26/27/28-38-41-43-44-50/53-68S: (1/2-)36/37-45-60-61  
609-021-00-5 sodium salt of DNOC;sodium 4,6-dinitro-o-cresolate; [1]potassium salt of DNOC;potassium 4,6-dinitro-o-cresolate [2] 219-007-7 [1][2] 2312-76-7 [1]5787-96-2 [2] T; R23/24/25R33N; R50-53 T; NR: 23/24/25-33-50/53S: (1/2-)13-45-60-61  
609-022-00-0 ammonium salt of DNOC;ammonium 4,6-dinitro-o-tolyl oxide 221-037-0 2980-64-5 T+; R26/27/28R33N; R50-53 T+; NR: 26/27/28-33-50/53S: (1/2-)13-28-45-60-61  
609-023-00-6 dinocap (ISO) 254-408-0 39300-45-3 Repr. Cat. 2; R61Xn; R20-48/22Xi; R38R43N; R50-53 T; NR: 61-20-22-38-43-48/22-50/53S: 53-45-60-61  E
609-024-00-1 binapacryl (ISO);2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate 207-612-9 485-31-4 Repr. Cat. 2; R61Xn; R21/22N; R50-53 T; NR: 61-21/22-50/53S: 53-45-60-61  E
609-025-00-7 dinoseb (ISO);6-sec-butyl-2,4-dinitrophenol 201-861-7 88-85-7 R44T; R24/25Repr. Cat. 2; R61Repr. Cat. 3; R62Xi; R36N; R50-53 T; NR: 61-62-24/25-36-44-50/53S: 53-45-60-61  E
609-026-00-2 salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex — — R44Repr. Cat. 2; R61Repr. Cat. 3; R62T; R24/25Xi; R36N; R50-53 T; NR: 61-62-24/25-36-44-50/53S: 53-45-60-61  AE
609-027-00-8 dinocton;reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate — 63919-26-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
609-028-00-3 dinex (ISO);2-cyclohexyl-4,6-dinitrophenol 205-042-5 131-89-5 T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)13-45-60-61  
609-029-00-9 salts and esters of dinex — — T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)13-45-60-61  A
609-030-00-4 dinoterb (ISO);2-tert-butyl-4,6-dinitrophenol 215-813-8 1420-07-1 Repr. Cat. 2; R61T+; R28T; R24R44N; R50-53 T+; NR: 61-24-28-44-50/53S: 53-45-60-61  E
609-031-00-X salts and esters of dinoterb — — Repr. Cat. 2; R61T+; R28T; R24N; R50-53 T+; NR: 61-24-28-50/53S: 45-53-60-61  AE
609-032-00-5 bromofenoxim (ISO);3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime 236-129-6 13181-17-4 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)25-60-61  
609-033-00-0 dinosam (ISO);2-(1-methylbutyl)-4,6-dinitrophenol — 4097-36-3 T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)13-45-60-61  
609-034-00-6 salts and esters of dinosam — — T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)13-45-60-61  A
609-035-00-1 nitroethane 201-188-9 79-24-3 R10Xn; R20/22 XnR: 10-20/22S: (2-)9-25-41 Xn; R20/22: C ≥ 12,5 % 
609-036-00-7 nitromethane 200-876-6 75-52-5 R5-10Xn; R22 XnR: 5-10-22S: (2-)41 Xn; R22: C ≥ 12,5 % 
609-037-00-2 5-nitroacenaphthene 210-025-0 602-87-9 Carc. Cat. 2; R45 TR: 45S: 53-45  
609-038-00-8 2-nitronaphthalene 209-474-5 581-89-5 Carc. Cat. 2; R45N; R51-53 T; NR: 45-51/53S: 53-45-61  
609-039-00-3 4-nitrobiphenyl 202-204-7 92-93-3 Carc. Cat. 2; R45N; R51-53 T; NR: 45-51/53S: 53-45-61  
609-040-00-9 nitrofen (ISO);2,4-dichlorophenyl 4-nitrophenyl ether 217-406-0 1836-75-5 Carc. Cat. 2; R45Repr. Cat. 2; R61Xn; R22N; R50-53 T; NR: 45-61-22-50/53S: 53-45-60-61  E
609-041-00-4 2,4-dinitrophenol 200-087-7 51-28-5 T; R23/24/25R33N; R50 T; NR: 23/24/25-33-50S: (1/2-)28-37-45-61  
609-042-00-X pendimethalin (ISO);N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine 254-938-2 40487-42-1 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-29-37-60-61  
609-043-00-5 quintozene (ISO);pentachloronitrobenzene 201-435-0 82-68-8 R43N; R50-53 Xi; NR: 43-50/53S: (2-)13-24-37-60-61  
609-044-00-0 tecnazene (ISO);1,2,4,5-tetrachloro-3-nitrobenzene 204-178-2 117-18-0 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61  
609-045-00-6 reaction mass of: 4,6-dinitro-2-(3-octyl)phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate;dinocton-6 — 8069-76-9 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
609-046-00-1 trifluralin (ISO) (containing < 0.5 ppm NPDA);α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0.5 ppm NPDA);2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0.5 ppm NPDA);N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0.5 ppm NPDA) 216-428-8 1582-09-8 Xi; R36R43N; R50-53 Xi; NR: 36-43-50/53S: (2-)24-37-60-61  
609-047-00-7 2-nitroanisole 202-052-1 91-23-6 Carc. Cat. 2; R45Xn; R22 TR: 45-22S: 53-45  E
609-048-00-2 sodium 3-nitrobenzenesulphonate 204-857-3 127-68-4 Xi; R36R43 XiR: 36-43S: (2-)24-26-37  
609-049-00-8 2,6-dinitrotoluene 210-106-0 606-20-2 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R23/24/25Xn; R48/22R52-53 TR: 45-23/24/25-48/22-62-68-52/53S: 53-45-61  E
609-050-00-3 2,3-dinitrotoluene 210-013-5 602-01-7 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R23/24/25Xn; R48/22N; R50-53 T; NR: 45-23/24/25-48/22-62-68-50/53S: 53-45-60-61  E
609-051-00-9 3,4-dinitrotoluene 210-222-1 610-39-9 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R23/24/25Xn; R48/22N; R51-53 T; NR: 45-23/24/25-48/22-62-68-51/53S: 53-45-61  E
609-052-00-4 3,5-dinitrotoluene 210-566-2 618-85-9 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R23/24/25Xn; R48/22R52-53 TR: 45-23/24/25-48/22-62-68-52/53S: 53-45-61  E
609-053-00-X hydrazine-trinitromethane 414-850-9 — E; R3O; R8Carc. Cat. 2; R45T; R23/25R43 E; TR: 45-3-8-23/25-43S: 53-45  E
609-054-00-5 2,3-dinitrophenol; [1]2,5-dinitrophenol; [2]2,6-dinitrophenol; [3]3,4-dinitrophenol; [4]salts of dinitrophenol [5] 200-628-7 [1]206-348-1 [2]209-357-9 [3]209-415-3 [4][5] 66-56-8 [1]329-71-5 [2]573-56-8 [3]577-71-9 [4][5] T; R23/24/25R33N; R51-53 T; NR: 23/24/25-33-51S: (1/2-)28-37-45-61  
609-055-00-0 2,5-dinitrotoluene 210-581-4 619-15-8 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R23/24/25Xn; R48/22N; R51-53 T; NR: 45-23/24/25-48/22-62-68-51/53S: 53-45-61  E
609-056-00-6 2,2-dibromo-2-nitroethanol 412-380-9 69094-18-4 E; R2Carc. Cat. 3; R40Xn; R22-48/22C; R35R43N; R50-53 E; C; NR: 2-22-35-40-43-48/22-50/53S: (1/2-)23-26-36/37/39-45-60-61 Xn; R22: C ≥ 10 %C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
609-057-00-1 3-chloro-2,4-difluoronitrobenzene 411-980-8 3847-58-3 Xn; R22C; R34R43N; R50-53 C; NR: 22-34-43-50/53S: (1/2-)22-26-28-36/37/39-45-60-61  
609-058-00-7 2-nitro-2-phenyl-1,3-propanediol 410-360-4 5428-02-4 T; R39-48/25Xn; R21/22Xi; R41R43N; R51-53 T; NR: 21/22-39-41-43-48/25-51/53S: 53-45-61  
609-059-00-2 2-chloro-6-(ethylamino)-4-nitrophenol 411-440-1 131657-78-8 Xn; R22R43N; R51-53 Xn; NR: 22-43-51/53S: (2-)22-24-37/39-61  
609-060-00-8 4-[(3-hydroxypropyl)amino]-3-nitrophenol 406-305-9 92952-81-3 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
609-061-00-3 (E,Z)-4-chlorophenyl(cyclopropyl)ketone O-(4-nitrophenylmethyl)oxime 406-100-4 94097-88-8 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
609-062-00-9 2-bromo-2-nitropropanol 407-030-7 24403-04-1 T; R24Xn; R22-48/22C; R34R43N; R50-53 T; NR: 22-24-34-43-48/22-50/53S: (1/2-)26-36/37/39-45-60-61  
609-063-00-4 2-[(4-chloro-2-nitrophenyl)amino]ethanol 413-280-8 59320-13-7 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)22-61  
609-064-00-X mesotrione (ISO);2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione — 104206-82-8 N; R50-53 NR: 50/53S: 60-61  
609-065-00-5 2-nitrotoluene 201-853-3 88-72-2 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 3; R62Xn; R22N; R51-53 T; NR: 45-46-22-62-51/53S: 53-45-61  E
609-066-00-0 lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate 418-870-9 154212-58-5 Xn; R20/21/22-68/20/21/22 XnR: 20/21/22-68/20/21/22S: (2-)36/37  
609-067-00-6 sodium and potassium 4-(3-aminopropylamino)-2,6-bis[3-(4-methoxy-2-sulfophenylazo)-4-hydroxy-2-sulfo-7-naphthylamino]-1,3,5-triazine 416-280-6 156769-97-0 R43 XiR: 43S: (2-)22-24-37  
609-068-00-1 musk xylene;5-tert-butyl-2,4,6-trinitro-m-xylene 201-329-4 81-15-2 E; R2Carc. Cat. 3; R40N; R50-53 E; Xn; NR: 2-40-50/53S: (2-)36/37-46-60-61  
609-070-00-2 1,4-dichloro-2-(1,1,2,3,3,3-hexafluoropropoxy)-5-nitrobenzene 415-580-4 130841-23-5 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)36/37/39-60-61  
609-071-00-8 reaction mass of: 2-methylsulfanyl-4,6-bis-(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-5-methoxy-phenol 423-520-3 156137-33-6 R43 XiR: 43S: (2-)22-24-37  
610-001-00-3 trichloronitromethane;chloropicrin 200-930-9 76-06-2 Xn; R22T+; R26Xi; R36/37/38 T+R: 22-26-36/37/38S: (1/2-)36/37-38-45  
610-002-00-9 1,1-dichloro-1-nitroethane 209-854-0 594-72-9 T; R23/24/25 TR: 23/24/25S: (1/2-)26-45  
610-003-00-4 chlorodinitrobenzene — — T; R23/24/25R33N; R50-53 T; NR: 23/24/25-33-50/53S: (1/2-)28-36/37-45-60-61  C
610-004-00-X 2-chloro-1,3,5-trinitrobenzene 201-864-3 88-88-0 E; R2T+; R26/27/28N; R50-53 E; T+; NR: 2-26/27/28-50/53S: (1/2-)28-36/37-45-60-61  
610-005-00-5 1-chloro-4-nitrobenzene 202-809-6 100-00-5 Carc. Cat. 3; R40Muta. Cat. 3; R68T; R23/24/25Xn; R48/20/21/22N; R51-53 T; NR: 23/24/25-40-48/20/21/22-68-51/53S: (1/2-)28-36/37-45-61  
610-006-00-0 chloronitroanilines with the exception of those specified elsewhere in this Annex — — T+; R26/27/28R33N; R51-53 T+; NR: 26/27/28-33-51/53S: (1/2-)28-36/37-45-61  A C
610-007-00-6 1-chloro-1-nitropropane 209-990-0 600-25-9 Xn; R20/22 XnR: 20/22S: (2-) Xn; R20/22: C ≥ 5 % 
610-008-00-1 2,6-dichloro-4-nitroanisole 403-350-6 17742-69-7 T; R25N; R51-53 T; NR: 25-51/53S: (1/2-)36/37-45-61  
610-009-00-7 2-chloro-4-nitroaniline 204-502-2 121-87-9 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)22-24-61  
610-010-00-2 2-bromo-1-(2-furyl)-2-nitroethylene 406-110-9 35950-52-8 Xn; R22-48/22C; R34R43N; R50-53 C; NR: 22-34-43-48/22-50/53S: (1/2-)22-26-36/37/39-45-60-61  
611-001-00-6 azobenzene 203-102-5 103-33-3 Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R20/22-48/22N; R50-53 T; NR: 45-20/22-48/22-68-50/53S: 53-45-60-61  E
611-002-00-1 azoxybenzene 207-802-1 495-48-7 Xn; R20/22 XnR: 20/22S: (2-)28  
611-003-00-7 fenaminosulf (ISO);sodium 4-dimethylaminobenzenediazosulphonate 205-419-4 140-56-7 T; R25Xn; R21R52-53 TR: 21-25-52/53S: (1/2-)36/37-45-61  
611-004-00-2 methyl-ONN-azoxymethyl acetate;methyl azoxy methyl acetate 209-765-7 592-62-1 Carc. Cat. 2; R45Repr. Cat. 2; R61 TR: 45-61S: 53-45  
611-005-00-8 disodium {5-[(4'-((2,6-hydroxy-3-((2-hydroxy-5-sulphophenyl)azo)phenyl)azo)(1,1'-biphenyl)-4-yl)azo]salicylato(4-)}cuprate(2-);CI Direct Brown 95 240-221-1 16071-86-6 Carc. Cat. 2; R45 TR: 45S: 53-45  
611-006-00-3 4-o-tolylazo-o-toluidine;4-amino-2',3-dimethylazobenzene;fast garnet GBC base;AAT;o-aminoazotoluene 202-591-2 97-56-3 Carc. Cat. 2; R45R43 TR: 45-43S: 53-45  
611-007-00-9 tricyclazole (ISO);5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole 255-559-5 41814-78-2 Xn; R22 XnR: 22S: (2-)  
611-008-00-4 4-aminoazobenzene;4-phenylazoaniline 200-453-6 60-09-3 Carc. Cat. 2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61  
611-009-00-X sodium (1-(5-(4-(4-anilino-3-sulphophenylazo)-2-methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II) 401-220-3 — Xn; R20R52-53 XnR: 20-52/53S: (2-)61  
611-010-00-5 2'-(2-cyano-4,6-dinitrophenylazo)-5'-(N,N-dipropylamino)propionanilide 403-010-7 106359-94-8 R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
611-011-00-0 N,N,N',N'-tetramethyl-3,3'-(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1-diyl)))di(propylammonium) dilactate 403-340-1 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
611-012-00-6 reaction mass of 2,2-iminodiethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and 2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-diamine 6-methyl-2-(4-(2,4,6-triaminopyrimidin-5-ylazo)phenyl)benzothiazole-7-sulfonate 403-410-1 114565-65-0 R43 XiR: 43S: (2-)22-24-26-37  
611-013-00-1 trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-methyl-4-(2-methoxy-4-(3-sulfonatophenylazo)phenylazo)phenylazo)naphthalene-3-sulfonate 403-650-7 117409-78-6 E; R2N; R51-53 E; NR: 2-51/53S: (2-)35-61  
611-014-00-7 (tetrasodium 1-(4-(3-acetamido-4-(4'-nitro-2,2'-disulfonatostilben-4-ylazo)anilino)-6-(2,5-disulfonatoanilino)-1,3,5-triazin-2-yl)-3-carboxypyridinium) hydroxide 404-250-5 115099-55-3 R43 XiR: 43S: (2-)22-24-37  
611-015-00-2 tetrasodium 4-amino-5-hydroxy-6-(4-(2-(2-(sulfonatooxy)ethylsulfonyl)ethylcarbamoyl)phenylazo)-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate 404-320-5 116889-78-2 R43 XiR: 43S: (2-)22-24-37  
611-016-00-8 reaction mass of 1,1'-((dihydroxyphenylene)bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-5-pyridinio-3-pyridylazo)phenylazo)-2,4(or2,6 or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium dichloride 404-540-1 — R43 XiR: 43S: (2-)22-24-37  
611-017-00-3 2-(4-(diethylaminopropylcarbamoyl)phenylazo)-3-oxo-N-(2,3-dihydro-2-oxobenzimidazol-5-yl)butyramide 404-910-2 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
611-018-00-9 tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato-2-naphthylazo)-6-sulfonato-1-naphthylazo)isophthalate 405-130-5 — R43 XiR: 43S: (2-)24-37  
611-019-00-4 tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-150-4 106028-58-4 R43 XiR: 43S: (2-)24-37  
611-020-00-X tetrakis(tetramethylammonium) 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-sulfonatophenylazo)-1-naphthylazo)naphthalene-2,7-disulfonate 405-170-3 116340-05-7 T; R25R43R52-53 TR: 25-43-52/53S: (1/2-)22-24-37-45-61  
611-021-00-5 2-(4-(4-cyano-3-methylisothiazol-5-ylazo)-N-ethyl-3-methylanilino)ethyl acetate 405-480-9 — Xn; R22-48/22Xi; R38R53 XnR: 22-38-48/22-53S: (2-)22-36/37-61  
611-022-00-0 4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate 404-980-4 — E; R2T; R23/25Xn; R21-48/22Xi; R41R43N; R50/53 E; T; NR: 2-21-23/25-41-43-48/22-50/53S: (1/2-)3-12-26-35-36/37/39-45-61  
611-023-00-6 disodium 7-(4,6-dichloro-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo) naphthalene-2-sulfonate 404-600-7 — R43 XR: 43S: (2-)22-24-37  
611-024-00-1 Benzidine based azo dyes;4,4'-diarylazobiphenyl dyes, with the exception of those specified elsewhere in this Annex — — Carc. Cat. 2; R45 TR: 45S: 53-45  A
611-025-00-7 disodium 4-amino-3-[[4'-[(2,4-diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)naphtalene-2,7-disulphonate;C.I. Direct Black 38 217-710-3 1937-37-7 Carc. Cat. 2; R45Repr. Cat. 3; R63 TR: 45-63S: 53-45  
611-026-00-2 tetrasodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonate];C.I. Direct Blue 6 220-012-1 2602-46-2 Carc. Cat. 2; R45Repr. Cat. 3; R63 TR: 45-63S: 53-45  
611-027-00-8 disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate);C.I. Direct Red 28 209-358-4 573-58-0 Carc. Cat. 2; R45Repr. Cat. 3; R63 TR: 45-63S: 53-45  
611-028-00-3 C,C'-azodi(formamide) 204-650-8 123-77-3 R42R44 ⊗ XnR: 42-44S: (2-)22-24-37  
611-029-00-9 o-dianisidine based azo dyes;4,4'-diarylazo-3,3'-dimethoxybiphenyl dyes with the exception of those mentioned elsewhere in this Annex — — Carc. Cat. 2; R45 TR: 45S: 53-45  A H
611-030-00-4 o-tolidine based dyes;4,4'-diarylazo-3,3'-dimethylbiphenyl dyes, with the exception of those mentioned elsewhere in this Annex — — Carc. Cat. 2; R45 TR: 45S: 53-45  A H
611-031-00-X 4,4'-(4-iminocyclohexa-2,5-dienylidenemethylene)dianiline hydrochloride;C.I. Basic Red 9 209-321-2 569-61-9 Carc. Cat. 2; R45 TR: 45S: 53-45  
611-032-00-5 1,4,5,8-tetraaminoanthraquinone;C.I. Disperse Blue 1 219-603-7 2475-45-8 Carc. Cat. 2; R45Xi; R38-41R43 TR: 45-38-41-43S: 53-45  
611-033-00-0 hexasodium [4,4''-azoxybis(2,2'-disulfonatostilbene-4,4'-diylazo)]-bis[5'-sulfonatobenzene-2,2'- diolato-O(2),O(2),N(1)]-copper(II) 400-020-3 82027-60-9 N; R51-53 NR: 51/53S: 61  
611-034-00-6 N-(5-(bis(2-methoxyethyl)amino)-2-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenylacetamide 402-430-8 105076-77-5 R53 R: 53S: 61  
611-035-00-1 tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate 403-660-1 107246-80-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
611-036-00-7 2-(4-(5,6(or 6,7)-dichloro-1,3-benzothiazol-2-ylazo)-N-methyl-m-toluidino)ethyl acetate 405-440-0 — R43 XiR: 43S: (2-)22-24-37  
611-037-00-2 3(or 5)-(4-(N-benzyl-N-ethylamino)-2-methylphenylazo)-1,4-dimethyl-1,2,4-triazolium methylsulphate 406-055-0 124584-00-5 Xn; R22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-51/53S: (2-)22-24-26-37/39-61  
611-038-00-8 trisodium 1-hydroxynaphthalene-2-azo-4'(5',5''-dimethylbiphenyl)-4''-azo(4''-phenylsulfonyloxybenzene)- 2',2'',4-trisulfonate 406-820-9 — Xi; R36 XiR: 36S: (2-)25-26  
611-039-00-3 7-[((4,6-dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(4-((2-sulfoxy)ethyl)sulfonyl)phenylazo]naphthalene-2-sulfonic acid 407-050-6 117715-57-8 R43 XiR: 43S: (2-)22-24-37  
611-040-00-9 3-(5-acetylamino-4-(4-[4,6-bis(3-diethylaminopropylamino)-1,3,5-triazin-2-ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6-amino-4-hydroxy-2-naphthalenesulfonic acid 407-670-7 115099-58-6 N; R50-53 NR: 50/53S: 60-61  
611-041-00-4 2-[[4[[4,6-bis[[3-(diethylamino)propyl]amino]-1,3,5-triazine-2-yl]amino]phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutanamide 407-680-1 98809-11-1 Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)24-26-37/39-61  
611-042-00-X trisodium 5-amino-3-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-4-hydroxy-6-(4-vinylsulfonylphenylazo)naphthalene-2,7-disulfonate 411-770-6 136213-71-3 R52-53 R: 52/53S: 61  
611-043-00-5 reaction mass of: trisodium N(1')-N(2):N(1''')-N(2'')-η-6-[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]-6''-(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'-azobenzene-1,2'-diolato-O(1),O(2'))-chromate;trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis(1-carbaniloyl-2-hydroxyprop-1-enylazo)-5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate;trisodium N(1')-N(2):N(1''')-N(2'')-η-6,6''-bis[2-amino-4-(or 6)-hydroxy-(or 4-amino-2-hydroxy)phenylazo]5',5'''-disulfamoyl-3,3''-disulfonatobis(naphthalene-2,1'azobenzene-1,2'-diolato-O(1),O(2'))-chromate (2:1:1) 402-850-1 — Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
611-044-00-0 reaction mass of: tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);tert-alkyl(C12-C14)ammonium bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]-chromate(1-);tert-alkyl(C12-C14)ammonium bis[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-chromate(1-);tert-alkyl(C12-C14)ammonium [[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);tert-alkyl(C12-C14)ammonium [[1-[[5-(1,1-dimethylpropyl)-2-hydroxy-3-nitrophenyl]azo]-2-naphthalenolato(2-)]-[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]]-chromate(1-);tert-alkyl(C12-C14)ammonium ((1-(4(or 5)-nitro-2-oxidophenylazo)-2-naphtholato)(1-(3-nitro-2-oxido-5-pentylphenylazo)-2-naphtholato))chromate(1-) 403-720-7 117527-94-3 N; R51-53 NR: 51/53S: 61  
611-045-00-6 2-[4-[N-(4-acetoxybutyl)-N-ethyl]amino-2-methylphenylazo]-3-acetyl-5-nitrothiophene 404-830-8 — R53 R: 53S: 61  
611-046-00-1 4,4'-diamino-2-methylazobenzene 407-590-2 43151-99-1 T; R25Xn; R48/22R43N; R50-53 T; NR: 25-43-48/22-50/53S: (1/2-)22-28-36/37-45-60-61  
611-047-00-7 reaction mass of: 2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;2-[[4-[N-ethyl-N-(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 407-890-3 111381-11-4 R53 R: 53S: 61  
611-048-00-2 reaction mass of: 2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-5,6-dichlorobenzothiazole;2-[[4-[bis(2-acetoxyethyl)amino]phenyl]azo]-6,7-dichlorobenzothiazole (1:1) 407-900-6 111381-12-5 R53 R: 53S: 61  
611-049-00-8 reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) 408-000-6 118658-98-3 Xn; R48/22R43R52-53 XnR: 43-48/22-52/53S: (2-)22-36/37-61  
611-051-00-9 2-(4-(N-ethyl-N-(2-hydroxy)ethyl)amino-2-methylphenyl)azo-6-methoxy-3-methyl-benzothiazolium chloride 411-110-7 136213-74-6 N; R50-53 NR: 50/53S: 60-61  
611-052-00-4 monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalensulfonate], iron complex 400-720-9 — R52-53 R: 52/53S: 61  
611-053-00-X 2,2'-azobis[2-methylpropionamidine] dihydrochloride 221-070-0 2997-92-4 Xn; R22R43 XnR: 22-43S: (2-)24-37  
611-055-00-0 C.I. Disperse Yellow 3;N-[4-[(2-hydroxy-5-methylphenyl)azo]phenyl]acetamide 220-600-8 2832-40-8 Carc. Cat. 3; R40R43 XnR: 40-43S: (2-)22-36/37-46  
611-056-00-6 C.I. Solvent Yellow 14;1-phenylazo-2-naphthol 212-668-2 842-07-9 Carc. Cat. 3; R40Muta. Cat. 3; R68R43R53 XnR: 40-43-53-68S: (2-)22-36/37-46-61  
611-057-00-1 6-hydroxy-1-(3-isopropoxypropyl)-4-methyl-2-oxo-5-[4-(phenylazo)phenylazo]-1,2-dihydro-3-pyridinecarbonitrile 400-340-3 85136-74-9 Carc. Cat. 2; R45R53 TR: 45-53S: 53-45-61  
611-058-00-7 (6-(4-hydroxy-3-(2-methoxyphenylazo)-2-sulfonato-7-naphthylamino)-1,3,5-triazin-2,4-diyl)bis[(amino-1-methylethyl)ammonium] formate 402-060-7 108225-03-2 Carc. Cat. 2; R45Xi; R41N; R51-53 T; NR: 45-41-51/53S: 53-45-61  
611-059-00-2 octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-naphthylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene-1,5-disulfonate 412-960-1 148878-21-1 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)22-24-26-37/39-61  
611-060-00-8 reaction mass of: sodium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;ammonium 5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonatonaphthalen-2-ylazo]-isophthalate;5-[8-[4-[4-[4-[7-(3,5-dicarboxylatophenylazo)-8-hydroxy-3,6-disulfonatonaphthalen-1-ylamino]-6-hydroxy-1,3,5-triazin-2-yl]-2,5-dimethylpiperazin-1-yl]-6-hydroxy-1,3,5-triazin-2-ylamino]-1-hydroxy-3,6-disulfonaphthalen-2-ylazo]-isophthalic acid 413-180-4 187285-15-0 Xi; R41 XiR: 41S: (2-)22-26-39  
611-061-00-3 disodium 5-[5-[4-(5-chloro-2,6-difluoropyrimidin-4-ylamino)benzamido]-2-sulfonatophenylazo]-1-ethyl-6-hydroxy-4-methyl-2-oxo-3-pyridylmethylsulfonate 412-530-3 — Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
611-062-00-9 octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)-3,6-disulfonato-1-hydroxynaphthalen-2-ylazo)naphthalene-1,5-disulfonate 413-550-5 — Xi; R38-41 XiR: 38-41S: (2-)22-26-37/39  
611-063-00-4 trisodium [4'-(8-acetylamino-3,6-disulfonato-2-naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2-naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato-O,O',O'',O''']copper(II) 413-590-3 164058-22-4 Carc. Cat. 2; R45 TR: 45S: 53-45  
611-064-00-X 4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol 410-600-8 124719-26-2 Xn; R48/22Xi; R38N; R50-53 Xn; NR: 38-48/22-50/53S: (2-)23-25-36/37-60-61  
611-065-00-5 4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol 410-610-2 111850-24-9 Xn; R48/22Xi; R36/38R43N; R50-53 Xn; NR: 36/38-43-48/22-50/53S: (2-)23-26-36/37-60-61  
611-066-00-0 tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 411-540-5 130201-57-9 Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)22-24-26-37/39-61  
611-067-00-6 reaction mass of: bis(tris(2-(2-hydroxy(1-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate;bis(tris(2-(2-hydroxy(2-methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-3-(2-methoxy-5-methyl-4-(4-sulfonatophenylazo)phenylazo)naphthalene-2-sulfonate 406-910-8 — Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)26-36/39-61  
611-068-00-1 tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-sulfonatophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 400-690-7 85665-98-1 N; R51-53 NR: 51/53S: 61  
611-069-00-7 N,N-di-[poly(oxyethylene)-co-poly(oxypropylene)]-4-[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline 413-380-1 — N; R51-53 NR: 51/53S: 61  
611-070-00-2 reaction mass of: disodium (6-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-);trisodium bis(5-(4-anisidino)-3-sulfonato-2-(3,5-dinitro-2-oxidophenylazo)-1-naphtholato)chromate(1-) 405-665-4 — R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
611-071-00-8 tris(tetramethylammonium) 5-hydroxy-1-(4-sulphonatophenyl)-4-(4-sulphonatophenylazo)pyrazole-3-carboxylate 406-073-9 131013-81-5 T; R25R52-53 TR: 25-52/53S: (1/2-)37-45-61  
611-072-00-3 2,4-bis[2,2'-[2-(N,N-dimethylamino)ethyloxycarbonyl]phenylazo]-1,3-dihydroxybenzene, dihydrochloride 407-010-8 118208-02-9 Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)26-39-61  
611-073-00-9 dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)-3-hydroxyphenyl)imino)dipropionate 407-310-9 122630-55-1 R53 R: 53S: 61  
611-074-00-4 reaction mass of: sodium/potassium (3-(4-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II);sodium/potassium (3-(4-(5-(5-chloro-4,6-difluoropyrimidin-2-ylamino)-2-methoxy-3-sulfonatophenylazo)-2-oxidophenylazo)-2,5,7-trisulfonato-4-naphtholato)copper(II) 407-100-7 — R43 XiR: 43S: (2-)22-24-37  
611-075-00-X reaction mass of: tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(2-amino-4-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate;tris(3,5,5-trimethylhexylammonium) 4-amino-3-(4-(4-(4-amino-2-hydroxyphenylazo)anilino)-3-sulfonatophenylazo)-5,6-dihydro-5-oxo-6-phenylhydrazononaphthalene-2,7-disulfonate (2:1) 406-000-0 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
611-076-00-5 3-(2,6-dichloro-4-nitrophenylazo)-1-methyl-2-phenylindole 406-280-4 117584-16-4 N; R50-53 NR: 50/53S: 60-61  
611-077-00-0 dilithium disodium (5,5'-diamino-(μ-4,4'-dihydroxy-1:2-κ-2,O4,O4',-3,3'-[3,3'-dihydroxy-1:2-κ-2-O3,O3'-biphenyl-4,4'-ylenebisazo-1:2-(N3,N4-η:N3',N4'-η)]-dinaphthalene-2,7-disulfonato(8)))dicuprate(2-) 407-230-4 126637-70-5 Xn; R22R43 XnR: 22-43S: (2-)22-24-37  
611-078-00-6 (2,2'-(3,3'-dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-(diethylamino)propylamino)-6-(3-(diethylammonio)propylamino)-1,3,5-triazin-2-ylamino)-3-sulfonato-1-naphtholato))dicopper(II) acetate lactate 407-240-9 159604-94-1 R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-61  
611-079-00-1 disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)-2-naphthalenesulfonate 410-390-8 147703-64-8 Xi; R41 XiR: 41S: (2-)22-26-39  
611-080-00-7 sodium 3-(2-acetamido-4-(4-(2-hydroxybutoxy)phenylazo)phenylazo)benzenesulfonate 410-150-2 147703-65-9 R43 XiR: 43S: (2-)22-24-37  
611-081-00-2 tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8-naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) 411-470-5 141048-13-7 R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
611-082-00-8 reaction mass of: pentasodium bis(1-(3(or 5)-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)ferrate(1-);pentasodium [(1-(3-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato)-(5-(4-anilino-3-sulfonatophenylazo)-4-hydroxy-2-oxidophenylazo)-6-nitro-4-sulfonato-2-naphtholato]ferrate(1-) 407-570-3 — N; R51-53 NR: 51/53S: 61  
611-083-00-3 reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate;2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) 411-560-4 — T; R48/25R43N; R51-53 T; NR: 43-48/25-51/53S: (1/2-)22-36/37-45-61  
611-084-00-9 reaction mass of: N-(4-chlorophenyl)-4-(2,5-dichloro-4-(dimethylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide;N-(4-chlorophenyl)-4-(2,5-dichloro-4-(methylsulfamoyl)phenylazo)-3-hydroxy-2-naphthalenecarboxamide 412-550-2 — R53 R: 53S: 61  
611-085-00-4 reaction mass of: 3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-(2-hydroxy-ethylamino)-4-methyl-6-[3-(2-phenoxyethoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-(2-hydroxy-ethylamino)-4-methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-2-amino-4-methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine;3-cyano-5-(2-cyano-4-nitro-phenylazo)-6-amino-4-methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine 411-880-4 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
611-086-00-X monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-dinitrophenyl)azo]phenyl]azo]-2-naphthalenesulfonate], iron complex, monohydrate 411-360-7 — R52-53 R: 52/53S: 61  
611-087-00-5 reaction mass of: 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxyl-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-phenoxyethane;3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-ethyloxy-2-(ethylphenol) 411-710-9 — R53 R: 53S: 61  
611-088-00-0 reaction mass of: trilithium 4-amino-3-((4-((4-((2-amino-4-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate;trilithium 4-amino-3-((4-((4-((4-amino-2-hydroxyphenyl)azo)phenyl)amino)-3-sulfophenyl)azo)-5-hydroxy-6-(phenylazo)naphthalene-2,7-disulfonate 411-890-9 — Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)22-26-39-61  
611-089-00-6 2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate 411-100-2 136213-73-5 Xn; R48/22R43N; R50-53 Xn; NR: 43-48/22-50/53S: (2-)22-36/37-60-61  
611-090-00-1 2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate 413-290-2 93672-52-7 F; R11Xn; R22Xi; R41R43R52-53 F; XnR: 11-22-41-43-52/53S: (2-)12-22-24-26-37/39-47-61  
611-091-00-7 sodium (1.0-1.95)/lithium (0.05-1) 5-((5-((5-chloro-6-fluoro-pyrimidin-4-yl)amino)-2-sulfonatophenyl)azo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-3-pyridinemethylsulfonate 413-470-0 134595-59-8 R43 XiR: 43S: (2-)22-24/25-37  
611-092-00-2 tert-(dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-methyl-5-hydroxy-(1H)pyrazol-1-yl)benzenesulfonamidato)chromate 413-210-6 — N; R51-53 NR: 51/53S: 61  
611-093-00-8 sodium 2-(4-(4-fluoro-6-(2-sulfo-ethylamino)-[1,3,5]triazin-2-ylamino)-2-ureido-phenylazo)-5-(4-sulfophenylazo)benzene-1-sulfonate 410-770-3 146177-84-6 R43 XiR: 43S: (2-)22-24-37  
611-094-00-3 reaction mass of: 2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-5,6-dichloro-1,3-benzothiazole;2-[2-acetylamino-4-[N,N-bis[2-ethoxy-carbonyloxy)ethyl]amino]phenylazo]-6,7-dichloro-1,3-benzotriazole (1:1) 411-600-0 143145-93-1 R53 R: 53S: 61  
611-095-00-9 hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] dihydroxide 412-240-7 89797-03-5 N; R51-53 NR: 51/53S: 22-61  
611-096-00-4 methyl N-[3-acetylamino)-4-(2-cyano-4-nitrophenylazo)phenyl]-N-[(1-methoxy)acetyl]glycinate 413-040-2 149850-30-6 R43 XiR: 43S: (2-)22-24-37  
611-097-00-X reaction mass of iron complexes of: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-(5-amino-sulfonyl-2-hydroxyphenylazo)benzene and: 1,3-dihydroxy-4-[(5-phenylaminosulfonyl)-2-hydroxyphenylazo]-n-[4-(4-nitro-2-sulfophenylamino)phenylazo]benzene (n=2,5,6) 414-150-3 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-61  
611-098-00-5 tetrakis(tetramethylammonium)3,3'-(6-(2-hydroxyethylamino)1,3,5-triazine-2,4-diylbisimino(2-methyl-4,1-phenyleneazo))bisnaphthalene-1,5-disulfonate 405-950-3 131013-83-7 T; R25R52-53 TR: 25-52/53S: (1/2-)37-45-61  
611-099-00-0 (methylenebis(4,1-phenylenazo(1-(3-(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium dichloride dihydrochloride 401-500-5 118658-99-4 Carc. Cat. 2; R45N; R51-53 T; NR: 45-51/53S: 53-45-61  
611-100-00-4 potassium sodium 3,3'-(3(or4)-methyl-1,2-phenylenebis(imino(6-chloro)-1,3,5-triazine-4,2-diylimino(2-acetamido-5-methoxy)-4,1-phenylenazo)dinaphthalene-1,5-disulfonate 403-810-6 140876-13-7 Xi; R41 XiR: 41S: (2-)26-39  
611-101-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienyl)azo-5'-diethylaminoacetanilide 405-200-5 104366-25-8 R43 XiR: 43S: (2-)22-24-37  
611-103-00-0 trisodium (1-(3-carboxylato-2-oxido-5-sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen-2-amido)nickel(II) 407-110-1 — Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)24-26-37/39-61  
611-104-00-6 reaction mass of: trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2or 6)-(4-(4-nitro-2-sulfonatoanilino)phenylazo)phenolato)ferrate(1-);trisodium bis(2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)ferrate(1-);trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(4-nitro-2-sulfonatophenylazo)phenolato)ferrate(1-);trisodium (2,4(or 2,6 or 4,6)-bis(3,5-dinitro-2-oxidophenylazo)-5-hydroxyphenolato)(2(or 4 or 6)-(3,5-dinitro-2-oxidophenylazo)-5-hydroxy-4(or 2 or 6)-(3-sulfonatophenylazo)phenolato)ferrate(1-);disodium 3,3'-(2,4-dihydroxy-1,3(or 1,5 or 3,5)-phenylenediazo)dibenzenesulfonate 406-870-1 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
611-105-00-1 sodium 4-(4-chloro-6-(N-ethylanilino)-1,3,5-triazin-2-ylamino)-2-(1-(2-chlorophenyl)-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)benzenesulfonate 407-800-2 136213-75-7 R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-61  
611-106-00-7 hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-sulfonatophenylazo)phenylazo]-7,7'[p-phenylenebis[imino(6-chloro-1,3,5-triazine-4,2-diyl)imino]]dinaphthalene-2-sulfonate 410-180-6 157627-99-1 Xi; R41 XiR: 41S: (2-)26-39  
611-107-00-2 potassium sodium 4-(4-chloro-6-(3,6-disulfonato-7-(5,8-disulfonato-naphthalen-2-ylazo)-8-hydroxy-naphthalen-1-ylamino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-(2-sulfatoethanesulfonyl)-phenylazo)-naphthalene-1,7-disulfonate 412-490-7 — R43 XiR: 43S: (2-)22-24-37  
611-108-00-8 disodium 5-((4-((4-chloro-3-sulfonatophenyl)azo)-1-naphthyl)azo)-8-(phenylamino)-1-naphthalenesulfonate 413-600-6 6527-62-4 R52-53 R: 52/53S: 61  
611-109-00-3 Reaction products of: copper(II) sulfate and tetrasodium 2,4-bis[6-(2-methoxy-5-sulfonatophenylazo)-5-hydroxy-7-sulfonato-2-naphthylamino]-6-(2-hydroxyethylamino)-1,3,5-triazine (2:1) 407-710-3 — N; R51-53 NR: 51/53S: 61  
611-110-00-9 tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato-1-naphthol-2-ylazo)-3-methylazobenzene 408-210-8 124605-82-9 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-28-37-61  
611-111-00-4 disodium 2-[[4-(2-chloroethylsulfonyl)phenyl]-[(2-hydroxy-5-sulfo-3-[3-[2-(2-(sulfooxy)ethylsulfonyl)ethylazo]-4-sulfobenzoato(3-)cuprate(1-) 414-230-8 — R43 XiR: 43S: (2-)22-24-37  
611-112-00-X tetrasodium 4-hydroxy-5-[4-[3-(2-sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2-ylazo)naphthalene-2,7-disulfonate 413-070-6 — R43 XiR: 43S: (2-)22-24-37  
611-113-00-5 lithium sodium (2-(((5-((2,5-dichlorophenyl)azo)-2-hydroxyphenyl)methylene)amino)benzoato(2-))(2-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-5-sulfobenzoato(3-)) chromate(2-) 414-280-0 149626-00-6 N; R51-53 NR: 51/53S: 24/25-61  
611-114-00-0 lithium sodium (4-((5-chloro-2-hydroxyphenyl)azo)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))(3-((4,5-dihydro-3-methyl-1-(4-methylphenyl)-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-5-nitrobenzenesulfonato(3-)) chromate(2-) 414-250-7 149564-66-9 Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)22-26-39-61  
611-115-00-6 trilithium bis(4-((4-(diethylamino)-2-hydroxyphenyl)azo)-3-hydroxy-1-naphthalenesulfonato(3-))chromate(3-) 414-290-5 149564-65-8 Xn; R22R52-53 XnR: 22-52/53S: (2-)22-61  
611-116-00-1 reaction mass of: trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[2-(2,6-dichloro-5-cyanopyrimidin-4-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalene-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-propylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[2-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-1-methyl-ethylamino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate 414-620-8 — Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
611-117-00-7 1,3-bis{6-fluoro-4-[1,5-disulfo-4-(3-aminocarbonyl-1-ethyl-6-hydroxy-4-methyl-pyrid-2-on-5-ylazo)-phenyl-2-ylamino]-1,3,5-triazin-2-ylamino}propane lithium-, sodium salt 415-100-3 149850-29-3 R43 XiR: 43S: (2-)22-24-37  
611-118-00-2 sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2-sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro-1,3,5-triazin-2-ylamino]-propane, sodium salt 413-990-8  R43 XiR: 43S: (2-)22-24-37  
611-119-00-8 tetrasodium 4-[4-chloro-6-(4-methyl-2-sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5-dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7-disulfonate 415-400-4 148878-22-2 Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
611-120-00-3 5-{4-[5-amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}-4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)-naphthalene-2,7-disulfonicacid sodium salt 418-340-7 157707-94-3 Xi; R41R52-53 XiR: 41-52/53S: (2-)22-26-39-61  
611-121-00-9 Main component 6 (isomer): asym. 1:2 Cr(III)-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)phenylazo]naphthalene-2-ol;Main component 8 (isomer): asym. 1:2 Cr-complex of: A: 3-hydroxy-4-(2-hydroxy-naphthalene-1-ylazo)-naphthalene-1-sulfonic acid, Na-salt and B: 1-[2-hydroxy-5-(4-methoxy-phenylazo)-phenylazo]-naphthalene-2-ol 417-280-9 30785-74-1 Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
611-122-00-4 hexasodium (di[N-(3-(4-[5-(5-amino-3-methyl-1-phenylpyrazol-4-yl-azo)-2,4-disulfo-anilino]-6-chloro-1,3,5-triazin-2-ylamino)phenyl)-sulfamoyl](di-sulfo)-phthalocyaninato)nickel 417-250-5 151436-99-6 Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
611-123-00-X 3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate 424-310-4 178452-66-9 Xi; R41 XiR: 41S: (2-)26-39  
611-124-00-5 reaction mass of: pentasodium 5-amino-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate;pentasodium 5-amino-6-[5-(2-bromoacryloylamino)-2-sulfonatophenylazo]-3-(5-{4-chloro-6-[4-(2-sulfoxyethoxysulfonato)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate;tetrasodium 5-amino-3-[5-{4-chloro-6-[4-(vinylsulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo]-6-[5-(2,3-dibromopropionylamino)-2-sulfonatophenylazo]-4-hydroxynaphthalene-2,7-disulfonate 424-320-9  Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
611-125-00-0 reaction mass of: Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(ethensulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex;Disodium 6-[3-carboxy-4,5-dihydro-5-oxo-4-sulfonatophenyl)pyrazolin-4-yl-azo]-3-[2-oxido-4-(2-hydroxyethylsulfonyl)-5-methoxyphenylazo]-4-oxidonaphthalene-2-sulfonate copper (II) complex 423-940-7 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
611-126-00-6 2,6-bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3-dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5-triazine, dichloride 424-120-1 174514-06-8 Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
611-127-00-1 pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate 423-790-2 — R5Xi; R41R43R52-53 XiR: 5-41-43-52/53S: (2-)22-26-36/37/39-41-61  
611-128-00-7 N,N'-bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin-2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium salt 419-500-9 171599-85-2 Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
611-129-00-2 reaction mass of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-phosphonophenyl)azo]benzoic acid;5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5-diethoxyphenyl)azo]-3-[(3-phosphonophenyl)azo]benzoic acid 418-230-9 163879-69-4 E; R2Repr. Cat. 3; R62Xn; R48/22R43N; R51-53 E; Xn; NR: 2-43-48/22-62-51/53S: (2-)26-35-36/37-61  
611-130-00-8 tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazin-2-ylamino]benzoate 418-520-5 183130-96-3 Xi; R36N; R50-53 Xi; NR: 36-50/53S: (2-)26-39-60-61  
611-131-00-3 2-[2-hydroxy-3-(2-chlorophenyl)carbamoyl-1-naphthylazo]-7-[2-hydroxy-3-(3-methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one 420-580-2 151798-26-4 Repr. Cat. 2; R61R53 TR: 61-53S: 53-45-61  
611-132-00-9 pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III) 419-210-2 178452-71-6 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
611-133-00-4 Product by process iron complex of azo dyestuffs obtained by coupling a mixture of diazotized 2-amino-1-hydroxybenzene-4-sulfanilide and 2-amino-1-hydroxybenzene-4-sulfonamide with resorcin, the obtained mixture being subsequently submitted to a second coupling reaction with a mixture of diazotized 3-aminobenzene-1-sulfonic acid (metanilic acid) and 4'-amino-4-nitro-1,1'-diphenylamine-2-sulfonic acid and metallization with ferric chloride, sodium salt 419-260-5 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
611-134-00-X trisodium 2-{α[2-hydroxy-3-[4-chloro-6-[4-(2,3-dibromopropionylamino)-2-sulfonatophenylamino]-1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]-benzylidenehydrazino}-4-sulfonatobenzoate, copper complex 423-770-3 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)22-26-39-61  
611-135-00-5 Reaction product of: 2-[[4-amino-2-ureidophenylazo]-5-[(2-(sulfooxy)ethyl)sulfonyl]]benzenesulfonic acid with 2,4,6-trifluoropyrimidine and partial hydrolysis to the corresponding vinylsulfonyl derivative,mixed potassium/sodium salt 424-250-9 — Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
611-136-00-0 2-{4-(2-ammoniopropylamino)-6-[4-hydroxy-3-(5-methyl-2-methoxy-4-sulfamoylphenylazo)-2-sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2-aminopropyl formate 424-260-3 — Repr. Cat. 3; R62Xi; R41N; R51-53 Xn; NR: 41-62-51/53S: (2-)22-26-36/37/39-61  
611-137-00-6 6-tert-butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H-pyrazolo[5,1-c]-1,2,4-triazole 419-870-1 159038-16-1 R53 R: 53S: 61  
611-138-00-1 2-(4-aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5-b][1,2,4]triazole 415-910-7 152828-25-6 R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-61  
611-140-00-2 azafenidin (ISO)2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one — 68049-83-2 Repr. Cat. 2; R61Repr. Cat. 3; R62Xn; R48/22N; R50-53 T; NR: 61-48/22-62-50/53S: 53-45-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % E
612-001-00-9 mono-methylamine; [1]di-methylamine; [2]tri-methylamine [3] 200-820-0 [1]204-697-4 [2]200-875-0 [3] 74-89-5 [1]124-40-3 [2]75-50-3 [3] F+; R12Xn; R20Xi; R37/38-41 F+; XnR: 12-20-37/38-41S: (2-)16-26-39 Xn; R20: C ≥ 5 %Xi; R37/38-41: C ≥ 5 %Xi; R36: 0,5 % ≤ C < 5 % 5
612-001-01-6 mono-methylamine ... %; [1]di-methylamine ... %; [2]tri-methylamine ... % [3] 200-820-0 [1]204-697-4 [2]200-875-0 [3] 74-89-5 [1]124-40-3 [2]75-50-3 [3] F+; R12Xn; R20/22C; R34 F+; CR: 12-20/22-34S: (1/2-)3-16-26-29-36/37/39-45 Xn; R20/22: C ≥ 15 %C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % B
612-002-00-4 ethylamine 200-834-7 75-04-7 F+; R12Xi; R36/37 F+; XiR: 12-36/37S: (2-)16-26-29  
612-003-00-X diethylamine 203-716-3 109-89-7 F; R11Xn; R20/21/22C; R35 F; CR: 11-20/21/22-35S: (1/2-)3-16-26-29-36/37/39-45 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
612-004-00-5 triethylamine 204-469-4 121-44-8 F; R11Xn; R20/21/22C; R35 F; CR: 11-20/21/22-35S: (1/2-)3-16-26-29-36/37/39-45 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
612-005-00-0 butylamine 203-699-2 109-73-9 F; R11Xn; R20/21/22C; R35 F; CR: 11-20/21/22-35S: (1/2-)3-16-26-29-36/37/39-45 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
612-006-00-6 ethylenediamine;1,2-diaminoethane 203-468-6 107-15-3 R10Xn; R21/22C; R34R42/43 CR: 10-21/22-34-42/43S: (1/2-)23-26-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/38: 2 % ≤ C < 10 % 
612-007-00-1 2-aminopropane;isopropylamine 200-860-9 75-31-0 F+; R12Xi; R36/37/38 F+; XiR: 12-36/37/38S: (2-)16-26-29  
612-008-00-7 aniline 200-539-3 62-53-3 Carc. Cat. 3; R40Muta. Cat. 3; R68T; R23/24/25-48/23/24/25Xi; R41R43N; R50 T; NR: 23/24/25-40-41-43-48/23/24/25-68-50S: (1/2-)26-27-36/37/39-45-46-61-63 T; R23/24/25: C ≥ 25 %Xn; R20/21/22: 1 % ≤ C < 25 %T; R48/23/24/25: C ≥ 1 %Xn; R48/20/21/22: 0,2 % ≤ C < 1 % 
612-009-00-2 salts of aniline — — Carc. Cat. 3; R40Muta. Cat. 3; R68T; R23/24/25-48/23/24/25Xi; R41R43N; R50 T; NR: 23/24/25-40-41-43-48/23/24/25-68-50S: (1/2-)26-27-36/37/39-45-61-63 T; R23/24/25: C ≥ 25 %Xn; R20/21/22: 1 % ≤ C < 25 %T; R48/23/24/25: C ≥ 1 %Xn; R48/20/21/22: 0,2 % ≤ C < 1 % A
612-010-00-8 chloroanilines, with exception of those specified elsewhere in this Annex — — T; R23/24/25R33N; R50-53 T; NR: 23/24/25-33-50/53S: (1/2-)28-36/37-45-60-61  C
612-011-00-3 4-nitrosoaniline 211-535-6 659-49-4 Xn; R20/21/22 XnR: 20/21/22S: (2-)25-28  
612-012-00-9 o-nitroaniline; [1]m-nitroaniline; [2]p-nitroaniline [3] 201-855-4 [1]202-729-1 [2]202-810-1 [3] 88-74-4 [1]99-09-2 [2]100-01-6 [3] T; R23/24/25R33R52-53 TR: 23/24/25-33-52/53S: (1/2-)28-36/37-45-61  C
612-013-00-4 3-aminobenzene sulphonic acid;metanilic acid 204-473-6 121-47-1 Xn; R20/21/22 XnR: 20/21/22S: (2-)25-28  
612-014-00-X sulphanilic acid;4-aminobenzenesulphonic acid 204-482-5 121-57-3 Xi; R36/38R43 XiR: 36/38-43S: (2-)24-37  
612-015-00-5 N-methylaniline 202-870-9 100-61-8 T; R23/24/25R33N; R50-53 T; NR: 23/24/25-33-50/53S: (1/2-)28-36/37-45-60-61  
612-016-00-0 N,N-dimethylaniline 204-493-5 121-69-7 Carc. Cat. 3; R40T; R23/24/25N; R51-53 T; NR: 23/24/25-40-51/53S: (1/2-)28-36/37-45-61  
612-017-00-6 N-methyl-N,2,4,6-tetranitroaniline;tetryl 207-531-9 479-45-8 E; R2 ⊗T; R23/24/25R33 E; TR: 2-23/24/25-33S: (1/2-)35-45  
612-018-00-1 bis(2,4,6-trinitrophenyl)amine;hexyl 205-037-8 131-73-7 E; R2 ⊗T+; R26/27/28R33N; R51-53 E; T+; NR: 2-26/27/28-33-51/53S: (1/2-)35-36-45-61  
612-019-00-7 dipicrylamine, ammonium salt 220-639-0 2844-92-0 E ⊗R1T+; R26/27/28R33N; R51-53 E; T+; NR: 1-26/27/28-33-51/53S: (1/2-)28-36/37-45-61  
612-020-00-2 1-naphthylamine 205-138-7 134-32-7 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)24-61  
612-022-00-3 2-naphthylamine 202-080-4 91-59-8 Carc. Cat. 1; R45Xn; R22N; R51-53 T; NR: 45-22-51/53S: 53-45-61 Carc. Cat. 1; R45: C ≥ 0,01 % E
612-023-00-9 phenylhydrazine; [1]phenylhydrazinium chloride; [2]phenylhydrazine hydrochloride; [3]phenylhydrazinium sulphate (2:1) [4] 202-873-5 [1]200-444-7 [2]248-259-0 [3]257-622-2 [4] 100-63-0 [1]59-88-1 [2]27140-08-5 [3]52033-74-6 [4] Carc. Cat. 2; R45Muta. Cat. 3; R68T; R23/24/25-48/23/24/25Xi; R36/38R43N; R50 T; NR: 45-23/24/25-36/38-43-48/23/24/25-68-50S: 53-45-61  E
612-024-00-4 m-toluidine;3-aminotoluene 203-583-1 108-44-1 T; R23/24/25R33N; R50 T; NR: 23/24/25-33-50S: (1/2-)28-36/37-45-61  
612-025-00-X nitrotoluidines, with the exception of those specified elsewhere in this Annex — — T; R23/24/25R33N; R51-53 T; NR: 23/24/25-33-51/53S: (1/2-)28-36/37-45-61  C
612-026-00-5 diphenylamine 204-539-4 122-39-4 T; R23/24/25R33N; R50-53 T; NR: 23/24/25-33-50/53S: (1/2-)28-36/37-45-60-61  
612-027-00-0 xylidines with the exception of those specified elsewhere in this Annex;dimethyl anilines with the exception of those specified elsewhere in this Annex — — T; R23/24/25R33N; R51-53 T; NR: 23/24/25-33-51/53S: (1/2-)28-36/37-45-61  C
612-028-00-6 p-phenylenediamine 203-404-7 106-50-3 T; R23/24/25Xi; R36R43N; R50-53 T+; NR: 23/24/25-36-43-50/53S: (1/2-)28-36/37-45-60-61  
612-029-00-1 benzene-1,4-diamine dihydrochloride;p-phenylenediamine dihydrochloride 210-834-9 624-18-0 T; R23/24/25Xi; R36R43N; R50-53 T; NR: 23/24/25-36-43-50/53S: (1/2-)28-36/37-45-60-61  
612-030-00-7 2-methyl-p-phenylenediamine sulphate [1] 210-431-8 [1]228-871-4 [2] 615-50-9 [1]6369-59-1 [2] T; R25Xn; R20/21R43N; R51-53 T; NR: 20/21-25-43-51/53S: (1/2-)24-37-45-61  
612-031-00-2 N,N-dimethylbenzene-1,3-diamine; [1]4-amino-N,N-dimethylaniline;3-amino-N,N'-dimethylaniline [2] 220-623-3 [1]202-807-5 [2] 2836-04-6 [1]99-98-9 [2] T; R23/24/25 TR: 23/24/25S: (1/2-)28-45  C
612-032-00-8 N,N,N',N'-tetramethyl-p-phenylenediamine 202-831-6 100-22-1 Xn; R20/21/22 XnR: 20/21/22S: (2-)28  
612-033-00-3 2-aminophenol 202-431-1 95-55-6 Xn; R20/22Muta. Cat. 3; R68 XnR: 20/22-68S: (2-)28-36/37  
612-034-00-9 2-amino-4,6-dinitrophenol;picramic acid 202-544-6 96-91-3 E; R1 ⊗Xn; R20/21/22R52-53 E; XnR: 1-20/21/22-52/53S: (2-)35-61  
612-035-00-4 2-methoxyaniline;o-anisidine 201-963-1 90-04-0 Carc. Cat. 2; R45Muta. Cat. 3; R68T; R23/24/25 TR: 45-23/24/25-68S: 53-45  E
612-036-00-X 3,3'-dimethoxybenzidine;o-dianisidine 204-355-4 119-90-4 Carc. Cat. 2; R45Xn; R22 TR: 45-22S: 53-45  E
612-037-00-5 salts of 3,3'-dimethoxybenzidine;salts of o-dianisidine — — Carc. Cat. 2; R45Xn; R22 TR: 45-22S: 53-45  AE
612-038-00-0 2-nitro-p-anisidine;4-methoxy-2-nitroaniline 202-547-2 96-96-8 T+; R26/27/28R33R52-53 T+R: 26/27/28-33-52/53S: (1/2-)28-36/37-45-61  
612-039-00-6 2-ethoxyaniline;o-phenetidine 202-356-4 94-70-2 T; R23/24/25R33 TR: 23/24/25-33S: (1/2-)28-36/37-45  
612-040-00-1 2,4-dinitroaniline 202-553-5 97-02-9 T+; R26/27/28R33N; R51-53 T+; NR: 26/27/28-33-51/53S: (1/2-)28-36/37-45-61  
612-041-00-7 4,4'-bi-o-toluidine 204-358-0 119-93-7 Carc. Cat. 2; R45Xn; R22N; R51-53 T; NR: 45-22-51/53S: 53-45-61  E
612-042-00-2 benzidine;1,1'-biphenyl-4,4'-diamine;4,4'-diaminobiphenyl;biphenyl-4,4'-ylenediamine 202-199-1 92-87-5 Carc. Cat. 1; R45Xn; R22N; R50-53 T; NR: 45-22-50/53S: 53-45-60-61 Carc. Cat. 1; R45: C ≥ 0,01 % E
612-043-00-8 N,N'-dimethylbenzidine — 2810-74-4 Xn; R20/21/22 XnR: 20/21/22S: (2-)22-36  
612-044-00-3 N,N'-diacetylbenzidine 210-338-2 613-35-4 Xn; R20/21/22 XnR: 20/21/22S: (2-)22-36  
612-046-00-4 allylamine 203-463-9 107-11-9 F; R11T; R23/24/25N; R51-53 F; T; NR: 11-23/24/25-51/53S: (1/2-)9-16-24/25-45-61  
612-047-00-X benzylamine 202-854-1 100-46-9 Xn; R21/22C; R34 CR: 21/22-34S: (1/2-)26-36/37/39-45  
612-048-00-5 dipropylamine 205-565-9 142-84-7 F; R11Xn; R20/21/22C; R35 F; CR: 11-20/21/22-35S: (1/2-)16-26-36/37/39-45 C; R35: C ≥ 10 %C; R34: 5 % ≤ C < 10 %Xi; R36/37/38: 1 % ≤ C < 5 % 
612-049-00-0 di-n-butylamine; [1]di-sec-butylamine [2] 203-921-8 [1]210-937-9 [2] 111-92-2 [1]626-23-3 [2] R10Xn; R20/21/22 XnR: 10-20/21/22S: (2-)  
612-050-00-6 cyclohexylamine 203-629-0 108-91-8 R10Xn; R21/22C; R34 CR: 10-21/22-34S: (1/2-)36/37/39-45 C; R34: C ≥ 10 %Xi; R36/38: 2 % ≤ C < 10 % 
612-051-00-1 4,4'-diaminodiphenylmethane;4,4'-methylenedianiline 202-974-4 101-77-9 Carc. Cat. 2; R45Muta. Cat. 3; R68T; R39/23/24/25Xn; R48/20/21/22R43N; R51-53 T; NR: 45-39/23/24/25-43-48/20/21/22-68-51/53S: 53-45-61  E
612-052-00-7 (S)-sec-butylamine;(S)-2-aminobutane; [1](R)-sec-butylamine;(R)-2-aminobutane; [2]sec-butylamine;2-aminobutane [3] 208-164-7 [1]236-232-6 [2]237-732-7 [3] 513-49-5 [1]13250-12-9 [2]13952-84-6 [3] F; R11Xn; R20/22C; R35N; R50 F; C; NR: 11-20/22-35-50S: (1/2-)9-16-26-28-36/37/39-45-61  C
612-053-00-2 N-ethylaniline 203-135-5 103-69-5 T; R23/24/25R33 TR: 23/24/25-33S: (1/2-)28-37-45  
612-054-00-8 N,N-diethylaniline 202-088-8 91-66-7 T; R23/24/25R33N; R51-53 T; NR: 23/24/25-33-51/53S: (1/2-)28-37-45-61 T; R23/24/25: C ≥ 5 %Xn; R20/21/22: 1 % ≤ C < 5 % 
612-055-00-3 N-methyl-o-toluidine; [1]N-methyl-m-toluidine; [2]N-methyl-p-toluidine [3] 210-260-9 [1]211-795-0 [2]210-769-6 [3] 611-21-2 [1]696-44-6 [2]623-08-5 [3] T; R23/24/25R33R52-53 TR: 23/24/25-33-52/53S: (1/2-)28-36/37-45-61  C
612-056-00-9 N,N-dimethyl-p-toluidine; [1]N,N-dimethyl-m-toluidine; [2]N,N-dimethyl-o-toluidine [3] 202-805-4 [1]204-495-6 [2]210-199-8 [3] 99-97-8 [1]121-72-2 [2]609-72-3 [3] T; R23/24/25R33R52-53 TR: 23/24/25-33-52/53S: (1/2-)28-36/37-45-61 T; R23/24/25: C ≥ 5 %Xn; R20/21/22: 1 % ≤ C < 5 % C
612-057-00-4 piperazine 203-808-3 110-85-0 C; R34R42/43R52-53 CR: 34-42/43-52/53S: (1/2-)22-26-36/37/39-45-61  
612-058-00-X 2,2'-iminodiethylamine;diethylenetriamine 203-865-4 111-40-0 Xn; R21/22C; R34R43 CR: 21/22-34-43S: (1/2-)26-36/37/39-45  
612-059-00-5 3,6-diazaoctanethylenediamin;triethylenetetramine 203-950-6 112-24-3 Xn; R21C; R34R43R52-53 CR: 21-34-43-52/53S: (1/2-)26-36/37/39-45-61  
612-060-00-0 3,6,9-triazaundecamethylenediamine;tetraethylenepentamine 203-986-2 112-57-2 Xn; R21/22C; R34R43N; R51-53 C; NR: 21/22-34-43-51/53S: (1/2-)26-36/37/39-45-61  
612-061-00-6 3-aminopropyldimethylamine;N,N-dimethyl-1,3-diaminopropane 203-680-9 109-55-7 R10Xn; R22C; R34R43 CR: 10-22-34-43S: (1/2-)26-36/37/39-45  
612-062-00-1 3-aminopropyldiethylamine;N,N-diethyl-1,3-diaminopropane 203-236-4 104-78-9 R10Xn; R21/22C; R34R43 CR: 10-21/22-34-43S: (1/2-)26-36/37/39-45  
612-063-00-7 3,3'-iminodi(propylamine);dipropylenetriamine 200-261-2 56-18-8 T+; R26T; R24Xn; R22C; R35R43 T+; CR: 22-24-26-35-43S: (1/2-)26-28-36/37/39-45  
612-064-00-2 3,6,9,12-tetra-azatetradecamethylenediamine;pentacthylenehexamine 223-775-9 4067-16-7 C; R34R43N; R50-53 C; NR: 34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
612-065-00-8 polyethlyenepolyamines with the exception of those specified elsewhere in this Annex — — Xn; R21/22C; R34R43N; R50-53 C; NR: 21/22-34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
612-066-00-3 dicyclohexylamine 202-980-7 101-83-7 Xn; R22C; R34N; R50-53 C; NR: 22-34-50/53S: (1/2-)26-36/37/39-45-60-61 C; R34: C ≥ 10 %Xi; R36/38: 2 % ≤ C < 10 % 
612-067-00-9 3-aminomethyl-3,5,5-trimethylcyclohexylamine 220-666-8 2855-13-2 Xn; R21/22C; R34R43R52-53 CR: 21/22-34-43-52/53S: (1/2-)26-36/37/39-45-61  
612-068-00-4 3,3'-dichlorobenzidine;3,3'-dichlorobiphenyl-4,4'-ylenediamine 202-109-0 91-94-1 Carc. Cat. 2; R45Xn; R21R43N; R50-53 T; NR: 45-21-43-50/53S: 53-45-60-61  E
612-069-00-X salts of 3,3'-dichlorobenzidine;salts of 3,3'-dichlorobiphenyl-4,4'-ylenediamine ——— ——— Carc. Cat. 2; R45Xn; R21R43N; R50-53 T; NR: 45-21-43-50/53S: 53-45-60-61  AE
612-070-00-5 salts of benzidine [ 208-519-6208-520-1244-236-4252-984-8 531-85-1531-86-221136-70-936341-27-2 Carc. Cat. 1; R45Xn; R22N; R50-53 T; NR: 45-22-50/53S: 53-45-60-61  AE
612-071-00-0 salts of 2-naphthylamine 209-030-0210-313-6 553-00-4612-52-2 Carc. Cat. 1; R45Xn; R22N; R51-53 T; NR: 45-22-51/53S: 53-45-61  AE
612-072-00-6 biphenyl-4-ylamine;xenylamine;4-aminobiphenyl 202-177-1 92-67-1 Carc. Cat. 1; R45Xn; R22 TR: 45-22S: 53-45  E
612-073-00-1 salts of biphenyl-4-ylamine;salts of xenylamine;salts of 4-aminobiphenyl — — Carc. Cat. 1; R45Xn; R22 TR: 45-22S: 53-45  AE
612-074-00-7 benzyldimethylamine 203-149-1 103-83-3 R10Xn; R20/21/22C; R34R52-53 CR: 10-20/21/22-34-52/53S: (1/2-)26-36-45-61  
612-075-00-2 2-aminoethyldimethylamine;2-dimethylaminoethylamine 203-541-2 108-00-9 F; R11Xn; R21/22C; R35 F; CR: 11-21/22-35S: (1/2-)16-23-26-28-36-45  
612-076-00-8 ethyldimethylamine 209-940-8 598-56-1 F+; R12 ⊗Xn; R20/22C; R34 F+; CR: 12-20/22-34S: (1/2-)3-16-26-36-45  
612-077-00-3 dimethylnitrosoamine;N-nitrosodimethylamine 200-549-8 62-75-9 Carc. Cat. 2; R45T+; R26T; R25-48/25N; R51-53 T+; NR: 45-25-26-48/25-51/53S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,001 % E
612-078-00-9 2,2'-dichloro-4,4'-methylenedianiline;4,4'-methylene bis(2-chloroaniline) 202-918-9 101-14-4 Carc. Cat. 2; R45Xn; R22N; R50-53 T; NR: 45-22-50/53S: 53-45-60-61  E
612-079-00-4 salts of 2,2'-dichloro-4,4'-methylenedianiline;salts of 4,4'-methylenebis(2-chloroaniline) — — Carc. Cat. 2; R45Xn; R22N; R50-53 T; NR: 45-22-50/53S: 53-45-60-61  AE
612-080-00-X 4-amino-N,N-diethylaniline;N,N-diethyl-p-phenylendiamine 202-214-1 93-05-0 T; R25C; R34 TR: 25-34S: (1/2-)26-36-45  
612-081-00-5 salts of 4,4'-bi-o-toluidine;salts of 3,3'-dimethylbenzidine;salts of o-tolidine 210-322-5265-294-7277-985-0 612-82-864969-36-474753-18-7 Carc. Cat. 2; R45Xn; R22N; R51-53 T; NR: 45-22-51/53S: 53-45-61  AE
612-082-00-0 thiourea;thiocarbamide 200-543-5 62-56-6 Carc. Cat. 3; R40Repr. Cat. 3; R63Xn; R22N; R51-53 Xn; NR: 22-40-51/53-63S: (2-)36/37-61  
612-083-00-6 1-methyl-3-nitro-1-nitrosoguanidine 200-730-1 70-25-7 Carc. Cat. 2; R45Xn; R20Xi; R36/38N; R51-53 T; NR: 45-20-36/38-51/53S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,01 % E
612-084-00-1 dapsone;4,4'-diamino diphenyl sulfone 201-248-4 80-08-0 Xn; R22 XnR: 22S: (2-)22  
612-085-00-7 4,4'-methylenedi-o-toluidine 212-658-8 838-88-0 Carc. Cat. 2; R45Xn; R22R43N; R50-53 T; NR: 45-22-43-50/53S: 53-45-60-61  E
612-086-00-2 amitraz (ISO);N,N-bis(2,4-xylyliminomethyl) methylamine 251-375-4 33089-61-1 Xn; R22-48/22R43N; R50-53 Xn; NR: 22-43-48/22-50/53S: (2-)22-24-60-36/37-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
612-087-00-8 guazatine (ISO)  108173-90-6 T+; R26Xn; R21/22Xi; R37/38-41N; R50-53 T+; NR: 21/22-26-37/38-41-50/53S: (1/2-)26-28-36/37/39-38-45-46-60-61-63  
612-088-00-3 simazine (ISO);6-chloro-N,N'-diethyl-1,3,5-triazine-2,4-diamine 204-535-2 122-34-9 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-46-60-61  
612-089-00-9 1,5-naphthylenediamine 218-817-8 2243-62-1 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-60-61  
612-090-00-4 2,2'-(nitrosoimino)bisethanol 214-237-4 1116-54-7 Carc. Cat. 2; R45 TR: 45S: 53-45  
612-091-00-X o-toluidine;2-aminotoluene 202-429-0 95-53-4 Carc. Cat. 2; R45T; R23/25Xi; R36N; R50 T; NR: 45-23/25-36-50S: 53-45-61  E
612-092-00-5 N,N'-(2,2-dimethylpropylidene)hexamethylenediamine 401-660-6 1000-78-8 Xi; R38R43 XiR: 38-43S: (2-)24-37  
612-093-00-0 3,5-dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline 401-790-3 104147-32-2 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)24/25-26-57-60-61  
612-094-00-6 4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride 402-190-4 — T; R48/25Xn; R22-48/20Xi; R41R43N; R50-53 T; NR: 22-41-43-48/20-48/25-50/53S: (1/2-)26-36/37/39-45-60-61  
612-095-00-1 benzyl-2-hydroxydodecyldimethylammonium benzoate 402-610-6 113694-52-3 C; R34Xn; R22N; R50-53 C; NR: 22-34-50/53S: (1/2-)26-28-36/37/39-45-60-61  
612-096-00-7 4,4'-carbonimidoylbis[N,N-dimethylaniline] 207-762-5 492-80-8 Carc. Cat. 3; R40Xn; R22Xi; R36N; R51-53 Xn; NR: 22-36-40-51/53S: (2-)36/37-61  
612-097-00-2 salts of 4,4'-carbonimidoylbis[N,N-dimethylaniline] — — Carc. Cat. 3; R40Xn; R22Xi; R36N; R51-53 Xn; NR: 22-36-40-51/53S: (2-)36/37-61  A
612-098-00-8 nitrosodipropylamine 210-698-0 621-64-7 Carc. Cat. 2; R45Xn; R22N; R51-53 T; NR: 45-22-51/53S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,001 % E
612-099-00-3 4-methyl-m-phenylenediamine;2,4-toluenediamine 202-453-1 95-80-7 Carc. Cat. 2; R45T; R25Xn; R21Xi; R36R43N; R51-53 T; NR: 45-21-25-36-43-51/53S: 53-45-61  E
612-100-00-7 propylenediamine 201-155-9 78-90-0 R10Xn; R21/22C; R35 CR: 10-21/22-35S: (1/2-)26-37/39-45  
612-101-00-2 methenamine;hexamethylenetetramine 202-905-8 100-97-0 F; R11R42/43 F; XnR: 11-42/43S: (2-)16-22-24-37  
612-102-00-8 N,N-bis(3-aminopropyl)methylamine 203-336-8 105-83-9 T; R23/24Xn; R22C; R34 TR: 22-23/24-34S: (1/2-)26-36/37/39-45  
612-103-00-3 N,N,N',N'-tetramethylethylenediamine 203-744-6 110-18-9 F; R11Xn; R20/22C; R34 F; CR: 11-20/22-34S: (1/2-)16-26-36/37/39-45  
612-104-00-9 hexamethylenediamine 204-679-6 124-09-4 Xn; R21/22Xi; R37C; R34 CR: 21/22-34-37S: (1/2-)22-26-36/37/39-45  
612-105-00-4 2-piperazin-1-ylethylamine 205-411-0 140-31-8 Xn; R21/22C; R34R43R52-53 CR: 21/22-34-43-52/53S: (1/2-)26-36/37/39-45-61  
612-106-00-X 2,6-diethylaniline 209-445-7 579-66-8 Xn; R22 XnR: 22S: (2-)23-24  
612-107-00-5 1-phenylethylamine; [1]Dl-α-methylbenzylamine [2] 202-706-6 [1]210-545-8 [2] 98-84-0 [1]618-36-0 [2] Xn; R21/22C; R34 CR: 21/22-34S: (1/2-)26-28-36/37/39-45  
612-108-00-0 3-aminopropyltriethoxysilane 213-048-4 919-30-2 Xn; R22C; R34 CR: 22-34S: (1/2-)26-36/37/39-45  
612-109-00-6 bis(2-dimethylaminoethyl)(methyl)amine 221-201-1 3030-47-5 T; R24Xn; R22C; R34 TR: 22-24-34S: (1/2-)26-36/37/39-45  
612-110-00-1 2,2'-dimethyl-4,4'-methylenebis(cyclohexylamine) 229-962-1 6864-37-5 T; R23/24Xn; R22C; R35N; R51-53 T; C; NR: 22-23/24-35-51/53S: (1/2-)26-36/37/39-45-61  
612-111-00-7 2-methyl-m-phenylenediamine;2,6-toluenediamine 212-513-9 823-40-5 Muta. Cat. 3; R68Xn; R21/22R43N; R51-53 Xn; NR: 21/22-43-51/53-68S: (2-)24-36/37-61  
612-112-00-2 p-anisidine;4-methoxyaniline 203-254-2 104-94-9 T+; R26/27/28R33N; R50 T+; NR: 26/27/28-33-50S: (1/2-)28-36/37-45-61  
612-113-00-8 6-methyl-2,4-bis(methylthio)phenylene-1,3-diamine 403-240-8 106264-79-3 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61  
612-114-00-3 R,R-2-hydroxy-5-(1-hydroxy-2-(4-phenylbut-2-ylamino)ethyl)benzamide hydrogen 2,3-bis(benzoyloxy)succinate 404-390-7 — F; R11R43R52-53 F; XiR: 11-43-52/53S: (2-)24-37-61  
612-115-00-9 dimethyldioctadecylammonium hydrogen sulfate 404-050-8 123312-54-9 Xi; R36R53 XiR: 36-53S: (2-)26-39-61  
612-116-00-4 C8-18alkylbis(2-hydroxyethyl)ammonium bis(2-ethylhexyl)phosphate 404-690-8 68132-19-4 T; R23C; R34R43N; R50-53 T; NR: 23-34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
612-117-00-X C12-14-tert-alkylamine, methylphosphonic acid salt 404-750-3 119415-07-5 Xn; R22C; R34N; R51-53 C; NR: 22-34-51/53S: (1/2-)26-28-36/37/39-45-61  
612-118-00-5 A reaction mass of: (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium 4-toluenesulfonate; (1,3-dioxo-2H-benz(de)isoquinolin-2-ylpropyl)hexadecyldimethylammonium bromide 405-080-4 — Xi; R41N; R50-53 X; NR: 41-50/53S: (2-)22-26-39-60-61  
612-119-00-0 benzyldimethyloctadecylammonium 3-nitrobenzenesulfonate 405-330-2 — Xi; R38-41N; R50-53 Xi; NR: 38-41-50/53S: (2-)26-37/39-60-61  
612-120-00-6 aclonifen (ISO);2-chloro-6-nitro-3-phenoxyaniline 277-704-1 74070-46-5 N; R50-53 NR: 50/53S: 60-61  
612-121-00-1 amines, polyethylenepoly-;HEPA 268-626-9 68131-73-7 Xn; R21/22C; R34R43N; R50-53 C; NR: 21/22-34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
612-122-00-7 hydroxylamine 232-259-2 7803-49-8 R5 ⊗Xn; R22-48/22Xi; R37/38-41R43N; R50 Xn; NR: 5-22-37/38-41-43-48/22-50S: (2-)22-26-36/37/39-61  
612-123-00-2 hydroxylammonium chloride;hydroxylamine hydrochloride; [1]bis(hydroxylammonium) sulphate;hydroxylamine sulphate (2:1); [2]hydroxylammonium hydrogensulphate;hydroxylamine sulphate (1:1) [3] 226-798-2 [1]233-118-8 [2]233-154-4 [3] 5470-11-1 [1]10039-54-0 [2]10046-00-1 [3] ⊗ Xn; R22-48/22Xi; R36/38R43N; R50 Xn; NR: 22-36/38-43-48/22-50S: (2-)22-24-37-61  
612-124-00-8 N,N,N-trimethylanilinium chloride 205-319-0 138-24-9 T; R24/25 TR: 24/25S: (1/2-)25-39-45-53  
612-125-00-3 2-methyl-p-phenylenediamine;2,5-toluenediamine 202-442-1 95-70-5 T; R25Xn; R20/21R43N; R51-53 T; NR: 20/21-25-43-51/53S: (1/2-)24-37-45-61  
612-126-00-9 toluene-2,4-diammonium sulphate;4-methyl-m-phenylenediamine sulfate 265-697-8 65321-67-7 Carc. Cat. 2; R45T; R25Xn; R21Xi; R36R43N; R51-53 T; NR: 45-21-25-36-43-51/53S: 53-45-61  E
612-127-00-4 3-aminophenol 209-711-2 591-27-5 Xn; R20/22N; R51-53 Xn; NR: 20/22-51/53S: (2-)28-61  
612-128-00-X 4-aminophenol 204-616-2 123-30-8 Muta. Cat. 3; R68Xn; R20/22N; R50-53 Xn; NR: 20/22-50/53-68S: (2-)28-36/37-60-61  
612-129-00-5 diisopropylamine 203-558-5 108-18-9 F; R11Xn; R20/22C; R34 F; CR: 11-20/22-34S: (1/2-)16-26-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
612-130-00-0 2,6-diamino-3,5-diethyltoluene;4,6-diethyl-2-methyl-1,3-benzenediamine; [1]2,4-diamino-3,5-diethyltoluene;2,4-diethyl-6-methyl-1,3-benzenediamine; [2]diethylmethylbenzenediamine [3] 218-255-3 [1]218-256-9 [2]270-877-4 [3] 2095-01-4 [1]2095-02-5 [2]68479-98-1 [3] Xn; R21/22-48/22Xi; R36N; R50-53 Xn; NR: 21/22-36-48/22-50/53S: (2-)26-28-36/37/39-60-61  C
612-131-00-6 didecyldimethylammonium chloride 230-525-2 7173-51-5 Xn; R22C; R34 CR: 22-34S: (2-)26-36/37/39-45  
612-132-00-1 N,N'-diphenyl-p-phenylenediamine;N,N'-diphenyl-1,4-benzenediamine 200-806-4 74-31-7 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
612-133-00-7 (4-ammonio-m-tolyl)ethyl(2-hydroxyethyl)ammonium sulphate;4-(N-ethyl-N-2-hydroxyethyl)-2-methylphenylenediamine sulphate 247-162-0 25646-77-9 T; R25Xn; R48/22R43N; R50-53 T; NR: 25-43-48/22-50/53S: (1/2-)24-37-45-60-61  
612-134-00-2 N-(2-(4-amino-N-ethyl-m-toluidino)ethyl)methanesulphonamide sesquisulphate;4-(N-ethyl-N-2-methanesulphonylaminoethyl)-2-methylphenylenediamine sesquisulphate monohydrate 247-161-5 25646-71-3 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61  
612-135-00-8 N-2-naphthylaniline;N-phenyl-2-naphthylamine 205-223-9 135-88-6 Carc. Cat. 3; R40Xi; R36/38R43N; R51-53 Xn; NR: 36/38-40-43-51/53S: (2-)26-36/37-61  
612-136-00-3 N-isopropyl-N'-phenyl-p-phenylenediamine 202-969-7 101-72-4 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61 R43: C ≥ 0,1 % 
612-137-00-9 4-chloroaniline 203-401-0 106-47-8 Carc. Cat. 2; R45T; R23/24/25R43N; R50-53 T; NR: 45-23/24/25-43-50/53S: 53-45-60-61  E
612-138-00-4 furalaxyl (ISO);methyl N-(2,6-dimethylphenyl)-N-(2-furylcarbonyl)-Dl-alaninate 260-875-1 57646-30-7 Xn; R22R52-53 XnR: 22-52/53S: (2-)36/37/39-61  
612-139-00-X mefenacet (ISO);2-(benzothiazol-2-yloxy)-N-methyl-N-phenylacetamide 277-328-8 73250-68-7 N; R51-53 NR: 51/53S: 61  
612-140-00-5 quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides 264-151-6 63449-41-2 Xn; R21/22C; R34N; R50 C; NR: 21/22-34-50S: (2-)36/37/39-45-61  
612-141-00-0 4,4'-methylenebis(2-ethylaniline);4,4'-methylenebis(2-ethylbenzeneamine) 243-420-1 19900-65-3 Carc. Cat. 3; R40Xn; R22N; R50-53 Xn; NR: 22-40-50/53S: (2-)36/37-60-61  
612-142-00-6 biphenyl-2-ylamine 201-990-9 90-41-5 Carc. Cat. 3; R40Xn; R22R52-53 XnR: 22-40-52/53S: (2-)36/37-61  
612-143-00-1 N5,N5-diethyltoluene-2,5-diamine monohydrochloride;4-diethylamino-2-methylaniline monohydrochloride 218-130-3 2051-79-8 T; R25Xi; R36R43N; R50-53 T; NR: 25-36-43-50/53S: (1/2-)24-26-37-45-60-61  
612-144-00-7 flumetralin (ISO);N-(2-chloro-6-fluorobenzyl)-N-ethyl-α,α,α-trifluoro-2,6-dinitro-p-toluidine — 62924-70-3 Xi; R36/38R43N; R50-53 Xi; NR: 36/38-43-50/53S: (2-)36/37-60-61  
612-145-00-2 o-phenylenediamine 202-430-6 95-54-5 Carc. Cat. 3; R40Muta. Cat. 3; R68T; R25Xn; R20/21Xi; R36R43N; R50-53 T; NR: 20/21-25-36-40-43-50/53-68S: (1/2-)28-36/37-45-60-61  
612-146-00-8 o-phenylenediamine dihydrochloride 210-418-7 615-28-1 Carc. Cat. 3; R40Muta. Cat. 3; R68T; R25Xn; R20/21Xi; R36R43N; R50-53 T; NR: 20/21-25-36-40-43-50/53-68S: (1/2-)28-36/37-45-60-61  
612-147-00-3 m-phenylenediamine 203-584-7 108-45-2 Muta. Cat. 3; R68T; R23/24/25Xi; R36R43N; R50-53 T; NR: 23/24/25-36-43-50/53-68S: (1/2-)28-36/37-45-60-61  
612-148-00-9 m-phenylenediamine dihydrochloride 208-790-0 541-69-5 Muta. Cat. 3; R68T; R23/24/25Xi; R36R43N; R50-53 T; NR: 23/24/25-36-43-50/53-68S: (1/2-)28-36/37-45-60-61  
612-149-00-4 1,3-diphenylguanidine 203-002-1 102-06-7 Repr. Cat. 3; R62Xn; R22Xi; R36/37/38N; R51-53 Xn; NR: 22-36/37/38-51/53-62S: (2-)26-36/37/39-61  
612-150-00-X spiroxamine (ISO);8-tert-butyl-1,4-dioxaspiro[4.5]decan-2-ylmethyl(ethyl)(propyl)amine — 118134-30-8 Xn; R20/21/22Xi; R38R43N; R50-53 Xn; NR: 20/21/22-38-43-50/53S: (2-)36/37/39-46-60-61  
612-151-00-5 diaminotoluene, technical product - reaction mass of [2] and [3];methyl-phenylenediamine; [1]4-methyl-m-phenylene diamine; [2]2-methyl-m-phenylene diamine [3] 246-910-3 [1]202-453-1 [2]212-513-9 [3] 25376-45-8 [1]95-80-7 [2]823-40-5 [3] Carc. Cat. 2; R45T; R25Xn; R20/21Xi; R36R43N; R51-53 T; NR: 45-20/21-25-36-43-51/53S: 53-45-61  E
612-152-00-0 N,N-diethyl-N',N'-dimethylpropan-1,3-diyl-diamine 406-610-7 62478-82-4 R10Xn; R20/22-48/20C; R35R52-53 CR: 10-20/22-35-48/20-52/53S: (1/2-)26-28-36/37/39-45-61  
612-153-00-6 4-[N-ethyl-N-(2-hydroxyethyl)amino]-1-(2-hydroxyethyl)amino-2-nitrobenzene, monohydrochloride 407-020-2 132885-85-9 Xn; R22R43R52-53 XnR: 22-43-52/53S: (2-)22-24-37-61  
612-154-00-1 6'-(isobutylethylamino)-3'-methyl-2'-phenylamino-spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene] 410-890-6 95235-29-3 R53 R: 53S: 61  
612-155-00-7 2'-anilino-6'-((3-ethoxypropyl)ethylamino)-3'-methylspiro(isobenzo-3-oxofuran)-1-(1H)-9'-xanthene 411-730-8 93071-94-4 R53 R: 53S: 61  
612-156-00-2 reaction mass of: trihexadecylmethylammonium chloride;dihexadecyldimethylammonium chloride 405-620-9 — Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
612-157-00-8 (Z)-1-benzo[b]thien-2-ylethanone oxime hydrochloride 410-780-8 — Xn; R22-48/22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-48/22-51/53S: (2-)22-26-36/37/39-61  
612-158-00-3 reaction mass of: bis(5-dodecyl-2-hydroxybenzald-oximate) copper (II) C12-alkyl group is branched;4-dodecylsalicylaldoxime 410-820-4 — R53 R: 53S: 61  
612-159-00-9 Reaction products of: trimethylhexamethylene diamine (a mixture of 2,2,4-trimethyl-1,6-hexanediamine and 2,4,4-trimethyl-1,6-hexanediamine, EINECS listed), Epoxide 8 (mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) and p-toluene-sulfonic acid 410-880-1 — Xn; R22C; R34N; R50-53 C; NR: 22-34-50/53S: (1/2-)23-26-36/37/39-45-60-61  
612-160-00-4 p-toluidine;4-aminotoluene; [1]toluidinium chloride; [2]toluidine sulphate (1:1) [3] 203-403-1 [1]208-740-8 [2]208-741-3 [3] 106-49-0 [1]540-23-8 [2]540-25-0 [3] Carc. Cat. 3; R40T; R23/24/25Xi; R36R43N; R50 T; NR: 23/24/25-36-40-43-50S: (1/2-)28-36/37-45-61  
612-161-00-X 2,6-xylidine;2,6-dimethylaniline 201-758-7 87-62-7 Carc. Cat. 3; R40Xn; R20/21/22Xi; R37/38N; R51-53 Xn; NR: 20/21/22-37/38-40-51/53S: (2-)23-25-36/37-61  
612-162-00-5 dimethyldioctadecylammonium chloride;DODMAC 203-508-2 107-64-2 Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)24-26-39-46-60-61  
612-163-00-0 metalaxyl-M (ISO);mefenoxam;(R)-2-[(2,6-dimethylphenyl)-methoxyacetylamino]propionic acid methyl ester — 70630-17-0 Xn; R22Xi; R41 XnR: 22-41S: (2-)26-39-46  
612-164-00-6 2-butyl-2-ethyl-1,5-diaminopentane 412-700-7 137605-95-9 Xn; R21/22-48/22C; R34R43R52-53 CR: 21/22-34-43-48/22-52/53S: (1/2-)26-36/37/39-45-61  
612-165-00-1 N,N'-diphenyl-N,N'-bis(3-methylphenyl)-(1,1'-diphenyl)-4,4'-diamine 413-810-8 65181-78-4 N; R51-53 NR: 51/53S: 61  
612-166-00-7 reaction mass of: cis-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1);trans-(5-ammonium-1,3,3-trimethyl)-cyclohexanemethylammonium phosphate (1:1) 411-830-1 114765-88-7 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)24-26-37/39-61  
612-167-00-2 5-acetyl-3-amino-10,11-dihydro-5H-dibenz[b,f]azepine-hydrochloride 410-490-1 — Xn; R22-48/22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-48/22-51/53S: (2-)22-26-36/37/39-61  
612-168-00-8 3,5-dichloro-2,6-difluoropyrdine-4-amine 220-630-1 2840-00-8 Xn; R21/22N; R51-53 Xn; NR: 21/22-51/53S: (2-)36/37-61  
612-170-00-9 4-chlorophenyl cyclopropyl ketone O-(4-aminobenzyl)oxime 405-260-2 — Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61  
612-171-00-4 N,N,N',N'-tetraglycidyl-4,4'-diamino-3,3'-diethyldiphenylmethane 410-060-3 130728-76-6 Muta. Cat. 3; R68R43N; R51-53 Xn; NR: 43-68-51/53S: (2-)36/37-61  
612-172-00-X 4,4'-methylenebis(N,N'-dimethylcyclohexanamine 412-840-9 13474-64-1 Xn; R22-48/22C; R35R52-53 CR: 22-35-48/22-52/53S: (1/2-)26-36/37/39-45-61  
612-173-00-5 lithium 1-amino-4-(4-tert-butylanilino)anthraquinone-2-sulfonate 411-140-0 125328-86-1 Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)22-26-36/37/39-61  
612-174-00-0 4,4-dimethoxybutylamine 407-690-6 19060-15-2 Xn; R22C; R34R43R52-53 CR: 22-34-43-52/53S: (1/2-)26-36/37/39-45-61  
612-175-00-6 2-(O-aminooxy)ethylamine dihydrochloride 412-310-7 37866-45-8 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
612-176-00-1 Polymer of 1,3-dibromopropane and N,N-diethyl-N',N'-dimethyl-1,3-propanediamine 410-570-6 143747-73-3 N; R50-53 NR: 50/53S: 60-61  
612-177-00-7 2-naphthylamino-6-sulfomethylamide 412-120-4 104295-55-8 Xn; R48/22R43N; R51-53 Xn; NR: 43-48/22-51/53S: (2-)22-36/37-61  
612-178-00-2 1,4,7,10-tetraazacyclododecane disulfate 412-080-8 112193-77-8 Xn; R22Xi; R37-41R52-53 XnR: 22-37-41-52/53S: (2-)26-36/37/39-61  
612-179-00-8 1-(2-propenyl)pyridinium chloride 412-740-5 25965-81-5 Xn; R22R43 XnR: 22-43S: (2-)24-37  
612-180-00-3 3-aminobenzylamine 412-230-2 4403-70-7 Xn; R22C; R34N; R51-53 C; NR: 22-34-51/53S: (1/2-)22-26-36/37/39-45-61  
612-181-00-9 2-phenylthioaniline 413-030-8 1134-94-7 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
612-182-00-4 1-ethyl-1-methylmorpholinium bromide 418-210-1 65756-41-4 Muta. Cat. 3; R68 XnR: 68S: (2-)36/37  
612-183-00-X 1-ethyl-1-methylpyrrolidinium bromide 418-200-5 69227-51-6 Muta. Cat. 3; R68 XnR: 68S: (2-)36/37  
612-184-00-5 6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one 403-830-5 89331-94-2 R52-53 R: 52/53S: 61  
612-185-00-0 1-[3-[4-((heptadecafluorononyl)oxy)-benzamido]propyl]-N,N,N-trimethylammonium iodide 407-400-8 59493-72-0 Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
612-186-00-6 bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate 406-770-8 149057-64-7 Xn; R48/22Xi; R41R43N; R50-53 Xn; NR: 41-43-48/22-50/53S: (2-)22-26-36/37/39-60-61  
612-187-00-1 2,3,4-trifluoroaniline 407-170-9 3862-73-5 Xn; R21/22-48/22Xi; R38-41N; R51-53 Xn; NR: 21/22-38-41-48/22-51/53S: (2-)23-26-36/37/39-61  
612-188-00-7 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline) 407-560-9 107934-68-9 N; R51-53 NR: 51/53S: 61  
612-189-00-2 4-amino-2-(aminomethyl)phenol dihydrochloride 412-510-4 135043-64-0 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)22-24-37-60-61  
612-190-00-8 4,4'-methylenebis(2-isopropyl-6-methylaniline) 415-150-6 16298-38-7 Xn; R48/22N; R51-53 Xn; NR: 48/22-51/53S: (2-)36-61  
612-191-00-3 Polymer of allylamine hydrochloride 415-050-2 71550-12-4 Xn; R22R43 XnR: 22-43S: (2-)36/37  
612-192-00-9 2-isopropyl-4-(N-methyl)aminomethylthiazole 414-800-6 154212-60-9 Xn; R21/22Xi; R38-41N; R51-53 Xn; NR: 21/22-38-41-51/53S: (2-)26-36/37/39-61  
612-193-00-4 3-methylaminomethylphenylamine 414-570-7 18759-96-1 Xn; R21/22C; R34R43N; R50-53 C; NR: 21/22-34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
612-194-00-X 2-hydroxy-3-[(2-hydroxyethyl)-[2-(1-oxotetradecyl)amino]ethyl]amino]-N,N,N-trimethyl-1-propanammonium chloride 414-670-0 141890-30-4 Xn; R22Xi; R41N; R50-53 Xn; NR: 22-41-50/53S: (2-)26-39-60-61  
612-195-00-5 bis[tributyl 4-(methylbenzyl)ammonium] 1,5-naphthalenedisulfonate 415-210-1 160236-81-7 Xn; R20/22Xi; R41N; R50-53 Xn; NR: 20/22-41-50/53S: (2-)26-36/39-60-61  
612-196-00-0 4-chloro-o-toluidine; [1]4-chloro-o-toluidine hydrochloride [2] 202-441-6 [1]221-627-8 [2] 95-69-2 [1]3165-93-3 [2] Carc. Cat. 2; R45Muta. Cat. 3; R68T; R23/24/25N; R50-53 T; NR: 45-23/24/25-68-50/53S: 53-45-60-61  E
612-197-00-6 2,4,5-trimethylaniline; [1]2,4,5-trimethylaniline hydrochloride [2] 205-282-0 [1][2] 137-17-7 [1]21436-97-5 [2] Carc. Cat. 2; R45T; R23/24/25N; R51-53 T; NR: 45-23/24/25-51/53S: 53-45-61  E
612-198-00-1 4,4'-thiodianiline and its salts 205-370-9 139-65-1 Carc. Cat. 2; R45Xn; R22N; R51-53 T; NR: 45-22-51/53S: 53-45-61  E
612-199-00-7 4,4'-oxydianiline and its salts;p-aminophenyl ether 202-977-0 101-80-4 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 3; R62T; R23/24/25N; R51-53 T; NR: 45-46-23/24/25-62-51/53S: 53-45-61  E
612-200-00-0 2,4-diaminoanisole;4-methoxy-m-phenylenediamine; [1]2,4-diaminoanisole sulphate [2] 210-406-1 [1]254-323-9 [2] 615-05-4 [1]39156-41-7 [2] Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R22N; R51-53 T; NR: 45-22-68-51/53S: 53-45-61  E
612-201-00-6 N,N,N',N'-tetramethyl-4,4'-methylendianiline 202-959-2 101-61-1 Carc. Cat. 2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61  
612-202-00-1 3,4-dichloroaniline 202-448-4 95-76-1 T; R23/24/25Xi; R41R43N; R50-53 T; NR: 23/24/25-41-43-50/53S: (1/2-)26-36/37/39-45-60-61  
612-204-00-2 C.I. Basic Violet 3;4-[4,4'-bis(dimethylamino) benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]dimethylammonium chloride 208-953-6 548-62-9 Carc. Cat. 3; R40Xn; R22Xi; R41N; R50-53 Xn; NR: 22-40-41-50/53S: (2-)26-36/37/39-46-60-61  
612-205-00-8 C.I. Basic Violet 3 with ≥ 0.1 % of Michler's ketone (EC no. 202-027-5) 208-953-6 548-62-9 Carc. Cat. 2; R45Xn; R22Xi; R41N; R50-53 T; NR: 45-22-41-50/53S: 53-45-60-61  E
612-206-00-3 famoxadone (ISO);3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione — 131807-57-3 Xn; R48/22N; R50-53 Xn; NR: 48/22-50/53S: (2-)46-60-61  
612-207-00-9 4-ethoxyaniline;p-phenetidine 205-855-5 156-43-4 Muta. Cat. 3; R68Xn; R20/21/22Xi; R36R43 XnR: 20/21/22-36-43-68S: (2-)36/37-46  
612-209-00-X 6-methoxy-m-toluidine;p-cresidine 204-419-1 120-71-8 Carc. Cat. 2; R45Xn; R22 TR: 45-22S: 53-45  E
612-210-00-5 5-nitro-o-toluidine; [1]5-nitro-o-toluidine hydrochloride [2] 202-765-8 [1]256-960-8 [2] 99-55-8 [1]51085-52-0 [2] Carc. Cat. 3; R40T; R23/24/25R52-53 TR: 23/24/25-40-52/53S: (1/2-)36/37-45-61  
612-211-00-0 N-[(benzotriazole-1-yl)methyl)]-4-carboxybenzenesulfonamide 416-470-9 170292-97-4 Xi; R36N; R51-53 Xi; NR: 36-51/53S: (2-)26-61  
612-212-00-6 2,6-dichloro-4-trifluoromethylaniline 416-430-0 24279-39-8 Xn; R20/22Xi; R38R43N; R50-53 Xn; NR: 20/22-38-43-50/53S: (2-)24-37-60-61  
612-213-00-1 isobutylidene-(2-(2-isopropyl-4,4-dimethyloxazolidine-3-yl)-1,1-dimethylethyl)amine 419-850-2 148348-13-4 C; R34R52-53 CR: 34-52/53S: (1/2-)23-26-36/37/39-45-61  
612-214-00-7 4-(2,2-diphenylethenyl)-N,N-di-phenylbenzenamine 421-390-2 89114-90-9 R53 R: 53S: 61  
612-215-00-2 3-chloro-2-(isopropylthio)aniline 421-700-6 179104-32-6 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
612-217-00-3 1-methoxy-2-propylamine 422-550-4 37143-54-7 F; R11C; R34Xn; R22R52-53 F; CR: 11-22-34-52/53S: (1/2-)9-26-36/37/39-45-61  
613-001-00-1 ethyleneimine;aziridine 205-793-9 151-56-4 F; R11Carc. Cat. 2; R45Muta. Cat. 2; R46T+; R26/27/28C; R34N; R51-53 F; T+; NR: 45-46-11-26/27/28-34-51/53S: 53-45-61  D E
613-002-00-7 pyridine 203-809-9 110-86-1 F; R11Xn; R20/21/22 F; XnR: 11-20/21/22S: (2-)26-28 Xn; R20/21/22: C ≥ 5 % 
613-003-00-2 1,2,3,4-tetranitrocarbazole — 6202-15-9 E ⊗R1Xn; R20/21/22 E; XnR: 1-20/21/22S: (2-)35  
613-004-00-8 crimidine (ISO);2-chloro-6-methylpyrimidin-4-yldimethylamine 208-622-6 535-89-7 T+; R28 T+R: 28S: (1/2-)36/37-45  
613-007-00-4 desmetryne (ISO);6-isopropylamino-2-methylamino-4-methylthio-1,3,5-triazine 213-800-1 1014-69-3 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-60-61  
613-008-00-X dazomet (ISO);tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione 208-576-7 533-74-4 Xn; R22Xi; R36N; R50-53 Xn; NR: 22-36-50/53S: (2-)15-22-24-60-61  
613-009-00-5 2,4,6-trichloro-1,3,5-triazine;cyanuric chloride 203-614-9 108-77-0 R14T+; R26Xn; R22C; R34R43 T+;R: 14-22-26-34-43S: (1/2-)26-28-36/37/39-45-46-63 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
613-010-00-0 ametryn (ISO);2-ethylamino-4-isopropylamino-6-methylthio-1,3,5-triazine 212-634-7 834-12-8 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)36-60-61  
613-011-00-6 amitrole (ISO);1,2,4-triazol-3-ylamine 200-521-5 61-82-5 Repr. Cat. 3; R63Xn; R48/22N; R51-53 Xn; NR: 48/22-63-51/53S: (2-)13-36/37-61  
613-012-00-1 bentazone (ISO);3-isopropyl-2,1,3-benzothiadiazine-4-one-2,2-dioxide 246-585-8 25057-89-0 Xn; R22Xi; R36R43R52-53 XnR: 22-36-43-52/53S: (2-)24-37-61  
613-013-00-7 cyanazine (ISO);2-(4-chloro-6-ethylamino-1,3,5-triazine-2-ylamino)-2-methylpropionitrile 244-544-9 21725-46-2 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)37-60-61  
613-014-00-2 ethoxyquin (ISO);6-ethoxy-1,2-dihydro-2,2,4-trimethylquinoline 202-075-7 91-53-2 Xn; R22 XnR: 22S: (2-)24  
613-015-00-8 fenazaflor (ISO);phenyl 5,6-dichloro-2-trifluoromethylbenzimidazole-1-carboxylate 238-134-9 14255-88-0 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-60-61  
613-016-00-3 fuberidazole (ISO);2-(2-furyl)benzimidazole 223-404-0 3878-19-1 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)22-60-61  
613-017-00-9 bis (8-hydroxyquinolinium) sulphate 205-137-1 134-31-6 Xn; R22 XnR: 22S: (2-)36  
613-018-00-4 morfamquat (ISO);1,1'-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4'-bipyridilium ion — 7411-47-4 Xn; R22Xi; R36/37/38R52-53 XnR: 22-36/37/38-52/53S: (2-)22-36-61  
613-019-00-X thioquinox (ISO);2-thio-1,3-dithiolo(4,5,b)quinoxaline 202-272-8 93-75-4 Xn; R22 XnR: 22S: (2-)24  
613-020-00-5 tridemorph (ISO);2,6-dimethyl-4-tridecylmorpholine 246-347-3 24602-86-6 Repr. Cat. 2; R61Xn; R20/22Xi; R38N; R50-53 T; NR: 61-20/22-38-50/53S: 53-45-60-61  E
613-021-00-0 dithianon (ISO);5,10-dihydro-5,10-dioxonaphtho(2,3-b)(1,4)dithiazine-2,3-dicarbonitrile 222-098-6 3347-22-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)24-60-61  
613-022-00-6 pyrethrins including cinerins, with the exception of those specified elsewhere in this Annex — — Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)13-60-61  A
613-023-00-1 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl [1R-[1α[S*(Z)],3β]]-chrysanthemate;pyrethrin I 204-455-8 121-21-1 Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)13-60-61  
613-024-00-7 2-methyl-4-oxo-3-(penta-2,4-dienyl)cyclopent-2-enyl[1R-[1α[S*(Z)](3β)]]-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;pyrethrin II 204-462-6 121-29-9 Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)13-60-61  
613-025-00-2 cinerin I;3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate 246-948-0 25402-06-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-026-00-8 cinerin II;3-(but-2-enyl)-2-methyl-4-oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate 204-454-2 121-20-0 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-027-00-3 piperidine 203-813-0 110-89-4 F; R11T; R23/24C; R34 F; TR: 11-23/24-34S: (1/2-)16-26-27-45 T; R23/24: C ≥ 5 %Xn; R20/21: 1 % ≤ C < 5 %C; R34: C ≥ 5 %Xi: R36/38: 1 % ≤ C < 5 % 
613-028-00-9 morpholine 203-815-1 110-91-8 R10Xn; R20/21/22C; R34 CR: 10-20/21/22-34S: (1/2-)23-36-45 C; R34: C ≥ 10 %Xi; R36/38: 1 % ≤ C < 10 % 
613-029-00-4 dichloro-1,3,5-triazinetrione;dichloroisocyanuric acid 220-487-5 2782-57-2 O; R8Xn; R22R31Xi; R36/37N; R50-53 O; Xn; NR: 8-22-31-36/37-50/53S: (2-)8-26-41-60-61  
613-030-00-X troclosene potassium; [1]troclosene sodium [2] 218-828-8 [1]220-767-7 [2] 2244-21-5 [1]2893-78-9 [2] O; R8 ⊗Xn; R22R31Xi; R36/37N; R50-53 O; Xn; NR: 8-22-31-36/37-50/53S: (2-)8-26-41-60-61 Xn; R22: C ≥ 10 %Xi; R36/37: C ≥ 10 %R31: C ≥ 10 % 
613-030-01-7 troclosene sodium, dihydrate 220-767-7 51580-86-0 Xn; R22R31Xi; R36/37N; R50-53 Xn; NR: 22-31-36/37-50/53S: (2-)8-26-41-60-61  
613-031-00-5 symclosene;trichloroisocyanuric acid;trichloro-1,3,5-triazinetrion 201-782-8 87-90-1 O; R8Xn; R22Xi; R36/37R31N; R50-53 O; Xn; NR: 8-22-31-36/37-50/53S: (2-)8-26-41-60-61  
613-032-00-0 methyl-2,3,5,6-tetrachloro-4-pyridylsulphone;2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine 236-035-5 13108-52-6 Xn; R21/22Xi; R36R43 XnR: 21/22-36-43S: (2-)26-28  
613-033-00-6 2-methylaziridine;propyleneimine 200-878-7 75-55-8 F; R11Carc. Cat. 2; R45T+; R26/27/28Xi; R41N; R51-53 F; T+; NR: 45-11-26/27/28-41-51/53S: 53-45-61 Carc. Cat. 2; R45: C ≥ 0,01 % E
613-034-00-1 1,2-dimethylimidazole 217-101-2 1739-84-0 Xn; R22Xi; R38-41 XnR: 22-38-41S: (2-)24-26  
613-035-00-7 1-methylimidazole 210-484-7 616-47-7 Xn; R21/22C; R34 CR: 21/22-34S: (1/2-)26-36-45  
613-036-00-2 2-methylpyridine;2-picoline 203-643-7 109-06-8 R10Xn; R20/21/22Xi; R36/37 XnR: 10-20/21/22-36/37S: (2-)26-36  
613-037-00-8 4-methylpyridine;4-picoline 203-626-4 108-89-4 R10T; R24Xn; R20/22Xi; R36/37/38 TR: 10-20/22-24-36/37/38S: (1/2-)26-36-45  
613-038-00-3 6-phenyl-1,3,5-triazine-2,4-diyldiamine;6-phenyl-1,3,5-triazine-2,4-diamine;benzoguanamine 202-095-6 91-76-9 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
613-039-00-9 ethylene thiourea;imidazolidine-2-thione;2-imidazoline-2-thiol 202-506-9 96-45-7 Repr. Cat. 2; R61Xn; R22 TR: 61-22S: 53-45  E
613-040-00-4 azaconazole (ISO);1-{[2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl]methyl}-1H-1,2.4-triazole 262-102-3 60207-31-0 Xn; R22 XnR: 22S: (2-)46  
613-041-00-X morpholine-4-carbonyl chloride 239-213-0 15159-40-7 R14Carc. Cat. 3; R40Xi; R36/38 XnR: 14-36/38-40S: (2-)26-30-36-38  
613-042-00-5 imazalil (ISO);1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole 252-615-0 35554-44-0 Xn; R20/22Xi; R41N; R50-53 Xn; NR: 20/22-41-50/53S: (2-)26-39-60-61  
613-043-00-0 imazalil sulphate (ISO) powder;1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1](±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1]281-291-3 [2] 58594-72-2 [1]83918-57-4 [2] Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24/25-37-46-60-61  
613-043-01-8 imazalil sulphate (ISO), aqueous solution;1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate; [1](±)-1- [2-(allyloxy)ethyl-2-(2,4-dichlorophenyl)]-1H-imidazolium hydrogen sulphate [2] 261-351-5 [1]281-291-3 [2] 58594-72-2 [1]83918-57-4 [2] Xn; R22C; R34R43N; R50-53 C; NR: 22-34-43-50/53S: (2-)26-36/37/39-45-60-61 C; R34: C ≥ 50 %Xi; R38: 30 % ≤ C < 50 %Xi; R41: 15 % ≤ C < 50 %Xi; R36: 5 % ≤ C < 15 % 
613-044-00-6 captan (ISO);1,2,3,6-tetrahydro-N-(trichloromethylthio)phthalimide 205-087-0 133-06-2 Carc. Cat. 3; R40T; R23Xi; R41R43N; R50 T; NR: 23-40-41-43-50S: (1/2-)26-29-36/37/39-45-61  
613-045-00-1 folpet (ISO);N-(trichloromethylthio)phthalimide 205-088-6 133-07-3 Carc. Cat. 3; R40Xn; R20Xi; R36R43N; R50 Xn; NR: 20-36-40-43-50S: (2-)36/37-46-61  
613-046-00-7 captafol (ISO);1,2,3,6-tetrahydro-N-(1,1,2,2-tetrachloroethylthio)phthalimide 219-363-3 2425-06-1 Carc. Cat. 2; R45R43N; R50-53 T; NR: 45-43-50/53S: 53-45-60-61  
613-047-00-2 1-dimethylcarbamoyl-5-methylpyrazol-3-yl dimethylcarbamate;dimetilan (ISO) 211-420-0 644-64-4 T; R25Xn; R21N; R50-53 T; NR: 21-25-50/53S: (1/2-)36/37-45-60-61  
613-048-00-8 carbendazim (ISO);methyl benzimidazol-2-ylcarbamate 234-232-0 10605-21-7 Muta. Cat. 2; R46Repr. Cat. 2; R60-61N; R50-53 T; NR: 46-60-61-50/53S: 53-45-60-61  
613-049-00-3 benomyl (ISO);methyl 1-(butylcarbamoyl)benzimidazol-2-ylcarbamate 241-775-7 17804-35-2 Muta. Cat. 2; R46Repr. Cat. 2; R60-61Xi; R37/38R43N; R50-53 T; NR: 46-60-61-37/38-43-50/53S: 53-45-60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
613-050-00-9 carbadox (INN);methyl 3-(quinoxalin-2-ylmethylene)carbazate 1,4-dioxide;2-(methoxycarbonylhydrazonomethyl)quinoxaline 1,4-dioxide 229-879-0 6804-07-5 F; R11Carc. Cat. 2; R45Xn; R22 F; TR: 45-11-22S: 53-45  E
613-051-00-4 molinate (ISO);S-ethyl 1-perhydroazepinecarbothioate;S-ethyl perhydroazepine-1-carbothioate 218-661-0 2212-67-1 Carc. Cat. 3; R40Repr. Cat. 3; R62Xn; R20/2248/22R43N; R50-53 Xn; NR: 20/22-40-43-48/22-62-50/53S: (2-)36/37-46-60-61 N; R50-53: C ≥ 0,25 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
613-052-00-X trifenmorph (ISO);4-tritylmorpholine 215-812-2 1420-06-0 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-053-00-5 anilazine (ISO);2-chloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)aniline 202-910-5 101-05-3 Xi; R36/38N; R50-53 Xi; NR: 36/38-50/53S: (2-)22-60-61  
613-054-00-0 thiabendazol (ISO);2-(thiazole-4-yl)benzimidazole 205-725-8 148-79-8 N; R50-53 NR: 50/53S: 60-61  
613-056-00-1 1,2-dimethyl-3,5-diphenylpyrazolium methylsulphate;difenzoquat methyl sulfate 256-152-5 43222-48-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-057-00-7 dodemorph (ISO);4-cyclododecyl-2,6-dimethylmorpholine 216-474-9 1593-77-7 Xi; R36/37/38N; R51-53 Xi; NR: 36/37/38-51/53S: (2-)26-61  
613-058-00-2 permethrin (ISO);m-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate 258-067-9 52645-53-1 Xn; R20/22R43N; R50-53 Xn; NR: 20/22-43-50/53S: (2-)13-24-36/37/39-60-61 N; R50-53: C ≥ 0,025 %N; R51-53: 0,0025 % ≤ C < 0,025 %R52-53: 0,00025 % ≤ C < 0,0025 % 
613-059-00-8 profluralin (ISO);N-(cyclopropylmethyl)-α,α,α-trifluoro-2,6-dinitro-N-propyl-p-toluidine 247-656-6 26399-36-0 Xi; R36N; R50-53 Xi; NR: 36-50/53S: (2-)60-61  
613-060-00-3 resmethrin (ISO);5-benzyl-3-furylmethyl (±)-cis-trans-chrysanthemate 233-940-7 10453-86-8 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60/61  
613-061-00-9 6-(1α,5aβ,8aβ,9-pentahydroxy-7β-isopropyl-2β,5β,8β-trimethylperhydro-8bα,9-epoxy-5,8-ethanocyclopenta[1,2-b]indenyl) pyrrole-2-carboxylate;ryania 239-732-2 15662-33-6 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-60-61  
613-062-00-4 sabadilla (ISO);veratrine — 8051-02-3 Xi; R36/37/38 XiR: 36/37/38S: (2-)36/37/39  
613-063-00-X secbumeton (ISO);2-sec-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 247-554-1 26259-45-0 Xn; R22Xi; R36N; R50-53 Xn; NR: 22-36-50/53S: (2-)60-61  
613-064-00-5 5-(3,6,9-trioxa-2-undecyloxy)benzo(d)-1,3-dioxolane;sesamex — 51-14-9 Xn; R22 XnR: 22S: (2-)  
613-065-00-0 simetryn (ISO);2,4-bis(ethylamino)-6-methylthio-1,3,5-triazine 213-801-7 1014-70-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-066-00-6 terbumeton (ISO);2-tert-butylamino-4-ethylamino-6-methoxy-1,3,5-triazine 251-637-8 33693-04-8 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-067-00-1 propazine (ISO);2-chloro-4,6-bis(isopropylamino)-1,3,5-triazine 205-359-9 139-40-2 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-60-61  
613-068-00-7 atrazine (ISO);2-chloro-4-ethylamine-6-isopropylamine-1,3,5-triazine 217-617-8 1912-24-9 Xn; R48/22R43N; R50-53 Xn; NR: 43-48/22-50/53S: (2-)36/37-60-61  
613-069-00-2 ε-caprolactam 203-313-2 105-60-2 Xn; R20/22Xi; R36/37/38 XnR: 20/22-36/37/38S: (2-)  
613-070-00-8 propylenethiourea — 2122-19-2 Repr. Cat. 3; R63Xn; R22R52-53 XnR: 22-52/53-63S: (2-)36/37-46-61  
613-071-00-3 2-fluoro-5-trifluoromethylpyridine 400-290-2 69045-82-5 R10R43R52-53 XiR: 10-43-52/53S: (2-)24-37-61  
613-072-00-9 N,N-bis(2-ethylhexyl)-((1,2,4-triazol-1-yl)methyl)amine 401-280-0 91273-04-0 C; R34R43N; R51-53 C; NR: 34-43-51/53S: (1/2-)26-28-36/37/39-45-61  
613-073-00-4 N,N-dimethyl-2-(3-(4-chlorophenyl)-4,5-dihydropyrazol-1-ylphenylsulphonyl)ethylamine 401-410-6 10357-99-0 Xn; R48/22R43N; R51-53 Xn; NR: 43-48/22-51/53S: (2-)24-37-61  
613-074-00-X 3-(3-methylpent-3-yl)isoxazol-5-ylamine 401-460-9 82560-06-3 T; R23/25Xi; R41R52-53 TR: 23/25-41-52/53S: (1/2-)22-26-36/37/39-45-61  
613-075-00-5 1,3-dichloro-5-ethyl-5-methylimidazolidine-2,4-dione 401-570-7 89415-87-2 O; R8T; R23C; R34Xn; R22R43N; R50 O; T; NR: 8-22-23-34-43-50S: (1/2-)8-26-36/37/39-45-61  
613-076-00-0 3-chloro-5-trifluoromethyl-2-pyridylamine 401-670-0 79456-26-1 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
613-077-00-6 reaction mass of 5-heptyl-1,2,4-triazol-3-ylamine and 5-nonyl-1,2,4-triazol-3-ylamine 401-940-8 — Xn; R22Xi; R36N; R51-53 Xn; NR: 22-36-51/53S: (2-)22-26-61  
613-078-00-1 N,N,N,N-tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7-diazadecane-1,10-diamine 401-990-0 106990-43-6 R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-61  
613-079-00-7 4-(1(or 4 or 5 or 6)-methyl-8,9,10-trinorborn-5-en-2-yl)pyridine, reaction mass of isomers 402-520-7 — Xn; R21/22Xi; R38R43N; R50-53 Xn; NR: 21/22-38-43-50/53S: (2-)36/37-60-61  
613-080-00-2 3-(bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)-thione 402-540-6 105254-85-1 C; R34R43N; R50-53 C; NR: 34-43-50/53S: (1/2-)26-28-36/37/39-45-60-61  
613-081-00-8 1-butyl-2-methylpyridinium bromide 402-680-8 26576-84-1 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
613-082-00-3 2-methyl-1-pentylpyridinium bromide 402-690-2 — Xn; R21/22R52-53 XnR: 21/22-52/53S: (2-)36/37-61  
613-083-00-9 2-(4-(3-(4-chlorophenyl)-2-pyrazolin-1-yl)phenylsulfonyl)ethyldimethylammonium formate 402-120-2 — C; R34Xn; R48/22R43N; R50-53 C; NR: 34-43-48/22-50/53S: (1/2-)24-26-28-37/39-45-60-61  
613-084-00-4 2-(4-(3-(4-chlorophenyl)-4,5-dihydropyrazolyl)phenylsulphonyl)ethyldimethylammonium hydrogen phosphonate 402-490-5 106359-93-7 Xi; R36N; R50-53 Xi; NR: 36-50/53S: (2-)26-60-61  
613-085-00-X reaction mass of 1,1'-(methylenebis(4,1-phenylene))dipyrrole-2,5-dione and N-(4-(4-(2,5-dioxopyrrol-1-yl)benzyl)phenyl)acetamide and 1-(4-(4-(5-oxo-2H-2-furylidenamino)benzyl)phenyl)pyrrole-2,5-dione 401-970-1 — R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
613-086-00-5 caffeine 200-362-1 58-08-2 Xn; R22 XnR: 22S: (2-)  
613-087-00-0 tetrahydrothiophene 203-728-9 110-01-0 F; R11Xn; R20/21/22Xi; R36/38R52-53 F; XnR: 11-20/21/22-36/38-52/53S: (2-)16-23-36/37-61  
613-088-00-6 1,2-benzisothiazol-3(2H)-one;1,2-benzisothiazolin-3-one 220-120-9 2634-33-5 Xn; R22Xi; R38-41R43N; R50 Xn; NR: 22-38-41-43-50S: (2-)24-26-37/39-61 R43: C ≥ 0,05 % 
613-089-00-1 diquat dibromide; [1]diquat dichloride; [2]6,7-dihydrodipyrido[1,2-α:2',1'-c]pyrazinediylium dihydroxide [3] 201-579-4 [1]223-714-6 [2]301-467-6 [3] 85-00-7 [1]4032-26-2 [2]94021-76-8 [3] T+; R26T; R48/25Xn; R22Xi; R36/37/38R43N; R50-53 T+; NR: 22-26-36/37/38-43-48/25-50/53S: (1/2-)28-36/37/39-45-60-61  
613-090-00-7 paraquat dichloride;1,1-dimethyl-4,4'-bipyridinium dichloride; [1]paraquat dimethylsulfate;1,1-dimethyl-4,4'-bipyridinium dimethyl sulphate [2] 217-615-7 [1]218-196-3 [2] 1910-42-5 [1]2074-50-2 [2] T+; R26T; R24/25-48/25Xi; R36/37/38N; R50-53 T+; NR: 24/25-26-36/37/38-48/25-50/53S: (1/2-)22-28-36/37/39-45-60-61  
613-091-00-2 morfamquat dichloride; [1]morfamquat sulfate [2] 225-062-8 [1][2] 4636-83-3 [1]29873-36-7 [2] Xn; R22Xi; R36/37/38R52-53 XnR: 22-36/37/38-52/53S: (2-)22-36-61  
613-092-00-8 1,10-phenanthroline 200-629-2 66-71-7 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)45-60-61  
613-093-00-3 hexasodium 6,13-dichloro-3,10-bis((4-(2,5-disulfonatoanilino)-6-fluoro-1,3,5-triazin-2-ylamino)prop-3-ylamino)-5,12-dioxa-7,14-diazapentacene-4,11-disulfonate 400-050-7 85153-92-0 R42/43 XnR: 42/43S: (2-)22-24-37  
613-094-00-9 4-methoxy-N,6-dimethyl-1,3,5-triazin-2-ylamine 401-360-5 5248-39-5 Xn; R22-48/22 XnR: 22-48/22S: (2-)22-36  
613-095-00-4 sodium 3-(2H-benzotriazol-2-yl)-5-sec-butyl-4-hydroxybenzenesulfonate 403-080-9 92484-48-5 Xi; R41 XiR: 41S: (2-)26-39  
613-096-00-X 2-amino-6-ethoxy-4-methylamino-1,3,5-triazine 403-580-7 62096-63-3 Xn; R22 XnR: 22S: (2-)  
613-097-00-5 7-amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 403-690-5 111298-82-9 R42/43R52-53 XnR: 42/43-52/53S: (2-)22-24-37-61  
613-098-00-0 N-(n-octyl)-2-pyrrolidone 403-700-8 2687-94-7 C; R34N; R51-53 C; NR: 34-51/53S: (1/2-)23-26-36/37/39-45  
613-099-00-6 1-dodecyl-2-pyrrolidone 403-730-1 2687-96-9 C; R34R43N; R50-53 C; NR: 34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
613-100-00-X 2,9-bis(3-(diethylamino)propylsulfamoyl)quino(2,3-b)acridine-7,14-dione 404-230-6 — R43R53 XiR: 43-53S: (2-)24-37-61  
613-101-00-5 N-tert-pentyl-2-benzothiazolesulfenamide 404-380-2 110799-28-5 R43R52-53 XiR: 43-52/53S: (2-)36/37-61  
613-102-00-0 dimethomorph (ISO);4-(3-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)acryloyl)morpholine 404-200-2 110488-70-5 N; R51-53 NR: 51/53S: 61  
613-103-00-6 sodium 5-n-butylbenzotriazole 404-450-2 118685-34-0 Xn; R22C; R34R43N; R51-53 C; NR: 22-34-43-51/53S: (1/2-)26-36/37/39-45-61  
613-104-00-1 5-tert-butyl-3-isoxazolylamine hydrochloride 404-840-2 — Xn; R22-48/22Xi; R41R52-53 XnR: 22-41-48/22-52/53S: (2-)26-36/39-61  
613-105-00-7 hexakis(tetramethylammonium) 4,4'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5-triazine-4,2-diyl)imino)bis(5-hydroxy-6-phenylazonaphthalene-2,7-disulfonate) 405-160-9 124537-30-0 T; R25R43R52-53 TR: 25-43-52/53S: (1/2-)24-37-45-61  
613-106-00-2 tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-dienylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1-yl)benzene-1,4-disulfonate 405-240-3 — R43 XiR: 43S: (2-)24-37  
613-107-00-8 hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-phenylene)imino(6-(N-cyanoethyl-N-(2-hydroxypropyl)amino)-1,3,5-triazine-4,2-diyl)imino)dibenzene-1,4-disulfonate 405-280-1 76508-02-6 Xi; R36 XiR: 36S: (2-)26  
613-108-00-3 benzothiazole-2-thiol 205-736-8 149-30-4 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
613-109-00-9 bis(piperidinothiocarbonyl) disulphide 202-328-1 94-37-1 Xi; R36/37/38R43 XiR: 36/37/38-43S: (2-)24-26-37  
613-110-00-4 dimepiperate (ISO);S-(1-methyl-1-phenylethyl) piperidine-1-carbothioate 262-784-2 61432-55-1 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
613-111-00-X 1,2,4-triazole 206-022-9 288-88-0 Repr. Cat. 3; R63Xn; R22Xi; R36 XnR: 22-36-63S: (2-)36/37  
613-112-00-5 octhilinone (ISO);2-octyl-2H-isothiazol-3-one 247-761-7 26530-20-1 T; R23/24Xn; R22C; R34R43N; R50-53 T; NR: 22-23/24-34-43-50/53S: (1/2-)26-36/37/39-45-60-61 R43: C ≥ 0,05 % 
613-113-00-0 2-(morpholinothio)benzothiazole 203-052-4 102-77-2 Xi; R36/38R43N; R51-53 Xi; NR: 36/38-43-51/53S: (2-)24-26-37-61  
613-114-00-6 2,2',2"-(hexahydro-1,3,5-triazine-1,3,5-triyl)triethanol;1,3,5-tris(2-hydroxyethyl)hexahydro-1,3,5-triazine 225-208-0 4719-04-4 Xn; R22R43 XnR: 22-43S: (2-)24-37 R43: C ≥ 0,1 % 
613-115-00-1 hymexazol (ISO);3-hydroxy-5-methylisoxazole 233-000-6 10004-44-1 Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)26-39-61  
613-116-00-7 tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide 211-986-9 731-27-1 T; R23Xn; R48/20Xi; R36/37/38R43N; R50-53 T; NR: 23-36/37/38-43-48/20-50/53S: (1/2-)24-26-37-38-45-60-61  
613-117-00-2 diniconazole (ISO);(E)-β-[(2,4-dichlorophenyl)methylene]-α-(1,1-dimethylethyl)-1H-1,2,4-triazol-1-ethanol;(E)-(RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol — 76714-88-0 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-118-00-8 flubenzimine (ISO);N-[3-phenyl-4,5-bis[(trifluoromethyl)imino]thiazolidin-2-ylidene]aniline; 253-703-1 37893-02-0 Xi; R36N; R50-53 Xi; NR: 36-50/53S: (2-)26-60-61  
613-119-00-3 (benzothiazol-2-ylthio)methyl thiocyanate;TCMTB 244-445-0 21564-17-0 T+; R26Xn; R22Xi; R36/38R43N; R50-53 T+; NR: 22-26-36/38-43-50/53S: (1/2-)28-36/37-38-45-60-61  
613-120-00-9 bioresmethrin;(5-bezylfur-3-yl)methyl(1R)-trans-2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboylate 249-014-0 28434-01-7 N; R50-53 NR: 50/53S: 60-61  
613-121-00-4 chlorsulfuron (ISO);2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulphonamide; 265-268-5 64902-72-3 N; R50-53 NR: 50/53S: 60-61  
613-122-00-X diclobutrazole (ISO);(R*, R*)-(±)-β-[(2,4-dichlorophenyl)methyl]-α-(1,1-dimethylethyl)-1H-1,2,4-triazole-1-ethanol;(2RS, 3RS)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1yl)pentan-3-ol — 75736-33-3 Xi; R36N; R51-53 Xi; NR: 36-51/53S: (2-)26-61  
613-123-00-5 5,6-dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole-3-thione;etem 251-684-4 33813-20-6 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-124-00-0 fenpropimorph (ISO);cis-4-[3-(p-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine 266-719-9 67564-91-4 Repr. Cat. 3; R63Xn; R22Xi; R38N; R51-53 Xn; NR: 22-38-63-51/53S: (2-)36/37-46-61  
613-125-00-6 hexythiazox (ISO);trans-5-(4-chlorophenyl)-N-cyclohexyl-4-methyl-2-oxo-3-thiazolidine-carboxamide — 78587-05-0 N; R50-53 NR: 50/53S: 60-61  
613-126-00-1 imazapyr (ISO);2-[4,5-dihydro-4-methyl-4-(1-methylethyl)-5-oxo-1H-imidazol-2-yl]-3-pyridine carboxylate — 81334-34-1 Xi; R36R52-53 XiR: 36-52/53S: (2-)26-61  
613-127-00-7 1,1-dimethylpiperidinium chloride;mepiquat chloride 246-147-6 24307-26-4 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
613-128-00-2 prochloraz (ISO);N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]-1H-imidazole-1-carboxamide; 266-994-5 67747-09-5 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
613-129-00-8 metamitron (ISO);4-amino-3-methyl-6-phenyl-1,2,4-triazin-5-one 255-349-3 41394-05-2 Xn; R22N; R50 Xn; NR: 22-50S: (2-)61  
613-131-00-9 pyroquilon (ISO);1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one — 57369-32-1 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
613-132-00-4 hexazinone (ISO);3-cyclohexyl-6-dimethylamino-1-methyl-1,2,3,4-tetrahydro-1,3,5-triazine-2,4-dione; 257-074-4 51235-04-2 Xn; R22Xi; R36N; R50-53 Xn; NR: 22-36-50/53S: (2-)60-61  
613-133-00-X etridiazole (ISO);5-ethoxy-3-trichloromethyl-1,2,4-thiadiazole 219-991-8 2593-15-9 Carc. Cat. 3; R40T; R23Xn; R21/22N; R50-53 T; NR: 21/22-23-40-50/53S: (1/2-)36/37-38-45-60-61  
613-134-00-5 myclobutanil (ISO);2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile — 88671-89-0 Repr. Cat. 3; R63Xn; R22Xi; R36N; R51-53 Xn; NR: 22-36-51/53-63S: (2-)36/37-46-61  
613-135-00-0 di(benzothiazol-2-yl) disulphide 204-424-9 120-78-5 R31R43N; R50-53 Xi; NR: 31-43-50/53S: (2-)36/37-60-61  
613-136-00-6 N-cyclohexylbenzothiazole-2-sulphenamide 202-411-2 95-33-0 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
613-137-00-1 methabenzthiazuron (ISO);1-(1,3-benzothiazol-2-yl)1,3-dimethylurea 242-505-0 18691-97-9 N; R50-53 NR: 50/53S: 60-61  
613-138-00-7 quinoxyfen (ISO);5,7-dichloro-4-(4-fluorophenoxy)quinoline — 124495-18-7 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-46-60-61  
613-139-00-2 metsulfuron-methyl;2-(4-methoxy-6-methyl-1,3,5-triazin-2-ylcarbamoylsulfamoyl) benzoic acid — 74223-64-6 N; R50-53 NR: 50/53S: 60-61  
613-140-00-8 cycloheximide (ISO);4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione 200-636-0 66-81-9 Muta. Cat. 3; R68Repr. Cat. 2; R61T+; R28N; R51-53 T+; NR: 61-28-51/53-68S: 53-45-61  E
613-141-00-3 1,4-diamino-2-(2-butyltetrazol-5-yl)-3-cyanoanthraquinone 401-470-3 93686-63-6 R53 R: 53S: 61  
613-142-00-9 trans-N-methyl-2-styryl-[4'-aminomethine-(1-acetyl-1-(2-methoxyphenyl)acetamido)]pyridinium acetate 405-860-4 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-61  
613-143-00-4 1-(3-phenylpropyl)-2-methylpyridinium bromide 405-930-4 10551-42-5 Xn; R22Xi; R36R52-53 XnR: 22-36-52/53S: (2-)26-36/37-61  
613-144-00-X Reaction products of: poly(vinyl acetate), partially hydrolyzed, with (E)-2-(4-formylstyryl)-3,4-dimethylthiazoliummethyl sulfate 406-460-2 125139-08-4 R52-53 R: 52/53S: 61  
613-145-00-5 (S)-3-benzyloxycarbonyl-1,2,3,4-tetrahydro-isoquinolinium 4-methylbenzenesulfonate 406-960-0 77497-97-3 N; R51-53 NR: 51/53S: 61  
613-146-00-0 N-ethyl-N-methylpiperidinium iodide 407-780-5 4186-71-4 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)22-61  
613-147-00-6 4-[2-(1-methyl-2-(4-morpholinyl)ethoxy)ethyl]morpholine 407-940-4 111681-72-2 Xi; R41 XiR: 41S: (2-)26-39  
613-148-00-1 tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3-sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane 411-240-4 143683-23-2 R43R52-53 XiR: 43-52/53S: (2-)22-24/25-37-61  
613-149-00-7 pyridaben (ISO);2-tert-butyl-5-(4-tert-butylbenzylthio)-4-chloropyridazin-3(2H)-one 405-700-3 96489-71-3 T; R23/25N; R50-53 T; NR: 23/25-50/53S: (1/2-)36/37-45-60-61  
613-150-00-2 2,2'-[3,3'-(piperazine-1,4-diyl)dipropyl]bis(1H-benzimidazo[2,1-b]benzo[l,m,n][3,8]phenanthroline-1,3,6-trione 406-295-6 — R53 R: 53S: 61  
613-151-00-8 1-(3-mesyloxy-5-trityloxymethyl-2-D-threofuryl)thymine 406-360-9 104218-44-2 R53 R: 53S: 61  
613-152-00-3 phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate 406-600-2 89392-03-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
613-153-00-9 2,3,5-trichloropyridine 407-270-2 16063-70-0 R52-53 R: 52/53S: 61  
613-154-00-4 2-amino-4-chloro-6-methoxypyrimidine 410-050-9 5734-64-5 Xn; R22 XnR: 22S: (2-)22  
613-155-00-X 5-chloro-2,3-difluoropyridine 410-090-7 89402-43-7 R10Xn; R22R52-53 XnR: 10-22-52/53S: (2-)23-36-61  
613-156-00-5 2-butyl-4-chloro-5-formylimidazole 410-260-0 83857-96-9 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
613-157-00-0 2,4-diamino-5-methoxymethylpyrimidine 410-330-0 54236-98-5 Xn; R22-48/22Xi; R36 XnR: 22-36-48/22S: (2-)22-26-36  
613-158-00-6 2,3-dichloro-5-trifluoromethyl-pyridine 410-340-5 69045-84-7 Xn; R20/22Xi; R41R43N; R51-53 Xn; NR: 20/22-41-43-51/53S: (2-)24-26-37/39-61  
613-159-00-1 fenazaquin (ISO);4-[2-[4-(1,1-dimethylethyl)phenyl]-ethoxy]quinazoline 410-580-0 120928-09-8 T; R25Xn; R20N; R50-53 T; NR: 20-25-50/53S: (1/2-)37-45-60-61  
613-160-00-7 (1S)-2-methyl-2,5-diazobicyclo[2.2.1]heptane dihydrobromide 411-000-9 125224-62-6 R43 XiR: 43S: (2-)24-37  
613-163-00-3 azimsulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5-ylsulfonyl]urea — 120162-55-2 N; R50-53 NR: 50/53S: 60-61  
613-164-00-9 flufenacet (ISO);N-(4-fluorophenyl)-N-isopropyl-2-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yloxy)acetamide — 142459-58-3 Xn; R22-48/22R43N; R50-53 Xn; NR: 22-43-48/22-50/53S: (2-)13-24-37-60-61  
613-165-00-4 flupyrsulfuron-methyl-sodium (ISO);methyl 2-[[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-6-trifluoromethyl]nicotinate, monosodium salt — 144740-54-5 N; R50-53 NR: 50/53S: 60-61  
613-166-00-X flumioxazin (ISO);N-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide — 103361-09-7 Repr. Cat. 2; R61N; R50-53 T; NR: 61-50/53S: 53-45-60-61  
613-167-00-5 reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-2H -isothiazol-3-one [EC no. 220-239-6] (3:1);reaction mass of: 5-chloro-2-methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2-methyl-4-isothiazolin-3-one [EC no. 220-239-6] (3:1) — 55965-84-9 T; R23/24/25C; R34R43N; R50-53 T; NR: 23/24/25-34-43-50/53S: (2-)26-28-36/37/39-45-60-61 C; R34: C ≥ 0,6 %Xi; R36/38: 0,06 % ≤ C < 0,6 %R43: C ≥ 0,0015 % 
613-168-00-0 1-vinyl-2-pyrrolidone 201-800-4 88-12-0 Carc. Cat. 3; R40Xn; R20/21/22-48/20Xi; R37-41 XnR: 20/21/22-37-40-41-48/20S: (2-)26-36/37/39  D
613-169-00-6 9-vinylcarbazole 216-055-0 1484-13-5 Muta. Cat. 3; R68Xn; R21/22Xi; R38R43N; R50-53 Xn; NR: 21/22-38-43-50/53-68S: 22-23-36/37-60-61  
613-170-00-1 2,2-ethylmethylthiazolidine 404-500-3 694-64-4 Xn; R22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-51/53S: (2-)24-26-37/39-61  
613-171-00-7 hexaconazole (ISO);(RS)-2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol 413-050-7 79983-71-4 Xn; R22R43N; R51-53 Xn; NR: 22-43-51/53S: (2-)24-37-61  
613-172-00-2 5-chloro-1,3-dihydro-2H-indol-2-one 412-200-9 17630-75-0 Repr. Cat. 3; R62Xn; R22R43R52-53 XnR: 22-43-62-52/53S: (2-)22-36/37-61  
613-173-00-8 fluquinconazole (ISO);3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)quinazolin-4-(3H)-one 411-960-9 136426-54-5 T; R23/25-48/25Xn; R21Xi; R38N; R50-53 T; NR: 21-23/25-38-48/25-50/53S: (1/2-)36/37/39-38-45-60-61  
613-174-00-3 (±) 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-tetrafluoroethylether 407-760-6 112281-77-3 Carc. Cat. 3; R40Xn; R20/22N; R51-53 Xn; NR: 20/22-40-51/53S: (2-)36/37-41-61  
613-175-00-9 epoxiconazole (ISO);(2RS,3SR)-3-(2-chlorophenyl)-2-(4-fluorophenyl)-[(1H-1,2,4-triazol-1-yl)methyl]oxirane 406-850-2 133855-98-8 Carc. Cat. 3; R40Repr. Cat. 3; R62Repr. Cat. 3; R63N; R51-53 Xn; NR: 40-62-63-51/53S: (2-)36/37-46-61  
613-176-00-4 2-methyl-2-azabicyclo[2.2.1]heptane 404-810-9 4524-95-2 R10Xn; R21/22-48/20C; R34 CR: 10-21/22-34-48/20S: (1/2-)16-26-36/37/39-45  
613-177-00-X 8-amino-7-methylquinoline 412-760-4 5470-82-6 Xn; R21/22R43N; R51-53 Xn; NR: 21/22-43-51/53S: (2-)36/37-61  
613-178-00-5 4-ethyl-2-methyl-2-isopentyl-1,3-oxazolidine 410-470-2 137796-06-6 C; R34R43 CR: 34-43S: (1/2-)7/8-26-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
613-179-00-0 lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide 411-690-1 111337-53-2 Xn; R22C; R34R43N; R51-53 C; NR: 22-34-43-51/53S: (1/2-)26-36/37/39-45-61  
613-180-00-6 N-(1,1-dimethylethyl)bis(2-benzothiazolesulfen)amide 407-430-1 3741-80-8 N; R50-53 NR: 50/53S: 60-61  
613-181-00-1 5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone 405-090-9 67485-29-4 T; R48/25Xn; R22Xi; R36N; R50-53 T; NR: 22-36-48/25-50/53S: (1/2-)22-26-36/37-45-60-61  
613-182-00-7 1-(1-naphthylmethyl)quinolinium chloride 406-220-7 65322-65-8 Carc. Cat. 3; R40Muta. Cat. 3; R68Xn; R22Xi; R38-41R52-53 XnR: 22-38-40-41-52/53-68S: (2-)22-26-36/37/39-61  
613-183-00-2 reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one;5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one 413-640-4 — Xn; R48/22N; R50-53 Xn; NR: 48/22-50/53S: (2-)36-60-61  
613-184-00-8 nitrilotriethyleneammoniopropane-2-ol 2-ethylhexanoate 413-670-8 — Xi; R36R43 XiR: 36-43S: (2-)24-26-37  
613-185-00-3 2,3,5,6-tetrahydro-2-methyl-2H-cyclopenta[d]-1,2-thiazol-3-one 407-630-9 82633-79-2 T; R25Xi; R41R43N; R50-53 T; NR: 25-41-43-50/53S: (1/2-)22-26-36/37/39-45-60-61  
613-186-00-9 (2R,3R)-3-((R)-1-(tert-butyldimethylsiloxy)ethyl)-4-oxoazetidin-2-yl acetate 408-050-9 76855-69-1 Xi; R36R43N; R51-53 Xi; NR: 36-43-51/53S: (2-)24-26-37-61  
613-188-00-X 1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinone 411-500-7 116256-11-2 Xn; R22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-51/53S: (2-)22-24-26-37/39-61  
613-189-00-5 1,4,7,10-tetrakis(p-toluensulfonyl)-1,4,7,10-tetraazacyclododecane 414-030-0 52667-88-6 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
613-190-00-0 disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4-ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10-dioxo-9,10-dihydro-anthracene-2-sulfonate 414-040-5 149530-93-8 Xn; R22R43 XnR: 22-43S: (2-)22-24-37  
613-191-00-6 3-ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine 421-150-7 143860-04-2 Repr. Cat. 2; R60C; R34N; R50-53 T; NR: 60-34-50/53S: 53-45-60-61  
613-193-00-7 pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane-1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] heptalactate 414-930-3 — N; R51-53 NR: 51/53S: 61  
613-194-00-2 6,13-dichloro-3,10-bis{2-[4-fluoro-6-(2-sulfophenylamino)-1,3,5-triazin-2-ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3-.b.]phenoxazine-4,11-disulphonic acid, lithium-, sodium salt 418-000-8 163062-28-0 Xi; R41 XiR: 41S: (2-)22-26-39  
613-195-00-8 2,2-(1,4-phenylene)bis((4H-3,1-benzoxazine-4-one) 418-280-1 18600-59-4 R43R53 XiR: 43-53S: (2-)24-37-61  
613-196-00-3 5-[[4-chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-methoxy-2-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4-(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene-2,7-disulfonic acid, sodium salt 418-380-5 168113-78-8 Xi; R41 XiR: 41S: (2-)26-39  
613-197-00-9 reaction mass of: 2,4,6-tri(butylcarbamoyl)-1,3,5-triazine;2,4,6-tri(methylcarbamoyl)-1,3,5-triazine;[(2-butyl-4,6-dimethyl)tricarbamoyl]-1,3,5-triazine;[(2,4-dibutyl-6-methyl)tricarbamoyl]-1,3,5-triazine 420-390-1 187547-46-2 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
613-199-00-X reaction mass of: 1,3,5-tris(3-aminomethylphenyl)-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione;reaction mass of oligomers of 3,5-bis(3-aminomethylphenyl)-1-poly[3,5-bis(3-aminomethylphenyl)-2,4,6-trioxo-1,3,5-(1H,3H,5H)-triazin-1-yl]-1,3,5-(1H,3H,5H)-triazine-2,4,6-trione 421-550-1 — Carc. Cat. 2; R45Repr. Cat. 2; R61R43R52-53 TR: 45-61-43-52/53S: 53-45-61  
613-200-00-3 Reaction product of: copper, (29H,31H-phthalocyaninato(2-)-N29,N30,N31,N32)-, chlorosulfuric acid and 3-(2-sulfooxyethylsulfonyl)aniline, sodium salts 420-980-7 — Xi; R41 XiR: 41S: (2-)22-26-39  
613-201-00-9 (R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole 422-390-5 143322-57-0 Repr. Cat. 3; R62T; R39-48/25Xn; R20/22Xi; R41R43N; R50-53 T; NR: 20/22-39-41-43-48/25-62-50/53S: (1/2-)53-45-60-61  
613-202-00-4 pymetrozine (ISO);(E)-4,5-dihydro-6-methyl-4-(3-pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one — 123312-89-0 Carc. Cat. 3; R40R52-53 XnR: 40-52/53S: (2-)36/37-61  
613-203-00-X pyraflufen-ethyl; [1]pyraflufen [2] [1][2] 129630-19-9 [1]129630-17-7 [2] N; R50-53 NR: 50/53S: 60-61  
613-204-00-5 oxadiargyl (ISO);3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one;5-tert-butyl-3-[2,4-dichloro-5-(prop-2-ynyloxy)phenyl]-1,3,4-oxadiazol-2(3H)-one 254-637-6 39807-15-3 Repr. Cat. 3; R63Xn; R48/22N; R50-53 Xn; NR: 48/22-63-50/53S: (2-)36/37-46-60-61  
613-205-00-0 propiconazole (ISO);(±)-1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole 262-104-4 60207-90-1 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)36/37-46-60-61  
613-206-00-6 fenamidone (ISO);(S)-5-methyl-2-methylthio-5-phenyl-3-phenylamino-3,5-dihydroimidazol-4-one — 161326-34-7 N; R50-53 NR: 50/53S: 60-61  
613-208-00-7 imazamox (ISO);(RS)-2-(4-isopropyl-4-methyl-5-oxo-2-imidazolin-2-yl)-5-methoxymethylnicotinic acid — 114311-32-9 N; R50-53 NR: 50/53S: 60-61  
613-209-00-2 cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride 417-430-3 63645-17-0 T; R25Xn; R48/22R43N; R51-53 T; NR: 25-43-48/22-51/53S: (1/2-)22-36/37-45-61  
613-210-00-8 2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane 417-650-1 88128-57-8 Xn; R48/22R52-53 XnR: 48/22-52/53S: (2-)23-25-36-61  
613-211-00-3 N-methyl-4-(p-formylstyryl)pyridinium methylsulfate 418-240-3 74401-04-0 R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
613-212-00-9 4-[4-(2-ethylhexyloxy)phenyl](1,4-thiazinane-1,1-dioxide) 418-320-8 133467-41-1 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)22-60-61  
613-213-00-4 cis-1-benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline 416-040-0 120807-02-5 R52-53 R: 52/53S: 61  
613-214-00-X N,N-di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2-quinolylidene)-1,3-dioxoindan-5-carboxamide 416-260-7 147613-95-4 R53 R: 53S: 61  
613-215-00-5 2-chloromethyl-3,4-dimethoxypyridinium chloride 416-440-5 72830-09-2 Xn; R21/22-48/22Xi; R38-41R43N; R51-53 Xn; NR: 21/22-38-41-43-48/22-51/53S: (2-)26-36/37/39-61  
613-216-00-0 6-tert-butyl-7-(6-diethylamino-2-methyl-3-pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2-c][1,2,4]triazole 416-490-8 162208-01-7 N; R50-53 NR: 50/53S: 60-61  
613-217-00-6 4-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionyloxy]-1-[2-[3-(3,5-di-tert-butyl-4-hydrophenyl)propionyloxy]ethyl]-2,2,6,6-tetramethylpiperidine 416-770-1 73754-27-5 R53 R: 53S: 61  
613-218-00-1 6-hydroxyindole 417-020-4 2380-86-1 Xn; R22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-51/53S: (2-)24-26-37/39-61  
613-219-00-7 7a-ethyl-3,5-bis(1-methylethyl)-2,3,4,5-tetrahydrooxazolo[3,4-c]-2,3,4,5-tetrahydrooxazole 417-140-7 79185-77-6 Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
613-220-00-2 trans-(4S,6S)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-ol, 7,7-dioxide 417-290-3 147086-81-5 Xn; R22 XnR: 22S: (2-)36  
613-221-00-8 2-chloro-5-methyl-pyridine 418-050-0 18368-64-4 Xn; R21/22Xi; R38R52-53 XnR: 21/22-38-52/53S: (2-)23-25-36/37-61  
613-222-00-3 4-(1-oxo-2-propenyl)-morpholine 418-140-1 5117-12-4 Xn; R22-48/22Xi; R41R43 XnR: 22-41-43-48/22S: (2-)23-26-36/37/39  
613-223-00-9 N-isopropyl-3-(4-fluorophenyl)-1H-indole 418-790-4 93957-49-4 R53 R: 53S: 61  
613-224-00-4 2,5-dimercaptomethyl-1,4-dithiane 419-770-8 136122-15-1 Xn; R22C; R34R43N; R50-53 C; NR: 22-34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
613-225-00-X reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine;2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. 421-290-9 — Xn; R48/22R53 XnR: 48/22-53S: (2-)22-36-61  
613-226-00-5 1-(2-(ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2-methylphenylazo)benzoylamino)-phenylazo)-3-methylphenyl)amino)ethyl)-pyridinium dichloride 420-950-3 163831-67-2 Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
613-227-00-0 (±)-[(R*,R*) and (R*,S*)]-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 419-600-2 99199-90-3 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-28-36/37-61  
613-228-00-6 (±)-(R*,S*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran 419-630-6 793669-26-8 N; R51-53 NR: 51/53S: 24-61  
613-230-00-7 florasulam (ISO);2',6',8-trifluoro-5-methoxy-5-triazolo[1,5-c];pyrimidine-2-sulfonanilide — 145701-23-1 N; R50-53 NR: 50/53S: 60-61  
613-233-00-3 4,4'-(oxy-(bismethylene))-bis-1,3-dioxolane 423-230-7 56552-15-9 Xi; R41 XiR: 41S: (2-)26-39  
614-001-00-4 nicotine (ISO);3-(N-methyl-2-pyrrolidinyl)pyridine 200-193-3 54-11-5 T+; R27T; R25N; R51-53 T+; NR: 25-27-51/53S: (1/2-)36/37-45-61  
614-002-00-X salts of nicotine — — T+; R26/27/28N; R51-53 T+; NR: 26/27/28-51/53S: (1/2-)13-28-45-61  A
614-003-00-5 strychnine 200-319-7 57-24-9 T+; R27/28N; R50-53 T+; NR: 27/28-50/53S: (1/2-)36/37-45-60-61  
614-004-00-0 salts of strychnine — — T+; R26/28N; R50-53 T+; NR: 26/28-50/53S: (1/2-)13-28-45-60-61  A
614-005-00-6 colchicine 200-598-5 64-86-8 T+; R26/28 T+R: 26/28S: (1/2-)13-45  
614-006-00-1 brucine;2,3-dimethoxystrychnine 206-614-7 357-57-3 T+; R26/28R52-53 T+R: 26/28-52/53S: (1/2-)13-45-61  
614-007-00-7 brucine sulphate; [1]brucine nitrate; [2]Strychnidin-10-one, 2,3-dimethoxy-, mono[(R)-1-methylheptyl 1,2-benzenedicarboxylate]; [3]Strychnidin-10-one, 2,3-dimethoxy-, compd. with (S)mono(1-methylheptyl)-1,2-benzenedicarboxylate (1:1) [4] 225-432-9 [1]227-317-9 [2]269-439-5 [3]269-710-8 [4] 4845-99-2 [1]5786-97-0 [2]68239-26-9 [3]68310-42-9 [4] T+; R26/28R52-53 T+R: 26/28-52/53S: (1/2-)13-45-61  A
614-008-00-2 aconitine 206-121-7 302-27-2 T+; R26/28 T+R: 26/28S: (1/2-)24-45  
614-009-00-8 salts of aconitine — — T+; R26/28 T+R: 26/28S: (1/2-)24-45  A
614-010-00-3 atropine 200-104-8 51-55-8 T+; R26/28 T+R: 26/28S: (1/2-)25-45  
614-011-00-9 salts of atropine — — T+; R26/28 T+R: 26/28S: (1/2-)25-45  A
614-012-00-4 hyoscyamine 202-933-0 101-31-5 T+; R26/28 T+R: 26/28S: (1/2-)24-45  
614-013-00-X salts of hyoscyamine — — T+; R26/28 T+R: 26/28S: (1/2-)24-45  A
614-014-00-5 hyoscine 200-090-3 51-34-3 T+; R26/27/28 T+R: 26/27/28S: (1/2-)25-45  
614-015-00-0 salts of hyoscine — — T+; R26/27/28 T+R: 26/27/28S: (1/2-)25-45  A
614-016-00-6 pilocarpine 202-128-4 92-13-7 T+; R26/28 T+R: 26/28S: (1/2-)25-45  
614-017-00-1 salts of pilocarpine — — T+; R26/28 T+R: 26/28S: (1/2-)25-45  A
614-018-00-7 papaverine 200-397-2 58-74-2 Xn; R22 XnR: 22S: (2-)22  
614-019-00-2 salts of papaverine — — Xn; R22 XnR: 22S: (2-)22  A
614-020-00-8 physostigmine 200-332-8 57-47-6 T+; R26/28 T+R: 26/28S: (1/2-)25-45  
614-021-00-3 salts of physostigmine — — T+; R26/28 T+R: 26/28S: (1/2-)25-45  A
614-022-00-9 digitoxin 200-760-5 71-63-6 T; R23/25R33 TR: 23/25-33S: (1/2-)45  
614-023-00-4 ephedrine 206-080-5 299-42-3 Xn; R22 XnR: 22S: (2-)22-25  
614-024-00-X salts of ephedrine — — Xn; R22 XnR: 22S: (2-)22-25  A
614-025-00-5 ouabain 211-139-3 630-60-4 T; R23/25R33 TR: 23/25-33S: (1/2-)45  
614-026-00-0 strophantin-K 234-239-9 11005-63-3 T; R23/25R33 TR: 23/25-33S: (1/2-)45  
614-027-00-6 bufa-4,20,22-trienolide, 6-(acetyloxy)-3-(β-D-glucopyranosyloxy)-8,14-dihydroxy-, (3β, 6β)-;red squill;scilliroside 208-077-4 507-60-8 T+; R28 T+R: 28S: (1/2-)36/37-45  
614-028-00-1 reaction mass of: 2-ethylhexyl mono-D-glucopyranoside;2-ethylhexyl di-D-glucopyranoside 414-420-0 — Xi; R41 XiR: 41S: (2-)26-39  
614-029-00-7 constitutional isomers of penta-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;constitutional isomers of hexa-O-allyl-β-D-fructofuranosyl-α-D-glucopyranoside;constitutional isomers of hepta-O-allyl-β-D-fructofuransoyl-α-D-glucopyranoside 419-640-0 68784-14-5 Xn; R22 XnR: 22S: (2-)  
615-001-00-7 methyl isocyanate 210-866-3 624-83-9 F+; R12 ⊗Repr. Cat. 3; R63T+; R26T; R24/25R42/43Xi; R37/38-41 F+; T+R: 12-24/25-26-37/38-41-42/43-63S: (1/2-)26-27/28-36/37/39-45-63  
615-002-00-2 methyl isothiocyanate 209-132-5 556-61-6 T; R23/25C; R34R43N; R50-53 T; NR: 23/25-34-43-50/53S: (1/2-)36/37-38-45-60-61  
615-003-00-8 thiocyanic acid 207-337-4 463-56-9 Xn; R20/21/22R32R52-53 XnR: 20/21/22-32-52/53S: (2-)13-61  
615-004-00-3 salts of thiocyanic acid — — Xn; R20/21/22R32R52-53 XnR: 20/21/22-32-52/53S: (2-)13-61  A
615-005-00-9 4,4'-methylenediphenyl diisocyanate;diphenylmethane-4,4'-diisocyanate; [1]2,2'-methylenediphenyl diisocyanate;diphenylmethane-2,2'-diisocyanate; [2]o-(p-isocyanatobenzyl)phenyl isocyanate;diphenylmethane-2,4'-diisocyanate; [3]methylenediphenyl diisocyanate [4] 202-966-0 [1]219-799-4 [2]227-534-9 [3]247-714-0 [4] 101-68-8 [1]2536-05-2 [2]5873-54-1 [3]26447-40-5 [4] Xn; R20Xi; R36/37/38R42/43 XnR: 20-36/37/38-42/43S: (1/2-)23-36/37-45 Xi; R36/37/38: C ≥ 5 %R42: C ≥ 0,1 % C2
615-006-00-4 2-methyl-m-phenylene diisocyanate;toluene-2,4-di-isocyanate; [1]4-methyl-m-phenylene diisocyanate;toluene-2,6-di-isocyanate; [2]m-tolylidene diisocyanate;toluene-diisocyanate [3] 202-039-0 [1]209-544-5 [2]247-722-4 [3] 91-08-7 [1]584-84-9 [2]26471-62-5 [3] Carc. Cat. 3; R40T+; R26Xi; R36/37/38R42/43R52-53 T+R: 26-36/37/38-40-42/43-52/53S: (1/2-)23-36/37-45-61 R42: C ≥ 0,1 % C2
615-007-00-X 1,5-naphthylene diisocyanate 221-641-4 3173-72-6 Xn; R20Xi; R36/37/38R42R52-53 XnR: 20-36/37/38-42-52/53S: (2-)26-28-38-45-61  
615-008-00-5 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate;isophorone di-isocyanate 223-861-6 4098-71-9 T; R23Xi; R36/37/38R42/43N; R51-53 T; NR: 23-36/37/38-42/43-51/53S: (1/2-)26-28-38-45-61 T; R23: C ≥ 2 %Xn; R20: 0,5 % ≤ C < 2 %R42/43: C ≥ 0,5 % 2
615-009-00-0 4,4'-methylenedi(cyclohexyl isocyanate);dicyclohexylmethane-4,4'-di-isocyanate 225-863-2 5124-30-1 T; R23Xi; R36/37/38R42/43 TR: 23-36/37/38-42/43S: (1/2-)26-28-38-45 T; R23: C ≥ 2 %Xn; R20: 0,5 % ≤ C < 2 %R42/43: C ≥ 0,5 % 2
615-010-00-6 2,2,4-trimethylhexamethylene-1,6-di-isocyanate; [1]2,4,4-trimethylhexamethylene-1,6-di-isocyanate [2] 241-001-8 [1]239-714-4 [2] 16938-22-0 [1]15646-96-5 [2] T; R23Xi; R36/37/38R42 TR: 23-36/37/38-42S: (1/2-)26-28-38-45 T; R23: C ≥ 2 %Xn; R20: 0,5 % ≤ C < 2 %R42: C ≥ 0,5 % C2
615-011-00-1 hexamethylene-di-isocyanate 212-485-8 822-06-0 T; R23Xi; R36/37/38R42/43 TR: 23-36/37/38-42/43S: (1/2-)26-28-38-45 T; R23: C ≥ 2 %Xn; R20: 0,5 % ≤ C < 2 %R42/43: C ≥ 0,5 % 2
615-012-00-7 4-isocyanatosulphonyltoluene;tosyl isocyanate 223-810-8 4083-64-1 R14Xi; R36/37/38R42 XnR: 14-36/37/38-42S: (2-)26-28-30 Xi; R36/37/38: C ≥ 5 % 
615-013-00-2 cyanamide;carbanonitril 206-992-3 420-04-2 T; R25Xn; R21Xi; R36/38R43 TR: 21-25-36/38-43S: (1/2-)3-22-36/37-45  
615-014-00-8 tris(1-dodecyl-3-methyl-2-phenylbenzimidazolium)hexacyanoferrate — 7276-58-6 Xn; R22 XnR: 22S: (2-)24  
615-015-00-3 1,7,7-trimethylbicyclo(2,2,1)hept-2-yl thiocyanatoacetate;isobornyl thiocyanoacetate 204-081-5 115-31-1 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)24/25-60-61  
615-016-00-9 potassium cyanate 209-676-3 590-28-3 Xn; R22 XnR: 22S: (2-)24/25  
615-017-00-4 calcium cyanamide 205-861-8 156-62-7 Xn; R22Xi; R37-41 XnR: 22-37-41S: (2-)22-26-36/37/39  
615-018-00-X 2-(2-butoxyethoxy)ethyl thiocyanate 203-985-7 112-56-1 R10T; R24/25 TR: 10-24/25S: (1/2-)13-36/37-45  
615-019-00-5 dicyclohexylcarbodiimide 208-704-1 538-75-0 T; R24Xn; R22Xi; R41R43 TR: 22-24-41-43S: (1/2-)24-26-37/39-45  
615-020-00-0 methylene dithiocyanate 228-652-3 6317-18-6 T+; R26T; R25C; R34R43N; R50 T+; NR: 25-26-34-43-50S: (1/2-)26-28-36/37/39-45-61  
615-021-00-6 1,3,5-tris(oxiranylmethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione;TGIC 219-514-3 2451-62-9 Muta. Cat. 2; R46T; R23/25Xn; R48/22Xi; R41R43R52-53 TR: 46-23/25-41-43-48/22-52/53S: 53-45-61  E
615-022-00-1 methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate 410-550-7 79277-18-2 E; R2 ⊗R14Xn; R48/22R42/43 E; XnR: 2-14-42/43-48/22S: (2-)22-30-35-36/37  
615-023-00-7 2-(isocyanatosulfonylmethyl)benzoic acid methyl ester;(alt.):methyl 2-(isocyanatosulfonylmethyl)benzoate 410-900-9 83056-32-0 R10R14Muta. Cat. 3; R68Xn; R20-48/22Xi; R41R42 XnR: 10-14-20-41-42-48/22-68S: (2-)23-26-36/37/39  
615-024-00-2 2-phenylethylisocyanate 413-080-0 1943-82-4 T; R23Xn; R22C; R35R42/43N; R51-53 T; C; NR: 22-23-35-42/43-51/53S: (1/2-)23-26-36/37/39-43-45-61  
615-025-00-8 4,4'-ethylidenediphenyl dicyanate 405-740-1 47073-92-7 Xn; R20/22-48/22Xi; R41N; R50-53 Xn; NR: 20/22-41-48/22-50/53S: (2-)26-36/37/39-60-61  
615-026-00-3 4,4'-methylenebis(2,6-dimethylphenyl cyanate) 405-790-4 101657-77-6 R43R52-53 XiR: 43-52/53S: (2-)22-24-37-61  
615-028-00-4 ethyl 2-(isocyanatosulfonyl)benzoate 410-220-2 77375-79-2 E; R2 ⊗R14Xn; R22-48/22Xi; R41R42/43 E; XnR: 2-14-22-41-42/43-48/22S: (2-)8-23-26-30-35-36/37/39  
615-029-00-X 2,5-bis-isocyanatomethyl-bicyclo[2.2.1]heptane 411-280-2 — T+; R26Xn; R22C; R34R42/43R52-53 T+R: 22-26-34-42/43-52/53S: (1/2-)23-26-28-36/37/39-45-61  
615-030-00-5 alkali salts, alkali earth salts and other salts of thiocyanic acid not mentioned elsewhere in this Annex — — Xn; R20/21/22R32R52-53 XnR: 20/21/22-32-52/53S: (2-)13-61  A
615-031-00-0 thallium salt of thiocyanic acid 222-571-7 3535-84-0 Xn; R20/21/22R32N; R51-53 Xn; NR: 20/21/22-32-51/53S: (2-)13-61  A
615-032-00-6 metal salts of thiocyanic acid not mentioned elsewhere in this Annex — — Xn; R20/21/22R32N; R50-53 Xn; NR: 20/21/22-32-50/53S: (2-)13-60-61  A
616-001-00-X N,N-dimethylformamide;dimethyl formamide 200-679-5 68-12-2 Repr. Cat. 2; R61Xn; R20/21Xi; R36 TR: 61-20/21-36S: 53-45  E
616-002-00-5 2-fluoroacetamide 211-363-1 640-19-7 T+; R28T; R24 T+R: 24-28S: (1/2-)36/37-45  
616-003-00-0 acrylamide;prop-2-enamide 201-173-7 79-06-1 Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 3; R62T; R25-48/23/24/25Xn; R20/21Xi; R36/38R43 TR: 45-46-20/21-25-36/38-43-48/23/24/25-62S: 53-45  DE
616-004-00-6 allidochlor (ISO);N,N-diallylchloroacetamide 202-270-7 93-71-0 Xn; R21/22Xi; R36/38N; R51-53 Xn; NR: 21/22-36/38-51/53S: (2-)26-28-36/37/39-61  
616-005-00-1 chlorthiamid (ISO);2,6-dichloro (thiobenzamide) 217-637-7 1918-13-4 Xn; R22 XnR: 22S: (2-)36  
616-006-00-7 dichlofluanid (ISO);N-dichlorofluoromethylthio-N',N'-dimethyl-N-phenylsulphamide 214-118-7 1085-98-9 Xn; R20Xi; R36R43N; R50-53 Xn; NR: 20-36-43-50/53S: (2-)24-37-60-61  
616-007-00-2 diphenamid (ISO);N,N-dimethyl-2,2-diphenylacetamide 213-482-4 957-51-7 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
616-008-00-8 propachlor (ISO);2-chloro-N-isopropylacetanilide;α-chloro-N-isopropylacetanilide 217-638-2 1918-16-7 Xn; R22Xi; R36R43N; R50-53 Xn; NR: 22-36-43-50/53S: (2-)24-37-60-61  
616-009-00-3 propanil (ISO);3',4'-dichloropropionanilide 211-914-6 709-98-8 Xn; R22N; R50 Xn; NR: 22-50S: (2-)22-61  
616-010-00-9 tosylchloramide sodium 204-854-7 127-65-1 Xn; R22R31C; R34R42 CR: 22-31-34-42S: (1/2-)7-22-26-36/37/39-45  
616-011-00-4 N,N-dimethylacetamide 204-826-4 127-19-5 Repr. Cat. 2; R61Xn; R20/21 TR: 61-20/21S: 53-45 Repr. Cat. 2; R61: C ≥ 5 % E
616-012-00-X N-(dichlorofluoromethylthio)phthalimide;N-(fluorodichloromethylthio)phthalimide 211-952-3 719-96-0 Xi; R38 XiR: 38S: (2-)28  
616-013-00-5 butyraldehyde oxime 203-792-8 110-69-0 T; R24Xn; R22Xi; R36 TR: 22-24-36S: (1/2-)23-36-45  
616-014-00-0 2-butanone oxime;ethyl methyl ketoxime;ethyl methyl ketone oxime 202-496-6 96-29-7 Carc. Cat. 3; R40Xn; R21Xi; R41R43 XnR: 21-40-41-43S: (2-)13-23-26-36/37/39  
616-015-00-6 alachlor (ISO);2-chloro-2',6'-diethyl-N-(methoxymethyl)acetanilide 240-110-8 15972-60-8 Carc. Cat. 3; R40Xn; R22R43N; R50-53 Xn; NR: 22-40-43-50/53S: (2-)36/37-46-60-61 N; R50-53: C ≥ 0,2,5 %N; R51-53: 0,025 % ≤ C < 0,25 %R52-53: 0,0025 % ≤ C < 0,025 % 
616-016-00-1 1-(3,4-dichlorophenylimino) thiosemicarbazide — 5836-73-7 T+; R28 T+R: 28S: (1/2-)22-36/37-45  
616-017-00-7 cartap hydrochloride 239-309-2 15263-52-2 Xn; R21/22N; R50-53 Xn; NR: 21/22-50/53S: (2-)36/37-60-61  
616-018-00-2 N,N-diethyl-m-toluamide;deet 205-149-7 134-62-3 Xn; R22Xi; R36/38R52-53 XnR: 22-36/38-52/53S: (2-)61  
616-019-00-8 perfluidone (ISO);1,1,1-trifluoro-N-(4-phenylsulphonyl-o-tolyl)methanesulphonamide 253-718-3 37924-13-3 Xn; R22Xi; R36 XnR: 22-36S: (2-)  
616-020-00-3 tebuthiuron (ISO);1-(5-tert-butyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 251-793-7 34014-18-1 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)37-60-61  
616-021-00-9 thiazafluron (ISO);1,3-dimethyl-1-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)urea 246-901-4 25366-23-8 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)60-61  
616-022-00-4 acetamide 200-473-5 60-35-5 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  
616-023-00-X N-hexadecyl(or octadecyl)-N-hexadecyl(or octadecyl)benzamide 401-980-6 — Xi; R38R43 XiR: 38-43S: (2-)24-37  
616-024-00-5 2-(4,4-dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4-dimethyl-3-oxovaleranilide 402-260-4 54942-74-4 R53 R: 53S: 61  
616-025-00-0 valinamide 402-840-7 20108-78-5 Repr. Cat. 3; R62Xi; R36R43 XnR: 36-43-62S: (2-)26-36/37  
616-026-00-6 thioacetamide 200-541-4 62-55-5 Carc. Cat. 2; R45Xn; R22Xi; R36/38R52-53 TR: 45-22-36/38-52/53S: 53-45-61  E
616-027-00-1 tris(2-(2-hydroxyethoxy)ethyl)ammonium 3-acetoacetamido-4-methoxybenzenesulfonate 403-760-5 — R43 XiR: 43S: (2-)24-37  
616-028-00-7 N-(4-(3-(4-cyanophenyl)ureido)-3-hydroxyphenyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 403-790-9 108673-51-4 R43R53 XiR: 43-53S: (2-)24-37-61  
616-029-00-2 N,N'-ethylenebis(vinylsulfonylacetamide) 404-790-1 66710-66-5 Xi; R41R43 XiR: 41-43S: (2-)24-26-37/39  
616-030-00-8 ethidimuron (ISO);1-(5-ethylsulphonyl-1,3,4-thiadiazol-2-yl)-1,3-dimethylurea 250-010-6 30043-49-3 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
616-031-00-3 dimethachlor (ISO);2-chloro-N-(2,6-dimethylphenyl)-N-(2-methoxyethyl)acetamide 256-625-6 50563-36-5 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61  
616-032-00-9 diflufenican (ISO);N-(2,4-difluorophenyl)-2-[3-(trifluoromethyl)phenoxy]-3-pyridinecarboxamide — 83164-33-4 R52-53 R: 52/53S: 61  
616-033-00-4 cyprofuram (ISO);N-(3-chlorophenyl)-N-(tetrahydro-2-oxo-3-furyl)cyclopropanecarboxamide 274-050-9 69581-33-5 T; R25Xn; R21N; R50-53 T; NR: 21-25-50/53S: (1/2-)36/37-60-61  
616-034-00-X pyracarbolid (ISO);3,4-dihydro-6-methyl-2H-pyran-5-carboxanilide 246-419-4 24691-76-7 R52-53 R: 52/53S: 61  
616-035-00-5 cymoxanil (ISO);2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide 261-043-0 57966-95-7 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)36/37-60-61  
616-036-00-0 2-chloracetamide 201-174-2 79-07-2 Repr. Cat. 3; R62T; R25R43 TR: 25-43-62S: (1/2-)22-36/37-45 R43: C ≥ 0,1 % 
616-037-00-6 acetochlor (ISO);2-chloro-N-(ethoxymethyl)-N-(2-ethyl-6-methylphenyl)acetamide 251-899-3 34256-82-1 Xn; R20Xi; R37/38R43N; R50-53 Xn; NR: 20-37/38-43-50/53S: (2-)36/37-60-61  
616-038-00-1 (4-aminophenyl)-N-methylmethylensulfonamide hydrochloride 406-010-5 88918-84-7 Xi; R41R43N; R51-53 Xi; NR: 41-43-51/53S: (2-)24-26-37/39-61  
616-039-00-7 3',5'-dichloro-4'-ethyl-2'-hydroxypalmitanilide 406-200-8 117827-06-2 R43 XiR: 43S: (2-)24-37  
616-040-00-2 potassium N-(4-toluenesulfonyl)-4-toluenesulfonamide 406-650-5 97888-41-0 Xi; R41 XiR: 41S: (2-)26-39  
616-041-00-8 3',5'-dichloro-2-(2,4-di-tert-pentylphenoxy)-4'-ethyl-2'-hydroxyhexananilide 406-840-8 101664-25-9 R53 R: 53S: 61  
616-042-00-3 N-(2-(6-ethyl-7-(4-methylphenoxy)-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)propyl)-2-octadecyloxybenzamide 407-070-5 142859-67-4 R43R53 XiR: 43-53S: (2-)22-24-37-61  
616-043-00-9 isoxaben (ISO);N-[3-(1-ethyl-1-methylpropyl)-1,2-oxazol-5-yl]-2,6-dimethoxybenzamide 407-190-8 82558-50-7 R53 R: 53S: 61  
616-044-00-4 N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-2-(3-pentadecylphenoxy)-butanamide 402-510-2 — N; R51-53 NR: 51/53S: 61  
616-045-00-X 2'-(4-chloro-3-cyano-5-formyl-2-thienylazo)-5'-diethylamino-2-methoxyacetanilide 405-190-2 122371-93-1 R43R53 XiR: 43-53S: 2-22-24-37-61  
616-046-00-5 N-(2-(6-chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4-yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide 406-390-2 — N; R50-53 NR: 50/53S: 60-61  
616-047-00-0 reaction mass of: 2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C16)alkylacetamide;2,2',2'',2'''-(ethylenedinitrilotetrakis-N,N-di(C18)alkylacetamide 406-640-0 — R43 XiR: 43S: (2-)24-37  
616-048-00-6 3'-trifluoromethylisobutyranilide 406-740-4 1939-27-1 Xn; R48/22N; R51-53 Xn; NR: 48/22-51/53S: (2-)22-36-61  
616-049-00-1 2-(2,4-bis(1,1-dimethylethyl)phenoxy)-N-(3,5-dichloro-4-ethyl-2-hydroxyphenyl)-hexanamide 408-150-2 99141-89-6 R53 R: 53S: 61  
616-050-00-7 lufenuron (ISO);N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide 410-690-9 103055-07-8 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
616-051-00-2 reaction mass of: 2,4 -bis(N'-(4-methylphenyl)-ureido)-toluene;2,6 -bis(N'-(4-methylphenyl)-ureido)-toluene 411-070-0 — R53 R: 53S: 61  
616-052-00-8 formamide 200-842-0 75-12-7 Repr. Cat. 2; R61 TR: 61S: 53-45  
616-053-00-3 N-methylacetamide 201-182-6 79-16-3 Repr. Cat. 2; R61 TR: 61S: 53-45  
616-054-00-9 iprodione (ISO);3-(3,5-dichlorophenyl)-2,4-dioxo-N-isopropylimidazolidine-1-carboxamide 253-178-9 36734-19-7 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-60-61  
616-055-00-4 propyzamide (ISO);3,5-dichloro-N-(1,1-dimethylprop-2-ynyl)benzamide 245-951-4 23950-58-5 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-60-61  
616-056-00-X N-methylformamide 204-624-6 123-39-7 Repr. Cat. 2; R61Xn; R21 TR: 61-21S: 53-45  E
616-057-00-5 reaction mass of: N-[3-hydroxy-2-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;N-[2,3-bis-(2-methylacryloylaminomethoxy)propoxymethyl]-2-methylacrylamide;methacrylamide;2-methyl-N-(2-methylacryloylaminomethoxymethyl)-acrylamide;N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide 412-790-8 — Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R48/22 TR: 45-48/22S: 53-45  E
616-058-00-0 1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene 412-570-1 119462-56-5 Xn; R48/22Xi; R41R43N; R50-53 Xn; NR: 41-43-48/22-50/53S: (2-)26-36/37/39-60-61  
616-059-00-6 4-((4-(diethylamino)-2-ethoxyphenyl)imino)-1,4-dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide 412-650-6 121487-83-0 R53 R: 53S: 61  
616-060-00-1 Condensation product of: 3-(7-carboxyhept-1-yl)-6-hexyl-4-cyclohexene-1,2-dicarboxylic acid with polyamines (primarily amino-ethyl-piperazine and triethylenetetramine) 413-770-1 — Xn; R22C; R34R43N; R50-53 C; NR: 22-34-43-50/53S: (1/2-)26-36/37/39-45-60-61  
616-061-00-7 N,N'-1,6-hexanediylbis(N-(2,2,6,6-tetramethyl-piperidin-4-yl)-formamide 413-610-0 124172-53-8 Xi; R36R52-53 XiR: 36-52/53S: (2-)26-61  
616-062-00-2 N-[3-[(2-acetyloxy)ethyl](phenyl-methyl)amino]-4-methoxyphenylacetamide 411-590-8 70693-57-1 C; R34R52-53 CR: 34-52/53S: (1/2-)26-36/37/39-45-61  
616-063-00-8 3-dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)-2,5-pyrrolidindione 411-920-0 106917-30-0 T; R23Xn; R22-48/22C; R35N; R50-53 T; C; NR: 22-23-35-48/22-50/53S: (1/2-)26-28-36/37/39-45-60-61  
616-064-00-3 N-tert-butyl-3-methylpicolinamide 406-720-5 32998-95-1 R52-53 R: 52/53S: 61  
616-065-00-9 3'-(3-acetyl-4-hydroxyphenyl)-1,1-diethylurea 411-970-3 79881-89-3 Xn; R22-48/22 XnR: 22-48/22S: (2-)22-36  
616-066-00-4 5,6,12,13-tetrachloroanthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone 405-100-1 115662-06-1 Repr. Cat. 3; R62 XnR: 62S: (2-)22-36/37  
616-067-00-X dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxovaleramido)-4-chlorobenzoate 407-300-4 92683-20-0 R53 R: 53S: 61  
616-068-00-5 potassium 4-(11-methacrylamidoundecanamido)benzenesulfonate 406-500-9 174393-75-0 R43 XiR: 43S: (2-)22-24-37  
616-069-00-0 1-hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3-dodecyloxypropyl)-2-naphthoamide 406-210-2 110560-22-0 R53 R: 53S: 61  
616-070-00-6 reaction mass of: 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea;3-cyclohexyl-1-(4-(4-(3-octadecylureido)benzyl)phenyl)urea;3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-530-2 — R53 R: 53S: 22-61  
616-071-00-1 reaction mass of: bis(N-cyclohexyl-N'-phenyleneureido)methylene;bis(N-octadecyl-N'-phenyleneureido)methylene;bis(N-dicyclohexyl-N'-phenyleneureido)methylene (1:2:1) 406-550-1 — R43R53 XiR: 43-53S: (2-)22-24-37-61  
616-072-00-7 1-(2-deoxy-5-O-trityl-β-D-threopentofuranosyl)thymine 407-120-6 55612-11-8 R53 R: 53S: 61  
616-073-00-2 4'-ethoxy-2-benzimidazoleanilide 407-600-5 120187-29-3 Muta. Cat. 3; R68R53 XnR: 68-53S: (2-)22-36/37-61  
616-074-00-8 N-butyl-2-(4-morpholinylcarbonyl)benzamide 407-730-2 104958-67-0 Xi; R36R43R52-53 XiR: 36-43-52/53S: (2-)24-26-37-61  
616-075-00-3 D,L-(N,N-diethyl-2-hydroxy-2-phenylacetamide) 408-120-9 65197-96-8 Xn; R22Xi; R41 XnR: 22-41S: (2-)26-39-46  
616-076-00-9 tebufenozide (ISO);N-tert-butyl-N'-(4-ethylbenzoyl)-3,5-dimethylbenzohydrazide 412-850-3 112410-23-8 N; R51-53 NR: 51/53S: 61  
616-077-00-4 reaction mass of: 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfonic acid;potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-d'e'f']diisoquinolin-2-ylethansulfate 411-310-4 — Xi; R41 XiR: 41S: (2-)26-39  
616-078-00-X 2-[2,4-bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5-methyl-phenyl)hexanamide 411-330-3 104541-33-5 R53 R: 53S: 61  
616-079-00-5 1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate 411-700-4 140921-24-0 R43 XiR: 43S: (2-)24-37  
616-080-00-0 4-(2-((3-ethyl-4-methyl-2-oxo-pyrrolin-1-yl)carboxamido)ethyl)benzenesulfonamide) 411-850-0 119018-29-0 R52-53 R: 52/53S: 61  
616-081-00-6 5-bromo-8-naphtholactam 413-480-5 24856-00-6 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)22-24-37-60-61  
616-082-00-1 N-(5-chloro-3-((4-(diethylamino)-2-methylphenyl)imino-4-methyl-6-oxo-1,4-cyclohexadien-1-yl)benzamide 413-200-1 129604-78-0 R43 XiR: 43S: (2-)24-37  
616-083-00-7 [2-[(4-nitrophenyl)amino]ethyl]urea 410-700-1 27080-42-8 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
616-084-00-2 2,4-bis[N'-(4-methylphenyl)ureido]toluene 411-790-5 — N; R50-53 NR: 50/53S: 60-61  
616-085-00-8 3-(2,4-dichlorophenyl)-6-fluoro-quinazoline-2,4(1H,3H)-dione 412-190-6 168900-02-5 N; R50-53 NR: 50/53S: 60-61  
616-086-00-3 2-acetylamino-6-chloro-4-[(4-diethylamino)2-methylphenyl-imino]-5-methyl-1-oxo-2,5-cyclohexadiene 412-250-1 102387-48-4 R53 R: 53S: 61  
616-087-00-9 reaction mass of: 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecane-1,16-diyl-prop-2-enoate;7,7,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan-1,16-diyl-prop-2-enoate 412-260-6 52658-19-2 Xi; R36R43N; R51-53 Xi; NR: 36-43-51/53S: (2-)26-36/37-61  
616-088-00-4 2-aminosulfonyl-N,N-dimethylnicotinamide 413-440-7 112006-75-4 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
616-089-00-X 5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidine)-3-fluoro-2-hydroxymethyltetrahydrofuran 415-360-8 41107-56-6 Muta. Cat. 3; R68 XnR: 68S: (2-)22-36/37  
616-090-00-5 1-(1,4-benzodioxan-2-ylcarbonyl)piperazine hydrochloride 415-660-9 70918-74-0 T; R23/24/25Xn; R48/22N; R51-53 T; NR: 23/24/25-48/22-51/53S: 53-45-61  
616-091-00-0 1,3,5-tris-[(2S and 2R)-2,3-epoxypropyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione 423-400-0 59653-74-6 Muta. Cat. 2; R46T; R23Xn; R22-48/22Xi; R41R43 TR: 46-22-23-41-43-48/22S: 53-45  E
616-092-00-6 Polymeric reaction product of bicyclo[2.2.1]hepta-2,5-diene, ethene, 1,4-hexadiene, 1-propene with N,N-di-2-propenylformamide 404-035-6 — R43R53 XiR: 43-53S: (2-)24-37-61  
616-093-00-1 Reaction products of: aniline-terephthalaldehyde-o-toluidine condensate with maleic anhydride 406-620-1 129217-90-9 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
616-094-00-7 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-phenylene)diurea 406-370-3 58890-25-8 R43R53 XiR: 43-53S: (2-)24-37-61  
616-095-00-2 3,3'-dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea 406-690-3 43136-14-7 R53 R: 53S: 61  
616-096-00-8 N-(3-hexadecyloxy-2-hydroxyprop-1-yl)-N-(2-hydroxyethyl)palmitamide 408-110-4 110483-07-3 R53 R: 53S: 61  
616-097-00-3 N,N'-1,4-phenylenebis(2-((2-methoxy-4-nitrophenyl)azo)-3-oxobutanamide 411-840-6 83372-55-8 R53 R: 53S: 61  
616-098-00-9 1-[4-chloro-3-((2,2,3,3,3-pentafluoropropoxy)methyl)phenyl]-5-phenyl-1H-1,2,4-triazole-3-carboxamide 411-750-7 119126-15-7 N; R51-53 NR: 51/53S: 61  
616-099-00-4 2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3-tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide 414-170-2 135937-20-1 R53 R: 53S: 61  
616-100-00-8 1,3-dimethyl-1,3-bis(trimethylsilyl)urea 414-180-7 10218-17-4 Xn; R22Xi; R38 XnR: 22-38S: (2-)36/37  
616-101-00-3 (S)-N-tert-butyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide 414-600-9 149182-72-9 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
616-102-00-9 reaction mass of: α-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl]-ω-[3-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyloxy]-poly-(oxyethylene-co-oxypropylene);1,2-(or 1,3-)bis[α-(3-mercaptopropanoxycarbonylamino)methylphenylaminocarbonyl)-ω-oxy-poly(oxyethylene-co-oxypropylene)]-3-(or 2-)propanol;1,2,3-tris[α-(3-mercaptopropanoxycarbonyl-amino)methylphenylaminocarbonyl)-ω-oxy-poly-(oxyethylene-co-oxypropylene)]propane] 415-870-0 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)36/37-61  
616-103-00-4 (S,S)-trans-4-(acetylamino)-5,6-dihydro-6-methyl-7,7-dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide 415-030-3 120298-38-6 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
616-104-00-X benalaxyl (ISO);methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)-DL-alaninate 275-728-7 71626-11-4 N; R50-53 NR: 50/53S: 60-61  
616-105-00-5 chlorotoluron (ISO);3-(3-chloro-p-tolyl)-1,1-dimethylurea 239-592-2 15545-48-9 Carc. Cat. 3; R40Repr. Cat. 3; R63N; R50-53 Xn; NR: 40-63-50/53S: (2-)26-36/37-46-60-61  
616-106-00-0 phenmedipham (ISO);methyl 3-(3-methylcarbaniloyloxy)carbanilate 237-199-0 13684-63-4 N; R50-53 NR: 50/53S: 60-61  
616-108-00-1 iodosulfuron-methyl-sodium;sodium ({[5-iodo-2-(methoxycarbonyl)phenyl]sulfonyl}carbamoyl)(4-methoxy-6-methyl-1,3,5-triazin-2-yl)azanide — 144550-36-7 N; R50-53 NR: 50/53S: 60-61  
616-109-00-7 sulfosulfuron (ISO);1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea — 141776-32-1 N; R50-53 NR: 50/53S: 60-61  
616-110-00-2 cyclanilide (ISO);1-(2,4-dichloroanilinocarbonyl)cyclopropanecarboxylic acid 419-150-7 113136-77-9 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
616-111-00-8 fenhexamid (ISO);N-(2,3-dichlor-4-hydroxyphenyl)-1-methylcyclohexancarboxamid 422-530-5 126833-17-8 N; R51-53 NR: 51/53S: 61  
616-112-00-3 oxasulfuron (ISO);oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate — 144651-06-9 Xn; R48/22N; R50-53 Xn; NR: 48/22-50/53S: (2-)46-60-61  
616-113-00-9 desmedipham (ISO);ethyl 3-phenylcarbamoyloxyphenylcarbamate 237-198-5 13684-56-5 N; R50-53 NR: 50/53S: 60-61 N; R50-53: C ≥ 2,5 %N; R51-53: 0,25 % ≤ C < 2,5 %R52-53: 0,025 % ≤ C < 0,25 % 
616-114-00-4 dodecanamide, N,N'-(9,9',10,10'-tetrahydro-9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis- 418-010-2 136897-58-0 R53 R: 53S: 22-61  
616-115-00-X N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide 416-150-9 136450-06-1 R53 R: 53S: 61  
616-116-00-5 N-(4-dimethylaminopyridinium)-3-methoxy-4-(1-methyl-5-nitroindol-3-ylmethyl)-N-(o-tolylsulfonyl)benzamidate 416-790-9 143052-96-4 R53 R: 53S: 61  
616-117-00-0 N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide 416-860-9 777891-21-1 Repr. Cat. 3; R62R43N; R50-53 Xn; NR: 43-62-50/53S: (2-)22-36/37-60-61  
616-118-00-6 N-(2',6'-dimethylphenyl)-2-piperidinecarboxamide hydrochloride 417-950-0 65797-42-4 Xn; R22R52-53 XnR: 22-52/53S: (2-)22-61  
616-119-00-1 2-(1-butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1-sulfonyl))propionylamino)-phenyl)-pentanamide 418-060-5 118020-93-2 R53 R: 53S: 61  
616-120-00-7 reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide;N-(3-dimethylamino-2-methyl-phenyl)-benzamide;N-(3-dimethylamino-3-methyl-phenyl)-benzamide 420-600-1 — Xn; R48/22N; R51-53 Xn; NR: 48/22-51/53S: (2-)36/37-61  
616-121-00-2 2,4-dihydroxy-N-(2-methoxyphenyl)benzamide 419-090-1 129205-19-2 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
616-123-00-3 N-[3-[[4-(diethylamino)-2-methylphenyl]imino]-6-oxo-1,4-cyclohexadienyl]acetamide 414-740-0 96141-86-5 N; R50-53 NR: 50/53S: 60-61  
616-124-00-9 lithium bis(trifluoromethylsulfonyl)imide 415-300-0 90076-65-6 T; R24/25C; R34R52-53 TR: 24/25-34-52/53S: (1/2-)22-26-36/37/39-45-61  
616-125-00-4 3-cyano-N-(1,1-dimethylethyl)androsta-3,5-diene-17-β-carboxamide 415-730-9 151338-11-3 N; R50-53 NR: 50/53S: 60-61  
616-127-00-5 reaction mass of: N,N'-Ethane-1,2-diylbis(decanamide);12-Hydroxy-N-[2-[1-oxydecyl)amino]ethyl]octadecanamide;N,N'-Ethane-1,2-diylbis(12-hydroxyoctadecanamide) 430-050-2 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
616-128-00-0 N-(2-(1-allyl-4,5-dicyanoimidazol-2-ylazo)-5-(dipropylamino)phenyl)-acetamide 417-530-7 123590-00-1 R53 R: 53S: 61  
616-129-00-6 N,N'-bis(2,2,6,6-tetramethyl-4-piperidyl)isophthalamide 419-710-0 42774-15-2 Xn; R22Xi; R36 XnR: 22-36S: (2-)22-25-26  
616-130-00-1 N-(3-(2-(4,4-dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-octadecanamide 421-780-2 150919-56-5 R53 R: 53S: 61  
616-132-00-2 N-[4-(4-cyano-2-furfurylidene-2,5-dihydro-5-oxo-3-furyl)phenyl]butane-1-sulfonamide 423-250-6 130016-98-7 N; R50-53 NR: 50/53S: 60-61  
616-133-00-8 N-cyclohexyl-S,S-dioxobenzo[b]tiophene-2-carboxamide 423-990-1 149118-66-1 Xn; R22Xi; R41N; R50-53 Xn; NR: 22-41-50/53S: (2-)22-26-39-60-61  
616-134-00-3 3,3'-bis(dioctyloxyphosphinothioylthio)-N,N'-oxybis(methylene)dipropionamide 401-820-5 793710-14-2 R52-53 R: 52/53S: 61  
616-135-00-9 (3S,4aS,8aS)-2-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-N-tert-butyldecahydroisoquinoline-3-carboxamide 430-230-0 136522-17-3 Xn; R22R52-53 XnR: 22-52/53S: (2-)22-61  
616-142-00-7 1,3-Bis(vinylsulfonylacetamido)propane 428-350-3 93629-90-4 Muta. Cat. 3; R68Xi; R41R43R52-53 XnR: 41-43-68-52/53S: (2-)22-26-36/37/39-61  
616-143-00-2 N,N'-dihexadecyl-N,N'-bis(2-hydroxyethyl)propanediamide 422-560-9 149591-38-8 Repr. Cat. 3; R62Xi; R36R53 XnR: 36-62-53S: (2-)26-36/37-61  
617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 O; R7F; R11 O; FR: 7-11S: (2-)3/7-14-16-36/37/39  
617-002-00-8 α,α-dimethylbenzyl hydroperoxide;cumene hydroperoxide 201-254-7 80-15-9 O; R7T; R23Xn; R21/22-48/20/22C; R34N; R51-53 O; T; NR: 7-21/22-23-34-48/20/22-51/53S: (1/2-)3/7-14-36/37/39-45-50-61 C; R34: C ≥ 10 %Xi; R37/38-41: 3 % ≤ C < 10 %Xi; R36/37: 1 % ≤ C < 3 % 
617-003-00-3 dilauroyl peroxide 203-326-3 105-74-8 O; R7 OR: 7S: (2-)3/7-14-36/37/39  
617-004-00-9 1,2,3,4-tetrahydro-1-naphthyl hydroperoxide 212-230-0 771-29-9 O; R7Xn; R22C; R34N; R50-53 O; C; NR: 7-22-34-50/53S: (1/2-)3/7-14-26-36/37/39-45-60-61 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
617-006-00-X bis(α,α-dimethylbenzyl) peroxide 201-279-3 80-43-3 O; R7Xi; R36/38N; R51-53 O; Xi; NR: 7-36/38-51/53S: (2-)3/7-14-36/37/39-61  
617-007-00-5 tert-butyl α,α-dimethylbenzyl peroxide 222-389-8 3457-61-2 O; R7Xi; R38N; R51-53 O; Xi; NR: 7-38-51/53S: (2-)3/7-14-36/37/39-61  
617-008-00-0 dibenzoyl peroxide;benzoyl peroxide 202-327-6 94-36-0 E; R2 ⊗Xi; R36R43 E; XiR: 2-36-43S: (2-)3/7-14-36/37/39  
617-010-00-1 1-hydroperoxycyclohexyl 1-hydroxycyclohexyl peroxide; [1]1,1'-dioxybiscyclohexan-1-ol; [2]cyclohexylidene hydroperoxide; [3]cyclohexanone, peroxide [4] 201-091-1 [1]219-306-2 [2]220-279-4 [3]235-527-7 [4] 78-18-2 [1]2407-94-5 [2]2699-11-8 [3]12262-58-7 [4] E; R2 ⊗Xn; R22C; R34 E; CR: 2-22-34S: (1/2-)3/7-14-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % C
617-012-00-2 8-p-menthyl hydroperoxide;p-menthane hydroperoxide 201-281-4 80-47-7 O; R7C; R34Xn; R20 O; CR: 7-20-34S: (1/2-)3/7-14-36/37/39-45 C; R34: C ≥ 10 %Xi; R36/37/38: 5 % ≤ C < 10 % 
617-013-00-8 O,O-tert-butyl O-docosyl monoperoxyoxalate 404-300-6 116753-76-5 O; R7N; R50-53 O; NR: 7-50/53S: (2-)7-14-36/37/39-47-60-61  
617-014-00-3 6-(nonylamino)-6-oxo-peroxyhexanoic acid 406-680-9 104788-63-8 O; R7Xi; R41R43N; R50 O; Xi; NR: 7-41-43-50S: (2-)3/7-14-26-36/37/39-61  
617-015-00-9 bis(4-methylbenzoyl)peroxide 407-950-9 895-85-2 E; R2O; R7N; R50-53 E; NR: 2-7-50/53S: (2-)7-14-36/37/39-47-60-61  
617-016-00-4 3-hydroxy-1,1-dimethylbutyl 2-ethyl-2-methylheptaneperoxoate 413-910-1 — O; R7R10Xi; R38N; R50-53 O; Xi; NR: 7-10-38-50/53S: (2-)7/47-14-36/37/39-60-61  
617-017-00-X reaction mass of: 2,2'-bis(tert-pentylperoxy)-p-diisopropylbenzene;2,2'-bis(tert-pentylperoxy)-m-diisopropylbenzene 412-140-3 32144-25-5 O; R7 ⊗R53 OR: 7-53S: (2-)3/7-14-36/37/39-61  
617-018-00-5 reaction mass of: 1-methyl-1-(3-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 63 % by weight;1-methyl-1-(4-(1-methylethyl)phenyl)ethyl-1-methyl-1-phenylethylperoxide, 31 % by weight 410-840-3 71566-50-2 O; R7N; R51-53 O; NR: 7-51/53S: (2-)3/7-14-36/37/39-61  
617-019-00-0 6-(phthalimido)peroxyhexanoic acid 410-850-8 128275-31-0 O; R7Xi; R41N; R50 O; Xi; NR: 7-41-50S: (2-)3/7-14-26-36/37/39-61  
617-020-00-6 1,3-di(prop-2,2-diyl)benzene bis(neodecanoylperoxide) 420-060-5 117663-11-3 R10O; R7N; R51-53 O; NR: 7-10-51/53S: (2-)7-14-36/37/39-47-61  
647-001-00-8 glucosidase, β- 232-589-7 9001-22-3 R42 XnR: 42S: (2-)22-24-36/37  
647-002-00-3 cellulase 232-734-4 9012-54-8 R42 XnR: 42S: (2-)22-24-36/37  
647-003-00-9 cellobiohydrolase, exo- 253-465-9 37329-65-0 R42 XnR: 42S: (2-)22-24-36/37  
647-004-00-4 cellulases with the exception of those specified elsewhere in this Annex — — R42 XnR: 42S: (2-)22-24-36/37  A
647-005-00-X bromelain, juice 232-572-4 9001-00-7 Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-006-00-5 ficin 232-599-1 9001-33-6 Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-007-00-0 papain 232-627-2 9001-73-4 Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-008-00-6 pepsin A 232-629-3 9001-75-6 Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-009-00-1 rennin 232-645-0 9001-98-3 Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-010-00-7 trypsin 232-650-8 9002-07-7 Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-011-00-2 chymotrypsin 232-671-2 9004-07-3 Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-012-00-8 subtilisin 232-752-2 9014-01-1 Xi; R37/38-41R42 XnR: 37/38-41-42S: (2-)22-24-26-36/37/39  
647-013-00-3 proteinase, microbial neutral 232-966-6 9068-59-1 Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-014-00-9 proteases with the exception of those specified elsewhere in this Annex — — Xi; R36/37/38R42 XnR: 36/37/38-42S: (2-)22-24-26-36/37  
647-015-00-4 amylase, α- 232-565-6 9000-90-2 R42 XnR: 42S: (2-)22-24-36/37  
647-016-00-X amylases with the exception of those specified elsewhere in this Annex — — R42 XnR: 42S: (2-)22-24-36/37  
648-001-00-0 Distillates (coal tar), benzole fraction;Light Oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists of hydrocarbons having carbon numbers primarily in the range of C4 to C10 and distilling in the approximate range of 80 oC to 160 oC (175 oF to 320 oF).] 283-482-7 84650-02-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-002-00-6 Tar oils, brown-coal;Light Oil;[The distillate from lignite tar boiling in the range of approximately 80 oC to 250 oC (176 oF to 482 oF). Composed primarily of aliphatic and aromatic hydrocarbons and monobasic phenols.] 302-674-4 94114-40-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-003-00-1 Benzol forerunnings (coal);Light Oil Redistillate, low boiling;[The distillate from coke oven light oil having an approximate distillation range below 100 oC (212 oF). Composed primarily of C4 to C6 aliphatic hydrocarbons.] 266-023-5 65996-88-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-004-00-7 Distillates (coal tar), benzole fraction, BTX-rich;Light Oil Redistillate, low boiling;[A residue from the distillation of crude benzole to remove benzole fronts. Composed primarily of benzene, toluene and xylenes boiling in the range of approximately 75 oC to 200 oC (167 oF to 392 oF).] 309-984-9 101896-26-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-005-00-2 Aromatic hydrocarbons, C6-10, C8-rich;Light Oil Redistillate, low boiling 292-697-5 90989-41-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-006-00-8 Solvent naphtha (coal), light;Light Oil Redistillate, low boiling 287-498-5 85536-17-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-007-00-3 Solvent naphtha (coal), xylene-styrene cut;Light Oil Redistillate, intermediate boiling 287-502-5 85536-20-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-008-00-9 Solvent naphtha (coal), coumarone-styrene contg.;Light Oil Redistillate, intermediate boiling 287-500-4 85536-19-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-009-00-4 Naphtha (coal), distn. residues;Light Oil Redistillate, high boiling;[The residue remaining from the distillation of recovered naphtha. Composed primarily of naphthalene and condensation products of indene and styrene.] 292-636-2 90641-12-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-010-00-X Aromatic hydrocarbons, C8;Light Oil Redistillate, high boiling 292-694-9 90989-38-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-012-00-0 Aromatic hydrocarbons, C8-9, hydrocarbon resin polymn. by-product;Light Oil Redistillate, high boiling;[A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120 oC to 215 oC (248 oF to 419 oF).] 295-281-1 91995-20-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-013-00-6 Aromatic hydrocarbons, C9-12, benzene distn.;Light Oil Redistillate, high boiling 295-551-9 92062-36-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-014-00-1 Extract residues (coal), benzole fraction alk., acid ext.;Light Oil Extract Residues, low boiling;[The redistillate from the distillate, freed of tar acids and tar bases, from bituminous coal high temperature tar boiling in the approximate range of 90 oC to 160 oC (194 oF to 320 oF). It consists predominantly of benzene, toluene and xylenes.] 295-323-9 91995-61-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-015-00-7 Extract residues (coal tar), benzole fraction alk., acid ext.;Light Oil Extract Residues, low boiling;[A complex combination of hydrocarbons obtained by the redistillation of the distillate of high temperature coal tar (tar acid and tar base free). It consists predominantly of unsubstituted and substituted mononuclear aromatic hydrocarbons boiling in the range of 85 oC-195 oC (185 oF-383 oF).] 309-868-8 101316-63-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-016-00-2 Extract residues (coal), benzole fraction acid;Light Oil Extract Residues, low boiling;[An acid sludge by-product of the sulphuric acid refining of crude high temperature coal. Composed primarily of sulfuric acid and organic compounds.] 298-725-2 93821-38-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-017-00-8 Extract residues (coal), light oil alk., distn. overheads;Light Oil Extract Residues, low boiling;[The first fraction from the distillation of aromatic hydrocarbons, coumarone, naphthalene and indene rich prefactionator bottoms or washed carbolic oil boiling substantially below 145 oC (293 oF). Composed primarily of C7 and C8 aliphatic and aromatic hydrocarbons.] 292-625-2 90641-02-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-018-00-3 Extract residues (coal), light oil alk., acid ext., indene fraction;Light Oil Extract Residues, intermediate boiling 309-867-2 101316-62-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-019-00-9 Extract residues (coal), light oil alk., indene naphtha fraction;Light Oil Extract Residues, high boiling;[The distillate from aromatic hydrocarbons, coumarone, naphthalene and indene rich prefractionator bottoms or washed carbolic oils, having an approximate boiling range of 155 oC to 180 oC (311 oF to 356 oF). Composed primarily of indene, indan and trimethylbenzenes.] 292-626-8 90641-03-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-020-00-4 Solvent naphtha (coal);Light Oil Extract Residues, high boiling;[The distillate from either high temperature coal tar, coke oven light oil, or coal tar oil alkaline extract residue having an approximate distillation range of 130 oC to 210 oC (266 oF to 410 oF) Composed primarily of indene and other polycyclic ring systems containing a single aromatic ring. May contain phenolic compounds and aromatic nitrogen bases.] 266-013-0 65996-79-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-021-00-X Distillates (coal tar), light oils, neutral fraction;Light Oil Extract Residues, high boiling;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of alkyl-substituted one ring aromatic hydrocarbons boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF). May also include unsaturated hydrocarbons such as indene and coumarone.] 309-971-8 101794-90-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-022-00-5 Distillates (coal tar), light oils, acid exts.;Light Oil Extract Residues, high boiling;[This oil is a complex mixture of aromatic hydrocarbons, primarily indene, naphthalene, coumarone, phenol, and o-, m- and p-cresol and boiling in the range of 140 oC to 215 oC (284 oF to 419 oF).] 292-609-5 90640-87-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-023-00-0 Distillates (coal tar), light oils;Carbolic Oil;[A complex combination of hydrocarbons obtained by distillation of coal tar. It consists of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills at the approximate range of 150 oC to 210 oC (302 oF to 410 oF).] 283-483-2 84650-03-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-024-00-6 Tar oils, coal;Carbolic Oil;[The distillate from high temperature coal tar having an approximate distillation range of 130 oC to 250 oC (266 oF to 410 oF). Composed primarily of naphthalene, alkylnaphthalenes, phenolic compounds, and aromatic nitrogen bases.] 266-016-7 65996-82-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-026-00-7 Extract residues (coal), light oil alk., acid ext.;Carbolic Oil Extract Residue;[The oil resulting from the acid washing of alkali-washed carbolic oil to remove the minor amounts of basic compounds (tar bases). Composed primarily of indene, indan and alkylbenzenes.] 292-624-7 90641-01-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-027-00-2 Extract residues (coal), tar oil alk.;Carbolic Oil Extract Residue;[The residue obtained from coal tar oil by an alkaline wash such as aqueous sodium hydroxide after the removal of crude coal tar acids. Composed primarily of naphthalenes and aromatic nitrogen bases.] 266-021-4 65996-87-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-028-00-8 Extract oils (coal), light oil;Acid Extract;[The aqueous extract produced by an acidic wash of alkali-washed carbolic oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-622-6 90640-99-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-029-00-3 Pyridine, alkyl derivs.;Crude Tar Bases;[The complex combination of polyalkylated pyridines derived from coal tar distillation or as high-boiling distillates approximately above 150 oC (302 oF) from the reaction of ammonia with acetaldehyde, formaldehyde or paraformaldehyde.] 269-929-9 68391-11-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-030-00-9 Tar bases, coal, picoline fraction;Distillate Bases;[Pyridine bases boiling in the range of approximately 125 oC to 160 oC (257 oF 320 oF) obtained by distillation of neutralized acid extract of the base-containing tar fraction obtained by the distillation of bituminous coal tars. Composed chiefly of lutidines and picolines.] 295-548-2 92062-33-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-031-00-4 Tar bases, coal, lutidine fraction;Distillate Bases 293-766-2 91082-52-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-032-00-X Extract oils (coal), tar base, collidine fraction;Distillate Bases;[The extract produced by the acidic extraction of bases from crude coal tar aromatic oils, neutralization, and distillation of the bases. Composed primarily of collidines, aniline, toluidines, lutidines, xylidines.] 273-077-3 68937-63-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-033-00-5 Tar bases, coal, collidine fraction;Distillate Bases;[The distillation fraction boiling in the range of approximately 181 oC to 186 oC (356 oF to 367 oF) from the crude bases obtained from the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of bituminous coal tar. It contains chiefly aniline and collidines.] 295-543-5 92062-28-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-034-00-0 Tar bases, coal, aniline fraction;Distillate Bases;[The distillation fraction boiling in the range of approximately 180 oC to 200 oC (356 oF to 392 oF) from the crude bases obtained by dephenolating and debasing the carbolated oil from the distillation of coal tar. It contains chiefly aniline, collidines, lutidines and toluidines.] 295-541-4 92062-27-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-035-00-6 Tar bases, coal, toluidine fraction;Distillate Bases 293-767-8 91082-53-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-036-00-1 Distillates (petroleum), alkene-alkyne manuf. pyrolysis oil, mixed with high-temp. coal tar, indene fraction;Redistillates;[A complex combination of hydrocarbons obtained as a redistillate from the fractional distillation of bituminous coal high temperature tar and residual oils that are obtained by the pyrolytic production of alkenes and alkynes from petroleum products or natural gas. It consists predominantly of indene and boils in a range of approximately 160 oC to 190 oC (320 oF to 374 oF).] 295-292-1 91995-31-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-037-00-7 Distillates (coal), coal tar-residual pyrolysis oils, naphthalene oils;Redistillates;[The redistillate obtained from the fractional distillation of bituminous coal high temperature tar and pyrolysis residual oils and boiling in the range of approximately 190 oC to 270 oC (374 oF to 518 oF). Composed primarily of substituted dinuclear aromatics.] 295-295-8 91995-35-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-038-00-2 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oil, redistillate;Redistillates;[The redistillate from the fractional distillation of dephenolated and debased methylnaphthalene oil obtained from bituminous coal high temperature tar and pyrolysis residual oils boiling in the approximate range of 220 oC to 230 oC (428 oF to 446 oF). It consists predominantly of unsubstituted and substituted dinuclear aromatic hydrocarbons.] 295-329-1 91995-66-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-039-00-8 Extract oils (coal), coal tar-residual pyrolysis oils, naphthalene oils;Redistillates;[A neutral oil obtained by debasing and dephenolating the oil obtained from the distillation of high temperature tar and pyrolysis residuel oils which has a boiling range of 225 oC to 255 oC (437 oF to 491 oF). Composed primarily of substituted dinuclear aromatic hydrocarbons.] 310-170-0 122070-79-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-040-00-3 Extract oils (coal), coal tar residual pyrolysis oils, naphthalene oil, distn. residues;Redistillates;[Residue from the distillation of dephenolated and debased methylnaphthalene oil (from bituminous coal tar and pyrolysis residual oils) with a boiling range of 240 oC to 260 oC (464 oF to 500 oF). Composed primarily of substituted dinuclear aromatic and heterocyclic hydrocarbons.] 310-171-6 122070-80-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-041-00-9 Absorption oils, bicyclo arom. and heterocyclic hydrocarbon fraction;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained as a redistillate from the distillation of wash oil. It consists predominantly of 2-ringed aromatic and heterocyclic hydrocarbons boiling in the range of approximately 260 oC to 290 oC (500 oF to 554 oF).] 309-851-5 101316-45-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-042-00-4 Distillates (coal tar), upper, fluorene-rich;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists af aromatic and polycyclic hydrocarbons primarily fluorene and some acenaphthene.] 284-900-0 84989-11-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-043-00-X Creosote oil, acenaphthene fraction, acenaphthene-free;Wash Oil Redistillate;[The oil remaining after removal by a crystallization process of acenaphthene from acenaphthene oil from coal tar. Composed primarily of naphthalene and alkylnaphthalenes.] 292-606-9 90640-85-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-044-00-5 Distillates (coal tar), heavy oils;Heavy Anthracene Oil;[Distillate from the fractional distillation of coal tar of bituminous coal, with boiling range of 240 oC to 400 oC (464 oF to 752 oF). Composed primarily of tri- and polynuclear hydrocarbons and heterocyclic compounds.] 292-607-4 90640-86-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-045-00-0 Distillates (coal tar), upper;Heavy Anthracene Oil;[The distillate from coal tar having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of three to four membered condensed ring aromatic hydrocarbons and other hydrocarbons.] 266-026-1 65996-91-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-046-00-6 Anthracene oil, acid ext.;Anthracene Oil Extract Residue;[A complex combination of hydrocarbons from the base-freed fraction obtained from the distillation of coal tar and boiling in the range of approximately 325 oC to 365 oC (617 oF to 689 oF). It contains predominantly anthracene and phenanthrene and their alkyl derivatives.] 295-274-3 91995-14-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-047-00-1 Distillates (coal tar);Heavy Anthracene Oil;[The distillate from coal tar having an approximate distillation range of 100 oC to 450 oC (212 oF to 842 oF). Composed primarily of two to four membered condensed ring aromatic hydrocarbons, phenolic compounds, and aromatic nitrogen bases.] 266-027-7 65996-92-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-048-00-7 Distillates (coal tar), pitch, heavy oils;Heavy Anthracene Oil;[The distillate from the distillation of the pitch obtained from bituminous high temperature tar. Composed primarily of tri- and polynuclear aromatic hydrocarbons and boiling in the range of approximately 300 oC to 470 oC (572 oF to 878 oF). The product may also contain heteroatoms.] 295-312-9 91995-51-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-049-00-2 Distillates (coal tar), pitch;Heavy Anthracene Oil;[The oil obtained from condensation of the vapors from the heat treatment of pitch. Composed primarily of two- to four-ring aromatic compounds boiling in the range of 200 oC to greater than 400 oC (392 oF to greater than 752 oF).] 309-855-7 101316-49-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-050-00-8 Distillates (coal tar), heavy oils, pyrene fraction;Heavy Anthracene Oil Redistillate;[The redistillate obtained from the fractional distillation of pitch distillate boiling in the range of approximately 350 oC to 400 oC (662 oF to 752 oF). Consists predominantly of tri- and polynuclear aromatics and heterocyclic hydrocarbons.] 295-304-5 91995-42-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-051-00-3 Distillates (coal tar), pitch, pyrene fraction;Heavy Anthracene Oil Redistillate;[The redistillate obtained from the fractional distillation of pitch distillate and boiling in the range of approximately 380 oC to 410 oC (7160 to 770 oF). Composed primarily of tri- and polynuclear aromatic hydrocarbons and heterocyclic compounds.] 295-313-4 91995-52-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-052-00-9 Paraffin waxes (coal), brown-coal high-temp. tar, carbon-treated;Coal Tar Extract;[A complet combination of hydrocarbons obtained by the treatment of lignite carbonization tar with activated carbon for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-296-6 97926-76-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-053-00-4 Paraffin waxes (coal), brown-coal high-temp tar, clay-treated;Coal Tar Extract;[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with bentonite for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-297-1 97926-77-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-054-00-X Pitch;Pitch 263-072-4 61789-60-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-055-00-5 Pitch, coal tar, high-temp.;Pitch;[The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 266-028-2 65996-93-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-056-00-0 Pitch, coal tar, high-temp., heat-treated;Pitch;[The heat treated residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 80 oC to 180 oC (176 oF to 356 oF). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.] 310-162-7 121575-60-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-057-00-6 Pitch, coal tar, high-temp., secondary;Pitch Redistillate;[The residue obtained during the distillation of high boiling fractions from bituminous coal high temperature tar and/or pitch coke oil, with a softening point of 140 oC to 170 oC (284 oF to 392 oF) according to DIN 52025. Composed primarily of tri- and polynuclear aromatic compounds which also contain heteroatoms.] 302-650-3 94114-13-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-058-00-1 Residues (coal tar), pitch distn.;Pitch Redistillate;[Residue from the fractional distillation of pitch distillate boiling in the range of approximately 400 oC to 470 oC (752 oF to 846 oF). Composed primarily of polynuclear aromatic hydrocarbons, and heterocyclic compounds.] 295-507-9 92061-94-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-059-00-7 Tar, coal, high-temp., distn. and storage residues;Coal Tar Solids Residue;[Coke- and ash-containing solid residues that separate on distillation and thermal treatment of bituminous coal high temperature tar in distillation installations and storage vessels. Consists predominantly of carbon and contains a small quantity of hetero compounds as well as ash components.] 295-535-1 92062-20-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-060-00-2 Tar, coal, storage residues;Coal Tar Solids Residue;[The deposit removed from crude coal tar storages. Composed primarily of coal tar and carbonaceous particulate matter.] 293-764-1 91082-50-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-061-00-8 Tar, coal, high-temp., residues;Coal Tar Solids Residue;[Solids formed during the coking of bituminous coal to produce crude bituminous coal high temperature tar. Composed primarily of coke and coal particles, highly aromatized compounds and mineral substances.] 309-726-5 100684-51-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-062-00-3 Tar, coal, high-temp., high-solids;Coal Tar Solids Residue;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons with a high solid content of coal-type materials.] 273-615-7 68990-61-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-063-00-9 Waste solids, coal-tar pitch coking;Coal Tar Solids Residue;[The combination of wastes formed by the coking of bituminous coal tar pitch. It consists predominantly of carbon.] 295-549-8 92062-34-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-064-00-4 Extract residues (coal), brown;Coal Tar Extract;[The residue from extraction of dried coal.] 294-285-0 91697-23-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-065-00-X Paraffin waxes (coal), brown-coal-high-temp. tar;Coal Tar Extract;[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-454-1 92045-71-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-066-00-5 Paraffin waxes (coal), brown-coal-high-temp. tar, hydrotreated;Coal Tar Extract;[A complex combination of hydrocarbons obtained from lignite carbonization tar by solvent crystallisation (solvent deoiling), by sweating or an adducting process treated with hydrogen in the presence of a catalyst. It consists predominantly of straight and branched chain saturated hydrocarbons having carbon numbers predominantly greater than C12.] 295-455-7 92045-72-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-067-00-0 Paraffin waxes (coal), brown-coal high-temp tar, silicic acid-treated;Coal Tar Extract;[A complex combination of hydrocarbons obtained by the treatment of lignite carbonization tar with silicic acid for removal of trace constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-298-7 97926-78-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-068-00-6 Tar, coal, low-temp., distn. residues;Tar Oil, intermediate boiling;[Residues from fractional distillation of low temperature coal tar to remove oils that boil in a range up to approximately 300 oC (572 oF). Composed primarily of aromatic compounds.] 309-887-1 101316-85-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-069-00-1 Pitch, coal tar, low-temp;Pitch Residue;[A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40 oC to 180 oC (104 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-651-4 90669-57-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-070-00-7 Pitch, coal tar, low-temp., oxidized;Pitch Residue, oxidised;[The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70 oC to 180 oC (158 oF to 356 oF). Composed primarily of a complex mixture of hydrocarbons.] 292-654-0 90669-59-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-071-00-2 Pitch, coal tar, low-temp., heat-treated;Pitch Residue, oxidised;Pitch Residue, heat-treated;[A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50 oC to 140 oC (122 oF to 284 oF). Composed primarily of a complex mixture of aromatic compounds.] 292-653-5 90669-58-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-072-00-8 Distillates (coal-petroleum), condensed-ring arom;Distillates;[The distillate from a mixture of coal and tar and aromatic petroleum streams having an approximate distillation range of 220 oC to 450 oC (428 oF to 842 oF). Composed primarily of 3- to 4-membered condensed ring aromatic hydrocarbons.] 269-159-3 68188-48-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-073-00-3 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene-polypropylene pyrolysis-derived;Pyrolysis Products;[A complex combination hydrocarbons obtained from mixed coal tar pitch-polyethylene-polypropylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-956-6 101794-74-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-074-00-9 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polyethylene pyrolysis-derived;Pyrolysis Products;[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polyethylene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-957-1 101794-75-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-075-00-4 Aromatic hydrocarbons, C20-28, polycyclic, mixed coal-tar pitch-polystyrene pyrolysis-derived;Pyrolysis Products;[A complex combination of hydrocarbons obtained from mixed coal tar pitch-polystyrene pyrolysis. Composed primarily of polycyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C28 and having a softening point of 100 oC to 220 oC (212 oF to 428 oF) according to DIN 52025.] 309-958-7 101794-76-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-076-00-X Pitch, coal tar-petroleum;Pitch Residues;[The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40 oC to 180 oC (140 oF to 356 oF). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.] 269-109-0 68187-57-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-077-00-5 Phenanthrene, distn. residues;Heavy Anthracene Oil Redistillate;[Residue from the distillation of crude phenanthrene boiling in the approximate range of 340 oC to 420 oC (644 oF to 788 oF). It consists predominantly of phenanthrene, anthracene and carbazole.] 310-169-5 122070-78-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-078-00-0 Distillates (coal tar), upper, fluorene-free;Wash Oil Redistillate;[A complex combination of hydrocarbons obtained by the crystallization of tar oil. It consists of aromatic polycyclic hydrocarbons, primarily diphenyl, dibenzofuran and acenaphthene.] 284-899-7 84989-10-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-079-00-6 Anthracene oil;Anthracene oil;[A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300 oC ot 400 oC (572 oF to 752 oF). Composed primarily of phenanthrene, anthracene and carbazole.] 292-602-7 90640-80-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-080-00-1 Residues (coal tar), creosote oil distn.;Wash Oil Redistillate;[The residue from the fractional distillation of wash oil boiling in the approximate range of 270 oC to 330 oC (518 oF to 626 oF). It consists predominantly of dinuclear aromatic and heterocyclic hydrocarbons.] 295-506-3 92061-93-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-081-00-7 Tar, coal;Coal tar;[The by-product from the destructive distillation of coal. Almost black semisolid. A complex combination of aromatic hydro-carbons, phenolic compounds, nitrogen bases and thiophene.] 232-361-7 8007-45-2 Carc. Cat. 1; R45 TR: 45S: 53-45  H
648-082-00-2 Tar, coal, high-temp.;Coal tar;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of a complex mixture of condensed ring aromatic hydrocarbons. May contain minor amounts of phenolic compounds and aromatic nitrogen bases.] 266-024-0 65996-89-6 Carc. Cat. 1; R45 TR: 45S: 53-45  H
648-083-00-8 Tar, coal, low-temp.;Coal oil;[The condensation product obtained by cooling, to approximately ambient temperature, the gas evolved in low temperature (less than 700 oC (1292 oF)) destructive distillation of coal. A black viscous liquid denser than water. Composed primarily of condensed ring aromatic hydrocarbons, phenolic compounds, aromatic nitrogen bases, and their alkyl derivatives.] 266-025-6 65996-90-9 Carc. Cat. 1; R45 TR: 45S: 53-45  H
648-084-00-3 Distillates (coal), coke-oven light oil, naphthalene cut;Naphthalene Oil;[The complex combination of hydrocarbons obtained from prefractionation (continuous distillation) of coke oven light oil. It consists predominantly of naphthalene, coumarone and indene and boils above 148 oC (298 oF).] 285-076-5 85029-51-2 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-085-00-9 Distillates (coal tar), naphthalene oils;Naphthalene Oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic and other hydrocarbons, phenolic compounds and aromatic nitrogen compounds and distills in the approximate range of 200 oC to 250 oC (392 oF to 482 oF).] 283-484-8 84650-04-4 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-086-00-4 Distillates (coal tar), naphthalene oils, naphthalene-low;Naphthalene Oil Redistillate;[A complex combination of hydrocarbons obtained by crystallization of naphthalene oil. Composed primarily of naphthalene, alkyl naphthalenes and phenolic compounds.] 284-898-1 84989-09-3 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-087-00-X Distillates (coal tar), naphthalene oil crystn. mother liquor;Naphthalene Oil Redistillate;[A complex combination of organic compounds obtained as a filtrate from the crystallization of the naphthalene fraction from coal tar and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Contains chiefly naphthalene, thionaphthene and alkylnaphthalenes.] 295-310-8 91995-49-2 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-088-00-5 Extract residues (coal), naphthalene oil, alk.;Naphthalene Oil Extract Residue; [A complex combination of hydrocarbons obtained from the alkali washing of naphthalene oil to remove phenolic compounds (tar acids). It is composed of naphthalene and alkyl naphthalenes.] 310-166-9 121620-47-1 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-089-00-0 Extract residues (coal), naphthalene oil, alk., naphthalene-low;Naphthalene Oil Extract Residue;[A complex combination of hydrocarbons remaining after the removal of naphthalene from alkali-washed naphthalene oil by a crystallization process. It is composed primarily of naphthalene and alkyl naphthalenes.] 310-167-4 121620-48-2 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-090-00-6 Distillates (coal tar), naphthalene oils, naphthalene-free, alk. exts.;Naphthalene Oil Extract Residue;[The oil remaining after the removal of phenolic compounds (tar acids) from drained naphthalene oil by an alkali wash. Composed primarily of naphthalene and alkyl naphthalenes.] 292-612-1 90640-90-7 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-091-00-1 Extract residues (coal), naphthalene oil alk., distn. overheads;Naphthalene Oil Extract Residue;[The distillation from alkali-washed naphthalene oil having an approximate distillation range of 180 oC to 220 oC (356 oF to 428 oF). Composed primarily of naphthalene, alkylbenzenes, indene and indan.] 292-627-3 90641-04-6 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-092-00-7 Distillates (coal tar), naphthalene oils, methylnaphthalene fraction;Methylnaphthalene Oil;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of substituted two ring aromatic hydrocarbons and aromatic nitrogen bases boiling in the range of approximately 225 oC to 255 oC (437 oF to 491 oF).] 309-985-4 101896-27-9 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-093-00-2 Distillates (coal tar), naphthalene oils, indole-methylnaphthalene fraction;Methylnaphthalene Oil;[A distillate from the fractional distillation of high temperature coal tar. Composed primarily of indole and methylnaphthalene boiling in the range of approximately 235 oC to 255 oC (455 oF to 491 oF).] 309-972-3 101794-91-6 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-094-00-8 Distillates (coal tar), naphthalene oils, acid exts.;Methylnaphthalene Oil Extract Residue;[A complex combination of hydrocarbons obtained by debasing the methylnaphthalene fraction obtained by the distillation of coal tar and boiling in the range of approximately 230 oC to 255 oC (446 oF to 491 oF). Contains chiefly 1(2)-methylnaphthalene, naphthalene, dimethylnaphthalene and biphenyl.] 295-309-2 91995-48-1 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-095-00-3 Extract residues (coal), naphthalene oil alk., distn. residues;Methylnaphthalene Oil Extract Residue;[The residue from the distillation of alkali-washed naphthalene oil having an approximate distillation range of 220 oC to 300 oC (428 oF to 572 oF). Composed primarily of naphthalene, alkylnaphthalenes and aromatic nitrogen bases.] 292-628-9 90641-05-7 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-096-00-9 Extract oils (coal), acidic, tar-base free;Methylnaphthalene Oil Extract Residue;[The extract oil boiling in the range of approximately 220 oC to 265 oC (428 oF to 509 oF) from coal tar alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillation to remove tar bases. Composed primarily of alkylnaphthalenes.] 284-901-6 84989-12-8 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-097-00-4 Distillates (coal tar), benzole fraction, distn. residues;Wash Oil;[A complex combination of hydrocarbons obtained from the distillation of crude benzole (high temperature coal tar). It may be a liquid with the approximate distillation range of 150 oC to 300 oC (302 oF to 572 oF) or a semi-solid or solid with a melting point up to 70 oC (158 oF). It is composed primarily of naphthalene and alkyl naphthalenes.] 310-165-3 121620-46-0 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-098-00-X Creosote oil, acenaphthene fraction;Wash Oil;[A complex combination of hydrocarbons produced by the distillation of coal tar and boiling in the range of approximately 240 oC to 280 oC (464 oF to 536 oF). Composed primarily of acenaphthene, naphthalene and alkyl naphthalene.] 292-605-3 90640-84-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-099-00-5 Creosote oil;[A complex combination of hydrocarbons obtained by the distillation of coal tar. It consists primarily of aromatic hydrocarbons and may contain appreciable quantities of tar acids and tar bases. It distills at the approximate range of 200 oC to 325 oC (392 oF to 617 oF).] 263-047-8 61789-28-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-100-00-9 Creosote oil, high-boiling distillate;Wash Oil;[The high-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillates, removed. It is crystal free at approximately 5 oC (41 oF).] 274-565-9 70321-79-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-101-00-4 Creosote;[The distillate of coal tar produced by the high temperature carbonization of bituminous coal. It consists primarily of aromatic hydrocarbons, tar acids and tar bases.] 232-287-5 8001-58-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-102-00-X Extract residues (coal), creosote oil acid;Wash Oil Extract Residue;[A complex combination of hydrocarbons from the base-freed fraction from the distillation of coal tar, boiling in the range of approximately 250 oC to 280 oC (482 oF to 536 oF). It consists predominantly of biphenyl and isomeric diphenylnaphthalenes.] 310-189-4 122384-77-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-103-00-5 Anthracene oil, anthracene paste;Anthracene Oil Fraction;[The anthracene-rich solid obtained by the crystallization and centrifuging of anthracene oil. It is composed primarily of anthracene, carbazole and phenanthrene.] 292-603-2 90640-81-6 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-104-00-0 Anthracene oil, anthracene-low;Anthracene Oil Fraction;[The oil remaining after the removal, by a crystallization process, of an anthracene-rich solid (anthracene paste) from anthracene oil. It is composed primarily of two, three and four membered aromatic compounds.] 292-604-8 90640-82-7 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-105-00-6 Residues (coal tar), anthracene oil distn.;Anthracene Oil Fraction;[The residue from the fraction distillation of crude anthracene boiling in the approximate range of 340 oC to 400 oC (644 oF to 752 oF). It consists predominantly of tri- and polynuclear aromatic and heterocyclic hydrocarbons.] 295-505-8 92061-92-2 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-106-00-1 Anthracene oil, anthracene paste, anthracene fraction;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by the crystallization of anthracene oil from bituminous high temperature tar and boiling in the range of 330 oC to 350 oC (626 oF to 662 oF). It contains chiefly anthracene, carbazole and phenanthrene.] 295-275-9 91995-15-2 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-107-00-7 Anthracene oil, anthracene paste, carbazole fraction;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthrancene oil from bituminous coal high temperature tar and boiling in the approximate range of 350 oC to 360 oC (662 oF to 680 oF). It contains chiefly anthacene, carbazole and phenanthrene.] 295-276-4 91995-16-3 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-108-00-2 Anthracene oil, anthracene paste, distn. lights;Anthracene Oil Fraction;[A complex combination of hydrocarbons from the distillation of anthracene obtained by crystallization of anthracene oil from bituminous light temperature tar and boiling in the range of approximately 290 oC to 340 oC (554 oF to 644 oF). It contains chiefly trinuclear aromatics and their dihydro derivatives.] 295-278-5 91995-17-4 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-109-00-8 Tar oils, coal, low-temp.;Tar Oil, high boiling;[A distillate from low-temperature coal tar. Composed primarily of hydrocarbons, phenolic compounds and aromatic nitrogen bases boiling in the range of approximately 160 oC to 340 oC (320 oF to 644 oF).] 309-889-2 101316-87-4 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-110-00-3 Extract residues (coal), low temp. coal atar alk.;[The residue from low temperature coal tar oils after an alkaline wash, such as aqueous sodium hydroxide, to remove crude coal tar acids. Composed primarily of hydrocarbons and aromatic nitrogen bases.] 310-191-5 122384-78-5 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-111-00-9 Phenols, ammonia liquor ext.;Alkaline Extract;[The combination of phenols extracted, using isobutyl acetate, from the ammonia liquor condensed from the gas evolved in low-temperature (less than 700 oC (1292 oF)) destructive distillation of coal. It consists predominantly of a mixture of monohydric and dihydric phenols.] 284-881-9 84988-93-2 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-112-00-4 Distillates (coal tar), light oils, alk. exts.;Alkaline Extract;[The aqueous extract from carbolic oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 292-610-0 90640-88-3 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-113-00-X Extracts, coal tar oil alk.;Alkaline Extract;[The extract from coal tar oil produced by an alkaline wash such as aqueous sodium hydroxide. Composed primarily of the alkali salts of various phenolic compounds.] 266-017-2 65996-83-0 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-114-00-5 Distillates (coal tar), naphthalene oils, alk. exts.;Alkaline Extract;[The aqueous extract from naphthalene oil produced by an alkaline wash such as aqueous sodium hydroxid. Composed primarily of the alkali salts of various phenolic compounds.] 292-611-6 90640-89-4 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-115-00-0 Extract residues (coal), tar oil alk., carbonated, limed;Crude Phenols;[The product obtained by treatment of coal tar oil alkaline extract with CO2 and CaO. Composed primarily of CaCO3, Ca(OH)2, Na2CO3 and other organic and inorganic impurities.] 292-629-4 90641-06-8 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-116-00-6 Tar acids, coal, crude;Crude Phenols;[The reaction product obtained by neutralizing coal tar oil alkaline extract with an acidic solution, such as aqueous sulfuric acid, or gaseous carbon dioxide, to obtain the free acids. Composed primarily of tar acids such as phenol, cresols, and xylenols.] 266-019-3 65996-85-2 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-117-00-1 Tar acids, brown-coal, crude;Crude Phenols;[An acidified alkaline extract of brown coal tar distillate. Composed primarily of phenol and phenol homologs.] 309-888-7 101316-86-3 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-118-00-7 Tar acids, brown-coal gasification;Crude Phenols;[A complex combination of organic compounds obtained from brown coal gasification. Composed primarily of C6-10 hydroxy aromatic phenols and their homologs.] 295-536-7 92062-22-1 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-119-00-2 Tar acids, distn. residues;Distillate Phenols;[A residue from the distillation of crude phenol from coal. It consists predominantly of phenols having carbon numbers in the range of C8 through C10 with a softening point of 60 oC to 80 oC (140 oF to 176 oF).] 306-251-5 96690-55-0 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-120-00-8 Tar acids, methylphenol fraction;Distillate Phenols;[The fraction of tar acid rich in 3- and 4-methylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-892-9 84989-04-8 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-121-00-3 Tar acids, polyalkylphenol fraction;Distillate Phenols;[The fraction of tar aicds, recovered by distillation of low-temperature coal tar crude tar acids, having an approximate boiling range of 225 oC to 320 oC (437 oF to 608 oF). Composed primarily of polyalkylphenols.] 284-893-4 84989-05-9 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-122-00-9 Tar acids, xylenol fraction;Distillate Phenols; [The fraction of tar acids, rich in 2,4- and 2,5-dimethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-895-5 84989-06-0 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-123-00-4 Tar acids, ethylphenol fraction;Distillate Phenols;[The fraction of tar acids, rich in 3- and 4-ethylphenol, recovered by distillation of low-temperature coal tar crude tar acids.] 284-891-3 84989-03-7 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-124-00-X Tar acids, 3,5-xylenol fraction;Distillate Phenols;[The fraction of tar acids, rich in 3,5-dimethylphenol, recovered by distillation of low-temperature coal tar acids.] 284-896-0 84989-07-1 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-125-00-5 Tar acids, residues, distillates, first-cut;Distillate Phenols;[The residue from the distillation in the range of 235 oC to 355 oC (481 oF to 697 oF) of light carbolic oil.] 270-713-1 68477-23-6 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-126-00-0 Tar acids, cresylic, residues;Distillate Phenols;[The residue from crude coal tar acids after removal of phenol, cresols, xylenols and any higher boiling phenols. A black solid with a melting point approximately 80 oC (176 oF). Composed primarily of polyalkyphenols, resin gums, and inorganic salts.] 271-418-0 68555-24-8 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-127-00-6 Phenols, C9-11;Distillate Phenols 293-435-2 91079-47-9 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-128-00-1 Tar acids, cresylic;Distillate Phenols;[A complex combination of organic compounds obtained from brown coal and boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). It contains chiefly phenols and pyridine bases.] 295-540-9 92062-26-5 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-129-00-7 Tar acids, brown-coal, C2-alkylphenol fraction;Distillate Phenols;[The distillate from the acidification of alkaline washed lignite tar distillate boiling in the range of approximately 200 oC to 230 oC (392 oF to 446 oF). Composed primarily of <{ITA}>m-<{/ITA}> and <{ITA}>p-<{/ITA}>ethylphenol as well as cresols and xylenols.] 302-662-9 94114-29-1 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-130-00-2 Extract oils (coal), naphthalene oils;Acid Extract;[The aqueous extract produced by an acidic wash of alkali-washed napthalene oil. Composed primarily of acid salts of various aromatic nitrogen bases including pyridine, quinoline and their alkyl derivatives.] 292-623-1 90641-00-2 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-131-00-8 Tar bases, quinoline derivs.;Distillate Bases 271-020-7 68513-87-1 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-132-00-3 Tar bases, coal, quinoline derivs. fraction;Distillate Bases 274-560-1 70321-67-4 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-133-00-9 Tar bases, coal, distn. residues;Distillate Bases;[The distillation residue remaining after the distillation of the neutralized, acid-extracted base-containing tar fractions obtained by the distillation of coal tars. It contains chiefly aniline, collidines, quinoline and quinoline derivatives and toluidines.] 295-544-0 92062-29-8 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-134-00-4 Hydrocarbon oils, arom., mixed with polyethylene and polypropylene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of a polyethylene/polypropylene mixture with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 120 oC (158 oF to 248 oF).] 309-745-9 100801-63-6 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-135-00-X Hydrocarbon oils, arom., mixed with polyethylene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of polyethylene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of 70 oC to 120 oC (158 oF to 248 oF).] 309-748-5 100801-65-8 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-136-00-5 Hydrocarbon oils, arom., mixed with polystyrene, pyrolyzed, light oil fraction;Heat Treatment Products;[The oil obtained from the heat treatment of polystyrene with coal tar pitch or aromatic oils. It consists predominantly of benzene and its homologs boiling in a range of approximately 70 oC to 210 oC (158 oF to 410 oF).] 309-749-0 100801-66-9 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-137-00-0 Extract residues (coal), tar oil alk., naphthalene distn. residues;Naphthalene Oil Extract Residue;[The residue obtained from chemical oil extracted after the removal of naphthalene by distillation composed primarily of two to four membered condensed ring aromatic hydrocarbons and aromatic nitrogen bases.] 277-567-8 73665-18-6 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-138-00-6 Creosote oil, low-boiling distillate;Wash Oil;[The low-boiling distillation fraction obtained from the high temperature carbonization of bituminous coal, which is further refined to remove excess crystalline salts. It consists primarily of creosote oil with some of the normal polynuclear aromatic salts, which are components of coal tar distillate, removed. It is crystal free at approximately 38 oC (100 oF).] 274-566-4 70321-80-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-139-00-1 Tar acids, cresylic, sodium salts, caustic solns.;Alkaline Extract 272-361-4 68815-21-4 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-140-00-7 Extract oils (coal), tar base;Acid Extract;[The extract from coal tar oil alkaline extract residue produced by an acidic wash such as aqueous sulfuric acid after distillatin to remove naphthalene. Composed primarily of the acid salts of various aromatic nitrogen bases including pyridine, quinoline, and their alkyl derivatives.] 266-020-9 65996-86-3 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-141-00-2 Tar bases, coal, crude;Crude Tar Bases;[The reaction product obtained by neutralizing coal tar base extract oil with an alkaline solution, such as aqueous sodium hydroxide, to obtain the free bases. Composed primarily of such organic bases as acridine, phenanthridine, pyridine, quinoline and their alkyl derivatives.] 266-018-8 65996-84-1 Carc. Cat. 2; R45 TR: 45S: 53-45  HJM
648-142-00-8 Residues (coal), liq. solvent extn.;[A cohesive powder composed of coal mineral matter and undissolved coal remaining after extraction of coal by a liquid solvent.] 302-681-2 94114-46-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-143-00-3 Coal liquids, liq. solvent extn. soln.;[The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] 302-682-8 94114-47-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-144-00-9 Coal liquids, liq. solvent extn.;[The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.] 302-683-3 94114-48-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H M
648-145-00-4 Tar brown-coal;[An oil distilled from brown-coal tar. Composed primarily of aliphatic, naphthenic and one- to three-ring aromatic hydrocarbons, their alkyl derivates, heteroaromatics and one- and two-ring phenols boiling in the range of approximately 150 oC to 360 oC (302 oF to 680 oF).] 309-885-0 101316-83-0 Carc. Cat. 1; R45 TR: 45S: 53-45  H
648-146-00-X Tar, brown-coal, low-temp.;[A tar obtained from low temperature carbonization and low temperature gasification of brown coal. Composed primarily of aliphatic, naphthenic and cyclic aromatic hydrocarbons, heteroaromatic hydrocarbons and cyclic phenols.] 309-886-6 101316-84-1 Carc. Cat. 1; R45 TR: 45S: 53-45  H
648-147-00-5 Light oil (coal), coke-oven;Crude benzole;[The volatile organic liquid extracted from the gas evolved in the high temperature (greater than 700 oC (1292 oF)) destructive distillation of coal. Composed primarily of benzene, toluene, and xylenes. May contain other minor hydrocarbon constituents.] 266-012-5 65996-78-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-148-00-0 Distillates (coal), liq. solvent extn., primary;[The liquid product of condensation of vapors emitted during the digestion of coal in a liquid solvent and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of partly hydrogenated condensed-ring aromatic hydrocarbons, aromatic compounds containing nitrogen, oxygen and sulfur, and their alkyl derivatives having carbon numbers predominantly in the range of C4 through C14.] 302-688-0 94114-52-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-149-00-6 Distillates (coal), solvent extn., hydrocracked;[Distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction process and boiling in the range of approximately 30 oC to 300 oC (86 oF to 572 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 through C14. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-689-6 94114-53-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-150-00-1 Naphtha (coal), solvent extn., hydrocracked;[Fraction of the distillate obtained by hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes with carbon numbers predominantly in the range of C4 to C9. Nitrogen, sulfur and oxygen-containing aromatic and hydrogenated aromatic compounds are also present.] 302-690-1 94114-54-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-151-00-7 Gasoline, coal solvent extn., hydrocracked naphtha;[Motor fuel produced by the reforming of the refined naphtha fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 30 oC to 180 oC (86 oF to 356 oF). Composed primarily of aromatic and naphthenic hydrocarbons, their alkyl derivatives and alkyl hydrocarbons having carbon numbers in the range of C4 through C9.] 302-691-7 94114-55-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H
648-152-00-2 Distillates (coal), solvent extn., hydrocracked middle;[Distillate obtained from the hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 300 oC (356 oF to 572 oF). Composed primarily of two-ring aromatic, hydrogenated aromatic and naphthenic compounds, their alkyl derivatives and alkanes having carbon numbers predominantly in the range of C9 through C14. Nitrogen, sulfur and oxygen-containing compounds are also present.] 302-692-2 94114-56-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-153-00-8 Distillates (coal), solvent extn., hydrocracked hydrogenated middle;[Distillate from the hydrogenation of hydrocracked middle distillate from coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 280 oC (356 oF to 536 oF). Composed primarily of hydrogenated two- ring carbon compounds and their alkyl derivatives having carbon numbers predominantly in the range of C9 through C14.] 302-693-8 94114-57-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
648-154-00-3 Fuels, jet aircraft, coal solvent extn., hydrocracked hydrogenated;[Jet engine fuel produced by hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 180 oC to 225 oC (356 oF to 473 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C10 through C12.] 302-694-3 94114-58-6 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  H
648-155-00-9 Fuels, diesel, coal solvent extn., hydrocracked hydrogenated;[Diesel engine fuel produced by the hydrogenation of the middle distillate fraction of the products of hydrocracking of coal extract or solution produced by the liquid solvent extraction or supercritical gas extraction processes and boiling in the range of approximately 200 oC to 280 oC (392 oF to 536 oF). Composed primarily of hydrogenated two-ring hydrocarbons and their alkyl derivatives having carbon numbers predominantly in the range of C11 through C14.] 302-695-9 94114-59-7 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  H
648-156-00-4 Light oil (coal), semi-coking process;Fresh oil;[The volatile organic liquid condensed from the gas evolved in the low temperature (less than 700 oC (1292 oF) destructive distillation of coal. Composed primarily of C6-10 hydrocarbons.] 292-635-7 90641-11-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H J
649-001-00-3 Extracts (petroleum), light naphthenic distillate solvent 265-102-1 64742-03-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-002-00-9 Extracts (petroleum), heavy paraffinic distillate solvent 265-103-7 64742-04-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-003-00-4 Extracts (petroleum), light paraffinic distillate solvent 265-104-2 64742-05-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-004-00-X Extracts (petroleum), heavy naphthenic distillate solvent 265-111-0 64742-11-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-005-00-5 Extracts (petroleum), light vacuum gas oil solvent 295-341-7 91995-78-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-006-00-0 hydrocarbons C26-55, arom-rich 307-753-7 97722-04-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-007-00-6 fatty acids, tall-oil, reaction products with iminodiethanol and boric acid 400-160-5 — Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)28-37-61  
649-008-00-1 Residues (petroleum), atm. tower;Heavy Fuel oil;[A complex residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-045-2 64741-45-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-009-00-7 Gas oils (petroleum), heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 265-058-3 64741-57-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-010-00-2 Distillates (petroleum), heavy catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-063-0 64741-61-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-011-00-8 Clarified oils (petroleum), catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-064-6 64741-62-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-012-00-3 Residues (petroleum), hydrocracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the products of a hydrocracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF).] 265-076-1 64741-75-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-013-00-9 Residues (petroleum), thermal cracked;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-081-9 64741-80-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-014-00-4 Distillates (petroleum), heavy thermal cracked;Heavy Fuel oil;[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C15 through C36 and boiling in the range of approximately 260 oC to 480 oC (500 oF to 896 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-082-4 64741-81-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-015-00-X Gas oils (petroleum), hydrotreated vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C50 and boiling in the range of approximately 230 oC to 600 oC (446 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-162-9 64742-59-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-016-00-5 Residues (petroleum), hydrodesulfurized atmospheric tower;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating an atmospheric tower residuum with hydrogen in the presence of a catalyst under conditions primarily to remove organic sulfur compounds. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-181-2 64742-78-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-017-00-0 Gas oils (petroleum), hydrodesulfurized heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and boiling in the range of approximately 350 oC to 600 oC (662 oF to 1112 oC). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-189-6 64742-86-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-018-00-6 Residues (petroleum), steam-cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained as the residual fraction from the distillation of the products of a steam cracking process (including steam cracking to produce ethylene). It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly greater than C14 and boiling above approximately 260 oC (500 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 265-193-8 64742-90-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-019-00-1 Residues (petroleum), atmospheric;Heavy Fuel oil;[A complex residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-777-3 68333-22-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-020-00-7 Clarified oils (petroleum), hydrodesulfurized catalytic cracked;Heavy Fuel oil; [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] 269-782-0 68333-26-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-021-00-2 Distillates (petroleum), hydrodesulfurized intermediate catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating intermediate catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 269-783-6 68333-27-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-022-00-8 Distillates (petroleum), hydrodesulfurized heavy catalytic cracked;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treatment of heavy catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C35 and boiling in the range of approximately 260 oC to 500 oC (500 oF to 932 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 269-784-1 68333-28-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-023-00-3 Fuel oil, residues-straight-run gas oils, high-sulfur;Heavy Fuel oil 270-674-0 68476-32-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-024-00-9 Fuel oil, residual;Heavy Fuel oil;[The liquid product from various refinery streams, usually residues. The composition is complex and varies with the source of the crude oil.] 270-675-6 68476-33-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-025-00-4 Residues (petroleum), catalytic reformer fractionator residue distn.;Heavy Fuel oil;[A complex residuum from the distillation of catalytic reformer fractionator residue. It boils approximately above 399 oC (750 oF).] 270-792-2 68478-13-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-026-00-X Residues (petroleum), heavy coker gas oil and vacuum gas oil;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and vacuum gas oil. It predominantly consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-796-4 68478-17-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-027-00-5 Residues (petroleum), heavy coker and light vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of heavy coker gas oil and light vacuum gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-983-0 68512-61-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-028-00-0 Residues (petroleum), light vacuum;Heavy Fuel oil;[A complex residuum from the vacuum distillation of the residuum from the atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly greater than C13 and boiling above approximately 230 oC (446 oF).] 270-984-6 68512-62-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-029-00-6 Residues (petroleum), steam-cracked light;Heavy Fuel oil;[A complex residuum from the distillation of the products from a steam-cracking process. It consists predominantly of aromatic and unsaturated hydrocarbons having carbon numbers greater than C7 and boiling in the range of approximately 101 oC to 555 oC (214 oF to 1030 oF).] 271-013-9 68513-69-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-030-00-1 Fuel oil, No 6;Heavy Fuel oil;[A distillate oil having a minimum viscosity of 900 SUS at 37.7 oC (100 oF) to a maximum of 9000 SUS at 37.7 oC (100 oF).] 271-384-7 68553-00-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-031-00-7 Residues (petroleum), topping plant, low-sulfur;Heavy Fuel oil;[A low-sulfur complex combination of hydrocarbons produced as the residual fraction from the topping plant distillation of crude oil. It is the residuum after the straight-run gasoline cut, kerosene cut and gas oil cut have been removed.] 271-763-7 68607-30-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-032-00-2 Gas oils (petroleum), heavy atmospheric;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C35 and boiling in the range of approximately 121 oC to 510 oC (250 oF to 950 oF).] 272-184-2 68783-08-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-033-00-8 Residues (petroleum), coker scrubber, Condensed-ring-arom.-contg.;Heavy Fuel oil;[A very complex combination of hydrocarbons produced as the residual fraction from the distillation of vaccum residuum and the products from a thermal cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 oC (662 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed rind aromatic hydrocarbons.] 272-187-9 68783-13-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-034-00-3 Distillates (petroleum), petroleum residues vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from the atmospheric distillation of crude oil.] 273-263-4 68955-27-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-035-00-9 Residues (petroleum), steam-cracked, resinous;Heavy Fuel oil;[A complex residuum from the distillation of steam-cracked petroleum residues.] 273-272-3 68955-36-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-036-00-4 Distillates (petroleum), intermediate vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum, distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C14 through C42 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 274-683-0 70592-76-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-037-00-X Distillates (petroleum), light vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C35 and boiling in the range of approximately 250 oC to 545 oC (482 oF to 1013 oF).] 274-684-6 70592-77-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-038-00-5 Distillates (petroleum), vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having numbers predominantly in the range of C15 through C50 and boiling in the range of approximately 270 oC to 600 oC (518 oF to 1112 oF). This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 274-685-1 70592-78-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-039-00-0 Gas oils (petroleum), hydrodesulfurized coker heavy vacuum;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by hydrodesulfurization of heavy coker distillate stocks, It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C18 to C44 and boiling in the range of approximately 304 oC to 548 oC (579 oF to 1018 oF). Likely to contain 5 % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 285-555-9 85117-03-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-040-00-6 Residues (petroleum), steam-cracked, distillates;Heavy Fuel oil;[A complex combination of hydrocarbons obtained during the production of refined petroleum tar by the distillation of steam cracked tar. It consists predominantly of aromatic and other hydrocarbons and organic sulfur compounds.] 292-657-7 90669-75-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-041-00-1 Residues (petroleum), vacuum, light;Heavy Fuel oil;[A complex residuum from the vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C24 and boiling above approximately 390 oC (734 oF).] 292-658-2 90669-76-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-042-00-7 Fuel oil, heavy, high-sulfur;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the distillation of crude petroleum. It consists predominantly of aliphatic, aromatic and cycloaliphatic hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 295-396-7 92045-14-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-043-00-2 Residues (petroleum), catalytic cracking;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C11 and boiling above approximately 200 oC (392 oF).] 295-511-0 92061-97-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-044-00-8 Distillates (petroleum), intermediate catalytic cracked, thermally degraded;Heavy Fuel oil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 220 oC to 450 oC (428 oF to 842 oF). This stream is likely to contain organic sulfur compounds.] 295-990-6 92201-59-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-045-00-3 Residual oils (petroleum);Heavy Fuel oil;[A complex combination of hydrocarbons, sulfur compounds and metal-containing organic compounds obtained as the residue from refinery fractionation cracking processes. It produces a finished oil with a viscosity above 2cSt. at 100 oC.] 298-754-0 93821-66-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-046-00-9 Residues, steam cracked, thermally treated;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by the treatment and distillation of raw steam-cracked naphtha. It consists predominantly of unsaturated hydrocarbons boiling in the range above approximately 180 oC (356 oF).] 308-733-0 98219-64-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-047-00-4 Distillates (petroleum), hydrodesulfurized full-range middle;Heavy Fuel oil;[A complex combination of hydrocarbons obtained by treating a petroleum stock with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF).] 309-863-0 101316-57-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-048-00-X Residues (petroleum), catalytic reformer fractionator;Heavy Fuel oil;[A complex combination of hydrocarbons produced as the residual fraction from distillation of the product from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C25 and boiling in the range of approximately 160 oC to 400 oC (320 oF to 725 oF). This stream is likely to contain 5 wt. % or more of 4- or 6-membered condensed ring aromatic hydrocarbons.] 265-069-3 64741-67-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-049-00-5 Petroleum;Crude oil;[A complex combination of hydrocarbons, It consists predominantly of aliphatic, alicyclic and aromatic hydrocarbons. It may also contain small amounts of nitrogen, oxygen and sulfur compounds. This category encompasses light, medium, and heavy petroleums, as well as the oils extended from tar sands. Hydrocarbonaceous materials requiring major chemical changes for their recovery or conversion to petroleum refinery feedstocks such as crude shale oils; upgraded shale oils and liquid coal fuels are not included in this definition.] 232-298-5 8002-05-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-050-00-0 Distillates (petroleum), light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons normally present in this distillation range of crude oil.] 265-051-5 64741-50-0 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-051-00-6 Distillates (petroleum), heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated aliphatic hydrocarbons.] 265-052-0 64741-51-1 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-052-00-1 Distillates (petroleum), light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-053-6 64741-52-2 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-053-00-7 Distillates (petroleum), heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by vacuum distillation of the residuum from atmospheric distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-054-1 64741-53-3 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-054-00-2 Distillates (petroleum), acid-treated heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-117-3 64742-18-3 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-055-00-8 Distillates (petroleum), acid-treated light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-118-9 64742-19-4 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-056-00-3 Distillates (petroleum), acid-treated heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of a least 100 SUS at 100 oF (19cSt at 40 oC).] 265-119-4 64742-20-7 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-057-00-9 Distillates (petroleum), acid-treated light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-121-5 64742-21-8 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-058-00-4 Distillates (petroleum), chemically neutralized heavy paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons obtained from a treating process to remove acidic materials. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of aliphatic hydrocarbons.] 265-127-8 64742-27-4 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-059-00-X Distillates (petroleum), chemically neutralized light paraffinic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-128-3 64742-28-5 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-060-00-5 Distillates (petroleum), chemically neutralized heavy naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-135-1 64742-34-3 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-061-00-0 Distillates (petroleum), chemically neutralized light naphthenic;Unrefined or mildly refined baseoil;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS a 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-136-7 64742-35-4 Carc. Cat. 1; R45 TR: 45S: 53-45  H
649-062-00-6 Gases (petroleum), catalytic cracked naphtha depropanizer overhead, C3-rich acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked hydrocarbons and treated to remove acidic impurities. It consists of hydrocarbons having carbon numbers in the range of C2 through C4, predominantly C3.] 270-755-0 68477-73-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-063-00-1 Gases (petroleum), catalytic cracker;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-756-6 68477-74-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-064-00-7 Gases (petroleum), catalytic cracker, C1-5-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C5.] 270-757-1 68477-75-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-065-00-2 Gases (petroleum), catalytic polymd. naphtha stabilizer overhead, C2-4-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic polymerized naphtha. It consists of aliphatic hydrocarbons having carbon numbers in the range of C2 through C6, predominantly C2 through C4.] 270-758-7 68477-76-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-066-00-8 Gases (petroleum), catalytic reformer, C1-4-rich;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers in the range of C1 through C6, predominantly C1 through C4.] 270-760-8 68477-79-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-067-00-3 Gases (petroleum), C3-5 olefinic-paraffinic alkylation feed;Petroleum gas;[A complex combination of olefinic and paraffinic hydrocarbons having carbon numbers in the range of C3 through C5 which are used as alkylation feed. Ambient temperatures normally exceed the critical temperature of these combinations.] 270-765-5 68477-83-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-068-00-9 Gases (petroleum), C4-rich;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from a catalytic fractionation process. It consists of aliphatic hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-767-6 68477-85-0 ⊗ ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-069-00-4 Gases (petroleum), deethanizer overheads;Petroleum gas;[A complex combination of hydrocarbons produced from distillation of the gas and gasoline fractions from the catalytic cracking process. It contains predominantly ethane and ethylene.] 270-768-1 68477-86-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-070-00-X Gases (petroleum), deisobutanizer tower overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-769-7 68477-87-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-071-00-5 Gases (petroleum), depropanizer dry, propene-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists predominantly of propylene with some ethane and propane.] 270-772-3 68477-90-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-072-00-0 Gases (petroleum), depropanizer overheads;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from the gas and gasoline fractions of a catalytic cracking process. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-773-9 68477-91-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-073-00-6 Gases (petroleum), gas recovery plant depropanizer overheads;Petroleum gas;[A complex combination of hydrocarbons obtained by fractionation of miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4, predominantly propane.] 270-777-0 68477-94-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-074-00-1 Gases (petroleum), Girbatol unit feed;Petroleum gas;[A complex combination of hydrocarbons that is used as the feed into the Girbatol unit to remove hydrogen sulfide. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 270-778-6 68477-95-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-075-00-7 Gases (petroleum), isomerized naphtha fractionator, C4-rich, hydrogen sulfide-free;Petroleum gas 270-782-8 68477-99-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-076-00-2 Tail gas (petroleum), catalytic cracked clarified oil and thermal cracked vacuum residue fractionation reflux drum;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked clarified oil and thermal cracked vacuum residue. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-802-5 68478-21-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-077-00-8 Tail gas (petroleum), catalytic cracked naphtha stabilization absorber;Petroleum gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-803-0 68478-22-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-078-00-3 Tail gas (petroleum), catalytic cracker, catalytic reformer and hydrodesulfurizer combined fractionater;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of products from catalytic cracking, catalytic reforming and hydrodesulfurizing processes treated to remove acidic impurities. It consists predominantly of hydrocarbons having cabon numbers predominantly in the range of C1 through C5.] 270-804-6 68478-24-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-079-00-9 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of catalytic reformed naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-806-7 68478-26-2 ⊗Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-080-00-4 Tail gas (petroleum), saturate gas plant mixed stream, C4-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of straight-run naphtha, distillation tail gas and catalytic reformed naphtha stabilizer tail gas. It consists of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly butane and isobutane.] 270-813-5 68478-32-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-081-00-X Tail gas (petroleum), saturate gas recovery plant, C1-2-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of distillate tail gas, straight-run naphtha, catalytic reformed naphtha stabilizer tail gas. It consists predominantly of hydrocarbons having carbon numbers in the range of C1through C5, predominantly methane and ethane.] 270-814-0 68478-33-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-082-00-5 Tail gas (petroleum), vacuum residues thermal cracker;Petroleum gas;[A complex combination of hydrocarbons obtained from the thermal cracking of vacuum residues. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-815-6 68478-34-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-083-00-0 Hydrocarbons, C3-4-rich, petroleum distillate;Petroleum gas;[A complex combination of hydrocarbons produced by distillation and condensation of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C3 through C4.] 270-990-9 68512-91-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-084-00-6 Gases (petroleum), full-range straight-run naphtha dehexanizer off;petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of the full-range straight-run naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-000-8 68513-15-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-085-00-1 Gases (petroleum), hydrocracking depropanizer off, hydrocarbon-rich;Petroleum gas;[A complex combination of hydrocarbon produced by the distillation of products from a hydrocracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4. It may also contain small amounts of hydrogen and hydrogen sulfide.] 271-001-3 68513-16-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-086-00-7 Gases (petroleum), light straight-run naphtha stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the stabilization of light straight-run naphtha. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-002-9 68513-17-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-087-00-2 Residues (petroleum), alkylation splitter, C4-rich;Petroleum gas;[A complex residuum from the distillation of streams various refinery operations. It consists of hydrocarbons having carbon numbers in the range of C4 through C5, predominantly butane and boiling in the range of approximately - 11.7 oC to 27.8 oC (11 oF to 82 oF).] 271-010-2 68513-66-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-088-00-8 Hydrocarbons, C1-4;Petroleum gas;[A complex combination of hydrocarbons provided by thermal cracking and absorber operations and by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately minus 164 oC to minus 0.5 oC (-263 oF to 31 oF).] 271-032-2 68514-31-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-089-00-3 Hydrocarbons, C1-4, sweetened;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting hydrocarbon gases to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 164 oC to - 0.5 oC (-263 oF to 31 oF).] 271-038-5 68514-36-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-090-00-9 Hydrocarbons, C1-3;Petroleum gas;[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C1 through C3 and boiling in the range of approximately minus 164 oC to minus 42 oC (-263 oF to - 44 oF).] 271-259-7 68527-16-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-091-00-4 Hydrocarbons, C1-4, debutanizer fraction;Petroleum gas 271-261-8 68527-19-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-092-00-X Gases (petroleum), C1-5, wet;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of crude oil and/or the cracking of tower gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 271-624-0 68602-83-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-093-00-5 Hydrocarbons, C2-4;Petroleum gas 271-734-9 68606-25-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-094-00-0 Hydrocarbons, C3;Petroleum gas 271-735-4 68606-26-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-095-00-6 Gases (petroleum), alkylation feed;Petroleum gas;[A complex combination of hydrocarbons produced by the catalytic cracking of gas oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 271-737-5 68606-27-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-096-00-1 Gases (petroleum), depropanizer bottoms fractionation off;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists predominantly of butane, isobutane and butadiene.] 271-742-2 68606-34-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-097-00-7 Gases (petroleum), refinery blend;Petroleum gas;[A complex combination obtained from various processes. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-183-7 68783-07-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-098-00-2 Gases (petroleum), catalytic cracking;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 272-203-4 68783-64-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-099-00-8 Gases (petroleum), C2-4, sweetened;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C2 through C4 and boiling in the range of approximately - 51 oC to - 34 oC (-60 oF to - 30 oF).] 272-205-5 68783-65-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-100-00-1 Gases (petroleum), crude oil fractionation off;Petroleum gas;[A complex combination of hydrocarbons produced by the fractionation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-871-7 68918-99-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-101-00-7 Gases (petroleum), dehexanizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of combined naphtha streams. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-872-2 68919-00-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-102-00-2 Gases (petroleum), light straight run gasoline fractionation stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of light straight-run gasoline. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-878-5 68919-05-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-103-00-8 Gases (petroleum), naphtha unifiner desulfurization stripper off;Petroleum gas;[A complex combination of hydrocarbons produced by a naphtha unifiner desulfurization process and stripped from the naphtha product. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-879-0 68919-06-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-104-00-3 Gases (petroleum), straight-run naphtha catalytic reforming off;Petroleum gas;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and fractionation of the total effluent. It consists of methane, ethane, and propane.] 272-882-7 68919-09-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-105-00-9 Gases (petroleum), fluidized catalytic cracker splitter overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the fractionation of the charge to the C3 -C4 splitter. It consists predominantly of C3 hydrocarbons.] 272-893-7 68919-20-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-106-00-4 Gases (petroleum), straight-run stabilizer off;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-883-2 68919-10-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45S: 53-45  H K
649-107-00-X Gases (petroleum), catalytic cracked naphtha debutanizer;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked naphtha. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-169-3 68952-76-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-108-00-5 Tail gas (petroleum), catalytic cracked distillate and naphtha stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained by the fractionation of catalytic cracked naphtha and distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-170-9 68952-77-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-109-00-0 Tail gas (petroleum), thermal-cracked distillate, gas oil and naphtha absorber;petroleum gas;[A complex combination of hydrocarbons obtained from the separation of thermal-cracked distillates, naphtha and gas oil. It consists pedrominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-175-6 68952-81-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-110-00-6 Tail gas (petroleum), thermal cracked hydrocarbon fractionation stabilizer, petroleum coking;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization of thermal cracked hydrocarbons from petroleum coking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-176-1 68952-82-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-111-00-1 Gases (petroleum, light steam-cracked, butadiene conc.;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process, It consists of hydrocarbons having a carbon number predominantly of C4.] 273-265-5 68955-28-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-112-00-7 Gases (petroleum), straight-run naphtha catalytic reformer stabilizer overhead;Petroleum gas;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha and the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 273-270-2 68955-34-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-113-00-2 Hydrocarbons, C4;Petroleum gas 289-339-5 87741-01-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-114-00-8 Alkanes, C1-4, C3-rich;Petroleum gas 292-456-4 90622-55-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-115-00-3 Gases (petroleum), steam-cracker C3-rich;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a steam cracking process. It consists predominantly of propylene with some propane and boils in the range of approximately - 70 oC to 0 oC (-94 oF to 32 oF).] 295-404-9 92045-22-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-116-00-9 Hydrocarbons, C4, steam-cracker distillate;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of the products of a steam cracking process. It consists predominantly of hydrocarbons having a carbon number of C4, predominantly 1-butene and 2-butene, containing also butane and isobutene and boiling in the range of approximately minus 12 oC to 5 oC (10.4 oF to 41 oF).] 295-405-4 92045-23-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-117-00-4 Petroleum gases, liquefied, sweetened, C4 fraction;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting a liquified petroleum gas mix to a sweetening process to oxidize mercaptans or to remove acidic impurities. It consists predominantly of C4 saturated and unsaturated hydrocarbons.] 295-463-0 92045-80-2 F+; R12Carc. Cat. 1; R45Muta. Cat. 2; R46 F+; TR: 12-45-46S: 53-45  HKS
649-118-00-X Hydrocarbons, C4, 1,3-butadiene- and isobutene-free;Petroleum gas 306-004-1 95465-89-7 ⊗ Carc. Cat. 2; R45 TR: 45S: 53-45  H K
649-119-00-5 Raffinates (petroleum), steam-cracked C4 fraction cuprous ammonium acetate extn., C3-5 and C3-5 unsatd., butadiene-free;Petroleum gas 307-769-4 97722-19-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-120-00-0 Gases (petroleum), amine system feed;Refinery gas;[The feed gas to the amine system for removal of hydrogen sulfide. It consists of hydrogen. Carbon monoxide, carbon dioxide, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 may also be present.] 270-746-1 68477-65-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-121-00-6 Gases (petroleum), benzene unit hydrodesulfurizer off;Refinery gas;[Off gases produced by the benzene unit. It consists primarily of hydrogen. Carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6, including benzene, may also be present.] 270-747-7 68477-66-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-122-00-1 Gases (petroleum), benzene unit recycle, hydrogen-rich;Refinery gas;[A complex combination of hydrocarbons obtained by recycling the gases of the benzene unit. It consists primarily of hydrogen with various small amounts of carbon monoxide and hydrocarbons having carbon numbers in the range of C1 through C6.] 270-748-2 68477-67-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-123-00-7 Gases (petroleum), blend oil, hydrogen-nitrogen-rich;Refinery gas;[A complex combination of hydrocarbons obtained by distillation of a blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide, and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-749-8 68477-68-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-124-00-2 Gases (petroleum), catalytic reformed naphtha stripper overheads;Refinery gas;[A complex combination of hydrocarbons obtained from stabilization of catalytic reformed naphtha. Its consists of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 270-759-2 68477-77-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-125-00-8 Gases (petroleum), C6-8 catalytic reformer recycle;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed and recycled to conserve hydrogen. It consists primarily of hydrogen. It may also contain various small amounts of carbon monoxide, carbon dioxide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-761-3 68477-80-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-126-00-3 Gases (petroleum), C6-8 catalytic reformer;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from catalytic reforming of C6-C8 feed. It consists of hydrocarbons having carbon numbers in the range of C1 through C5 and hydrogen.] 270-762-9 68477-81-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-127-00-9 Gases (petroleum), C6-8 catalytic reformer recycle, hydrogen-rich;Refinery gas 270-763-4 68477-82-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-128-00-4 Gases (petroleum), C2-return stream;Refinery gas;[A complex combination of hydrocarbons obtained by the extraction of hydrogen from a gas stream which consists primarily of hydrogen with small amounts of nitrogen, carbon monoxide, methane, ethane, and ethylene. It contains predominantly hydrocarbons such as methane, ethane, and ethylene with small amounts of hydrogen, nitrogen and carbon monoxide.] 270-766-0 68477-84-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-129-00-X Gases (petroleum), dry sour, gas-concn.-unit-off;Refinery gas;[The complex combination of dry gases from a gas concentration unit. It consists of hydrogen, hydrogen sulfide and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-774-4 68477-92-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-130-00-5 Gases (petroleum), gas concn. reabsorber distn.;Refinery gas;[A complex combination of hydrocarbons produced by distillation of products from combined gas streams in a gas concentration reabsorber. It consists predominantly of hydrogen, carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide and hydrocarbons having carbon numbers in the range of C1 through C3.] 270-776-5 68477-93-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-131-00-0 Gases (petroleum), hydrogen absorber off;Refinery gas;[A complex combination obtained by absorbing hydrogen from a hydrogen rich stream. It consists of hydrogen, carbon monoxide, nitrogen, and methane with small amounts of C2 hydrocarbons.] 270-779-1 68477-96-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-132-00-6 Gases (petroleum), hydrogen-rich;Refinery gas;[A complex combination separated as a gas from hydrocarbon gases by chilling. It consists primarily of hydrogen with various small amounts of carbon monoxide, nitrogen, methane, and C2 hydrocarbons.] 270-780-7 68477-97-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-133-00-1 Gases (petroleum), hydrotreater blend oil recycle, hydrogen-nitrogen-rich;Refinery gas;[A complex combination obtained from recycled hydrotreated blend oil. It consists primarily of hydrogen and nitrogen with various small amounts of carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-781-2 68477-98-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-134-00-7 Gases (petroleum), recycle, hydrogen-rich;Refinery gas;[A complex combination obtained from recycled reactor gases. It consists primarily of hydrogen with various small amounts of carbon monoxide, carbon dioxide, nitrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 270-783-3 68478-00-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-135-00-2 Gases (petroleum), reformer make-up, hydrogen-rich;Refinery gas;[A complex combination obtained from the reformers. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-784-9 68478-01-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-136-00-8 Gases (petroleum), reforming hydrotreater;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen, methane, and ethane with various small amounts of hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 thorugh C5.] 270-785-4 68478-02-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-137-00-3 Gases (petroleum), reforming hydrotreater, hydrogen-methane-rich;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen and methane with various small amounts of carbon monoxide, carbon dioxide, nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C5.] 270-787-5 68478-03-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-138-00-9 Gases (petroleum), reforming hydrotreater make-up, hydrogen-rich;Refinery gas;[A complex combination obtained from the reforming hydrotreating process. It consists primarily of hydrogen with various small amounts of carbon monoxide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-788-0 68478-04-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-139-00-4 Gases (petroleum), thermal cracking distn.;Refinery gas;[A complex combination produced by distillation of products from a thermal cracking process. It consists of hydrogen, hydrogen sulfide, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-789-6 68478-05-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-140-00-X Tail gas (petroleum), catalytic cracker refractionation absorber;Refinery gas;[A complex combination of hydrocarbons obtained from refractionation of products from a catalytic cracking process. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 270-805-1 68478-25-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-141-00-5 Tail gas (petroleum), catalytic reformed naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from the catalytic reforming of straight run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-807-2 68478-27-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-142-00-0 Tail gas (petroleum), catalytic reformed naphtha stabilizer;Refinery gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic reformed naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-808-8 68478-28-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-143-00-6 Tail gas (petroleum), cracked distillate hydrotreater separator;Refinery gas;[A complex combination of hydrocarbons obtained by treating cracked distillates with hydrogen in the presence of a catalyst. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 270-809-3 68478-29-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-144-00-1 Tail gas (petroleum), hydrodesulfurized straight-run naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from hydrodesulfurization of straight-run naphtha. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 270-810-9 68478-30-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-145-00-7 Gases (petroleum), catalytic reformed straight-run naphtha stabilizer overheads;Refinery gas;[A complex combination of hydrocarbons obtained from the catalytic reforming of straight-run naphtha followed by fractionation of the total effluent. It consists of hydrogen, methane, ethane and propane.] 270-999-8 68513-14-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-146-00-2 Gases (petroleum), reformer effluent high-pressure flash drum off;Refinery gas;[A complex combination produced by the high-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-003-4 68513-18-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-147-00-8 Gases (petroleum), reformer effluent low-pressure flash drum off;Refinery gas;[A complex combination produced by low-pressure flashing of the effluent from the reforming reactor. It consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-005-5 68513-19-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-148-00-3 Gases (petroleum), oil refinery gas distn. off;Refinery gas;[A complex combination separated by distillation of a gas stream containing hydrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers in the range of C1 through C6 or obtained by cracking ethane and propane. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C2, hydrogen, nitrogen, and carbon monoxide.] 271-258-1 68527-15-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-149-00-9 Gases (petroleum), benzene unit hydrotreater depentanizer overheads;Refinery gas;[A complex combination produced by treating the feed from the benzene unit with hydrogen in the presence of a catalyst followed by depentanizing. It consists primarily of hydrogen, ethane and propane with various small amounts of nitrogen, carbon monoxide, carbon dioxide and hydrocarbons having carbon numbers predominantly in the range of C1 through C6. It may contain trace amounts of benzene.] 271-623-5 68602-82-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-150-00-4 Gases (petroleum), secondary absorber off, fluidized catalytic cracker overheads fractionator;Refinery gas;[A complex combination produced by the fractionation of the overhead products from the catalytic cracking process in the fluidized catalytic cracker. It consists of hydrogen, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 271-625-6 68602-84-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-151-00-X Petroleum products, refinery gases;Refinery gas;[A complex combination which consists primarily of hydrogen with various small amounts of methane, ethane, and propane.] 271-750-6 68607-11-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-152-00-5 Gases (petroleum), hydrocracking low-pressure separator;Refinery gas;[A complex combination obtained by the liquid-vapor separation of the hydrocracking process reactor effluent. It consists predominantly of hydrogen and saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-182-1 68783-06-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-153-00-0 Gases (petroleum), refinery;Refinery gas;[A complex combination obtained from various petroleum refining operations. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 272-338-9 68814-67-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-154-00-6 Gases (petroleum), platformer products separator off;Refinery gas;[A complex combination obtained from the chemical reforming of naphthenes to aromatics. It consists of hydrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C4.] 272-343-6 68814-90-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-155-00-1 Gases (petroleum), hydrotreated sour kerosine depentanizer stabilizer off;Refinery gas;[The complex combination obtained from the depentanizer stabilization of hydrotreated kerosine. It consists primarily of hydrogen, methane, ethane, and propane with various small amounts of nitrogen, hydrogen sulfide, carbon monoxide and hydrocarbons having carbon numbers predominantly in the range of C4 through C5.] 272-775-5 68911-58-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-156-00-7 Gases (petroleum), hydrotreated sour kerosine flash drum;Refinery gas;[A complex combination obtained from the flash drum of the unit treating sour kerosine with hydrogen in the presence of a catalyst. It consists primarily of hydrogen and methane with various small amounts of nitrogen, carbon monoxide, and hydro-carbons having carbon numbers predominantly in the range of C2 through C5.] 272-776-0 68911-59-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-157-00-2 Gases (petroleum), distillate unifiner desulfurization stripper off;Refinery gas;[A complex combination stripped from the liquid product of the unifiner desulfurization process. It consists of hydrogen sulfide, methane, ethane, and propane.] 272-873-8 68919-01-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-158-00-8 Gases (petroleum), fluidized catalytic cracker fractionation off;Refinery gas;[A complex combination produced by the fractionation of the overhead product of the fluidized catalytic cracking process. It consists of hydrogen, hydrogen sulfide, nitrogen, and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-874-3 68919-02-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-159-00-3 Gases (petroleum), fluidized catalytic cracker scrubbing secondary absorber off;Refinery gas;[A complex combination produced by scrubbing the overhead gas from the fluidized catalytic cracker. It consists of hydrogen, nitrogen, methane, ethane and propane.] 272-875-9 68919-03-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-160-00-9 Gases (petroleum), heavy distillate hydrotreater desulfurization stripper off;Refinery gas;[A complex combination stripped from the liquid product of the heavy distillate hydrotreater desulfurization process. It consists of hydrogen, hydrogen sulfide, and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-876-4 68919-04-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-161-00-4 Gases (petroleum), platformer stabilizer off, light ends fractionation;Refinery gas;[A complex combination obtained by the fractionation of the light ends of the platinum reactors of the plattformer unit. It consists of hydrogen, methane, ethane and propane.] 272-880-6 68919-07-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-162-00-X Gases (petroleum), preflash tower off, crude distn.;Refinery gas;[A complex combination produced from the first tower used in the distillation of crude oil. It consists of nitrogen and saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-881-1 68919-08-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-163-00-5 Gases (petroleum), tar stripper off;Refinery gas;[A complex combination obtained by the fractionation of reduced crude oil. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 272-884-8 68919-11-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-164-00-0 Gases (petroleum), unifiner stripper off;Refinery gas;[A combination of hydrogen and methane obtained by fractionation of the products from the unifiner unit.] 272-885-3 68919-12-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-165-00-6 Tail gas (petroleum), catalytic hydrodesulfurized naphtha separator;Refinery gas;[A complex combination of hydrocarbons obtained from the hydrodesulfurization of naphtha. It consists of hydrogen, methane, ethane, and propane.] 273-173-5 68952-79-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-166-00-1 Tail gas (petroleum), straight-run naphtha hydrodesulfurizer;Refinery gas;[A complex combination obtained from the hydrodesulfurization of straight-run naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 273-174-0 68952-80-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-167-00-7 Gases (petroleum), sponge absorber off, fluidized catalytic cracker and gas oil desulfurizer overhead fractionation;Refinery gas;[A complex combination obtained by the fractionation of products from the fluidized catalytic cracker and gas oil desulfurizer. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 273-269-7 68955-33-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-168-00-2 Gases (petroleum), crude distn. and catalytic cracking;Refinery gas;[A complex combination produced by crude distillation and catalytic cracking processes. It consists of hydrogen, hydrogen sulfide, nitrogen, carbon monoxide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 273-563-5 68989-88-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-169-00-8 Gases (petroleum), gas oil diethanolamine scrubber off;Refinery gas;[A complex combination produced by desulfurization of gas oils with diethanolamine. It consists predominantly of hydrogen sulfide, hydrogen and aliphatic hydrocarbons having carbon numbers in the range of C1 through C5.] 295-397-2 92045-15-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-170-00-3 Gases (petroleum), gas oil hydrodesulfurization effluent;Refinery gas;[A complex combination obtained by separation of the liquid phase from the effluent from the hydrogenation reaction. It consists predominantly of hydrogen, hydrogen sulfide and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C3.] 295-398-8 92045-16-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-171-00-9 Gases (petroleum), gas oil hydrodesulfurization purge;Refinery gas;[A complex combination of gases obtained from the reformer and from the purges from the hydrogenation reactor. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 295-399-3 92045-17-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-172-00-4 Gases (petroleum), hydrogenator effluent flash drum off;Refinery gas;[A complex combination of gases obtained from flash of the effluents after the hydrogenation reaction. It consists predominantly of hydrogen and aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 295-400-7 92045-18-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-173-00-X Gases (petroleum), naphtha steam cracking high-pressure residual;Refinery gas;[A complex combination obtained as a mixture of the non-condensable portions from the product of a naphtha steam cracking process as well as residual gases obtained during the preparation of subsequent products. It consists predominantly of hydrogen and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5 with which natural gas may also be mixed.] 295-401-2 92045-19-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-174-00-5 Gases (petroleum), residue visbaking off;Refinery gas;A complex combination obtained from viscosity reduction of residues in a furnace. It consists predominantly of hydrogen sulfide and paraffinic and olefinic hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 295-402-8 92045-20-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-175-00-0 Foots oil (petroleum), acid-treated;Foots oil;[A complex combination of hydrocarbons obtained by treatment of Foot's oil with sulfuric acid. It consists predominantly of branched-chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-225-7 93924-31-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-176-00-6 Foots oil (petroleum), clay-treated;Foots oil;[A complex combination of hydrocarbons obtained by treatment of Foot's oil with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of branched chain hydrocarbons with carbon numbers predominantly in the range of C20 through C50.] 300-226-2 93924-32-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-177-00-1 Gases (petroleum), C3-4;Petroleum gas;[A complex combination of hydrocarbons produced by distillation of products from the cracking of crude oil. It consists of hydrocarbons having carbon numbers in the range of C3 through C4, predominantly of propane and propylene, and boiling in the range of approximately - 51 oC to - 1 oC (-60 oF to 30 oF.)] 268-629-5 68131-75-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-178-00-7 Tail gas (petroleum), catalytic cracked distillate and catalytic cracked naphtha fractionation absorber;Petroleum gas;[The complex combination of hydrocarbons from the distillation of the products from catalytic cracked distillates and catalytic cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-617-2 68307-98-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-179-00-2 Tail gas (petroleum), catalytic polymn. naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons from the fractionation stabilization products from polymerization of naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C1 through C4.] 269-618-8 68307-99-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-180-00-8 Tail gas (petroleum), catalytic reformed naphtha fractionation stabilizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation stabilization of catalytic reformed naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-619-3 68308-00-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-181-00-3 Tail gas (petroleum), cracked distillate hydrotreater stripper;Petroleum gas;[A complex combination of hydrocarbons obtained by treating thermal cracked distillates with hydrogen in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-620-9 68308-01-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-182-00-9 Tail gas (petroleum), straight-run distillate hydrodesulfurizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of straight run distillates and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-630-3 68308-10-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-183-00-4 Tail gas (petroleum), gas oil catalytic cracking absorber;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of products from the catalytic cracking of gas oil. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-623-5 68308-03-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-184-00-X Tail gas (petroleum), gas recovery plant;Petroleum gas;[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-624-0 68308-04-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-185-00-5 Tail gas (petroleum), gas recovery plant deethanizer;Petroleum gas;[A complex combination of hydrocarbons from the distillation of products from miscellaneous hydrocarbon streams. It consists of hydrocarbon having carbon numbers predominantly in the range of C1 through C4.] 269-625-6 68308-05-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-186-00-0 Tail gas (petroleum), hydrodesulfurized distillate and hydrodesulfurized naphtha fractionator, acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of hydrodesulfurized naphtha and distillate hydrocarbon streams and treated to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-626-1 68308-06-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-187-00-6 Tail gas (petroleum), hydrodesulfurized vacuum gas oil stripper, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from stripping stabilization of catalytic hydrodesulfurized vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-627-7 68308-07-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-188-00-1 Tail gas (petroleum), light straight-run naphtha stabilizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation stabilization of light straight run naphtha and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 269-629-8 68308-09-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-189-00-7 Tail gas (petroleum), propane-propylene alkylation feed prep deethanizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of the reaction products of propane with propylene. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-631-9 68308-11-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-190-00-2 Tail gas (petroleum), vacuum gas oil hydrodesulfurizer, hydrogen sulfide-free;Petroleum gas;[A complex combination of hydrocarbons obtained from catalytic hydrodesulfurization of vacuum gas oil and from which hydrogen sulfide has been removed by amine treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C6.] 269-632-4 68308-12-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-191-00-8 Gases (petroleum), catalytic cracked overheads;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from the catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C5 and boiling in the range of approximately - 48 oC to 32 oC (-54 oF to 90 oF).] 270-071-2 68409-99-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-193-00-9 Alkanes, C1-2;Petroleum gas 270-651-5 68475-57-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-194-00-4 Alkanes, C2-3;Petroleum gas 270-652-0 68475-58-1 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-195-00-X Alkanes, C3-4;Petroleum gas 270-653-6 68475-59-2 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-196-00-5 Alkanes, C4-5;Petroleum gas 270-654-1 68475-60-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-197-00-0 Fuel gases;Petroleum gas;[A combination of light gases. It consists predominantly of hydrogen and/or low molecular weight hydrocarbons.] 270-667-2 68476-26-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-198-00-6 Fuel gases, crude oil of distillates;Petroleum gas;[A complex combination of light gases produced by distillation of crude oil and by catalytic reforming of naphtha. It consists of hydrogen and hydrocarbons having carbon numbers predominantly in the range of C1 through C4 and boiling in the range of approximately - 217 oC to - 12 oC (- 423 oF to 10 oF).] 270-670-9 68476-29-9 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-199-00-1 Hydrocarbons, C3-4;Petroleum gas 270-681-9 68476-40-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-200-00-5 Hydrocarbons, C4-5;Petroleum gas 270-682-4 68476-42-6 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-201-00-0 Hydrocarbons, C2-4, C3-rich;Petroleum gas 270-689-2 68476-49-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-202-00-6 Petroleum gases, liquefied;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (- 40 oF to 176 oF).] 270-704-2 68476-85-7 F+; R12Carc. Cat. 1; R45Muta. Cat. 2; R46 F+; TR: 12-45-46S: 53-45  HKS
649-203-00-1 Petroleum gases, liquefied, sweetened;Petroleum gas;[A complex combination of hydrocarbons obtained by subjecting liquefied petroleum gas mix to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C7 and boiling in the range of approximately - 40 oC to 80 oC (-40 oF to 176 oF).] 270-705-8 68476-86-8 F+; R12Carc. Cat. 1; R45Muta. Cat. 2; R46 F+; TR: 12-45-46S: 45-53  HKS
649-204-00-7 Gases (petroleum), C3-4, isobutane-rich;Petroleum gas;[A complex combination of hydrocarbons from the distillation of saturated and unsaturated hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly butane and isobutane. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C4, predominantly isobutane.] 270-724-1 68477-33-8 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-205-00-2 Distillates (petroleum), C3-6, piperylene-rich;Petroleum gas;[A complex combination of hydrocarbons from the distillation of saturated and unsaturated aliphatic hydrocarbons usually ranging in the carbon numbers C3 through C6. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C6, predominantly piperylenes.] 270-726-2 68477-35-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-206-00-8 Gases (petroleum), butane splitter overheads;Petroleum gas;[A complex combination of hydrocarbons obtained from the distillation of the butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.] 270-750-3 68477-69-0 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-207-00-3 Gases (petroleum), C2-;Petroleum gas;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic fractionation process. It contains predominantly ethane, ethylene, propane, and propylene.] 270-751-9 68477-70-3 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-208-00-9 Gases (petroleum), catalytic-cracked gas oil depropanizer bottoms, C4-rich acid-free;Petroleum gas;[A complex combination of hydrocarbons obtained from fractionation of catalytic cracked gas oil hydrocarbon stream and treated to remove hydrogen sulfide and other acidic components. It consists of hydrocarbons having carbon numbers in the range of C3 through C5, predominantly C4.] 270-752-4 68477-71-4 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-209-00-4 Gases (petroleum), catalytic-cracked naphtha debutanizer bottoms, C3-5-rich;Petroleum gas;[A complex combination of hydrocarbons obtained from the stabilization of catalytic cracked naphtha. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C5.] 270-754-5 68477-72-5 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-210-00-X Tail gas (petroleum), isomerized naphtha fractionation stabilizer;Petroleum gas;[A complex combination of hydrocarbons obtained from the fractionation stabilization products from isomerized naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C1 through C4.] 269-628-2 68308-08-7 ⊗ Carc. Cat. 1; R45Muta. Cat. 2; R46 TR: 45-46S: 53-45  H K
649-211-00-5 Foots oil (petroleum), carbon-treated;Foots oil;[A complex combination of hydrocarbons obtained by the treatment of Foots oil with activated carbon for the removal of trace constituents and impurities. It consists predominantly of saturated straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-126-0 97862-76-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-212-00-0 Distillates (petroleum), sweetened middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-088-7 64741-86-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-213-00-6 Gas oils (petroleum), solvent-refined;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-092-9 64741-90-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-214-00-1 Distillates (petroleum), solvent-refined middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-093-4 64741-91-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-215-00-7 Gas oils (petroleum), acid-treated;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-112-6 64742-12-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-216-00-2 Distillates (petroleum), acid-treated middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-113-1 64742-13-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-217-00-8 Distillates (petroleum), acid-treated light;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-114-7 64742-14-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-218-00-3 Gas oils (petroleum), chemically neutralized;Gasoil — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-129-9 64742-29-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-219-00-9 Distillates (petroleum), chemically neutralized middle;Gasoil — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C20 and boiling in the range of approximately 205 oC to 345 oC (401 oF to 653 oF).] 265-130-4 64742-30-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-220-00-4 Distillates (petroleum), clay-treated middle;Gasoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 150 oC to 345 oC (302 oF to 653 oF).] 265-139-3 64742-38-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-221-00-X Distillates (petroleum), hydrotreated middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-148-2 64742-46-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-222-00-5 Gas oils (petroleum), hydrodesulfurized;Gasoil — unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C25 and boiling in the range of approximately 230 oC to 400 oC (446 oF to 752 oF).] 265-182-8 64742-79-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-223-00-0 Distillates (petroleum), hydrodesulfurized middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 265-183-3 64742-80-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-224-00-6 Fuels, diesel;Gasoil — unspecified;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C20 and boiling in the range of approximately 163 oC to 357 oC (325 oF to 675 oF).] 269-822-7 68334-30-5 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  H N
649-225-00-1 Fuel oil, No 2;Gasoil — unspecified;[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF) to a maximum of 37,9 SUS at 37,7 oC (100 oF).] 270-671-4 68476-30-2 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  H
649-226-00-7 Fuel oil, No 4;Gasoil — unspecified;[A distillate oil having a minimum viscosity of 45 SUS at 37,7 oC (100 oF) to a maximum of 125 SUS at 37,7 oC (100 oF).] 270-673-5 68476-31-3 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  H
649-227-00-2 Fuels, diesel, No 2;Gasoil — unspecified;[A distillate oil having a minimum viscosity of 32,6 SUS at 37,7 oC (100 oF).] 270-676-1 68476-34-6 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  H
649-228-00-8 Distillates (petroleum), catalytic reformer fractionator residue, high-boiling;Gasoil — unspecified; [A complex combination of hydrocarbons from the distillation of catalytic reformer fracftionator residue. It boils in the range of approximately 343 oC to 399 oC (650 oF to 750 oF).] 270-719-4 68477-29-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-229-00-3 Distillates (petroleum), catalytic reformer fractionator residue, intermediate-boiling;Gasoil — unspecified;[A complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils in the range of approximately 288 oC to 371 oC (550 oF to 700 oF).] 270-721-5 68477-30-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-230-00-9 Distillates (petroleum), catalytic reformer fractionator residue, low-boiling;Gasoil — unspecified;[The complex combination of hydrocarbons from the distillation of catalytic reformer fractionator residue. It boils approximately below 288 oC (550 oF).] 270-722-0 68477-31-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-231-00-4 Distillates (petroleum), highly refined middle;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by the subjection of a petroleum fraction to several of the following steps: filtration, centrifugation, atmospheric distillation, vacuum distillation, acidification, neutralization and clay treatment. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C20.] 292-615-8 90640-93-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-232-00-X Distillates (petroleum) catalytic reformer, heavy arom. conc.;Gasoil — unspecified;[A complex combination of hydrocarbons obtained from the distillation of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C10 through C16 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).] 295-294-2 91995-34-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-233-00-5 Gas oils, paraffinic;Gasoil — unspecified;[A distillate obtained from the redistillation of a complex combination of hydrocarbons obtained by the distillation of the effluents from a severe catalytic hydrotreatment of paraffins. It boils in the range of approximately 190 oC to 330 oC (374 oF to 594 oF).] 300-227-8 93924-33-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-234-00-0 Naphtha (petroleum), solvent-refined hydrodesulfurized heavy;Gasoil — unspecified 307-035-3 97488-96-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-235-00-6 Hydrocarbons, C16-20, hydrotreated middle distillate, distn. lights;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a middle distillate with hydrogen. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 290 oC to 350 oC (554 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-659-6 97675-85-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-236-00-1 Hydrocarbons, C12-20, hydrotreated paraffinic, distn. lights;Gasoil — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of heavy paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C20 and boiling in the range of approximately 230 oC to 350 oC (446 oF to 662 oF). It produces a finished oil having a viscosity of 2cSt at 100 oC (212 oF).] 307-660-1 97675-86-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-237-00-7 Hydrocarbons, C11-17, solvent-extd. light naphthenic;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a visciosity of 2.2 cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 200 oC to 300 oC (392 oF to 572 oF).] 307-757-9 97722-08-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-238-00-2 Gas oils, hydrotreated;Gasoil — unspecified;[A complex combination of hydrocarbons obtained from the redistillation of the effluents from the treatment of paraffins with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C27 and boiling in the range of approximately 330 oC to 340 oC (626 oF to 644 oF).] 308-128-1 97862-78-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-239-00-8 Distillates (petroleum), carbon-treated light paraffinic;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by the treatment of a petroleum oil fraction with activated charcoal for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C28.] 309-667-5 100683-97-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-240-00-3 Distillates (petroleum), intermediate paraffinic, carbon-treated;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by the treatment of petroleum with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-668-0 100683-98-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-241-00-9 Distillates (petroleum), intermediate paraffinic, clay-treated;Gasoil — unspecified;[A complex combination of hydrocarbons obtained by the treatment of petroleum with bleaching earth for the removal of trace polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 309-669-6 100683-99-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-242-00-4 Alkanes, C12-26-branched and linear 292-454-3 90622-53-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-243-00-X Lubricating greases;Grease;[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C12 through C50. May contain organic salts of alkali metals, alkaline earth metals, and/or aluminium compounds.] 278-011-7 74869-21-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-244-00-5 Slack wax (petroleum);Slack wax;[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent crystallization (solvent dewaxing) or as a distillation fraction from a very waxy crude. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 265-165-5 64742-61-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-245-00-0 Slack wax (petroleum), acid-treated;Slack wax;[A complex combination of hydrocarbons obtained as a raffinate by treatment of a petroleum slack wax fraction with sulfuric acid treating process. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 292-659-8 90669-77-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-246-00-6 Slack wax (petroleum), clay-treated;Slack wax;[A complex combination of hydrocarbons obtained by treatment of a petroleum slack wax fraction with natural or modified clay in either a contacting or percolation process. It consists predominantly of saturated straight and branched hydrocarbons having carbon numbers predominantly greater than C20.] 292-660-3 90669-78-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-247-00-1 Slack wax (petroleum), hydrotreated;Slack wax;[A complex combination of hydrocarbons obtained by treating slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C20.] 295-523-6 92062-09-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-248-00-7 Slack wax (petroleum), low-melting;Slack wax;[A complex combination of hydrocarbons obtained from a petroleum fraction by solvent deparaffination. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-524-1 92062-10-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-249-00-2 Slack wax (petroleum), low-melting, hydrotreated;Slack wax;[A complex combination of hydrocarbons obtained by treatment of low-melting petroleum slack wax with hydrogen in the presence of a catalyst. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 295-525-7 92062-11-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-250-00-8 Slack wax (petroleum), low-melting, carbon-treated;Slack wax;[A complex combination of hydrocarbons obtained by the treatment of low-melting slack wax with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-155-9 97863-04-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-251-00-3 Slack wax (petroleum), low-melting, clay-treated;Slack wax;[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with bentonite for removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-156-4 97863-05-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-252-00-9 Slack wax (petroleum), low-melting, silicic acid-treated;Slack wax;[A complex combination of hydrocarbons obtained by the treatment of low-melting petroleum slack wax with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated straight and branched chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-158-5 97863-06-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-253-00-4 Slack wax (petroleum), carbon-treated;Slack wax;[A complex combination of hydrocarbons obtained by treatment of petroleum slack wax with activated charcoal for the removal of trace polar constituents and impurities.] 309-723-9 100684-49-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-254-00-X Petrolatum;Petrolatum;[A complex combination of hydrocarbons obtained as a semi-solid from dewaxing paraffinic residual oil. It consists predominantly of saturated crystalline and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 232-373-2 8009-03-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-255-00-5 Petrolatum (petroleum), oxidized;Petrolatum;[A complex combination of organic compounds, predominantly high molecular weight carboxylic acids, obtained by the air oxidation of petrolatum.] 265-206-7 64743-01-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-256-00-0 Petrolatum (petroleum), alumina-treated;Petrolatum;[A complex combination of hydrocarbons obtained when petrolatum is treated with Al2O3 to remove polar components and impurities. It consists predominantly of saturated, crystalline, and liquid hydrocarbons having carbon numbers predominantly greater than C25.] 285-098-5 85029-74-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-257-00-6 Petrolatum (petroleum), hydrotreated;Petrolatum;[A complex combination of hydrocarbons obtained as a semi-solid from dewaxed paraffinic residual oil treated with hydrogen in the presence of a catalyst. It consists predominantly of saturated microcrystalline and liquid hydrocarbons having carbon numbers predominantly greater than C20.] 295-459-9 92045-77-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-258-00-1 Petrolatum (petroleum), carbon-treated;Petrolatum;[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with activated carbon for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-149-6 97862-97-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-259-00-7 Petrolatum (petroleum), silicic acid-treated;Petrolatum;[A complex combination of hydrocarbons obtained by the treatment of petroleum petrolatum with silicic acid for the removal of trace polar constituents and impurities. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly greater than C20.] 308-150-1 97862-98-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-260-00-2 Petrolatum (petroleum), clay-treated;Petrolatum;[A complex combination of hydrocarbons obtained by treatment of petrolatum with bleaching earth for the removal of traces of polar constituents and impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of greater than C25.] 309-706-6 100684-33-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H N
649-261-00-8 Gasoline, natural;Low boiling point naphtha;[A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20 oC to 120 oC (-4 oF to 248 oF).] 232-349-1 8006-61-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-262-00-3 Naphtha;Low boiling point naphtha;[Refined, partly refined, or unrefined petroleum products by the distillation of natural gas. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).] 232-443-2 8030-30-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-263-00-9 Ligroine;Low boiling point naphtha;[A complex combination of hydrocarbons obtained by the fractional distillation of petroleum. This fraction boils in a range of approximately 20 oC to 135 oC (58 oF to 275 oF).] 232-453-7 8032-32-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-264-00-4 Naphtha (petroleum), heavy straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-041-0 64741-41-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-265-00-X Naphtha (petroleum), full-range straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 220 oC (-4 oF to 428 oF).] 265-042-6 64741-42-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-266-00-5 Naphtha (petroleum), light straight-run;Low boiling point naphtha;[A complex combination of hydrocarbons produced by distillation of crude oil. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately minus 20 oC to 180 oC (-4 oF to 356 oF).] 265-046-8 64741-46-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-267-00-0 Solvent naphtha (petroleum), light aliph.;Low boiling point naphtha;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 35 oC to 160 oC (95 oF to 320 oF).] 265-192-2 64742-89-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-268-00-6 Distillates (petroleum), straight-run light;Low boiling point naphtha;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C7 and boiling in the range of approximately - 88 oC to 99 oC (-127 oF to 210 oF).] 270-077-5 68410-05-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-269-00-1 Gasoline, vapor-recovery;Low boiling point naphtha;[A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 196 oC (-4 oF to 384 oF).] 271-025-4 68514-15-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-270-00-7 Gasoline, straight-run, topping-plant;Low boiling point naphtha;[A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36,1 oC to 193,3 oC (97 oF to 380 oF).] 271-727-0 68606-11-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-271-00-2 Naphtha (petroleum), unsweetened;Low boiling point naphtha;[A complex combination of hydrocarbons produced from the distillation of naphtha streams from various refinery processes. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 0 oC to 230 oC (25 oF to 446 oF).] 272-186-3 68783-12-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-272-00-8 Distillates (petroleum), light straight-run gasoline fractionation stabilizer overheads;Low boiling point naphtha;[A complex combination of hydrocarbons having carbon numbers predominantly in the range of C3 through C6..] 272-931-2 68921-08-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-273-00-3 Naphtha (petroleum), heavy straight run, arom.-contg.;Low boiling point naphtha;[A complex combination of hydrocarbons obtained from a distillation process of crude petroleum. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).] 309-945-6 101631-20-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-274-00-9 Naphtha (petroleum), full-range alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consist of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).] 265-066-7 64741-64-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-275-00-4 Naphtha (petroleum), heavy alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 to C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 150 oC to 220 oC (302 oF to 428 oF).] 265-067-2 64741-65-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-276-00-X Naphtha (petroleum), light alkylate;Low boiling point modified naphtha;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of aproximately 90 oC to 160 oC (194 oF to 320 oF).] 265-068-8 64741-66-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-277-00-5 Naphtha (petroleum), isomerization;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained from catalytic isomerization of straight chain paraffinic C4 through C6 hydrocarbons. It consists predominantly of saturated hydrocarbons such as isobutane, isopentane, 2,2-dimethylbutane, 2-methylpentane, and 3-methylpentane.] 265-073-5 64741-70-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-278-00-0 Naphtha (petroleum), solvent-refined light;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).] 265-086-6 64741-84-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-279-00-6 Naphtha (petroleum), solvent-refined heavy;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-095-5 64741-92-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-280-00-1 Raffinates (petroleum), catalytic reformer ethylene glycol-water countercurrent exts.;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinate from the UDEX extraction process on the catalytic reformer stream. It consists of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C9.] 270-088-5 68410-71-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-281-00-7 Raffinates (petroleum), reformer, Lurgi unit-sepd.;Low boiling point modified naphtha;[The complex combination of hydrocarbons obtained as a raffinate from a Lurgi separation unit. It consists predominantly of non-aromatic hydrocarbons with various small amounts of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8.] 270-349-3 68425-35-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-282-00-2 Naphtha (petroleum), full-range alkylate, butane-contg.;Low boiling point modified naphta;[A complex combination of hydrocarbons produced by the distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydrocarbons having carbon numbers predominantly in the range of C7 through C12 with some butanes and boiling in the range of approximately 35 oC to 200 oC (95 oF to 428 oF).] 271-267-0 68527-27-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-283-00-8 Distillates (petroleum), naphtha steam cracking-derived, solvent-refined light hydrotreated;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained as the raffinates from a solvent extraction process of hydrotreated light distillate from steam-cracked naphtha.] 295-315-5 91995-53-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-284-00-3 Naphtha (petroleum), C4-12 butane-alkylate, isooctane-rich;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained by alkylation of butanes. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12, rich in isooctane, and boiling in the range of approximately 35 oC to 210 oC (95 oF to 410 oF).] 295-430-0 92045-49-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-285-00-9 Hydrocarbons, hydrotreated light naphtha distillates, solvent-refined;Low boiling point modified naphtha;[A combination of hydrocarbons obtained from the distillation of hydrotreated naphtha followed by a solvent extraction and distillation process. It consists predominantly of saturated hydrocarbons boiling in the range of approximately 94 oC to 99 oC (201 oF to 210 oF).] 295-436-3 92045-55-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-286-00-4 Naphtha (petroleum), isomerization, C6-fraction;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained by distillation of a gasoline which has been catalytically isomerized. It consists predominantly of hexane isomers boiling in the range of approximately 60 oC to 66 oC (140 oF to 151 oF).] 295-440-5 92045-58-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-287-00-X Hydrocarbons, C6-7, naphtha-cracking, solvent-refined;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained by the sorption of benzene from a catalytically fully hydrogenated benzene-rich hydrocarbon cut that was distillatively obtained from prehydrogenated cracked naphtha. It consists predominantly of paraffinic and naphthenic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 70 oC to 100 oC (158 oF to 212 oF).] 295-446-8 92045-64-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-288-00-5 Hydrocarbons, C6-rich, hydrotreated light naphtha distillates, solvent-refined;Low boiling point modified naphtha;[A complex combination of hydrocarbons obtained by distillation of hydrotreated naphtha followed by solvent extraction. It consists predominantly of saturated hydrocarbons and boiling in the range of approximately 65 oC to 70 oC (149 oF to 158 oF).] 309-871-4 101316-67-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-289-00-0 Naphtha (petroleum), heavy catalytic cracked;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by a distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-055-7 64741-54-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-290-00-6 Naphtha (petroleum), light catalytic cracked;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (-4 oF to 374 oF). It contains a relatively large proportion of unsaturated hydrocarbons.] 265-056-2 64741-55-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-291-00-1 Hydrocarbons, C3-11, catalytic cracker distillates;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillations of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C11 and boiling in a range approximately up to 204 oC (400 oF).] 270-686-6 68476-46-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-292-00-7 Naphtha (petroleum), catalytic cracked light distd.;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C1 through C5.] 272-185-8 68783-09-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-293-00-2 Distillates (petroleum), naphtha steam cracking-derived, hydrotreated light arom.;Low boiling point cat-cracked naphtha.;[A complex combination of hydrocarbons obtained by treating a light distillate from steam-cracked naphtha. It consists predom-inantly of aromatic hydrocarbons.] 295-311-3 91995-50-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-294-00-8 Naphtha (petroleum), heavy catalytic cracked, sweetened;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting a catalytic cracked petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 60 oC to 200 oC (140 oF to 392 oF).] 295-431-6 92045-50-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-295-00-3 Naphtha (petroleum), light catalytic cracked sweetened;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting naphtha from a catalytic cracking process to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons boiling in a range of approxim-ately 35 oC to 210 oC (95 oF to 410 oF).] 295-441-0 92045-59-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-296-00-9 Hydrocarbons, C8-12, catalytic-cracking, chem. neutralized;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of a cut from the catalytic cracking process, having undergone an alkaline washing. It consists predominantly of hydrocarbons having carbon numbers in the range of C8 through C12 and boiling in the range of approximately 130 oC to 210 oC (266 oF to 410 oF).] 295-794-0 92128-94-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-297-00-4 Hydrocarbons, C8-12, catalytic cracker distillates;Low boiling point cat-cracked naphtha;[A complex combination of hydrocarbons obtained by distillation of products from a catalytic cracking process. It consists pre-dominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C12 and boiling in the range of approximately 140 oC to 210 oC (284 oF to 410 oF).] 309-974-4 101794-97-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-298-00-X Hydrocarbons, C8-12, catalytic cracking, chem. neutralized, sweetened;Low boiling point cat-cracked naphtha 309-987-5 101896-28-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-299-00-5 Naphtha (petroleum), light catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.] 265-065-1 64741-63-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-300-00-9 Naphtha (petroleum), heavy catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced from the distillation of products from a catalytic reforming process. It consists of predominantly aromatic hydrocarbons having numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-070-9 64741-68-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-301-00-4 Distillates (petroleum), catalytic reformed depentanizer;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons from the distillation of products from a catalytic reforming process. It consists predominantly of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 63 oC - 57 oF to 145 oF).] 270-660-4 68475-79-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-302-00-X Hydrocarbons, C2-6, C6-8 catalytic reformer;Low boiling point cat-reformed naphtha 270-687-1 68476-47-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-303-00-5 Residues (petroleum), C6-8 catalytic reformer;Low boiling point cat-reformed naphtha;[A complex residuum from the catalytic reforming of C6-8 feed. It consists of hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 270-794-3 68478-15-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-304-00-0 Naphtha (petroleum), light catalytic reformed, arom.-free;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained from distillation of products from a catalytic reforming process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 35 oC to 120 oC (95 oF to 248 oF). It contains a relatively large proportion of branched chain hydrocarbons with the aromatic components removed.] 270-993-5 68513-03-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-305-00-6 Distillates (petroleum), catalytic reformed straight-run naphtha overheads;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by the catalytic reforming of straight-run naphtha followed by the fractionation of the total effluent. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 271-008-1 68513-63-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-306-00-1 Petroleum products, hydrofiner-powerformer reformates;Low boiling point cat-reformed naphtha;[The complex combination of hydrocarbons obtained in a hydrofiner-powerformer process and boiling in a range of approximately 27 oC to 210 oC (80 oF to 410 oF).] 271-058-4 68514-79-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-307-00-7 Naphtha (petroleum, full-range reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced by the distillation of the products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).] 272-895-8 68919-37-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-308-00-2 Naphtha (petroleum), catalytic reformed;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic reforming process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 220 oC (90 oF to 430 oF). It contains a relatively large proportion of aromatic and branched chain hydrocarbons. This stream may contain 10 vol. % or more benzene.] 273-271-8 68955-35-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-309-00-8 Distillates (petroleum), catalytic reformed hydrotreated light, C8-12 arom. fraction;Low boiling point cat-reformed naphtha;[A complex combination of alkylbenzenes obtained by the catalytic reforming of petroleum naphtha. It consists predominantly of alkylbenzenes having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 160 oC to 180 oC (320 oF to 356 oF).] 285-509-8 85116-58-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-310-00-3 Aromatic hydrocarbons, C8, catalytic reforming-derived;Low boiling point cat-reformed naphtha 295-279-0 91995-18-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-311-00-9 Aromatic hydrocarbons, C7-12, C8-rich;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130 oC to 200 oC (266 oF to 392 oF).] 297-401-8 93571-75-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-312-00-4 Gasoline, C5-11, high-octane stabilized reformed;Low boiling point cat-reformed naphtha;[A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45 oC to 185 oC (113 oF to 365 oF).] 297-458-9 93572-29-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-313-00-X Hydrocarbons, C7-12, C >9-arom.-rich, reforming heavy fraction;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 120 oC to 210 oC (248 oF to 380 oF) and C9 and higher aromatic hydrocarbons.] 297-465-7 93572-35-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-314-00-5 Hydrocarbons, C5-11, nonaroms.-rich, reforming light fraction;Low boiling point cat-reformed naphtha;[A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of nonaromatic hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 35 oC to 125 oC (94 oF to 257 oF), benzene and toluene.] 297-466-2 93572-36-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-315-00-0 Foots oil (petroleum), silicic acid-treated;Foots oil;[A complex combination of hydrocarbons obtained by the treatment of Foots oil with silicic acid for removal of trace constituents and impurities. It consists predominantly of straight chain hydrocarbons having carbon numbers predominantly greater than C12.] 308-127-6 97862-77-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-316-00-6 Naphtha (petroleum), light thermal cracked;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons from distillation of products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 10 oC to 130 oC (14 oF to 266 oF).] 265-075-6 64741-74-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-317-00-1 Naphtha (petroleum), heavy thermal cracked;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons from distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 220 oC (148 oF to 428 oF).] 265-085-0 64741-83-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-318-00-7 Distillates (petroleum), heavy arom.;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This higher boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having carbon number predominantly of C5. This stream may contain benzene.] 267-563-4 67891-79-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-319-00-2 Distillates (petroleum), light arom.;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons from the distillation of the products from the thermal cracking of ethane and propane. This lower boiling fraction consists predominantly of C5-C7 aromatic hydrocarbons with some unsaturated aliphatic hydrocarbons having a carbon number predominantly of C5. This stream may contain benzene.] 267-565-5 67891-80-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-320-00-8 Distillates (petroleum), naphtha-raffinate pyrolyzate-derived, gasoline-blending;Low boiling point thermally cracked naphtha;[The complex combination of hydrocarbons obtained by the pyrolysis fractionation at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of hydrocarbons having a carbon number of C9 and boiling at approximately 204 oC (400 oF).] 270-344-6 68425-29-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-321-00-3 Aromatic hydrocarbons, C6-8, naphtha-raffinate pyrolyzate-derived;Low boiling point thermally cracked naphtha;A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816 oC (1500 oF) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.] 270-658-3 68475-70-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-322-00-9 Distillates (petroleum), thermal cracked naphtha and gas oil;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by distillation of thermally cracked naphtha and/or gas oil. It consists predominantly of olefinic hydrocarbons having a carbon number of C5 and boiling in the range of approximately 33 oC to 60 oC (91 oF to 140 oF).] 271-631-9 68603-00-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-323-00-4 Distillates (petroleum), thermal cracked naphtha and gas oil, C5-dimer-contg.;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists predominantly of hydrocarbons having a carbon number of C5 with some dimerized C5 olefins and boiling in the range of approximately 33 oC to 184 oC (91 oF to 363 oF).] 271-632-4 68603-01-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-324-00-X Distillates (petroleum), thermal cracked naphtha and gas oil, extractive;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by the extractive distillation of thermal cracked naphtha and/or gas oil. It consists of paraffinic and olefinic hydrocarbons, predominantly isoamylenes such as 2-methyl-1-butene and 2-methyl-2-butene and boiling in the range of approximately 31 oC to 40 oC (88 oF to 104 oF).] 271-634-5 68603-03-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-325-00-5 Distillates (petroleum), light thermal cracked, debutanized arom.;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons produced by the distillation of products from a thermal cracking process. It consists predominantly of aromatic hydrocarbons, primarily benzene.] 273-266-0 68955-29-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-326-00-0 Naphtha (petroleum), light thermal cracked, sweetened;Low boiling point thermally cracked naphtha;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate from the high temperature thermal cracking of heavy oil fractions to a sweetening process to convert mercaptans. It consists predominantly of aromatics, olefins and saturated hydrocarbons boiling in the range of approximately 20 oC to 100 oC (68 oF to 212 oF).] 295-447-3 92045-65-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-327-00-6 Naphtha (petroleum), hydrotreated heavy;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C13 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-150-3 64742-48-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-328-00-1 Naphtha (petroleum), hydrotreated light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-151-9 64742-49-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-329-00-7 Naphtha (petroleum), hydrodesulfurized light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-178-6 64742-73-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-330-00-2 Naphtha (petroleum), hydrodesulfurized heavy;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-185-4 64742-82-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-331-00-8 Distillates (petroleum), hydrotreated middle, intermediate boiling;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by the distillation of products from a middle distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C5 through C10 and boiling in the range of approximately 127 oC to 188 oC (262 oF to 370 oF).] 270-092-7 68410-96-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-332-00-3 Distillates (petroleum), light distillate hydrotreating process, low-boiling;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by the distillation of products from the light distillate hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C9 and boiling in the range of approximately 3 oC to 194 oC (37 oF to 382 oF).] 270-093-2 68410-97-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-333-00-9 Distillates (petroleum), hydrotreated heavy naphtha, deisohexanizer overheads;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by distillation of the products from a heavy naphtha hydrotreating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 49 oC to 68 oC (- 57 oF to 155 oF).] 270-094-8 68410-98-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-334-00-4 Solvent naphtha (petroleum), light arom., hydrotreated;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).] 270-988-8 68512-78-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-335-00-X Naphtha (petroleum), hydrodesulfurized thermal cracked light;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by fractionation of hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 195 oC (73 oF to 383 oF).] 285-511-9 85116-60-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-336-00-5 Naphtha (petroleum), hydrotreated light, cycloalkane-contg.;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from the distillation of a petroleum fraction. It consists predominantly of alkanes and cycloalkanes boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 285-512-4 85116-61-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-337-00-0 Naphtha (petroleum), heavy steam-cracked, hydrogenated;Low boiling point hydrogen treated naphtha 295-432-1 92045-51-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-338-00-6 Naphtha (petroleum), hydrodesulfurized full-range;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained from a catalytic hydrodesulfurization process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately 30 oC to 250 oC (86 oF to 482 oF).] 295-433-7 92045-52-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-339-00-1 Naphtha (petroleum), hydrotreated light steam-cracked;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction, derived from a pyrolysis process, with hydrogen in the presence of a catalyst. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 35 oC to 190 oC (95 oF to 374 oF).] 295-438-4 92045-57-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-340-00-7 Hydrocarbons, C4-12, naphtha-cracking, hydrotreated;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by distillation from the product of a naphtha steam cracking process and subsequent catalytic selective hydrogenation of gum formers. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 30 oC to 230 oC (86 oF to 446 oF).] 295-443-1 92045-61-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-341-00-2 Solvent naphtha (petroleum), hydrotreated light naphthenic;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists predominantly of cycloparaffinic hydrocarbons having carbon numbers predominantly in the range of C6 through C7 and boiling in the range of approximately 73 oC to 85 oC (163 oF to 185 oF).] 295-529-9 92062-15-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-342-00-8 Naphtha (petroleum), light steam-cracked, hydrogenated;Low boiling point hydrogen treated naphtha;[A complex comination of hydrocarbons produced from the separation and subsequent hydrogenation of the products of a steam-cracking process to produce ethylene. It consists predominantly of saturated and unsaturated paraffins, cyclic paraffins and cyclic aromatic hydrocarbons having carbon numbers predominantly in the range of C4 through C10 and boiling in the range of approximately 50 oC to 200 oC (122 oF to 392 oF). The proportion of benzene hydrocarbons may vary up to 30 wt. % and the stream may also contain small amounts of sulphur and oxygenated compounds.] 296-942-7 93165-55-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-343-00-3 Hydrocarbons, C6-11, hydrotreated, dearomatized;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-852-0 93763-33-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-344-00-9 Hydrocarbons, C9-12, hydrotreated, dearomatized;Low boiling point hydrogen treated naphtha;[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-853-6 93763-34-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-345-00-4 Stoddard solvent;Low boiling point naphtha — unspecified;[A colourless, refined petroleum distillate that is free from rancid or objectionable odors and that boils in a range of approximately 300 oF to 400 oF.] 232-489-3 8052-41-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-346-00-X Natural gas condensates (petroleum);Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons separated as a liquid from natural gas in a surface separator by retrograde condensation. It consists mainly of hydrocarbons having carbon numbers predominantly in the range of C2 to C20. It is a liquid at atmospheric temperature and pressure.] 265-047-3 64741-47-5 Carc. Cat. 2; R4Xn; R65 TR: 45-65S: 53-45  H P
649-347-00-5 Natural gas (petroleum), raw liq. mix;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons separated as a liquid from natural gas in a gas recycling plant by processes such as refrigeration or absorption. It consists mainly of saturated aliphatic hydrocarbons having carbon numbers in the range of C2 through C8.] 265-048-9 64741-48-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-348-00-0 Naphtha (petroleum), light hydrocracked;Low boiling naphtha — unspecified;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C4 through C10, and boiling in the range of approximately minus 20 oC to 180 oC (- 4 oF to 356 oF).] 265-071-4 64741-69-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-349-00-6 Naphtha (petroleum), heavy hydrocracked;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C6 through C12, and boiling in the range of approximately 65 oC to 230 oC (148 oF to 446 oF).] 265-079-8 64741-78-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-350-00-1 Naphtha (petroleum), sweetened;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately minus 10 oC to 230 oC (14 oF to 446 oF).] 265-089-2 64741-87-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-351-00-7 Naphtha (petroleum), acid-treated;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained as a raffinate from a sulfuric acid treating process. It consists of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 230 oC (194 oF to 446 oF).] 265-115-2 64742-15-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-352-00-2 Naphtha (petroleum), chemically neutralized heavy;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C6 through C12 and boiling in the range of approximately 65 oC to 230 oC (149 oF to 446 oF).] 265-122-0 64742-22-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-353-00-8 Naphtha (petroleum), chemically neutralized light;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF).] 265-123-6 64742-23-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-354-00-3 Naphtha (petroleum), catalytic dewaxed;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from the catalytic dewaxing of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12 and boiling in the range of approximately 35 oC to 230 oC (95 oF to 446 oF).] 265-170-2 64742-66-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-355-00-9 Naphtha (petroleum), light steam-cracked;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately minus 20 oC to 190 oC (- 4 oF to 374 oF). This stream is likely to contain 10 vol.% or more benzene.] 265-187-5 64742-83-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-356-00-4 Solvent naphtha (petroleum), light arom.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C10 and boiling in the range of approximately 135 oC to 210 oC (275 oF to 410 oF).] 265-199-0 64742-95-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-357-00-X Aromatic hydrocarbons, C6-10, acid-treated, neutralized;Low boiling point naphtha — unspecified 268-618-5 68131-49-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-358-00-5 Distillates (petroleum), C3-5, 2-methyl-2-butene-rich;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons from the distillation of hydrocarbons usually ranging in carbon numbers from C3 through C5, predominantly isopentane and 3-methyl-1-butene. It consists of saturated and unsaturated hydrocarbons having carbon numbers in the range of C3 through C5, predominantly 2-methyl-2-butene.] 270-725-7 68477-34-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-359-00-0 Distillates (petroleum), polymd. steam-cracked petroleum distillates, C5-12 fraction;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from the distillation of polymerized steam-cracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] 270-735-1 68477-50-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-360-00-6 Distillates (petroleum), steam-cracked, C5-12 fraction;Low boiling point naphtha — unspecified;[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists of unsaturated hydrocarbons having carbon numbers predominantly in the range of C5 through C12.] 270-736-7 68477-53-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-361-00-1 Distillates (petroleum), steam-cracked, C5-10 fraction, mixed with light steam-cracked petroleum naphtha C5 fraction;Low boiling point naphtha — unspecified 270-738-8 68477-55-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-362-00-7 Extracts (petroleum), cold-acid, C4-6;Low boiling point naphtha — unspecified;[A complex combination of organic compounds produced by cold acid unit extraction of saturated and unsaturated aliphatic hydrocarbons usually ranging in carbon numbers from C3 through C6, predominantly pentanes and amylenes. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 270-741-4 68477-61-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-363-00-2 Distillates (petroleum), depentanizer overheads;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from a catalytic cracked gas stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-771-8 68477-89-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-364-00-8 Residues (petroleum), butane splitter bottoms;Low boiling point naphtha — unspecified;[A complex residuum from the distillation of butane stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4through C6.] 270-791-7 68478-12-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-365-00-3 Residual oils (petroleum), deisobutanizer tower;Low boiling point naphtha — unspecified;[A complex residuum from the atmospheric distillation of the butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C6.] 270-795-9 68478-16-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-366-00-9 Naphtha (petroleum), full-range coker;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C4 through C15 and boiling in the range of approximately 43 oC to 250 oC (110 oF to 500 oF).] 270-991-4 68513-02-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-367-00-4 Naphtha (petroleum), steam-cracked middle arom.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by the distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 130 oC to 220 oC (266 oF to 428 oF).] 271-138-9 68516-20-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-368-00-X Naphtha (petroleum), clay-treated full-range straight-run;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons resulting from treatment of full-range straight-run naphtha with natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately - 20 oC to 220 oC (- 4 oF to 429 oF).] 271-262-3 68527-21-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-369-00-5 Naphtha (petroleum), clay-treated light straight-run;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons resulting from treatment of light straight-run naphtha with a natural or modified clay, usually in a percolation process to remove the trace amounts of polar compounds and impurities, present. It consists of hydro-carbons having carbon numbers predominantly in the range of C7 through C10 and boiling in the range of approximately 93 oC to 180 oC (200 oF to 356 oF.] 271-263-9 68527-22-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-370-00-0 Naphtha (petroleum), light steam-cracked arom.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C9 and boiling in the range of approximately 110 oC to 165 oC (230 oF to 329 oF).] 271-264-4 68527-23-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-371-00-6 Naphtha (petroleum), light steam-cracked, debenzenized;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by distillation of products from a steam-cracking process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C12 and boiling in the range of approximately 80 oC to 218 oC (176 oF to 424 oF).] 271-266-5 68527-26-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-372-00-1 Naphtha (petroleum), arom.-contg.;Low boiling point naphtha — unspecified 271-635-0 68603-08-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-373-00-7 Gasoline, pyrolysis, debutanizer bottoms;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.] 271-726-5 68606-10-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-374-00-2 Naphtha (petroleum), light, sweetened;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of saturated and unsaturated hydrocarbons having carbon numbers predominantly in the range of C3 through C6 and boiling in the range of approximately - 20 oC to 100 oC (- 4 oF to 212 oF).] 272-206-0 68783-66-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-375-00-8 Natural gas condensates;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons separated and/or condensed from natural gas during transportation and collected at the wellhead and/or from the production, gathering, transmission, and distribution pipelines in deeps, scrubbers, etc. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C2 through C8.] 272-896-3 68919-39-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H J
649-376-00-3 Distillates (petroleum), naphtha unifiner stripper;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons produced by stripping the products from the naphtha unifiner. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C2 through C6.] 272-932-8 68921-09-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-377-00-9 Naphtha (petroleum), catalytic reformed light, arom.-free fraction;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons remaining after removal of aromatic compounds from catalytic reformed light naphtha in a selective absorption process. It consists predominantly of paraffinic and cyclic compounds having carbon numbers predominantly in the range of C5 to C8 and boiling in the range of approximately 66 oC to 121 oC (151 oF to 250 oF).] 285-510-3 85116-59-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-378-00-4 Gasoline;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30 oC to 260 oC (86 oF to 500 oF).] 289-220-8 86290-81-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-379-00-X Aromatic hydrocarbons, C7-8, dealkylation products, distn. residues;Low boiling point naphtha — unspecified 292-698-0 90989-42-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-380-00-5 Hydrocarbons, C4-6, depentanizer lights, arom. hydrotreater;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the depentanizer column before hydrotreatment of the aromatic charges. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C4 through C6, predominantly pentanes and pentenes, and boiling in the range of approximately 25 oC to 40 oC (77 oF to 104 oF).] 295-298-4 91995-38-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-381-00-0 Distillates (petroleum), heat-soaked steam-cracked naphtha, C5-rich;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of heat-soaked steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C4 through C6, predominantly C5.] 295-302-4 91995-41-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-382-00-6 Extracts (petroleum), catalytic reformed light naphtha solvent;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained as the extract from the solvent extraction of a catalytically reformed petroleum cut. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C8 and boiling in the range of approximately 100 oC to 200 oC (212 oF to 392 oF).] 295-331-2 91995-68-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-383-00-1 Naphtha (petroleum), hydrodesulfurized light, dearomatized; Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of hydrodesulfurized and dearomatized light petroleum fractions. It consists predominantly of C7 paraffins and cycloparaffins boiling in a range of approximately 90 oC to 100 oC (194 oF to 212 oF).] 295-434-2 92045-53-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-384-00-7 Naphtha (petroleum), light, C5-rich, sweetened;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C5, predominantly C5, and boiling in the range of approximately minus 10 oC to 35 oC (14 oF to 95 oF).] 295-442-6 92045-60-8 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-385-00-2 Hydrocarbons, C8-11, naphtha-cracking, toluene cut;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation from prehydrogenated cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C11 and boiling in the range of approximately 130 oC to 205 oC (266 oF to 401 oF).] 295-444-7 92045-62-0 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-386-00-8 Hydrocarbons, C4-11, naphtha-cracking, arom.-free;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from prehydrogenated cracked naphtha after distillative separation of benzene- and toluene-containing hydrocarbon cuts and a higher boiling fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range C4 through C11 and boiling in the range of approximately 30 oC to 205 oC (86 oF to 401 oF).] 295-445-2 92045-63-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-387-00-3 Naphtha (petroleum), light heat-soaked, steam-cracked;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the fractionation of steam cracked naphtha after recovery from a heat soaking process. It consists predominantly of hydrocarbons having a carbon numbers predominantly in the range of C4 through C6 and boiling in the range of approximately 0 oC to 80 oC (32 oF to 176 oF.] 296-028-8 92201-97-3 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-388-00-9 Distillates (petroleum), C6-rich;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained from the distillation of a petroleum feedstock. It consists predominantly of hydrocarbons having carbon numbers of C5 through C7, rich in C6, and boiling in the range of approximately 60 oC to 70 oC (140 oF to 158 oF).] 296-903-4 93165-19-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-389-00-4 Gasoline, pyrolysis, hydrogenated;Low boiling point naphtha-unspecified;[A distillation fraction from the hydrogenation of pyrolysis gasoline boiling in the range of approximately 20 oC to 200 oC (68 oF to 392 oF).] 302-639-3 94114-03-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-390-00-X Distillates (petroleum), steam-cracked, C8-12 fraction, polymd., distn. lights;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 305-750-5 95009-23-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-391-00-5 Extracts (petroleum) heavy naphtha solvent, clay-treated;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the treatment of heavy naphthic solvent petroleum extract with bleaching earth. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C18 and boiling in the range of approximately 80 oC to 180 oC (175 oF to 356 oF).] 308-261-5 97926-43-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-392-00-0 Naphtha (petroleum), light steam-cracked, debenzenized, thermally treated;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the treatment and distillation of debenzenized light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 95 oC to 200 oC (203 oF to 392 oF).] 308-713-1 98219-46-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-393-00-6 Naphtha (petroleum), light steam-cracked, thermally treated;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the treatment and distillation of light steam-cracked petroleum naphtha. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C6 and boiling in the range of approximately 35 oC to 80 oC (95 oF to 176 oF).] 308-714-7 98219-47-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-394-00-1 Distillates (petroleum), C7-9, C8-rich, hydrodesulfurized dearomatized;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the distillation of petroleum light fraction, hydrodesulfurized and dearomatized. It consists predominantly of hydrocarbons having carbon numbers in the range of C7 through C9, predominantly C8 paraffins and cycloparaffins, boiling in the range of approximately 120 oC to 130 oC (248 oF to 266 oF).] 309-862-5 101316-56-7 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-395-00-7 Hydrocarbons, C6-8, hydrogenated sorption-dearomatized, toluene raffination;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained during the sorptions of toluene from a hydrocarbon fraction from cracked gasoline treated with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C6 through C8 and boiling in the range of approximately 80 oC to 135 oC (176 oF to 275 oF).] 309-870-9 101316-66-9 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-396-00-2 Naphtha (petroleum), hydrodesulfurized full-range coker;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 to C11 and boiling in the range of approximately 23 oC to 196 oC (73 oF to 385 oF).] 309-879-8 101316-76-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-397-00-8 Naphtha (petroleum), sweetened light;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum naphtha to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C5 through C8 and boiling in the range of approximately 20 oC to 130 oC (68 oF to 266 oF).] 309-976-5 101795-01-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-398-00-3 Hydrocarbons, C3-6, C5-rich, steam-cracked naphtha;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of steam-cracked naphtha. It consists predominantly of hydrocarbons having carbon numbers in the range of C3 through C6, predominantly C5.] 310-012-0 102110-14-5 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-399-00-9 Hydrocarbons, C5-rich, dicyclopentadiene-contg.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by distillation of the products from a stream-cracking process. It consists predominantly of hydrocarbons having carbon numbers of C5 and dicyclopentadiene and boiling in the range of approximately 30 oC to 170 oC (86 oF to 338 oF).] 310-013-6 102110-15-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-400-00-2 Residues (petroleum), steam-cracked light, arom.;Low boiling point naphtha — unspecified;[A complex combination of hydrocarbons obtained by the distillation of the products of steam cracking or similar processes after taking off the very light products resulting in a residue starting with hydrocarbons having carbon numbers greater than C5. It consists predominantly of aromatic hydrocarbons having carbon numbers greater than C5 and boiling above approximately 40 oC (104 oF).] 310-057-6 102110-55-4 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-401-00-8 Hydrocarbons, C ≥ 5, C5-6-rich;Low boiling point naphtha — unspecified 270-690-8 68476-50-6 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-402-00-3 Hydrocarbons, C5-rich;Low boiling point naphtha — unspecified 270-695-5 68476-55-1 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-403-00-9 Aromatic hydrocarbons, C8-10;Low boiling point naphtha — unspecified 292-695-4 90989-39-2 Carc. Cat. 2; R45Xn; R65 TR: 45-65S: 53-45  H P
649-404-00-4 Kerosine (petroleum);Straight run kerosine;[A complex combination of hydrocarbons produced by the distillation of crude oil. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (320 oF to 554 oF).] 232-366-4 8008-20-6 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-405-00-X Solvent naphtha (petroleum), medium aliph.;Straight run kerosine;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140 oC to 220 oC (284 oF to 428 oF).] 265-191-7 64742-88-7 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-406-00-5 Solvent naphtha (petroleum) heavy aliph.;Straight run kerosine;[A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C11 through C16 and boiling in the range of approximately 190 oC to 290 oC (374 oF to 554 oF).] 265-200-4 64742-96-7 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-407-00-0 Kerosine (petroleum), straight-run wide-cut;Straight run kerosine;[A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70 oC to 220 oC (158 oF to 428 oF).] 295-418-5 92045-37-9 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-408-00-6 Distillates (petroleum), steam-cracked;Cracked kerosine;[A complex combination of hydrocarbons obtained by the distillation of the products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C7 through C16 and boiling in the range of approximately 90 oC to 290 oC (190 oF to 554 oF).] 265-194-3 64742-91-2 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-409-00-1 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C8-10 fraction;Cracked kerosine;[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists of hydro-carbons having carbon numbers in the range of C8 through C10 and boiling in the range of approximately 129 oC to 194 oC (264 oF to 382 oF).] 270-728-3 68477-39-4 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-410-00-7 Distillates (petroleum), cracked stripped steam-cracked petroleum distillates, C10-12 fraction;Cracked kerosine;[A complex combination of hydrocarbons obtained by distilling cracked stripped steam-cracked distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C10 through C12.] 270-729-9 68477-40-7 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-411-00-2 Distillates (petroleum), steam-cracked, C8-12 fraction;Cracked kerosine;[A complex combination of organic compounds obtained by the distillation of products from a steam cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C8 through C12.] 270-737-2 68477-54-3 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-412-00-8 Kerosine (petroleum), hydrodesulfurized thermal cracked;Cracked kerosine;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120 oC to 283 oC (284 oF to 541 oF).] 285-507-7 85116-55-8 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-413-00-3 Aromtic hydrocarbons, C≥10, steam-cracking, hydrotreated;Cracked kerosine;[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150 oC to 320 oC (302 oF to 608 oF).] 292-621-0 90640-98-5 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-414-00-9 Naphtha (petroleum), steam-cracked, hydrotreated, C9-10-arom.-rich;Cracked kerosine;[A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process thereafter treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers in the range of C9 through C10 and boiling in the range of approximately 140 oC to 200 oC (284 oF to 392 oF).] 292-637-8 90641-13-7 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-415-00-4 Distillates (petroleum), thermal-cracked, alkylarom. hydrocarbon-rich;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of thermal-cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF.] 309-866-7 101316-61-4 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-416-00-X Distillates (petroleum), catalytic cracked heavy tar light;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of catalytic cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-938-8 101631-13-4 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-417-00-5 Solvent naphtha (petroleum), hydrocracked heavy arom.;Cracked kerosine;[A complex combination of hydrocarbons obtained by the distillation of hydrocracked petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 235 oC to 290 oC (455 oF to 554 oF).] 309-881-9 101316-80-7 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-418-00-0 Distillates (petroleum), steam-cracked heavy tar light;Cracked kerosine;[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy tars. It consists predominantly of highly alkylated aromatic hydrocarbons boiling in the range of approximately 100 oC to 250 oC (212 oF to 482 oF).] 309-940-9 101631-15-6 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-419-00-6 Distillates (petroleum), alkylate;Kerosine — unspecified;[A complex combination of hydrocarbons produced by distillation of the reaction products of isobutane with monoolefinic hydrocarbons usually ranging in carbon numbers from C3 through C5. It consists of predominantly branched chain saturated hydro-carbons having carbon numbers predominantly in the range of C11 through C17 and boiling in the range of approximately 205 oC to 320 oC (401 oF to 608 oF).] 265-074-0 64741-73-7 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-420-00-1 Extracts (petroleum), heavy naphtha solvent;Kerosine — unspecified;[A complex combination of hydrocarbons obtained as the extract from a solvent extraction process. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 and boiling in the range of approximately 90 oC to 220 oC (194 oF to 428 oF).] 265-099-7 64741-98-6 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-421-00-7 Distillates (petroleum), chemically neutralized light;Kerosine — unspecified;[A complex combination of hydrocarbons produced by a treating process to remove acidic materials. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-132-5 64742-31-0 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-422-00-2 Distillates (petroleum), hydrotreated light;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-149-8 64742-47-8 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-423-00-8 Kerosine (petroleum), hydrodesulfurized;Kerosine — unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150 oC to 290 oC (302 oF to 554 oF).] 265-184-9 64742-81-0 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-424-00-3 Solvent naphtha (petroleum), heavy arom.; Kerosine — unspecified;[A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 165 oC to 290 oC (330 oF to 554 oF).] 265-198-5 64742-94-5 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-425-00-9 Naphtha (petroleum), heavy coker;Kerosine — unspecified;[A complex combination of hydrocarbons from the distillation of products from a fluid coker. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C6 through C15 and boiling in the range of approximately 157 oC to 288 oC (315 oF to 550 oF).] 269-778-9 68333-23-3 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-426-00-4 Naphtha (petroleum), catalytic reformed hydrodesulfurized heavy, arom. fraction;Kerosine — unspecified;[A complex combination of hydrocarbons produced by fractionation from catalytically reformed hydrodesulfurized naphtha. It consists predominantly of aromatic hydrocarbons having carbon numbers predominently in the range of C7 to C 13 and boiling in the range of approximately 98 oC to 218 oC (208 oF to 424 oF).] 285-508-2 85116-57-0 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-427-00-X Kerosine (petroleum), sweetened;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by subjecting a petroleum distillate to a sweetening process to convert mercaptans or to remove acidic impurities. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of 130 oC to 290 oC (266 oF to 554 oF).] 294-799-5 91770-15-9 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-428-00-5 Kerosine (petroleum), solvent-refined sweetened;Kerosine — unspecified;[A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150 oC to 260 oC (302 oF to 500 oF).] 295-416-4 92045-36-8 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-429-00-0 Hydrocarbons, C9-16, hydrotreated, dearomatized;Kerosine — unspecified;[A complex combination of hydrocarbons obtained as solvents which have been subjected to hydrotreatment in order to convert aromatics to naphthenes by catalytic hydrogenation.] 297-854-1 93763-35-0 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-430-00-6 Kerosine (petroleum), solvent-refined hydrodesulfurized;Kerosine — unspecified 307-033-2 97488-94-3 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-431-00-1 Distillates (petroleum), hydrodesulfurized full-range middle coker;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized coker distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C8 through C16 and boiling in the range of approximately 120 oC to 283 oC (248 oF to 541 oF).] 309-864-6 101316-58-9 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-432-00-7 Solvent naphtha (petroleum), hydrodesulfurized heavy arom.;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 180 oC to 240 oC (356 oF to 464 oF).] 309-882-4 101316-81-8 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-433-00-2 Solvent naphtha (petroleum), hydrodesulfurized medium;Kerosine — unspecified;[A complex combination of hydrocarbons obtained by the catalytic hydrodesulfurization of a petroleum fraction. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C10 through C13 and boiling in the range of approximately 175 oC to 220 oC (347 oF to 428 oF).] 309-884-5 101316-82-9 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-434-00-8 Kerosine (petroleum), hydrotreated;Kerosine — unspecified;[A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230 oC to 270 oC (446 oF to 518 oF).] 309-944-0 101631-19-0 Xn; R65 XnR: 65S: (2-)23-24-62  H
649-435-00-3 Distillates (petroleum), light catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 265-060-4 64741-59-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-436-00-9 Distillates (petroleum), intermediate catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C11 through C30 and boiling in the range of approximately 205 oC to 450 oC (401 oF to 842 oF). It contains a relatively large proportion of tricyclic aromatic hydrocarbons.] 265-062-5 64741-60-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-437-00-4 Distillates (petroleum), light hydrocracked;Cracked gasoil;[A complex combination of hydrocarbons from distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C10 through C18 and boiling in the range of approximately 160 oC to 320 oC (320 oF to 608 oF).] 265-078-2 64741-77-1 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  H
649-438-00-X Distillates (petroleum), light thermal cracked;Cracked gasoil;[A complex combination of hydrocarbons from the distillation of the products from a thermal cracking process. It consists predominantly of unsaturated hydrocarbons having carbon numbers predominantly in the range of C10 through C22 and boiling in the range of approximately 160 oC to 370 oC (320 oF to 698 oF).] 265-084-5 64741-82-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-439-00-5 Distillates (petroleum), hydrodesulfurized light catalytic cracked;Cracked gasoil;[A complex combination of hydrocarbons obtained by treating light catalytic cracked distillates with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C25 and boiling in the range of approximately 150 oC to 400 oC (302 oF to 752 oF). It contains a relatively large proportion of bicyclic aromatic hydrocarbons.] 269-781-5 68333-25-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-440-00-0 Distillates (petroleum), light steam-cracked naphtha;Cracked gasoil;[A complex combination of hydrocarbons from the multiple distillation of products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly in the range of C10 through C18.] 270-662-5 68475-80-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-441-00-6 Distillates (petroleum), cracked steam-cracked petroleum distillates;Cracked gasoil;[A complex combination of hydrocarbons produced by distilling cracked steam cracked distillate and/or its fractionation products. It consists of hydrocarbons having carbon numbers predominently in the range of C10 to low molecular weight polymers.] 270-727-8 68477-38-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-442-00-1 Gas oils (petroleum), steam-cracked;Cracked gasoil;[A complex combination of hydrocarbons produced by distillation of the products from a steam cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C9 and boiling in the range of from approximately 205 oC to 400 oC (400 oF to 752 oF).] 271-260-2 68527-18-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-443-00-7 Distillates (petroleum), hydrodesulfurized thermal cracked middle;Cracked gasoil;[A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized themal cracker distillate stocks. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C11 to C25 and boiling in the range of approximately 205 oC to 400 oC (401 oF to 752 oF).] 285-505-6 85116-53-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-444-00-2 Gas oils (petroleum), thermal-cracked, hydrodesulfurized;Cracked gasoil 295-411-7 92045-29-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-445-00-8 Residues (petroleum), hydrogenated steam-cracked naphtha;Cracked gasoil;[A complex combination of hydrocarbons obtained as a residual fraction from the distillation of hydrotreated steam-cracked naphtha. It consists predominantly of hydrocarbons boiling in the range of approximately 200 oC to 350 oC (32 oF to 662 oF).] 295-514-7 92062-00-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-446-00-3 Residues (petroleum), steam-cracked naphtha distn.;Cracked gasoil;[A complex combination of hydrocarbons obtained as a column bottom from the separation of effluents from steam cracking naphtha at a high temperature. It boils in the range of approximately 147 oC to 300 oC (297 oF to 572 oF) and produces a finished oil having a viscosity of 18cSt at 50 oC.] 295-517-3 92062-04-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-447-00-9 Distillates (petroleum), light catalytic cracked, thermally degraded;Cracked gasoil;[A complex combination of hydrocarbons produced by the distillation of products from a catalytic cracking process which has been used as a heat transfer fluid. It consists predominantly of hydrocarbons boiling in the range of approximately 190 oC to 340 oC (374 oF to 644 oF). This stream is likely to contain organic sulfur compounds.] 295-991-1 92201-60-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-448-00-4 Residues (petroleum), steam-cracked heat-soaked naphtha;Cracked gasoil;[A complex combination of hydrocarbons obtained as residue from the distillation of steam cracked heat soaked naphtha and boiling in the range of approximately 150 oC to 350 oC (302 oF to 662 oF).] 297-905-8 93763-85-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-449-00-X Hydrocarbons, C16-20, solvent-dewaxed hydrocracked paraffinic distn. residue;Cracked gasoil;[A complex combination of hydrocarbons obtained by solvent dewaxing of a distillation residue from a hydrocracked paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C16 through C20 and boiling in the range of approximately 360 oC to 500 oC (680 oF to 932 oF). It produces a finished oil having a viscosity of 4,5 cSt at approximately 100 oC (212 oF).] 307-662-2 97675-88-2 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  H
649-450-00-5 Gas oils (petroleum), light vacuum, thermal-cracked hydrodesulfurized;Cracked gasoil;[A complex combination of hydrocarbons obtained by catalytic dehydrosulfurization of thermal-cracked light vacuum petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C20 and boiling in the range of approximately 270 oC to 370 oC (518 oF to 698 oF).] 308-278-8 97926-59-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-451-00-0 Distillates (petroleum), hydrodesulfurized middle coker;Cracked gasoil;[A complex combination of hydrocarbons by fractionation from hydrodesulfurised coker distillate stocks. Is consists of hydro-carbons having carbon numbers predominantly in the range of C12 through C21 and boiling in the range of approximately 200 oC to 360 oC (392 oF to 680 oF).] 309-865-1 101316-59-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-452-00-6 Distillates (petroleum), heavy steam-cracked;Cracked gasoil;[A complex combination of hydrocarbons obtained by distillation of steam cracking heavy residues. It consists predominantly of highly alkylated heavy aromatic hydrocarbons boiling in the range of approximately 250 oC to 400 oC (482 oF to 752 oF).] 309-939-3 101631-14-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H
649-453-00-1 Distillates (petroleum), heavy hydrocracked;Baseoil — unspecified;[A complex combination of hydrocarbons from the distillation of the products from a hydrocracking process. It consists predominantly of saturated hydrocarbons having carbon numbers in the range of C15-C39 and boiling in the range of approximately 260 oC to 600 oC (500 oF to 1112 oF).] 265-077-7 64741-76-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-454-00-7 Distillates (petroleum), solvent-refined heavy paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-090-8 64741-88-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-455-00-2 Distillates (petroleum), solvent-refined light paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-091-3 64741-89-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-456-00-8 Residual oils (petroleum), solvent deasphalted;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the solvent soluble fraction from C3-C4 solvent deasphalting of a residuum. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-096-0 64741-95-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-457-00-3 Distillates (petroleum), solvent-refined heavy naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt a 40 oC). It contains relatively few normal paraffins.] 265-097-6 64741-96-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-458-00-9 Distillates (petroleum), solvent-refined light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as the raffinate from a solvent extraction process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-098-1 64741-97-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-459-00-4 Residual oils (petroleum,) solvent-refined;Baseoil — unspecified;[A complex combination by hydrocarbons obtained as the solvent insoluble fraction from solvent refining of a residuum using a polar organic solvent such as phenol or furfural. It consists of hydrocarbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-101-6 64742-01-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-460-00-X Distillates (petroleum), clay-treated paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-137-2 64742-36-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-461-00-5 Distillates (petroleum), clay-treated light paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-138-8 64742-37-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-462-00-0 Residual oils (petroleum), clay-treated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treatment of a residual oil with a natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydro-carbons having carbon numbers predominantly higher than C25 and boiling above approximately 400 oC (752 oF).] 265-143-5 64742-41-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-463-00-6 Distillates (petroleum), clay-treated heavy naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-146-1 64742-44-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-464-00-1 Distillates (petroleum), clay-treated light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contacting or percolation process to remove the trace amounts of polar compounds and impurities present. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-147-7 64742-45-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-465-00-7 Distillates (petroleum), hydrotreated heavy naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-155-0 64742-52-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-466-00-2 Distillates (petroleum), hydrotreated light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-156-6 64742-53-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-467-00-8 Distillates (petroleum), hydrotreated heavy paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-157-1 64742-54-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-468-00-3 Distillates (petroleum), hydrotreated light paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains a relatively large proportion of saturated hydrocarbons.] 265-158-7 64742-55-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-469-00-9 Distillates (petroleum), solvent-dewaxed light paraffinic;Baseoil — unspecified;[A complex comination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-159-2 64742-56-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-470-00-4 Residual oils (petroleum), hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-160-8 64742-57-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-471-00-X Residual oils (petroleum), solvent-dewaxed;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removal of long, branched chain hydrocarbons from a residual oil by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly greater than C25 and boiling above approximately 400 oC (752 oF).] 265-166-0 64742-62-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-472-00-5 Distillates (petroleum), solvent-dewaxed heavy naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 . through C50 and produces a finished oil of not less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-167-6 64742-63-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-473-00-0 Distillates (petroleum), solvent-dewaxed light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists of hydrocarbons having carbon numbers predominantly in the range C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-168-1 64742-64-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-474-00-6 Distillates (petroleum), solvent-dewaxed heavy paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removal of normal paraffins from a petroleum fraction by solvent crystallization. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity not less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-169-7 64742-65-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-475-00-1 Naphthenic oils (petroleum), catalytic dewaxed heavy;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-172-3 64742-68-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-476-00-7 Naphthenic oils (petroleum), catalytic dewaxed light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-173-9 64742-69-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-477-00-2 Paraffin oils (petroleum), catalytic dewaxed heavy;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC).] 265-174-4 64742-70-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-478-00-8 Paraffin oils (petroleum), catalytic dewaxed light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewxing process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC).] 265-176-5 64742-71-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-479-00-3 Naphthenic oils (petroleum), complex dewaxed heavy;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by removing straight chain paraffin hydrocarbons as a solid by treatment with an agent such as urea. It consists of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of at least 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-179-1 64742-75-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-480-00-9 Naphthenic oils (petroleum), complex dewaxed light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from a catalytic dewaxing process. It consists of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 265-180-7 64742-76-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-481-00-4 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based, high-viscosity;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil, and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil having a viscosity of approximately 112cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-736-3 72623-85-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-482-00-X Lubricating oils (petroleum), C15-30, hydrotreated neutral oil-based;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating light vacuum gas oil and heavy vacuum gas oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil having a viscosity of approximately 15cSt at 40 oC. It contains a relatively large proportion of saturated hydrocabons.] 276-737-9 72623-86-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-483-00-5 Lubricating oils (petroleum), C20-50, hydrotreated neutral oil-based;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating light vacuum gas oil, heavy vacuum gas oil and solvent deasphalted residual oil with hydrogen in the presence of a catalyst in a two stage process with dewaxing being carried out between the two stages. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of approximately 32cSt at 40 oC. It contains a relatively large proportion of saturated hydrocarbons.] 276-738-4 72623-87-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-484-00-0 Lubricating oils;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from solvent extraction and dewaxing processes. It consists predominantly of saturated hydrocarbons having carbon numbers in the range C15 through C50.] 278-012-2 74869-22-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-485-00-6 Distillates (petroleum), complex dewaxed heavy paraffinci;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by dewaxing heavy paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil with a viscosity of equal to or greater than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-613-7 90640-91-8 Carc. Cat. 2; R45 TR: 4S: 53-45  H L
649-486-00-1 Distillates (petroleum), complex dewaxed light paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by dewaxing light paraffinic distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C12 through C30 and produces a finished oil with a viscosity of less than 100 SUS at 100 oF (19cSt at 40 oC). It contains relatively few normal paraffins.] 292-614-2 90640-92-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-487-00-7 Distillates (petroleum), solvent dewaxed heavy paraffinic, clay-treated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating dewaxed heavy paraffinic distillate with neutral or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-616-3 90640-94-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-488-00-2 Hydrocarbons, C20-50, solvent dewaxed heavy paraffinic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons produced by treating dewaxed heavy paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 292-617-9 90640-95-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-489-00-8 Distillates (petroleum), solvent dewaxed light paraffinic, clay-treated;Baseoil — unspecified;[A complex combination of hydrocarbons resulting from treatment of dewaxed light paraffinic distillate with natural or modified clay in either a contacting or percolation process. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-618-4 90640-96-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-490-00-3 Distillates (petroleum), solvent dewaxed light paraffinic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons produced by treating a dewaxed light paraffinic distillate with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C30.] 292-620-5 90640-97-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-491-00-9 Residual oils (petroleum), hydrotreated solvent dewaxed;Baseoil — unspecified 292-656-1 90669-74-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-492-00-4 Residual oils (petroleum), catalytic dewaxed;Baseoil — unspecified 294-843-3 91770-57-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-493-00-X Distillates (petroleum), dewaxed heavy paraffinic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C25 through C39 and produces a finished oil with a viscosity of approximately 44 cSt at 50 oC.] 295-300-3 91995-39-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-494-00-5 Distillates (petroleum), dewaxed light paraffinic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from an intensive treatment of dewaxed distillate by hydrogenation in the presence of a catalyst. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C21 through C29 and produces a finished oil with a viscosity of approximately 13 cSt at 50 oC.] 295-301-9 91995-40-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-495-00-0 Distillates (petroleum), hydrocracked solvent-refined, dewaxed;Baseoil — unspecified;[A complex combination of liquid hydrocarbons obtained by recrystallization of dewaxed hydrocracked solvent-refined petroleum distillates.] 295-306-6 91995-45-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-496-00-6 Distillates (petroleum), solvent-refined light naphthenic, hydrotreated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treating a petroleum fraction with hydrogen in the presence of a catalyst and removing the aromatic hydrocarbons by solvent extraction. It consists predominantly of naphthenic hydrocarbons having carbon numbers predominantly in the range of C15 through C30 and produces a finished oil with a viscosity of between 13-15cSt at 40 oC.] 295-316-0 91995-54-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-497-00-1 Lubricating oils (petroleum), C17-35, solvent-extd., dewaxed, hydrotreated;Baseoil — unspecified 295-423-2 92045-42-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-498-00-7 Lubricating oils (petroleum), hydrocracked nonarom. solvent-deparaffined;Baseoil — unspecified 295-424-8 92045-43-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-499-00-2 Residual oils (petroleum), hydrocracked acid-treated solvent-dewaxed;Baseoil — unspecified;[A complex combination of hydrocarbons produced by solvent removal of paraffins from the residue of the distillation of acid-treated, hydrocracked heavy paraffins and boiling approximately above 380 oC (716 oF).] 295-499-7 92061-86-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-500-00-6 Paraffin oils (petroleum), solvent-refined dewaxed heavy;Baseoil — unspecified;[A complex combination of hydrocarbons obtained from sulfur-containing paraffinic crude oil. It consists predominantly of a solvent refined deparaffinated lubricating oil with a viscosity of 65cSt at 50 oC.] 295-810-6 92129-09-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-501-00-1 Lubricating oils (petroleum), base oils, paraffinic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by refining of crude oil. It consists predominantly of aromatics, naphthenics and paraffinics and produces a finished oil with a viscosity of 120 SUS at 100 oF (23cSt at 40 oC).] 297-474-6 93572-43-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-502-00-7 Hydrocarbons, hydrocracked paraffinic distn. residues, solvent-dewaxed;Baseoil — unspecified 297-857-8 93763-38-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-503-00-2 Hydrocarbons, C20-50, residual oil hydrogenation vacuum distillate;Baseoil — unspecified 300-257-1 93924-61-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-504-00-8 Distillates (petroleum), solvent-refined hydrotreated heavy, hydrogenated;Baseoil — unspecified 305-588-5 94733-08-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-505-00-3 Distillates (petroleum), solvent-refined hydrocracked light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent dearomatization of the residue of hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF).] 305-589-0 94733-09-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-506-00-9 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrocracked distillate-based;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent deparaffination of the distillation residue from hydrocracked petroleum. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-594-8 94733-15-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-507-00-4 Lubricating oils (petroleum), C18-40, solvent-dewaxed hydrogenated raffinate-based;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent deparaffination of the hydrogenated raffinate obtained by solvent extraction of a hydrotreated petroleum distillate. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C40 and boiling in the range of approximately 370 oC to 550 oC (698 oF to 1022 oF).] 305-595-3 94733-16-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-508-00-X Hydrocarbons, C13-30, arom.-rich, solvent-extd. naphthenic distillate;Baseoil — unspecified 305-971-7 95371-04-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-509-00-5 Hydrocarbons, C16-32, arom. rich, solvent-extd. naphthenic distillate;Baseoil — unspecified 305-972-2 95371-05-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-510-00-0 Hydrocarbons, C37-68, dewaxed deasphalted hydrotreated vacuum distn. residues;Baseoil — unspecified 305-974-3 95371-07-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-511-00-6 Hydrocarbons, C37-65, hydrotreated deasphalted vacuum distn. residues;Baseoil — unspecified 305-975-9 95371-08-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-512-00-1 Distillates (petroleum), hydrocracked solvent-refined light;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by the solvent treatment of a distillate from hydrocracked petroleum distillates. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C18 through C27 and boiling in the range of approximately 370 oC to 450 oC (698 oF to 842 oF.] 307-010-7 97488-73-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-513-00-7 Distillates (petroleum), solvent-refined hydrogenated heavy;Baseoil — unspecified;[A complex combination of hydrocarbons, obtained by the treatment of a hydrogenated petroleum distillate with a solvent. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C19 through C40 and boiling in the range of approximately 390 oC to 550 oC (734 oF to 1022 oF).] 307-011-2 97488-74-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-514-00-2 Lubricating oils (petroleum), C18-27, hydrocracked solvent-dewaxed;Baseoil — unspecified 307-034-8 97488-95-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-515-00-8 Hydrocarbons, C17-30, hydrotreated solvent-deasphalted atm. distn. residue, distn. lights;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the treatment of a solvent deasphalted short residue with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C30 and boiling in the range of approximately 300 oC to 400 oC (572 oF to 752 oF). It produces a finished oil having a viscosity of 4cSt at approximately 100 oC (212 oF).] 307-661-7 97675-87-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-516-00-3 Hydrocarbons, C17-40, hydrotreated solvent-deasphalted distn. residue, vacuum distn. lights;Baseoil — unspecified;[A complex combination of hydrocarbons obtained as first runnings from the vacuum distillation of effluents from the catalytic hydrotreatment of a solvent deasphalted short residue having a viscosity of 8cSt at approximately 100 oC (212 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C40 and boiling in the range of approximately 300 oC to 500 oC (592 oF to 932 oF).] 307-755-8 97722-06-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-517-00-9 Hydrocarbons, C13-27, solvent-extd. light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 9.5cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C13 through C27 and boiling in the range of approximately 240 oC to 400 oC (464 oF to 752 oF.] 307-758-4 97722-09-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-518-00-4 Hydrocarbons, C14-29, solvent-extd. light naphthenic;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by extraction of the aromatics from a light naphthenic distillate having a viscosity of 16cSt at 40 oC (104 oF). It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C14 through C29 and boiling in the range of approximately 250 oC to 425 oC (482 oF to 797 oF).] 307-760-5 97722-10-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-519-00-X Hydrocarbons, C27-42, dearomatized;Baseoil — unspecified 308-131-8 97862-81-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-520-00-5 Hydrocarbons, C17-30, hydrotreated distillates, distn. lights;Baseoil — unspecified 308-132-3 97862-82-3 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-521-00-0 Hydrocarbons, C27-45, naphthenic vacuum distn.;Baseoil — unspecified 308-133-9 97862-83-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-522-00-6 Hydrocarbons, C27-45, dearomatized;Baseoil — unspecified 308-287-7 97926-68-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-523-00-1 Hydrocarbons, C20-58, hydrotreated;Baseoil — unspecified 308-289-8 97926-70-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-524-00-7 Hydrocarbons, C27-42, naphthenic;Baseoil — unspecified 308-290-3 97926-71-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-525-00-2 Residual oils (petroleum), carbon-treated solvent-dewaxed;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by the treatment of solvent-dewaxed petroleum residual oils with activated charcoal for the removal of trace polar constituents and impurities.] 309-710-8 100684-37-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-526-00-8 Residual oils (petroleum), clay-treated solvent-dewaxed;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by treatment of solvent-dewaxed petroleum residual oils with bleaching earth for the removal of trace polar constituents and impurities.] 309-711-3 100684-38-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-527-00-3 Lubricating oils (petroleum), C >25, solvent-extd., deasphalted, dewaxed, hydrogenated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of vacuum distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly greater than C25 and produces a finished oil with a viscosity in the order of 32cSt to 37cSt at 100 oC (212 oF).] 309-874-0 101316-69-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-528-00-9 Lubricating oils (petroleum), C17-32, solvent-extd., dewaxed, hydrogenated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C32 and produced a finished oil with a viscosity in the order of 17cSt to 23cSt at 40 oC (104 oF.] 309-875-6 101316-70-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-529-00-4 Lubricating oils (petroleum), C20-35, solvent-extd., dewaxed, hydrogenated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C20 through C35 and produces a finished oil with a viscosity in the order of 37cSt to 44cSt at 40 oC (104 oF).] 309-876-1 101316-71-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-530-00-X Lubricating oils (petroleum), C24-50, solvent-extd., dewaxed, hydrogenated;Baseoil — unspecified;[A complex combination of hydrocarbons obtained by solvent extraction and hydrogenation of atmospheric distillation residues. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C24 through C50 and produces a finished oil with a viscosity in the order of 16cSt to 75cSt at 40 oC (104 oF).] 309-877-7 101316-72-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-531-00-5 Extracts (petroleum), heavy naphthenic distillate solvent, arom. conc.;Distillate aromatic extract (treated);[An aromatic concentrate produced by adding water to heavy naphthenic distillate solvent extract and extraction solvent.] 272-175-3 68783-00-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-532-00-0 Extracts (petroleum), solvent-refined heavy paraffinic distillate solvent;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from the re-extraction of solvent-refined heavy paraffinic distillate. It consists of saturated and aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 272-180-0 68783-04-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-533-00-6 Extracts (petroleum), heavy paraffinic distillates, solvent-deasphalted;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from a solvent extraction of heavy paraffinic distillate.] 272-342-0 68814-89-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-534-00-1 Extracts (petroleum), heavy naphthenic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by treating a heavy naphthenic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50 and produces a finished oil of at least 19cSt at 40 oC (100 SUS at 100 oF).] 292-631-5 90641-07-9 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-535-00-7 Extracts (petroleum), heavy paraffinic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons produced by treating a heavy paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C21 through C33 and boiling in the range of approximately 350 oC to 480 oC (662 oF to 896 oF). 292-632-0 90641-08-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-536-00-2 Extracts (petroleum), light paraffinic distillate solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons produced by treating a light paraffinic distillate solvent extract with hydrogen in the presence of a catalyst. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C17 through C26 and boiling in the range of approximately 280 oC to 400 oC (536 oF to 752 oF).] 292-633-6 90641-09-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-537-00-8 Extracts (petroleum), hydrotreated light paraffinic distillate solvent;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as the extract from solvent extraction of intermediate paraffinic top solvent distillate that is treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C36.] 295-335-4 91995-73-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-538-00-3 Extracts (petroleum), light naphthenic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by treating the extract, obtained from a solvent extraction process, with hydrogen in the presence of a catalyst under conditions primarily to remove sulfur compounds. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C15 through C30. This stream is likely to contain 5 wt.% or more of 4- to 6-membered condensed ring aromatic hydrocarbons.] 295-338-0 91995-75-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-539-00-9 Extracts (petroleum), light paraffinic distillate solvent, acid-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction of the distillation of an extract from the solvent extraction of light paraffinic top petroleum distillates that is subjected to a sulfuric acid refining. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 295-339-6 91995-76-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-540-00-4 Extracts (petroleum), light paraffinic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of a light paraffin distillate and treated with hydrogen to convert the organic sulfur to hydrogen sulfide which is eliminated. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C40 and produces a finished oil with a viscosity of greater than 10cSt at 40 oC.] 295-340-1 91995-77-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-541-00-X Extracts (petroleum), light vacuum gas oil solvent, hydrotreated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons, obtained by solvent extraction from light vacuum petroleum gas oils and treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 295-342-2 91995-79-8 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-542-00-5 Extracts (petroleum), heavy paraffinic distillate solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons resulting from treatment of a petroleum fraction with natural or modified clay in either a contact or percolation process to remove the trace amounts of polar compounds and impurities present. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C20 through C50. This stream is likely to contain 5 wt.% or more 4-6 membered ring aromatic hydrocarbons.] 296-437-1 92704-08-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-543-00-0 Extracts (petroleum), heavy naphthenic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-827-4 93763-10-1 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-544-00-6 Extracts (petroleum), solvent-dewaxed heavy paraffinic distillate solvent, hydrodesulfurized;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained from a solvent dewaxed petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists predominantly of hydrocarbons having carbon numbers predominantly in the range of C15 through C50 and produces a finished oil with a viscosity of greater than 19cSt at 40 oC.] 297-829-5 93763-11-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-545-00-1 Extracts (petroleum), light paraffinic distillate solvent, carbon-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillate treated with activated charcoal to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-672-2 100684-02-4 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-546-00-7 Extracts (petroleum), light paraffinic distillate solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained as a fraction from distillation of an extract recovered by solvent extraction of light paraffinic top petroleum distillates treated with bleaching earth to remove traces of polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C16 through C32.] 309-673-8 100684-03-5 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-547-00-2 Extracts (petroleum), light vacuum, gas oil solvent, carbon-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oil treated with activated charcoal for the removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-674-3 100684-04-6 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-548-00-8 Extracts (petroleum), light vacuum gas oil solvent, clay-treated;Distillate aromatic extract (treated);[A complex combination of hydrocarbons obtained by solvent extraction of light vacuum petroleum gas oils treated with bleaching earth for removal of trace polar constituents and impurities. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C13 through C30.] 309-675-9 100684-05-7 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-549-00-3 Foots oil (petroleum);Foots oil;[A complex combination of hydrocarbons obtained as the oil fraction from a solvent deoiling or a wax sweating process. It consists predominantly of branched chain hydrocarbons having carbon numbers predominantly in the range of C20 through C50.] 265-171-8 64742-67-2 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
649-550-00-9 Foots oil (petroleum), hydrotreated;Foots oil 295-394-6 92045-12-0 Carc. Cat. 2; R45 TR: 45S: 53-45  H L
650-002-00-6 turpentine, oil 232-350-7 8006-64-2 R10Xn; R20/21/22-65Xi; R36/38R43N; R51-53 Xn; NR: 10-20/21/22-36/38-43-51/53-65S: (2-)36/37-46-61-62  
650-003-00-1 fenson (ISO);4-chlorophenyl benzenesulphonate; 201-274-6 80-38-6 Xn; R22Xi; R36N; R51-53 Xn; NR: 22-36-51/53S: (2-)24-26-61  
650-004-00-7 norbormide (ISO);5-(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)bicyclo [2.2.1] hept-5-ene-2,3-dicarboximide 213-589-6 991-42-4 Xn; R22 XnR: 22S: (2-)  
650-005-00-2 (2R,6aS,12aS)-1,2,6,6a,12,12a-hexahydro-2-isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3-h]chromen-6-one, rotenone 201-501-9 83-79-4 T; R25Xi; R36/37/38N; R50-53 T; NR: 25-36/37/38-50/53S: (1/2-)22-24/25-36-45-60-61  
650-006-00-8 benquinox (ISO);p-benzoquinone 1-benzoylhydrazone 4-oxime 207-807-9 495-73-8 T; R25Xn; R21 TR: 21-25S: (1/2-)36/37-45  
650-007-00-3 chlordimeform (ISO);N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine 228-200-5 6164-98-3 Carc. Cat. 3; R40Xn; R21/22N; R50-53 Xn; NR: 21/22-40-50/53S: (2-)22-36/37-60-61  
650-008-00-9 drazoxolon (ISO);4-(2-chlorophenylhydrazone)-3-methyl-5-isoxazolone 227-197-8 5707-69-7 T; R25N; R50-53 T; NR: 25-50/53S: (1/2-)22-24-36/37-45-60-61  
650-009-00-4 chlordimeform hydrochloride;N'-(4-chloro-o-tolyl)-N,N-dimethylformamidine monohydrochloride;N2-(4-chloro-o-tolyl)-N1,N1-dimethylformamidine hydorchloride 243-269-1 19750-95-9 Carc. Cat. 3; R40Xn; R22N; R50-53 Xn; NR: 22-40-50/53S: (2-)22-36/37-60-61  
650-010-00-X benzyl violet 4B; α-[4-(4-dimethylamino-α-{4-[ethyl(3-sodiosulphonatobenzyl)amino] phenyl}benzylidene)cyclohexa-2,5-dienylidene(ethyl)ammonio]toluene-3-sulphonate 216-901-9 1694-09-3 Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  
650-012-00-0 erionite — 12510-42-8 Carc. Cat. 1; R45 TR: 45S: 53-45  
650-013-00-6 asbestos ——————— 12001-28-4132207-32-012172-73-577536-66-477536-68-677536-67-512001-29-5 Carc. Cat. 1; R45T; R48/23 TR: 45-48/23 S: 53-45  E
650-014-00-1 diethyl 2,4-dihydroxycyclodisiloxane-2,4-diylbis(trimethylene)diphosphonate, tetrasodium salt, reaction products with disodium metasilicate 401-770-4 — C; R34Xn; R22 CR: 22-34S: (1/2-)26-36/37/39-45  
650-015-00-7 rosin; colophony 232-475-7232-484-6277-299-1 8050-09-78052-10-673138-82-6 R43 XiR: 43S: (2-)24-37  
650-016-00-2 Mineral wool, with the exception of those specified elsewhere in this Annex;[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] — — Carc. Cat. 3; R40Xi; R38 XnR: 38-40S: (2-)36/37  AQR
650-017-00-8 Refractory Ceramic Fibres;Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] — — Carc. Cat. 2; R49Xi; R38 TR: 49-38S: 53-45  A R
650-018-00-3 reaction product of: acetophenone, formaldehyde, cyclohexylamine, methanol and acetic acid 406-230-1 — R10Carc. Cat. 3; R40C; R34Xn; R20R43N; R50-53 C; NR: 10-20-34-40-43-50/53S: (1/2-)26-36/37/39-45-60-61  
650-031-00-4 bis(4-hydroxy-N-methylanilinium) sulphate 200-237-1 55-55-0 Xn; R22-48/22R43N; R50-53 Xn; NR: 22-43-48/22-50/53S: (2-)36/37-46-60-61  
650-032-00-X cyproconazole (ISO);(2RS,3RS;2RS,3SR)-2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol — 94361-06-5 Repr. Cat. 3; R63Xn; R22N; R50-53 Xn; NR: 22-50/53-63S: (2-)36/37-60-61  
650-033-00-5 (S)-α-cyano-3-phenoxybenzyl-(S)-2-(4-chlorophenyl)-3-methylbutyrate; esfenvalerate — 66230-04-4 T; R23/25R43N; R50-53 T; NR: 23/25-43-50/53S: (1/2-)24-36/37/39-45-60-61  
650-041-00-9 triasulfuron (ISO);1-[2-(2-chloroethoxy)phenylsulfonyl]-3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)urea — 82097-50-5 N; R50-53 NR: 50/53S: 60-61  
650-042-00-4 reaction product of: polyethylene-polyamine-(C16-C18)-alkylamides with monothio-(C2)-alkyl phosphonates 417-450-2 — Xi; R36/38R43R52-53 XiR: 36/38-43-52/53S: (2-)24-26-37-61  
650-043-00-X reaction product of: 3,5-bis-tert-butylsalicylic acid and aluminiumsulfate 420-310-3 — Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)22-56-60-61  
650-044-00-5 mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin 420-480-9 158570-99-1 Xi; R38R43N; R50-53 Xi; NR: 38-43-50/53S: (2-)24-37-60-61  
650-045-00-0 reaction product of: 1,2,3-propanetricarboxylic acid, 2-hydroxy, diethyl ester, 1-propanol and zirconium tetra-n-propanolate 417-110-3 — F; R11Xi; R38-41N; R51-53 F; Xi; NR: 11-38-41-51/53S: (2-)9-16-26-37/39-61  
650-046-00-6 di(tetramethylammonium)(29H,31H-phthalocyanin-N29,N30,N31,N32)disulfonamide disulfonate, cuprate(2-)complex, derivates 416-180-2 12222-04-7 Xn; R22-48/22N; R51-53 Xn; NR: 22-48/22-51/53S: (2-)22-36-61  
650-047-00-1 dibenzylphenylsulfonium hexafluoroantimonate 417-760-8 134164-24-2 T; R48/25Xn; R22Xi; R41R43N; R51-53 T; NR: 22-41-43-48/25-51/53S: (1/2-)22-26-36/37/39-45-61  
650-048-00-7 reaction product of: borax, hydrogen peroxide, acetic acid anhydride and acetic acid 420-070-1 — O; R7Xn; R20/21/22C; R35N; R50 O; C; NR: 7-20/21/22-35-50S: (1/2-)3/7-14-26-36/37/39-45-61  
650-049-00-2 2-alkoyloxyethyl hydrogen maleate, where alkoyl represents (by weight) 70 to 85 % unsaturated octadecoyl, 0.5 to 10 % saturated octadecoyl, and 2 to 18 % saturated hexadecoyl 417-960-5 — Xi; R38-41R43N; R50-53 Xi; NR: 38-41-43-50/53S: (2-)24-26-37/39-60-61  
650-050-00-8 reaction mass of: 1-methyl-3-hydroxypropyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydro-cinnamate and/or 3-hydroxybutyl 3,5-[1,1-dimethylethyl]-4-hydroxydihydrocinnamate;1,3-butanediol bis[3-(3'-(1,1-dimethylethyl)4'-hydroxy-phenyl)propionate] isomers;1,3-butanediol bis[3-(3',5'-(1,1-dimethylethyl)-4'-hydroxyphenyl)propionate] isomers 423-600-8 — N; R51-53 NR: 51/53S: 61  
650-055-00-5 silver sodium zirconium hydrogenphosphate 422-570-3 155925-27-2 N; R50-53 NR: 50/53S: 60-61  

ANNEX VII
This Annex includes a table to assist translation of a classification made for a substance or a mixture under Directive 67/548/EEC or Directive 1999/45/EC, respectively, into the corresponding classification under this Regulation. Whenever data for the substance or mixture are available, an evaluation and classification shall be done in accordance with Articles 9 to13 of this Regulation.

1. 
The codes used are introduced in Table 1.1 and section 1.1.2.2 of Annex VI.


Classification under Directive 67/548/EEC Physical state of the substance when relevant Classification under this Regulation Note
Hazard Class-and-Category Hazard statement
E; R2  No direct translation possible.
E; R3  No direct translation possible.
O; R7  Org. Perox. CD H242 
Org. Perox. EF H242 
O; R8 gas Ox. Gas 1 H270 
O; R8 liquid, solid No direct translation possible.
O; R9 liquid Ox. Liq. 1 H271 
O; R9 solid Ox. Sol. 1 H271 
R10 liquid No direct translation possible.Correct translation of R10, liquid is:
— Flam. Liq. 1, H224 if flashpoint < 23 oC and initial boiling point ≤ 35 oC
— Flam. Liq. 2, H225 if flashpoint < 23 oC and initial boiling point > 35 oC
— Flam. Liq. 3, H226 if flashpoint ≥ 23 oC
F; R11 liquid No direct translation possible.Correct translation of F; R11, liquid is:
— Flam. Liq. 1, H224 if initial boiling point ≤ 35 oC
— Flam. Liq. 2, H225 if initial boiling point > 35 oC
F; R11 solid No direct translation possible.
F+; R12 gas No direct translation possible.Correct translation of F+; R12, gaseous results either in Flam. Gas 1, H220 or Flam. Gas 2, H221.
F+; R12 liquid Flam. Liq. 1 H224 
F+; R12 liquid Self-react. CD H242 
Self-react. EF H242
Self-react. G none
F; R15  No translation possible.
F; R17 liquid Pyr. Liq. 1 H250 
F; R17 solid Pyr. Sol. 1 H250 
Xn; R20 gas Acute Tox. 4 H332 (1)
Xn; R20 vapours Acute Tox. 4 H332 (1)
Xn; R20 dust/mist Acute Tox. 4 H332 
Xn; R21  Acute Tox. 4 H312 (1)
Xn; R22  Acute Tox. 4 H302 (1)
T; R23 gas Acute Tox. 3 H331 (1)
T; R23 vapour Acute Tox. 2 H330 
T; R23 dust/mist Acute Tox. 3 H331 (1)
T; R24  Acute Tox. 3 H311 (1)
T; R25  Acute Tox. 3 H301 (1)
T+; R26 gas Acute Tox. 2 H330 (1)
T+; R26 vapour Acute Tox. 1 H330 
T+; R26 dust/mist Acute Tox. 2 H330 (1)
T+; R27  Acute Tox. 1 H310 
T+; R28  Acute Tox. 2 H300 (1)
R33  STOT RE 2 H373 (3)
C; R34  Skin Corr. 1B H314 (2)
C; R35  Skin Corr. 1A H314 
Xi; R36  Eye Irrit. 2 H319 
Xi; R37  STOT SE 3 H335 
Xi; R38  Skin Irrit. 2 H315 
T; R39/23  STOT SE 1 H370 (3)
T; R39/24  STOT SE 1 H370 (3)
T; R39/25  STOT SE 1 H370 (3)
T+; R39/26  STOT SE 1 H370 (3)
T+; R39/27  STOT SE 1 H370 (3)
T+; R39/28  STOT SE 1 H370 (3)
Xi; R41  Eye Dam. 1 H318 
R42  Resp. Sens. 1 H334 
R43  Skin Sens. 1 H317 
Xn; R48/20  STOT RE 2 H373 (3)
Xn; R48/21  STOT RE 2 H373 (3)
Xn; R48/22  STOT RE 2 H373 (3)
T; R48/23  STOT RE 1 H372 (3)
T; R48/24  STOT RE 1 H372 (3)
T; R48/25  STOT RE 1 H372 (3)
R64  Lact. H362 
Xn; R65  Asp. Tox. 1 H304 
R67  STOT SE 3 H336 
Xn; R68/20  STOT SE 2 H371 (3)
Xn; R68/21  STOT SE 2 H371 (3)
Xn; R68/22  STOT SE 2 H371 (3)
Carc. Cat. 1; R45  Carc. 1A H350 
Carc. Cat. 2; R45  Carc. 1B H350 
Carc. Cat. 1; R49  Carc. 1A H350i 
Carc. Cat. 2; R49  Carc. 1B H350i 
Carc. Cat. 3; R40  Carc. 2 H351 
Muta. Cat. 2; R46  Muta. 1B H340 
Muta. Cat. 3; R68  Muta. 2 H341 
Repr. Cat. 1; R60  Repr. 1A H360F (4)
Repr. Cat. 2; R60  Repr. 1B H360F (4)
Repr. Cat. 1; R61  Repr. 1A H360D (4)
Repr. Cat. 2; R61  Repr. 1B H360D (4)
Repr. Cat. 3; R62  Repr. 2 H361f (4)
Repr. Cat. 3; R63  Repr. 2 H361d (4)
Repr. Cat. 1; R60-61  Repr. 1A H360FD 
Repr. Cat. 1; R60Repr. Cat. 2; R61  Repr. 1A H360FD 
Repr. Cat. 2; R60Repr. Cat. 1; R61  Repr. 1A H360FD 
Repr. Cat. 2; R60-61  Repr. 1B H360FD 
Repr. Cat. 3; R62-63  Repr. 2 H361fd 
Repr. Cat. 1; R60Repr. Cat. 3; R63  Repr. 1A H360Fd 
Repr. Cat. 2; R60Repr. Cat. 3; R63  Repr. 1B H360Fd 
Repr. Cat. 1; R61Repr. Cat. 3; R62  Repr. 1A H360Df 
Repr. Cat. 2; R61Repr. Cat. 3; R62  Repr. 1B H360Df 
N; R50  Aquatic. Acute 1 H400 
N; R50-53  Aquatic Acute 1Aquatic Chronic 1 H400H410 
N; R51-53  Aquatic Chronic 2 H411 
R52-53  Aquatic Chronic 3 H412 
R53  Aquatic Chronic 4 H413 
N; R59  Ozone EUH059 
Note 1For these classes it is possible to use the recommended minimum classification as defined in section 1.2.1.1 in Annex VI. Data or other information may be available to indicate that re-classification in a more severe category is appropriate.
Note 2It is recommended to classify in Category 1B even if it also could be possible that 1C could be applicable for certain cases. Going back to original data, may not result in a possibility to distinguish between Category 1B or 1C, since the exposure period has normally been up to 4 hours according to Regulation (EC) No 440/2008. However, for the future, when data are derived from tests following a sequential approach as foreseen in the Regulation (EC) No 440/2008, Category 1C should be considered.
Note 3The route of exposure could be added to the hazard statement if it is conclusively proven that no other routes of exposure cause the hazard.
Note 4Hazard statements H360 and H361 indicate a general concern for both the reproductive properties related to fertility and developmental effects; ‘May damage/Suspected of damaging fertility or the unborn child’. According to the classification criteria (Annex I, section 3.7) the general hazard statement can be replaced by the hazard statement indicating only the property of concern, in case either fertility or developmental effects are proven to be not relevant.


Directive 67/548/EEC This Regulation
R1 EUH001
R6 EUH006
R14 EUH014
R18 EUH018
R19 EUH019
R44 EUH044
R29 EUH029
R31 EUH031
R32 EUH032
R66 EUH066
R39-41 EUH070
